<SEC-DOCUMENT>0001628280-25-015469.txt : 20250328
<SEC-HEADER>0001628280-25-015469.hdr.sgml : 20250328
<ACCEPTANCE-DATETIME>20250328164203
ACCESSION NUMBER:		0001628280-25-015469
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		156
CONFORMED PERIOD OF REPORT:	20241228
FILED AS OF DATE:		20250328
DATE AS OF CHANGE:		20250328

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALT5 Sigma Corp
		CENTRAL INDEX KEY:			0000862861
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				411454591
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19621
		FILM NUMBER:		25787079

	BUSINESS ADDRESS:	
		STREET 1:		325 E. WARM SPRINGS ROAD
		STREET 2:		SUITE 102
		CITY:			LAS VEGAS
		STATE:			NV
		ZIP:			89119
		BUSINESS PHONE:		702-997-5968

	MAIL ADDRESS:	
		STREET 1:		325 E. WARM SPRINGS ROAD
		STREET 2:		SUITE 102
		CITY:			LAS VEGAS
		STATE:			NV
		ZIP:			89119

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	JanOne Inc.
		DATE OF NAME CHANGE:	20190912

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	APPLIANCE RECYCLING CENTERS OF AMERICA INC /MN
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>alts-20241228.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:2830d163-e030-49d1-a620-63415283e8e5,g:d25a092d-1f61-4617-aa79-df61d6af7f3a,d:213e3c881f5e4982994be533c682ff6b-->
<html xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:alts="http://www.alt5sigma.com/20241228" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2024" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>alts-20241228</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-31">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-32">0000862861</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-33">2024</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-34">FY</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="c-177" decimals="5" name="us-gaap:PreferredStockConvertibleConversionRatio" scale="0" id="f-837">0.00001</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="c-14" decimals="3" name="us-gaap:PreferredStockConvertibleConversionRatio" scale="-2" id="f-1073">12.5</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="alts-20241228.xsd"/></ix:references><ix:resources><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>alts:segment</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="tranche"><xbrli:measure>alts:tranche</xbrli:measure></xbrli:unit><xbrli:unit id="patent"><xbrli:measure>alts:patent</xbrli:measure></xbrli:unit><xbrli:unit id="debenture"><xbrli:measure>alts:debenture</xbrli:measure></xbrli:unit><xbrli:unit id="investor"><xbrli:measure>alts:investor</xbrli:measure></xbrli:unit><xbrli:unit id="addition"><xbrli:measure>alts:addition</xbrli:measure></xbrli:unit><xbrli:unit id="consultant"><xbrli:measure>alts:consultant</xbrli:measure></xbrli:unit><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="insurance_policy"><xbrli:measure>alts:insurance_policy</xbrli:measure></xbrli:unit><xbrli:unit id="trading_day"><xbrli:measure>alts:trading_day</xbrli:measure></xbrli:unit><xbrli:unit id="officer"><xbrli:measure>alts:officer</xbrli:measure></xbrli:unit><xbrli:unit id="payment"><xbrli:measure>alts:payment</xbrli:measure></xbrli:unit><xbrli:unit id="landlord"><xbrli:measure>alts:landlord</xbrli:measure></xbrli:unit><xbrli:unit id="guarantee"><xbrli:measure>alts:guarantee</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesSConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesSConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesA1ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesA1ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesMPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesMPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesQConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesQConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesVConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesVConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesA1PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesS1PreferredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesIPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesMPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesQPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesVPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesA1PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesA1PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesS1PreferredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesIPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesMPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesQPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesVPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesIPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesMPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesA1PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesVPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesQPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">alts:QodenTechnologiesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">alts:QodenTechnologiesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesA1PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesS1PreferredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesIPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesMPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesQPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesVPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">alts:OtherSignificantNoncashTransactionBusinessAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">alts:OtherSignificantNoncashTransactionBusinessAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">alts:OtherSignificantNoncashTransactionConsultingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">alts:OtherSignificantNoncashTransactionConsultingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">alts:OtherSignificantNoncashTransactionLiabilityObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">alts:OtherSignificantNoncashTransactionLiabilityObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">alts:OtherSignificantNoncashTransactionInterestObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">alts:OtherSignificantNoncashTransactionInterestObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">alts:OtherSignificantNoncashTransactionPropertyAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">alts:OtherSignificantNoncashTransactionPropertyAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">alts:OtherSignificantNoncashTransactionIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">alts:OtherSignificantNoncashTransactionIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">alts:SubscriptionsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:MarketingRelatedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:MarketingRelatedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">alts:QodenTechnologiesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-08</xbrli:startDate><xbrli:endDate>2024-11-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesQConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">alts:QodenTechnologiesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-08</xbrli:startDate><xbrli:endDate>2024-11-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">alts:QodenTechnologiesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-11-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-15</xbrli:startDate><xbrli:endDate>2024-05-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-15</xbrli:startDate><xbrli:endDate>2024-05-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesMPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-15</xbrli:startDate><xbrli:endDate>2024-05-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-15</xbrli:startDate><xbrli:endDate>2024-05-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-30</xbrli:startDate><xbrli:endDate>2024-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">us-gaap:ScenarioAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">us-gaap:ScenarioAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:SoinTherapeuticsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">alts:SoinAgreementConvertibleTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-24</xbrli:startDate><xbrli:endDate>2024-01-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:SoinTherapeuticsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:SoinTherapeuticsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">alts:BusinessAcquisitionConsiderationTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-01</xbrli:startDate><xbrli:endDate>2024-03-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:SoinTherapeuticsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">alts:BusinessAcquisitionConsiderationTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-01</xbrli:startDate><xbrli:endDate>2024-03-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:SoinTherapeuticsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">alts:BusinessAcquisitionConsiderationTrancheThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-01</xbrli:startDate><xbrli:endDate>2024-03-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:DrSoinMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:DrSoinMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-01</xbrli:startDate><xbrli:endDate>2025-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:SoinTherapeuticsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">alts:SoinAgreementConvertibleTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-28</xbrli:startDate><xbrli:endDate>2022-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:SoinTherapeuticsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">alts:SoinAgreementConvertibleTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-24</xbrli:startDate><xbrli:endDate>2024-01-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:SoinTherapeuticsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">alts:SoinAgreementConvertibleTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-28</xbrli:startDate><xbrli:endDate>2022-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:SoinTherapeuticsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">alts:SOINAgreementConvertibleTrancheThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:SoinTherapeuticsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">alts:SOINAgreementConvertibleTrancheThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-28</xbrli:startDate><xbrli:endDate>2022-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:VM7CorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">alts:StockPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:VM7CorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">alts:StockPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-09</xbrli:startDate><xbrli:endDate>2023-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:VM7CorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">alts:StockPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">alts:ARCAAndSubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-09</xbrli:startDate><xbrli:endDate>2023-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">alts:ARCAAndSubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:RecyclingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">alts:ARCAAndSubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:RecyclingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">alts:ARCAAndSubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:RecyclingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">alts:ARCAAndSubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:RecyclingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">alts:ARCAAndSubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:RecyclingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetUnderConstructionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetUnderConstructionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:SpyrTechnologiesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-24</xbrli:startDate><xbrli:endDate>2022-05-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:GeoTraqIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:SpyrTechnologiesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:SpyrTechnologiesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:SpyrTechnologiesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:GeoTraqIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:GeoTraqIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">alts:SoinIntangiblesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">alts:SoinIntangiblesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">alts:CryptocurrencyExchangeSoftwareIntangibleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">alts:CryptocurrencyExchangeSoftwareIntangibleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">alts:PatentsAndDomainsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">alts:PatentsAndDomainsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">alts:QodenIntangibleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">alts:QodenTechnologiesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-11-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:ALT5SubsidiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:ALT5SubsidiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:ALT5SubsidiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">alts:SoinIntangiblesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:CommonShareEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:CommonShareEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:CommonShareEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:CommonShareEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:CommonShareEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:A15DebenturesMaturingJune302025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:DebenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:A15DebenturesMaturingJune302025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:DebenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:DebenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:DebenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:DebenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:A12DebenturesMaturingJune302025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:DebenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:A12DebenturesMaturingJune302024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:DebenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:DebenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LegacySubsidiaryFixedDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LegacySubsidiaryFixedDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LegacySubsidiaryLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LegacySubsidiaryLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LegacyUnaffiliatedThirdPartyNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LegacyUnaffiliatedThirdPartyNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:OtherLegacyNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:OtherLegacyNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LegacySubsidiaryFixedDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">alts:ALT5SubsidiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:FixedDepositAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LegacySubsidiaryFixedDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">alts:ALT5SubsidiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:FixedDepositAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LegacySubsidiaryFixedDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">alts:ALT5SubsidiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:FixedDepositAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LegacySubsidiaryFixedDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">alts:ALT5SubsidiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:FixedDepositAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-22</xbrli:startDate><xbrli:endDate>2024-03-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LegacySubsidiaryLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:NotesPayableWithLiveVenturesAndICGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:NotesPayableWithLiveVenturesAndICGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:NotesPayableWithLiveVenturesAndICGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LiveNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:NotesPayableWithLiveVenturesAndICGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LiveNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:NotesPayableWithLiveVenturesAndICGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LiveNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:NotesPayableWithLiveVenturesAndICGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:SkybridgeLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:SkyBridgeAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-10</xbrli:startDate><xbrli:endDate>2024-04-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">alts:LegalFeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:SkybridgeLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:SkyBridgeAmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-10</xbrli:startDate><xbrli:endDate>2024-04-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:SkybridgeLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:PromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:PromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:SkybridgeLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:UnaffiliatedThirdPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-23</xbrli:startDate><xbrli:endDate>2024-12-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NonConvertibleDebentureBigDebentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NonConvertibleDebentureBigDebentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:InvestorOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">alts:BigWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:InvestorOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NonConvertibleDebentureSmallDebentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:InvestorTwoAndInvestorThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:InvestorTwoAndInvestorThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="alts:DebtInstrumentCovenantPeriodAxis">alts:DebtInstrumentCovenantPeriodPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NonConvertibleDebentureBigAndSmallDebentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="alts:DebtInstrumentCovenantPeriodAxis">alts:DebtInstrumentCovenantPeriodPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NonConvertibleDebentureBigAndSmallDebentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="alts:DebtInstrumentCovenantPeriodAxis">alts:DebtInstrumentCovenantPeriodPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NonConvertibleDebentureBigAndSmallDebentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="alts:DebtInstrumentOriginalIssueDiscountExpansionAxis">alts:DebtInstrumentOriginalIssueDiscountExpansionOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NonConvertibleDebentureBigDebentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="alts:DebtInstrumentOriginalIssueDiscountExpansionAxis">alts:DebtInstrumentOriginalIssueDiscountExpansionTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NonConvertibleDebentureBigDebentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NonConvertibleDebentureSmallDebentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="alts:DebtInstrumentOriginalIssueDiscountExpansionAxis">alts:DebtInstrumentOriginalIssueDiscountExpansionOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NonConvertibleDebentureSmallDebentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="alts:DebtInstrumentOriginalIssueDiscountExpansionAxis">alts:DebtInstrumentOriginalIssueDiscountExpansionTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NonConvertibleDebentureSmallDebentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">alts:BigWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="alts:DebtInstrumentCovenantPeriodAxis">alts:DebtInstrumentCovenantPeriodPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">alts:BigWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="alts:DebtInstrumentCovenantPeriodAxis">alts:DebtInstrumentCovenantPeriodPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">alts:BigWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="alts:DebtInstrumentCovenantPeriodAxis">alts:DebtInstrumentCovenantPeriodPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">alts:BigWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">alts:SmallWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="alts:DebtInstrumentCovenantPeriodAxis">alts:DebtInstrumentCovenantPeriodPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">alts:SmallWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="alts:DebtInstrumentCovenantPeriodAxis">alts:DebtInstrumentCovenantPeriodPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">alts:SmallWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="alts:DebtInstrumentCovenantPeriodAxis">alts:DebtInstrumentCovenantPeriodPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">alts:SmallWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-20</xbrli:startDate><xbrli:endDate>2024-08-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">alts:BigWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-29</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">alts:SmallWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-29</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NonConvertibleDebentureBigAndSmallDebentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-22</xbrli:startDate><xbrli:endDate>2024-03-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NonConvertibleDebentureBigAndSmallDebentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:FixedDepositAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:FixedDepositAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:ALT5SubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-19</xbrli:startDate><xbrli:endDate>2024-09-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:FixedDepositAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:FixedDepositAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:ALT5SubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:FixedDepositAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:FixedDepositAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:ALT5SubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IsaacCapitalGroupNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IsaacCapitalGroupNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NotePayableToIsaacCapitalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NotePayableToIsaacCapitalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NotePayableToLiveVentureIncorporatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NotePayableToLiveVentureIncorporatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IsaacCapitalGroupShortTermDemandAdvanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IsaacCapitalGroupShortTermDemandAdvanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NovalkAppsSAALLPShortTermDemandAdvanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NovalkAppsSAALLPShortTermDemandAdvanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NotesPayableRelatedPartiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IsaacCapitalGroupShortTermDemandAdvanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-18</xbrli:startDate><xbrli:endDate>2024-04-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IsaacCapitalGroupShortTermDemandAdvanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IsaacCapitalGroupShortTermDemandAdvanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IsaacCapitalGroupShortTermDemandAdvanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LiveNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:LiveVentureIncorporatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LiveNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:LiveVentureIncorporatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LiveNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:LiveVentureIncorporatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LiveNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:LiveVentureIncorporatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:A10ConvertiblePromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:Mr.JonIsaacMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-04</xbrli:startDate><xbrli:endDate>2024-03-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:A10ConvertiblePromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-04</xbrli:startDate><xbrli:endDate>2024-03-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:A10ConvertiblePromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:Mr.JonIsaacMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:A10ConvertiblePromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-23</xbrli:startDate><xbrli:endDate>2024-12-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:Mr.JonIsaacMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:NovalkAppsSAALLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:RelatedPartyTransactionShortTermAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-28</xbrli:startDate><xbrli:endDate>2024-05-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:NovalkAppsSAALLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:RelatedPartyTransactionShortTermAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-03</xbrli:startDate><xbrli:endDate>2024-06-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:NovalkAppsSAALLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:RelatedPartyTransactionShortTermAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:NovalkAppsSAALLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:RelatedPartyTransactionShortTermAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:NovalkAppsSAALLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:RelatedPartyTransactionShortTermAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:NovalkAppsSAALLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:RelatedPartyTransactionShortTermAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:Mr.TonyIsaacMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:RelatedPartyTransactionShortTermAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-03</xbrli:startDate><xbrli:endDate>2024-06-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:Mr.TonyIsaacMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:RelatedPartyTransactionShortTermAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:Mr.TonyIsaacMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:RelatedPartyTransactionShortTermAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:Mr.TonyIsaacMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:RelatedPartyTransactionShortTermAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:GeoTraqIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-08-18</xbrli:startDate><xbrli:endDate>2017-08-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:GeoTraqIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">alts:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-08-18</xbrli:startDate><xbrli:endDate>2017-08-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:GeoTraqIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">alts:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-08-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">alts:SeriesA1ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">alts:SeriesA1ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-285"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">alts:SeriesA1ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-286"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">alts:SeriesA1ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:OwnersOfALT5SubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-15</xbrli:startDate><xbrli:endDate>2024-05-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-02</xbrli:startDate><xbrli:endDate>2024-12-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-291"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:QodenTechnologiesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-06</xbrli:startDate><xbrli:endDate>2024-11-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-292"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:QodenTechnologiesLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesQConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-06</xbrli:startDate><xbrli:endDate>2024-11-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-293"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesQConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-06</xbrli:startDate><xbrli:endDate>2024-11-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:UnaffiliatedThirdPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesVConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-04</xbrli:startDate><xbrli:endDate>2024-05-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:SoinTherapeuticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesSConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:SoinTherapeuticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesSConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-28</xbrli:startDate><xbrli:endDate>2022-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">alts:StockConversion1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesSConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:DrSoinMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-28</xbrli:startDate><xbrli:endDate>2022-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-298"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">alts:StockConversion1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesSConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:DrSoinMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-299"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">alts:StockConversion2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesSConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:DrSoinMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-28</xbrli:startDate><xbrli:endDate>2022-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-300"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">alts:StockConversion3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesSConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:DrSoinMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">alts:StockConversion3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesSConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:DrSoinMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-28</xbrli:startDate><xbrli:endDate>2022-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">alts:StockConversion3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:DrSoinMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-28</xbrli:startDate><xbrli:endDate>2022-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:DrSoinMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-28</xbrli:startDate><xbrli:endDate>2022-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesSConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesSConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-306"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">alts:ArticlesOfIncorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">alts:ArticlesOfIncorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-22</xbrli:startDate><xbrli:endDate>2023-03-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-18</xbrli:startDate><xbrli:endDate>2023-08-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">alts:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-314"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-23</xbrli:startDate><xbrli:endDate>2024-02-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-23</xbrli:startDate><xbrli:endDate>2024-02-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-317"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">alts:ThirdPartyExchangeForBrokerageServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-23</xbrli:startDate><xbrli:endDate>2024-02-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:Mr.JonIsaacMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-04</xbrli:startDate><xbrli:endDate>2024-03-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-319"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-22</xbrli:startDate><xbrli:endDate>2024-03-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-320"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-22</xbrli:startDate><xbrli:endDate>2024-03-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-25</xbrli:startDate><xbrli:endDate>2024-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-25</xbrli:startDate><xbrli:endDate>2024-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-10</xbrli:startDate><xbrli:endDate>2024-04-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-10</xbrli:startDate><xbrli:endDate>2024-04-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-325"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-12</xbrli:startDate><xbrli:endDate>2024-04-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-12</xbrli:startDate><xbrli:endDate>2024-04-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-01</xbrli:startDate><xbrli:endDate>2024-05-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-01</xbrli:startDate><xbrli:endDate>2024-05-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:NorthYorkLTDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-04</xbrli:startDate><xbrli:endDate>2024-03-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesVConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:NorthYorkLTDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-04</xbrli:startDate><xbrli:endDate>2024-03-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-332"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:NorthYorkLTDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-333"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:NorthYorkLTDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-04</xbrli:startDate><xbrli:endDate>2024-03-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-334"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-03</xbrli:startDate><xbrli:endDate>2024-06-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-335"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-06</xbrli:startDate><xbrli:endDate>2024-06-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-336"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-18</xbrli:startDate><xbrli:endDate>2024-09-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-337"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-338"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-18</xbrli:startDate><xbrli:endDate>2024-10-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-339"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NonConvertibleDebentureBigAndSmallDebentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-29</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-340"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-341"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-03</xbrli:startDate><xbrli:endDate>2024-12-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-342"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">alts:A2023EquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-343"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">alts:A2024EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-344"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">alts:A2024EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-345"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">alts:A2023EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-346"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">alts:A2023EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-347"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">alts:Plan2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-348"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">alts:Plan2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-349"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">alts:Plan2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-350"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">alts:Plan2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-351"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">alts:Plan2011Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-352"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">alts:Plan2011Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-353"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">alts:Plan2011Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-354"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-02</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-355"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">alts:ExercisePriceRangeOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-356"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">alts:ExercisePriceRangeOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-357"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">alts:ExercisePriceRangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-358"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">alts:ExercisePriceRangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-359"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-360"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-361"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-362"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-363"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-364"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-365"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-366"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-367"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:LiveVenturesIncorporatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-368"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:LiveVenturesIncorporatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-369"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:LiveVenturesIncorporatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-370"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LiveVenturesAndICGNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:NotesPayableWithLiveVenturesAndICGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-371"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LiveVenturesAndICGNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:NotesPayableWithLiveVenturesAndICGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-07</xbrli:startDate><xbrli:endDate>2024-02-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-372"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LiveVenturesAndICGNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:NotesPayableWithLiveVenturesAndICGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-373"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:Mr.JonIsaacMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">alts:UniversalLifeInsurancePolicyPolicyOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-374"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:Mr.JonIsaacMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">alts:UniversalLifeInsurancePolicyPolicyTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-375"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:A10ConvertiblePromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-376"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:A10ConvertiblePromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-377"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:Mr.JonIsaacMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-378"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-379"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">alts:ARCAAndSubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:BeneficialOwnerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:RecyclingSegmentAndTechnologySegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-380"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">alts:ARCAAndSubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">alts:JanOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">alts:IsaacCapitalGroupLLCICGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:BeneficialOwnerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:RecyclingSegmentAndTechnologySegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-381"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-382"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">alts:ARCAAndSubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:BeneficialOwnerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:RecyclingSegmentAndTechnologySegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-383"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">alts:ARCAAndSubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:BeneficialOwnerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:RecyclingSegmentAndTechnologySegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-24</xbrli:startDate><xbrli:endDate>2023-05-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-384"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-385"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:SECComplaintMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-386"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:SECComplaintMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-28</xbrli:startDate><xbrli:endDate>2024-05-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-387"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:SECComplaintMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-388"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:GeoTraqIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:Mr.SullivanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-389"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:GeoTraqIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:Mr.SullivanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-390"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:AlixpartnersLLCLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:AlixpartnersLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-19</xbrli:startDate><xbrli:endDate>2022-10-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-391"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:AlixpartnersLLCLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:AlixpartnersLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-392"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:AlixpartnersLLCLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:AlixpartnersLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-393"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:Main270LLCLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:TrusteesMain270LlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-394"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">alts:ApplianceSmartIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:Main270LLCLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:TrusteesMain270LlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-395"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:WestervilleSquareLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:WestervilleSquareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-396"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:WestervilleSquareLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:WestervilleSquareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-04</xbrli:startDate><xbrli:endDate>2023-06-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-397"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:OtherCommitmentsAndLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">alts:ApplianceSmartIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-398"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:OtherCommitmentsAndLitigationCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-399"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:OtherCommitmentsAndLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">alts:ApplianceSmartIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-400"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:OtherCommitmentsAndLitigationCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:FintechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:FintechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:BiotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:BiotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:RecyclingSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-408"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:RecyclingSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-409"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">alts:ContinuingOperationsAndDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-31</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-410"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">alts:ContinuingOperationsAndDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-411"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:FintechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:FintechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-413"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:BiotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:BiotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-416"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-417"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:RecyclingSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:RecyclingSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-419"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">alts:ContinuingOperationsAndDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">alts:ContinuingOperationsAndDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000862861</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-29</xbrli:startDate><xbrli:endDate>2024-12-28</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i213e3c881f5e4982994be533c682ff6b_1"></div><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-K</ix:nonNumeric></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="f-2">x</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-4"><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-3">December 28</ix:nonNumeric>, 2024</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-5">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File No. <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-6">000-19621</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-7">ALT5 Sigma Corporation</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.596%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-8">Nevada</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-9">41-1454591</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(I.R.S. Employer Identification No.)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-10">325 E. Warm Springs Road</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-11">Las Vegas</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-12">Nevada</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-13">89119</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(Zip Code)</span></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Registrant&#8217;s telephone number, including area code: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-14">702</ix:nonNumeric>-<ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-15">997-5968</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-16">Common Stock, $0.001 par value</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Title of each class</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-17">ALTS</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Trading Symbol(s)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-18">Nasdaq</ix:nonNumeric> Capital Market</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Name of each exchange on which registered</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(g) of the Act: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">None</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="dei:EntityWellKnownSeasonedIssuer" id="f-19">No</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="dei:EntityVoluntaryFilers" id="f-20">No</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-21">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> No</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-22">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> No</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:6pt;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.727%"><tr><td style="width:1.0%"/><td style="width:26.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.292%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.292%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.293%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Large accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-23">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">x</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="f-24">x</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-25">o</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">If any emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal controls over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-false" id="f-26">o</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-false" id="f-27">o</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive o&#64259;cers during the relevant recovery period pursuant to &#167;240.10D-1(b). </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-28">o</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> No</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The aggregate market value of the registrant&#8217;s common stock held by non-affiliates, based on the closing sales price of such stock on July 1, 2024 was approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-5" name="dei:EntityPublicFloat" scale="6" id="f-29">26.7</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The number of shares outstanding of the registrant&#8217;s common stock as of March&#160;25, 2025 was <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-30">16,078,647</ix:nonFraction>.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i213e3c881f5e4982994be533c682ff6b_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:72.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Page</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_10">PART I</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_13">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_13">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_13">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_16">Item 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_16">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_16">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_19">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_19">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_19">66</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_22">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_22">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_22">66</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_25">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_25">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_25">66</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_28">PART II</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_31">Item 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_31">Market for Our Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_31">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_34">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_34">Selected Financial Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_34">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_37">Item 7.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_37">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_37">68</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_100">Item 7A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_100">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_100">73</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_103">Item 8.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_103">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_103">74</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_208">Item 9.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_208">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_208">57</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_211">Item 9A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_211">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_211">57</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_214">Item 9B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_214">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_214">58</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_217">Item 9C</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_217">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_217">58</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_220">PART III</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_223">Item 10.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_223">Directors, Executive Officers, and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_223">59</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_226">Item 11.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_226">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_226">62</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_229">Item 12.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_229">Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_229">64</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_232">Item 13.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_232">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_232">66</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_235">Item 14.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_235">Principal Accounting Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_235">67</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_238">PART IV</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_241">Item 15.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_241">Exhibits and Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_241">69</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_244">Item 16.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_244">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_244">69</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_247">Index to Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_247">70</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_250">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_250">75</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i213e3c881f5e4982994be533c682ff6b_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="i213e3c881f5e4982994be533c682ff6b_13"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BUSINESS</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">General</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ALT5 Sigma Corporation, (formerly known as JanOne Inc.) and subsidiaries (collectively, &#8220;we,&#8221; &#8220;us,&#8221; the &#8220;Company,&#8221; or &#8220;ALT5&#8221;). Through our Fintech segment, the Company provides next generation blockchain-powered technologies to enable a migration to a new global financial paradigm, and, through our Biotechnology segment, we are focused on finding treatments for conditions that cause chronic pain and bringing to market drugs with non-addictive and non-sedative pain-relieving properties.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 15, 2024, the Company acquired ALT5 Sigma, Inc., and on July 15, 2024, changed its corporate name from JanOne Inc. to ALT5 Sigma Corporation. ALT5 Sigma, Inc., is a financial services and Fintech holding company. ALT5 Sigma, Inc. was created by financial industry specialists out of the necessity to provide the digital asset economy with the best practices of the industry and state of the art over-the-counter trading.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through March 8, 2023, the Company operated its discontinued legacy businesses through its Recycling Subsidiaries, consisting of: (a) ARCA Recycling, Inc., a California corporation (&#8220;ARCA Recycling&#8221;), (b) ARCA Canada Inc., a corporation organized under the laws of Ontario, Canada (&#8220;ARCA Canada&#8221;), and (c) Customer Connexx, LLC, a Nevada limited liability company (&#8220;Connexx&#8221;). ARCA Recycling and ARCA Canada recycle major household appliances in North America by providing turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs. Connexx is a company that provides call center services for recycling businesses. On March 9, 2023, we entered into a Stock Purchase Agreement (the &#8220;Recycling Purchase Agreement&#8221;) with VM7 Corporation, a Delaware corporation (&#8220;VM7&#8221;), under which it agreed to acquire all of the outstanding equity interests of the Recycling Subsidiaries. The principal of VM7 is Virland A. Johnson, our Chief Financial Officer.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information contained in or accessible from our website is not incorporated into this Annual Report on Form 10-K (the &#8220;Form 10-K&#8221;), and it should not be considered part of this Form 10-K. We have included our website address in this Form 10-K solely as an inactive textual reference.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s legal address is located at 325 E Warm Springs Rd #102, Las Vegas, NV 89119, with subsidiary offices in Newmarket, and Montreal, Canada.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Fintech</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Overview</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ALT5 Sigma, Inc., through its subsidiaries, offers two main platforms to its customers: &#8220;ALT5 Pay&#8221; and &#8220;ALT5 Prime.&#8221; ALT5 Pay is a crypto-currency payment gateway that enables registered and approved global merchants to accept and make crypto-currency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay&#8217;s checkout widgets and APIs. Merchants have the option to convert to fiat currency (US Dollars, Canadian Dollars, Euros, and British Pounds Sterling) automatically or to receive their payment in digital assets. ALT5 Prime is an electronic over-the-counter trading platform that enables registered and approved customers to buy and sell digital assets. Customers can purchase digital assets with fiat and, equally, can sell digital assets and receive fiat. ALT5 Prime is available through a browser-based access, mobile phone application named &#8220;ALT5 Pro&#8221; that can be downloaded from the Apple App Store, from Google Play, through ALT5 Prime&#8217;s FIX API, as well as through Broadridge Financial Solutions&#8217; NYFIX gateway for approved customers.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ALT5 Sigma, Inc., has two wholly owned subsidiaries, ALT5 Sigma Canada, Inc., and ALT5 Securities, Inc. ALT5 Sigma Canada, Inc. has four wholly owned subsidiaries, ALT5 AI, Inc. (Canada), ALT5 Pro, LLC. (Saint-Vincent and the Grenadines), UAB ALT5 Sigma Prudentia (Lithuania), and ALT5 Sigma Prudentia s.r.o. (Czech Republic) formerly Cypherlynx s.r.o.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ALT5 Sigma develops, commercializes products and services based on four key fundamental principles of 1) Safety, Security and Trust, 2) Accessibility 3) Regulations, 4) Transparency:</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Safety, Security and Trust</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Develop and deploy products and services that increase our clients and customers' trust in our organization. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accessibility</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Develop and deploy products and services that are easy to use, accessible everywhere and with no barriers. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Regulations</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deploy and deploy the best practices in the industry to comply with KYC, KYT, AML reporting and always be at the forefront of all regulatory requirements. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transparency</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Develop and deploy the best practices in financial reporting, as well as best practices in communication of all material events for all stakeholders i.e. customers, shareholders, suppliers and employees.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Background</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate History and Organizational Structure</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ALT5 Sigma, Inc. was formed and incorporated in the State of Delaware on March 5, 2018 under the name Buttonwood ARCA Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 28, 2018, the Company filed a Certificate of Amendment with the State of Delaware changing our name to ALT5 Sigma. The Company entered into a Share Exchange and Reorganization Agreement on March 21, 2018 with Soci&#233;t&#233; AVA Inc., a Canadian corporation, and as a result Soci&#233;t&#233; AVA Inc. became a wholly owned subsidiary of the Company. On March 28, 2018 the Company changed the name of Soci&#233;t&#233; AVA Inc. to ALT5 Sigma Canada Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 14, 2019, ALT5 Sigma Canada Inc., acquired 100% of Miningcrypt Inc., a Canadian crypto currency mining company, and on November 25, 2019, Miningcrypt Inc., changed its name to ALT5 AI Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2020, due to a severe storm, the mining equipment suffered fatal damages and the mining operations ceased.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ALT5 AI Inc. is intended to be used to hold intellectual properties and develop machine learning and or artificial intelligence software.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ALT5 AI Inc., does not currently have any assets and is not currently operating.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 21, 2020, ALT5 Sigma Canada Inc., formed a wholly owned limited liability company named ALT5 Pro LLC in the country of Saint-Vincent and the Grenadines. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 10, 2023, ALT5 Sigma Canada Inc., formed a wholly owned corporation in the country of Lithuania named UAB ALT5 Sigma Prudentia and have applied for a cryptocurrency exchange license with the Central Bank of Lithuania.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The application was filed and is pending approval. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 16, 2023, ALT5 Sigma, Inc., formed a wholly owned corporation in the State of New York, by the name of ALT5 Securities Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 28, 2023, ALT5 Sigma Canada Inc., acquired all of the shares of a company in the Czech Republic by the name of Cypherlynx s.r.o.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cypherlynx s.r.o. has limited operating history and is licensed in the Czech Republic to operate a cryptocurrency exchange. The company has filed a name change to ALT5 Sigma Prudentia s.r.o. and the name change is pending. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 10, 2024, ALT5 Sigma, Inc. was acquired by JanOne Inc.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Organizational Structure Chart</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><img src="alts-20241228_g1.jpg" alt="Org Chart.jpg" style="height:284px;margin-bottom:5pt;vertical-align:text-bottom;width:480px"/></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Executive Summary</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ALT5 Sigma, Inc., is a financial services and Fintech holding company. ALT5 Sigma, Inc. was created by financial industry specialists out of the necessity to provide the digital asset economy with the best practices of the industry and state of the art over-the-counter trading of securities. ALT5 Sigma, Inc., operates two distinct wholly owned subsidiaries, ALT5 Sigma Canada Inc., and ALT5 Securities Inc. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ALT5 Sigma Canada Inc., provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment and custodianship of digital assets through its wholly owned subsidiaries. ALT5 Sigma Canada has four wholly owned subsidiaries, ALT5 AI Inc., ALT5 Pro LLC, UAB ALT5 Sigma Prudentia and ALT5 Prudentia s.r.o. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ALT5 Sigma Canada group of companies&#8217; products and services are target at business two business (B2B) only and not a retail clientele.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global target market for ALT5 Sigma Canada group of companies are banks, broker dealers, funds, family offices, proprietary trading firms, liquidity providers, financial information providers, and merchants.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Business Model/ Revenue Model</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company obtains its revenue from initial installation fees or setup fees, monthly maintenance fees, spreads and transaction commissions fees.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Our Clients</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products and services are marketed to banks, broker dealers, funds, family offices, proprietary trading firms, liquidity providers, financial information providers, payment processing partners and merchants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a total of approximately 1,900 corporate clients&#8217; customers located in 50 countries.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Product Overview</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ALT5 Prime</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ALT5 Prime is an electronic over-the-counter trading platform, enabling registered and approved customers to buy and sell digital assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers can purchase digital assets with US dollars, Canadian dollars, Euros, and British Pounds and customers may sell digital assets and receive US dollars, Canadian dollars, Euros and British Pounds. ALT5 Prime is available through a browser-based access, mobile phone application named ALT5 Pro that can be downloaded from the Apple store and Google Play store, or through the company&#8217;s FIX API as well as through Broadridge&#8217;s NYFIX gateway to approved customers.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on their geographic location, registered and approved Customers may buy and sell a number of digital assets including, but not limited to:</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.090%"><tr><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Name</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AAVE</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aave</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DASH</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dash</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SNX</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Synthetix</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">APE</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Apecoin</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DOGE</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dogecoin</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SOL</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solana</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ADA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardano</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DOT</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Polkadot</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SUSHI</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sushiswap</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ALGO</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Algorand</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ETH</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ethereum</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TRUMP</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Official Trump</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ATOM</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cosmos</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FTM</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fantom / Sonic</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TRX</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tron</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AU</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AutoCrypto</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HKD</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HongKongDao</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UNI</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Uniswap</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AVAX</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Avalanche</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LINK</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chainlink</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">USDC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">USD Coin</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BCH</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bitcoin-Cash</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LTC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litecoin</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">USDT</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tether USD</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BNB</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BNB</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MANA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Decentraland </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UST</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TerraClassicUSD</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BSV</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bitcoin SV</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MATIC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Polygon</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XLM</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stellar</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BTC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bitcoin</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MKR</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maker</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XRP</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ripple</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BTCN</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BitcoinNote</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MXN</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moneta Digital</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XTZ</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tezos</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMP</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compound</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">QNT</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quant</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">YFI</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yearn.finance</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DAI</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dai</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SHIB</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shiba-inu</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ALT5 Prime screen sample:</span></div><div style="margin-top:12pt"><img src="alts-20241228_g2.jpg" alt="Prime Screen.jpg" style="height:285px;margin-bottom:5pt;vertical-align:text-bottom;width:581px"/></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ALT5 Pay</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ALT5 Pay is a crypto currency payment gateway enabling registered and approved global merchants to accept and make crypto currency payments or integrate the payment platform into their application or operations using the plug in with WooCommerce and or the company&#8217;s checkout widgets and APIs. Merchants have the option to automatically convert to US dollars, Canadian Dollars, Euros and/or British Pound or hold the digital assets.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ALT5 Pay screen sample:</span></div><div style="margin-top:12pt;text-align:justify"><img src="alts-20241228_g3.jpg" alt="Pay Screen.jpg" style="height:295px;margin-bottom:5pt;vertical-align:text-bottom;width:444px"/></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Technology</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.969%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.78pt">Ability to offer multiple digital assets</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Support 24/7</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Complete backend control through customizable administration dashboard.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Audit trades for clients</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Automated trade confirmation email and customized Monthly statements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Ability to place edit and cancel limit orders into order book via API</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Unlimited Accounts per user</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Accept fiat deposits (USD, CAD, EUR and GBP).</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Supported order types including market, limit and stop</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Endpoints supporting connections to trading interfaces, API, and related user-directed systems</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Integrated system to document customer KYC for onboarding process</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Connect to FIX, Binary, WebSocket, REST and custom APIs.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Run reports, transactions, treasury</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Unlimited user profile</span></div></td></tr></table></div><div><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Security</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.969%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Global setting protections in force to prevent unauthorized account activity, including unusual withdrawal requests.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">All platform data is replicated and backed up in real-time.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Built in protection against brute force denial of service (DoS) and distributed denial of service (DDoS) attacks and active whitelist/blacklist management control.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Internal Service interaction utilize separate authentication contexts and are not exposed to the Internet</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">All website data is transmitted via encrypted transport layer security (TLS) connections (i.e. HTTPS)</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Cold Storage Wallet Management</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Encrypted User Information</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Two Factor authentication</span></div></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trading Features</span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.969%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.78pt">Multiple available views, including price chart, depth chart, order book and recent trades ticker.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Live order book displays buy and sell orders with live spread calculation.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Six chart styles including line, bar, area and candles.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Ability to set custom chart durations ranging from one minute to years</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Ability to customize color and styles of bars, borders, wicks, price lines, backgrounds and grid</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Multiple scale styles including auto, percentage and logarithmic</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Ability to report block trade Integrated ability to save current chart view to jpeg</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">58 available indicators including linear</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Regression curves, moving averages and oscillators</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Ability to draw custom trendlines, pitchforks, and more that scales and move with chart.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">11 available trendlines styles including rays, angles and arrows</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">18 available pitchforks styles including pitchforks, Gann boxes, and Fibonacci&#8217;s</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">9 available brushes including ellipses, triangles and rectangles</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">12 available test box styles including flag marks, arrows and price labels</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">14 available pattern descriptors including cypher, ABCD and Elliott formations</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">9 available forecasting markers including bars, ghosts, spreads and areas</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">300+ available icons to markup charts.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Custom area measurement tool to find duration percentage change and price change Automatic calculation of fees included in order price</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.11pt">Multiple custom user reports including trade activity, transaction activity, and treasury activity</span></div></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Competition</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The digital assets market for our ALT5 Prime and ALT5 Pay products and services is a relatively new industry and only a hand full of companies have emerged as recognized brands providing exchange or trading platforms such as Coinbase, Kraken, and Binance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These platforms target the retail digital asset investors but currently account for the largest trading volume in dollar equivalent and number of coins traded.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that some of the leading financial institutions license or buy the technology and services necessary to be able to be effectively and quickly provide these services to their customers and prevent the attrition of assets under management due to the movement of same to digital assets investments and whereby the ALT5 products are services are highly advantageous for these customers as they provide a best-of-breed solutions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Market Size</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s products and services are designed for banks, broker dealers, funds, family offices, proprietary trading firms, liquidity providers, financial information providers, and merchants.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our main target market and focus are FINRA-registered broker dealers and global merchants.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">According to the most recent information from FINRA, there are 3,712 broker-dealers registered and under FINRA&#8217;s supervision, representing 629,112 registered representatives. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 2024, the U.S. equity markets remain the largest globally, with a market capitalization of approximately $63 trillion, accounting for over 50% of the global equity market's value (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Morningstar)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This reflects significant growth from previous years, with the U.S. market adding nearly $11 trillion in value in 2024 alone. In comparison, the global digital assets market experienced substantial growth in 2024, with its market capitalization nearly doubling to approximately $3.91 trillion by mid-December, before consolidating at $3.40 trillion (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Crowdfund Insider)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Bitcoin continues to lead the digital assets market, maintaining a significant share of the total market capitalization.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company projects that 3% of assets currently allocated to U.S. equities will transition to digital assets over the next 36 to 60 months. Based on the current U.S. equity market capitalization of $63 trillion, this 3% shift represents approximately $1.89 trillion. Such a reallocation could increase the global digital assets market capitalization to approximately $5.29 trillion. Given that average trading volumes of digital assets have been around 19% of the total market capitalization, this would correspond to daily trading volumes of approximately $1.0 trillion globally and $380 billion in the U.S.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company further believes that retail and institutional investors will continue to seek advice, trade execution, and safekeeping of their assets, including digital assets such as Bitcoin, through their FINRA-registered broker-dealers. Therefore, we anticipate that our main target market, FINRA broker-dealers, will aggregate 90% of the daily trading volume, representing $342 billion of daily trading volume or $124.8 trillion in annual trading volume and potential revenues of $8.64 billion.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">According to a McKinsey report, the global payments industry revenue reached $2.1 trillion in 2021. If calculated at an annualized growth rate of 9%, global payments industry revenue is projected to reach $3.3 trillion in 2026. Specifically, the crypto payment gateway market size is expected to reach $4.12 billion by 2029, growing at a CAGR of 16.8% from $1.19 billion in 2022, according to Maximize Market Research Private Limited.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Looking ahead, the Boston Consulting Group (BCG) projects that global payments revenues will continue to grow, albeit at a moderated pace. BCG's Global Payments Report 2023 forecasts an annual growth rate of 6.2%, with revenues expected to reach $2.2 trillion by 2027 (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">BCG Global)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This adjustment reflects a combination of market dynamics and macroeconomic factors influencing the industry. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the realm of cryptocurrency payments, the market is experiencing significant growth. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Future Market Insights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> projects that the crypto payment gateways market will expand from $1.29 billion in 2023 to approximately $4.85 billion by 2033, representing a compound annual growth rate (CAGR) of 14.1% (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Future Market Insights). </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This growth is driven by increasing adoption of cryptocurrencies and advancements in payment technologies.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sales and Marketing</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ALT5 Sigma has outsourced a portion of its sales and business development to resellers. It is the company&#8217;s strategy to target its primary market through conferences, tradeshows, direct mailing and other digital advertising.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company intends on concentrating its marketing efforts in the United States and Canada as well as establish partnerships in other markets such as Europe, and Asia.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revenue Model</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ALT5 Sigma generates revenue through three main line items. </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Installation or a onetime setup fee, which may vary depending on size and depth of installation. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Monthly maintenance, which may also vary depending on the size and depth of installation.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Transaction fees, which range from 0.25% to 5% on all transactions, buy and or sell or payment processing depending on industry and volume.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Historical Transaction Volume, Revenue, Profit</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ALT5 Sigma, Inc., transaction volume reached a cumulative of $4.5 billion since inception and more specifically was $39.0 million in 2020, $442.0 million in 2021, $743.0 million in 2022 and has $1.1 billion in 2023 and $2.2 billion in 2024 with corresponding consolidated revenue of $12.5 million and profit of $0.7 million in revenue and $4.3 million in net loss for 2020, $3.5 million in revenue and $12.3 million in net loss for 2021, $9.1 million and $0.5 million in net profit for 2022 and $11.9 million in revenue and $3.4 million in profit for 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Biotechnology</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Overview</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also a clinical-stage biopharmaceutical company focused on becoming the leader in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large, unmet medical need for the treatment of pain and addiction. JAN101 (formerly known as TV1001SR) is a potential treatment for PAD, a vascular disease that affects more than 8.5 million people in the U.S. and more than 60 million people </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">worldwide. We expected to commence Phase IIb/III clinical trials for the treatment of PAD in 2025. We are also working with a novel formulation of LDN that we call JAN 123, which includes a biphasic release of the product. The release properties of JAN123 provide for an immediate release of a portion of the product with a slow, sustained release of the remaining product. Importantly, the rapid release of LDN has been reported to lead to vivid and lucid unpleasant dreams, which should be eliminated with the formulation of JAN123. Initially, we expect that a single tablet of JAN123 will be administered orally, once a day before sleep, with eventual titration up to two tablets before sleep.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of our 2024 fiscal year, our board of directors determined that we would form a new subsidiary and capitalize it with JAN123 and certain of our other biopharma assets. Accordingly, we incorporated a Nevada corporation known as Alyea Therapeutics Corporation (&#8220;Alyea&#8221;) and expect to build upon and complete the capitalization of Alyea during the first half of our current fiscal year. In that context, our financial statements for the 2023 and 2024 fiscal years will show some, if not all, of our biopharmacy segment as a discontinued operation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Pain</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pain is a protective reaction that alerts the body to the presence of actual or potential tissue damage so that necessary corrective responses can be mounted. The National Institutes of Health (the &#8220;NIH&#8221;) defines chronic pain as pain that persists beyond the normal healing time of an injury or that persists longer than three months. It is estimated that chronic pain affects 100 million individuals in the United States and over 1.5 billion people worldwide; thus, more people suffer from chronic pain than diabetes, heart disease, and cancer combined (Cowen Therapeutic Categories Outlook, March 2019). Chronic pain exacts a tremendous cost in terms of direct treatment and rehabilitation expenditures, lost worker productivity, prevalent addiction to opioid-based drugs, and emotional and financial burden for patients and their families. According to an Institute of Medicine of the National Academies report, pain is a significant public health problem in the United States that costs society between $560 billion and $635 billion annually. Despite the magnitude of the pain problem, innovation in the development of therapeutic solutions has been largely absent. Since 2010, there have been 20 approvals by the FDA for the treatment of pain, of which 12 were opioid variants, one was an extended-release generic corticosteroid, five were variants of aspirin, and two were variants of other existing drugs. We are developing a novel product candidate designed to overcome the limitations of current treatment options for patients with PAD who suffer from chronic pain. According to a research study by Stanford University, more than 24% of patients with PAD are at risk of high opioid use. By treating pain at the source and presenting patients and physicians with better and safer treatment alternatives, we expect to minimize opioids at the prescription pad. Given the properties of JAN101, we have made the strategic decision to focus initially on pain associated with PAD by treating the underlying cause of PAD.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Chronic Pain</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The NIH defines chronic pain as pain that persists either beyond the normal healing time of an injury or longer than three months. We believe that chronic pain represents a significant public health crisis. It is estimated that chronic pain affects 100 million individuals in the United States and over 1.5 billion people worldwide; thus, more people suffer from chronic pain than diabetes, heart disease, and cancer combined (Cowen Therapeutic Categories Outlook, March 2019). Chronic pain exacts a tremendous cost in terms of direct treatment and rehabilitation expenditures, lost worker productivity, prevalent addiction to opioid-based drugs, and emotional and financial burden for patients and their families. According to an Institute of Medicine of the National Academies report, pain is a significant public health problem in the United States that costs society between $560 billion and $635 billion annually. Chronic pain is the leading cause of long-term disability in the United States, and approximately 23 million adults in the United States experience severe pain over a three-month period. Globally, the prevalence of chronic pain is even larger, with over one billion people worldwide affected each year.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common types of chronic pain include those of neuropathic and inflammatory origin and may involve the skin, muscles, joints, bones, tendons, ligaments, and other soft tissues. Chronic pain is associated with a variety of clinical conditions including, but not limited to, arthritis, spinal conditions, cancer, fibromyalgia, diabetes, surgical recovery, visceral injury, and general trauma.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pain is a necessary protective reaction that alerts the body to the presence of actual or potential tissue damage so that necessary corrective responses can be mounted. Pain is signaled by specialized cells in the peripheral nervous system called nociceptors, or pain-sensing fibers. These pain-sensing fibers normally transmit information about stimuli that approach or exceed harmful intensity from different locations in the body to the brain, which registers this information as a sensation of pain. In the case of tissue injury due to trauma or infection, pain accompanies the associated inflammation, persists for the duration of the inflammatory response, and aids healing by inhibiting use of the affected body part.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pain also can modify the central nervous system, such that the brain becomes sensitized and registers more pain with less provocation. This is called central sensitization. When central sensitization occurs, the nervous system goes through a process called wind-up and gets regulated in a persistent state of high reactivity. This persistent, or up-regulated, state of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reactivity lowers the threshold for what triggers the sensation of pain and can result in the sensation of pain even after the initial injury might have healed.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When there is dysfunction in pain signaling, injury to the nervous system, or an unhealed injury, pain becomes no longer just a symptom, but a disease in itself.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Soin Therapeutics</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ALT5 Sigma Corporation acquired Soin Therapeutics, a company focused on the development of a novel formulation of low-dose naltrexone (&#8220;LDN&#8221;) for the treatment of chronic regional pain syndrome (&#8220;CRPS&#8221;) in 2022. CRPS is a rare pain disorder, characterized by a complex set of symptoms, affecting approximately 200,000 patients annually in the US. There are currently no approved treatments for patients with CRPS. Prior to the acquisition, Soin Therapeutics received Orphan Drug Designation for the product, which provides a variety of incentives for developing the product in this indication.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">JAN123</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Generally</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">JAN123 is a novel formulation of 2.0 mg of LDN that results in a biphasic release of the product. The release properties of JAN123 provide for an immediate release of less than half the product with a slow, sustained release of the remaining product. Importantly, the rapid release of LDN has been reported to lead to vivid and lucid unpleasant dreams, which should be eliminated with the formulation of JAN123. Initially, a single tablet of JAN123 will be administered orally, once a day before sleep, with eventual titration up to two tablets (4 mg) before sleep.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Naltrexone</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Naltrexone was first synthesized in 1965 and approved by the FDA for the oral treatment of opioid dependence in 1984, with the brand name Trexan. Later it was approved for the oral treatment of alcohol dependence in 1995, when the brand name was changed by DuPont to ReVia. A depot formulation for intramuscular injection was approved by the FDA under the brand name Vivitrol for alcohol dependence in 2006 and opioid dependence in 2010. Typical oral doses are 50 to 100 mg daily, with a once-monthly intramuscular formulation also available. At these doses, Naltrexone has been shown to function as a nonselective opioid antagonist with a high affinity for &#181; opioid receptors, which decreases addiction cravings (Schumacher, Basbaum et al. 2017, Opioid Agonists &amp;amp; Antagonists. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Basic &amp;amp; Clinical Pharmacology, 14e</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. B. G. Katzung. New York, NY, McGraw-Hill Education). However, there is a risk that patients who are non-compliant with oral naltrexone may experience opioid intoxication simply by skipping doses of naltrexone. Oral bioavailability is also variable from patient to patient, largely due to first-pass metabolism. Thus, naltrexone is pharmacologically effective, but may be ineffective in a real world setting without counseling and strong patient support (Minozzi, 2011, Oral naltrexone maintenance treatment for opioid dependence. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chchrane Database Syst Rev</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4), CD001333). There are also multiple generic Naltrexone tablets available on the market for oral administration.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Low-Dose Naltrexone (LDN)</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compared to the standard dose, LDN is defined as a daily dose of Naltrexone of 1 to 5 mg, which is 10- to 100-fold lower than the dose used to manage substance use disorders (LDN Research Trust, Toljan and Vrooman 2018, Low-Dose Naltrexone (LDN)-Review of Therapeutic Utilization. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Med Sci (Basel)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)). Off-label uses of Naltrexone at lower doses have been explored based on a different mechanism of action for the treatment of inflammatory, rheumatologic, and neurologic conditions. These include multiple sclerosis, fibromyalgia, Crohn disease, chronic fatigue syndrome (CFS), and, more recently, CRPS. At the low doses used for these conditions, Naltrexone is thought to act as an immune modulator. Some speculate that this effect is related to reduced neuroinflammation in the case of disorders like CFS (Cant, Dalgleish et al. 2017, Naltrexone Inhibits IL-6 and TNFalpha Production in Human Immune Cell Subsets following Stimulation with Ligands for Intracellular Toll-Like Receptors. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Front Immunol</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: 809). </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Evidence suggests that, at low doses, Naltrexone antagonizes TLR4 on activated glial cells without the previously mentioned function as a mu-opioid receptor antagonist (Chopra and Cooper 2013, Treatment of Complex Regional Pain Syndrome (CRPS) using low-dose naltrexone LDN). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">J Neuroimmune Pharmacol</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3): 470-476.). TLR4 has been shown to be a key mediator of microglial activation, which has been identified as a causal mechanism of neuropathic pain in CRPS. Microglial activation is associated with the release of pro-inflammatory cytokines, reactive oxygen species, and prostaglandins, which amplify the inflammatory response (Carniglia, Ram&#237;rez et al. 2017, Neuropeptides and Microglial Activation in Inflammation, Pain, and Neurodegenerative Diseases. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Mediators of Inflammation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2017</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: 5048616). Thus, LDN presents a promising therapeutic avenue for the treatment of CRPS, a condition in which TLR4 upregulation is a </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primary pathway, through attenuation of glial activation and direct targeting of TLR4 activity (Del Valle, Schwartzman et al. 2009, Spinal cord histopathological alterations in a patient with longstanding complex regional pain syndrome. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Brain Behav Immun</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">23</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1): 85-91. By downregulating the inflammatory cytokine release, LDN should be beneficial for CRPS patients. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CRPS patients suffer from severe debilitating pain, and even light touch or benign stimulation elicits extreme amounts of pain. Microglial cells and glial cells oftentimes are involved in this pain-signaling pathway. By reducing glial cell activation, Low-dose Naltrexone can treat this pain syndrome. Another potential mechanism of action of LDN treatment on pain is a paradoxical upregulation of opioid signaling. It is noted that, when taken at bedtime, the short-acting low-dose Naltrexone binds to receptors, which leads to a brief blockade of opioid receptors between 2 and 4 a.m. This blockade is believed to upregulate vital life elements of the body and cause an increase in endorphin and enkephalin production. This increase in endorphins and enkephalins will likely cause a decrease in pain that the patient experiences overall. Therefore, LDN leads to transient opioid receptor blockade, which triggers a positive feedback mechanism that increases the production of endogenous opioids (endogenous endorphins and enkephalins) and opioid signaling (Ludwig, Zagon et al. 2017, Serum [Met(5)]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exp Biol Med (Maywood)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">242</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15): 1524-1533; Toljan and Vrooman 2018, Low-Dose Naltrexone (LDN)-Review of Therapeutic Utilization. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Med Sci (Basel)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)). Together, these mechanisms may work to alleviate pain associated with CRPS.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interestingly, low-dose Naltrexone also has effects on the peripheral nervous system. In the peripheral nervous system, it was found that low-dose Naltrexone can modulate T and B lymphocyte production. And it was noticed that low-dose Naltrexone could reduce interleukin 6, interleukin 12, and tumor necrosis factor alpha in the periphery regarding peripheral nervous systems. CRPS patients often have an increase in inflammatory cytokines and may often note an increase in interleukin 6, 12, and tumor necrosis factor alpha. By reducing these inflammatory cytokines back to a normal state, it is predicted that low-dose Naltrexone could treat the actual disease state of CRPS.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In summary, low-dose Naltrexone has a very specific mechanism of action that will distinctly treat CRPS through inhibition of inflammatory cytokines, glial cell activation, neuroinflammation, and increase of endogenous enkephalins and endorphins. In other words, low-dose Naltrexone is not just treating the symptoms with this medication but also treating the underlying disease state and process specific to CRPS.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Chronic Regional Pain Syndrome (CRPS)</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CRPS, also termed reflex sympathetic dystrophy (RSD), is a chronic, orphan neurologic condition that typically affects the extremities after trauma or nerve injury, and can cause severe pain. As the most common and prominent symptom of CRPS, the pain is often deep inside the limbs with a burning, stinging, or tearing sensation. Sensory changes are also common and may include increased sensitivity to painful stimuli, feeling pain from stimuli that are usually non-painful, and in some instances, sensory loss (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, numbness). In addition to pain, patients commonly experience an affected extremity that is warm, red, and swollen, at least initially. As CRPS progresses, it becomes refractory to sympathetic nerve blocks, conventional analgesics, anticonvulsants, and antidepressants. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CRPS is a rare neurologic disease. It is a painful progressive condition and is listed in the rare disease database of the National Organization for Rare Disorders (NORD). CRPS is subdivided into two categories: type I and type II CRPS. In CRPS type I, there are no nerve injuries or lesions identified. CRPS type I is also known as &#8220;reflex sympathetic dystrophy,&#8221; and it comprises about 90 percent of all cases of CRPS. CRPS type II (causalgia), on the other hand, is diagnosed when there is evidence of nerve damage. As described in the NORD, it was found that CRPS type I developed in 5.46 persons out of every 100,000 per year and the incidence rate of CRPS type 2 was 0.82 persons out of every 100,000 per year, giving rise to a combined incidence rate for both CRPS types I and II of 6.28 per 100,000 person-years (Sandroni, Benrud-Larson et al. 2003, Complex regional pain syndrome type I: incidence and prevalence in Olmsted county, a population-based study. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Pain</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">103</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1-2): 199-207; Goh, Chidambaram et al. 2017, Complex regional pain syndrome: a recent update. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Burns Trauma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: 2.). </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underlying cause of CRPS is not well understood. In most cases, it occurs after an illness or injury that did not directly damage the nerves in the affected area (Type I). In some cases, it occurs after a specific nerve injury (Type II). The exact trigger of CRPS after an injury is not known, but it may be due to abnormal interactions between the central and peripheral nervous systems and/or inappropriate inflammatory responses. There are multiple factors that may contribute to CRPS development, including immobilization, alterations to the nervous system of the body, and inflammation. Genetic factors and psychological factors, such as anxiety, depression, and anger, may also contribute to the symptoms of CRPS. However, there is no evidence that CRPS is a disease that can be caused by genetic factors alone, and the role of psychological factors in CRPS development remains unproven. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CRPS is treated by approaching it from different areas: physical therapy (PT), occupational therapy (OT), medications for pain management, neuromodulation through implantable devices, and/or nerve blocks targeting the sympathetic chain. Neridronate and zoledronate D,L-lysine monohydrate (ZLM) has been designated as an orphan drugs for the treatment of CRPS in 2013 and 2015, respectively. However, neither of them has been approved. Thus, there is no current FDA-approved drug for CRPS.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Clinical Studies of LDN on CRPS</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LDN has been widely used for chronic pain and inflammatory condition and has been shown to alleviate symptoms of pain in patients with chronic pain. A number of case studies have also reported positive effects for LDN in the treatment of CRPS. Chopra et al. reported 2 patient case studies with CRPS who experienced significantly less pain with 4.5 mg daily LDN treatment (Chopra and Cooper 2013, Treatment of Complex Regional Pain Syndrome (CRPS) using low-dose naltrexone (LDN). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">J Neuroimmune Pharmacol</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3): 470-476). The remission of pain and dystonic spasms in Case 1, as well as remission of all CRPS symptoms (including fixed dystonia) in Case 2, provide evidence that a multi-modal interventional approach, which includes low-dose Naltrexone (a known glial attenuator), should be considered as a treatment option for the treatment of CRPS patients, particularly those patients with dystonic movement disorders. In another CRPS case study, Sturn and Collin found alleviation of pain symptoms as early as 2 days after beginning LDN therapy, with significantly less pain at 4 weeks (Sturn and Collin 2016, Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Int J Pharm Compd</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">20</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3): 197-201). Weinstock et al reported alleviation of pain symptoms within one month of LDN treatment, with complete remission of CRPS leg symptoms by 16 months (Weinstock, Myers et al. 2016, Identification and Treatment of New Inflammatory Triggers for Complex Regional Pain Syndrome: Small Intestinal Bacterial Overgrowth and Obstructive Sleep Apnea. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">A A Case Rep</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9): 272-276). In a recent case study, an CRPS patient was able to discontinue gabapentin and amitriptyline via the use of LDN, while simultaneously achieving superior pain relied (Soin, 2021, Management of pediatric complex regional pain syndrome with low-dose naltrexone. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pain Medicine Case Reports, 5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3), 109-113). LDN has been reported to have benefits related to other symptoms of chronic pain syndromes as well, including dystonic spasms, CRPS flares, energy, sleep disturbances, and mood.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Systematic literature review of LDN use showed that the most commonly reported AEs with LDN use were dizziness, vomiting, nausea, and vivid dreams (Soin et al. 2021, Low-Dose Naltrexone Use for Patients with Chronic Regional Pain Syndrome: A Systematic Literature Review. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Pain Physician</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4): E393-E406.). Other reported AEs included headaches, abdominal pain, gastrointestinal issues, peripheral edema, restlessness, falls, somnolence, irritability, hematological abnormalities, urinary infection, difficulty concentrating, anxiety, sleepiness, hot flashes/sweating, tachycardia, depression, muscle and joint pain, fatigue, tinnitus, heartburn, dry mouth, and joint pain. Another systematic review also evaluated occurrence of adverse events (AEs) and serious adverse events (SAEs) with LDN use and found that only mild AEs reported among the included studies (89 studies), including nausea, vomiting, and dizziness (Bolton, Hodkinson et al. 2019, Serious adverse events reported in placebo randomized controlled trials of oral naltrexone: a systematic review and meta-analysis. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">BMC Med</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1): 10). Although 119 patients reported at least one SAE in the naltrexone study arm, meta-analysis found no difference between occurrence of SAEs in naltrexone and placebo groups. Furthermore, secondary analysis found only 6 AEs that were statistically significant: decreased appetite, dizziness, nausea, sleepiness, sweating, and vomiting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Efficacy of low-dose naltrexone treatment on CRPS</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:14.203%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.508%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Author (year)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Symptoms</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Symptoms alleviated</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Time to alleviation of symptoms</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dose</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AEs and SAEs</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chopra et al (2013)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">swelling, allodynia, color change, temperature change, some weakness, blisters, skin ulceration, dystonic spasms, dysesthesia</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dystonic spasms, CRPS flares, energy, pain tolerance, sleep disturbances, pain, mood</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&lt; 2 months</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.5 mg/day</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sturn et al (2016)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pain</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pain</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 days</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.5 mg</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weinstock et al (2016)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Severe leg pain, episodic pain in arms and nose, asymmetric and shiny skin with fluctuating temperature changes, color change, edema, IBS, atypical chest pain and fatigue, edema, blue discoloration, tenderness, joint hypermobility with EDS diagnosis</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leg and bowel symptoms; all CRPS pain, bowel symptoms, and fatigue</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&lt; 1 month</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.5 mg/day</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Orphan Drug Designation</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An orphan disease is a rare disease affecting fewer than 200,000 people in the US. It is often a serious or fatal condition for which there are no effective therapies. In 1983, the Orphan Drug Act was passed to incentivize companies to develop drugs for patients with rare diseases. Orphan drug designation provides incentives to companies, including:</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Tax credits for qualifies clinical trials</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Exemption from user fees</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Potential for seven years of market exclusivity after approval</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, given the small number of patients with a disease and the severity of the disease, approvals are often granted with fewer and smaller trials, saving costs and time. JAN123 was granted Orphan Status for the treatment of CRPS.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Clinical Development Plan</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LDN can be rapidly developed in the US via the 505(b)(2) regulatory pathway. This pathway is used for candidates that contain drugs that are already approved but come in a dosage form or delivery system that is different than the original, approved product. In this case, JAN123 fits these criteria perfectly. LDN has the added benefit of being developed at a much lower dose (&lt; 5 milligrams) compared to approved naltrexone products, which are 50 milligrams per tablet. Therefore, it is likely that product development will consist of the following general steps:</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Manufacturing and approval of clinical batches of LDN tablets prior to clinical studies; </span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Phase I pharmacokinetic study(ies) to confirm the release profile of LDN; and</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">A single Phase III study to demonstrate efficacy in CRPS. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A protocol synopsis of the development plan is presented below: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:71.325%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Title of study </span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Phase I: The Pharmacokinetincs of LDN in the fed and fasted state of a Single Oral Dose of LDN, 4 mg <br/>Phase III: Double-Blind Placebo-Controlled Trial of Low-Dose Naltrexone to Treat Complex Regional Pain Syndrome (CRPS)</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Clinical Phase </span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Phase I: The Pharmacokinetincs of LDN in the fed and fasted state <br/>Phase III: Registration/Efficacy Study to hopefully facilitate an NDA application for the use of low-dose naltrexone to treat CRPS</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:71.325%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Objectives:</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Phase I: To determine pharmacokinetics of single oral low-dose naltrexone in healthy participants in fasting and fed state<br/>Phase3: The primary objective is to assess the efficacy of low-dose naltrexone in treating complex regional pain syndrome symptoms (CRPS).<br/>We plan to conduct a double-blind, randomized, placebo-controlled trial to treat CRPS using low-dose naltrexone.<br/>For Efficacy: <br/>1- Assess daily NRS (numerical pain scale 0 &#8211; 10) scores through the 3-month study<br/>2- Study the possible changes or improvement in the Brief Pain Inventory (BPI) and Oswestry Disability Index (ODI) over the three-month study<br/>For Safety:<br/>We will also monitor safety labs on enrollment and termination of the study. However, we would like to point out that this drug has been available and FDA approved at much higher doses (50 &#8211; 150mg or higher) orally with a long-standing proven safety track record. The drug has been available with multiple different embodiments, route of administration and at much higher doses for quite a long time and the safety of the drug has already been extensively established and published.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investigational product </span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">JAN123</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Study Design</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Phase 1: Single-center, dual-arm, cross-over, open-label study <br/>Phase 3: Study Description<br/>We plan to conduct a randomized, double blind placebo controlled trial to treat Complex Regional Pain Syndrome. The study duration will be three months long. Patients in the treatment group will receive a single tablet for the first month of a 2mg dose of Naltrexone. Then, after 1 month, the patient will take 2 tablets for a total of 4mg for months 2 and 3. Study conclusion will be after 3 months.<br/>Patients in the placebo group will take a single tablet for 1 month followed by 2 tablets for month 2 and 3. <br/>A total number of 200 patients with a 1:1 randomization will used. Since CRPS is an orphan disease, we will likely have to use a total of 25 clinical sites or more to be able to adequately recruit the study.<br/>Safety labs will be completed prior to first dose and upon study completion.<br/>For clinical efficacy, we will be assessing daily NRS (1-10) pain scores, a brief pain inventory (BPI) at enrollment and at months 1, 2, and 3 (study completion) and Oswestry Disability Index (ODI) at enrollment and at months 1, 2, and 3 (study completion). Statistically significant improvement in pain scores or any scales in the BPI or ODI are desired outcomes.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Treatment Regimen and Route of Administration</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Study Drugs are as follows:<br/>Phase I: Single Oral dose of JAN123, 4 mg given on separate days with and without food separated by a washout period of no less than 7 days<br/>Phase III: Patients will be dosed with either the low-dose naltrexone or placebo for three months. Initially for the first month patients will take 1 tablet at bedtime (typically in the evenings) for the first month and then increase to 2 tablets for month 2 and 3. Specifically the Naltrexone will be 2mg tablets, such that for the first month with the 1 tablet per day the patient will be on 2mg doses and subsequently increase to 2 tablets in the evening for a total of 4mg.</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Duration of treatment: </span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Phase I: One day for each dose. Two doses of 2 mg each, in total, separated by a washout period of no less than 7 days.<br/>Phase III: This will be a 3 month trial or approximately 90 days. Upon enrollment, patients will be on either low-dose naltrexone or placebo for 90 days.<br/>Participant duration is expected to be 121 days, and at the conclusion of the study (approximately day 90 post-treatment) patients will come in for a final site visit to complete remaining surveys and within 7 days of completion the patients will obtain final safety labs which are anticipated to be a complete blood count and a comprehensive metabolic panel. Since Naltrexone is non-opioid based and does not have withdrawal issues, patients can immediately discontinue the therapy without concerns. As referenced earlier, the safety of Naltrexone orally is already well established and our tested doses are low.</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:71.325%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of Centers </span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Phase 1: Single Center Clinical Trial<br/>Phase 3: Multicenter Clinical Trial<br/>Likely 25 total sites. Keeping in mind this is an Orphan Disease state and recruitment may be quite difficult, we feel the need to have 25 clinical sites to enroll 200 patients.<br/>Clinical sites will be likely Pain Management Centers, both academic and private practice facilities that have access to patients who suffer from CRPS and also include local PIs who have the skill set and ability to properly diagnose CRPS. <br/>Local or regional clinical trial coordinators will be assigned to each site as well.<br/>Enrolling participants are those who meet the diagnosis criteria of CRPS. Typically CRPS is diagnosed using the Budapest Criteria. Age range of 18 - 65 for enrollment, negative pregnancy test, and stable therapy for 3 months.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subjects:</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Phase I: Adult male and female healthy subjects, 18-65 years of age, satisfying all inclusion and exclusion criteria.<br/>Phase III: Patients diagnosed with CRPS (Complex Regional Pain Syndrome), Adult male and female patients, 18-65 years of age.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of <br/>Subjects</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Phase I: 10 patients<br/>Phase III: 200 patients</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Endpoints</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Phase1: Primary Outcome Measure:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PK profile for low-dose naltrexone (Time Frame: Day 1: predose and at multiple time points after low-dose naltrexone administration).</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">max</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Maximum observed plasma concentration)</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">max</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Time to reach maximum plasma concentration)</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">AUC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">0-t</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Area under the plasma concentration-time curve from 0 hour to the time of the last quantifiable concentration)</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">AUC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">0-inf</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Area under the plasma concentration-time curve from 0 hour extrapolated to infinity)</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">CL/F (Oral clearance) </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Phase 3: </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Primary Outcome Measure: Improvement in NRS pain scores over a 3-month time period.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Secondary Outcome Measure: Improvement in Brief Pain Inventory and Oswestry Disability Index (ODI) or other verified pain scales.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">End of Study will occur upon completion of the 90-day trial of the low-dose naltrexone or placebo. It is expected that patients will complete all required surveys and testing requirements of the study. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Early termination is also a possible way to end the study due to issues such as side effects, adverse events or patient desire to withdraw from the study, among other reasons.</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Safety<br/>Assessments </span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Standard clinical evaluation and objective measures will be employed to monitor and assess safety during the conduct of the trial. Furthermore, the results of safety assessments will be used during the trial to monitor and protect the safety of enrolled subjects. Strict subject and study stopping criteria will be implemented to protect the subject's well-being.</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Intellectual Property</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The composition of Naltrexone is off-patent and generic versions of the drug are available at 50 mg doses. LDN has been routinely compounded in compounding pharmacies and used clinically off-label. However, the 4.5 mg compounded tablets are associated with sleep disturbances, manifested in vivid and lucid unpleasant dreams. For these reasons, JAN-123 was developed as a biphasic release, orally available tablet to reduce the likelihood of unpleasant dreams. A provisional patent was filed in December 2020 and converted to a PCT application in November 2021 (Pub. No. US 2022/0202807 A1). US Patent number 11,752,143 B2 issued on September 12, 2023.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The issued claims in this patent cover the use of the biphasic LDN formulation for treatment of patients with chronic pain. In addition, claims are made to the titration of the LDN for treating chronic pain. While there is no guarantee that the pending applications or future pending claims will issue, the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issued US patent will provide protection of JAN123 through 2040 and the Orphan Drug Designation provides 7 years of market exclusivity after drug approval in the event that there are any challenges to this patent.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Trade Secrets and Other Proprietary Information</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to patents, we rely on trade secrets and know-how to develop and maintain our competitive position. For example, we have developed methods for more efficient manufacture of the biphasic LDN. We seek to protect our proprietary information, in part, by confidentiality agreements and invention assignment agreements with our employees, consultants, scientific advisors, contractors, and commercial partners.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Soin Purchase Agreement</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 28, 2022, we entered into a Purchase Agreement (the &#8220;Soin Purchase Agreement&#8221;) with Soin Therapeutics, LLC. Under the Soin Purchase Agreement, ALT5 Sigma Corporation acquired Soin Therapeutics and its LDN product, now known as JAN123. This all- stock transaction has a value of $13M, with up to an additional $17M depending on revenues generated by the product, for a total value of up to $30M. The transaction includes restrictions on the maximum number of shares of preferred stock and common stock that can be issued to or transferred by Soin Therapeutics at any given time.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Our Team</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tony Giordano, Ph.D.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our Chief Scientific Officer, joined the Company in December 2019 from the Cleveland Clinic, the No.2 rated hospital in the country, where he served as Senior Director of Special Projects in the Business Development group. Dr. Giordano has extensive experience in drug development, having served as Vice President or President of seven different biotechnology companies he co-founded, including companies developing platform technologies, a cancer vaccine, and Alzheimer&#8217;s Disease and cardiovascular therapies. He has managed numerous clinical trials and the launch of a medical food product. Dr. Giordano has also served as an Associate Professor and Assistant Dean of Research and Business Development at LSU Health Sciences Center in Shreveport, Louisiana (&#8220;LSU Health Shreveport&#8221;), at which he led the licensing efforts at the campus and at Abbott Labs, where, in addition to serving as a Senior Research Scientist, he was involved in technology assessment activities. Dr. Giordano has a Ph.D. focused in Molecular Genetics from The Ohio State University and completed Fellowships at the NIH National Cancer Institute and the NIH National Institute of Aging.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">JAN101</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Generally</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">JAN101, formerly known as TV1001SR, is a patented oral, sustained-release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities, such as those with vascular complications of diabetes or PAD and treats pain. A conclusion from a round of human studies found JAN101 prevents the prevalent reports of headaches by patients treated with an immediate release formulation of sodium nitrite. In a previous study of patients with PAD, a 40 mg BID treatment with immediate release sodium nitrite led to a statistically significant reduction in reported pain, while an 80 mg BID treatment had a more pronounced effect on bioactivity and Flow Mediated Dilation, a measure of vascular function. However, a number of subjects in both treatment groups reported headaches and dizziness following treatment. Although this did not result in subjects discontinuing treatment, JAN101 was developed to overcome this side effect. JAN101 was tested in a bridging study of diabetic neuropathy subjects and, during that bridging study, the subjects did not report headaches or dizziness. Subjects in this bridging study also reported less pain following treatment and improvements in bioactivity (quantitative sensory testing, a measure of nerve function) were similar to the PAD study, where the 80 mg dosing group had the greatest improvement in Flow Mediated Dilation. The ability to alleviate pain with BID treatment of JAN101 offers promise for a new non-addictive, non-sedating treatment of chronic pain.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Clinical Studies in Humans JAN101 Attributes</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Well-established safety profile</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Excellent bioavailability</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Lack of induced tolerance</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Non-narcotic</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">JAN101 does not mask pain, but instead treats the cause of pain by improving tissue and vascular function.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Benefits of Sodium Nitrite on Vascular Health</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In initial research studies, sodium nitrite effectively restored ischemic tissue blood flow and was effective in a wide range of pathologies involving alterations of angiogenesis &#8211; development of new blood vessels &#8211; including diabetes, wound healing, and tissue necrosis. Beneficial effects include enhancing angiogenesis, endothelial cell proliferation, and arteriogenesis. There is also a strong association between reduced circulating nitrite levels and cardiovascular diseases in humans. We describe some of the associations and beneficial effects of sodium nitrite/nitrite below.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Plasma nitrite levels are negatively correlated to cardiovascular disease</span></div><div style="margin-top:12pt"><img src="alts-20241228_g4.jpg" alt="Annotation 2023-05-27 120434.jpg" style="height:194px;margin-bottom:5pt;vertical-align:text-bottom;width:416px"/></div><div style="margin-top:12pt;text-align:justify"><img src="alts-20241228_g5.jpg" alt="img253501747_1.jpg" style="height:192px;margin-bottom:5pt;vertical-align:text-bottom;width:143px"/></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plasma nitrite levels were inversely related to number of cardiovascular risk factors a subject had and decreased plasma nitrite was associated with decreased flow mediated vasodilation (FMD) and increased intimal medial thickness (IMT) (both are indicators of vascular pathology). Kleinbongard, et al. (2006) Free Radic Biol and Medicine 40:295-302. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Plasma nitrite levels are reduced in diabetic and PAD patients </span></div><div style="margin-top:12pt;text-align:justify"><img src="alts-20241228_g6.jpg" alt="Annotation 2023-05-27 120832.jpg" style="height:286px;margin-bottom:5pt;vertical-align:text-bottom;width:368px"/></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercise is a well-known stimulator of endothelial nitric oxide synthase activity, an enzyme that enhances nitric oxide (NO) production, which leads to increased plasma nitrite. In the study by Allen, et al., these authors revealed that baseline plasma levels of nitrite were less in patients with diabetes mellitus (DM) or DM + PAD. Importantly, increases in plasma nitrite levels were not observed in either DM, PAD, or DM + PAD patients after supervised exercise. These data reveal that baseline nitrite availability is compromised in DM patients and that supervised exercise is unable to increase plasma nitrite levels but actually results in a decrease</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in nitrite, highlighting a physiological efficiency of this molecule. Allen, et al., Nitric Oxide 2009 20:231-2377. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Skeletal Muscle Nitrite and Metabolite Levels are Reduced in Critical Limb Ischemia (CLI) Patients</span></div><div style="margin-top:12pt;text-align:justify"><img src="alts-20241228_g7.jpg" alt="Annotation 2023-05-27 120945.jpg" style="height:301px;margin-bottom:5pt;vertical-align:text-bottom;width:436px"/></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skeletal muscle nitrite, nitrosothiol (RSNO), nitric oxide-heme, and cGMP are all significantly reduced in CLI (the most severe form of PAD) patients. Diabetic patients with CLI show even further nitrite reductions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In summary, nitrite levels in various cardiovascular and vascular diseases appear to be inversely related to the severity of the disease in humans:</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Lower nitrite levels are associated with higher level of heart failure; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Lower nitrite levels are observed in diabetic patients with PAD and are not compensated by exercise; and</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Nitrite levels are lower in the muscles of patients with critical limb ischemia and are further reduced in diabetic subjects with critical limb ischemia. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the association between low levels of circulating nitrite and human diseases, supplementation with sodium nitrite has been studied preclinically in animals. Below are summaries of some of the more important findings: </span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Promotes angiogenesis </span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Stimulates wound healing</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Prevents tissue necrosis</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From Arya, et al. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nitrite Therapy Selectively Increases Ischemic Tissue Vascular Density in a NO-dependent Manner</span></div><div style="margin-top:12pt;text-align:justify"><img src="alts-20241228_g8.jpg" alt="Annotation 2023-05-27 121141.jpg" style="height:598px;margin-bottom:5pt;vertical-align:text-bottom;width:432px"/></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chronic sodium nitrite therapy increases ischemic tissue vascular density in a NO-dependent manner. A and B show representative images of CD31 (red) and DAPI nuclear (blue) staining from sodium nitrite and sodium nitrate ischemic gastrocnemius muscle tissue at day 7. C and D report the vascular density of ischemic gastrocnemius muscle tissue at days </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 and 7 for 165 &#956;g/kg sodium nitrite and nitrate treatments, respectively. E and F demonstrate the vascular density of ischemic gastrocnemius muscle tissue at days 3 and 7 from 165 &#956;g/kg sodium nitrite plus carboxy PTIO. (Scale bar, 150 &#956;m.) n = 10 mice per treatment group. Kumar D., et al., PNAS; 2008; 105:7540-7545.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nitrite Therapy Augments Arterial Perfusion of Ischemic Tissue</span></div><div style="margin-top:12pt"><img src="alts-20241228_g9.jpg" alt="Annotation 2023-05-27 121347.jpg" style="height:321px;margin-bottom:5pt;vertical-align:text-bottom;width:660px"/></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chronic sodium nitrite therapy acutely increases ischemic tissue blood flow and stimulates arteriogenesis. A and B report 165 &#956;g/kg sodium nitrite-induced acute changes in blood flow of chronically ischemic tissues at various time points with or without cPTIO, respectively. C reports the number of arterial branches between PBS and nitrite therapies. D and E illustrate vascular casting of the arterial vasculature in ischemic hind limbs of day 7 nitrite or PBS-treated mice, respectively. *, P &lt; 0.01 vs. sodium nitrite. N = 10 mice per treatment group. Kumar D., et.al., PNAS;2008; 105:7540-7545. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nitrite Therapy Restores Diabetic Ischemic Hind-Limb Blood Flow and Promotes Wound Heal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify"><img src="alts-20241228_g10.jpg" alt="Annotation 2023-05-27 121529.jpg" style="height:440px;margin-bottom:5pt;vertical-align:text-bottom;width:429px"/></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unilateral femoral artery ligation was performed on 18-20 week old male Db/Db mice. Mice were randomized to PBS or sodium nitrite (165 &#956;g/kg) therapy twice daily via I.P. injection. Laser doppler flowmetry was performed at the indicated time points. Increased wound dehiscence was noted in the PBS treated animals at day 7 but not in nitrite treated animals. (Bir, et al., Diabetes 2014, 63(1):270-81).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nitrite Therapy Increases Diabetic Ischemia Induced Angiogenesis</span></div><div style="margin-top:12pt"><img src="alts-20241228_g11.jpg" alt="Annotation 2023-05-27 121649.jpg" style="height:343px;margin-bottom:5pt;vertical-align:text-bottom;width:588px"/></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nitrite therapy prevented ischemia mediated endothelial cell density loss in normal C57BL/6J ischemic limbs. Nitrite therapy significantly restored endothelial cell density in ischemic limbs of diabetic mice to normal C57BL/6J levels compared to PBS therapy of non-ischemic and ischemic conditions. These data suggest that nitrite therapy may be useful in attenuating microvascular rarefaction due to loss of nitric oxide that is observed during metabolic dysfunction (Frisbee JC AJP Integr Comp Physiol 2005 289(2):R307-16; Stepp et al Microcirculation 2007 14(4-5): 311-6).</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Delayed Nitrite Therapy Restores Ischemic Hind-Limb Blood Flow</span></div><div style="margin-top:12pt"><img src="alts-20241228_g12.jpg" alt="Annotation 2023-05-27 122116.jpg" style="height:350px;margin-bottom:5pt;vertical-align:text-bottom;width:450px"/></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Studies were performed to determine whether nitrite mediated therapy would be effective in tissue that had been left ischemic for 5 days after femoral artery ligation. Femoral artery ligation was performed in C57BL/6J mice and the animals </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">randomized to either PBS or sodium nitrite therapy 5 days after artery ligation. Treatments were given b.i.d. via I.P. injection. Ischemic limb blood flow was measured using laser doppler flowmetry. (Bir, et al., Diabetes 2014, 63(1):270-81).</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Delayed nitrite therapy increases SPY angiogram arteriogenesis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt"><img src="alts-20241228_g13.jpg" alt="Annotation 2023-05-27 122308.jpg" style="height:580px;margin-bottom:5pt;vertical-align:text-bottom;width:430px"/></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Delayed nitrite therapy increases SPY angiogram arteriogenesis. Representative temporal SPY angiogram image stills (3&#8211;6s) are shown at 11 days following ligation and 6 days after beginning therapy (either PBS or sodium nitrite). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Left</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: PBS control angiogram. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Right</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: sodium nitrite angiogram following injection of ICG. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">n </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">= 5 animals per cohort. Circles identify limb anatomical regions of vascular blush, whereas arrows indicate perfused vessels that progressively occur over time.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bir, et al., Am J Physiol Heart Circ Physiol 2012;303:H178-H188.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nitrite Therapy Prevents Tissue Necrosis in Aged Db/Db Mice</span></div><div style="margin-top:12pt;text-align:justify"><img src="alts-20241228_g14.jpg" alt="Annotation 2023-05-27 122514.jpg" style="height:264px;margin-bottom:5pt;vertical-align:text-bottom;width:500px"/></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Delayed sodium nitrite (165 ug/kg) or control PBS therapy was stated 5 days post-femoral artery ligation in nine-month old Db/Db mice. Nitrite therapy significantly prevented tissue necrosis (panel B) compared to control PBS therapy (panel A). Panel D reports tissue necrosis severity as a function of degree of limb and digit involvement. Nitrite therapy, but not PBS control or sodium nitrate, significantly prevented tissue necrosis. (Bir, et al., Diabetes 2014, 63(1):270-81).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Nitrite and Hind Limb Ischemia Summary</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sodium nitrite has long been known to be a potent vasodilator (transiently increasing blood vessel diameter) that can lead to a drop in blood pressure when given acutely. The above studies indicate that chronic administration at low doses promotes angiogenesis, unlike one-time nitrite therapy, which does not stimulate angiogenesis. In addition, these studies and a large number of other studies not reviewed above show:</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Nitrite therapy is very specific, acting only in damaged, ischemic tissue;</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Delayed nitrite therapy effectively restores ischemic tissue blood flow;</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Nitrite therapy is effective in a wide range of pathologies involving alterations of angiogenesis including critical limb ischemia, heart failure, and tissue necrosis; </span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Nitrite supplementation has had positive effects in various diabetes models, including diabetic nephropathy and diabetic wound healing;</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Beneficial effects center on enhancing angiogenesis, endothelial cell proliferation, and arteriogenesis; and</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Sustained release nitrite therapy, unlike immediate release therapy, does not lead to vasodilation or a drop in blood pressure.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">JAN101</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">JAN 101 is designed to treat diseases associated with poor vascular function. The following table summarizes our current product candidate:</span></div><div style="margin-top:12pt;text-align:justify"><img src="alts-20241228_g15.jpg" alt="Annotation 2023-05-27 122643.jpg" style="height:81px;margin-bottom:5pt;vertical-align:text-bottom;width:500px"/></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">According to a research study by Stanford University, more than 24% of patients with PAD are at risk of high opioid use. By treating pain at the source and presenting patients and physicians with better and safer treatment alternatives, we expect to minimize opioids at the prescription pad.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Peripheral artery disease</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Peripheral artery disease (&#8220;PAD&#8221;) is a general term for conditions in which arterial blood flow to the limbs is partially blocked. When there is less blood present in the extremities relative to demand, muscle pain and fatigue result, especially in the calf, which is also known as &#8220;intermittent claudication.&#8221; In many patients, pain and fatigue are relieved through rest. Roughly half of patients with PAD are asymptomatic. The most common cause of PAD / intermittent claudication is atherosclerosis. Diabetes, chronic kidney disease, hypertension, and smoking are all risk factors that can increase the likelihood of PAD. In atherosclerosis, fat deposits (plaques) build up along arterial walls, resulting in a reduction in blood flow in the legs. This same process can cause strokes if the arteries leading up to the brain are affected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the high rate of asymptomatic patients, prevalence figures vary widely. Some estimate that up to 200 million people worldwide have PAD, ranging from asymptomatic disease to severe. Prevalence increases as a function of patient age, rising sharply after the age of 60. Thus, in countries with an aging population, it is expected that the prevalence of PAD will only increase. There is also a strong ethnic and racial component to PAD prevalence, which may be due to cultural differences in diet and exercise, along with genetic differences. Some suggest a prevalence of eight to 12 million in the United States alone, with roughly one-third experiencing pain when walking, which improves upon resting. The diagnosis of PAD usually begins with patient complaints of pain in the extremities. If the patient is already being treated or monitored for diabetes or other risk factors, then the physician will check for a weak or absent pulse in the extremity. Decreased blood pressure, poor wound healing, and whooshing sounds (via stethoscope) in the legs are also tell-tale signs of PAD / intermittent claudication. Angiograms, electrocardiograms, and ultrasounds can also be used to image and confirm the diagnosis.</span></div><div style="margin-top:12pt;padding-left:36pt"><img src="alts-20241228_g16.jpg" alt="18870" style="height:300px;margin-bottom:5pt;vertical-align:text-bottom;width:500px"/></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Figure 1: Ethnic-specific prevalence of PAD in men in the US, by age. NHW = Non-Hispanic Whites, <br/>AA = African American, HS = Hispanics, AS = Asian Americans, AI = American Indians. Source: (Criqui, 2015)</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The non-drug treatment of PAD / intermittent claudication may be divided into four general categories:</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:32.5pt">Lifestyle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; Primarily changes in diet and smoking cessation.</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:32.5pt">Exercise </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; Patients who walk, cycle, stretch, or swim can experience marked improvement. Formal programs involving treadmills and track walking (usually three to five times per week) are frequently provided to patients. However, if the pain is triggered by exercise (claudication) and is significant, it can discourage the patient from exercise.</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:32.5pt">Angioplasty </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; A procedure by which the affected artery is stretched with a balloon-like device. This procedure has limited effectiveness and is reserved for severely blocked arteries.</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:32.5pt">Bypass Surgery </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; Arteries that are beyond angioplasty can be bypassed entirely. This procedure is typically reserved for cases where the blockage is considered very long (~10 centimeters) and nearly complete.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underlying condition is not addressed by surgery. Surgical approaches will not, in the long run, improve exercise capacity and walking distance. Only exercise itself, coupled with lifestyle changes and drug approaches, has this benefit. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prescription drugs for the treatment of the underlying PAD may be divided into multiple categories, depending on the underlying condition and severity: </span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:32.5pt">Cholesterol-Lowering Agents &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Statins and bile acid sequestrants. </span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:32.5pt">Antiplatelet Medications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; Aspirin and related drugs, such as clopidogrel. Cilostazol also has antiplatelet properties. </span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:32.5pt">Antihypertensives </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; Patients with underlying high blood pressure can and will receive any number of medications to reduce blood pressure, such as ACE inhibitors and diuretics.</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:32.5pt">Diabetes Therapies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; While a substantial portion of PAD patients may have pre-diabetes or fulminant diabetes, it is unknown if aggressive treatment of diabetes has a positive effect on PAD.</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:32.5pt">Pain </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; To our knowledge, no drugs are specifically indicated for PAD-associated pain. Pentoxifylline, for example, is indicated &#8220;&#8230;for the treatment of patients with intermittent claudication on the basis of chronic occlusive arterial disease of the limbs.&#8221; (Sanofi-Aventis U.S. LLC, 2010). However, the evidence supporting the effectiveness of pentoxifylline is mixed. Short-term courses of NSAIDs, such as ibuprofen, may be used, provided the patient is not on another anticoagulant, like aspirin. Non-drug pain relievers, such as TENS and massage therapy, may also be used in these patients. Opioids may also be used, which creates a risk for addiction and potential misuse at the medicine cabinet by family members.</span></div><div style="margin-top:12pt;text-indent:36pt"><img src="alts-20241228_g17.jpg" alt="img253501747_13.jpg" style="height:325px;margin-bottom:5pt;vertical-align:text-bottom;width:450px"/></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lack of any truly effective treatment of PAD, along with encouraging early trial results using JAN101 on both improving vascular function and reducing pain in PAD patients, has created an opportunity potentially to treat this large unmet medical need. By improving vascular function, JAN101 has the potential to reduce associated pain and improve PAD patients&#8217; quality of life.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Our Strategy</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our focus is to develop and commercialize novel, non-opioid, and non-addictive therapies to address, safely and effectively, the significant unmet medical need of chronic pain or treat conditions that cause pain. The principal elements of our strategy to achieve this mission are the following:</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.5pt">License, acquire, develop, and create novel, non-opioid and non-addictive therapies by leveraging our understanding of pain biology to address the large and growing problem of pain.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> While innovation in medical sciences has led to exciting new treatment options in many disease areas, pain has seen limited innovation in recent years. We have a deep understanding of the pathophysiology of pain and diseases that cause pain. We intend to leverage this understanding to bring innovation in the pain treatment paradigm through targeted acquisitions of companies or assets in development. Our advisors and doctors have years of collective experience in leadership positions at institutions and substantial scientific experience and understand the complexity of designing and executing clinical trials for and developing therapies.</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.5pt">Leverage our management team background and expertise. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have assembled a team with extensive experience described above. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Current Therapeutic Approaches to Treating Chronic Pain and Their Limitations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">NSAIDs</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the most widely used therapies to treat chronic inflammatory pain are non-steroidal anti-inflammatory drugs (&#8220;NSAIDs&#8221;). NSAIDs can have significant side effects that include gastrointestinal bleeding, gastritis, high blood pressure, fluid retention, kidney problems, heart problems, and rashes. On April 7, 2005, the FDA announced a decision to require boxed warnings of potential cardiovascular risk for all NSAIDs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Corticosteroids</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corticosteroids, or steroids, also possess anti-inflammatory properties and are commonly used in the practice of pain management, either systemically or locally, depending on the condition. Steroids work by decreasing inflammation and reducing the activity of the immune system. While steroids are commonly used, they may have numerous and serious side effects. These side effects may include allergic or hypersensitivity reactions, increased risk for infection, adrenal insufficiency, diabetes or decreased glucose tolerance, hypertension, loss of bone density, and loss of joint cartilage volume. In addition, steroids should not be administered when there is an infection present because steroids can inhibit the body&#8217;s natural infection-fighting immune response. Also, if a joint is already damaged or is subject to chronic deterioration, intra-articular, or IA steroid injections are not likely to provide any long-term restorative benefit. For the above reasons, IA steroid injections are generally recommended to be administered no more often than every six weeks and not more than three to four times per year.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Opioids</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Opioids are some of the most widely prescribed therapeutics for chronic and acute pain, and sales of these drugs have quadrupled between 1999 and 2010. According to a National Survey on Drug Use and Health report, in 2016 more than one-third of adult Americans were prescribed opioids and 230 million opioid prescriptions were written that year in the United States. Opioids act by binding to specific receptors located on neurons in both the central and peripheral nervous system throughout the body including in the brain, spinal cord, and other nervous tissue. Although they can be effective in providing pain relief, the increased medical use of opioids has been accompanied by an increase in the abuse and misuse of prescription opioids. In addition, for most patients, chronic opioid use is a poor option due to an intolerance to the many side effects, including nausea, vomiting, drowsiness, and constipation, and the propensity for opioids to become less effective with long-term use. According to the Centers for Disease Control and Prevention (the &#8220;CDC&#8221;), almost two million individuals abused or were dependent on prescription opioids in 2014. CDC figures show that the number of opioid-related overdose deaths has quadrupled between 1999 and 2010, and currently approximately 40% of opioid overdose deaths in the United States involve a prescription opioid. This increase in prescription opioid-related deaths in the United States prompted former President Trump to declare the opioid crisis a national Public Health Emergency in October </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2017. Opioid abuse has become an epidemic in the United States, ranking as the nation&#8217;s second most prevalent illegal drug problem. These major issues create the need to find new approaches to treating chronic pain.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Our Approach to Treating PAD and Chronic Pain</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unmet medical need for treating PAD and chronic pain reflects the historic failure to develop novel classes of analgesics with comparable or greater efficacy, an acceptable level of adverse effects and a lower abuse liability than those currently available. Some of the reasons for this include the heterogeneity of chronic pain and its related conditions, and the complexity and diversity of the underlying pathophysiological mechanisms for pain. However, recent advances in the understanding of the neurobiology of pain are beginning to offer opportunities to identify new drug targets and develop new therapeutic strategies.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have taken an innovative and targeted approach to identifying treatments for chronic pain that leverages our understanding of the pathophysiology of pain. Pain is variable. For example, it can be inflammatory or neuropathic in nature, and it may be localized to a specific area of the body or it may be generalized throughout. We believe that the most effective way to treat chronic pain is through therapies that specifically target the origin of the pain signal. We strive to maximize JAN 101&#8217;s potential based on its unique mechanism of action related to the origin of the pain signal.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A Randomized, Double-Blind Study of the Effects of a Sustained Release Formulation of Sodium Nitrite (SR-nitrite) on Patients with Diabetic Neuropathy</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Background:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Sodium nitrite has been reported to be effective in reducing chronic peripheral pain.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Objectives:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> To evaluate the safety and efficacy of 40 and 80 mg, BID, of an oral sustained-release formulation of sodium nitrite (SR-nitrite) in patients suffering from diabetic neuropathy, and to determine whether SR-nitrite would reduce the frequency of headaches reported previously by subjects receiving the same doses of an immediate release formulation. Study Design: Phase II, single-center, randomized, double-blind, placebo-controlled clinical trial. Setting: The Ohio Pain Clinic and Kettering Medical Center.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Methods:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Twenty-four patients were randomized to 40 mg or 80 mg SR-nitrite or placebo twice daily for 12 weeks. The primary objective was to determine whether headaches would be reduced using SR-nitrite. The primary efficacy endpoint was the mean difference in the change of the Neuropathic Pain Symptom Inventory (NPSI) pain score from baseline to that reported after 12 weeks of treatment. Secondary endpoints included changes from baseline for the Brief Pain Inventory (BPI) Scale, the RAND 36 questionnaire, Short-Form McGill Questionnaire, daily patient reported score for neuropathic pain, changes in HbA1c, PulseOx, and quantitative sensory testing. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The number of subjects reporting adverse events and the number of adverse events did not change with dose. There were no reports of treatment-related headaches. Although no significant differences were identified in patient responses to the questionnaires, a trend was observed. In the NPSI assessment, patients in the 40 mg and 80 mg dosing groups reported a 12.7% and 22.0% reduction in pain, respectively, compared to an 8.4% reduction by patients in the placebo group. A trend was also observed with the BPI total severity score. However, the 40 mg dosing group reported the greatest reduction in pain using the McGill Pain index and via patient logs of daily pain scores, where the mean of pain scores reported by subjects in the 40 mg group dropped by day 41 and generally stayed lower than the mean of scores reported by subjects in either of the other two groups. Patients in the 80 mg SR-nitrite group had an improvement in both Nerve Sensory Conductance and Nerve Sensory Velocity. No changes were observed in HbA1c levels or PulseOx.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Limitations:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Small sample size.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Conclusion:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Sustained release sodium nitrite prevents the prevalent reports of headaches by patients treated with an immediate release formulation of sodium nitrite. In a previous study of patients with peripheral arterial disease (PAD), 40 mg BID treatment led to a statistically significant reduction in reported pain. Similar trends were observed at the end of the trial period for most of the pain questionnaires used in the study. The 80 mg BID treatment had the more pronounced effect on bioactivity (quantitative sensory testing), which was similar to the PAD study, where this dosing group had the greatest improvement in Flow Mediated Dilation . The ability to alleviate pain with BID treatment of SR-nitrite offers promise for a new non-addictive, non-sedating treatment of chronic pain and warrants further study.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">JAN101&#8212;Regulatory Strategy</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sodium nitrite has been previously approved as one of the active components of cyanide poisoning antidote. This means the approval path for JAN101 is likely through a 505(b)(2) (&#8220;NDA&#8221;).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">JAN101&#8212;Commercial Strategy</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently intend to use third-party providers and manufacturers to support the commercialization JAN101, if we are successful in obtaining FDA approval. We believe that we can promote JAN101 to the patients suffering from PAD in a cost effective manner. We anticipate our commercial operation will include outside sales management, outside sales support, distribution support, and an internal marketing group. Additional requisite capabilities will include focused management of key accounts, such as managed-care organizations, group purchasing organizations, and government accounts. We intend selectively to partner with third parties with vast experience in the space, as we have been partnering for every aspect of development. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Competition</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The biotechnology and pharmaceutical industries are characterized by extensive research and development efforts, rapidly advancing technologies, intense competition, and a strong emphasis on proprietary products. We are currently focused on the development and commercialization of our asset pipeline of novel, non-opioid, and non-addictive therapies for PAD. The number of patients suffering from chronic PAD is large and growing. While we believe that JAN 101 and our Chief Scientific Officer&#8217;s development experience and scientific knowledge provide us with competitive advantages, we face potential competition from many different sources, including pharmaceutical, biotechnology, and specialty pharmaceutical companies that market or develop therapeutics to treat chronic pain. Academic research institutions, governmental agencies, as well as public and private institutions are also potential sources of competitive products and technologies. Our competitors may have significantly greater financial resources, robust drug pipelines, established presence in the market, and expertise in research and development, manufacturing, pre-clinical and clinical testing, obtaining regulatory approvals and reimbursement, and marketing approved products than we do. These competitors also compete with us in recruiting and retaining qualified clinical, regulatory, scientific, sales, marketing, and management personnel, establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. The key competitive factors affecting the success of JAN 101 (as well as other subsequent product candidates), if and when approved, is likely to be its efficacy, durability, safety, price, and the availability of reimbursement from government and other third-party payors.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant competition exists in the PAD pain field. Although we believe our approach to developing novel treatments for pain is unique from most other existing or investigational therapies, such as NSAIDs, corticosteroids, and opioids, we will need to compete with all currently available and future therapies within the indications where our development is focused. With respect to JAN101, the main classes of marketed products that are available for the treatment of PAD pain include NSAIDs and opioids. Furthermore, numerous monoclonal antibodies targeting nerve growth factor, or NGF inhibitors, are in clinical development, including two product candidates in Phase III.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a number of companies developing or marketing therapies for the treatment and management of pain that may compete with JAN 101, including many major pharmaceutical and biotechnology companies.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Intellectual Property</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends in large part upon our ability to obtain and maintain proprietary protection for our products and technologies, and to operate without infringing or otherwise violating the proprietary rights of others. We endeavor to protect our products using a combination of intellectual property protections and available government regulatory and marketing exclusivities afforded to new medicines. For example, we endeavor to protect our products by, among other methods, filing United States and foreign patent applications related to our proprietary technology, inventions, and improvements that are important to the development and implementation of our business. We also use other forms of protection, such as confidential information, trade secrets, and know-how, and trademarks to protect our intellectual property, particularly where we do not believe patent protection is appropriate or obtainable.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The proprietary nature of, and protection for, JAN 101, processes, and know-how are important to our business. Our policy is to pursue, maintain, and defend intellectual property rights, and to protect the technology, inventions, and improvements that are commercially important to our business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Trade Secrets and Other Proprietary Information</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to patents, we rely on trade secrets and know-how to develop and maintain our competitive position. For example, we have developed methods for more efficient manufacture of sustained released sodium nitrite tablets. We seek </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to protect our proprietary information, in part, by confidentiality agreements and invention assignment agreements with our employees, consultants, scientific advisors, contractors, and commercial partners.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">License Agreement</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 19, 2019, we entered into a Patent and Know How License Agreement (the &#8220;License Agreement&#8221;) with UAB Research Foundation (&#8220;UABRF&#8221;), TheraPAD, and the Board of Supervisors of Louisiana State University and Agricultural and Mechanical College, acting on behalf of LSU Health Shreveport, together with UABRF and TheraPAD collectively, the &#8220;Licensors&#8221;). Under the License Agreement, the Licensors have agreed to grant to ALT5 Sigma Corporation an exclusive, worldwide license, including the right to sublicense, to the Licensors&#8217; patent rights and know-how related to the Licensors&#8217; sustained release formulation of sodium nitrite. Under the License Agreement, we have agreed to pay a non-refundable upfront license fee and certain milestone payments upon the achievement of certain milestones of up to approximately $6.5 million and certain royalty payments and annual license maintenance fees. The License Agreement requires us to use commercially reasonable efforts to develop and commercialize JAN101. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Commercial Operations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently do not have any marketing and sales organization dedicated to the Biotechnology segment. We have retained global rights to JAN-101 and JAN123, and, if either of them or one of our potential subsequent product candidates is approved by the FDA to market in the United States, we expect that our sales force will be supported by sales management, internal sales support, an outside marketing group, and distribution support. We intend to invest in our commercial capabilities prudently by focusing our marketing efforts on the physician subspecialties that treat patients. These physicians include, but are not limited to, pain management specialists, rheumatologist, surgeons, and sports medicine physicians. We will also evaluate licensing and partnering with third parties to help us reach other sales channels and geographic markets inside and outside of the United States.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Government Regulation</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA and comparable regulatory authorities in state and local jurisdictions and in other countries impose substantial and burdensome requirements upon companies involved in the clinical development, manufacture, marketing, and distribution of drugs, such as those we are developing. These agencies, and other federal, state, and local entities regulate, among other things, the research and development, testing, manufacture, quality control, safety, effectiveness, labeling, storage, record keeping, approval, advertising and promotion, distribution, post-approval monitoring and reporting, sampling, and export and import of product candidates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">U.S. Government Regulation of Drug Products</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, the FDA regulates drugs under the Federal Food, Drug, and Cosmetic Act (the &#8220;FDCA&#8221;) and its implementing regulations. The process of obtaining regulatory approvals and the subsequent compliance with applicable federal, state, local, and foreign statutes and regulations requires the expenditure of substantial time and financial resources. Failure to comply with the applicable United States requirements at any time during the product development process, the approval process, or thereafter, may subject an applicant to a variety of administrative or judicial sanctions, such as the FDA&#8217;s refusal to approve pending applications, withdrawal of an approval, imposition of a clinical hold, issuance of warning letters, product recalls, product seizures, total or partial suspension of production or distribution, injunctions, fines, refusals of government contracts, restitution, disgorgement, or civil or criminal penalties.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The process required by the FDA before a drug may be marketed in the United States generally involves the following:</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">completion of pre-clinical laboratory tests, animal studies, and formulation studies in compliance with the FDA&#8217;s good laboratory practice (&#8220;GLP&#8221;), regulations;</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">submission to the FDA of an Investigational New Drug Application (&#8220;IND&#8221;), which must become effective before human clinical trials may begin;</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">approval by an institutional research board (&#8220;IRB&#8221;) at each clinical site before each trial may be initiated;</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">performance of adequate and well-controlled human clinical trials in accordance with good clinical practice (&#8220;GCP&#8221;) requirements to establish the safety and efficacy of the proposed drug product for each indication;</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">submission to the FDA of a new drug application (NDA);</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">satisfactory completion of an FDA advisory committee review, if applicable;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">satisfactory completion of an FDA inspection of the manufacturing facility or facilities at which the product is produced to assess compliance with current good manufacturing practices (&#8220;cGMP&#8221;) requirements and to assure that the facilities, methods, and controls are adequate to preserve the drug&#8217;s identity, strength, quality, and purity; </span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">satisfactory completion of FDA audits of clinical trial sites to assure compliance with GCPs and the integrity of the clinical data; </span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">payment of user fees and securing FDA and approval of the NDA; and</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">compliance with any post-approval requirements, including the potential requirement to implement a risk evaluation and mitigation strategy (&#8220;REMS&#8221;), and the potential requirement to conduct post-approval studies.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Pre-clinical Studies</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-clinical studies include laboratory evaluation of product chemistry, toxicity, and formulation, as well as animal studies to assess potential safety and efficacy. An IND sponsor must submit the results of the pre-clinical tests, together with manufacturing information, analytical data, and any available clinical data or literature, among other things, to the FDA as part of an IND. Some pre-clinical testing may continue even after the IND is submitted. An IND automatically becomes effective 30 days after receipt by the FDA, unless before that time the FDA raises concerns or questions related to one or more proposed clinical trials and places the clinical trial on a clinical hold. In such a case, the IND sponsor and the FDA must resolve any outstanding concerns before the clinical trial can begin. As a result, submission of an IND may not result in the FDA allowing clinical trials to commence. Clinical holds also may be imposed by the FDA at any time before or during clinical trials, due to safety concerns about on-going or proposed clinical trials, or non-compliance with specific FDA requirements, and the trials may not begin or continue until the FDA notifies the sponsor that the hold has been lifted. Through the 505(b)2 regulatory path, the FDA allows a sponsor to rely on well documented, published studies to support the clinical development of the product. The FDA has indicated that it will accept published data in support of the Company&#8217;s development program for JAN101 but prior to filing an NDA would require the Company to complete developmental and reproductive toxicology studies.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Clinical Trials</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical trials involve the administration of the investigational new drug to human subjects under the supervision of qualified investigators in accordance with GCP requirements, which include the requirement that all research subjects provide their informed consent in writing for their participation in any clinical trial. Clinical trials are conducted under protocols detailing, among other things, the objectives of the trial, the parameters to be used in monitoring safety, and the effectiveness criteria to be evaluated. A protocol for each clinical trial and any subsequent protocol amendments must be submitted to the FDA as part of the IND. In addition, an IRB at each institution participating in the clinical trial must review and approve the plan for any clinical trial before it commences at that institution. Information about certain clinical trials must be submitted within specific timeframes to the NIH for public dissemination on their www.clinicaltrials.gov website. The information contained in, or accessible through, this website does not constitute a part of this Annual Report. We have included this website address solely as an inactive, textual reference.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Human clinical trials are typically conducted in three sequential phases, which may overlap or be combined:</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Phase I: The drug is initially introduced into healthy human subjects or patients with the target disease or condition and tested for safety, dosage tolerance, absorption, metabolism, distribution, and excretion and, if possible, to gain an early indication of its effectiveness.</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Phase II: The drug is administered to a limited patient population to identify possible adverse effects and safety risks, to evaluate the efficacy of the product for specific targeted diseases preliminarily, and to determine dosage tolerance and optimal dosage.</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Phase III: The drug is administered to an expanded patient population, generally at geographically dispersed clinical trial sites, in well-controlled clinical trials to generate sufficient data statistically to evaluate the efficacy and safety of the product for approval, to establish the overall risk-benefit profile of the product, and to provide adequate information for the labeling of the product.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Post-approval trials, sometimes referred to as Phase IV clinical trials, may be conducted after initial marketing approval. These trials are used to gain additional experience from the treatment of patients in the intended therapeutic indication. In certain instances, the FDA may mandate the performance of Phase IV clinical trials as a condition of approval of an NDA.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA or the sponsor may suspend a clinical trial at any time on various grounds, including a finding that the research subjects or patients are being exposed to an unacceptable health risk. Similarly, an IRB can suspend or terminate approval of a clinical trial at its institution if the clinical trial is not being conducted in accordance with the IRB&#8217;s requirements or if the drug has been associated with unexpected serious harm to patients. In addition, some clinical trials are overseen by an independent group of qualified experts organized by the sponsor, known as a data safety monitoring board or committee. Depending on its charter, this group may determine whether a trial may move forward at designated check points based on access to certain data from the trial.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the development of a new drug, sponsors are given opportunities to meet with the FDA at certain points. These points may be prior to submission of an IND, at the end of Phase II, and before an NDA is submitted. Meetings at other times may be requested. These meetings can provide an opportunity for the sponsor to share information about the data gathered to date, for the FDA to provide advice, and for the sponsor and the FDA to reach agreement on the next phase of development. Sponsors typically use the meetings at the end of the Phase II clinical trial to discuss Phase II clinical results and present plans for the pivotal Phase III clinical trials that they believe will support approval of the new drug. ALT5 Sigma Corporation submitted briefing materials in 2021 describing the previous research and development activities and planned clinical trials.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with clinical trials, companies usually complete additional animal studies and must also develop additional information about the chemistry and physical characteristics of the drug and finalize a process for manufacturing the product in commercial quantities in accordance with cGMP requirements. The manufacturing process must be capable of consistently producing quality batches of product candidates and, among other things, the manufacturer must develop methods for testing the identity, strength, quality, and purity of the final drug. In addition, appropriate packaging must be selected and tested and stability studies must be conducted to demonstrate that the product candidate does not undergo unacceptable deterioration over its shelf life.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the IND is active and before approval, progress reports summarizing the results of the clinical trials and non-clinical studies performed since the last progress report must be submitted at least annually to the FDA, and written IND safety reports must be submitted to the FDA and investigators for serious and unexpected suspected adverse events, findings from other studies suggesting a significant risk to humans exposed to the same or similar drugs, findings from animal or in vitro testing suggesting a significant risk to humans, and any clinically important increased incidence of a serious suspected adverse reaction compared to that listed in the protocol or investigator brochure.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">United States Review and Approval Process</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of product development, pre-clinical, and other non-clinical studies and clinical trials, along with descriptions of the manufacturing process, analytical tests conducted on the chemistry of the drug, proposed labeling, and other relevant information are submitted to the FDA as part of an NDA requesting approval to market the product. The submission of an NDA is subject to the payment of substantial user fees; a waiver of such fees may be obtained under certain limited circumstances. The FDA reviews an NDA to determine, among other things, whether a product is safe and effective for its intended use and whether its manufacturing is cGMP-compliant to assure and preserve the product&#8217;s identity, strength, quality and purity. Under the Prescription Drug User Fee Act (the &#8220;PDUFA&#8221;), guidelines that are currently in effect, the FDA has a goal of 10 months from the date of &#8220;filing&#8221; of a standard NDA for a new molecular entity to review and act on the submission. This review typically takes 12 months from the date the NDA is submitted to FDA because the FDA has approximately two months to make a &#8220;filing&#8221; decision after the application is submitted. The FDA conducts a preliminary review of all NDAs within the first 60 days after submission, before accepting them for filing, to determine whether they are sufficiently complete to permit substantive review. The FDA may request additional information rather than accept an NDA for filing. In this event, the NDA must be resubmitted with the additional information. The resubmitted application also is subject to review before the FDA accepts it for filing.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA may refer an application for a novel drug to an advisory committee. An advisory committee is a panel of independent experts, including clinicians and other scientific experts, that reviews, evaluates, and provides a recommendation as to whether the application should be approved and under what conditions. The FDA is not bound by the recommendations of an advisory committee; but, it considers such recommendations carefully when making decisions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before approving an NDA, the FDA will inspect the facility or facilities where the product is manufactured. The FDA will not approve an application unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and adequate to assure consistent production of the product within required specifications. Additionally, before approving an NDA, the FDA may inspect one or more clinical trial sites to assure compliance with GCP requirements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the FDA evaluates an NDA, it will issue an approval letter or a Complete Response Letter. An approval letter authorizes commercial marketing of the drug with prescribing information for specific indications.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Complete Response Letter indicates that the review cycle of the application is complete and the application will not be approved in its present form. A Complete Response Letter usually describes the specific deficiencies in the NDA identified by the FDA and may require additional clinical data, such as an additional Phase III trial or other significant and time-consuming requirements related to clinical trials, non-clinical studies, or manufacturing. If a Complete Response Letter is issued, the sponsor must resubmit the NDA that addresses all of the deficiencies identified in the letter, or withdraw the application. Even if such additional data and information are submitted, the FDA may decide that the NDA does not satisfy the criteria for approval.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a product receives regulatory approval, the approval may be significantly limited to specific diseases and dosages or the indications for use may otherwise be limited, which could restrict the commercial value of the product. In addition, the FDA may require a sponsor to conduct Phase IV clinical testing, which involves clinical trials designed to assess a drug&#8217;s safety and effectiveness further after NDA approval, and may require testing and surveillance programs to monitor the safety of approved products that already have been commercialized. The FDA may also place other conditions on approval, including the requirement for REMS, to assure the safe use of the drug. If the FDA concludes a REMS is needed, the sponsor of the NDA must submit a proposed REMS. The FDA will not approve the NDA without an approved REMS, if required. A REMS could include medication guides, physician communication plans, or elements to assure safe use, such as restricted distribution methods, patient registries, and other risk minimization tools. Any of these limitations on approval or marketing could restrict the commercial promotion, distribution, prescription, or dispensing of products. Marketing approval may be withdrawn for non-compliance with regulatory requirements or if problems occur following initial marketing.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Food and Drug Administration Safety and Innovation Act (the &#8220;FDASIA&#8221;) made permanent the Pediatric Research Equity Act (the &#8220;PREA&#8221;), which requires a sponsor to conduct pediatric clinical trials for most drugs, for a new active ingredient, new indication, new dosage form, new dosing regimen, or new route of administration. Under PREA, original NDAs and supplements must contain a pediatric assessment unless the sponsor has received a deferral or waiver. The required assessment must evaluate the safety and effectiveness of the product for the claimed indications in all relevant pediatric subpopulations and support dosing and administration for each pediatric subpopulation for which the product is safe and effective. The sponsor or the FDA may request a deferral of pediatric clinical trials for some or all of the pediatric subpopulations. A deferral may be granted for several reasons, including a finding that the drug is ready for approval for use in adults before pediatric clinical trials are complete or that additional safety or effectiveness data needs to be collected before the pediatric clinical trials begin. The FDA must send a non-compliance letter to any sponsor that fails to submit the required assessment, keep a deferral current or fails to submit a request for approval of a pediatric formulation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Special FDA Expedited Review and Approval Programs</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has various programs, including Fast Track Designation, accelerated approval, priority review, and breakthrough therapy designation, which are intended to expedite or simplify the process for the development and FDA review of drugs that are intended for the treatment of serious or life-threatening diseases or conditions and demonstrate the potential to address unmet medical needs. The purpose of these programs is to provide important new drugs to patients earlier than under standard FDA review procedures.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To be eligible for a Fast Track Designation, the FDA must determine, based on the request of a sponsor, that a product is intended to treat a serious or life-threatening disease or condition and demonstrates the potential to address an unmet medical need. The FDA will determine that a product will fill an unmet medical need if it will provide a therapy where none exists or provide a therapy that may be potentially superior to existing therapy based on efficacy or safety factors. The FDA may review sections of the NDA for a fast track product on a rolling basis before the complete application is submitted, if the sponsor provides a schedule for the submission of the sections of the NDA, the FDA agrees to accept sections of the NDA and determines that the schedule is acceptable, and the sponsor pays any required user fees upon submission of the first section of the NDA.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA may give a priority review designation to drugs that offer major advances in treatment, or provide a treatment where no adequate therapy exists. A priority review means that the goal for the FDA to review an application is six months, rather than the standard review of 10 months under current PDUFA guidelines. Under the new PDUFA agreement, these six- and 10-month review periods are measured from the &#8220;filing&#8221; date, rather than the receipt date for NDAs for new molecular entities, which typically adds approximately two months to the timeline for review and decision from the date of submission. Most products that are eligible for Fast Track Designation are also likely to be considered appropriate to receive a priority review.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, products studied for their safety and effectiveness in treating serious or life-threatening illnesses and that provide meaningful therapeutic benefit over existing treatments may be eligible for accelerated approval and may be approved on the basis of adequate and well-controlled clinical trials that establish that the drug product has an effect (i) on a surrogate endpoint that is reasonably likely to predict clinical benefit or (ii) on a clinical endpoint that can be measured earlier than irreversible morbidity or mortality that is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit, including taking into account the severity, rarity, or prevalence of the condition and the availability or lack of alternative treatments. As a condition of approval, the FDA may require a sponsor of a drug receiving accelerated approval to perform post-marketing studies to verify and describe the predicted effect on irreversible morbidity or mortality or other clinical endpoint, and the drug may be subject to accelerated withdrawal procedures.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, under the provisions of the FDASIA, a sponsor can request designation of a product candidate as a &#8220;breakthrough therapy.&#8221; A breakthrough therapy is defined as a drug that is intended, alone or in combination with one or more other drugs, to treat a serious or life-threatening disease or condition, and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. Drugs designated as breakthrough therapies are also eligible for accelerated approval. The FDA must take certain actions, such as holding timely meetings and providing advice, intended to expedite the development and review of an application for approval of a breakthrough therapy.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if a product qualifies for one or more of these programs, the FDA may later decide that the product no longer meets the conditions for qualification or decide that the time period for FDA review or approval will not be shortened. We may explore some of these opportunities for our initial (or subsequent) product candidates, as appropriate.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Post-Approval Requirements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Drugs manufactured or distributed pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA, including, among other things, requirements relating to recordkeeping, periodic reporting, product sampling and distribution, advertising and promotion and reporting of adverse experiences with the product. After approval, most changes to the approved product, such as adding new indications or other labeling claims are subject to prior FDA review and approval. There also are continuing, annual user program fee requirements for any marketed products.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA may impose a number of post-approval requirements as a condition of approval of an NDA. For example, the FDA may require post-marketing testing, including Phase IV clinical trials, and surveillance to assess further and monitor the product&#8217;s safety and effectiveness after commercialization.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, drug manufacturers and other entities involved in the manufacture and distribution of approved drugs are required to register their establishments with the FDA and state agencies, and are subject to periodic unannounced inspections by the FDA and these state agencies for compliance with cGMP requirements. Changes to the manufacturing process are strictly regulated and often require prior FDA approval before being implemented. FDA regulations also require investigation and correction of any deviations from cGMP requirements and impose reporting and documentation requirements upon the sponsor and any third-party manufacturers that the sponsor may decide to use. Accordingly, manufacturers must continue to expend time, money, and effort in the area of production and quality control to maintain cGMP compliance.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once an approval of a drug or medical device is granted, the FDA may withdraw the approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in mandatory revisions to the approved labeling to add new safety information; imposition of post-market studies or clinical trials to assess new safety risks; or imposition of distribution or other restrictions under a REMS program. Other potential consequences include, among other things: </span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">restrictions on the marketing or manufacturing of the product, complete withdrawal of the product from the market or product recalls; </span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">fines, warning letters or holds on post-approval clinical trials;</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">refusal of the FDA to approve pending NDAs or supplements to approved NDAs, or suspension or revocation of product approvals; </span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">product seizure or detention, or refusal to permit the import or export of products; or </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">injunctions or the imposition of civil or criminal penalties.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA strictly regulates marketing, labeling, advertising and promotion of products that are placed on the market. Drugs or devices may be promoted only for the approved indications and in accordance with the provisions of the approved label. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses, and a company that is found to have promoted off-label uses improperly may be subject to significant liability.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">The Hatch-Waxman Amendments</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Drug Price Competition and Patent Term Restoration Act of 1984, known as the Hatch-Waxman Act, added two pathways for FDA drug approval. First, the Hatch-Waxman amendments to the FDCA authorized the FDA to approve an alternative type of NDA under Section 505(b)(2) of the FDCA. Section 505(b)(2) permits the filing of an NDA where at least some of the information required for approval comes from trials not conducted by or for the applicant and for which the applicant has not obtained a right of reference from the data owner. The applicant may rely upon the FDA&#8217;s findings of safety and efficacy for an approved product that acts as the &#8220;listed drug.&#8221; The FDA may also require 505(b)(2) applicants to perform additional studies or measurements to support the change from the listed drug. The FDA may then approve a new product candidate for all, or some, of the label indications for which the branded reference drug has been approved, as well as for any new indication sought by the 505(b)(2) applicant.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Second, the Hatch-Waxman amendments to the FDCA also established a statutory procedure for submission and FDA review and approval of abbreviated new drug applications (&#8220;ANDAs&#8221;) for generic versions of branded drugs previously approved by the FDA (such previously approved drugs are referred to as &#8220;listed drugs&#8221;). An ANDA is a comprehensive submission that contains, among other things, data and information pertaining to the active pharmaceutical ingredient, drug product formulation, specifications, and stability of the generic drug, as well as analytical methods, manufacturing process validation data and quality control procedures. Premarket applications for generic drugs are termed abbreviated because they generally do not include pre-clinical and clinical data to demonstrate safety and effectiveness. However, a generic manufacturer is typically required to conduct bioequivalence studies of its test product against the listed drug. The bioequivalence studies for orally administered, systemically available drug products assess the rate and extent to which the active pharmaceutical ingredient (the &#8220;API&#8221;) is absorbed into the bloodstream from the drug product and becomes available at the site of action. Bioequivalence is established when there is an absence of a significant difference in the rate and extent for absorption of the generic product and the listed drug. For some drugs, other means of demonstrating bioequivalence may be required by the FDA, especially where rate and/or extent of absorption are difficult or impossible to measure. The FDA will approve the generic product as suitable for an ANDA application if it finds that the generic product does not raise new questions of safety and effectiveness as compared to the innovator product. A product is not eligible for ANDA approval if the FDA determines that it is not bioequivalent to the referenced innovator drug, if it is intended for a different use, or if it is not subject to an approved Suitability Petition.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In seeking approval for a drug through an NDA, including a 505(b)(2) NDA, applicants are required to list with the FDA certain patents whose claims cover the applicant&#8217;s product. Upon approval of an NDA, each of the patents listed in the application for the drug is then published in the Orange Book. Any applicant who files an ANDA seeking approval of a generic equivalent version of a drug listed in the Orange Book or a 505(b)(2) NDA that references a drug listed in the Orange Book must certify to the FDA that (1) no patent information on the drug product that is the subject of the application has been submitted to the FDA; (2) such patent has expired; (3) the date on which such patent expires; or (4) such patent is invalid or will not be infringed upon by the manufacture, use, or sale of the drug product for which the application is submitted. This last certification is known as a paragraph IV certification. A notice of the paragraph IV certification must be provided to each owner of the patent that is the subject of the certification and to the holder of the approved NDA to which the ANDA or 505(b)(2) application refers. The applicant may also elect to submit a &#8220;section viii&#8221; statement certifying that its proposed label does not contain (or carves out) any language regarding the patented method-of-use rather than certify to a listed method-of-use patent.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the referenced NDA holder and patent owners assert a patent challenge directed to one of the Orange Book-listed patents within 45 days of the receipt of the paragraph IV certification notice, the FDA is prohibited from approving the application until the earlier of 30 months from the receipt of the paragraph IV certification expiration of the patent, settlement of the lawsuit, or a decision in the infringement case that is favorable to the applicant. The ANDA or 505(b)(2) application also will not be approved until any applicable non-patent exclusivity listed in the Orange Book for the branded reference drug has expired.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Marketing Exclusivity</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market exclusivity provisions under the FDCA can delay the submission or the approval of certain marketing applications. The FDCA provides a five-year period of non-patent marketing exclusivity within the United States to the first applicant to obtain approval of an NDA for a new chemical entity. A drug is a new chemical entity if the FDA has not previously approved any other new drug containing the same active moiety, which is the molecule or ion responsible for the action of the drug substance. During the exclusivity period, the FDA may not approve or even accept for review an abbreviated new drug application, or ANDA, or a NDA submitted under Section 505(b)(2), or 505(b)(2) NDA, submitted by another company for another drug based on the same active moiety, regardless of whether the drug is intended for the same indication as the original innovative drug or for another indication, where the applicant does not own or have a legal right of reference to all the data required for approval. However, an application may be submitted after four years if it contains a certification of patent invalidity or non-infringement to one of the patents listed with the FDA by the innovator NDA holder. The FDCA alternatively provides three years of marketing exclusivity for an NDA, or supplement to an existing NDA if new clinical investigations, other than bioavailability studies, that were conducted or sponsored by the applicant are deemed by the FDA to be essential to the approval of the application, for example new indications, dosages or strengths of an existing drug. This three-year exclusivity covers only the modification for which the drug received approval on the basis of the new clinical investigations and does not prohibit the FDA from approving ANDAs or 505(b)(2) NDAs for drugs containing the active agent for the original indication or condition of use. Five-year and three-year exclusivity will not delay the submission or approval of a full NDA. However, an applicant submitting a full NDA would be required to conduct or obtain a right of reference to all of the pre-clinical studies and adequate and well-controlled clinical trials necessary to demonstrate safety and effectiveness. Pediatric exclusivity is another type of marketing exclusivity available in the United States. Pediatric exclusivity provides for an additional six months of marketing exclusivity attached to another period of exclusivity if a sponsor conducts clinical trials in children in response to a written request from the FDA. The issuance of a written request does not require the sponsor to undertake the described clinical trials. In addition, orphan drug exclusivity, as described above, may offer a seven-year period of marketing exclusivity, except in certain circumstances.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">United States Coverage and Reimbursement</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant uncertainty exists as to the coverage and reimbursement status of any therapeutic product candidate for which we may seek regulatory approval. Sales in the United States will depend in part on the availability of adequate financial coverage and reimbursement from third-party payors, which include government health programs such as Medicare, Medicaid, TRICARE, and the Veterans Administration, as well as managed care organizations and private health insurers. Prices at which we or our customers seek reimbursement for our initial or subsequent therapeutic product candidates can be subject to challenge, reduction, or denial by payors.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The process for determining whether a payor will provide coverage for a product is typically separate from the process for setting the reimbursement rate that the payor will pay for the product. A payor&#8217;s decision to provide coverage for a product does not imply that an adequate reimbursement rate will be available. Third-party payors are increasingly challenging the price and examining the medical necessity and cost-effectiveness of medical products and services, in addition to their safety and efficacy. In order to obtain coverage and reimbursement for any product that might be approved for marketing, we may need to conduct expensive pharmacoeconomic studies in order to demonstrate the medical necessity and cost-effectiveness of any products, which would be in addition to the costs expended to obtain regulatory approvals. Third-party payors may not consider our initial or subsequent product candidates to be medically necessary or cost-effective compared to other available therapies, or the rebate percentages required to secure favorable coverage may not yield an adequate margin over cost or may not enable us to maintain price levels sufficient to realize an appropriate return on our investment in drug development.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Healthcare Reform</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States and some foreign jurisdictions, there have been, and continue to be, several legislative and regulatory changes and proposed changes regarding the healthcare system that could prevent or delay marketing approval of drug product candidates, restrict or regulate post-approval activities, and affect the profitable sale of drug product candidates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among policy makers and payors in the United States and elsewhere, there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare costs, improving quality, and/or expanding access. In the United States, the pharmaceutical industry has been a particular focus of these efforts and has been significantly affected by major legislative initiatives. In March 2010, the Affordable Care Act, formally known as the Patient Protection and Affordable Care Act (the &#8220;ACA&#8221;), was enacted by Congress and signed into law by the President. It substantially changed the methods by which healthcare is financed by both the government and private insurers, and significantly impacted the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States pharmaceutical industry. The ACA, among other things: (i) increased the minimum Medicaid rebates owed by manufacturers under the Medicaid Drug Rebate Program and extended the rebate program to individuals enrolled in Medicaid-managed care organizations; (ii) established an annual, nondeductible fee on any entity that manufactures or imports certain specified branded prescription drugs and biologic agents apportioned among these entities according to their market share in some government healthcare programs; (iii) expanded the availability of lower pricing under the 340B drug pricing program by adding new entities to the program; (iv) increased the statutory minimum rebates a manufacturer must pay under the Medicaid Drug Rebate Program; (v) expanded the eligibility criteria for Medicaid programs; (vi) created a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative clinical effectiveness research, along with funding for such research; and (vii) established a Center for Medicare &amp; Medicaid Innovation to test innovative payment and service delivery models to lower Medicare and Medicaid spending, potentially including prescription drugs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the provisions of the ACA have yet to be implemented, and there have been judicial and Congressional challenges to certain aspects of the ACA. While Congress has not passed comprehensive repeal legislation, bills affecting the implementation of certain taxes under the ACA have been signed into law. The Tax Cuts and Jobs Act of 2017 includes a provision repealing, effective January 1, 2019, the tax-based shared responsibility payment imposed by the ACA on certain individuals who fail to maintain qualifying health coverage for all or part of a year that is commonly referred to as the &#8220;individual mandate.&#8221; Additionally, on January 22, 2018, former President Trump signed a continuing resolution on appropriations for fiscal year 2018 that delayed the implementation of certain ACA-mandated fees, including the so-called &#8220;Cadillac&#8221; tax on certain high-cost employer-sponsored insurance plans, the annual fee imposed on certain health insurance providers based on market share, and the medical device excise tax on non-exempt medical devices.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other legislative changes have been proposed and adopted since the ACA was enacted, including aggregate reductions of Medicare payments to providers of two percent per fiscal year and reduced payments to several types of Medicare providers. Moreover, there has recently been heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products, which has resulted in several Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drug products. At the state level, legislatures have increasingly passed legislation and implemented regulations designed to control pharmaceutical product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">United States Healthcare Fraud and Abuse Laws and Compliance Requirements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal and state healthcare laws and regulations restrict business practices in the pharmaceutical industry. The United States laws that may affect our ability to operate include:</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the federal Anti-Kickback Statute, which prohibits, among other things, persons from soliciting, receiving, offering or paying remuneration, directly or indirectly, to induce, or in return for, the purchase or recommendation of an item or service reimbursable under a federal healthcare program, such as the Medicare and Medicaid programs;</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the federal civil and criminal false claims laws and civil monetary penalty laws, which prohibit, among other things, individuals or entities from knowingly presenting, or causing to be presented, claims for payment from Medicare, Medicaid or other third-party payors that are false or fraudulent;</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">HIPAA, which created new federal criminal statutes that prohibit executing a scheme to defraud any healthcare benefit program and making false statements relating to healthcare matters;</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">HIPAA, as amended by the federal Health Information Technology for Economic and Clinical Health Act and its implementing regulations, also imposes certain requirements relating to the privacy, security and transmission of individually identifiable health information; </span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the federal Physician Payments Sunshine Act, which among other things, requires certain manufacturers of drugs, devices, and biologics that are reimbursable by a federal healthcare program to report annually to the United States Department of Health and Human Services information related to payments and other transfers of value to physicians and teaching hospitals, and ownership and investment interests held by physicians and their immediate family members; and</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">similar federal laws and state law equivalents of each of the above federal laws.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Regulation Outside of the United States</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that our initial or subsequent product candidates, if and when approved, are sold in a foreign country, we may be subject to similar foreign laws and regulations, which may include, for instance, applicable post-marketing requirements, including safety surveillance, anti-fraud and abuse laws and implementation of corporate compliance programs and reporting of payments or other transfers of value to healthcare professionals.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to market our future products in the European Economic Area (the &#8220;EEA&#8221;) and many other foreign jurisdictions, we must obtain separate regulatory approvals. More concretely, in the EEA, medicinal products can only be commercialized after obtaining a Marketing Authorization (an &#8220;MA&#8221;). There are two types of Marketing Authorizations:</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the Community MA, which is issued by the European Commission through the Centralized Procedure, based on the opinion of the Committee for Medicinal Products for Human Use of the European Medicines Agency (the &#8220;EMA&#8221;) and which is valid throughout the entire territory of the EEA. The Centralized Procedure is mandatory for certain types of products, such as biotechnology medicinal products, orphan medicinal products, advanced therapy products, and medicinal products containing a new active substance indicated for the treatment certain diseases, such as AIDS, cancer, neurodegenerative disorders, diabetes, and auto-immune and viral diseases. The Centralized Procedure is optional for products that contain a new active substance not yet authorized in the EEA, or for products that constitute a significant therapeutic, scientific, or technical innovation or that are in the interest of public health in the EU; and </span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">National MAs, which are issued by the competent authorities of the Member States of the EEA and only cover their respective territory, are available for products not falling within the mandatory scope of the Centralized Procedure. Where a product has already been authorized for marketing in a Member State of the EEA, a National MA can be recognized in another Member State through the Mutual Recognition Procedure. If the product has not received a National MA in any Member State at the time of application, it can be approved simultaneously in various Member States through the Decentralized Procedure.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the above-described procedures, before granting the MA, the EMA or the competent authorities of the Member States of the EEA make an assessment of the risk-benefit balance of the product on the basis of scientific criteria concerning its quality, safety and efficacy.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Data and Marketing Exclusivity</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the EEA, new products authorized for marketing, or reference products, qualify for eight years of data exclusivity and an additional two years of market exclusivity upon marketing authorization. The data exclusivity period prevents generic or biosimilar applicants from relying on the pre-clinical and clinical trial data contained in the dossier of the reference product when applying for a generic or biosimilar marketing authorization in the EU during a period of eight years from the date on which the reference product was first authorized in the EU. The market exclusivity period prevents a successful generic or biosimilar applicant from commercializing its product in the EU until 10 years have elapsed from the initial authorization of the reference product in the EU. The 10-year market exclusivity period can be extended to a maximum of 11 years if, during the first eight years of those 10 years, the marketing authorization holder obtains an authorization for one or more new therapeutic indications that, during the scientific evaluation prior to their authorization, are held to bring a significant clinical benefit in comparison with existing therapies. In Japan, medicinal products approved for administration to a patient via a new route of administration qualify for six years of market exclusivity.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Clinical Trials</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical trials of medicinal products in the European Union must be conducted in accordance with European Union and national regulations and the International Conference on Harmonization (the &#8220;ICH&#8221;) guidelines on GCPs. Additional GCP guidelines from the European Commission, focusing in particular on traceability, apply to clinical trials of advanced therapy medicinal products. If the sponsor of the clinical trial is not established within the European Union, it must appoint an entity within the European Union to act as its legal representative. The sponsor must purchase a clinical trial insurance policy and, in most EU countries, the sponsor is liable to provide &#8220;no fault&#8221; compensation to any study subject injured in the clinical trial.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to commencing a clinical trial, the sponsor must obtain a clinical trial authorization from the competent authority, and a positive opinion from an IEC. The application for a clinical trial authorization must include, among other things, a copy of the trial protocol and an investigational medicinal product dossier that contains information about the manufacture and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">quality of the medicinal product under investigation. Currently, clinical trial authorization applications must be submitted to the competent authority in each EU Member State in which the trial will be conducted. Under the new Clinical Trials Regulation (Regulation (EU) No 536/2014), which took effect on January 31, 2022, there will be a centralized application procedure where one national authority takes the lead in reviewing the application and the other national authorities have only a limited involvement. Any substantial changes to the trial protocol or other information submitted with the clinical trial applications must be notified to or approved by the relevant competent authorities and ethics committees. Medicines used in clinical trials must be manufactured in accordance with cGMP. Other national and European Union-wide regulatory requirements also apply.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Recycling Segment - Discontinued Operations</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our wholly-owned Recycling Subsidiaries in our Recycling segment included ARCA Recycling and ARCA Canada, which recycle major household appliances in North America by providing turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs, and Connexx, which provides call center services for the recycling segment. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ARCA business was disposed of on March 8, 2023. The business started in 1976 as a used appliance retailer that reconditioned old appliances to sell in their stores. Any old appliances that could not be sold in ARCA stores were sold to scrap metal processors. In the late 1980s, stricter environmental regulations began to affect the disposal of unwanted appliances and ARCA was no longer able to take appliances that contained hazardous components to scrap metal processors. At that time, ARCA began to develop systems and equipment to remove the harmful materials so that metal processors would accept the appliance shells for processing. ARCA then offered their services for disposing of appliances in an environmentally sound manner to appliance manufacturers and retailers, waste hauling companies, rental property managers, local governments, and the public. In 1989, ARCA began contracting with electric utility companies to provide turnkey appliance recycling services to support their energy conservation efforts. Since that time, through March 8, 2023, ARCA provided services to approximately 400 utilities and other providers of energy efficiency programs throughout North America.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through March 8, 2023, when we disposed of our recycling business, we had contracts to recycle, or to replace and recycle, major household appliances for approximately 100 utilities and other providers of energy efficiency services across North America. ARCA operated 17 recycling centers in the United States and Canada to process and recycle old appliances according to all federal, state, provincial, and local rules and regulations. We used United States Environmental Protection Agency (the &#8220;EPA&#8221;) Responsible Appliance Disposal (&#8220;RAD&#8221;) Program-compliant methods to remove and manage hazardous components and materials properly, including CFC refrigerants, mercury, polyurethane foam insulation, and recyclable materials, such as ferrous and nonferrous metals, plastics, and glass. During our operations of the recycling business, all of our facilities complied with licensing and permitting requirements, and employees who process appliances receive extensive safety and hazardous materials training.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Disposition of our Recycling Business</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 19, 2023, the Company entered into a Stock Purchase Agreement (the &#8220;Recycling Purchase Agreement&#8221;) with VM7 Corporation (&#8220;VM7&#8221;), under which it agreed to acquire all of the outstanding equity interests of the Recycling Subsidiaries, consisting of: (a) ARCA Recycling, (b) ARCA Canada, and (c) Connexx. The principal of VM7 is Virland A. Johnson, our Chief Financial Officer. The sale of all of the outstanding equity interests of the Recycling Subsidiaries to VM7 under the Recycling Purchase Agreement (the &#8220;Disposition Transaction&#8221;) was consummated simultaneously with the execution of the Recycling Purchase Agreement. Our Board of Directors unanimously approved the Recycling Purchase Agreement and the Disposition Transaction.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The economic aspects of the Disposition Transaction are: (i) we reduced the liabilities on our consolidated balance sheets by approximately $17.6 million (excluding those related to the California Business Fee and Tax Division, as discussed below); (ii) we will receive not less than $24.0 million in aggregate monthly payments from VM7, which payments are subject to potential increase due to the Recycling Subsidiaries&#8217; future performance; and (iii) during the next five years, we may request that VM7 prepay aggregate monthly payments in the aggregate amount of $1 million. We also received one thousand dollars for the equity of each of the Recycling Subsidiaries at the closing. Each monthly payment is to be the greater of (a) $140,000 (or $100,000 for each January and February during the 15-year payment period) or (b) a monthly percentage-based payment, which is an amount calculated as follows: (i) 5% of the Recycling Subsidiaries&#8217; aggregate gross revenues up to $2,000,000 for the relevant month, plus (ii) 4% of the Recycling Subsidiaries&#8217; aggregate gross revenues between $2,000,000 and $3,000,000 for the relevant month, plus (iii) 3% of the Recycling Subsidiaries aggregate gross revenues over $3,000,000 for the relevant month. VM7 will receive credit toward the payment of the first monthly payment </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(March of 2023) for any payments, distributions, or cash dividends paid by any of the Recycling Subsidiaries to the Company on or after March 19, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VM7 may prepay, at any time and in total, the estimated aggregate of the future monthly payments. That amount will be an amount equal to the then-present value of the estimated future monthly payments, discounted at the rate of 5% per annum (the &#8220;Prepayment Price&#8221;). Furthermore, VM7 will be required to pay the Prepayment Price upon the earliest of (i) Mr. Johnson holding less than 75% of the capital stock of VM7, (ii) VM7 selling substantially all of its assets, (iii) VM7 holding less than 50% of the capital stock of the Recycling Subsidiaries, or (iv) the Recycling Subsidiaries selling substantially all of their respective assets. Upon payment of the Prepayment Price, VM7 will have no further purchase price payment obligations to the Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional terms of the Disposition Transaction are: (i) we have the right to appoint one member of VM7&#8217;s board of directors until the sooner of VM7 having paid the Prepayment Price or having tendered all of the monthly payments; (ii) Mr. Johnson&#8217;s annual salary as Chief Executive Officer of VM7 shall be $400,000, prorated, for the remainder of the 2023 calendar year, and then adjusted annually to an amount equal to 1% of the Recycling Subsidiaries&#8217; aggregate gross revenues, until the sooner of VM7 having paid the Prepayment Price or having tendered all of the monthly payments; and (iii) we will receive additional payments from VM7 (that are not related to the on-going monthly payments) that relate to certain taxing agency issues. Upon settlement of the continuing dispute between ARCA Recycling and the California Business Fee and Tax Division (as to which settlement, there can be no assurance), ARCA Recycling will pay to us 50% of the amount of the reduction between the current assessment and any such settlement. The payment will be memorialized by a three-year promissory note with interest at five percent per annum. The first payment under the note will be on the last day of VM7&#8217;s fiscal year in which the settlement occurs and the remaining payments each year thereafter. If ARCA Recycling receives a refund from the agency for payments previously made, it shall pay to us an amount equivalent to 25% of such refund after reduction for the legal fees payable to counsel for this proceeding. ARCA Recycling and Connexx are due to receive from the Internal Revenue Service two payments in the aggregate amount of approximately $931,000 in connection with the Employee Retention Credit provisions of the Coronavirus Aid, Relief, and Economic Security Act and the Taxpayer Certainty and Disaster Tax Relief Act of 2020. Those payments are to be tendered to us within 10 days of receipt by ARCA Recycling or Connexx.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To secure VM7&#8217;s obligations under the Recycling Purchase Agreement and pursuant to a Stock and Membership Interests Pledge Agreement dated March 19, 2023 (the &#8220;Pledge Agreement&#8221;), Mr. Johnson pledged to us all of the capital stock in VM7 (&#8220;VM7&#8217;s Capital Stock&#8221;) and VM7 pledged to us all of the equity interests of the Recycling Subsidiaries (the &#8220;Subject Securities&#8221;). Under the terms of the Pledge Agreement, upon an Event of Default (as defined in the Pledge Agreement), among other remedies in our favor, we may foreclose on any or all of VM7&#8217;s Capital Stock and the Subject Securities. We may also cause the ownership of VM7&#8217;s Capital Stock and of the Subject Securities to be transferred to us automatically, pursuant to an irrevocable transfer entered in our favor, as referenced in the Pledge Agreement. In the event of an automatic transfer, all of the monthly payments previously made by VM7 pursuant to the terms of the Recycling Purchase Agreement will then be characterized as contributions to the capital of the Company without dilution of the Company&#8217;s capital stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The parties have made customary representations, warranties, covenants, and indemnities in connection with the Disposition Transaction.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Recycling Purchase Agreement contains certain representations and warranties that the parties made to each other as of the date of the Recycling Purchase Agreement or such other date as explicitly referenced therein. The representations and warranties were made solely for purposes of the Recycling Purchase Agreement and (i) are subject to limitations agreed by the parties in negotiating the terms and conditions thereof, (ii) may not be accurate or complete as of any specified date, (iii) will be qualified by the underlying disclosure schedules, (iv) may be subject to a contractual standard of materiality different from those generally applicable to investors, and (v) may have been used for the purpose of allocating risk among the parties thereto, rather than for establishing any matters as facts. Information concerning the subject matter of the representations and warranties may change after March 8, 2023, and subsequent information may or may not be fully reflected in ALT5 Sigma Corporation&#8217;s public disclosures. For the foregoing reasons, the representations and warranties contained in the Recycling Purchase Agreement should not be relied upon as statements of factual information.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the closing of the Disposition Transaction, VM7 determined that, after expending significant amounts of time and resources, it was unable to obtain sufficient equity or debt financing to continue the operations of the Recycling Subsidiaries. Accordingly, we were advised that the operations of the Recycling Subsidiaries were wound down and, ultimately, ceased. Because we did not receive all of the economic benefits of the Disposition Transaction and understand </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that we will not receive any future benefits of the Disposition Transaction, we determined to fully impair the approximately $5.3 million carrying value of the Disposition Transaction on our balance sheet. We also determined not to exercise any of our remedies under the Recycling Purchase Agreement so that we could maintain our focus on our clinical-stage biopharmaceutical activities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Corporate and Other</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate and other segment consists of certain corporate general and administrative costs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Employees</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;28, 2024, the Company had 10 employees, all of whom were full-time.</span></div><div id="i213e3c881f5e4982994be533c682ff6b_16"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISK FACTORS</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.090%"><tr><td style="width:1.0%"/><td style="width:85.597%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.203%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Index to Risk Factors</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Section</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Page Number</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i272ab477404c49489c7330cc5841dd26_274772">Risks Relating to Our Business Generally</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i272ab477404c49489c7330cc5841dd26_274772">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i272ab477404c49489c7330cc5841dd26_274773">Risks Relating to our Fintech Segment</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i272ab477404c49489c7330cc5841dd26_274773">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i272ab477404c49489c7330cc5841dd26_274774">Risks Relating to Our Biotechnology Segment</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i272ab477404c49489c7330cc5841dd26_274774">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i272ab477404c49489c7330cc5841dd26_274775">G</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i272ab477404c49489c7330cc5841dd26_274775">en</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i272ab477404c49489c7330cc5841dd26_274775">eral Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i272ab477404c49489c7330cc5841dd26_274775">65</a></span></div></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should carefully consider the risks described below with respect to an investment in our shares. If any of the following risks actually occur, our business, financial condition, operating results or cash provided by operations could be materially harmed. As a result, the trading price of our common stock could decline, and you might lose all or part of your investment. When evaluating an investment in our common stock, you should also refer to the other information in this Form 10-K, including our consolidated financial statements and related notes.</span></div><div style="margin-top:12pt;text-align:justify"><span id="i272ab477404c49489c7330cc5841dd26_274772"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Our Business Generally</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have identified and disclosed in this Form 10-K material weaknesses in our internal control over financial reporting. If we are not able to remediate these material weaknesses and maintain an effective system of internal controls, we may not be able to accurately or timely report our financial results, which could cause our stock price to fall or result in our stock being delisted. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We need to devote significant resources and time to comply with the requirements of the Sarbanes-Oxley Act of 2002 (&#8220;Sarbanes-Oxley&#8221;) with respect to internal control over financial reporting. In addition, Section 404 under Sarbanes-Oxley requires that we assess the design and operating effectiveness of our controls over financial reporting, which are necessary for us to provide reliable and accurate financial reports.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As reported in Part II &#8211; Item 9A, Controls and Procedures, there were material weaknesses in our internal controls over financial reporting at January 1, 2022. Specifically, management noted the following material weaknesses in internal control when conducting their evaluation of internal control as of January 1, 2022: (1) insufficient information technology general controls and segregation of duties. It was noted that people who were negotiating a contract were also involved in approving invoices without proper oversight. Additional controls and procedures are necessary and are being implemented to have checks and balances on significant transactions and governance with those charged with governance authority; (2) inadequate control design or lack of sufficient controls over significant accounting processes; the cutoff and reconciliation procedures were not effective with certain accrued and deferred expenses; (3) insufficient assessment of the impact of potentially significant transactions; and (4) insufficient processes and procedures related to proper recordkeeping of agreements and contracts. In addition, contract-to-invoice reconciliation was not effective with certain transportation service providers. As part of its remediation plan, processes and procedures have been implemented to help ensure accruals and invoices are reviewed for accuracy and properly recorded in the appropriate period. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our systems and controls to become increasingly complex to the extent that we integrate acquisitions and if and as our business grows. To effectively manage our Company today and this anticipated complexity, we need to remediate these material weaknesses and continue to improve our operational, financial, and management controls and our reporting systems and procedures. Any failure to remediate these material weaknesses and implement required new or improved controls, or difficulties encountered in the implementation or operation of these controls, could harm our operating results </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or cause us to fail to meet our financial reporting obligations, which could adversely affect our business and jeopardize our listing on the Nasdaq Capital Market, either of which would harm our stock price.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our estimates or judgment relating to our critical accounting estimates prove to be incorrect, our operating results could be adversely affected.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with generally accepted accounting principles (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect the amounts reported in the Consolidated Financial Statements and accompanying notes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, as provided in the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Application of Critical Accounting Policies&#8221; in Part II, Item 7 of this Annual Report on Form 10-K.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of these estimates form the basis for making judgments about the carrying values of assets, liabilities, and equity, and the amount of expenses that are not readily apparent from other sources.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant estimates and judgments that comprise our critical accounting estimates involve the valuation of assets acquired and liabilities assumed in business combinations, valuation of strategic investments, evaluation of tax positions, and evaluation of legal and other contingencies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business, operating results, and financial condition could be adversely affected if our assumptions change or if actual circumstances differ from those in our assumptions, which could cause our operating results to differ from the expectations of analysts and investors, resulting in a decline in the trading price of our Common Stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to maintain an effective system of disclosure controls and procedures and internal control over our financial reporting, our ability to produce timely and accurate financial statements or comply with applicable regulations could be impaired.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a public company we incur significant legal, accounting, and other expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sarbanes-Oxley Act of 2002 and related rules of the SEC require, among other things, that we maintain effective disclosure controls and procedures and internal control over financial reporting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to maintain and, if required, improve our disclosure controls and procedures and internal control over financial reporting to meet this standard, we have expended, and anticipate that we will continue to expend, significant resources, including accounting-related costs and significant management oversight.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we encounter material weaknesses or deficiencies in our internal control over financial reporting, we may not detect errors on a timely basis and our Consolidated Financial Statements may be materially misstated.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any failure to implement and maintain effective internal control over financial reporting could also adversely affect the results of periodic management evaluations and annual independent registered public accounting firm attestation reports regarding the effectiveness of our internal control over financial reporting that are required to be included in our periodic reports filed with the SEC.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ineffective disclosure controls and procedures or internal control over financial reporting may adversely affect investor confidence in us and, as a result, negatively impact the price of our Common Stock and have a material and adverse effect on our business, operating results, and financial condition.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adverse economic conditions could adversely affect our business.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our performance is subject to general economic conditions, and their impact on the crypto asset markets and our customers.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United States and other key international economies have experienced cyclical downturns from time to time in which economic activity declined resulting in lower consumption rates, restricted credit, reduced profitability, weaknesses in financial markets, bankruptcies, and overall uncertainty with respect to the economy.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adverse general economic conditions have impacted in the past, and may impact in the future, the crypto-economy, although the extent of such impacts remains uncertain and dependent on a variety of factors, including market adoption of crypto assets, global trends in the crypto-economy, central bank monetary policies, instability in the global banking system, volatility and disruptions in the capital and credit markets, and other events beyond our control.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Geopolitical developments, such as trade and tariff wars and foreign exchange limitations, can also increase the severity and levels of unpredictability globally and increase the volatility of global financial and crypto asset markets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, in the past the capital and credit markets have experienced extreme volatility and disruptions, resulting in steep declines in the value of crypto assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent general economic conditions and crypto assets markets materially deteriorate or decline for a prolonged period, our ability to generate revenue and to attract and retain customers could suffer and our business, operating results and financial condition could be adversely affected.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, even if general economic conditions were to improve following any such deterioration, there is no guarantee that the crypto-economy would similarly improve.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual events involving limited liquidity, defaults, non-performance, or other adverse developments that affect financial institutions, transactional counterparties or other companies in the financial services industry, or the financial services industry generally, or concerns or rumors about any such events or other similar risks, have in the past and may in the future lead to market-wide liquidity problems.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may require additional capital to support business growth, and this capital might not be available.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have funded our operations since inception primarily through equity financings, debt, and cash flows generated from operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot be certain that our operations will continue to fund our ongoing operations or the growth of our business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to continue to make investments in our business, which investments may require us to secure additional funds.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional financing may not be available on terms favorable to us, if at all, including due to general macroeconomic conditions, crypto market conditions and any disruptions in the crypto market, instability in the global banking system, increasing regulatory uncertainty and scrutiny or other unforeseen factors.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a downgrade of our credit rating, our ability to raise additional financing may be adversely affected and any future debt offerings or credit arrangements we propose to enter into may be on less favorable terms or terms that may not be acceptable to us.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, even if debt financing is available, the cost of additional financing may be significantly higher than our current debt.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we incur additional debt, the debt holders would have rights senior to holders of our Common Stock to make claims on our assets, and the terms of any debt could restrict our operations, including our ability to pay dividends on our Common Stock.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, we have authorized the issuance of &#8220;blank check&#8221; preferred stock and Common Stock that our board of directors could use to, among other things, issue shares of our capital stock in the form of blockchain tokens, implement a stockholder rights plan, or issue other shares of preferred stock or Common Stock.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may issue shares of capital stock, including in the form of blockchain tokens, to our customers in connection with customer reward or loyalty programs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we issue additional equity securities, stockholders will experience dilution, and the new equity securities could have rights senior to those of our currently authorized and issued Common Stock.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading prices for our Common Stock may be highly volatile, which may reduce our ability to access capital on favorable terms or at all.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, a slowdown or other sustained adverse downturn in the general economic or crypto asset markets could adversely affect our business and the value of our Common Stock.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because our decision to raise capital in the future will depend on numerous considerations, including factors beyond our control, we cannot predict or estimate the amount, timing, or nature of any future issuances of securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, our stockholders bear the risk of future issuances of debt or equity securities reducing the value of our Common Stock and diluting their interests.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be adversely affected by natural disasters, pandemics, and other catastrophic events, and by man-made problems such as terrorism, that could disrupt our business operations, and our business continuity and disaster recovery plans may not adequately protect us from a serious disaster.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Natural disasters or other catastrophic events may also cause damage or disruption to our operations, international commerce, and the global economy, and could have an adverse effect on our business, operating results, and financial condition.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business operations are subject to interruption by natural disasters, fire, power shortages, and other events beyond our control.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our global operations expose us to risks associated with public health crises, such as pandemics and epidemics, which could harm our business and cause our operating results to suffer.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, the COVID-19 pandemic and the related precautionary measures that we adopted have in the past resulted, and could in the future result, in difficulties or changes to our customer support, or create operational or other challenges, any of which could adversely affect our business, operating results, and financial condition.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, acts of terrorism, labor activism or unrest, and other geopolitical unrest, including ongoing regional conflicts around the world, could cause disruptions in our business or the businesses of our partners or the economy as a whole.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a natural disaster, including a major earthquake, blizzard, or hurricane, or a catastrophic event such as a fire, power loss, or telecommunications failure, we may be unable to continue our operations and may endure system interruptions, reputational harm, delays in development of our platform, lengthy interruptions in service, breaches of data security, and loss of critical data, all of which could have an adverse effect on our future operating results.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not maintain insurance sufficient to compensate us for the potentially significant losses that could result from disruptions to our services.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, all the aforementioned risks may be further increased if we do not implement a disaster recovery plan or our partners&#8217; disaster recovery plans prove to be inadequate.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent natural disasters or other catastrophic events concurrently impact data centers we rely on in connection with private key restoration, customers will experience significant delays in withdrawing funds, or in the extreme we may suffer loss of customer funds.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span id="i272ab477404c49489c7330cc5841dd26_274773"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to our Fintech Segment</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operating results have and will significantly fluctuate, including due to the highly volatile nature of crypto.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the highly volatile nature of the crypto economy and the prices of crypto assets, our operating results have, and will continue to, fluctuate significantly from quarter to quarter in accordance with market sentiments and movements in the broader crypto-economy. Our operating results will continue to fluctuate significantly as a result of a variety of factors, many of which are unpredictable and in certain instances are outside of our control, including:</span></div><div><span><br/></span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">crypto asset trading activity, including trading volume and the prevailing trading prices for crypto assets, which can be highly volatile;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to attract, maintain, grow, and engage our customer base;</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the legislative or regulatory environment, or actions by Common Stock or foreign governments or regulators, including fines, orders, or consent decrees;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory changes or scrutiny that impact our ability to offer certain products or services;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pricing for or temporary suspensions of our products and services;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to establish and maintain partnerships, collaborations, joint ventures, or strategic alliances with third parties;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">market conditions of, and overall sentiment towards, the crypto-economy;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">macroeconomic conditions, including interest rates, inflation, and instability in the global banking system;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adverse legal proceedings or regulatory enforcement actions, judgments, settlements, or other legal proceedings, and enforcement-related costs;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the development and introduction of existing and new products and services by us or our competitors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the amount and timing of our operating expenses related to the maintenance and expansion of our business and operations, including investments we make in the development of products and services;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">system failures, outages, or interruptions, including with respect to our platform and third-party crypto networks;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our lack of control over decentralized or third-party blockchains and networks that may experience downtime, cyberattacks, critical failures, errors, bugs, corrupted files, data losses, or other similar software failures, outages, breaches, and losses;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">breaches of security or privacy;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">inaccessibility of our platform due to our or third-party actions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to attract and retain talent; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to compete with our competitors.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of these factors, it is difficult for us to forecast growth trends accurately and our business and future prospects are difficult to evaluate, particularly in the short term. Therefore, our operating results could fluctuate significantly as a result of changes in the demand for our subscription and service offerings, in interest rates, and to our ongoing relationships with third parties.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In view of the rapidly evolving nature of our business and the crypto-economy, period-to-period comparisons of our operating results may not be meaningful, and you should not rely upon them as an indication of future performance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quarterly and annual expenses reflected in our financial statements may be significantly different from historical or projected rates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating results in one or more future quarters may fall below the expectations of securities analysts and investors.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, the trading price of our Common Stock may increase or decrease significantly.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our total fintech revenue is substantially dependent on the volume of transactions conducted on our platform.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If volume declines, our business, operating results, and financial condition would be adversely affected and the price of our Common Stock could decline.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate a large portion of our total fintech (and corporate) revenue from transaction fees on our platform.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction revenue is based on transaction fees.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Such revenue has grown over time.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Declines in the volume of crypto asset transactions, among other reasons, may result in lower total revenue to us.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price of crypto assets and associated demand for buying, selling, and trading crypto assets and conversions back and forth with fiat have historically been subject to significant volatility.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the volume of such transactions declines in the future, our ability to generate revenue, which could adversely affect our business, operating results, and financial condition and cause the price of our Common Stock to decline.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction volume of any crypto asset is subject to significant uncertainty and volatility, depending on a number of factors, including:</span></div><div><span><br/></span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">market conditions of, and overall sentiment towards, crypto assets and the crypto-economy, including, but not limited to, as a result of actions taken by or developments of other companies in the crypto-economy;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">trading activities on other crypto platforms worldwide, many of which may be unregulated, and may include manipulative activities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">investment and trading activities of highly active consumer and institutional users, speculators, miners, and investors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">the speed and rate at which crypto is able to gain adoption as a medium of exchange, utility, store of value, consumptive asset, security instrument, or other financial assets worldwide, if at all;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">decreased user and investor confidence in crypto assets and crypto platforms;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">negative publicity and events relating to the crypto-economy;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">unpredictable social media coverage or &#8220;trending&#8221; of, or other rumors and market speculation regarding, crypto assets;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">the ability for crypto assets to meet user and investor demands;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">the functionality and utility of crypto assets and their associated ecosystems and networks, including crypto assets designed for use in various applications;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">consumer preferences and perceived value of crypto assets and crypto asset markets;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">increased competition from other payment services or other crypto assets that may exhibit better speed, security, scalability, or other characteristics;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">adverse legal proceedings or regulatory enforcement actions, judgments, or settlements impacting crypto-economy participants;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">regulatory or legislative changes, scrutiny, and updates affecting the crypto-economy;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">the characterization of crypto assets under the laws of various jurisdictions around the world;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">the adoption of unfavorable taxation policies on crypto asset investments by governmental entities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">ongoing technological viability and security of crypto assets and their associated smart contracts, applications, and networks, including vulnerabilities against hacks and scalability;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">speed and fees associated with processing crypto asset transactions, including on the underlying blockchain networks and on crypto platforms;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">financial strength of market participants;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">the availability and cost of funding and capital;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">the liquidity and credit risk of other crypto platforms and other participants of the crypto-economy;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">interruptions or temporary suspensions or other compulsory restrictions in products or services from or failures of major crypto platforms;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">availability of an active derivatives market for various crypto assets;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">availability of banking and payment services to support crypto-related projects;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">instability in the global banking system and the level of interest rates and inflation;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">monetary policies of governments, trade restrictions, and fiat currency devaluations; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">national and international economic and political conditions.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is no assurance that any supported crypto asset will maintain its value or that there will be meaningful levels of trading activities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that the price of crypto assets or the demand for trading crypto assets decline, our business, operating results, and financial condition would be adversely affected and the price of our Common Stock could decline.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cyberattacks and security breaches of our platform, or those impacting our customers or third parties, could adversely affect our brand, reputation, business, operating results, and financial condition.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business involves the collection, storage, processing, and transmission of confidential information, customer, employee, service provider, and other personal data, as well as information required to access customer assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have built our reputation on the premise that our platform offers customers a secure way to purchase, store, and transact in crypto assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, any actual or perceived security breach of us or our third-party partners may:</span></div><div><span><br/></span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.76pt">harm our reputation and brand;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">result in our systems or services being unavailable and interrupt our operations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">result in improper disclosure of data and violations of applicable privacy and data protection laws;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">result in significant regulatory scrutiny, investigations, fines, penalties, and other legal, regulatory, and financial exposure;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">cause us to incur significant remediation costs;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">lead to theft or irretrievable loss of our or our customers&#8217; fiat currencies or crypto assets;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">reduce customer confidence in, or decrease customer use of, our products and services;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">divert the attention of management from the operation of our business;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">result in significant compensation or contractual penalties payable by us to our customers or third parties as a result of losses to them or claims by them; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">adversely affect our business, operating results, and financial condition.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, any actual or perceived breach or cybersecurity attack directed at other financial institutions or crypto companies, whether or not we are directly impacted, could lead to a general loss of customer confidence in the crypto-economy or in the use of technology to conduct financial transactions, which could negatively impact us, including the market perception of the effectiveness of our security measures and technology infrastructure.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An increasing number of organizations, including large merchants, businesses, technology companies, and financial institutions, as well as government institutions, have disclosed breaches of their information security systems, some of which have involved sophisticated and highly targeted attacks, including on their websites, mobile applications, and infrastructure.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attacks upon systems across a variety of industries, including the crypto industry, are increasing in their frequency, persistence, and sophistication, and, in many cases, are being conducted by sophisticated, well-funded, and organized groups and individuals, including state actors.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The techniques used to obtain unauthorized, improper, or illegal access to systems and information (including customers&#8217; personal data and crypto assets), disable or degrade services, or sabotage systems are constantly evolving, may be difficult to detect quickly, and often are not recognized or detected until after they </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have been launched against a target.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These attacks may occur on our systems or those of our third-party service providers or partners.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain types of cyberattacks could harm us even if our systems are left undisturbed.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, attacks may be designed to deceive employees and service providers into releasing control of our systems to a hacker, while others may aim to introduce computer viruses or malware into our systems with a view to stealing confidential or proprietary data.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, certain threats are designed to remain dormant or undetectable until launched against a target, and we may not be able to implement adequate preventative measures.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we have developed systems and processes designed to protect the data we manage, prevent data loss, and other security breaches, effectively to respond to known and potential risks, and expect to continue to expend significant resources to bolster these protections, there can be no assurance that these security measures will provide absolute security or prevent breaches or attacks.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may experience in the future, breaches of our security measures due to human error, malfeasance, insider threats, system errors or vulnerabilities, or other irregularities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unauthorized parties may attempt to gain access to our systems and facilities, as well as those of our customers, partners, and third-party service providers, through various means, including hacking, social engineering, phishing, and attempting to fraudulently induce individuals (including employees, service providers, and our customers) into disclosing usernames, passwords, payment card information, or other sensitive information, which may in turn be used to access our information technology systems and customers&#8217; crypto assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Threats can come from a variety of sources, including criminal hackers, hacktivists, state-sponsored intrusions, industrial espionage, and insiders.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain threat actors may be supported by significant financial and technological resources, making them even more sophisticated and difficult to detect.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we acquire a third-party entity, as to which we do not have any current plans, r companies that expose us to unexpected security risks or increase costs to improve the security posture of the acquired company.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, there has been an increase in such threat actor activities as a result of the increased prevalence of hybrid and remote working arrangements in recent years.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, our costs and the resources we devote to protecting against these advanced threats and their consequences may continue to increase over time.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outages and disruptions of our platform, including any caused by cyberattacks, may harm our reputation, business, operating results, and financial condition.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to an extensive, highly-evolving, and uncertain regulatory landscape and any adverse changes to, or our failure to comply with, any laws and regulations could adversely affect our brand, reputation, business, operating results, and financial condition.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is subject to extensive laws, rules, regulations, policies, orders, determinations, directives, treaties, and legal and regulatory interpretations and guidance in the markets in which we operate, including those governing financial services and banking, federal government contractors, trust companies, securities, derivative transactions and markets, broker-dealers and alternative trading systems (&#8220;ATS&#8221;), commodities, credit, crypto asset custody, exchange, and transfer, cross-border and domestic money and crypto asset transmission, commercial lending, usury, foreign currency exchange, privacy, data governance, data protection, cybersecurity, fraud detection, payment services (including payment processing and settlement services), consumer protection, escheatment, antitrust and competition, bankruptcy, tax, anti-bribery, economic and trade sanctions, anti-money laundering, and counter-terrorist financing.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of these legal and regulatory regimes were adopted prior to the advent of the internet, mobile technologies, crypto assets, generative artificial intelligence (&#8220;AI&#8221;) and related technologies and may not directly apply to our fintech business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, some applicable laws and regulations do not contemplate or address unique issues associated with the crypto-economy, are subject to significant uncertainty, and vary widely across US. federal, state, and local and international jurisdictions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These legal and regulatory regimes, including the laws, rules, and regulations thereunder, evolve frequently and may be modified, interpreted, and applied in an inconsistent manner from one jurisdiction to another, and may conflict with one another.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, the complexity and evolving nature of our business and the significant uncertainty surrounding the regulation of the crypto-economy requires us to exercise our judgment as to whether certain laws, rules, and regulations apply to us, and it is possible that governmental bodies and regulators may disagree with our conclusions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent we have not complied with (or are deemed not to have complied with) such laws, rules, and regulations, we could be subject to significant fines, revocation of licenses, limitations on or temporary or permanent suspensions of our products and services, reputational harm, and other regulatory consequences, each of which may be significant and could adversely affect our business, operating results, and financial condition.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Governmental and regulatory bodies, including in the United States, may introduce new policies, laws, and regulations relating to crypto assets and the crypto-economy generally, and crypto asset platforms in particular.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other companies&#8217; failures of risk management and other control functions could contribute to stricter oversight of crypto asset platforms and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the crypto-economy.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, new interpretations of existing laws and regulations may be issued by such bodies or the judiciary, which may adversely impact the development of the crypto-economy as a whole and our legal and regulatory status in particular by changing how we operate our business, how our products and services are regulated, and what products or services we and our competitors can offer, requiring changes to our compliance and risk mitigation measures, imposing new licensing requirements, or imposing a total ban on certain crypto asset transactions, as has occurred in certain jurisdictions in the past.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to comply with any new requirements, our ability to offer our products and services in their current form may be adversely affected.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, under recommendations from the Financial Crimes Enforcement Network (&#8220;FinCEN&#8221;), and the Financial Action Task Force, the United States and several foreign jurisdictions have or are likely to impose the Funds Travel Rule and the Funds Transfer Rule (commonly referred to collectively as the Travel Rule) on financial service providers in the crypto-economy.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may face substantial costs to operationalize and comply with the Travel Rule and may be further subject to administrative sanctions for technical violations or customer attrition if the user experience suffers as a result.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are substantial uncertainties regarding the scope of these requirements in practice, and we may face substantial costs to operationalize and comply with these rules.</span></div><div><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, we offer and may in the future offer products and services whose functionality or value depends in part on our management of token transaction smart contracts, liquid staking, asset tracking, or other applications that provide novel forms of customer engagement and interaction delivered via blockchain protocols.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also offer products and services whose functionality or value depends on our ability to develop, integrate, or otherwise interact with such applications within the bounds of our legal and compliance obligations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The legal and regulatory landscape for such products, including the law governing the rights and obligations between and among smart contract developers and users and the extent to which such relationships entail regulated activity is uncertain and rapidly evolving.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our interaction with those applications, and the interaction of other blockchain users with any smart contracts or assets we may generate or control, could present legal, operational, reputational, and regulatory risks for our business.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to our business activities, we are subject to ongoing examinations, oversight, and reviews and currently are, and expect in the future, to be subject to investigations and inquiries, by U.S. federal and state regulators and foreign financial service regulators, many of which have broad discretion to audit and examine our business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are periodically subject to audits and examinations by these regulatory authorities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of findings from these audits and examinations, regulators may in the future require us to take certain actions, including amending, updating, or revising our compliance measures from time to time, limiting the kinds of customers that we provide services to, changing, terminating, or delaying our licenses and the introduction of new products or services, and undertaking further external audit or being subject to further regulatory scrutiny, including investigations and inquiries.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may in the future receive examination reports citing violations of rules and regulations, inadequacies in existing compliance programs, and requiring us to initiate or enhance certain practices with respect to our compliance program, including due diligence, monitoring, training, reporting, and recordkeeping.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Implementing appropriate measures to properly remediate these examination findings may require us to incur significant costs, and if we fail to remediate properly any of these examination findings, we could face civil litigation, significant fines, damage awards, forced removal of certain employees including members of our executive team, barring of certain employees from participating in our business in whole or in part, revocation of existing licenses, limitations on existing and new products and services, reputational harm, negative impact to our existing relationships with regulators, exposure to criminal liability, or other regulatory consequences.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, we believe increasingly strict legal and regulatory requirements and additional regulatory investigations and enforcement, any of which could occur or intensify, may continue to result in changes to our business, as well as increased costs, and supervision and examination for ourselves, our agents, and service providers.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, new laws, regulations, or interpretations may result in additional litigation, regulatory investigations, and enforcement or other actions, including preventing or delaying us from offering certain products or services offered by our competitors or could impact how we offer such products and services.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adverse changes to, or our failure to comply with, any laws and regulations have had, and may continue to have, an adverse effect on our reputation and brand and our business, operating results, and financial condition.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any significant disruption in our products and services, in our information technology systems, or in any of the blockchain networks we support, could result in a loss of customers or funds and adversely affect our brand, reputation, business, operating results, and financial condition.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reputation and ability to attract and retain customers and grow our business depends on our ability to operate our service at high levels of reliability, scalability, and performance, including the ability to process and monitor, on a daily basis, a large number of transactions that occur at high volume and frequencies across multiple systems.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our platform, the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ability of our customers to trade, and our ability to operate at a high level, are dependent on our ability to access the blockchain networks underlying the supported crypto assets, for which access is dependent on our systems&#8217; ability to access the internet.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, the successful and continued operations of such blockchain networks will depend on a network of computers, miners, or validators, and their continued operations, all of which may be impacted by service interruptions.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The systems of our third-party service providers and certain crypto asset and blockchain networks have experienced from time to time, and may experience in the future service interruptions or degradation because of hardware and software defects or malfunctions, distributed denial-of-service and other cyberattacks, insider threats, break-ins, sabotage, human error, vandalism, earthquakes, hurricanes, floods, fires, and other natural disasters, power losses, disruptions in telecommunications services, fraud, military or political conflicts, terrorist attacks, computer viruses or other malware, or other events.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, extraordinary trading volumes or site usage could cause our computer systems to operate at an unacceptably slow speed or even fail.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of our systems, or those of our third-party service providers, are disrupted for any reason, our products and services may fail, resulting in unanticipated disruptions, slower response times and delays in our customers&#8217; trade execution and processing, failed settlement of trades, incomplete or inaccurate accounting, recording or processing of trades, unauthorized trades, loss of customer information, increased demand on limited customer support resources, customer claims, complaints with regulatory organizations, lawsuits, or enforcement actions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, when these disruptions occur, we have in the past, and may in the future, fulfill customer transactions using inventory to prevent adverse user impact and limit detrimental impact to our operating results.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A prolonged interruption in the availability or reduction in the availability, speed, or functionality of our products and services could harm our business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant or persistent interruptions in our services could cause current or potential customers or partners to believe that our systems are unreliable, leading them to switch to our competitors or to avoid or reduce the use of our products and services, and could permanently harm our reputation and brands.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, to the extent that any system failure or similar event results in damages to our customers or their business partners, these customers or partners could seek significant compensation or contractual penalties from us for their losses, and those claims, even if unsuccessful, would likely be time-consuming and costly for us to address.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Problems with the reliability or security of our systems would harm our reputation and the cost of remedying these problems could negatively affect our business, operating results, and financial condition.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we are a regulated financial institution in certain jurisdictions, interruptions have resulted and in the future may result in regulatory scrutiny, and significant or persistent interruptions could lead to significant fines and penalties, and mandatory and costly changes to our business practices, and ultimately could cause us to lose existing licenses or banking relationships that we need to operate or prevent or delay us from obtaining additional licenses that may be required for our business.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we are continually improving and upgrading our information systems and technologies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Implementation of new systems and technologies is complex, expensive, time-consuming, and may not be successful.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to timely and successfully implement new information systems and technologies, or improvements or upgrades to existing information systems and technologies, or if such systems and technologies do not operate as intended, it could adversely affect our internal controls (including internal controls over financial reporting), and our business, operating results, and financial condition.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to retain existing customers or add new customers, or if our customers decrease their level of engagement with our products, services and platform, our business, operating results, and financial condition may be significantly harmed.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends on our ability to retain existing customers and attract new customers, including developers, to increase engagement with our products, services, and platform.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To do so, we must continue to offer leading technologies and ensure that our products and services are secure, reliable, and engaging.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We must also expand our products and services, and offer competitive prices in an increasingly crowded and price-sensitive market.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is no assurance that we will be able to continue to do so, that we will be able to retain our current customers or attract new customers, or keep our customers engaged.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any number of factors can negatively affect customer retention, growth, and engagement, including if:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.76pt">customers increasingly engage with competing products and services, including products and services that we are unable to offer due to regulatory reasons;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">we fail to introduce new and improved products and services, or if we introduce new products or services that are not favorably received;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">we fail to support new and in-demand crypto assets or if we elect to support crypto assets with negative reputations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">there are changes in sentiment about the quality or usefulness of our products and services or concerns related to privacy, security, fiat pegging, or other factors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">there are adverse changes in our products and services that are mandated by legislation, regulatory authorities, or litigation;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">customers perceive the crypto assets on our platform to be bad investments, or experience significant losses in investments made on our platform;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">technical or other problems prevent us from delivering our products and services with the speed, functionality, security, and reliability that our customers expect;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">cybersecurity incidents, employee or service provider misconduct, or other unforeseen activities cause losses to us or our customers, including losses to assets held by us on behalf of our customers;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">modifications to our pricing model or modifications by competitors to their pricing models;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">we fail to provide adequate customer service;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">regulatory and governmental bodies in countries that we target for expansion express negative views towards crypto asset trading platforms and, more broadly, the crypto-economy; or</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.37pt">we or other companies or high-profile figures in our industry are the subject of adverse media reports or other negative publicity.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, certain of these factors may negatively affect customer retention, growth, and engagement to varying degrees.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to maintain or increase our customer base and customer engagement, our revenue and financial results may be adversely affected.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any decrease in user retention, growth, or engagement could render our products and services less attractive to customers and lead to a decrease in revenue, and our business, operating results, and financial condition could be adversely affected.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our customer growth rate slows or declines, we will become increasingly dependent on our ability to maintain or increase levels of user engagement and monetization in order to drive growth of revenue.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our operating expenses may increase in the future and we may not be successful in increasing our revenue to sufficiently offset these higher expenses, which could impact our ability to achieve profitability or positive cash flow from operations on a consistent basis and cause our business, operating results, and financial condition to be adversely affected.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating expenses may increase in the future as we continue to grow our business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we consistently evaluate opportunities to drive efficiency, we cannot guarantee that these efforts will be successful or that we will not need to accelerate operating expenditures in the future.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations may prove more expensive than we currently anticipate, and we may not succeed in increasing our net revenue sufficiently to offset these higher expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, our revenue growth may be negatively impacted by, among other things, reduced demand for our offerings, increased competition, adverse macroeconomic conditions, any decrease in the growth or size of the crypto-economy, regulatory uncertainty or scrutiny, changes that impact our ability to offer certain products or services, or failure of new products and services to gain market adoption.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, we cannot be certain that we will be able to achieve profitability or achieve positive operating cash flow on any quarterly or annual basis.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to effectively manage these risks and difficulties as we encounter them, our business, operating results, and financial condition may suffer.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we do not effectively manage our growth, including by maintaining and improving our systems and processes, our business, operating results, and financial condition could be adversely affected.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced, and may experience in the future, periods of significant growth.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To manage and capitalize on our growth periods effectively, we will need to manage headcount, capital, and processes efficiently, while making investments, such as expanding our information technology and financial, operating, and administrative systems and controls, and such initiatives could strain our resources.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We could experience operating difficulties in managing our business as it expands across numerous jurisdictions, including difficulties in hiring, training, managing, and retaining a </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">remote and evolving employee base.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we do not adapt or scale to meet these evolving challenges, we may experience erosion to our brand, the quality of our products and services may suffer, and our Company&#8217;s culture may be harmed.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, the failure of our systems and processes could undermine our ability to provide accurate, timely, and reliable reports on our financial and operating results, including the financial statements provided herein, and could impact the effectiveness of our internal controls over financial reporting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our systems and processes may not prevent or detect all errors, omissions, or fraud.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of the foregoing operational failures could lead to noncompliance with laws and regulations, loss of operating licenses or other authorizations, or loss of bank relationships that could substantially impair or even suspend company operations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Successful implementation of our growth strategy will also require significant expenditures possibly prior to the generation of any substantial associated revenue and we cannot guarantee that these increased investments will result in corresponding and offsetting revenue growth.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we have a limited history operating our business at its current scale, it is difficult to evaluate our current business and future prospects, including our ability to plan for and model future growth.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our limited operating experience at this scale, combined with the rapidly evolving and volatile nature of the cryptoasset market in which we operate, and other economic factors beyond our control, reduces our ability to accurately forecast quarterly or annual revenue accurately.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Due to our limited fintech operating history, it may be difficult to evaluate our business and future prospects, and we may not be able to achieve or maintain profitability in any given period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We acquired our crypto processing segment in Spring of 2024 with the acquisition of our operating subsidiary and since then our business model has continued to evolve.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net revenue has significantly grown since that acquisition; but, there is no assurance that growth will continue in future periods and you should not rely on growth of our revenue in any given prior quarterly or annual period as an indication of our future performance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our net revenue were to decline significantly for any extended period of time, our business, operating results, and financial condition could be adversely affected.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our limited operating history and the volatile nature of our business make it difficult to evaluate our current business and our future prospects.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have encountered and will continue to encounter risks and difficulties as described in this section.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we do not manage these risks successfully, our business, operating results, and financial condition could be adversely affected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any acquisitions and investments that we make could require significant management attention, disrupt our business, result in dilution to our stockholders, and could adversely affect our business, operating results, and financial condition.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our business strategy, we routinely conduct discussions and evaluate opportunities for possible acquisitions, strategic investments, entries into new businesses, joint ventures, and other transactions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made, and may make, acquisitions of and investments in, among other things, specialized employees and complementary companies, products, services, licenses, or technologies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the future, the pace and scale of our acquisitions may increase and may include larger acquisitions than we have done historically.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the future, we may not be able to find other suitable acquisition candidates, and we may not be able to complete acquisitions on favorable terms, if at all.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some cases, the costs of such acquisitions may be substantial, and there is no assurance that we will receive a favorable return on investment for our acquisitions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our acquisitions may not achieve our goals, and any future acquisitions we complete could be viewed negatively by customers, developers, or investors.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if we fail to successfully close or integrate any acquisitions, or integrate the products or technologies associated with such acquisitions into our Company, our business, operating results, and financial condition could be adversely affected.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to acquire and integrate companies, products, services, licenses, employees, or technologies in a successful manner is unproven.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any integration process may require significant time and resources, and we may not be able to manage the process successfully, including successfully securing regulatory approvals which may be required to close the transaction and to continue to operate the target firm&#8217;s business or products in a manner that is useful to us.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not successfully evaluate or utilize the acquired products, services, technology, or personnel, or accurately forecast the financial impact of an acquisition transaction, including accounting charges.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may have to pay cash, incur debt, or issue equity securities to pay for any such acquisition, which could adversely affect our business, operating results, and financial condition.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sale of equity or issuance of debt to finance any such acquisitions could result in dilution to our stockholders, which, depending on the size of the acquisition, may be significant.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The incurrence of indebtedness would result in increased fixed obligations and could also include covenants or other restrictions that would impede our ability to manage our operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to develop, maintain, and enhance our brand and reputation, our business, operating results, and financial condition could be adversely affected.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our brand and reputation are key assets and a competitive advantage.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maintaining, protecting, and enhancing our brand depends largely on the success of our marketing efforts, ability to provide consistent, high-quality, and secure products, services, features, and support, and our ability to successfully secure, maintain, and defend our rights to use the ALT5 and ALT5 Sigma branding.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the importance of our brand will increase as competition further intensifies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our brand and reputation could be harmed if we fail to achieve these objectives or if our public image were to be tarnished by negative publicity, unexpected events, or actions by third parties.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unfavorable publicity regarding, for example, our product changes, product quality, litigation or regulatory activity, privacy and data security practices, terms of service, employment matters, the use of our products or services for illicit or objectionable ends, the actions of our customers, or the actions of other companies that provide similar services to ours, has in the past, and could in the future, adversely affect our reputation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, to the extent that we acquire a company and maintain that acquired company&#8217;s separate brand, we could experience brand dilution or fail to retain positive impressions of our own brand to the extent such impressions are instead attributed to the acquired company&#8217;s brand.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Such negative publicity also could have an adverse effect on the size and engagement of our customers and could result in decreased revenue, which could adversely affect our business, operating results, and financial condition.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Internal key business metrics and other estimates are subject to inherent challenges in measurement and change as our business evolves, and our business, operating results, and financial condition could be adversely affected by real or perceived inaccuracies in those metrics or any changes in metrics we disclose.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly review our internal key business metrics to evaluate our business, measure our performance, identify trends affecting our business, and make strategic decisions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These internal key business metrics are calculated using internal company data and have not been validated by an independent third party.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While these numbers are based on what we believe to be reasonable estimates for the applicable period of measurement at the time of reporting, there are inherent challenges in such measurements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to maintain an effective analytics platform, our internal key business metrics calculations may be inaccurate, and we may not be able to identify those inaccuracies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we may in the future calculate certain internal key business metrics using third-party data.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we believe the third-party data we may use in the future will be reliable, we may not in the future independently verify the accuracy or completeness of the data contained in such sources and there can be no assurance that such data is free of error.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any inaccuracy in the third-party data we use could cause us to overstate or understate our internal key business metrics.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly review our processes for calculating these metrics, and from time to time we have made adjustments that we believe may improve their accuracy.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our platform may be exploited to facilitate illegal activity such as fraud, money laundering, gambling, tax evasion, and scams.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our platform is used to further such illegal activities, our business, operating results, and financial condition could be adversely affected.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our platform may be exploited to facilitate illegal activity such as fraud, money laundering, gambling, tax evasion, and scams.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We or our partners may be specifically targeted by individuals seeking to conduct fraudulent transfers, and it may be difficult or impossible for us to detect and avoid such transactions in certain circumstances.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The use of our platform for illegal or improper purposes could subject us to claims, individual and class action lawsuits, and government and regulatory investigations, prosecutions, enforcement actions, inquiries, or requests that could result in liability and reputational harm for us.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, certain activities that may be legal in one jurisdiction may be illegal in another jurisdiction, and certain activities that are at one time legal may in the future be deemed illegal in the same jurisdiction.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, there is significant uncertainty and cost associated with detecting and monitoring transactions for compliance with local laws.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that a customer is found responsible for intentionally or inadvertently violating the laws in any jurisdiction, we may be subject to governmental inquiries, enforcement actions, prosecuted, or otherwise held secondarily liable for aiding or facilitating such activities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in law have also increased the penalties for money transmitters for certain illegal activities, and government authorities may consider increased or additional penalties from time to time.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Owners of intellectual property rights or government authorities may seek to bring legal action against money transmitters, including us, for involvement in the sale of infringing or allegedly infringing items.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any threatened or resulting claims could result in reputational harm, and any resulting liabilities, loss of transaction volume, or increased costs could harm our business.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, while fiat currencies can be used to facilitate illegal activities, crypto assets are relatively new and, in many jurisdictions, may be lightly regulated or largely unregulated.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many types of crypto assets have characteristics, such as the speed with which digital currency transactions can be conducted, the ability to conduct transactions without the involvement of regulated intermediaries, the ability to engage in transactions across multiple jurisdictions, the irreversible nature of certain crypto asset transactions, and encryption technology that anonymizes these transactions, that make crypto assets susceptible to use in illegal activity.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. federal and state and foreign regulatory authorities and law enforcement agencies, such as the Department of Justice, Securities and Exchange Commission, Commodity Futures Trading Commission, Federal Trade Commission, or the Internal Revenue Service, and various state securities and financial regulators have taken and continue to take legal action against persons and entities alleged to be engaged in fraudulent schemes or other illicit activity involving crypto assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also support crypto assets that incorporate privacy-enhancing features, and may from time to time support additional crypto assets with similar functionalities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These privacy-enhancing crypto assets obscure the identities of sender and receiver, and may prevent law enforcement officials from tracing the source of funds on the blockchain.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facilitating transactions in these crypto assets may cause us to be at increased risk of liability arising out of anti-money laundering and economic sanctions laws and regulations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our compliance and risk management methods might not be effective and may result in outcomes that could adversely affect our reputation, operating results, and financial condition.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to comply with applicable complex and evolving laws, regulations, and rules is largely dependent on the establishment, maintenance, and scaling of our compliance, internal audit, and reporting systems continuously to keep pace with our customer activity and transaction volume, as well as our ability to attract and retain qualified compliance and other risk management personnel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we have devoted comparatively significant resources to develop policies and procedures to identify, monitor, and manage our risks, and expect to continue to do so in the future, we cannot assure you that our policies and procedures are and will always be effective or that we have been and will always be successful in monitoring or evaluating the risks to which we are or may be exposed in all market environments or against all types of risks, including unidentified or unanticipated risks.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our risk management policies and procedures rely on a combination of technical and human controls and supervision that are subject to error and failure.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our methods for managing risk are discretionary by nature and are based on internally developed controls and observed historical market behavior, and also involve reliance on standard industry practices.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These methods may not adequately prevent losses, particularly as they relate to extreme market movements, which may be significantly greater than historical fluctuations in the market.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, in the future, we may identify gaps in such policies and procedures or existing gaps may become higher risk, and may require significant resources and management attention.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our risk management policies and procedures also may not adequately prevent losses due to technical errors if our testing and quality control practices are not effective in preventing failures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may elect to adjust our risk management policies and procedures to allow for an increase in risk tolerance, which could expose us to the risk of greater losses.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The crypto-economy is novel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">As a result, policymakers are just beginning to consider what a regulatory regime for crypto would look like and the elements that would serve as the foundation for such a regime.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">This less developed consideration of crypto may harm our ability to effectively react to proposed legislation and regulation of crypto assets or crypto asset platforms adverse to our business.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As crypto assets have grown in both popularity and market size, various U.S. federal, state, and local and foreign governmental organizations, consumer agencies, and public advocacy groups have been examining the operations of crypto networks, users, and platforms, with a focus on how crypto assets can be used to launder the proceeds of illegal activities, fund criminal or terrorist enterprises, and simultaneously how to ensure the safety and soundness of platforms and other service providers that hold crypto assets for users.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of these entities have called for heightened regulatory oversight, and have issued consumer advisories describing the risks posed by crypto assets to users and investors.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competitors, including traditional financial services, have spent years cultivating professional relationships with relevant policymakers on behalf of their industry so that those policymakers may understand that industry, the current legal landscape affecting that industry, and the specific policy proposals that could be implemented in order to responsibly develop that industry.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lobbyists working for these competitors have similarly spent years developing and working to implement strategies to advance these industries.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Members of the crypto-economy have started to engage policymakers directly and with the help of external advisors and lobbyists.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, these efforts to educate policymakers and advocate for sensible regulation are nascent compared to more established industries, and may be perceived unfavorably by investors and the public and have an adverse impact on our brand and reputation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, new laws and regulations may be </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">proposed and adopted in the United States and internationally, or existing laws and regulations may be interpreted in new ways, that harm the crypto-economy or crypto asset platforms, which could adversely affect our business, operating results, and financial condition.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We obtain and process a large amount of sensitive customer data.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any real or perceived improper use of, disclosure of, or access to such data could harm our reputation, as well as adversely affect our business, operating results, and financial condition.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtain and process large amounts of sensitive data, including personal data related to our customers and their transactions, such as their names, addresses, social security numbers, visa information, copies of government-issued identification, facial recognition data (from scanning of photographs for identity verification), trading data, tax identification, and bank account information.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face risks, including to our reputation, in the handling and protection of this data, and these risks will increase as our business continues to expand, including through our acquisition of, and investment in, other companies and technologies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal, state, and international laws and regulations governing privacy, data protection, and e-commerce transactions require us to safeguard our customers&#8217;, employees&#8217;, and service providers&#8217; personal data.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have administrative, technical, and physical security measures and controls in place and maintain a robust information security program.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, our security measures, those of our vendors or service providers, or the security measures of companies we acquire, may be inadequate or breached as a result of third-party action, employee or service provider error, malfeasance, malware, phishing, hacking attacks, system error, trickery, advances in computer capabilities, new discoveries in the field of cryptography, inadequate facility security or otherwise, and, as a result, someone may be able to obtain unauthorized access to sensitive information, including personal data, on our systems.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We could be the target of a cybersecurity incident, which could result in harm to our reputation and financial losses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, privacy and data protection laws are evolving, and these laws may be interpreted and applied in a manner that is inconsistent with our data handling safeguards and practices that could result in fines, lawsuits, and other penalties, and significant changes to our or our third-party partners&#8217; business practices and products and service offerings.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future success depends on the reliability and security of our platform.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that the measures we, any companies we acquire, or our third-party service providers, vendors, or business partners have taken prove to be insufficient or inadequate, or to the extent we discover a security breach suffered by a company we acquire following the closing of such acquisition, we may become subject to litigation, breach notification obligations, or regulatory or administrative sanctions, which could result in significant fines, penalties, damages, harm to our reputation, or loss of customers.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our own confidential business information or sensitive customer information were improperly disclosed, our business, operating results, and financial condition could be adversely affected.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, a party who circumvents our security measures could, among other effects, appropriate customer information or other proprietary data, cause interruptions in our operations, or expose customers to hacks, viruses, and other disruptions.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the nature of the information compromised, in the event of a data breach or other unauthorized access to our customer data, we may also have obligations to notify customers and regulators about the incident, and we may need to provide some form of remedy, such as a subscription to credit monitoring services, pay significant fines to one or more regulators, or pay compensation in connection with a class-action settlement.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Breach notification laws continue to evolve and may be inconsistent from one jurisdiction to another.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, the SEC has adopted rules for mandatory disclosure of material cybersecurity incidents suffered by public companies, as well as cybersecurity governance and risk management.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Complying with these obligations could cause us to incur substantial costs and could increase negative publicity surrounding any incident that compromises customer data.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any failure or perceived failure by us to comply with these laws may also subject us to enforcement action or litigation, any of which could harm our business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the financial exposure from the events referenced above could either not be insured against or not be fully covered through any insurance that we may maintain, and there can be no assurance that the limitations of liability in any of our contracts would be enforceable or adequate or would otherwise protect us from liabilities or damages as a result of the events referenced above.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of the foregoing could adversely affect our business, reputation, operating results, and financial condition.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, we may be required to disclose personal data pursuant to demands from individuals, regulators, government agencies, and law enforcement agencies in various jurisdictions with conflicting privacy and security laws, which could result in a breach of privacy and data protection policies, notices, laws, rules, court orders, and regulations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, changes in the laws and regulations that govern our collection, use, and disclosure of customer data could impose additional requirements with respect to the retention and security of customer data, could limit our marketing activities, and adversely affect our business, operating results, and financial condition.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to laws, regulations, and industry requirements related to data privacy, data protection and information security, and user protection where we conduct our business, and industry requirements and such laws, regulations, and industry requirements are constantly evolving and changing.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any actual or perceived failure to comply with such laws, regulations, and industry requirements, or our privacy policies, could harm our business.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various local, state, federal, and international laws, directives, and regulations apply to our collection, use, retention, protection, disclosure, transfer, and processing of personal data.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These data protection and privacy laws and regulations are subject to uncertainty and continue to evolve in ways that could adversely affect our business, operating results, and financial condition.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These laws have a substantial impact on our operations both outside and in the United States, either directly or as a data processor and handler for various offshore entities.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, state and federal lawmakers and regulatory authorities have increased their attention on the collection and use of user data and various laws and regulations apply to the collection, processing, disclosure, and security of certain types of data, including the Gramm Leach Bliley Act (&#8220;GLBA&#8221;) and state laws relating to privacy and data security.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GLBA requires financial institutions to explain their information sharing practices to their customers and to safeguard sensitive data.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Federal Trade Commission and many state attorneys general are interpreting federal and state consumer protection laws as imposing standards for the online collection, use, dissemination, and security of data.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, California has enacted the California Consumer Privacy Act (the &#8220;CCPA&#8221;).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CCPA requires covered companies to, among other things, provide disclosures to individuals in California, and affords such individuals new privacy rights such as the ability to opt-out of certain sales of personal information and expanded rights to access and require deletion of their personal information, opt out of certain personal information sharing, and receive detailed information about how their personal information is collected, used, and shared.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CCPA provides for civil penalties for violations, as well as a private right of action for security breaches that may increase security breach litigation.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, other U.S. states have proposed or enacted laws that contain obligations similar to the CCPA that have taken effect or will take effect in coming years.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot fully predict the impact of recently proposed or enacted laws or regulations on our business or operations, but compliance may require us to modify our data processing practices and policies incurring costs and expense.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, to the extent multiple state-level laws are introduced with inconsistent or conflicting standards, it may require costly and difficult efforts to achieve compliance with such laws.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our failure or perceived failure to comply with state privacy laws or regulations passed in the future could adversely affect our business, including how we use personal information, operating results, and financial condition.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is a risk that as we expand, we may assume liabilities for breaches experienced by the companies that we may acquire.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, there are potentially inconsistent world-wide government regulations pertaining to data protection and privacy.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite our efforts to comply with applicable laws, regulations, and other obligations relating to privacy, data protection, and information security, it is possible that our practices, offerings, or platform could fail, or be alleged to fail to meet applicable requirements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For instance, the overall regulatory framework governing the application of privacy laws to blockchain technology is still highly undeveloped and likely to evolve.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further there are also changes in the regulatory landscape relating to new and evolving technologies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our failure, or the failure by our third-party providers or partners, to comply with applicable laws or regulations and to prevent unauthorized access to, or use or release of personal data, or the perception that any of the foregoing types of failure has occurred, even if unfounded, could subject us to audits, inquiries, whistleblower complaints, adverse media coverage, investigations, severe criminal, or civil sanctions, damage our reputation, or result in fines or proceedings by governmental agencies and private claims and litigation, any of which could adversely affect our business, operating results, and financial condition.</span></div><div style="margin-top:15pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our intellectual property rights are valuable, and any inability to protect them could adversely affect our business, operating results, and financial condition.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business depends in large part on our proprietary technology and, to a smaller extent, on our brand.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on, and expect to continue to rely on, a combination of trade dress, domain name, and trade secrets, as well as confidentiality and license agreements with our employees, contractors, consultants, and third parties with whom we have relationships, to establish and protect our brand and other intellectual property rights.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, our efforts to protect our intellectual property rights may not be sufficient or effective.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our proprietary technology and trade secrets could be lost through misappropriation or breach of our confidentiality and license agreements, and any of our intellectual property rights may be challenged, which could result in them being narrowed in scope or declared invalid or unenforceable.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There can be no </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">assurance that our intellectual property rights will be sufficient to protect against others offering products, services, or technologies that are substantially similar to ours and that compete with our business.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective protection of our intellectual property may be expensive and difficult to maintain, both in terms of application and registration costs as well as the costs of defending and enforcing those rights.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, intellectual property protection may not be available to us in every country in which our products and services are available, and the regulatory landscape in such jurisdictions may evolve rapidly, leading to an unanticipated change in the ability to obtain and enforce intellectual property rights in these jurisdictions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The loss of one or more of our key personnel, or our failure to attract and retain other highly qualified personnel in the future, could adversely affect our business, operating results, and financial condition.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a relatively new industry that is not widely understood and requires highly skilled and technical personnel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our future success is highly dependent on the talents and contributions of our operating subsidiary&#8217;s management team and other key employees across product, engineering, risk management, finance, and marketing.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future success depends on our ability to attract, develop, motivate, and retain highly qualified and skilled employees.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pool of qualified talent in our industry is extremely limited, particularly with respect to executive talent, engineering, risk management, and financial regulatory expertise.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face intense competition for qualified individuals from numerous software and other technology companies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To attract and retain key personnel, we incur significant costs, including salaries and benefits and equity incentives.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even so, these measures may not be enough to attract and retain the personnel we require to operate our business effectively.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss of even a few key employees or senior leaders, or an inability to attract, retain and motivate additional highly skilled employees required for the planned expansion of our business could adversely affect our business, operating results, and financial condition and impair our ability to grow.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our culture emphasizes innovation, and if we cannot maintain this culture, our business, operating results, and financial condition could be adversely affected.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our entrepreneurial and innovative corporate culture has been a key contributor to our success since our acquisition of our operating subsidiary.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We encourage and empower our employees to develop new and innovative products and services, which we believe is essential to attracting high quality talent, partners, and developers, as well as serving the best, long-term interests of our company.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we cannot maintain this culture, we could lose the innovation, creativity, and teamwork that has been integral to our operating crypto business.</span></div><div style="margin-top:12pt;text-align:justify"><span id="i272ab477404c49489c7330cc5841dd26_274774"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Our Biotechnology Segment</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to implement our biopharmaceutical business strategy or if our biopharmaceutical business strategy is ineffective, our financial performance could be materially and adversely affected.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future financial performance and success are dependent in large part upon the effectiveness of our new biopharmaceutical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">business strategy and our ability to implement our biopharmaceutical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">business strategy successfully. Implementation of our strategy will require effective management of our operational, financial, and human resources and will place significant demands on those resources. There are risks involved in pursuing our strategy, including those under the caption &#8220;Risks Relating to Our Biotechnology Segment&#8221;. In addition to the risks set forth elsewhere in this Form 10-K, effectiveness of and the successful implementation of our business strategy could also be affected by a number of factors beyond our control, such as increased competition, legal developments, government regulation, general economic conditions, increased operating costs or expenses, and changes in industry trends. We may decide to alter or discontinue certain aspects of our business strategy at any time. If we are not able to implement our business strategy successfully, our long-term growth and profitability may be adversely affected. Even if we are able to implement some or all of the initiatives of our business strategy successfully, our operating results may not improve and could decline substantially.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our biotechnology business has a limited operating history.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our biotechnology business was started in September 2019 and has a limited operating history. We have not commenced revenue-producing operations. To date, our biotechnology-related operations have consisted of preliminary research and development, and characterization and testing of SR TV1001 (now known as JAN101) and our December 2022 acquisition of Soin Therapeutics and its LDN product (now known as JAN123). Our limited operating history makes it difficult for potential investors to evaluate our technology or the prospective operations of our biotechnology business. You should consider the prospects of our biotechnology business in light of the costs, uncertainties, delays, and difficulties frequently encountered by companies in the early stages of development, especially clinical-stage biopharmaceutical businesses such </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as ours. Potential investors should carefully consider the risks and uncertainties that a biotechnology business with a limited operating history faces. In particular, potential investors should consider that we may be unable to (i) successfully implement or execute the business plan of our biotechnology business or currently validate that our biotechnology business plan is sound; (ii) successfully complete clinical trials and obtain regulatory approval for the marketing of JAN101 or JAN123; (iii) successfully demonstrate a favorable differentiation between JAN101 or JAN123 and the current products on the market; (iv) successfully manufacture our clinical drug product and establish a commercial drug supply; (v) secure market exclusivity and/or adequate intellectual property protection for JAN101 or JAN123; and (vi) raise sufficient funds in the capital markets to effectuate our biotechnology business plan, including product and clinical development, regulatory approval, and commercialization for JAN101 or JAN123.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business model is partially dependent on certain patent rights licensed to us from the Licensors (as defined below), and the loss of those license rights would, in all likelihood, cause our business, as presently contemplated, to fail.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, UABRF, TheraVasc, and the Board of Supervisors of Louisiana State University and Agricultural and Mechanical College, acting on behalf of LSU Health Shreveport, together with UABRF and TheraVasc, (collectively, the &#8220;Licensors&#8221;), granted us an exclusive worldwide, royalty-bearing license to the patent rights for SR TV1001 (now known as JAN101) in the negotiated fields of use. The patent license agreement requires us to pay royalties and milestone payments and conform to a variety of covenants and agreements, and in the event of our breach of the agreement, the Licensors may elect to terminate the agreement. As of the date of this Form 10-K, we believe we are in compliance with the patent license agreement and consider our relationship with the Licensors to be excellent. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will be completely dependent on third parties to manufacture JAN101 and JAN123, and their commercialization could be halted, delayed, or made less profitable if those third parties fail to obtain manufacturing approval from the FDA or comparable foreign regulatory authorities, fail to provide us with sufficient quantities of JAN101 or JAN123, or fail to do so at acceptable quality levels or prices. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not currently have, nor do we plan to acquire, the capability or infrastructure to manufacture our drug candidate for use in our clinical trials or for commercial sales, if any. As a result, we will be obligated to rely on contract manufacturers when we conduct clinical trials and if and when our initial or subsequent product candidates are approved for commercialization. In January 2020, we entered into a Master Agreement for Development, Manufacturing and Supply with CoreRx Inc. (&#8220;CoreRx&#8221;), pursuant to which CoreRx has agreed to provide to us certain product testing, development, and clinical manufacturing services for JAN101. We have not yet entered into any manufacturing agreements for the manufacture of JAN123 and must identify and contract with a company capable of producing sufficient quantities of this product for our clinical trials.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not entered into agreements with any contract manufacturers for commercial supply for either JAN101 or JAN123 and may not be able to engage contract manufacturers for commercial supply of our initial or subsequent product candidates on favorable terms to us, or at all, should the need arise.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not currently have, nor do we plan to acquire, the capability or infrastructure to manufacture our drug candidate for use in our clinical trials or for commercial sales, if any. As a result, we will be obligated to rely on contract manufacturers when we conduct clinical trials and if and when our initial or subsequent product candidates are approved for commercialization. In January 2020, we entered into a Master Agreement for Development, Manufacturing and Supply with CoreRx Inc. (&#8220;CoreRx&#8221;), pursuant to which CoreRx has agreed to provide to us certain product testing, development, and clinical manufacturing services for JAN 101. We have not entered into agreements with any contract manufacturers for commercial supply and may not be able to engage contract manufacturers for commercial supply of our initial or subsequent product candidates on favorable terms to us, or at all, should the need arise.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In a previous clinical trial, the manufacture of JAN101 by a different manufacturing company resulted in a product that demonstrated initial instability that led to the product being out-of-specification. While the FDA allowed the trial to continue, there is no guarantee that, if the product manufactured by CoreRx is similarly unstable, the FDA will allow us to continue to develop that product. Even if the product manufactured by CoreRx is stable, the FDA may require additional studies to confirm the stability of the product, increasing development cost and times.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The facilities used by CoreRx to manufacture JAN101 must be approved by the FDA or comparable foreign regulatory authorities. Such approvals are subject to inspections that will be conducted after we submit an NDA to the FDA or their equivalents to other relevant regulatory authorities. We will not control the manufacturing process of JAN101, JAN123 or subsequent product candidates and will be completely dependent on our contract manufacturing partners for compliance with cGMPs, for manufacture of both active drug substances and finished drug products. These cGMP regulations cover all aspects of the manufacturing, testing, quality control, storage, distribution, and record keeping relating to our initial or subsequent product candidates. If our contract manufacturers do not successfully manufacture material that conforms to our specifications and the strict regulatory requirements of the FDA or others, we will not be able to secure or maintain regulatory approval for products made at their manufacturing facilities. If the FDA or a comparable foreign regulatory </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">authority does not approve these facilities for the manufacture of our initial or subsequent product candidates or if it withdraws any such approval in the future, we may need to find alternative manufacturing facilities, which would significantly impact our ability to develop, manufacture, obtain regulatory approval for, or market our initial or subsequent product candidates, if approved. Likewise, we could be negatively impacted if any of our contract manufacturers elect to discontinue their business relationship with us.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contract manufacturer will be subject to ongoing periodic unannounced inspections by the FDA and corresponding state and foreign agencies for compliance with cGMPs and similar regulatory requirements. We will not have control over our contract manufacturer&#8217;s compliance with these regulations and standards. Failure by our contract manufacturer to comply with applicable regulations could result in sanctions being imposed on us, including fines, injunctions, civil penalties, failure to grant approval to market JAN101 or JAN123, delays, suspensions or withdrawals of approvals, inability to supply product, operating restrictions, and criminal prosecutions, any of which could significantly and adversely affect our biotechnology business. In addition, we will not have control over the ability of our contract manufacturer to maintain adequate quality control, quality assurance, and qualified personnel. Failure by our contract manufacturer to comply with or maintain any of these standards could adversely affect our ability to develop, manufacture, obtain regulatory approval for or market JAN101 or JAN123, if approved.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our manufacturer must obtain the API from a third party. A number of groups manufacture our API; however, some of these are manufactured as a food product, and others, while manufactured under GMP, do not have the required Drug Master File on file with the FDA. CoreRx identified an API from Merck KGaA for use in the current production of clinical grade JAN101. At the time of the manufacture of the API, the product met the specifications outlined in both the drug substance monographs for Europe and the US. However, subsequent to the manufacture of the API, the US monograph was changed in the US Pharmacopeia (&#8220;USP&#8221;) and, while most of the tests conform, Merck KGaA was unable to complete two of the new testing requirements. Although the two tests are not considered safety issues and do not impact the quality of the product, there is no guarantee the FDA will approve the product for clinical trials if the two tests are not completed, which could delay our ability to start the Phase IIb clinical trial, as planned. Identifying an analytical laboratory to perform the two tasks may be difficult and could require development and validation of the tests, adding both time and costs to us. In addition, there is no guarantee that, once developed, the product will meet the specifications as outlined in the USP. Even if the FDA allows the current product to be used in the Phase IIb clinical trial, there is no guarantee that the FDA will allow further clinical work with the product or commercialization of the product until it is shown to conform to USP standards. We may be required to work with the API manufacturer to file the appropriate documents and there is no guarantee that the FDA will approve the filing. This could necessitate additional funding to hire an API manufacturer and produce the product under GMP with all necessary filings.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If, for any reason, these third parties are unable or unwilling to perform, we may not be able to locate alternative manufacturers or formulators or enter into favorable agreements with them and we cannot be certain that any such third parties will have the manufacturing capacity to meet future requirements. If these manufacturers or any alternate manufacturer of finished drug product experiences any significant difficulties in its respective manufacturing processes for APIs or finished products or should cease doing business with us for any reason, we could experience significant interruptions in the supply of our initial or subsequent product candidates or may not be able to create a supply of any of our ls at all. Were we to encounter manufacturing difficulties, our ability to produce a sufficient supply of any of our product candidates might be negatively affected. Our inability to coordinate the efforts of our third-party manufacturing partners, or the lack of capacity available at our third-party manufacturing partners, could impair our ability to supply any of our product candidates at required levels. Because of the significant regulatory requirements that we would need to satisfy in order to qualify a new bulk drug substance or finished product manufacturer, if we face these or other difficulties with our then-current manufacturing partners, we could experience significant interruptions in the supply of any of our product candidates if we decided to transfer the manufacture of any of our product candidates to one or more alternative manufacturers in an effort to deal with such difficulties.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CoreRx currently serves as our sole manufacturer of JAN101. As CoreRx also manufactures other products, there can be no guarantee that CoreRx will have the capacity to manufacture additional clinical product for us in a timely manner, when required, which could lead to significant delays in initiating other clinical studies. CoreRx will unlikely have the capacity to manufacture the amount of product needed, if and when JAN101 is approved for marketing. This would necessitate identifying additional manufacturer(s) who may or may not be able to replicate the manufacturing process developed at CoreRx. In addition, the increase in quantities required for commercialization of the product, if commercialization occurs, could require modifying the manufacturing process to produce larger quantities of tablets more efficiently. Such modifications of the manufacturing process, if even possible, could result in significant delays in the delivery of the product.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will be validating the manufacturing process, with appropriate process parameters and critical process, at CoreRx in 2024. Based on current batch sizes, these validated processes will support the manufacture of approximately 6.5 million </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tablets a month. This would allow us to enter the marketplace, but would support sales of only 1-2% of the addressable market. There is no guarantee that CoreRx will increase its manufacturing capacity when needed by us; thus, we will likely need to identify another approved manufacturer with increased capacity. In addition, we will need to revalidate the manufacturing process to demonstrate to the FDA the ability to reproducibly manufacture larger batch sizes, which will increase time and costs. If these activities are not carried out in a timely manner, a shortage of product could result following commercial launch, which could significantly affect sales and overall valuation of the Company.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any manufacturing problem or the loss of our contract manufacturer could be disruptive to our operations and result in development delays and lost sales. Additionally, we will rely on third parties to supply the raw materials needed to manufacture our initial or subsequent product candidates. Any such reliance on suppliers may involve several risks, including a potential inability to obtain critical materials and reduced control over production costs, delivery schedules, reliability, and quality. Any unanticipated disruption to the operation of one of our contract manufacturers caused by problems with suppliers could delay shipment of any of our product candidates, increase our cost of goods sold and result in lost sales.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pharmacies may be able to compound LDN in competition with us, but the economic impact may not be material.</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">JAN123 is a biphaisc formulation of LDN being developed for CRPS. However, compounding pharmacies have already sold a non-biphasic LDN for this purpose and for other purposes. The patent ALT5 Sigma Corporation was issued for JAN123, in conjunction with Orphan Drug approval, will provide additional marketing protection for CRPS. Compounding pharmacies are not subject to FDA approval and could compound LDN for their patients. We believe that production and sales by a single compounding pharmacy of a material amount of a compounded product would transform such compounding pharmacy into a pharmaceutical manufacturer, which would then subject it to all of the FDA approval protocols, including cGMP requirements. Thus, compounding pharmacies would not be able to scale their compounding activities for LDN to facilitate their material sales growth of LDN or to become impactful in the marketplace</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As disclosed below, we cannot provide assurances with respect to third-party coverage and reimbursement. We believe that persons who purchase LDN from a compounding pharmacy may need to pay out-of-pocket for the product with limited or no insurance coverage.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If product liability lawsuits are brought against us, we may incur substantial liabilities and may be required to limit commercialization of our initial or subsequent product candidates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will face a potential risk of product liability as a result of the clinical testing of our initial or subsequent product candidates. For example, we may be sued if any product we develop, including JAN101, JAN123 or any materials that we use in it, allegedly causes injury or is found to be otherwise unsuitable during product testing and manufacturing. Any such product liability claims may include allegations of defects in manufacturing, defects in design, a failure to warn of dangers inherent in the product, negligence, strict liability, and a breach of warranties. In the United States, claims could also be asserted against us under state consumer protection acts. If we cannot successfully defend ourselves against product liability claims, we may incur substantial liabilities or be required to limit commercialization of our initial or subsequent product candidates. Even successful defense of these claims would require us to employ significant financial and management resources. Regardless of the merits or eventual outcome, liability claims may result in, among other things (i) decreased demand for JAN101, JAN123 or any future products that we may develop; (ii) failure to obtain regulatory approval for our product candidates; (iii) withdrawal of participants in our clinical trials; (iv) substantial monetary awards to trial participants or patients; (v) product recalls or withdrawals or labeling, marketing, or promotional restrictions; and (vi) the inability to commercialize our initial or subsequent product candidates. As of the date of this Form 10-K, we do not carry product liability insurance. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The success of our biotechnology business is entirely dependent on our ability to obtain the marketing approval for our product candidates by the FDA and the regulatory authorities in foreign jurisdictions in which we intend to market them, of which there can be no assurance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not permitted to market JAN101 or JAN123 as prescription pharmaceutical products in the United States until we receive approval of an NDA from the FDA, or in any foreign countries until we receive the requisite approval from such countries. In the United States, the FDA generally requires the completion of clinical trials of each drug to establish its safety and efficacy and extensive pharmaceutical development to ensure its quality before an NDA is approved. Of the large number of drugs in development, only a small percentage result in the submission of an NDA to the FDA and even fewer are eventually approved for commercialization. As of the date of this Form 10-K, we have not submitted an NDA to the FDA or comparable applications to other regulatory authorities for any subsequent product candidates.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the clinical trial history of JAN101, we believe that JAN101 will qualify for FDA approval through the FDA&#8217;s 505(b)(2) regulatory pathway and in corresponding regulatory paths in other foreign jurisdictions. Notwithstanding the use </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the FDA&#8217;s 505(b)(2) regulatory pathway, we will be required to conduct Phase IIb and Phase III studies prior to filing for marketing approval of JAN101. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The active ingredient in JAN123 is naltrexone, which has been approved for use at much higher doses by the FDA for other indications, thus we believe that JAN123 will also qualify for the 505(b)(2) regulatory pathway.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the FDA has approved the Orphan Designation for JAN123, which could lead to approval after just two clinical trials.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, based on the strength of the results of the registration trial, the FDA could request additional clinical studies prior to approval.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends on our receipt of the regulatory approvals described above, and the issuance of such regulatory approvals is uncertain and subject to a number of risks, including the following: (i) the results of toxicology studies may not support the filing of an NDA for JAN101; (ii) the FDA may require additional pharmacokinetic studies with JAN101, including studies with food, prior to allowing the Company to conduct Phase IIb and Phase III clinical trials; (iii) the FDA or comparable foreign regulatory authorities or Institutional Review Boards (&#8220;IRBs&#8221;) may disagree with the design or implementation of our clinical trials; (iv) we may not be able to provide acceptable evidence of JAN101&#8217;s safety and efficacy; (v) the results of our clinical trials may not be satisfactory or may not meet the level of statistical or clinical significance required by the FDA, the EMA, or other regulatory agencies for us to receive marketing approval for JAN101; (vi) the dosing of JAN101 in a particular clinical trial may not be at an optimal level; (vii) patients in our clinical trials may suffer adverse effects for reasons that may or may not be related to JAN101; (viii) the data collected from clinical trials may not be sufficient to support the submission of an NDA or other submission or to obtain regulatory approval in the United States or elsewhere; (ix) the FDA or comparable foreign regulatory authorities may fail to approve the manufacturing processes or facilities of third-party manufacturers with which we contract for clinical and commercial supplies; and (x) the approval policies or regulations of the FDA or comparable foreign regulatory authorities may significantly change in a manner rendering our clinical data insufficient for approval of JAN101.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The process of obtaining regulatory approvals is expensive, often takes many years, if approval is obtained at all, and can vary substantially based upon, among other things, the type, complexity, and novelty of the product candidates involved, the jurisdiction in which regulatory approval is sought, and the substantial discretion of the regulatory authorities. Changes in regulatory approval policies during the development period, changes in or the enactment of additional statutes or regulations, or changes in regulatory review for a submitted product application may cause delays in the approval or rejection of an application. Regulatory approval obtained in one jurisdiction does not necessarily mean that a product candidate will receive regulatory approval in any or all other jurisdictions in which we may seek approval; but, the failure to obtain approval in one jurisdiction may negatively impact our ability to seek approval in a different jurisdiction. Failure to obtain regulatory approval for JAN101 or JAN123 for the foregoing, or any other reasons, will prevent us from commercializing JAN101 or JAN123, and our ability to generate revenue will be materially impaired.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clinical testing is expensive, is difficult to design and implement, can take many years to complete, and is uncertain as to outcome</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business model depends in part on the successful development, regulatory approval, and commercialization of JAN101 or JAN123, which may never occur. Both JAN101 and JAN123 are in the early stages of development and, as of the date of this Form 10-K, we have not progressed JAN101 beyond early clinical studies designed only to show safety, nor has JAN123 been tested in any FDA approved clinical trials. Three INDs have previously been submitted by previous licensees/assignees of JAN101 and were accepted by the FDA. These INDs were transferred to ALT5 Sigma Corporation in 2020. Even though the INDs were transferred to us, the FDA may still require additional work prior to re-initiation of clinical trials. If we do not obtain such approvals to re-initiate trials as presently planned, the time in which we expect to commence clinical programs for any product candidate will be extended and such extension will increase our expenses, delay our potential receipt of any revenues, and increase our need for additional capital. Moreover, there is no guarantee that we will receive approval to commence human clinical trials or, if we do receive approval, that our clinical trials will be successful or that we will continue clinical development in support of an approval from the FDA or comparable foreign regulatory authorities for any indication. We note that most product candidates never reach the clinical development stage and even those that do commence clinical development have only a small chance of successfully completing clinical development and gaining regulatory approval. Success in early phases of pre-clinical and clinical trials does not ensure that later clinical trials will be successful, and interim results of a clinical trial do not necessarily predict final results. A failure of one or more of our clinical trials can occur at any stage of testing. We may experience numerous unforeseen events during, or as a result of, the clinical trial process that could delay or prevent our ability to receive regulatory approval or commercialize our initial or any subsequent product candidates. Therefore, our business currently depends entirely on the successful development, regulatory approval, and commercialization of our product candidates, which may never occur.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">JAN123 has received Orphan Drug designation from the FDA, allowing for fewer and smaller clinical trials prior to approval.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In part, this is due to fewer patients being available for treatment and may lead to delays in recruiting subjects for the trial and therefore delays in reaching the market.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Even if we receive regulatory approval for JAN101 or JAN123, we may not be able to commercialize it successfully and the revenue that we generate from its sales, if any, may be limited.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If approved for marketing, the commercial success of JAN101 will depend upon the product&#8217;s acceptance by the medical community, including physicians, patients, and health care payors. The degree of market acceptance for JAN101 will depend on a number of factors, including (i) demonstration of clinical safety and efficacy; (ii) relative convenience, dosing burden, and ease of administration; (iii) the prevalence and severity of any adverse effects; (iv) the willingness of physicians to prescribe JAN101 and the target patient population to try new therapies; (v) efficacy of JAN 101 compared to competing products; (vi) the introduction of any new products that may in the future become available, targeting indications for which JAN101 may be approved; (vii) new procedures or therapies that may reduce the incidences of any of the indications in which JAN101 may show utility; (viii) pricing and cost-effectiveness; (ix) the inclusion or omission of JAN101 in applicable guidelines; (x) the effectiveness of our own or any future collaborators&#8217; sales and marketing strategies; (xi) limitations or warnings contained in approved labeling from regulatory authorities; (xii) our ability to obtain and maintain sufficient third-party coverage or reimbursement from government health care programs, including Medicare and Medicaid, private health insurers, and other third-party payors or to receive the necessary pricing approvals from government bodies regulating the pricing and usage of therapeutics; and (xiii) the willingness of patients to pay out-of-pocket in the absence of third-party coverage or reimbursement or government pricing approvals.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">JAN123 will face al the commercialization factors described above with an additional risk of compounding pharmacies prescribing the product to patients.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The active ingredient, naltrexone, is available and has been compounded into LDN formulations similar to JAN123.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These compounded LDN formulations have been provided to numerous patients with different forms of pain.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While not approved for the treatment of pain and therefore unlikely to be reimbursed, the low cost of the compounded LDN could cause reduce pricing of JAN123.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that JAN123 will have advantages over the compounded LDN in terms of reduced side effects, but many patients currently have not had the side effects or accepted these as part of reducing their pain with compounded LDN.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ALT5 Sigma Corporation may have to enforce its patents, which could result in lengthy and costly litigation, to prevent compounding pharmacies from selling LDN for indications for which ALT5 Sigma Corporation has received patent protection. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If JAN101 or JAN123 is approved but does not achieve an adequate level of acceptance by physicians, health care payors, and patients, our biotechnology business may not generate sufficient revenue to cover costs. Our efforts to educate the medical community and third-party payors on the benefits of JAN101 or JAN123 may require significant resources and may never be successful.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, even if we obtain regulatory approvals, the timing or scope of any approvals may prohibit or reduce our ability to commercialize JAN101 or JAN123 successfully. For example, if the approval process takes too long, we may miss market opportunities and give other companies the ability to develop competing products or establish market dominance. Any regulatory approval we ultimately obtain may be limited or subject to restrictions or post-approval commitments that renders our product candidate not commercially viable. For example, regulatory authorities may approve our product candidate for fewer or more limited indications than we request, may not approve the price we intend to charge for our product candidate, may grant approval contingent on the performance of costly post-marketing clinical trials, or may approve any of our product candidates with a label that does not include the labeling claims necessary or desirable for the successful commercialization of that indication. Further, the FDA or comparable foreign regulatory authorities may place conditions on approvals or require risk management plans or a REMS to assure the safe use of the drug. Moreover, product approvals may be withdrawn for non-compliance with regulatory standards or if problems occur following the initial marketing of the product. Any of the foregoing scenarios could materially harm the commercial success of our product candidate.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Even if we obtain marketing approval for our product candidate, we will be subject to ongoing obligations and continued regulatory review, which may result in significant additional expense. Additionally, our product candidate could be subject to labeling and other restrictions and withdrawal from the market and we may be subject to penalties if we fail to comply with regulatory requirements or if we experience unanticipated problems with our product candidate.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we obtain regulatory approval for our product candidate for an indication, the FDA or foreign equivalent may still impose significant restrictions on its indicated uses or marketing or the conditions of approval, or impose ongoing requirements for potentially costly and time-consuming post-approval studies, including Phase IV clinical trials, and post-market surveillance to monitor safety and efficacy. Our product candidate will also be subject to ongoing regulatory </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">requirements governing the manufacturing, labeling, packaging, storage, distribution, safety surveillance, advertising, promotion, recordkeeping and reporting of adverse events, and other post-market information. These requirements include registration with the FDA, as well as continued compliance with current good clinical practices regulations for any clinical trials that we conduct post-approval. In addition, manufacturers of drug products and their facilities are subject to continual review and periodic inspections by the FDA and other regulatory authorities for compliance with current cGMPs, requirements relating to quality control, quality assurance and corresponding maintenance of records and documents.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has the authority to require a REMS as part of an NDA or after approval, which may impose further requirements or restrictions on the distribution or use of an approved drug, such as limiting prescribing to certain physicians or medical centers that have undergone specialized training, limiting treatment to patients who meet certain safe-use criteria or requiring patient testing, monitoring and/or enrollment in a registry.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to sales and marketing activities related to our product candidate, advertising and promotional materials must comply with FDA rules in addition to other applicable federal, state, and local laws in the United States and similar legal requirements in other countries. In the United States, the distribution of product samples to physicians must comply with the requirements of the United States Prescription Drug Marketing Act. Application holders must obtain FDA approval for product and manufacturing changes, depending on the nature of the change. We may also be subject, directly or indirectly through our customers and partners, to various fraud and abuse laws, including, without limitation, the United States Anti-Kickback Statute, United States False Claims Act, and similar state laws, which impact, among other things, our proposed sales, marketing, and scientific/educational grant programs. If we participate in the United States Medicaid Drug Rebate Program, the Federal Supply Schedule of the United States Department of Veterans Affairs, or other government drug programs, we will be subject to complex laws and regulations regarding reporting and payment obligations. All of these activities are also potentially subject to United States federal and state consumer protection and unfair competition laws. Similar requirements exist in many of these areas in other countries.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if JAN101 or JAN123 is approved for a particular indication, our product labeling, advertising, and promotion would be subject to regulatory requirements and continuing regulatory review. The FDA strictly regulates the promotional claims that may be made about prescription products. In particular, a product may not be promoted for uses that are not approved by the FDA as reflected in the product&#8217;s approved labeling. If we receive marketing approval for JAN101 or JAN123, physicians may nevertheless legally prescribe our product to their patients in a manner that is inconsistent with the approved label. If we are found to have promoted such off-label uses, we may become subject to significant liability and government fines. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses, and a company that is found to have improperly promoted off-label uses may be subject to significant sanctions. The federal government has levied large civil and criminal fines against companies for alleged improper promotion and has enjoined several companies from engaging in off-label promotion. The FDA has also requested that companies enter into consent decrees of permanent injunctions under which specified promotional conduct is changed or curtailed.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we or a regulatory agency discover previously unknown problems with one of our product candidates, such as adverse events of unanticipated severity or frequency, problems with the facility where the product is manufactured, or we or our manufacturers fail to comply with applicable regulatory requirements, we may be subject to the following administrative or judicial sanctions: (i) restrictions on the marketing or manufacturing of the product, withdrawal of the product from the market, or voluntary or mandatory product recalls; (ii) issuance of warning letters or untitled letters; (iii) clinical holds; (iv) injunctions or the imposition of civil or criminal penalties or monetary fines; (v) suspension or withdrawal of regulatory approval; (vi) suspension of any ongoing clinical trials; (vii) refusal to approve pending applications or supplements to approved applications filed by us, or suspension or revocation of product license approvals; (viii) suspension or imposition of restrictions on operations, including costly new manufacturing requirements; or (ix) product seizure or detention or refusal to permit the import or export of product. The occurrence of any event or penalty described above may inhibit our ability to commercialize our product candidates and generate revenue. Adverse regulatory action, whether pre- or post-approval, can also potentially lead to product liability claims and increase our product liability exposure.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Obtaining and maintaining regulatory approval of JAN101 or JAN123 in one jurisdiction does not mean that we will be successful in obtaining regulatory approval of JAN101 or JAN123 in other jurisdictions.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Obtaining and maintaining regulatory approval of our initial or subsequent product candidates in one jurisdiction does not guarantee that we will be able to obtain or maintain regulatory approval in any other jurisdiction; but, a failure or delay in obtaining regulatory approval in one jurisdiction may have a negative effect on the regulatory approval process in others. For example, even if the FDA grants marketing approval of a product candidate, comparable regulatory authorities in foreign jurisdictions must also approve the manufacturing, marketing, and promotion of that product candidate in those countries. Approval procedures vary among jurisdictions and can involve requirements and administrative review periods different from those in the United States, including additional preclinical studies or clinical trials, as clinical studies </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">conducted in one jurisdiction may not be accepted by regulatory authorities in other jurisdictions. In many jurisdictions outside the United States, a product candidate must be approved for reimbursement before it can be approved for sale in that jurisdiction. In some cases, the price that we intend to charge for our products is also subject to approval.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Current and future legislation may increase the difficulty and cost for us to obtain marketing approval of and commercialize our initial or subsequent product candidates and affect the prices we may obtain.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States and some foreign jurisdictions, there have been a number of legislative and regulatory changes and proposed changes regarding the healthcare system that could prevent or delay marketing approval for JAN101 or JAN123, restrict, or regulate post-approval activities and affect our ability to profitably sell JAN101 or JAN123. Legislative and regulatory proposals have been made to expand post-approval requirements and restrict sales and promotional activities for pharmaceutical products. We do not know whether additional legislative changes will be enacted, or whether the FDA regulations, guidance, or interpretations will be changed, or what the impact of such changes on the marketing approvals of JAN101 or JAN123, if any, may be. In addition, increased scrutiny by Congress of the FDA&#8217;s approval process may significantly delay or prevent marketing approval, as well as subject us to more stringent product labeling and post-marketing testing and other requirements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any termination or suspension of, or delays in the commencement or completion of, any necessary studies of any of our product candidate for any indications could result in increased costs to us, delay or limit our ability to generate revenue and adversely affect our commercial prospects</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The commencement and completion of clinical studies can be delayed for a number of reasons, including delays related to: (i) the FDA or a comparable foreign regulatory authority failing to grant permission to proceed and placing the clinical study on hold; (ii) subjects for clinical testing failing to enroll or remain enrolled in our trials at the rate we expect; (iii) a facility manufacturing our initial or subsequent product candidates being ordered by the FDA or other government or regulatory authorities to shut down, temporarily or permanently, due to violations of cGMP requirements or other applicable requirements, or cross-contaminations of the product candidates in the manufacturing process; (iv) any changes to our manufacturing process that may be necessary or desired; (v) subjects choosing an alternative treatment for the indications for which we are developing our initial or subsequent product candidates, or participating in competing clinical studies; (vi) subjects experiencing severe or unexpected drug-related adverse effects; (vii) reports from clinical testing on similar technologies and products raising safety and/or efficacy concerns; (viii) third-party clinical investigators losing their licenses or permits necessary to perform our clinical trials, not performing our clinical trials on our anticipated schedule, or employing methods consistent with the clinical trial protocol, cGMP requirements, or other third parties not performing data collection and analysis in a timely or accurate manner; (ix) inspections of clinical study sites by the FDA, comparable foreign regulatory authorities, or IRBs finding regulatory violations that require us to undertake corrective action, result in suspension or termination of one or more sites or the imposition of a clinical hold on the entire study, or that prohibit us from using some or all of the data in support of our marketing applications; (x) third-party contractors becoming debarred or suspended or otherwise penalized by the FDA or other government or regulatory authorities for violations of regulatory requirements, in which case we may need to find a substitute contractor, and we may not be able to use some or any of the data produced by such contractors in support of our marketing applications; (xi) one or more IRBs refusing to approve, suspending, or terminating the study at an investigational site, precluding enrollment of additional subjects, or withdrawing its approval of the trial; (xii) reaching agreement on acceptable terms with prospective contract research organizations, or CROs, and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and trial sites; (xiii) deviations of the clinical sites from trial protocols or dropping out of a trial; (xiv) adding new clinical trial sites; (xv) the inability of the CRO to execute any clinical trials for any reason; and (xvi) government or regulatory delays or &#8220;clinical holds&#8221; requiring suspension or termination of a trial.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product development costs for our initial and any subsequent product candidates will increase if we have delays in testing or approval or if we need to perform more or larger clinical studies than planned. Additionally, changes in regulatory requirements and policies may occur and we may need to amend study protocols to reflect these changes. Amendments may require us to resubmit our study protocols to the FDA, comparable foreign regulatory authorities, and IRBs for reexamination, which may impact the costs, timing, or successful completion of that study. If we experience delays in completion of, or if we, the FDA or other regulatory authorities, the IRB, or other reviewing entities, or any of our clinical study sites suspend or terminate any of our clinical studies of any of our product candidates, their commercial prospects may be materially harmed and our ability to generate product revenues will be delayed. Any delays in completing our clinical trials will increase our costs, slow our development and approval process, and jeopardize our ability to commence product sales and generate revenues. Any of these occurrences may harm our business, financial condition, and prospects significantly. In addition, many of the factors that cause, or lead to, termination or suspension of, or a delay in the commencement or completion of, clinical studies may also ultimately lead to the denial of regulatory approval of one of more of our product candidates. In addition, if one or more clinical studies are delayed, our competitors may be able to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">bring competing products to market before we do, and the commercial viability of our affected product candidates could be significantly reduced.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Third-party coverage and reimbursement and health care cost containment initiatives and treatment guidelines may constrain our future revenues.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to market JAN101 or JAN123 successfully will depend in part on the level of reimbursement that government health administration authorities, private health coverage insurers, and other organizations provide for the cost of JAN101 or JAN123 and related treatments. Countries in which JAN101 or JAN123 is sold through reimbursement schemes under national health insurance programs frequently require that manufacturers and sellers of pharmaceutical products obtain governmental approval of initial prices and any subsequent price increases. In certain countries, including the United States, government-funded and private medical care plans can exert significant indirect pressure on prices. We may not be able to sell JAN101 or JAN123 profitably if adequate prices are not approved or coverage and reimbursement is unavailable or limited in scope. Increasingly, third-party payors attempt to contain health care costs in ways that are likely to impact the development of our product including: (i) failing to approve or challenging the prices charged for health care products; (ii) introducing reimportation schemes from lower priced jurisdictions; (iii) limiting both coverage and the amount of reimbursement for new therapeutic products; (iv) denying or limiting coverage for products that are approved by the regulatory agencies but are considered to be experimental or investigational by third-party payors; and (v) refusing to provide coverage when an approved product is used in a way that has not received regulatory marketing approval.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">It is difficult and costly to protect our intellectual property rights, and we cannot ensure the protection of these rights.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends on successfully blocking others from developing and commercializing similar products. As repurposed drugs, our APIs have previously been approved for other indications, none of which currently represent a threat to our products, and therefore cannot be protected. We will rely on our method of use and oral formulation patents to protect our products, which may also put our products at risk from companies developing oral formulations using the same API for other indications. Even though our patents provide protection for specific uses, we will not be able to prevent other companies from developing the same APIs for other uses. If a similar dose, formulation, and route of administration is developed for another indication by a different company, we cannot guarantee that the product they market for the other indication will not be prescribed off-label by doctors or filled by pharmacists for use in indications our patents cover and that if less expensive, would not negatively affect our sales, if our products are ultimately approved by the FDA.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The degree of future protection afforded by the patent rights licensed to us is uncertain, because legal means afford only limited protection and may not adequately protect our rights, permit us to gain or keep our competitive advantage, or provide us with any competitive advantage at all. We cannot be certain that any patent application owned by a third party will not have priority over patent applications in which we hold license rights or that we will not be involved in interference, opposition or invalidity proceedings before United States or foreign patent offices.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, if the Licensors were to initiate legal proceedings against a third party to enforce a patent covering JAN101, the defendant could counterclaim that such patent is invalid and/or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity and/or unenforceability are commonplace. Grounds for a validity challenge include alleged failures to meet any of several statutory requirements, including lack of novelty, obviousness, or non-enablement. Grounds for unenforceability assertions include allegations that someone connected with prosecution of the patent withheld relevant information from the United States Patent and Trademark Office (the &#8220;PTO&#8221;) or made a misleading statement during prosecution. Third parties may also raise similar claims before administrative bodies in the United States or abroad, even outside the context of litigation. Such mechanisms include regarding-examination, post-grant review, and equivalent proceedings in foreign jurisdictions, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">e.g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, opposition proceedings. Such proceedings could result in revocation or amendment of the Licensors&#8217; patents in such a way that they no longer cover JAN101 or competitive products. The outcome following legal assertions of invalidity and unenforceability is unpredictable. With respect to validity, for example, we cannot be certain that there is no invalidating prior art, of which the Licensors and the patent examiner were unaware during prosecution. If a defendant were to prevail on a legal assertion of invalidity and/or unenforceability, we would lose at least part, and perhaps all, of the patent protection on any of our product candidates. Such a loss of patent protection would have a material adverse impact on our business.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the future, we may rely on know-how and trade secrets to protect technology, especially in cases in which we believe patent protection is not appropriate or obtainable. However, know-how and trade secrets are difficult to protect. While we intend to require employees, academic collaborators, consultants, and other contractors to enter into confidentiality agreements, we may not be able adequately to protect our trade secrets or other proprietary or licensed information. Typically, research collaborators and scientific advisors have rights to publish data and information in which we may have rights. Enforcing a claim that a third party illegally obtained and is using any of our trade secrets is expensive and time </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consuming, and the outcome is unpredictable. In addition, courts are sometimes less willing to protect trade secrets than patents. Moreover, our competitors may independently develop equivalent or better knowledge, methods, and know-how.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to obtain or maintain patent protection or trade secret protection for our product candidates or our technologies, third parties could use our proprietary information, which could impair our ability to compete in the market and adversely affect our ability to generate revenues and attain profitability.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">It is difficult and costly to block others from developing similar products for other indications, and we cannot ensure that these products will not be less expensive and thus be prescribed off-label by physicians for use in our indications.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends on successfully blocking others from developing and commercializing similar products. As a repurposed drugs, our APIs have previously been approved for other indications and therefore cannot be protected. Although none of the approved indications for the API used in JAN101 represent a threat to JAN101, the API used in naltrexone has been formulated by compounding pharmacies to treat the indication ALT5 Sigma Corporation is pursuing and thus represents a real threat in commercialization of JAN123.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will rely on our method of use and oral formulation patents to protect JAN101 and JAN123, which may also put JAN101 and JAN123 at risk from companies developing oral formulations using the same API for other indications. Even though our patents provide protection for specific uses, we will not be able to prevent other companies from developing the same API for other uses. If a similar dose, formulation, and route of administration is developed for another indication by a different company, we cannot guarantee that the product they market for the other indication will not be prescribed off-label by doctors or filled by pharmacists for use in indications our patents cover and that if less expensive, would not negatively affect our sales, if JAN101 or JAN123 is ultimately approved by the FDA. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">JAN101 or JAN123 may infringe the intellectual property rights of others, which could increase our costs and delay or prevent our development and commercialization efforts.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends in part on avoiding infringement of the proprietary technologies of others. The pharmaceutical industry has been characterized by frequent litigation regarding patent and other intellectual property rights. Identification of third-party patent rights that may be relevant to our proprietary technology is difficult because patent searching is imperfect due to differences in terminology among patents, incomplete databases, and the difficulty in assessing the meaning of patent claims. Additionally, because patent applications are maintained in secrecy until the application is published, we may be unaware of third-party patents that may be infringed by commercialization of JAN101, JAN123 or any subsequent product candidate. There may be certain issued patents and patent applications claiming subject matter that we may be required to license in order to research, develop, or commercialize any of our product candidates, and we do not know if such patents and patent applications would be available to license on commercially reasonable terms, or at all. Any claims of patent infringement asserted by third parties would be time-consuming and may: (i) result in costly litigation; (ii) divert the time and attention of our technical personnel and management; (iii) prevent us from commercializing a product candidate until the asserted patent expires or is held finally invalid or not infringed in a court of law; (iv) require us to cease or modify our use of the technology and/or develop non-infringing technology; or (v) require us to enter into royalty or licensing agreements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third parties may hold proprietary rights that could prevent JAN101 or JAN123 from being marketed. Any patent-related legal action against us claiming damages and seeking to enjoin commercial activities relating to any of our product candidates or our processes could subject us to potential liability for damages and require us to obtain a license to continue to manufacture or market JAN101, JAN123 or any subsequent product candidates. We cannot predict whether we would prevail in any such actions or that any license required under any of these patents would be made available on commercially acceptable terms, if at all. In addition, we cannot be sure that we could redesign JAN101, JAN123 or any subsequent product candidates or processes to avoid infringement, if necessary. Accordingly, an adverse determination in a judicial or administrative proceeding, or the failure to obtain necessary licenses, could prevent us from developing and commercializing JAN101, JAN123 or a subsequent product candidate, which could harm our business, financial condition, and results of operations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that there are other companies, including major pharmaceutical companies, working in the areas competitive to JAN101 or JAN123 that either have resulted, or may result, in the filing of patent applications that may be deemed related to our activities. If we were to challenge the validity of these or any issued United States patent in court, we would need to overcome a statutory presumption of validity that attaches to every issued United States patent. This means that, in order to prevail, we would have to present clear and convincing evidence as to the invalidity of the patent&#8217;s claims. If we were to challenge the validity of these or any issued United States patent in an administrative trial before the Patent Trial and Appeal Board in the PTO, we would have to prove that the claims are unpatentable by a preponderance of the evidence. There is no assurance that a jury and/or court would find in our favor on questions of infringement, validity, or enforceability. Even if we are successful, litigation could result in substantial costs and be a distraction to management.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span id="i272ab477404c49489c7330cc5841dd26_274775"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL RISK FACTORS</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The market price of our common stock has been, and may continue to be volatile and fluctuate significantly, which could result in substantial losses for investors and subject us to securities class action litigation.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading price for our common stock has been, and we expect it to continue to be, volatile. The price at which our common stock trades depends upon a number of factors, including our historical and anticipated operating results, our financial situation, announcements of technological innovations or new products by us, our ability or inability to raise the additional capital we may need and the terms on which we raise it, and general market and economic conditions. Some of these factors are beyond our control. Broad market fluctuations may lower the market price of our common stock and affect the volume of trading in our stock, regardless of our financial condition, results of operations, business or prospects. Among the factors that may cause the market price of our common stock to fluctuate are the risks described in this &#8220;Risk Factors&#8221; section. In addition, the stock markets, in general, The Nasdaq Capital Market and the market for biopharmaceutical companies in particular, may experience a loss of investor confidence. Such loss of investor confidence may result in extreme price and volume fluctuations in our common stock that are unrelated or disproportionate to the operating performance of our business, financial condition or results of operations. These broad market and industry factors may materially harm the market price of our common stock and expose us to securities class action litigation. Such litigation, even if unsuccessful, could be costly to defend and divert management&#8217;s attention and resources, which could further materially harm our financial condition and results of operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales or distribution of substantial amounts of our Common Stock, or the perception that such sales or distributions might occur, could cause the market price of our Common Stock to decline.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sale or distribution of a substantial number of shares of our Common Stock, particularly sales by us or our directors, executive officers, and principal stockholders, or the perception that these sales or distributions might occur in large quantities, could cause the market price of our Common Stock to decline.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If securities or industry analysts do not publish or cease publishing research, or publish inaccurate or unfavorable research, about our business, the price of our Common Stock and its liquidity could decline.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for our Common Stock may be influenced by the research and reports that securities or industry analysts publish about us or our business, our market, and our competitors.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have any control over these analysts.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If securities and industry analysts cease coverage of us altogether, the market price for our Common Stock may be negatively affected.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If one or more of the analysts who cover us downgrade our Common Stock, or publish inaccurate or unfavorable research about our business, the price of our Common Stock may decline.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If one or more of these analysts cease coverage of us or fail to publish reports on us regularly, demand for our Common Stock could decrease, which might cause our Common Stock price and trading volume to decline.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In light of the unpredictability inherent in our business, our financial outlook commentary may differ from analysts&#8217; expectations, which could cause volatility to the price of our Common Stock.</span></div><div id="i213e3c881f5e4982994be533c682ff6b_808"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1B.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNRESOLVED STAFF COMMENTS</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i213e3c881f5e4982994be533c682ff6b_802"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1C.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CYBERSECURITY</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management and Board Oversight</span></div><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" id="f-36" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskRoleOfManagementTextBlock" id="f-35" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we collect, use, store, and digitally transmit confidential, sensitive, proprietary, and personal information. The secure maintenance of this information and our information technology systems are important to our operations and business strategy. <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-37" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" id="f-39" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" id="f-38" escape="true">The <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" format="ixt:fixed-true" id="f-40">Audit Committee</ix:nonNumeric>, which is composed solely of independent directors, has been designated by our Board to review and discuss with management the Company&#8217;s risk assessment and risk management policies, including the steps that management has taken to monitor and control related cybersecurity risks and exposures.</ix:nonNumeric></ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-42" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" format="ixt:fixed-true" id="f-41">Management</ix:nonNumeric> updates the Audit Committee and the Board as necessary about significant cybersecurity occurrences and measures the Company is taking to prevent the same.</ix:nonNumeric></ix:nonNumeric></span></div></ix:nonNumeric></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Management and Strategy</span></div><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock" id="f-44" continuedAt="f-44-1" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" id="f-43" continuedAt="f-43-1" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on our subsidiary-level information technology professionals to continuously monitor and update our IT networks and infrastructure. Their role is to prevent, detect, address, and mitigate risks related to unauthorized access, misuse, </span></div></ix:nonNumeric></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><ix:continuation id="f-43-1"><ix:continuation id="f-44-1"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">malware, and other security threats. To safeguard our data and business processes, as well as those of our subsidiaries, we invest in industry-standard security technologies to defend against cyber risks.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag" format="ixt:fixed-true" id="f-45">To further strengthen our cybersecurity efforts, with our subsidiary&#8217;s assistance, we are establishing an &#8220;IT Steering Committee&#8221; composed of IT professionals from our subsidiary. This committee will meet quarterly to discuss cybersecurity threats, emerging attack methods, and best practices.</ix:nonNumeric></span></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" format="ixt:fixed-true" id="f-46">In fiscal year 2024, our crypto-processing subsidiary engaged an external consultant to conduct a cybersecurity risk assessment of our business operations.</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" format="ixt:fixed-true" id="f-47">This assessment examined both internal and external threats to our systems and data handling processes, providing a structured framework for evaluating, prioritizing, and enhancing our cybersecurity initiatives.</ix:nonNumeric> On a going-forward basis, in collaboration with our Audit Committee, management will determine and implement appropriate measures based on these findings.</span></div><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" id="f-48" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our cybersecurity risk management program, we are working with our crypto-processing subsidiary to develop a cyber training curriculum for our employees. The training may cover topics such as phishing awareness, cybersecurity best practices, and e-mail security.</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite our commitment to cybersecurity, no system can fully eliminate technology risks. As of now, <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" format="ixt:fixed-false" id="f-49">we are unaware of any cybersecurity incidents that have had, or are reasonably likely to have, a material impact on our business or operations.</ix:nonNumeric> However, the increasing volume and sophistication of cyberattacks&#8212;including data breaches, ransomware, and similar threats&#8212;pose ongoing risks. Incidents that occur could result in reputational, competitive, operational, or financial harm, as well as regulatory consequences. For a more detailed discussion of how cybersecurity threats may affect our business strategy, operations, or financial condition, see Item 1A, &#8220;Risk Factors,&#8221; which is incorporated by reference into Item 1C.</span></div></ix:continuation><div id="i213e3c881f5e4982994be533c682ff6b_19"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPERTIES</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;28, 2024, our executive offices were located in Las Vegas, Nevada in a leased facility consisting of 800 square feet of office space. We believe our executive office space is sufficient to meet our current needs.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;28, 2024, our Fintech segment&#8217;s offices were located in Montreal, Quebec, Canada in a leased facility consisting of approximately 2,100 square feet. We believe our Fintech segment's office space is sufficient to meet our current needs.</span></div><div id="i213e3c881f5e4982994be533c682ff6b_22"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LEGAL PROCEEDINGS</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information in response to this item is included in Note 21, Commitments and Contingencies, to the Consolidated Financial Statements included in Part II, Item 8, of this Form 10-K.</span></div><div id="i213e3c881f5e4982994be533c682ff6b_25"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MINE SAFETY DISCLOSURES</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><div id="i213e3c881f5e4982994be533c682ff6b_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="i213e3c881f5e4982994be533c682ff6b_31"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MARKET FOR OUR COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Information and Dividends</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock trades under the symbol &#8220;ALTS&#8221; on The Nasdaq Capital Market. As of March&#160;25, 2025, there were approximately 279 stockholders of record, which excludes stockholders whose shares were held in nominee or street name by brokers. We have no record of the number of holders of our common stock who hold their shares in &#8220;street name&#8221; with various brokers.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not paid dividends on our common stock and do not presently plan to pay dividends on our common stock for the foreseeable future.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning securities authorized for issuance under equity compensation plans is included in Part III, Item 12 of this report.</span></div><div id="i213e3c881f5e4982994be533c682ff6b_34"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SELECTED FINANCIAL DATA</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><div id="i213e3c881f5e4982994be533c682ff6b_37"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of our significant accounting policies and an understanding of the significant factors that influenced our performance during the fiscal year ended December&#160;28, 2024, this &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; (hereafter referred to as &#8220;MD&amp;A&#8221;) should be read in conjunction with the consolidated financial statements, including the related notes, appearing in Part II, Item 8 of this 10-K for the fiscal year ended December&#160;28, 2024.</span></div><div id="i213e3c881f5e4982994be533c682ff6b_40"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note about Forward-Looking Statements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Form 10-K contains &#8220;forward-looking statements&#8221; within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which involve risks and uncertainties. You can identify forward-looking statements because they contain words such as &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;seeks,&#8221; &#8220;approximately,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;estimates&#8221;, or &#8220;anticipates&#8221; or similar expressions that concern our strategy, plans or intentions. Any statements we make relating to our future operations, performance and results, and anticipated liquidity are forward-looking statements. All forward-looking statements are subject to risks and uncertainties that may change at any time, and, therefore, our actual results may differ materially from those we expected. We derive most of our forward-looking statements from our operating budgets and forecasts, which are based upon many detailed assumptions. While we believe that our assumptions are reasonable, we caution that it is very difficult to predict the impact of known factors, and, of course, it is impossible for us to anticipate all factors that could affect our actual results.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the foregoing factors may generally affect our business, results of operations and financial position. Forward-looking statements speak only as of the date the statements were made. We do not undertake and specifically decline any obligation to update any forward-looking statements. Any information contained on our website www.alt5sigma.com or any other websites referenced in this Form 10-K are not part of this Form 10-K.</span></div><div id="i213e3c881f5e4982994be533c682ff6b_43"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Company</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our Fintech segment, we provide next generation blockchain-powered technologies to enable a migration to a new global financial paradigm, and, through our Biotechnology segment, we are focused on finding treatments for conditions that cause chronic pain and bringing to market drugs with non-addictive and non-sedative pain-relieving properties. In addition, through our sale of subsidiaries ARCA Recycling, Connexx, and ARCA Canada and the assets of GeoTraq Inc., we have exited these legacy businesses; Consequently, the results for these businesses are reported as discontinued operations for the years ended December&#160;28, 2024 and December&#160;30, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate three reportable segments:</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Fintech: Our Fintech segment provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Biotechnology: Our Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. We have previously announced our intention to capitalize a subsidiary with certain of our biotechnology assets, acquire an additional biotechnology asset, and then engage in a financing of that subsidiary. The short-term intended result of that series of transactions would be for to decouple it from us so that it would operate on a stand-alone basis.</span></div><div style="margin-top:6pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Corporate and Other: Our Corporate and Other segment consists of certain corporate general and administrative costs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reporting Period. We report on a 52- or 53-week fiscal year. Our 2024 fiscal year ended on December&#160;28, 2024 (&#8220;fiscal 2024&#8221;). Our 2023 fiscal year ended on December&#160;30, 2023 (&#8220;fiscal 2023&#8221;). </span></div><div id="i213e3c881f5e4982994be533c682ff6b_46"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Application of Critical Accounting Policies</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our discussion of the financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in conformity with accounting principles generally accepted in the United States. The preparation of our consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses, and related disclosure of any contingent assets and liabilities at the date of the financial statements. Management regularly reviews its estimates and assumptions, which are </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">based on historical factors and other factors believed to be relevant under the circumstances. Actual results may differ from these estimates under different assumptions, estimates or conditions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Critical accounting policies are defined as those that are reflective of significant judgments and uncertainties and potentially result in materially different results under different assumptions and conditions. Critical accounting policies include intangible impairment under ASC 350, revenue recognition under ASC 606, and going concern under ASC 205.</span></div><div id="i213e3c881f5e4982994be533c682ff6b_49"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth certain statement of operations items from continuing and discontinued operations and as a percentage of revenue, for the periods indicated (in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.575%"><tr><td style="width:1.0%"/><td style="width:69.767%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.138%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.454%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.141%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fiscal Year Ended<br/>December 28, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fiscal Year Ended<br/>December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Statement of Operations Data:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Cost of revenue</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6,238&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6,294&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13,856&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4,746&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Operating loss</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7,562)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(19,846)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Interest (expense) income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(879)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Gain on litigation settlement</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">374&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Unrealized loss on marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1,058)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(926)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Other income, net</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(161)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">998&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net loss before provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(9,286)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(17,524)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Income tax benefit</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3,041)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(429)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net loss income from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6,245)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(17,095)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Income from discontinued operations</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10,254&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Income tax provision for discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net income from discontinued operations</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9,283&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6,245)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7,812)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth revenues for key product and service categories, percentages of total revenue and gross profits earned by key product and service categories and gross profit percent as compared to revenues for each key product category indicated (in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fiscal Year Ended<br/>December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fiscal Year Ended<br/>December 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Net<br/>Revenue</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Percent <br/>of Total </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Net<br/>Revenue</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Percent <br/>of Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Fintech</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,532&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">100&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Biotech</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Corporate and other</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3,795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total revenue</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,532&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">100&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3,795&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">100&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fiscal Year Ended<br/>December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fiscal Year Ended<br/>December 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Gross<br/>Profit</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Gross <br/>Profit % </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Gross<br/>Profit</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Gross <br/>Profit %</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Gross Profit</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Fintech</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6,294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Biotech</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Corporate and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(197)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total gross profit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6,294&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">50&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(197)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div id="i213e3c881f5e4982994be533c682ff6b_52"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue increased by approximately $8.8 million for the fiscal year ended December&#160;28, 2024, as compared to the year ended December&#160;30, 2023. The increase is due to the acquisition of ALT5 Subsidiary during May 2024, partially offset by no revenue from discontinued operations for the fiscal year ended December&#160;28, 2024. </span></div><div id="i213e3c881f5e4982994be533c682ff6b_55"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Profit</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit increased by approximately $6.5 million for the fiscal year ended December&#160;28, 2024, as compared to the year ended December&#160;30, 2023. The increase is due to the acquisition of ALT5 Subsidiary during May 2024, partially offset by no revenue from discontinued operations for the fiscal year ended December&#160;28, 2024.</span></div><div id="i213e3c881f5e4982994be533c682ff6b_58"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Selling, General and Administrative Expense</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses from continuing operations increased by approximately $7.6 million for the fiscal year ended December&#160;28, 2024, as compared to the year ended December&#160;30, 2023, primarily due to the acquisition of ALT5 Subsidiary during May 2024, increased amortization costs relating to the Soin intangibles in our Biotech segment, and increased stock-based compensation expense related to grants of RSU's, as well as costs for professional services in our Corporate and Other segment.</span></div><div id="i213e3c881f5e4982994be533c682ff6b_61"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment Charges</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Impairment charges recorded during the fiscal year ended December&#160;30, 2023 were approximately $15.1 million. These charges relate to the full impairment of the VM7 and SPYR notes receivable of approximately $5.3 million and $9.8 million, respectively (See Note 9 of the Consolidated Financial Statements). No impairment charges were recorded during the fiscal year ended December&#160;28, 2024.</span></div><div id="i213e3c881f5e4982994be533c682ff6b_64"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Income (Expense), net</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net, was approximately $880,000 for the fiscal year ended December&#160;28, 2024, as compared to interest income, net, of approximately $2.3 million for the year ended December&#160;30, 2023. The change was primarily due to no longer accreting the discounts in connection with the promissory note with SPYR and the receivable from VM7, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">promissory notes entered into during the year ended December&#160;28, 2024, as well as the acquisition of ALT5 Subsidiary during May 2024.</span></div><div id="i213e3c881f5e4982994be533c682ff6b_67"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gain on Sale of the Recycling Subsidiaries</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal year ended December&#160;30, 2023, we recorded a gain on the sale of the Recycling Subsidiaries of approximately $12.1 million from discontinued operations. See Note 4 of the Consolidated Financial Statements.</span></div><div id="i213e3c881f5e4982994be533c682ff6b_73"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrealized Loss on Marketable Securities</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized loss on marketable securities for the fiscal year ended December&#160;28, 2024 was approximately $1.1 million, as compared to a loss of approximately $925,000 for the fiscal year ended December&#160;30, 2023. An unrealized gain or loss on marketable securities is recorded to mark to fair value securities received in connection to the sale of GeoTraq.</span></div><div id="i213e3c881f5e4982994be533c682ff6b_85"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations by Segment</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the results of operations by segment (in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:8.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.394%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Fiscal Year Ended December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Fiscal Year Ended December 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Fintech</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Biotech</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Corporate and other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Discontinued Operations</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Fintech</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Biotech</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Corporate and other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Discontinued Operations</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Revenue</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12,532&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">12,532&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,795&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,795&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Gross profit</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,294&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,294&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(197)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(197)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">5,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">2,148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">13,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">3,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">1,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">6,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Impairment charges</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">15,100&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">15,100&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Gain on sale of ARCA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(12,102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(12,102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Operating (loss) income</span></td><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">905&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(2,148)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(6,206)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(7,449)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1,531)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(18,315)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">10,438&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(9,408)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div id="i213e3c881f5e4982994be533c682ff6b_88"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fintech Segment</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Fintech segment consists of ALT5 Subsidiary, which was acquired during May 2024. Revenue for the fiscal year ended December&#160;28, 2024 was approximately $12.5 million, and gross margin percentage was 50.2%. Operating income for the fiscal year ended December&#160;28, 2024 was approximately $900,000.</span></div><div id="i213e3c881f5e4982994be533c682ff6b_624"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Biotech Segment</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Biotech segment generated no revenue for the fiscal year ended December&#160;28, 2024. Selling, general and administrative expenses increased primarily due to increased amortization costs relating to the Soin intangibles. </span></div><div id="i213e3c881f5e4982994be533c682ff6b_616"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate and Other Segment</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Corporate and Other segment generated no revenue for the fiscal year ended December&#160;28, 2024. Selling, general and administrative expenses increased primarily due to increased stock-based compensation expense related to grants of RSU's, as well as increased costs for professional services. </span></div><div id="i213e3c881f5e4982994be533c682ff6b_91"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Discontinued Operations</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discontinued operations consist of our Recycling segment, which was disposed of effective March 1, 2023. We had no discontinued operations for the fiscal year ended December&#160;28, 2024.</span></div><div id="i213e3c881f5e4982994be533c682ff6b_94"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overview</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying financial statements have been prepared under the assumption that we will continue as a going concern. Such assumption contemplates the realization of assets and satisfaction of liabilities in the normal course of business.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;28, 2024, our cash on hand was approximately $7.2 million. We intend to raise funds to support future development of JAN 123 either through capital raises or structured arrangements, which would include effectuating our previously announced intention to capitalize a subsidiary with certain of our biotechnology assets, acquire an additional biotechnology asset, and then engage in a financing of that subsidiary. The short-term intended result of that series of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">transactions would be for us to own a controlling interest in that subsidiary, but to decouple it from us so that it would operate on a stand-alone basis, although its financial statements would continue to be consolidated with ours for as long as we have a controlling interest.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to continue as a going concern is dependent upon the success of future capital raises or structured settlements and cash flows from the acquisition of ALT5 Subsidiary to fund the required testing to obtain FDA approval of JAN 123, as well as to fund our day-to-day operations. The accompanying financial statements do not include any adjustments that might be necessary should we be unable to continue as a going concern. While we will actively pursue these additional sources of financing, management cannot make any assurances that such financing will be secured. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flows</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal year ended December&#160;28, 2024, cash provided by operations was approximately $1.8 million, compared to cash provided by operations of approximately $855,000 during the fiscal year ended December&#160;30, 2023. Cash provided by operating activities from discontinued operations during the fiscal year ended December&#160;30, 2023 was approximately $2.3 million. We had no discontinued operations during the fiscal year ended December&#160;28, 2024. The change in cash was primarily due to results of operations as discussed above.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by investing activities was approximately $5.9 million for the fiscal year ended December&#160;28, 2024, compared to cash used in investing activities of approximately $156,000 for the fiscal year ended December&#160;30, 2023. Cash provided by investing activities for the fiscal year ended December&#160;28, 2024 was related to cash acquired in the acquisition of ALT5 Subsidiary, while cash used in investing activities for the fiscal year ended December&#160;30, 2023 was all associated with discontinued operations and was related to purchases of property and equipment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by financing activities was approximately $6.1 million for the fiscal year ended December&#160;28, 2024, and relates to proceeds from notes payable, proceeds from equity financing and warrants exercised, and proceeds from related party notes payable, partially offset by payments on notes payable, as well as payments on related party notes payable. Cash provided by financing activities was approximately $777,000 for the fiscal year ended December&#160;30, 2023. Cash used in financing activities from discontinued operations for the fiscal year ended December&#160;30, 2023 was approximately $2.2 million and was primarily due to the repayment of debt obligations in the amount of approximately $7.3 million, partially offset by proceeds from the issuance of debt obligations of approximately $5.1 million. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sources of Liquidity</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We acknowledge that we continue to face a challenging competitive environment as we continue to focus on our overall profitability, including managing expenses. We reported a net loss of approximately $6.2 million for the fiscal year ended December&#160;28, 2024, and net loss from continuing operations of approximately $17.1 million for the fiscal year ended December&#160;30, 2023, for the reasons discussed above. Additionally, the Company has total current assets of approximately $35.0 million and total current liabilities approximately of $40.9 million, resulting in a net negative working capital of approximately $5.9 million. Cash provided operations was approximately $1.0 million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Item 1A. Risk Factors, management has addressed and evaluated the risk factors that could materially and adversely affect the entity&#8217;s business, financial condition and results of operations, cash flows, and liquidity. The Company has determined that the risk factors do not materially affect the Company&#8217;s ability to continue as a going concern within one year after the date that the financial statements are issued.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the above, management has concluded that the Company is not aware and did not identify any other conditions or events that would cause the Company to not be able to continue business as a going concern for the next 12 months.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Future Sources of Cash; New Acquisitions, Products and Services</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We acquired ALT5 Subsidiary during May 2024, as discussed above. We may require additional debt financing and/or capital to finance new acquisitions or consummate other strategic investments in our business. We currently expect that the biotechnology subsidiary transaction discussed above will allow us to finance our Phase IIb clinical trials, No assurance can be given any financing obtained may not further dilute or otherwise impair the ownership interest of our existing stockholders or our ownership interest in the to-be-effectuated biotechnology subsidiary. </span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><div id="i213e3c881f5e4982994be533c682ff6b_97"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off Balance Sheet Arrangements </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;28, 2024, we had no off-balance sheet arrangements, commitments or guarantees that require additional disclosure or measurement.</span></div><div id="i213e3c881f5e4982994be533c682ff6b_100"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;28, 2024, we did not participate in any market risk-sensitive commodity instruments for which fair value disclosure would be required. We believe we are not subject in any material way to other forms of market risk, such as foreign currency exchange risk or foreign customer purchases or commodity price risk.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><div id="i213e3c881f5e4982994be533c682ff6b_103"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div><div id="i213e3c881f5e4982994be533c682ff6b_106"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:90.263%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.931%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Page</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reports of Independent Registered Public Accounting Firm</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_109">Report of Hudgens CPA, PLLC (PCAOB ID </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:AuditorFirmId" id="f-50">6849</ix:nonNumeric></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_109">)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_109">1</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Financial Statements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_115">Consolidated Balance Sheets as of December </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_115">28</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_115">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_115">4</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_115"> and December 3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_115">0</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_115">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_115">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_115"> </a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_115">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_118">Consolidated Statements of Operations and Comprehensive </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_118">Loss</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_118"> for the fiscal years ended December </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_118">28</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_118">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_118">4</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_118"> and December </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_118">30</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_118">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_118">3</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_118">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_121">Consolidated Statements of Changes in Stockholders&#8217; </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_121">E</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_121">q</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_121">u</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_121">i</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_121">t</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_121">y</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_121"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_121">(Deficit) for the fiscal years ended December </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_121">28</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_121">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_121">4</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_121"> and December 3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_121">0</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_121">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_121">3</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_121">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_124">Consolidated Statements of Cash Flows for the fiscal years ended December </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_124">28</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_124">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_124">4</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_124"> and December 3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_124">0</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_124">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_124">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_124"> </a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_124">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_127">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i213e3c881f5e4982994be533c682ff6b_127">7</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><div id="i213e3c881f5e4982994be533c682ff6b_109"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Board of Directors </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Stockholders of ALT5 Sigma Corporation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheet of ALT5 Sigma Corporation (the Company) as of December 28, 2024 and December 30, 2023, and the related consolidated statements of operations and comprehensive loss, stockholders&#8217; equity (deficit), and cash flows for each of the the years in the two-year period ended December 28, 2024, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 28, 2024 and December 30, 2023, and the results of its operations and its cash flows for each of the years in the two-year period December 28, 2024, in conformity with accounting principles generally accepted in the United States of America.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Substantial Doubt About the Company&#8217;s Ability to Continue as a Going Concern</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements, the Company has negative working capital, an accumulated deficit, a history of significant operating losses from continuing operations, and a history of negative operating cash flow. These factors raise substantial doubt about its ability to continue as a going concern. Management's plans in regard to these matters are also described in Note 1. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation of Intangible Assets associated with the business combination in accordance with ASC 805</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Description of the matter:</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company closed its acquisition of the assets of its ALT5 Subsidiary on May 14, 2024. The Company accounted for the acquisitions under the acquisition method of accounting for business combination. Accordingly, the purchase price was primarily allocated to the assets acquired based on their respective fair values, including related intangible assets. The fair value determination of the intangible assets required management to make significant assumptions related to the forecasted </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">revenue growth rates and the selection of the discount rates. We identified the intangible assets for the business combination as a critical audit matter because of the significant assumptions management makes to fair value these assets. This required a high degree of auditor judgment and an increased extent of effort, including the need to involve our fair value specialists, when performing audit procedures to evaluate the reasonableness of management&#8217;s assumptions related to the revenue growth rates and the selection of the discount rates utilized to value these intangible assets.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">How we addressed the matter in our audit: </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit procedures related to the revenue growth rates and the selection of the assumptions for the intangible assets acquired included the following, among others:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We assessed the reasonableness of the revenue growth rates by comparing the assumptions used in the projections to external market sources, historical data, and results from other areas of the audit.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We performed qualitative and quantitative analyses to assess the assumptions that would significantly impact the overall valuation of the intangible assets acquired. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We evaluated the completeness of the financial statement presentation and disclosure of the acquisitions. </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ <ix:nonNumeric contextRef="c-1" name="dei:AuditorName" id="f-51">Hudgens CPA, PLLC</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">www.hudgenscpas.com</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2023.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:AuditorLocation" id="f-52">Houston, Texas</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 28, 2025</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-2</span></div></div></div><div id="i213e3c881f5e4982994be533c682ff6b_115"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars in thousands, except per share amounts)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-53">7,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="f-54">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Trade and other receivables, net</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsAndOtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-55">2,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsAndOtherReceivablesNetCurrent" scale="3" id="f-56">266</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Digital assets receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="alts:PlatformOperatorCryptoAssetHeldForUserCurrent" format="ixt:num-dot-decimal" scale="3" id="f-57">23,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="alts:PlatformOperatorCryptoAssetHeldForUserCurrent" format="ixt:fixed-zero" scale="3" id="f-58">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-59">1,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="f-60">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-61">35,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AssetsCurrent" scale="3" id="f-62">346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-63">1,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:fixed-zero" scale="3" id="f-64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Right of use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="f-65">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:fixed-zero" scale="3" id="f-66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-67">34,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-68">17,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:MarketableSecuritiesNoncurrent" format="ixt:fixed-zero" scale="3" id="f-69">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:MarketableSecuritiesNoncurrent" scale="3" id="f-70">286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Deposits and other assets</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="alts:DepositsAndOtherAssetsNoncurrent" format="ixt:fixed-zero" scale="3" id="f-71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="alts:DepositsAndOtherAssetsNoncurrent" scale="3" id="f-72">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-73">11,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Goodwill" format="ixt:fixed-zero" scale="3" id="f-74">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total assets</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-75">82,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-76">18,487</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Liabilities, Mezzanine Equity, and Stockholders' Equity (Deficit)</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Liabilities:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-77">3,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-78">2,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-79">2,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-80">3,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Digital assets payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="alts:DigitalAssetLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-81">30,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="alts:DigitalAssetLiabilityCurrent" format="ixt:fixed-zero" scale="3" id="f-82">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Due to Soin</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-83">2,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:fixed-zero" scale="3" id="f-84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Convertible debentures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ConvertibleDebtCurrent" scale="3" id="f-85">563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ConvertibleDebtCurrent" format="ixt:fixed-zero" scale="3" id="f-86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="f-87">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:fixed-zero" scale="3" id="f-88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Related party notes payable and advances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:NotesPayableCurrent" scale="3" id="f-89">812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:NotesPayableCurrent" format="ixt:fixed-zero" scale="3" id="f-90">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total current liabilities</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-91">40,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-92">5,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-93">1,041</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="f-94">639</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Related party notes payable</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherLongTermNotesPayable" format="ixt:fixed-zero" scale="3" id="f-95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherLongTermNotesPayable" scale="3" id="f-96">707</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Notes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermNotesPayable" format="ixt:num-dot-decimal" scale="3" id="f-97">11,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LongTermNotesPayable" format="ixt:fixed-zero" scale="3" id="f-98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="f-99">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="f-100">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="f-101">108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="f-102">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total liabilities</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-103">53,769</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-104">7,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Commitments and Contingencies (Note 21)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-105"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-5" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-106"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Mezzanine equity</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Convertible preferred stock, series S - par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-8" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="f-107"><ix:nonFraction unitRef="usdPerShare" contextRef="c-9" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="f-108">0.001</ix:nonFraction></ix:nonFraction> per share <ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-109"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-110">200,000</ix:nonFraction></ix:nonFraction> authorized, <ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-111"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-112"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-113"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-114">100,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding at December&#160;28, 2024 and December&#160;30, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-115">3,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-116">14,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Stockholders' equity:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Convertible preferred stock, series A-1 - par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-10" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-117"><ix:nonFraction unitRef="usdPerShare" contextRef="c-11" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-118">0.001</ix:nonFraction></ix:nonFraction> per share <ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-119"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-120">2,000,000</ix:nonFraction></ix:nonFraction> authorized, <ix:nonFraction unitRef="shares" contextRef="c-10" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-121"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-122">23,480</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-123"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-124">193,730</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December&#160;28, 2024 and December&#160;30, 2023, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-125">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-126">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Preferred stock, series B - par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-127"><ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-128">0.001</ix:nonFraction></ix:nonFraction> per share, <ix:nonFraction unitRef="shares" contextRef="c-13" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-129"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-130">34,250</ix:nonFraction></ix:nonFraction> authorized, <ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-131"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-132">34,207</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-13" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="f-133"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="INF" name="us-gaap:PreferredStockSharesIssued" scale="0" id="f-134">0</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December&#160;28, 2024 and December&#160;30, 2023, respectively</span></div></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:num-dot-decimal" scale="3" id="f-135">8,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-136">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Convertible preferred stock, series I - par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-14" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-137"><ix:nonFraction unitRef="usdPerShare" contextRef="c-15" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-138">0.001</ix:nonFraction></ix:nonFraction> per share, <ix:nonFraction unitRef="shares" contextRef="c-14" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-139"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-140">2,000,000</ix:nonFraction></ix:nonFraction> authorized,  <ix:nonFraction unitRef="shares" contextRef="c-14" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-141"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-142">17,000</ix:nonFraction></ix:nonFraction>  and <ix:nonFraction unitRef="shares" contextRef="c-15" decimals="INF" name="us-gaap:PreferredStockSharesIssued" scale="0" id="f-143"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="f-144">0</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December&#160;28, 2024 and December&#160;30, 2023, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-145">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-146">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Preferred stock, series M - par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-16" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-147"><ix:nonFraction unitRef="usdPerShare" contextRef="c-17" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-148">0.001</ix:nonFraction></ix:nonFraction> per share, <ix:nonFraction unitRef="shares" contextRef="c-16" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-149"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-150">3,200</ix:nonFraction></ix:nonFraction> authorized,  <ix:nonFraction unitRef="shares" contextRef="c-16" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-151"><ix:nonFraction unitRef="shares" contextRef="c-16" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-152">3,200</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-17" decimals="INF" name="us-gaap:PreferredStockSharesIssued" scale="0" id="f-153"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="f-154">0</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December&#160;28, 2024 and December&#160;30, 2023, respectively</span></div></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-155">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-156">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Convertible Preferred stock, series Q - par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-18" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-157"><ix:nonFraction unitRef="usdPerShare" contextRef="c-19" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-158">0.001</ix:nonFraction></ix:nonFraction> per share, <ix:nonFraction unitRef="shares" contextRef="c-19" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-159"><ix:nonFraction unitRef="shares" contextRef="c-18" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-160">2,000,000</ix:nonFraction></ix:nonFraction> authorized,  <ix:nonFraction unitRef="shares" contextRef="c-18" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-161"><ix:nonFraction unitRef="shares" contextRef="c-18" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-162">925,212</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-19" decimals="INF" name="us-gaap:PreferredStockSharesIssued" scale="0" id="f-163"><ix:nonFraction unitRef="shares" contextRef="c-19" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="f-164">0</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December&#160;28, 2024 and December&#160;30, 2023, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:num-dot-decimal" scale="3" id="f-165">1,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-166">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Convertible preferred stock, series S - par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-8" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-167"><ix:nonFraction unitRef="usdPerShare" contextRef="c-9" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-168">0.001</ix:nonFraction></ix:nonFraction> per share, <ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-169"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-170">200,000</ix:nonFraction></ix:nonFraction> authorized,  <ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-171"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-172"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-173"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-174">100,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-175"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-176"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-177"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-178">100,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding at December&#160;28, 2024 and December&#160;30, 2023, respectively</span></div></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:num-dot-decimal" scale="3" id="f-179">7,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-180">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Convertible preferred stock, series V - par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-20" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-181"><ix:nonFraction unitRef="usdPerShare" contextRef="c-21" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-182">0.001</ix:nonFraction></ix:nonFraction> per share, <ix:nonFraction unitRef="shares" contextRef="c-20" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-183"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-184">125,000</ix:nonFraction></ix:nonFraction> authorized,  <ix:nonFraction unitRef="shares" contextRef="c-20" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-185"><ix:nonFraction unitRef="shares" contextRef="c-20" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-186">5,000</ix:nonFraction></ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="c-21" decimals="INF" name="us-gaap:PreferredStockSharesIssued" scale="0" id="f-187"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="f-188">0</ix:nonFraction></ix:nonFraction> issued and outstanding at December&#160;28, 2024 and December&#160;30, 2023, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-189">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-190">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-191"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-192">0.001</ix:nonFraction></ix:nonFraction> per share, <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-193"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-194">200,000,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-195"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-196">15,417,693</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-197"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-198">2,827,410</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December&#160;28, 2024 and at December&#160;30, 2023, respectively</span></div></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-199">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-200">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Additional paid in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-201">62,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-202">47,323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-203">56,879</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-204">50,634</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-205">2,317</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="3" id="f-206">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 17.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Equity attributable to ALT5 Sigma Corporation shareholders</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-207">20,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-208">3,308</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="f-209">3,925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:fixed-zero" scale="3" id="f-210">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total stockholders' equity</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-211">24,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-212">3,308</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Total liabilities, mezzanine equity, and stockholders' equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-213">82,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-214">18,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-3</span></div></div></div><div id="i213e3c881f5e4982994be533c682ff6b_118"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars in thousands, except per share amounts)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Years Ended </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-215">12,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-216">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="f-217">6,238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:fixed-zero" scale="3" id="f-218">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="f-219">6,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:GrossProfit" format="ixt:fixed-zero" scale="3" id="f-220">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-221">13,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-222">4,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="3" id="f-223">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="f-224">15,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-225">13,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-226">19,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-227">7,562</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-228">19,846</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest (expense) income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="f-229">879</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="f-230">2,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized gain on exchange transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="alts:RealizedGainLossOnExchangeTransactions" scale="3" id="f-231">374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="alts:RealizedGainLossOnExchangeTransactions" format="ixt:fixed-zero" scale="3" id="f-232">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized loss on marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-233">1,058</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="f-234">926</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-235">161</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-236">998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other (expense) income, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-237">1,724</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-238">2,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss before benefit from income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-239">9,286</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-240">17,524</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-241">3,041</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-242">429</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="f-243">6,245</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="f-244">17,095</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" format="ixt:fixed-zero" scale="3" id="f-245">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" format="ixt:num-dot-decimal" scale="3" id="f-246">10,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax provision for discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation" format="ixt:fixed-zero" scale="3" id="f-247">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation" scale="3" id="f-248">971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:fixed-zero" scale="3" id="f-249">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:num-dot-decimal" scale="3" id="f-250">9,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-251">6,245</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-252">7,812</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Loss) income per share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per share from continuing operations, basic and diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="f-253"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="f-254">0.56</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-22" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="f-255"><ix:nonFraction unitRef="usdPerShare" contextRef="c-22" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="f-256">4.27</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income per share from discontinued operations, basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" format="ixt:fixed-zero" scale="0" id="f-257">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-22" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" scale="0" id="f-258">2.32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income per share from discontinued operations, diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" format="ixt:fixed-zero" scale="0" id="f-259">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-22" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="f-260">2.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per share, basic and diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-261"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-262">0.56</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-22" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-263"><ix:nonFraction unitRef="usdPerShare" contextRef="c-22" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-264">1.95</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-265">11,148,493</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-22" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-266">4,005,334</ix:nonFraction></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-267">11,148,493</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-22" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-268">4,444,361</ix:nonFraction></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-4</span></div></div></div><div id="i213e3c881f5e4982994be533c682ff6b_121"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars in thousands)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"><tr><td style="width:1.0%"/><td style="width:11.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.775%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.187%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.187%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.187%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.187%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.000%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.187%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.187%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.000%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.187%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.187%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.097%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.187%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.187%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.097%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.187%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.187%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.000%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.187%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.187%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.775%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.187%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.187%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.163%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.187%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.229%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.187%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.004%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.187%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.187%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.122%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Series A-1 Preferred</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Series S-1 Preferred</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Series B Preferred</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Series I Preferred</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Series M Preferred</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Series Q Preferred</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Series V Preferred</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Additional<br/>Paid in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Accumulated <br/>Deficit </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Accumulated<br/>Other<br/>Comprehensive <br/>Deficit </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Noncontrolling Interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Total </span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Shares </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">Balance, December 31, 2022</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-23" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-269">222,588</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="f-270">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-24" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-271">100,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="f-272">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-25" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="f-273">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="f-274">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-26" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="f-275">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="f-276">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-27" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="f-277">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="f-278">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-28" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="f-279">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="f-280">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-29" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="f-281">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="f-282">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-30" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-283">3,150,230</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-284">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-285">45,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-286">42,822</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-287">621</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="f-288">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-289">2,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="3" id="f-290">621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="3" id="f-291">621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">Common stock issued for equity financing</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-37" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-292">779,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-293">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-294">792</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-295">793</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">Share based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-296">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-297">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">Series A-1 preferred converted for legal settlement</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-39" decimals="0" sign="-" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-298">27,353</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-37" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-299">547,069</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="f-300">510</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="f-301">510</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">Series A-1 preferred forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-39" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" format="ixt:num-dot-decimal" scale="0" id="f-302">1,505</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">Common stock issued for warrants exercised</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-37" decimals="0" name="alts:StockIssuedDuringPeriodSharesWarrantsExercised" format="ixt:num-dot-decimal" scale="0" id="f-303">481,348</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="alts:StockIssuedDuringPeriodValueWarrantsExercised" scale="3" id="f-304">259</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="alts:StockIssuedDuringPeriodValueWarrantsExercised" scale="3" id="f-305">259</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-306">7,812</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:fixed-zero" scale="3" id="f-307">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-308">7,812</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">Balance, December 30, 2023</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-42" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-309">193,730</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="f-310">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-43" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-311">100,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="0" id="f-312">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-44" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-313">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="0" id="f-314">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-45" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-315">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="0" id="f-316">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-46" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-317">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="0" id="f-318">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-47" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-319">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="0" id="f-320">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-48" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-321">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="0" id="f-322">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-49" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-323">4,957,647</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-324">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-325">47,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-326">50,634</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="f-327">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="f-328">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-329">3,308</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">Reclassification of Series S S-1 Preferred Stock to liability</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="alts:AdjustmentToAdditionalPaidInCapitalReclassificationsOfTemporaryToLiability" scale="3" id="f-330">339</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="alts:AdjustmentToAdditionalPaidInCapitalReclassificationsOfTemporaryToLiability" scale="3" id="f-331">339</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">Reclassification of Series S S-1 Preferred Stock to permanent equity</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ReclassificationsOfTemporaryToPermanentEquity" format="ixt:num-dot-decimal" scale="3" id="f-332">7,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">Share based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-55" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-333">1,250,027</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-334">1,656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-335">1,656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">Common stock issued for equity financing</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-55" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-336">1,030,478</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-337">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-338">1,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-339">1,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">Common stock issued for consulting agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-55" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" format="ixt:num-dot-decimal" scale="0" id="f-340">477,923</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="3" id="f-341">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:num-dot-decimal" scale="3" id="f-342">1,020</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:num-dot-decimal" scale="3" id="f-343">1,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">Common stock issued in lieu of notes payable obligation</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-55" decimals="0" name="alts:StockIssuedDuringPeriodSharesIssuedInLieuOfNotesPayable" format="ixt:num-dot-decimal" scale="0" id="f-344">2,031,595</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="alts:StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable" scale="3" id="f-345">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="alts:StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable" format="ixt:num-dot-decimal" scale="3" id="f-346">2,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="alts:StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable" format="ixt:num-dot-decimal" scale="3" id="f-347">2,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">Common stock issued for acquisition of Alt5 Subsidiary</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-56" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="f-348">1,799,115</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:fixed-zero" scale="3" id="f-349">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-350">7,447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-351">7,447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">Preferred stock issued for acquisition of Alt5 Subsidiary</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-59" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="f-352">34,207</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-353">8,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-60" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="f-354">17,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-61" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="f-355">3,200</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-356">8,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">Conversion of Series A-1 Preferred to common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-63" decimals="0" sign="-" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-357">170,250</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-55" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-358">3,055,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">Preferred stock issued for property and equipment</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-64" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets" format="ixt:num-dot-decimal" scale="0" id="f-359">5,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">Common stock issued for property and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-55" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets" format="ixt:num-dot-decimal" scale="0" id="f-360">300,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets" format="ixt:num-dot-decimal" scale="3" id="f-361">1,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets" format="ixt:num-dot-decimal" scale="3" id="f-362">1,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">Preferred stock issued for Qoden asset acquisition</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-65" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="f-363">925,212</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-364">1,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-365">1,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">Common stock issued for prepaid interest</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-55" decimals="0" name="alts:StockIssuedDuringPeriodSharesPrepaidInterest" format="ixt:num-dot-decimal" scale="0" id="f-366">225,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="alts:StockIssuedDuringPeriodValuePrepaidInterest" scale="3" id="f-367">380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="alts:StockIssuedDuringPeriodValuePrepaidInterest" scale="3" id="f-368">380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">Common stock issued for warrants exercised</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-55" decimals="0" name="alts:StockIssuedDuringPeriodSharesWarrantsExercised" format="ixt:num-dot-decimal" scale="0" id="f-369">290,908</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="alts:StockIssuedDuringPeriodValueWarrantsExercised" scale="3" id="f-370">497</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="alts:StockIssuedDuringPeriodValueWarrantsExercised" scale="3" id="f-371">497</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">Foreign currency adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-372">2,317</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-373">2,317</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-374">6,245</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-375">3,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-376">2,320</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">Balance, December 28, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-70" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-377">23,480</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="0" id="f-378">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-71" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-379">100,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="0" id="f-380">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-72" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-381">34,207</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-382">8,552,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-73" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-383">17,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="0" id="f-384">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-74" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-385">3,200</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="0" id="f-386">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-75" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-387">925,212</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-388">1,321,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-76" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-389">5,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="0" id="f-390">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-77" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-391">15,417,693</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-392">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-393">62,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-394">56,879</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-395">2,317</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-396">3,925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-397">24,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-5</span></div></div></div><div id="i213e3c881f5e4982994be533c682ff6b_124"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars in thousands)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Years Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">OPERATING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net loss from continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="f-398">6,245</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="f-399">17,095</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Adjustments to reconcile net loss to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-400">3,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-401">1,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Change in reserve for uncollectible accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="f-402">254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:fixed-zero" scale="3" id="f-403">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accretion of note receivable discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinancialGuaranteeInsuranceContractsPremiumsReceivableAccretionOfDiscountOnPremiumReceivable" format="ixt:fixed-zero" scale="3" id="f-404">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:FinancialGuaranteeInsuranceContractsPremiumsReceivableAccretionOfDiscountOnPremiumReceivable" format="ixt:num-dot-decimal" scale="3" id="f-405">1,223</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Stock based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-406">1,657</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:ShareBasedCompensation" scale="3" id="f-407">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Bad debt expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProvisionForLoanLeaseAndOtherLosses" format="ixt:fixed-zero" scale="3" id="f-408">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:ProvisionForLoanLeaseAndOtherLosses" scale="3" id="f-409">617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Noncash expense for consulting services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NoncashContributionExpense" scale="3" id="f-410">271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:NoncashContributionExpense" format="ixt:fixed-zero" scale="3" id="f-411">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Related party notes issued for shared services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="f-412">800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="f-413">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Write off of VM7 note receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:fixed-zero" scale="3" id="f-414">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="3" id="f-415">5,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Write off of SPYR note receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="alts:GainLossOnWriteOffOfNotesReceivable" format="ixt:fixed-zero" scale="3" id="f-416">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="alts:GainLossOnWriteOffOfNotesReceivable" format="ixt:num-dot-decimal" scale="3" id="f-417">9,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Unrealized loss on marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-418">1,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="f-419">926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="f-420">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:fixed-zero" scale="3" id="f-421">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Unrealized gain on digital assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CryptoAssetUnrealizedGainLossOperating" format="ixt:fixed-zero" scale="3" id="f-422">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:CryptoAssetUnrealizedGainLossOperating" format="ixt:fixed-zero" scale="3" id="f-423">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Change in deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-424">3,229</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="f-425">444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-426">1,876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="f-427">367</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Digital assets receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="alts:IncreaseDecreaseInDigitalAssetsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-428">14,694</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="alts:IncreaseDecreaseInDigitalAssetsReceivable" format="ixt:fixed-zero" scale="3" id="f-429">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="f-430">780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="f-431">320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="f-432">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="f-433">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-434">1,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-435">1,052</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Digital assets payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="alts:IncreaseDecreaseInDigitalAssetsPayable" format="ixt:num-dot-decimal" scale="3" id="f-436">14,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="alts:IncreaseDecreaseInDigitalAssetsPayable" format="ixt:fixed-zero" scale="3" id="f-437">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;Operating cash flows provided by discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" format="ixt:fixed-zero" scale="3" id="f-438">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-439">2,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-440">1,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-441">1,463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">INVESTING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Cash acquired in ALT5 Subsidiary acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CashAcquiredFromAcquisition" format="ixt:num-dot-decimal" scale="3" id="f-442">5,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:CashAcquiredFromAcquisition" format="ixt:fixed-zero" scale="3" id="f-443">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Investing cash flows used in discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" format="ixt:fixed-zero" scale="3" id="f-444">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" scale="3" id="f-445">155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-446">5,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="f-447">155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FINANCING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Proceeds from issuance of notes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromNotesPayable" format="ixt:num-dot-decimal" scale="3" id="f-448">7,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:ProceedsFromNotesPayable" format="ixt:fixed-zero" scale="3" id="f-449">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Payments on related party notes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RepaymentsOfRelatedPartyDebt" scale="3" id="f-450">248</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:RepaymentsOfRelatedPartyDebt" format="ixt:fixed-zero" scale="3" id="f-451">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Proceeds from the issuance of related party note payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromRelatedPartyDebt" scale="3" id="f-452">603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:ProceedsFromRelatedPartyDebt" format="ixt:fixed-zero" scale="3" id="f-453">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Proceeds from equity financings, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="f-454">851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="f-455">792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Warrants exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" scale="3" id="f-456">497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" scale="3" id="f-457">259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Payments on short term notes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="3" id="f-458">2,847</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:RepaymentsOfNotesPayable" scale="3" id="f-459">274</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Financing cash flows used in discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" format="ixt:fixed-zero" scale="3" id="f-460">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-461">2,212</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-462">6,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-463">1,435</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Effect of changes in exchange rate on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-464">6,551</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="3" id="f-465">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-466">7,172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="f-467">110</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CASH AND CASH EQUIVALENTS, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="3" id="f-468">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="3" id="f-469">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">LESS CASH OF DISCONTINUED OPERATIONS, end of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" format="ixt:fixed-zero" scale="3" id="f-470">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" format="ixt:fixed-zero" scale="3" id="f-471">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CASH AND CASH EQUIVALENTS OF CONTINUING OPERATIONS, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-472">7,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-473">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Supplemental cash flow disclosures:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Noncash recognition of new leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="alts:NoncashRecognitionOfNewLeases" scale="3" id="f-474">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="alts:NoncashRecognitionOfNewLeases" format="ixt:fixed-zero" scale="3" id="f-475">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Interest paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="f-476">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="f-477">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Income tax refunds received, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="f-478">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:fixed-zero" scale="3" id="f-479">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Noncash financing and investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Stock issued for the acquisition of Alt5 Subsidiary</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:StockIssued1" format="ixt:num-dot-decimal" scale="3" id="f-480">16,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="us-gaap:StockIssued1" format="ixt:fixed-zero" scale="3" id="f-481">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Common stock issued for consulting services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" name="us-gaap:StockIssued1" scale="3" id="f-482">853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-3" name="us-gaap:StockIssued1" format="ixt:fixed-zero" scale="3" id="f-483">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Common stock issued for liability obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-3" name="us-gaap:StockIssued1" scale="3" id="f-484">367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-3" name="us-gaap:StockIssued1" format="ixt:fixed-zero" scale="3" id="f-485">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Notes payable converted to common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DebtConversionConvertedInstrumentAmount1" format="ixt:num-dot-decimal" scale="3" id="f-486">1,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:DebtConversionConvertedInstrumentAmount1" format="ixt:fixed-zero" scale="3" id="f-487">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Common stock issued for interest obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-3" name="us-gaap:StockIssued1" scale="3" id="f-488">380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-3" name="us-gaap:StockIssued1" format="ixt:fixed-zero" scale="3" id="f-489">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Common stock issued for property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-3" name="us-gaap:StockIssued1" format="ixt:num-dot-decimal" scale="3" id="f-490">1,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-3" name="us-gaap:StockIssued1" format="ixt:fixed-zero" scale="3" id="f-491">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Preferred stock issued for intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-3" name="us-gaap:StockIssued1" format="ixt:num-dot-decimal" scale="3" id="f-492">1,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-3" name="us-gaap:StockIssued1" format="ixt:fixed-zero" scale="3" id="f-493">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-6</span></div></div></div><div id="i213e3c881f5e4982994be533c682ff6b_127"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:120%"> </span></div><div id="i213e3c881f5e4982994be533c682ff6b_130"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1: <ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="f-494" continuedAt="f-494-1" escape="true">Background and Basis of Presentation</ix:nonNumeric></span></div><ix:continuation id="f-494-1" continuedAt="f-494-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements include the accounts of ALT5 Sigma Corporation, a Nevada corporation, and its subsidiaries (collectively, the &#8220;Company&#8221; or &#8220;ALT5&#8221;). Effective July 15, 2024, the Company changed its corporate name from &#8220;JanOne Inc.&#8221; to &#8220;ALT5 Sigma Corporation,&#8221; and also changed its Nasdaq common stock ticker symbol from &#8220;JAN&#8221; to &#8220;ALTS&#8221;. The corporate name change was effected through a parent/subsidiary short-form merger of ALT5 Sigma Corporation, the Company&#8217;s wholly-owned Nevada subsidiary formed solely for the purpose of effectuating the name change), whereby it merged with and into the Company, with the Company being the surviving entity, albeit with its new name.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="f-495">three</ix:nonFraction> operating segments &#8211; Fintech, Biotechnology, and Corporate and Other. In connection with the sale of ARCA Recycling, Inc. (&#8220;ARCA Recycling&#8221;), the accounts for the Recycling segment have been presented as discontinued operations in the accompanying consolidated financial statements (See Note 4).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Fintech</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 15, 2024, the Company acquired ALT5 Sigma, Inc. (&#8220;ALT5 Subsidiary&#8221;). ALT5 Subsidiary is a fintech company that provides next generation blockchain-powered technologies to enable a migration to a new global financial paradigm. ALT5 Subsidiary, through its respective subsidiaries, offers two main platforms to its customers: &#8220;ALT5 Pay&#8221; and &#8220;ALT5 Prime.&#8221; ALT5 Pay is a crypto-currency payment gateway that enables registered and approved global merchants to accept and make crypto-currency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay&#8217;s checkout widgets and APIs. Merchants have the option to convert to fiat currency (US Dollars, Canadian Dollars, Euros, and British Pounds Sterling) automatically or to receive their payment in digital assets (see Note 3).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Biotechnology</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During September 2019, ALT5 Sigma Corporation, through its biotechnology segment, broadened its business perspectives to become a pharmaceutical company focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. Effective December 28, 2022, the Company acquired Soin Therapeutics LLC, a Delaware limited liability company (&#8220;STLLC&#8221;), and its product, a patent-pending, novel formulation of low-dose naltrexone, (&#8220;JAN123&#8221;). The product is being developed for the treatment of Complex Regional Pain Syndrome (CRPS), an indication that causes severe, chronic pain generally affecting the arms or legs. At present, there are no truly effective treatments for CRPS. Because of the relatively small number of patients afflicted with CRPS, the FDA has granted Orphan Drug Designation for any product approved for treatment of CRPS. This designation will provide the Company with tax credits for its clinical trials, exemption of user fees, and the potential of <ix:nonNumeric contextRef="c-1" name="alts:PotentialMarketExclusivityPeriod" format="ixt-sec:durwordsen" id="f-496">seven years</ix:nonNumeric> of market exclusivity following approval. In addition, development of orphan drugs currently also involves smaller trials and quicker times to approval, given the limited number of patients available to study. However, there can be no assurance that the product will receive FDA approval or that it will result in material sales. In that regard, we have previously announced our intention to capitalize a subsidiary with certain of our biotechnology assets, acquire an additional biotechnology asset, and then engage in a financing of that subsidiary. The short-term intended result of that series of transactions would be for us to own a controlling interest in that subsidiary, but to decouple it from us so that it would operate on a stand-alone basis.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Recycling</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Recycling Subsidiaries constituted the Company&#8217;s Recycling segment and provided turnkey recycling services for electric utility energy efficiency programs in the United States. ARCA Recycling and ARCA Canada recycled major household appliances in North America by providing turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs. Connexx provided call center services for ARCA Recycling and ARCA Canada. On March 9, 2023, retroactive to March 1, 2023, the Company entered into a Stock Purchase Agreement (the &#8220;Recycling Purchase Agreement&#8221; with VM7 Corporation (&#8220;VM7&#8221;), under which it agreed to acquire all of the outstanding equity interests of the Recycling Subsidiaries. The principal of VM7 is Virland A. Johnson, our Chief Financial Officer. The sale of all of the outstanding equity interests of the Recycling Subsidiaries to VM7 under the Recycling Purchase Agreement was consummated simultaneously with the execution of the Recycling Purchase Agreement (see Note 4). The Company&#8217;s Board of Directors unanimously approved the Recycling Purchase Agreement and the Disposition Transaction. In connection with the disposition of the Recycling Subsidiaries, accounts for the Recycling segment have been presented as discontinued operations in the accompanying consolidated financial statements (See Note 4).</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-494-2"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Corporate and Other</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Corporate and Other segment consists of certain corporate general and administrative costs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports on a 52- or 53-week fiscal year. The Company's 2024 fiscal year (&#8220;2024&#8221;) ended on December&#160;28, 2024, and our fiscal year (&#8220;2022&#8221;) ended on December&#160;30, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Going concern</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying financial statements have been prepared under the assumption that the Company will continue as a going concern. Such assumption contemplates the realization of assets and satisfaction of liabilities in the normal course of business, however, the issues described below raise substantial doubt about the Company&#8217;s ability to do so.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company currently faces a challenging competitive environment and is focused on improving its overall profitability, which includes managing expenses. The Company reported a net loss from continuing operations of approximately $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="f-497">6.2</ix:nonFraction> million for the year ended December&#160;28, 2024, and net loss from continuing operations of approximately $<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="f-498">17.1</ix:nonFraction> million for the fiscal year ended December&#160;30, 2023. Additionally, as of December&#160;28, 2024, the Company has total current assets of approximately $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AssetsCurrent" scale="6" id="f-499">35.0</ix:nonFraction> million and total current liabilities of approximately $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="f-500">40.9</ix:nonFraction> million resulting in a net negative working capital of approximately $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="alts:CurrentAssetsCurrentLiabilitiesNet" scale="6" id="f-501">5.9</ix:nonFraction> million. Cash provided by operations was approximately $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="alts:NetCashProvidedByOperatingActivitiesContinuingOperations" scale="6" id="f-502">1.0</ix:nonFraction> million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company intends to raise funds to support future development of JAN 123 and JAN 101 and through a combination of cash flows derived from its acquisition of ALT5 (see Note 3), capital raises, and/or structured arrangements. However, the success of such funding cannot be assured. We currently expect that the biotechnology subsidiary transaction discussed above will allow us to finance our Phase III clinical trial for JAN123. No assurance can be given any financing obtained may not further dilute or otherwise impair the ownership interest of our existing stockholders or our ownership interest in the to-be-effectuated biotechnology subsidiary. The short-term intended result of that transaction would be for us to own a controlling interest in that subsidiary, but to decouple it from us so that it would operate on a stand-alone basis.</span></div></ix:continuation><div id="i213e3c881f5e4982994be533c682ff6b_133"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2: <ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-503" continuedAt="f-503-1" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="f-503-1" continuedAt="f-503-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-504" continuedAt="f-504-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-504-1">The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="f-505" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Statement Reclassification</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain account balances from prior periods have been reclassified in these consolidated financial statements to conform to current period classifications.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-506" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumption that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant estimates made in connection with the accompanying consolidated financial statements include the fair values in connection with the GeoTraq promissory note, analysis of other intangibles and long-lived assets for impairment, valuation allowance against deferred tax assets, lease terminations, and estimated useful lives for intangible assets and property and equipment.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="f-507" continuedAt="f-507-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Instruments</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments consist primarily of cash equivalents, trade and other receivables, notes receivables, and obligations under accounts payable, accrued expenses and notes payable. The carrying amounts of cash equivalents, trade receivables and other receivables, accounts payable, accrued expenses and short-term notes payable approximate fair value because of the short maturity of these instruments. The fair value of the long-term debt is calculated based on interest rates available for debt with terms and maturities similar to the Company&#8217;s existing debt arrangements, unless quoted market prices were </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-503-2" continuedAt="f-503-3"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-507-1">available (Level 2 inputs). The carrying amounts of long-term debt at December&#160;28, 2024 and December&#160;30, 2023 approximate fair value.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="f-508" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of highly liquid investments with a maturity of three months or less at the time of purchase. Fair value of cash equivalents approximates carrying value.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="alts:DigitalAssetsAndOtherReceivablesPolicyPolicyTextBlock" id="f-509" continuedAt="f-509-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Digital Assets and other Receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">s</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-509-1">Digital assets and other receivables are the Company&#8217;s digital assets and its customer prepayments in the form of digital assets. The Company holds all digital assets in secure non-custodial wallets through the wallet services from Fireblocks.</ix:continuation> As of December&#160;28, 2024, the outstanding balance of digital assets and other receivables was approximately $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="alts:PlatformOperatorCryptoAssetHeldForUserCurrent" scale="6" id="f-510">23.8</ix:nonFraction> million.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="f-511" continuedAt="f-511-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Receivables and Allowance for Doubtful Accounts</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-511-1">The Company carries unsecured other receivables at the original invoice amount less an estimate made for doubtful accounts based on a monthly review of all outstanding amounts. Management determines the allowance for doubtful accounts by regularly evaluating receivables based on current economic conditions. The Company writes off receivables when it deems them to be uncollectible. The Company records recoveries of receivables previously written off when payment is received. The Company considers a receivable to be past due if any portion of the receivable balance is outstanding for more than ninety days. The Company does not charge interest on past due receivables.</ix:continuation> The Company had <ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:fixed-zero" scale="3" id="f-512"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:fixed-zero" scale="3" id="f-513">no</ix:nonFraction></ix:nonFraction> allowance for doubtful accounts for the years ended December&#160;28, 2024 and December&#160;30, 2023.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="f-514" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table details the Company's trade and other receivables as of December&#160;28, 2024 and December&#160;30, 2023 (in $000&#8217;s):</span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.393%"><tr><td style="width:1.0%"/><td style="width:57.893%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.162%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.162%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.165%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other receivables</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-515">2,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" scale="3" id="f-516">266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" scale="3" id="f-517">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade and other receivables, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsAndOtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-518">2,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsAndOtherReceivablesNetCurrent" scale="3" id="f-519">266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:AccountsAndOtherReceivablesNetCurrent" scale="3" id="f-520">106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;28, 2024, other receivables includes approximately $<ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="f-521">2.2</ix:nonFraction>&#160;million in subscriptions receivable (see Note 18).</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:IntangibleAssetsFiniteLivedPolicy" id="f-522" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s intangible assets consist of customer relationship intangibles, favorable leases, trade names, licenses for the use of internet domain names, Universal Resource Locators, or URL&#8217;s, software, patents, and marketing and technology related intangibles. Upon acquisition, estimates are made in valuing acquired intangible assets, which include but are not limited to, future expected cash flows from customer contracts, customer lists, and estimating cash flows from projects when completed; tradename and market position, as well as assumptions about the period of time that customer relationships will continue; and discount rates. Management's estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from the assumptions used in determining the fair values. All intangible assets are capitalized at their original cost and amortized over their estimated useful lives as follows: domain name and marketing &#8211; <ix:nonNumeric contextRef="c-95" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-523">3</ix:nonNumeric>-to-<ix:nonNumeric contextRef="c-96" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-524">20</ix:nonNumeric> years; software &#8211; <ix:nonNumeric contextRef="c-97" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-525">3</ix:nonNumeric>-to-<ix:nonNumeric contextRef="c-98" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-526">5</ix:nonNumeric> years; technology intangibles &#8211; <ix:nonNumeric contextRef="c-99" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-527">7</ix:nonNumeric> years; customer relationships &#8211; <ix:nonNumeric contextRef="c-100" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-528">7</ix:nonNumeric>-to-<ix:nonNumeric contextRef="c-101" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-529">15</ix:nonNumeric> years.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="alts:DigitalAssetsAndOtherPayablesPolicyPolicyTextBlock" id="f-530" continuedAt="f-530-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Digital Assets and other Payables</span></div></ix:nonNumeric><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-530-1">Digital assets and other payables are liabilities that represent the Company&#8217;s obligation to deliver the settlement of transactions in the form of digital assets and or cash. The Company safeguards these digital assets and cash for customers and is obligated to safeguard them from loss, theft, or other misuse. The Company recognizes digital assets and other payables, on initial recognition and at each reporting date, at fair value of the digital assets. Any loss, theft, or other misuse would impact the measurement of digital assets and other payables.</ix:continuation> As of December&#160;28, 2024, the outstanding balance of digital assets and other payables was approximately $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="alts:DigitalAssetLiabilityCurrent" scale="6" id="f-531">30.9</ix:nonFraction> million, of which approximately $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="alts:DigitalAssetLiabilityCurrentDigitalAssets" scale="6" id="f-532">23.8</ix:nonFraction> million was digital assets and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="alts:DigitalAssetLiabilityCurrentCashDeposits" scale="6" id="f-533">7.1</ix:nonFraction> million was cash deposits.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="f-534" continuedAt="f-534-1" escape="true"><ix:continuation id="f-503-3" continuedAt="f-503-4"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognition applies to the Company&#8217;s Fintech segment only, as the Company&#8217;s Biotech segment has not recognized revenue to date. Revenue is recognized under Topic 606 in a manner that reasonably reflects the delivery of its services and products to customers in return for expected consideration and includes the following elements:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Executed contracts with the Company&#8217;s customers that it believes are legally enforceable;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Identification of performance obligations in the respective contract;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Determination of the transaction price for each performance obligation in the respective contract;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Allocation of the transaction price to each performance obligation; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Recognition of revenue only when the Company satisfies each performance obligation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fintech Revenue</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The five elements above, as applied to each of the Fintech segment's revenue categories, is summarized below:</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Product sales &#8211; revenue is recognized at the time of sale of equipment to the customer.</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Service sales &#8211; revenue is recognized based on when the service has been provided to the customer.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s service is comprised of a single performance obligation to buy and sell or convert digital assets to currencies. That is, the Company is the counter party to all transactions between customers and liquidity providers and presents revenue for the fees earned on a net basis.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is acting as principal in all transactions, and control the digital assets being provided before it is transferred to the buyer, and has risk related to the digital assets, and is responsible for the fulfillment of the digital asset transactions. The Company sets the price for the digital assets by aggregating prices from several liquidity providers and displays them on the Company&#8217;s platform. As a result, the Company acts as a price discovery service and acts as a principal facilitating the ability for a customer to purchase or sell digital assets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers its performance obligation satisfied, and recognizes revenue, at the point in time the transaction is processed. Contracts with customers are usually open-ended and can be terminated by either party without a termination penalty. Therefore, contracts are defined at the transaction level and do not extend beyond the service already provided.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company charges a fee at the transaction level. The transaction price, represented by the trading fee, is calculated based on volume and varies depending on payment type and the value of the transaction. Digital asset purchases or sale transactions executed by a customer on the Company&#8217;s platform is based on tiered pricing that is driven primarily by transaction volume processed for a specific historical period. The Company has concluded that this volume-based pricing approach does not constitute a future material right since the discount is within a range typically offered to a class of customers with similar volume. The transaction fee is collected from the customer at the time the transaction is executed. In certain instances, the transaction fee can be collected in digital assets, with revenue measured based on the amount of digital assets received and the fair value of the digital assets at the time of the transaction. The Company also marks up or down the digital asset prices and earns revenue from the spread between the buying and selling price. The Company also earns a fee from transfers of currencies and or digital assets. The transfer fees are nominal and are set to offset the fees associated with banking and or blockchain mining fees.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Biotechnology Revenue</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company currently generates no revenue from its Biotechnology segment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Discontinued Operations Revenue</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 9, 2023, retroactive to March 1, 2023, the Company entered into the Recycling Purchase Agreement with VM7, under which VM7 agreed to acquire all of the outstanding equity interests of the Recycling Subsidiaries. As discussed </span></div></ix:continuation></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-503-4" continuedAt="f-503-5"><ix:continuation id="f-534-1"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">previously, the accounts for the Recycling segment have been presented as discontinued operations in the accompanying consolidated financial statements.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="f-535" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC Topic 820, &#8220;Fair Value Measurements and Disclosures,&#8221; requires disclosure of the fair value of financial instruments held by the Company. ASC Topic 825, &#8220;Financial Instruments,&#8221; defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The three levels of valuation hierarchy are defined as follows: Level 1 - inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets. Level 2 &#8211; to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. Level 3 &#8211; inputs to the valuation methodology are unobservable and significant to the fair value measurement.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxPolicyTextBlock" id="f-536" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes using the asset and liability method. The asset and liability method requires recognition of deferred tax assets and liabilities for expected future tax consequences of temporary differences that currently exist between tax bases and financial reporting bases of the Company's assets and liabilities. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is provided on deferred taxes if it is determined that it is more likely than not that the asset will not be realized. The Company recognizes penalties and interest accrued related to income tax liabilities in the provision for income taxes in its Consolidated Statements of Income.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant management judgment is required to determine the amount of benefit to be recognized in relation to an uncertain tax position. The Company uses a two-step process to evaluate tax positions. The first step requires an entity to determine whether it is more likely than not (greater than 50% chance) that the tax position will be sustained. The second step requires an entity to recognize in the financial statements the benefit of a tax position that meets the more-likely-than-not recognition criterion. The amounts ultimately paid upon resolution of issues raised by taxing authorities may differ materially from the amounts accrued and may materially impact the financial statements of the Company in future periods.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="f-537" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company from time to time grants stock options to employees, non-employees and Company executives and directors. Such awards are valued based on the grant date fair-value of the instruments. The value of each award is amortized on a straight-line basis over the vesting period.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerSharePolicyTextBlock" id="f-538" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings Per Share</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share is calculated in accordance with ASC 260, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;. Under ASC 260 basic earnings per share is computed using the weighted average number of common shares outstanding during the period except that it does not include unvested restricted stock subject to cancellation. Diluted earnings per share is computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of warrants, options, restricted shares and convertible preferred stock. The dilutive effect of outstanding restricted shares, options and warrants is reflected in diluted earnings per share by application of the treasury stock method. Convertible preferred stock is reflected on an if-converted basis.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="f-539" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Reporting</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC Topic 280, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; requires use of the &#8220;management approach&#8221; model for segment reporting. The management approach model is based on the way a Company&#8217;s management organizes segments within the Company for making operating decisions and assessing performance. The Company determined it had <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-540">three</ix:nonFraction> reportable segments. The Recycling segment has been presented as discontinued operations (see Note 23).</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-503-5"><ix:nonNumeric contextRef="c-1" name="us-gaap:ConcentrationRiskCreditRisk" id="f-541" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains cash balances at banks in Nevada and Minnesota. The account is insured by the Federal Deposit Insurance Corporation up to $250,000. At times, balances may exceed federally insured limits.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-542" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update ("ASU") 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures ("ASU 2023-07"). ASU 2023-07 requires, among other updates, enhanced disclosures about significant segment expenses that are regularly provided to the CODM, as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and requires retrospective adoption. Early adoption is permitted. The Company is evaluating the impact of this guidance on its consolidated financial statements and related disclosures.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU No. 2023-08, Intangibles&#8212;Goodwill and Other&#8212;Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets. The amendments in ASU No. 2023-08 are intended to improve the accounting for certain crypto assets by requiring an entity to measure those crypto assets at fair value each reporting period with changes in fair value recognized in net income. The amendments also improve the information provided to investors about an entity&#8217;s crypto asset holdings by requiring disclosure about significant holdings, contractual sale restrictions, and changes during the reporting period. The amendments are effective for all entities for fiscal years beginning after December 15, 2024, including interim periods within those fiscal years. The Company is evaluating the impact of this guidance on its consolidated financial statements and related disclosures.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures ("ASU 2023-09"). ASU 2023-09 requires enhanced annual disclosures regarding the rate reconciliation and income taxes paid information. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, and may be adopted on a prospective or retrospective basis. Early adoption is permitted. The Company is evaluating the impact of this guidance on its consolidated financial statements and related disclosures.</span></div></ix:nonNumeric></ix:continuation><div id="i213e3c881f5e4982994be533c682ff6b_136"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3: <ix:nonNumeric contextRef="c-1" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="f-543" continuedAt="f-543-1" escape="true">Mergers and Acquisitions</ix:nonNumeric></span></div><ix:continuation id="f-543-1" continuedAt="f-543-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Qoden</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 8, 2024, the Company acquired the Qodex Cryptocurrency Exchange Software platform and other related assets from Qoden Technologies, LLC, a provider of technology solutions for the blockchain industry. The purchase price was $<ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-5" name="us-gaap:AssetAcquisitionConsiderationTransferred" scale="6" id="f-544">2.2</ix:nonFraction> million, consisting of $<ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-5" name="us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" scale="6" id="f-545">2.0</ix:nonFraction> million, or <ix:nonFraction unitRef="shares" contextRef="c-103" decimals="0" name="alts:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares" format="ixt:num-dot-decimal" scale="0" id="f-546">771,010</ix:nonFraction> shares, of the Company&#8217;s Series Q Convertible Preferred Stock and $<ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-5" name="alts:AssetAcquisitionConsiderationCashPayable" scale="6" id="f-547">0.2</ix:nonFraction> million in cash. The Series Q Convertible Stock was valued at $<ix:nonFraction unitRef="usdPerShare" contextRef="c-103" decimals="3" name="alts:AssetAcquisitionConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare" scale="0" id="f-548">2.594</ix:nonFraction> per share on the date issued, and is subject to a mandatory eight-calendar-quarter leak-out, such that no more than twelve-and-one-half percent of the shares may be converted into shares of the Company&#8217;s common stock on a trailing quarterly basis over a period of <ix:nonNumeric contextRef="c-102" name="alts:AssetAcquisitionEquityInstrumentsIssuableValidConversionPeriod" format="ixt-sec:durwordsen" id="f-549">two years</ix:nonNumeric>, and are subject to vesting provisions. The $<ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-5" name="alts:AssetAcquisitionConsiderationCashPayable" scale="6" id="f-550">0.2</ix:nonFraction> million in cash is payable in increments of $<ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="alts:AssetAcquisitionConsiderationPeriodicCashPayment" format="ixt:num-dot-decimal" scale="0" id="f-551">10,000</ix:nonFraction> per month for 24 months, commencing on the first day of the month following closing. The acquisition was determined to be an asset acquisition for accounting purposes.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">ALT5</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;14, 2024, the Company acquired its ALT5 Subsidiary, which is a fintech company that provides next generation blockchain-powered technologies to enable a migration to a new global financial paradigm. ALT5 Subsidiary, through its respective subsidiaries, offers two main platforms to its customers: &#8220;ALT5 Pay&#8221; and &#8220;ALT5 Prime.&#8221; ALT5 Pay is a crypto-currency payment gateway that enables registered and approved global merchants to accept and make crypto-currency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay&#8217;s checkout widgets and APIs. Merchants have the option to convert to fiat currency (US Dollars, Canadian Dollars, Euros, and British Pounds Sterling) automatically or to receive their payment in digital assets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As consideration under the acquisition, the Company issued <ix:nonFraction unitRef="shares" contextRef="c-105" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-552">1,799,100</ix:nonFraction> shares of its common stock to the legacy equity holders of the capital stock of ALT5 Subsidiary. Those shares represented approximately <ix:nonFraction unitRef="number" contextRef="c-106" decimals="3" name="alts:BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfIssuedAndOutstandingShares" scale="-2" id="f-553">19.9</ix:nonFraction>% of the Company's then-issued and outstanding shares of common stock. Each of the shares of the Company's newly-issued common stock was valued at $<ix:nonFraction unitRef="usdPerShare" contextRef="c-107" decimals="2" name="us-gaap:SharePrice" scale="0" id="f-554">4.14</ix:nonFraction>, which was the Nasdaq Historical NOCP on Thursday, May 9, 2024, the day immediately prior to the date on which the agreement was executed. The Company also issued <ix:nonFraction unitRef="shares" contextRef="c-108" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-555">34,207</ix:nonFraction> shares of its newly-designated Series B Preferred </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-543-2" continuedAt="f-543-3"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock (the &#8220;Series B Stock&#8221;) to the legacy equity holders of the capital stock of ALT5. In connection with the closing of the acquisition of ALT5 Subsidiary, the Company also issued <ix:nonFraction unitRef="shares" contextRef="c-109" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-556">3,200</ix:nonFraction> shares of its newly-designated Series M Preferred Stock (the &#8220;Series M Stock&#8221;) to two entities that acted as finders for the transaction.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="f-557" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the purchase price components outlined above was $<ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="6" id="f-558">16.0</ix:nonFraction> million due to fair value adjustments for the shares of Series B Stock and Series M Stock, as detailed below (in $000&#8217;s):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="3" id="f-559">7,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series B preferred stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="3" id="f-560">8,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total purchase price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="f-561">16,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the preliminary purchase price allocation, the Company recognized goodwill of approximately $<ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="us-gaap:Goodwill" scale="6" id="f-562">11.7</ix:nonFraction> million, which is calculated as the excess of both the consideration exchanged and liabilities assumed as compared to the fair value of the identifiable assets acquired. The values assigned to the assets acquired and liabilities assumed are based on their estimates of fair value available as of May&#160;10, 2024, as calculated by an independent third-party firm. Because the transaction was considered a stock purchase for tax purposes, <ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt-sec:numwordsen" scale="0" id="f-563">none</ix:nonFraction> of the goodwill arising from the acquisition will be deductible for tax purposes. During the thirteen weeks ended September&#160;28, 2024, the Company recorded a noncash fair value adjustment related to deferred tax liabilities and other liabilities acquired in the aggregate amount of approximately $<ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-564">7.9</ix:nonFraction> million, which was recorded to goodwill. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="f-565" continuedAt="f-565-1" escape="true">The table below outlines the purchase price allocation of the purchase for ALT5 Subsidiary to the acquired identifiable assets, liabilities assumed and goodwill (in $000&#8217;s):</ix:nonNumeric></span></div><ix:continuation id="f-565-1"><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.515%"><tr><td style="width:1.0%"/><td style="width:66.874%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total purchase price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="f-566">16,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="3" id="f-567">267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="alts:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-568">7,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Digital assets payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="alts:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsPayable" format="ixt:num-dot-decimal" scale="3" id="f-569">16,763</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-570">7,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities assumed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-571">32,509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="3" id="f-572">48,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-573">5,853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" format="ixt:num-dot-decimal" scale="3" id="f-574">2,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Digital assets receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="alts:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-575">9,082</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-576">13,925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-577">2,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-578">1,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subtotal intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-579">18,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="3" id="f-580">493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" format="ixt:num-dot-decimal" scale="3" id="f-581">36,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-582">11,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proforma Information</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="f-583" continuedAt="f-583-1" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents selected proforma information for the Company for the years ended December&#160;28, 2024 and December&#160;30, 2023, assuming that the acquisition had occurred on January 1, 2023 (the beginning of the Company&#8217;s 2023 fiscal year), pursuant to ASC 805-10-50 (in $000&#8217;s). This proforma information does not purport to represent what the </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-543-3"><ix:continuation id="f-583-1"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">actual results of operations of the Company would have been had the acquisition occurred on that date, nor does it purport to predict the results of operations for future periods.</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended<br/>December 28, 2024</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As Reported</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Proforma</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ALT5 Sigma Corporation (1)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ALT5 Subsidiary (2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Adjustments (3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-584">12,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="3" id="f-585">2,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-586">15,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-587">6,245</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="3" id="f-588">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-589">1,343</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-590">7,517</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per basic common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-591">0.56</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-116" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-592">0.11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per basic diluted share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-593">0.56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-116" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-594">0.11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended<br/>December 30, 2023</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As Reported</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Proforma</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ALT5 Sigma Corporation (4)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ALT5 Subsidiary (5)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Adjustments (3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="f-595">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="3" id="f-596">7,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-597">7,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-598">7,812</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-599">3,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-600">2,148</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-601">6,601</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per basic common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-22" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-602">1.95</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-119" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-603">1.65</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per basic diluted share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-22" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-604">1.95</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-119" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-605">1.65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">ALT5 Sigma Corporation for the year ended December&#160;28, 2024. Includes ALT5 Subsidiary from May 15, 2024 through December&#160;28, 2024.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">ALT5 Subsidiary from December 31, 2023 through the acquisition date of May&#160;14, 2024.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Reflects adjustments for amortization expense of definite-lived intangible assets has been adjusted based on the preliminary fair value at the acquisition date..</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">ALT5 Sigma Corporation for the year ended December&#160;30, 2023.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    ALT5 Subsidiary for the year ended December&#160;30, 2023.</span></div></ix:continuation><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Soin Pharmaceuticals</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January&#160;24, 2024, the Company, Amol Soin (&#8220;Dr. Soin&#8221;), and Soin Therapeutics LLC, a wholly-owned subsidiary of the Company that we had acquired from Dr. Soin, entered into an amendment (the &#8220;Soin Amendment&#8221;) to the parties&#8217; Agreement and Plan of Merger that was dated as of December 28, 2022 (the &#8220;Soin Agreement&#8221;). With reference to the Soin Agreement, the parties to the Soin Amendment agreed that the $<ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="6" id="f-606">3.0</ix:nonFraction> million convertible tranche (the first of the <ix:nonFraction unitRef="tranche" contextRef="c-122" decimals="INF" name="alts:NumberOfTranches" format="ixt-sec:numwordsen" scale="0" id="f-607">three</ix:nonFraction> original conversion tranches under the Soin Agreement) would be payable to Dr. Soin in cash rather than through his conversion of shares of the Series S Convertible Preferred Stock (the &#8220;Soin Preferred&#8221;) that constituted the consideration under the Soin Agreement. We tendered the first $<ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities" scale="6" id="f-608">0.1</ix:nonFraction> million amended tranche cash payment to Dr. Soin in March 2024; the second amended tranche cash payment to Dr. Soin, also in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" scale="6" id="f-609">0.1</ix:nonFraction> million, was due on July 1, 2024; and the third amended tranche cash payment to Dr. Soin, in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" scale="6" id="f-610">2.8</ix:nonFraction> million, was due on December 31, 2024. During the pendency of the amended cash tranche period, Dr. Soin agreed that he would not convert any of his shares of Soin Preferred. After we have tendered the second and third amended tranche cash payments to Dr. Soin, his conversion rights for the second and third original conversion tranches will remain convertible under the original provisions of the Soin Agreement and the related Certificate of Designation for the Soin Preferred. If we do not tender the second and third amended tranche cash payments to Dr. Soin, we agreed that we will transfer to him the membership interests of Soin Therapeutics LLC, and he will transfer to us the shares of Soin Preferred for cancellation. During the year ended December&#160;28, 2024, we tendered an aggregate of $<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" id="f-611">150,000</ix:nonFraction> to Dr. Soin and during February 2025, we tendered an additional $<ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="0" id="f-612">350,000</ix:nonFraction>.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Soin Amendment, the Company reclassified the $<ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="6" id="f-613">3.0</ix:nonFraction> million convertible tranche, originally valued at approximately $<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="6" id="f-614">2.7</ix:nonFraction> million on our balance sheet, from mezzanine equity to current liabilities, and reclassified the $<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="6" id="f-615">10.0</ix:nonFraction> million convertible tranche, originally valued at approximately $<ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="6" id="f-616">8.0</ix:nonFraction> million on our balance sheet, to permanent equity. As of December&#160;28, 2024, the outstanding balance in mezzanine equity relates to the $<ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="6" id="f-617">17.0</ix:nonFraction> million convertible tranche originally valued at approximately $<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="6" id="f-618">3.9</ix:nonFraction> million.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-14</span></div></div></div><div id="i213e3c881f5e4982994be533c682ff6b_139"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4: <ix:nonNumeric contextRef="c-1" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="f-619" continuedAt="f-619-1" escape="true">Sale of Recycling Subsidiaries</ix:nonNumeric></span></div><ix:continuation id="f-619-1" continuedAt="f-619-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 9, 2023, the Company entered into a Stock Purchase Agreement (the &#8220;Recycling Purchase Agreement&#8221;) with VM7 Corporation, a Delaware corporation (&#8220;VM7&#8221;), under which it agreed to acquire all of the outstanding equity interests of the Recycling Subsidiaries, consisting of: (a) ARCA Recycling, (b) ARCA Canada, and (c) Connexx. The principal of VM7 is Virland A. Johnson, our Chief Financial Officer. The sale of all of the outstanding equity interests of the Recycling Subsidiaries to VM7 under the Recycling Purchase Agreement was consummated simultaneously with the execution of the Recycling Purchase Agreement. The Recycling Purchase Agreement is retroactive to March 1, 2023 (see Note 4).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation, factoring in the discount rate that the Company used, yielded a present value of approximately $<ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-5" name="alts:DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount" scale="6" id="f-620">6.0</ix:nonFraction> million, which, in addition to the $<ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:PaymentsForCommissions" format="ixt:num-dot-decimal" scale="0" id="f-621">3,000</ix:nonFraction> paid at close, comprised the approximately <ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-5" name="alts:DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount" scale="6" id="f-622">6.0</ix:nonFraction> million of net consideration. The amount of the revised discount amount, or approximately $<ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-5" name="alts:RevisedDiscountAmount" scale="6" id="f-623">18.0</ix:nonFraction> million, was recorded as an offset to the principal amount of the Note, and was to have been accreted ratably to interest income over the term of the Note. During the year ended December&#160;30, 2023, approximately $<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:InterestIncomeInterestEarningAsset" format="ixt:num-dot-decimal" scale="0" id="f-624">720,000</ix:nonFraction> of the discount was recorded as interest income. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of fiscal 2023, VM7 determined that, after expending significant amounts of time and resources, it was unable to obtain sufficient equity or debt financing to continue the operations of the Recycling Subsidiaries. Accordingly, the Company was advised that the operations of the Recycling Subsidiaries were wound down and, ultimately, ceased. For a variety of related reasons, the Company determined fully to impair the $<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="us-gaap:GainLossOnDispositionOfAssets1" scale="6" id="f-625">5.3</ix:nonFraction> million carrying value of the Disposition Transaction on its balance sheet and determined not to exercise any of its remedies under the Recycling Purchase Agreement so that it could maintain its focus on its clinical-stage biopharmaceutical activities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary calculation of the <ix:nonNumeric contextRef="c-1" name="alts:DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag" id="f-626">gain on sale</ix:nonNumeric> was approximately $<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-5" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="f-627">15.8</ix:nonFraction> million. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="f-628" continuedAt="f-628-1" escape="true">The following table details the final calculation of the gain on sale of the Recycling Subsidiaries, as shown on the income statement (in $000&#8217;s):</ix:nonNumeric></span></div><ix:continuation id="f-628-1" continuedAt="f-628-2"><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.151%"><tr><td style="width:1.0%"/><td style="width:82.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.824%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total minimum consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="alts:TotalGuaranteedConsideration" format="ixt:num-dot-decimal" scale="3" id="f-629">6,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment from buyer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="alts:PaymentFromBuyer" scale="3" id="f-630">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net consideration</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="alts:NetConsideration" format="ixt:num-dot-decimal" scale="3" id="f-631">6,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="alts:DisposalOfAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-632">5,323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="alts:DisposalOfAccruedLiability" format="ixt:num-dot-decimal" scale="3" id="f-633">1,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities - California state sales tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="alts:DisposalOfAccruedLiabilityCaliforniaStateSalesTax" format="ixt:num-dot-decimal" scale="3" id="f-634">6,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="alts:DisposalOfLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-635">5,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="alts:DisposalOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-636">2,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="3" id="f-637">604</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total disposal of liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="alts:TotalDisposalOfLiability" format="ixt:num-dot-decimal" scale="3" id="f-638">20,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total consideration</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="alts:TotalConsiderations" format="ixt:num-dot-decimal" scale="3" id="f-639">26,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="alts:CashDisposal" scale="3" id="f-640">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="alts:DisposalOfAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-641">4,884</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="alts:DisposalOfInventory" scale="3" id="f-642">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="alts:DisposalOfPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-643">2,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="alts:DisposalOfIntangibleAssets" scale="3" id="f-644">732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="alts:DisposalOfRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="f-645">5,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="alts:DisposalOfOtherAssets" scale="3" id="f-646">574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total disposal of assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="alts:TotalDisposalOfAssets" format="ixt:num-dot-decimal" scale="3" id="f-647">14,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total gain on sale</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="alts:TotalGainOnSale" format="ixt:num-dot-decimal" scale="3" id="f-648">12,102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div id="i213e3c881f5e4982994be533c682ff6b_145"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5: <ix:continuation id="f-619-2" continuedAt="f-619-3">Discontinued Operations</ix:continuation></span></div><ix:continuation id="f-619-3" continuedAt="f-619-4"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;30, 2023, the Company discontinued operations of its Recycling segment as follows:</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 9, 2023, the Company executed a Recycling Purchase Agreement with VM7, under which, as of March 1, 2023, it agreed to acquire all of the outstanding equity interests of the Recycling Subsidiaries, consisting of (a) ARCA Recycling, </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-619-4" continuedAt="f-619-5"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) ARCA Canada, and (c) Connexx. The principal of VM7 is Virland A. Johnson, our Chief Financial Officer. The sale of all of the outstanding equity interests of the Recycling Subsidiaries to VM7 under the Recycling Purchase Agreement was consummated simultaneously with the execution of the Recycling Purchase Agreement (See Note 4).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the provisions of ASC 205-20, the Company has not included in the results of continuing operations the results of operations of the discontinued operations in the consolidated statements of operations and comprehensive income (loss). <ix:continuation id="f-628-2" continuedAt="f-628-3">The results of operations for these entities for the year ended December&#160;28, 2024 and December&#160;30, 2023, respectively, have been reflected as discontinued operations in the consolidated statements of operations and comprehensive income (loss) and consist of the following (in $000&#8217;s):</ix:continuation></span></div><ix:continuation id="f-628-3" continuedAt="f-628-4"><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:fixed-zero" scale="3" id="f-649">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:num-dot-decimal" scale="3" id="f-650">3,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" format="ixt:fixed-zero" scale="3" id="f-651">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" format="ixt:num-dot-decimal" scale="3" id="f-652">3,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" format="ixt:fixed-zero" scale="3" id="f-653">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" sign="-" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" scale="3" id="f-654">197</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses from discontinued operations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" format="ixt:fixed-zero" scale="3" id="f-655">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-656">1,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain on sale of ARCA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" format="ixt:fixed-zero" scale="3" id="f-657">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" format="ixt:num-dot-decimal" scale="3" id="f-658">12,102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="alts:DisposalGroupIncludingDiscontinuedOperationTotalOperatingIncomeExpensesFromDiscontinuedOperations" format="ixt:fixed-zero" scale="3" id="f-659">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="alts:DisposalGroupIncludingDiscontinuedOperationTotalOperatingIncomeExpensesFromDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-660">10,635</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" format="ixt:fixed-zero" scale="3" id="f-661">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-662">10,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense from discontinued operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense" format="ixt:fixed-zero" scale="3" id="f-663">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense" scale="3" id="f-664">181</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="alts:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" format="ixt:fixed-zero" scale="3" id="f-665">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="alts:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" scale="3" id="f-666">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other expense, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="alts:DisposalGroupIncludingDiscontinuedOperationsTotalOtherIncomeLossNet" format="ixt:fixed-zero" scale="3" id="f-667">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" sign="-" name="alts:DisposalGroupIncludingDiscontinuedOperationsTotalOtherIncomeLossNet" scale="3" id="f-668">184</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before provision for income taxes from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" format="ixt:fixed-zero" scale="3" id="f-669">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" format="ixt:num-dot-decimal" scale="3" id="f-670">10,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" format="ixt:fixed-zero" scale="3" id="f-671">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" scale="3" id="f-672">971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income from discontinued operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:fixed-zero" scale="3" id="f-673">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:num-dot-decimal" scale="3" id="f-674">9,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the provisions of ASC 205-20, the Company has separately reported the cash flow activity of the discontinued operations in the consolidated statements of cash flows. <ix:continuation id="f-628-4" continuedAt="f-628-5">The cash flow activity from discontinued operations for the year ended December&#160;28, 2024 and December&#160;30, 2023 have been reflected as discontinued operations in the consolidated statements of cash flows and consist of the following (in $000&#8217;s):</ix:continuation></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-628-5"><ix:continuation id="f-619-5"><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DISCONTINUED OPERATING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:fixed-zero" scale="3" id="f-675">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:num-dot-decimal" scale="3" id="f-676">9,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:fixed-zero" scale="3" id="f-677">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="f-678">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:fixed-zero" scale="3" id="f-679">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="f-680">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="alts:AmortizationOfRightOfUseAssets" format="ixt:fixed-zero" scale="3" id="f-681">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="alts:AmortizationOfRightOfUseAssets" scale="3" id="f-682">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain on sale of ARCA, net of cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="alts:GainOnSaleNetOfCash" format="ixt:fixed-zero" scale="3" id="f-683">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="alts:GainOnSaleNetOfCash" format="ixt:num-dot-decimal" scale="3" id="f-684">12,248</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:fixed-zero" scale="3" id="f-685">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-686">2,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:fixed-zero" scale="3" id="f-687">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="f-688">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidExpense" format="ixt:fixed-zero" scale="3" id="f-689">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="3" id="f-690">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" format="ixt:fixed-zero" scale="3" id="f-691">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" format="ixt:num-dot-decimal" scale="3" id="f-692">1,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:fixed-zero" scale="3" id="f-693">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="f-694">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities from discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:fixed-zero" scale="3" id="f-695"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" format="ixt:fixed-zero" scale="3" id="f-696">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-697"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-698">2,319</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DISCONTINUED INVESTING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="f-699">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="f-700">123</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchase of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:fixed-zero" scale="3" id="f-701">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="f-702">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities from discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" format="ixt:fixed-zero" scale="3" id="f-703">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" sign="-" name="us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" scale="3" id="f-704">155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DISCONTINUED FINANCING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from note payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:ProceedsFromNotesPayable" format="ixt:fixed-zero" scale="3" id="f-705">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:ProceedsFromNotesPayable" format="ixt:num-dot-decimal" scale="3" id="f-706">5,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments on related party note</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:RepaymentsOfRelatedPartyDebt" format="ixt:fixed-zero" scale="3" id="f-707">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:RepaymentsOfRelatedPartyDebt" scale="3" id="f-708">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments on notes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:fixed-zero" scale="3" id="f-709">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="3" id="f-710">7,336</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities from discontinued operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" format="ixt:fixed-zero" scale="3" id="f-711"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-712">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-713"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" sign="-" name="us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-714">2,212</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effect of changes in exchange rate on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:fixed-zero" scale="3" id="f-715">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="3" id="f-716">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DECREASE IN CASH AND CASH EQUIVALENTS</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:fixed-zero" scale="3" id="f-717">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="f-718">53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CASH AND CASH EQUIVALENTS, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:fixed-zero" scale="3" id="f-719">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="3" id="f-720">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CASH AND CASH EQUIVALENTS, end of period</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:fixed-zero" scale="3" id="f-721">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:fixed-zero" scale="3" id="f-722">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div><span><br/></span></div><div id="i213e3c881f5e4982994be533c682ff6b_148"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6: <ix:nonNumeric contextRef="c-1" name="us-gaap:OtherCurrentAssetsTextBlock" id="f-723" continuedAt="f-723-1" escape="true">Prepaids and other current assets</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" id="f-724" escape="true"><ix:continuation id="f-723-1"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaids and other current assets as of December&#160;28, 2024 and December&#160;30, 2023 consist of the following (in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"><tr><td style="width:1.0%"/><td style="width:67.849%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.120%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.123%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid insurance</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidInsurance" scale="3" id="f-725">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PrepaidInsurance" scale="3" id="f-726">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherPrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="3" id="f-727">1,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherPrepaidExpenseCurrent" scale="3" id="f-728">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total prepaids and other current assets</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-729">1,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="f-730">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-17</span></div></div></div><div id="i213e3c881f5e4982994be533c682ff6b_698"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7: <ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="f-731" continuedAt="f-731-1" escape="true">Property and Equipment</ix:nonNumeric></span></div><ix:continuation id="f-731-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-732" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment as of December&#160;28, 2024 and December&#160;30, 2023 consist of the following (in $000&#8217;s):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"><tr><td style="width:1.0%"/><td style="width:65.006%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.410%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.235%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.410%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Projects under construction</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-733">1,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:fixed-zero" scale="3" id="f-734">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-735">1,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:fixed-zero" scale="3" id="f-736">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded <ix:nonFraction unitRef="usd" contextRef="c-22" decimals="0" name="us-gaap:Depreciation" format="ixt:fixed-zero" scale="0" id="f-737"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:Depreciation" format="ixt:fixed-zero" scale="0" id="f-738">no</ix:nonFraction></ix:nonFraction> depreciation expense from continuing operations for the years ended December&#160;28, 2024 and December&#160;30, 2023.</span></div></ix:continuation><div id="i213e3c881f5e4982994be533c682ff6b_704"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8: <ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-739" continuedAt="f-739-1" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="f-739-1"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with its acquisition of ALT5 Subsidiary (see Note 3), the Company leases commercial office space. These assets and properties are leased under noncancelable agreements that expire at various future dates. The agreements, which have been classified as operating leases, provide for minimum rent and require the Company to pay all insurance, taxes, and other maintenance costs. As a result, the Company recognizes assets and liabilities for leases with lease terms greater than 12 months. The amounts recognized reflect the present value of remaining lease payments for all leases. The discount rate used is an estimate of the Company&#8217;s blended incremental borrowing rate based on information available associated with each subsidiary&#8217;s debt outstanding at lease commencement. In considering the lease asset value, the Company considers fixed and variable payment terms, prepayments and options to extend, terminate or purchase. Renewal, termination, or purchase options affect the lease term used for determining lease asset value only if the option is reasonably certain to be exercised.</span></div><ix:nonNumeric contextRef="c-1" name="alts:ScheduleOfOperatingLeaseRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock" id="f-740" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table details the Company&#8217;s right of use assets and lease liabilities as of December&#160;28, 2024 and December&#160;30, 2023 (in $000&#8217;s):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.636%"><tr><td style="width:1.0%"/><td style="width:65.413%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.336%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.337%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right of use asset - operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="f-741">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:fixed-zero" scale="3" id="f-742">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current - operating</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="f-743">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:fixed-zero" scale="3" id="f-744">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long term - operating</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="f-745">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="f-746">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;28, 2024, the weighted average remaining lease term for operating leases is <ix:nonNumeric contextRef="c-4" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-747">4.9</ix:nonNumeric> years. The Company&#8217;s weighted average discount rate for operating leases is <ix:nonFraction unitRef="number" contextRef="c-4" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-748">12.8</ix:nonFraction>%. <ix:nonFraction unitRef="usd" contextRef="c-22" decimals="0" name="us-gaap:OperatingLeasePayments" format="ixt-sec:numwordsen" scale="0" id="f-749"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:OperatingLeasePayments" format="ixt-sec:numwordsen" scale="0" id="f-750">No</ix:nonFraction></ix:nonFraction> cash payments for operating leases were made during the years ended December&#160;28, 2024 and December&#160;30, 2023. Additionally, the Company recognized approximately $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="0" id="f-751">123,000</ix:nonFraction> in right of use assets and liabilities upon commencement of operating leases during the year ended December&#160;28, 2024.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-752" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total present value of future lease payments of operating leases as of September&#160;28, 2024 (in $000&#8217;s): </span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.809%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.991%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Twelve months ended:</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="f-753">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="f-754">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="f-755">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="f-756">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2029</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="3" id="f-757">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:fixed-zero" scale="3" id="f-758">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="f-759">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less implied interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="f-760">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Present value of payments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiability" scale="3" id="f-761">123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-18</span></div></div></div><div id="i213e3c881f5e4982994be533c682ff6b_151"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9: <ix:nonNumeric contextRef="c-1" name="us-gaap:FinancingReceivablesTextBlock" id="f-762" continuedAt="f-762-1" escape="true">Notes receivable </ix:nonNumeric></span></div><ix:continuation id="f-762-1"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">SPYR Note</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;24, 2022, the Company entered into an Asset Purchase Agreement with SPYR Technologies Inc. (&#8220;SPYR&#8221;), pursuant to which the Company sold to SPYR substantially all of the assets and none of the specified liabilities of GeoTraq. In connection with the Purchase Agreement, SPYR delivered to the Company a <ix:nonNumeric contextRef="c-145" name="alts:NotesReceivableTerm" format="ixt-sec:durwordsen" id="f-763">five-year</ix:nonNumeric> Promissory Note in the initial principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-5" name="alts:NoteReceivableFaceAmount" scale="6" id="f-764">12.6</ix:nonFraction> million. The Promissory Note bears simple interest at the rate of <ix:nonFraction unitRef="number" contextRef="c-146" decimals="2" name="alts:NoteReceivableStatedInterestRate" scale="-2" id="f-765">8.0</ix:nonFraction>% per annum, provides quarterly interest payments due on the first day of each calendar quarter, and may be prepaid at any time without penalty. Interest payments may be remitted in either restricted shares of common stock or restricted shares of Series G Convertible Preferred Stock of SPYR, or in cash. The Promissory Note matures on May 24, 2027. The Company had received restricted shares of Series G Convertible Preferred Stock of SPYR equivalent to approximately <ix:nonFraction unitRef="shares" contextRef="c-147" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" format="ixt:num-dot-decimal" scale="0" id="f-766">26,253,900,000</ix:nonFraction> shares of its common stock during the year ended December&#160;28, 2024, and <ix:nonFraction unitRef="shares" contextRef="c-148" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" format="ixt:num-dot-decimal" scale="0" id="f-767">922,442,000</ix:nonFraction> shares of SPYR's common stock during the year ended December&#160;30, 2023. As of December&#160;30, 2023, the Company had <ix:nonFraction unitRef="usd" contextRef="c-149" decimals="0" name="us-gaap:InterestReceivable" format="ixt:fixed-zero" scale="0" id="f-768">no</ix:nonFraction> accrued receivables related to the Promissory Note.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;30, 2023, the Company performed a qualitative analysis of the SPYR note receivable and concluded that, due to a number of triggering factors, it was probable that SPYR would be unable to fulfill its obligation to repay the principal amount under the promissory note on or before the maturity date. Consequently, the Company recorded an impairment charge of approximately $<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" sign="-" name="alts:GainLossOnWriteOffOfNotesReceivable" format="ixt:num-dot-decimal" scale="6" id="f-769">9.8</ix:nonFraction>&#160;million for the fiscal year ended December&#160;30, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal years ended December&#160;28, 2024 and December&#160;30, 2023, approximately $<ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:InterestIncomeInterestEarningAsset" scale="0" id="f-770">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:InterestIncomeInterestEarningAsset" format="ixt:num-dot-decimal" scale="0" id="f-771">806,000</ix:nonFraction>, respectively, of the discount was recorded as interest income. As of December&#160;28, 2024 and December&#160;30, 2023, <ix:nonFraction unitRef="usd" contextRef="c-5" decimals="INF" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:fixed-zero" scale="0" id="f-772"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="INF" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:fixed-zero" scale="0" id="f-773">no</ix:nonFraction></ix:nonFraction> principal balance on the Note was outstanding.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">VM7 Note</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 9, 2023, the Company entered into a Stock Purchase Agreement (the &#8220;Recycling Purchase Agreement&#8221;) with VM7 Corporation, a Delaware corporation (&#8220;VM7&#8221;), under which it agreed to acquire all of the outstanding equity interests of the Recycling Subsidiaries, consisting of: (a) ARCA Recycling, (b) ARCA Canada, and (c) Connexx. The principal of VM7 is Virland A. Johnson, our Chief Financial Officer. The sale of all of the outstanding equity interests of the Recycling Subsidiaries to VM7 under the Recycling Purchase Agreement was consummated simultaneously with the execution of the Recycling Purchase Agreement. The Recycling Purchase Agreement is retroactive to March 1, 2023 (see Note 4).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation, factoring in the discount rate that the Company used, yielded a present value of approximately $<ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-5" name="alts:DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount" scale="6" id="f-774">6.0</ix:nonFraction> million, which, in addition to the $<ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:PaymentsForCommissions" format="ixt:num-dot-decimal" scale="0" id="f-775">3,000</ix:nonFraction> paid at close, comprised the approximately <ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-5" name="alts:DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount" scale="6" id="f-776">6.0</ix:nonFraction> million of net consideration. The amount of the revised discount amount, or approximately $<ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-5" name="alts:RevisedDiscountAmount" scale="6" id="f-777">18.0</ix:nonFraction> million, was recorded as an offset to the principal amount of the Note, and was to have been accreted ratably to interest income over the term of the Note. During the year ended December&#160;30, 2023, approximately $<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:InterestIncomeInterestEarningAsset" format="ixt:num-dot-decimal" scale="0" id="f-778">720,000</ix:nonFraction> of the discount was recorded as interest income. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of fiscal 2023, VM7 determined that, after expending significant amounts of time and resources, it was unable to obtain sufficient equity or debt financing to continue the operations of the Recycling Subsidiaries. Accordingly, the Company was advised that the operations of the Recycling Subsidiaries were wound down and, ultimately, ceased. For a variety of related reasons, the Company determined fully to impair the $<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="us-gaap:GainLossOnDispositionOfAssets1" scale="6" id="f-779">5.3</ix:nonFraction> million carrying value of the Disposition Transaction on its balance sheet and determined not to exercise any of its remedies under the Recycling Purchase Agreement so that it could maintain its focus on its clinical-stage biopharmaceutical activities.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-19</span></div></div></div><div id="i213e3c881f5e4982994be533c682ff6b_154"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10: <ix:nonNumeric contextRef="c-1" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="f-780" continuedAt="f-780-1" escape="true">Intangible assets</ix:nonNumeric></span></div><ix:continuation id="f-780-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="f-781" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets as of consist of the following (in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soin intangibles</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-782">19,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-783">19,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Qoden intangible</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-784">1,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:fixed-zero" scale="3" id="f-785">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patents and domains</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="f-786">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="f-787">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-788">2,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:fixed-zero" scale="3" id="f-789">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-790">13,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:fixed-zero" scale="3" id="f-791">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-792">1,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:fixed-zero" scale="3" id="f-793">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total intangible assets</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-794">39,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-795">19,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-796">4,853</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-797">1,451</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total intangible assets, net</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-798">34,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-799">17,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible amortization expense for continuing operations was approximately $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-800">3.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-801">1.5</ix:nonFraction> million, respectively, for the fiscal years ended December&#160;28, 2024 and December&#160;30, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Qoden Intangible Assets</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 8, 2024, the Company acquired the Qodex Cryptocurrency Exchange Software platform and other related assets from Qoden Technologies, LLC, a provider of technology solutions for the blockchain industry. The Company will amortize the intangible assets over a <ix:nonNumeric contextRef="c-164" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:durwordsen" id="f-802">two-year</ix:nonNumeric> period (see Note 3).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ALT5 Subsidiary Intangible Assets</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;14, 2024, the Company acquired its ALT5 Subsidiary, which is a fintech company that provides next generation blockchain-powered technologies to enable a migration to a new global financial paradigm. As part of the acquisition, the Company acquired trade names, customer relationships, and developed technology, which will be amortized over a period of <ix:nonNumeric contextRef="c-165" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:durwordsen" id="f-803">seven years</ix:nonNumeric>, <ix:nonNumeric contextRef="c-166" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-804">10</ix:nonNumeric> years, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-167" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:durwordsen" id="f-805" continuedAt="f-805-1">five</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-805-1"> years</ix:continuation>, respectively (see Note 3). </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Soin Intangible Assets</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective as of December 28, 2022, the Company acquired Soin Therapeutics LLC, a Delaware limited liability company (&#8220;STLLC&#8221;), and its product, a patent-pending, novel formulation of low-dose naltrexone. The assets acquired by the Company consist of 1) <ix:nonFraction unitRef="patent" contextRef="c-168" decimals="INF" name="alts:NumberOfAcquiredIntangibleAssets" format="ixt-sec:numwordsen" scale="0" id="f-806">three</ix:nonFraction> pending patents related to the methods of using low-dose Naltrexone to treat chronic pain, 2) final formula for Naltrexone, and 3) orphan drug designation as approved by the FDA. The Company reviewed the assets acquired and determined that no in-process research and development costs were acquired as part of the transaction, and, thus, all assets acquired represent intellectual property and should be capitalized. The Company will amortize the intangible assets ratably over a <ix:nonNumeric contextRef="c-168" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-807">10</ix:nonNumeric>-year period.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-20</span></div></div></div><div id="i213e3c881f5e4982994be533c682ff6b_157"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11: <ix:nonNumeric contextRef="c-1" name="us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock" id="f-808" continuedAt="f-808-1" escape="true">Marketable Securities</ix:nonNumeric></span></div><ix:continuation id="f-808-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:MarketableSecuritiesTextBlock" id="f-809" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities consist of the following (in $000&#8217;s, except shares):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.666%"><tr><td style="width:1.0%"/><td style="width:45.921%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.141%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.141%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.145%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Series G Convertible Preferred Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Common Shares Equivalent</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Amount </span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning balance, December 31, 2022</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-169" decimals="0" name="alts:MarketableSecuritiesSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-810">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-170" decimals="0" name="alts:MarketableSecuritiesSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-811">30,000,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:MarketableSecurities" scale="3" id="f-812">315</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities received</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-171" decimals="0" name="alts:NoncashOrPartNoncashDivestitureConsiderationReceivedShares" format="ixt:num-dot-decimal" scale="0" id="f-813">9,224</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-172" decimals="0" name="alts:NoncashOrPartNoncashDivestitureConsiderationReceivedShares" format="ixt:num-dot-decimal" scale="0" id="f-814">922,442,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="3" id="f-815">897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mark-to-market</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments" scale="3" id="f-816">926</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning balance, December 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-173" decimals="0" name="alts:MarketableSecuritiesSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-817">9,224</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-174" decimals="0" name="alts:MarketableSecuritiesSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-818">952,442,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:MarketableSecurities" scale="3" id="f-819">286</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities received</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-175" decimals="0" name="alts:NoncashOrPartNoncashDivestitureConsiderationReceivedShares" format="ixt:num-dot-decimal" scale="0" id="f-820">33,876</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-176" decimals="0" name="alts:NoncashOrPartNoncashDivestitureConsiderationReceivedShares" format="ixt:num-dot-decimal" scale="0" id="f-821">26,253,900,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="3" id="f-822">518</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mark-to-market</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments" scale="3" id="f-823">370</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Write-off marketable securities</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-175" decimals="INF" name="alts:MarketableSecurityWriteOffShares" format="ixt:num-dot-decimal" scale="0" id="f-824">43,100</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-176" decimals="INF" name="alts:MarketableSecurityWriteOffShares" format="ixt:num-dot-decimal" scale="0" id="f-825">27,206,342,000</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments" scale="3" id="f-826">434</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance, December 28, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-177" decimals="0" name="alts:MarketableSecuritiesSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-827">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-178" decimals="0" name="alts:MarketableSecuritiesSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-828">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="3" id="f-829">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities reflect shares of SPYR stock received by the Company in connection with the sale of GeoTraq. Quarterly interest payments may be remitted in either restricted shares of common stock or restricted shares of Series G Convertible Preferred Stock of SPYR, or in cash. Shares of Series G Convertible Preferred Stock are convertible into the SPYR&#8217;s common shares at a ratio of 1:100,000. Shares held are marked to fair market value as of each balance sheet date, with the resulting change recorded as an unrealized gain or loss. For the year ended December&#160;28, 2024, the Company received <ix:nonFraction unitRef="shares" contextRef="c-175" decimals="INF" name="alts:NoncashOrPartNoncashDivestitureConsiderationReceivedShares" format="ixt:num-dot-decimal" scale="0" id="f-830">33,876</ix:nonFraction> shares of Series G Convertible Preferred Stock, which are convertible into approximately <ix:nonFraction unitRef="shares" contextRef="c-178" decimals="-5" name="alts:ConvertiblePreferredStockSharesIssuableUponConversion" format="ixt:num-dot-decimal" scale="0" id="f-831">26,253,900,000</ix:nonFraction> shares of SPYR&#8217;s common stock. For the year ended December&#160;30, 2023, the Company received <ix:nonFraction unitRef="shares" contextRef="c-171" decimals="INF" name="alts:NoncashOrPartNoncashDivestitureConsiderationReceivedShares" format="ixt:num-dot-decimal" scale="0" id="f-832">9,224</ix:nonFraction> shares of Series G Convertible Preferred Stock, which are convertible into approximately <ix:nonFraction unitRef="shares" contextRef="c-174" decimals="-3" name="alts:ConvertiblePreferredStockSharesIssuableUponConversion" format="ixt:num-dot-decimal" scale="0" id="f-833">922,442,000</ix:nonFraction> shares of SPYR&#8217;s common stock. Unrealized loss was approximately $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="6" id="f-834">1.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="0" id="f-835">926,000</ix:nonFraction> for the years ended December&#160;28, 2024 and December&#160;30, 2023, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;28, 2024, the Company was notified that SPYR Technologies, Inc. (&#8220;SPYR&#8221;) had ceased operations, and that no future quarterly interest payments on the promissory note, which may be remitted in either restricted shares of common stock or restricted shares of Series G Convertible Preferred Stock of SPYR, or in cash, would be made. Consequently, the Company recorded a full write-off of approximately $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments" format="ixt:num-dot-decimal" scale="0" id="f-836">434,000</ix:nonFraction> of its Series G Convertible Preferred shares of SPYR.</span></div></ix:continuation><div id="i213e3c881f5e4982994be533c682ff6b_163"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12: <ix:nonNumeric contextRef="c-1" name="us-gaap:OtherAssetsDisclosureTextBlock" id="f-838" continuedAt="f-838-1" escape="true">Deposits and other assets</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfOtherAssetsTableTextBlock" id="f-839" escape="true"><ix:continuation id="f-838-1"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deposits and other assets consist of the following (in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deposits and other assets</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:fixed-zero" scale="3" id="f-840">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="f-841">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total deposits and other assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="alts:DepositsAndOtherAssetsNoncurrent" format="ixt:fixed-zero" scale="3" id="f-842">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="alts:DepositsAndOtherAssetsNoncurrent" scale="3" id="f-843">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-21</span></div></div></div><div id="i213e3c881f5e4982994be533c682ff6b_166"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 13: <ix:nonNumeric contextRef="c-1" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" id="f-844" continuedAt="f-844-1" escape="true">Accrued liabilities</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="f-845" escape="true"><ix:continuation id="f-844-1"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities of continuing consist of the following (in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation and benefits</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="f-846">204</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="f-847">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued guarantees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" scale="3" id="f-848">309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-849">3,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued taxes</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" scale="3" id="f-850">362</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" scale="3" id="f-851">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:InterestPayableCurrent" scale="3" id="f-852">789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InterestPayableCurrent" format="ixt:fixed-zero" scale="3" id="f-853">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued Qoden payments</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="alts:AccruedExpensesAssetAcquisitionCurrent" scale="3" id="f-854">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="alts:AccruedExpensesAssetAcquisitionCurrent" format="ixt:fixed-zero" scale="3" id="f-855">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued litigation/legal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LitigationReserveCurrent" scale="3" id="f-856">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LitigationReserveCurrent" scale="3" id="f-857">397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="f-858">730</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="f-859">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-860">2,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-861">3,633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="margin-top:12pt"><span><br/></span></div><div id="i213e3c881f5e4982994be533c682ff6b_169"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 14: <ix:nonNumeric contextRef="c-1" name="us-gaap:LongTermDebtTextBlock" id="f-862" continuedAt="f-862-1" escape="true">Debentures</ix:nonNumeric></span></div><ix:continuation id="f-862-1" continuedAt="f-862-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="f-863" continuedAt="f-863-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debentures outstanding as of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;28, 2024 and December&#160;30, 2023 consisted for the following (in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate of <ix:nonFraction unitRef="number" contextRef="c-179" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-864"><ix:nonFraction unitRef="number" contextRef="c-180" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-865">15</ix:nonFraction></ix:nonFraction>%, maturity date of June 30, 2025</span></div></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-3" name="us-gaap:LongTermDebt" scale="3" id="f-866">563</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="3" id="f-867">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total debentures</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-3" name="us-gaap:LongTermDebt" scale="3" id="f-868">563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="3" id="f-869">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ALT5 Subsidiary issued <ix:nonFraction unitRef="debenture" contextRef="c-183" decimals="INF" name="alts:DebtInstrumentNumberOfDebenturesIssued" scale="0" id="f-870">39</ix:nonFraction> debentures over a period from October 2018 through September 2019. The debentures bear interest at <ix:nonFraction unitRef="number" contextRef="c-184" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-871"><ix:nonFraction unitRef="number" contextRef="c-185" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-872">12</ix:nonFraction></ix:nonFraction>% per annum and mature as of June&#160;30, 2024 or June&#160;30, 2025. During the year ended December&#160;28, 2024, ALT5 Subsidiary repaid <ix:nonFraction unitRef="debenture" contextRef="c-186" decimals="INF" name="alts:DebtInstrumentNumberOfDebenturesRepaid" scale="0" id="f-873">33</ix:nonFraction> of the debentures in the amount of approximately $<ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-5" name="us-gaap:RepaymentsOfDebt" scale="6" id="f-874">1.1</ix:nonFraction> million.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-22</span></div></div></div><div id="i213e3c881f5e4982994be533c682ff6b_690"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 15:<ix:continuation id="f-862-2" continuedAt="f-862-3"> Long-Term Debt</ix:continuation></span></div><ix:continuation id="f-862-3" continuedAt="f-862-4"><ix:continuation id="f-863-1"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt as of December&#160;28, 2024 and December&#160;30, 2023 consisted of the following (in $000&#8217;s):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legacy subsidiary fixed deposits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-875">4,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="3" id="f-876">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legacy subsidiary loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-877">3,782</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="3" id="f-878">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unaffiliated third-party</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-879">3,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="3" id="f-880">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-3" name="us-gaap:LongTermDebt" scale="3" id="f-881">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="3" id="f-882">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total notes payable, related parties</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-883">11,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="3" id="f-884">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="3" id="f-885">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="3" id="f-886">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total long-term notes payable, related parties</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-887">11,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="3" id="f-888">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Legacy Subsidiary Fixed Deposits</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;28, 2024, ALT5 Subsidiary entered into several Corporate Fixed Deposit Agreements with otherwise unaffiliated third-parties, pursuant to which the Company became obligated for an aggregate of $<ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-889">4.7</ix:nonFraction> million, as set forth in the respective agreements. Each obligation bears interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-196" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-890">13</ix:nonFraction>% or <ix:nonFraction unitRef="number" contextRef="c-197" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-891">15</ix:nonFraction>% per annum, and has a maturity date range of March&#160;18, 2026 to March&#160;13, 2027. During the year ended December&#160;28, 2024, several of these unaffiliated third-parties agreed to convert their respective investments into Future Equity Agreements for shares of the Company&#8217;s subsidiary, Alyea Therapeutic and, consequently, approximately $<ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" name="us-gaap:DebtConversionOriginalDebtAmount1" format="ixt:num-dot-decimal" scale="0" id="f-892">475,000</ix:nonFraction> of these deposits were reclassified as non-controlling interest. As of December&#160;28, 2024, the outstanding aggregate obligations totaled approximately $<ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="f-893">4.2</ix:nonFraction> million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Legacy Subsidiary Loan</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 10, 2023, ALT5 Subsidiary entered into an extension agreement for a Bitcoin promissory note with an otherwise unaffiliated third-party. The Bitcoin promissory note is denominated in Bitcoin and, thus, is adjusted to its fair value each period. Pursuant to the terms of an extension agreement, the maturity date is August&#160;29, 2025. The promissory note bears interest at <ix:nonFraction unitRef="number" contextRef="c-199" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-894">15</ix:nonFraction>% per annum. As of December&#160;28, 2024, the outstanding balance of the note was approximately $<ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="f-895">3.8</ix:nonFraction> million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Unaffiliated Third-Party Loans</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">ICG Note</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 7, 2024, the Company amended its outstanding related party promissory obligations (the &#8220;ICG Note&#8221;) in favor of Isaac Capital Group LLC (&#8220;ICG&#8221;) to add a convertibility provision. In accordance with Nasdaq Rules, the per-share conversion price was set at $<ix:nonFraction unitRef="usdPerShare" contextRef="c-200" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="f-896">0.61</ix:nonFraction>, subject to standard adjustments for (i) stock dividends and splits, (ii) subsequent rights offerings, and (iii) pro rata distributions. The Company&#8217;s board of directors provided its approvals of the amendments on February 7, 2024. On March 6, 2024, ICG entered into a Note Purchase Agreement with an otherwise unaffiliated third party, under which the third party acquired the ICG Note. The terms and conditions of the ICG Note were not modified in connection with its acquisition by the third party. The principal amount of the ICG Note on the date of acquisition was approximately $<ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-897">1.2</ix:nonFraction> million. During the year ended December&#160;28, 2024, the third party converted $<ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-2" name="us-gaap:DebtConversionOriginalDebtAmount1" format="ixt:num-dot-decimal" scale="0" id="f-898">548,900</ix:nonFraction> of the Company&#8217;s obligations under the ICG Note into <ix:nonFraction unitRef="shares" contextRef="c-201" decimals="-3" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" format="ixt:num-dot-decimal" scale="0" id="f-899">900,000</ix:nonFraction> shares of the Company&#8217;s common stock. As of December&#160;28, 2024, the amount outstanding on the ICG Note was approximately $<ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="f-900">0.7</ix:nonFraction> million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Live Note</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 7, 2024, the Company amended its outstanding related party promissory obligations (the &#8220;Live Note&#8221;) in favor of Live Ventures Incorporated (&#8220;Live&#8221;) to add a convertibility provision. In accordance with Nasdaq Rules, the per-share conversion price for each obligation, as amended, was set at $<ix:nonFraction unitRef="usdPerShare" contextRef="c-203" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="f-901">0.61</ix:nonFraction>, subject to standard adjustments for (i) stock dividends and splits, (ii) subsequent rights offerings, and (iii) pro rata distributions. The Company&#8217;s board of directors provided its final approvals of the amendments on February 7, 2024. On March 6, 2024, Live entered into a Note Purchase Agreement with another otherwise unaffiliated third party, under which the third party acquired the Live Note. The terms and conditions of the acquired Live Note were not modified in connection with its acquisition by the third party. The principal amount of the Live Note on the date of acquisition was approximately $<ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-902">1.0</ix:nonFraction> million. During the year ended </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-862-4" continuedAt="f-862-5"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;28, 2024, the third party converted $<ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-2" name="us-gaap:DebtConversionOriginalDebtAmount1" format="ixt:num-dot-decimal" scale="0" id="f-903">243,900</ix:nonFraction> of the Company&#8217;s obligations under the Live Note into <ix:nonFraction unitRef="shares" contextRef="c-204" decimals="-3" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" format="ixt:num-dot-decimal" scale="0" id="f-904">400,000</ix:nonFraction> shares of the Company&#8217;s common stock. As of December&#160;28, 2024, the amount outstanding on the Live Note was approximately $<ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="f-905">0.8</ix:nonFraction> million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Skybridge Obligation</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;10, 2024, Skybridge Americas, Inc. (&#8220;SA&#8221;) sold its judgment to an otherwise unaffiliated third party for the face value of the judgment and the interest accrued thereon through that date (an aggregate of $<ix:nonFraction unitRef="usd" contextRef="c-206" decimals="0" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:num-dot-decimal" scale="0" id="f-906">433,920</ix:nonFraction>), plus accrued legal fees (in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-207" decimals="0" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:num-dot-decimal" scale="0" id="f-907">18,124</ix:nonFraction>) to which SA was entitled in accordance with the terms of the underlying agreement with the Company and with the judgment. The purchaser agreed to forbear from enforcing the judgment, subject to the Company&#8217;s repayment or his conversion thereof. In connection with the third-party&#8217;s forbearance, the Company issued its promissory note to such person in the initial principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-208" decimals="0" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="0" id="f-908">147,956</ix:nonFraction>, which bears interest at the rate of <ix:nonFraction unitRef="number" contextRef="c-208" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-909">10</ix:nonFraction>% per annum, and, as with the underlying judgment, is convertible into shares of the Company&#8217;s common stock at a fixed per-share conversion price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-208" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="f-910">2.60</ix:nonFraction> (see Note 21).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;23, 2024, pursuant to the terms of the agreement, the unaffiliated third party converted the obligation, plus accrued interest under the agreements, in the amount of approximately $<ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-3" name="us-gaap:DebtConversionOriginalDebtAmount1" format="ixt:num-dot-decimal" scale="0" id="f-911">691,000</ix:nonFraction>, into <ix:nonFraction unitRef="shares" contextRef="c-209" decimals="0" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" format="ixt:num-dot-decimal" scale="0" id="f-912">265,842</ix:nonFraction> shares of the Company&#8217;s common stock (see Note 18). As of December&#160;28, 2024, there was no balance outstanding.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Big/Small Debentures</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August&#160;20, 2024, the Company entered into three Purchase Agreements with <ix:nonFraction unitRef="investor" contextRef="c-210" decimals="INF" name="alts:NumberOfUnaffiliatedThirdPartyInvestors" format="ixt-sec:numwordsen" scale="0" id="f-913">three</ix:nonFraction> otherwise unaffiliated third-party investors (the &#8220;Investors&#8221;), pursuant to which (1) one Investor agreed to purchase a unit (the &#8220;Unit&#8221;), consisting of (i) a non-convertible debenture in the principal amount of up to approximately $<ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-914">1.8</ix:nonFraction> million (the &#8220;Big Debenture&#8221;), and (ii) a warrant (the &#8220;Big Warrant&#8221;) for the purchase of up to <ix:nonFraction unitRef="shares" contextRef="c-212" decimals="-3" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-915">400,000</ix:nonFraction> shares of the Company&#8217;s Common Stock and (2) the two other Investors each agreed to purchase a Unit, consisting of (i) a non-convertible debenture in the principal amount of up to $<ix:nonFraction unitRef="usd" contextRef="c-213" decimals="0" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="0" id="f-916">404,454</ix:nonFraction> (the &#8220;Small Debenture&#8221;, and, together with the Big Debenture, the &#8220;Debentures&#8221;) and (ii) a warrant (the &#8220;Small Warrant&#8221;, and, together with the Big Warrant, the &#8220;Warrants&#8221;) for the purchase of up <ix:nonFraction unitRef="shares" contextRef="c-214" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-917">90,909</ix:nonFraction> shares of Common Stock.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Debentures are unsecured and subordinated to any existing or future debt.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Debentures bear interest at a rate of (i) <ix:nonFraction unitRef="number" contextRef="c-215" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-918">1</ix:nonFraction>% per month from and after August 20, 2024 (&#8220;Original Issue Date&#8221;) through and including October 31, 2024, (ii) <ix:nonFraction unitRef="number" contextRef="c-216" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-919">3</ix:nonFraction>% per month from and after November 1, 2024 through and including January 29, 2025, and (iii) <ix:nonFraction unitRef="number" contextRef="c-217" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-920">4</ix:nonFraction>% per month from and after January 30, 2025 through and including the date of repayment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Big Debenture was issued with an original issue discount (an &#8220;OID&#8221;) initially of $<ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="0" id="f-921">171,000</ix:nonFraction>, which OID can be expanded with up to <ix:nonFraction unitRef="addition" contextRef="c-210" decimals="INF" name="alts:DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions" format="ixt-sec:numwordsen" scale="0" id="f-922">two</ix:nonFraction> potential additions, the first in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="0" id="f-923">171,000</ix:nonFraction> and, thereafter, in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="0" id="f-924">342,000</ix:nonFraction>, which OIDs will increase the principal amount owing on the Big Debenture.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the original OID, the initial principal amount owing under the Big Debenture is approximately $<ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="f-925">1.3</ix:nonFraction> million; if, expanded, the principal amount would increase to approximately $<ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="f-926">1.4</ix:nonFraction> million and, thereafter, potentially to approximately $<ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="f-927">1.8</ix:nonFraction> million. The first potential increase in the Big Debenture OID would occur if the initial principal amount and interest accrued thereon is not paid in full on or before October 31, 2024. The second potential increase in the OID would occur if the initial principal amount (including the first potential increase in the OID) and interest accrued thereon is not paid in full on or before January 29, 2025.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Small Debentures were issued with an OID initially of $<ix:nonFraction unitRef="usd" contextRef="c-220" decimals="0" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="0" id="f-928">38,863</ix:nonFraction>, which OID can be expanded with up to <ix:nonFraction unitRef="addition" contextRef="c-220" decimals="INF" name="alts:DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions" format="ixt-sec:numwordsen" scale="0" id="f-929">two</ix:nonFraction> potential additions, the first in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-221" decimals="0" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="0" id="f-930">38,863</ix:nonFraction> and, thereafter, in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-222" decimals="0" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="0" id="f-931">77,728</ix:nonFraction>, which OIDs will increase the principal amount owing on the Small Debentures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the original OID, the initial principal amount owing under a Small Debenture is $<ix:nonFraction unitRef="usd" contextRef="c-220" decimals="0" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="0" id="f-932">288,864</ix:nonFraction>; if, expanded, the principal amount would increase to $<ix:nonFraction unitRef="usd" contextRef="c-221" decimals="0" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="0" id="f-933">327,726</ix:nonFraction> and, thereafter, potentially to $<ix:nonFraction unitRef="usd" contextRef="c-222" decimals="0" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="0" id="f-934">404,454</ix:nonFraction>.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The first potential increase in the Small Debenture OID would occur if the initial principal amount and interest accrued thereon is not paid in full on or before October 31, 2024.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The second potential increase in the OID would occur if the initial principal amount (including the first potential increase in the OID) and interest accrued thereon is not paid in full on or before January 29, 2025.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of November&#160;1, 2024, the first of the <ix:nonFraction unitRef="addition" contextRef="c-210" decimals="INF" name="alts:DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions" format="ixt-sec:numwordsen" scale="0" id="f-935"><ix:nonFraction unitRef="addition" contextRef="c-220" decimals="INF" name="alts:DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions" format="ixt-sec:numwordsen" scale="0" id="f-936">two</ix:nonFraction></ix:nonFraction> additional OIDs was effective.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final maturity date for each of the Debentures is April 28, 2025.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Big Warrant is exercisable, at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-223" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-937">1.71</ix:nonFraction> per share, as follows: (i) <ix:nonFraction unitRef="shares" contextRef="c-224" decimals="-3" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-938">100,000</ix:nonFraction> shares of Common Stock as of Original Issue Date, (ii) contingently for an additional <ix:nonFraction unitRef="shares" contextRef="c-225" decimals="-3" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-939">100,000</ix:nonFraction> shares of Common Stock as of October 31, 2024, if, as of such date, the Company has not repaid in full its obligations under the Big Debenture, and (iii) contingently for an </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-862-5"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">additional <ix:nonFraction unitRef="shares" contextRef="c-226" decimals="-3" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-940">200,000</ix:nonFraction> shares of Common Stock as of January 29, 2025, if, as of such date, the Company has not repaid in full its obligations under the Big Debenture.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Small Warrant is exercisable, at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-227" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-941">1.71</ix:nonFraction> per share, as follows: (i) <ix:nonFraction unitRef="shares" contextRef="c-228" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-942">22,727</ix:nonFraction> shares of Common Stock as of Original Issue Date, (ii) contingently for an additional <ix:nonFraction unitRef="shares" contextRef="c-229" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-943">22,727</ix:nonFraction> shares of Common Stock as of October 31, 2024, if, as of such date, the Company has not repaid in full its obligations under the Small Debenture, and (iii) <ix:nonFraction unitRef="shares" contextRef="c-230" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-944">45,455</ix:nonFraction> shares of Common Stock as of January 29, 2025, if, as of such date, the Company has not repaid in full its obligations under the Small Debenture.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of November 1, 2024, the contingent second tranche of the Warrants vested.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Investor is required to exercise the initial tranche of each Warrant within <ix:nonNumeric contextRef="c-231" name="alts:ClassOfWarrantOrRightExercisePeriod" format="ixt-sec:durday" id="f-945">15</ix:nonNumeric> days of the Original Issue Date.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the vesting of each contingent tranche of a Warrant vest, each Investor shall exercise such vested, contingent tranche within <ix:nonNumeric contextRef="c-231" name="alts:ClassOfWarrantOrRightExercisePeriod" format="ixt-sec:durday" id="f-946">15</ix:nonNumeric> days of the vesting of such contingent tranche.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company consummates any equity or debt financing before satisfying in full its obligations under the Debentures, then <ix:nonFraction unitRef="number" contextRef="c-231" decimals="2" name="alts:PercentageOfNetDollarReceivedToBeIssuedToDebentureHoldersOnAProRataBasis" scale="-2" id="f-947">50</ix:nonFraction>% of every net dollar received by the Company from any such financing transaction shall be paid by the Company to the holders of the Debentures, on a pro rata basis, as a mandatory pre-payment thereof.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event the Company has repaid all sums owing under a Debenture to the Investor, except for an amount equal to any non-conditional OID, the Company has the right, not the obligation, to exercise the vested portion of the Warrant held by the Debenture holder through a set-off of any or all such unpaid OID, on a dollar-for-dollar basis.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Warrants also feature a &#8220;cashless&#8221; exercise provision.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In lieu of making the cash payment otherwise contemplated to be made to the Company upon exercise of a Warrant in payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the net number of shares of Common Stock determined according to a formula set forth in the Warrant. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of the year ended December&#160;28, 2024, the non-affiliated Investor exercised the Big Warrant for a total of <ix:nonFraction unitRef="shares" contextRef="c-232" decimals="-3" name="alts:StockIssuedDuringPeriodSharesWarrantsExercised" format="ixt:num-dot-decimal" scale="0" id="f-948">200,000</ix:nonFraction> shares of the Company&#8217;s common stock, and the other two non-affiliated Investors exercised the Small Warrant for a total of <ix:nonFraction unitRef="shares" contextRef="c-233" decimals="0" name="alts:StockIssuedDuringPeriodSharesWarrantsExercised" format="ixt:num-dot-decimal" scale="0" id="f-949">90,908</ix:nonFraction> shares (see Note 18). Additionally, during the fourth quarter of the year ended December&#160;28, 2024, these unaffiliated third-parties agreed to convert a portion their respective investment into Future Equity Agreements of the Company&#8217;s subsidiary, Alyea Therapeutics and, consequently, approximately $<ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-5" name="us-gaap:DebtConversionOriginalDebtAmount1" scale="6" id="f-950">1.3</ix:nonFraction> million was reclassified as non-controlling interest. As of December&#160;28, 2024, the outstanding balance due on the debentures was approximately $<ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="0" id="f-951">500,000</ix:nonFraction>, consisting of principal and accrued interest.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Corporate Fixed Deposit Agreement</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;19, 2024, ALT5 Subsidiary and an investor entered into a <ix:nonNumeric contextRef="c-236" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-952">12-month</ix:nonNumeric> Corporate Fixed Deposit Agreement, pursuant to which ALT5 Subsidiary borrowed $<ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-953">1.5</ix:nonFraction> million at an interest rate of <ix:nonFraction unitRef="number" contextRef="c-237" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-954">12</ix:nonFraction>% per annum, payable monthly, calculated on the then-unpaid principal amount.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon maturity, ALT5 Subsidiary is obligated to repay the principal amount in full and any accrued and unpaid interest.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal may be repaid in full, but not in part, with a pre-payment penalty equivalent to three month&#8217;s of interest. As of December&#160;28, 2024, the outstanding balance was $<ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="f-955">1.5</ix:nonFraction> million.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-25</span></div></div></div><div id="i213e3c881f5e4982994be533c682ff6b_710"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 16: <ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-956" continuedAt="f-956-1" escape="true">Related Party Debt</ix:nonNumeric></span></div><ix:continuation id="f-956-1" continuedAt="f-956-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDebtTableTextBlock" id="f-957" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt payable to related parties (see Note 20) as of December&#160;28, 2024 and December&#160;30, 2023 consisted of the following (in $000&#8217;s):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Isaac Capital Group</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-958">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="f-959">707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Isaac Capital Group, <ix:nonFraction unitRef="number" contextRef="c-241" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-960"><ix:nonFraction unitRef="number" contextRef="c-242" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-961">10</ix:nonFraction></ix:nonFraction>% interest rate, matures December 31, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="f-962">327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-963">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Live Ventures Incorporated, <ix:nonFraction unitRef="number" contextRef="c-243" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-964"><ix:nonFraction unitRef="number" contextRef="c-244" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-965">10</ix:nonFraction></ix:nonFraction>% interest rate, matures December 31, 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="f-966">327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-967">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Isaac Capital Group short-term demand advance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-245" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="f-968">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-969">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Novalk Apps SAA, LLP  short-term demand advance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="f-970">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-971">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total notes payable, related parties</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="f-972">812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="f-973">707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-3" name="us-gaap:LongTermDebtCurrent" scale="3" id="f-974">812</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="3" id="f-975">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total long-term notes payable, related parties</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="3" id="f-976">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="f-977">707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="f-978" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total future maturities of long-term debt to related parties is as follows (in $000&#8217;s):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.748%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.052%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Twelve months ending September 30,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-251" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="3" id="f-979">812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total future maturities of long-term debt, related parties</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-251" decimals="-3" name="us-gaap:LongTermDebt" scale="3" id="f-980">812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Isaac Capital Group LLC</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;7, 2024, the Company amended its outstanding related party promissory obligations (the &#8220;ICG Note&#8221;) in favor of ICG to add a convertibility provision. In accordance with Nasdaq Rules, the per-share conversion price was set at $<ix:nonFraction unitRef="usdPerShare" contextRef="c-252" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="f-981">0.61</ix:nonFraction>, subject to standard adjustments for (i) stock dividends and splits, (ii) subsequent rights offerings, and (iii) pro rata distributions. The Company&#8217;s board of directors provided its approvals of the amendments on February&#160;7, 2024. On March&#160;6, 2024, ICG entered into a Note Purchase Agreement with an otherwise unaffiliated third party, under which the third party acquired the ICG Note. The terms and conditions of the ICG Note were not modified in connection with its acquisition by the third party. The principal amount of the ICG Note on the date of acquisition was approximately $<ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-982">1.2</ix:nonFraction> million. As of December&#160;28, 2024, the third party converted $<ix:nonFraction unitRef="usd" contextRef="c-253" decimals="-3" name="us-gaap:DebtConversionOriginalDebtAmount1" format="ixt:num-dot-decimal" scale="0" id="f-983">183,000</ix:nonFraction> of the Company&#8217;s obligation under the ICG Note into <ix:nonFraction unitRef="shares" contextRef="c-254" decimals="-3" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" format="ixt:num-dot-decimal" scale="0" id="f-984">300,000</ix:nonFraction> shares of the Company&#8217;s common stock. As of December&#160;28, 2024, the amount outstanding on the ICG Note was approximately $<ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="f-985">0.3</ix:nonFraction> million (see Note 20).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;18, 2024, ICG made a short-term demand advance to the Company in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-256" decimals="-3" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:num-dot-decimal" scale="0" id="f-986">100,000</ix:nonFraction>. The advance bears interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-257" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-987"><ix:nonFraction unitRef="number" contextRef="c-258" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-988"><ix:nonFraction unitRef="number" contextRef="c-259" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-989">10</ix:nonFraction></ix:nonFraction></ix:nonFraction>% per annum until repaid. As of December&#160;28, 2024, the principal amount outstanding was $<ix:nonFraction unitRef="usd" contextRef="c-257" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="0" id="f-990">48,000</ix:nonFraction> (see Note 20).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Live Ventures Incorporated</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;7, 2024, the Company amended its outstanding related party promissory obligations (the &#8220;Live Note&#8221;) in favor of Live Ventures to add a convertibility provision. In accordance with Nasdaq Rules, the per-share conversion price for each obligation, as amended, was set at $<ix:nonFraction unitRef="usdPerShare" contextRef="c-260" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="f-991">0.61</ix:nonFraction>, subject to standard adjustments for (i) stock dividends and splits, (ii) subsequent rights offerings, and (iii) pro rata distributions. The Company&#8217;s board of directors provided its final approvals of the amendments on February&#160;7, 2024. On March&#160;6, 2024, Live Ventures entered into a Note Purchase Agreement with another otherwise unaffiliated third party, under which under which the third party acquired the Live Note. The terms and conditions of the acquired Live Note were not modified in connection with its acquisition by the third party. The principal amount of the Live Note on the date of acquisition was approximately $<ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-992">1.0</ix:nonFraction> million. As of December&#160;28, 2024, the third party converted $<ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-3" name="us-gaap:DebtConversionOriginalDebtAmount1" format="ixt:num-dot-decimal" scale="0" id="f-993">183,000</ix:nonFraction> of the Company&#8217;s obligation under the Live Note into <ix:nonFraction unitRef="shares" contextRef="c-262" decimals="-3" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" format="ixt:num-dot-decimal" scale="0" id="f-994">300,000</ix:nonFraction> shares of the Company&#8217;s common stock. As of December&#160;28, 2024, the amount outstanding on the Live Note was approximately $<ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="f-995">0.3</ix:nonFraction> million (see Note 20).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Jon Isaac</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;4, 2024, the Company entered into a <ix:nonNumeric contextRef="c-264" name="alts:RelatedPartyTransactionConsultingAgreementTerm" format="ixt-sec:durwordsen" id="f-996">two-year</ix:nonNumeric> Consulting Agreement with Jon Isaac, pursuant to which he will provide to the Company (the &#8220;Services&#8221;): (i) strategic financial advice, including growth strategies, capital allocation, and financial restructuring; (ii) sales and business development advice, including for the acquisition of new clients and new products through networking, referrals, and marketing efforts for our prospective products; (iii) in-depth research and </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-956-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">market intelligence on specific industries, sectors, and market trends; (iv) financial models and financial analysis to support strategic decision-making; (v) assistance, through site visits, in the preparation of new client offers and bids for proposed projects; (vi) weekly update calls with management to align on progress of objectives and goals; (vii) enhanced non-confidential materials; (viii) business risk management support; and (ix) other services to which the Company and he may agree that will be memorialized in writing if, when, and as needed during the <ix:nonNumeric contextRef="c-264" name="alts:RelatedPartyTransactionConsultingAgreementTerm" format="ixt-sec:durwordsen" id="f-997">two-year</ix:nonNumeric> term. In connection with the Consulting Agreement, the Company entered into a a <ix:nonNumeric contextRef="c-265" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-998">two-year</ix:nonNumeric>, straight <ix:nonFraction unitRef="number" contextRef="c-266" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-999">10</ix:nonFraction>% convertible promissory note in the initial principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="0" id="f-1000">500,000</ix:nonFraction>, and a per-share conversion price equivalent to the per-share value of the restricted common stock that he was granted ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-267" decimals="2" name="alts:RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice" scale="0" id="f-1001">1.16</ix:nonFraction>). The maturity date of the promissory note is March&#160;4, 2026. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;23, 2024, pursuant to the terms of his Consulting Agreement, Mr. Isaac converted the principal and accrued interest on the convertible promissory note, in the amount of approximately $<ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:DebtConversionOriginalDebtAmount1" format="ixt:num-dot-decimal" scale="0" id="f-1002">540,000</ix:nonFraction>, into <ix:nonFraction unitRef="shares" contextRef="c-268" decimals="0" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" format="ixt:num-dot-decimal" scale="0" id="f-1003">465,753</ix:nonFraction> shares of the Company&#8217;s common stock. As of December&#160;28, 2024, there was <ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="0" id="f-1004">no</ix:nonFraction> principal balance outstanding on the promissory note (see Note 20).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Novalk Apps SAA, LLP</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;28, 2024 and June&#160;3, 2024, Novalk Apps SAA, LLP (&#8220;Novalk&#8221;) made short-term demand advances in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:num-dot-decimal" scale="0" id="f-1005">120,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:num-dot-decimal" scale="0" id="f-1006">100,000</ix:nonFraction>, respectively, to the Company. The advances bears interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-272" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1007"><ix:nonFraction unitRef="number" contextRef="c-273" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1008"><ix:nonFraction unitRef="number" contextRef="c-274" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1009"><ix:nonFraction unitRef="number" contextRef="c-275" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1010">10</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>% per annum until repaid. As of December&#160;28, 2024, the principal amount outstanding was $<ix:nonFraction unitRef="usd" contextRef="c-274" decimals="-3" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="0" id="f-1011">110,000</ix:nonFraction> (see Note 20).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Tony Isaac</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During June&#160;3, 2024, Tony Isaac made a number of short-term demand advances in the aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="c-276" decimals="-3" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:num-dot-decimal" scale="0" id="f-1012">62,000</ix:nonFraction> to the Company. The advances bears interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-277" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1013"><ix:nonFraction unitRef="number" contextRef="c-278" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1014"><ix:nonFraction unitRef="number" contextRef="c-279" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1015">10</ix:nonFraction></ix:nonFraction></ix:nonFraction>% per annum until repaid. As of December&#160;28, 2024, the principal amount outstanding was fully repaid (see Note 20).</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-27</span></div></div></div><div id="i213e3c881f5e4982994be533c682ff6b_172"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 17: <ix:nonNumeric contextRef="c-1" name="us-gaap:PreferredStockTextBlock" id="f-1016" continuedAt="f-1016-1" escape="true">Preferred Stock</ix:nonNumeric></span></div><ix:continuation id="f-1016-1" continuedAt="f-1016-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Series A-1 Convertible Preferred Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">History</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August&#160;18, 2017, the Company acquired GeoTraq by way of merger. In connection with this transaction, the Company tendered to the owners of GeoTraq $<ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="0" id="f-1017">200,000</ix:nonFraction>, issued to them an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-280" decimals="0" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1018">288,588</ix:nonFraction> shares (number of shares specific &#8211; not rounded) of the Company&#8217;s Series A Convertible Preferred Stock valued at $<ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="6" id="f-1019">12.3</ix:nonFraction> million, including the beneficial conversion feature of $<ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-5" name="alts:BusinessCombinationConsiderationTransferredBeneficialConversionFeatureValue" scale="6" id="f-1020">2.6</ix:nonFraction> million, and entered into <ix:nonNumeric contextRef="c-280" name="alts:BusinessCombinationConsiderationTransferredLiabilitiesIncurredTerm" format="ixt-sec:durwordsen" id="f-1021">one-year</ix:nonNumeric> unsecured promissory notes in the aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="0" id="f-1022">800,000</ix:nonFraction>.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The &#8220;Conversion Ratio&#8221; per share of the Series A-1 Convertible Preferred Stock in connection with any conversion shall be at a ratio of <ix:nonFraction unitRef="number" contextRef="c-283" decimals="INF" name="us-gaap:PreferredStockConvertibleConversionRatio" scale="0" id="f-1023">20</ix:nonFraction>:1, one share of Series A-1 Convertible Preferred Stock, if and when converted into shares of Common Stock, shall convert into twenty shares Common Stock. Each holder shall have the right, exercisable at any time and from time to time (unless otherwise prohibited by law, rule, or regulation, or as restricted below), to convert any or all of such holder&#8217;s shares of Series A-1 Convertible Preferred Stock into shares of Common Stock at the Conversion Ratio.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;28, 2024 and December&#160;30, 2023, <ix:nonFraction unitRef="shares" contextRef="c-283" decimals="0" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" scale="0" id="f-1024">0</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-284" decimals="0" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" format="ixt:num-dot-decimal" scale="0" id="f-1025">27,353</ix:nonFraction> shares of the Company&#8217;s Series A-1 Convertible Preferred Stock were converted into <ix:nonFraction unitRef="shares" contextRef="c-285" decimals="0" name="us-gaap:ConversionOfStockSharesIssued1" scale="0" id="f-1026">0</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-286" decimals="0" name="us-gaap:ConversionOfStockSharesIssued1" format="ixt:num-dot-decimal" scale="0" id="f-1027">547,069</ix:nonFraction> shares, respectively, of the Company&#8217;s common stock. Additionally, during the year ended December&#160;28, 2024, <ix:nonFraction unitRef="shares" contextRef="c-285" decimals="0" name="alts:ConversionOfStockSharesForfeited" scale="0" id="f-1028">0</ix:nonFraction> shares of the Company&#8217;s Series A-1 Convertible Preferred Stock were forfeited. As of December&#160;28, 2024 and December&#160;30, 2023, there were <ix:nonFraction unitRef="shares" contextRef="c-283" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1029">23,480</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-284" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1030">193,730</ix:nonFraction> shares, respectively, of Series A-1 Convertible Preferred Stock outstanding.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company cannot declare, pay or set aside any dividends on shares of any other class or series of our capital stock unless (in addition to the obtaining of any consents required by our Articles of Incorporation) the holders of the Series A Convertible Preferred Stock then outstanding shall first receive, or simultaneously receive, a dividend in the aggregate amount of one dollar, regardless of the number of then-issued and outstanding shares of Series A Convertible Preferred Stock. Any remaining dividends allocated by the Board of Directors shall be distributed in an equal amount per share to the holders of outstanding common stock and Series A-1 Convertible Preferred Stock (on an as-if-converted to common stock basis pursuant to the Conversion Ratio as defined below).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voting Rights</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each holder of a share of Series A Convertible Preferred Stock has a number of votes as is determined by multiplying (i) the number of shares of Series A Preferred Stock held by such holder, and (ii) 17. The holders of Series A-1 Convertible Preferred Stock vote together with all other classes and series of common and preferred stock of the Company as a single class on all actions to be taken by the common stockholders of the Company, except to the extent that voting as a separate class or series is required by law.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redemption</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series A-1 Convertible Preferred Stock has no redemption rights by the Company, or any other entity.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preemptive Rights</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Series A-1 Convertible Preferred Stock and holders of ALT5 Sigma Corporation&#8217;s common stock are not entitled to any preemptive, subscription, or similar rights in respect of any securities of the Company, except as set forth in the Amended and Restated Series A-1 Certificate of Designation or in any other document agreed to by ALT5 Sigma Corporation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Protective Provisions</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Without first obtaining the affirmative approval of a majority of the holders of the shares of Series A-1 Convertible Preferred Stock, the Company may not directly or indirectly (i) increase or decrease (other than by redemption or conversion) the total number of authorized shares of Series A-1 Convertible Preferred Stock; (ii) effect an exchange, reclassification, or cancellation of all or a part of the Series A-1 Convertible Preferred Stock, but excluding a stock split or </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1016-2" continuedAt="f-1016-3"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reverse stock split or combination of the common stock or preferred stock; (iii) effect an exchange, or create a right of exchange, of all or part of the shares of another class of shares into shares of Series A-1 Convertible Preferred Stock; or (iv) alter or change the rights, preferences or privileges of the shares of Series A-1 Convertible Preferred Stock so as to affect adversely the shares of such series, including the rights set forth in this Designation; provided, however, that we may, without any vote of the holders of shares of the Series A-1 Convertible Preferred Stock, make technical, corrective, administrative or similar changes to the Amended and Restated Series A-1 Certificate of Designation that do not, individually or in the aggregate, materially adversely affect the rights or preferences of the holders of shares of the Series A-1 Convertible Preferred Stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Series B Preferred Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">History</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;15, 2024 the Company acquired acquired its ALT5 Subsidiary by way of merger (see Note 3). the Company tendered to the owners of ALT5 Subsidiary <ix:nonFraction unitRef="shares" contextRef="c-287" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1031">34,250</ix:nonFraction> shares of the Company&#8217;s Series B Preferred Stock valued at approximately $<ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="6" id="f-1032">8.6</ix:nonFraction> million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series B Preferred Stock are not be convertible into any class or series of capital stock of the Company. As of the year ended December&#160;28, 2024, <ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1033">34,207</ix:nonFraction> shares of Series B Preferred Stock were outstanding.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company shall not declare, pay, or set aside any dividends on shares of Series B Preferred Stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voting Rights</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as required by the General Corporation Law of the State of Nevada, the Series B Preferred Stock shall not have any voting rights.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redemption</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series B Preferred Stock has no redemption rights by ALT5 Sigma Corporation, or any other entity.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preemptive Rights</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of Series B Preferred Stock and holders of Common Stock are not be entitled to any preemptive, subscription, or similar rights in respect of any securities of the Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Protective Provisions</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Without first obtaining the affirmative approval of a majority of the holders of the shares of Series B Preferred Stock, the Company may not directly or indirectly (i) increase or decrease (other than by redemption or conversion) the total number of authorized shares of Series B Preferred Stock; (ii) effect an exchange, reclassification, or cancellation of all or a part of the Series B Preferred Stock, but excluding a stock split or reverse stock split or combination of the common stock or preferred stock; (iii) effect an exchange, or create a right of exchange, of all or part of the shares of another class of shares into shares of Series B Preferred Stock; (iv) permit the convertibility, whether mandatory or permissible, of some or all of the then-outstanding shares of Series B Preferred Stock, or (v) alter or change the rights, preferences or privileges of the shares of Series B Preferred Stock so as to affect adversely the shares of such series, including the rights set forth in this Designation; provided, however, that we may, without any vote of the holders of shares of the Series B Preferred Stock, </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1016-3" continuedAt="f-1016-4"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">make technical, corrective, administrative or similar changes that do not, individually or in the aggregate, materially adversely affect the rights or preferences of the holders of shares of the Series B Preferred Stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Series I Convertible Preferred Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">History</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with its acquisition of ALT5 Subsidiary (see Note 3), on December&#160;2, 2024, the Company tendered <ix:nonFraction unitRef="shares" contextRef="c-288" decimals="0" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1034">17,000</ix:nonFraction> shares of Series I Convertible Preferred Stock to <ix:nonFraction unitRef="consultant" contextRef="c-289" decimals="INF" name="alts:NumberOfConsultants" format="ixt-sec:numwordsen" scale="0" id="f-1035">two</ix:nonFraction> consultants of ALT5 Subsidiary.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series I Convertible Preferred Stock is subject to a mandatory eight-calendar-quarter leak-out, such that no more than twelve-and-one-half percent of the shares may be converted into shares of the Company&#8217;s common stock on a trailing quarterly basis over a period of <ix:nonNumeric contextRef="c-290" name="alts:CommonStockConversionValidConversionPeriod" format="ixt-sec:durwordsen" id="f-1036">two years</ix:nonNumeric>, and are subject to vesting provisions. The conversion ratio per share of the Series I Convertible Preferred Stock shall be one hundred shares of the Company&#8217;s common stock for each share of Series </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1016-4" continuedAt="f-1016-5"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I Convertible Preferred Stock subject to certain adjustments. As of the year ended December&#160;28, 2024, <ix:nonFraction unitRef="shares" contextRef="c-14" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1037">17,000</ix:nonFraction> shares of Series I Convertible Preferred Stock were outstanding.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Original Issue Date, the holders of this series of Preferred Stock shall be entitled to receive dividends on an as-converted into-Common Stock basis contemporaneously with the declaration and payment to the holders of Common Stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voting Rights</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as required by the General Corporation Law of the State of Nevada, the Series I Convertible Preferred Stock shall not have any voting rights.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redemption</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Certificate of Designation for the Series I Convertible Preferred Stock does not provide any redemption rights by ALT5 Sigma Corporation, or any other entity.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preemptive Rights</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Certificate of Designation for the Series I Convertible Preferred Stock does not provide the holders thereof with any preemptive, subscription, or similar rights in respect of any securities of the Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Protective Provisions</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Certificate of Designation for the Series I Convertible Preferred Stock does not provide the holders thereof with any protective provisions in their favor for so long as shares of such series remain outstanding.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Series M Preferred Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">History</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with its acquisition of ALT5 Subsidiary (see Note 3), the Company issued <ix:nonFraction unitRef="shares" contextRef="c-109" decimals="-2" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1038">3,200</ix:nonFraction> shares of Series M Preferred Stock to two entities that acted as finders for the transaction.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series M Preferred Stock shall not be convertible into any class or series of capital stock of the Company. As of the year ended December&#160;28, 2024, <ix:nonFraction unitRef="shares" contextRef="c-16" decimals="-2" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1039">3,200</ix:nonFraction> shares of Series M Preferred Stock were outstanding.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company shall not declare, pay, or set aside any dividends on shares of Series M Preferred Stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voting Rights</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as required by the General Corporation Law of the State of Nevada, the Series M Preferred Stock shall not have any voting rights.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redemption</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series M Preferred Stock has no redemption rights by ALT5 Sigma Corporation, or any other entity.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preemptive Rights</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of Series M Preferred Stock and holders of Common Stock shall not be entitled to any preemptive, subscription, or similar rights in respect of any securities of the Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Protective Provisions</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Without first obtaining the affirmative approval of a majority of the holders of the shares of Series M Preferred Stock, the Company may not directly or indirectly (i) increase or decrease (other than by redemption or conversion) the total number of authorized shares of Series M Preferred Stock; (ii) effect an exchange, reclassification, or cancellation of all or a part of </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1016-5" continuedAt="f-1016-6"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Series M Preferred Stock, but excluding a stock split or reverse stock split or combination of the common stock or preferred stock; (iii) effect an exchange, or create a right of exchange, of all or part of the shares of another class of shares into shares of Series M Preferred Stock; (iv) permit the convertibility, whether mandatory or permissible, of some or all of the then-outstanding shares of Series M Preferred Stock, or (v) alter or change the rights, preferences or privileges of the shares of Series M Preferred Stock so as to affect adversely the shares of such series, including the rights set forth in this Designation; provided, however, that we may, without any vote of the holders of shares of the Series M Preferred Stock, make technical, corrective, administrative or similar changes that do not, individually or in the aggregate, materially adversely affect the rights or preferences of the holders of shares of the Series M Preferred Stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Series Q Convertible Preferred Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">History</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;6, 2024 acquired the Qodex Cryptocurrency Exchange Software platform and other related assets from Qoden Technologies, LLC by way of an asset purchase agreement (see Note 3). The Company tendered to the owners of Qoden Technologies, LLC <ix:nonFraction unitRef="shares" contextRef="c-291" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1040">771,010</ix:nonFraction> shares of the Company&#8217;s Series Q Convertible Preferred Stock valued at approximately $<ix:nonFraction unitRef="usd" contextRef="c-292" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="6" id="f-1041">1.3</ix:nonFraction> million. Additionally, the Company tendered and additional <ix:nonFraction unitRef="shares" contextRef="c-292" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1042">154,202</ix:nonFraction> shares of the Company&#8217;s Series Q Convertible Preferred Stock to a third-party contractor to act as a consultant in implementing and enhancing the platform.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series Q Convertible Preferred Stock was valued at $<ix:nonFraction unitRef="usdPerShare" contextRef="c-293" decimals="3" name="alts:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare" scale="0" id="f-1043">2.594</ix:nonFraction> per share on the date issued, and is subject to a mandatory eight-calendar-quarter leak-out, such that no more than twelve-and-one-half percent of the shares may be converted into shares of the Company&#8217;s common stock on a trailing quarterly basis over a period of two years, and are subject to vesting provisions. The conversion ratio per share of the Series Q Convertible Preferred Stock shall be one share of the Company&#8217;s common stock for each share of Series Q Convertible Preferred Stock subject to certain adjustments. As of the year ended December&#160;28, 2024, <ix:nonFraction unitRef="shares" contextRef="c-18" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1044">925,212</ix:nonFraction> shares of Series Q Convertible Preferred Stock were outstanding.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Original Issue Date, holders of Series Q Convertible Preferred Stock shall not be entitled to receive any dividends.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voting Rights</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as required by the General Corporation Law of the State of Nevada, the Series Q Convertible Preferred Stock shall not have any voting rights.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redemption</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series Q Convertible Preferred Stock has no redemption rights by ALT5 Sigma Corporation, or any other entity.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preemptive Rights</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of Series Q Convertible Preferred Stock and holders of Common Stock shall not be entitled to any preemptive, subscription, or similar rights in respect of any securities of the Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Protective Provisions</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Without first obtaining the affirmative approval of a majority of the holders of the shares of Series Q Convertible Preferred Stock, the Company may not directly or indirectly (i) increase or decrease (other than by redemption or conversion) the total number of authorized shares of Series Q Convertible Preferred Stock; (ii) effect an exchange, reclassification, or cancellation of all or a part of the Series Q Convertible Preferred Stock, but excluding a stock split or reverse stock split or combination of the common stock or preferred stock; (iii) effect an exchange, or create a right of exchange, of all or part of the shares of another class of shares into shares of Series Q Preferred Stock; (iv) permit the convertibility, whether mandatory or permissible, of some or all of the then-outstanding shares of Series B Preferred Stock, or (v) alter or change the rights, preferences or privileges of the shares of Series Q Convertible Preferred Stock so as to affect adversely the shares of such series, including the rights set forth in this Designation; provided, however, that we may, without any vote of the holders of shares of the Series Q Convertible Preferred Stock, make technical, corrective, administrative or similar </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1016-6" continuedAt="f-1016-7"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">changes that do not, individually or in the aggregate, materially adversely affect the rights or preferences of the holders of shares of the Series Q Convertible Preferred Stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Series V Convertible Preferred Stock</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">History</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;4, 2024, entered into an Asset Purchase Agreement for the purchase of specified assets of an unaffiliated third-party (see Note 18). In connection with this transaction, the Company tendered <ix:nonFraction unitRef="shares" contextRef="c-294" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1045">5,000</ix:nonFraction> shares of the Company's Series V Convertible Preferred Stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The conversion ratio per share of the Series V Convertible Preferred Stock in connection with any Conversion shall be at a ratio of 1:1, meaning every one share of Series V Convertible Preferred Stock, if and when converted into shares of Common Stock, shall convert into one share of Common Stock. Each Holder shall have the right, exercisable at any time and from time to time, unless otherwise prohibited by law, rule, or regulation, to convert any or all of such Holder&#8217;s shares of Series V Convertible Preferred Stock into shares of Common Stock at the Conversion Ratio. As of the year ended December&#160;28, 2024, <ix:nonFraction unitRef="shares" contextRef="c-20" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1046">5,000</ix:nonFraction> shares of Series Q Convertible Preferred Stock were outstanding.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares of Series V Convertible Preferred Stock do not have dividend rights.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voting Rights</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Holder of each share of Series V Convertible Preferred Stock shall have such number of votes as is determined by multiplying (a) the number of shares of Series V Convertible Preferred Stock held by such Holder by (b) one. Such voting calculation is hereby authorized by the Company and the Company acknowledges such calculation may result in the total number of possible votes cast by the Series V Convertible Preferred Stock Holders and all other classes of the Company&#8217;s Common Stock in any given voting matter exceeding the total aggregate number of shares that this Company shall have authority to issue.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redemption</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series V Convertible Preferred Stock has no redemption rights by ALT5 Sigma Corporation, or any other entity.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preemptive Rights</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of Series V Convertible Preferred Stock and holders of Common Stock shall not be entitled to any preemptive, subscription, or similar rights in respect of any securities of the Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Protective Provisions</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Without first obtaining the affirmative approval of a majority of the holders of the shares of Series V Convertible Preferred Stock, the Company may not directly or indirectly (i) increase or decrease (other than by redemption or conversion) the total number of authorized shares of Series V Convertible Preferred Stock; (ii) effect an exchange, reclassification, or cancellation of all or a part of the Series V Convertible Preferred Stock, but excluding a stock split or reverse stock split or combination of the common stock or preferred stock; (iii) effect an exchange, or create a right of exchange, of all or part of the shares of another class of shares into shares of Series V Preferred Stock; (iv) permit the convertibility, whether mandatory or permissible, of some or all of the then-outstanding shares of Series V Preferred Stock, or (v) alter or change the rights, preferences or privileges of the shares of Series V Convertible Preferred Stock so as to affect adversely the shares of such series, including the rights set forth in this Designation; provided, however, that we may, without any vote of the holders of shares of the Series V Convertible Preferred Stock, make technical, corrective, administrative or similar </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1016-7" continuedAt="f-1016-8"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">changes that do not, individually or in the aggregate, materially adversely affect the rights or preferences of the holders of shares of the Series V Convertible Preferred Stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Series S Convertible Preferred Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">History</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 28, 2022 the Company acquired Soin Therapeutics by way of merger. In connection with this transaction, with a potential value of up to $<ix:nonFraction unitRef="usd" contextRef="c-295" decimals="-6" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" scale="6" id="f-1047">30</ix:nonFraction> million, the Company tendered <ix:nonFraction unitRef="shares" contextRef="c-296" decimals="0" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1048">100,000</ix:nonFraction> shares of the Company's Series S Convertible Preferred Stock. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Initially, Dr. Soin was entitled to convert up to <ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-6" name="alts:ConversionOfStockAmountConvertible" format="ixt-sec:numwordsen" scale="6" id="f-1049">three</ix:nonFraction> million dollars of value of the Series S Stock into shares of the Company&#8217;s common stock commencing <ix:nonNumeric contextRef="c-298" name="alts:ConversionOfStockCommencementPeriod" format="ixt-sec:durwordsen" id="f-1050">one year</ix:nonNumeric> from the closing and may also convert up to an additional $<ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-6" name="alts:ConversionOfStockAmountConvertible" scale="6" id="f-1051">10</ix:nonFraction> million of value of the Series S Stock into shares of the Company's common stock from and after the sooner of (y) the issuance by the FDA of New Drug Approval for low-dose naltrexone for treating pain or (z) <ix:nonNumeric contextRef="c-300" name="alts:ConversionOfStockPeriodFollowingClosing" format="ixt-sec:duryear" id="f-1052">10</ix:nonNumeric> years from the closing. Further, during the <ix:nonNumeric contextRef="c-300" name="alts:ConversionOfStockPeriodFollowingClosing" format="ixt-sec:duryear" id="f-1053">10</ix:nonNumeric>-year period following the closing, Dr. Soin may convert up to an additional $<ix:nonFraction unitRef="usd" contextRef="c-301" decimals="-6" name="alts:ConversionOfStockAmountConvertible" scale="6" id="f-1054">17</ix:nonFraction> million of value at a rate of <ix:nonFraction unitRef="number" contextRef="c-302" decimals="3" name="alts:PercentageOfGrossRevenue" format="ixt-sec:numwordsen" scale="-2" id="f-1055">five</ix:nonFraction> percent of the gross revenues that the Company receives in connection with sales or license revenue from the product.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Soin further agreed to certain restrictions on the maximum number of shares of Series S Stock that he may ultimately keep or that he may convert into shares of our common stock or sell into the public markets at any given time: (i) Dr. Soin may not convert shares of Series S Stock into shares of the Company's common stock in an amount such that, upon any such conversion, he beneficially own shares of the Company's common stock in excess of <ix:nonFraction unitRef="number" contextRef="c-303" decimals="4" name="alts:CommonStockSharesOutstandingPercentage" scale="-2" id="f-1056">4.99</ix:nonFraction>% of the Company's then-outstanding common stock and (ii) during the five-year period that commences on the date that Dr. Soin is first eligible to convert any shares of Series S Stock into shares of the Company's common stock, he will not dispose of any of such shares into the public markets in an amount that exceeds five percent of the daily trading volume of the Company's common stock during any trading day.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares of Series S Convertible Preferred Stock are convertible into the Company&#8217;s common shares at a ratio of 1:1. During the year ended December&#160;28, 2024, in connection with the amended agreement disclosed in Note 3, the Company reclassified approximately $<ix:nonFraction unitRef="usd" contextRef="c-304" decimals="-5" name="alts:ReclassificationOfTemporaryToCurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-1057">2.7</ix:nonFraction>&#160;million from mezzanine equity to current liabilities, and approximately $<ix:nonFraction unitRef="usd" contextRef="c-304" decimals="-5" name="us-gaap:ReclassificationsOfTemporaryToPermanentEquity" format="ixt:num-dot-decimal" scale="6" id="f-1058">8.0</ix:nonFraction>&#160;million from mezzanine equity to permanent equity (see Note 3). <ix:nonNumeric contextRef="c-1" name="us-gaap:TemporaryEquityTableTextBlock" id="f-1059" continuedAt="f-1059-1" escape="true">As of December&#160;28, 2024 and December&#160;30, 2023, there were <ix:nonFraction unitRef="shares" contextRef="c-9" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1060"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1061">100,000</ix:nonFraction></ix:nonFraction> shares of Series S Convertible Preferred Stock outstanding, as reflected in the following (dollars in $000&#8217;s):</ix:nonNumeric></span></div><ix:continuation id="f-1059-1"><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Series S Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance, December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-305" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1062">100,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-305" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-1063">14,510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance, December 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1064">100,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100000</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-1065">14,510</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassification to permanent equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-304" decimals="INF" name="alts:ReclassificationsOfTemporaryToPermanentEquityShares" scale="0" id="f-1066">0</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-304" decimals="-3" name="us-gaap:ReclassificationsOfTemporaryToPermanentEquity" format="ixt:num-dot-decimal" scale="3" id="f-1067">7,993</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassification to current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-304" decimals="INF" name="alts:ReclassificationOfTemporaryToCurrentLiabilitiesShares" scale="0" id="f-1068">0</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-304" decimals="-3" name="alts:ReclassificationOfTemporaryToCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1069">2,661</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance, December 28, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1070">100,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-1071">3,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares of Series S Convertible Preferred Stock do not have dividend rights.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voting Rights</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Holder of each share of Series S Convertible Preferred Stock shall have <ix:nonFraction unitRef="number" contextRef="c-9" decimals="INF" name="us-gaap:PreferredStockConvertibleConversionRatio" format="ixt-sec:numwordsen" scale="0" id="f-1072">one</ix:nonFraction> vote for such share. With respect to any stockholder vote, the Holder shall have full voting rights and powers equal to the voting rights and powers of the Common Stock stockholders, and shall be entitled to notice of any stockholders' meeting in accordance with the Bylaws of the Company, and shall be entitled to vote, together with Common Stock stockholders, with respect to any question upon which the Common Stock stockholders have the right to vote. The Holders of Series S Convertible Preferred Stock shall vote together with all other classes and series of common and preferred stock of the Company as a single class on all actions to be taken by the Common Stock stockholders, except to the extent that voting as a separate class or series is required by law.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1016-8"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redemption</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series S Convertible Preferred Stock has no redemption rights by ALT5 Sigma Corporation, or any other entity.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preemptive Rights</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Series S Convertible Preferred Stock and holders of ALT5 Sigma Corporation common stock are not entitled to any preemptive, subscription, or similar rights in respect of any securities of ALT5 Sigma Corporation, except as set forth in the Amended and Restated Series A-1 Certificate of Designation or in any other document agreed to by ALT5 Sigma Corporation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Protective Provisions</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Without first obtaining the affirmative approval of a majority of the holders of the shares of Series S Convertible Preferred Stock, the Company may not directly or indirectly (i) increase or decrease (other than by redemption or conversion) the total number of authorized shares of Series S Convertible Preferred Stock; (ii) effect an exchange, reclassification, or cancellation of all or a part of the Series S Convertible Preferred Stock, but excluding a stock split or reverse stock split or combination of the common stock or preferred stock; (iii) effect an exchange, or create a right of exchange, of all or part of the shares of another class of shares into shares of Series S Convertible Preferred Stock; (iv) issue additional shares of Series S Convertible Preferred Stock other than in connection with the merger agreement, or (v) alter or change the rights, preferences or privileges of the shares of Series S Convertible Preferred Stock so as to affect adversely the shares of such series, including the rights set forth in this Designation; provided, however, that we may, without any vote of the holders of shares of the Series S Convertible Preferred Stock, make technical, corrective, administrative or similar changes to the Amended and Restated Series S Certificate of Designation that do not, individually or in the aggregate, materially adversely affect the rights or preferences of the holders of shares of the Series S Convertible Preferred Stock.</span></div></ix:continuation><div id="i213e3c881f5e4982994be533c682ff6b_181"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 18: <ix:nonNumeric contextRef="c-1" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock" id="f-1074" continuedAt="f-1074-1" escape="true">Stockholders&#8217; Equity</ix:nonNumeric></span></div><ix:continuation id="f-1074-1" continuedAt="f-1074-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The Company's Articles of Incorporation authorize <ix:nonFraction unitRef="shares" contextRef="c-306" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-1075">200,000,000</ix:nonFraction> shares of common stock that may be issued from time to time having such rights, powers, preferences and designations as the Board of Directors may determine. As of December&#160;28, 2024, and December&#160;30, 2023, there were <ix:nonFraction unitRef="shares" contextRef="c-306" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1076">15,417,687</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-307" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1077">4,957,647</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares, respectively, of common stock issued and outstanding.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Equity Offerings:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;22, 2023, the Company entered into a Securities Purchase Agreement with certain institutional investors for the sale by the Company in a registered direct offering of <ix:nonFraction unitRef="shares" contextRef="c-308" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-1078">361,000</ix:nonFraction> shares of the Company&#8217;s common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-309" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-1079">0.001</ix:nonFraction> per share, at a purchase price per share of Common Stock of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-309" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-1080">1.17</ix:nonFraction>. The offering closed on March&#160;24, 2023. The aggregate gross proceeds for the sale of the shares of Common Stock were approximately $<ix:nonFraction unitRef="usd" contextRef="c-308" decimals="-3" name="us-gaap:ProceedsFromSaleOfInterestInPartnershipUnit" format="ixt:num-dot-decimal" scale="0" id="f-1081">422,000</ix:nonFraction>, before deducting the placement agent fees and related expenses. The Company utilized the net proceeds for working capital and general corporate purposes.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August&#160;18, 2023, the Company entered into a Securities Purchase Agreement with a certain institutional investor for the sale by the Company in a registered direct offering of: (i) <ix:nonFraction unitRef="shares" contextRef="c-310" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-1082">418,000</ix:nonFraction> shares of the Company&#8217;s common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-311" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-1083">0.001</ix:nonFraction> per share, at an offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-311" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-1084">0.8811</ix:nonFraction> per share and (ii) pre-funded warrants exercisable for up to <ix:nonFraction unitRef="shares" contextRef="c-312" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-1085">481,348</ix:nonFraction> shares of Common Stock to the Investor at an offering price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-312" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-1086">0.8801</ix:nonFraction> per pre-funded Warrant. In connection with the Securities Purchase Agreement, during the year ended December&#160;28, 2024, the Company issued <ix:nonFraction unitRef="shares" contextRef="c-313" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" format="ixt:num-dot-decimal" scale="0" id="f-1087">27,738</ix:nonFraction> shares of its common stock to three third-parties in exchange for brokerage services.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;23, 2024, the Company entered into Unit Purchase Agreements with <ix:nonFraction unitRef="investor" contextRef="c-314" decimals="INF" name="alts:NumberOfAgreementsToBePurchased" format="ixt-sec:numwordsen" scale="0" id="f-1088">two</ix:nonFraction> otherwise unaffiliated third-party investors, pursuant to which each Investor agreed to purchase <ix:nonFraction unitRef="shares" contextRef="c-315" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-1089">408,163</ix:nonFraction> units of securities from the Company, at a price per Unit of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-314" decimals="3" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-1090">0.7350</ix:nonFraction>, for an aggregate purchase price of $<ix:nonFraction unitRef="usd" contextRef="c-316" decimals="-3" name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" format="ixt:num-dot-decimal" scale="0" id="f-1091">300,000</ix:nonFraction> per investor for an aggregate price of $<ix:nonFraction unitRef="usd" contextRef="c-316" decimals="-3" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="0" id="f-1092">600,000</ix:nonFraction>. Each Unit consists of <ix:nonFraction unitRef="shares" contextRef="c-316" decimals="INF" name="alts:SaleOfStockUnitCompositionNumberOfCommonSharesInEachUnit" format="ixt-sec:numwordsen" scale="0" id="f-1093">one</ix:nonFraction> share of the Company&#8217;s common stock and <ix:nonFraction unitRef="shares" contextRef="c-316" decimals="INF" name="alts:SaleOfStockUnitCompositionNumberOfWarrantsIssuedInEachUnit" format="ixt-sec:numwordsen" scale="0" id="f-1094">one</ix:nonFraction> warrant to purchase an additional share of common stock. The per-Unit price is allocated as follows: $<ix:nonFraction unitRef="usdPerShare" contextRef="c-314" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-1095">0.61</ix:nonFraction> per share of common stock and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-316" decimals="3" name="alts:ClassOfWarrantPricePerShare" scale="0" id="f-1096">0.125</ix:nonFraction> per Warrant. The Warrant has a <ix:nonNumeric contextRef="c-314" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-1097">three-year</ix:nonNumeric> term and will be immediately exercisable. Each Warrant is exercisable at $<ix:nonFraction unitRef="usdPerShare" contextRef="c-314" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-1098">0.61</ix:nonFraction> per share. The Company utilized the proceeds from the Unit Purchases for its working capital needs. Further, the Company issued an additional <ix:nonFraction unitRef="shares" contextRef="c-317" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-1099">81,632</ix:nonFraction> shares of its common stock to another party in exchange for brokerage services rendered.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;4, 2024, the Company entered into a <ix:nonNumeric contextRef="c-318" name="alts:RelatedPartyTransactionConsultingAgreementTerm" format="ixt-sec:durwordsen" id="f-1100">two-year</ix:nonNumeric> Consulting Agreement (the &#8220;Consulting Agreement&#8221;) with Jon Isaac, pursuant to which he will provide a variety of services to the Company. In connection with the Consulting Agreement, the Company issued to Mr. Isaac <ix:nonFraction unitRef="shares" contextRef="c-318" decimals="0" name="alts:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares" format="ixt:num-dot-decimal" scale="0" id="f-1101">200,000</ix:nonFraction> restricted shares of its common stock (see Note 20).</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1074-2" continuedAt="f-1074-3"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;22, 2024, pursuant to the terms and conditions of a promissory note, the Company converted $<ix:nonFraction unitRef="usd" contextRef="c-319" decimals="-3" name="us-gaap:DebtConversionOriginalDebtAmount1" format="ixt:num-dot-decimal" scale="0" id="f-1102">183,000</ix:nonFraction> of obligations into <ix:nonFraction unitRef="shares" contextRef="c-320" decimals="0" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" format="ixt:num-dot-decimal" scale="0" id="f-1103">300,000</ix:nonFraction> shares of the Company&#8217;s common stock (see Note 20).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;25, 2024, pursuant to the terms and conditions of a promissory note, the Company converted $<ix:nonFraction unitRef="usd" contextRef="c-321" decimals="-3" name="us-gaap:DebtConversionOriginalDebtAmount1" format="ixt:num-dot-decimal" scale="0" id="f-1104">183,000</ix:nonFraction> of obligations into <ix:nonFraction unitRef="shares" contextRef="c-322" decimals="0" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" format="ixt:num-dot-decimal" scale="0" id="f-1105">300,000</ix:nonFraction> shares of the Company&#8217;s common stock (see Note 20).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;10, 2024, pursuant to the terms and conditions of a promissory note, the Company converted $<ix:nonFraction unitRef="usd" contextRef="c-323" decimals="-2" name="us-gaap:DebtConversionOriginalDebtAmount1" format="ixt:num-dot-decimal" scale="0" id="f-1106">60,900</ix:nonFraction> of obligations into <ix:nonFraction unitRef="shares" contextRef="c-324" decimals="0" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" format="ixt:num-dot-decimal" scale="0" id="f-1107">100,000</ix:nonFraction> shares of the Company&#8217;s common stock (see Note 20).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;12, 2024, pursuant to the terms and conditions of a promissory note, the Company converted $<ix:nonFraction unitRef="usd" contextRef="c-325" decimals="-2" name="us-gaap:DebtConversionOriginalDebtAmount1" format="ixt:num-dot-decimal" scale="0" id="f-1108">60,900</ix:nonFraction> of obligations into <ix:nonFraction unitRef="shares" contextRef="c-326" decimals="0" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" format="ixt:num-dot-decimal" scale="0" id="f-1109">100,000</ix:nonFraction> shares of the Company&#8217;s common stock (see Note 20).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;1, 2024, the Company entered into a Securities Purchase Agreement with <ix:nonFraction unitRef="investor" contextRef="c-327" decimals="INF" name="alts:NumberOfAgreementsToBePurchased" format="ixt-sec:numwordsen" scale="0" id="f-1110">two</ix:nonFraction> institutional investors for the sale by the Company of <ix:nonFraction unitRef="shares" contextRef="c-328" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-1111">79,782</ix:nonFraction> units of the Company&#8217;s securities at a purchase price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-327" decimals="3" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-1112">3.775</ix:nonFraction> per unit, each unit consisting of <ix:nonFraction unitRef="shares" contextRef="c-329" decimals="INF" name="alts:SaleOfStockUnitCompositionNumberOfCommonSharesInEachUnit" format="ixt-sec:numwordsen" scale="0" id="f-1113">one</ix:nonFraction> share of the Company&#8217;s common stock and <ix:nonFraction unitRef="shares" contextRef="c-329" decimals="INF" name="alts:SaleOfStockUnitCompositionNumberOfWarrantsIssuedInEachUnit" format="ixt-sec:numwordsen" scale="0" id="f-1114">one</ix:nonFraction> common stock purchase warrant for the purchase of an additional share of Common Stock. Each <ix:nonNumeric contextRef="c-327" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-1115">three-year</ix:nonNumeric> warrant is exercisable immediately at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-327" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-1116">3.63</ix:nonFraction> per share. The gross proceeds were approximately $<ix:nonFraction unitRef="usd" contextRef="c-329" decimals="-3" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="0" id="f-1117">300,000</ix:nonFraction>, before deducting related expenses.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;4, 2024, the Company entered into an Asset Purchase Agreement for the purchase of specified assets of an unaffiliated third-party. For the purchase of the assets, the Company (i) issued <ix:nonFraction unitRef="shares" contextRef="c-330" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-1118">300,000</ix:nonFraction> restricted shares of its common stock, (ii) issued <ix:nonFraction unitRef="shares" contextRef="c-331" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-1119">5,000</ix:nonFraction> shares of its Series V Convertible Preferred Stock, and (iii) granted a <ix:nonNumeric contextRef="c-332" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-1120">three-year</ix:nonNumeric> warrant for the purchase of up to <ix:nonFraction unitRef="shares" contextRef="c-333" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-1121">125,000</ix:nonFraction> shares of its common stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-332" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-1122">1.25</ix:nonFraction> per share.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;15, 2024, the Company acquired ALT5 Subsidiary. As consideration under the acquisition, the Company issued <ix:nonFraction unitRef="shares" contextRef="c-105" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1123">1,799,100</ix:nonFraction> shares of its common stock to the legacy equity holders of the capital stock of ALT5 (see Note 3).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;3, 2024, the Company entered into a <ix:nonNumeric contextRef="c-334" name="alts:RelatedPartyTransactionConsultingAgreementTerm" format="ixt-sec:durwordsen" id="f-1124">six-month</ix:nonNumeric> marketing agreement with a non-affiliated third-party, pursuant to which the third-party will provide a variety of marketing-related services to the Company. In connection with the marketing agreement, the Company issued to the third-party <ix:nonFraction unitRef="shares" contextRef="c-334" decimals="0" name="alts:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares" format="ixt:num-dot-decimal" scale="0" id="f-1125">47,923</ix:nonFraction> shares of its common stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;6, 2024, the Company entered into a <ix:nonNumeric contextRef="c-335" name="alts:RelatedPartyTransactionConsultingAgreementTerm" format="ixt-sec:durwordsen" id="f-1126">one-year</ix:nonNumeric> consulting agreement with a non-affiliated third-party, pursuant to which the third party will provide a variety of finance and investor-related services to the Company. In connection with the marketing agreement, the Company issued to the third-party <ix:nonFraction unitRef="shares" contextRef="c-335" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" format="ixt:num-dot-decimal" scale="0" id="f-1127">150,000</ix:nonFraction> shares of its common stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;18, 2024, the Company entered into a <ix:nonNumeric contextRef="c-336" name="alts:RelatedPartyTransactionConsultingAgreementTerm" format="ixt-sec:durwordsen" id="f-1128">six-month</ix:nonNumeric> marketing agreement with a non-affiliated third-party, pursuant to which the third-party will provide a variety of marketing-related services to the Company. In connection with the marketing agreement, the Company issued to the third-party <ix:nonFraction unitRef="shares" contextRef="c-336" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" format="ixt:num-dot-decimal" scale="0" id="f-1129">20,000</ix:nonFraction> shares of its common stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During October 2024, the Company issued <ix:nonFraction unitRef="shares" contextRef="c-337" decimals="0" name="alts:StockIssuedDuringPeriodSharesPrepaidInterest" format="ixt:num-dot-decimal" scale="0" id="f-1130">225,000</ix:nonFraction> shares of its common stock as prepayment of one year&#8217;s interest on its Bitcoin loan.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Big/Small Debenture (see Note 15), on October&#160;18, 2024, the Company issued an additional <ix:nonFraction unitRef="shares" contextRef="c-338" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" format="ixt:num-dot-decimal" scale="0" id="f-1131">25,000</ix:nonFraction> shares of its common stock to another party in exchange for brokerage services rendered.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of the fiscal year ended December&#160;28, 2024, the Company issued <ix:nonFraction unitRef="shares" contextRef="c-339" decimals="0" name="alts:StockIssuedDuringPeriodSharesWarrantsExercised" format="ixt:num-dot-decimal" scale="0" id="f-1132">290,908</ix:nonFraction> shares of its common stock related to the exercise of warrants under Big/Small Debenture (see Note 15).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July&#160;1, 2024, the Company entered into a <ix:nonNumeric contextRef="c-340" name="alts:RelatedPartyTransactionConsultingAgreementTerm" format="ixt-sec:durwordsen" id="f-1133">one-year</ix:nonNumeric> consulting agreement with a non-affiliated third-party, pursuant to which the third-party will provide a variety of communication-related consulting services to the Company. In connection with the marketing agreement, on December&#160;3, 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company issued to the third-party <ix:nonFraction unitRef="shares" contextRef="c-341" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" format="ixt:num-dot-decimal" scale="0" id="f-1134">60,000</ix:nonFraction> shares of its common stock.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1074-3" continuedAt="f-1074-4"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;23, 2024, pursuant to the terms of his Consulting Agreement, Mr. Isaac converted the existing obligation on the convertible promissory note, in the amount of approximately $<ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:DebtConversionOriginalDebtAmount1" format="ixt:num-dot-decimal" scale="0" id="f-1135">540,000</ix:nonFraction>, into <ix:nonFraction unitRef="shares" contextRef="c-268" decimals="0" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" format="ixt:num-dot-decimal" scale="0" id="f-1136">465,753</ix:nonFraction> shares of the Company&#8217;s common stock (see Note 16).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;23, 2024, pursuant to the terms of the judgment and forbearance agreements, a non-affiliated third-party converted the existing obligation plus accrued interest due under the agreements, in the amount of approximately $<ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-3" name="us-gaap:DebtConversionOriginalDebtAmount1" format="ixt:num-dot-decimal" scale="0" id="f-1137">691,000</ix:nonFraction>, into <ix:nonFraction unitRef="shares" contextRef="c-209" decimals="0" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" format="ixt:num-dot-decimal" scale="0" id="f-1138">265,842</ix:nonFraction> shares of the Company&#8217;s common stock (see Note 15).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;28, 2024, the Company issued an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-342" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-1139">341,175</ix:nonFraction> shares of its common stock to four individuals under the Company&#8217;s 2023 Equity Incentive Plan. The aggregate value of the shares at issuance was approximately $<ix:nonFraction unitRef="usd" contextRef="c-342" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="f-1140">1.3</ix:nonFraction> million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Equity Incentives</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The Company&#8217;s 2024 Plan, which was adopted by the Board in November 2024 and approved by the stockholders at the 2024 annual meeting of stockholders, replaces the 2023 Plan, which replaced the 2016 Plan, which replaced the 2011 Plan. Under the 2024 Plan, the maximum aggregate number of shares, which may be subject to or delivered under Awards granted under the Plan is <ix:nonFraction unitRef="shares" contextRef="c-343" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-1141">2,800,000</ix:nonFraction> shares. Awards may be in the form of a Stock Award, Option, Stock Appreciation Right, Stock Unit, or Other Stock-based Award granted in accordance with the terms of the respective Plan. During the year ended December&#160;28, 2024, there were <ix:nonFraction unitRef="shares" contextRef="c-344" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt-sec:numwordsen" scale="0" id="f-1142">no</ix:nonFraction> grants under the 2024 Plan.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s 2023 Plan, which was adopted by the Board in August 2023 and approved by the stockholders at the 2023 Annual Meeting of Stockholders, replaces the 2016 Plan, which replaced the 2011 Plan. Under the 2023 Plan, the maximum aggregate number of shares, which may be subject to or delivered under Awards granted under the Plan is two million (<ix:nonFraction unitRef="shares" contextRef="c-345" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-1143">2,000,000</ix:nonFraction>) shares. Awards may be in the form of a Stock Award, Option, Stock Appreciation Right, Stock Unit, or Other Stock-based Award granted in accordance with the terms of the respective Plan. During the year ended December&#160;28, 2024, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="c-346" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1144">1.2</ix:nonFraction> million and in share-based compensation expense related to the <ix:nonFraction unitRef="shares" contextRef="c-346" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" format="ixt:num-dot-decimal" scale="0" id="f-1145">908,852</ix:nonFraction> RSU&#8217;s that were awarded and immediately vested, as well as <ix:nonFraction unitRef="shares" contextRef="c-342" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" format="ixt:num-dot-decimal" scale="0" id="f-1146">295,000</ix:nonFraction> shares of the Company&#8217;s common stock issued (see above).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s 2016 Plan authorizes the granting of awards in any of the following forms: (i) incentive stock options, (ii) nonqualified stock options, (iii) restricted stock awards, and (iv) restricted stock units, and expires on the earlier of October&#160;28, 2026, or the date that all shares reserved under the 2016 Plan are issued or no longer available. On November&#160;4, 2020, the Company amended the 2016 Plan to increase the issuance of common shares from <ix:nonFraction unitRef="shares" contextRef="c-347" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-1147">400,000</ix:nonFraction> to <ix:nonFraction unitRef="shares" contextRef="c-348" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-1148">800,000</ix:nonFraction>. The vesting period is determined by the Board of Directors at the time of the stock option grant. As of December&#160;28, 2024 and December&#160;30, 2023, <ix:nonFraction unitRef="shares" contextRef="c-349" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1149"><ix:nonFraction unitRef="shares" contextRef="c-350" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1150">100,000</ix:nonFraction></ix:nonFraction> options were outstanding under the 2016 Plan.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s 2011 Plan authorizes the granting of awards in any of the following forms: (i) stock options, (ii) stock appreciation rights, and (iii) other share-based awards, including but not limited to, restricted stock, restricted stock units or performance shares, and expired on the earlier of May&#160;12, 2021, or the date that all shares reserved under the 2011 Plan are issued or no longer available. As of December&#160;28, 2024 and December&#160;30, 2023, <ix:nonFraction unitRef="shares" contextRef="c-351" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1151">8,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-352" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1152">14,000</ix:nonFraction> options, respectively, were outstanding under the 2011 Plan. <ix:nonFraction unitRef="shares" contextRef="c-353" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt-sec:numwordsen" scale="0" id="f-1153">No</ix:nonFraction> additional awards will be granted under the 2011 Plan.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-1154" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity for the fiscal years ended December&#160;28, 2024, and December&#160;30, 2023 (Aggregate Intrinsic Value in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Options <br/>Outstanding </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate<br/>Intrinsic<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-35" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1155">110,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-35" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1156">6.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:fixed-zero" scale="3" id="f-1157">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-354" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1158">6.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-22" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-1159">10,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-22" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1160">1.53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cancelled/expired</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-22" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1161">6,000</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1162">114,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1163">5.68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:fixed-zero" scale="3" id="f-1164">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-22" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1165">6.1</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cancelled/expired</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1166">6,000</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="f-1167">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 28, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1168">108,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1169">5.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="f-1170">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1171">5.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercisable at December 28, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-1172">60,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-1173">3.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" id="f-1174">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-1175">5.8</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1074-4"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" id="f-1176" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exercise price for stock options outstanding and exercisable outstanding at December&#160;28, 2024 is as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.447%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercisable</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Options</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercise Price ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Options</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercise Price ($)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-355" decimals="0" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="f-1177">42,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-356" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="f-1178">5.70</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-356" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="f-1179">9.90</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-355" decimals="0" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="f-1180">10,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-356" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="f-1181">5.70</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-356" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="f-1182">9.90</ix:nonFraction></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-357" decimals="0" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="f-1183">66,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-358" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="f-1184">3.54</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-358" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="f-1185">5.25</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-357" decimals="0" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="f-1186">50,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-358" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="f-1187">3.54</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-358" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="f-1188">5.25</ix:nonFraction></span></div></td></tr><tr><td colspan="3" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="0" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="f-1189">108,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="0" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="f-1190">60,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized share-based compensation expense related to equity incentive awards of approximately $<ix:nonFraction unitRef="usd" contextRef="c-359" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1191">1.7</ix:nonFraction> million and approximately $<ix:nonFraction unitRef="usd" contextRef="c-360" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="0" id="f-1192">14,000</ix:nonFraction> for the fiscal years ended December&#160;28, 2024, and December&#160;30, 2023, respectively. As of December&#160;28, 2024, the Company had <ix:nonFraction unitRef="usd" contextRef="c-361" decimals="0" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:fixed-zero" scale="3" id="f-1193">no</ix:nonFraction> unrecognized share-based compensation expense, and there were <ix:nonFraction unitRef="shares" contextRef="c-361" decimals="0" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" format="ixt:fixed-zero" scale="0" id="f-1194">no</ix:nonFraction> non-vested shares associated with stock option awards.</span></div></ix:continuation><div id="i213e3c881f5e4982994be533c682ff6b_184"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 19: <ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-1195" continuedAt="f-1195-1" escape="true">Income taxes</ix:nonNumeric></span></div><ix:continuation id="f-1195-1" continuedAt="f-1195-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="f-1196" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For fiscal years ended December&#160;28, 2024, and December&#160;30, 2023, the Company recorded an income tax benefit from continuing operations of approximately $<ix:nonFraction unitRef="usd" contextRef="c-362" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1197">3.0</ix:nonFraction> million and an income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="f-1198">0.4</ix:nonFraction>&#160;million, respectively, and an income tax provision from discontinued operations of $<ix:nonFraction unitRef="usd" contextRef="c-363" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" id="f-1199">0</ix:nonFraction> and approximately $<ix:nonFraction unitRef="usd" contextRef="c-364" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1200">1.0</ix:nonFraction> million, respectively, which consisted of the following (in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current tax expense:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="f-1201">102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-1202">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="f-1203">44</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="f-1204">98</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="f-1205">334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-1206">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current tax expense</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="f-1207">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="f-1208">98</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax (benefit) provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1209">3,229</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="f-1210">444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total (benefit) provision of income taxes</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="alts:ProvisionBenefitOfIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="f-1211">3,041</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="alts:ProvisionBenefitOfIncomeTaxes" scale="3" id="f-1212">542</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="f-1213" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the Company's income tax benefit (provision) with the federal statutory tax rate for the fiscal years ended December&#160;28, 2024, and December&#160;30, 2023, respectively, is shown below:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Years Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. statutory rate</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-1214">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-22" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-1215">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="f-1216">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-22" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="f-1217">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign rate differential</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="f-1218">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-22" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="f-1219">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Permanent differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="alts:EffectiveIncomeTaxRateReconciliationPermanentDifferences" scale="-2" id="f-1220">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-<ix:nonFraction unitRef="number" contextRef="c-22" decimals="3" name="alts:EffectiveIncomeTaxRateReconciliationPermanentDifferences" scale="-2" id="f-1221">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Impact of sale of ARCA Recycling and Canada</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" format="ixt:fixed-zero" scale="-2" id="f-1222">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-<ix:nonFraction unitRef="number" contextRef="c-22" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" scale="-2" id="f-1223">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="f-1224">12.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-<ix:nonFraction unitRef="number" contextRef="c-22" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="f-1225">25.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="f-1226">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-<ix:nonFraction unitRef="number" contextRef="c-22" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="f-1227">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1228">32.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-<ix:nonFraction unitRef="number" contextRef="c-22" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1229">7.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="f-1230" continuedAt="f-1230-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) before provision of income taxes was derived from the following sources for fiscal years December&#160;28, 2024 and December&#160;30, 2023, respectively, as shown below (in $000&#8217;s):</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1195-2"><ix:continuation id="f-1230-1"><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Years Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="f-1231">12,825</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="f-1232">6,613</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Canada</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="f-1233">3,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="f-1234">657</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="alts:IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="f-1235">9,286</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="alts:IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="f-1236">7,270</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="f-1237" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net deferred tax assets (liabilities) as of December&#160;28, 2024 and December&#160;30, 2023, respectively, are as follows (in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets (liabilities):</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="3" id="f-1238">152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="3" id="f-1239">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allowance for bad debts</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="3" id="f-1240">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" format="ixt:fixed-zero" scale="3" id="f-1241">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" scale="3" id="f-1242">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" scale="3" id="f-1243">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 174 expenses</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="alts:Section174Expenses" scale="3" id="f-1244">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="alts:Section174Expenses" scale="3" id="f-1245">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPrepaidExpenses" scale="3" id="f-1246">128</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPrepaidExpenses" scale="3" id="f-1247">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-1248">7,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-1249">5,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="alts:DeferredTaxAssetsLeaseLiability" scale="3" id="f-1250">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="alts:DeferredTaxAssetsLeaseLiability" format="ixt:fixed-zero" scale="3" id="f-1251">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax credits</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" format="ixt:fixed-zero" scale="3" id="f-1252">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="3" id="f-1253">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="3" id="f-1254">114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="3" id="f-1255">136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangibles</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-1256">6,909</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-1257">3,747</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="alts:DeferredTaxLiabilitiesRightOfUseAssets" scale="3" id="f-1258">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="alts:DeferredTaxLiabilitiesRightOfUseAssets" format="ixt:fixed-zero" scale="3" id="f-1259">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment sale</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="alts:DeferredTaxLiabilitiesInstallmentSale" format="ixt:fixed-zero" scale="3" id="f-1260">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="alts:DeferredTaxLiabilitiesInstallmentSale" format="ixt:fixed-zero" scale="3" id="f-1261">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses" scale="3" id="f-1262">794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses" scale="3" id="f-1263">327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 163(j) interest</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="alts:DeferredTaxAssetsInterest" scale="3" id="f-1264">138</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="alts:DeferredTaxAssetsInterest" format="ixt:fixed-zero" scale="3" id="f-1265">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="alts:DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-1266">1,878</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="alts:DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-1267">2,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-1268">2,919</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-1269">2,773</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net deferred tax liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1270">1,041</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxLiabilities" scale="3" id="f-1271">639</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;28, 2024, the Company has net operating loss carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="c-365" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-1272">19.5</ix:nonFraction> million for federal income tax purposes, and approximately $<ix:nonFraction unitRef="usd" contextRef="c-366" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-1273">11.8</ix:nonFraction> million for state income tax purposes, which will be available to offset future taxable income. Due to recent tax legislation, the federal net operating losses are eligible for indefinite carryforward, limited by certain taxable income limitations. State net operating losses begin to expire in 2032. The Company evaluates all available evidence to determine if a valuation allowance is needed to reduce its deferred tax assets. During the fourth quarter of fiscal year 2023, management concluded that a valuation allowance is necessary for the state net operating loss carryforward and a portion of the federal net operating loss carryforward. Due to the 2023 sale of ARCA Canada (as part of the Recycling Subsidiaries transaction), the valuation allowance was released. The Company has recorded a valuation allowance of approximately $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingLossCarryforwardsValuationAllowance" scale="6" id="f-1274"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLossCarryforwardsValuationAllowance" scale="6" id="f-1275">2.9</ix:nonFraction></ix:nonFraction> million as of December&#160;28, 2024, and December&#160;30, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company annually conducts an analysis of its uncertain tax positions and has concluded that it has no uncertain tax positions as of December&#160;28, 2024. The Company&#8217;s policy is to record uncertain tax positions as a component of income tax expense.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files U.S. and state income tax returns in jurisdictions with differing statutes of limitations. The 2021 through 2024 tax years remain subject to selection for examination as of December&#160;28, 2024. None of the Company&#8217;s income tax returns are currently under audit.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-39</span></div></div></div><div id="i213e3c881f5e4982994be533c682ff6b_190"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 20: <ix:nonNumeric contextRef="c-1" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="f-1276" continuedAt="f-1276-1" escape="true">Related parties</ix:nonNumeric></span></div><ix:continuation id="f-1276-1" continuedAt="f-1276-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Shared Services</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tony Isaac, the Company&#8217;s President, is the father of Jon Isaac, President and Chief Executive Officer of Live Ventures and managing member of ICG. Tony Isaac and Richard Butler, Board of Directors members of the Company, are members of the Board of Directors of Live Ventures. The Company also shares certain executive, accounting and legal services with Live Ventures. The total services shared were approximately $<ix:nonFraction unitRef="usd" contextRef="c-367" decimals="-3" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" format="ixt:num-dot-decimal" scale="0" id="f-1277">144,000</ix:nonFraction> and approximately $<ix:nonFraction unitRef="usd" contextRef="c-368" decimals="-3" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" format="ixt:num-dot-decimal" scale="0" id="f-1278">203,000</ix:nonFraction> for fiscal years ending December&#160;28, 2024 and December&#160;30, 2023, respectively. Customer Connexx rented approximately <ix:nonFraction unitRef="sqft" contextRef="c-369" decimals="0" name="us-gaap:NetRentableArea" format="ixt:num-dot-decimal" scale="0" id="f-1279">9,900</ix:nonFraction> square feet of office space from Live Ventures in Las Vegas, Nevada. Effective August 2023, due to the winding down of operations of the Recycling Subsidiaries, the Company ceased leasing office space in the Las Vegas, Nevada facility. The total rent and common area expenses for Connexx at the Las Vegas, Nevada office were approximately $<ix:nonFraction unitRef="usd" contextRef="c-367" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="0" id="f-1280">17,000</ix:nonFraction> and approximately $<ix:nonFraction unitRef="usd" contextRef="c-368" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="0" id="f-1281">103,000</ix:nonFraction> for fiscal years ending December&#160;28, 2024 and December&#160;30, 2023, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During Q4 2023, operations of the Recycling Subsidiaries were wound down and, ultimately, ceased. See Note 4. Consequently, outstanding liabilities for shared rent and services for the Recycling Subsidiaries reverted to the Company. As such, the Company has recorded a liability in the amount of approximately $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AccruedRentCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="0" id="f-1282">258,000</ix:nonFraction>, which was offset against the gain on sale of the Recycling Subsidiaries.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Notes with Live Ventures and ICG</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;7, 2024, the Company entered into a promissory notes with each of Live Ventures and ICG. The initial principal amount of each note is $<ix:nonFraction unitRef="usd" contextRef="c-370" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="0" id="f-1283">300,000</ix:nonFraction>, with an interest rate of <ix:nonFraction unitRef="number" contextRef="c-370" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1284">10</ix:nonFraction>% per annum. Pursuant to an amendment to each note, $<ix:nonFraction unitRef="usd" contextRef="c-371" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPayment" format="ixt:num-dot-decimal" scale="0" id="f-1285">100,000</ix:nonFraction> of principal, and accrued interest thereon, is due on September&#160;7, 2024 for each note, and the balance of each note is due on December&#160;31, 2024. At the Company&#8217;s option, the obligation under each note is convertible after the six-month anniversary thereof at a per-share conversion price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-370" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="f-1286">0.61</ix:nonFraction>, subject to standard adjustments for (i) stock dividends and splits, (ii) subsequent rights offerings, and (iii) pro rata distributions. The Company&#8217;s board of directors approved the issuance of the two notes on February&#160;7, 2024. As of December&#160;28, 2024, the principal balances outstanding on each of the promissory notes was $<ix:nonFraction unitRef="usd" contextRef="c-372" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="0" id="f-1287">327,000</ix:nonFraction>.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Isaac Consulting Agreement</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;4, 2024, the Company entered into a <ix:nonNumeric contextRef="c-264" name="alts:RelatedPartyTransactionConsultingAgreementTerm" format="ixt-sec:durwordsen" id="f-1288">two-year</ix:nonNumeric> Consulting Agreement with Jon Isaac, pursuant to which he will provide to the Company (the &#8220;Services&#8221;): (i) strategic financial advice, including growth strategies, capital allocation, and financial restructuring; (ii) sales and business development advice, including for the acquisition of new clients and new products through networking, referrals, and marketing efforts for our prospective products; (iii) in-depth research and market intelligence on specific industries, sectors, and market trends; (iv) financial models and financial analysis to support strategic decision-making; (v) assistance, through site visits, in the preparation of new client offers and bids for proposed projects; (vi) weekly update calls with management to align on progress of objectives and goals; (vii) enhanced non-confidential materials; (viii) business risk management support; and (ix) other services to which the Company and he may agree that will be memorialized in writing if, when, and as needed during the <ix:nonNumeric contextRef="c-264" name="alts:RelatedPartyTransactionConsultingAgreementTerm" format="ixt-sec:durwordsen" id="f-1289">two-year</ix:nonNumeric> term.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As compensation for the Services, the Company (i) assigned to him <ix:nonFraction unitRef="insurance_policy" contextRef="c-267" decimals="INF" name="alts:RelatedPartyTransactionConsultingAgreementNumberOfLifeInsurancePoliciesAssigned" format="ixt-sec:numwordsen" scale="0" id="f-1290">two</ix:nonFraction> universal life insurance policies that relate to the life of one of the founders of our now-disposed legacy recycling business (as of March 4, 2024, the first policy had an accumulated value/surrender value of approximately $<ix:nonFraction unitRef="usd" contextRef="c-373" decimals="0" name="us-gaap:CashSurrenderValueOfLifeInsurance" format="ixt:num-dot-decimal" scale="0" id="f-1291">3,854</ix:nonFraction> and the second had an accumulated value/surrender value of approximately $<ix:nonFraction unitRef="usd" contextRef="c-374" decimals="0" name="us-gaap:CashSurrenderValueOfLifeInsurance" scale="0" id="f-1292">468</ix:nonFraction>); (ii) agreed to tender to him funds in our Canadian counsel&#8217;s trust account in the event that the prospective Order of the Court of Appeal for Ontario Canada in the matter styled, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amtim Capital Inc. and Appliance Recycling Centers of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case No. COA-23-CV-0156, became the final Order of the Court, which amount we received during the reporting period and tendered to Mr. Isaac $<ix:nonFraction unitRef="usd" contextRef="c-318" decimals="-3" name="alts:RelatedPartyTransactionConsultingAgreementContingentlyTenderedFunds" format="ixt:num-dot-decimal" scale="0" id="f-1293">220,000</ix:nonFraction>; (iii) issued to him <ix:nonFraction unitRef="shares" contextRef="c-318" decimals="0" name="alts:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares" format="ixt:num-dot-decimal" scale="0" id="f-1294">200,000</ix:nonFraction> restricted shares of our common stock with the per-share value being the average of the Nasdaq Historical NOCP closing price during the <ix:nonFraction unitRef="trading_day" contextRef="c-267" decimals="INF" name="alts:NumberOfTradingDaysBeforeBoardApproval" format="ixt-sec:numwordsen" scale="0" id="f-1295">five</ix:nonFraction> trading days prior to our board approving the Consulting Agreement, which shares were awarded from our 2023 Equity Incentive Plan; and (iv) issued to him a <ix:nonNumeric contextRef="c-264" name="alts:RelatedPartyTransactionConsultingAgreementTerm" format="ixt-sec:durwordsen" id="f-1296">two-year</ix:nonNumeric>, straight <ix:nonFraction unitRef="number" contextRef="c-266" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1297"><ix:nonFraction unitRef="number" contextRef="c-375" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1298"><ix:nonFraction unitRef="number" contextRef="c-376" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1299">10.0</ix:nonFraction></ix:nonFraction></ix:nonFraction>% convertible promissory note in the initial principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="0" id="f-1300">500,000</ix:nonFraction>, with an interest rate of <ix:nonFraction unitRef="number" contextRef="c-266" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1301"><ix:nonFraction unitRef="number" contextRef="c-375" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1302"><ix:nonFraction unitRef="number" contextRef="c-376" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1303">10.0</ix:nonFraction></ix:nonFraction></ix:nonFraction>% and a per-share conversion price equivalent to the per-share value of the restricted common stock that he was granted ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-267" decimals="2" name="alts:RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice" scale="0" id="f-1304">1.16</ix:nonFraction>). The maturity date of the promissory note is March&#160;4, 2026. The value of the restricted shares was $<ix:nonFraction unitRef="shares" contextRef="c-377" decimals="-3" name="alts:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares" format="ixt:num-dot-decimal" scale="0" id="f-1305">232,000</ix:nonFraction> on the date issued. As of December&#160;28, 2024, there was <ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt-sec:numwordsen" id="f-1306">no</ix:nonFraction> principal balance outstanding on the promissory note.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1276-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Short-Term Advances</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;18, 2024, ICG made a short-term demand advance to the Company in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-256" decimals="-3" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:num-dot-decimal" scale="0" id="f-1307">100,000</ix:nonFraction>. The advance bears interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-257" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1308"><ix:nonFraction unitRef="number" contextRef="c-258" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1309"><ix:nonFraction unitRef="number" contextRef="c-259" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1310">10</ix:nonFraction></ix:nonFraction></ix:nonFraction>% per annum until repaid. As of December&#160;28, 2024, the principal amount outstanding was $<ix:nonFraction unitRef="usd" contextRef="c-257" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="0" id="f-1311">48,000</ix:nonFraction>.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;28, 2024 and June&#160;3, 2024, Novalk made short-term demand advances in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:num-dot-decimal" scale="0" id="f-1312">120,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:num-dot-decimal" scale="0" id="f-1313">100,000</ix:nonFraction>, respectively, to the Company. Juan Yunis, an employee of Live Ventures, is the managing member of Novalk. The advances bears interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-272" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1314"><ix:nonFraction unitRef="number" contextRef="c-273" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1315"><ix:nonFraction unitRef="number" contextRef="c-274" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1316"><ix:nonFraction unitRef="number" contextRef="c-275" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1317">10</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>% per annum until repaid. As of December&#160;28, 2024, the principal amount outstanding was $<ix:nonFraction unitRef="usd" contextRef="c-274" decimals="-3" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="0" id="f-1318">110,000</ix:nonFraction>.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During June&#160;3, 2024, Tony Isaac made a number of short-term demand advances in the aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="c-276" decimals="-3" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:num-dot-decimal" scale="0" id="f-1319">62,000</ix:nonFraction> to the Company. The advances bears interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-277" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1320"><ix:nonFraction unitRef="number" contextRef="c-278" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1321"><ix:nonFraction unitRef="number" contextRef="c-279" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1322">10</ix:nonFraction></ix:nonFraction></ix:nonFraction>% per annum until repaid. As of December&#160;28, 2024, the Company had repaid the advance in full (see Note 20).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Sale of Recycling Subsidiaries</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 9, 2023, the Company entered into a Stock Purchase Agreement (the &#8220;Recycling Purchase Agreement&#8221;) with VM7 Corporation, a Delaware corporation (&#8220;VM7&#8221;), under which it agreed to acquire all of the outstanding equity interests of the Recycling Subsidiaries consisting of: (a) ARCA Recycling, Inc., (b) ARCA Canada, and (c) Connexx. The principal of VM7 is Virland A. Johnson, our Chief Financial Officer. The sale of all of the outstanding equity interests of the Recycling Subsidiaries to VM7 under the Recycling Purchase Agreement was consummated simultaneously with the execution of the Recycling Agreement. The Company's Board of Directors unanimously approved the Recycling Purchase Agreement and the Disposition Transaction. The Recycling Purchase Agreement is retroactively effective as of March 1, 2023. During the fourth quarter of fiscal 2023, VM7 determined that, after expending significant amounts of time and resources, it was unable to obtain sufficient equity or debt financing to continue the operations of the Recycling Subsidiaries. Accordingly, the Company was advised that the operations of the Recycling Subsidiaries were wound down and, ultimately, ceased. Because the Company did not receive all of the economic benefits of the Disposition Transaction and understands that it will not receive any future benefits of the Disposition Transaction, the Company determined to fully impair the $<ix:nonFraction unitRef="usd" contextRef="c-378" decimals="-5" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="f-1323">5.3</ix:nonFraction>&#160;million carrying value of the Disposition Transaction on its balance sheet. The Company also determined not to exercise any of its remedies under the Recycling Purchase Agreement so that the Company could maintain its focus on its clinical-stage biopharmaceutical activities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ICG Note</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August&#160;28, 2019, ARCA Recycling entered into and delivered to ICG a secured revolving line of credit promissory note, whereby ICG agreed to provide ARCA Recycling with a $<ix:nonFraction unitRef="usd" contextRef="c-379" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="f-1324">2.5</ix:nonFraction> million revolving credit facility (the &#8220;ICG Note&#8221;). Jon Isaac is the manager and sole member of ICG, and the son of Tony Isaac, the President of ALT5 Sigma Corporation and, previously, ARCA Recycling. ICG is a record and beneficial owner of <ix:nonFraction unitRef="number" contextRef="c-380" decimals="3" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-1325">13.6</ix:nonFraction>% of the outstanding common stock of the Company. The ICG Note was originally a component of the sale of the Recycling Subsidiaries in March 2023; however, because of the winding down of operations of the Recycling Subsidiaries during Q4 2023, and because the ICG Note was guaranteed by the Company, it recorded a liability in the amount of approximately $<ix:nonFraction unitRef="usd" contextRef="c-381" decimals="-3" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" format="ixt:num-dot-decimal" scale="0" id="f-1326">690,000</ix:nonFraction> for the principal balance due on the note, which was offset against the gain on sale of the Recycling Subsidiaries (see Note 4). Additionally, effective February 2024, the ICG Note was amended to reflect the Company as co-maker on the ICG Note (see Note 20). The ICG Note matures in March 2026, and bears interest at <ix:nonFraction unitRef="number" contextRef="c-382" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1327">8.75</ix:nonFraction>% per annum. Monthly payments on the note are approximately $<ix:nonFraction unitRef="usd" contextRef="c-383" decimals="0" name="us-gaap:DebtInstrumentPeriodicPayment" format="ixt:num-dot-decimal" scale="0" id="f-1328">24,767</ix:nonFraction>. As of December&#160;28, 2024 and December&#160;30, 2023, the balance outstanding was $<ix:nonFraction unitRef="usd" contextRef="c-384" decimals="-3" name="us-gaap:OtherLiabilities" scale="0" id="f-1329">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-381" decimals="-3" name="us-gaap:OtherLiabilities" format="ixt:num-dot-decimal" scale="0" id="f-1330">706,000</ix:nonFraction>, respectively.</span></div></ix:continuation><div id="i213e3c881f5e4982994be533c682ff6b_196"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 21: <ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-1331" continuedAt="f-1331-1" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="f-1331-1" continuedAt="f-1331-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">SEC Complaint</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 2, 2021, the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) filed a civil complaint (the &#8220;SEC Complaint&#8221;) in the United States District Court for the District of Nevada naming the Company and <ix:nonFraction unitRef="officer" contextRef="c-385" decimals="INF" name="alts:LossContingencyNumberOfExecutiveOfficersNamedInComplaint" format="ixt-sec:numwordsen" scale="0" id="f-1332">one</ix:nonFraction> of its executive officers, Virland Johnson, the Company's Chief Financial Officer, as defendants (collectively, the &#8220;Defendants&#8221;). Pursuant to an agreed-upon Order of the Court, on May 28, 2024, the Company settled its litigation with the SEC. The Settlement Agreement provided, in pertinent part: &#8220;Without admitting or denying the allegations of the complaint (except as provided herein in paragraph 12 and except as to personal and subject matter jurisdiction, which [the Company] admits), [the Company] hereby consents to the entry of the final Judgment in the form attached hereto (the &#8220;Final Judgment&#8221;) and </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1331-2" continuedAt="f-1331-3"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">incorporated by reference herein, which, among other things: &#8220;(a) permanently restrains and enjoins [the Company] from violation of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder [15 U.S.C. &#167; 78j(b) and 17 C.F.R. &#167;&#167; 240.10b-5]; and (c)[sic] orders [the Company] to pay a civil penalty in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-386" decimals="INF" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="0" id="f-1333">250,000</ix:nonFraction> under Section 21(d)(3) of the Exchange Act [15 U.S.C. &#167; 78u(d)(3)).&#8221; The SEC has agreed to accept <ix:nonFraction unitRef="payment" contextRef="c-387" decimals="INF" name="alts:LitigationSettlementAmountAwardedToOtherPartyNumberOfPeriodicPayments" format="ixt-sec:numwordsen" scale="0" id="f-1334">four</ix:nonFraction> quarterly payments from the Company, each in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-386" decimals="INF" name="alts:LitigationSettlementAmountAwardedToOtherPartyPeriodicPayments" format="ixt:num-dot-decimal" scale="0" id="f-1335">62,500</ix:nonFraction>. The Settlement Agreement is attached to the Order as Exhibit 1, both of which documents may be viewed at https://ecf.nvd.uscourts.gov/doc1/115110470966.</span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SEC Complaint's remaining allegations relate to financial, disclosure and reporting violations against the executive officer under Section 10(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Rule 10b-5. The SEC Complaint also alleges various claims against the executive officer under Sections 13(a), 13(b)(2)(A), 13(b)(2)(B) and 13(b)(5) of the Exchange Act and Rules 12b-20, 13a-1, 13a-13, 13a-14, 13b2-1, and 13b2-2. The SEC continues to seek a permanent injunction, civil penalties, and an officer-and-director bar against the executive officer. The foregoing is only a general summary of the SEC Complaint, which may be accessed on the SEC&#8217;s website at https://www.sec.gov/litigation/litreleases/2021/lr25155.htm.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Skybridge</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 29, 2016, the Company served a Minnesota state court complaint for breach of contract on Skybridge Americas, Inc. (&#8220;SA&#8221;), the Company&#8217;s primary call center vendor throughout 2015 and most of 2016. On April 10 2024, subsequent to the conclusion of litigation at the trial court and appellate court levels, SA sold its judgment to an otherwise unaffiliated third party for the face value of the judgment and the interest accrued thereon through that date (an aggregate of $<ix:nonFraction unitRef="usd" contextRef="c-206" decimals="0" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:num-dot-decimal" scale="0" id="f-1336">433,920</ix:nonFraction>), plus accrued legal fees (in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-207" decimals="0" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:num-dot-decimal" scale="0" id="f-1337">18,124</ix:nonFraction>) to which SA was entitled in accordance with the terms of the underlying agreement with the Company and with the judgment. The purchaser agreed to forbear from enforcing the judgment, subject to the Company&#8217;s repayment or his conversion thereof. In connection with the third-party&#8217;s forbearance, the Company issued its promissory note to such person in the initial principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-208" decimals="0" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="0" id="f-1338">147,956</ix:nonFraction>, which bears interest at the rate of <ix:nonFraction unitRef="number" contextRef="c-208" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1339">10</ix:nonFraction>% per annum, and, as with the underlying judgment, is convertible into shares of the Company&#8217;s common stock at a fixed per-share conversion price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-208" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="f-1340">2.60</ix:nonFraction>. On December&#160;23, 2024, pursuant to the terms of the agreement, the unaffiliated third party converted the obligation, plus accrued interest under the agreements, in the amount of approximately $<ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-3" name="us-gaap:DebtConversionOriginalDebtAmount1" format="ixt:num-dot-decimal" scale="0" id="f-1341">691,000</ix:nonFraction>, into <ix:nonFraction unitRef="shares" contextRef="c-209" decimals="0" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" format="ixt:num-dot-decimal" scale="0" id="f-1342">265,842</ix:nonFraction> shares of the Company&#8217;s common stock (see Note 18). As of December&#160;28, 2024, there was no balance outstanding.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">GeoTraq</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or about April&#160;9, 2021, GeoTraq, Gregg Sullivan, Tony Isaac, and the Company, among others, resolved all of the claims that related to, among other items, the Company's acquisition of GeoTraq in August 2017, all post-acquisition activities, and Mr. Sullivan&#8217;s post-acquisition employment relationship with GeoTraq (all of such claims, the &#8220;GeoTraq Matters&#8221;). The resolution was effectuated through the parties&#8217; execution and delivery of a Settlement Agreement and Mutual Agreement of Claims (the &#8220;GeoTraq Settlement Agreement&#8221;). </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The parties to the Settlement Agreement released and forever discharged one another from any and all known and unknown claims that were asserted or could have been asserted arising out of the GeoTraq Litigation Matters. The accrued liability for payments due to Mr. Sullivan is $<ix:nonFraction unitRef="usd" contextRef="c-388" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" scale="0" id="f-1343">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-389" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="0" id="f-1344">510,000</ix:nonFraction> as of December&#160;28, 2024 and December&#160;30, 2023, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Alixpartners, LLC</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;19, 2022, Alixpartners, LLC filed a complaint in the Supreme Court of the State of New York, County of New York, styled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Alixpartners, LLC, plaintiff/petitioner, against JanOne Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Index No. 653877/2022. Plaintiff alleged the breach of an agreement and sought damages in the amount of approximately $<ix:nonFraction unitRef="usd" contextRef="c-390" decimals="-3" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="0" id="f-1345">345,000</ix:nonFraction>. The Company denied that obligation. After extensive negotiations, the parties reached a settlement, pursuant to which the Company agreed to pay to Alixpartners the sum of $<ix:nonFraction unitRef="usd" contextRef="c-391" decimals="-3" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="0" id="f-1346">125,000</ix:nonFraction> in <ix:nonFraction unitRef="tranche" contextRef="c-392" decimals="INF" name="alts:NumberOfTranches" format="ixt-sec:numwordsen" scale="0" id="f-1347">two</ix:nonFraction> tranches and to provide a confession of judgment in its favor in the amount of approximately $<ix:nonFraction unitRef="usd" contextRef="c-391" decimals="-3" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:num-dot-decimal" scale="0" id="f-1348">450,000</ix:nonFraction>, which represented the amount sought in the complaint plus interest thereon. The confession of judgment will be null and void and the complaint will be dismissed with prejudice upon the Company tendering both tranches timely. The Company tendered both settlement payments in May 2023, and the complaint was subsequently dismissed.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sieggreen</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In a matter pending in the United States District Court for the District Of Nevada, Case No. 2:21-cv-01517-CDS-EJY, styled as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sieggreen, Individually and On Behalf of All Others Similarly Situated, Plaintiff, v. Live Ventures Incorporated, </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1331-3"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jon Isaac, and Virland A. Johnson, Defendants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company was added as a defendant on March 6, 2023, and was served on March 23, 2023. Plaintiff has alleged causes of action against the Company for (i) violation of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder and (ii) violation of Section 10(b) of the Securities Exchange Act of 1934 and Rules 10b-5(a) and 10b-5(c) promulgated thereunder. In June 2023 the Company filed a Motion to Dismiss, regarding which, as of the date of these financial statements, the Court has not ruled. The Company strongly disputes and denies all of the allegations contained therein and will continue to defend itself vigorously against the claims.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Main/270</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a defendant in an action filed on April 11, 2022, in the U.S. District Court Southern District of Ohio, Eastern Division, styled, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trustees Main/270, LLC, Plaintiff, vs ApplianceSmart, Inc. and JANONE, Inc., Defendant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case no.: 2:22-cv-01938-ALM-EPD. The Company was a guarantor of the lease between the Plaintiff and ApplianceSmart, Inc. Plaintiff alleged a cause of action against the Company in respect of the guaranty and seeks approximately $<ix:nonFraction unitRef="usd" contextRef="c-393" decimals="-3" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="0" id="f-1349">90,000</ix:nonFraction> therefor. Plaintiff also seeks approximately $<ix:nonFraction unitRef="usd" contextRef="c-394" decimals="-3" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="0" id="f-1350">1,420,000</ix:nonFraction> against ApplianceSmart and the Company on a joint and several basis. The Company does not believe that it is obligated to Plaintiff in that amount and the parties continue to negotiate a potential settlement.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Westerville Square</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In an attempt to recover payments due under a lease, in 2022, Westerville Square, Inc., as the landlord, initiated a civil action against the Company, styled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Westerville Square, Inc. v. Appliance Recycling Centers Of America, Inc., et al., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the Court of Common Pleas of Franklin County, Ohio, Case No. 19 CV 8627. The case was stayed during the bankruptcy proceedings of ApplianceSmart, Inc., and was reinstated on June 7, 2021. The landlord is currently seeking $<ix:nonFraction unitRef="usd" contextRef="c-395" decimals="-3" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="0" id="f-1351">120,000</ix:nonFraction>, which amount is disputed by the Company. Effective June 4, 2023, the parties settled the matter, pursuant to which settlement the Company tendered the sum of $<ix:nonFraction unitRef="usd" contextRef="c-396" decimals="-3" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="0" id="f-1352">110,000</ix:nonFraction> to the landlord, the parties entered into a Settlement Agreement and Release, and the case was dismissed with prejudice.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Commitments</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2017, the Company disposed of its retail appliance segment and sold ApplianceSmart to Live Ventures, a related party. In connection with that sale, as of January&#160;1, 2022, the Company accrued an aggregate amount of future real property lease payments of approximately $<ix:nonFraction unitRef="usd" contextRef="c-397" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="0" id="f-1353">767,000</ix:nonFraction> which represented amounts guaranteed or which may have been owed under certain lease agreements to <ix:nonFraction unitRef="landlord" contextRef="c-398" decimals="INF" name="alts:OtherCommitmentsNumberOfLandlordsOriginallyPurportedToBeLiableFor" format="ixt-sec:numwordsen" scale="0" id="f-1354">three</ix:nonFraction> third party landlords in which the Company either remained the counterparty, was a guarantor, or had agreed to remain contractually liable under the lease (&#8220;ApplianceSmart Leases&#8221;). A final decree was issued by the court on February 28, 2022, upon the full satisfaction of the Plan, at which time ApplianceSmart emerged from Chapter 11. During the year ended December&#160;28, 2024, the Company reversed approximately $<ix:nonFraction unitRef="usd" contextRef="c-399" decimals="-3" name="alts:OperatingLeasesFutureMinimumPaymentsDue1" format="ixt:num-dot-decimal" scale="0" id="f-1355">637,000</ix:nonFraction> of the accrual, as the Company is no longer liable for <ix:nonFraction unitRef="guarantee" contextRef="c-400" decimals="INF" name="alts:OtherCommitmentsNumberOfLandlordsCompanyIsNoLongerLiableFor" format="ixt-sec:numwordsen" scale="0" id="f-1356">two</ix:nonFraction> of these guarantees upon ApplianceSmart's emergence from bankruptcy. As of December&#160;28, 2024, a balance of approximately $<ix:nonFraction unitRef="usd" contextRef="c-399" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="0" id="f-1357">130,000</ix:nonFraction> remains as an accrued liability due to an ongoing dispute concerning one of the leases. The Company and Live Ventures have agreed to divide in half between them any ultimate balance owing thereunder and any attorneys&#8217; fees expended in relation thereto.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is party from time to time to other ordinary course disputes that we do not believe to be material to our financial condition as of December&#160;28, 2024.</span></div></ix:continuation><div id="i213e3c881f5e4982994be533c682ff6b_199"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 22: <ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-1358" continuedAt="f-1358-1" escape="true">Earnings (Loss) per share</ix:nonNumeric></span></div><ix:continuation id="f-1358-1" continuedAt="f-1358-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per share is calculated using the weighted average number of shares of common stock outstanding during the applicable period. Basic weighted average common shares outstanding do not include shares of restricted stock that have not yet vested, although such shares are included as outstanding shares in the Company&#8217;s Consolidated Balance Sheet. Diluted net earnings per share is computed using the weighted average number of common shares outstanding, and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the additional common shares issuable with respect to restricted share awards, stock options and convertible preferred stock.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-1359" escape="true"><ix:continuation id="f-1358-2" continuedAt="f-1358-3"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the computation of basic and diluted net loss per share (in $000&#8217;s, except per share data):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the Years Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">Continuing Operations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Basic and diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net (loss) income from continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-1360"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="f-1361">6,245</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="f-1362"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-1363">17,095</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1364">11,148,493</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-22" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1365">4,005,334</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic and diluted (loss) income per share from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="f-1366"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="f-1367">0.56</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-22" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="f-1368"><ix:nonFraction unitRef="usdPerShare" contextRef="c-22" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="f-1369">4.27</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">Discontinued Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income from discontinued operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic" format="ixt:fixed-zero" scale="3" id="f-1370">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-1371">9,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1372">11,148,493</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-22" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1373">4,005,334</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic income per share from discontinued operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" format="ixt:fixed-zero" scale="0" id="f-1374">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-22" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" scale="0" id="f-1375">2.32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income from discontinued operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted" format="ixt:fixed-zero" scale="3" id="f-1376">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="f-1377">9,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1378">11,148,493</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-22" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1379">4,444,361</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Diluted income per share from discontinued operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" format="ixt:fixed-zero" scale="0" id="f-1380">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-22" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="f-1381">2.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Basic and diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net (loss) income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="f-1382"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-1383">6,245</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="f-1384"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-1385">7,812</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1386"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1387">11,148,493</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-22" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1388">4,005,334</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic and diluted (loss) income per share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1389"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1390">0.56</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-22" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1391"><ix:nonFraction unitRef="usdPerShare" contextRef="c-22" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1392">1.95</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-1358-3">Potentially dilutive securities totaling approximately <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="f-1393">9.0</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="shares" contextRef="c-22" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="f-1394">3.9</ix:nonFraction>&#160;million shares, respectively, were excluded from the calculation of diluted net earnings (loss) per share for the years ended December&#160;28, 2024 and December&#160;30, 2023 because the effects were anti-dilutive based on the application of the treasury stock method.</ix:continuation> </span></div><div id="i213e3c881f5e4982994be533c682ff6b_202"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 23: <ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-1395" continuedAt="f-1395-1" escape="true">Segment information</ix:nonNumeric></span></div><ix:continuation id="f-1395-1" continuedAt="f-1395-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates within targeted markets through <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-1396">three</ix:nonFraction> reportable segments for continuing operations: Fintech, Biotech, and Corporate and Other. Due the sale of Company&#8217;s Recycling segment during March 2023, it is being presented as discontinued operations for the years ended December&#160;28, 2024 and December&#160;30, 2023.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-1397" continuedAt="f-1397-1" escape="true"><ix:continuation id="f-1395-2" continuedAt="f-1395-3"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present our segment information (in $000&#8217;s): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the Years Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fintech</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-401" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1398">12,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-402" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1399">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biotech</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-403" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1400">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1401">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-405" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1402">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-406" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1403">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-407" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1404">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-408" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1405">3,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-409" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1406">12,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-410" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1407">3,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fintech</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-401" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="f-1408">6,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-402" decimals="-3" name="us-gaap:GrossProfit" format="ixt:fixed-zero" scale="3" id="f-1409">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biotech</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-403" decimals="-3" name="us-gaap:GrossProfit" format="ixt:fixed-zero" scale="3" id="f-1410">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-3" name="us-gaap:GrossProfit" format="ixt:fixed-zero" scale="3" id="f-1411">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-405" decimals="-3" name="us-gaap:GrossProfit" format="ixt:fixed-zero" scale="3" id="f-1412">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-406" decimals="-3" name="us-gaap:GrossProfit" format="ixt:fixed-zero" scale="3" id="f-1413">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-407" decimals="-3" name="us-gaap:GrossProfit" format="ixt:fixed-zero" scale="3" id="f-1414">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-408" decimals="-3" sign="-" name="us-gaap:GrossProfit" scale="3" id="f-1415">197</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Gross profit</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-409" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="f-1416">6,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-410" decimals="-3" sign="-" name="us-gaap:GrossProfit" scale="3" id="f-1417">197</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating loss</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fintech</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-401" decimals="-3" name="us-gaap:OperatingIncomeLoss" scale="3" id="f-1418">905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-402" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:fixed-zero" scale="3" id="f-1419">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biotech</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-403" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1420">2,148</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1421">1,531</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-405" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1422">6,319</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-406" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1423">18,315</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-407" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:fixed-zero" scale="3" id="f-1424">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-408" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1425">10,438</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Operating loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-409" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1426">7,562</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,562)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-410" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1427">9,408</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fintech</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-401" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1428">1,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-402" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:fixed-zero" scale="3" id="f-1429">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biotech</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-403" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1430">2,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1431">1,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-405" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:fixed-zero" scale="3" id="f-1432">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-406" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:fixed-zero" scale="3" id="f-1433">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-407" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:fixed-zero" scale="3" id="f-1434">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-408" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="f-1435">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-409" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1436">3,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-410" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1437">1,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest (expense) income, net</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fintech</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-401" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="f-1438">499</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-402" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:fixed-zero" scale="3" id="f-1439">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biotech</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-403" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:fixed-zero" scale="3" id="f-1440">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:fixed-zero" scale="3" id="f-1441">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-405" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="f-1442">380</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-406" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="f-1443">2,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-407" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:fixed-zero" scale="3" id="f-1444">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-408" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="f-1445">181</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Interest (expense) income, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-409" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="f-1446">879</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-410" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="f-1447">2,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net loss after provision for income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fintech</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-401" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="f-1448">469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-402" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="f-1449">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biotech</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-403" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1450">2,086</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1451">1,532</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-405" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1452">4,628</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-406" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1453">15,563</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-407" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="f-1454">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-408" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1455">9,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total net loss after provision for income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-409" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1456">6,245</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-410" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1457">7,812</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1397-1"><ix:continuation id="f-1395-3"><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of <br/>December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of <br/>December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fintech</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-411" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1458">64,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-412" decimals="-3" name="us-gaap:Assets" format="ixt:fixed-zero" scale="3" id="f-1459">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biotech</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-413" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1460">16,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-414" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1461">17,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-415" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1462">1,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-416" decimals="-3" name="us-gaap:Assets" scale="3" id="f-1463">641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discontinue operations</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-417" decimals="-3" name="us-gaap:Assets" format="ixt:fixed-zero" scale="3" id="f-1464">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-418" decimals="-3" name="us-gaap:Assets" format="ixt:fixed-zero" scale="3" id="f-1465">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-419" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1466">82,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-420" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1467">18,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill and other intangible Assets</span></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fintech</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-411" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1468">30,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-412" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:fixed-zero" scale="3" id="f-1469">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biotech</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-413" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1470">15,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-414" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1471">17,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-415" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="3" id="f-1472">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-416" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:fixed-zero" scale="3" id="f-1473">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discontinued operations</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-417" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:fixed-zero" scale="3" id="f-1474">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-418" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:fixed-zero" scale="3" id="f-1475">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total goodwill and other intangible Assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-419" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1476">46,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-420" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1477">17,846</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div id="i213e3c881f5e4982994be533c682ff6b_205"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 24: <ix:nonNumeric contextRef="c-1" name="us-gaap:SubsequentEventsTextBlock" id="f-1478" continuedAt="f-1478-1" escape="true">Subsequent events</ix:nonNumeric></span></div><ix:continuation id="f-1478-1"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated subsequent events through the filing of this Form 10-K, and determined that there have been no events that have occurred that would require adjustments to disclosures in its consolidated financial statements other than as discussed below:</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-46</span></div></div></div><div id="i213e3c881f5e4982994be533c682ff6b_208"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosures</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i213e3c881f5e4982994be533c682ff6b_211"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9A. Controls and Procedures</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Evaluation of Disclosure control and Procedures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We carried out an evaluation, under the supervision, and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)). Based upon that evaluation, our principal executive officer and principal financial officer concluded that, as of December&#160;28, 2024, the period covered in this report, our disclosure controls and procedures were not effective to ensure that information required to be disclosed in reports filed under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the required time periods and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure due to material weaknesses in internal control over financial reporting further described below. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite the identified material weaknesses, management concluded that the consolidated financial statements included in this Annual Report on Form 10-K present fairly, in all material respects, the financial position, results of operations and cash flows for the periods disclosed in conformity with GAAP. Hudgens CPA, PLLC, the Company&#8217;s independent registered public accounting firm, has issued an unqualified opinion on our consolidated financial statements as of and for the year ended December&#160;28, 2024. They were not engaged to perform, and did not perform, an audit of internal control over financial reporting. This material weakness has no impact on our consolidated financial statements in prior years.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Management&#8217;s Report on Internal Control Over Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)). Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management, including the Company&#8217;s CEO and CFO, do not expect that the Company&#8217;s disclosure controls and procedures or the Company&#8217;s internal control over financial reporting will prevent or detect all errors and all fraud. A control system, regardless of how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system will be met. These inherent limitations include the following: judgements in decision-making can be faulty, and control and process breakdowns can occur because of simple errors or mistakes, controls can be circumvented by individuals, acting alone or in collusion with each other, or by management override. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management assessed the design and effectiveness of our internal control over financial reporting as of December&#160;28, 2024. In making this assessment, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO&#8221;) of 2013 regarding Internal Control &#8211; Integrated Framework. Based on our assessment using those criteria, our management concluded that our internal controls over financial reporting were ineffective as of September 30, 2021. Management noted the following deficiencies that management believes to be material weaknesses: </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company does not have sufficient written documentation of our internal control policies and procedures. Written documentation of key internal controls over financial reporting is a requirement of Section 404 of the Sarbanes-Oxley Act; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management does not have sufficient resources to maintain adequate segregation of duties and maintain its internal control environment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the above identified weaknesses in our internal control over financial reporting, we plan to improve the documentation of our internal control policies and procedures and develop an internal testing plan to document our evaluation of effectiveness of the internal controls. We expect to conclude these remediation initiatives during the fiscal year ended December 27, 2025. We continue to evaluate testing of our internal control policies and procedures, including </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">assessing internal and external resources that may be available to complete these tasks, but do not know when these tasks will be completed.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A material weakness (within the meaning of PCAOB Auditing Standard No. 5) is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. A significant deficiency is a deficiency, or a combination of deficiencies, in internal control over financial reporting that is less severe than a material weakness, yet important enough to merit attention by those responsible for oversight of the company&#8217;s financial reporting.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management&#8217;s report was not subject to attestation by our registered public accounting firm pursuant to temporary rules of the Securities and Exchange Commission that permit us to provide only management&#8217;s report in this annual report.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Changes in Internal Control Over Financial Reporting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> There were no changes in the Company&#8217;s internal control over financial reporting identified in management's evaluation pursuant to Rule 13a-15and 15d-15 of the Exchange Act that occurred during the fourth quarter of the fiscal year ended December&#160;28, 2024 that have materially affected, or are reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</span></div><div id="i213e3c881f5e4982994be533c682ff6b_214"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9B. Other Information</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-421" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-1479"><ix:nonNumeric contextRef="c-421" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1480"><ix:nonNumeric contextRef="c-421" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-1481"><ix:nonNumeric contextRef="c-421" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1482">None</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric>.</span></div><div id="i213e3c881f5e4982994be533c682ff6b_217"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="i213e3c881f5e4982994be533c682ff6b_220"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="i213e3c881f5e4982994be533c682ff6b_223"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The directors and executive officers of the Company and their ages as of December&#160;28, 2024, are as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:42.754%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:42.757%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Age</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Position</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Peter Tassiopoulos</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Director and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tony Isaac</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director and President</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Richard D. Butler, Jr.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ron Pitters</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nael Hajjar</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">John Bitar</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vay Tham</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Revenue Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Virland A. Johnson</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Peter Tassiopoulos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has been our Chief Executive Officer since August 2024. Mr. Tassiopoulos has over 30 years of leadership experience across healthcare, finance, and technology sectors. From April 4, 2022, until his appointment as our Chief Executive Officer, Mr. Tassiopoulos served as an independent mergers and acquisitions (M&amp;A) consultant, consulting for various companies. During that time, he restructured in excess of $150 million in debt and facilitated a $35 million asset purchase for a Canadian public company. Prior to that, from March 2013 through December 1, 2014, Peter served as the Chief Executive Officer of Sphere 3D Corp. (Nasdaq: ANY), and then, from December 1, 2014 until November 14, 2018, as its President, and, from November 14, 2018 to April 2022, as its Chief Executive Officer again. He also served as one of its directors from March 2014 through April 4, 2022. Mr. Tassiopoulos has successfully completed over $1 billion in M&amp;A, divestitures, and financing transactions throughout his career. He has led teams in executing complex transactions with a focus on mergers and acquisitions, capital market strategies, and strategic relationships. His industry experience spans cryptocurrency, technology, IT, healthcare, and gaming. We believe that Mr. Tassiopoulos brings a wealth of experience in finance, mergers and acquisitions and strategic planning to our Board.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tony Isaac</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has been one of our directors since May 2015, served as our President since May 2015, and served as our Chief Executive Officer from May 2016 until August 2024; he also became our Corporate Secretary in 2021. He served as our Interim Chief Executive Officer from February 2016 until May 2016. Mr. Isaac has served as Financial Planning and Strategist/Economist of Live Ventures Incorporated (&#8220;Live Ventures&#8221;) (Nasdaq: LIVE), a holding company for diversified businesses, since July 2012. He is the Chairman and Co-Founder of Isaac Organization, a privately held investment company. Mr. Isaac has invested in various companies, both private and public from 1980 to present. Mr. Isaac&#8217;s specialty is negotiation and problem-solving of complex real estate and business transactions. Mr. Isaac has served as a director of Live Ventures since December 2011. Mr. Isaac graduated from Ottawa University in 1981, where he majored in Commerce and Business Administration and Economics. We believe that Mr. Isaac brings to our Board significant investment and financial expertise and public board experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Richard D. Butler, Jr.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has been one of our directors since May 2015. Mr. Butler is the owner of an advisory firm that provides real estate, corporate, and financial advisory services since 1999, and is the co-Founder, Managing Director, and, since 2005, a major stockholder of Ref-Razzer Company, a whistle manufacturing and vending company. Prior to this, Mr. Butler was the Co-Founder and Executive Vice President of Aspen Healthcare, Inc. from 1996 to 1999. From 1993 to 1996, Mr. Butler was a Managing Director at Landmark Financial and from 1989 to 1993 he was a Partner at Cal Ventures Real Estate Investment Group. Prior to this, Mr. Butler also served as the President and Chief Executive Officer of Mt. Whitney Savings Bank, Chief Executive Officer of First Federal Mortgage Bank, Chief Executive Officer of Trafalgar Mortgage, and Executive Officer and Member of the President&#8217;s Advisory Committee at State Savings &amp; Loan Association (peak assets $14 billion) and American Savings &amp; Loan Association (NYSE: FCA; peak assets $34 billion). Mr. Butler has served on the Board of Directors of Live Ventures Incorporated (&#8220;Live Ventures&#8221;) (Nasdaq: LIVE) since August 2006. Mr. Butler attended Bowling Green University in Ohio, San Joaquin Delta College in California, and Southern Oregon State College. We believe that Mr. Butler brings to our Board extensive experience in financial management and executive roles, which enable him to provide important expertise in financial, operating, and strategic matters that impact our Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ron Pitters </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has been one of our directors since November 2024. Until January 2025, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ron held executive leadership positions with Axos Financial, Inc. for 11 years, including President and Chief Operating Officer of Axos Digital Assets, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LLC, Business Unit Leader and Chief Operating Officer of Axos Securities, LLC, and President and Chief Operating Officer of Axos Business Center, Inc. (Philippines). Prior to his service with Axos Bank, Mr. Pitters founded and was managing director of MindAlign, LLC. He also has served as the Head of Technology &amp; Transformation (Global Markets &amp; Risk) for OCBC Singapore; Group CIO at the Commercial Bank of Qatar; Business Unit CIO for ABN AMRO Global Markets in Chicago, London, Amsterdam; and Head of Trading (FX/Futures Arbitrage) for ABN AMRO Global Markets. He also currently is an independent director of Cozera, Inc. Ron is an accomplished C-level executive, with over 20 years of experience generating and delivering revenue opportunities, and working in business and corporate development, regulatory compliance, credit and risk management, strategy and architecture and delivery management and has held varying leadership roles, including technology, management consulting, business turnarounds, corporate transformations, and start-ups. His most recent accomplishments include successful start-ups in the captive offshore space, self-direct trading, and digital assets business. Mr. Pitters has completed business turnarounds of a securities clearing firm and a digital robo-advisory business. We believe that Mr. Pitters brings to our Board a broad range of experience that will prove invaluable as we continue to expand our fintech operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nael Hajjar</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has been one of our directors since August 2018. Mr. Hajjar is currently the Unit Head for the Annual Wholesale Trade Survey in Statistics Canada&#8217;s Manufacturing and Wholesale Trade Division. From March 2011 through May 2016, Mr. Hajjar was a Senior Analyst&#8201;&#8212;&#8201;Economist of Statistics Canada&#8217;s Producer Prices Division, where he developed Canada&#8217;s first ever Investment Banking Services Price Index while leading the development of a variety of Financial Services Price Index development projects. We believe that Mr. Hajjar brings to our Board extensive experience in research and analysis of financial statistics, economics, and business practices in a variety of industries, including manufacturing, logging, Wholesale Trade, and financial services. We believe that Mr. Hajjar also has extensive experience in project management, and he holds a Bachelor of Social Science, Honors in Economics (which he earned in 2006), and Bachelor of Commerce, Option in Finance (which he earned in 2008), both from the University of Ottawa.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">John Bitar </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has been one of our directors since January 2020. Since 2012, Mr. Bitar has been providing consulting services to companies and clients on business and legal strategies, management, operations, and cost controls. From 2007 to 2012, Mr. Bitar co-founded and was Managing Partner of a worker&#8217;s compensation law firm. Mr. Bitar has been an attorney admitted to the California State Bar since 1999. Mr. Bitar graduated from the University of Southern California in 1996 and earned his Juris Doctorate Degree in 1999 from University of the Pacific, McGeorge School of Law. We believe that Mr. Bitar brings to our Board significant business experience and brings operational expertise.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vay Tham </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was appointed our Chief Revenue Officer in June 2024. Prior to joining ALT5, from 2018 to 2024, Mr. Tham was Managing Director and Head of Technology Investment Banking for PI Financial Corporation, where he was responsible for investment banking and merger and acquisition execution. Prior to joining PI Financial Corporation, Mr. Tham provided strategic leadership for companies such as Forge First Asset Management, Cormark Securities, Waterfall Investments, and National Bank Financial. Mr. Tham has in excess of 20 years of experience in the areas of investment banking, raising capital, launching start ups, and executing mergers and acquisitions. We believe that Mr. Tham&#8217;s significant experience in raising capital and investment management will be invaluable as we develop and grow our fintech operations. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Virland A. Johnson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was appointed our Chief Financial Officer on August 21, 2017. Mr.&#160;Johnson had previously served us as a consultant beginning in February 2017. Mr. Johnson served as Chief Financial Officer for Live Ventures </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Nasdaq: LIVE) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">between January 3, 2017 and September 21, 2021. Prior to joining Live Ventures, Mr. Johnson was Sr. Director of Revenue for JDA Software from February 2010 to April 2016, where he was responsible for revenue recognition determination, sales and contract support while acting as a subject matter expert. Prior to joining JDA, Mr. Johnson provided leadership and strategic direction while serving in C-Level executive roles in public and privately held companies such as Cultural Experiences Abroad, Inc., Fender Musical Instruments Corp., Triumph Group, Inc., Unitech Industries, Inc. and Younger Brothers Group, Inc. Mr. Johnson&#8217;s more than 30 years of experience is primarily in the areas of process improvement, complex debt financings, SEC and financial reporting, turn-arounds, corporate restructuring, global finance, merger and acquisitions and returning companies to profitability and enhancing stockholder value. Mr. Johnson holds a Bachelor&#8217;s degree in Accountancy from Arizona State University which he earned in 1982, and holds a CPA license in "Retired" status in the State of Arizona.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Delinquent Section 16(a) Reports </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 16(a) of the Securities Exchange Act of 1934, as amended, requires the Company&#8217;s officers and directors, and persons who own more than 10% of a registered class of the Company&#8217;s equity securities, to file reports of ownership on Form 3 and changes in ownership on Form 4 or Form 5 with the SEC. Such officers, directors and 10% stockholders are also required by SEC rules to furnish the Company with copies of all Section 16(a) forms they file.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based solely on its review of copies of such forms received by it, or written representations from certain reporting persons, the Company believes that, during the fiscal year ended December&#160;28, 2024, all of its officers, directors and 10% stockholders complied with all Section 16(a) timely filing requirements.</span></div><ix:nonNumeric contextRef="c-1" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" format="ixt:fixed-true" id="f-1483"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Code of Ethics</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Audit Committee has adopted a code of ethics applicable to our directors and officers (including our Chief Executive Officer, President, and Chief Financial Officer) and other of our senior executives and employees in accordance with applicable rules and regulations of the SEC and Nasdaq. A copy of the code of ethics may be obtained upon request, without charge, by addressing a request to Corporate Secretary, ALT5 Sigma Corporation, 325 E. Warm Springs Road, Suite 102, Las Vegas, Nevada 89119. The code of ethics is also posted on our website at www.alt5sigma.com under &#8220;Investors&#8201;&#8212;&#8201;Governance&#8201;&#8212;&#8201;Governance Documents.&#8221;</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to satisfy the disclosure requirement under Item 5.05 of Form 8-K regarding the amendment to, or waiver from, a provision of the code of ethics by posting such information on our website at the address and location specified above and, to the extent required by the listing standards of the Nasdaq Capital Market, by filing a Current Report on Form 8-K with the SEC disclosing such information.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Audit Committee</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee (the &#8220;Audit Committee&#8221;) of our Board is comprised entirely of non-employee directors. In fiscal 2024, the members of our Audit Committee were Mr. Bitar, Mr. Butler (Chair), and Mr. Hajjar. Each of Messrs. Bitar, Butler, and Hajjar was an &#8220;independent&#8221; director as defined under Nasdaq rules. Our Audit Committee is responsible for selecting and approving our independent auditors, for relations with the independent auditors, for review of internal auditing functions (whether formal or informal) and internal controls, and for review of financial reporting policies to assure full disclosure of financial condition. Our Audit Committee operates under a written charter adopted by our Board, which is posted on our website at www.alt5sigma.com under the caption &#8220;Investors&#8201;&#8212;&#8201;Governance&#8201;&#8212;&#8201;Governance Documents.&#8221; The Board has determined that Mr. Butler is an &#8220;audit committee financial expert&#8221; as defined in SEC rules. Our Audit Committee operates under a written charter adopted by our Board, which is posted on our website at www.alt5sigma.com under the caption &#8220;Investors&#8201;&#8212;&#8201;Governance&#8201;&#8212;&#8201;Governance Documents.&#8221; </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation Committee</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee (the &#8220;Compensation Committee&#8221;) of our Board is comprised entirely of non-employee directors. In fiscal 2024, the members of our Compensation Committee were Mr. Hajjar and Mr. Butler (Chair), each of whom was also an &#8220;independent&#8221; director as defined under Nasdaq rules. Our Compensation Committee is responsible for review and approval of officer salaries and other compensation and benefits programs and determination of officer bonuses. Annual compensation for our executive officers, other than our Chief Executive Officer, is recommended by our Chief Executive Officer and approved by our Compensation Committee. The annual compensation for our Chief Executive Officer is recommended by our Compensation Committee and formally approved by our full Board. Our Compensation Committee may approve grants of equity awards under our stock compensation plans. Our Compensation Committee operates under a written charter adopted by our Board in March 2011, which is posted on our website at www.alt5sigma.com under the caption &#8220;Investors&#8201;&#8212;&#8201;Governance&#8201;&#8212;&#8201;Governance Documents.&#8221; </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the performance of its duties, our Compensation Committee may select independent compensation consultants to advise the committee when appropriate. No compensation consultant played a role in the executive officer and director compensation for fiscal 2024. In addition, our Compensation Committee may delegate authority to subcommittees where appropriate. Our Compensation Committee may separately meet with management if deemed necessary and appropriate.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Governance Committee</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Nominating and Corporate Governance Committee (our &#8220;Governance Committee&#8221;) is comprised entirely of non-employee directors. In fiscal 2024, the members of our Governance Committee were Mr. Butler and Mr. Bitar, each of whom was also an &#8220;independent&#8221; director as defined under Nasdaq rules. The primary purpose of our Governance Committee is to ensure an appropriate and effective role for our Board in our governance. The principal recurring duties and responsibilities of our Governance Committee include (i) making recommendations to our Board regarding the size and composition of our Board, (ii) identifying and recommending to our Board candidates for election as directors, (iii) reviewing our Board&#8217;s committee structure, composition and membership and recommending to our Board candidates for appointment as members of our Board&#8217;s standing committees, (iv) reviewing and recommending to our Board corporate governance policies and procedures, (v) reviewing our Code of Business Ethics and Conduct and compliance therewith, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and (vi) ensuring that emergency succession planning occurs for the positions of Chief Executive Officer, other key management positions, our Board chairperson and Board members. Our Governance Committee operates under a written charter adopted by our Board, which is posted on our website at www.alt5sigma.com under the caption &#8220;Investors&#8201;&#8212;&#8201;Governance&#8201;&#8212;&#8201;Governance Documents.&#8221;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Governance Committee will consider director candidates recommended by stockholders. The criteria applied by our Governance Committee in the selection of director candidates is the same whether the candidate was recommended by a Board member, an executive officer, a stockholder, or a third party, and accordingly, our Governance Committee has not deemed it necessary to adopt a formal policy regarding consideration of candidates recommended by stockholders. Stockholders wishing to recommend candidates for Board membership should submit the recommendations in writing to our Secretary.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Governance Committee identifies director candidates primarily by considering recommendations made by directors, management, and stockholders. Our Governance Committee also has the authority to retain third parties to identify and evaluate director candidates and to approve any associated fees or expenses. Board candidates are evaluated on the basis of a number of factors, including the candidate&#8217;s background, skills, judgment, diversity, experience with companies of comparable complexity and size, the interplay of the candidate&#8217;s experience with the experience of other Board members, the candidate&#8217;s independence or lack of independence, and the candidate&#8217;s qualifications for committee membership. Our Governance Committee does not assign any particular weighting or priority to any of these factors and considers each director candidate in the context of the current needs of our Board as a whole. Director candidates recommended by stockholders are evaluated in the same manner as candidates recommended by other persons.</span></div><div id="i213e3c881f5e4982994be533c682ff6b_226"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 11. EXECUTIVE COMPENSATION</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the cash and non-cash compensation for fiscal years ended December&#160;28, 2024 and December&#160;30, 2023, earned by each person who served as Chief Executive Officer during fiscal 2024, and our other most highly compensated executive officer who held office as of December&#160;28, 2024 (&#8220;named executive officers&#8221;):</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary Compensation Table </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:16.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.056%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name and Principal Position</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Salary ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Bonus ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock Award ($) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option Award ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">All Other Compensation ($) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total ($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Peter Tassiopoulos</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">928,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">140,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,068,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Chief Executive Officer</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Tony Isaac</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">692,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">250,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">942,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">President and Secretary</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">617,709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">817,709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Virland A. Johnson</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">87,692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">87,692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Chief Financial Officer</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">224,346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">125,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">349,346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________________________________</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">On August 28, 2024, as an inducement grant, the Compensation Committee granted Mr. Tassiopoulos 400,000 restricted stock units, which vested immediately. The per-share pricing of the underlying shares of our common stock was $2.32.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">In lieu of a salary, Mr. Tassiopoulos was paid a consulting fee for the period beginning on August 28, 2024 and ending on December 28, 2024. Mr. Tassiopoulos was not employed by us in 2023, nor was he a consultant to us in that fiscal year.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Outstanding Equity Awards at December&#160;28, 2024</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of stock options outstanding for our Named Executive Officers at December&#160;28, 2024: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.748%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Securities Underlying Unexercised Options (in shares) exercisable </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Securities Underlying Unexercised Options (in shares) unexercisable</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option Exercise Price ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option Expiration Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Peter Tassiopoulos</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Tony Isaac</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9.90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5/18/2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Virland A. Johnson</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, during the year ended December&#160;28, 2024, the Company granted $928,000 in restricted stock units, or 400,000 in underlying shares of the Company's common stock, to Mr. Tassiopoulos, which were immediately vested. As of December&#160;28, 2024, Mr. Tassiopoulos&#8217; restricted stock units were outstanding.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Incentive Plans</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use stock options, restricted stock awards, and restricted stock units to attract and retain executives, directors, consultants, and key employees. Stock options are currently outstanding under the 2011 Plan and the 2016 Plan, and restricted stock units are outstanding under the 2023 Plan. Our 2024 Equity Incentive Plan (the &#8220;</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024 Plan&#8221;</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) was adopted by our Board in November 2024 and approved by the stockholders at the 2024 Annual Meeting of stockholders. Under the 2024 Plan, the maximum aggregate number of shares that may be subject to or delivered under Awards granted under the Plan is two million (2,800,000) shares. Awards may be in the form of a Stock Award, Option, Stock Appreciation Right, Stock Unit, or Other Stock-based Award granted in accordance with the terms of the respective Plan. Our 2023 Equity Incentive Plan (the &#8220;</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023 Plan</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) was adopted by our Board in August 2023 and approved by the stockholders at the 2023 Annual Meeting of stockholders. Under the 2023 Plan, the maximum aggregate number of shares that may be subject to or delivered under Awards granted under the Plan is two million (2,000,000) shares. Awards may be in the form of a Stock Award, Option, Stock Appreciation Right, Stock Unit, or Other Stock-based Award granted in accordance with the terms of the respective Plan. Our 2016 Stock Compensation Plan (the &#8220;</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2016 Plan</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) was adopted by our Board in October 2016 and approved by the stockholders at the 2016 Annual Meeting of Stockholders. Under the Plan, we reserved an aggregate of 400,000 shares of our Common Stock for option grants. Our 2011 Stock Compensation Plan (the &#8220;</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2011 Plan</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) was adopted by our Board in March 2011 and approved by our stockholders at the 2011 Annual Meeting of Stockholders. The 2011 Plan expired on December 29, 2016, but options granted under the 2011 Plan before it expired will continue to be exercisable in accordance with their terms. As of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;28, 2024</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, options to purchase an aggregate of up to 114,000 shares of our Common Stock were outstanding, including options to purchase an aggregate of up to 100,000 shares of our Common Stock under the 2016 Plan and options to purchase an aggregate of up to 14,000 shares of our Common Stock under the 2011 Plan. As of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;28, 2024</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 1.7 million in restricted stock units, or 1.3 million underlying shares of our Common Stock, were outstanding. The Plans are administered by our Compensation Committee or our full Board, acting as the Committee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation of Non-Employee Directors</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use a combination of cash and share-based incentive compensation to attract and retain qualified candidates to serve on our Board. In setting director compensation, we consider the significant amount of time that directors expend fulfilling their duties to the Company, as well as the skill level that we require of members of our Board.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents cash and non-cash compensation paid to non-employee directors during the 2024 fiscal year.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Management Director Compensation for Fiscal Year Ended December&#160;28, 2024</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.272%"><tr><td style="width:1.0%"/><td style="width:28.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.423%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.423%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.423%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.423%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.423%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.454%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fees Earned or Paid in Cash ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Option Awards ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock Award ($) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">All Other Compensation ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total ($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">John Bitar</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Richard D. Butler, Jr.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">30,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">30,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Nael Hajjar</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">14,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">14,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Ron Pitters</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Mr. Pitters was granted 50,000 restricted stock units, which vest quarterly with vesting having commenced on December 24, 2024. The per-share pricing of the underlying shares of our common stock is $2.00.</span></div><div id="i213e3c881f5e4982994be533c682ff6b_229"></div><div style="margin-top:12pt"><span id="i595dc57796a8446fb6b9cfc9a2703304_4977"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth as of March&#160;25, 2025 the beneficial ownership of common stock by each of the Company&#8217;s directors, each of the named executive officers, and all directors and executive officers of the Company as a group, as well as information about beneficial owners of 5.0% or more of the Company&#8217;s voting securities. Beneficial ownership includes shares that may be acquired in the next 60 days through the exercise of options or warrants.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Beneficial Owner</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Position with Company</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Number of Shares Beneficially Owned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Percent of Outstanding Common </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Executive Officers &amp; Directors:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Peter Tassiopoulos </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Chief Executive Officer and Director</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">420,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Tony Isaac </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">President and Secretary</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">246,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Virland A. Johnson </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Chief Financial Officer</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vay Tham</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Chief Revenue Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Richard D. Butler, Jr. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ron Pitters </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">John Bitar</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Nael Hajjar</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All Executive Officers and Directors as a group (8 persons):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">752,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________________________________</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4pt">Indicates ownership of less than 1% of the outstanding shares</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Unless otherwise noted, each person or group identified possesses sole voting and investment power with respect to such shares.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Applicable percentage of ownership is based on 16,370,647 shares of common stock outstanding, plus issuances pending at our transfer agent as of March&#160;25, 2025, </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">plus, for each stockholder, all shares that such stockholder could acquire within 60 days of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;25, 2025</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, upon the exercise of existing stock options and warrants or conversion of existing convertible securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Includes 20,000 shares of the Company's common stock and 400,000 Restricted Stock Units (&#8220;RSUs&#8221;). The address for Mr. Tassiopoulos is 325 E. Warm Springs Road, Suite 102, Las Vegas, Nevada 89119.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Includes shares that could be purchased within 60 days of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;25, 2025</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, upon the exercise of existing stock options or warrants, as follows: Mr. Isaac, 2,000 shares and Mr. Butler, 4,000 shares. The address for each individual is 325 E. Warm Springs Road Suite 102, Las Vegas, Nevada 89119</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Includes 3,000 shares of the Company's common stock and 13,000 RSUs. The address for Mr. Johnson is 325 E. Warm Springs Road, Suite 102, Las Vegas, Nevada 89119.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Includes 50,000 RSUs. The address for Mr. Pitters is 325 E. Warm Springs Road, Suite 102, Las Vegas, Nevada 89119.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Beneficial Ownership of Series A-1 Convertible Preferred Stock</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth, as of March&#160;25, 2025, the beneficial ownership of Series A-1 Convertible Preferred Stock by each owner of 5% or more of the Company&#8217;s Series A-1 Convertible Preferred Stock. No officers or directors of the Company have beneficial ownership of Series A-1 Convertible Preferred Stock. There are no options or warrants to purchase shares of Series A-1 Convertible Preferred Stock.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Name of Beneficial Owner</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of Shares Beneficially Owned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Percentage Outstanding Series A Preferred </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Greenfield Investments, LTD. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23,480</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________________________________</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Unless otherwise noted, each person or group identified possesses sole voting and investment power with respect to such shares.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Applicable percentage of ownership is based on 23,480 shares of Series A-1 Convertible Preferred Stock outstanding as of March&#160;25, 2025.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">The business address for Greenfield with respect to the shares of Series A-1 Preferred Stock is P.O. Box 926, Regent Village Grace Bay Provenciales, Turks &amp; Caicos Islands, British West Indies.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Beneficial Ownership of Series S Preferred Stock</span></div><div style="margin-top:12pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.710%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Name of Beneficial Owner</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Amount and Nature of Beneficial Ownership </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Outstanding Series S Preferred </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amol Soin, MD </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">100,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Unless otherwise noted, each person or group identified possesses sole voting and investment power with respect to such shares.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Applicable percentage of ownership is based on 100,000 shares of Series S Preferred Stock outstanding as of March&#160;25, 2025. As of this date, Dr. Soin has not converted any of his shares of Series S Preferred Stock into shares of our Common Stock and is precluded from any such conversions due to certain contractual restrictions and other temporal and FDA restrictions set forth in the Certificate of Designation for the Series S Preferred Stock.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">The business address for Dr. Soin with respect to the shares of Series S Preferred Stock is c/o ALT5 Sigma Corporation, 325 E. Warm Springs Road, Suite 102, Las Vegas, Nevada 89119. Under the Amended and Restated Certificate of Designation of our Series S Preferred Stock, Dr. Soin is restricted to a beneficial ownership limit of 4.99% of our then outstanding Common Stock. Separate from this limitation, as of the Record Date, Dr. Soin could not convert any shares of his Series S Preferred Stock due to certain contractual restrictions and other temporal and FDA restrictions set forth in the Certificate of Designation for the Series S Preferred Stock. Separate from such restrictions, as of March&#160;25, 2025, Dr. Soin could convert his shares of Series S Preferred Stock into 5,769,231 shares of our Common Stock, which would result in his reporting beneficial ownership of 35.2% in the &#8220;Percent of Outstanding Common&#8221; in the Common Stock chart, above.</span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><div id="i213e3c881f5e4982994be533c682ff6b_232"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 13.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Review, Approval or Ratification of Transactions with Related Persons</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no family relationships among any of the directors or executive officers of the Company. Of the current directors, each of Messrs. Butler, Pitters, Bitar, and Hajjar is an &#8220;independent&#8221; director, as defined under the rules of The Nasdaq Stock Market and each has been an independent director since each joined the Board.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with its charter, the Audit Committee reviews and recommends for approval all related party transactions (as such term is defined for purposes of Item 404 of Regulation S-K). The Audit Committee participated in the approval of the transactions described above. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Shared Services</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tony Isaac, the Company&#8217;s President, is the father of Jon Isaac, President and Chief Executive Officer of Live Ventures and managing member of Isaac Capital Group LLC (&#8220;ICG&#8221;). Tony Isaac, President and Richard Butler, Board of Directors member of the Company, are both Board of Directors members of Live Ventures. The Company also shares certain executive, accounting and legal services with Live Ventures. The total services shared were approximately $144,000 and approximately $203,000 for fiscal years ending December&#160;28, 2024 and December&#160;30, 2023, respectively. Connexx rents approximately 9,900 square feet of office space from Live Ventures at its Las Vegas, Nevada office. Effective August 2023, due to the winding down of operations of the Recycling Subsidiaries, we ceased leasing office space in the Las Vegas, Nevada facility. The total rent and common area expenses for Connexx at the Las Vegas, Nevada office were approximately $17,000 and approximately $103,000 for fiscal years ending December&#160;28, 2024 and December&#160;30, 2023, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During Q4 2023, operations of the Recycling Subsidiaries were wound down and, ultimately, ceased. See Note 4 of the Consolidated Financial Statements. Consequently, outstanding liabilities for shared rent and services for the Recycling Subsidiaries reverted to the Company. As such, the Company has recorded a liability in the amount of approximately $258,000, which was offset against the gain on sale of the Recycling Subsidiaries.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Notes with Live Ventures and ICG</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;7, 2024, the Company entered into a promissory notes with each of Live Ventures and ICG. The initial principal amount of each note is $300,000, with an interest rate of 10% per annum. Pursuant to an amendment to each note, $100,000 of principal, and accrued interest thereon, is due on September&#160;7, 2024 for each note, and the balance of each note is due on December&#160;31, 2024. At the Company&#8217;s option, the obligation under each note is convertible after the six-month anniversary thereof at a per-share conversion price of $0.61, subject to standard adjustments for (i) stock dividends and splits, (ii) subsequent rights offerings, and (iii) pro rata distributions. The Company&#8217;s board of directors approved the issuance of the two notes on February&#160;7, 2024. As of December&#160;28, 2024, the principal balances outstanding on each of the promissory notes was $327,000.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Isaac Consulting Agreement</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;4, 2024, the Company entered into a two-year Consulting Agreement with Jon Isaac, pursuant to which he will provide to the Company (the &#8220;Services&#8221;): (i) strategic financial advice, including growth strategies, capital allocation, and financial restructuring; (ii) sales and business development advice, including for the acquisition of new clients and new products through networking, referrals, and marketing efforts for our prospective products; (iii) in-depth research and market intelligence on specific industries, sectors, and market trends; (iv) financial models and financial analysis to support strategic decision-making; (v) assistance, through site visits, in the preparation of new client offers and bids for proposed projects; (vi) weekly update calls with management to align on progress of objectives and goals; (vii) enhanced non-confidential materials; (viii) business risk management support; and (ix) other services to which the Company and he may agree that will be memorialized in writing if, when, and as needed during the two-year term.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As compensation for the Services, the Company (i) assigned to him two universal life insurance policies that relate to the life of one of the founders of our now-disposed legacy recycling business (as of March 4, 2024, the first policy had an accumulated value/surrender value of approximately $3,854 and the second had an accumulated value/surrender value of approximately $468); (ii) agreed to tender to him funds in our Canadian counsel&#8217;s trust account in the event that the prospective Order of the Court of Appeal for Ontario Canada in the matter styled, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amtim Capital Inc. and Appliance Recycling Centers of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case No. COA-23-CV-0156, became the final Order of the Court, which amount we received during the reporting period and tendered to Mr. Isaac $220,000; (iii) issued to him 200,000 restricted shares of our </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">common stock with the per-share value being the average of the Nasdaq Historical NOCP closing price during the five trading days prior to our board approving the Consulting Agreement, which shares were awarded from our 2023 Equity Incentive Plan; and (iv) issued to him a two-year, straight 10.0% convertible promissory note in the initial principal amount of $500,000, with an interest rate of 10.0% and a per-share conversion price equivalent to the per-share value of the restricted common stock that he was granted ($1.16). The maturity date of the promissory note is March&#160;4, 2026. The value of the restricted shares was $232,000 on the date issued. As of December&#160;28, 2024, the principal balance outstanding on the promissory note was $&#8212;.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Short-Term Advances</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;18, 2024, ICG made a short-term demand advance to the Company in the amount of $100,000. The advance bears interest at a rate of 10% per annum until repaid. As of December&#160;28, 2024, the principal amount outstanding was $48,000.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;28, 2024 and June&#160;3, 2024, Novalk made short-term demand advances in the amount of $120,000 and $100,000, respectively, to the Company. Juan Yunis, an employee of Live Ventures, is the managing member of Novalk. The advances bears interest at a rate of 10% per annum until repaid. As of December&#160;28, 2024, the principal amount outstanding was $110,000.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During June&#160;3, 2024, Tony Isaac made a number of short-term demand advances in the aggregate amount of $62,000 to the Company. The advances bears interest at a rate of 10% per annum until repaid. As of December&#160;28, 2024, the Company had repaid the advance in full (see Note 20 of the Consolidated Financial Statements).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Sale of Recycling Subsidiaries</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 9, 2023, the Company entered into a Stock Purchase Agreement (the &#8220;Recycling Purchase Agreement&#8221;) with VM7 Corporation, a Delaware corporation (&#8220;VM7&#8221;), under which it agreed to acquire all of the outstanding equity interests of the Recycling Subsidiaries consisting of: (a) ARCA Recycling, Inc., (b) ARCA Canada, and (c) Connexx. The principal of VM7 is Virland A. Johnson, our Chief Financial Officer. The sale of all of the outstanding equity interests of the Recycling Subsidiaries to VM7 under the Recycling Purchase Agreement was consummated simultaneously with the execution of the Recycling Agreement. The Company's Board of Directors unanimously approved the Recycling Purchase Agreement and the Disposition Transaction. The Recycling Purchase Agreement is retroactively effective as of March 1, 2023. During the fourth quarter of fiscal 2023, VM7 determined that, after expending significant amounts of time and resources, it was unable to obtain sufficient equity or debt financing to continue the operations of the Recycling Subsidiaries. Accordingly, the Company was advised that the operations of the Recycling Subsidiaries were wound down and, ultimately, ceased. Because the Company did not receive all of the economic benefits of the Disposition Transaction and understands that it will not receive any future benefits of the Disposition Transaction, the Company determined to fully impair the $5.3&#160;million carrying value of the Disposition Transaction on its balance sheet. The Company also determined not to exercise any of its remedies under the Recycling Purchase Agreement so that the Company could maintain its focus on its clinical-stage biopharmaceutical activities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ICG Note</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August&#160;28, 2019, ARCA Recycling entered into and delivered to ICG a secured revolving line of credit promissory note, whereby ICG agreed to provide ARCA Recycling with a $2.5 million revolving credit facility (the &#8220;ICG Note&#8221;). Jon Isaac is the manager and sole member of ICG, and the son of Tony Isaac, the President of ALT5 Sigma Corporation and, previously, ARCA Recycling. ICG is a record and beneficial owner of 13.6% of the outstanding common stock of the Company. The ICG Note was originally a component of the sale of the Recycling Subsidiaries in March 2023; however, because of the winding down of operations of the Recycling Subsidiaries during Q4 2023, and because the ICG Note was guaranteed by the Company, it recorded a liability in the amount of approximately $690,000 for the principal balance due on the note, which was offset against the gain on sale of the Recycling Subsidiaries (see Note 4). Additionally, effective February 2024, the ICG Note was amended to reflect the Company as co-maker on the ICG Note (see Note 20). The ICG Note matures in March 2026, and bears interest at 8.75% per annum. Monthly payments on the note are approximately $24,767. As of December&#160;28, 2024 and December&#160;30, 2023, the balance outstanding was $0 and $706,000, respectively.</span></div><div id="i213e3c881f5e4982994be533c682ff6b_235"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each year, the Audit Committee approves the annual audit engagement in advance. The Audit Committee also has established procedures to pre-approve all non-audit services provided by the Company&#8217;s independent registered public accounting firm. All non-audit services for the fiscal years ended December&#160;28, 2024, and December&#160;30, 2023 that are listed below were pre-approved.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Audit Fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Audit fees include fees for the audit of the Corporation&#8217;s consolidated financial statements and interim reviews of the Corporation&#8217;s quarterly financial statements, comfort letters, consents and other services related to Securities and Exchange Commission matters.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Audit-Related Fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Audit-related fees primarily include fees for certain audits of subsidiaries not required for purposes of WSRP's audit of the Corporation&#8217;s consolidated financial statements or for any other statutory or regulatory requirements, and consultations on various other accounting and reporting matters</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tax Fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: This category consists of professional services rendered by our independent auditors for tax compliance.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">All Other Fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consist of fees for services other than the services described above.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following fees were billed to us by our independent registered public accounting firm Hudgens CPA, PLLC (&#8220;Hudgens&#8221;):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Audit fees</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">104,988&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">295,508&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Audit-related Fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Tax fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All other fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">104,988&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">295,508&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><div id="i213e3c881f5e4982994be533c682ff6b_238"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="i213e3c881f5e4982994be533c682ff6b_241"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Financial Statements, Financial Statement Schedules and Exhibits</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:28.5pt">Financial Statements</span></div><div style="padding-left:72pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Index to Financial Statements under Item 8 of this report.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:28.5pt">Financial Statement Schedules</span></div><div style="padding-left:72pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:28.5pt">Exhibits</span></div><div style="padding-left:72pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Index to Exhibits</span></div><div id="i213e3c881f5e4982994be533c682ff6b_244"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 16. FORM 10-K SUMMARY</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><div id="i213e3c881f5e4982994be533c682ff6b_247"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:6pt;padding-left:6pt;padding-right:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Index to Exhibits</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.839%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:47.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.963%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exhibit<br/>No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exhibit Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Form</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">File<br/>Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exhibit <br/>Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Filing Date</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000168316818000651/arca_8k-ex0303.htm">Articles of Incorporation of Appliance Recycling Centers of America, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3/13/2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000168316818000651/arca_8k-ex0301.htm">Articles of Conversion</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3/13/2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000168316818000651/arca_8k-ex0302.htm">Articles of Conversion</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3/13/2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000168316818000651/arca_8k-ex0301.htm">Certificate of Correction to Articles of Incorporation</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-Q</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6/30/2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000168316819001137/arca_ex0301.htm">Certificate of Change</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4/22/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000168316819001983/arca_8k-ex0307.htm">Certificate of Correction to Articles of Incorporation of Appliance Recycling Centers of America, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.7</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6/24/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.7</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000168316819001983/arca_8k-ex0308.htm">Certificate of Designation of Powers, Preferences, and Rights of Series A-1 Convertible Preferred Stock of Appliance Recycling Centers of America, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6/24/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.8(a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000168316820003334/janone_8k-ex0308a.htm">Amended and Restated Certificate of Designation of the Preferences, Rights, and Limitations of the Series A-1 Convertible Preferred Stock of JanOne Inc., dated October 1, 2020</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.8(a)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10/2/2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.8(b)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000156459021019200/jan-ex38b_22.htm">Second Amendment and Restated Certificate of Designation of the Preferences, Rights, and Limitations of the Series A-1 Convertible Preferred Stock of JanOne Inc., dated April 13, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.8(b)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4/16/2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000168316819002925/janone_ex0309.htm">Articles of Incorporation of JanOne Inc. (the Name Change Subsidiary), filed with the Secretary of State of the State of Nevada on September 6, 2019</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9/13/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.10</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000156459020052676/jan-ex39_224.htm">Certificate of Amendment to Articles of Incorporation, filed with the Secretary of State for the State of Nevada on November 5, 2020</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-Q</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11/10/2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.11</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000168316819002925/janone_ex0310.htm">Articles of Merger for JanOne Inc. into Appliance Recycling Centers of America, Inc., filed with the Secretary of State of the State of Nevada on September 9, 2019, and effective on September 10, 2019</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.10</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9/13/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.12</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000168316818000651/arca_8k-ex0304.htm">Bylaws of Appliance Recycling Centers of America, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3/3/2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.13</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000168316818003829/arca_8k-ex0301.htm">First Amendment to Bylaws of Appliance Recycling Centers of America, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12/31/2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.14</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000095017023013095/jan-ex3_14.htm">Certificate of Designation of the Rights, Preferences, and Limitations of Series S Convertible Preferred Stock, filed with the Secretary of State of the State of Nevada on December 28, 2022.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.14</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4/17/2023</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.16</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/862861/000162828024037717/alts-20240629.htm">Certificate of Merger of Domestic Corporations filed with the Secretary of State of the State of Delaware on May 15, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.16</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5/21/2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.17</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/862861/000162828024037717/alts-20240629.htm">Certificate of Designation of the Rights, Privileges, Preferences, and Limitations of the Series B Preferred Stock, filed with the Secretary of State of the State of Nevada on May 14, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.17</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5/21/2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.839%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:47.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.963%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.18</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/862861/000162828024037717/alts-20240629.htm">Certificate of Designation of the Rights, Privileges, Preferences, and Limitations of the Series M Preferred Stock, filed with the Secretary of State of the State of Nevada on May 14, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.18</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5/21/2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.19</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/862861/000162828024047204/alts-20240928.htm">Articles of Incorporation of ALT5 Sigma Corporation (the Name Change Subsidiary), filed with the Secretary of State for the State of Nevada on July 10, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.19</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7/17/2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.20</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/862861/000162828024047204/alts-20240928.htm">Articles of Merger for ALT5 Sigma Corporation with and into JanOne Inc., filed with the Secretary of State for the State of Nevada on July 11, 2024, and effective on July 15, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.20</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7/17/2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.21</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/862861/000162828024047204/alts-20240928.htm">Certificate of Designation of the Rights, Preferences, and Limitations of Series Q Convertible Preferred Stock, filed with the Secretary of State of the State of Nevada on November 8, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.21</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7/17/2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000095017023013095/jan-ex4_1.htm">Description of Our Securities</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4/17/2023</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000156459020052676/jan-ex42_14.htm">Specimen Stock Certificate</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-Q</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11/10/2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000162828023030392/ex44jancommonwarrantfinal.htm">Form of Warrant, dated August 22, 2023.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8/23/2023</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000162828023030392/ex45janplacementagentwarra.htm">Form of Placement Agent Warrant, dated August 22, 2023.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8/23/2023</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#215;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000168316819003807/janone_8k-ex1001.htm">Patent and Know How License Agreement dated November 19, 2019, by and among JanOne Inc., and UAB Research Foundation, TheraVasc, Inc., and the Board of Supervisors of Louisiana State University and Agricultural and Mechanical College, acting on behalf of LSU Health Sciences Center at Shreveport</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11/25/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#215;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000156459020003764/jan-ex101_6.htm">Master Agreement for Development, Manufacturing and Supply Services dated February 5, 2020 by and between JanOne Inc. and CoreRx Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2/7/2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.10</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000168316819002793/arca_ex1001.htm">Secured Revolving Line of Credit Promissory Note</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8/30/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.11</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000156459020052676/jan-ex102_13.htm">Amendment to Secured Line of Credit Promissory Note dated August 25, 2020 between ARCA Recycling, Inc. and Isaac Capital Group, LLC</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-Q</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11/10/2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.12</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000156459021016696/jan-ex1012_320.htm">Second Amendment and Waiver to Secured Line of Credit Promissory Note dated March 30, 2021 between ARCA Recycling, Inc. and Isaac Capital Group, LLC</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.12</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3/30/2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.13</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000168316816000662/appliance_10q-ex1001.htm">Securities Purchase Agreement dated November 8, 2016, between Energy Efficiency Investments, LLC and the Company</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-Q</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11/15/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.17</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000110465911017989/a11-2661_1def14a.htm">2011 Stock Compensation Plan</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DEF 14A</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3/31/2011</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.18</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000168316817000707/arca_10k-ex1003.htm">2016 Equity Incentive Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12/31/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.19</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000156459020045736/jan-def14a_20201104.htm">First Amendment to the JanOne Inc. 2016 Equity Incentive Plan</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DEF 14A</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10/2/2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.20</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#215;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000156459021016696/jan-ex1020_399.htm">Master Equipment Finance Agreement dated as of March 25, 2021 between KLC Financial, Inc. and ARCA Recycling, Inc</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3/30/2021</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.839%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:47.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.963%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.22</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000156459021016696/jan-ex1012_320.htm">Second Amendment and Waiver to Secured Line of Credit Promissory Note dated March 30, 2021 between ARCA Recycling, Inc. and Isaac Capital Group, LLC</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.12</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3/30/2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.24</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000156459021028450/jan-ex102_13.htm">Addendum to Master Equipment Finance Agreement dated as of April 14, 2021 between KLC Financial, LLC and ARCA Recycling, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-Q</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5/17/2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.27</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000095017023013095/jan-ex10_27.htm">Third Amendment to Secured Revolving Line of Credit Promissory Note dated March 17, 2022 with Isaac Capital Group, LLC.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.27</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4/17/2023</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.28</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000095017022010897/jan-ex10_28.htm">Asset Purchase Agreement between JanOne Inc. and SPYR Technologies Inc., dated May 24, 2022</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.28</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5/31/2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.29</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000095017022010897/jan-ex10_29.htm">Promissory Note of SPYR Technologies Inc. in favor of JanOne Inc., dated May 24, 2022.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.29</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5/31/2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.92</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000095017022019120/jan-ex10_92.htm">General Credit and Security Agreement, dated as of September 26, 2022, between Gulf Coast Bank and Trust Company and ARCA.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10/92</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9/28/2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.93</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000095017022019120/jan-ex10_93.htm">Guaranty to Gulf Coast Bank and Trust by JanOne Inc., dated as of September 21, 2022.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.93</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9/28/2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.94</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000095017022019120/jan-ex10_94.htm">Debt Subordination Agreement by Isaac Capital Group, dated as of September 21, 2022.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.94</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9/28/2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.95</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000095017023008681/jan-ex10_95.htm">Agreement and Plan of Merger made and entered into as of December 28, 2022, among the registrant, STI Merger Sub Inc., Soin Therapeutics, LLC, and Amol Soin, M.D. </a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.95</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4/17/2023</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.96</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000095017023008681/jan-ex10_95.htm">Stock Purchase Agreement between JanOne Inc. and VM7 Corporation, dated as of March 19, 2023 (Filed as Exhibit 10.95)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.95</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3/20/2023</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.97</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000095017023008681/jan-ex10_96.htm">Stock and Membership Interests Pledge Agreement made by VM7 Corporation and Virland Johnson in favor of JanOne Inc., dated March 19, 2023 (Filed as Exhibit 10.96)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.96</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3/20/2023</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.98</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000095017023009752/jan-ex10_98.htm">Form of Securities Purchase Agreement dated March 22, 2023.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.98</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3/24/2023</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.99</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000162828023030392/ex1099janspafinal2.htm">Form of Securities Purchase Agreement, dated August 18, 2023.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.99</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8/23/2023</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.100</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000162828024001259/exh10100_janwarrantrepurch.htm">Warrant Purchase Agreement by and between JanOne, Inc. or its assigns and the Investor made effective as of January 12, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.100</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1/12/2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.101</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000162828024003865/ex10101_icgjanonefourthame.htm">Form of Fourth Amendment to Secured Revolving Line of Credit with Isaac Capital Group LLC, dated February 7, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.101</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2/9/2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.102</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000162828024003865/ex10102_livejanonefirstame.htm">Form of First Amendment to Promissory Note with Live Ventures Incorporated, dated February 7, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.102</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2/9/2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.103</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000162828024003865/ex10103_janonepromissoryno.htm">Form of Promissory Note in favor of Isaac Capital Group LLC, dated February 7, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.103</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2/9/2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/862861/000162828024003865/ex10104_janonepromissoryno.htm">Form of Promissory Note in favor of Live Ventures Incorporated, dated February 7, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2/9/2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.839%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:47.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.963%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.105</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000862861/000162828024007613/jan-20240223.htm">Form of First Amendment to Agreement and Plan of Merger among the registrant, STI Merger Sub Inc., Soin Therapeutics, LLC, and Amol Soin, M.D., dated January 24, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.105</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2/28/2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.106</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000862861/000162828024007613/jan-20240223.htm">Form of Promissory Note in favor of Jon Isaac, dated March 4, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.106</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2/28/2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.107</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000862861/000162828024015260/jan-20231230.htm">Consulting Agreement with Jon Isaac, dated March 4, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.107</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4/8/2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.108</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/862861/000162828024037717/alts-20240629.htm">Form of Securities Purchase Agreement, dated May 1, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.108</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5/6/2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.109</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/862861/000162828024037717/alts-20240629.htm">Form of Agreement and Plan of Merger among the issuer, J1 A5 Merger Sub Inc., and Alt 5 Sigma, Inc., dated May 10, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.109</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5/21/2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.110</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/862861/000162828024047204/alts-20240928.htm">Form of Unit Purchase Agreement for the &#8220;Big Debenture&#8221; and &#8220;Big Warrant,&#8221; dated August 20, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.110</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8/23/2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.111</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/862861/000162828024047204/alts-20240928.htm">Form of Non-Convertible Debenture for the &#8220;Big Debenture,&#8221; dated August 20, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.111</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8/23/2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.112</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/862861/000162828024047204/alts-20240928.htm">Form of Common Stock Purchase Warrant for the &#8220;Big Warrant,&#8221; dated August 20, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.112</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8/23/2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.113</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/862861/000162828024047204/alts-20240928.htm">Form of Unit Purchase Agreement for the &#8220;Small Debenture&#8221; and &#8220;Small Warrant,&#8221; dated August 20, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.113</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8/23/2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.114</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/862861/000162828024047204/alts-20240928.htm">Form of Non-Convertible Debenture for the &#8220;Small Debenture&#8221;, dated August 20, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.114</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8/23/2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.115</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/862861/000162828024047204/alts-20240928.htm">Form of Common Stock Purchase Warrant for the &#8220;Small Warrant,&#8221; dated August 20, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.115</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8/23/2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.116</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/862861/000162828024047204/alts-20240928.htm">Employment Agreement, dated August 26, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.116</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8/30/2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.117</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/862861/000162828024047204/alts-20240928.htm">Form of Asset Purchase and Sale Agreement, dated November 8, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-Q</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.117</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11/12/2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.118</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000862861/000162828024049241/jan-20241119.htm">Non-binding Term Sheet between Alyea Technologies Corporation and Soin Bioscience LLC, dated November 19, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-19621</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.118</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11/26/2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.119</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="ex10119_qodonassetpurchase.htm">A</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="ex10119_qodonassetpurchase.htm">sset Purchase an</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="ex10119_qodonassetpurchase.htm">d Sale Agreement with Qoden Te</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="ex10119_qodonassetpurchase.htm">chn</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="ex10119_qodonassetpurchase.htm">ologies LLC, dated November 8, 2024</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="alt5-exhibit21xexx211.htm">List of Subsidiaries of the Registrant</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="ex231_consentofhudgenscpap.htm">Consent of Hudgens, LLC, Independent Registered Public Accounting Firm.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="alt5-20241228xex311.htm">Certification by Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="alt5-20241228xex312.htm">Certification by Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="alt5-20241228xex321.htm">Certification by Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="alt5-20241228xex322.htm">Certification by Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.839%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:47.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.963%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following materials from our Annual Report on Form 10-K for the fiscal year ended December 28, 2024, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations and Comprehensive Income, (iii) the Consolidated Statements of Cash Flows, (iv) the Consolidated Statements of Shareholders&#8217; Equity, (v) the Notes to Consolidated Financial Statements, and (vi) document and entity information.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 12.25pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Items that are management contracts or compensatory plans or arrangements required to be filed as an exhibit pursuant to Item 14(a)3 of this Form 10-K.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furnished herewith.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">[For the exhibits that are being incorporated by reference, we need to say what filings they came from and I don&#8217;t know that I see that here.]</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#215;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Portions of this exhibit have been redacted in compliance with Regulation S-K Item 601(b)(10)(iv).</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><div id="i213e3c881f5e4982994be533c682ff6b_250"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i213e3c881f5e4982994be533c682ff6b_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or Section 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on our behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:47.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;28, 2025</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALT5 SIGMA CORPORATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Peter Tassiopoulos</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Peter Tassiopoulos</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.113%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Signature</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Title</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Date</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principal Executive Officer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Peter Tassiopoulos</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;28, 2025</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Peter Tassiopoulos</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principal Financial and Accounting Officer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Virland A. Johnson</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;28, 2025</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Virland A. Johnson</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Directors</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Tony Isaac</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">President and Treasurer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;28, 2025</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tony Isaac</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Richard Butler</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;28, 2025</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Richard Butler</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Ron Pitters</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;28, 2025</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ron Pitters</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ John Bitar</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;28, 2025</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">John Bitar</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Nael Hajjar</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;28, 2025</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nael Hajjar</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.119
<SEQUENCE>2
<FILENAME>ex10119_qodonassetpurchase.htm
<DESCRIPTION>EX-10.119
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ifea7957234684252863246a07d1f397e_1"></div><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.95pt;padding-left:169.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ASSET PURCHASE AND SALE AGREEMENT</font></div><div style="margin-top:11.9pt;padding-left:61pt;padding-right:6.4pt;text-indent:1.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">THIS ASSET PURCHASE AND SALE AGREEMENT </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) is entered into as November </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, 2024 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), by and between ALT5 Sigma Corporation, or its permitted nominees, designees, or assignees (including a wholly-owned subsidiary of the Buyer to be formed in connection with transactions contemplated herein) with an address of </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">325 E. Warm Springs Road, Suite 102, Las Vegas, Nevada 89119 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Buyer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and Qoden Technologies LLC, a Nevada limited liability company with an address of 5348 Vegas Drive 172, Las Vegas, Nevada 89108 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Seller</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-top:0.25pt;padding-left:26.7pt;padding-right:26.7pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">RECITALS</font></div><div style="margin-top:11.65pt;padding-left:61pt;padding-right:10.95pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:35.39pt">The Seller develops and markets software products and services and owns certain intellectual property that enables the Seller to operate its business (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-top:12pt;padding-left:61pt;padding-right:5.55pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:0.05pt">Each of the Buyer and the Seller desires to enter into this Agreement, pursuant to which the Seller proposes to sell to the Buyer, and the Buyer proposes to purchase from the Seller, certain assets used or held for use by the Seller in the conduct of the Business.</font></div><div style="margin-top:12pt;padding-left:61pt;padding-right:5.6pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:0.05pt">The Buyer shall use its commercially reasonable efforts to retain the services of two key employees of the Seller from and after the Closing through consulting agreements (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Consulting Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) between such individuals and the Buyer or a subsidiary or division thereof.</font></div><div style="margin-top:12pt;padding-left:61pt;padding-right:5.55pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:35.39pt">The Seller shall use its commercially reasonable efforts to retain the services of its current chief executive officer from and after the Closing through such arrangements as are commercially reasonable (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Executive Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-top:12.05pt;padding-left:61pt;padding-right:5.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of these presents and for such other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto intending to be legally bound hereby, agree as follows&#58;</font></div><div style="margin-top:12pt;padding-left:26.7pt;padding-right:26.7pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 1</font></div><div style="margin-top:0.1pt;padding-left:26.8pt;padding-right:26.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">CERTAIN DEFINITIONS</font></div><div style="margin-top:11.9pt;padding-left:61pt;padding-right:5.5pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In addition to other terms defined elsewhere in this Agreement, the following terms will be defined as follows&#58;</font></div><div style="margin-top:12pt;padding-left:61pt;padding-right:5.5pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:29.05pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Assigned Contracts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means those contracts that the Seller entered into in the course of operating the Business, which are listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, attached to this Agreement and incorporated herein by reference.</font></div><div style="margin-top:12.05pt;padding-left:61pt;padding-right:5.55pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:29.05pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Bill of Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a bill of sale and assignment and assumption agreement between the Seller and the Buyer in substantially the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit 1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, attached to this Agreement and incorporated herein by reference.</font></div><div style="margin-top:12pt;padding-left:133pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">LOSING</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">OR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">LOSING </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">ATE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font></div><div style="margin-top:1.05pt"><font><br></font></div><div style="padding-left:61pt;padding-right:5.5pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The transactions contemplated by this Agreement shall be consummated within thirty (30) days of the Effective Date, subject to the Buyer receiving all prerequisite regulatory approvals, as applicable, unless otherwise agreed to in writing by the Buyer and the Seller. The Closing may be consummated (a) electronically, via the exchange of executed counterparts of, and the delivery of</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:3.1pt;padding-left:61pt;padding-right:5.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">all deliverables required pursuant to, this Agreement in portable document format (PDF) or (b) at such other place or in such other manner as agreed upon by the parties to this Agreement. The Closing will be deemed effective as of 5&#58;00 p.m. Eastern Time on the Closing Date. Title to the Purchased Assets (as defined below) and all rights related to them shall pass and possession shall be delivered to Buyer at the Closing.</font></div><div style="margin-top:12.05pt;padding-left:97pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.4&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Due Diligence Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font></div><div style="margin-top:1.15pt"><font><br></font></div><div style="padding-left:61pt;padding-right:5.25pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The period of time starting on the Effective Date and ending at 5&#58;00 p.m. Central Time on the 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> day following the Effective Date, within which time the Buyer shall complete its due diligence as described in Section 8 below.</font></div><div style="margin-top:11.9pt;padding-left:97pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.5.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Purchase Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font></div><div style="margin-top:1.25pt"><font><br></font></div><div style="padding-left:61pt;padding-right:5.5pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Equity Purchase Price component of the Purchase Price means the sum of Two Million Dollars (US$2,000,000.00) payable as specified in Section 3.1, below. The Cash Purchase Price component of the Purchase Price means the sum of Two Hundred Forty Thousand Dollars (US$240,000.00) payable as specified in Section 3.2, below.</font></div><div style="margin-top:12pt;padding-left:26.7pt;padding-right:26.7pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 2</font></div><div style="margin-top:0.1pt;padding-left:26.85pt;padding-right:26.85pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">PURCHASE AND SALE</font></div><div style="margin-top:11.9pt;padding-left:133pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt">Purchase and Sale.</font></div><div style="margin-top:1.05pt"><font><br></font></div><div style="padding-left:61pt;padding-right:5.5pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Upon and subject to the terms and conditions set forth in this Agreement, the Seller hereby sells, transfer, assigns, and delivers, or causes to be sold, transferred, assigned, and delivered, to the Buyer or its designees or assigns, all of Seller&#8217;s right, title, title, and interest in and to the assets, properties, and rights of every kind and description, real, personal, and mixed, tangible and intangible, wherever situated, that are related to the past, current, or potential conduct of the Business, other than the Excluded Assets (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Purchased Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) as further listed in Schedule 1.5. The Purchased Assets include, without limitation, the following&#58;</font></div><div style="margin-top:12.05pt;padding-left:241.75pt;text-indent:-35.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.45pt">All source code&#59;</font></div><div style="margin-top:12pt;padding-left:133pt;padding-right:5.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:33.02pt">copies of all software development documentation, third- party licenses, software development tools, or licenses as applicable&#59;</font></div><div style="margin-top:12pt;padding-left:241pt;text-indent:-35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.65pt">the goodwill value of the Business as a going concern&#59;</font></div><div style="margin-top:12.05pt;padding-left:133pt;padding-right:5.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:33.02pt">claims, deposits, prepayments, cash-in-lieu-of-bonds, refunds, or similar items, if any&#59;</font></div><div style="margin-top:12pt;padding-left:133pt;padding-right:5.55pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:33.7pt">all patents (whether issued or applied for, including continuing patent applications) wherever situated, trademarks, copyrights, intellectual property rights, and other intangible property held by, or for, the Seller and specifically relating to the Business, if any&#59;</font></div><div style="margin-top:12pt;padding-left:241pt;text-indent:-35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:23.98pt">all rights under the Assigned Contracts listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule</font></div><div style="padding-left:134.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#59;</font></div><div><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-top:3.1pt;padding-left:133pt;padding-right:5.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:33.02pt">to the extent legally transferrable, any authorization, approval, consent, certificate, license, permit, or franchise of or from any governmental entity or pursuant to any law which are necessary to conduct the Business as currently conducted or as proposed to be conducted.</font></div><div style="margin-top:12.05pt;padding-left:133pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt">Excluded Assets.</font></div><div style="margin-top:1.05pt"><font><br></font></div><div style="padding-left:61pt;padding-right:5.6pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding anything to the contrary in this Agreement, the Buyer and the Seller agree that the Purchased Assets shall not include the following assets, property, and rights of the Seller (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Excluded Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#58;</font></div><div style="margin-top:12pt;padding-left:61pt;padding-right:5.4pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:33.75pt">the Seller&#8217;s cash, bank accounts, cash equivalents, accounts receivable&#59; the Seller&#8217;s rights under this Agreement&#59; all income tax refunds due to the Seller and tax deposits of the Seller&#59; tax returns and financial information and statements of the Seller&#59; and insurance policies of the Seller and all claims thereunder&#59;</font></div><div style="margin-top:12.05pt;padding-left:172.15pt;text-align:justify;text-indent:-39.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:25.17pt">all contracts to which the Seller is a party that are not Assigned Contracts&#59;</font></div><div style="margin-top:12pt;padding-left:133pt;padding-right:10.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:33.7pt">the corporate seals, charter documents, minutes books, stock books, tax returns, books of account, or other records having to do with the corporate organization of the Seller&#59;</font></div><div style="margin-top:12pt;padding-left:133pt;padding-right:6.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:33.02pt">any other assets of the Seller not specifically related to the past, current, or potential conduct of the Business&#59;</font></div><div style="margin-top:12pt;padding-left:133pt;padding-right:5.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:33.7pt">any contracts or operating business relationships of the Seller as they pertain to the past, current, or potential conduct of the business in Russia or for the benefit of past or current Russian customers&#59; and</font></div><div style="margin-top:12pt;padding-left:133pt;padding-right:5.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:35.03pt">any other assets of the Seller that the Buyer, or its nominees, designees, or assignees, elects not to purchase or is prohibited from purchasing under applicable law.</font></div><div style="margin-top:12.05pt;padding-left:61pt;padding-right:5.35pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:32.05pt">A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">SSUMPTION OF </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">L</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">IABILITIES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. With the exception of all responsibilities and obligations required by a holder of the Licenses, Purchased Assets, and those obligations required by the Assigned Contracts (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Assumed Liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), the Buyer shall not assume any liability or obligation of the Seller whatsoever in connection with the transactions contemplated by this Agreement, and the Seller shall retain responsibility for all liabilities and obligations accrued thereunder as of the Closing Date.</font></div><div style="margin-top:12pt;padding-left:26.7pt;padding-right:26.7pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 3</font></div><div style="margin-top:0.15pt;padding-left:26.85pt;padding-right:26.85pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ECONOMIC ISSUES</font></div><div style="margin-top:11.85pt;padding-left:133pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt">The Preferred Stock (The Equity Purchase Price Component).</font></div><div style="margin-top:1.1pt"><font><br></font></div><div style="padding-left:133pt;padding-right:5.25pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:33.7pt">On or before the Closing Date, the Buyer shall tender the Equity Purchase Price component of the Purchase Price to the Seller through the issuance of seven hundred seventy-one thousand ten (771,010) shares of Series Q Convertible Preferred Stock of the Buyer (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Preferred Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), which number of shares was calculated by dividing the Equity Purchase Price by $2.594 (the </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:133pt;padding-right:5.25pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Volume Weighted Average Price (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">VWAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) of the Buyer&#8217;s common stock, $0.001</font></div><div style="text-align:justify"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:3.1pt;padding-left:133pt;padding-right:5.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">par value per share (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), as reported by the Nasdaq Capital Market, for the five trading days immediately preceding the Effective Date), and which calculation assumes the initial one-to-one conversion ratio of shares of Preferred Stock into shares of Common Stock.</font></div><div style="margin-top:12.05pt;padding-left:133pt;padding-right:5.4pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:33.02pt">In addition to all applicable regulatory restrictions on the disposition of the shares of Preferred Stock, all of such shares shall be subject to a mandatory eight-calendar-quarter leak-out, such that no more than twelve-and-one- half percent (12.5%) of the shares of Preferred Stock may be converted into shares of Common Stock on a trailing quarterly basis (each quarter based upon the Effective Date) over the course of two years, subject to standard vesting provisions&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the Seller may not assign, transfer, hypothecate, lien, or otherwise obtain any economic value for any shares of its Preferred Stock that have not been converted into shares of Common Stock in accordance with the provisions of this Section 3.1(b).</font></div><div style="margin-top:12pt;padding-left:133pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt">The Monthly Payments (the Cash Purchase Price Component).</font></div><div style="margin-top:1.1pt"><font><br></font></div><div style="padding-left:61pt;padding-right:5.6pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Buyer shall tender to the Seller the Cash Purchase Price component of the Purchase Price in Twenty-four (24) equal monthly installments of Ten Thousand Dollars (US$10,000.00) per month on the first day of each month after the Closing, subject to standard payment provisions.</font></div><div style="margin-top:12pt;padding-left:133pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt">Transition Period Services.</font></div><div style="margin-top:1.2pt"><font><br></font></div><div style="padding-left:61pt;padding-right:5.25pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As a specific condition of the tender of both Equity Purchase Price Component and the Cash Purchase Price Component, the Seller shall make Andrei Verbin (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Mr. Verbin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) available to the Buyer on an as-needed basis for the post-Closing Date period of Twenty-Four (24) Months (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Transition Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) for such services in respect of the Business as the Buyer, from time to time, may reasonably request of Mr. Verbin that he provide during normal business hours (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Transition Services</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  The Seller expressly agrees, acknowledges, and understands that Mr. Verbin&#8217;s failure or refusal to perform and provide, timely and competently, in any material respect, the Transition Services at any time during the Transition Period shall constitute a material breach of this Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and shall provide the Buyer with the right, but not the obligation, to cause all of the shares of the Seller&#8217;s Preferred Stock (and all of the shares of Common Stock into which the shares of its Preferred Stock could have been converted, as well as all of the shares of Common Stock then owned of record or beneficially by the Seller), then and there, to be deemed</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:7.4pt"><img alt="image_0.jpg" src="image_0.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:192px"></div><div style="margin-top:4.65pt;padding-left:61pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Such failure shall include, but not be limited to&#58;</font></div><div style="margin-top:6pt;padding-left:97pt;padding-right:5.8pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.12pt">Mr. Verbin&#8217;s failure or refusal to perform and provide, timely and competently, in any material respect, the Transition Services (for the avoidance of doubt, Mr. Verbin&#8217;s refusal to take any action or refrain from taking any action that would violate any law, rule, regulation, governmental pronouncement, court order, decree, or judgment shall not constitute a breach of this Agreement)&#59;</font></div><div style="margin-top:3.05pt;padding-left:97pt;padding-right:6.15pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:4.68pt">gross negligence, recklessness, willful misconduct, or intentional misrepresentation by Mr. Verbin in the performance of the Transition Services&#59;</font></div><div style="margin-top:3.05pt;padding-left:97pt;padding-right:9.55pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.68pt">the commission by Mr. Verbin of any act of fraud, embezzlement, theft, or other financial dishonesty, or of any felony, or of any crime involving moral turpitude&#59; or</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:2.95pt;padding-left:97pt;padding-right:11.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.12pt">Mr. Verbin&#8217;s violation of state or federal law relating to sexual harassment or other prohibited harassment or discrimination or any policy of the Buyer of which Mr. Verbin had been provided notice.</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ifea7957234684252863246a07d1f397e_4"></div><hr style="page-break-after:always"><div style="min-height:5.76pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.9pt;padding-left:5.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Docusign Envelope ID&#58; BCE1695E-3E64-49C6-87AF-40D5DD88E71B</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:10.6pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:61pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">to have been returned to the treasury for cancellation and no longer to be issued and outstanding shares of capital stock of the Buyer.</font></div><div style="margin-top:12pt;padding-left:133pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt">Consulting Agreements.</font></div><div style="margin-top:1.05pt"><font><br></font></div><div style="padding-left:61pt;padding-right:5.6pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In connection with the transactions contemplated by this Agreement, the Buyer shall use its commercially reasonable efforts to retain the services of two key employees of the Seller from and after the Closing through consulting agreements between such individuals and the Buyer or a subsidiary or division thereof. More specifically&#58;</font></div><div style="margin-top:12pt;padding-left:97pt;padding-right:5.3pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:8.69pt">the Buyer and Vlad Tikhomirov (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Vlad</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) shall enter into a standard-form, two-year consulting agreement (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Consulting Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) in the form attached hereto as Exhibit 1.3, pursuant to which, subject to standard termination provisions, Vlad shall perform and provide, timely and competently, the services referenced therein (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Consulting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Services</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and the Buyer shall (y) issue to Vlad one hundred fifty-four thousand two hundred two (154,202) shares of Preferred Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, which number of shares was calculated by dividing Four Hundred Thousand Dollars (US$400,000.00) by the VWAP and which calculation assumes the initial one-to-one conversion ratio of shares of Preferred Stock into shares of Common Stock and (z) tender to Vlad the sum of Ten Thousand Dollars (US$10,000.00) per month on the first day of each month after the Closing</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-top:12.05pt;padding-left:97pt;padding-right:5.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:8.01pt">the Buyer and Kirill Rachenkov (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Kirill</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) shall enter into a standard-form, two-year Consulting Agreement in the form attached hereto as Exhibit 1.3, pursuant to which, subject to standard termination provisions, Kirill shall perform and provide, timely and competently, the Consulting Services referenced therein and the Buyer shall tender to Kirill the sum of Nine Thousand Dollars (US$9,000.00) per month on the first day of each month after the Closing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-top:11.9pt;padding-left:96.85pt;text-indent:-17.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:8.54pt">for the post-Closing Date period of two years during the pendency of each </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Consulting</font></div><div style="margin-top:4pt"><img alt="image_0.jpg" src="image_0.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:192px"></div><div style="margin-top:4.6pt;padding-left:70pt;padding-right:5.8pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> All of such shares are subject to a mandatory eight-calendar-quarter leak-out, such that no more than twelve-and- one-half percent (12.5%) of the shares of Preferred Stock may be converted into shares of Common Stock on a trailing quarterly basis (each quarter based upon the Effective Date) over the course of two years, subject to standard vesting provisions&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that Vlad may not assign, transfer, hypothecate, lien, or otherwise obtain any economic value for any shares of his Preferred Stock that have not been converted into shares of Common Stock in accordance with the provisions of this Section 3.4(a).</font></div><div style="margin-top:6pt;padding-left:70pt;padding-right:5.9pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Notwithstanding anything to the contrary or otherwise in this Agreement or in the Consulting Agreement between the Buyer and Vlad, Vlad understands, acknowledges, and agrees that his failure or refusal to perform and provide the Consulting Services, timely and competently, during the term of his Consulting Agreement shall constitute a material breach of this Agreement and his Consulting Agreement. Any of the following shall be deemed to constitute such a breach&#58;</font></div><div style="margin-top:5.9pt;padding-left:97pt;padding-right:5.9pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.12pt">Vlad&#8217;s failure or refusal to perform, in any material respect his duties under his Consulting Agreement, where such action would be in the ordinary course of Vlad&#8217;s duties (for the avoidance of doubt, Vlad&#8217;s refusal to take any action or refrain from taking any action that would violate any law, rule, regulation, governmental pronouncement, court order, decree, or judgment or breach a fiduciary duty will not constitute Cause)&#59;</font></div><div style="margin-top:3pt;padding-left:97pt;padding-right:6.05pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.68pt">gross negligence, recklessness, willful misconduct, or intentional misrepresentation by Vlad in the performance of his duties under his Consulting Agreement&#59;</font></div><div style="margin-top:2.9pt;padding-left:97pt;padding-right:6.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.68pt">the commission by Vlad of any act of fraud, embezzlement, theft, or other financial dishonesty, or of any felony, or of any crime involving moral turpitude&#59; or</font></div><div style="margin-top:2.85pt;padding-left:97pt;padding-right:10.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:2.74pt">Vlad&#8217;s violation of state or federal law relating to sexual harassment or other prohibited harassment or discrimination or any policy of the Buyer of which Vlad had been provided notice.</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ifea7957234684252863246a07d1f397e_7"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.1pt;padding-left:97pt;padding-right:5.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> each of Vlad and Kirill, severally and not jointly, expressly agrees, acknowledges, and understands that their individual failure or refusal to perform and provide, timely and competently, in any material respect, their respective Consulting Services at any time during the term of their respective Consulting Agreement shall constitute a material breach of this Agreement and of their respective Consulting Agreement and (i) in respect of Vlad only, shall provide the Buyer with the right, but not the obligation, to cause all of the shares of his Preferred Stock (and all of the shares of Common Stock into which his shares of Preferred Stock could have been converted, as well as all of the shares of Common Stock then owned of record or beneficially by Vlad), then and there, to be deemed to have been returned to the treasury for cancellation and no longer to be issued and outstanding shares of capital stock of the Buyer and (ii) in respect of Vlad or Kirill, as relevant, shall provide the Buyer with the right, but not the obligation, to cease the tender of the monthly payments that otherwise might have been due to Vlad, or Kirill, as relevant, under his specific Consulting Agreement.</font></div><div style="margin-top:12.05pt;padding-left:26.7pt;padding-right:26.7pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 4</font></div><div style="margin-top:0.15pt;padding-left:26.85pt;padding-right:26.85pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">REPRESENTATIONS AND WARRANTIES</font></div><div style="margin-top:11.85pt;padding-left:133pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt">Seller&#8217;s Representations.</font></div><div style="margin-top:1.1pt"><font><br></font></div><div style="padding-left:61pt;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Seller represents and warrants to the Buyer as of the Effective Date and as of the Closing Date as follows&#58;</font></div><div style="margin-top:12pt;padding-left:133pt;padding-right:5.4pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:33.7pt">The Seller is a duly formed and validly existing limited liability company and in good standing pursuant to the laws of Nevada and has the full power, authority, and legal right to execute and deliver and perform its obligations under this Agreement.</font></div><div style="margin-top:12pt;padding-left:133pt;padding-right:5.45pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:33.02pt">The Seller has good and marketable title to all of the Purchased Assets, free and clear of any and all encumbrances. Upon consummation of the transactions contemplated by this Agreement, the Buyer will have acquired all of the Seller&#8217;s right, title, and interest in and to each of the Purchased Assets, free and clear of all encumbrances but subject to all applicable laws.</font></div><div style="margin-top:12.05pt;padding-left:133pt;padding-right:5.35pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:33.7pt">The execution and delivery of this Agreement, the consummation of the transactions provided for herein, and the fulfillment of the terms hereof on the part of the Seller will not result in a breach of any instrument to which the Seller is a party or by which the Seller is bound or of any judgment, decree, or order of any court or governmental body or any law, rule, or regulation applicable to the Seller.</font></div><div style="margin-top:12pt;padding-left:133pt;padding-right:5.4pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:33.02pt">The execution, delivery, and performance of this Agreement and the transactions contemplated herein by the persons executing the same on behalf of the Seller have been duly and validly authorized and this Agreement and the other agreements and instruments contemplated hereby constitute legal, valid, and binding obligations of the Seller, enforceable in accordance with their respective terms.</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;padding-left:133pt;padding-right:5.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:33.7pt">Except as otherwise provided in this Agreement, no consent, approval, or authorization of any governmental authority or private party that has</font></div><div style="text-align:justify"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:3.1pt;padding-left:133pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">not been obtained and is in effect is required on the part of the Seller in connection with the execution, delivery, and performance of this Agreement by the Seller.</font></div><div style="margin-top:12pt;padding-left:133pt;padding-right:5.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:35.03pt">No litigation, arbitration, claim, investigation, or similar proceedings are pending or, to the Seller&#8217;s knowledge after due inquiry, threatened relative to the Purchased Assets, the Assumd Liabilities, or the Business, nor to Seller&#8217;s knowledge after due inquiry, is there any basis for any such litigation, arbitration, claim, investigation, or similar proceedings.</font></div><div style="margin-top:12.05pt;padding-left:133pt;padding-right:5.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:33.02pt">The Seller has strictly complied with all laws, regulations, rules, or orders relating to the operations of the Business from inception.</font></div><div style="margin-top:12pt;padding-left:133pt;padding-right:5.6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:33.02pt">All information provided to the Buyer by or on behalf of the Seller during the Due Diligence Period is true and correct, including, without limitation, the unaudited financial statements for the fiscal years ended December 31, 2022 and 2023, and the three- and six-month periods ended June 30, 2024 and</font></div><div style="padding-left:133pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2023.</font></div><div style="margin-top:12pt;padding-left:133pt;padding-right:5.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:35.69pt">There are no liabilities relating to the Purchased Assets or the Business, whether known or unknown, whether asserted or unasserted, whether absolute or contingent, whether accrued or unaccrued, whether liquidated or unliquidated, and whether due or to become due.</font></div><div style="margin-top:12pt;padding-left:133pt;padding-right:5.4pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:35.69pt">From and after January 1, 2022, there has not been any material adverse change in the Purchased Assets or the Business or the Assumed Liabilities&#59; the Seller has not entered into any transaction or incurred any liability or obligation that is material to the Business or the operation of the Business except in the ordinary course of its business&#59; and the Seller has not sold or transferred any of its assets relating to the Business other than in the ordinary course of business consistent with Seller&#8217;s past practices.</font></div><div style="margin-top:12.05pt;padding-left:133pt;padding-right:5.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:33.02pt">The Seller has not retained any broker or finder pursuant to any contract or arrangement in connection with the transactions contemplated hereby under which such broker or finder could be entitled to a fee or a commission from the Buyer.</font></div><div style="margin-top:12pt;padding-left:133pt;padding-right:5.45pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:35.69pt">The Seller holds all permits and licenses for operation of the Business as operated in the past, currently, or as proposed that it requires, or is required to have, to own, lease, and maintain its properties and assets and to carry on the Business. The Seller has not received any notice that any of the Seller&#8217;s permits or licenses are not in good standing or are not in full force and effect. The Seller currently is and, from and after January 1, 2022, has been in material compliance with all the terms and conditions relating to the permits and licenses, and there are no proceedings, investigations, or inquiries of any kind in progress pending or, to Seller&#8217;s knowledge after due inquiry, threatened that relate to any of the permits or licenses previously, currently, or prospectively used or to be used in the Seller&#8217;s conduct of the Business. None of the permits or licenses is subject to any variances, conditions, waivers, or other matters which are of a material nature.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:3.1pt;padding-left:133pt;padding-right:5.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:29.69pt">The Seller on its own behalf, and on behalf of its members, represents and warrants to the Buyer that, as of the Effective Date and the Closing Date&#58;</font></div><div style="margin-top:12.05pt;padding-left:205.05pt;padding-right:5.25pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:29.06pt;text-decoration:underline">Investment Purpose</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Seller on its own behalf, and on behalf of its members, is acquiring the shares of Preferred Stock for its own account for investment purposes and not with a view toward, or for resale in connection with, the public sale or distribution thereof, except pursuant to sales registered under or exempt from the registration requirements of the Securities Act of 1933, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that, by making the representations herein, the Seller on its own behalf, and on behalf of its members, does not agree, or make any representation or warranty, to hold any of the shares of Preferred Stock for any minimum or other specific term and reserves the right to dispose of the shares of Preferred Stock at any time in accordance with, or pursuant to, a registration statement covering the Securities or an available exemption under the Securities Act. The Seller on its own behalf, and on behalf of its members, does not presently have any agreement or understanding, directly or indirectly, with any person to distribute any of the shares of Preferred Stock.</font></div><div style="margin-top:12.05pt;padding-left:205.05pt;padding-right:5.4pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:25.07pt;text-decoration:underline">Reliance on Exemptions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Seller on its own behalf, and on behalf of its members, understands that the shares of Preferred Stock are being offered and sold to it in reliance on specific exemptions from the registration requirements of United States federal and state securities laws and that the Buyer is relying in part upon the truth and accuracy of, and the Seller on its own behalf, and on behalf of its members&#8217;, compliance with, the representations, warranties, agreements, acknowledgments, and understandings of the Seller on its own behalf, and on behalf of its members, set forth herein in order to determine the availability of the exemptions and the eligibility of the Seller on its own behalf, and on behalf of its members, to acquire the shares of Preferred Stock.</font></div><div style="margin-top:12pt;padding-left:205.05pt;padding-right:5.5pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.08pt">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Seller on its own behalf, and on behalf of its members, and their respective advisors and counsel, if any, (a) have had the opportunity of reviewing all of the publicly available filings by the Buyer with the Commission on its EDGAR website, (b) have been furnished with all materials relating to the business, finances, and operations of the Buyer that the Seller on its own behalf, and on behalf of its members, deemed material to making an informed investment decision regarding the acquisition of the shares of Preferred Stock, and (c) the Seller on its own behalf, and on behalf of its members, have been afforded the opportunity to ask questions of the Buyer and its management. The Seller on its own behalf, and on behalf of its members, understands that ownership of the shares </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;padding-left:205.05pt;padding-right:5.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">of Preferred Stock involves a high degree of risk. The Seller on its own behalf, and on behalf of its members, has sought the</font></div><div style="text-align:justify"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:3.1pt;padding-left:205.05pt;padding-right:5.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">accounting, legal, and tax advice as they have considered necessary to make an informed investment decision with respect to the acquisition of the shares of Preferred Stock.</font></div><div style="margin-top:12.05pt;padding-left:205.05pt;padding-right:5.5pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IV.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.4pt;text-decoration:underline">Transfer or Resale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Seller on its own behalf, and on behalf of its members, understands that&#58; (i) the shares of Preferred Stock have not been registered under the Securities Act or qualified under any state securities laws, and may not be offered for sale, sold, assigned, or transferred unless (A) subsequently registered thereunder, (B) the Seller on its own behalf, and on behalf of its members, shall have delivered to the Buyer an opinion of counsel, in a generally acceptable form, to the effect that the Securities to be sold, assigned, or transferred may be sold, assigned, or transferred pursuant to an exemption from the registration requirements, or (C) the Seller on its own behalf, and on behalf of its members, provides the Buyer with reasonable assurances (in the form of seller and broker representation letters) that the Securities can be sold, assigned, or transferred pursuant to Rule 144, in each case following the applicable holding period set forth therein and (ii) any sale of the shares of Preferred Stock made in reliance on Rule 144 may be made only in accordance with the terms of Rule 144 and, further, if Rule 144 is not applicable, any resale of the shares of Preferred Stock under circumstances in which the Buyer or any of its relevant members (or the person through whom the sale is made) may be deemed to be an &#8220;underwriter&#8221; (as that term is defined in the Securities Act) may require compliance with some other exemption under the Securities Act or the rules and regulations of the Commission thereunder.</font></div><div style="margin-top:12.05pt;padding-left:205.05pt;padding-right:5.65pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">V.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.39pt;text-decoration:underline">Legends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Seller on its own behalf, and on behalf of its members, agrees to the imprinting, so long as its required by this Section 4.1(m)(V), of a restrictive legend on the shares of Preferred Stock in substantially the following form&#58;</font></div><div style="margin-top:12pt;padding-left:205.05pt;padding-right:5.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR QUALIFIED UNDER APPLICABLE STATE SECURITIES LAWS. THE SECURITIES HAVE BEEN ACQUIRED SOLELY FOR INVESTMENT PURPOSES AND NOT WITH A VIEW TOWARD RESALE AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED, OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS, OR AN OPINION OF COUNSEL, IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;padding-left:205.05pt;padding-right:5.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">REQUIRED UNDER SAID ACT OR APPLICABLE STATE SECURITIES LAWS.</font></div><div style="margin-top:12.05pt;padding-left:133pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt">Buyer&#8217;s Representations.</font></div><div><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-top:3.1pt;padding-left:61pt;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Buyer represents and warrants to the Seller as of the Effective Date and as of the Closing Date as follows&#58;</font></div><div style="margin-top:12pt;padding-left:133pt;padding-right:5.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:33.7pt">Buyer is a duly formed and validly existing corporation in good standing pursuant to the laws of the State of Delaware and has the full power, authority, and legal right to execute and deliver and perform its obligations under this Agreement.</font></div><div style="margin-top:12.05pt;padding-left:133pt;padding-right:5.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:33.02pt">The execution and delivery of this Agreement, the consummation of the transactions provided for herein and the fulfillment of the terms hereof on the part of the Buyer will not result in a breach of any instrument to which the Buyer is a party or by which the Buyer is bound or of any judgment, decree or order of any court or governmental body or any law, rule, or regulation applicable to the Buyer.</font></div><div style="margin-top:12pt;padding-left:133pt;padding-right:5.3pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:33.7pt">The execution, delivery, and performance of this Agreement and the transactions contemplated herein by the persons executing the same on behalf of the Buyer have been duly and validly authorized and this Agreement and the other agreements and instruments contemplated hereby constitute legal, valid, and binding obligations of the Buyer, enforceable in accordance with their respective terms.</font></div><div style="margin-top:12pt;padding-left:133pt;padding-right:5.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:33.02pt">Except as otherwise provided in this Agreement, no consent, approval, or authorization of any governmental authority or private party that has not been obtained and is in effect is required on the part of the Buyer in connection with the execution, delivery, and performance of this Agreement by the Buyer.</font></div><div style="margin-top:12.05pt;padding-left:133pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt">Reliance.</font></div><div style="margin-top:1.05pt"><font><br></font></div><div style="padding-left:61pt;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The representations and warranties contained herein are made with the knowledge and expectation that the Buyer and the Seller, as the case may be, are placing complete reliance thereon.</font></div><div><font><br></font></div><div style="margin-top:10.2pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:26.7pt;padding-right:26.7pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 5</font></div><div style="margin-top:0.1pt;padding-left:26.8pt;padding-right:26.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">DUE DILIGENCE</font></div><div style="margin-top:11.9pt;padding-left:133pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt">Investigations.</font></div><div style="margin-top:12pt;padding-left:61pt;padding-right:5.4pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Seller shall promptly and reasonably respond to the Buyer&#8217;s requests for information (in no event later than one (1) business day after receipt of such request) and shall afford the Buyer access to the books and records of the Seller and any other materials requested by the Buyer. The Buyer shall have the right, at any time up to and including the day on which the Due Diligence Period is to expire, to terminate this Agreement for any reason or no reason, in Buyer&#8217;s sole and absolute discretion upon written notice to the Seller. In the event the Buyer so terminates this Agreement, the Buyer shall return to the Seller any materials regarding the Purchased Assets, Seller, or Licenses provided by Seller and copies of any investigations or reports conducted by or for the Buyer regarding the same, all at no cost to Seller.</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;padding-left:133pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt">Notice of Termination.</font></div><div><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-top:3.1pt;padding-left:61pt;padding-right:5.6pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If the Buyer fails to terminate this Agreement as provided in Section 5.1, the Buyer shall be deemed to have approved all matters pertaining to or affecting the Purchased Assets, the Seller, and the Licenses, and the Buyer shall have no further right to terminate this Agreement pursuant to this Section 5.</font></div><div style="margin-top:12.05pt;padding-left:133pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt">Confidentiality.</font></div><div style="margin-top:1.05pt"><font><br></font></div><div style="padding-left:61pt;padding-right:5.4pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:33.75pt">The Buyer agrees that all documents and information regarding the Purchased Assets, and the Seller, of whatsoever nature made available to the Buyer or its affiliates or agents by the Seller or the Seller&#8217;s affiliates or agents and the results of all tests and studies of the Purchased Assets, the Seller, and the Licenses, are confidential and, subject to court order and other requirements of law, the Buyer shall not disclose any such information to any other person except those assisting it with the analysis of the Purchased Assets, the Seller, and the Licenses and only after procuring such person&#8217;s agreement to abide by these confidentiality restrictions. The term, &#8220;requirements of law&#8221; include, without limitation, disclosure to regulatory agencies including the Canadian Securities Administrators and the United States Securities and Exchange Commission&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the Buyer shall notify the Seller in writing of such disclosure to any such agency no less than five (5) business days before such disclosure or less time if not otherwise reasonably practicable. In the event this Agreement is terminated or the Closing does not occur for any reason, the Buyer shall return to the Seller all documents and information that were provided by the Seller or the Seller&#8217;s affiliates or agents to the Buyer or the Buyer&#8217;s affiliates or agents, or any such materials made available to and copied by the Buyer or the Buyer&#8217;s affiliates or agents, and any copies of such materials. This Section 5.3(a) shall survive the Closing or termination of this Agreement.</font></div><div style="margin-top:12.05pt;padding-left:61pt;padding-right:5.45pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:33.07pt">The Seller agrees that all documents and information regarding the Buyer, of whatsoever nature made available to the Seller or the Seller&#8217;s affiliates or agents by the Buyer or the Buyer&#8217;s affiliates or agents are confidential and, subject to court order and other requirements of law, Seller shall not disclose any such information to any other person. In the event this Agreement is terminated or the Closing does not occur for any reason, the Seller shall return to the Buyer all documents and information that were provided by the Buyer or the Buyer&#8217;s affiliates or agents to the Seller or the Seller&#8217;s affiliates or agents, or any such materials made available to and copied by the Seller or the Seller&#8217;s affiliates or agents, and any copies of such materials. This Section 5.3(b) shall survive the Closing or termination of this Agreement.</font></div><div style="margin-top:12.05pt;padding-left:133pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt">A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">CCESS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:12pt;padding-left:61pt;padding-right:5.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Buyer and the Buyer&#8217;s employees, representatives, consultants, and contractors will be afforded access to the books and records of the Seller for the purposes of conducting an investigation of the Purchased Assets.</font></div><div style="margin-top:12pt;padding-left:26.7pt;padding-right:26.7pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 6</font></div><div style="margin-top:0.15pt;padding-left:26.92pt;padding-right:26.92pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">PRESS RELEASE</font></div><div style="margin-top:11.85pt;padding-left:61pt;padding-right:5.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.1&#160;&#160;&#160;&#160;If either the Seller or the Buyer desires to issue a press release or public announcement concerning the entering into this Agreement, such party shall submit such request to the other party for approval, which approval shall not be unreasonably withheld, delayed, denied, or conditioned.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:3.1pt;padding-left:26.7pt;padding-right:26.7pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 7</font></div><div style="margin-top:0.15pt;padding-left:26.87pt;padding-right:26.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">COSTS AND EXPENSES</font></div><div style="margin-top:11.85pt;padding-left:61pt;padding-right:11.1pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Buyer and the Seller will each pay all legal and professional fees and fees of other consultants incurred by the Buyer and the Seller, respectively.</font></div><div style="margin-top:12.05pt;padding-left:26.7pt;padding-right:26.7pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 8</font></div><div style="margin-top:0.1pt;padding-left:26.82pt;padding-right:26.82pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">INDEMNIFICATION</font></div><div style="margin-top:11.9pt;padding-left:61pt;padding-right:5.35pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Seller shall assume and pay all debts, charges, claims, damages, and liabilities attributable to the operation of the Purchased Assets, the Business, and the Seller prior to Closing and shall hold the Buyer harmless therefrom and indemnify and defend against the same. The Buyer shall assume and pay all debts, charges, claims, damages, and liabilities attributable to the operation of the Purchased Assets from and after the Closing and shall hold the Seller harmless therefrom and indemnify and defend against the same, except liabilities expressly assumed in writing by the Seller.</font></div><div style="margin-top:12pt;padding-left:26.7pt;padding-right:26.7pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 9</font></div><div style="margin-top:0.15pt;padding-left:26.97pt;padding-right:26.97pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">BROKERS</font></div><div style="margin-top:11.85pt;padding-left:61pt;padding-right:5.45pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Seller represents and warrants to the Buyer, and the Buyer represents and warrants to the Seller that no broker or finder has been engaged by either of them in connection with any of the transactions contemplated by this Agreement. The Buyer and the Seller will indemnify, save harmless and defend the other from any liability, cost or expense arising out of or connected with any claim for any commission or compensation made by any person or entity claiming to have been retained or contacted by them in connection with the transactions contemplated by this Agreement.</font></div><div style="margin-top:12.05pt;padding-left:26.7pt;padding-right:26.7pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 10</font></div><div style="margin-top:0.1pt;padding-left:26.85pt;padding-right:26.85pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">NOTICES</font></div><div style="margin-top:11.9pt;padding-left:133pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt">N</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">OTICE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:12pt;padding-left:61pt;padding-right:5.5pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Any and all notices and demands by either party hereto to the other party, required or desired to be given hereunder shall be in writing and shall be validly given only if deposited in the United States mail, certified or registered, postage prepaid, return receipt requested, or if made by Federal Express or other delivery service which keeps records of deliveries and attempted deliveries, or, if made by facsimile machine (receipt of which is acknowledged or if a copy thereof is delivered the following day by a delivery service which keeps records of deliveries and attempted deliveries). Service of notice shall be conclusively deemed made on the first business day delivery is attempted or upon receipt, whichever is sooner, provided that such notice is addressed as follows&#58;</font></div><div style="margin-top:12.05pt;padding-left:313.05pt;padding-right:99.3pt;text-indent:-180.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To the Seller&#58;&#160;&#160;&#160;&#160;Qoden Technologies LLC 5348 Vegas Drive 172 Las Vegas, Nevada 89108</font></div><div style="margin-top:12pt;padding-left:133pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">With a mandatory copy</font></div><div style="padding-left:133pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Which shall not constitute notice to&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div><img alt="image_2.jpg" src="image_2.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:144px"></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ifea7957234684252863246a07d1f397e_10"></div><hr style="page-break-after:always"><div style="min-height:84.24pt;width:100%"><div><font><br></font></div></div><div style="padding-left:313.05pt"><img alt="image_3.jpg" src="image_3.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:144px"></div><div style="margin-top:12pt;padding-left:133pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To the Buyer and the Buyer Sub&#58;&#160;&#160;&#160;&#160;ALT5 Sigma Corporation</font></div><div style="padding-left:313.05pt;padding-right:40.35pt"><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">325 E. Warm Springs Road, Suite 102 Las Vegas, Nevada 89119</font></div><div style="margin-top:12pt;padding-left:133pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">With a mandatory copy to</font></div><div style="padding-left:133pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.75pt">Which shall not constitute notice&#58;&#160;&#160;&#160;&#160;Clark Hill LLP</font></div><div style="padding-left:313.05pt;padding-right:40.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">555 South Flower Street, 24</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:117%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%"> Floor Los Angeles, California 90071</font></div><div style="margin-top:11.8pt;padding-left:133pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">HANGES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:12pt;padding-left:61pt;padding-right:5.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A party hereto may change its address for the purpose of receiving notices or demands as herein provided by a written notice given in the manner aforesaid to the other party hereto, which notice of change of address shall not become effective, however, until the actual receipt thereof by the other party.</font></div><div style="margin-top:12pt;padding-left:26.7pt;padding-right:26.7pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 11</font></div><div style="margin-top:0.15pt;padding-left:26.92pt;padding-right:26.92pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">MISCELLANEOUS PROVISIONS</font></div><div style="margin-top:12pt;padding-left:133pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Governing Law&#58; Jurisdiction and Venue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.95pt"><font><br></font></div><div style="padding-left:61pt;padding-right:5.5pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement, for all purposes, shall be construed in accordance with the laws of Nevada without regard to conflicts of law principles. Any action or proceeding by either of the parties to enforce an arbitration award with respect to this Agreement shall be brought only in a state or federal court located in the State of Nevada, Clark County. The parties hereby irrevocably submit to the non-exclusive jurisdiction of such courts and waive the defense of inconvenient forum to the maintenance of any such action or proceeding in such venue.</font></div><div style="margin-top:12.05pt;padding-left:133pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt">Successors.</font></div><div style="margin-top:1.05pt"><font><br></font></div><div style="padding-left:61pt;padding-right:6.15pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective successors, nominees, designees, and assignees.</font></div><div style="margin-top:12pt;padding-left:133pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt">Assignment.</font></div><div style="margin-top:1.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:61pt;padding-right:5.4pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Buyer may assign this Agreement to any designee, nominee, or assignee of its choice&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, any such assignment (1) shall not delay any approvals required for the Buyer to purchase the Purchased Assets as set forth in this Agreement and (2) must be in writing, a copy of which must promptly be provided to Seller. No such assignment shall relieve the original Buyer under this Agreement of its liability under this Agreement for any matters occurring prior to such assignment, all of which obligations shall survive against the original Buyer shall in no way such original Buyer be released from the full and complete performance of all the terms hereof.</font></div><div style="margin-top:12pt;padding-left:133pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt">N</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">ON</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-W</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">AIVER</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:12pt;padding-left:61pt;padding-right:5.6pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The failure to enforce or the delay in enforcement of any provision of this Agreement by a party hereto or the failure of a party to exercise any right hereunder shall in no way be construed </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:84.24pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;padding-left:61pt;padding-right:5.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">to be a waiver of such provision or right (or of any other provision or right hereof whether of a similar or dissimilar nature) unless such party expressly waives such provision or right in writing.</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ifea7957234684252863246a07d1f397e_13"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.1pt;padding-left:133pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt">Partial Invalidity.</font></div><div style="margin-top:1.1pt"><font><br></font></div><div style="padding-left:61pt;padding-right:5.5pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If any term, provision, covenant or condition of this Agreement, or any application thereof, should be held by a court of competent jurisdiction to be invalid, void, or unenforceable, all provisions, covenants, and conditions of this Agreement, and all applications thereof, not held invalid, void, or unenforceable, shall continue in full force and effect and shall in no way be affected, impaired, or invalidated thereby.</font></div><div style="margin-top:12pt;padding-left:133pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt">Attorneys&#8217; Fees.</font></div><div style="margin-top:1.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:61pt;padding-right:5.55pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In the event any action is commenced by either party against the other in connection herewith (including any action to lift a stay or other bankruptcy proceeding), the unsuccessful party shall pay the costs and expenses, including reasonable attorneys&#8217; fees, as determined by the court, of the prevailing party.</font></div><div style="margin-top:12pt;padding-left:133pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt">Entire Agreement.</font></div><div style="margin-top:1.1pt"><font><br></font></div><div style="padding-left:61pt;padding-right:5.5pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement constitutes the entire agreement between the parties pertaining to the subject matter contained herein and supersedes all prior representations, agreements, and understandings of the parties, including any &#8220;letter of intent&#8221;, &#8220;letter of understanding&#8221;, or similar documents. No addition to or modification of this Agreement shall be binding unless executed in writing by the parties hereto.</font></div><div style="margin-top:12pt;padding-left:133pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt">Time of Essence.</font></div><div style="margin-top:1.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:61pt;padding-right:5.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Time is of the essence in the performance of the parties&#8217; respective obligations set forth in this Agreement and all the terms, provisions, covenants, and conditions hereof.</font></div><div style="margin-top:12pt;padding-left:133pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt">Counterparts.</font></div><div style="margin-top:1.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:61pt;padding-right:5.6pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement may be executed in any number of counterparts, each of which when executed and delivered shall be an original, but all such counterparts shall constitute one and the same Agreement. Any signature page of this Agreement may be detached from any counterpart without impairing the legal effect of any signatures thereon, and may be attached to another counterpart, identical in form thereto, but having attached to it one or more additional signature pages. To facilitate execution of this Agreement, the parties may execute and exchange by telephone or electronic facsimile counterparts of the signature pages.</font></div><div style="margin-top:12pt;padding-left:133pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12pt">H</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">EADINGS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:12pt;padding-left:61pt;padding-right:5.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The headings of the various paragraphs of this Agreement have been inserted only for convenience, and shall not be deemed in any manner to modify or limit any of the provisions of this Agreement, or be used in any manner in the interpretation of this Agreement.</font></div><div style="margin-top:12pt;padding-left:131.75pt;text-indent:-34.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:10.75pt">Interpretation.</font></div><div style="margin-top:1.1pt"><font><br></font></div><div style="padding-left:61pt;padding-right:5.6pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Whenever the context so requires, all words used in the singular shall be construed to have been used in the plural (and vice versa), each gender shall be construed to include any other genders, and the word &#8220;person&#8221; shall be construed to include a natural person, a corporation, a firm, a partnership, a joint venture, a trust, an estate, or any other entity.</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ifea7957234684252863246a07d1f397e_16"></div><hr style="page-break-after:always"><div style="min-height:5.76pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.9pt;padding-left:5.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Docusign Envelope ID&#58; BCE1695E-3E64-49C6-87AF-40D5DD88E71B</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:131.75pt;text-indent:-34.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:10.75pt">Further assurances.</font></div><div style="margin-top:1.05pt"><font><br></font></div><div style="padding-left:61pt;padding-right:5.4pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In addition to the acts and deed recited herein and contemplated to be performed, executed, or delivered by Seller or Buyer, Seller and Buyer hereby agree to perform, execute, and deliver, or cause to be performed, executed and delivered, on the Closing Date or thereafter, any and all such further acts, deeds and assurances as Buyer or Seller, as the case may be, may reasonably require in order to consummate fully the transactions contemplated hereunder.</font></div><div style="margin-top:12pt;padding-left:131.75pt;text-indent:-34.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:10.75pt">Waiver of Jury Trial.</font></div><div style="margin-top:1.1pt"><font><br></font></div><div style="padding-left:61pt;padding-right:5.85pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">TO THE EXTENT PERMITTED BY APPLICABLE LAW, THE PARTIES HEREBY WAIVE ANY RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDINGS ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT.</font></div><div style="margin-top:12pt;padding-left:133pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12pt">D</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">ATES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:12pt;padding-left:61pt;padding-right:5.5pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The term &#8220;business day&#8221; shall mean calendar days other than a Saturday, Sunday, or United States national or State of Nevada holiday. If any dates hereunder for the taking of some action or the expiration of some time period fall on a day that is not a business day, such date shall be the next following business day.</font></div><div><font><br></font></div><div style="margin-top:10.2pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:213.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;SIGNATURE PAGE FOLLOW&#93;</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ifea7957234684252863246a07d1f397e_19"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.1pt;padding-left:61pt;padding-right:2.8pt;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Buyer and the Seller have executed this Agreement as of the day and year first above written.</font></div><div style="margin-top:12.25pt;padding-left:61pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Seller&#58;</font></div><div style="margin-top:11.9pt;padding-left:61pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">QODEN TECHNOLOGIES LLC</font></div><div><font><br></font></div><div style="margin-top:8.25pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:97pt;padding-right:258.15pt;text-indent:-34.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Andrei Verbin</font></div><div style="margin-top:0.1pt;padding-left:97pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Chief Executive Officer</font></div><div style="margin-top:11.9pt;padding-left:61pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Buyer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58;</font></div><div style="margin-top:12pt;padding-left:61pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ALT5 SIGMA CORPORATION</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:97pt;padding-right:258.15pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Peter Tassiopoulos</font></div><div style="padding-left:97pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.70pt">Chief Executive Officer</font></div><div><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-top:3.5pt;padding-left:182.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">INDEX OF EXHIBITS AND SCHEDULES</font></div><div style="margin-top:11.75pt;padding-right:58.35pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Schedule 1.1&#160;&#160;&#160;&#160;Assigned Contracts</font></div><div style="margin-top:12pt;padding-right:55.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 1.2&#160;&#160;&#160;&#160;Form of Bill of Sale</font></div><div style="margin-top:12pt;padding-right:53.4pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 1.3&#160;&#160;&#160;&#160;List of Consultants &#47;</font></div><div style="padding-right:53.35pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C and PI Agreement</font></div><div style="margin-top:12pt;padding-left:61pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 1.3(a)&#160;&#160;&#160;&#160;Consulting Agreement</font></div><div style="padding-left:385.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">for Vlad</font></div><div style="margin-top:12pt;padding-left:61pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 1.3(b)&#160;&#160;&#160;&#160;Consulting Agreement</font></div><div style="padding-left:385.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">for Kirill</font></div><div style="margin-top:11.9pt;padding-left:61pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Schedule 1.5&#160;&#160;&#160;&#160;Purchased Assets</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ifea7957234684252863246a07d1f397e_22"></div><hr style="page-break-after:always"><div style="min-height:10.08pt;width:100%"><div><font><br></font></div></div><div style="padding-left:4pt"><img alt="image_4.jpg" src="image_4.jpg" style="height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:10.55pt"><font><br></font></div><div style="padding-left:225.65pt;padding-right:172.4pt;text-indent:28.05pt"><img alt="image_5.jpg" src="image_5.jpg" style="height:12px;margin-bottom:5pt;vertical-align:text-bottom;width:332px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SCHEDULE 1.1 ASSIGNED CONTRACTS</font></div><div style="margin-top:11.65pt;padding-left:79pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">Alt 5 Sigma, Inc., 3500 De Maisonneuve West, Suite 2401, Westmount, QC., H3Z 3C, Canada&#59;</font></div><div style="margin-top:12pt;padding-left:79pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">Genie Technologies Pte Ltd., 6 Raffles Quay #16-01, Singapore 048580&#59;</font></div><div style="margin-top:12pt;padding-left:79pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">WallBTC PTE LTD, 400 Orchard Road #05-25, Orchard Towers, Singapore 238875&#59;</font></div><div style="margin-top:12pt;padding-left:79pt;padding-right:10.35pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">PT Daxwise Digital, Scientia Business Park Tower II 2nd Floor, Curug Sangereng, Kecamatan Serpong, Tangerang, Banten, 15810, Indonesia&#59;</font></div><div style="margin-top:12pt;padding-left:79pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">COINSATE DOO, D&#382;ord&#382;a Va&#353;ingtona Br, 44, Podgorica, Montenegro&#59; and</font></div><div style="margin-top:12.15pt;padding-left:79pt;padding-right:11.05pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">Yupiter Investland Ltd. Suite 1, Second Floor, Sound &#38; Vision House, Francis Rachel Str., Victoria, Mahe, Seychelles.</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ifea7957234684252863246a07d1f397e_25"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.95pt;padding-left:26.72pt;padding-right:26.72pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXHIBIT 1.2</font></div><div style="margin-top:11.75pt;padding-left:26.82pt;padding-right:26.82pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;FORM OF BILL OF SALE&#93;</font></div><div style="margin-top:0.4pt;padding-left:26.67pt;padding-right:26.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">BILL OF SALE</font></div><div style="margin-top:11.65pt;padding-left:61pt;padding-right:5.3pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Bill of Sale (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Bill of Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) is made by Qoden Technologies LLC, a Nevada limited liability company with an address of 5348 Vegas Drive 172, Las Vegas, Nevada 89108, United States (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Seller</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and is dated as of the Closing Date as that term is defined in that certain Asset Purchase and Sale Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Purchase Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), entered into contemporaneously herewith, by and between Seller and ALT5 Sigma Corporation, or its permitted designees, nominees, or assignees with an address of </font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">325 E. Warm Springs Road, Suite 102, Las Vegas, Nevada 89119 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Buyer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). Capitalized terms used herein and not defined have the meaning ascribed to them in the Purchase Agreement, the terms of which are specifically incorporated by reference into this Bill of Sale.</font></div><div style="margin-top:12.25pt;padding-left:26.67pt;padding-right:26.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">R E C I T A L S</font></div><div style="margin-top:11.75pt;padding-left:61pt;padding-right:10.95pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, Section 1.2(b) of the Purchase Agreement requires the Seller to execute this Bill of Sale as a condition of the Purchase Agreement&#59; and</font></div><div style="margin-top:12pt;padding-left:61pt;padding-right:5.45pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, Seller desires to sell and to deliver and to assign any and all of the Seller&#8217;s right, title, and interest in and to the Purchased Assets to the Buyer.</font></div><div style="margin-top:12pt;padding-left:61pt;padding-right:5.85pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of these presents and for such other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto intending to be legally bound hereby, agree as follows&#58;</font></div><div style="margin-top:12.05pt;padding-left:61pt;padding-right:5.4pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:2.05pt">Subject to the terms of this Bill of Sale, the Seller sells and delivers and assigns any and all of the Seller&#8217;s right, title, and interest in and to the Purchased Assets free and clear of all liens and encumbrances to the Buyer.</font></div><div style="margin-top:12pt;padding-left:61pt;padding-right:5.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:2.05pt">The Seller shall use commercially reasonable best efforts to secure all regulatory approvals necessary, if applicable, to effectuate the terms of this Bill of Sale and the transactions contemplated by the Purchase Agreement.</font></div><div style="margin-top:12pt;padding-left:61pt;padding-right:10.9pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF the Seller has executed this Bill of Sale effective as of the Closing Date.</font></div><div style="margin-top:12.1pt;padding-left:61pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">QODEN TECHNOLOGIES LLC</font></div><div><font><br></font></div><div style="margin-top:8.35pt"><font><br></font></div><div style="padding-left:97pt;padding-right:258.15pt;text-indent:-34.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Andrei Verbin</font></div><div style="padding-left:97pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Chief Executive Officer</font></div><div><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:30.706%"><div><font><br></font></div><div><font><br></font></div><div style="margin-top:1.8pt"><font><br></font></div><div style="padding-left:61pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Mr. Vlad Tikhomirov Mr. Kirill Rachenkov</font></div><div style="margin-top:3.95pt;padding-left:56.82pt;padding-right:56.82pt;text-align:center"><font><br></font></div></div><div style="display:inline-block;max-width:0.369%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:68.925%"><div style="padding-left:56.82pt;padding-right:56.82pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXHIBIT 1.3</font></div><div style="padding-left:57.05pt;padding-right:57.05pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">LIST OF CONSULTANTS &#47; C and PI Agreement</font></div><div style="text-align:center"><font><br></font></div></div></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:30.706%"><div style="text-align:center"><font><br></font></div></div><div style="display:inline-block;max-width:0.369%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:68.925%"></div></div><div style="margin-bottom:0.4pt;margin-top:3.5pt;padding-left:26.65pt;padding-right:26.65pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SCHEDULE 1.5</font></div><div style="padding-left:76.85pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.504%"><tr><td style="width:1.0%"></td><td style="width:2.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.855%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:11.35pt;padding-right:-2.63pt"><font><br></font></div><div style="padding-right:-2.63pt"><font style="color:#1d2128;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:11.35pt;padding-right:-2.63pt"><font><br></font></div><div style="padding-right:-1.33pt;text-align:right"><font style="color:#1d2128;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Qodex</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:100.72pt;padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:13.30pt">PURCHASED ASSETS</font></div><div style="margin-top:11.75pt;padding-right:-2.63pt"><font style="color:#1d2128;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cryptocurrency Exchange Software including&#58;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.75pt;padding-left:19.92pt;padding-right:-2.63pt"><font style="color:#1d2128;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font></div><div style="margin-top:13.8pt;padding-left:19.92pt;padding-right:-2.63pt"><font style="color:#1d2128;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.05pt">b.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.75pt;padding-right:-2.63pt"><font style="color:#1d2128;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Trading Module providing spot trading functions and API, charts, and liquidity management&#59;</font></div><div style="padding-right:-2.63pt"><font style="color:#1d2128;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.05pt">Wallet module integrating with blockchains, custodians, and AML providers&#59;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:19.92pt;padding-right:-2.63pt"><font style="color:#1d2128;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.55pt">c.</font></div><div style="padding-right:-2.63pt"><font><br></font></div><div style="padding-left:19.92pt;padding-right:-2.63pt"><font style="color:#1d2128;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.05pt">d.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#1d2128;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">KYC service implementing KYC function as well as integrations with KYC providers&#59;</font></div><div style="padding-right:-2.63pt"><font style="color:#1d2128;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.05pt">System monitoring modules&#59; and</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:4.37pt;text-align:right"><font style="color:#1d2128;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:12.55pt">e.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#1d2128;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:12.55pt">Web and Mobile terminals.</font></div></td></tr></table></div><div style="margin-top:12.2pt;padding-left:97pt;text-indent:-18pt"><font style="color:#1d2128;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#1d2128;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">Mobile apps currently deployed and in development.</font></div><div style="margin-top:12pt;padding-left:97pt;padding-right:28.65pt;text-indent:-18pt"><font style="color:#1d2128;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#1d2128;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">Futures trading module (It is alpha version, capable of maintaining positions, charging funding fees and liquidating. Estimated at 50% complete).</font></div><div style="margin-top:12pt;padding-left:97pt;text-indent:-18pt"><font style="color:#1d2128;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#1d2128;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">All source code, documentation, data, and bug repositories.</font></div><div style="margin-top:12pt;padding-left:97pt;text-indent:-18pt"><font style="color:#1d2128;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#1d2128;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt">All Trademarks.</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>3
<FILENAME>alt5-exhibit21xexx211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i5e72f3217c6d445c9cf235811c88e873_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:18.7pt;text-align:justify;text-indent:-18.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 21.1</font></div><div style="padding-left:18.7pt;text-align:justify;text-indent:-18.7pt"><font><br></font></div><div style="padding-left:18.7pt;text-align:justify;text-indent:-18.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsidiaries of ALT5 Sigma Corporation&#58;</font></div><div style="padding-left:18.7pt;text-align:justify;text-indent:-18.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.306%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.612%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:64.682%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="border-left:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:0.5pt solid #bfbfbf;border-right:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:2px 2.38pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Incorporation</font></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">JanOne Biotech Holdings Inc.</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.5pt solid #bfbfbf;border-right:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:2px 2.38pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ARCA Recycling, Inc. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="border-left:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:0.5pt solid #bfbfbf;border-right:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:2px 2.38pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ARCA Canada Inc.</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.5pt solid #bfbfbf;border-right:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:2px 2.38pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ontario, Canada</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Customer Connexx, LLC </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="border-left:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:0.5pt solid #bfbfbf;border-right:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:2px 2.38pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GeoTraq Inc.</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.5pt solid #bfbfbf;border-right:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:2px 2.38pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ALT5 Sigma, Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-left:0.5pt solid #bfbfbf;border-right:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:2px 2.38pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Alyea Therapeutics Corporation</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.5pt solid #bfbfbf;border-right:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:2px 2.38pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ALT5 Sigma Canada, Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #bfbfbf;border-right:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:2px 2.38pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ontario, Canada</font></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ALT5 Sigma ATM, Inc.</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:0.5pt solid #bfbfbf;border-right:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:2px 2.38pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ontario, Canada</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ALT5 Markets, Inc.</font></td><td colspan="3" style="border-left:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #bfbfbf;border-right:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:2px 2.38pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-bottom:0.5pt solid #bfbfbf;border-left:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">UAB ALT5 Sigma Prudentia</font></td><td colspan="3" style="background-color:#f2f2f2;border-bottom:0.5pt solid #bfbfbf;border-left:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-bottom:0.5pt solid #bfbfbf;border-left:0.5pt solid #bfbfbf;border-right:0.5pt solid #bfbfbf;border-top:0.5pt solid #bfbfbf;padding:2px 2.38pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lithuania</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All subsidiaries are 100% owned by the Company.</font></div><div><font><br></font></div><div style="padding-right:21.6pt;text-align:justify"><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">(1) On February </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">19, </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">2021, JanOne </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">Inc. </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">(the &#34;Company&#34;), together with </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">its </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">subsidiaries ARCA Recycling, </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">Inc. </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">(&#34;ARCA </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">Recycling&#34;) </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">and Customer Connexx </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">LLC </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">(&#34;Connexx&#34;), entered </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">into an </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">Asset Purchase </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">Agreement </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">with </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">ARCA Affiliated </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">Holdings Corporation, </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">ARCA </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">Services </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">Inc</font><font style="color:#525252;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">., </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">and Connexx Services </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">Inc. </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">(collectively, the </font><font style="color:#424242;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">&#34;Buyers&#34;) </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">pursuant to </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">which </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">the Buyers </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">agreed to acquire substantially all of </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">the </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">assets, and assume certain </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">liabilities, </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">of </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">ARCA </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">Recycling and Connexx. See </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">the </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">Current </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">Report </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">on Form 8-K </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">filed by the </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">Company with </font><font style="color:#1a1a1a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">the </font><font style="color:#2a2a2a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:123%">U.S. Securities and Exchange Commission on February 25, 2021.</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>ex231_consentofhudgenscpap.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ib41f34351639432db7af7f1045dc944b_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Exhibit 23.1</font></div><div style="margin-bottom:8pt;text-align:center"><font><br></font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Consent of Independent Registered Public Accounting Firm</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-251645) and Form S-8 (Nos. 333-226775 and 333-254873) of our report dated March 28, 2025 relating to the consolidated financial statements of JanOne Inc. which appear in this Annual Report on Form 10-K.</font></div><div style="margin-top:12pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47;Hudgens CPA, PLLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Houston, Texas</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 28, 2025</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>alt5-20241228xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="iab008e5460ce46639a7e0ed0cf9e8bc9_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Tony Isaac, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">I have reviewed this Annual Report on Form 10-K for the fiscal year ended December&#160;28, 2024 of ALT5 Sigma Corporation (the &#8220;registrant&#8221;)&#59;</font></div><div style="margin-top:12pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; Peter Tassiopoulos</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Peter Tassiopoulos</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Principal Executive Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; March&#160;28, 2025</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:6pt;padding-right:6pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>alt5-20241228xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ib76b990d196140f289284a2c1e701aab_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Virland A. Johnson, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">I have reviewed this Annual Report on Form 10-K for the fiscal year ended January December&#160;28, 2024 of ALT5 Sigma Corporation (the &#8220;registrant&#8221;)&#59;</font></div><div style="margin-top:12pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; Virland A. Johnson</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Virland A. Johnson</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Principal Financial Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; March&#160;28, 2025</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:6pt;padding-right:6pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>alt5-20241228xex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i3f91da2bd3d44381b7e7a288e188c8d1_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report of ALT5 Sigma Corporation (the &#8220;Company&#8221;) on Form 10-K for the fiscal year ended December&#160;28, 2024, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Tony Isaac, the President and Chief Executive Officer of the Company, to the best of my knowledge and belief, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; Peter Tassiopoulos</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Peter Tassiopoulos</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Principal Executive Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; March&#160;28, 2025</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The certification set forth above is being furnished as an exhibit solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and is not being filed as part of the Report as a separate disclosure document of the Company or the certifying officers.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>8
<FILENAME>alt5-20241228xex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ic02eed989d47465597e2106ff8e5466f_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report of ALT5 Sigma Corporation (the &#8220;Company&#8221;) on Form 10-K for the fiscal year ended December&#160;28, 2024, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Virland A. Johnson, the Chief Financial Officer (Principal Financial Officer) of the Company, to the best of my knowledge and belief, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; Virland A. Johnson</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Virland A. Johnson</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Principal Financial Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; March&#160;28, 2025</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The certification set forth above is being furnished as an exhibit solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and is not being filed as part of the Report as a separate disclosure document of the Company or the certifying officers.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>alts-20241228.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:2830d163-e030-49d1-a620-63415283e8e5,g:d25a092d-1f61-4617-aa79-df61d6af7f3a-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:alts="http://www.alt5sigma.com/20241228" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.alt5sigma.com/20241228">
  <xs:import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/cyd-af-sub/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-af-sub-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="alts-20241228_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="alts-20241228_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="alts-20241228_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="alts-20241228_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.alt5sigma.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.alt5sigma.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>9952151 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>9952152 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" roleURI="http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS">
        <link:definition>9952153 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT" roleURI="http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT">
        <link:definition>9952154 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>9952155 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundandBasisofPresentation" roleURI="http://www.alt5sigma.com/role/BackgroundandBasisofPresentation">
        <link:definition>9952156 - Disclosure - Background and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.alt5sigma.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>9952157 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MergersandAcquisitions" roleURI="http://www.alt5sigma.com/role/MergersandAcquisitions">
        <link:definition>9952158 - Disclosure - Mergers and Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SaleofRecyclingSubsidiaries" roleURI="http://www.alt5sigma.com/role/SaleofRecyclingSubsidiaries">
        <link:definition>9952159 - Disclosure - Sale of Recycling Subsidiaries</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DiscontinuedOperations" roleURI="http://www.alt5sigma.com/role/DiscontinuedOperations">
        <link:definition>9952160 - Disclosure - Discontinued Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Prepaidsandothercurrentassets" roleURI="http://www.alt5sigma.com/role/Prepaidsandothercurrentassets">
        <link:definition>9952161 - Disclosure - Prepaids and other current assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipment" roleURI="http://www.alt5sigma.com/role/PropertyandEquipment">
        <link:definition>9952162 - Disclosure - Property and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.alt5sigma.com/role/Leases">
        <link:definition>9952163 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Notesreceivable" roleURI="http://www.alt5sigma.com/role/Notesreceivable">
        <link:definition>9952164 - Disclosure - Notes receivable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Intangibleassets" roleURI="http://www.alt5sigma.com/role/Intangibleassets">
        <link:definition>9952165 - Disclosure - Intangible assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecurities" roleURI="http://www.alt5sigma.com/role/MarketableSecurities">
        <link:definition>9952166 - Disclosure - Marketable Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Depositsandotherassets" roleURI="http://www.alt5sigma.com/role/Depositsandotherassets">
        <link:definition>9952167 - Disclosure - Deposits and other assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Accruedliabilities" roleURI="http://www.alt5sigma.com/role/Accruedliabilities">
        <link:definition>9952168 - Disclosure - Accrued liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debentures" roleURI="http://www.alt5sigma.com/role/Debentures">
        <link:definition>9952169 - Disclosure - Debentures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://www.alt5sigma.com/role/LongTermDebt">
        <link:definition>9952170 - Disclosure - Long-Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyDebt" roleURI="http://www.alt5sigma.com/role/RelatedPartyDebt">
        <link:definition>9952171 - Disclosure - Related Party Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PreferredStock" roleURI="http://www.alt5sigma.com/role/PreferredStock">
        <link:definition>9952172 - Disclosure - Preferred Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.alt5sigma.com/role/StockholdersEquity">
        <link:definition>9952173 - Disclosure - Stockholders&#8217; Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Incometaxes" roleURI="http://www.alt5sigma.com/role/Incometaxes">
        <link:definition>9952174 - Disclosure - Income taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Relatedparties" roleURI="http://www.alt5sigma.com/role/Relatedparties">
        <link:definition>9952175 - Disclosure - Related parties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.alt5sigma.com/role/CommitmentsandContingencies">
        <link:definition>9952176 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLosspershare" roleURI="http://www.alt5sigma.com/role/EarningsLosspershare">
        <link:definition>9952177 - Disclosure - Earnings (Loss) per share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Segmentinformation" roleURI="http://www.alt5sigma.com/role/Segmentinformation">
        <link:definition>9952178 - Disclosure - Segment information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Subsequentevents" roleURI="http://www.alt5sigma.com/role/Subsequentevents">
        <link:definition>9952179 - Disclosure - Subsequent events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>9955512 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MergersandAcquisitionsTables" roleURI="http://www.alt5sigma.com/role/MergersandAcquisitionsTables">
        <link:definition>9955513 - Disclosure - Mergers and Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SaleofRecyclingSubsidiariesTables" roleURI="http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesTables">
        <link:definition>9955514 - Disclosure - Sale of Recycling Subsidiaries (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DiscontinuedOperationsTables" roleURI="http://www.alt5sigma.com/role/DiscontinuedOperationsTables">
        <link:definition>9955515 - Disclosure - Discontinued Operations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidsandothercurrentassetsTables" roleURI="http://www.alt5sigma.com/role/PrepaidsandothercurrentassetsTables">
        <link:definition>9955516 - Disclosure - Prepaids and other current assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentTables" roleURI="http://www.alt5sigma.com/role/PropertyandEquipmentTables">
        <link:definition>9955517 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.alt5sigma.com/role/LeasesTables">
        <link:definition>9955518 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleassetsTables" roleURI="http://www.alt5sigma.com/role/IntangibleassetsTables">
        <link:definition>9955519 - Disclosure - Intangible assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesTables" roleURI="http://www.alt5sigma.com/role/MarketableSecuritiesTables">
        <link:definition>9955520 - Disclosure - Marketable Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DepositsandotherassetsTables" roleURI="http://www.alt5sigma.com/role/DepositsandotherassetsTables">
        <link:definition>9955521 - Disclosure - Deposits and other assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedliabilitiesTables" roleURI="http://www.alt5sigma.com/role/AccruedliabilitiesTables">
        <link:definition>9955522 - Disclosure - Accrued liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebenturesTables" roleURI="http://www.alt5sigma.com/role/DebenturesTables">
        <link:definition>9955523 - Disclosure - Debentures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTables" roleURI="http://www.alt5sigma.com/role/LongTermDebtTables">
        <link:definition>9955524 - Disclosure - Long-Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyDebtTables" roleURI="http://www.alt5sigma.com/role/RelatedPartyDebtTables">
        <link:definition>9955525 - Disclosure - Related Party Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PreferredStockTables" roleURI="http://www.alt5sigma.com/role/PreferredStockTables">
        <link:definition>9955526 - Disclosure - Preferred Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.alt5sigma.com/role/StockholdersEquityTables">
        <link:definition>9955527 - Disclosure - Stockholders&#8217; Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxesTables" roleURI="http://www.alt5sigma.com/role/IncometaxesTables">
        <link:definition>9955528 - Disclosure - Income taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLosspershareTables" roleURI="http://www.alt5sigma.com/role/EarningsLosspershareTables">
        <link:definition>9955529 - Disclosure - Earnings (Loss) per share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentinformationTables" roleURI="http://www.alt5sigma.com/role/SegmentinformationTables">
        <link:definition>9955530 - Disclosure - Segment information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundandBasisofPresentationDetails" roleURI="http://www.alt5sigma.com/role/BackgroundandBasisofPresentationDetails">
        <link:definition>9955531 - Disclosure - Background and Basis of Presentation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>9955532 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofTradeandOtherReceivablesDetails" roleURI="http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesScheduleofTradeandOtherReceivablesDetails">
        <link:definition>9955533 - Disclosure - Summary of Significant Accounting Policies - Schedule of Trade and Other Receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MergersandAcquisitionsQodenDetails" roleURI="http://www.alt5sigma.com/role/MergersandAcquisitionsQodenDetails">
        <link:definition>9955534 - Disclosure - Mergers and Acquisitions - Qoden (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MergersandAcquisitionsALT5Details" roleURI="http://www.alt5sigma.com/role/MergersandAcquisitionsALT5Details">
        <link:definition>9955535 - Disclosure - Mergers and Acquisitions - ALT5 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MergersandAcquisitionsScheduleofFairValueAdjustmentsforSharesofSeriesBandSeriesMPreferredStockDetails" roleURI="http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofFairValueAdjustmentsforSharesofSeriesBandSeriesMPreferredStockDetails">
        <link:definition>9955536 - Disclosure - Mergers and Acquisitions - Schedule of Fair Value Adjustments for Shares of Series B and Series M Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails" roleURI="http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails">
        <link:definition>9955537 - Disclosure - Mergers and Acquisitions - Schedule of Purchase Price Allocation of Purchase for ALT5 Subsidiary to Acquired Identifiable Assets, Liabilities Assumed and Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MergersandAcquisitionsScheduleofProformaInformationDetails" roleURI="http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofProformaInformationDetails">
        <link:definition>9955538 - Disclosure - Mergers and Acquisitions - Schedule of Proforma Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MergersandAcquisitionsSoinPharmaceuticalsDetails" roleURI="http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails">
        <link:definition>9955539 - Disclosure - Mergers and Acquisitions - Soin Pharmaceuticals (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SaleofRecyclingSubsidiariesNarrativeDetails" roleURI="http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesNarrativeDetails">
        <link:definition>9955540 - Disclosure - Sale of Recycling Subsidiaries - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails" roleURI="http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails">
        <link:definition>9955541 - Disclosure - Sale of Recycling Subsidiaries - Schedule of Gain on Sale of Recycling Subsidiaries (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails" roleURI="http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails">
        <link:definition>9955542 - Disclosure - Discontinued Operations - Schedule of Discontinued Operations in Consolidated Statements of Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails" roleURI="http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails">
        <link:definition>9955543 - Disclosure - Discontinued Operations - Schedule of Discontinued Operations in the Consolidated Statements of Cash Flows (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidsandothercurrentassetsDetails" roleURI="http://www.alt5sigma.com/role/PrepaidsandothercurrentassetsDetails">
        <link:definition>9955544 - Disclosure - Prepaids and other current assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentScheduleofPropertyandEquipmentDetails" roleURI="http://www.alt5sigma.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails">
        <link:definition>9955545 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNarrativeDetails" roleURI="http://www.alt5sigma.com/role/PropertyandEquipmentNarrativeDetails">
        <link:definition>9955546 - Disclosure - Property and Equipment - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofCompanysRightofUseAssetsandLeaseLiabilitiesDetails" roleURI="http://www.alt5sigma.com/role/LeasesScheduleofCompanysRightofUseAssetsandLeaseLiabilitiesDetails">
        <link:definition>9955547 - Disclosure - Leases - Schedule of Company's Right of Use Assets and Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.alt5sigma.com/role/LeasesNarrativeDetails">
        <link:definition>9955548 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails" roleURI="http://www.alt5sigma.com/role/LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails">
        <link:definition>9955549 - Disclosure - Leases - Schedule of Total Present Value of Future Lease Payments of Operating Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails_1" roleURI="http://www.alt5sigma.com/role/LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails_1">
        <link:definition>9955549 - Disclosure - Leases - Schedule of Total Present Value of Future Lease Payments of Operating Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NotesreceivableDetails" roleURI="http://www.alt5sigma.com/role/NotesreceivableDetails">
        <link:definition>9955550 - Disclosure - Notes receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleassetsScheduleofIntangibleAssetsDetails" roleURI="http://www.alt5sigma.com/role/IntangibleassetsScheduleofIntangibleAssetsDetails">
        <link:definition>9955551 - Disclosure - Intangible assets - Schedule of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleassetsNarrativeDetails" roleURI="http://www.alt5sigma.com/role/IntangibleassetsNarrativeDetails">
        <link:definition>9955552 - Disclosure - Intangible assets - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesScheduleofMarketableSecuritiesDetails" roleURI="http://www.alt5sigma.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails">
        <link:definition>9955553 - Disclosure - Marketable Securities - Schedule of Marketable Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesNarrativeDetails" roleURI="http://www.alt5sigma.com/role/MarketableSecuritiesNarrativeDetails">
        <link:definition>9955554 - Disclosure - Marketable Securities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DepositsandotherassetsDetails" roleURI="http://www.alt5sigma.com/role/DepositsandotherassetsDetails">
        <link:definition>9955555 - Disclosure - Deposits and other assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedliabilitiesDetails" roleURI="http://www.alt5sigma.com/role/AccruedliabilitiesDetails">
        <link:definition>9955556 - Disclosure - Accrued liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebenturesScheduleofDebenturesOutstandingDetails" roleURI="http://www.alt5sigma.com/role/DebenturesScheduleofDebenturesOutstandingDetails">
        <link:definition>9955557 - Disclosure - Debentures - Schedule of Debentures Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebenturesNarrativeDetails" roleURI="http://www.alt5sigma.com/role/DebenturesNarrativeDetails">
        <link:definition>9955558 - Disclosure - Debentures - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtScheduleofLongTermDebtDetails" roleURI="http://www.alt5sigma.com/role/LongTermDebtScheduleofLongTermDebtDetails">
        <link:definition>9955559 - Disclosure - Long-Term Debt - Schedule of Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtNarrativeDetails" roleURI="http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails">
        <link:definition>9955560 - Disclosure - Long-Term Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyDebtScheduleofLongTermDebtPayabletoRelatedPartiesDetails" roleURI="http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofLongTermDebtPayabletoRelatedPartiesDetails">
        <link:definition>9955561 - Disclosure - Related Party Debt - Schedule of Long-Term Debt Payable to Related Parties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyDebtScheduleofFutureMaturitiesofLongTermDebtDetails" roleURI="http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofFutureMaturitiesofLongTermDebtDetails">
        <link:definition>9955562 - Disclosure - Related Party Debt - Schedule of Future Maturities of Long Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyDebtNarrativeDetails" roleURI="http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails">
        <link:definition>9955563 - Disclosure - Related Party Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PreferredStockSeriesA1ConvertiblePreferredStockDetails" roleURI="http://www.alt5sigma.com/role/PreferredStockSeriesA1ConvertiblePreferredStockDetails">
        <link:definition>9955564 - Disclosure - Preferred Stock - Series A-1 Convertible Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PreferredStockSeriesBPreferredStockDetails" roleURI="http://www.alt5sigma.com/role/PreferredStockSeriesBPreferredStockDetails">
        <link:definition>9955565 - Disclosure - Preferred Stock - Series B Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PreferredStockSeriesIConvertiblePreferredStockDetails" roleURI="http://www.alt5sigma.com/role/PreferredStockSeriesIConvertiblePreferredStockDetails">
        <link:definition>9955566 - Disclosure - Preferred Stock - Series I Convertible Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PreferredStockSeriesMPreferredStockDetails" roleURI="http://www.alt5sigma.com/role/PreferredStockSeriesMPreferredStockDetails">
        <link:definition>9955567 - Disclosure - Preferred Stock - Series M Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PreferredStockSeriesQConvertiblePreferredStockDetails" roleURI="http://www.alt5sigma.com/role/PreferredStockSeriesQConvertiblePreferredStockDetails">
        <link:definition>9955568 - Disclosure - Preferred Stock - Series Q Convertible Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PreferredStockSeriesVConvertiblePreferredStockDetails" roleURI="http://www.alt5sigma.com/role/PreferredStockSeriesVConvertiblePreferredStockDetails">
        <link:definition>9955569 - Disclosure - Preferred Stock - Series V Convertible Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PreferredStockSeriesSConvertiblePreferredStockDetails" roleURI="http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails">
        <link:definition>9955570 - Disclosure - Preferred Stock - Series S Convertible Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PreferredStockScheduleofSeriesSConvertiblePreferredStockOutstandingDetails" roleURI="http://www.alt5sigma.com/role/PreferredStockScheduleofSeriesSConvertiblePreferredStockOutstandingDetails">
        <link:definition>9955571 - Disclosure - Preferred Stock - Schedule of Series S Convertible Preferred Stock Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityCommonStockDetails" roleURI="http://www.alt5sigma.com/role/StockholdersEquityCommonStockDetails">
        <link:definition>9955572 - Disclosure - Stockholders' Equity - Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityEquityOfferingsDetails" roleURI="http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails">
        <link:definition>9955573 - Disclosure - Stockholders' Equity - Equity Offerings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityEquityIncentivesDetails" roleURI="http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails">
        <link:definition>9955574 - Disclosure - Stockholders' Equity - Equity Incentives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityScheduleofStockOptionsActivityDetails" roleURI="http://www.alt5sigma.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails">
        <link:definition>9955575 - Disclosure - Stockholders' Equity - Schedule of Stock Options Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityScheduleofExercisePriceforStockOptionsOutstandingandExercisableOutstandingDetails" roleURI="http://www.alt5sigma.com/role/StockholdersEquityScheduleofExercisePriceforStockOptionsOutstandingandExercisableOutstandingDetails">
        <link:definition>9955576 - Disclosure - Stockholders' Equity - Schedule of Exercise Price for Stock Options Outstanding and Exercisable Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxesNarrativeDetails" roleURI="http://www.alt5sigma.com/role/IncometaxesNarrativeDetails">
        <link:definition>9955577 - Disclosure - Income taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxesScheduleofIncomeTaxProvisionBenefitDetails" roleURI="http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeTaxProvisionBenefitDetails">
        <link:definition>9955578 - Disclosure - Income taxes - Schedule of Income Tax Provision (Benefit) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxesScheduleofReconciliationofIncomeTaxBenefitProvisionwiththeFederalStatutoryTaxRateDetails" roleURI="http://www.alt5sigma.com/role/IncometaxesScheduleofReconciliationofIncomeTaxBenefitProvisionwiththeFederalStatutoryTaxRateDetails">
        <link:definition>9955579 - Disclosure - Income taxes - Schedule of Reconciliation of Income Tax Benefit (Provision) with the Federal Statutory Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxesScheduleofIncomeLossBeforeProvisionofIncomeTaxesDetails" roleURI="http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeLossBeforeProvisionofIncomeTaxesDetails">
        <link:definition>9955580 - Disclosure - Income taxes - Schedule of Income (Loss) Before Provision of Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails" roleURI="http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails">
        <link:definition>9955581 - Disclosure - Income taxes - Schedule of Components of Net Deferred Tax Assets (Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedpartiesDetails" roleURI="http://www.alt5sigma.com/role/RelatedpartiesDetails">
        <link:definition>9955582 - Disclosure - Related parties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails">
        <link:definition>9955583 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLosspershareScheduleofComputationofBasicandDilutedNetLossPerShareDetails" roleURI="http://www.alt5sigma.com/role/EarningsLosspershareScheduleofComputationofBasicandDilutedNetLossPerShareDetails">
        <link:definition>9955584 - Disclosure - Earnings (Loss) per share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLosspershareNarrativeDetails" roleURI="http://www.alt5sigma.com/role/EarningsLosspershareNarrativeDetails">
        <link:definition>9955585 - Disclosure - Earnings (Loss) per share - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentinformationNarrativeDetails" roleURI="http://www.alt5sigma.com/role/SegmentinformationNarrativeDetails">
        <link:definition>9955586 - Disclosure - Segment information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentinformationScheduleofSegmentInformationDetails" roleURI="http://www.alt5sigma.com/role/SegmentinformationScheduleofSegmentInformationDetails">
        <link:definition>9955587 - Disclosure - Segment information - Schedule of Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentinformationScheduleofBalanceSheetInformationDetails" roleURI="http://www.alt5sigma.com/role/SegmentinformationScheduleofBalanceSheetInformationDetails">
        <link:definition>9955588 - Disclosure - Segment information - Schedule of Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="alts_AuditorAbstract" abstract="true" name="AuditorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="alts_SeriesA1ConvertiblePreferredStockMember" abstract="true" name="SeriesA1ConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="alts_SeriesIConvertiblePreferredStockMember" abstract="true" name="SeriesIConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_SeriesMPreferredStockMember" abstract="true" name="SeriesMPreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_SeriesQConvertiblePreferredStockMember" abstract="true" name="SeriesQConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_SeriesSConvertiblePreferredStockMember" abstract="true" name="SeriesSConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="alts_SeriesVConvertiblePreferredStockMember" abstract="true" name="SeriesVConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_PlatformOperatorCryptoAssetHeldForUserCurrent" abstract="false" name="PlatformOperatorCryptoAssetHeldForUserCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_DepositsAndOtherAssetsNoncurrent" abstract="false" name="DepositsAndOtherAssetsNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_DigitalAssetLiabilityCurrent" abstract="false" name="DigitalAssetLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_MezzanineEquityAbstract" abstract="true" name="MezzanineEquityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="alts_RealizedGainLossOnExchangeTransactions" abstract="false" name="RealizedGainLossOnExchangeTransactions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_SeriesA1PreferredStockMember" abstract="true" name="SeriesA1PreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_SeriesS1PreferredMember" abstract="true" name="SeriesS1PreferredMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_SeriesIPreferredStockMember" abstract="true" name="SeriesIPreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_SeriesQPreferredStockMember" abstract="true" name="SeriesQPreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_SeriesVPreferredStockMember" abstract="true" name="SeriesVPreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_QodenTechnologiesLLCMember" abstract="true" name="QodenTechnologiesLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_AdjustmentToAdditionalPaidInCapitalReclassificationsOfTemporaryToLiability" abstract="false" name="AdjustmentToAdditionalPaidInCapitalReclassificationsOfTemporaryToLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_StockIssuedDuringPeriodSharesIssuedInLieuOfNotesPayable" abstract="false" name="StockIssuedDuringPeriodSharesIssuedInLieuOfNotesPayable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="alts_StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable" abstract="false" name="StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_StockIssuedDuringPeriodSharesPrepaidInterest" abstract="false" name="StockIssuedDuringPeriodSharesPrepaidInterest" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="alts_StockIssuedDuringPeriodValuePrepaidInterest" abstract="false" name="StockIssuedDuringPeriodValuePrepaidInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_StockIssuedDuringPeriodSharesWarrantsExercised" abstract="false" name="StockIssuedDuringPeriodSharesWarrantsExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="alts_StockIssuedDuringPeriodValueWarrantsExercised" abstract="false" name="StockIssuedDuringPeriodValueWarrantsExercised" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_GainLossOnWriteOffOfNotesReceivable" abstract="false" name="GainLossOnWriteOffOfNotesReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_IncreaseDecreaseInDigitalAssetsReceivable" abstract="false" name="IncreaseDecreaseInDigitalAssetsReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_IncreaseDecreaseInDigitalAssetsPayable" abstract="false" name="IncreaseDecreaseInDigitalAssetsPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_NoncashRecognitionOfNewLeases" abstract="false" name="NoncashRecognitionOfNewLeases" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_OtherSignificantNoncashTransactionBusinessAcquisitionMember" abstract="true" name="OtherSignificantNoncashTransactionBusinessAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_OtherSignificantNoncashTransactionConsultingServicesMember" abstract="true" name="OtherSignificantNoncashTransactionConsultingServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_OtherSignificantNoncashTransactionLiabilityObligationsMember" abstract="true" name="OtherSignificantNoncashTransactionLiabilityObligationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_OtherSignificantNoncashTransactionInterestObligationsMember" abstract="true" name="OtherSignificantNoncashTransactionInterestObligationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_OtherSignificantNoncashTransactionPropertyAndEquipmentMember" abstract="true" name="OtherSignificantNoncashTransactionPropertyAndEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_OtherSignificantNoncashTransactionIntangibleAssetsMember" abstract="true" name="OtherSignificantNoncashTransactionIntangibleAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_DigitalAssetsAndOtherReceivablesPolicyPolicyTextBlock" abstract="false" name="DigitalAssetsAndOtherReceivablesPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="alts_DigitalAssetsAndOtherPayablesPolicyPolicyTextBlock" abstract="false" name="DigitalAssetsAndOtherPayablesPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="alts_ScheduleOfOperatingLeaseRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock" abstract="false" name="ScheduleOfOperatingLeaseRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="alts_PotentialMarketExclusivityPeriod" abstract="false" name="PotentialMarketExclusivityPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="alts_CurrentAssetsCurrentLiabilitiesNet" abstract="false" name="CurrentAssetsCurrentLiabilitiesNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_NetCashProvidedByOperatingActivitiesContinuingOperations" abstract="false" name="NetCashProvidedByOperatingActivitiesContinuingOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_SubscriptionsReceivableMember" abstract="true" name="SubscriptionsReceivableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_DigitalAssetLiabilityCurrentDigitalAssets" abstract="false" name="DigitalAssetLiabilityCurrentDigitalAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_DigitalAssetLiabilityCurrentCashDeposits" abstract="false" name="DigitalAssetLiabilityCurrentCashDeposits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares" abstract="false" name="AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="alts_AssetAcquisitionConsiderationCashPayable" abstract="false" name="AssetAcquisitionConsiderationCashPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_AssetAcquisitionConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare" abstract="false" name="AssetAcquisitionConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="alts_AssetAcquisitionEquityInstrumentsIssuableValidConversionPeriod" abstract="false" name="AssetAcquisitionEquityInstrumentsIssuableValidConversionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="alts_AssetAcquisitionConsiderationPeriodicCashPayment" abstract="false" name="AssetAcquisitionConsiderationPeriodicCashPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_Alt5SigmaInc.Member" abstract="true" name="Alt5SigmaInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfIssuedAndOutstandingShares" abstract="false" name="BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfIssuedAndOutstandingShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsPayable" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsReceivable" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_SoinTherapeuticsLLCMember" abstract="true" name="SoinTherapeuticsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="alts_BusinessAcquisitionConsiderationTrancheOneMember" abstract="true" name="BusinessAcquisitionConsiderationTrancheOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_BusinessAcquisitionConsiderationTrancheTwoMember" abstract="true" name="BusinessAcquisitionConsiderationTrancheTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_BusinessAcquisitionConsiderationTrancheThreeMember" abstract="true" name="BusinessAcquisitionConsiderationTrancheThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_SoinAgreementConvertibleTrancheOneMember" abstract="true" name="SoinAgreementConvertibleTrancheOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_SoinAgreementConvertibleTrancheTwoMember" abstract="true" name="SoinAgreementConvertibleTrancheTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_SOINAgreementConvertibleTrancheThreeMember" abstract="true" name="SOINAgreementConvertibleTrancheThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_DrSoinMember" abstract="true" name="DrSoinMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="alts_NumberOfTranches" abstract="false" name="NumberOfTranches" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="alts_VM7CorporationMember" abstract="true" name="VM7CorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="alts_StockPurchaseAgreementMember" abstract="true" name="StockPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="alts_ARCAAndSubsidiariesMember" abstract="true" name="ARCAAndSubsidiariesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_RevisedDiscountAmount" abstract="false" name="RevisedDiscountAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag" abstract="false" name="DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:tokenItemType"/>
  <xs:element id="alts_TotalGuaranteedConsideration" abstract="false" name="TotalGuaranteedConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_PaymentFromBuyer" abstract="false" name="PaymentFromBuyer" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_NetConsideration" abstract="false" name="NetConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_DisposalOfAccountsPayable" abstract="false" name="DisposalOfAccountsPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_DisposalOfAccruedLiability" abstract="false" name="DisposalOfAccruedLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_DisposalOfAccruedLiabilityCaliforniaStateSalesTax" abstract="false" name="DisposalOfAccruedLiabilityCaliforniaStateSalesTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_DisposalOfLeaseLiability" abstract="false" name="DisposalOfLeaseLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_DisposalOfDebt" abstract="false" name="DisposalOfDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_TotalDisposalOfLiability" abstract="false" name="TotalDisposalOfLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_TotalConsiderations" abstract="false" name="TotalConsiderations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_CashDisposal" abstract="false" name="CashDisposal" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_DisposalOfAccountsReceivable" abstract="false" name="DisposalOfAccountsReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_DisposalOfInventory" abstract="false" name="DisposalOfInventory" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_DisposalOfPropertyPlantAndEquipment" abstract="false" name="DisposalOfPropertyPlantAndEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_DisposalOfIntangibleAssets" abstract="false" name="DisposalOfIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_DisposalOfRightOfUseAssets" abstract="false" name="DisposalOfRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_DisposalOfOtherAssets" abstract="false" name="DisposalOfOtherAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_TotalDisposalOfAssets" abstract="false" name="TotalDisposalOfAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_TotalGainOnSale" abstract="false" name="TotalGainOnSale" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_RecyclingSegmentMember" abstract="true" name="RecyclingSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_OperatingExpensesFromDiscontinuedOperationsAbstract" abstract="true" name="OperatingExpensesFromDiscontinuedOperationsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="alts_DisposalGroupIncludingDiscontinuedOperationTotalOperatingIncomeExpensesFromDiscontinuedOperations" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationTotalOperatingIncomeExpensesFromDiscontinuedOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract" abstract="true" name="OtherIncomeExpenseFromDiscontinuedOperationsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="alts_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_DisposalGroupIncludingDiscontinuedOperationsTotalOtherIncomeLossNet" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationsTotalOtherIncomeLossNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_DiscontinuedOperatingActivities" abstract="true" name="DiscontinuedOperatingActivities" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="alts_AmortizationOfRightOfUseAssets" abstract="false" name="AmortizationOfRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_GainOnSaleNetOfCash" abstract="false" name="GainOnSaleNetOfCash" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_DiscontinuedInvestingActivities" abstract="true" name="DiscontinuedInvestingActivities" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="alts_DiscontinuedFinancingActivities" abstract="true" name="DiscontinuedFinancingActivities" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="alts_SpyrTechnologiesIncMember" abstract="true" name="SpyrTechnologiesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="alts_GeoTraqIncMember" abstract="true" name="GeoTraqIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="alts_NotesReceivableTerm" abstract="false" name="NotesReceivableTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="alts_NoteReceivableFaceAmount" abstract="false" name="NoteReceivableFaceAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_NoteReceivableStatedInterestRate" abstract="false" name="NoteReceivableStatedInterestRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="alts_SoinIntangiblesMember" abstract="true" name="SoinIntangiblesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="alts_CryptocurrencyExchangeSoftwareIntangibleMember" abstract="true" name="CryptocurrencyExchangeSoftwareIntangibleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_PatentsAndDomainsMember" abstract="true" name="PatentsAndDomainsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="alts_QodenIntangibleMember" abstract="true" name="QodenIntangibleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_ALT5SubsidiaryMember" abstract="true" name="ALT5SubsidiaryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_NumberOfAcquiredIntangibleAssets" abstract="false" name="NumberOfAcquiredIntangibleAssets" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="alts_SeriesGConvertiblePreferredStockMember" abstract="true" name="SeriesGConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_CommonShareEquivalentsMember" abstract="true" name="CommonShareEquivalentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_MarketableSecuritiesSharesOutstanding" abstract="false" name="MarketableSecuritiesSharesOutstanding" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares" abstract="false" name="NoncashOrPartNoncashDivestitureConsiderationReceivedShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="alts_MarketableSecurityWriteOffShares" abstract="false" name="MarketableSecurityWriteOffShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="alts_ConvertiblePreferredStockSharesIssuableUponConversion" abstract="false" name="ConvertiblePreferredStockSharesIssuableUponConversion" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="alts_AccruedExpensesAssetAcquisitionCurrent" abstract="false" name="AccruedExpensesAssetAcquisitionCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_A15DebenturesMaturingJune302025Member" abstract="true" name="A15DebenturesMaturingJune302025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_DebenturesMember" abstract="true" name="DebenturesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_A12DebenturesMaturingJune302024Member" abstract="true" name="A12DebenturesMaturingJune302024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_A12DebenturesMaturingJune302025Member" abstract="true" name="A12DebenturesMaturingJune302025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_DebtInstrumentNumberOfDebenturesIssued" abstract="false" name="DebtInstrumentNumberOfDebenturesIssued" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="alts_DebtInstrumentNumberOfDebenturesRepaid" abstract="false" name="DebtInstrumentNumberOfDebenturesRepaid" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="alts_LegacySubsidiaryFixedDepositsMember" abstract="true" name="LegacySubsidiaryFixedDepositsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_LegacySubsidiaryLoanMember" abstract="true" name="LegacySubsidiaryLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_LegacyUnaffiliatedThirdPartyNotesMember" abstract="true" name="LegacyUnaffiliatedThirdPartyNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_OtherLegacyNotesPayableMember" abstract="true" name="OtherLegacyNotesPayableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_IcgNoteMember" abstract="true" name="IcgNoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="alts_LiveNoteMember" abstract="true" name="LiveNoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_NonConvertibleDebentureBigAndSmallDebentureMember" abstract="true" name="NonConvertibleDebentureBigAndSmallDebentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_NonConvertibleDebentureBigDebentureMember" abstract="true" name="NonConvertibleDebentureBigDebentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_NonConvertibleDebentureSmallDebentureMember" abstract="true" name="NonConvertibleDebentureSmallDebentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_FixedDepositAgreementMember" abstract="true" name="FixedDepositAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_PromissoryNoteMember" abstract="true" name="PromissoryNoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_NotesPayableWithLiveVenturesAndICGMember" abstract="true" name="NotesPayableWithLiveVenturesAndICGMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_InvestorOneMember" abstract="true" name="InvestorOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_InvestorTwoAndInvestorThreeMember" abstract="true" name="InvestorTwoAndInvestorThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_SkyBridgeAmericasMember" abstract="true" name="SkyBridgeAmericasMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="alts_UnaffiliatedThirdPartyMember" abstract="true" name="UnaffiliatedThirdPartyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_BigWarrantMember" abstract="true" name="BigWarrantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_SmallWarrantMember" abstract="true" name="SmallWarrantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_DebtInstrumentOriginalIssueDiscountExpansionAxis" abstract="true" name="DebtInstrumentOriginalIssueDiscountExpansionAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="alts_DebtInstrumentOriginalIssueDiscountExpansionDomain" abstract="true" name="DebtInstrumentOriginalIssueDiscountExpansionDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_DebtInstrumentOriginalIssueDiscountExpansionOneMember" abstract="true" name="DebtInstrumentOriginalIssueDiscountExpansionOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_DebtInstrumentOriginalIssueDiscountExpansionTwoMember" abstract="true" name="DebtInstrumentOriginalIssueDiscountExpansionTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_DebtInstrumentCovenantPeriodAxis" abstract="true" name="DebtInstrumentCovenantPeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="alts_DebtInstrumentCovenantPeriodDomain" abstract="true" name="DebtInstrumentCovenantPeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_DebtInstrumentCovenantPeriodPeriodOneMember" abstract="true" name="DebtInstrumentCovenantPeriodPeriodOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_DebtInstrumentCovenantPeriodPeriodTwoMember" abstract="true" name="DebtInstrumentCovenantPeriodPeriodTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_DebtInstrumentCovenantPeriodPeriodThreeMember" abstract="true" name="DebtInstrumentCovenantPeriodPeriodThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_SkybridgeLitigationMember" abstract="true" name="SkybridgeLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_LegalFeesMember" abstract="true" name="LegalFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_NumberOfUnaffiliatedThirdPartyInvestors" abstract="false" name="NumberOfUnaffiliatedThirdPartyInvestors" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="alts_DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions" abstract="false" name="DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="alts_ClassOfWarrantOrRightExercisePeriod" abstract="false" name="ClassOfWarrantOrRightExercisePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="alts_PercentageOfNetDollarReceivedToBeIssuedToDebentureHoldersOnAProRataBasis" abstract="false" name="PercentageOfNetDollarReceivedToBeIssuedToDebentureHoldersOnAProRataBasis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="alts_IsaacCapitalGroupNoteMember" abstract="true" name="IsaacCapitalGroupNoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_NotePayableToIsaacCapitalGroupMember" abstract="true" name="NotePayableToIsaacCapitalGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_NotePayableToLiveVentureIncorporatedMember" abstract="true" name="NotePayableToLiveVentureIncorporatedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_IsaacCapitalGroupShortTermDemandAdvanceMember" abstract="true" name="IsaacCapitalGroupShortTermDemandAdvanceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_NovalkAppsSAALLPShortTermDemandAdvanceMember" abstract="true" name="NovalkAppsSAALLPShortTermDemandAdvanceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_NotesPayableRelatedPartiesMember" abstract="true" name="NotesPayableRelatedPartiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="alts_A10ConvertiblePromissoryNoteMember" abstract="true" name="A10ConvertiblePromissoryNoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_Mr.JonIsaacMember" abstract="true" name="Mr.JonIsaacMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_LiveVentureIncorporatedMember" abstract="true" name="LiveVentureIncorporatedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_IsaacConsultingAgreementMember" abstract="true" name="IsaacConsultingAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_RelatedPartyTransactionShortTermAdvancesMember" abstract="true" name="RelatedPartyTransactionShortTermAdvancesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_NovalkAppsSAALLPMember" abstract="true" name="NovalkAppsSAALLPMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_Mr.TonyIsaacMember" abstract="true" name="Mr.TonyIsaacMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_RelatedPartyTransactionConsultingAgreementTerm" abstract="false" name="RelatedPartyTransactionConsultingAgreementTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice" abstract="false" name="RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="alts_SeriesAConvertiblePreferredStockMember" abstract="true" name="SeriesAConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="alts_BusinessCombinationConsiderationTransferredBeneficialConversionFeatureValue" abstract="false" name="BusinessCombinationConsiderationTransferredBeneficialConversionFeatureValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_BusinessCombinationConsiderationTransferredLiabilitiesIncurredTerm" abstract="false" name="BusinessCombinationConsiderationTransferredLiabilitiesIncurredTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="alts_ConversionOfStockSharesForfeited" abstract="false" name="ConversionOfStockSharesForfeited" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="alts_OwnersOfALT5SubsidiaryMember" abstract="true" name="OwnersOfALT5SubsidiaryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_NumberOfConsultants" abstract="false" name="NumberOfConsultants" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="alts_CommonStockConversionValidConversionPeriod" abstract="false" name="CommonStockConversionValidConversionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="alts_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare" abstract="false" name="BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="alts_NorthYorkLTDMember" abstract="true" name="NorthYorkLTDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_StockConversion1Member" abstract="true" name="StockConversion1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="alts_StockConversion2Member" abstract="true" name="StockConversion2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="alts_StockConversion3Member" abstract="true" name="StockConversion3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="alts_SoinTherapeuticsMember" abstract="true" name="SoinTherapeuticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_ConversionOfStockAmountConvertible" abstract="false" name="ConversionOfStockAmountConvertible" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_ConversionOfStockCommencementPeriod" abstract="false" name="ConversionOfStockCommencementPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="alts_ConversionOfStockPeriodFollowingClosing" abstract="false" name="ConversionOfStockPeriodFollowingClosing" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="alts_PercentageOfGrossRevenue" abstract="false" name="PercentageOfGrossRevenue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="alts_CommonStockSharesOutstandingPercentage" abstract="false" name="CommonStockSharesOutstandingPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="alts_ReclassificationOfTemporaryToCurrentLiabilities" abstract="false" name="ReclassificationOfTemporaryToCurrentLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_ReclassificationsOfTemporaryToPermanentEquityShares" abstract="false" name="ReclassificationsOfTemporaryToPermanentEquityShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="alts_ReclassificationOfTemporaryToCurrentLiabilitiesShares" abstract="false" name="ReclassificationOfTemporaryToCurrentLiabilitiesShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="alts_ShareholdersEquityTable" abstract="true" name="ShareholdersEquityTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="alts_ArticlesOfIncorporationMember" abstract="true" name="ArticlesOfIncorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="alts_ShareholdersEquityLineItems" abstract="true" name="ShareholdersEquityLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="alts_ThirdPartyExchangeForBrokerageServicesMember" abstract="true" name="ThirdPartyExchangeForBrokerageServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_PreFundedWarrantsMember" abstract="true" name="PreFundedWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_A2023EquityIncentivePlanMember" abstract="true" name="A2023EquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_NumberOfAgreementsToBePurchased" abstract="false" name="NumberOfAgreementsToBePurchased" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="alts_SaleOfStockUnitCompositionNumberOfCommonSharesInEachUnit" abstract="false" name="SaleOfStockUnitCompositionNumberOfCommonSharesInEachUnit" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="alts_SaleOfStockUnitCompositionNumberOfWarrantsIssuedInEachUnit" abstract="false" name="SaleOfStockUnitCompositionNumberOfWarrantsIssuedInEachUnit" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="alts_ClassOfWarrantPricePerShare" abstract="false" name="ClassOfWarrantPricePerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="alts_A2024EquityIncentivePlanMember" abstract="true" name="A2024EquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_Plan2016Member" abstract="true" name="Plan2016Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="alts_Plan2011Member" abstract="true" name="Plan2011Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="alts_AggregateIntrinsicValueAbstract" abstract="true" name="AggregateIntrinsicValueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="alts_ExercisePriceRangeOneMember" abstract="true" name="ExercisePriceRangeOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="alts_ExercisePriceRangeTwoMember" abstract="true" name="ExercisePriceRangeTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="alts_ProvisionBenefitOfIncomeTaxes" abstract="false" name="ProvisionBenefitOfIncomeTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_EffectiveIncomeTaxRateReconciliationPermanentDifferences" abstract="false" name="EffectiveIncomeTaxRateReconciliationPermanentDifferences" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="alts_IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes" abstract="false" name="IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_Section174Expenses" abstract="false" name="Section174Expenses" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_DeferredTaxAssetsLeaseLiability" abstract="false" name="DeferredTaxAssetsLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_DeferredTaxLiabilitiesRightOfUseAssets" abstract="false" name="DeferredTaxLiabilitiesRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_DeferredTaxLiabilitiesInstallmentSale" abstract="false" name="DeferredTaxLiabilitiesInstallmentSale" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_DeferredTaxAssetsInterest" abstract="false" name="DeferredTaxAssetsInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance" abstract="false" name="DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_LiveVenturesIncorporatedMember" abstract="true" name="LiveVenturesIncorporatedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="alts_LiveVenturesAndICGNotesMember" abstract="true" name="LiveVenturesAndICGNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_UniversalLifeInsurancePolicyPolicyOneMember" abstract="true" name="UniversalLifeInsurancePolicyPolicyOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_UniversalLifeInsurancePolicyPolicyTwoMember" abstract="true" name="UniversalLifeInsurancePolicyPolicyTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_RecyclingSegmentAndTechnologySegmentMember" abstract="true" name="RecyclingSegmentAndTechnologySegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_JanOneMember" abstract="true" name="JanOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_IsaacCapitalGroupLLCICGMember" abstract="true" name="IsaacCapitalGroupLLCICGMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_RelatedPartyTransactionConsultingAgreementNumberOfLifeInsurancePoliciesAssigned" abstract="false" name="RelatedPartyTransactionConsultingAgreementNumberOfLifeInsurancePoliciesAssigned" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="alts_RelatedPartyTransactionConsultingAgreementContingentlyTenderedFunds" abstract="false" name="RelatedPartyTransactionConsultingAgreementContingentlyTenderedFunds" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_NumberOfTradingDaysBeforeBoardApproval" abstract="false" name="NumberOfTradingDaysBeforeBoardApproval" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="alts_SECComplaintMember" abstract="true" name="SECComplaintMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_AlixpartnersLLCLitigationMember" abstract="true" name="AlixpartnersLLCLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_Main270LLCLitigationMember" abstract="true" name="Main270LLCLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_WestervilleSquareLitigationMember" abstract="true" name="WestervilleSquareLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_OtherCommitmentsAndLitigationCasesMember" abstract="true" name="OtherCommitmentsAndLitigationCasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_AlixpartnersLLCMember" abstract="true" name="AlixpartnersLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_TrusteesMain270LlcMember" abstract="true" name="TrusteesMain270LlcMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="alts_WestervilleSquareMember" abstract="true" name="WestervilleSquareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="alts_Mr.SullivanMember" abstract="true" name="Mr.SullivanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="alts_ApplianceSmartIncMember" abstract="true" name="ApplianceSmartIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="alts_LossContingencyNumberOfExecutiveOfficersNamedInComplaint" abstract="false" name="LossContingencyNumberOfExecutiveOfficersNamedInComplaint" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="alts_LitigationSettlementAmountAwardedToOtherPartyNumberOfPeriodicPayments" abstract="false" name="LitigationSettlementAmountAwardedToOtherPartyNumberOfPeriodicPayments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="alts_LitigationSettlementAmountAwardedToOtherPartyPeriodicPayments" abstract="false" name="LitigationSettlementAmountAwardedToOtherPartyPeriodicPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_OtherCommitmentsNumberOfLandlordsOriginallyPurportedToBeLiableFor" abstract="false" name="OtherCommitmentsNumberOfLandlordsOriginallyPurportedToBeLiableFor" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="alts_OperatingLeasesFutureMinimumPaymentsDue1" abstract="false" name="OperatingLeasesFutureMinimumPaymentsDue1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="alts_OtherCommitmentsNumberOfLandlordsCompanyIsNoLongerLiableFor" abstract="false" name="OtherCommitmentsNumberOfLandlordsCompanyIsNoLongerLiableFor" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="alts_FintechMember" abstract="true" name="FintechMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="alts_BiotechnologyMember" abstract="true" name="BiotechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="alts_ContinuingOperationsAndDiscontinuedOperationsMember" abstract="true" name="ContinuingOperationsAndDiscontinuedOperationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>alts-20241228_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:2830d163-e030-49d1-a620-63415283e8e5,g:d25a092d-1f61-4617-aa79-df61d6af7f3a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="alts-20241228.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8e3722c6-20da-4ccc-822c-80b8b4e2b975" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_1ddbcd9a-778e-445d-84fe-487e849bf595" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8e3722c6-20da-4ccc-822c-80b8b4e2b975" xlink:to="loc_us-gaap_PreferredStockValue_1ddbcd9a-778e-445d-84fe-487e849bf595" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_d3e1787e-55f0-4cc6-881a-c21a41ccce44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8e3722c6-20da-4ccc-822c-80b8b4e2b975" xlink:to="loc_us-gaap_CommonStockValue_d3e1787e-55f0-4cc6-881a-c21a41ccce44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_5e02755c-d9d2-4a2c-8cb0-4b261400d71f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8e3722c6-20da-4ccc-822c-80b8b4e2b975" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_5e02755c-d9d2-4a2c-8cb0-4b261400d71f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5630ed98-d548-46ca-99bd-51a1dda8c8ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8e3722c6-20da-4ccc-822c-80b8b4e2b975" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5630ed98-d548-46ca-99bd-51a1dda8c8ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7eb87ea5-a4b6-49e5-8896-89c3c97fe2ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8e3722c6-20da-4ccc-822c-80b8b4e2b975" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7eb87ea5-a4b6-49e5-8896-89c3c97fe2ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6849b7a5-6f2b-44c3-9e12-f3b7be433c50" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_04334994-fc7d-41de-8988-cd8791370ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6849b7a5-6f2b-44c3-9e12-f3b7be433c50" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_04334994-fc7d-41de-8988-cd8791370ed2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cc58647c-3ede-4b8d-b4c5-23fc34c1a216" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6849b7a5-6f2b-44c3-9e12-f3b7be433c50" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cc58647c-3ede-4b8d-b4c5-23fc34c1a216" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_5c9e98d7-d628-45aa-ab9f-45bb4ef27256" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6849b7a5-6f2b-44c3-9e12-f3b7be433c50" xlink:to="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_5c9e98d7-d628-45aa-ab9f-45bb4ef27256" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PlatformOperatorCryptoAssetHeldForUserCurrent_e878449d-51b1-4017-bb43-34785a9f5f23" xlink:href="alts-20241228.xsd#alts_PlatformOperatorCryptoAssetHeldForUserCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6849b7a5-6f2b-44c3-9e12-f3b7be433c50" xlink:to="loc_alts_PlatformOperatorCryptoAssetHeldForUserCurrent_e878449d-51b1-4017-bb43-34785a9f5f23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_61c8731a-52b7-46ad-ba3f-8c605cb820d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_5905a326-fb08-426f-bb79-caff68e2a234" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_61c8731a-52b7-46ad-ba3f-8c605cb820d7" xlink:to="loc_us-gaap_MinorityInterest_5905a326-fb08-426f-bb79-caff68e2a234" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8f03c8a3-8dc7-477f-992c-5c419cd5a170" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_61c8731a-52b7-46ad-ba3f-8c605cb820d7" xlink:to="loc_us-gaap_StockholdersEquity_8f03c8a3-8dc7-477f-992c-5c419cd5a170" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_6134a3df-d8f3-4ab0-b941-1f2757fb4652" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermNotesPayable_0b4c462b-d6a7-4353-8179-d7b201befb3c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLongTermNotesPayable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6134a3df-d8f3-4ab0-b941-1f2757fb4652" xlink:to="loc_us-gaap_OtherLongTermNotesPayable_0b4c462b-d6a7-4353-8179-d7b201befb3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_da45e08d-a169-4e42-b4ec-e19f6d2a1a95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6134a3df-d8f3-4ab0-b941-1f2757fb4652" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_da45e08d-a169-4e42-b4ec-e19f6d2a1a95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_584c4389-af83-4763-9141-7ef0cd976ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6134a3df-d8f3-4ab0-b941-1f2757fb4652" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_584c4389-af83-4763-9141-7ef0cd976ef9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_4f9cb733-138d-4d90-a566-98a8bdbdb256" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6134a3df-d8f3-4ab0-b941-1f2757fb4652" xlink:to="loc_us-gaap_LiabilitiesCurrent_4f9cb733-138d-4d90-a566-98a8bdbdb256" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_b7023921-3a77-4726-97e0-9a186f178a16" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermNotesPayable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6134a3df-d8f3-4ab0-b941-1f2757fb4652" xlink:to="loc_us-gaap_LongTermNotesPayable_b7023921-3a77-4726-97e0-9a186f178a16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_63c9216f-751d-4517-be91-1da233317df3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6134a3df-d8f3-4ab0-b941-1f2757fb4652" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_63c9216f-751d-4517-be91-1da233317df3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_7bd98c55-b88f-405f-a239-e3b431491e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DigitalAssetLiabilityCurrent_c3d37237-4d0e-46c0-b377-37e6ae66745c" xlink:href="alts-20241228.xsd#alts_DigitalAssetLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7bd98c55-b88f-405f-a239-e3b431491e1e" xlink:to="loc_alts_DigitalAssetLiabilityCurrent_c3d37237-4d0e-46c0-b377-37e6ae66745c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_0ef41051-1f63-428f-822b-1829048449e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7bd98c55-b88f-405f-a239-e3b431491e1e" xlink:to="loc_us-gaap_NotesPayableCurrent_0ef41051-1f63-428f-822b-1829048449e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_3a54fa17-dd05-422a-9f3d-88c2e2e4a199" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7bd98c55-b88f-405f-a239-e3b431491e1e" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_3a54fa17-dd05-422a-9f3d-88c2e2e4a199" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_e11532a7-237c-4698-9777-ebca86e3c4bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7bd98c55-b88f-405f-a239-e3b431491e1e" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_e11532a7-237c-4698-9777-ebca86e3c4bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_ac7ad76c-0c34-49eb-97de-979e47f702a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7bd98c55-b88f-405f-a239-e3b431491e1e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_ac7ad76c-0c34-49eb-97de-979e47f702a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtCurrent_28378759-1efc-4ad7-be98-f2c0e7edfc87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7bd98c55-b88f-405f-a239-e3b431491e1e" xlink:to="loc_us-gaap_ConvertibleDebtCurrent_28378759-1efc-4ad7-be98-f2c0e7edfc87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_1788fa8c-dd09-4570-876f-46b4c46d9bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7bd98c55-b88f-405f-a239-e3b431491e1e" xlink:to="loc_us-gaap_AccountsPayableCurrent_1788fa8c-dd09-4570-876f-46b4c46d9bdd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e01e9f15-fa25-4b83-975a-a137fa324fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_26dddc5b-5343-44ee-882e-ffde7b905528" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e01e9f15-fa25-4b83-975a-a137fa324fd1" xlink:to="loc_us-gaap_Goodwill_26dddc5b-5343-44ee-882e-ffde7b905528" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_53d96de5-0566-47e6-afba-3e99c805dec3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e01e9f15-fa25-4b83-975a-a137fa324fd1" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_53d96de5-0566-47e6-afba-3e99c805dec3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3614a4ed-7936-4d87-9897-27522e54c093" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e01e9f15-fa25-4b83-975a-a137fa324fd1" xlink:to="loc_us-gaap_AssetsCurrent_3614a4ed-7936-4d87-9897-27522e54c093" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6bf474c7-36d2-4230-b894-60272c506f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e01e9f15-fa25-4b83-975a-a137fa324fd1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6bf474c7-36d2-4230-b894-60272c506f1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9c81d027-90bb-4f29-a144-4f7db757023f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e01e9f15-fa25-4b83-975a-a137fa324fd1" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9c81d027-90bb-4f29-a144-4f7db757023f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DepositsAndOtherAssetsNoncurrent_e265ddfd-4ea0-41bc-bbf4-51d0455160d3" xlink:href="alts-20241228.xsd#alts_DepositsAndOtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e01e9f15-fa25-4b83-975a-a137fa324fd1" xlink:to="loc_alts_DepositsAndOtherAssetsNoncurrent_e265ddfd-4ea0-41bc-bbf4-51d0455160d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_659e11bd-ffa4-4421-b514-ef84fcbeef6f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e01e9f15-fa25-4b83-975a-a137fa324fd1" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_659e11bd-ffa4-4421-b514-ef84fcbeef6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_5af493fd-b3f8-4cb8-a82f-65bfc0d61ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a2868739-360c-4bfc-adc3-02eb7652906b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5af493fd-b3f8-4cb8-a82f-65bfc0d61ba3" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a2868739-360c-4bfc-adc3-02eb7652906b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_11499e25-3857-4b93-ab26-1d79bb9fe75f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5af493fd-b3f8-4cb8-a82f-65bfc0d61ba3" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_11499e25-3857-4b93-ab26-1d79bb9fe75f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_3cab4df7-92d3-41f1-9dfa-90058874271b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5af493fd-b3f8-4cb8-a82f-65bfc0d61ba3" xlink:to="loc_us-gaap_CommitmentsAndContingencies_3cab4df7-92d3-41f1-9dfa-90058874271b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4e9de025-a1f0-462d-bc91-8f0dbdd13d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5af493fd-b3f8-4cb8-a82f-65bfc0d61ba3" xlink:to="loc_us-gaap_Liabilities_4e9de025-a1f0-462d-bc91-8f0dbdd13d0f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="alts-20241228.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"/>
  <link:calculationLink xlink:role="http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_83130886-4318-418d-8232-b52340dd6aec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a53b880e-bf58-4526-ab3e-b82215cb2577" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_83130886-4318-418d-8232-b52340dd6aec" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a53b880e-bf58-4526-ab3e-b82215cb2577" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_0ce1d8f8-62a9-4653-9dc1-7213ecc7fb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_83130886-4318-418d-8232-b52340dd6aec" xlink:to="loc_us-gaap_AssetImpairmentCharges_0ce1d8f8-62a9-4653-9dc1-7213ecc7fb5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_d535db7b-225c-4ec8-9221-15ad53c2106d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_36a3a743-5d1f-4e8f-9e50-fac006392bff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_d535db7b-225c-4ec8-9221-15ad53c2106d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_36a3a743-5d1f-4e8f-9e50-fac006392bff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_685b3d94-d55c-40d5-ba65-08e4f9f1afd4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_d535db7b-225c-4ec8-9221-15ad53c2106d" xlink:to="loc_us-gaap_CostOfRevenue_685b3d94-d55c-40d5-ba65-08e4f9f1afd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_69a4251d-1289-4dc5-9b74-f551dac93d14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b50519c5-1429-48c2-be00-6cceb1ca8e38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_69a4251d-1289-4dc5-9b74-f551dac93d14" xlink:to="loc_us-gaap_OperatingIncomeLoss_b50519c5-1429-48c2-be00-6cceb1ca8e38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_0293485f-e8f4-4281-bb15-512fc36140ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_69a4251d-1289-4dc5-9b74-f551dac93d14" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_0293485f-e8f4-4281-bb15-512fc36140ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_be7b18b3-183a-4426-aa07-71ce91dbb0f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_a24b5f42-14f4-4139-bd5b-9d8f3d010624" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_be7b18b3-183a-4426-aa07-71ce91dbb0f4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_a24b5f42-14f4-4139-bd5b-9d8f3d010624" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_2cd2a21b-60d8-47ff-857e-333735c30fce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_be7b18b3-183a-4426-aa07-71ce91dbb0f4" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_2cd2a21b-60d8-47ff-857e-333735c30fce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1126af28-0799-4887-84c9-c635e90fb962" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_7e65d39e-673b-419d-ae17-85302f8d7adb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_1126af28-0799-4887-84c9-c635e90fb962" xlink:to="loc_us-gaap_GrossProfit_7e65d39e-673b-419d-ae17-85302f8d7adb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_26cef4e2-5a3b-46d8-9d63-28158706c229" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_1126af28-0799-4887-84c9-c635e90fb962" xlink:to="loc_us-gaap_OperatingExpenses_26cef4e2-5a3b-46d8-9d63-28158706c229" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_4e6b53f9-a7d9-4c08-a55a-d38bed33bb04" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_da553548-1327-49fe-b9e1-7586b09e7665" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_4e6b53f9-a7d9-4c08-a55a-d38bed33bb04" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_da553548-1327-49fe-b9e1-7586b09e7665" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9791877e-5efe-4313-a3e5-fead6abfe566" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_4e6b53f9-a7d9-4c08-a55a-d38bed33bb04" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9791877e-5efe-4313-a3e5-fead6abfe566" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_7781d7ef-cb25-43f3-bae2-eb35b4bc6887" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_b991b6f6-a4f7-4e91-a6d8-d99478b90104" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_7781d7ef-cb25-43f3-bae2-eb35b4bc6887" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_b991b6f6-a4f7-4e91-a6d8-d99478b90104" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RealizedGainLossOnExchangeTransactions_7a00afc6-ca59-4804-8fc6-266bc55cb573" xlink:href="alts-20241228.xsd#alts_RealizedGainLossOnExchangeTransactions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_7781d7ef-cb25-43f3-bae2-eb35b4bc6887" xlink:to="loc_alts_RealizedGainLossOnExchangeTransactions_7a00afc6-ca59-4804-8fc6-266bc55cb573" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_7e0c8458-bebd-429b-8b9b-dfc4236b1d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_7781d7ef-cb25-43f3-bae2-eb35b4bc6887" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_7e0c8458-bebd-429b-8b9b-dfc4236b1d8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_bb24edba-e26e-4258-b0de-e85ec2dbdb0a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_7781d7ef-cb25-43f3-bae2-eb35b4bc6887" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_bb24edba-e26e-4258-b0de-e85ec2dbdb0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_67dedfbc-e52b-4b1a-a4d4-85992bce2f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_30c9f5f8-2165-4631-8e41-635d192650ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_67dedfbc-e52b-4b1a-a4d4-85992bce2f2f" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_30c9f5f8-2165-4631-8e41-635d192650ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation_dc0c8062-c2cd-4024-b2b0-6d397a0236bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_67dedfbc-e52b-4b1a-a4d4-85992bce2f2f" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation_dc0c8062-c2cd-4024-b2b0-6d397a0236bf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="alts-20241228.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_184670d6-cd34-4d52-9ec0-4bb9a6dfcb37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CryptoAssetUnrealizedGainLossOperating_59434f2b-b71e-4a25-a5e1-df9a747064a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetUnrealizedGainLossOperating"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_184670d6-cd34-4d52-9ec0-4bb9a6dfcb37" xlink:to="loc_us-gaap_CryptoAssetUnrealizedGainLossOperating_59434f2b-b71e-4a25-a5e1-df9a747064a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IncreaseDecreaseInDigitalAssetsPayable_affa04c2-050b-4ff3-867c-1064aaac7aa1" xlink:href="alts-20241228.xsd#alts_IncreaseDecreaseInDigitalAssetsPayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_184670d6-cd34-4d52-9ec0-4bb9a6dfcb37" xlink:to="loc_alts_IncreaseDecreaseInDigitalAssetsPayable_affa04c2-050b-4ff3-867c-1064aaac7aa1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_6f24e8f0-c30f-48e9-84e1-7b1724a8f16b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_184670d6-cd34-4d52-9ec0-4bb9a6dfcb37" xlink:to="loc_us-gaap_ShareBasedCompensation_6f24e8f0-c30f-48e9-84e1-7b1724a8f16b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_c3e87b82-753e-4f85-9b6b-d829410adb4a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_184670d6-cd34-4d52-9ec0-4bb9a6dfcb37" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_c3e87b82-753e-4f85-9b6b-d829410adb4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_7e088ab2-675c-4819-bfc3-a9dfbe1162d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_184670d6-cd34-4d52-9ec0-4bb9a6dfcb37" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_7e088ab2-675c-4819-bfc3-a9dfbe1162d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d8f65199-8c64-42d0-9842-de34a4690995" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_184670d6-cd34-4d52-9ec0-4bb9a6dfcb37" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d8f65199-8c64-42d0-9842-de34a4690995" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_e6e34919-0b3a-4aba-a610-1c43d2b70b58" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_184670d6-cd34-4d52-9ec0-4bb9a6dfcb37" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_e6e34919-0b3a-4aba-a610-1c43d2b70b58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a25c5245-c78e-42da-aa37-29aa758e4cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_184670d6-cd34-4d52-9ec0-4bb9a6dfcb37" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a25c5245-c78e-42da-aa37-29aa758e4cbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_93ec77d1-3e81-4a1b-ae4c-0a284faef734" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_184670d6-cd34-4d52-9ec0-4bb9a6dfcb37" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_93ec77d1-3e81-4a1b-ae4c-0a284faef734" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4884dcae-c125-4c45-a902-21ec04b084ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_184670d6-cd34-4d52-9ec0-4bb9a6dfcb37" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4884dcae-c125-4c45-a902-21ec04b084ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_8ab4dc10-a4c0-47a8-b1e8-0f70f73376f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_184670d6-cd34-4d52-9ec0-4bb9a6dfcb37" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_8ab4dc10-a4c0-47a8-b1e8-0f70f73376f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumsReceivableAccretionOfDiscountOnPremiumReceivable_727b833c-1a38-4f1f-9542-9c0729825b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialGuaranteeInsuranceContractsPremiumsReceivableAccretionOfDiscountOnPremiumReceivable"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_184670d6-cd34-4d52-9ec0-4bb9a6dfcb37" xlink:to="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumsReceivableAccretionOfDiscountOnPremiumReceivable_727b833c-1a38-4f1f-9542-9c0729825b7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_fb94b083-c144-4ba1-a820-75648e551657" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_184670d6-cd34-4d52-9ec0-4bb9a6dfcb37" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_fb94b083-c144-4ba1-a820-75648e551657" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_GainLossOnWriteOffOfNotesReceivable_9ff9c076-3528-4a48-92df-11050c779199" xlink:href="alts-20241228.xsd#alts_GainLossOnWriteOffOfNotesReceivable"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_184670d6-cd34-4d52-9ec0-4bb9a6dfcb37" xlink:to="loc_alts_GainLossOnWriteOffOfNotesReceivable_9ff9c076-3528-4a48-92df-11050c779199" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a7a6b110-14a6-40d2-96e7-7f1cc7890eac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_184670d6-cd34-4d52-9ec0-4bb9a6dfcb37" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a7a6b110-14a6-40d2-96e7-7f1cc7890eac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses_96b2543a-e9d9-408e-b448-45fce467e8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForLoanLeaseAndOtherLosses"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_184670d6-cd34-4d52-9ec0-4bb9a6dfcb37" xlink:to="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses_96b2543a-e9d9-408e-b448-45fce467e8d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_98118060-fb74-497f-ae10-29f9a86cd7fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_184670d6-cd34-4d52-9ec0-4bb9a6dfcb37" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_98118060-fb74-497f-ae10-29f9a86cd7fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_03560933-698c-4d3e-84b8-d7f907046940" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_184670d6-cd34-4d52-9ec0-4bb9a6dfcb37" xlink:to="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_03560933-698c-4d3e-84b8-d7f907046940" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_a7aea54f-d9f1-4ed6-9eb0-1f68be203bee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_184670d6-cd34-4d52-9ec0-4bb9a6dfcb37" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_a7aea54f-d9f1-4ed6-9eb0-1f68be203bee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IncreaseDecreaseInDigitalAssetsReceivable_9a9d2ba3-4adc-41bf-927f-36eb5018983a" xlink:href="alts-20241228.xsd#alts_IncreaseDecreaseInDigitalAssetsReceivable"/>
    <link:calculationArc order="20" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_184670d6-cd34-4d52-9ec0-4bb9a6dfcb37" xlink:to="loc_alts_IncreaseDecreaseInDigitalAssetsReceivable_9a9d2ba3-4adc-41bf-927f-36eb5018983a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashContributionExpense_68b4114a-82de-456c-af8e-31a225788668" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashContributionExpense"/>
    <link:calculationArc order="21" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_184670d6-cd34-4d52-9ec0-4bb9a6dfcb37" xlink:to="loc_us-gaap_NoncashContributionExpense_68b4114a-82de-456c-af8e-31a225788668" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2812f2f4-25ce-4679-a3db-f2892c3a1103" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_d6901eb6-dc82-4f14-99e7-8c3b9636fe8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2812f2f4-25ce-4679-a3db-f2892c3a1103" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_d6901eb6-dc82-4f14-99e7-8c3b9636fe8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_b1412da3-8e28-467a-b78d-dd62589eaedc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2812f2f4-25ce-4679-a3db-f2892c3a1103" xlink:to="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_b1412da3-8e28-467a-b78d-dd62589eaedc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_87d422dc-d952-4e4a-979d-f52032df5896" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1cf2010d-792f-437b-8e75-0a095bcc3819" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_87d422dc-d952-4e4a-979d-f52032df5896" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1cf2010d-792f-437b-8e75-0a095bcc3819" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ee7c96e-dc97-4586-a7b4-96b9491a1d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_87d422dc-d952-4e4a-979d-f52032df5896" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ee7c96e-dc97-4586-a7b4-96b9491a1d8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f75a0362-7c05-4ba8-a12f-94ac99a11526" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_87d422dc-d952-4e4a-979d-f52032df5896" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f75a0362-7c05-4ba8-a12f-94ac99a11526" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f22b57d2-b945-4694-a5b2-a74ad3fbf4fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_87d422dc-d952-4e4a-979d-f52032df5896" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f22b57d2-b945-4694-a5b2-a74ad3fbf4fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_97d677e7-0bdf-40c7-adcf-6bce178169ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_c8d4ed4b-4d7d-4623-87f3-7bd1e2d35af5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_97d677e7-0bdf-40c7-adcf-6bce178169ed" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_c8d4ed4b-4d7d-4623-87f3-7bd1e2d35af5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5f15eb52-2e04-4768-8575-c8fb5345fd61" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_97d677e7-0bdf-40c7-adcf-6bce178169ed" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5f15eb52-2e04-4768-8575-c8fb5345fd61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8ec23c22-5093-4dd3-90e3-a86a5fa57a27" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_8cd7a767-ac86-47c7-a1ed-85378a1feb19" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8ec23c22-5093-4dd3-90e3-a86a5fa57a27" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_8cd7a767-ac86-47c7-a1ed-85378a1feb19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_df375870-13f6-423a-abd9-255d0e0fa4dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8ec23c22-5093-4dd3-90e3-a86a5fa57a27" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_df375870-13f6-423a-abd9-255d0e0fa4dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_28bdd806-885c-4f48-9243-81e78e15161d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8ec23c22-5093-4dd3-90e3-a86a5fa57a27" xlink:to="loc_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_28bdd806-885c-4f48-9243-81e78e15161d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_5808dd52-47a8-4e2a-a0a3-c48c1c203f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8ec23c22-5093-4dd3-90e3-a86a5fa57a27" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_5808dd52-47a8-4e2a-a0a3-c48c1c203f4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_065ce1ed-b9e6-458b-b856-de988225cd11" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8ec23c22-5093-4dd3-90e3-a86a5fa57a27" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_065ce1ed-b9e6-458b-b856-de988225cd11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt_7ea968d8-9ba3-4eb2-8554-a6c92f7e5f06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8ec23c22-5093-4dd3-90e3-a86a5fa57a27" xlink:to="loc_us-gaap_ProceedsFromRelatedPartyDebt_7ea968d8-9ba3-4eb2-8554-a6c92f7e5f06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt_0e7c6036-6069-4720-a500-ada46645d468" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8ec23c22-5093-4dd3-90e3-a86a5fa57a27" xlink:to="loc_us-gaap_RepaymentsOfRelatedPartyDebt_0e7c6036-6069-4720-a500-ada46645d468" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"/>
  <link:calculationLink xlink:role="http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_alts_NetConsideration_2f190e75-6b61-4346-98ac-688f5b5fc462" xlink:href="alts-20241228.xsd#alts_NetConsideration"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_TotalGuaranteedConsideration_a4ad83ff-4263-4161-8faf-68e0e5351359" xlink:href="alts-20241228.xsd#alts_TotalGuaranteedConsideration"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_NetConsideration_2f190e75-6b61-4346-98ac-688f5b5fc462" xlink:to="loc_alts_TotalGuaranteedConsideration_a4ad83ff-4263-4161-8faf-68e0e5351359" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PaymentFromBuyer_9313e3cc-c78d-454b-939c-da1c851f9caf" xlink:href="alts-20241228.xsd#alts_PaymentFromBuyer"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_NetConsideration_2f190e75-6b61-4346-98ac-688f5b5fc462" xlink:to="loc_alts_PaymentFromBuyer_9313e3cc-c78d-454b-939c-da1c851f9caf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_TotalConsiderations_3bc76376-0c4c-497c-b601-2adf52bcf8c1" xlink:href="alts-20241228.xsd#alts_TotalConsiderations"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NetConsideration_5d3c1f37-d5d8-4d48-b38b-09a9a4a83ee0" xlink:href="alts-20241228.xsd#alts_NetConsideration"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_TotalConsiderations_3bc76376-0c4c-497c-b601-2adf52bcf8c1" xlink:to="loc_alts_NetConsideration_5d3c1f37-d5d8-4d48-b38b-09a9a4a83ee0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_TotalDisposalOfLiability_5e931829-6f36-42c5-acd3-e8a133120755" xlink:href="alts-20241228.xsd#alts_TotalDisposalOfLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_TotalConsiderations_3bc76376-0c4c-497c-b601-2adf52bcf8c1" xlink:to="loc_alts_TotalDisposalOfLiability_5e931829-6f36-42c5-acd3-e8a133120755" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_TotalDisposalOfAssets_0f21edfe-493a-4b74-a034-206a8d358b6e" xlink:href="alts-20241228.xsd#alts_TotalDisposalOfAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_CashDisposal_2f3d78ed-aad5-4a16-9241-88e83c7f23bf" xlink:href="alts-20241228.xsd#alts_CashDisposal"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_TotalDisposalOfAssets_0f21edfe-493a-4b74-a034-206a8d358b6e" xlink:to="loc_alts_CashDisposal_2f3d78ed-aad5-4a16-9241-88e83c7f23bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfAccountsReceivable_fc0ac09f-fccd-45ce-a1ea-17213219e939" xlink:href="alts-20241228.xsd#alts_DisposalOfAccountsReceivable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_TotalDisposalOfAssets_0f21edfe-493a-4b74-a034-206a8d358b6e" xlink:to="loc_alts_DisposalOfAccountsReceivable_fc0ac09f-fccd-45ce-a1ea-17213219e939" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfInventory_0931ae3e-efb4-4444-9aaf-24fa43127b7a" xlink:href="alts-20241228.xsd#alts_DisposalOfInventory"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_TotalDisposalOfAssets_0f21edfe-493a-4b74-a034-206a8d358b6e" xlink:to="loc_alts_DisposalOfInventory_0931ae3e-efb4-4444-9aaf-24fa43127b7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfRightOfUseAssets_b9528f2f-28ae-4491-9cc0-924ce1b9d424" xlink:href="alts-20241228.xsd#alts_DisposalOfRightOfUseAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_TotalDisposalOfAssets_0f21edfe-493a-4b74-a034-206a8d358b6e" xlink:to="loc_alts_DisposalOfRightOfUseAssets_b9528f2f-28ae-4491-9cc0-924ce1b9d424" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfOtherAssets_d59b38f1-57cd-424e-a060-2e5a62418739" xlink:href="alts-20241228.xsd#alts_DisposalOfOtherAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_TotalDisposalOfAssets_0f21edfe-493a-4b74-a034-206a8d358b6e" xlink:to="loc_alts_DisposalOfOtherAssets_d59b38f1-57cd-424e-a060-2e5a62418739" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfPropertyPlantAndEquipment_551fa293-b85b-49b3-8a40-5e3e1adec171" xlink:href="alts-20241228.xsd#alts_DisposalOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_TotalDisposalOfAssets_0f21edfe-493a-4b74-a034-206a8d358b6e" xlink:to="loc_alts_DisposalOfPropertyPlantAndEquipment_551fa293-b85b-49b3-8a40-5e3e1adec171" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfIntangibleAssets_63e58bd0-90b2-4644-9c65-6131088faa65" xlink:href="alts-20241228.xsd#alts_DisposalOfIntangibleAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_TotalDisposalOfAssets_0f21edfe-493a-4b74-a034-206a8d358b6e" xlink:to="loc_alts_DisposalOfIntangibleAssets_63e58bd0-90b2-4644-9c65-6131088faa65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_TotalDisposalOfLiability_e9d156eb-f679-46ea-b0c3-3475bf040ef3" xlink:href="alts-20241228.xsd#alts_TotalDisposalOfLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_9d94a432-a1a0-4906-87a0-a206bbd502ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_TotalDisposalOfLiability_e9d156eb-f679-46ea-b0c3-3475bf040ef3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_9d94a432-a1a0-4906-87a0-a206bbd502ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfDebt_4f8eee0c-cf6a-41ce-83d4-2bb8dbdd73e6" xlink:href="alts-20241228.xsd#alts_DisposalOfDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_TotalDisposalOfLiability_e9d156eb-f679-46ea-b0c3-3475bf040ef3" xlink:to="loc_alts_DisposalOfDebt_4f8eee0c-cf6a-41ce-83d4-2bb8dbdd73e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfLeaseLiability_9b8d7e28-6607-471c-91da-de22eef310a2" xlink:href="alts-20241228.xsd#alts_DisposalOfLeaseLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_TotalDisposalOfLiability_e9d156eb-f679-46ea-b0c3-3475bf040ef3" xlink:to="loc_alts_DisposalOfLeaseLiability_9b8d7e28-6607-471c-91da-de22eef310a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfAccruedLiabilityCaliforniaStateSalesTax_864b322d-fc90-4ff1-b58e-94a91bc539d8" xlink:href="alts-20241228.xsd#alts_DisposalOfAccruedLiabilityCaliforniaStateSalesTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_TotalDisposalOfLiability_e9d156eb-f679-46ea-b0c3-3475bf040ef3" xlink:to="loc_alts_DisposalOfAccruedLiabilityCaliforniaStateSalesTax_864b322d-fc90-4ff1-b58e-94a91bc539d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfAccruedLiability_d94d8e7c-95db-4a31-8cdd-4eada0933a9f" xlink:href="alts-20241228.xsd#alts_DisposalOfAccruedLiability"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_TotalDisposalOfLiability_e9d156eb-f679-46ea-b0c3-3475bf040ef3" xlink:to="loc_alts_DisposalOfAccruedLiability_d94d8e7c-95db-4a31-8cdd-4eada0933a9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfAccountsPayable_70ddb715-d52d-42da-80a5-d151caa5fea4" xlink:href="alts-20241228.xsd#alts_DisposalOfAccountsPayable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_TotalDisposalOfLiability_e9d156eb-f679-46ea-b0c3-3475bf040ef3" xlink:to="loc_alts_DisposalOfAccountsPayable_70ddb715-d52d-42da-80a5-d151caa5fea4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_TotalGainOnSale_270ee271-3db5-411c-a81b-ccc445da30f0" xlink:href="alts-20241228.xsd#alts_TotalGainOnSale"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_TotalConsiderations_9435096a-666a-4813-ba7d-42746020d6e2" xlink:href="alts-20241228.xsd#alts_TotalConsiderations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_TotalGainOnSale_270ee271-3db5-411c-a81b-ccc445da30f0" xlink:to="loc_alts_TotalConsiderations_9435096a-666a-4813-ba7d-42746020d6e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_TotalDisposalOfAssets_725cb907-da1b-4539-8966-1e464f86d14a" xlink:href="alts-20241228.xsd#alts_TotalDisposalOfAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_TotalGainOnSale_270ee271-3db5-411c-a81b-ccc445da30f0" xlink:to="loc_alts_TotalDisposalOfAssets_725cb907-da1b-4539-8966-1e464f86d14a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails"/>
  <link:calculationLink xlink:role="http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_f26c9518-640b-4ac9-be22-a0216aa186da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_24234c06-f558-4c14-9cef-e84b95991d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_f26c9518-640b-4ac9-be22-a0216aa186da" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_24234c06-f558-4c14-9cef-e84b95991d4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_68292248-dc92-46d7-9ce1-52dea10c7bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_f26c9518-640b-4ac9-be22-a0216aa186da" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_68292248-dc92-46d7-9ce1-52dea10c7bcd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/PrepaidsandothercurrentassetsDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#PrepaidsandothercurrentassetsDetails"/>
  <link:calculationLink xlink:role="http://www.alt5sigma.com/role/PrepaidsandothercurrentassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6aca7a7e-a8fa-4dd0-8ab9-cb18590aefcd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_9d2de0ae-e123-434f-a942-61760ba9f42c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidInsurance"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6aca7a7e-a8fa-4dd0-8ab9-cb18590aefcd" xlink:to="loc_us-gaap_PrepaidInsurance_9d2de0ae-e123-434f-a942-61760ba9f42c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_c8338190-a8fb-4a0f-894c-2ac14bf310d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6aca7a7e-a8fa-4dd0-8ab9-cb18590aefcd" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent_c8338190-a8fb-4a0f-894c-2ac14bf310d3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails"/>
  <link:calculationLink xlink:role="http://www.alt5sigma.com/role/LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_648db143-d0ca-4491-aa19-5befc58c266d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_e94a1eec-e1b0-45bf-aaf4-62880f5549cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_648db143-d0ca-4491-aa19-5befc58c266d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_e94a1eec-e1b0-45bf-aaf4-62880f5549cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_8162dfda-ac93-4363-b574-2cd5ef42fb39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_648db143-d0ca-4491-aa19-5befc58c266d" xlink:to="loc_us-gaap_OperatingLeaseLiability_8162dfda-ac93-4363-b574-2cd5ef42fb39" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails_1" xlink:type="simple" xlink:href="alts-20241228.xsd#LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails_1"/>
  <link:calculationLink xlink:role="http://www.alt5sigma.com/role/LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2717bcd2-d22f-4e68-a307-49e36c9815ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_22d9a143-c78d-419f-8574-9debc00ae1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2717bcd2-d22f-4e68-a307-49e36c9815ea" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_22d9a143-c78d-419f-8574-9debc00ae1f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a7fd8e70-a0b3-47b9-908f-9600d096ce51" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2717bcd2-d22f-4e68-a307-49e36c9815ea" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a7fd8e70-a0b3-47b9-908f-9600d096ce51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8fb56518-f29d-467e-a6d3-592b8b423619" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2717bcd2-d22f-4e68-a307-49e36c9815ea" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8fb56518-f29d-467e-a6d3-592b8b423619" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_4d46f7c4-65ba-4a3b-8907-be8d3c8185a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2717bcd2-d22f-4e68-a307-49e36c9815ea" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_4d46f7c4-65ba-4a3b-8907-be8d3c8185a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_ee85fe7f-68a0-4753-9e31-347fea814263" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2717bcd2-d22f-4e68-a307-49e36c9815ea" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_ee85fe7f-68a0-4753-9e31-347fea814263" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_8fd5c20d-10f7-42e1-8c86-ddfe91323233" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2717bcd2-d22f-4e68-a307-49e36c9815ea" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_8fd5c20d-10f7-42e1-8c86-ddfe91323233" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/IntangibleassetsScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#IntangibleassetsScheduleofIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.alt5sigma.com/role/IntangibleassetsScheduleofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9855c939-9c08-4ba2-98fa-8ccdd15f9651" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_60d70e56-3c57-4478-9296-1b56cc37074e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9855c939-9c08-4ba2-98fa-8ccdd15f9651" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_60d70e56-3c57-4478-9296-1b56cc37074e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1f9ee599-b6d3-4ff3-bca6-465a52c86964" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9855c939-9c08-4ba2-98fa-8ccdd15f9651" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1f9ee599-b6d3-4ff3-bca6-465a52c86964" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/AccruedliabilitiesDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#AccruedliabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.alt5sigma.com/role/AccruedliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_a0a1a0ee-c1ff-4bde-b37b-6b4d854473bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_9d489f59-ed67-4ff8-983c-eb3cc5da5fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_a0a1a0ee-c1ff-4bde-b37b-6b4d854473bf" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_9d489f59-ed67-4ff8-983c-eb3cc5da5fd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_1bad924b-bbba-4948-ac65-25e1fbb686ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_a0a1a0ee-c1ff-4bde-b37b-6b4d854473bf" xlink:to="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_1bad924b-bbba-4948-ac65-25e1fbb686ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_5a28ebb2-85f6-42d5-8813-bcaeb1ed65ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_a0a1a0ee-c1ff-4bde-b37b-6b4d854473bf" xlink:to="loc_us-gaap_LitigationReserveCurrent_5a28ebb2-85f6-42d5-8813-bcaeb1ed65ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_1cdb19e2-9504-4d17-b4df-dc932728defa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_a0a1a0ee-c1ff-4bde-b37b-6b4d854473bf" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_1cdb19e2-9504-4d17-b4df-dc932728defa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_aa1a1388-5d0f-46f0-ad97-ca18516037f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_a0a1a0ee-c1ff-4bde-b37b-6b4d854473bf" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_aa1a1388-5d0f-46f0-ad97-ca18516037f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AccruedExpensesAssetAcquisitionCurrent_9d915210-0e47-4528-8d95-c0bc0a4000dd" xlink:href="alts-20241228.xsd#alts_AccruedExpensesAssetAcquisitionCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_a0a1a0ee-c1ff-4bde-b37b-6b4d854473bf" xlink:to="loc_alts_AccruedExpensesAssetAcquisitionCurrent_9d915210-0e47-4528-8d95-c0bc0a4000dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_e9ab1f2e-16ff-4067-b5f8-e4d047d3e2a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_a0a1a0ee-c1ff-4bde-b37b-6b4d854473bf" xlink:to="loc_us-gaap_InterestPayableCurrent_e9ab1f2e-16ff-4067-b5f8-e4d047d3e2a1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#LongTermDebtScheduleofLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.alt5sigma.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_14448043-7aae-4c3d-ada3-ed6c6aeabcef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_c3a3158d-f319-4ded-9a63-9342e215cf05" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_14448043-7aae-4c3d-ada3-ed6c6aeabcef" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_c3a3158d-f319-4ded-9a63-9342e215cf05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_dc441dfc-0f10-451f-9226-2082b036702b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_14448043-7aae-4c3d-ada3-ed6c6aeabcef" xlink:to="loc_us-gaap_LongTermDebtCurrent_dc441dfc-0f10-451f-9226-2082b036702b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofFutureMaturitiesofLongTermDebtDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#RelatedPartyDebtScheduleofFutureMaturitiesofLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofFutureMaturitiesofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_94369652-809a-4bf7-9cb7-8cafe9440389" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_3d351fcc-780c-4bcc-922a-115d5e6381f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_94369652-809a-4bf7-9cb7-8cafe9440389" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_3d351fcc-780c-4bcc-922a-115d5e6381f1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeTaxProvisionBenefitDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#IncometaxesScheduleofIncomeTaxProvisionBenefitDetails"/>
  <link:calculationLink xlink:role="http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeTaxProvisionBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_alts_ProvisionBenefitOfIncomeTaxes_92b3b47b-01b2-43b8-9128-0d404b02458c" xlink:href="alts-20241228.xsd#alts_ProvisionBenefitOfIncomeTaxes"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_8ba4977b-7e18-4ad3-aefc-b0e760f857c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_ProvisionBenefitOfIncomeTaxes_92b3b47b-01b2-43b8-9128-0d404b02458c" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_8ba4977b-7e18-4ad3-aefc-b0e760f857c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_bc910027-5103-4d37-93b6-7003ba59815c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_ProvisionBenefitOfIncomeTaxes_92b3b47b-01b2-43b8-9128-0d404b02458c" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_bc910027-5103-4d37-93b6-7003ba59815c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_4fee5750-2e1c-4a79-96bb-a063c9851725" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_8e63efe6-1f13-45ef-971e-8719b6b1955d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_4fee5750-2e1c-4a79-96bb-a063c9851725" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_8e63efe6-1f13-45ef-971e-8719b6b1955d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_0f083759-3e8c-4966-bffd-74c8b38cbfcc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_4fee5750-2e1c-4a79-96bb-a063c9851725" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_0f083759-3e8c-4966-bffd-74c8b38cbfcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_a9ef5e0b-1af3-4998-9723-541ba79a4c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_4fee5750-2e1c-4a79-96bb-a063c9851725" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_a9ef5e0b-1af3-4998-9723-541ba79a4c5b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/IncometaxesScheduleofReconciliationofIncomeTaxBenefitProvisionwiththeFederalStatutoryTaxRateDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#IncometaxesScheduleofReconciliationofIncomeTaxBenefitProvisionwiththeFederalStatutoryTaxRateDetails"/>
  <link:calculationLink xlink:role="http://www.alt5sigma.com/role/IncometaxesScheduleofReconciliationofIncomeTaxBenefitProvisionwiththeFederalStatutoryTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c6409d1a-3973-4c07-b527-0d7db1c82fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_c3b44f81-5f9f-499f-98e4-16935f88b0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c6409d1a-3973-4c07-b527-0d7db1c82fbb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_c3b44f81-5f9f-499f-98e4-16935f88b0b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_bef7db4a-aa93-4c0a-8b40-ce14e35c7d02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c6409d1a-3973-4c07-b527-0d7db1c82fbb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_bef7db4a-aa93-4c0a-8b40-ce14e35c7d02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_6180c7a6-547a-4ad2-9fc8-63d8990ff0a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c6409d1a-3973-4c07-b527-0d7db1c82fbb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_6180c7a6-547a-4ad2-9fc8-63d8990ff0a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_EffectiveIncomeTaxRateReconciliationPermanentDifferences_c616c157-f18a-45b9-a529-2c6fd3ff1ff0" xlink:href="alts-20241228.xsd#alts_EffectiveIncomeTaxRateReconciliationPermanentDifferences"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c6409d1a-3973-4c07-b527-0d7db1c82fbb" xlink:to="loc_alts_EffectiveIncomeTaxRateReconciliationPermanentDifferences_c616c157-f18a-45b9-a529-2c6fd3ff1ff0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_65b44d35-c9ce-43c1-b588-efa38e8d7c40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c6409d1a-3973-4c07-b527-0d7db1c82fbb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_65b44d35-c9ce-43c1-b588-efa38e8d7c40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_74d90fa5-9ec2-41e6-84f6-791bcaf7b3e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c6409d1a-3973-4c07-b527-0d7db1c82fbb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_74d90fa5-9ec2-41e6-84f6-791bcaf7b3e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_5aec02aa-6e39-4149-a80b-2ba93a86c59d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c6409d1a-3973-4c07-b527-0d7db1c82fbb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_5aec02aa-6e39-4149-a80b-2ba93a86c59d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeLossBeforeProvisionofIncomeTaxesDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#IncometaxesScheduleofIncomeLossBeforeProvisionofIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeLossBeforeProvisionofIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_alts_IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes_6de221dc-89a4-49bf-9ec7-638b5d3a9269" xlink:href="alts-20241228.xsd#alts_IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_3b5f9123-f6b2-4a07-a843-a183293627f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes_6de221dc-89a4-49bf-9ec7-638b5d3a9269" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_3b5f9123-f6b2-4a07-a843-a183293627f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_3872fbfb-dd37-44fd-9696-8c0e1956f210" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes_6de221dc-89a4-49bf-9ec7-638b5d3a9269" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_3872fbfb-dd37-44fd-9696-8c0e1956f210" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance_0362cc1c-cf27-4fbf-ba8b-485dd8ac95f3" xlink:href="alts-20241228.xsd#alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_e4c63c9a-18a4-4859-9828-f2736226f392" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance_0362cc1c-cf27-4fbf-ba8b-485dd8ac95f3" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_e4c63c9a-18a4-4859-9828-f2736226f392" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DeferredTaxAssetsLeaseLiability_182d9b85-6387-4604-8622-0d734d02ac90" xlink:href="alts-20241228.xsd#alts_DeferredTaxAssetsLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance_0362cc1c-cf27-4fbf-ba8b-485dd8ac95f3" xlink:to="loc_alts_DeferredTaxAssetsLeaseLiability_182d9b85-6387-4604-8622-0d734d02ac90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_ace40d84-4179-4d18-be9d-b90f305f9a08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance_0362cc1c-cf27-4fbf-ba8b-485dd8ac95f3" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_ace40d84-4179-4d18-be9d-b90f305f9a08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_b86cc979-e543-4a88-aeff-8d3d253fb10d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance_0362cc1c-cf27-4fbf-ba8b-485dd8ac95f3" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_b86cc979-e543-4a88-aeff-8d3d253fb10d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DeferredTaxLiabilitiesRightOfUseAssets_73bad50b-3c2e-4da8-beae-02cb4fa59bec" xlink:href="alts-20241228.xsd#alts_DeferredTaxLiabilitiesRightOfUseAssets"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance_0362cc1c-cf27-4fbf-ba8b-485dd8ac95f3" xlink:to="loc_alts_DeferredTaxLiabilitiesRightOfUseAssets_73bad50b-3c2e-4da8-beae-02cb4fa59bec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DeferredTaxAssetsInterest_b7a31338-ca69-4176-a3f7-7e2cf516c165" xlink:href="alts-20241228.xsd#alts_DeferredTaxAssetsInterest"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance_0362cc1c-cf27-4fbf-ba8b-485dd8ac95f3" xlink:to="loc_alts_DeferredTaxAssetsInterest_b7a31338-ca69-4176-a3f7-7e2cf516c165" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_f0543383-d6a8-4761-bb3e-ae00677ade05" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance_0362cc1c-cf27-4fbf-ba8b-485dd8ac95f3" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_f0543383-d6a8-4761-bb3e-ae00677ade05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DeferredTaxLiabilitiesInstallmentSale_a5dd918b-843d-4c4d-9a52-e520ec308c07" xlink:href="alts-20241228.xsd#alts_DeferredTaxLiabilitiesInstallmentSale"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance_0362cc1c-cf27-4fbf-ba8b-485dd8ac95f3" xlink:to="loc_alts_DeferredTaxLiabilitiesInstallmentSale_a5dd918b-843d-4c4d-9a52-e520ec308c07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_af361ccb-6560-4e2b-af09-02538218fbfe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance_0362cc1c-cf27-4fbf-ba8b-485dd8ac95f3" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_af361ccb-6560-4e2b-af09-02538218fbfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_c2f61c8a-4b10-421a-8da2-dd879cc3c7fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance_0362cc1c-cf27-4fbf-ba8b-485dd8ac95f3" xlink:to="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_c2f61c8a-4b10-421a-8da2-dd879cc3c7fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_36ffdf89-6430-47ed-9cf3-6e07330f503f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance_0362cc1c-cf27-4fbf-ba8b-485dd8ac95f3" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_36ffdf89-6430-47ed-9cf3-6e07330f503f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Section174Expenses_a6d03bd5-6f42-49e0-ae1f-efe9bddad1c3" xlink:href="alts-20241228.xsd#alts_Section174Expenses"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance_0362cc1c-cf27-4fbf-ba8b-485dd8ac95f3" xlink:to="loc_alts_Section174Expenses_a6d03bd5-6f42-49e0-ae1f-efe9bddad1c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_68246e8b-23d1-4437-8b1c-2b863dd08743" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance_0362cc1c-cf27-4fbf-ba8b-485dd8ac95f3" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_68246e8b-23d1-4437-8b1c-2b863dd08743" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_d5ce7d66-5108-4444-b49c-a7919e6df23a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance_0362cc1c-cf27-4fbf-ba8b-485dd8ac95f3" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_d5ce7d66-5108-4444-b49c-a7919e6df23a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_92ace8be-9193-4fe5-b9de-6206cc24e76f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance_d7eb9a72-f9a5-4bf3-ac1f-ccfe6704e7b5" xlink:href="alts-20241228.xsd#alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_92ace8be-9193-4fe5-b9de-6206cc24e76f" xlink:to="loc_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance_d7eb9a72-f9a5-4bf3-ac1f-ccfe6704e7b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_3a2b919f-38aa-4994-a249-d08cf43c5d15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_92ace8be-9193-4fe5-b9de-6206cc24e76f" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_3a2b919f-38aa-4994-a249-d08cf43c5d15" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>alts-20241228_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:2830d163-e030-49d1-a620-63415283e8e5,g:d25a092d-1f61-4617-aa79-df61d6af7f3a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="alts-20241228.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b61933c7-ef72-4dcf-ba4c-d6d2ddc9c007" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_84b4f5f5-64ff-449d-b943-0f5b3d9fc00a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_b61933c7-ef72-4dcf-ba4c-d6d2ddc9c007" xlink:to="loc_us-gaap_StatementTable_84b4f5f5-64ff-449d-b943-0f5b3d9fc00a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0354fc9c-09f4-4b0d-8818-ee2c9c91f560" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_84b4f5f5-64ff-449d-b943-0f5b3d9fc00a" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0354fc9c-09f4-4b0d-8818-ee2c9c91f560" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_0354fc9c-09f4-4b0d-8818-ee2c9c91f560_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0354fc9c-09f4-4b0d-8818-ee2c9c91f560" xlink:to="loc_us-gaap_RelatedPartyDomain_0354fc9c-09f4-4b0d-8818-ee2c9c91f560_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_3b3c8a36-afa0-4182-9340-4ce2cd258732" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0354fc9c-09f4-4b0d-8818-ee2c9c91f560" xlink:to="loc_us-gaap_RelatedPartyDomain_3b3c8a36-afa0-4182-9340-4ce2cd258732" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_c516f072-f03f-44c6-b0b0-555552feb5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3b3c8a36-afa0-4182-9340-4ce2cd258732" xlink:to="loc_us-gaap_RelatedPartyMember_c516f072-f03f-44c6-b0b0-555552feb5bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_997617e2-f03d-4d85-8fec-e88ac5c34c51" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_84b4f5f5-64ff-449d-b943-0f5b3d9fc00a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_997617e2-f03d-4d85-8fec-e88ac5c34c51" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_997617e2-f03d-4d85-8fec-e88ac5c34c51_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_997617e2-f03d-4d85-8fec-e88ac5c34c51" xlink:to="loc_us-gaap_ClassOfStockDomain_997617e2-f03d-4d85-8fec-e88ac5c34c51_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_de6455b3-2784-4b22-a659-cf3d486e3f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_997617e2-f03d-4d85-8fec-e88ac5c34c51" xlink:to="loc_us-gaap_ClassOfStockDomain_de6455b3-2784-4b22-a659-cf3d486e3f7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesA1ConvertiblePreferredStockMember_997f5235-4f28-4e50-92cf-2808532c22b2" xlink:href="alts-20241228.xsd#alts_SeriesA1ConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_de6455b3-2784-4b22-a659-cf3d486e3f7c" xlink:to="loc_alts_SeriesA1ConvertiblePreferredStockMember_997f5235-4f28-4e50-92cf-2808532c22b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_d7c3ee5d-4656-4c04-acbb-42ca71034d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_de6455b3-2784-4b22-a659-cf3d486e3f7c" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_d7c3ee5d-4656-4c04-acbb-42ca71034d7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesIConvertiblePreferredStockMember_e8a1b9fe-1ca9-4417-8475-385f2e07e8db" xlink:href="alts-20241228.xsd#alts_SeriesIConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_de6455b3-2784-4b22-a659-cf3d486e3f7c" xlink:to="loc_alts_SeriesIConvertiblePreferredStockMember_e8a1b9fe-1ca9-4417-8475-385f2e07e8db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesMPreferredStockMember_309fe8b1-cb7c-4a7e-b888-b79bb99859f4" xlink:href="alts-20241228.xsd#alts_SeriesMPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_de6455b3-2784-4b22-a659-cf3d486e3f7c" xlink:to="loc_alts_SeriesMPreferredStockMember_309fe8b1-cb7c-4a7e-b888-b79bb99859f4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesQConvertiblePreferredStockMember_48c32dcc-ef87-46b6-8012-554435554a08" xlink:href="alts-20241228.xsd#alts_SeriesQConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_de6455b3-2784-4b22-a659-cf3d486e3f7c" xlink:to="loc_alts_SeriesQConvertiblePreferredStockMember_48c32dcc-ef87-46b6-8012-554435554a08" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesSConvertiblePreferredStockMember_abbbdeea-18d0-4445-a7ec-90e3727272cf" xlink:href="alts-20241228.xsd#alts_SeriesSConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_de6455b3-2784-4b22-a659-cf3d486e3f7c" xlink:to="loc_alts_SeriesSConvertiblePreferredStockMember_abbbdeea-18d0-4445-a7ec-90e3727272cf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesVConvertiblePreferredStockMember_07aa0227-ab8a-40ef-ad04-3c2276b7133a" xlink:href="alts-20241228.xsd#alts_SeriesVConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_de6455b3-2784-4b22-a659-cf3d486e3f7c" xlink:to="loc_alts_SeriesVConvertiblePreferredStockMember_07aa0227-ab8a-40ef-ad04-3c2276b7133a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_46af28fd-ae05-4de2-988b-b6dd3d2a4104" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b61933c7-ef72-4dcf-ba4c-d6d2ddc9c007" xlink:to="loc_us-gaap_AssetsAbstract_46af28fd-ae05-4de2-988b-b6dd3d2a4104" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cb047196-734b-4e19-abc7-1498fd8acc2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_46af28fd-ae05-4de2-988b-b6dd3d2a4104" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cb047196-734b-4e19-abc7-1498fd8acc2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_0cb9352c-4718-4562-8ae5-030329e99819" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_46af28fd-ae05-4de2-988b-b6dd3d2a4104" xlink:to="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_0cb9352c-4718-4562-8ae5-030329e99819" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PlatformOperatorCryptoAssetHeldForUserCurrent_b58061d6-7159-44bf-8d6d-6966caa40be3" xlink:href="alts-20241228.xsd#alts_PlatformOperatorCryptoAssetHeldForUserCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_46af28fd-ae05-4de2-988b-b6dd3d2a4104" xlink:to="loc_alts_PlatformOperatorCryptoAssetHeldForUserCurrent_b58061d6-7159-44bf-8d6d-6966caa40be3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2cc7858d-9e95-4a66-aea7-5cbc444e5412" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_46af28fd-ae05-4de2-988b-b6dd3d2a4104" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2cc7858d-9e95-4a66-aea7-5cbc444e5412" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_fc38f417-3900-49a1-b77c-fd6623fee9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_46af28fd-ae05-4de2-988b-b6dd3d2a4104" xlink:to="loc_us-gaap_AssetsCurrent_fc38f417-3900-49a1-b77c-fd6623fee9b6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_02ace519-2004-409e-bfe4-0b7912d3529f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_46af28fd-ae05-4de2-988b-b6dd3d2a4104" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_02ace519-2004-409e-bfe4-0b7912d3529f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_6c00d4f2-adcc-47d2-b275-94d6e75fbc4e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_46af28fd-ae05-4de2-988b-b6dd3d2a4104" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_6c00d4f2-adcc-47d2-b275-94d6e75fbc4e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f4430662-9f11-4aa9-ad75-6ec0f0a01a80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_46af28fd-ae05-4de2-988b-b6dd3d2a4104" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f4430662-9f11-4aa9-ad75-6ec0f0a01a80" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_243fe15c-fc31-4b54-8fea-305aa5ff74ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_46af28fd-ae05-4de2-988b-b6dd3d2a4104" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_243fe15c-fc31-4b54-8fea-305aa5ff74ca" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DepositsAndOtherAssetsNoncurrent_87e3355c-c02e-4ec9-973a-3fd172c73401" xlink:href="alts-20241228.xsd#alts_DepositsAndOtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_46af28fd-ae05-4de2-988b-b6dd3d2a4104" xlink:to="loc_alts_DepositsAndOtherAssetsNoncurrent_87e3355c-c02e-4ec9-973a-3fd172c73401" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0461cc4d-a1e6-4afe-9ac1-6d6b6f045472" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_46af28fd-ae05-4de2-988b-b6dd3d2a4104" xlink:to="loc_us-gaap_Goodwill_0461cc4d-a1e6-4afe-9ac1-6d6b6f045472" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_4f483dcf-089d-4b0d-9ab4-23b9583436a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_46af28fd-ae05-4de2-988b-b6dd3d2a4104" xlink:to="loc_us-gaap_Assets_4f483dcf-089d-4b0d-9ab4-23b9583436a4" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3661d527-c568-469c-bcfa-734cd894819e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b61933c7-ef72-4dcf-ba4c-d6d2ddc9c007" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3661d527-c568-469c-bcfa-734cd894819e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3661d527-c568-469c-bcfa-734cd894819e" xlink:to="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_0afb7cdc-c096-4176-a02b-1efcd1fa53d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:to="loc_us-gaap_AccountsPayableCurrent_0afb7cdc-c096-4176-a02b-1efcd1fa53d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_1b8391e9-6632-4045-8d60-832590fdcff3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_1b8391e9-6632-4045-8d60-832590fdcff3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DigitalAssetLiabilityCurrent_ddec5de4-8983-4a81-b4c9-2d58ca46834e" xlink:href="alts-20241228.xsd#alts_DigitalAssetLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:to="loc_alts_DigitalAssetLiabilityCurrent_ddec5de4-8983-4a81-b4c9-2d58ca46834e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_e6cb3d69-a020-4e26-9357-dbabb091bd0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_e6cb3d69-a020-4e26-9357-dbabb091bd0e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtCurrent_29d2dd64-7972-494f-b39f-b237dcf3c148" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:to="loc_us-gaap_ConvertibleDebtCurrent_29d2dd64-7972-494f-b39f-b237dcf3c148" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_e8100562-0831-482f-8dff-7c7bf36ad47c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_e8100562-0831-482f-8dff-7c7bf36ad47c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_9e86f350-ad24-437e-888f-1ff8c7bad84a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:to="loc_us-gaap_NotesPayableCurrent_9e86f350-ad24-437e-888f-1ff8c7bad84a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_0cb52030-2bb5-484c-993b-083b179ecb1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:to="loc_us-gaap_LiabilitiesCurrent_0cb52030-2bb5-484c-993b-083b179ecb1e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d7c31e3f-bf29-4714-9577-efc855748079" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d7c31e3f-bf29-4714-9577-efc855748079" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermNotesPayable_cf1941ec-5ba8-4a91-8ca9-0b83912f7b34" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLongTermNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:to="loc_us-gaap_OtherLongTermNotesPayable_cf1941ec-5ba8-4a91-8ca9-0b83912f7b34" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_259aa54d-1e6a-45bb-9b97-1c402d185642" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:to="loc_us-gaap_LongTermNotesPayable_259aa54d-1e6a-45bb-9b97-1c402d185642" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_aa1508be-c680-4427-8a9c-cc934e442d90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_aa1508be-c680-4427-8a9c-cc934e442d90" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_edc11238-f6f6-4dfa-b875-df7cbd86d59e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_edc11238-f6f6-4dfa-b875-df7cbd86d59e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_531e263a-a13f-4796-895c-5925f9888162" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:to="loc_us-gaap_Liabilities_531e263a-a13f-4796-895c-5925f9888162" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_5bad8fd9-b08b-4d9b-971c-3875c52cf45e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3661d527-c568-469c-bcfa-734cd894819e" xlink:to="loc_us-gaap_CommitmentsAndContingencies_5bad8fd9-b08b-4d9b-971c-3875c52cf45e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_MezzanineEquityAbstract_bbe62772-5c8a-4648-b696-dbc57a818d62" xlink:href="alts-20241228.xsd#alts_MezzanineEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3661d527-c568-469c-bcfa-734cd894819e" xlink:to="loc_alts_MezzanineEquityAbstract_bbe62772-5c8a-4648-b696-dbc57a818d62" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_3695b6be-d822-48cf-9b7a-4f9be51b89f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_MezzanineEquityAbstract_bbe62772-5c8a-4648-b696-dbc57a818d62" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_3695b6be-d822-48cf-9b7a-4f9be51b89f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_1b048cae-5964-4af3-b3f5-1e12137fbade" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3661d527-c568-469c-bcfa-734cd894819e" xlink:to="loc_us-gaap_StockholdersEquityAbstract_1b048cae-5964-4af3-b3f5-1e12137fbade" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_4feaf0ae-a40a-40ec-87f4-f735a362b23e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1b048cae-5964-4af3-b3f5-1e12137fbade" xlink:to="loc_us-gaap_PreferredStockValue_4feaf0ae-a40a-40ec-87f4-f735a362b23e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_6be80438-3918-4037-b12c-9dbbfbf580b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1b048cae-5964-4af3-b3f5-1e12137fbade" xlink:to="loc_us-gaap_CommonStockValue_6be80438-3918-4037-b12c-9dbbfbf580b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_47ad8843-f622-4675-8da6-80b28c1309c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1b048cae-5964-4af3-b3f5-1e12137fbade" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_47ad8843-f622-4675-8da6-80b28c1309c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3bc866c6-9fd1-4837-b760-9c025c80bc94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1b048cae-5964-4af3-b3f5-1e12137fbade" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3bc866c6-9fd1-4837-b760-9c025c80bc94" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c5b8a7e8-3f08-4364-84b3-5a679fab355a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1b048cae-5964-4af3-b3f5-1e12137fbade" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c5b8a7e8-3f08-4364-84b3-5a679fab355a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8f681063-61af-4196-b140-6fb69d56130c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1b048cae-5964-4af3-b3f5-1e12137fbade" xlink:to="loc_us-gaap_StockholdersEquity_8f681063-61af-4196-b140-6fb69d56130c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_6eb051b5-21eb-4a27-bf8d-b199468ca946" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1b048cae-5964-4af3-b3f5-1e12137fbade" xlink:to="loc_us-gaap_MinorityInterest_6eb051b5-21eb-4a27-bf8d-b199468ca946" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1f6fea79-7234-41bb-990f-2e9a5a55def9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1b048cae-5964-4af3-b3f5-1e12137fbade" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1f6fea79-7234-41bb-990f-2e9a5a55def9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_5ca7a305-0c5f-4179-95e8-32ed778edb94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3661d527-c568-469c-bcfa-734cd894819e" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_5ca7a305-0c5f-4179-95e8-32ed778edb94" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="alts-20241228.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6fe4b312-d06e-4d57-b44b-be860cc6e787" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_588968d3-1202-4752-8f0d-5f539fce2c99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_6fe4b312-d06e-4d57-b44b-be860cc6e787" xlink:to="loc_us-gaap_StatementTable_588968d3-1202-4752-8f0d-5f539fce2c99" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b98b78b6-fb3a-436b-a691-23d314d51b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_588968d3-1202-4752-8f0d-5f539fce2c99" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b98b78b6-fb3a-436b-a691-23d314d51b1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b98b78b6-fb3a-436b-a691-23d314d51b1f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b98b78b6-fb3a-436b-a691-23d314d51b1f" xlink:to="loc_us-gaap_ClassOfStockDomain_b98b78b6-fb3a-436b-a691-23d314d51b1f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c088e001-ceed-4e69-b62e-66f570e953cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b98b78b6-fb3a-436b-a691-23d314d51b1f" xlink:to="loc_us-gaap_ClassOfStockDomain_c088e001-ceed-4e69-b62e-66f570e953cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesA1ConvertiblePreferredStockMember_da3c2ecd-735d-409a-82be-a143f288e760" xlink:href="alts-20241228.xsd#alts_SeriesA1ConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_c088e001-ceed-4e69-b62e-66f570e953cc" xlink:to="loc_alts_SeriesA1ConvertiblePreferredStockMember_da3c2ecd-735d-409a-82be-a143f288e760" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_20c545d2-6784-4408-bed0-aae7ebf8e9ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_c088e001-ceed-4e69-b62e-66f570e953cc" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_20c545d2-6784-4408-bed0-aae7ebf8e9ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesIConvertiblePreferredStockMember_a07df097-ab93-4640-b413-42617eb06d08" xlink:href="alts-20241228.xsd#alts_SeriesIConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_c088e001-ceed-4e69-b62e-66f570e953cc" xlink:to="loc_alts_SeriesIConvertiblePreferredStockMember_a07df097-ab93-4640-b413-42617eb06d08" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesMPreferredStockMember_7cdd78e0-65bc-420e-be8e-539ca7cfdeef" xlink:href="alts-20241228.xsd#alts_SeriesMPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_c088e001-ceed-4e69-b62e-66f570e953cc" xlink:to="loc_alts_SeriesMPreferredStockMember_7cdd78e0-65bc-420e-be8e-539ca7cfdeef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesQConvertiblePreferredStockMember_8d4160a6-870f-493f-af63-652e8e7958f4" xlink:href="alts-20241228.xsd#alts_SeriesQConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_c088e001-ceed-4e69-b62e-66f570e953cc" xlink:to="loc_alts_SeriesQConvertiblePreferredStockMember_8d4160a6-870f-493f-af63-652e8e7958f4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesSConvertiblePreferredStockMember_83d150e7-3aba-4f6f-b8f5-333d1f1a0b57" xlink:href="alts-20241228.xsd#alts_SeriesSConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_c088e001-ceed-4e69-b62e-66f570e953cc" xlink:to="loc_alts_SeriesSConvertiblePreferredStockMember_83d150e7-3aba-4f6f-b8f5-333d1f1a0b57" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesVConvertiblePreferredStockMember_cdf20542-b1ab-49ed-bea4-d7d1d779a63e" xlink:href="alts-20241228.xsd#alts_SeriesVConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_c088e001-ceed-4e69-b62e-66f570e953cc" xlink:to="loc_alts_SeriesVConvertiblePreferredStockMember_cdf20542-b1ab-49ed-bea4-d7d1d779a63e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_3e5ff5b5-a3c3-4002-8b40-3e128947b5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6fe4b312-d06e-4d57-b44b-be860cc6e787" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_3e5ff5b5-a3c3-4002-8b40-3e128947b5b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_e1ecd259-1d97-4b42-ba83-c03b139d17c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6fe4b312-d06e-4d57-b44b-be860cc6e787" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_e1ecd259-1d97-4b42-ba83-c03b139d17c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_30e367d7-96b2-4bad-be39-3bcc315de3a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6fe4b312-d06e-4d57-b44b-be860cc6e787" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_30e367d7-96b2-4bad-be39-3bcc315de3a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_26a8ac29-02c8-44f0-a7e6-ba128c6a330e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6fe4b312-d06e-4d57-b44b-be860cc6e787" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_26a8ac29-02c8-44f0-a7e6-ba128c6a330e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1f3cc578-1b4b-4fff-8c1f-701233f92e92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6fe4b312-d06e-4d57-b44b-be860cc6e787" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1f3cc578-1b4b-4fff-8c1f-701233f92e92" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_7893e02e-0636-4e86-baa1-41c1006f8746" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6fe4b312-d06e-4d57-b44b-be860cc6e787" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_7893e02e-0636-4e86-baa1-41c1006f8746" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_3b30a1b4-9415-4909-80a5-7b7b31f29639" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6fe4b312-d06e-4d57-b44b-be860cc6e787" xlink:to="loc_us-gaap_PreferredStockSharesIssued_3b30a1b4-9415-4909-80a5-7b7b31f29639" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_e6425141-4a15-4070-88ed-f84f65f06c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6fe4b312-d06e-4d57-b44b-be860cc6e787" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_e6425141-4a15-4070-88ed-f84f65f06c1d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_b8d22ba6-6590-423f-b3f4-bab9ff339e34" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6fe4b312-d06e-4d57-b44b-be860cc6e787" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_b8d22ba6-6590-423f-b3f4-bab9ff339e34" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_d10e0849-d32f-415c-a880-b17156a35d75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6fe4b312-d06e-4d57-b44b-be860cc6e787" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_d10e0849-d32f-415c-a880-b17156a35d75" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_e08c6144-2108-47a4-9cb1-f63acd2821e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6fe4b312-d06e-4d57-b44b-be860cc6e787" xlink:to="loc_us-gaap_CommonStockSharesIssued_e08c6144-2108-47a4-9cb1-f63acd2821e4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_5a74e6ca-37b6-48a9-b92b-576517b8a247" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6fe4b312-d06e-4d57-b44b-be860cc6e787" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_5a74e6ca-37b6-48a9-b92b-576517b8a247" xlink:type="arc" order="11"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="alts-20241228.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_87fe3223-db68-4b6b-a610-1c9f68d7d4b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_df964fa3-0467-4cf4-9486-e519c6360246" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_87fe3223-db68-4b6b-a610-1c9f68d7d4b5" xlink:to="loc_us-gaap_StatementTable_df964fa3-0467-4cf4-9486-e519c6360246" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_db69a13c-4777-4abd-912f-5feea6f3f53e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_df964fa3-0467-4cf4-9486-e519c6360246" xlink:to="loc_us-gaap_StatementClassOfStockAxis_db69a13c-4777-4abd-912f-5feea6f3f53e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_db69a13c-4777-4abd-912f-5feea6f3f53e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_db69a13c-4777-4abd-912f-5feea6f3f53e" xlink:to="loc_us-gaap_ClassOfStockDomain_db69a13c-4777-4abd-912f-5feea6f3f53e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0709bbe8-8f03-400d-a05e-12b1239f284e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_db69a13c-4777-4abd-912f-5feea6f3f53e" xlink:to="loc_us-gaap_ClassOfStockDomain_0709bbe8-8f03-400d-a05e-12b1239f284e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesA1PreferredStockMember_41d833e4-e001-40d7-991a-813489946d3f" xlink:href="alts-20241228.xsd#alts_SeriesA1PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0709bbe8-8f03-400d-a05e-12b1239f284e" xlink:to="loc_alts_SeriesA1PreferredStockMember_41d833e4-e001-40d7-991a-813489946d3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesS1PreferredMember_1df53d3c-7d24-4415-8e7f-69c7c4185eb7" xlink:href="alts-20241228.xsd#alts_SeriesS1PreferredMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0709bbe8-8f03-400d-a05e-12b1239f284e" xlink:to="loc_alts_SeriesS1PreferredMember_1df53d3c-7d24-4415-8e7f-69c7c4185eb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_0d9baccb-acb6-43bd-8f34-0694fce34826" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0709bbe8-8f03-400d-a05e-12b1239f284e" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_0d9baccb-acb6-43bd-8f34-0694fce34826" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesIPreferredStockMember_647e4cba-8eb3-442a-b8a6-47d0ded506c9" xlink:href="alts-20241228.xsd#alts_SeriesIPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0709bbe8-8f03-400d-a05e-12b1239f284e" xlink:to="loc_alts_SeriesIPreferredStockMember_647e4cba-8eb3-442a-b8a6-47d0ded506c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesMPreferredStockMember_c7dee9ab-44ab-4ed3-8845-a08a85ea61a9" xlink:href="alts-20241228.xsd#alts_SeriesMPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0709bbe8-8f03-400d-a05e-12b1239f284e" xlink:to="loc_alts_SeriesMPreferredStockMember_c7dee9ab-44ab-4ed3-8845-a08a85ea61a9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesQPreferredStockMember_147b6a90-56dd-47d8-9b26-4d1a939599f0" xlink:href="alts-20241228.xsd#alts_SeriesQPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0709bbe8-8f03-400d-a05e-12b1239f284e" xlink:to="loc_alts_SeriesQPreferredStockMember_147b6a90-56dd-47d8-9b26-4d1a939599f0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesVPreferredStockMember_5529e920-91e3-4bd1-ab32-9a9b87b4dd9e" xlink:href="alts-20241228.xsd#alts_SeriesVPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0709bbe8-8f03-400d-a05e-12b1239f284e" xlink:to="loc_alts_SeriesVPreferredStockMember_5529e920-91e3-4bd1-ab32-9a9b87b4dd9e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_d2e03619-2fae-4117-a411-43e0b6866c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0709bbe8-8f03-400d-a05e-12b1239f284e" xlink:to="loc_us-gaap_CommonClassAMember_d2e03619-2fae-4117-a411-43e0b6866c7d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_80d320b4-a91b-4d66-ba93-76918b71e021" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_df964fa3-0467-4cf4-9486-e519c6360246" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_80d320b4-a91b-4d66-ba93-76918b71e021" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_80d320b4-a91b-4d66-ba93-76918b71e021_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_80d320b4-a91b-4d66-ba93-76918b71e021" xlink:to="loc_us-gaap_EquityComponentDomain_80d320b4-a91b-4d66-ba93-76918b71e021_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_afdb6f8a-a086-4664-b789-17e4ef530982" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_80d320b4-a91b-4d66-ba93-76918b71e021" xlink:to="loc_us-gaap_EquityComponentDomain_afdb6f8a-a086-4664-b789-17e4ef530982" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_8c089abc-fb58-49f3-b08b-f7d9c91671a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_afdb6f8a-a086-4664-b789-17e4ef530982" xlink:to="loc_us-gaap_PreferredStockMember_8c089abc-fb58-49f3-b08b-f7d9c91671a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4f0563bd-6041-4c5a-8316-d546e1690b55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_afdb6f8a-a086-4664-b789-17e4ef530982" xlink:to="loc_us-gaap_CommonStockMember_4f0563bd-6041-4c5a-8316-d546e1690b55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f2e4599b-8fb4-4af6-88f8-0dec99f88bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_afdb6f8a-a086-4664-b789-17e4ef530982" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f2e4599b-8fb4-4af6-88f8-0dec99f88bcf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9c378cd4-e5da-4a37-b135-190fa4bb7502" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_afdb6f8a-a086-4664-b789-17e4ef530982" xlink:to="loc_us-gaap_RetainedEarningsMember_9c378cd4-e5da-4a37-b135-190fa4bb7502" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9f2bba40-f24a-48e2-8c12-78423ecf3bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_afdb6f8a-a086-4664-b789-17e4ef530982" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9f2bba40-f24a-48e2-8c12-78423ecf3bd6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_9e6ad6bb-2a1c-4966-979b-9c84811d028f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_afdb6f8a-a086-4664-b789-17e4ef530982" xlink:to="loc_us-gaap_NoncontrollingInterestMember_9e6ad6bb-2a1c-4966-979b-9c84811d028f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_ef3e387e-8a90-474d-bf6a-ae880625350f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_df964fa3-0467-4cf4-9486-e519c6360246" xlink:to="loc_us-gaap_AssetAcquisitionAxis_ef3e387e-8a90-474d-bf6a-ae880625350f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_ef3e387e-8a90-474d-bf6a-ae880625350f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_ef3e387e-8a90-474d-bf6a-ae880625350f" xlink:to="loc_us-gaap_AssetAcquisitionDomain_ef3e387e-8a90-474d-bf6a-ae880625350f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_0f7d2676-4f02-49f3-8579-5fd5645618b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_ef3e387e-8a90-474d-bf6a-ae880625350f" xlink:to="loc_us-gaap_AssetAcquisitionDomain_0f7d2676-4f02-49f3-8579-5fd5645618b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_QodenTechnologiesLLCMember_ea8c83a4-4dd8-477c-a8b7-ee017eb373b7" xlink:href="alts-20241228.xsd#alts_QodenTechnologiesLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_0f7d2676-4f02-49f3-8579-5fd5645618b1" xlink:to="loc_alts_QodenTechnologiesLLCMember_ea8c83a4-4dd8-477c-a8b7-ee017eb373b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_87fe3223-db68-4b6b-a610-1c9f68d7d4b5" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_22d7c2a1-7771-4003-bbc0-699ff04d44f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_22d7c2a1-7771-4003-bbc0-699ff04d44f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0631fd4b-1bae-4878-ab69-fe5934eeea40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0631fd4b-1bae-4878-ab69-fe5934eeea40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_5d3c9604-8b79-4a27-b12f-8e303963c7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_5d3c9604-8b79-4a27-b12f-8e303963c7cd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_d812e26f-3c0f-4d28-a9a1-2928f5dc72a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_d812e26f-3c0f-4d28-a9a1-2928f5dc72a7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_73bc8d75-9fba-4e98-b9c8-a1b24d36d18b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_73bc8d75-9fba-4e98-b9c8-a1b24d36d18b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_5b5f5cde-d259-49d6-844d-5228b31f8291" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_5b5f5cde-d259-49d6-844d-5228b31f8291" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AdjustmentToAdditionalPaidInCapitalReclassificationsOfTemporaryToLiability_4b79bfe4-bf8a-4b30-9f91-56c6ae476b80" xlink:href="alts-20241228.xsd#alts_AdjustmentToAdditionalPaidInCapitalReclassificationsOfTemporaryToLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_alts_AdjustmentToAdditionalPaidInCapitalReclassificationsOfTemporaryToLiability_4b79bfe4-bf8a-4b30-9f91-56c6ae476b80" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_82bfadc4-c2e4-4885-85c9-f6cb210884c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_82bfadc4-c2e4-4885-85c9-f6cb210884c7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_29811f70-efe9-47b1-bded-5394ea06f36e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_29811f70-efe9-47b1-bded-5394ea06f36e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9c9c0d15-89f4-4fa6-b5f2-b0c73c09a19b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9c9c0d15-89f4-4fa6-b5f2-b0c73c09a19b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_94f6d0a4-e680-4bf8-85df-265e2c484b44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_94f6d0a4-e680-4bf8-85df-265e2c484b44" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_e7ca3f6b-fb10-43b1-904a-577d51bba679" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_e7ca3f6b-fb10-43b1-904a-577d51bba679" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_5bd662ad-3253-4929-95cc-85a184180f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_5bd662ad-3253-4929-95cc-85a184180f3c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_b90e29c3-89aa-4ad2-82ab-44b082cb7715" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_b90e29c3-89aa-4ad2-82ab-44b082cb7715" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_81e04bcc-e6ae-4509-a9ae-0cedf27be7df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_81e04bcc-e6ae-4509-a9ae-0cedf27be7df" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockIssuedDuringPeriodSharesIssuedInLieuOfNotesPayable_81e74c8b-342a-4556-9ba6-3888c7c97d84" xlink:href="alts-20241228.xsd#alts_StockIssuedDuringPeriodSharesIssuedInLieuOfNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_alts_StockIssuedDuringPeriodSharesIssuedInLieuOfNotesPayable_81e74c8b-342a-4556-9ba6-3888c7c97d84" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable_95a656a5-c662-4c6b-86d0-36c42381d336" xlink:href="alts-20241228.xsd#alts_StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_alts_StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable_95a656a5-c662-4c6b-86d0-36c42381d336" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_56d9cf1e-9895-477b-b4c3-82fadecb7712" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_56d9cf1e-9895-477b-b4c3-82fadecb7712" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_fece43e9-eb89-4eaa-86ca-8cc7c8e7e92b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_fece43e9-eb89-4eaa-86ca-8cc7c8e7e92b" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_1c091dc6-465e-4ae4-a964-ab5a28193722" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_1c091dc6-465e-4ae4-a964-ab5a28193722" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_ec74eb8e-0d2a-438b-a2cf-edbde60c3b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_ec74eb8e-0d2a-438b-a2cf-edbde60c3b7d" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockIssuedDuringPeriodSharesPrepaidInterest_c48b43e6-cde6-41cd-acf4-9ccdd37d850d" xlink:href="alts-20241228.xsd#alts_StockIssuedDuringPeriodSharesPrepaidInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_alts_StockIssuedDuringPeriodSharesPrepaidInterest_c48b43e6-cde6-41cd-acf4-9ccdd37d850d" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockIssuedDuringPeriodValuePrepaidInterest_0ab9bcaa-2da1-493c-9e0b-70417ca2f858" xlink:href="alts-20241228.xsd#alts_StockIssuedDuringPeriodValuePrepaidInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_alts_StockIssuedDuringPeriodValuePrepaidInterest_0ab9bcaa-2da1-493c-9e0b-70417ca2f858" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockIssuedDuringPeriodSharesWarrantsExercised_47d52a17-81dc-44a6-b15d-eb993995a7c3" xlink:href="alts-20241228.xsd#alts_StockIssuedDuringPeriodSharesWarrantsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_alts_StockIssuedDuringPeriodSharesWarrantsExercised_47d52a17-81dc-44a6-b15d-eb993995a7c3" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockIssuedDuringPeriodValueWarrantsExercised_6519791a-ab90-4eb9-a9c9-8ecff3ce1efd" xlink:href="alts-20241228.xsd#alts_StockIssuedDuringPeriodValueWarrantsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_alts_StockIssuedDuringPeriodValueWarrantsExercised_6519791a-ab90-4eb9-a9c9-8ecff3ce1efd" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7fc3ac17-94dd-4321-8c18-6604064310c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7fc3ac17-94dd-4321-8c18-6604064310c0" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_54b3e95b-ea42-4cf8-9995-79ae37687531" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_ProfitLoss_54b3e95b-ea42-4cf8-9995-79ae37687531" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_5a5d7dc4-e292-47c7-9455-2729ae153856" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8521c0ff-3752-4218-bcd3-b4db6e6df66e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d636c3d7-1a96-47a4-bd8b-032b8be32cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="alts-20241228.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSignificantNoncashTransactionsLineItems_bcf5db8e-88d0-463e-b4ca-cb27849468a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherSignificantNoncashTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSignificantNoncashTransactionsTable_82e23335-4158-442e-8c02-d2946f778f48" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherSignificantNoncashTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionsLineItems_bcf5db8e-88d0-463e-b4ca-cb27849468a7" xlink:to="loc_us-gaap_OtherSignificantNoncashTransactionsTable_82e23335-4158-442e-8c02-d2946f778f48" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis_0a28dbcf-9f82-45af-b76d-6a57263e717e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionsTable_82e23335-4158-442e-8c02-d2946f778f48" xlink:to="loc_us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis_0a28dbcf-9f82-45af-b76d-6a57263e717e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSignificantNoncashTransactionNameDomain_0a28dbcf-9f82-45af-b76d-6a57263e717e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherSignificantNoncashTransactionNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis_0a28dbcf-9f82-45af-b76d-6a57263e717e" xlink:to="loc_us-gaap_OtherSignificantNoncashTransactionNameDomain_0a28dbcf-9f82-45af-b76d-6a57263e717e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSignificantNoncashTransactionNameDomain_97a6d4c2-05ac-41d0-81b6-217487b96e95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherSignificantNoncashTransactionNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis_0a28dbcf-9f82-45af-b76d-6a57263e717e" xlink:to="loc_us-gaap_OtherSignificantNoncashTransactionNameDomain_97a6d4c2-05ac-41d0-81b6-217487b96e95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherSignificantNoncashTransactionBusinessAcquisitionMember_4df44924-cf90-49c3-829d-1c45e65621c0" xlink:href="alts-20241228.xsd#alts_OtherSignificantNoncashTransactionBusinessAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionNameDomain_97a6d4c2-05ac-41d0-81b6-217487b96e95" xlink:to="loc_alts_OtherSignificantNoncashTransactionBusinessAcquisitionMember_4df44924-cf90-49c3-829d-1c45e65621c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherSignificantNoncashTransactionConsultingServicesMember_47357d71-4c76-4099-8e57-5efb9ee68ec0" xlink:href="alts-20241228.xsd#alts_OtherSignificantNoncashTransactionConsultingServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionNameDomain_97a6d4c2-05ac-41d0-81b6-217487b96e95" xlink:to="loc_alts_OtherSignificantNoncashTransactionConsultingServicesMember_47357d71-4c76-4099-8e57-5efb9ee68ec0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherSignificantNoncashTransactionLiabilityObligationsMember_d5333d73-e6dc-481b-9e61-b5340c9844b5" xlink:href="alts-20241228.xsd#alts_OtherSignificantNoncashTransactionLiabilityObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionNameDomain_97a6d4c2-05ac-41d0-81b6-217487b96e95" xlink:to="loc_alts_OtherSignificantNoncashTransactionLiabilityObligationsMember_d5333d73-e6dc-481b-9e61-b5340c9844b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherSignificantNoncashTransactionInterestObligationsMember_a347be99-5d9a-4174-a874-8f3de9d78b04" xlink:href="alts-20241228.xsd#alts_OtherSignificantNoncashTransactionInterestObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionNameDomain_97a6d4c2-05ac-41d0-81b6-217487b96e95" xlink:to="loc_alts_OtherSignificantNoncashTransactionInterestObligationsMember_a347be99-5d9a-4174-a874-8f3de9d78b04" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherSignificantNoncashTransactionPropertyAndEquipmentMember_105a8da0-d386-4e39-83e6-9f07f57f12f1" xlink:href="alts-20241228.xsd#alts_OtherSignificantNoncashTransactionPropertyAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionNameDomain_97a6d4c2-05ac-41d0-81b6-217487b96e95" xlink:to="loc_alts_OtherSignificantNoncashTransactionPropertyAndEquipmentMember_105a8da0-d386-4e39-83e6-9f07f57f12f1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherSignificantNoncashTransactionIntangibleAssetsMember_8fa6ea66-e984-4788-959d-c75f957fce00" xlink:href="alts-20241228.xsd#alts_OtherSignificantNoncashTransactionIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionNameDomain_97a6d4c2-05ac-41d0-81b6-217487b96e95" xlink:to="loc_alts_OtherSignificantNoncashTransactionIntangibleAssetsMember_8fa6ea66-e984-4788-959d-c75f957fce00" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1_d0363ba2-b159-44c6-b707-b3c10c75cae9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionsLineItems_bcf5db8e-88d0-463e-b4ca-cb27849468a7" xlink:to="loc_us-gaap_StockIssued1_d0363ba2-b159-44c6-b707-b3c10c75cae9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_bc40d75e-09d9-49dc-b21d-6617218b5df4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionsLineItems_bcf5db8e-88d0-463e-b4ca-cb27849468a7" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_bc40d75e-09d9-49dc-b21d-6617218b5df4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7d596e25-88e4-4e63-9fc3-86cba65c62f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1e0b48ff-29b5-4883-9ee8-949bd5d2f1ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7d596e25-88e4-4e63-9fc3-86cba65c62f3" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1e0b48ff-29b5-4883-9ee8-949bd5d2f1ca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_8f146d1d-8fa9-458b-9b6a-8e2b941ed732" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1e0b48ff-29b5-4883-9ee8-949bd5d2f1ca" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_8f146d1d-8fa9-458b-9b6a-8e2b941ed732" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_8f146d1d-8fa9-458b-9b6a-8e2b941ed732_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_8f146d1d-8fa9-458b-9b6a-8e2b941ed732" xlink:to="loc_us-gaap_ReceivableTypeDomain_8f146d1d-8fa9-458b-9b6a-8e2b941ed732_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_1f28f6ba-aaa7-4736-a810-c60838185133" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_8f146d1d-8fa9-458b-9b6a-8e2b941ed732" xlink:to="loc_us-gaap_ReceivableTypeDomain_1f28f6ba-aaa7-4736-a810-c60838185133" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SubscriptionsReceivableMember_711b393d-a61d-4214-b2b4-41c3b03f3764" xlink:href="alts-20241228.xsd#alts_SubscriptionsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_1f28f6ba-aaa7-4736-a810-c60838185133" xlink:to="loc_alts_SubscriptionsReceivableMember_711b393d-a61d-4214-b2b4-41c3b03f3764" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e019a22c-911a-417f-a3f9-c1c8d4b3748a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1e0b48ff-29b5-4883-9ee8-949bd5d2f1ca" xlink:to="loc_srt_RangeAxis_e019a22c-911a-417f-a3f9-c1c8d4b3748a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e019a22c-911a-417f-a3f9-c1c8d4b3748a_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e019a22c-911a-417f-a3f9-c1c8d4b3748a" xlink:to="loc_srt_RangeMember_e019a22c-911a-417f-a3f9-c1c8d4b3748a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_693b5bdc-f2a4-49df-acf7-9f4eaec715ec" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e019a22c-911a-417f-a3f9-c1c8d4b3748a" xlink:to="loc_srt_RangeMember_693b5bdc-f2a4-49df-acf7-9f4eaec715ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_89ce2931-7372-4a8b-a65a-65c1091e0266" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_693b5bdc-f2a4-49df-acf7-9f4eaec715ec" xlink:to="loc_srt_MinimumMember_89ce2931-7372-4a8b-a65a-65c1091e0266" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4ac1e68f-e274-402e-ad05-6aaefab05d53" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_693b5bdc-f2a4-49df-acf7-9f4eaec715ec" xlink:to="loc_srt_MaximumMember_4ac1e68f-e274-402e-ad05-6aaefab05d53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b5c7dec6-62f7-4270-9bb1-b1f173794714" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1e0b48ff-29b5-4883-9ee8-949bd5d2f1ca" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b5c7dec6-62f7-4270-9bb1-b1f173794714" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b5c7dec6-62f7-4270-9bb1-b1f173794714_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b5c7dec6-62f7-4270-9bb1-b1f173794714" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b5c7dec6-62f7-4270-9bb1-b1f173794714_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d06c60aa-1349-4982-8f31-4fb3b7550e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b5c7dec6-62f7-4270-9bb1-b1f173794714" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d06c60aa-1349-4982-8f31-4fb3b7550e1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingRelatedIntangibleAssetsMember_a0b4ef8e-aa1b-4669-84b3-ca0fa979260e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketingRelatedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d06c60aa-1349-4982-8f31-4fb3b7550e1b" xlink:to="loc_us-gaap_MarketingRelatedIntangibleAssetsMember_a0b4ef8e-aa1b-4669-84b3-ca0fa979260e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_ce646169-20fe-4976-a809-7402fcd2bd9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d06c60aa-1349-4982-8f31-4fb3b7550e1b" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_ce646169-20fe-4976-a809-7402fcd2bd9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_6c02ca1c-c01f-4f6a-bee3-0ee527babc62" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d06c60aa-1349-4982-8f31-4fb3b7550e1b" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_6c02ca1c-c01f-4f6a-bee3-0ee527babc62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_49c97ea1-2152-4d0a-acd5-8a35741f042e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d06c60aa-1349-4982-8f31-4fb3b7550e1b" xlink:to="loc_us-gaap_CustomerRelationshipsMember_49c97ea1-2152-4d0a-acd5-8a35741f042e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PlatformOperatorCryptoAssetHeldForUserCurrent_ca7982a6-4574-4b49-983d-41062303fdf3" xlink:href="alts-20241228.xsd#alts_PlatformOperatorCryptoAssetHeldForUserCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7d596e25-88e4-4e63-9fc3-86cba65c62f3" xlink:to="loc_alts_PlatformOperatorCryptoAssetHeldForUserCurrent_ca7982a6-4574-4b49-983d-41062303fdf3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_0f5cc42f-c516-4150-9625-519498d53e54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7d596e25-88e4-4e63-9fc3-86cba65c62f3" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_0f5cc42f-c516-4150-9625-519498d53e54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_e5009573-8cb7-4219-b931-2746da143aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7d596e25-88e4-4e63-9fc3-86cba65c62f3" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_e5009573-8cb7-4219-b931-2746da143aa1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_8db3dcbe-1e59-4566-a5e6-7257b664f82b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7d596e25-88e4-4e63-9fc3-86cba65c62f3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_8db3dcbe-1e59-4566-a5e6-7257b664f82b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DigitalAssetLiabilityCurrent_cdb379cf-4e53-45c0-963a-261f901184c9" xlink:href="alts-20241228.xsd#alts_DigitalAssetLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7d596e25-88e4-4e63-9fc3-86cba65c62f3" xlink:to="loc_alts_DigitalAssetLiabilityCurrent_cdb379cf-4e53-45c0-963a-261f901184c9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DigitalAssetLiabilityCurrentDigitalAssets_a8668c97-4813-4c80-97df-aed02cd0bf31" xlink:href="alts-20241228.xsd#alts_DigitalAssetLiabilityCurrentDigitalAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7d596e25-88e4-4e63-9fc3-86cba65c62f3" xlink:to="loc_alts_DigitalAssetLiabilityCurrentDigitalAssets_a8668c97-4813-4c80-97df-aed02cd0bf31" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DigitalAssetLiabilityCurrentCashDeposits_8be427cf-0287-4418-a023-9a7490eb664e" xlink:href="alts-20241228.xsd#alts_DigitalAssetLiabilityCurrentCashDeposits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7d596e25-88e4-4e63-9fc3-86cba65c62f3" xlink:to="loc_alts_DigitalAssetLiabilityCurrentCashDeposits_8be427cf-0287-4418-a023-9a7490eb664e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_38c55702-62f3-4054-b601-4f48d3db6720" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7d596e25-88e4-4e63-9fc3-86cba65c62f3" xlink:to="loc_us-gaap_NumberOfReportableSegments_38c55702-62f3-4054-b601-4f48d3db6720" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/MergersandAcquisitionsQodenDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#MergersandAcquisitionsQodenDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/MergersandAcquisitionsQodenDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionLineItems_35fb1833-203f-423f-b03c-c587d99781df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionTable_43709e97-682a-48f0-b902-97dd5c753180" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_35fb1833-203f-423f-b03c-c587d99781df" xlink:to="loc_us-gaap_AssetAcquisitionTable_43709e97-682a-48f0-b902-97dd5c753180" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_54dbc365-1019-41ce-b9c0-7a13abf04a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AssetAcquisitionTable_43709e97-682a-48f0-b902-97dd5c753180" xlink:to="loc_us-gaap_AssetAcquisitionAxis_54dbc365-1019-41ce-b9c0-7a13abf04a4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_54dbc365-1019-41ce-b9c0-7a13abf04a4e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_54dbc365-1019-41ce-b9c0-7a13abf04a4e" xlink:to="loc_us-gaap_AssetAcquisitionDomain_54dbc365-1019-41ce-b9c0-7a13abf04a4e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_776c1de6-6e4d-4bf6-bc9a-9ed8c883c8e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_54dbc365-1019-41ce-b9c0-7a13abf04a4e" xlink:to="loc_us-gaap_AssetAcquisitionDomain_776c1de6-6e4d-4bf6-bc9a-9ed8c883c8e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_QodenTechnologiesLLCMember_ad8b62ae-c963-4e76-8431-a16643a51a5f" xlink:href="alts-20241228.xsd#alts_QodenTechnologiesLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_776c1de6-6e4d-4bf6-bc9a-9ed8c883c8e5" xlink:to="loc_alts_QodenTechnologiesLLCMember_ad8b62ae-c963-4e76-8431-a16643a51a5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0b13b003-66fa-4480-8fd2-1be024a6e842" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AssetAcquisitionTable_43709e97-682a-48f0-b902-97dd5c753180" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0b13b003-66fa-4480-8fd2-1be024a6e842" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_0b13b003-66fa-4480-8fd2-1be024a6e842_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0b13b003-66fa-4480-8fd2-1be024a6e842" xlink:to="loc_us-gaap_RelatedPartyDomain_0b13b003-66fa-4480-8fd2-1be024a6e842_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_549fc595-2240-4487-bacb-2efabde72edc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0b13b003-66fa-4480-8fd2-1be024a6e842" xlink:to="loc_us-gaap_RelatedPartyDomain_549fc595-2240-4487-bacb-2efabde72edc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_7db59620-da15-4f54-8edc-19a153f5d88c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_549fc595-2240-4487-bacb-2efabde72edc" xlink:to="loc_us-gaap_RelatedPartyMember_7db59620-da15-4f54-8edc-19a153f5d88c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_eb372728-4a86-4b89-98af-878bee2720aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AssetAcquisitionTable_43709e97-682a-48f0-b902-97dd5c753180" xlink:to="loc_us-gaap_StatementClassOfStockAxis_eb372728-4a86-4b89-98af-878bee2720aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_eb372728-4a86-4b89-98af-878bee2720aa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_eb372728-4a86-4b89-98af-878bee2720aa" xlink:to="loc_us-gaap_ClassOfStockDomain_eb372728-4a86-4b89-98af-878bee2720aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8ec3c2dd-6a72-4588-a489-2660e872d7da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_eb372728-4a86-4b89-98af-878bee2720aa" xlink:to="loc_us-gaap_ClassOfStockDomain_8ec3c2dd-6a72-4588-a489-2660e872d7da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesQConvertiblePreferredStockMember_0067db02-0c5d-46dd-bb1a-bc5c842640b0" xlink:href="alts-20241228.xsd#alts_SeriesQConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_8ec3c2dd-6a72-4588-a489-2660e872d7da" xlink:to="loc_alts_SeriesQConvertiblePreferredStockMember_0067db02-0c5d-46dd-bb1a-bc5c842640b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred_f12507b0-f020-4bcf-8dc6-97e7c9fc98a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_35fb1833-203f-423f-b03c-c587d99781df" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferred_f12507b0-f020-4bcf-8dc6-97e7c9fc98a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_ea42711f-faa8-4e6f-95d5-3f5bdfdb8bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_35fb1833-203f-423f-b03c-c587d99781df" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_ea42711f-faa8-4e6f-95d5-3f5bdfdb8bfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares_1b7edab4-a0d7-49bd-a4ac-7a621cae4a7e" xlink:href="alts-20241228.xsd#alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_35fb1833-203f-423f-b03c-c587d99781df" xlink:to="loc_alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares_1b7edab4-a0d7-49bd-a4ac-7a621cae4a7e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AssetAcquisitionConsiderationCashPayable_453407b7-5955-4721-af61-fa86bc03ecfd" xlink:href="alts-20241228.xsd#alts_AssetAcquisitionConsiderationCashPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_35fb1833-203f-423f-b03c-c587d99781df" xlink:to="loc_alts_AssetAcquisitionConsiderationCashPayable_453407b7-5955-4721-af61-fa86bc03ecfd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AssetAcquisitionConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare_0f1556a9-0200-4311-b70b-f4da7befc775" xlink:href="alts-20241228.xsd#alts_AssetAcquisitionConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_35fb1833-203f-423f-b03c-c587d99781df" xlink:to="loc_alts_AssetAcquisitionConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare_0f1556a9-0200-4311-b70b-f4da7befc775" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AssetAcquisitionEquityInstrumentsIssuableValidConversionPeriod_e95f7e62-a366-4495-b3b0-748c37a093cd" xlink:href="alts-20241228.xsd#alts_AssetAcquisitionEquityInstrumentsIssuableValidConversionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_35fb1833-203f-423f-b03c-c587d99781df" xlink:to="loc_alts_AssetAcquisitionEquityInstrumentsIssuableValidConversionPeriod_e95f7e62-a366-4495-b3b0-748c37a093cd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AssetAcquisitionConsiderationPeriodicCashPayment_eeb6b817-d791-4712-ae10-2ba8f0792eea" xlink:href="alts-20241228.xsd#alts_AssetAcquisitionConsiderationPeriodicCashPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_35fb1833-203f-423f-b03c-c587d99781df" xlink:to="loc_alts_AssetAcquisitionConsiderationPeriodicCashPayment_eeb6b817-d791-4712-ae10-2ba8f0792eea" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/MergersandAcquisitionsALT5Details" xlink:type="simple" xlink:href="alts-20241228.xsd#MergersandAcquisitionsALT5Details"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/MergersandAcquisitionsALT5Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_9fc02a8a-24af-41f7-a4a4-de3dcd912ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bb47750d-4003-499c-8493-6f47de1af980" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fc02a8a-24af-41f7-a4a4-de3dcd912ee0" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bb47750d-4003-499c-8493-6f47de1af980" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_da8186d6-6e83-4ef3-b2d3-5e3c8c8d69ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bb47750d-4003-499c-8493-6f47de1af980" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_da8186d6-6e83-4ef3-b2d3-5e3c8c8d69ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_da8186d6-6e83-4ef3-b2d3-5e3c8c8d69ee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_da8186d6-6e83-4ef3-b2d3-5e3c8c8d69ee" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_da8186d6-6e83-4ef3-b2d3-5e3c8c8d69ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_da454633-d99f-40f5-9c94-dbea90c5b76b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_da8186d6-6e83-4ef3-b2d3-5e3c8c8d69ee" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_da454633-d99f-40f5-9c94-dbea90c5b76b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Alt5SigmaInc.Member_a495e0ef-250f-4251-9349-8bb9753812df" xlink:href="alts-20241228.xsd#alts_Alt5SigmaInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_da454633-d99f-40f5-9c94-dbea90c5b76b" xlink:to="loc_alts_Alt5SigmaInc.Member_a495e0ef-250f-4251-9349-8bb9753812df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_6b51851f-56a8-4bdd-9a8e-b92396b8f1a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bb47750d-4003-499c-8493-6f47de1af980" xlink:to="loc_us-gaap_StatementClassOfStockAxis_6b51851f-56a8-4bdd-9a8e-b92396b8f1a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6b51851f-56a8-4bdd-9a8e-b92396b8f1a9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_6b51851f-56a8-4bdd-9a8e-b92396b8f1a9" xlink:to="loc_us-gaap_ClassOfStockDomain_6b51851f-56a8-4bdd-9a8e-b92396b8f1a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d0409e2b-8601-425b-991e-d86f89a878a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_6b51851f-56a8-4bdd-9a8e-b92396b8f1a9" xlink:to="loc_us-gaap_ClassOfStockDomain_d0409e2b-8601-425b-991e-d86f89a878a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_f90e1007-accc-4b52-8430-fa76d899484c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d0409e2b-8601-425b-991e-d86f89a878a0" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_f90e1007-accc-4b52-8430-fa76d899484c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesMPreferredStockMember_c38120ae-00ff-460b-97f6-9ac6bdd4273a" xlink:href="alts-20241228.xsd#alts_SeriesMPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d0409e2b-8601-425b-991e-d86f89a878a0" xlink:to="loc_alts_SeriesMPreferredStockMember_c38120ae-00ff-460b-97f6-9ac6bdd4273a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_eb6c6acb-8b79-4162-8043-74a38990a1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fc02a8a-24af-41f7-a4a4-de3dcd912ee0" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_eb6c6acb-8b79-4162-8043-74a38990a1e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfIssuedAndOutstandingShares_8f8ca827-8d73-48ff-8649-399c82093971" xlink:href="alts-20241228.xsd#alts_BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfIssuedAndOutstandingShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fc02a8a-24af-41f7-a4a4-de3dcd912ee0" xlink:to="loc_alts_BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfIssuedAndOutstandingShares_8f8ca827-8d73-48ff-8649-399c82093971" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_75e96bde-89e9-4a33-ba8d-1b14e0195bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fc02a8a-24af-41f7-a4a4-de3dcd912ee0" xlink:to="loc_us-gaap_SharePrice_75e96bde-89e9-4a33-ba8d-1b14e0195bc5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_4a564a4c-fbab-445d-80de-8dfb4a78cd1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fc02a8a-24af-41f7-a4a4-de3dcd912ee0" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_4a564a4c-fbab-445d-80de-8dfb4a78cd1b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a6dda6a0-5dfa-44ed-a052-260afe1c36d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fc02a8a-24af-41f7-a4a4-de3dcd912ee0" xlink:to="loc_us-gaap_Goodwill_a6dda6a0-5dfa-44ed-a052-260afe1c36d6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_442a156c-1b44-4229-b3d7-a4d23975fb23" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fc02a8a-24af-41f7-a4a4-de3dcd912ee0" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_442a156c-1b44-4229-b3d7-a4d23975fb23" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6d0b7a96-9a9f-4fa7-88f5-81871e658a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fc02a8a-24af-41f7-a4a4-de3dcd912ee0" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6d0b7a96-9a9f-4fa7-88f5-81871e658a3e" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofFairValueAdjustmentsforSharesofSeriesBandSeriesMPreferredStockDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#MergersandAcquisitionsScheduleofFairValueAdjustmentsforSharesofSeriesBandSeriesMPreferredStockDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofFairValueAdjustmentsforSharesofSeriesBandSeriesMPreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_bafe9aa4-1a9b-4cd5-9cb2-8f8571729664" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationSegmentAllocationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationTable_e98e7979-f551-418f-82ad-e854d0991eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationSegmentAllocationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_bafe9aa4-1a9b-4cd5-9cb2-8f8571729664" xlink:to="loc_us-gaap_BusinessCombinationSegmentAllocationTable_e98e7979-f551-418f-82ad-e854d0991eb2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_443515bf-89d9-4f2c-9893-c37875a82db5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable_e98e7979-f551-418f-82ad-e854d0991eb2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_443515bf-89d9-4f2c-9893-c37875a82db5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_443515bf-89d9-4f2c-9893-c37875a82db5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_443515bf-89d9-4f2c-9893-c37875a82db5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_443515bf-89d9-4f2c-9893-c37875a82db5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_907957f2-fd4b-47c9-9b4c-058d58088cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_443515bf-89d9-4f2c-9893-c37875a82db5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_907957f2-fd4b-47c9-9b4c-058d58088cb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Alt5SigmaInc.Member_86e2abd6-25d5-46d4-8b84-a9c3697b67fc" xlink:href="alts-20241228.xsd#alts_Alt5SigmaInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_907957f2-fd4b-47c9-9b4c-058d58088cb5" xlink:to="loc_alts_Alt5SigmaInc.Member_86e2abd6-25d5-46d4-8b84-a9c3697b67fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_4ea36f97-757d-4630-ae54-31f406ea4d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable_e98e7979-f551-418f-82ad-e854d0991eb2" xlink:to="loc_us-gaap_StatementClassOfStockAxis_4ea36f97-757d-4630-ae54-31f406ea4d0f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4ea36f97-757d-4630-ae54-31f406ea4d0f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4ea36f97-757d-4630-ae54-31f406ea4d0f" xlink:to="loc_us-gaap_ClassOfStockDomain_4ea36f97-757d-4630-ae54-31f406ea4d0f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f5349fe2-ef68-4c58-93bb-f60409c1f49e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4ea36f97-757d-4630-ae54-31f406ea4d0f" xlink:to="loc_us-gaap_ClassOfStockDomain_f5349fe2-ef68-4c58-93bb-f60409c1f49e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_366b2f0e-05ff-421c-a354-ec9b1c1d2ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_f5349fe2-ef68-4c58-93bb-f60409c1f49e" xlink:to="loc_us-gaap_CommonStockMember_366b2f0e-05ff-421c-a354-ec9b1c1d2ed4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_7eaabde2-5e08-40b5-811b-ddf06a234c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_f5349fe2-ef68-4c58-93bb-f60409c1f49e" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_7eaabde2-5e08-40b5-811b-ddf06a234c9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_1100dae3-29c3-46a7-adc7-e978d6d4314d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_bafe9aa4-1a9b-4cd5-9cb2-8f8571729664" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_1100dae3-29c3-46a7-adc7-e978d6d4314d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_83913ba3-1e40-4b24-86a6-2c91bfae9bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_bafe9aa4-1a9b-4cd5-9cb2-8f8571729664" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_83913ba3-1e40-4b24-86a6-2c91bfae9bdd" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationSegmentAllocationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationTable_66c75166-bb02-4c63-9297-6188efa5f737" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationSegmentAllocationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:to="loc_us-gaap_BusinessCombinationSegmentAllocationTable_66c75166-bb02-4c63-9297-6188efa5f737" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4aab2deb-1b28-4e32-8a2d-f0bcccbea1a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable_66c75166-bb02-4c63-9297-6188efa5f737" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4aab2deb-1b28-4e32-8a2d-f0bcccbea1a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4aab2deb-1b28-4e32-8a2d-f0bcccbea1a4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4aab2deb-1b28-4e32-8a2d-f0bcccbea1a4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4aab2deb-1b28-4e32-8a2d-f0bcccbea1a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87b166ad-b734-46d9-af16-d212e7f19221" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4aab2deb-1b28-4e32-8a2d-f0bcccbea1a4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87b166ad-b734-46d9-af16-d212e7f19221" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Alt5SigmaInc.Member_2f4b4e1c-5444-4e56-a72a-c050dd7941a3" xlink:href="alts-20241228.xsd#alts_Alt5SigmaInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87b166ad-b734-46d9-af16-d212e7f19221" xlink:to="loc_alts_Alt5SigmaInc.Member_2f4b4e1c-5444-4e56-a72a-c050dd7941a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_QodenTechnologiesLLCMember_b539e029-546b-4e36-9a77-9ac971d95a45" xlink:href="alts-20241228.xsd#alts_QodenTechnologiesLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87b166ad-b734-46d9-af16-d212e7f19221" xlink:to="loc_alts_QodenTechnologiesLLCMember_b539e029-546b-4e36-9a77-9ac971d95a45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8da80c1c-c6ac-42c2-83cf-5ada1f6db120" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable_66c75166-bb02-4c63-9297-6188efa5f737" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8da80c1c-c6ac-42c2-83cf-5ada1f6db120" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8da80c1c-c6ac-42c2-83cf-5ada1f6db120_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8da80c1c-c6ac-42c2-83cf-5ada1f6db120" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8da80c1c-c6ac-42c2-83cf-5ada1f6db120_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fdd1b29d-5765-493d-8e3c-70d2abb36211" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8da80c1c-c6ac-42c2-83cf-5ada1f6db120" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fdd1b29d-5765-493d-8e3c-70d2abb36211" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_5702570a-7a0a-400a-aa4d-3f92ad3ea535" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fdd1b29d-5765-493d-8e3c-70d2abb36211" xlink:to="loc_us-gaap_CustomerRelationshipsMember_5702570a-7a0a-400a-aa4d-3f92ad3ea535" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_62e68ec6-2fc0-4fb8-a67d-99787f3815e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fdd1b29d-5765-493d-8e3c-70d2abb36211" xlink:to="loc_us-gaap_TradeNamesMember_62e68ec6-2fc0-4fb8-a67d-99787f3815e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_8b4c3345-303d-463f-b555-84f8b5c75abf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fdd1b29d-5765-493d-8e3c-70d2abb36211" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_8b4c3345-303d-463f-b555-84f8b5c75abf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_96e6d5ab-ed5b-47fa-9aec-2c360a333699" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_96e6d5ab-ed5b-47fa-9aec-2c360a333699" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_1f967c01-4a42-42a0-ad64-773e7f305da7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_1f967c01-4a42-42a0-ad64-773e7f305da7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_133ebdf8-e5d1-4f31-b360-6cf1a14968d6" xlink:href="alts-20241228.xsd#alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:to="loc_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_133ebdf8-e5d1-4f31-b360-6cf1a14968d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsPayable_c8ba7408-ae09-4167-8383-41026c42c204" xlink:href="alts-20241228.xsd#alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:to="loc_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsPayable_c8ba7408-ae09-4167-8383-41026c42c204" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_b9e93f95-18df-46f5-bced-2fdb6e8a53f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_b9e93f95-18df-46f5-bced-2fdb6e8a53f5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_3ac12d42-5230-41f4-a2ef-bb5857831347" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_3ac12d42-5230-41f4-a2ef-bb5857831347" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_271098e5-c66a-414f-bce0-fa1bdce68ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_271098e5-c66a-414f-bce0-fa1bdce68ce7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_dadd4f1b-8bce-4975-a724-f896625b8838" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_dadd4f1b-8bce-4975-a724-f896625b8838" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a4107923-e8f1-4785-ae4c-9f891879e609" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a4107923-e8f1-4785-ae4c-9f891879e609" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsReceivable_fa2da656-c025-4946-9206-ed774faba567" xlink:href="alts-20241228.xsd#alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:to="loc_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsReceivable_fa2da656-c025-4946-9206-ed774faba567" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_de10d6db-6db3-4066-9abf-96e064794a81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_de10d6db-6db3-4066-9abf-96e064794a81" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_c496a5b5-f0f0-4858-b9a5-f2169fb98158" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_c496a5b5-f0f0-4858-b9a5-f2169fb98158" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7096fba2-8670-46c9-8811-bac59a587220" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7096fba2-8670-46c9-8811-bac59a587220" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_55d6fd49-a098-4412-8990-fefeb743d47b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:to="loc_us-gaap_Goodwill_55d6fd49-a098-4412-8990-fefeb743d47b" xlink:type="arc" order="13"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofProformaInformationDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#MergersandAcquisitionsScheduleofProformaInformationDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofProformaInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_a3547209-6382-47b0-9c49-31334997a91b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationSegmentAllocationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationTable_f6c401e2-f1a8-4bf3-aa5f-0ff4783ee109" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationSegmentAllocationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_a3547209-6382-47b0-9c49-31334997a91b" xlink:to="loc_us-gaap_BusinessCombinationSegmentAllocationTable_f6c401e2-f1a8-4bf3-aa5f-0ff4783ee109" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_721f9271-a60d-4c6c-80e4-0ab46fb7e218" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable_f6c401e2-f1a8-4bf3-aa5f-0ff4783ee109" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_721f9271-a60d-4c6c-80e4-0ab46fb7e218" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_721f9271-a60d-4c6c-80e4-0ab46fb7e218_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_721f9271-a60d-4c6c-80e4-0ab46fb7e218" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_721f9271-a60d-4c6c-80e4-0ab46fb7e218_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a816e77d-c12c-42af-8193-6f9923535397" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_721f9271-a60d-4c6c-80e4-0ab46fb7e218" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a816e77d-c12c-42af-8193-6f9923535397" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Alt5SigmaInc.Member_f9484482-9a23-40c6-b4e5-e3b4db384a50" xlink:href="alts-20241228.xsd#alts_Alt5SigmaInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a816e77d-c12c-42af-8193-6f9923535397" xlink:to="loc_alts_Alt5SigmaInc.Member_f9484482-9a23-40c6-b4e5-e3b4db384a50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_dc18adc5-4093-42b4-8737-4d9be3adb56c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable_f6c401e2-f1a8-4bf3-aa5f-0ff4783ee109" xlink:to="loc_srt_StatementScenarioAxis_dc18adc5-4093-42b4-8737-4d9be3adb56c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_dc18adc5-4093-42b4-8737-4d9be3adb56c_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_dc18adc5-4093-42b4-8737-4d9be3adb56c" xlink:to="loc_srt_ScenarioUnspecifiedDomain_dc18adc5-4093-42b4-8737-4d9be3adb56c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_0e20039f-aa34-4934-8e4a-a297dc18110a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_dc18adc5-4093-42b4-8737-4d9be3adb56c" xlink:to="loc_srt_ScenarioUnspecifiedDomain_0e20039f-aa34-4934-8e4a-a297dc18110a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScenarioAdjustmentMember_7bacf69a-7c40-423b-8841-d12993e8ec3c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScenarioAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_0e20039f-aa34-4934-8e4a-a297dc18110a" xlink:to="loc_us-gaap_ScenarioAdjustmentMember_7bacf69a-7c40-423b-8841-d12993e8ec3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProFormaMember_5f5e580c-8a44-4473-847b-dc0e9f842a0b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProFormaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_0e20039f-aa34-4934-8e4a-a297dc18110a" xlink:to="loc_srt_ProFormaMember_5f5e580c-8a44-4473-847b-dc0e9f842a0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b6043a86-4b1d-462c-b8b4-b1c4e4be5889" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_a3547209-6382-47b0-9c49-31334997a91b" xlink:to="loc_us-gaap_Revenues_b6043a86-4b1d-462c-b8b4-b1c4e4be5889" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_2718a079-2c6e-4f3f-93bc-5a2ada250ada" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_a3547209-6382-47b0-9c49-31334997a91b" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_2718a079-2c6e-4f3f-93bc-5a2ada250ada" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a973e043-43a4-4b3e-8d65-7933bd3e81ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_a3547209-6382-47b0-9c49-31334997a91b" xlink:to="loc_us-gaap_NetIncomeLoss_a973e043-43a4-4b3e-8d65-7933bd3e81ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_103cd46d-c10c-48a9-a858-51b33add0dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_a3547209-6382-47b0-9c49-31334997a91b" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_103cd46d-c10c-48a9-a858-51b33add0dd4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a22bcbfa-3ea7-4ff8-b161-0ee15ea94003" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_a3547209-6382-47b0-9c49-31334997a91b" xlink:to="loc_us-gaap_EarningsPerShareBasic_a22bcbfa-3ea7-4ff8-b161-0ee15ea94003" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_cc7f05f7-12bc-4c74-bcb7-04ea45157381" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_a3547209-6382-47b0-9c49-31334997a91b" xlink:to="loc_us-gaap_EarningsPerShareDiluted_cc7f05f7-12bc-4c74-bcb7-04ea45157381" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#MergersandAcquisitionsSoinPharmaceuticalsDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_fc13078b-417b-4791-8899-4d174e675cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_236a3e51-fd00-42bc-ba8a-563632a765c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc13078b-417b-4791-8899-4d174e675cf8" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_236a3e51-fd00-42bc-ba8a-563632a765c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_770aeb8c-4729-42bd-b36c-ae843317d19d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_236a3e51-fd00-42bc-ba8a-563632a765c3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_770aeb8c-4729-42bd-b36c-ae843317d19d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_770aeb8c-4729-42bd-b36c-ae843317d19d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_770aeb8c-4729-42bd-b36c-ae843317d19d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_770aeb8c-4729-42bd-b36c-ae843317d19d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b3ddab29-c50a-4833-be8d-47f2c4b28eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_770aeb8c-4729-42bd-b36c-ae843317d19d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b3ddab29-c50a-4833-be8d-47f2c4b28eb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SoinTherapeuticsLLCMember_9dbf21c0-a3ca-4bdd-8306-d5bfa3add54c" xlink:href="alts-20241228.xsd#alts_SoinTherapeuticsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b3ddab29-c50a-4833-be8d-47f2c4b28eb8" xlink:to="loc_alts_SoinTherapeuticsLLCMember_9dbf21c0-a3ca-4bdd-8306-d5bfa3add54c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_d4cb9c31-a870-42fa-800e-59457db3ed3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_236a3e51-fd00-42bc-ba8a-563632a765c3" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_d4cb9c31-a870-42fa-800e-59457db3ed3a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_d4cb9c31-a870-42fa-800e-59457db3ed3a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_d4cb9c31-a870-42fa-800e-59457db3ed3a" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_d4cb9c31-a870-42fa-800e-59457db3ed3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_106d902f-5f77-4e55-b666-0ecaf7c60a44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_d4cb9c31-a870-42fa-800e-59457db3ed3a" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_106d902f-5f77-4e55-b666-0ecaf7c60a44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessAcquisitionConsiderationTrancheOneMember_210b8973-7460-4fce-8a3f-90bfff0da2a0" xlink:href="alts-20241228.xsd#alts_BusinessAcquisitionConsiderationTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_106d902f-5f77-4e55-b666-0ecaf7c60a44" xlink:to="loc_alts_BusinessAcquisitionConsiderationTrancheOneMember_210b8973-7460-4fce-8a3f-90bfff0da2a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessAcquisitionConsiderationTrancheTwoMember_315938a3-6ccd-421a-b968-40d5c5d3b537" xlink:href="alts-20241228.xsd#alts_BusinessAcquisitionConsiderationTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_106d902f-5f77-4e55-b666-0ecaf7c60a44" xlink:to="loc_alts_BusinessAcquisitionConsiderationTrancheTwoMember_315938a3-6ccd-421a-b968-40d5c5d3b537" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessAcquisitionConsiderationTrancheThreeMember_6787a632-c70f-4deb-82b0-b9b7dadcc41c" xlink:href="alts-20241228.xsd#alts_BusinessAcquisitionConsiderationTrancheThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_106d902f-5f77-4e55-b666-0ecaf7c60a44" xlink:to="loc_alts_BusinessAcquisitionConsiderationTrancheThreeMember_6787a632-c70f-4deb-82b0-b9b7dadcc41c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SoinAgreementConvertibleTrancheOneMember_ddb365a2-2f21-4bac-867e-89054ae09ce4" xlink:href="alts-20241228.xsd#alts_SoinAgreementConvertibleTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_106d902f-5f77-4e55-b666-0ecaf7c60a44" xlink:to="loc_alts_SoinAgreementConvertibleTrancheOneMember_ddb365a2-2f21-4bac-867e-89054ae09ce4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SoinAgreementConvertibleTrancheTwoMember_1517f79c-6a8f-4c2e-a73c-9012772bd416" xlink:href="alts-20241228.xsd#alts_SoinAgreementConvertibleTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_106d902f-5f77-4e55-b666-0ecaf7c60a44" xlink:to="loc_alts_SoinAgreementConvertibleTrancheTwoMember_1517f79c-6a8f-4c2e-a73c-9012772bd416" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SOINAgreementConvertibleTrancheThreeMember_c139236d-ae29-463d-9232-7e5ba69137ea" xlink:href="alts-20241228.xsd#alts_SOINAgreementConvertibleTrancheThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_106d902f-5f77-4e55-b666-0ecaf7c60a44" xlink:to="loc_alts_SOINAgreementConvertibleTrancheThreeMember_c139236d-ae29-463d-9232-7e5ba69137ea" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_a88180e4-eec3-4513-86f9-a6621fb604cd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_236a3e51-fd00-42bc-ba8a-563632a765c3" xlink:to="loc_srt_CounterpartyNameAxis_a88180e4-eec3-4513-86f9-a6621fb604cd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a88180e4-eec3-4513-86f9-a6621fb604cd_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_a88180e4-eec3-4513-86f9-a6621fb604cd" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a88180e4-eec3-4513-86f9-a6621fb604cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18671b8f-1742-46aa-9592-669b59ba3b79" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_a88180e4-eec3-4513-86f9-a6621fb604cd" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18671b8f-1742-46aa-9592-669b59ba3b79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DrSoinMember_b61f1901-532a-4fa3-ad25-ea6a22ce1c17" xlink:href="alts-20241228.xsd#alts_DrSoinMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18671b8f-1742-46aa-9592-669b59ba3b79" xlink:to="loc_alts_DrSoinMember_b61f1901-532a-4fa3-ad25-ea6a22ce1c17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_88974e98-acc1-42bb-934d-237eba7c3da8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_236a3e51-fd00-42bc-ba8a-563632a765c3" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_88974e98-acc1-42bb-934d-237eba7c3da8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_88974e98-acc1-42bb-934d-237eba7c3da8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_88974e98-acc1-42bb-934d-237eba7c3da8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_88974e98-acc1-42bb-934d-237eba7c3da8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_47af7462-dc4a-46ee-9b14-7e2323964e86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_88974e98-acc1-42bb-934d-237eba7c3da8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_47af7462-dc4a-46ee-9b14-7e2323964e86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_8afd94de-280b-4aad-86bb-0065f0643c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_47af7462-dc4a-46ee-9b14-7e2323964e86" xlink:to="loc_us-gaap_SubsequentEventMember_8afd94de-280b-4aad-86bb-0065f0643c7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_b7649488-c1a9-4604-953f-910bf4a58e68" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc13078b-417b-4791-8899-4d174e675cf8" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_b7649488-c1a9-4604-953f-910bf4a58e68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NumberOfTranches_7dc683a4-4d70-49eb-a0f6-9c414ce1df1a" xlink:href="alts-20241228.xsd#alts_NumberOfTranches"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc13078b-417b-4791-8899-4d174e675cf8" xlink:to="loc_alts_NumberOfTranches_7dc683a4-4d70-49eb-a0f6-9c414ce1df1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_419dba9f-251b-451d-bda8-dc919fc49d18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc13078b-417b-4791-8899-4d174e675cf8" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_419dba9f-251b-451d-bda8-dc919fc49d18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_8a60d29e-8ff7-4f83-8420-18e552fa51b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc13078b-417b-4791-8899-4d174e675cf8" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_8a60d29e-8ff7-4f83-8420-18e552fa51b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_7ad0b9ea-c4fc-4db7-ac9f-399b0ef23985" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc13078b-417b-4791-8899-4d174e675cf8" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_7ad0b9ea-c4fc-4db7-ac9f-399b0ef23985" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesNarrativeDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#SaleofRecyclingSubsidiariesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c185e28c-2186-4098-a9a9-646c4a1eeec7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_746e0311-113e-4f34-8388-3774bb29cae2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c185e28c-2186-4098-a9a9-646c4a1eeec7" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_746e0311-113e-4f34-8388-3774bb29cae2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_af0808a6-6dcd-4cf5-803e-2c57b375123c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_746e0311-113e-4f34-8388-3774bb29cae2" xlink:to="loc_srt_CounterpartyNameAxis_af0808a6-6dcd-4cf5-803e-2c57b375123c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_af0808a6-6dcd-4cf5-803e-2c57b375123c_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_af0808a6-6dcd-4cf5-803e-2c57b375123c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_af0808a6-6dcd-4cf5-803e-2c57b375123c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bcfe41d5-8091-45c3-b35a-c6dd5c8e4fa2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_af0808a6-6dcd-4cf5-803e-2c57b375123c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bcfe41d5-8091-45c3-b35a-c6dd5c8e4fa2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_VM7CorporationMember_d65b4a64-6748-4cba-8ad9-3737f4192519" xlink:href="alts-20241228.xsd#alts_VM7CorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bcfe41d5-8091-45c3-b35a-c6dd5c8e4fa2" xlink:to="loc_alts_VM7CorporationMember_d65b4a64-6748-4cba-8ad9-3737f4192519" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_752fe73a-d23b-4cd8-88b6-9820d97090ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_746e0311-113e-4f34-8388-3774bb29cae2" xlink:to="loc_us-gaap_TypeOfArrangementAxis_752fe73a-d23b-4cd8-88b6-9820d97090ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_752fe73a-d23b-4cd8-88b6-9820d97090ad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_752fe73a-d23b-4cd8-88b6-9820d97090ad" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_752fe73a-d23b-4cd8-88b6-9820d97090ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_be752534-f53a-4083-b3d8-7c7919423a25" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_752fe73a-d23b-4cd8-88b6-9820d97090ad" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_be752534-f53a-4083-b3d8-7c7919423a25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockPurchaseAgreementMember_0618290c-af02-498b-a795-91cdccb854c2" xlink:href="alts-20241228.xsd#alts_StockPurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_be752534-f53a-4083-b3d8-7c7919423a25" xlink:to="loc_alts_StockPurchaseAgreementMember_0618290c-af02-498b-a795-91cdccb854c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_593212a1-de0e-4856-afc2-479f4fa611e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_746e0311-113e-4f34-8388-3774bb29cae2" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_593212a1-de0e-4856-afc2-479f4fa611e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_593212a1-de0e-4856-afc2-479f4fa611e9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_593212a1-de0e-4856-afc2-479f4fa611e9" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_593212a1-de0e-4856-afc2-479f4fa611e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_2b2b1499-b6c7-41ad-9ebf-4f71e5473a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_593212a1-de0e-4856-afc2-479f4fa611e9" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_2b2b1499-b6c7-41ad-9ebf-4f71e5473a5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_bbe08809-2089-44c9-bf4b-71735d855b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_2b2b1499-b6c7-41ad-9ebf-4f71e5473a5c" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_bbe08809-2089-44c9-bf4b-71735d855b6f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_52945589-8d7d-4618-8b3a-12591a9b903c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_746e0311-113e-4f34-8388-3774bb29cae2" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_52945589-8d7d-4618-8b3a-12591a9b903c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_52945589-8d7d-4618-8b3a-12591a9b903c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_52945589-8d7d-4618-8b3a-12591a9b903c" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_52945589-8d7d-4618-8b3a-12591a9b903c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2a824948-0b3b-46b3-95a5-508f01d43e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_52945589-8d7d-4618-8b3a-12591a9b903c" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2a824948-0b3b-46b3-95a5-508f01d43e4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ARCAAndSubsidiariesMember_cf05eb50-8698-4486-ad13-0aa8806db8ad" xlink:href="alts-20241228.xsd#alts_ARCAAndSubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2a824948-0b3b-46b3-95a5-508f01d43e4c" xlink:to="loc_alts_ARCAAndSubsidiariesMember_cf05eb50-8698-4486-ad13-0aa8806db8ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount_a5e1eb5b-d81b-4849-8e9e-f90cab2219f4" xlink:href="alts-20241228.xsd#alts_DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c185e28c-2186-4098-a9a9-646c4a1eeec7" xlink:to="loc_alts_DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount_a5e1eb5b-d81b-4849-8e9e-f90cab2219f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForCommissions_a2f65735-8f18-45d8-8036-c85af2a40b65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForCommissions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c185e28c-2186-4098-a9a9-646c4a1eeec7" xlink:to="loc_us-gaap_PaymentsForCommissions_a2f65735-8f18-45d8-8036-c85af2a40b65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RevisedDiscountAmount_eb5c7ac2-57b0-457d-92a9-bd37776a371e" xlink:href="alts-20241228.xsd#alts_RevisedDiscountAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c185e28c-2186-4098-a9a9-646c4a1eeec7" xlink:to="loc_alts_RevisedDiscountAmount_eb5c7ac2-57b0-457d-92a9-bd37776a371e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeInterestEarningAsset_9d0a829d-5ecf-4f0c-9abc-72d1ec404f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeInterestEarningAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c185e28c-2186-4098-a9a9-646c4a1eeec7" xlink:to="loc_us-gaap_InterestIncomeInterestEarningAsset_9d0a829d-5ecf-4f0c-9abc-72d1ec404f7c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_efa0414c-3dd1-47cf-bbc9-8616b0aeaccb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c185e28c-2186-4098-a9a9-646c4a1eeec7" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_efa0414c-3dd1-47cf-bbc9-8616b0aeaccb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag_2ca5d5cb-3f5c-4770-8d15-0b0cda6c6fa2" xlink:href="alts-20241228.xsd#alts_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c185e28c-2186-4098-a9a9-646c4a1eeec7" xlink:to="loc_alts_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag_2ca5d5cb-3f5c-4770-8d15-0b0cda6c6fa2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_c63d3138-e3f3-4fbd-b064-d3bfa1b1ba9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c185e28c-2186-4098-a9a9-646c4a1eeec7" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_c63d3138-e3f3-4fbd-b064-d3bfa1b1ba9b" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_554d3de5-9541-435d-9124-e1b8a38379ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_554d3de5-9541-435d-9124-e1b8a38379ea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_8b397562-ba7c-4078-aace-37547658d39c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_554d3de5-9541-435d-9124-e1b8a38379ea" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_8b397562-ba7c-4078-aace-37547658d39c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_8b397562-ba7c-4078-aace-37547658d39c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_8b397562-ba7c-4078-aace-37547658d39c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_8b397562-ba7c-4078-aace-37547658d39c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_a55933ae-7270-4f70-88c5-bab6e0af2d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_8b397562-ba7c-4078-aace-37547658d39c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_a55933ae-7270-4f70-88c5-bab6e0af2d2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_53bd185a-ca80-4d8a-948b-327e5fb8fa56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_a55933ae-7270-4f70-88c5-bab6e0af2d2d" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_53bd185a-ca80-4d8a-948b-327e5fb8fa56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_da8b40d7-ef70-473a-94f4-9715da9f4ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_554d3de5-9541-435d-9124-e1b8a38379ea" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_da8b40d7-ef70-473a-94f4-9715da9f4ee1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_da8b40d7-ef70-473a-94f4-9715da9f4ee1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_da8b40d7-ef70-473a-94f4-9715da9f4ee1" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_da8b40d7-ef70-473a-94f4-9715da9f4ee1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d429e662-98ba-4063-acb0-744d1ab4b040" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_da8b40d7-ef70-473a-94f4-9715da9f4ee1" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d429e662-98ba-4063-acb0-744d1ab4b040" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ARCAAndSubsidiariesMember_d0a82a75-36bb-467d-84d7-9b17c68107f2" xlink:href="alts-20241228.xsd#alts_ARCAAndSubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d429e662-98ba-4063-acb0-744d1ab4b040" xlink:to="loc_alts_ARCAAndSubsidiariesMember_d0a82a75-36bb-467d-84d7-9b17c68107f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_TotalGuaranteedConsideration_75c00566-bc25-4cae-a5e3-94e54ea883f9" xlink:href="alts-20241228.xsd#alts_TotalGuaranteedConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_TotalGuaranteedConsideration_75c00566-bc25-4cae-a5e3-94e54ea883f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PaymentFromBuyer_4869cb6a-6b8b-48dc-8d86-f1695a0589ef" xlink:href="alts-20241228.xsd#alts_PaymentFromBuyer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_PaymentFromBuyer_4869cb6a-6b8b-48dc-8d86-f1695a0589ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NetConsideration_09ce55ad-dc54-4bf7-bd77-171969469eea" xlink:href="alts-20241228.xsd#alts_NetConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_NetConsideration_09ce55ad-dc54-4bf7-bd77-171969469eea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfAccountsPayable_a4cb96b9-7d8d-484d-90a5-18e0d45c6d2a" xlink:href="alts-20241228.xsd#alts_DisposalOfAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_DisposalOfAccountsPayable_a4cb96b9-7d8d-484d-90a5-18e0d45c6d2a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfAccruedLiability_5e191186-b663-469d-9e22-61afc38d21f8" xlink:href="alts-20241228.xsd#alts_DisposalOfAccruedLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_DisposalOfAccruedLiability_5e191186-b663-469d-9e22-61afc38d21f8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfAccruedLiabilityCaliforniaStateSalesTax_e7d39b92-a347-4fb4-aa21-10d11c848be6" xlink:href="alts-20241228.xsd#alts_DisposalOfAccruedLiabilityCaliforniaStateSalesTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_DisposalOfAccruedLiabilityCaliforniaStateSalesTax_e7d39b92-a347-4fb4-aa21-10d11c848be6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfLeaseLiability_7394db35-1923-41d8-9805-ce401247370a" xlink:href="alts-20241228.xsd#alts_DisposalOfLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_DisposalOfLeaseLiability_7394db35-1923-41d8-9805-ce401247370a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfDebt_c05cc51c-42ac-4f7a-b294-0160ed0fe38e" xlink:href="alts-20241228.xsd#alts_DisposalOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_DisposalOfDebt_c05cc51c-42ac-4f7a-b294-0160ed0fe38e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_df47c0f2-3dfb-4e12-a7ba-dbdb750348d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_df47c0f2-3dfb-4e12-a7ba-dbdb750348d4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_TotalDisposalOfLiability_16b5817d-07f2-4241-a3a5-2e89e2c5a73d" xlink:href="alts-20241228.xsd#alts_TotalDisposalOfLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_TotalDisposalOfLiability_16b5817d-07f2-4241-a3a5-2e89e2c5a73d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_TotalConsiderations_2dced91a-4d0f-4ae2-8194-b68fb803384f" xlink:href="alts-20241228.xsd#alts_TotalConsiderations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_TotalConsiderations_2dced91a-4d0f-4ae2-8194-b68fb803384f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_CashDisposal_7af38e31-e574-4470-a4ad-d06a38634069" xlink:href="alts-20241228.xsd#alts_CashDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_CashDisposal_7af38e31-e574-4470-a4ad-d06a38634069" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfAccountsReceivable_823af8f8-986f-4d1f-9493-1a6294da390e" xlink:href="alts-20241228.xsd#alts_DisposalOfAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_DisposalOfAccountsReceivable_823af8f8-986f-4d1f-9493-1a6294da390e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfInventory_4eafb7ee-d371-402b-9de6-684f157f68a7" xlink:href="alts-20241228.xsd#alts_DisposalOfInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_DisposalOfInventory_4eafb7ee-d371-402b-9de6-684f157f68a7" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfPropertyPlantAndEquipment_51fe3a14-c3dd-4ee7-b093-b0df4222f33d" xlink:href="alts-20241228.xsd#alts_DisposalOfPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_DisposalOfPropertyPlantAndEquipment_51fe3a14-c3dd-4ee7-b093-b0df4222f33d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfIntangibleAssets_06a7bd99-a397-493f-af7d-6f1a5410b19a" xlink:href="alts-20241228.xsd#alts_DisposalOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_DisposalOfIntangibleAssets_06a7bd99-a397-493f-af7d-6f1a5410b19a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfRightOfUseAssets_33a6bc70-2b8f-4f49-ab52-366743ddd43d" xlink:href="alts-20241228.xsd#alts_DisposalOfRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_DisposalOfRightOfUseAssets_33a6bc70-2b8f-4f49-ab52-366743ddd43d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfOtherAssets_2e7096fb-4b09-4dd8-b51f-360b8f702348" xlink:href="alts-20241228.xsd#alts_DisposalOfOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_DisposalOfOtherAssets_2e7096fb-4b09-4dd8-b51f-360b8f702348" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_TotalDisposalOfAssets_8aa0437c-e12a-4f8e-a718-a826796b4d10" xlink:href="alts-20241228.xsd#alts_TotalDisposalOfAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_TotalDisposalOfAssets_8aa0437c-e12a-4f8e-a718-a826796b4d10" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_TotalGainOnSale_4a69336e-44e0-4988-bc9f-7feac44af69d" xlink:href="alts-20241228.xsd#alts_TotalGainOnSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_TotalGainOnSale_4a69336e-44e0-4988-bc9f-7feac44af69d" xlink:type="arc" order="19"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_95d78dde-a071-431f-bbd8-cc9f7ac003ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9d5ce94d-0a2a-4977-84f4-3a2552d517f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_95d78dde-a071-431f-bbd8-cc9f7ac003ed" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9d5ce94d-0a2a-4977-84f4-3a2552d517f9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_554380a5-9b57-4e0e-95f3-fb7f44257bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9d5ce94d-0a2a-4977-84f4-3a2552d517f9" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_554380a5-9b57-4e0e-95f3-fb7f44257bc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_554380a5-9b57-4e0e-95f3-fb7f44257bc8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_554380a5-9b57-4e0e-95f3-fb7f44257bc8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_554380a5-9b57-4e0e-95f3-fb7f44257bc8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_85110004-66e3-4aaf-8592-18d7d2c78567" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_554380a5-9b57-4e0e-95f3-fb7f44257bc8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_85110004-66e3-4aaf-8592-18d7d2c78567" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_3211c533-1264-455d-8ecf-e57408ee86db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_85110004-66e3-4aaf-8592-18d7d2c78567" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_3211c533-1264-455d-8ecf-e57408ee86db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_37c4bb5e-c45a-4317-8435-a2c1f6d05d17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9d5ce94d-0a2a-4977-84f4-3a2552d517f9" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_37c4bb5e-c45a-4317-8435-a2c1f6d05d17" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_37c4bb5e-c45a-4317-8435-a2c1f6d05d17_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_37c4bb5e-c45a-4317-8435-a2c1f6d05d17" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_37c4bb5e-c45a-4317-8435-a2c1f6d05d17_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8177d096-7f31-492e-a88b-4d87e217313e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_37c4bb5e-c45a-4317-8435-a2c1f6d05d17" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8177d096-7f31-492e-a88b-4d87e217313e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ARCAAndSubsidiariesMember_0f210800-8a47-4366-be27-5446f1a54ae4" xlink:href="alts-20241228.xsd#alts_ARCAAndSubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8177d096-7f31-492e-a88b-4d87e217313e" xlink:to="loc_alts_ARCAAndSubsidiariesMember_0f210800-8a47-4366-be27-5446f1a54ae4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a1b00151-2b11-42e9-96bf-e4b75cbd6255" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9d5ce94d-0a2a-4977-84f4-3a2552d517f9" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a1b00151-2b11-42e9-96bf-e4b75cbd6255" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a1b00151-2b11-42e9-96bf-e4b75cbd6255_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a1b00151-2b11-42e9-96bf-e4b75cbd6255" xlink:to="loc_us-gaap_SegmentDomain_a1b00151-2b11-42e9-96bf-e4b75cbd6255_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6715414d-3f38-4a47-b3f5-7edd95dfb356" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a1b00151-2b11-42e9-96bf-e4b75cbd6255" xlink:to="loc_us-gaap_SegmentDomain_6715414d-3f38-4a47-b3f5-7edd95dfb356" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RecyclingSegmentMember_a9ebae33-2ed5-4a93-98ab-9a54b92e146f" xlink:href="alts-20241228.xsd#alts_RecyclingSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6715414d-3f38-4a47-b3f5-7edd95dfb356" xlink:to="loc_alts_RecyclingSegmentMember_a9ebae33-2ed5-4a93-98ab-9a54b92e146f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_c7d87493-efec-477d-9814-668ee1c2151c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_95d78dde-a071-431f-bbd8-cc9f7ac003ed" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_c7d87493-efec-477d-9814-668ee1c2151c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_4321c6d5-23f5-4eb2-b2f5-ef2b9e509c02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_95d78dde-a071-431f-bbd8-cc9f7ac003ed" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_4321c6d5-23f5-4eb2-b2f5-ef2b9e509c02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_cbe5ec33-ba63-4dbe-93ce-d9a155fe4e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_95d78dde-a071-431f-bbd8-cc9f7ac003ed" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_cbe5ec33-ba63-4dbe-93ce-d9a155fe4e3a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OperatingExpensesFromDiscontinuedOperationsAbstract_6cb04e0e-a81f-4730-b5a0-a2511e7ecc85" xlink:href="alts-20241228.xsd#alts_OperatingExpensesFromDiscontinuedOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_95d78dde-a071-431f-bbd8-cc9f7ac003ed" xlink:to="loc_alts_OperatingExpensesFromDiscontinuedOperationsAbstract_6cb04e0e-a81f-4730-b5a0-a2511e7ecc85" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_9d3921ae-2617-4e0d-9309-9f25221e9c88" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_OperatingExpensesFromDiscontinuedOperationsAbstract_6cb04e0e-a81f-4730-b5a0-a2511e7ecc85" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_9d3921ae-2617-4e0d-9309-9f25221e9c88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_7a5b6794-6d4a-4920-ba33-8c3371b2df1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_OperatingExpensesFromDiscontinuedOperationsAbstract_6cb04e0e-a81f-4730-b5a0-a2511e7ecc85" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_7a5b6794-6d4a-4920-ba33-8c3371b2df1f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalGroupIncludingDiscontinuedOperationTotalOperatingIncomeExpensesFromDiscontinuedOperations_ed282ac8-9de2-4421-a5fc-7dabb7aa4d35" xlink:href="alts-20241228.xsd#alts_DisposalGroupIncludingDiscontinuedOperationTotalOperatingIncomeExpensesFromDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_OperatingExpensesFromDiscontinuedOperationsAbstract_6cb04e0e-a81f-4730-b5a0-a2511e7ecc85" xlink:to="loc_alts_DisposalGroupIncludingDiscontinuedOperationTotalOperatingIncomeExpensesFromDiscontinuedOperations_ed282ac8-9de2-4421-a5fc-7dabb7aa4d35" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_d82512c5-8087-4907-a6d8-be12289c4b54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_OperatingExpensesFromDiscontinuedOperationsAbstract_6cb04e0e-a81f-4730-b5a0-a2511e7ecc85" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_d82512c5-8087-4907-a6d8-be12289c4b54" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract_3deb7479-68ba-47cf-b460-71dec3ba54ed" xlink:href="alts-20241228.xsd#alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_95d78dde-a071-431f-bbd8-cc9f7ac003ed" xlink:to="loc_alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract_3deb7479-68ba-47cf-b460-71dec3ba54ed" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_a2474d65-c3e2-4db2-86f0-b69f37bffc29" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract_3deb7479-68ba-47cf-b460-71dec3ba54ed" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_a2474d65-c3e2-4db2-86f0-b69f37bffc29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet_2dd721d4-99f8-403f-9418-00f52545f8fa" xlink:href="alts-20241228.xsd#alts_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract_3deb7479-68ba-47cf-b460-71dec3ba54ed" xlink:to="loc_alts_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet_2dd721d4-99f8-403f-9418-00f52545f8fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalGroupIncludingDiscontinuedOperationsTotalOtherIncomeLossNet_b3e2eaef-50a6-45f0-9852-5ed210c87487" xlink:href="alts-20241228.xsd#alts_DisposalGroupIncludingDiscontinuedOperationsTotalOtherIncomeLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract_3deb7479-68ba-47cf-b460-71dec3ba54ed" xlink:to="loc_alts_DisposalGroupIncludingDiscontinuedOperationsTotalOtherIncomeLossNet_b3e2eaef-50a6-45f0-9852-5ed210c87487" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_07c9e263-c069-4da1-be83-e51e0c2aa920" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract_3deb7479-68ba-47cf-b460-71dec3ba54ed" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_07c9e263-c069-4da1-be83-e51e0c2aa920" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_d1ea3263-6eb8-4503-a977-dcd037fe7f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract_3deb7479-68ba-47cf-b460-71dec3ba54ed" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_d1ea3263-6eb8-4503-a977-dcd037fe7f9c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_a4979b81-df76-448c-a1a7-fd9e10f39264" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract_3deb7479-68ba-47cf-b460-71dec3ba54ed" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_a4979b81-df76-448c-a1a7-fd9e10f39264" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2bf7ec8f-efec-4380-b0d6-c387c3d37eac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_32557b2b-1e64-40e1-8d5c-0959dd1d4682" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2bf7ec8f-efec-4380-b0d6-c387c3d37eac" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_32557b2b-1e64-40e1-8d5c-0959dd1d4682" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_642dcedb-a66e-44c6-a436-630949356c26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_32557b2b-1e64-40e1-8d5c-0959dd1d4682" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_642dcedb-a66e-44c6-a436-630949356c26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_642dcedb-a66e-44c6-a436-630949356c26_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_642dcedb-a66e-44c6-a436-630949356c26" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_642dcedb-a66e-44c6-a436-630949356c26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_2ae77460-74d7-4733-9739-78a30d0c77b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_642dcedb-a66e-44c6-a436-630949356c26" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_2ae77460-74d7-4733-9739-78a30d0c77b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_5b6f3b29-f0d1-4b55-93e1-0b3cb12b61d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_2ae77460-74d7-4733-9739-78a30d0c77b6" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_5b6f3b29-f0d1-4b55-93e1-0b3cb12b61d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a54507a8-78ef-4b8e-b314-1f1fb37da0de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_32557b2b-1e64-40e1-8d5c-0959dd1d4682" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a54507a8-78ef-4b8e-b314-1f1fb37da0de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a54507a8-78ef-4b8e-b314-1f1fb37da0de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a54507a8-78ef-4b8e-b314-1f1fb37da0de" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a54507a8-78ef-4b8e-b314-1f1fb37da0de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_11a375bd-c981-41d3-9295-05d4014719c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a54507a8-78ef-4b8e-b314-1f1fb37da0de" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_11a375bd-c981-41d3-9295-05d4014719c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ARCAAndSubsidiariesMember_85ff439f-b76e-4975-833a-27f44413fa09" xlink:href="alts-20241228.xsd#alts_ARCAAndSubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_11a375bd-c981-41d3-9295-05d4014719c7" xlink:to="loc_alts_ARCAAndSubsidiariesMember_85ff439f-b76e-4975-833a-27f44413fa09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_803626f4-aa1e-49ac-a363-9f054a62a5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_32557b2b-1e64-40e1-8d5c-0959dd1d4682" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_803626f4-aa1e-49ac-a363-9f054a62a5d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_803626f4-aa1e-49ac-a363-9f054a62a5d8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_803626f4-aa1e-49ac-a363-9f054a62a5d8" xlink:to="loc_us-gaap_SegmentDomain_803626f4-aa1e-49ac-a363-9f054a62a5d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f6080acc-d574-47c5-8bbc-62e989bbbee7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_803626f4-aa1e-49ac-a363-9f054a62a5d8" xlink:to="loc_us-gaap_SegmentDomain_f6080acc-d574-47c5-8bbc-62e989bbbee7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RecyclingSegmentMember_a025f163-9ad9-409d-9114-7ca553d7fcce" xlink:href="alts-20241228.xsd#alts_RecyclingSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f6080acc-d574-47c5-8bbc-62e989bbbee7" xlink:to="loc_alts_RecyclingSegmentMember_a025f163-9ad9-409d-9114-7ca553d7fcce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DiscontinuedOperatingActivities_230b81c3-394b-4d9c-b183-2db4f409c213" xlink:href="alts-20241228.xsd#alts_DiscontinuedOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2bf7ec8f-efec-4380-b0d6-c387c3d37eac" xlink:to="loc_alts_DiscontinuedOperatingActivities_230b81c3-394b-4d9c-b183-2db4f409c213" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_95a66e8a-6f25-44f2-a4d4-3f2a05413d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_DiscontinuedOperatingActivities_230b81c3-394b-4d9c-b183-2db4f409c213" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_95a66e8a-6f25-44f2-a4d4-3f2a05413d7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_013aaf91-6a65-40b2-bac0-cf58001da482" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_DiscontinuedOperatingActivities_230b81c3-394b-4d9c-b183-2db4f409c213" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_013aaf91-6a65-40b2-bac0-cf58001da482" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_6a296c31-ae11-43c9-88d8-0f1c0a5d7a80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_DiscontinuedOperatingActivities_230b81c3-394b-4d9c-b183-2db4f409c213" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_6a296c31-ae11-43c9-88d8-0f1c0a5d7a80" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AmortizationOfRightOfUseAssets_f984deb2-db04-4a16-88fa-e6e4bdff4e9a" xlink:href="alts-20241228.xsd#alts_AmortizationOfRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_DiscontinuedOperatingActivities_230b81c3-394b-4d9c-b183-2db4f409c213" xlink:to="loc_alts_AmortizationOfRightOfUseAssets_f984deb2-db04-4a16-88fa-e6e4bdff4e9a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_GainOnSaleNetOfCash_d058a836-6d98-44bb-83b9-f488f7e72d1c" xlink:href="alts-20241228.xsd#alts_GainOnSaleNetOfCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_DiscontinuedOperatingActivities_230b81c3-394b-4d9c-b183-2db4f409c213" xlink:to="loc_alts_GainOnSaleNetOfCash_d058a836-6d98-44bb-83b9-f488f7e72d1c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7cba04d7-2af8-4b8b-baee-04a988fea6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_DiscontinuedOperatingActivities_230b81c3-394b-4d9c-b183-2db4f409c213" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7cba04d7-2af8-4b8b-baee-04a988fea6b8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_4fec7db6-7a6c-477e-8bad-3eb5261a1217" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7cba04d7-2af8-4b8b-baee-04a988fea6b8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_4fec7db6-7a6c-477e-8bad-3eb5261a1217" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_8e5664a0-80ec-4bac-904b-1d6bc10e586e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7cba04d7-2af8-4b8b-baee-04a988fea6b8" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_8e5664a0-80ec-4bac-904b-1d6bc10e586e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_7b8c0c4b-b18c-460f-bab4-107a242b8c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7cba04d7-2af8-4b8b-baee-04a988fea6b8" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_7b8c0c4b-b18c-460f-bab4-107a242b8c2f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_bbf09092-ef5b-4399-9789-631259f4afb6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7cba04d7-2af8-4b8b-baee-04a988fea6b8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_bbf09092-ef5b-4399-9789-631259f4afb6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_8b6c9a1a-90c2-4799-80d9-7fb7d35c7723" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7cba04d7-2af8-4b8b-baee-04a988fea6b8" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_8b6c9a1a-90c2-4799-80d9-7fb7d35c7723" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_3cefb376-dec5-4cfd-a2f3-4d0353990e33" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7cba04d7-2af8-4b8b-baee-04a988fea6b8" xlink:to="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_3cefb376-dec5-4cfd-a2f3-4d0353990e33" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4c641221-d6b6-40cb-bc9d-ff6c7e89df8a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7cba04d7-2af8-4b8b-baee-04a988fea6b8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4c641221-d6b6-40cb-bc9d-ff6c7e89df8a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DiscontinuedInvestingActivities_8b03dc27-37d7-48d2-ac7f-a0f2c8086d16" xlink:href="alts-20241228.xsd#alts_DiscontinuedInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2bf7ec8f-efec-4380-b0d6-c387c3d37eac" xlink:to="loc_alts_DiscontinuedInvestingActivities_8b03dc27-37d7-48d2-ac7f-a0f2c8086d16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7fcd2b87-b98f-4940-9332-d66880d45059" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_DiscontinuedInvestingActivities_8b03dc27-37d7-48d2-ac7f-a0f2c8086d16" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7fcd2b87-b98f-4940-9332-d66880d45059" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_20424bfa-226c-467a-9b40-71f76ebcfcd3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_DiscontinuedInvestingActivities_8b03dc27-37d7-48d2-ac7f-a0f2c8086d16" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_20424bfa-226c-467a-9b40-71f76ebcfcd3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_2ff722bc-db2b-477e-a978-b997b53730ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_DiscontinuedInvestingActivities_8b03dc27-37d7-48d2-ac7f-a0f2c8086d16" xlink:to="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_2ff722bc-db2b-477e-a978-b997b53730ff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DiscontinuedFinancingActivities_a2e1d5bb-2dbd-4568-8ae2-077818e5d22c" xlink:href="alts-20241228.xsd#alts_DiscontinuedFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2bf7ec8f-efec-4380-b0d6-c387c3d37eac" xlink:to="loc_alts_DiscontinuedFinancingActivities_a2e1d5bb-2dbd-4568-8ae2-077818e5d22c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_168c1d37-1044-495a-8ab5-bb4a623d573f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_DiscontinuedFinancingActivities_a2e1d5bb-2dbd-4568-8ae2-077818e5d22c" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_168c1d37-1044-495a-8ab5-bb4a623d573f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt_8e494708-e3cc-4eb8-b688-62dc03df68cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_DiscontinuedFinancingActivities_a2e1d5bb-2dbd-4568-8ae2-077818e5d22c" xlink:to="loc_us-gaap_RepaymentsOfRelatedPartyDebt_8e494708-e3cc-4eb8-b688-62dc03df68cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_03a9abe3-0859-4d90-80e4-4ace032b13ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_DiscontinuedFinancingActivities_a2e1d5bb-2dbd-4568-8ae2-077818e5d22c" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_03a9abe3-0859-4d90-80e4-4ace032b13ae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_8645d956-fc8c-4d5f-82e2-360f6da49ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_DiscontinuedFinancingActivities_a2e1d5bb-2dbd-4568-8ae2-077818e5d22c" xlink:to="loc_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_8645d956-fc8c-4d5f-82e2-360f6da49ac6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_892c3252-c6b9-4ef0-8453-47d1c3434a58" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_DiscontinuedFinancingActivities_a2e1d5bb-2dbd-4568-8ae2-077818e5d22c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_892c3252-c6b9-4ef0-8453-47d1c3434a58" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_d347b01c-aac7-47b7-8e72-4684232cd2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2bf7ec8f-efec-4380-b0d6-c387c3d37eac" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_d347b01c-aac7-47b7-8e72-4684232cd2ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cb6b3d98-adc4-4f3d-8ef3-c6bdcb75bbeb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2bf7ec8f-efec-4380-b0d6-c387c3d37eac" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cb6b3d98-adc4-4f3d-8ef3-c6bdcb75bbeb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_159048f7-d807-48cd-97f9-910098880374" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2bf7ec8f-efec-4380-b0d6-c387c3d37eac" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_159048f7-d807-48cd-97f9-910098880374" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_b69ea704-7b35-4b26-bcb4-edaa67c948ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#PropertyandEquipmentScheduleofPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d01ca818-edd3-4030-bbe2-d4c929bda9f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ead949dc-dacc-432c-b26b-b121543a39f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d01ca818-edd3-4030-bbe2-d4c929bda9f1" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ead949dc-dacc-432c-b26b-b121543a39f1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c1dc4a7d-fc30-4558-89a3-177671914742" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ead949dc-dacc-432c-b26b-b121543a39f1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c1dc4a7d-fc30-4558-89a3-177671914742" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c1dc4a7d-fc30-4558-89a3-177671914742_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c1dc4a7d-fc30-4558-89a3-177671914742" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c1dc4a7d-fc30-4558-89a3-177671914742_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_dcf83149-3829-4401-a90f-0749a554284a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c1dc4a7d-fc30-4558-89a3-177671914742" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_dcf83149-3829-4401-a90f-0749a554284a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetUnderConstructionMember_c53c38e3-e7fb-4713-b0c2-47c25c5085af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetUnderConstructionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_dcf83149-3829-4401-a90f-0749a554284a" xlink:to="loc_us-gaap_AssetUnderConstructionMember_c53c38e3-e7fb-4713-b0c2-47c25c5085af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3691bad6-1218-41ae-b438-9bd5bec74994" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d01ca818-edd3-4030-bbe2-d4c929bda9f1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3691bad6-1218-41ae-b438-9bd5bec74994" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/NotesreceivableDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#NotesreceivableDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/NotesreceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c096b956-353c-4d7b-aff0-5b036c306453" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_6974f17c-d295-45b7-a2b9-ff6f41cce1f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c096b956-353c-4d7b-aff0-5b036c306453" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_6974f17c-d295-45b7-a2b9-ff6f41cce1f6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_70f1eb20-9402-4089-853b-149dfd180a6b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_6974f17c-d295-45b7-a2b9-ff6f41cce1f6" xlink:to="loc_srt_CounterpartyNameAxis_70f1eb20-9402-4089-853b-149dfd180a6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_70f1eb20-9402-4089-853b-149dfd180a6b_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_70f1eb20-9402-4089-853b-149dfd180a6b" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_70f1eb20-9402-4089-853b-149dfd180a6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c358bfc3-a25d-4b3c-bc77-4c25fef01421" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_70f1eb20-9402-4089-853b-149dfd180a6b" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c358bfc3-a25d-4b3c-bc77-4c25fef01421" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SpyrTechnologiesIncMember_87357f14-5617-444d-980c-f8a19a0a04b9" xlink:href="alts-20241228.xsd#alts_SpyrTechnologiesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c358bfc3-a25d-4b3c-bc77-4c25fef01421" xlink:to="loc_alts_SpyrTechnologiesIncMember_87357f14-5617-444d-980c-f8a19a0a04b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_VM7CorporationMember_7916dc41-2b4e-4196-be22-96ff7678a02d" xlink:href="alts-20241228.xsd#alts_VM7CorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c358bfc3-a25d-4b3c-bc77-4c25fef01421" xlink:to="loc_alts_VM7CorporationMember_7916dc41-2b4e-4196-be22-96ff7678a02d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e1eedf72-6755-44fb-b907-047fa6ebd6ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_6974f17c-d295-45b7-a2b9-ff6f41cce1f6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e1eedf72-6755-44fb-b907-047fa6ebd6ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e1eedf72-6755-44fb-b907-047fa6ebd6ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e1eedf72-6755-44fb-b907-047fa6ebd6ef" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e1eedf72-6755-44fb-b907-047fa6ebd6ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a27f566b-f089-45be-9e72-1f421e8fa92c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e1eedf72-6755-44fb-b907-047fa6ebd6ef" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a27f566b-f089-45be-9e72-1f421e8fa92c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_GeoTraqIncMember_0e351bb0-24e2-4e40-b494-8fda96e9cb96" xlink:href="alts-20241228.xsd#alts_GeoTraqIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a27f566b-f089-45be-9e72-1f421e8fa92c" xlink:to="loc_alts_GeoTraqIncMember_0e351bb0-24e2-4e40-b494-8fda96e9cb96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_8f434206-de67-4594-a43d-33b9815053da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_6974f17c-d295-45b7-a2b9-ff6f41cce1f6" xlink:to="loc_us-gaap_TypeOfArrangementAxis_8f434206-de67-4594-a43d-33b9815053da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_8f434206-de67-4594-a43d-33b9815053da_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_8f434206-de67-4594-a43d-33b9815053da" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_8f434206-de67-4594-a43d-33b9815053da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_475c468d-2d6e-48c6-aacd-809813a4210a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_8f434206-de67-4594-a43d-33b9815053da" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_475c468d-2d6e-48c6-aacd-809813a4210a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockPurchaseAgreementMember_13db7949-7212-4a9f-8896-0590d08f1f7e" xlink:href="alts-20241228.xsd#alts_StockPurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_475c468d-2d6e-48c6-aacd-809813a4210a" xlink:to="loc_alts_StockPurchaseAgreementMember_13db7949-7212-4a9f-8896-0590d08f1f7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NotesReceivableTerm_b4661982-1f95-4fa5-9b1a-f302937971ee" xlink:href="alts-20241228.xsd#alts_NotesReceivableTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c096b956-353c-4d7b-aff0-5b036c306453" xlink:to="loc_alts_NotesReceivableTerm_b4661982-1f95-4fa5-9b1a-f302937971ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NoteReceivableFaceAmount_f127874b-94f0-4a6a-a604-4dca98e19234" xlink:href="alts-20241228.xsd#alts_NoteReceivableFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c096b956-353c-4d7b-aff0-5b036c306453" xlink:to="loc_alts_NoteReceivableFaceAmount_f127874b-94f0-4a6a-a604-4dca98e19234" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NoteReceivableStatedInterestRate_a22138f5-7142-4feb-a656-3624e072e1d2" xlink:href="alts-20241228.xsd#alts_NoteReceivableStatedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c096b956-353c-4d7b-aff0-5b036c306453" xlink:to="loc_alts_NoteReceivableStatedInterestRate_a22138f5-7142-4feb-a656-3624e072e1d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_bf0b3f17-ebb6-4aff-bc45-e97ba7925fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c096b956-353c-4d7b-aff0-5b036c306453" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_bf0b3f17-ebb6-4aff-bc45-e97ba7925fb9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable_e869d94a-1ad1-4967-8ad0-d792fbcb274c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c096b956-353c-4d7b-aff0-5b036c306453" xlink:to="loc_us-gaap_InterestReceivable_e869d94a-1ad1-4967-8ad0-d792fbcb274c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_GainLossOnWriteOffOfNotesReceivable_37a81316-fe21-4d3d-a430-9e554c65e736" xlink:href="alts-20241228.xsd#alts_GainLossOnWriteOffOfNotesReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c096b956-353c-4d7b-aff0-5b036c306453" xlink:to="loc_alts_GainLossOnWriteOffOfNotesReceivable_37a81316-fe21-4d3d-a430-9e554c65e736" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeInterestEarningAsset_531678d2-849a-4917-bdf0-4c46cb6f46cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeInterestEarningAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c096b956-353c-4d7b-aff0-5b036c306453" xlink:to="loc_us-gaap_InterestIncomeInterestEarningAsset_531678d2-849a-4917-bdf0-4c46cb6f46cf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_c60724c4-605b-4fb9-a874-320c4e593b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c096b956-353c-4d7b-aff0-5b036c306453" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_c60724c4-605b-4fb9-a874-320c4e593b7e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForCommissions_f8037a7d-aab3-44d0-919a-61a55d31aec8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForCommissions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c096b956-353c-4d7b-aff0-5b036c306453" xlink:to="loc_us-gaap_PaymentsForCommissions_f8037a7d-aab3-44d0-919a-61a55d31aec8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RevisedDiscountAmount_80a39c2e-a0f8-488c-80bd-bc3fcf272819" xlink:href="alts-20241228.xsd#alts_RevisedDiscountAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c096b956-353c-4d7b-aff0-5b036c306453" xlink:to="loc_alts_RevisedDiscountAmount_80a39c2e-a0f8-488c-80bd-bc3fcf272819" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_2bede758-3179-468e-825a-e24a0ea75fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c096b956-353c-4d7b-aff0-5b036c306453" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_2bede758-3179-468e-825a-e24a0ea75fe0" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/IntangibleassetsScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#IntangibleassetsScheduleofIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/IntangibleassetsScheduleofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fe6eeea3-9f3c-4a88-a01a-de28c9e2ee50" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_70f6f3b6-a8d1-4e7c-9255-0d58531cd57e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fe6eeea3-9f3c-4a88-a01a-de28c9e2ee50" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_70f6f3b6-a8d1-4e7c-9255-0d58531cd57e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c7788a11-129c-423d-9c9c-5ad76a50e4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_70f6f3b6-a8d1-4e7c-9255-0d58531cd57e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c7788a11-129c-423d-9c9c-5ad76a50e4bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c7788a11-129c-423d-9c9c-5ad76a50e4bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c7788a11-129c-423d-9c9c-5ad76a50e4bf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c7788a11-129c-423d-9c9c-5ad76a50e4bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1b3e9b7-ab25-4152-ad9d-0d341228ea2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c7788a11-129c-423d-9c9c-5ad76a50e4bf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1b3e9b7-ab25-4152-ad9d-0d341228ea2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SoinIntangiblesMember_9390545d-8c89-4d1b-a5ac-63810ecf5cd3" xlink:href="alts-20241228.xsd#alts_SoinIntangiblesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1b3e9b7-ab25-4152-ad9d-0d341228ea2c" xlink:to="loc_alts_SoinIntangiblesMember_9390545d-8c89-4d1b-a5ac-63810ecf5cd3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_CryptocurrencyExchangeSoftwareIntangibleMember_1185cdf4-76d9-4ba4-97f7-2dd1d981fc44" xlink:href="alts-20241228.xsd#alts_CryptocurrencyExchangeSoftwareIntangibleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1b3e9b7-ab25-4152-ad9d-0d341228ea2c" xlink:to="loc_alts_CryptocurrencyExchangeSoftwareIntangibleMember_1185cdf4-76d9-4ba4-97f7-2dd1d981fc44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PatentsAndDomainsMember_fcac0095-a6e2-45b5-b17a-b2cb6a591631" xlink:href="alts-20241228.xsd#alts_PatentsAndDomainsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1b3e9b7-ab25-4152-ad9d-0d341228ea2c" xlink:to="loc_alts_PatentsAndDomainsMember_fcac0095-a6e2-45b5-b17a-b2cb6a591631" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_0e1ae506-6b63-4f57-9238-cc7204d2098b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1b3e9b7-ab25-4152-ad9d-0d341228ea2c" xlink:to="loc_us-gaap_TradeNamesMember_0e1ae506-6b63-4f57-9238-cc7204d2098b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3e169dad-27c6-408e-bca9-d167ca90dbfa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1b3e9b7-ab25-4152-ad9d-0d341228ea2c" xlink:to="loc_us-gaap_CustomerRelationshipsMember_3e169dad-27c6-408e-bca9-d167ca90dbfa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_6d0e9d02-f5c1-47f2-ba69-5dbd95100307" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1b3e9b7-ab25-4152-ad9d-0d341228ea2c" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_6d0e9d02-f5c1-47f2-ba69-5dbd95100307" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_8b46495e-7fa6-4a04-b0b3-4e60d2dbe652" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fe6eeea3-9f3c-4a88-a01a-de28c9e2ee50" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_8b46495e-7fa6-4a04-b0b3-4e60d2dbe652" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1861e453-04bb-4148-a25c-89f8144490b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fe6eeea3-9f3c-4a88-a01a-de28c9e2ee50" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1861e453-04bb-4148-a25c-89f8144490b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7b436ddb-9cf2-4295-8875-34aacc610662" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fe6eeea3-9f3c-4a88-a01a-de28c9e2ee50" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7b436ddb-9cf2-4295-8875-34aacc610662" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/IntangibleassetsNarrativeDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#IntangibleassetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/IntangibleassetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4b2b1c8e-d46e-4cdd-957e-0500d331ee56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9d839578-c9c2-4c5c-8d41-1892ddf73bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4b2b1c8e-d46e-4cdd-957e-0500d331ee56" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9d839578-c9c2-4c5c-8d41-1892ddf73bd4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_6ca70ba3-9a01-4597-a37c-1c8d46afd087" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9d839578-c9c2-4c5c-8d41-1892ddf73bd4" xlink:to="loc_us-gaap_AssetAcquisitionAxis_6ca70ba3-9a01-4597-a37c-1c8d46afd087" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_6ca70ba3-9a01-4597-a37c-1c8d46afd087_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_6ca70ba3-9a01-4597-a37c-1c8d46afd087" xlink:to="loc_us-gaap_AssetAcquisitionDomain_6ca70ba3-9a01-4597-a37c-1c8d46afd087_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_e91292a9-7560-4600-a9ca-78acd9128e50" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_6ca70ba3-9a01-4597-a37c-1c8d46afd087" xlink:to="loc_us-gaap_AssetAcquisitionDomain_e91292a9-7560-4600-a9ca-78acd9128e50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_QodenTechnologiesLLCMember_727e86ec-e3f5-4a72-9761-4830464d2d64" xlink:href="alts-20241228.xsd#alts_QodenTechnologiesLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_e91292a9-7560-4600-a9ca-78acd9128e50" xlink:to="loc_alts_QodenTechnologiesLLCMember_727e86ec-e3f5-4a72-9761-4830464d2d64" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f5b40cbb-f5c7-48d7-a38f-95255bb1b4e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9d839578-c9c2-4c5c-8d41-1892ddf73bd4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f5b40cbb-f5c7-48d7-a38f-95255bb1b4e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f5b40cbb-f5c7-48d7-a38f-95255bb1b4e5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f5b40cbb-f5c7-48d7-a38f-95255bb1b4e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f5b40cbb-f5c7-48d7-a38f-95255bb1b4e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_eed44eda-8bb5-4571-a8c5-9122d3329c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f5b40cbb-f5c7-48d7-a38f-95255bb1b4e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_eed44eda-8bb5-4571-a8c5-9122d3329c5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_QodenIntangibleMember_827beac7-b215-4563-9284-e808e49506cf" xlink:href="alts-20241228.xsd#alts_QodenIntangibleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_eed44eda-8bb5-4571-a8c5-9122d3329c5f" xlink:to="loc_alts_QodenIntangibleMember_827beac7-b215-4563-9284-e808e49506cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_9067301c-026a-4ac7-9942-1e3a2aa66c53" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_eed44eda-8bb5-4571-a8c5-9122d3329c5f" xlink:to="loc_us-gaap_TradeNamesMember_9067301c-026a-4ac7-9942-1e3a2aa66c53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_a1e2fd52-0df0-4e37-bc17-dafe16059e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_eed44eda-8bb5-4571-a8c5-9122d3329c5f" xlink:to="loc_us-gaap_CustomerRelationshipsMember_a1e2fd52-0df0-4e37-bc17-dafe16059e7c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_60c2c59f-f128-4274-986a-fc86621de46a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_eed44eda-8bb5-4571-a8c5-9122d3329c5f" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_60c2c59f-f128-4274-986a-fc86621de46a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SoinIntangiblesMember_fbdd2d65-639e-4fb1-a8ea-a135d42fffea" xlink:href="alts-20241228.xsd#alts_SoinIntangiblesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_eed44eda-8bb5-4571-a8c5-9122d3329c5f" xlink:to="loc_alts_SoinIntangiblesMember_fbdd2d65-639e-4fb1-a8ea-a135d42fffea" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_34da2c1e-d4aa-4fae-b744-dc46c1f5b14e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9d839578-c9c2-4c5c-8d41-1892ddf73bd4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_34da2c1e-d4aa-4fae-b744-dc46c1f5b14e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_34da2c1e-d4aa-4fae-b744-dc46c1f5b14e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_34da2c1e-d4aa-4fae-b744-dc46c1f5b14e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_34da2c1e-d4aa-4fae-b744-dc46c1f5b14e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d193cb4b-ed72-434a-9d58-0111c65066ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_34da2c1e-d4aa-4fae-b744-dc46c1f5b14e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d193cb4b-ed72-434a-9d58-0111c65066ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ALT5SubsidiaryMember_aab359ff-07f5-437d-a15c-afa1dd3b68f5" xlink:href="alts-20241228.xsd#alts_ALT5SubsidiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d193cb4b-ed72-434a-9d58-0111c65066ad" xlink:to="loc_alts_ALT5SubsidiaryMember_aab359ff-07f5-437d-a15c-afa1dd3b68f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_4c9a3605-6027-4509-bcc2-6ee10250e9e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4b2b1c8e-d46e-4cdd-957e-0500d331ee56" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_4c9a3605-6027-4509-bcc2-6ee10250e9e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_6603f4bb-b58d-45da-acc8-f1a83e7bdf6b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4b2b1c8e-d46e-4cdd-957e-0500d331ee56" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_6603f4bb-b58d-45da-acc8-f1a83e7bdf6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NumberOfAcquiredIntangibleAssets_b50d31e8-8e43-4066-b50d-14b3dbf07c0f" xlink:href="alts-20241228.xsd#alts_NumberOfAcquiredIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4b2b1c8e-d46e-4cdd-957e-0500d331ee56" xlink:to="loc_alts_NumberOfAcquiredIntangibleAssets_b50d31e8-8e43-4066-b50d-14b3dbf07c0f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#MarketableSecuritiesScheduleofMarketableSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_7233cc31-766d-4d7e-8c99-488f49a04094" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_a078be66-73ab-4153-a81a-5584f34265c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_7233cc31-766d-4d7e-8c99-488f49a04094" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_a078be66-73ab-4153-a81a-5584f34265c7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_5da5142d-8825-4d15-af3e-48b800f7f8e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a078be66-73ab-4153-a81a-5584f34265c7" xlink:to="loc_us-gaap_StatementClassOfStockAxis_5da5142d-8825-4d15-af3e-48b800f7f8e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_5da5142d-8825-4d15-af3e-48b800f7f8e1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_5da5142d-8825-4d15-af3e-48b800f7f8e1" xlink:to="loc_us-gaap_ClassOfStockDomain_5da5142d-8825-4d15-af3e-48b800f7f8e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_002a9e5f-f603-4339-a027-28c2d6772833" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_5da5142d-8825-4d15-af3e-48b800f7f8e1" xlink:to="loc_us-gaap_ClassOfStockDomain_002a9e5f-f603-4339-a027-28c2d6772833" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesGConvertiblePreferredStockMember_ec7921ad-ca4e-4507-86a5-339bb2d3f765" xlink:href="alts-20241228.xsd#alts_SeriesGConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_002a9e5f-f603-4339-a027-28c2d6772833" xlink:to="loc_alts_SeriesGConvertiblePreferredStockMember_ec7921ad-ca4e-4507-86a5-339bb2d3f765" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_CommonShareEquivalentsMember_8feb02c7-19f7-44d1-9f84-1e85a8938e59" xlink:href="alts-20241228.xsd#alts_CommonShareEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_002a9e5f-f603-4339-a027-28c2d6772833" xlink:to="loc_alts_CommonShareEquivalentsMember_8feb02c7-19f7-44d1-9f84-1e85a8938e59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInAuctionMarketPreferredSecuritiesSharesOutstandingRollForward_2918a559-7a83-4591-b5ad-782ac3e8b455" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MovementInAuctionMarketPreferredSecuritiesSharesOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_7233cc31-766d-4d7e-8c99-488f49a04094" xlink:to="loc_us-gaap_MovementInAuctionMarketPreferredSecuritiesSharesOutstandingRollForward_2918a559-7a83-4591-b5ad-782ac3e8b455" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_MarketableSecuritiesSharesOutstanding_5442303b-e379-4ecf-8805-b304a2f43193" xlink:href="alts-20241228.xsd#alts_MarketableSecuritiesSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInAuctionMarketPreferredSecuritiesSharesOutstandingRollForward_2918a559-7a83-4591-b5ad-782ac3e8b455" xlink:to="loc_alts_MarketableSecuritiesSharesOutstanding_5442303b-e379-4ecf-8805-b304a2f43193" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares_42fd2382-c647-4175-a5c8-82619cfd988f" xlink:href="alts-20241228.xsd#alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInAuctionMarketPreferredSecuritiesSharesOutstandingRollForward_2918a559-7a83-4591-b5ad-782ac3e8b455" xlink:to="loc_alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares_42fd2382-c647-4175-a5c8-82619cfd988f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_MarketableSecurityWriteOffShares_2a4d859e-4306-4009-957d-285065aa7642" xlink:href="alts-20241228.xsd#alts_MarketableSecurityWriteOffShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInAuctionMarketPreferredSecuritiesSharesOutstandingRollForward_2918a559-7a83-4591-b5ad-782ac3e8b455" xlink:to="loc_alts_MarketableSecurityWriteOffShares_2a4d859e-4306-4009-957d-285065aa7642" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_MarketableSecuritiesSharesOutstanding_c5fd4bc2-8b93-45c4-a2c0-d5a1ac7357e4" xlink:href="alts-20241228.xsd#alts_MarketableSecuritiesSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesPurchasedUnderAgreementsToResellAllowanceForCreditLossRollForward_9b2a1fff-a6e5-4dcf-aeb2-7b014c4bbcad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecuritiesPurchasedUnderAgreementsToResellAllowanceForCreditLossRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_7233cc31-766d-4d7e-8c99-488f49a04094" xlink:to="loc_us-gaap_SecuritiesPurchasedUnderAgreementsToResellAllowanceForCreditLossRollForward_9b2a1fff-a6e5-4dcf-aeb2-7b014c4bbcad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_37f5fc5e-da39-4cd7-90ea-4f5e7aa5b391" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuritiesPurchasedUnderAgreementsToResellAllowanceForCreditLossRollForward_9b2a1fff-a6e5-4dcf-aeb2-7b014c4bbcad" xlink:to="loc_us-gaap_MarketableSecurities_37f5fc5e-da39-4cd7-90ea-4f5e7aa5b391" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_cef71c5a-0477-4996-9186-17bba8658f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuritiesPurchasedUnderAgreementsToResellAllowanceForCreditLossRollForward_9b2a1fff-a6e5-4dcf-aeb2-7b014c4bbcad" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_cef71c5a-0477-4996-9186-17bba8658f6c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments_c689ba9c-04c9-48e9-99bb-0dd6e093af47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuritiesPurchasedUnderAgreementsToResellAllowanceForCreditLossRollForward_9b2a1fff-a6e5-4dcf-aeb2-7b014c4bbcad" xlink:to="loc_us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments_c689ba9c-04c9-48e9-99bb-0dd6e093af47" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_fef61475-f064-42d1-8b29-b6e33318898a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuritiesPurchasedUnderAgreementsToResellAllowanceForCreditLossRollForward_9b2a1fff-a6e5-4dcf-aeb2-7b014c4bbcad" xlink:to="loc_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_fef61475-f064-42d1-8b29-b6e33318898a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_33e41871-aeca-4de1-9f33-922e6d198297" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecurities"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/MarketableSecuritiesNarrativeDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#MarketableSecuritiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/MarketableSecuritiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_d83cad25-891d-4f37-8d37-3553a343d133" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_0295c986-b1ac-4429-b3af-b11b72893cef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_d83cad25-891d-4f37-8d37-3553a343d133" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_0295c986-b1ac-4429-b3af-b11b72893cef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2329efc4-1315-4cb4-a0aa-0f57c517056b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_0295c986-b1ac-4429-b3af-b11b72893cef" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2329efc4-1315-4cb4-a0aa-0f57c517056b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_2329efc4-1315-4cb4-a0aa-0f57c517056b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2329efc4-1315-4cb4-a0aa-0f57c517056b" xlink:to="loc_us-gaap_ClassOfStockDomain_2329efc4-1315-4cb4-a0aa-0f57c517056b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_67d2eb69-3709-4d24-aba5-178dd17939c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2329efc4-1315-4cb4-a0aa-0f57c517056b" xlink:to="loc_us-gaap_ClassOfStockDomain_67d2eb69-3709-4d24-aba5-178dd17939c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesGConvertiblePreferredStockMember_25bd5f9b-2b03-4aee-b781-ae0c456692c6" xlink:href="alts-20241228.xsd#alts_SeriesGConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_67d2eb69-3709-4d24-aba5-178dd17939c6" xlink:to="loc_alts_SeriesGConvertiblePreferredStockMember_25bd5f9b-2b03-4aee-b781-ae0c456692c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_CommonShareEquivalentsMember_8caf8c8e-489b-4940-bfcf-cc15018b5a11" xlink:href="alts-20241228.xsd#alts_CommonShareEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_67d2eb69-3709-4d24-aba5-178dd17939c6" xlink:to="loc_alts_CommonShareEquivalentsMember_8caf8c8e-489b-4940-bfcf-cc15018b5a11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleConversionRatio_1b9added-d210-4d3e-b637-e8c90f787c12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d83cad25-891d-4f37-8d37-3553a343d133" xlink:to="loc_us-gaap_PreferredStockConvertibleConversionRatio_1b9added-d210-4d3e-b637-e8c90f787c12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares_c73b1677-8936-4342-ab08-69539a993062" xlink:href="alts-20241228.xsd#alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d83cad25-891d-4f37-8d37-3553a343d133" xlink:to="loc_alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares_c73b1677-8936-4342-ab08-69539a993062" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ConvertiblePreferredStockSharesIssuableUponConversion_b5c8d412-0c7d-411b-8728-a5b0c69c7a62" xlink:href="alts-20241228.xsd#alts_ConvertiblePreferredStockSharesIssuableUponConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d83cad25-891d-4f37-8d37-3553a343d133" xlink:to="loc_alts_ConvertiblePreferredStockSharesIssuableUponConversion_b5c8d412-0c7d-411b-8728-a5b0c69c7a62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_b7343b13-a298-4c89-8ec4-60f1e49d59c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d83cad25-891d-4f37-8d37-3553a343d133" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_b7343b13-a298-4c89-8ec4-60f1e49d59c0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_481f89aa-23e3-4a3f-a3f0-92b3674baae7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_d83cad25-891d-4f37-8d37-3553a343d133" xlink:to="loc_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_481f89aa-23e3-4a3f-a3f0-92b3674baae7" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/DebenturesScheduleofDebenturesOutstandingDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#DebenturesScheduleofDebenturesOutstandingDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/DebenturesScheduleofDebenturesOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_dd69b3f8-0329-4ed1-9aa1-e6d9063e45ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1f44652e-baf5-45b6-a7ba-aa3632e0e4bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dd69b3f8-0329-4ed1-9aa1-e6d9063e45ac" xlink:to="loc_us-gaap_DebtInstrumentTable_1f44652e-baf5-45b6-a7ba-aa3632e0e4bc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e8f99403-bd4c-46a8-8c94-bcddd82db050" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1f44652e-baf5-45b6-a7ba-aa3632e0e4bc" xlink:to="loc_us-gaap_DebtInstrumentAxis_e8f99403-bd4c-46a8-8c94-bcddd82db050" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e8f99403-bd4c-46a8-8c94-bcddd82db050_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_e8f99403-bd4c-46a8-8c94-bcddd82db050" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e8f99403-bd4c-46a8-8c94-bcddd82db050_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6e2e8694-6814-4e76-ba57-d4d7a0c11aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_e8f99403-bd4c-46a8-8c94-bcddd82db050" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6e2e8694-6814-4e76-ba57-d4d7a0c11aeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_A15DebenturesMaturingJune302025Member_ce400952-6200-4fa5-a09d-2ef6efbdd6f7" xlink:href="alts-20241228.xsd#alts_A15DebenturesMaturingJune302025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e2e8694-6814-4e76-ba57-d4d7a0c11aeb" xlink:to="loc_alts_A15DebenturesMaturingJune302025Member_ce400952-6200-4fa5-a09d-2ef6efbdd6f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0e4b2633-14ee-4f71-a9cc-bc8b19bb3dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1f44652e-baf5-45b6-a7ba-aa3632e0e4bc" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_0e4b2633-14ee-4f71-a9cc-bc8b19bb3dfd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0e4b2633-14ee-4f71-a9cc-bc8b19bb3dfd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0e4b2633-14ee-4f71-a9cc-bc8b19bb3dfd" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0e4b2633-14ee-4f71-a9cc-bc8b19bb3dfd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ac001357-e9ee-40e1-8a3e-c2d955cfcf88" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0e4b2633-14ee-4f71-a9cc-bc8b19bb3dfd" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ac001357-e9ee-40e1-8a3e-c2d955cfcf88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebenturesMember_75d1232a-127c-4069-b8aa-4cf55c9ab781" xlink:href="alts-20241228.xsd#alts_DebenturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ac001357-e9ee-40e1-8a3e-c2d955cfcf88" xlink:to="loc_alts_DebenturesMember_75d1232a-127c-4069-b8aa-4cf55c9ab781" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_52735770-fa66-4b05-9b82-8a9281d26976" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dd69b3f8-0329-4ed1-9aa1-e6d9063e45ac" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_52735770-fa66-4b05-9b82-8a9281d26976" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_5aeb4538-d310-43c4-b783-e862e9fcd68b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dd69b3f8-0329-4ed1-9aa1-e6d9063e45ac" xlink:to="loc_us-gaap_LongTermDebt_5aeb4538-d310-43c4-b783-e862e9fcd68b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/DebenturesNarrativeDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#DebenturesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/DebenturesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c6384e1b-51b3-426d-b227-ece28ccde95d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2fbd2e41-ef12-4a87-b165-fc73ac18f1e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c6384e1b-51b3-426d-b227-ece28ccde95d" xlink:to="loc_us-gaap_DebtInstrumentTable_2fbd2e41-ef12-4a87-b165-fc73ac18f1e3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ef475652-85c1-4a54-afb4-62aec9126c34" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2fbd2e41-ef12-4a87-b165-fc73ac18f1e3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ef475652-85c1-4a54-afb4-62aec9126c34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ef475652-85c1-4a54-afb4-62aec9126c34_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ef475652-85c1-4a54-afb4-62aec9126c34" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ef475652-85c1-4a54-afb4-62aec9126c34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_62659b77-7629-430c-a459-4d0c84201042" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ef475652-85c1-4a54-afb4-62aec9126c34" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_62659b77-7629-430c-a459-4d0c84201042" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebenturesMember_b58e45f2-110f-4972-a4db-c29e1b11beb7" xlink:href="alts-20241228.xsd#alts_DebenturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_62659b77-7629-430c-a459-4d0c84201042" xlink:to="loc_alts_DebenturesMember_b58e45f2-110f-4972-a4db-c29e1b11beb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_dd7abf1f-4d9c-4607-9394-3f8da33650c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2fbd2e41-ef12-4a87-b165-fc73ac18f1e3" xlink:to="loc_us-gaap_DebtInstrumentAxis_dd7abf1f-4d9c-4607-9394-3f8da33650c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dd7abf1f-4d9c-4607-9394-3f8da33650c4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_dd7abf1f-4d9c-4607-9394-3f8da33650c4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dd7abf1f-4d9c-4607-9394-3f8da33650c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e1992029-a0f8-44f4-9442-525f93d7a61e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_dd7abf1f-4d9c-4607-9394-3f8da33650c4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e1992029-a0f8-44f4-9442-525f93d7a61e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_A12DebenturesMaturingJune302024Member_c85d2c4c-428c-4f82-8bca-4e672e50e36f" xlink:href="alts-20241228.xsd#alts_A12DebenturesMaturingJune302024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e1992029-a0f8-44f4-9442-525f93d7a61e" xlink:to="loc_alts_A12DebenturesMaturingJune302024Member_c85d2c4c-428c-4f82-8bca-4e672e50e36f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_A12DebenturesMaturingJune302025Member_ed8a90a5-28e8-4663-b18a-ffe803add1cc" xlink:href="alts-20241228.xsd#alts_A12DebenturesMaturingJune302025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e1992029-a0f8-44f4-9442-525f93d7a61e" xlink:to="loc_alts_A12DebenturesMaturingJune302025Member_ed8a90a5-28e8-4663-b18a-ffe803add1cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentNumberOfDebenturesIssued_14b099f0-e86a-4bc2-a3d1-4f31e44c5a01" xlink:href="alts-20241228.xsd#alts_DebtInstrumentNumberOfDebenturesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c6384e1b-51b3-426d-b227-ece28ccde95d" xlink:to="loc_alts_DebtInstrumentNumberOfDebenturesIssued_14b099f0-e86a-4bc2-a3d1-4f31e44c5a01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0f63311c-3cea-442c-9ae9-506dbf7a9865" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c6384e1b-51b3-426d-b227-ece28ccde95d" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0f63311c-3cea-442c-9ae9-506dbf7a9865" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentNumberOfDebenturesRepaid_3d51883f-28cc-40cd-acb8-19b28fb63eac" xlink:href="alts-20241228.xsd#alts_DebtInstrumentNumberOfDebenturesRepaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c6384e1b-51b3-426d-b227-ece28ccde95d" xlink:to="loc_alts_DebtInstrumentNumberOfDebenturesRepaid_3d51883f-28cc-40cd-acb8-19b28fb63eac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_e5e5d182-93c4-4789-9d27-7c9d23d9446b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c6384e1b-51b3-426d-b227-ece28ccde95d" xlink:to="loc_us-gaap_RepaymentsOfDebt_e5e5d182-93c4-4789-9d27-7c9d23d9446b" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#LongTermDebtScheduleofLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_be58825c-fb4f-465a-a7f7-654526ca5707" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_fc1a5334-1441-49ae-b0f7-209e4c2deb74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_be58825c-fb4f-465a-a7f7-654526ca5707" xlink:to="loc_us-gaap_DebtInstrumentTable_fc1a5334-1441-49ae-b0f7-209e4c2deb74" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a0ae9a44-2741-45c2-8bc6-b014a9898bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_fc1a5334-1441-49ae-b0f7-209e4c2deb74" xlink:to="loc_us-gaap_DebtInstrumentAxis_a0ae9a44-2741-45c2-8bc6-b014a9898bb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a0ae9a44-2741-45c2-8bc6-b014a9898bb5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_a0ae9a44-2741-45c2-8bc6-b014a9898bb5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a0ae9a44-2741-45c2-8bc6-b014a9898bb5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_93ab529c-267a-4bf5-b517-5de97c5c83c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_a0ae9a44-2741-45c2-8bc6-b014a9898bb5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_93ab529c-267a-4bf5-b517-5de97c5c83c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LegacySubsidiaryFixedDepositsMember_7bebebf6-2105-4f20-9c31-f921a712abd4" xlink:href="alts-20241228.xsd#alts_LegacySubsidiaryFixedDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_93ab529c-267a-4bf5-b517-5de97c5c83c5" xlink:to="loc_alts_LegacySubsidiaryFixedDepositsMember_7bebebf6-2105-4f20-9c31-f921a712abd4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LegacySubsidiaryLoanMember_dbd628a4-7a28-48c8-8b1d-297b9628cb9a" xlink:href="alts-20241228.xsd#alts_LegacySubsidiaryLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_93ab529c-267a-4bf5-b517-5de97c5c83c5" xlink:to="loc_alts_LegacySubsidiaryLoanMember_dbd628a4-7a28-48c8-8b1d-297b9628cb9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LegacyUnaffiliatedThirdPartyNotesMember_e9dbd67c-f3c8-4d74-ab30-337fb502f9a7" xlink:href="alts-20241228.xsd#alts_LegacyUnaffiliatedThirdPartyNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_93ab529c-267a-4bf5-b517-5de97c5c83c5" xlink:to="loc_alts_LegacyUnaffiliatedThirdPartyNotesMember_e9dbd67c-f3c8-4d74-ab30-337fb502f9a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherLegacyNotesPayableMember_f401d42c-8c93-49de-a939-0cd4f4d59086" xlink:href="alts-20241228.xsd#alts_OtherLegacyNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_93ab529c-267a-4bf5-b517-5de97c5c83c5" xlink:to="loc_alts_OtherLegacyNotesPayableMember_f401d42c-8c93-49de-a939-0cd4f4d59086" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_63e529d7-c2ee-4010-b3b4-d18c84417b13" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_fc1a5334-1441-49ae-b0f7-209e4c2deb74" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_63e529d7-c2ee-4010-b3b4-d18c84417b13" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_63e529d7-c2ee-4010-b3b4-d18c84417b13_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_63e529d7-c2ee-4010-b3b4-d18c84417b13" xlink:to="loc_us-gaap_RelatedPartyDomain_63e529d7-c2ee-4010-b3b4-d18c84417b13_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_60715338-149a-4718-a50a-a203e4b5428b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_63e529d7-c2ee-4010-b3b4-d18c84417b13" xlink:to="loc_us-gaap_RelatedPartyDomain_60715338-149a-4718-a50a-a203e4b5428b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_a3869915-a252-48c6-82ec-41812b8a7c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_60715338-149a-4718-a50a-a203e4b5428b" xlink:to="loc_us-gaap_RelatedPartyMember_a3869915-a252-48c6-82ec-41812b8a7c5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6f9e0ffa-d053-4087-a3e4-8763e56a1bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_be58825c-fb4f-465a-a7f7-654526ca5707" xlink:to="loc_us-gaap_LongTermDebt_6f9e0ffa-d053-4087-a3e4-8763e56a1bdd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_24e81878-94e7-4e3d-9433-93a038bf0364" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_be58825c-fb4f-465a-a7f7-654526ca5707" xlink:to="loc_us-gaap_LongTermDebtCurrent_24e81878-94e7-4e3d-9433-93a038bf0364" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_a3064ff6-f65a-4ece-9d22-a99c74f8894f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_be58825c-fb4f-465a-a7f7-654526ca5707" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_a3064ff6-f65a-4ece-9d22-a99c74f8894f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#LongTermDebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_4a168a33-0ea2-45da-8e71-98ce4e069570" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_us-gaap_DebtInstrumentTable_4a168a33-0ea2-45da-8e71-98ce4e069570" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_396a8110-4e6b-4463-af65-3d32d429a0e2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4a168a33-0ea2-45da-8e71-98ce4e069570" xlink:to="loc_dei_LegalEntityAxis_396a8110-4e6b-4463-af65-3d32d429a0e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_396a8110-4e6b-4463-af65-3d32d429a0e2_default" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_396a8110-4e6b-4463-af65-3d32d429a0e2" xlink:to="loc_dei_EntityDomain_396a8110-4e6b-4463-af65-3d32d429a0e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b43775e9-076d-43b6-b7d0-fab71d780846" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_396a8110-4e6b-4463-af65-3d32d429a0e2" xlink:to="loc_dei_EntityDomain_b43775e9-076d-43b6-b7d0-fab71d780846" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ALT5SubsidiaryMember_37878230-c9e8-431f-bc4a-6279c075d920" xlink:href="alts-20241228.xsd#alts_ALT5SubsidiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_b43775e9-076d-43b6-b7d0-fab71d780846" xlink:to="loc_alts_ALT5SubsidiaryMember_37878230-c9e8-431f-bc4a-6279c075d920" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_873fc338-17eb-4dca-a0df-7fddf626efb7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4a168a33-0ea2-45da-8e71-98ce4e069570" xlink:to="loc_us-gaap_DebtInstrumentAxis_873fc338-17eb-4dca-a0df-7fddf626efb7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_873fc338-17eb-4dca-a0df-7fddf626efb7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_873fc338-17eb-4dca-a0df-7fddf626efb7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_873fc338-17eb-4dca-a0df-7fddf626efb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4b888866-21a6-4cb4-9f16-ee4acc1a5934" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_873fc338-17eb-4dca-a0df-7fddf626efb7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4b888866-21a6-4cb4-9f16-ee4acc1a5934" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LegacySubsidiaryFixedDepositsMember_3d397696-7d8a-4e15-a58b-a37b5ac1dd69" xlink:href="alts-20241228.xsd#alts_LegacySubsidiaryFixedDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4b888866-21a6-4cb4-9f16-ee4acc1a5934" xlink:to="loc_alts_LegacySubsidiaryFixedDepositsMember_3d397696-7d8a-4e15-a58b-a37b5ac1dd69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LegacySubsidiaryLoanMember_50d0ef76-cbbe-466f-9dde-1026b92e7e70" xlink:href="alts-20241228.xsd#alts_LegacySubsidiaryLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4b888866-21a6-4cb4-9f16-ee4acc1a5934" xlink:to="loc_alts_LegacySubsidiaryLoanMember_50d0ef76-cbbe-466f-9dde-1026b92e7e70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IcgNoteMember_9a73051f-848f-4ff3-9349-3b4a77a0c519" xlink:href="alts-20241228.xsd#alts_IcgNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4b888866-21a6-4cb4-9f16-ee4acc1a5934" xlink:to="loc_alts_IcgNoteMember_9a73051f-848f-4ff3-9349-3b4a77a0c519" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LiveNoteMember_762edea2-1ba8-4f7a-84bc-8fb451dc965f" xlink:href="alts-20241228.xsd#alts_LiveNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4b888866-21a6-4cb4-9f16-ee4acc1a5934" xlink:to="loc_alts_LiveNoteMember_762edea2-1ba8-4f7a-84bc-8fb451dc965f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NonConvertibleDebentureBigAndSmallDebentureMember_7bc97ebb-8228-43ab-8380-c1a5aa22a86d" xlink:href="alts-20241228.xsd#alts_NonConvertibleDebentureBigAndSmallDebentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4b888866-21a6-4cb4-9f16-ee4acc1a5934" xlink:to="loc_alts_NonConvertibleDebentureBigAndSmallDebentureMember_7bc97ebb-8228-43ab-8380-c1a5aa22a86d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NonConvertibleDebentureBigDebentureMember_cf8aa52b-d105-4c16-a886-73e26be293dd" xlink:href="alts-20241228.xsd#alts_NonConvertibleDebentureBigDebentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_NonConvertibleDebentureBigAndSmallDebentureMember_7bc97ebb-8228-43ab-8380-c1a5aa22a86d" xlink:to="loc_alts_NonConvertibleDebentureBigDebentureMember_cf8aa52b-d105-4c16-a886-73e26be293dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NonConvertibleDebentureSmallDebentureMember_0e35ffea-9cc7-4d19-8785-355e43162cce" xlink:href="alts-20241228.xsd#alts_NonConvertibleDebentureSmallDebentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_NonConvertibleDebentureBigAndSmallDebentureMember_7bc97ebb-8228-43ab-8380-c1a5aa22a86d" xlink:to="loc_alts_NonConvertibleDebentureSmallDebentureMember_0e35ffea-9cc7-4d19-8785-355e43162cce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_FixedDepositAgreementMember_3dd5ea00-d1fb-4255-ae20-a33b9f536932" xlink:href="alts-20241228.xsd#alts_FixedDepositAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4b888866-21a6-4cb4-9f16-ee4acc1a5934" xlink:to="loc_alts_FixedDepositAgreementMember_3dd5ea00-d1fb-4255-ae20-a33b9f536932" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PromissoryNoteMember_75142141-512e-4165-824b-ad52e9684caa" xlink:href="alts-20241228.xsd#alts_PromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4b888866-21a6-4cb4-9f16-ee4acc1a5934" xlink:to="loc_alts_PromissoryNoteMember_75142141-512e-4165-824b-ad52e9684caa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a1b7bc84-88ed-4460-970a-01c001c496c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4a168a33-0ea2-45da-8e71-98ce4e069570" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a1b7bc84-88ed-4460-970a-01c001c496c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a1b7bc84-88ed-4460-970a-01c001c496c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a1b7bc84-88ed-4460-970a-01c001c496c6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a1b7bc84-88ed-4460-970a-01c001c496c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_806875b0-0284-4a8e-956e-8ed3c022d4af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a1b7bc84-88ed-4460-970a-01c001c496c6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_806875b0-0284-4a8e-956e-8ed3c022d4af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_FixedDepositAgreementMember_ccb565c4-33c8-439d-9636-b25054ca43a6" xlink:href="alts-20241228.xsd#alts_FixedDepositAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_806875b0-0284-4a8e-956e-8ed3c022d4af" xlink:to="loc_alts_FixedDepositAgreementMember_ccb565c4-33c8-439d-9636-b25054ca43a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_a5414d68-ceae-459a-ad1d-b928a4f6f360" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_806875b0-0284-4a8e-956e-8ed3c022d4af" xlink:to="loc_us-gaap_LoansPayableMember_a5414d68-ceae-459a-ad1d-b928a4f6f360" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PromissoryNoteMember_b13bb4ba-882d-44a8-820a-4cf5cf621787" xlink:href="alts-20241228.xsd#alts_PromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_806875b0-0284-4a8e-956e-8ed3c022d4af" xlink:to="loc_alts_PromissoryNoteMember_b13bb4ba-882d-44a8-820a-4cf5cf621787" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_65af83df-4f7e-4e2a-a759-c0279d65d254" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_806875b0-0284-4a8e-956e-8ed3c022d4af" xlink:to="loc_us-gaap_UnsecuredDebtMember_65af83df-4f7e-4e2a-a759-c0279d65d254" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_57a7c283-90ea-4b35-83df-750ca7770f54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4a168a33-0ea2-45da-8e71-98ce4e069570" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_57a7c283-90ea-4b35-83df-750ca7770f54" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_57a7c283-90ea-4b35-83df-750ca7770f54_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_57a7c283-90ea-4b35-83df-750ca7770f54" xlink:to="loc_us-gaap_RelatedPartyDomain_57a7c283-90ea-4b35-83df-750ca7770f54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_721ef67c-387b-4771-8c3b-cecf5dbd635a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_57a7c283-90ea-4b35-83df-750ca7770f54" xlink:to="loc_us-gaap_RelatedPartyDomain_721ef67c-387b-4771-8c3b-cecf5dbd635a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_b77b3b21-a638-4126-9fc3-d9d19220bfeb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_721ef67c-387b-4771-8c3b-cecf5dbd635a" xlink:to="loc_us-gaap_RelatedPartyMember_b77b3b21-a638-4126-9fc3-d9d19220bfeb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_cd481475-20d9-491f-9ebe-f96f9ad07416" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4a168a33-0ea2-45da-8e71-98ce4e069570" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_cd481475-20d9-491f-9ebe-f96f9ad07416" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_cd481475-20d9-491f-9ebe-f96f9ad07416_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_cd481475-20d9-491f-9ebe-f96f9ad07416" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_cd481475-20d9-491f-9ebe-f96f9ad07416_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_30caede6-e5d2-433b-b56d-350bc31bf116" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_cd481475-20d9-491f-9ebe-f96f9ad07416" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_30caede6-e5d2-433b-b56d-350bc31bf116" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NotesPayableWithLiveVenturesAndICGMember_ba252b40-72bb-44bd-bb14-accb229fc451" xlink:href="alts-20241228.xsd#alts_NotesPayableWithLiveVenturesAndICGMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_30caede6-e5d2-433b-b56d-350bc31bf116" xlink:to="loc_alts_NotesPayableWithLiveVenturesAndICGMember_ba252b40-72bb-44bd-bb14-accb229fc451" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_16e1ee39-b2f4-4475-9527-3020d221c0d0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4a168a33-0ea2-45da-8e71-98ce4e069570" xlink:to="loc_srt_CounterpartyNameAxis_16e1ee39-b2f4-4475-9527-3020d221c0d0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_16e1ee39-b2f4-4475-9527-3020d221c0d0_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_16e1ee39-b2f4-4475-9527-3020d221c0d0" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_16e1ee39-b2f4-4475-9527-3020d221c0d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_98811ac9-9e9f-4edc-a2c8-579548f202e1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_16e1ee39-b2f4-4475-9527-3020d221c0d0" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_98811ac9-9e9f-4edc-a2c8-579548f202e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_InvestorOneMember_85579789-5ec7-43d8-b18c-82cb6ef070bc" xlink:href="alts-20241228.xsd#alts_InvestorOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_98811ac9-9e9f-4edc-a2c8-579548f202e1" xlink:to="loc_alts_InvestorOneMember_85579789-5ec7-43d8-b18c-82cb6ef070bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_InvestorTwoAndInvestorThreeMember_5bbe0523-284d-4546-994d-39696de6c1df" xlink:href="alts-20241228.xsd#alts_InvestorTwoAndInvestorThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_98811ac9-9e9f-4edc-a2c8-579548f202e1" xlink:to="loc_alts_InvestorTwoAndInvestorThreeMember_5bbe0523-284d-4546-994d-39696de6c1df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ALT5SubsidiaryMember_972ae398-24b4-4cae-9044-26cf2027e748" xlink:href="alts-20241228.xsd#alts_ALT5SubsidiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_98811ac9-9e9f-4edc-a2c8-579548f202e1" xlink:to="loc_alts_ALT5SubsidiaryMember_972ae398-24b4-4cae-9044-26cf2027e748" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SkyBridgeAmericasMember_4434c0fa-9b69-4806-9e96-65829a4cd5fc" xlink:href="alts-20241228.xsd#alts_SkyBridgeAmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_98811ac9-9e9f-4edc-a2c8-579548f202e1" xlink:to="loc_alts_SkyBridgeAmericasMember_4434c0fa-9b69-4806-9e96-65829a4cd5fc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_UnaffiliatedThirdPartyMember_f3c15fda-28ed-4012-b4ac-625b213ee98c" xlink:href="alts-20241228.xsd#alts_UnaffiliatedThirdPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_98811ac9-9e9f-4edc-a2c8-579548f202e1" xlink:to="loc_alts_UnaffiliatedThirdPartyMember_f3c15fda-28ed-4012-b4ac-625b213ee98c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_6e70ef4d-78e9-4fa8-81f7-fd0aa98d2b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4a168a33-0ea2-45da-8e71-98ce4e069570" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_6e70ef4d-78e9-4fa8-81f7-fd0aa98d2b5b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_6e70ef4d-78e9-4fa8-81f7-fd0aa98d2b5b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_6e70ef4d-78e9-4fa8-81f7-fd0aa98d2b5b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_6e70ef4d-78e9-4fa8-81f7-fd0aa98d2b5b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_92d8e33c-a5f1-4989-8ff9-0c80a0e4b205" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_6e70ef4d-78e9-4fa8-81f7-fd0aa98d2b5b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_92d8e33c-a5f1-4989-8ff9-0c80a0e4b205" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_eae40666-22cf-4137-ad21-d9e7dc646656" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_92d8e33c-a5f1-4989-8ff9-0c80a0e4b205" xlink:to="loc_us-gaap_WarrantMember_eae40666-22cf-4137-ad21-d9e7dc646656" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BigWarrantMember_bc4bb237-3593-4e5d-852f-d66ea3651e3d" xlink:href="alts-20241228.xsd#alts_BigWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WarrantMember_eae40666-22cf-4137-ad21-d9e7dc646656" xlink:to="loc_alts_BigWarrantMember_bc4bb237-3593-4e5d-852f-d66ea3651e3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SmallWarrantMember_1284d1f4-be89-4186-9b98-2a56b7095a45" xlink:href="alts-20241228.xsd#alts_SmallWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WarrantMember_eae40666-22cf-4137-ad21-d9e7dc646656" xlink:to="loc_alts_SmallWarrantMember_1284d1f4-be89-4186-9b98-2a56b7095a45" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionAxis_31e75380-8572-4463-ad43-2755898d08b1" xlink:href="alts-20241228.xsd#alts_DebtInstrumentOriginalIssueDiscountExpansionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4a168a33-0ea2-45da-8e71-98ce4e069570" xlink:to="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionAxis_31e75380-8572-4463-ad43-2755898d08b1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionDomain_31e75380-8572-4463-ad43-2755898d08b1_default" xlink:href="alts-20241228.xsd#alts_DebtInstrumentOriginalIssueDiscountExpansionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionAxis_31e75380-8572-4463-ad43-2755898d08b1" xlink:to="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionDomain_31e75380-8572-4463-ad43-2755898d08b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionDomain_ac0dc18b-fdf1-453b-95a9-ab53d5c26ec9" xlink:href="alts-20241228.xsd#alts_DebtInstrumentOriginalIssueDiscountExpansionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionAxis_31e75380-8572-4463-ad43-2755898d08b1" xlink:to="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionDomain_ac0dc18b-fdf1-453b-95a9-ab53d5c26ec9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionOneMember_b0ff8448-a613-4f28-b3d4-28b170be4baf" xlink:href="alts-20241228.xsd#alts_DebtInstrumentOriginalIssueDiscountExpansionOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionDomain_ac0dc18b-fdf1-453b-95a9-ab53d5c26ec9" xlink:to="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionOneMember_b0ff8448-a613-4f28-b3d4-28b170be4baf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionTwoMember_0b324932-4ec7-4ae9-89bf-26c2289ec1c2" xlink:href="alts-20241228.xsd#alts_DebtInstrumentOriginalIssueDiscountExpansionTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionDomain_ac0dc18b-fdf1-453b-95a9-ab53d5c26ec9" xlink:to="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionTwoMember_0b324932-4ec7-4ae9-89bf-26c2289ec1c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentCovenantPeriodAxis_1adcebde-0e26-4f38-b7db-bb83f9e20e2d" xlink:href="alts-20241228.xsd#alts_DebtInstrumentCovenantPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4a168a33-0ea2-45da-8e71-98ce4e069570" xlink:to="loc_alts_DebtInstrumentCovenantPeriodAxis_1adcebde-0e26-4f38-b7db-bb83f9e20e2d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentCovenantPeriodDomain_1adcebde-0e26-4f38-b7db-bb83f9e20e2d_default" xlink:href="alts-20241228.xsd#alts_DebtInstrumentCovenantPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_alts_DebtInstrumentCovenantPeriodAxis_1adcebde-0e26-4f38-b7db-bb83f9e20e2d" xlink:to="loc_alts_DebtInstrumentCovenantPeriodDomain_1adcebde-0e26-4f38-b7db-bb83f9e20e2d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentCovenantPeriodDomain_119d889d-7d53-48a2-a95b-8e61855e5625" xlink:href="alts-20241228.xsd#alts_DebtInstrumentCovenantPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_alts_DebtInstrumentCovenantPeriodAxis_1adcebde-0e26-4f38-b7db-bb83f9e20e2d" xlink:to="loc_alts_DebtInstrumentCovenantPeriodDomain_119d889d-7d53-48a2-a95b-8e61855e5625" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentCovenantPeriodPeriodOneMember_4d0a5c4a-9c9f-4f2a-96f9-d952515cf8dd" xlink:href="alts-20241228.xsd#alts_DebtInstrumentCovenantPeriodPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_DebtInstrumentCovenantPeriodDomain_119d889d-7d53-48a2-a95b-8e61855e5625" xlink:to="loc_alts_DebtInstrumentCovenantPeriodPeriodOneMember_4d0a5c4a-9c9f-4f2a-96f9-d952515cf8dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentCovenantPeriodPeriodTwoMember_ee2d45ff-9418-471f-9e1d-237451d86677" xlink:href="alts-20241228.xsd#alts_DebtInstrumentCovenantPeriodPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_DebtInstrumentCovenantPeriodDomain_119d889d-7d53-48a2-a95b-8e61855e5625" xlink:to="loc_alts_DebtInstrumentCovenantPeriodPeriodTwoMember_ee2d45ff-9418-471f-9e1d-237451d86677" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentCovenantPeriodPeriodThreeMember_6b10ba35-981e-4231-ba61-f359217104e6" xlink:href="alts-20241228.xsd#alts_DebtInstrumentCovenantPeriodPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_DebtInstrumentCovenantPeriodDomain_119d889d-7d53-48a2-a95b-8e61855e5625" xlink:to="loc_alts_DebtInstrumentCovenantPeriodPeriodThreeMember_6b10ba35-981e-4231-ba61-f359217104e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_34f54b07-3f0d-428f-bbfb-a78e2e9dac47" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4a168a33-0ea2-45da-8e71-98ce4e069570" xlink:to="loc_srt_LitigationCaseAxis_34f54b07-3f0d-428f-bbfb-a78e2e9dac47" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_34f54b07-3f0d-428f-bbfb-a78e2e9dac47_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_34f54b07-3f0d-428f-bbfb-a78e2e9dac47" xlink:to="loc_srt_LitigationCaseTypeDomain_34f54b07-3f0d-428f-bbfb-a78e2e9dac47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_06c661d4-9576-49a7-bcd1-daf84b07364f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_34f54b07-3f0d-428f-bbfb-a78e2e9dac47" xlink:to="loc_srt_LitigationCaseTypeDomain_06c661d4-9576-49a7-bcd1-daf84b07364f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SkybridgeLitigationMember_dce8b1e4-77c0-4dfa-902e-29537e2ae6f3" xlink:href="alts-20241228.xsd#alts_SkybridgeLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_06c661d4-9576-49a7-bcd1-daf84b07364f" xlink:to="loc_alts_SkybridgeLitigationMember_dce8b1e4-77c0-4dfa-902e-29537e2ae6f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_cb2f8bae-9fb6-43a3-8fd9-61092e7981ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4a168a33-0ea2-45da-8e71-98ce4e069570" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_cb2f8bae-9fb6-43a3-8fd9-61092e7981ec" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_cb2f8bae-9fb6-43a3-8fd9-61092e7981ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_cb2f8bae-9fb6-43a3-8fd9-61092e7981ec" xlink:to="loc_us-gaap_LossContingencyNatureDomain_cb2f8bae-9fb6-43a3-8fd9-61092e7981ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_e0af46da-7e62-4b65-a584-3937437ec0cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_cb2f8bae-9fb6-43a3-8fd9-61092e7981ec" xlink:to="loc_us-gaap_LossContingencyNatureDomain_e0af46da-7e62-4b65-a584-3937437ec0cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LegalFeesMember_c56b4c00-a6df-4732-b880-a8bdf802916a" xlink:href="alts-20241228.xsd#alts_LegalFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_e0af46da-7e62-4b65-a584-3937437ec0cf" xlink:to="loc_alts_LegalFeesMember_c56b4c00-a6df-4732-b880-a8bdf802916a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ec257606-fa33-4a0f-a14a-37b37cf361dd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_4a168a33-0ea2-45da-8e71-98ce4e069570" xlink:to="loc_srt_RangeAxis_ec257606-fa33-4a0f-a14a-37b37cf361dd" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ec257606-fa33-4a0f-a14a-37b37cf361dd_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ec257606-fa33-4a0f-a14a-37b37cf361dd" xlink:to="loc_srt_RangeMember_ec257606-fa33-4a0f-a14a-37b37cf361dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b6de4071-8502-4fc0-8b42-c6942df8847c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ec257606-fa33-4a0f-a14a-37b37cf361dd" xlink:to="loc_srt_RangeMember_b6de4071-8502-4fc0-8b42-c6942df8847c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f8605c88-9cf3-4fc8-a267-0700f8d9555e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b6de4071-8502-4fc0-8b42-c6942df8847c" xlink:to="loc_srt_MinimumMember_f8605c88-9cf3-4fc8-a267-0700f8d9555e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cb3e23f1-157d-4581-a001-537f0df98f97" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b6de4071-8502-4fc0-8b42-c6942df8847c" xlink:to="loc_srt_MaximumMember_cb3e23f1-157d-4581-a001-537f0df98f97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_c7a99894-d533-4e00-8edb-29ff3c0701c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_c7a99894-d533-4e00-8edb-29ff3c0701c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ccbb6dea-6698-49e1-8e4d-b58d8262fdcd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ccbb6dea-6698-49e1-8e4d-b58d8262fdcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_825a36f3-560b-4f4d-98bc-10e39a6d747e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_us-gaap_LongTermDebt_825a36f3-560b-4f4d-98bc-10e39a6d747e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_70146f8f-5d1d-47cf-a7ed-3d326d32d943" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_70146f8f-5d1d-47cf-a7ed-3d326d32d943" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1_c75a508c-5b0f-4090-9480-ba1b4a45a145" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionOriginalDebtAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_us-gaap_DebtConversionOriginalDebtAmount1_c75a508c-5b0f-4090-9480-ba1b4a45a145" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_e42db3f7-0966-462a-bd89-a61d1d928578" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_e42db3f7-0966-462a-bd89-a61d1d928578" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_4dcdca44-1d2f-43f9-9cf8-b40ad4063638" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_4dcdca44-1d2f-43f9-9cf8-b40ad4063638" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_1fbec6a0-bbb3-42a0-ae01-db2c1e40d72f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_1fbec6a0-bbb3-42a0-ae01-db2c1e40d72f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NumberOfUnaffiliatedThirdPartyInvestors_706d2490-f55a-4d58-a1e1-5424b8f94244" xlink:href="alts-20241228.xsd#alts_NumberOfUnaffiliatedThirdPartyInvestors"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_alts_NumberOfUnaffiliatedThirdPartyInvestors_706d2490-f55a-4d58-a1e1-5424b8f94244" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_4ebc5393-21b7-44f2-a87a-d2c1fe16287e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_4ebc5393-21b7-44f2-a87a-d2c1fe16287e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_daba3b09-f151-4497-b049-143fa79c3df3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_daba3b09-f151-4497-b049-143fa79c3df3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions_7583b74b-938b-45d0-9a1a-00fcd44d0eb6" xlink:href="alts-20241228.xsd#alts_DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_alts_DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions_7583b74b-938b-45d0-9a1a-00fcd44d0eb6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8a650446-58ba-433e-a68c-87322c7ab713" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8a650446-58ba-433e-a68c-87322c7ab713" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ClassOfWarrantOrRightExercisePeriod_fcff8db5-ae69-4d7c-b8e9-7d6ec05006b4" xlink:href="alts-20241228.xsd#alts_ClassOfWarrantOrRightExercisePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_alts_ClassOfWarrantOrRightExercisePeriod_fcff8db5-ae69-4d7c-b8e9-7d6ec05006b4" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PercentageOfNetDollarReceivedToBeIssuedToDebentureHoldersOnAProRataBasis_807bd5ba-65b2-4f74-a44e-49e7f79c2e14" xlink:href="alts-20241228.xsd#alts_PercentageOfNetDollarReceivedToBeIssuedToDebentureHoldersOnAProRataBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_alts_PercentageOfNetDollarReceivedToBeIssuedToDebentureHoldersOnAProRataBasis_807bd5ba-65b2-4f74-a44e-49e7f79c2e14" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockIssuedDuringPeriodSharesWarrantsExercised_ddede734-f5c7-4a7d-a937-5a14fbc1eccf" xlink:href="alts-20241228.xsd#alts_StockIssuedDuringPeriodSharesWarrantsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_alts_StockIssuedDuringPeriodSharesWarrantsExercised_ddede734-f5c7-4a7d-a937-5a14fbc1eccf" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_d547a220-9560-485a-9102-aa1834c3ee84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_us-gaap_DebtInstrumentTerm_d547a220-9560-485a-9102-aa1834c3ee84" xlink:type="arc" order="16"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofLongTermDebtPayabletoRelatedPartiesDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#RelatedPartyDebtScheduleofLongTermDebtPayabletoRelatedPartiesDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofLongTermDebtPayabletoRelatedPartiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f64afe6e-aa47-4c50-9ff4-2612e280270d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_794cab1a-12e7-4b4b-88e1-92380d993181" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f64afe6e-aa47-4c50-9ff4-2612e280270d" xlink:to="loc_us-gaap_DebtInstrumentTable_794cab1a-12e7-4b4b-88e1-92380d993181" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_74523088-a4f4-4537-b6db-01e2fc574e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_794cab1a-12e7-4b4b-88e1-92380d993181" xlink:to="loc_us-gaap_DebtInstrumentAxis_74523088-a4f4-4537-b6db-01e2fc574e2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_74523088-a4f4-4537-b6db-01e2fc574e2e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_74523088-a4f4-4537-b6db-01e2fc574e2e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_74523088-a4f4-4537-b6db-01e2fc574e2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_08bd893b-c75f-4652-83d3-c46df675743a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_74523088-a4f4-4537-b6db-01e2fc574e2e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_08bd893b-c75f-4652-83d3-c46df675743a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IsaacCapitalGroupNoteMember_57508e79-0b2c-45e2-bfaf-4c1450697444" xlink:href="alts-20241228.xsd#alts_IsaacCapitalGroupNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_08bd893b-c75f-4652-83d3-c46df675743a" xlink:to="loc_alts_IsaacCapitalGroupNoteMember_57508e79-0b2c-45e2-bfaf-4c1450697444" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NotePayableToIsaacCapitalGroupMember_1a979798-2816-4dc1-9a19-858574dc87c8" xlink:href="alts-20241228.xsd#alts_NotePayableToIsaacCapitalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_08bd893b-c75f-4652-83d3-c46df675743a" xlink:to="loc_alts_NotePayableToIsaacCapitalGroupMember_1a979798-2816-4dc1-9a19-858574dc87c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NotePayableToLiveVentureIncorporatedMember_bc6ef691-50a2-4db8-8781-f41d90fea214" xlink:href="alts-20241228.xsd#alts_NotePayableToLiveVentureIncorporatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_08bd893b-c75f-4652-83d3-c46df675743a" xlink:to="loc_alts_NotePayableToLiveVentureIncorporatedMember_bc6ef691-50a2-4db8-8781-f41d90fea214" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IsaacCapitalGroupShortTermDemandAdvanceMember_93587faf-3e0e-4558-82ee-2264936d1841" xlink:href="alts-20241228.xsd#alts_IsaacCapitalGroupShortTermDemandAdvanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_08bd893b-c75f-4652-83d3-c46df675743a" xlink:to="loc_alts_IsaacCapitalGroupShortTermDemandAdvanceMember_93587faf-3e0e-4558-82ee-2264936d1841" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NovalkAppsSAALLPShortTermDemandAdvanceMember_e4ee6dac-b832-4324-b9c4-bb8e7f959db8" xlink:href="alts-20241228.xsd#alts_NovalkAppsSAALLPShortTermDemandAdvanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_08bd893b-c75f-4652-83d3-c46df675743a" xlink:to="loc_alts_NovalkAppsSAALLPShortTermDemandAdvanceMember_e4ee6dac-b832-4324-b9c4-bb8e7f959db8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_279e8b09-a1fc-43b9-9bf8-b652947781f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_794cab1a-12e7-4b4b-88e1-92380d993181" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_279e8b09-a1fc-43b9-9bf8-b652947781f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_279e8b09-a1fc-43b9-9bf8-b652947781f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_279e8b09-a1fc-43b9-9bf8-b652947781f7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_279e8b09-a1fc-43b9-9bf8-b652947781f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4b45c0b5-eb23-4236-8471-35b9d857f0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_279e8b09-a1fc-43b9-9bf8-b652947781f7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4b45c0b5-eb23-4236-8471-35b9d857f0c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_6966cfb1-498f-4570-a979-c4a449846f38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4b45c0b5-eb23-4236-8471-35b9d857f0c1" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_6966cfb1-498f-4570-a979-c4a449846f38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_10b80061-3671-4662-912b-a8bd29cf8acd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_794cab1a-12e7-4b4b-88e1-92380d993181" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_10b80061-3671-4662-912b-a8bd29cf8acd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_10b80061-3671-4662-912b-a8bd29cf8acd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_10b80061-3671-4662-912b-a8bd29cf8acd" xlink:to="loc_us-gaap_RelatedPartyDomain_10b80061-3671-4662-912b-a8bd29cf8acd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_4d6c1c81-83f1-4dde-9e62-7bbc4bbfa9da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_10b80061-3671-4662-912b-a8bd29cf8acd" xlink:to="loc_us-gaap_RelatedPartyDomain_4d6c1c81-83f1-4dde-9e62-7bbc4bbfa9da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_3da0326f-3185-477e-89c9-882289c5fbc0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_4d6c1c81-83f1-4dde-9e62-7bbc4bbfa9da" xlink:to="loc_us-gaap_RelatedPartyMember_3da0326f-3185-477e-89c9-882289c5fbc0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_239a08d5-99a5-4c28-a52e-eca597a1769f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f64afe6e-aa47-4c50-9ff4-2612e280270d" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_239a08d5-99a5-4c28-a52e-eca597a1769f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_5ec50ddc-99b0-4a9c-b31c-027f29d2315a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f64afe6e-aa47-4c50-9ff4-2612e280270d" xlink:to="loc_us-gaap_LongTermDebtCurrent_5ec50ddc-99b0-4a9c-b31c-027f29d2315a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_90d086f4-c6e5-49bd-934c-e1e085de9dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f64afe6e-aa47-4c50-9ff4-2612e280270d" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_90d086f4-c6e5-49bd-934c-e1e085de9dbe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_09d594de-cf6f-47ba-84f3-4c387bbd6dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f64afe6e-aa47-4c50-9ff4-2612e280270d" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_09d594de-cf6f-47ba-84f3-4c387bbd6dc7" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofFutureMaturitiesofLongTermDebtDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#RelatedPartyDebtScheduleofFutureMaturitiesofLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofFutureMaturitiesofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b60394f9-696c-4998-92d6-17b395777ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_31c6c5f1-b6ab-4a0b-a989-c6f8b6613b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b60394f9-696c-4998-92d6-17b395777ed8" xlink:to="loc_us-gaap_DebtInstrumentTable_31c6c5f1-b6ab-4a0b-a989-c6f8b6613b3a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_557e62b1-b952-4f59-a888-d05ac36c8be6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_31c6c5f1-b6ab-4a0b-a989-c6f8b6613b3a" xlink:to="loc_us-gaap_DebtInstrumentAxis_557e62b1-b952-4f59-a888-d05ac36c8be6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_557e62b1-b952-4f59-a888-d05ac36c8be6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_557e62b1-b952-4f59-a888-d05ac36c8be6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_557e62b1-b952-4f59-a888-d05ac36c8be6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4aa52832-7087-4d9c-b3ee-4df6503cdece" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_557e62b1-b952-4f59-a888-d05ac36c8be6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4aa52832-7087-4d9c-b3ee-4df6503cdece" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NotesPayableRelatedPartiesMember_d50fb3a8-3934-4e59-89a8-4cbbf3ec6f34" xlink:href="alts-20241228.xsd#alts_NotesPayableRelatedPartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4aa52832-7087-4d9c-b3ee-4df6503cdece" xlink:to="loc_alts_NotesPayableRelatedPartiesMember_d50fb3a8-3934-4e59-89a8-4cbbf3ec6f34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1f1fb263-7a30-462e-9a2a-9e155815d594" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_31c6c5f1-b6ab-4a0b-a989-c6f8b6613b3a" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1f1fb263-7a30-462e-9a2a-9e155815d594" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_1f1fb263-7a30-462e-9a2a-9e155815d594_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1f1fb263-7a30-462e-9a2a-9e155815d594" xlink:to="loc_us-gaap_RelatedPartyDomain_1f1fb263-7a30-462e-9a2a-9e155815d594_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_51262bd6-7437-43c1-9759-12fb71332e07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1f1fb263-7a30-462e-9a2a-9e155815d594" xlink:to="loc_us-gaap_RelatedPartyDomain_51262bd6-7437-43c1-9759-12fb71332e07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_e5b64a68-54d9-449a-a5c6-f28364e6bc2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_51262bd6-7437-43c1-9759-12fb71332e07" xlink:to="loc_us-gaap_RelatedPartyMember_e5b64a68-54d9-449a-a5c6-f28364e6bc2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_16f09f0b-0b9f-42c0-af3a-3e0346090f99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b60394f9-696c-4998-92d6-17b395777ed8" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_16f09f0b-0b9f-42c0-af3a-3e0346090f99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_a0cfce76-9f6f-47ee-88b1-8b549026b133" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b60394f9-696c-4998-92d6-17b395777ed8" xlink:to="loc_us-gaap_LongTermDebt_a0cfce76-9f6f-47ee-88b1-8b549026b133" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#RelatedPartyDebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_0c547b82-33ac-4421-878a-4c43a26b2813" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_3cdd38b3-8e96-455d-84f1-05c624bf9434" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c547b82-33ac-4421-878a-4c43a26b2813" xlink:to="loc_us-gaap_DebtInstrumentTable_3cdd38b3-8e96-455d-84f1-05c624bf9434" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a5fc1635-cb03-40a3-bdcf-f1d196a2237f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3cdd38b3-8e96-455d-84f1-05c624bf9434" xlink:to="loc_us-gaap_DebtInstrumentAxis_a5fc1635-cb03-40a3-bdcf-f1d196a2237f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a5fc1635-cb03-40a3-bdcf-f1d196a2237f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_a5fc1635-cb03-40a3-bdcf-f1d196a2237f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a5fc1635-cb03-40a3-bdcf-f1d196a2237f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_23697c27-5f4e-4db8-9cc1-819da2b4d846" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_a5fc1635-cb03-40a3-bdcf-f1d196a2237f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_23697c27-5f4e-4db8-9cc1-819da2b4d846" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IcgNoteMember_fc64aaec-da79-4e91-a9bd-8a1b155e0966" xlink:href="alts-20241228.xsd#alts_IcgNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_23697c27-5f4e-4db8-9cc1-819da2b4d846" xlink:to="loc_alts_IcgNoteMember_fc64aaec-da79-4e91-a9bd-8a1b155e0966" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IsaacCapitalGroupShortTermDemandAdvanceMember_60487df9-f7b3-4071-a7b3-698ee0d5e15b" xlink:href="alts-20241228.xsd#alts_IsaacCapitalGroupShortTermDemandAdvanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_23697c27-5f4e-4db8-9cc1-819da2b4d846" xlink:to="loc_alts_IsaacCapitalGroupShortTermDemandAdvanceMember_60487df9-f7b3-4071-a7b3-698ee0d5e15b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LiveNoteMember_3f798a6e-4ee3-4c3f-bcc1-213a34f5c808" xlink:href="alts-20241228.xsd#alts_LiveNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_23697c27-5f4e-4db8-9cc1-819da2b4d846" xlink:to="loc_alts_LiveNoteMember_3f798a6e-4ee3-4c3f-bcc1-213a34f5c808" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_A10ConvertiblePromissoryNoteMember_05c7641f-89f0-4fff-bc3f-8819a385b1da" xlink:href="alts-20241228.xsd#alts_A10ConvertiblePromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_23697c27-5f4e-4db8-9cc1-819da2b4d846" xlink:to="loc_alts_A10ConvertiblePromissoryNoteMember_05c7641f-89f0-4fff-bc3f-8819a385b1da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Mr.JonIsaacMember_3bda5c94-5f23-484e-bde4-e2cfcd3fb012" xlink:href="alts-20241228.xsd#alts_Mr.JonIsaacMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_23697c27-5f4e-4db8-9cc1-819da2b4d846" xlink:to="loc_alts_Mr.JonIsaacMember_3bda5c94-5f23-484e-bde4-e2cfcd3fb012" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3fea437f-51f0-45ca-a2f1-465bdce0f5fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3cdd38b3-8e96-455d-84f1-05c624bf9434" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3fea437f-51f0-45ca-a2f1-465bdce0f5fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3fea437f-51f0-45ca-a2f1-465bdce0f5fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3fea437f-51f0-45ca-a2f1-465bdce0f5fc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3fea437f-51f0-45ca-a2f1-465bdce0f5fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f853b0b8-590e-490a-8a01-eca584d089cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3fea437f-51f0-45ca-a2f1-465bdce0f5fc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f853b0b8-590e-490a-8a01-eca584d089cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_078027d6-84de-4215-9bb3-ec441acd72fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f853b0b8-590e-490a-8a01-eca584d089cd" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_078027d6-84de-4215-9bb3-ec441acd72fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_29f65bd2-8e39-4601-bf9f-76277116f37c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3cdd38b3-8e96-455d-84f1-05c624bf9434" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_29f65bd2-8e39-4601-bf9f-76277116f37c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_29f65bd2-8e39-4601-bf9f-76277116f37c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_29f65bd2-8e39-4601-bf9f-76277116f37c" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_29f65bd2-8e39-4601-bf9f-76277116f37c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_f19625b7-3e80-440a-8208-e2668323a1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_29f65bd2-8e39-4601-bf9f-76277116f37c" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_f19625b7-3e80-440a-8208-e2668323a1a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IcgNoteMember_5c87ee1b-a854-4936-a856-70860953ee5e" xlink:href="alts-20241228.xsd#alts_IcgNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_f19625b7-3e80-440a-8208-e2668323a1a8" xlink:to="loc_alts_IcgNoteMember_5c87ee1b-a854-4936-a856-70860953ee5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LiveVentureIncorporatedMember_2b2d9414-31e5-4ff1-a4cb-1e5d1671a47b" xlink:href="alts-20241228.xsd#alts_LiveVentureIncorporatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_f19625b7-3e80-440a-8208-e2668323a1a8" xlink:to="loc_alts_LiveVentureIncorporatedMember_2b2d9414-31e5-4ff1-a4cb-1e5d1671a47b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IsaacConsultingAgreementMember_2e88221d-97f2-4915-94d6-365e041dc80c" xlink:href="alts-20241228.xsd#alts_IsaacConsultingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_f19625b7-3e80-440a-8208-e2668323a1a8" xlink:to="loc_alts_IsaacConsultingAgreementMember_2e88221d-97f2-4915-94d6-365e041dc80c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RelatedPartyTransactionShortTermAdvancesMember_be1aca24-b6ec-405e-a51a-8ef047ed6c27" xlink:href="alts-20241228.xsd#alts_RelatedPartyTransactionShortTermAdvancesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_f19625b7-3e80-440a-8208-e2668323a1a8" xlink:to="loc_alts_RelatedPartyTransactionShortTermAdvancesMember_be1aca24-b6ec-405e-a51a-8ef047ed6c27" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5cdd70fa-59d6-4a64-9e21-fda759c48e81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3cdd38b3-8e96-455d-84f1-05c624bf9434" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5cdd70fa-59d6-4a64-9e21-fda759c48e81" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_5cdd70fa-59d6-4a64-9e21-fda759c48e81_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5cdd70fa-59d6-4a64-9e21-fda759c48e81" xlink:to="loc_us-gaap_RelatedPartyDomain_5cdd70fa-59d6-4a64-9e21-fda759c48e81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_20bfd83a-d019-48cf-8792-3a7e2a9bb6f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5cdd70fa-59d6-4a64-9e21-fda759c48e81" xlink:to="loc_us-gaap_RelatedPartyDomain_20bfd83a-d019-48cf-8792-3a7e2a9bb6f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_4a3e8701-a34b-4019-a024-f395774c217c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_20bfd83a-d019-48cf-8792-3a7e2a9bb6f9" xlink:to="loc_us-gaap_RelatedPartyMember_4a3e8701-a34b-4019-a024-f395774c217c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_4e9a82c6-cfd8-4de3-9539-4f1d2962b40e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3cdd38b3-8e96-455d-84f1-05c624bf9434" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_4e9a82c6-cfd8-4de3-9539-4f1d2962b40e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4e9a82c6-cfd8-4de3-9539-4f1d2962b40e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_4e9a82c6-cfd8-4de3-9539-4f1d2962b40e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4e9a82c6-cfd8-4de3-9539-4f1d2962b40e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8424d235-3a36-4f54-bd2e-da95c8cbef2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_4e9a82c6-cfd8-4de3-9539-4f1d2962b40e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8424d235-3a36-4f54-bd2e-da95c8cbef2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityUnitPurchaseAgreementsMember_eab69690-0ae0-4d3e-89e2-71c9c3f4476b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityUnitPurchaseAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8424d235-3a36-4f54-bd2e-da95c8cbef2c" xlink:to="loc_us-gaap_EquityUnitPurchaseAgreementsMember_eab69690-0ae0-4d3e-89e2-71c9c3f4476b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_214a3802-2064-49d1-a808-8811c2c81463" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3cdd38b3-8e96-455d-84f1-05c624bf9434" xlink:to="loc_srt_CounterpartyNameAxis_214a3802-2064-49d1-a808-8811c2c81463" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_214a3802-2064-49d1-a808-8811c2c81463_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_214a3802-2064-49d1-a808-8811c2c81463" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_214a3802-2064-49d1-a808-8811c2c81463_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_973f2bcc-dbc4-4309-84a8-2b86fc3dd581" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_214a3802-2064-49d1-a808-8811c2c81463" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_973f2bcc-dbc4-4309-84a8-2b86fc3dd581" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Mr.JonIsaacMember_611cc267-d143-4ffd-9700-a040a80fe4c2" xlink:href="alts-20241228.xsd#alts_Mr.JonIsaacMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_973f2bcc-dbc4-4309-84a8-2b86fc3dd581" xlink:to="loc_alts_Mr.JonIsaacMember_611cc267-d143-4ffd-9700-a040a80fe4c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NovalkAppsSAALLPMember_19728f62-13de-478d-90e1-413e00cecee7" xlink:href="alts-20241228.xsd#alts_NovalkAppsSAALLPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_973f2bcc-dbc4-4309-84a8-2b86fc3dd581" xlink:to="loc_alts_NovalkAppsSAALLPMember_19728f62-13de-478d-90e1-413e00cecee7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Mr.TonyIsaacMember_192f9a75-19ab-4560-ad7c-172ac6b8dfb0" xlink:href="alts-20241228.xsd#alts_Mr.TonyIsaacMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_973f2bcc-dbc4-4309-84a8-2b86fc3dd581" xlink:to="loc_alts_Mr.TonyIsaacMember_192f9a75-19ab-4560-ad7c-172ac6b8dfb0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_dcba790a-214d-48e9-a07d-5434fe4a0323" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c547b82-33ac-4421-878a-4c43a26b2813" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_dcba790a-214d-48e9-a07d-5434fe4a0323" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_6aab8f69-9d37-49b9-a849-92157dcc1b88" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c547b82-33ac-4421-878a-4c43a26b2813" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_6aab8f69-9d37-49b9-a849-92157dcc1b88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1_c5fbc429-3eb4-4c72-87cc-ceb1e160045a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionOriginalDebtAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c547b82-33ac-4421-878a-4c43a26b2813" xlink:to="loc_us-gaap_DebtConversionOriginalDebtAmount1_c5fbc429-3eb4-4c72-87cc-ceb1e160045a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_d922ef1e-f8fa-4614-baf1-d8f7aa736264" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c547b82-33ac-4421-878a-4c43a26b2813" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_d922ef1e-f8fa-4614-baf1-d8f7aa736264" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_a89b6c73-98b3-40c0-9d96-a73827698590" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c547b82-33ac-4421-878a-4c43a26b2813" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_a89b6c73-98b3-40c0-9d96-a73827698590" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_c3574da1-8e7b-454c-b897-d020e78e6e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c547b82-33ac-4421-878a-4c43a26b2813" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_c3574da1-8e7b-454c-b897-d020e78e6e5c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_85bce256-a4b4-4a57-b3de-78679d35a92a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c547b82-33ac-4421-878a-4c43a26b2813" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_85bce256-a4b4-4a57-b3de-78679d35a92a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RelatedPartyTransactionConsultingAgreementTerm_d800a62b-3a82-4477-9f96-f7238842d588" xlink:href="alts-20241228.xsd#alts_RelatedPartyTransactionConsultingAgreementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c547b82-33ac-4421-878a-4c43a26b2813" xlink:to="loc_alts_RelatedPartyTransactionConsultingAgreementTerm_d800a62b-3a82-4477-9f96-f7238842d588" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_a3c9a7cf-d290-48e9-82b9-6991f39ed052" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c547b82-33ac-4421-878a-4c43a26b2813" xlink:to="loc_us-gaap_DebtInstrumentTerm_a3c9a7cf-d290-48e9-82b9-6991f39ed052" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice_53eb37c6-b81e-4a3c-acac-f43868c2e3bd" xlink:href="alts-20241228.xsd#alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c547b82-33ac-4421-878a-4c43a26b2813" xlink:to="loc_alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice_53eb37c6-b81e-4a3c-acac-f43868c2e3bd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_1ff58e3a-5de9-48a2-889e-2d0a98e13263" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c547b82-33ac-4421-878a-4c43a26b2813" xlink:to="loc_us-gaap_ShortTermBorrowings_1ff58e3a-5de9-48a2-889e-2d0a98e13263" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/PreferredStockSeriesA1ConvertiblePreferredStockDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#PreferredStockSeriesA1ConvertiblePreferredStockDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/PreferredStockSeriesA1ConvertiblePreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_c5c8e5bd-2e9c-41ed-b2d4-f58283c1c701" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_0d412d94-be11-4e7b-85ce-3ed02aa3c758" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_c5c8e5bd-2e9c-41ed-b2d4-f58283c1c701" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_0d412d94-be11-4e7b-85ce-3ed02aa3c758" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6d59ca42-556e-48da-bab2-308a72e5ef75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_0d412d94-be11-4e7b-85ce-3ed02aa3c758" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6d59ca42-556e-48da-bab2-308a72e5ef75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6d59ca42-556e-48da-bab2-308a72e5ef75_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6d59ca42-556e-48da-bab2-308a72e5ef75" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6d59ca42-556e-48da-bab2-308a72e5ef75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d0ce5810-8f9d-4769-ba27-b40e98cef331" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6d59ca42-556e-48da-bab2-308a72e5ef75" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d0ce5810-8f9d-4769-ba27-b40e98cef331" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_GeoTraqIncMember_b73bd98c-9f43-4e5b-adb3-c36c312c4bf1" xlink:href="alts-20241228.xsd#alts_GeoTraqIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d0ce5810-8f9d-4769-ba27-b40e98cef331" xlink:to="loc_alts_GeoTraqIncMember_b73bd98c-9f43-4e5b-adb3-c36c312c4bf1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_b67be714-7e5d-4368-afdc-a8f8c6b63047" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_0d412d94-be11-4e7b-85ce-3ed02aa3c758" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_b67be714-7e5d-4368-afdc-a8f8c6b63047" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_b67be714-7e5d-4368-afdc-a8f8c6b63047_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_b67be714-7e5d-4368-afdc-a8f8c6b63047" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_b67be714-7e5d-4368-afdc-a8f8c6b63047_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_9ad537f6-c364-4c45-a3a8-8da1279100b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_b67be714-7e5d-4368-afdc-a8f8c6b63047" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_9ad537f6-c364-4c45-a3a8-8da1279100b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesAConvertiblePreferredStockMember_df933a23-cb89-4e3f-aca3-73bba99ead5e" xlink:href="alts-20241228.xsd#alts_SeriesAConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_9ad537f6-c364-4c45-a3a8-8da1279100b7" xlink:to="loc_alts_SeriesAConvertiblePreferredStockMember_df933a23-cb89-4e3f-aca3-73bba99ead5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesA1ConvertiblePreferredStockMember_24d4a2ca-6965-47d5-b0cb-c466ea0e87c4" xlink:href="alts-20241228.xsd#alts_SeriesA1ConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_9ad537f6-c364-4c45-a3a8-8da1279100b7" xlink:to="loc_alts_SeriesA1ConvertiblePreferredStockMember_24d4a2ca-6965-47d5-b0cb-c466ea0e87c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_082f825f-37d9-49b8-95c7-56857e220ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c5c8e5bd-2e9c-41ed-b2d4-f58283c1c701" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_082f825f-37d9-49b8-95c7-56857e220ddb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_1dad5f8d-b7fe-4e94-8334-f5597620bb36" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c5c8e5bd-2e9c-41ed-b2d4-f58283c1c701" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_1dad5f8d-b7fe-4e94-8334-f5597620bb36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessCombinationConsiderationTransferredBeneficialConversionFeatureValue_5f788c98-da8b-495a-8164-617c93401002" xlink:href="alts-20241228.xsd#alts_BusinessCombinationConsiderationTransferredBeneficialConversionFeatureValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c5c8e5bd-2e9c-41ed-b2d4-f58283c1c701" xlink:to="loc_alts_BusinessCombinationConsiderationTransferredBeneficialConversionFeatureValue_5f788c98-da8b-495a-8164-617c93401002" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessCombinationConsiderationTransferredLiabilitiesIncurredTerm_e608692e-e15a-4455-933a-aba73424f0bd" xlink:href="alts-20241228.xsd#alts_BusinessCombinationConsiderationTransferredLiabilitiesIncurredTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c5c8e5bd-2e9c-41ed-b2d4-f58283c1c701" xlink:to="loc_alts_BusinessCombinationConsiderationTransferredLiabilitiesIncurredTerm_e608692e-e15a-4455-933a-aba73424f0bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_deb3dbce-b7ba-4eff-8667-16cf7b3205cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c5c8e5bd-2e9c-41ed-b2d4-f58283c1c701" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_deb3dbce-b7ba-4eff-8667-16cf7b3205cd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleConversionRatio_7acb0495-51fa-4ba8-a03d-2ee7a1ee8bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c5c8e5bd-2e9c-41ed-b2d4-f58283c1c701" xlink:to="loc_us-gaap_PreferredStockConvertibleConversionRatio_7acb0495-51fa-4ba8-a03d-2ee7a1ee8bcd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_e3107ca7-d1bc-40b9-9811-70be46aa9e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c5c8e5bd-2e9c-41ed-b2d4-f58283c1c701" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_e3107ca7-d1bc-40b9-9811-70be46aa9e4c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_091cacc8-814c-4ac5-95a5-dd0160d5a3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c5c8e5bd-2e9c-41ed-b2d4-f58283c1c701" xlink:to="loc_us-gaap_ConversionOfStockSharesIssued1_091cacc8-814c-4ac5-95a5-dd0160d5a3e0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ConversionOfStockSharesForfeited_cbe2abd7-69b8-40b6-9f02-9cc143957d5b" xlink:href="alts-20241228.xsd#alts_ConversionOfStockSharesForfeited"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c5c8e5bd-2e9c-41ed-b2d4-f58283c1c701" xlink:to="loc_alts_ConversionOfStockSharesForfeited_cbe2abd7-69b8-40b6-9f02-9cc143957d5b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_0106ac0b-d496-4b0e-8fca-39480c8bbe40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c5c8e5bd-2e9c-41ed-b2d4-f58283c1c701" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_0106ac0b-d496-4b0e-8fca-39480c8bbe40" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/PreferredStockSeriesBPreferredStockDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#PreferredStockSeriesBPreferredStockDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/PreferredStockSeriesBPreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_48da4bc6-b841-4f08-9e88-4394520cc068" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_038767ba-3976-4e77-ab59-217b7c5f8940" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_48da4bc6-b841-4f08-9e88-4394520cc068" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_038767ba-3976-4e77-ab59-217b7c5f8940" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_afcefc94-5de2-49a8-a8cd-836f3c95fc1c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_038767ba-3976-4e77-ab59-217b7c5f8940" xlink:to="loc_srt_CounterpartyNameAxis_afcefc94-5de2-49a8-a8cd-836f3c95fc1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_afcefc94-5de2-49a8-a8cd-836f3c95fc1c_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_afcefc94-5de2-49a8-a8cd-836f3c95fc1c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_afcefc94-5de2-49a8-a8cd-836f3c95fc1c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2b0285f5-1b00-4e8b-b1cb-f505a11b1e7d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_afcefc94-5de2-49a8-a8cd-836f3c95fc1c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2b0285f5-1b00-4e8b-b1cb-f505a11b1e7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OwnersOfALT5SubsidiaryMember_40b4e505-0da1-4b70-ab59-6391de034baa" xlink:href="alts-20241228.xsd#alts_OwnersOfALT5SubsidiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2b0285f5-1b00-4e8b-b1cb-f505a11b1e7d" xlink:to="loc_alts_OwnersOfALT5SubsidiaryMember_40b4e505-0da1-4b70-ab59-6391de034baa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_396595d3-0f14-4dcc-96f7-3cc5e24597ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_038767ba-3976-4e77-ab59-217b7c5f8940" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_396595d3-0f14-4dcc-96f7-3cc5e24597ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_396595d3-0f14-4dcc-96f7-3cc5e24597ee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_396595d3-0f14-4dcc-96f7-3cc5e24597ee" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_396595d3-0f14-4dcc-96f7-3cc5e24597ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_83f70dde-05c0-42e7-9a01-94555b79b0b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_396595d3-0f14-4dcc-96f7-3cc5e24597ee" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_83f70dde-05c0-42e7-9a01-94555b79b0b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Alt5SigmaInc.Member_a1c9a740-a30e-4619-80ac-835f5d0a613d" xlink:href="alts-20241228.xsd#alts_Alt5SigmaInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_83f70dde-05c0-42e7-9a01-94555b79b0b8" xlink:to="loc_alts_Alt5SigmaInc.Member_a1c9a740-a30e-4619-80ac-835f5d0a613d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_eac831e3-1c3e-4e6e-845e-a23b05e335b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_038767ba-3976-4e77-ab59-217b7c5f8940" xlink:to="loc_us-gaap_StatementClassOfStockAxis_eac831e3-1c3e-4e6e-845e-a23b05e335b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_eac831e3-1c3e-4e6e-845e-a23b05e335b9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_eac831e3-1c3e-4e6e-845e-a23b05e335b9" xlink:to="loc_us-gaap_ClassOfStockDomain_eac831e3-1c3e-4e6e-845e-a23b05e335b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d9c7f9d0-adf6-4105-89fe-3bf55d9e06bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_eac831e3-1c3e-4e6e-845e-a23b05e335b9" xlink:to="loc_us-gaap_ClassOfStockDomain_d9c7f9d0-adf6-4105-89fe-3bf55d9e06bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_14da29c9-0756-4cb8-abbb-c24e340adf5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d9c7f9d0-adf6-4105-89fe-3bf55d9e06bd" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_14da29c9-0756-4cb8-abbb-c24e340adf5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_950ef034-7561-4094-8394-149e31149180" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_48da4bc6-b841-4f08-9e88-4394520cc068" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_950ef034-7561-4094-8394-149e31149180" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_90372057-b146-481a-b5ef-1aa5a5cdc73d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_48da4bc6-b841-4f08-9e88-4394520cc068" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_90372057-b146-481a-b5ef-1aa5a5cdc73d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_fdf1c734-4e5a-4775-9d43-46432a153807" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_48da4bc6-b841-4f08-9e88-4394520cc068" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_fdf1c734-4e5a-4775-9d43-46432a153807" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/PreferredStockSeriesIConvertiblePreferredStockDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#PreferredStockSeriesIConvertiblePreferredStockDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/PreferredStockSeriesIConvertiblePreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_7fc8971f-4b9b-4c23-8099-287516f5c0e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_cd412062-7dc5-402a-bca6-7959cf1e71b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_7fc8971f-4b9b-4c23-8099-287516f5c0e7" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_cd412062-7dc5-402a-bca6-7959cf1e71b6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0d7436a6-e2c4-4a8f-85da-c828dd20592c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_cd412062-7dc5-402a-bca6-7959cf1e71b6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0d7436a6-e2c4-4a8f-85da-c828dd20592c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0d7436a6-e2c4-4a8f-85da-c828dd20592c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0d7436a6-e2c4-4a8f-85da-c828dd20592c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0d7436a6-e2c4-4a8f-85da-c828dd20592c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_40ac5b99-abf2-41e8-8bd5-15f584eb3330" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0d7436a6-e2c4-4a8f-85da-c828dd20592c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_40ac5b99-abf2-41e8-8bd5-15f584eb3330" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Alt5SigmaInc.Member_6c6afd48-0eb2-45a4-b7c5-a305f7206755" xlink:href="alts-20241228.xsd#alts_Alt5SigmaInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_40ac5b99-abf2-41e8-8bd5-15f584eb3330" xlink:to="loc_alts_Alt5SigmaInc.Member_6c6afd48-0eb2-45a4-b7c5-a305f7206755" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b6cbe439-329f-418a-aee4-570ea19829d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_cd412062-7dc5-402a-bca6-7959cf1e71b6" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b6cbe439-329f-418a-aee4-570ea19829d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b6cbe439-329f-418a-aee4-570ea19829d9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b6cbe439-329f-418a-aee4-570ea19829d9" xlink:to="loc_us-gaap_ClassOfStockDomain_b6cbe439-329f-418a-aee4-570ea19829d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_7061a74d-3855-4b50-8cfd-5a762c2280b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b6cbe439-329f-418a-aee4-570ea19829d9" xlink:to="loc_us-gaap_ClassOfStockDomain_7061a74d-3855-4b50-8cfd-5a762c2280b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesIConvertiblePreferredStockMember_4e51c545-a5a7-424e-9f04-7adf020b93cd" xlink:href="alts-20241228.xsd#alts_SeriesIConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7061a74d-3855-4b50-8cfd-5a762c2280b3" xlink:to="loc_alts_SeriesIConvertiblePreferredStockMember_4e51c545-a5a7-424e-9f04-7adf020b93cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_3d4796ff-5f4c-455e-a1ab-88eb9c588567" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_7fc8971f-4b9b-4c23-8099-287516f5c0e7" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_3d4796ff-5f4c-455e-a1ab-88eb9c588567" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NumberOfConsultants_bd14d9de-efaf-4668-ac0f-679026abd182" xlink:href="alts-20241228.xsd#alts_NumberOfConsultants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_7fc8971f-4b9b-4c23-8099-287516f5c0e7" xlink:to="loc_alts_NumberOfConsultants_bd14d9de-efaf-4668-ac0f-679026abd182" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleConversionRatio_f1d6947b-750a-4738-a3d5-2b5d72505cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_7fc8971f-4b9b-4c23-8099-287516f5c0e7" xlink:to="loc_us-gaap_PreferredStockConvertibleConversionRatio_f1d6947b-750a-4738-a3d5-2b5d72505cc5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_CommonStockConversionValidConversionPeriod_8e11a816-a068-46de-bc19-518125838049" xlink:href="alts-20241228.xsd#alts_CommonStockConversionValidConversionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_7fc8971f-4b9b-4c23-8099-287516f5c0e7" xlink:to="loc_alts_CommonStockConversionValidConversionPeriod_8e11a816-a068-46de-bc19-518125838049" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_e53d95b0-12ad-4b5e-a2db-eab211f9b2fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_7fc8971f-4b9b-4c23-8099-287516f5c0e7" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_e53d95b0-12ad-4b5e-a2db-eab211f9b2fb" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/PreferredStockSeriesMPreferredStockDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#PreferredStockSeriesMPreferredStockDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/PreferredStockSeriesMPreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_40d41acc-2264-49bc-a213-a678bae53095" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_c4c61965-31b7-48b7-a53b-796f47284deb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_40d41acc-2264-49bc-a213-a678bae53095" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_c4c61965-31b7-48b7-a53b-796f47284deb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e67a3277-e84b-46b2-9177-7cb7beacd8b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_c4c61965-31b7-48b7-a53b-796f47284deb" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e67a3277-e84b-46b2-9177-7cb7beacd8b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e67a3277-e84b-46b2-9177-7cb7beacd8b5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e67a3277-e84b-46b2-9177-7cb7beacd8b5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e67a3277-e84b-46b2-9177-7cb7beacd8b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2621afd8-4f3f-47e5-9a1f-1a374fcf413f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e67a3277-e84b-46b2-9177-7cb7beacd8b5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2621afd8-4f3f-47e5-9a1f-1a374fcf413f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Alt5SigmaInc.Member_fae79eb4-34d0-4416-9e1a-e07ea77e228c" xlink:href="alts-20241228.xsd#alts_Alt5SigmaInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2621afd8-4f3f-47e5-9a1f-1a374fcf413f" xlink:to="loc_alts_Alt5SigmaInc.Member_fae79eb4-34d0-4416-9e1a-e07ea77e228c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_13a5efce-bbc8-4ca6-a404-fb8b0844cdac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_c4c61965-31b7-48b7-a53b-796f47284deb" xlink:to="loc_us-gaap_StatementClassOfStockAxis_13a5efce-bbc8-4ca6-a404-fb8b0844cdac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_13a5efce-bbc8-4ca6-a404-fb8b0844cdac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_13a5efce-bbc8-4ca6-a404-fb8b0844cdac" xlink:to="loc_us-gaap_ClassOfStockDomain_13a5efce-bbc8-4ca6-a404-fb8b0844cdac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8c158395-fedc-4b0d-8409-cf7482d2e207" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_13a5efce-bbc8-4ca6-a404-fb8b0844cdac" xlink:to="loc_us-gaap_ClassOfStockDomain_8c158395-fedc-4b0d-8409-cf7482d2e207" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesMPreferredStockMember_af436c2b-4f4b-46bc-bb2d-1dbc4919ed74" xlink:href="alts-20241228.xsd#alts_SeriesMPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_8c158395-fedc-4b0d-8409-cf7482d2e207" xlink:to="loc_alts_SeriesMPreferredStockMember_af436c2b-4f4b-46bc-bb2d-1dbc4919ed74" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_3423c47e-f1c3-4ffe-a64c-9c9e9209c903" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_40d41acc-2264-49bc-a213-a678bae53095" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_3423c47e-f1c3-4ffe-a64c-9c9e9209c903" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_3d0fce8c-15ea-4525-ad94-2b8899e77edf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_40d41acc-2264-49bc-a213-a678bae53095" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_3d0fce8c-15ea-4525-ad94-2b8899e77edf" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/PreferredStockSeriesQConvertiblePreferredStockDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#PreferredStockSeriesQConvertiblePreferredStockDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/PreferredStockSeriesQConvertiblePreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_0b7dfab3-3e18-4ccb-9ef2-2c71737998e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_2eb53b59-986b-49e0-be3f-8695941da866" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_0b7dfab3-3e18-4ccb-9ef2-2c71737998e7" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_2eb53b59-986b-49e0-be3f-8695941da866" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_aff001f0-2d96-411a-8998-bc8ee557a256" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_2eb53b59-986b-49e0-be3f-8695941da866" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_aff001f0-2d96-411a-8998-bc8ee557a256" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_aff001f0-2d96-411a-8998-bc8ee557a256_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_aff001f0-2d96-411a-8998-bc8ee557a256" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_aff001f0-2d96-411a-8998-bc8ee557a256_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a3d219b-560a-4047-8950-883b695239cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_aff001f0-2d96-411a-8998-bc8ee557a256" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a3d219b-560a-4047-8950-883b695239cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_QodenTechnologiesLLCMember_01850654-c3c7-43fa-979a-36169ba81d83" xlink:href="alts-20241228.xsd#alts_QodenTechnologiesLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a3d219b-560a-4047-8950-883b695239cb" xlink:to="loc_alts_QodenTechnologiesLLCMember_01850654-c3c7-43fa-979a-36169ba81d83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_06557518-1619-4e37-a345-ed1e68ed0243" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_2eb53b59-986b-49e0-be3f-8695941da866" xlink:to="loc_us-gaap_StatementClassOfStockAxis_06557518-1619-4e37-a345-ed1e68ed0243" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_06557518-1619-4e37-a345-ed1e68ed0243_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_06557518-1619-4e37-a345-ed1e68ed0243" xlink:to="loc_us-gaap_ClassOfStockDomain_06557518-1619-4e37-a345-ed1e68ed0243_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_18c5b162-8566-4d15-9e76-9bddb4afc56e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_06557518-1619-4e37-a345-ed1e68ed0243" xlink:to="loc_us-gaap_ClassOfStockDomain_18c5b162-8566-4d15-9e76-9bddb4afc56e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesQConvertiblePreferredStockMember_bd497516-4889-4e08-b4f5-08fa67742618" xlink:href="alts-20241228.xsd#alts_SeriesQConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_18c5b162-8566-4d15-9e76-9bddb4afc56e" xlink:to="loc_alts_SeriesQConvertiblePreferredStockMember_bd497516-4889-4e08-b4f5-08fa67742618" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8a474f89-d820-4bde-99d8-f540b123d2dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0b7dfab3-3e18-4ccb-9ef2-2c71737998e7" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8a474f89-d820-4bde-99d8-f540b123d2dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_2a070d05-6f91-4f95-b7b6-0e2fb722f3a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0b7dfab3-3e18-4ccb-9ef2-2c71737998e7" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_2a070d05-6f91-4f95-b7b6-0e2fb722f3a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare_89dce91f-2708-4b05-82c3-fcd564d35fce" xlink:href="alts-20241228.xsd#alts_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0b7dfab3-3e18-4ccb-9ef2-2c71737998e7" xlink:to="loc_alts_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare_89dce91f-2708-4b05-82c3-fcd564d35fce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_be19d40c-15cb-45d2-ab0f-ad0164c2299f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0b7dfab3-3e18-4ccb-9ef2-2c71737998e7" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_be19d40c-15cb-45d2-ab0f-ad0164c2299f" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/PreferredStockSeriesVConvertiblePreferredStockDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#PreferredStockSeriesVConvertiblePreferredStockDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/PreferredStockSeriesVConvertiblePreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_f0ab866b-1569-4479-bcfe-cf6ec5990c91" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_81fa6220-587d-47c1-b0ee-302afec4e29a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_f0ab866b-1569-4479-bcfe-cf6ec5990c91" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_81fa6220-587d-47c1-b0ee-302afec4e29a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_794001a6-84a9-476b-a7c8-3752a6d46df1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_81fa6220-587d-47c1-b0ee-302afec4e29a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_794001a6-84a9-476b-a7c8-3752a6d46df1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_794001a6-84a9-476b-a7c8-3752a6d46df1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_794001a6-84a9-476b-a7c8-3752a6d46df1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_794001a6-84a9-476b-a7c8-3752a6d46df1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2540c90c-4c4e-40dd-a73d-57c08ae25b06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_794001a6-84a9-476b-a7c8-3752a6d46df1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2540c90c-4c4e-40dd-a73d-57c08ae25b06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NorthYorkLTDMember_102355d4-a7f5-4f7c-ae0d-9f8dabb1bae0" xlink:href="alts-20241228.xsd#alts_NorthYorkLTDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2540c90c-4c4e-40dd-a73d-57c08ae25b06" xlink:to="loc_alts_NorthYorkLTDMember_102355d4-a7f5-4f7c-ae0d-9f8dabb1bae0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_UnaffiliatedThirdPartyMember_a913f5f8-a503-4864-a71d-e236bbe2146f" xlink:href="alts-20241228.xsd#alts_UnaffiliatedThirdPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2540c90c-4c4e-40dd-a73d-57c08ae25b06" xlink:to="loc_alts_UnaffiliatedThirdPartyMember_a913f5f8-a503-4864-a71d-e236bbe2146f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_86c0af51-9f3d-42a9-a55f-6d0cc628cc4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_81fa6220-587d-47c1-b0ee-302afec4e29a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_86c0af51-9f3d-42a9-a55f-6d0cc628cc4f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_86c0af51-9f3d-42a9-a55f-6d0cc628cc4f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_86c0af51-9f3d-42a9-a55f-6d0cc628cc4f" xlink:to="loc_us-gaap_ClassOfStockDomain_86c0af51-9f3d-42a9-a55f-6d0cc628cc4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0a2a5bad-8cdb-4da0-8207-ab696cf961a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_86c0af51-9f3d-42a9-a55f-6d0cc628cc4f" xlink:to="loc_us-gaap_ClassOfStockDomain_0a2a5bad-8cdb-4da0-8207-ab696cf961a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesVConvertiblePreferredStockMember_dc8d3edb-17f3-49e7-a2df-1b3f94417140" xlink:href="alts-20241228.xsd#alts_SeriesVConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0a2a5bad-8cdb-4da0-8207-ab696cf961a9" xlink:to="loc_alts_SeriesVConvertiblePreferredStockMember_dc8d3edb-17f3-49e7-a2df-1b3f94417140" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_f53082c2-1363-428c-bfa7-7f55787939f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f0ab866b-1569-4479-bcfe-cf6ec5990c91" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_f53082c2-1363-428c-bfa7-7f55787939f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_f6e8a844-4652-4ca6-b517-3681a549cb6c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f0ab866b-1569-4479-bcfe-cf6ec5990c91" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_f6e8a844-4652-4ca6-b517-3681a549cb6c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#PreferredStockSeriesSConvertiblePreferredStockDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_6059ea33-a007-4693-aa16-f35334f4a08b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_852ba34a-a8e3-421b-bb1e-ce66d7e56a10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_6059ea33-a007-4693-aa16-f35334f4a08b" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_852ba34a-a8e3-421b-bb1e-ce66d7e56a10" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_32a13746-0a26-4986-928f-d547ccdc99c6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_852ba34a-a8e3-421b-bb1e-ce66d7e56a10" xlink:to="loc_srt_CounterpartyNameAxis_32a13746-0a26-4986-928f-d547ccdc99c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_32a13746-0a26-4986-928f-d547ccdc99c6_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_32a13746-0a26-4986-928f-d547ccdc99c6" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_32a13746-0a26-4986-928f-d547ccdc99c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c136cece-cb5f-4163-97f5-331e90ec0b0c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_32a13746-0a26-4986-928f-d547ccdc99c6" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c136cece-cb5f-4163-97f5-331e90ec0b0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DrSoinMember_18cd987b-c748-4b82-8e3a-c0a76e2dfd83" xlink:href="alts-20241228.xsd#alts_DrSoinMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c136cece-cb5f-4163-97f5-331e90ec0b0c" xlink:to="loc_alts_DrSoinMember_18cd987b-c748-4b82-8e3a-c0a76e2dfd83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_1cfb9ce4-33d9-47c7-9b4e-079dea2b3c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_852ba34a-a8e3-421b-bb1e-ce66d7e56a10" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_1cfb9ce4-33d9-47c7-9b4e-079dea2b3c4b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_1cfb9ce4-33d9-47c7-9b4e-079dea2b3c4b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_1cfb9ce4-33d9-47c7-9b4e-079dea2b3c4b" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_1cfb9ce4-33d9-47c7-9b4e-079dea2b3c4b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_8566b3f4-a174-42a4-b514-686a81317d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_1cfb9ce4-33d9-47c7-9b4e-079dea2b3c4b" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_8566b3f4-a174-42a4-b514-686a81317d8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockConversion1Member_8c046de4-13eb-46cd-9f24-e5d95dbff9ba" xlink:href="alts-20241228.xsd#alts_StockConversion1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_8566b3f4-a174-42a4-b514-686a81317d8c" xlink:to="loc_alts_StockConversion1Member_8c046de4-13eb-46cd-9f24-e5d95dbff9ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockConversion2Member_f39665ab-8c74-4cc4-8ff1-511f6ff9a16d" xlink:href="alts-20241228.xsd#alts_StockConversion2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_8566b3f4-a174-42a4-b514-686a81317d8c" xlink:to="loc_alts_StockConversion2Member_f39665ab-8c74-4cc4-8ff1-511f6ff9a16d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockConversion3Member_184cc4e4-ddae-4bf0-a277-5c3a3b89329b" xlink:href="alts-20241228.xsd#alts_StockConversion3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_8566b3f4-a174-42a4-b514-686a81317d8c" xlink:to="loc_alts_StockConversion3Member_184cc4e4-ddae-4bf0-a277-5c3a3b89329b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b94ff653-7055-4772-a793-a5773304c679" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_852ba34a-a8e3-421b-bb1e-ce66d7e56a10" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b94ff653-7055-4772-a793-a5773304c679" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_b94ff653-7055-4772-a793-a5773304c679_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b94ff653-7055-4772-a793-a5773304c679" xlink:to="loc_us-gaap_RelatedPartyDomain_b94ff653-7055-4772-a793-a5773304c679_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_87244270-8358-438e-a8c2-171b811f1188" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b94ff653-7055-4772-a793-a5773304c679" xlink:to="loc_us-gaap_RelatedPartyDomain_87244270-8358-438e-a8c2-171b811f1188" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_84633782-e104-4666-bc1a-70829a085c86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_87244270-8358-438e-a8c2-171b811f1188" xlink:to="loc_us-gaap_RelatedPartyMember_84633782-e104-4666-bc1a-70829a085c86" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a4854731-ac3e-44bd-8993-db9a1a504b41" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_852ba34a-a8e3-421b-bb1e-ce66d7e56a10" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a4854731-ac3e-44bd-8993-db9a1a504b41" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a4854731-ac3e-44bd-8993-db9a1a504b41_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a4854731-ac3e-44bd-8993-db9a1a504b41" xlink:to="loc_us-gaap_ClassOfStockDomain_a4854731-ac3e-44bd-8993-db9a1a504b41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c9d94a0c-3f9c-4d5e-a7b7-17a3ebd1fc34" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a4854731-ac3e-44bd-8993-db9a1a504b41" xlink:to="loc_us-gaap_ClassOfStockDomain_c9d94a0c-3f9c-4d5e-a7b7-17a3ebd1fc34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesSConvertiblePreferredStockMember_04b0ea25-d6d0-4fc1-bb5e-23afe2079bdd" xlink:href="alts-20241228.xsd#alts_SeriesSConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_c9d94a0c-3f9c-4d5e-a7b7-17a3ebd1fc34" xlink:to="loc_alts_SeriesSConvertiblePreferredStockMember_04b0ea25-d6d0-4fc1-bb5e-23afe2079bdd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9a1d6549-693e-4b43-a974-d87b5f89ff77" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_852ba34a-a8e3-421b-bb1e-ce66d7e56a10" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9a1d6549-693e-4b43-a974-d87b5f89ff77" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9a1d6549-693e-4b43-a974-d87b5f89ff77_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9a1d6549-693e-4b43-a974-d87b5f89ff77" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9a1d6549-693e-4b43-a974-d87b5f89ff77_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22e8fdee-36ea-4d0d-8ce3-f5d5ab9ca5cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9a1d6549-693e-4b43-a974-d87b5f89ff77" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22e8fdee-36ea-4d0d-8ce3-f5d5ab9ca5cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SoinTherapeuticsMember_c095c52e-87d8-42d5-abaf-5a9bcde15f7f" xlink:href="alts-20241228.xsd#alts_SoinTherapeuticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22e8fdee-36ea-4d0d-8ce3-f5d5ab9ca5cc" xlink:to="loc_alts_SoinTherapeuticsMember_c095c52e-87d8-42d5-abaf-5a9bcde15f7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_f092dafb-7313-45cb-9009-10fd4966645b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_6059ea33-a007-4693-aa16-f35334f4a08b" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_f092dafb-7313-45cb-9009-10fd4966645b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_148d3e0a-08c4-4b25-9970-191a8e5ab846" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_6059ea33-a007-4693-aa16-f35334f4a08b" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_148d3e0a-08c4-4b25-9970-191a8e5ab846" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ConversionOfStockAmountConvertible_db5872c2-5e55-48c4-9d24-b1d41a2efd2c" xlink:href="alts-20241228.xsd#alts_ConversionOfStockAmountConvertible"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_6059ea33-a007-4693-aa16-f35334f4a08b" xlink:to="loc_alts_ConversionOfStockAmountConvertible_db5872c2-5e55-48c4-9d24-b1d41a2efd2c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ConversionOfStockCommencementPeriod_b3fdd76a-22b8-42fd-b29d-8d8ad4896e25" xlink:href="alts-20241228.xsd#alts_ConversionOfStockCommencementPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_6059ea33-a007-4693-aa16-f35334f4a08b" xlink:to="loc_alts_ConversionOfStockCommencementPeriod_b3fdd76a-22b8-42fd-b29d-8d8ad4896e25" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ConversionOfStockPeriodFollowingClosing_9ad58b00-6a23-4aab-aab2-37b64854614a" xlink:href="alts-20241228.xsd#alts_ConversionOfStockPeriodFollowingClosing"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_6059ea33-a007-4693-aa16-f35334f4a08b" xlink:to="loc_alts_ConversionOfStockPeriodFollowingClosing_9ad58b00-6a23-4aab-aab2-37b64854614a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PercentageOfGrossRevenue_e18ca459-4e49-4a74-9730-9637b6c287f3" xlink:href="alts-20241228.xsd#alts_PercentageOfGrossRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_6059ea33-a007-4693-aa16-f35334f4a08b" xlink:to="loc_alts_PercentageOfGrossRevenue_e18ca459-4e49-4a74-9730-9637b6c287f3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_CommonStockSharesOutstandingPercentage_43e3af71-736f-4922-ba1d-f049cc1ee855" xlink:href="alts-20241228.xsd#alts_CommonStockSharesOutstandingPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_6059ea33-a007-4693-aa16-f35334f4a08b" xlink:to="loc_alts_CommonStockSharesOutstandingPercentage_43e3af71-736f-4922-ba1d-f049cc1ee855" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ReclassificationOfTemporaryToCurrentLiabilities_7391a9a0-1ede-4345-8edd-e8ffc6349e7c" xlink:href="alts-20241228.xsd#alts_ReclassificationOfTemporaryToCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_6059ea33-a007-4693-aa16-f35334f4a08b" xlink:to="loc_alts_ReclassificationOfTemporaryToCurrentLiabilities_7391a9a0-1ede-4345-8edd-e8ffc6349e7c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_636a2ca3-94de-483c-8043-d9d2aafed206" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_6059ea33-a007-4693-aa16-f35334f4a08b" xlink:to="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_636a2ca3-94de-483c-8043-d9d2aafed206" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleConversionRatio_e8980e50-b72e-4e69-bfab-f0a7bfbd1dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_6059ea33-a007-4693-aa16-f35334f4a08b" xlink:to="loc_us-gaap_PreferredStockConvertibleConversionRatio_e8980e50-b72e-4e69-bfab-f0a7bfbd1dc4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_bd4c876d-8082-4393-bd5c-d2e472710856" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_6059ea33-a007-4693-aa16-f35334f4a08b" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_bd4c876d-8082-4393-bd5c-d2e472710856" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/PreferredStockScheduleofSeriesSConvertiblePreferredStockOutstandingDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#PreferredStockScheduleofSeriesSConvertiblePreferredStockOutstandingDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/PreferredStockScheduleofSeriesSConvertiblePreferredStockOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_ac6561d4-91a1-47a0-92c1-e06f4f945910" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_fa0db615-5f16-4c35-a0b2-37b3af6d6540" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_ac6561d4-91a1-47a0-92c1-e06f4f945910" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_fa0db615-5f16-4c35-a0b2-37b3af6d6540" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2597a45f-6487-49f2-b9b7-2833ee8611f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_fa0db615-5f16-4c35-a0b2-37b3af6d6540" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2597a45f-6487-49f2-b9b7-2833ee8611f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_2597a45f-6487-49f2-b9b7-2833ee8611f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2597a45f-6487-49f2-b9b7-2833ee8611f9" xlink:to="loc_us-gaap_ClassOfStockDomain_2597a45f-6487-49f2-b9b7-2833ee8611f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a684042a-f022-4600-b665-7fbfb0b4d92c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2597a45f-6487-49f2-b9b7-2833ee8611f9" xlink:to="loc_us-gaap_ClassOfStockDomain_a684042a-f022-4600-b665-7fbfb0b4d92c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesSConvertiblePreferredStockMember_cb37ca0d-bf4b-427e-8584-a01b84d7158f" xlink:href="alts-20241228.xsd#alts_SeriesSConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_a684042a-f022-4600-b665-7fbfb0b4d92c" xlink:to="loc_alts_SeriesSConvertiblePreferredStockMember_cb37ca0d-bf4b-427e-8584-a01b84d7158f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a0c6a91d-6013-464d-afb1-b82ee863ca3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_ac6561d4-91a1-47a0-92c1-e06f4f945910" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a0c6a91d-6013-464d-afb1-b82ee863ca3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_044830c5-ab1f-4f6c-9c62-6cd6b6da5673" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a0c6a91d-6013-464d-afb1-b82ee863ca3b" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_044830c5-ab1f-4f6c-9c62-6cd6b6da5673" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_3756c996-215b-4a52-ad49-b24b5181c8e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a0c6a91d-6013-464d-afb1-b82ee863ca3b" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_3756c996-215b-4a52-ad49-b24b5181c8e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ReclassificationsOfTemporaryToPermanentEquityShares_f28e3add-d783-4d44-a85b-6b135903df2c" xlink:href="alts-20241228.xsd#alts_ReclassificationsOfTemporaryToPermanentEquityShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a0c6a91d-6013-464d-afb1-b82ee863ca3b" xlink:to="loc_alts_ReclassificationsOfTemporaryToPermanentEquityShares_f28e3add-d783-4d44-a85b-6b135903df2c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_792d6434-eba7-422e-8db4-a322b9d1f90d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a0c6a91d-6013-464d-afb1-b82ee863ca3b" xlink:to="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_792d6434-eba7-422e-8db4-a322b9d1f90d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ReclassificationOfTemporaryToCurrentLiabilitiesShares_a091ba5b-6fc9-42de-aff5-ae206ed8cf45" xlink:href="alts-20241228.xsd#alts_ReclassificationOfTemporaryToCurrentLiabilitiesShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a0c6a91d-6013-464d-afb1-b82ee863ca3b" xlink:to="loc_alts_ReclassificationOfTemporaryToCurrentLiabilitiesShares_a091ba5b-6fc9-42de-aff5-ae206ed8cf45" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ReclassificationOfTemporaryToCurrentLiabilities_f3fecd03-ec51-4134-8427-521c2f6223e0" xlink:href="alts-20241228.xsd#alts_ReclassificationOfTemporaryToCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a0c6a91d-6013-464d-afb1-b82ee863ca3b" xlink:to="loc_alts_ReclassificationOfTemporaryToCurrentLiabilities_f3fecd03-ec51-4134-8427-521c2f6223e0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_f2c52dc5-28fe-4c65-8b16-2d8d68f9d325" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_df2b3c37-de20-4616-942c-c619b80191d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/StockholdersEquityCommonStockDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#StockholdersEquityCommonStockDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/StockholdersEquityCommonStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_alts_ShareholdersEquityLineItems_ba221a47-224f-496e-9f81-8c32467aa2b0" xlink:href="alts-20241228.xsd#alts_ShareholdersEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ShareholdersEquityTable_3b1fa5cf-6d09-447e-80fb-ece4e6dfc1c6" xlink:href="alts-20241228.xsd#alts_ShareholdersEquityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_alts_ShareholdersEquityLineItems_ba221a47-224f-496e-9f81-8c32467aa2b0" xlink:to="loc_alts_ShareholdersEquityTable_3b1fa5cf-6d09-447e-80fb-ece4e6dfc1c6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_9dc3cd23-2998-406d-b878-67a09749e7ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_alts_ShareholdersEquityTable_3b1fa5cf-6d09-447e-80fb-ece4e6dfc1c6" xlink:to="loc_us-gaap_TypeOfArrangementAxis_9dc3cd23-2998-406d-b878-67a09749e7ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_9dc3cd23-2998-406d-b878-67a09749e7ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_9dc3cd23-2998-406d-b878-67a09749e7ba" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_9dc3cd23-2998-406d-b878-67a09749e7ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6f62fef8-76a6-4d99-b506-24da0d7ce94d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_9dc3cd23-2998-406d-b878-67a09749e7ba" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6f62fef8-76a6-4d99-b506-24da0d7ce94d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ArticlesOfIncorporationMember_7377db79-1762-4470-9211-ac22b4f768e7" xlink:href="alts-20241228.xsd#alts_ArticlesOfIncorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6f62fef8-76a6-4d99-b506-24da0d7ce94d" xlink:to="loc_alts_ArticlesOfIncorporationMember_7377db79-1762-4470-9211-ac22b4f768e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_a81c10a6-b86f-4644-9a34-a37f3b001019" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_ba221a47-224f-496e-9f81-8c32467aa2b0" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_a81c10a6-b86f-4644-9a34-a37f3b001019" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_f82162c0-8ea8-4f84-9b8b-a060b077e7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_ba221a47-224f-496e-9f81-8c32467aa2b0" xlink:to="loc_us-gaap_CommonStockSharesIssued_f82162c0-8ea8-4f84-9b8b-a060b077e7a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_47f6d3f5-6986-43ad-af72-24988340e2e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_ba221a47-224f-496e-9f81-8c32467aa2b0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_47f6d3f5-6986-43ad-af72-24988340e2e2" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#StockholdersEquityEquityOfferingsDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:href="alts-20241228.xsd#alts_ShareholdersEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ShareholdersEquityTable_8c6b37b2-aa72-4d29-b310-9651eaaefe3d" xlink:href="alts-20241228.xsd#alts_ShareholdersEquityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_alts_ShareholdersEquityTable_8c6b37b2-aa72-4d29-b310-9651eaaefe3d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_17316731-c03b-406b-89f9-94b1311d0dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_alts_ShareholdersEquityTable_8c6b37b2-aa72-4d29-b310-9651eaaefe3d" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_17316731-c03b-406b-89f9-94b1311d0dd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_17316731-c03b-406b-89f9-94b1311d0dd6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_17316731-c03b-406b-89f9-94b1311d0dd6" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_17316731-c03b-406b-89f9-94b1311d0dd6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_77000ee9-9b0f-4e5b-9f9c-1dbd26028600" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_17316731-c03b-406b-89f9-94b1311d0dd6" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_77000ee9-9b0f-4e5b-9f9c-1dbd26028600" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_1287af6d-ac22-4fb2-a905-b7c88787c85f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_77000ee9-9b0f-4e5b-9f9c-1dbd26028600" xlink:to="loc_us-gaap_PrivatePlacementMember_1287af6d-ac22-4fb2-a905-b7c88787c85f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityUnitPurchaseAgreementsMember_4ffbf3b6-7d46-40b7-a860-cca6dee3b022" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityUnitPurchaseAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_77000ee9-9b0f-4e5b-9f9c-1dbd26028600" xlink:to="loc_us-gaap_EquityUnitPurchaseAgreementsMember_4ffbf3b6-7d46-40b7-a860-cca6dee3b022" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ThirdPartyExchangeForBrokerageServicesMember_8980f8da-0a4c-48b0-b845-c1894b40a61d" xlink:href="alts-20241228.xsd#alts_ThirdPartyExchangeForBrokerageServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_77000ee9-9b0f-4e5b-9f9c-1dbd26028600" xlink:to="loc_alts_ThirdPartyExchangeForBrokerageServicesMember_8980f8da-0a4c-48b0-b845-c1894b40a61d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_22a21111-1d50-4cee-97c4-5b50a85824cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_alts_ShareholdersEquityTable_8c6b37b2-aa72-4d29-b310-9651eaaefe3d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_22a21111-1d50-4cee-97c4-5b50a85824cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_22a21111-1d50-4cee-97c4-5b50a85824cf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_22a21111-1d50-4cee-97c4-5b50a85824cf" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_22a21111-1d50-4cee-97c4-5b50a85824cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_5283ae28-28aa-47d3-b634-2f11dcaa1dec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_22a21111-1d50-4cee-97c4-5b50a85824cf" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_5283ae28-28aa-47d3-b634-2f11dcaa1dec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PreFundedWarrantsMember_c9716912-8bb3-41f7-a7ce-346da96137e0" xlink:href="alts-20241228.xsd#alts_PreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_5283ae28-28aa-47d3-b634-2f11dcaa1dec" xlink:to="loc_alts_PreFundedWarrantsMember_c9716912-8bb3-41f7-a7ce-346da96137e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_4cb38026-161d-4414-ada6-d9dc14bbed19" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_alts_ShareholdersEquityTable_8c6b37b2-aa72-4d29-b310-9651eaaefe3d" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_4cb38026-161d-4414-ada6-d9dc14bbed19" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_4cb38026-161d-4414-ada6-d9dc14bbed19_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_4cb38026-161d-4414-ada6-d9dc14bbed19" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_4cb38026-161d-4414-ada6-d9dc14bbed19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_014661ae-1b92-4aa8-8896-ec3cd6ea58e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_4cb38026-161d-4414-ada6-d9dc14bbed19" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_014661ae-1b92-4aa8-8896-ec3cd6ea58e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IcgNoteMember_b633b716-8d76-4b47-a47d-15eee0b755f8" xlink:href="alts-20241228.xsd#alts_IcgNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_014661ae-1b92-4aa8-8896-ec3cd6ea58e7" xlink:to="loc_alts_IcgNoteMember_b633b716-8d76-4b47-a47d-15eee0b755f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IsaacConsultingAgreementMember_7489caea-3075-4fa8-aa3a-205e513d8ded" xlink:href="alts-20241228.xsd#alts_IsaacConsultingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_014661ae-1b92-4aa8-8896-ec3cd6ea58e7" xlink:to="loc_alts_IsaacConsultingAgreementMember_7489caea-3075-4fa8-aa3a-205e513d8ded" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NorthYorkLTDMember_fd03af4c-b614-4528-ae43-afe18120c83c" xlink:href="alts-20241228.xsd#alts_NorthYorkLTDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_014661ae-1b92-4aa8-8896-ec3cd6ea58e7" xlink:to="loc_alts_NorthYorkLTDMember_fd03af4c-b614-4528-ae43-afe18120c83c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f91f8f42-801d-47a7-a340-01ce185584b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_alts_ShareholdersEquityTable_8c6b37b2-aa72-4d29-b310-9651eaaefe3d" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f91f8f42-801d-47a7-a340-01ce185584b9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_f91f8f42-801d-47a7-a340-01ce185584b9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f91f8f42-801d-47a7-a340-01ce185584b9" xlink:to="loc_us-gaap_RelatedPartyDomain_f91f8f42-801d-47a7-a340-01ce185584b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_ea80eff1-ce60-4297-b0b3-3fe3578065da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f91f8f42-801d-47a7-a340-01ce185584b9" xlink:to="loc_us-gaap_RelatedPartyDomain_ea80eff1-ce60-4297-b0b3-3fe3578065da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_e9599664-0efc-4057-9076-f6d329f2a5a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_ea80eff1-ce60-4297-b0b3-3fe3578065da" xlink:to="loc_us-gaap_RelatedPartyMember_e9599664-0efc-4057-9076-f6d329f2a5a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_9ab78ec7-c317-4ca0-88c7-d94ebc0fb72a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_alts_ShareholdersEquityTable_8c6b37b2-aa72-4d29-b310-9651eaaefe3d" xlink:to="loc_srt_CounterpartyNameAxis_9ab78ec7-c317-4ca0-88c7-d94ebc0fb72a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9ab78ec7-c317-4ca0-88c7-d94ebc0fb72a_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_9ab78ec7-c317-4ca0-88c7-d94ebc0fb72a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9ab78ec7-c317-4ca0-88c7-d94ebc0fb72a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4036f8a6-bbc8-4608-9dab-bd28777f2533" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_9ab78ec7-c317-4ca0-88c7-d94ebc0fb72a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4036f8a6-bbc8-4608-9dab-bd28777f2533" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Mr.JonIsaacMember_816b3a36-04d7-41bf-a1c8-ece9480b079d" xlink:href="alts-20241228.xsd#alts_Mr.JonIsaacMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4036f8a6-bbc8-4608-9dab-bd28777f2533" xlink:to="loc_alts_Mr.JonIsaacMember_816b3a36-04d7-41bf-a1c8-ece9480b079d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_UnaffiliatedThirdPartyMember_98fc0882-f48c-4176-a520-0229f3897191" xlink:href="alts-20241228.xsd#alts_UnaffiliatedThirdPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4036f8a6-bbc8-4608-9dab-bd28777f2533" xlink:to="loc_alts_UnaffiliatedThirdPartyMember_98fc0882-f48c-4176-a520-0229f3897191" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_96c25663-5a57-4440-9cce-adb8a93ac274" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_alts_ShareholdersEquityTable_8c6b37b2-aa72-4d29-b310-9651eaaefe3d" xlink:to="loc_us-gaap_DebtInstrumentAxis_96c25663-5a57-4440-9cce-adb8a93ac274" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_96c25663-5a57-4440-9cce-adb8a93ac274_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_96c25663-5a57-4440-9cce-adb8a93ac274" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_96c25663-5a57-4440-9cce-adb8a93ac274_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0c15e4e0-5b6e-4a58-aa85-679ec4375d29" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_96c25663-5a57-4440-9cce-adb8a93ac274" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0c15e4e0-5b6e-4a58-aa85-679ec4375d29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IcgNoteMember_da3e1e3a-d824-4528-a3ed-ab7c2fa8643b" xlink:href="alts-20241228.xsd#alts_IcgNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0c15e4e0-5b6e-4a58-aa85-679ec4375d29" xlink:to="loc_alts_IcgNoteMember_da3e1e3a-d824-4528-a3ed-ab7c2fa8643b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NonConvertibleDebentureBigAndSmallDebentureMember_5790140e-9d27-4865-a210-c42f7558fed1" xlink:href="alts-20241228.xsd#alts_NonConvertibleDebentureBigAndSmallDebentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0c15e4e0-5b6e-4a58-aa85-679ec4375d29" xlink:to="loc_alts_NonConvertibleDebentureBigAndSmallDebentureMember_5790140e-9d27-4865-a210-c42f7558fed1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PromissoryNoteMember_898c66a1-f021-4d3e-80e9-86c1af2ccc6e" xlink:href="alts-20241228.xsd#alts_PromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0c15e4e0-5b6e-4a58-aa85-679ec4375d29" xlink:to="loc_alts_PromissoryNoteMember_898c66a1-f021-4d3e-80e9-86c1af2ccc6e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_A10ConvertiblePromissoryNoteMember_eacde7e6-f3ff-4d4b-93ed-4478c2474e22" xlink:href="alts-20241228.xsd#alts_A10ConvertiblePromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0c15e4e0-5b6e-4a58-aa85-679ec4375d29" xlink:to="loc_alts_A10ConvertiblePromissoryNoteMember_eacde7e6-f3ff-4d4b-93ed-4478c2474e22" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7d573546-7973-4277-b49c-061cf25f4aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_alts_ShareholdersEquityTable_8c6b37b2-aa72-4d29-b310-9651eaaefe3d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7d573546-7973-4277-b49c-061cf25f4aeb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7d573546-7973-4277-b49c-061cf25f4aeb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7d573546-7973-4277-b49c-061cf25f4aeb" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7d573546-7973-4277-b49c-061cf25f4aeb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c80ee933-84a3-4a54-8f53-f4778b039edf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7d573546-7973-4277-b49c-061cf25f4aeb" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c80ee933-84a3-4a54-8f53-f4778b039edf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PromissoryNoteMember_d5296e80-9c92-4480-82bc-3198bfb590cf" xlink:href="alts-20241228.xsd#alts_PromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c80ee933-84a3-4a54-8f53-f4778b039edf" xlink:to="loc_alts_PromissoryNoteMember_d5296e80-9c92-4480-82bc-3198bfb590cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_f4da6a93-b654-4e48-a98d-4b0074b7ff93" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c80ee933-84a3-4a54-8f53-f4778b039edf" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_f4da6a93-b654-4e48-a98d-4b0074b7ff93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a64d71e7-d4f2-431f-9c5f-e6f9a75d7dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_alts_ShareholdersEquityTable_8c6b37b2-aa72-4d29-b310-9651eaaefe3d" xlink:to="loc_us-gaap_AwardTypeAxis_a64d71e7-d4f2-431f-9c5f-e6f9a75d7dbc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a64d71e7-d4f2-431f-9c5f-e6f9a75d7dbc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a64d71e7-d4f2-431f-9c5f-e6f9a75d7dbc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a64d71e7-d4f2-431f-9c5f-e6f9a75d7dbc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d62aa19-5903-44e1-937d-a521f45f7ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a64d71e7-d4f2-431f-9c5f-e6f9a75d7dbc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d62aa19-5903-44e1-937d-a521f45f7ae9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_713099b0-e459-44ee-9e13-e40dd69e86b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d62aa19-5903-44e1-937d-a521f45f7ae9" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_713099b0-e459-44ee-9e13-e40dd69e86b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_ad94603e-a6f2-4170-badf-b460efae7ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_alts_ShareholdersEquityTable_8c6b37b2-aa72-4d29-b310-9651eaaefe3d" xlink:to="loc_us-gaap_StatementClassOfStockAxis_ad94603e-a6f2-4170-badf-b460efae7ce4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ad94603e-a6f2-4170-badf-b460efae7ce4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ad94603e-a6f2-4170-badf-b460efae7ce4" xlink:to="loc_us-gaap_ClassOfStockDomain_ad94603e-a6f2-4170-badf-b460efae7ce4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b1f2dd03-e2bf-4834-916f-8c048f3acdbe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ad94603e-a6f2-4170-badf-b460efae7ce4" xlink:to="loc_us-gaap_ClassOfStockDomain_b1f2dd03-e2bf-4834-916f-8c048f3acdbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_922da69e-7deb-4bd8-a439-6923d369c6bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_b1f2dd03-e2bf-4834-916f-8c048f3acdbe" xlink:to="loc_us-gaap_CommonStockMember_922da69e-7deb-4bd8-a439-6923d369c6bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesVConvertiblePreferredStockMember_6cd3e91e-d219-45ab-835e-3d37262107fc" xlink:href="alts-20241228.xsd#alts_SeriesVConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_b1f2dd03-e2bf-4834-916f-8c048f3acdbe" xlink:to="loc_alts_SeriesVConvertiblePreferredStockMember_6cd3e91e-d219-45ab-835e-3d37262107fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c5eba3c1-d2de-4a46-828c-de4d9b1e09fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_alts_ShareholdersEquityTable_8c6b37b2-aa72-4d29-b310-9651eaaefe3d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c5eba3c1-d2de-4a46-828c-de4d9b1e09fe" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c5eba3c1-d2de-4a46-828c-de4d9b1e09fe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c5eba3c1-d2de-4a46-828c-de4d9b1e09fe" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c5eba3c1-d2de-4a46-828c-de4d9b1e09fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5704d3c8-77c9-496a-990a-11318cafdb90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c5eba3c1-d2de-4a46-828c-de4d9b1e09fe" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5704d3c8-77c9-496a-990a-11318cafdb90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Alt5SigmaInc.Member_16903778-8692-4139-965c-d3c315a3e079" xlink:href="alts-20241228.xsd#alts_Alt5SigmaInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5704d3c8-77c9-496a-990a-11318cafdb90" xlink:to="loc_alts_Alt5SigmaInc.Member_16903778-8692-4139-965c-d3c315a3e079" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_1c2030d2-3600-4f47-9366-c0ec718599c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_alts_ShareholdersEquityTable_8c6b37b2-aa72-4d29-b310-9651eaaefe3d" xlink:to="loc_us-gaap_PlanNameAxis_1c2030d2-3600-4f47-9366-c0ec718599c5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1c2030d2-3600-4f47-9366-c0ec718599c5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_1c2030d2-3600-4f47-9366-c0ec718599c5" xlink:to="loc_us-gaap_PlanNameDomain_1c2030d2-3600-4f47-9366-c0ec718599c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_bb4785dc-c7da-49f1-92de-f8452e3b229b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_1c2030d2-3600-4f47-9366-c0ec718599c5" xlink:to="loc_us-gaap_PlanNameDomain_bb4785dc-c7da-49f1-92de-f8452e3b229b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_A2023EquityIncentivePlanMember_ac8b61b3-8871-4d25-ab55-cf7531a1834a" xlink:href="alts-20241228.xsd#alts_A2023EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_bb4785dc-c7da-49f1-92de-f8452e3b229b" xlink:to="loc_alts_A2023EquityIncentivePlanMember_ac8b61b3-8871-4d25-ab55-cf7531a1834a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_1584e80e-26f5-48aa-89fa-8a1e31d114ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_1584e80e-26f5-48aa-89fa-8a1e31d114ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_3196900b-c02a-49e2-b396-42ee634170bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_3196900b-c02a-49e2-b396-42ee634170bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_cd4e393b-af19-4fdb-9be0-e4d52e0cd471" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_cd4e393b-af19-4fdb-9be0-e4d52e0cd471" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfInterestInPartnershipUnit_092ab43d-6ff4-4ace-b0d6-caca6778c672" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfInterestInPartnershipUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_ProceedsFromSaleOfInterestInPartnershipUnit_092ab43d-6ff4-4ace-b0d6-caca6778c672" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_b0b19916-67a2-4707-abf8-0f87cc64614a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_b0b19916-67a2-4707-abf8-0f87cc64614a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_24a7a018-76e8-48ba-834c-3570e4fbd585" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_24a7a018-76e8-48ba-834c-3570e4fbd585" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_d34ff796-e786-41fa-971b-8c9e450a2d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_d34ff796-e786-41fa-971b-8c9e450a2d6e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NumberOfAgreementsToBePurchased_c1711ecd-47ad-45ba-892a-9cc90ffa82f3" xlink:href="alts-20241228.xsd#alts_NumberOfAgreementsToBePurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_alts_NumberOfAgreementsToBePurchased_c1711ecd-47ad-45ba-892a-9cc90ffa82f3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_85d067d7-6822-4f46-be6b-73081b670854" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_85d067d7-6822-4f46-be6b-73081b670854" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_9f5d841d-373b-4939-8c8f-0be1dfe91fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_9f5d841d-373b-4939-8c8f-0be1dfe91fb5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SaleOfStockUnitCompositionNumberOfCommonSharesInEachUnit_cf5fcddf-a779-4bb9-9ce6-af05b045b032" xlink:href="alts-20241228.xsd#alts_SaleOfStockUnitCompositionNumberOfCommonSharesInEachUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_alts_SaleOfStockUnitCompositionNumberOfCommonSharesInEachUnit_cf5fcddf-a779-4bb9-9ce6-af05b045b032" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SaleOfStockUnitCompositionNumberOfWarrantsIssuedInEachUnit_4927fa2a-cbef-4fab-99fa-8fd4ba7e539e" xlink:href="alts-20241228.xsd#alts_SaleOfStockUnitCompositionNumberOfWarrantsIssuedInEachUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_alts_SaleOfStockUnitCompositionNumberOfWarrantsIssuedInEachUnit_4927fa2a-cbef-4fab-99fa-8fd4ba7e539e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ClassOfWarrantPricePerShare_539bda34-ad9b-4f45-9102-a7f0cafb9f33" xlink:href="alts-20241228.xsd#alts_ClassOfWarrantPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_alts_ClassOfWarrantPricePerShare_539bda34-ad9b-4f45-9102-a7f0cafb9f33" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_6c7031a6-b9b0-4573-885c-dbc4ea3f6339" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_6c7031a6-b9b0-4573-885c-dbc4ea3f6339" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RelatedPartyTransactionConsultingAgreementTerm_23a96660-7d88-4206-8488-6571ff9e0a88" xlink:href="alts-20241228.xsd#alts_RelatedPartyTransactionConsultingAgreementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_alts_RelatedPartyTransactionConsultingAgreementTerm_23a96660-7d88-4206-8488-6571ff9e0a88" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares_58aa2b1d-4f12-49d6-adff-566d145bf676" xlink:href="alts-20241228.xsd#alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares_58aa2b1d-4f12-49d6-adff-566d145bf676" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1_d5c5dd4b-4f4a-4037-a86e-947ea45e7f55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionOriginalDebtAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_DebtConversionOriginalDebtAmount1_d5c5dd4b-4f4a-4037-a86e-947ea45e7f55" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_3866f05e-95f4-4645-90bb-182658c0886d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_3866f05e-95f4-4645-90bb-182658c0886d" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_43190825-8382-462c-bc90-571019acd3fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_43190825-8382-462c-bc90-571019acd3fd" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockIssuedDuringPeriodSharesPrepaidInterest_e349e540-ff5e-425b-ad24-f4512f26c335" xlink:href="alts-20241228.xsd#alts_StockIssuedDuringPeriodSharesPrepaidInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_alts_StockIssuedDuringPeriodSharesPrepaidInterest_e349e540-ff5e-425b-ad24-f4512f26c335" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockIssuedDuringPeriodSharesWarrantsExercised_b7bcd931-92e4-4dec-9978-45e6f86c1358" xlink:href="alts-20241228.xsd#alts_StockIssuedDuringPeriodSharesWarrantsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_alts_StockIssuedDuringPeriodSharesWarrantsExercised_b7bcd931-92e4-4dec-9978-45e6f86c1358" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e8c35a93-d379-4c32-9fdc-32c107e52e94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e8c35a93-d379-4c32-9fdc-32c107e52e94" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_f8485a00-4d6f-408f-9b55-c4090353791b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_f8485a00-4d6f-408f-9b55-c4090353791b" xlink:type="arc" order="22"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#StockholdersEquityEquityIncentivesDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_alts_ShareholdersEquityLineItems_8921b5d6-ad93-4f20-90e8-5f081ad921c3" xlink:href="alts-20241228.xsd#alts_ShareholdersEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ShareholdersEquityTable_26520993-b29f-4827-8f2f-d926b21a5e82" xlink:href="alts-20241228.xsd#alts_ShareholdersEquityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_alts_ShareholdersEquityLineItems_8921b5d6-ad93-4f20-90e8-5f081ad921c3" xlink:to="loc_alts_ShareholdersEquityTable_26520993-b29f-4827-8f2f-d926b21a5e82" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_1270bb9d-e6fc-4e65-a62c-bea41f43b914" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_alts_ShareholdersEquityTable_26520993-b29f-4827-8f2f-d926b21a5e82" xlink:to="loc_us-gaap_PlanNameAxis_1270bb9d-e6fc-4e65-a62c-bea41f43b914" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1270bb9d-e6fc-4e65-a62c-bea41f43b914_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_1270bb9d-e6fc-4e65-a62c-bea41f43b914" xlink:to="loc_us-gaap_PlanNameDomain_1270bb9d-e6fc-4e65-a62c-bea41f43b914_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_c5d4148b-cc34-453d-89d1-6c6f837de91f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_1270bb9d-e6fc-4e65-a62c-bea41f43b914" xlink:to="loc_us-gaap_PlanNameDomain_c5d4148b-cc34-453d-89d1-6c6f837de91f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_A2024EquityIncentivePlanMember_d00840f2-ccf2-4115-9f90-8edded1a58eb" xlink:href="alts-20241228.xsd#alts_A2024EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_c5d4148b-cc34-453d-89d1-6c6f837de91f" xlink:to="loc_alts_A2024EquityIncentivePlanMember_d00840f2-ccf2-4115-9f90-8edded1a58eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_A2023EquityIncentivePlanMember_248f8c7c-0622-4658-a730-cf4c6d1ba5eb" xlink:href="alts-20241228.xsd#alts_A2023EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_c5d4148b-cc34-453d-89d1-6c6f837de91f" xlink:to="loc_alts_A2023EquityIncentivePlanMember_248f8c7c-0622-4658-a730-cf4c6d1ba5eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Plan2016Member_ab7f427e-6de5-4e94-b572-c5d6d076e0ce" xlink:href="alts-20241228.xsd#alts_Plan2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_c5d4148b-cc34-453d-89d1-6c6f837de91f" xlink:to="loc_alts_Plan2016Member_ab7f427e-6de5-4e94-b572-c5d6d076e0ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Plan2011Member_46a64224-ced1-4dc2-8bbf-fe6c2a97274f" xlink:href="alts-20241228.xsd#alts_Plan2011Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_c5d4148b-cc34-453d-89d1-6c6f837de91f" xlink:to="loc_alts_Plan2011Member_46a64224-ced1-4dc2-8bbf-fe6c2a97274f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1bfc053a-dbe9-4435-bcc0-abc9b4ec23c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_alts_ShareholdersEquityTable_26520993-b29f-4827-8f2f-d926b21a5e82" xlink:to="loc_us-gaap_AwardTypeAxis_1bfc053a-dbe9-4435-bcc0-abc9b4ec23c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1bfc053a-dbe9-4435-bcc0-abc9b4ec23c3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1bfc053a-dbe9-4435-bcc0-abc9b4ec23c3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1bfc053a-dbe9-4435-bcc0-abc9b4ec23c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2ccbf68c-49ea-4b96-810b-5755e04c294f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1bfc053a-dbe9-4435-bcc0-abc9b4ec23c3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2ccbf68c-49ea-4b96-810b-5755e04c294f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a9321536-5c49-422f-b227-6f855f83ae9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2ccbf68c-49ea-4b96-810b-5755e04c294f" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a9321536-5c49-422f-b227-6f855f83ae9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_6dc09372-7590-441a-b9bd-7a2515fcab94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2ccbf68c-49ea-4b96-810b-5755e04c294f" xlink:to="loc_us-gaap_EmployeeStockOptionMember_6dc09372-7590-441a-b9bd-7a2515fcab94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_35740d51-2a4d-4afb-ac8a-f0d25a86098b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_alts_ShareholdersEquityTable_26520993-b29f-4827-8f2f-d926b21a5e82" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_35740d51-2a4d-4afb-ac8a-f0d25a86098b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_35740d51-2a4d-4afb-ac8a-f0d25a86098b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_35740d51-2a4d-4afb-ac8a-f0d25a86098b" xlink:to="loc_us-gaap_RelatedPartyDomain_35740d51-2a4d-4afb-ac8a-f0d25a86098b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_0e6fa5bf-b282-4c1e-829c-785e38b33b86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_35740d51-2a4d-4afb-ac8a-f0d25a86098b" xlink:to="loc_us-gaap_RelatedPartyDomain_0e6fa5bf-b282-4c1e-829c-785e38b33b86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_ac9a41b3-ad1d-4961-a3fa-da3d86c5ee9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_0e6fa5bf-b282-4c1e-829c-785e38b33b86" xlink:to="loc_us-gaap_RelatedPartyMember_ac9a41b3-ad1d-4961-a3fa-da3d86c5ee9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4c0f9aa1-8b2e-4eb5-a657-ead90d47b382" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_8921b5d6-ad93-4f20-90e8-5f081ad921c3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4c0f9aa1-8b2e-4eb5-a657-ead90d47b382" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_26ae6308-69bb-4c48-8093-4cd1709e3fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_8921b5d6-ad93-4f20-90e8-5f081ad921c3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_26ae6308-69bb-4c48-8093-4cd1709e3fc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_e76230c4-607b-4b83-8b1c-695f6c43840e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_8921b5d6-ad93-4f20-90e8-5f081ad921c3" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_e76230c4-607b-4b83-8b1c-695f6c43840e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_481d42ee-3202-43d2-9a6c-ff4b40432d28" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_8921b5d6-ad93-4f20-90e8-5f081ad921c3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_481d42ee-3202-43d2-9a6c-ff4b40432d28" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a7834c56-ef11-4622-bbb3-bb78a52a14e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_8921b5d6-ad93-4f20-90e8-5f081ad921c3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a7834c56-ef11-4622-bbb3-bb78a52a14e3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_e1f159c1-4632-48cc-85c5-44c6d490aa8b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_8921b5d6-ad93-4f20-90e8-5f081ad921c3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_e1f159c1-4632-48cc-85c5-44c6d490aa8b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_ec9d16b3-b2a2-454f-9d34-ac62c554f0de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_8921b5d6-ad93-4f20-90e8-5f081ad921c3" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_ec9d16b3-b2a2-454f-9d34-ac62c554f0de" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_11156199-bafa-415f-8260-d190400ecce6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_alts_ShareholdersEquityLineItems_8921b5d6-ad93-4f20-90e8-5f081ad921c3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_11156199-bafa-415f-8260-d190400ecce6" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/StockholdersEquityScheduleofExercisePriceforStockOptionsOutstandingandExercisableOutstandingDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#StockholdersEquityScheduleofExercisePriceforStockOptionsOutstandingandExercisableOutstandingDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/StockholdersEquityScheduleofExercisePriceforStockOptionsOutstandingandExercisableOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_f8f93d5f-bf2b-4a47-b4d5-aaf116669a96" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_927fcbb7-05e5-4376-9f02-c99b5ec64155" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_f8f93d5f-bf2b-4a47-b4d5-aaf116669a96" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_927fcbb7-05e5-4376-9f02-c99b5ec64155" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_cf55943e-d34c-4ff2-b499-01f9fcab4140" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_927fcbb7-05e5-4376-9f02-c99b5ec64155" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_cf55943e-d34c-4ff2-b499-01f9fcab4140" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_cf55943e-d34c-4ff2-b499-01f9fcab4140_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_cf55943e-d34c-4ff2-b499-01f9fcab4140" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_cf55943e-d34c-4ff2-b499-01f9fcab4140_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_db1e2c54-f9a7-4e98-9902-58123ccb449e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_cf55943e-d34c-4ff2-b499-01f9fcab4140" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_db1e2c54-f9a7-4e98-9902-58123ccb449e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ExercisePriceRangeOneMember_a5ba38b6-899a-453e-a8c0-08aabf4f7018" xlink:href="alts-20241228.xsd#alts_ExercisePriceRangeOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_db1e2c54-f9a7-4e98-9902-58123ccb449e" xlink:to="loc_alts_ExercisePriceRangeOneMember_a5ba38b6-899a-453e-a8c0-08aabf4f7018" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ExercisePriceRangeTwoMember_ec7d7208-2605-409d-8f29-9fbd2ca480e6" xlink:href="alts-20241228.xsd#alts_ExercisePriceRangeTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_db1e2c54-f9a7-4e98-9902-58123ccb449e" xlink:to="loc_alts_ExercisePriceRangeTwoMember_ec7d7208-2605-409d-8f29-9fbd2ca480e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_97cc0e51-f3f5-41b7-99be-81567815ada7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f8f93d5f-bf2b-4a47-b4d5-aaf116669a96" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_97cc0e51-f3f5-41b7-99be-81567815ada7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_8cf34cf9-e694-4e88-ab51-bfb16c304133" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f8f93d5f-bf2b-4a47-b4d5-aaf116669a96" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_8cf34cf9-e694-4e88-ab51-bfb16c304133" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_a0c724ff-458c-47d8-9de3-8a1375298aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f8f93d5f-bf2b-4a47-b4d5-aaf116669a96" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_a0c724ff-458c-47d8-9de3-8a1375298aa0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_cec8c539-47dc-46ee-91f2-e7f2234e9347" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_f8f93d5f-bf2b-4a47-b4d5-aaf116669a96" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_cec8c539-47dc-46ee-91f2-e7f2234e9347" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/IncometaxesNarrativeDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#IncometaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/IncometaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_c8d24fcc-2ea9-4797-bc1f-97d3ccb198ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_5e92a8e3-08ed-4117-aaf0-e7dcf592f4d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_c8d24fcc-2ea9-4797-bc1f-97d3ccb198ba" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_5e92a8e3-08ed-4117-aaf0-e7dcf592f4d8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_14baf174-42fc-4ef6-94bd-c6d0d1284cba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_5e92a8e3-08ed-4117-aaf0-e7dcf592f4d8" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_14baf174-42fc-4ef6-94bd-c6d0d1284cba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_14baf174-42fc-4ef6-94bd-c6d0d1284cba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_14baf174-42fc-4ef6-94bd-c6d0d1284cba" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_14baf174-42fc-4ef6-94bd-c6d0d1284cba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_f2d0cebf-df3e-42c1-9e1d-d532ecb50df1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_14baf174-42fc-4ef6-94bd-c6d0d1284cba" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_f2d0cebf-df3e-42c1-9e1d-d532ecb50df1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_25a19bc3-514f-4d75-ac12-b6b3ce51ae49" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f2d0cebf-df3e-42c1-9e1d-d532ecb50df1" xlink:to="loc_us-gaap_DomesticCountryMember_25a19bc3-514f-4d75-ac12-b6b3ce51ae49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_48bc24d5-fe81-44ec-860c-13025f2ca881" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f2d0cebf-df3e-42c1-9e1d-d532ecb50df1" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_48bc24d5-fe81-44ec-860c-13025f2ca881" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_c0933081-0e02-40fe-a86d-c371803112f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_c8d24fcc-2ea9-4797-bc1f-97d3ccb198ba" xlink:to="loc_us-gaap_OperatingLossCarryforwards_c0933081-0e02-40fe-a86d-c371803112f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_dcd2f444-0498-43b4-9956-35a70e02177c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_c8d24fcc-2ea9-4797-bc1f-97d3ccb198ba" xlink:to="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_dcd2f444-0498-43b4-9956-35a70e02177c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeTaxProvisionBenefitDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#IncometaxesScheduleofIncomeTaxProvisionBenefitDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeTaxProvisionBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_bbea0285-9e6a-4009-8213-6aa3424be8ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_051b2ccd-4f1f-4f5b-8465-f58ca04dacba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_bbea0285-9e6a-4009-8213-6aa3424be8ea" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_051b2ccd-4f1f-4f5b-8465-f58ca04dacba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_6be2ac91-5213-4b2a-8774-6f9523909e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_051b2ccd-4f1f-4f5b-8465-f58ca04dacba" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_6be2ac91-5213-4b2a-8774-6f9523909e8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_6be2ac91-5213-4b2a-8774-6f9523909e8d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_6be2ac91-5213-4b2a-8774-6f9523909e8d" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_6be2ac91-5213-4b2a-8774-6f9523909e8d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_9ec79e01-2dc5-4169-8fb7-8400de7da920" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_6be2ac91-5213-4b2a-8774-6f9523909e8d" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_9ec79e01-2dc5-4169-8fb7-8400de7da920" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentContinuingOperationsMember_5bbcdf96-c189-4573-9f0e-14c36818d746" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentContinuingOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_9ec79e01-2dc5-4169-8fb7-8400de7da920" xlink:to="loc_us-gaap_SegmentContinuingOperationsMember_5bbcdf96-c189-4573-9f0e-14c36818d746" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_c6679d30-2b58-47f7-8552-915715bc8676" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_9ec79e01-2dc5-4169-8fb7-8400de7da920" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_c6679d30-2b58-47f7-8552-915715bc8676" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_fb7ca665-974e-4d34-aac9-3f3018b063c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_bbea0285-9e6a-4009-8213-6aa3424be8ea" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_fb7ca665-974e-4d34-aac9-3f3018b063c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_58800811-ac24-4045-9d64-7b9440ae8bb3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_bbea0285-9e6a-4009-8213-6aa3424be8ea" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_58800811-ac24-4045-9d64-7b9440ae8bb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_da246c9f-93dd-4259-8756-9db1ff3316a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_58800811-ac24-4045-9d64-7b9440ae8bb3" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_da246c9f-93dd-4259-8756-9db1ff3316a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_bd744e1a-e153-44a0-ba83-19b5a3985076" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_58800811-ac24-4045-9d64-7b9440ae8bb3" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_bd744e1a-e153-44a0-ba83-19b5a3985076" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_170eefbe-797b-4950-8e6f-05413587ee82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_58800811-ac24-4045-9d64-7b9440ae8bb3" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_170eefbe-797b-4950-8e6f-05413587ee82" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_b3406a2d-4148-4496-8759-1ff92d9f3143" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_58800811-ac24-4045-9d64-7b9440ae8bb3" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_b3406a2d-4148-4496-8759-1ff92d9f3143" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_10d4e7cd-5c95-419c-8710-621313b89497" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_bbea0285-9e6a-4009-8213-6aa3424be8ea" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_10d4e7cd-5c95-419c-8710-621313b89497" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ProvisionBenefitOfIncomeTaxes_b1f2db3b-5aef-4697-8f38-6d97d94bb282" xlink:href="alts-20241228.xsd#alts_ProvisionBenefitOfIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_bbea0285-9e6a-4009-8213-6aa3424be8ea" xlink:to="loc_alts_ProvisionBenefitOfIncomeTaxes_b1f2db3b-5aef-4697-8f38-6d97d94bb282" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/RelatedpartiesDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#RelatedpartiesDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/RelatedpartiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c51f330d-87f3-437b-9ac8-bdee24198e75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c51f330d-87f3-437b-9ac8-bdee24198e75" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_aa866be8-debe-4fd1-ba27-34fe969df846" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c51f330d-87f3-437b-9ac8-bdee24198e75" xlink:to="loc_srt_CounterpartyNameAxis_aa866be8-debe-4fd1-ba27-34fe969df846" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_aa866be8-debe-4fd1-ba27-34fe969df846_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_aa866be8-debe-4fd1-ba27-34fe969df846" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_aa866be8-debe-4fd1-ba27-34fe969df846_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d3f303f0-ac65-4d21-ae5b-8e3e1a778181" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_aa866be8-debe-4fd1-ba27-34fe969df846" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d3f303f0-ac65-4d21-ae5b-8e3e1a778181" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LiveVenturesIncorporatedMember_7f318188-a430-4816-807b-a9c9cbd4aab2" xlink:href="alts-20241228.xsd#alts_LiveVenturesIncorporatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d3f303f0-ac65-4d21-ae5b-8e3e1a778181" xlink:to="loc_alts_LiveVenturesIncorporatedMember_7f318188-a430-4816-807b-a9c9cbd4aab2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Mr.JonIsaacMember_bc36ccbc-8796-4b92-96cd-2a95ff324cc0" xlink:href="alts-20241228.xsd#alts_Mr.JonIsaacMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d3f303f0-ac65-4d21-ae5b-8e3e1a778181" xlink:to="loc_alts_Mr.JonIsaacMember_bc36ccbc-8796-4b92-96cd-2a95ff324cc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NovalkAppsSAALLPMember_6ae5a0b9-c53f-40ff-8eaf-fd6af482d599" xlink:href="alts-20241228.xsd#alts_NovalkAppsSAALLPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d3f303f0-ac65-4d21-ae5b-8e3e1a778181" xlink:to="loc_alts_NovalkAppsSAALLPMember_6ae5a0b9-c53f-40ff-8eaf-fd6af482d599" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Mr.TonyIsaacMember_37bfa781-bca4-4fd9-aaf2-76f75e2b043b" xlink:href="alts-20241228.xsd#alts_Mr.TonyIsaacMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d3f303f0-ac65-4d21-ae5b-8e3e1a778181" xlink:to="loc_alts_Mr.TonyIsaacMember_37bfa781-bca4-4fd9-aaf2-76f75e2b043b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_f463c40d-dabc-4746-b7a5-643579d5c564" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c51f330d-87f3-437b-9ac8-bdee24198e75" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_f463c40d-dabc-4746-b7a5-643579d5c564" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_f463c40d-dabc-4746-b7a5-643579d5c564_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_f463c40d-dabc-4746-b7a5-643579d5c564" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_f463c40d-dabc-4746-b7a5-643579d5c564_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_ab084aec-4349-47df-95b3-0186e01e6e45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_f463c40d-dabc-4746-b7a5-643579d5c564" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_ab084aec-4349-47df-95b3-0186e01e6e45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NotesPayableWithLiveVenturesAndICGMember_6ba5a46f-b88a-4a58-9b7e-1f283eb13c1f" xlink:href="alts-20241228.xsd#alts_NotesPayableWithLiveVenturesAndICGMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_ab084aec-4349-47df-95b3-0186e01e6e45" xlink:to="loc_alts_NotesPayableWithLiveVenturesAndICGMember_6ba5a46f-b88a-4a58-9b7e-1f283eb13c1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IsaacConsultingAgreementMember_528f997d-b13f-4bc5-9cff-5f4d4c062525" xlink:href="alts-20241228.xsd#alts_IsaacConsultingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_ab084aec-4349-47df-95b3-0186e01e6e45" xlink:to="loc_alts_IsaacConsultingAgreementMember_528f997d-b13f-4bc5-9cff-5f4d4c062525" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IcgNoteMember_14b1e21b-6f32-4ef8-bd91-cf36e2f447aa" xlink:href="alts-20241228.xsd#alts_IcgNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_ab084aec-4349-47df-95b3-0186e01e6e45" xlink:to="loc_alts_IcgNoteMember_14b1e21b-6f32-4ef8-bd91-cf36e2f447aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RelatedPartyTransactionShortTermAdvancesMember_7a68754e-0559-45b6-b3d3-07396579b0f2" xlink:href="alts-20241228.xsd#alts_RelatedPartyTransactionShortTermAdvancesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_ab084aec-4349-47df-95b3-0186e01e6e45" xlink:to="loc_alts_RelatedPartyTransactionShortTermAdvancesMember_7a68754e-0559-45b6-b3d3-07396579b0f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_48e945d4-0c78-4511-887f-fb4e37807467" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c51f330d-87f3-437b-9ac8-bdee24198e75" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_48e945d4-0c78-4511-887f-fb4e37807467" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_48e945d4-0c78-4511-887f-fb4e37807467_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_48e945d4-0c78-4511-887f-fb4e37807467" xlink:to="loc_us-gaap_RelatedPartyDomain_48e945d4-0c78-4511-887f-fb4e37807467_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_d24dc26a-546b-45da-ad12-ce2ee909f8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_48e945d4-0c78-4511-887f-fb4e37807467" xlink:to="loc_us-gaap_RelatedPartyDomain_d24dc26a-546b-45da-ad12-ce2ee909f8a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_969293dd-764f-48e6-8e07-247b1f38cc57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_d24dc26a-546b-45da-ad12-ce2ee909f8a5" xlink:to="loc_us-gaap_RelatedPartyMember_969293dd-764f-48e6-8e07-247b1f38cc57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BeneficialOwnerMember_bfa56d1f-5b50-4cbc-9f98-69010dfa2719" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BeneficialOwnerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_d24dc26a-546b-45da-ad12-ce2ee909f8a5" xlink:to="loc_us-gaap_BeneficialOwnerMember_bfa56d1f-5b50-4cbc-9f98-69010dfa2719" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3a806e61-58bf-4fa4-aa40-b5d369e9ab30" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c51f330d-87f3-437b-9ac8-bdee24198e75" xlink:to="loc_us-gaap_DebtInstrumentAxis_3a806e61-58bf-4fa4-aa40-b5d369e9ab30" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3a806e61-58bf-4fa4-aa40-b5d369e9ab30_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_3a806e61-58bf-4fa4-aa40-b5d369e9ab30" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3a806e61-58bf-4fa4-aa40-b5d369e9ab30_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c498ef53-9303-4eaa-b7a2-113300f30772" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_3a806e61-58bf-4fa4-aa40-b5d369e9ab30" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c498ef53-9303-4eaa-b7a2-113300f30772" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LiveVenturesAndICGNotesMember_153ff960-1817-4cea-a3ee-d8b34affe625" xlink:href="alts-20241228.xsd#alts_LiveVenturesAndICGNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c498ef53-9303-4eaa-b7a2-113300f30772" xlink:to="loc_alts_LiveVenturesAndICGNotesMember_153ff960-1817-4cea-a3ee-d8b34affe625" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IsaacConsultingAgreementMember_24b8dffe-1deb-4998-8769-647521888f1a" xlink:href="alts-20241228.xsd#alts_IsaacConsultingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c498ef53-9303-4eaa-b7a2-113300f30772" xlink:to="loc_alts_IsaacConsultingAgreementMember_24b8dffe-1deb-4998-8769-647521888f1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_A10ConvertiblePromissoryNoteMember_8e2547bd-7957-4f11-9909-ec13bbffd400" xlink:href="alts-20241228.xsd#alts_A10ConvertiblePromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c498ef53-9303-4eaa-b7a2-113300f30772" xlink:to="loc_alts_A10ConvertiblePromissoryNoteMember_8e2547bd-7957-4f11-9909-ec13bbffd400" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IsaacCapitalGroupShortTermDemandAdvanceMember_c34f1457-2a5e-433b-a233-7aa57bc42c73" xlink:href="alts-20241228.xsd#alts_IsaacCapitalGroupShortTermDemandAdvanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c498ef53-9303-4eaa-b7a2-113300f30772" xlink:to="loc_alts_IsaacCapitalGroupShortTermDemandAdvanceMember_c34f1457-2a5e-433b-a233-7aa57bc42c73" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d79e2125-082b-4c3c-92bd-544f62b0fce0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c51f330d-87f3-437b-9ac8-bdee24198e75" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d79e2125-082b-4c3c-92bd-544f62b0fce0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d79e2125-082b-4c3c-92bd-544f62b0fce0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d79e2125-082b-4c3c-92bd-544f62b0fce0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d79e2125-082b-4c3c-92bd-544f62b0fce0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_43c04b59-ab26-4e61-99c6-a7844f691267" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d79e2125-082b-4c3c-92bd-544f62b0fce0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_43c04b59-ab26-4e61-99c6-a7844f691267" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PromissoryNoteMember_a0e8ea2d-9aa4-4e76-b7ae-9754ee7eab02" xlink:href="alts-20241228.xsd#alts_PromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_43c04b59-ab26-4e61-99c6-a7844f691267" xlink:to="loc_alts_PromissoryNoteMember_a0e8ea2d-9aa4-4e76-b7ae-9754ee7eab02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_718c01fe-cd52-46d9-9682-218863a22a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_43c04b59-ab26-4e61-99c6-a7844f691267" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_718c01fe-cd52-46d9-9682-218863a22a1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f554b47e-ac68-4916-9c80-859ad6f25607" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c51f330d-87f3-437b-9ac8-bdee24198e75" xlink:to="loc_srt_ProductOrServiceAxis_f554b47e-ac68-4916-9c80-859ad6f25607" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f554b47e-ac68-4916-9c80-859ad6f25607_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_f554b47e-ac68-4916-9c80-859ad6f25607" xlink:to="loc_srt_ProductsAndServicesDomain_f554b47e-ac68-4916-9c80-859ad6f25607_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_06666c15-b413-48c4-adc0-3c30f74908ee" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_f554b47e-ac68-4916-9c80-859ad6f25607" xlink:to="loc_srt_ProductsAndServicesDomain_06666c15-b413-48c4-adc0-3c30f74908ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_UniversalLifeInsurancePolicyPolicyOneMember_a7be70af-be4a-41ca-a953-606bbbe0b9e4" xlink:href="alts-20241228.xsd#alts_UniversalLifeInsurancePolicyPolicyOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_06666c15-b413-48c4-adc0-3c30f74908ee" xlink:to="loc_alts_UniversalLifeInsurancePolicyPolicyOneMember_a7be70af-be4a-41ca-a953-606bbbe0b9e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_UniversalLifeInsurancePolicyPolicyTwoMember_86dd4690-8564-4aca-a457-e970bf5e9bb6" xlink:href="alts-20241228.xsd#alts_UniversalLifeInsurancePolicyPolicyTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_06666c15-b413-48c4-adc0-3c30f74908ee" xlink:to="loc_alts_UniversalLifeInsurancePolicyPolicyTwoMember_86dd4690-8564-4aca-a457-e970bf5e9bb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_ee3fc3f3-e278-42c2-a185-ec32ba3b07ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c51f330d-87f3-437b-9ac8-bdee24198e75" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_ee3fc3f3-e278-42c2-a185-ec32ba3b07ff" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_ee3fc3f3-e278-42c2-a185-ec32ba3b07ff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_ee3fc3f3-e278-42c2-a185-ec32ba3b07ff" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_ee3fc3f3-e278-42c2-a185-ec32ba3b07ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_72f0f149-61ff-41a5-bb65-602f2c3e11d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_ee3fc3f3-e278-42c2-a185-ec32ba3b07ff" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_72f0f149-61ff-41a5-bb65-602f2c3e11d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_7d7e1af0-7b3f-4d75-9f09-3d359895343c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_72f0f149-61ff-41a5-bb65-602f2c3e11d5" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_7d7e1af0-7b3f-4d75-9f09-3d359895343c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_23dec12c-8bf4-45e3-9845-87975537aed5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_72f0f149-61ff-41a5-bb65-602f2c3e11d5" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_23dec12c-8bf4-45e3-9845-87975537aed5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_76af8e91-ad9f-4fdd-8945-643bfbcdc25f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c51f330d-87f3-437b-9ac8-bdee24198e75" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_76af8e91-ad9f-4fdd-8945-643bfbcdc25f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_76af8e91-ad9f-4fdd-8945-643bfbcdc25f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_76af8e91-ad9f-4fdd-8945-643bfbcdc25f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_76af8e91-ad9f-4fdd-8945-643bfbcdc25f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8509b5a7-bec5-414f-936f-d37354f0f7c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_76af8e91-ad9f-4fdd-8945-643bfbcdc25f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8509b5a7-bec5-414f-936f-d37354f0f7c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ARCAAndSubsidiariesMember_58843dc1-ee01-44de-ae60-fbf514ebf4ab" xlink:href="alts-20241228.xsd#alts_ARCAAndSubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8509b5a7-bec5-414f-936f-d37354f0f7c4" xlink:to="loc_alts_ARCAAndSubsidiariesMember_58843dc1-ee01-44de-ae60-fbf514ebf4ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_8581d295-02b0-42e6-bbbb-a3cd74e71e73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c51f330d-87f3-437b-9ac8-bdee24198e75" xlink:to="loc_us-gaap_CreditFacilityAxis_8581d295-02b0-42e6-bbbb-a3cd74e71e73" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8581d295-02b0-42e6-bbbb-a3cd74e71e73_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_8581d295-02b0-42e6-bbbb-a3cd74e71e73" xlink:to="loc_us-gaap_CreditFacilityDomain_8581d295-02b0-42e6-bbbb-a3cd74e71e73_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b455b1be-f5ab-4fe9-bef6-f621f7ca3466" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_8581d295-02b0-42e6-bbbb-a3cd74e71e73" xlink:to="loc_us-gaap_CreditFacilityDomain_b455b1be-f5ab-4fe9-bef6-f621f7ca3466" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_0c99083c-d09e-48a7-9ac9-8b17502cf6df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_b455b1be-f5ab-4fe9-bef6-f621f7ca3466" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_0c99083c-d09e-48a7-9ac9-8b17502cf6df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_bee4ac81-34e9-4853-809e-94e0c178f7ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c51f330d-87f3-437b-9ac8-bdee24198e75" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_bee4ac81-34e9-4853-809e-94e0c178f7ad" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bee4ac81-34e9-4853-809e-94e0c178f7ad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bee4ac81-34e9-4853-809e-94e0c178f7ad" xlink:to="loc_us-gaap_SegmentDomain_bee4ac81-34e9-4853-809e-94e0c178f7ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e15d9064-7acf-40ed-ae78-4907037ed8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bee4ac81-34e9-4853-809e-94e0c178f7ad" xlink:to="loc_us-gaap_SegmentDomain_e15d9064-7acf-40ed-ae78-4907037ed8dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RecyclingSegmentAndTechnologySegmentMember_1492fe1c-dd3a-4c8d-8b07-0a1088fdbfcf" xlink:href="alts-20241228.xsd#alts_RecyclingSegmentAndTechnologySegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e15d9064-7acf-40ed-ae78-4907037ed8dc" xlink:to="loc_alts_RecyclingSegmentAndTechnologySegmentMember_1492fe1c-dd3a-4c8d-8b07-0a1088fdbfcf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f1670017-490d-4de3-a24c-dd6d995a1dfe" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c51f330d-87f3-437b-9ac8-bdee24198e75" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f1670017-490d-4de3-a24c-dd6d995a1dfe" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_f1670017-490d-4de3-a24c-dd6d995a1dfe_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f1670017-490d-4de3-a24c-dd6d995a1dfe" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_f1670017-490d-4de3-a24c-dd6d995a1dfe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_4360878b-f66c-4da5-8e85-b6d1c00bf483" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f1670017-490d-4de3-a24c-dd6d995a1dfe" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_4360878b-f66c-4da5-8e85-b6d1c00bf483" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_JanOneMember_cd6f57bf-2018-4c5d-a65c-11ba521cdc5d" xlink:href="alts-20241228.xsd#alts_JanOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4360878b-f66c-4da5-8e85-b6d1c00bf483" xlink:to="loc_alts_JanOneMember_cd6f57bf-2018-4c5d-a65c-11ba521cdc5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_50904271-2087-40df-9045-db2e3f368e19" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c51f330d-87f3-437b-9ac8-bdee24198e75" xlink:to="loc_dei_LegalEntityAxis_50904271-2087-40df-9045-db2e3f368e19" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_50904271-2087-40df-9045-db2e3f368e19_default" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_50904271-2087-40df-9045-db2e3f368e19" xlink:to="loc_dei_EntityDomain_50904271-2087-40df-9045-db2e3f368e19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8a16420c-441a-46c8-ad16-5e0c7a5d2ee3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_50904271-2087-40df-9045-db2e3f368e19" xlink:to="loc_dei_EntityDomain_8a16420c-441a-46c8-ad16-5e0c7a5d2ee3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IsaacCapitalGroupLLCICGMember_bdc83442-226d-4d89-9432-a9ebe849dffe" xlink:href="alts-20241228.xsd#alts_IsaacCapitalGroupLLCICGMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_8a16420c-441a-46c8-ad16-5e0c7a5d2ee3" xlink:to="loc_alts_IsaacCapitalGroupLLCICGMember_bdc83442-226d-4d89-9432-a9ebe849dffe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_3f18a783-1fc1-4b11-89b5-d999d01e6b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_3f18a783-1fc1-4b11-89b5-d999d01e6b9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetRentableArea_560e6c06-49a1-40a7-8355-6bdc623b6872" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetRentableArea"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_NetRentableArea_560e6c06-49a1-40a7-8355-6bdc623b6872" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_42f5dcc0-5474-4ea2-9b94-ddbd61735779" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_OperatingLeaseExpense_42f5dcc0-5474-4ea2-9b94-ddbd61735779" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRentCurrentAndNoncurrent_a7c604b2-92c2-4f0a-9284-84481718c68b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedRentCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_AccruedRentCurrentAndNoncurrent_a7c604b2-92c2-4f0a-9284-84481718c68b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_99c75ae1-e2ee-4cdb-b5c2-d227c5cf366a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_99c75ae1-e2ee-4cdb-b5c2-d227c5cf366a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b6a785df-e87c-495e-88a1-5dcbbae4a50f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b6a785df-e87c-495e-88a1-5dcbbae4a50f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment_96649cd4-6933-418b-bd59-5444ccda5e75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPayment_96649cd4-6933-418b-bd59-5444ccda5e75" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_ac121f4b-00c4-48e4-b6e1-cc1c19fd152f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_ac121f4b-00c4-48e4-b6e1-cc1c19fd152f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_9a450293-06b7-4b9b-92e7-a79420c06d09" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_9a450293-06b7-4b9b-92e7-a79420c06d09" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RelatedPartyTransactionConsultingAgreementTerm_d54c4b01-397b-4ced-bd9c-f470ffeeb7b4" xlink:href="alts-20241228.xsd#alts_RelatedPartyTransactionConsultingAgreementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_alts_RelatedPartyTransactionConsultingAgreementTerm_d54c4b01-397b-4ced-bd9c-f470ffeeb7b4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RelatedPartyTransactionConsultingAgreementNumberOfLifeInsurancePoliciesAssigned_cc757d39-9c95-445d-947f-f723e2b120d7" xlink:href="alts-20241228.xsd#alts_RelatedPartyTransactionConsultingAgreementNumberOfLifeInsurancePoliciesAssigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_alts_RelatedPartyTransactionConsultingAgreementNumberOfLifeInsurancePoliciesAssigned_cc757d39-9c95-445d-947f-f723e2b120d7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueOfLifeInsurance_e9e419b7-75d5-490f-b44f-a65f6dabaddb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashSurrenderValueOfLifeInsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_CashSurrenderValueOfLifeInsurance_e9e419b7-75d5-490f-b44f-a65f6dabaddb" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RelatedPartyTransactionConsultingAgreementContingentlyTenderedFunds_ebf30732-4557-4e1f-9c89-138a1ba30c09" xlink:href="alts-20241228.xsd#alts_RelatedPartyTransactionConsultingAgreementContingentlyTenderedFunds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_alts_RelatedPartyTransactionConsultingAgreementContingentlyTenderedFunds_ebf30732-4557-4e1f-9c89-138a1ba30c09" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares_a33648ba-0c5b-4813-932b-f587278b0fdf" xlink:href="alts-20241228.xsd#alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares_a33648ba-0c5b-4813-932b-f587278b0fdf" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NumberOfTradingDaysBeforeBoardApproval_8dc582ed-3624-412f-945f-d45312c4fbbd" xlink:href="alts-20241228.xsd#alts_NumberOfTradingDaysBeforeBoardApproval"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_alts_NumberOfTradingDaysBeforeBoardApproval_8dc582ed-3624-412f-945f-d45312c4fbbd" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice_b9f129cf-ee80-4d46-8b7c-f03555363543" xlink:href="alts-20241228.xsd#alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice_b9f129cf-ee80-4d46-8b7c-f03555363543" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_5576ee97-d51a-4bd0-b929-a3b5f1874843" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_5576ee97-d51a-4bd0-b929-a3b5f1874843" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_958c7728-c64f-409f-ab9f-df5d0f627ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_ShortTermBorrowings_958c7728-c64f-409f-ab9f-df5d0f627ee3" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_60a9f227-e961-4de8-9e61-641ae23f8a28" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_60a9f227-e961-4de8-9e61-641ae23f8a28" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_97fba758-8529-43fa-9b6c-75bbc1637547" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_97fba758-8529-43fa-9b6c-75bbc1637547" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_90c5d506-c27c-4e24-be09-b0fad22f563d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_90c5d506-c27c-4e24-be09-b0fad22f563d" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_dd083b5d-4ec5-43fe-ae50-65f5d9a8760c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_dd083b5d-4ec5-43fe-ae50-65f5d9a8760c" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_32635e19-55f0-4974-aee5-d40cfada387c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_OtherLiabilities_32635e19-55f0-4974-aee5-d40cfada387c" xlink:type="arc" order="22"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_ba0d1c78-014f-4d06-ac16-594c85151b68" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_us-gaap_LossContingenciesTable_ba0d1c78-014f-4d06-ac16-594c85151b68" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_4c7b0508-c13e-4501-bfb5-9a047205367c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_ba0d1c78-014f-4d06-ac16-594c85151b68" xlink:to="loc_srt_LitigationCaseAxis_4c7b0508-c13e-4501-bfb5-9a047205367c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_4c7b0508-c13e-4501-bfb5-9a047205367c_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_4c7b0508-c13e-4501-bfb5-9a047205367c" xlink:to="loc_srt_LitigationCaseTypeDomain_4c7b0508-c13e-4501-bfb5-9a047205367c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b616d20c-b2c4-4138-aebf-d903cb267430" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_4c7b0508-c13e-4501-bfb5-9a047205367c" xlink:to="loc_srt_LitigationCaseTypeDomain_b616d20c-b2c4-4138-aebf-d903cb267430" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SECComplaintMember_64fb199c-f9fa-4e47-9006-dfe48ad5e582" xlink:href="alts-20241228.xsd#alts_SECComplaintMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b616d20c-b2c4-4138-aebf-d903cb267430" xlink:to="loc_alts_SECComplaintMember_64fb199c-f9fa-4e47-9006-dfe48ad5e582" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SkybridgeLitigationMember_1947241b-5ceb-4edf-a20a-1dc315dd575e" xlink:href="alts-20241228.xsd#alts_SkybridgeLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b616d20c-b2c4-4138-aebf-d903cb267430" xlink:to="loc_alts_SkybridgeLitigationMember_1947241b-5ceb-4edf-a20a-1dc315dd575e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AlixpartnersLLCLitigationMember_822426b8-bd8c-4a2d-80a1-7fde0fd787d8" xlink:href="alts-20241228.xsd#alts_AlixpartnersLLCLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b616d20c-b2c4-4138-aebf-d903cb267430" xlink:to="loc_alts_AlixpartnersLLCLitigationMember_822426b8-bd8c-4a2d-80a1-7fde0fd787d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Main270LLCLitigationMember_7e0e63dd-3849-44a6-be32-094d564259db" xlink:href="alts-20241228.xsd#alts_Main270LLCLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b616d20c-b2c4-4138-aebf-d903cb267430" xlink:to="loc_alts_Main270LLCLitigationMember_7e0e63dd-3849-44a6-be32-094d564259db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_WestervilleSquareLitigationMember_d8c4afa2-3855-4da3-81c2-386aaa8898b4" xlink:href="alts-20241228.xsd#alts_WestervilleSquareLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b616d20c-b2c4-4138-aebf-d903cb267430" xlink:to="loc_alts_WestervilleSquareLitigationMember_d8c4afa2-3855-4da3-81c2-386aaa8898b4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherCommitmentsAndLitigationCasesMember_335fd752-71e0-4eec-b3ec-10d48d75d98d" xlink:href="alts-20241228.xsd#alts_OtherCommitmentsAndLitigationCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b616d20c-b2c4-4138-aebf-d903cb267430" xlink:to="loc_alts_OtherCommitmentsAndLitigationCasesMember_335fd752-71e0-4eec-b3ec-10d48d75d98d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_5d869c6c-8432-484a-afc0-b27da228ff70" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_ba0d1c78-014f-4d06-ac16-594c85151b68" xlink:to="loc_srt_CounterpartyNameAxis_5d869c6c-8432-484a-afc0-b27da228ff70" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5d869c6c-8432-484a-afc0-b27da228ff70_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_5d869c6c-8432-484a-afc0-b27da228ff70" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5d869c6c-8432-484a-afc0-b27da228ff70_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c5a3ce4-271a-48d7-a55e-298918644d46" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_5d869c6c-8432-484a-afc0-b27da228ff70" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c5a3ce4-271a-48d7-a55e-298918644d46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SkyBridgeAmericasMember_8e4ef081-0002-481f-a200-67f39825a415" xlink:href="alts-20241228.xsd#alts_SkyBridgeAmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c5a3ce4-271a-48d7-a55e-298918644d46" xlink:to="loc_alts_SkyBridgeAmericasMember_8e4ef081-0002-481f-a200-67f39825a415" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AlixpartnersLLCMember_5edc46c8-beff-435d-a41c-c1825f5aabdd" xlink:href="alts-20241228.xsd#alts_AlixpartnersLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c5a3ce4-271a-48d7-a55e-298918644d46" xlink:to="loc_alts_AlixpartnersLLCMember_5edc46c8-beff-435d-a41c-c1825f5aabdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_TrusteesMain270LlcMember_66d0c37c-d629-4e2f-9470-4dfcd0524f8c" xlink:href="alts-20241228.xsd#alts_TrusteesMain270LlcMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c5a3ce4-271a-48d7-a55e-298918644d46" xlink:to="loc_alts_TrusteesMain270LlcMember_66d0c37c-d629-4e2f-9470-4dfcd0524f8c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_WestervilleSquareMember_5e69aa3e-0d3d-49fc-beaa-d8e514ce33ec" xlink:href="alts-20241228.xsd#alts_WestervilleSquareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c5a3ce4-271a-48d7-a55e-298918644d46" xlink:to="loc_alts_WestervilleSquareMember_5e69aa3e-0d3d-49fc-beaa-d8e514ce33ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_UnaffiliatedThirdPartyMember_cb9d4720-39a2-4545-b521-95354151cbbd" xlink:href="alts-20241228.xsd#alts_UnaffiliatedThirdPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c5a3ce4-271a-48d7-a55e-298918644d46" xlink:to="loc_alts_UnaffiliatedThirdPartyMember_cb9d4720-39a2-4545-b521-95354151cbbd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Mr.SullivanMember_fa937b86-75a5-4f8f-ac63-5a8e664eca35" xlink:href="alts-20241228.xsd#alts_Mr.SullivanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c5a3ce4-271a-48d7-a55e-298918644d46" xlink:to="loc_alts_Mr.SullivanMember_fa937b86-75a5-4f8f-ac63-5a8e664eca35" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_c9a18ca1-6f35-4894-bba6-1ec06b4ebaf1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_ba0d1c78-014f-4d06-ac16-594c85151b68" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_c9a18ca1-6f35-4894-bba6-1ec06b4ebaf1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_c9a18ca1-6f35-4894-bba6-1ec06b4ebaf1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_c9a18ca1-6f35-4894-bba6-1ec06b4ebaf1" xlink:to="loc_us-gaap_LossContingencyNatureDomain_c9a18ca1-6f35-4894-bba6-1ec06b4ebaf1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_9d5bf6bb-a4e9-441c-96dc-353c6b9407c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_c9a18ca1-6f35-4894-bba6-1ec06b4ebaf1" xlink:to="loc_us-gaap_LossContingencyNatureDomain_9d5bf6bb-a4e9-441c-96dc-353c6b9407c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LegalFeesMember_7b5d8a99-2155-4c16-bea5-f8ef7c6f2166" xlink:href="alts-20241228.xsd#alts_LegalFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_9d5bf6bb-a4e9-441c-96dc-353c6b9407c6" xlink:to="loc_alts_LegalFeesMember_7b5d8a99-2155-4c16-bea5-f8ef7c6f2166" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8b683a02-7b3f-4545-95ad-5f12793666f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_ba0d1c78-014f-4d06-ac16-594c85151b68" xlink:to="loc_us-gaap_DebtInstrumentAxis_8b683a02-7b3f-4545-95ad-5f12793666f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8b683a02-7b3f-4545-95ad-5f12793666f0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_8b683a02-7b3f-4545-95ad-5f12793666f0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8b683a02-7b3f-4545-95ad-5f12793666f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b209632b-1eb2-4061-b3b7-4bc0ff1f9fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_8b683a02-7b3f-4545-95ad-5f12793666f0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b209632b-1eb2-4061-b3b7-4bc0ff1f9fc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PromissoryNoteMember_ea8fd04f-1e19-4a55-9a02-1ccea93c5333" xlink:href="alts-20241228.xsd#alts_PromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b209632b-1eb2-4061-b3b7-4bc0ff1f9fc1" xlink:to="loc_alts_PromissoryNoteMember_ea8fd04f-1e19-4a55-9a02-1ccea93c5333" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3e3ef649-e64e-4a01-841a-ea7d08151387" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_ba0d1c78-014f-4d06-ac16-594c85151b68" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3e3ef649-e64e-4a01-841a-ea7d08151387" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3e3ef649-e64e-4a01-841a-ea7d08151387_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3e3ef649-e64e-4a01-841a-ea7d08151387" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3e3ef649-e64e-4a01-841a-ea7d08151387_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f84bb40d-2252-483a-8ad8-5421a1adccc3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3e3ef649-e64e-4a01-841a-ea7d08151387" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f84bb40d-2252-483a-8ad8-5421a1adccc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_GeoTraqIncMember_7e3dccee-e6a1-4d94-8626-2cc510ca7957" xlink:href="alts-20241228.xsd#alts_GeoTraqIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f84bb40d-2252-483a-8ad8-5421a1adccc3" xlink:to="loc_alts_GeoTraqIncMember_7e3dccee-e6a1-4d94-8626-2cc510ca7957" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_ec268977-a757-4ca2-b9c5-62f501dd1e31" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_ba0d1c78-014f-4d06-ac16-594c85151b68" xlink:to="loc_dei_LegalEntityAxis_ec268977-a757-4ca2-b9c5-62f501dd1e31" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ec268977-a757-4ca2-b9c5-62f501dd1e31_default" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_ec268977-a757-4ca2-b9c5-62f501dd1e31" xlink:to="loc_dei_EntityDomain_ec268977-a757-4ca2-b9c5-62f501dd1e31_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_06b9941a-cc94-4050-a3b4-a18785768417" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_ec268977-a757-4ca2-b9c5-62f501dd1e31" xlink:to="loc_dei_EntityDomain_06b9941a-cc94-4050-a3b4-a18785768417" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ApplianceSmartIncMember_68ed091a-c51a-4c08-b4df-87a129cad9f9" xlink:href="alts-20241228.xsd#alts_ApplianceSmartIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_06b9941a-cc94-4050-a3b4-a18785768417" xlink:to="loc_alts_ApplianceSmartIncMember_68ed091a-c51a-4c08-b4df-87a129cad9f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_15a39001-50aa-47e0-ae7b-31e31a7c4406" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_ba0d1c78-014f-4d06-ac16-594c85151b68" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_15a39001-50aa-47e0-ae7b-31e31a7c4406" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_15a39001-50aa-47e0-ae7b-31e31a7c4406_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_15a39001-50aa-47e0-ae7b-31e31a7c4406" xlink:to="loc_us-gaap_RelatedPartyDomain_15a39001-50aa-47e0-ae7b-31e31a7c4406_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_4753b739-403d-401c-b833-270d44bc87ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_15a39001-50aa-47e0-ae7b-31e31a7c4406" xlink:to="loc_us-gaap_RelatedPartyDomain_4753b739-403d-401c-b833-270d44bc87ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_5ecf8de1-8eb2-4af8-8c20-b7f54f270242" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_4753b739-403d-401c-b833-270d44bc87ab" xlink:to="loc_us-gaap_RelatedPartyMember_5ecf8de1-8eb2-4af8-8c20-b7f54f270242" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LossContingencyNumberOfExecutiveOfficersNamedInComplaint_85c4c6e8-a664-404c-b6c5-efd934475c7f" xlink:href="alts-20241228.xsd#alts_LossContingencyNumberOfExecutiveOfficersNamedInComplaint"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_alts_LossContingencyNumberOfExecutiveOfficersNamedInComplaint_85c4c6e8-a664-404c-b6c5-efd934475c7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_96e1a915-6c0f-4b51-b1d1-9d0e1f80a601" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_96e1a915-6c0f-4b51-b1d1-9d0e1f80a601" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LitigationSettlementAmountAwardedToOtherPartyNumberOfPeriodicPayments_f6791096-1900-4eca-9c4f-6017662e999b" xlink:href="alts-20241228.xsd#alts_LitigationSettlementAmountAwardedToOtherPartyNumberOfPeriodicPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_alts_LitigationSettlementAmountAwardedToOtherPartyNumberOfPeriodicPayments_f6791096-1900-4eca-9c4f-6017662e999b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LitigationSettlementAmountAwardedToOtherPartyPeriodicPayments_ad7ec5c3-09d6-4d9e-afe2-eceb0ba401b6" xlink:href="alts-20241228.xsd#alts_LitigationSettlementAmountAwardedToOtherPartyPeriodicPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_alts_LitigationSettlementAmountAwardedToOtherPartyPeriodicPayments_ad7ec5c3-09d6-4d9e-afe2-eceb0ba401b6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_a1da4c5e-ae26-4cad-993d-1447ff881591" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_a1da4c5e-ae26-4cad-993d-1447ff881591" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_9bbba3e8-a1c2-47ce-bdb4-ffc4f809735d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_9bbba3e8-a1c2-47ce-bdb4-ffc4f809735d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_05921929-5855-4b35-ade9-851ce275009e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_05921929-5855-4b35-ade9-851ce275009e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_8dee4d75-6b1f-4964-8344-3c4859d273d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_8dee4d75-6b1f-4964-8344-3c4859d273d8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1_b0e1f6c8-3ae9-4da5-ad29-8a74882e6ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionOriginalDebtAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_us-gaap_DebtConversionOriginalDebtAmount1_b0e1f6c8-3ae9-4da5-ad29-8a74882e6ccd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_58f8ff58-8b35-4617-84bc-eab1e443736b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_58f8ff58-8b35-4617-84bc-eab1e443736b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_de8706a8-1cb9-4788-9733-f8d8dea1f922" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_de8706a8-1cb9-4788-9733-f8d8dea1f922" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_bb86fa77-abf2-49b0-808b-d81c7387ea2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_bb86fa77-abf2-49b0-808b-d81c7387ea2e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NumberOfTranches_6ded67d4-7fdd-4853-8801-770a5b43a8f6" xlink:href="alts-20241228.xsd#alts_NumberOfTranches"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_alts_NumberOfTranches_6ded67d4-7fdd-4853-8801-770a5b43a8f6" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_5ba22989-2572-4a73-bd74-4eab9767b11b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_5ba22989-2572-4a73-bd74-4eab9767b11b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b95659cf-26e8-49de-9e93-91b382697568" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b95659cf-26e8-49de-9e93-91b382697568" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherCommitmentsNumberOfLandlordsOriginallyPurportedToBeLiableFor_2afe9742-dd33-4720-a8a6-6f09bdbe3b8c" xlink:href="alts-20241228.xsd#alts_OtherCommitmentsNumberOfLandlordsOriginallyPurportedToBeLiableFor"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_alts_OtherCommitmentsNumberOfLandlordsOriginallyPurportedToBeLiableFor_2afe9742-dd33-4720-a8a6-6f09bdbe3b8c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OperatingLeasesFutureMinimumPaymentsDue1_43a8f546-1979-4d7a-837a-ad24b5be9289" xlink:href="alts-20241228.xsd#alts_OperatingLeasesFutureMinimumPaymentsDue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_alts_OperatingLeasesFutureMinimumPaymentsDue1_43a8f546-1979-4d7a-837a-ad24b5be9289" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherCommitmentsNumberOfLandlordsCompanyIsNoLongerLiableFor_1ab9902d-fa67-4a98-a508-6e4bb0b7d4af" xlink:href="alts-20241228.xsd#alts_OtherCommitmentsNumberOfLandlordsCompanyIsNoLongerLiableFor"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_alts_OtherCommitmentsNumberOfLandlordsCompanyIsNoLongerLiableFor_1ab9902d-fa67-4a98-a508-6e4bb0b7d4af" xlink:type="arc" order="17"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/SegmentinformationScheduleofSegmentInformationDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#SegmentinformationScheduleofSegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/SegmentinformationScheduleofSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_21636b3a-5bc2-4c86-9d7d-b3fa732de7ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_309c7d72-7f1d-4dde-94fb-53b7300bf459" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_21636b3a-5bc2-4c86-9d7d-b3fa732de7ae" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_309c7d72-7f1d-4dde-94fb-53b7300bf459" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b981e062-cd78-4094-ae0a-6b74a8fac616" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_309c7d72-7f1d-4dde-94fb-53b7300bf459" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b981e062-cd78-4094-ae0a-6b74a8fac616" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b981e062-cd78-4094-ae0a-6b74a8fac616_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b981e062-cd78-4094-ae0a-6b74a8fac616" xlink:to="loc_us-gaap_SegmentDomain_b981e062-cd78-4094-ae0a-6b74a8fac616_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6de0c085-1cd2-4174-86d5-1ab4cbe57af7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b981e062-cd78-4094-ae0a-6b74a8fac616" xlink:to="loc_us-gaap_SegmentDomain_6de0c085-1cd2-4174-86d5-1ab4cbe57af7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_FintechMember_e7339430-62be-468f-9a38-6bc66fbbcba0" xlink:href="alts-20241228.xsd#alts_FintechMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6de0c085-1cd2-4174-86d5-1ab4cbe57af7" xlink:to="loc_alts_FintechMember_e7339430-62be-468f-9a38-6bc66fbbcba0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BiotechnologyMember_22cebe16-4ebc-4d4c-99eb-8e7c75abf7a4" xlink:href="alts-20241228.xsd#alts_BiotechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6de0c085-1cd2-4174-86d5-1ab4cbe57af7" xlink:to="loc_alts_BiotechnologyMember_22cebe16-4ebc-4d4c-99eb-8e7c75abf7a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember_d82e65c6-c4d1-4c35-8c16-df4d5114747f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6de0c085-1cd2-4174-86d5-1ab4cbe57af7" xlink:to="loc_us-gaap_CorporateAndOtherMember_d82e65c6-c4d1-4c35-8c16-df4d5114747f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RecyclingSegmentMember_dc439d1b-b891-45af-a202-c5055e53133b" xlink:href="alts-20241228.xsd#alts_RecyclingSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6de0c085-1cd2-4174-86d5-1ab4cbe57af7" xlink:to="loc_alts_RecyclingSegmentMember_dc439d1b-b891-45af-a202-c5055e53133b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_59173380-a279-4490-bc93-eb8bc90340b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_309c7d72-7f1d-4dde-94fb-53b7300bf459" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_59173380-a279-4490-bc93-eb8bc90340b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_59173380-a279-4490-bc93-eb8bc90340b6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_59173380-a279-4490-bc93-eb8bc90340b6" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_59173380-a279-4490-bc93-eb8bc90340b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_a1101097-2c90-4565-925d-2eb4882d6e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_59173380-a279-4490-bc93-eb8bc90340b6" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_a1101097-2c90-4565-925d-2eb4882d6e4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_2800d228-03ee-4c3b-9fe8-8cafa746206e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_a1101097-2c90-4565-925d-2eb4882d6e4c" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_2800d228-03ee-4c3b-9fe8-8cafa746206e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ContinuingOperationsAndDiscontinuedOperationsMember_8e142e6a-4716-4cd7-8f71-a4c274be7dcc" xlink:href="alts-20241228.xsd#alts_ContinuingOperationsAndDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_a1101097-2c90-4565-925d-2eb4882d6e4c" xlink:to="loc_alts_ContinuingOperationsAndDiscontinuedOperationsMember_8e142e6a-4716-4cd7-8f71-a4c274be7dcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e689ed51-55a5-4288-9b9d-cb998b2841df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_21636b3a-5bc2-4c86-9d7d-b3fa732de7ae" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e689ed51-55a5-4288-9b9d-cb998b2841df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_a5863d54-5bcf-496b-be1e-d61f7284a02d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_21636b3a-5bc2-4c86-9d7d-b3fa732de7ae" xlink:to="loc_us-gaap_GrossProfit_a5863d54-5bcf-496b-be1e-d61f7284a02d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e021a549-f73c-483e-8d18-bd55888043fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_21636b3a-5bc2-4c86-9d7d-b3fa732de7ae" xlink:to="loc_us-gaap_OperatingIncomeLoss_e021a549-f73c-483e-8d18-bd55888043fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_a0bd3d66-e2a6-4ac2-b65a-a39278aec12f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_21636b3a-5bc2-4c86-9d7d-b3fa732de7ae" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_a0bd3d66-e2a6-4ac2-b65a-a39278aec12f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_4220448f-66e8-4d56-98d8-d6945d3682d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_21636b3a-5bc2-4c86-9d7d-b3fa732de7ae" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_4220448f-66e8-4d56-98d8-d6945d3682d2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ec10df8d-a6c6-4e68-921e-cf1caa6fe6dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_21636b3a-5bc2-4c86-9d7d-b3fa732de7ae" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ec10df8d-a6c6-4e68-921e-cf1caa6fe6dc" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/SegmentinformationScheduleofBalanceSheetInformationDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#SegmentinformationScheduleofBalanceSheetInformationDetails"/>
  <link:definitionLink xlink:role="http://www.alt5sigma.com/role/SegmentinformationScheduleofBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_66718cc7-205a-48ef-a003-430abe428ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_27218ae9-a3d3-442a-9d7a-c0c3b454ed08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_66718cc7-205a-48ef-a003-430abe428ad9" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_27218ae9-a3d3-442a-9d7a-c0c3b454ed08" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3232f3c9-25ad-4d23-920e-20f325f63711" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_27218ae9-a3d3-442a-9d7a-c0c3b454ed08" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3232f3c9-25ad-4d23-920e-20f325f63711" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3232f3c9-25ad-4d23-920e-20f325f63711_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3232f3c9-25ad-4d23-920e-20f325f63711" xlink:to="loc_us-gaap_SegmentDomain_3232f3c9-25ad-4d23-920e-20f325f63711_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_664c59cd-7434-4994-9eab-78ee2c59e957" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3232f3c9-25ad-4d23-920e-20f325f63711" xlink:to="loc_us-gaap_SegmentDomain_664c59cd-7434-4994-9eab-78ee2c59e957" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_FintechMember_63d5596f-f247-4ff3-b1ea-a66c766c5f29" xlink:href="alts-20241228.xsd#alts_FintechMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_664c59cd-7434-4994-9eab-78ee2c59e957" xlink:to="loc_alts_FintechMember_63d5596f-f247-4ff3-b1ea-a66c766c5f29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BiotechnologyMember_0c3d5151-a31f-4c3f-b439-9336f109e872" xlink:href="alts-20241228.xsd#alts_BiotechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_664c59cd-7434-4994-9eab-78ee2c59e957" xlink:to="loc_alts_BiotechnologyMember_0c3d5151-a31f-4c3f-b439-9336f109e872" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember_c58a0c81-ec1a-47b1-9dc8-8e955162e8b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_664c59cd-7434-4994-9eab-78ee2c59e957" xlink:to="loc_us-gaap_CorporateAndOtherMember_c58a0c81-ec1a-47b1-9dc8-8e955162e8b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RecyclingSegmentMember_0ba317cc-ebf9-44e8-bee4-bf5bfc5982f7" xlink:href="alts-20241228.xsd#alts_RecyclingSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_664c59cd-7434-4994-9eab-78ee2c59e957" xlink:to="loc_alts_RecyclingSegmentMember_0ba317cc-ebf9-44e8-bee4-bf5bfc5982f7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_cb857321-6d6c-4b55-9dcf-2658e5ac42de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_27218ae9-a3d3-442a-9d7a-c0c3b454ed08" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_cb857321-6d6c-4b55-9dcf-2658e5ac42de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_cb857321-6d6c-4b55-9dcf-2658e5ac42de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_cb857321-6d6c-4b55-9dcf-2658e5ac42de" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_cb857321-6d6c-4b55-9dcf-2658e5ac42de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_4638500b-7eda-495a-9dfd-275dbb4851d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_cb857321-6d6c-4b55-9dcf-2658e5ac42de" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_4638500b-7eda-495a-9dfd-275dbb4851d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_240060b3-48ed-41ee-811f-5d91b38585d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_4638500b-7eda-495a-9dfd-275dbb4851d2" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_240060b3-48ed-41ee-811f-5d91b38585d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ContinuingOperationsAndDiscontinuedOperationsMember_84fb9b51-d1d4-4058-8ef8-6975dcb05128" xlink:href="alts-20241228.xsd#alts_ContinuingOperationsAndDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_4638500b-7eda-495a-9dfd-275dbb4851d2" xlink:to="loc_alts_ContinuingOperationsAndDiscontinuedOperationsMember_84fb9b51-d1d4-4058-8ef8-6975dcb05128" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_f4c5b00b-5597-4583-8973-af279a2e6351" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_66718cc7-205a-48ef-a003-430abe428ad9" xlink:to="loc_us-gaap_Assets_f4c5b00b-5597-4583-8973-af279a2e6351" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_fe3616b0-1f08-4ffe-bdf1-d19c55db8a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_66718cc7-205a-48ef-a003-430abe428ad9" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_fe3616b0-1f08-4ffe-bdf1-d19c55db8a1e" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>alts-20241228_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:2830d163-e030-49d1-a620-63415283e8e5,g:d25a092d-1f61-4617-aa79-df61d6af7f3a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent_67a6dafc-b54d-4412-941a-589950884c9e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade and other receivables, net</link:label>
    <link:label id="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent_6b49d9fa-83cf-4178-9fdd-639a1cdafe65_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Trade and other receivables, net</link:label>
    <link:label id="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts and Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:to="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_AlixpartnersLLCMember_7c2ca396-2add-4682-ae7b-ff5983bb5fbf_terseLabel_en-US" xlink:label="lab_alts_AlixpartnersLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Alixpartners, LLC</link:label>
    <link:label id="lab_alts_AlixpartnersLLCMember_label_en-US" xlink:label="lab_alts_AlixpartnersLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alixpartners, LLC [Member]</link:label>
    <link:label id="lab_alts_AlixpartnersLLCMember_documentation_en-US" xlink:label="lab_alts_AlixpartnersLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Alixpartners, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AlixpartnersLLCMember" xlink:href="alts-20241228.xsd#alts_AlixpartnersLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_AlixpartnersLLCMember" xlink:to="lab_alts_AlixpartnersLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_ProvisionBenefitOfIncomeTaxes_2580a8e5-6f08-4f63-9bae-c5fb74f4e149_totalLabel_en-US" xlink:label="lab_alts_ProvisionBenefitOfIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total (benefit) provision of income taxes</link:label>
    <link:label id="lab_alts_ProvisionBenefitOfIncomeTaxes_label_en-US" xlink:label="lab_alts_ProvisionBenefitOfIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Provision (Benefit) Of Income Taxes</link:label>
    <link:label id="lab_alts_ProvisionBenefitOfIncomeTaxes_documentation_en-US" xlink:label="lab_alts_ProvisionBenefitOfIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Provision (Benefit) Of Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ProvisionBenefitOfIncomeTaxes" xlink:href="alts-20241228.xsd#alts_ProvisionBenefitOfIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_ProvisionBenefitOfIncomeTaxes" xlink:to="lab_alts_ProvisionBenefitOfIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2335c34e-112b-4102-9748-26d23271d724_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net loss to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_588c9951-c6c4-4d5c-854d-f2aaf92c989b_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related parties</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetUnderConstructionMember_02bc1703-704c-42d8-8b19-36c1524e0c27_terseLabel_en-US" xlink:label="lab_us-gaap_AssetUnderConstructionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Projects under construction</link:label>
    <link:label id="lab_us-gaap_AssetUnderConstructionMember_label_en-US" xlink:label="lab_us-gaap_AssetUnderConstructionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset under Construction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetUnderConstructionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetUnderConstructionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetUnderConstructionMember" xlink:to="lab_us-gaap_AssetUnderConstructionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_6f3fa385-c6f6-42ae-afe4-ad30eb4fbf37_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_d5a8737d-0e67-4dd2-83e6-6e5e371cdd93_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ee9a2b5a-1616-4baa-a12b-1c0f7e3af1c4_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ea39680b-0211-47ec-a84e-5f74d3e040e1_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">DECREASE IN CASH AND CASH EQUIVALENTS</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_SaleOfStockUnitCompositionNumberOfCommonSharesInEachUnit_c048edf6-d078-455d-9c5a-f585304979bf_terseLabel_en-US" xlink:label="lab_alts_SaleOfStockUnitCompositionNumberOfCommonSharesInEachUnit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of common shares in each unit (in shares)</link:label>
    <link:label id="lab_alts_SaleOfStockUnitCompositionNumberOfCommonSharesInEachUnit_label_en-US" xlink:label="lab_alts_SaleOfStockUnitCompositionNumberOfCommonSharesInEachUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Unit Composition, Number Of Common Shares In Each Unit</link:label>
    <link:label id="lab_alts_SaleOfStockUnitCompositionNumberOfCommonSharesInEachUnit_documentation_en-US" xlink:label="lab_alts_SaleOfStockUnitCompositionNumberOfCommonSharesInEachUnit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale of Stock, Unit Composition, Number Of Common Shares In Each Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SaleOfStockUnitCompositionNumberOfCommonSharesInEachUnit" xlink:href="alts-20241228.xsd#alts_SaleOfStockUnitCompositionNumberOfCommonSharesInEachUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_SaleOfStockUnitCompositionNumberOfCommonSharesInEachUnit" xlink:to="lab_alts_SaleOfStockUnitCompositionNumberOfCommonSharesInEachUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_60541767-a0cf-4f2c-8d04-14258e78b95a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Total Present Value of Future Lease Payments of Operating Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_5922eb81-68fe-4815-b9c6-cb172c20a8e8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DigitalAssetLiabilityCurrent_77d2ce72-c60b-473c-9662-87f375a735a9_terseLabel_en-US" xlink:label="lab_alts_DigitalAssetLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Digital assets payable</link:label>
    <link:label id="lab_alts_DigitalAssetLiabilityCurrent_label_en-US" xlink:label="lab_alts_DigitalAssetLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Digital Asset, Liability, Current</link:label>
    <link:label id="lab_alts_DigitalAssetLiabilityCurrent_documentation_en-US" xlink:label="lab_alts_DigitalAssetLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Digital Asset, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DigitalAssetLiabilityCurrent" xlink:href="alts-20241228.xsd#alts_DigitalAssetLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DigitalAssetLiabilityCurrent" xlink:to="lab_alts_DigitalAssetLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScenarioAdjustmentMember_eb318bbd-ee24-41b8-b007-858f764d3d1e_terseLabel_en-US" xlink:label="lab_us-gaap_ScenarioAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments</link:label>
    <link:label id="lab_us-gaap_ScenarioAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_ScenarioAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScenarioAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScenarioAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScenarioAdjustmentMember" xlink:to="lab_us-gaap_ScenarioAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_7c148a7d-86db-42f9-bc5e-357470c50078_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_a56d003f-b22c-4e36-9901-87e58e7f9339_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding, ownership (as percent)</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DisposalOfAccountsPayable_368f1831-b7ac-4c6d-8e85-a3b041840da4_terseLabel_en-US" xlink:label="lab_alts_DisposalOfAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_alts_DisposalOfAccountsPayable_label_en-US" xlink:label="lab_alts_DisposalOfAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal of Accounts Payable</link:label>
    <link:label id="lab_alts_DisposalOfAccountsPayable_documentation_en-US" xlink:label="lab_alts_DisposalOfAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal of Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfAccountsPayable" xlink:href="alts-20241228.xsd#alts_DisposalOfAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DisposalOfAccountsPayable" xlink:to="lab_alts_DisposalOfAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_SeriesS1PreferredMember_3ae2432d-e55f-444c-8cfd-55e1a3258dda_terseLabel_en-US" xlink:label="lab_alts_SeriesS1PreferredMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series S-1 Preferred</link:label>
    <link:label id="lab_alts_SeriesS1PreferredMember_label_en-US" xlink:label="lab_alts_SeriesS1PreferredMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series S - 1 Preferred [Member]</link:label>
    <link:label id="lab_alts_SeriesS1PreferredMember_documentation_en-US" xlink:label="lab_alts_SeriesS1PreferredMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series S - 1 Preferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesS1PreferredMember" xlink:href="alts-20241228.xsd#alts_SeriesS1PreferredMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_SeriesS1PreferredMember" xlink:to="lab_alts_SeriesS1PreferredMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_79e33a0c-9cb6-4515-bc6d-0e162eaa1b55_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetRentableArea_404e9e74-e2b4-4e47-82d8-d8aa116dac08_terseLabel_en-US" xlink:label="lab_us-gaap_NetRentableArea" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rented office space (in sqft)</link:label>
    <link:label id="lab_us-gaap_NetRentableArea_label_en-US" xlink:label="lab_us-gaap_NetRentableArea" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Rentable Area</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetRentableArea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetRentableArea"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetRentableArea" xlink:to="lab_us-gaap_NetRentableArea" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a49f7aef-f131-4f48-93ac-6359cf95a2d2_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Name</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DebtInstrumentCovenantPeriodDomain_684e4121-6713-4930-8e5e-be6bdda82f05_terseLabel_en-US" xlink:label="lab_alts_DebtInstrumentCovenantPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant Period [Domain]</link:label>
    <link:label id="lab_alts_DebtInstrumentCovenantPeriodDomain_label_en-US" xlink:label="lab_alts_DebtInstrumentCovenantPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant Period [Domain]</link:label>
    <link:label id="lab_alts_DebtInstrumentCovenantPeriodDomain_documentation_en-US" xlink:label="lab_alts_DebtInstrumentCovenantPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentCovenantPeriodDomain" xlink:href="alts-20241228.xsd#alts_DebtInstrumentCovenantPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DebtInstrumentCovenantPeriodDomain" xlink:to="lab_alts_DebtInstrumentCovenantPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_398d8fb9-0e69-4f32-8def-1cdb41b144d1_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_80384966-0f3c-489a-af95-3edd02634fd1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_08a7b626-aef2-4560-a6be-7b2b1428d502_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_0a7324ae-1e45-4db8-8fcf-2e9b6184bc69_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Background and Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_AdjustmentToAdditionalPaidInCapitalReclassificationsOfTemporaryToLiability_f78d5c93-93da-4ee6-92c4-0c9529430ba5_negatedTerseLabel_en-US" xlink:label="lab_alts_AdjustmentToAdditionalPaidInCapitalReclassificationsOfTemporaryToLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Reclassification of Series S S-1 Preferred Stock to liability</link:label>
    <link:label id="lab_alts_AdjustmentToAdditionalPaidInCapitalReclassificationsOfTemporaryToLiability_label_en-US" xlink:label="lab_alts_AdjustmentToAdditionalPaidInCapitalReclassificationsOfTemporaryToLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To Additional Paid in Capital, Reclassifications of Temporary To Liability</link:label>
    <link:label id="lab_alts_AdjustmentToAdditionalPaidInCapitalReclassificationsOfTemporaryToLiability_documentation_en-US" xlink:label="lab_alts_AdjustmentToAdditionalPaidInCapitalReclassificationsOfTemporaryToLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustment To Additional Paid in Capital, Reclassifications of Temporary To Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AdjustmentToAdditionalPaidInCapitalReclassificationsOfTemporaryToLiability" xlink:href="alts-20241228.xsd#alts_AdjustmentToAdditionalPaidInCapitalReclassificationsOfTemporaryToLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_AdjustmentToAdditionalPaidInCapitalReclassificationsOfTemporaryToLiability" xlink:to="lab_alts_AdjustmentToAdditionalPaidInCapitalReclassificationsOfTemporaryToLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashSurrenderValueOfLifeInsurance_0243cce1-6634-49bb-af3a-8b632d97960c_terseLabel_en-US" xlink:label="lab_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash surrender value of life insurance</link:label>
    <link:label id="lab_us-gaap_CashSurrenderValueOfLifeInsurance_label_en-US" xlink:label="lab_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Surrender Value of Life Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashSurrenderValueOfLifeInsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:to="lab_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_NumberOfTranches_a9e47a4f-0e49-48db-9b94-00a73d7edd2b_terseLabel_en-US" xlink:label="lab_alts_NumberOfTranches" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of tranches</link:label>
    <link:label id="lab_alts_NumberOfTranches_label_en-US" xlink:label="lab_alts_NumberOfTranches" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Tranches</link:label>
    <link:label id="lab_alts_NumberOfTranches_documentation_en-US" xlink:label="lab_alts_NumberOfTranches" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Tranches</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NumberOfTranches" xlink:href="alts-20241228.xsd#alts_NumberOfTranches"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_NumberOfTranches" xlink:to="lab_alts_NumberOfTranches" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_19300563-4800-4937-8021-231b39936fb3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_b2247740-e0e6-49ba-9ce6-beea0ee6d719_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_PercentageOfGrossRevenue_365a28e7-4831-4d63-bc99-ef33b9b9a71e_terseLabel_en-US" xlink:label="lab_alts_PercentageOfGrossRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of gross revenue</link:label>
    <link:label id="lab_alts_PercentageOfGrossRevenue_label_en-US" xlink:label="lab_alts_PercentageOfGrossRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage of Gross Revenue</link:label>
    <link:label id="lab_alts_PercentageOfGrossRevenue_documentation_en-US" xlink:label="lab_alts_PercentageOfGrossRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage of Gross Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PercentageOfGrossRevenue" xlink:href="alts-20241228.xsd#alts_PercentageOfGrossRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_PercentageOfGrossRevenue" xlink:to="lab_alts_PercentageOfGrossRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_d942b5ba-c252-483a-a8c7-10bdc4039075_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Series A-1 Preferred forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_7bf7e840-1ec4-4e7c-9831-75c88ac746e0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Securities received</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_LossContingencyNumberOfExecutiveOfficersNamedInComplaint_dc82e64a-efc4-47d3-9bf7-a1c909556a0b_terseLabel_en-US" xlink:label="lab_alts_LossContingencyNumberOfExecutiveOfficersNamedInComplaint" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of executive officers named in complaint</link:label>
    <link:label id="lab_alts_LossContingencyNumberOfExecutiveOfficersNamedInComplaint_label_en-US" xlink:label="lab_alts_LossContingencyNumberOfExecutiveOfficersNamedInComplaint" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number Of Executive Officers Named In Complaint</link:label>
    <link:label id="lab_alts_LossContingencyNumberOfExecutiveOfficersNamedInComplaint_documentation_en-US" xlink:label="lab_alts_LossContingencyNumberOfExecutiveOfficersNamedInComplaint" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number Of Executive Officers Named In Complaint</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LossContingencyNumberOfExecutiveOfficersNamedInComplaint" xlink:href="alts-20241228.xsd#alts_LossContingencyNumberOfExecutiveOfficersNamedInComplaint"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_LossContingencyNumberOfExecutiveOfficersNamedInComplaint" xlink:to="lab_alts_LossContingencyNumberOfExecutiveOfficersNamedInComplaint" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_88fb6748-66ed-4818-829a-15530a8b8c04_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_ece9977e-5d31-442a-8c75-0b5b12a08b5f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax credits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_59aab56c-4e55-4fb2-a106-4b4dfc07c3d4_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, price per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_56b18417-f567-4c2c-9446-5a1ba73de2a1_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_9cf4c4f3-a707-4b36-9651-96fb6ce84199_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deposits and other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_8b47785d-90a0-4686-9a1a-a638bf3e7aaa_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_2c18a0da-f8ee-4445-9549-c606ee6d8c28_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesIssued" xlink:to="lab_us-gaap_TemporaryEquitySharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_0565fa6a-4e62-446e-86e1-64597b808fa5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_391ead2e-4be2-43c1-a4aa-03babe71ce9d_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments for legal settlements</link:label>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_label_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLegalSettlements" xlink:to="lab_us-gaap_PaymentsForLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_4c88ca1c-53ab-4a86-ba1d-b2e174164db8_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of provision for income taxes with federal statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_8a0cace6-c14a-42d3-af87-efb199087c60_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_label_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_eeaaad78-79ff-42d2-9a45-cdccecc3442b_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_af34673d-4786-41b9-a990-424830e57f0a_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">OPERATING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DisposalOfRightOfUseAssets_a41ab630-0dd6-4ffb-8b27-c3a5a4b44cb5_terseLabel_en-US" xlink:label="lab_alts_DisposalOfRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_alts_DisposalOfRightOfUseAssets_label_en-US" xlink:label="lab_alts_DisposalOfRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal of Right-of-use Assets</link:label>
    <link:label id="lab_alts_DisposalOfRightOfUseAssets_documentation_en-US" xlink:label="lab_alts_DisposalOfRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal of Right-of-use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfRightOfUseAssets" xlink:href="alts-20241228.xsd#alts_DisposalOfRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DisposalOfRightOfUseAssets" xlink:to="lab_alts_DisposalOfRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_1183736e-9ba0-4d16-bd8d-26a4411a4a31_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_SmallWarrantMember_5e76b196-de82-4370-aaaf-a0974bba15a9_terseLabel_en-US" xlink:label="lab_alts_SmallWarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Small Warrant</link:label>
    <link:label id="lab_alts_SmallWarrantMember_label_en-US" xlink:label="lab_alts_SmallWarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Small Warrant [Member]</link:label>
    <link:label id="lab_alts_SmallWarrantMember_documentation_en-US" xlink:label="lab_alts_SmallWarrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Small Warrant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SmallWarrantMember" xlink:href="alts-20241228.xsd#alts_SmallWarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_SmallWarrantMember" xlink:to="lab_alts_SmallWarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_2c30c969-39ca-43e0-ba26-2425120ba2c6_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract_7660d3d5-08eb-40ca-8b71-a4f98450a914_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Continuing Operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_d2cf11a0-5ec6-45f2-867e-21571157de91_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_88568c07-aafa-4276-879d-0f2a4128a12d_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_4f0e3b77-dce2-4c8e-bfd1-d3a009cfb8db_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_d835454f-16cf-4ace-93e1-d36206a0e66a_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DigitalAssetLiabilityCurrentDigitalAssets_b770e2f3-e412-486a-b77a-fc7f5aec3046_terseLabel_en-US" xlink:label="lab_alts_DigitalAssetLiabilityCurrentDigitalAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Digital assets</link:label>
    <link:label id="lab_alts_DigitalAssetLiabilityCurrentDigitalAssets_label_en-US" xlink:label="lab_alts_DigitalAssetLiabilityCurrentDigitalAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Digital Asset, Liability, Current, Digital Assets</link:label>
    <link:label id="lab_alts_DigitalAssetLiabilityCurrentDigitalAssets_documentation_en-US" xlink:label="lab_alts_DigitalAssetLiabilityCurrentDigitalAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Digital Asset, Liability, Current, Digital Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DigitalAssetLiabilityCurrentDigitalAssets" xlink:href="alts-20241228.xsd#alts_DigitalAssetLiabilityCurrentDigitalAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DigitalAssetLiabilityCurrentDigitalAssets" xlink:to="lab_alts_DigitalAssetLiabilityCurrentDigitalAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_SkybridgeLitigationMember_d40763a6-fe6d-45b5-ac84-5f07bcac980f_terseLabel_en-US" xlink:label="lab_alts_SkybridgeLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Skybridge Litigation</link:label>
    <link:label id="lab_alts_SkybridgeLitigationMember_label_en-US" xlink:label="lab_alts_SkybridgeLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Skybridge Litigation [Member]</link:label>
    <link:label id="lab_alts_SkybridgeLitigationMember_documentation_en-US" xlink:label="lab_alts_SkybridgeLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Skybridge Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SkybridgeLitigationMember" xlink:href="alts-20241228.xsd#alts_SkybridgeLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_SkybridgeLitigationMember" xlink:to="lab_alts_SkybridgeLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_AggregateIntrinsicValueAbstract_9fcbae5c-9aa9-4827-baff-0576e035f74c_terseLabel_en-US" xlink:label="lab_alts_AggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_alts_AggregateIntrinsicValueAbstract_label_en-US" xlink:label="lab_alts_AggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Intrinsic Value [Abstract]</link:label>
    <link:label id="lab_alts_AggregateIntrinsicValueAbstract_documentation_en-US" xlink:label="lab_alts_AggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AggregateIntrinsicValueAbstract" xlink:href="alts-20241228.xsd#alts_AggregateIntrinsicValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_AggregateIntrinsicValueAbstract" xlink:to="lab_alts_AggregateIntrinsicValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_20814a4f-b212-4bbe-ab6c-6992df985205_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Potentially dilutive shares excluded from earnings per share calculation (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_1686d12d-b3ac-416f-a3ef-f730d33c5237_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionAxis" xlink:to="lab_us-gaap_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_SeriesSConvertiblePreferredStockMember_d9520c83-76f5-446c-b7d6-31f04e4a4922_netLabel_en-US" xlink:label="lab_alts_SeriesSConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Convertible preferred stock, series S - par value $0.001 per share, 200,000 authorized, 100,000 and 100,000 shares issued and outstanding at December&#160;28, 2024 and December&#160;30, 2023, respectively</link:label>
    <link:label id="lab_alts_SeriesSConvertiblePreferredStockMember_468df5d7-be5d-48cb-a8b3-e7a45337dc77_verboseLabel_en-US" xlink:label="lab_alts_SeriesSConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Series S Convertible Preferred Stock</link:label>
    <link:label id="lab_alts_SeriesSConvertiblePreferredStockMember_1675fb28-bcc7-42ba-acb7-63d247d8272c_terseLabel_en-US" xlink:label="lab_alts_SeriesSConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series S</link:label>
    <link:label id="lab_alts_SeriesSConvertiblePreferredStockMember_label_en-US" xlink:label="lab_alts_SeriesSConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series S Convertible Preferred Stock [Member]</link:label>
    <link:label id="lab_alts_SeriesSConvertiblePreferredStockMember_documentation_en-US" xlink:label="lab_alts_SeriesSConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series S Convertible Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesSConvertiblePreferredStockMember" xlink:href="alts-20241228.xsd#alts_SeriesSConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_SeriesSConvertiblePreferredStockMember" xlink:to="lab_alts_SeriesSConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_34d59dcb-1dff-4274-ac46-5e48d3b4e4d7_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_0aa38aa2-df59-4121-a008-dba9ed76d176_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts and Financing Receivables [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts and Financing Receivables [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_66c73a90-c922-42f7-ae6f-7e29e0c82c10_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_67da0710-ca00-4286-a9bb-0f2a34568ab3_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_5d4a0cec-6b19-47b3-96cc-5378aed3cc91_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_e2c41b61-2c1f-488b-9d89-707ee4715924_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7dc25021-8464-41dc-b033-dae67ac14cd8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeInterestEarningAsset_ee53d401-5535-43a7-9eb3-47b5bf221722_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeInterestEarningAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeInterestEarningAsset_label_en-US" xlink:label="lab_us-gaap_InterestIncomeInterestEarningAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income, Interest-Earning Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeInterestEarningAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeInterestEarningAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeInterestEarningAsset" xlink:to="lab_us-gaap_InterestIncomeInterestEarningAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_4c4e2644-28b2-4d7d-95ec-ebcf933dd745_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_65fad416-aa4e-40b3-b734-68a3b72d191e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DisposalOfAccruedLiability_a4f88466-8865-4b28-a88b-e658027c524a_terseLabel_en-US" xlink:label="lab_alts_DisposalOfAccruedLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_alts_DisposalOfAccruedLiability_label_en-US" xlink:label="lab_alts_DisposalOfAccruedLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal of Accrued liability</link:label>
    <link:label id="lab_alts_DisposalOfAccruedLiability_documentation_en-US" xlink:label="lab_alts_DisposalOfAccruedLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal of Accrued liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfAccruedLiability" xlink:href="alts-20241228.xsd#alts_DisposalOfAccruedLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DisposalOfAccruedLiability" xlink:to="lab_alts_DisposalOfAccruedLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_4eb12432-9443-4083-a4bb-db1cea892381_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_NoteReceivableStatedInterestRate_3cf16f3e-e841-4b16-b999-7c7ce296e2ac_terseLabel_en-US" xlink:label="lab_alts_NoteReceivableStatedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Note receivable interest rate (as percent)</link:label>
    <link:label id="lab_alts_NoteReceivableStatedInterestRate_label_en-US" xlink:label="lab_alts_NoteReceivableStatedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note Receivable Stated Interest Rate</link:label>
    <link:label id="lab_alts_NoteReceivableStatedInterestRate_documentation_en-US" xlink:label="lab_alts_NoteReceivableStatedInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Note receivable interest rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NoteReceivableStatedInterestRate" xlink:href="alts-20241228.xsd#alts_NoteReceivableStatedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_NoteReceivableStatedInterestRate" xlink:to="lab_alts_NoteReceivableStatedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_dc858b03-6e23-4c8a-a6d8-7177aeadede1_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Net deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_73361369-b5ae-4afe-ae31-257628bd75dd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Exercise Price for Stock Options Outstanding and Exercisable Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_0e400540-db55-4b6a-9845-fb76761174ff_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_f2ccdf96-c019-4f05-a2bb-c7b465b97506_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_0b4c98be-727e-487b-a7e4-d55d037e5c77_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_f378cc53-08cd-4d6b-afa3-eda49e396b84_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_e051fa50-b5d6-45b3-ad91-dad6a6976940_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_eb34f581-7dd5-4d5b-a95c-8ab767f0b693_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_92788ffe-82e8-4819-9e8c-3adfbad50929_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentContinuingOperationsMember_f1412af1-17c4-4449-a785-be9d112b7b36_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentContinuingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Continuing Operations</link:label>
    <link:label id="lab_us-gaap_SegmentContinuingOperationsMember_label_en-US" xlink:label="lab_us-gaap_SegmentContinuingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Continuing Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentContinuingOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentContinuingOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentContinuingOperationsMember" xlink:to="lab_us-gaap_SegmentContinuingOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ba35fd30-2c42-4bce-849a-0a019f7dc159_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_QodenIntangibleMember_d1f79a9f-e8aa-4848-b934-9dacb99008b3_terseLabel_en-US" xlink:label="lab_alts_QodenIntangibleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Qoden intangible</link:label>
    <link:label id="lab_alts_QodenIntangibleMember_label_en-US" xlink:label="lab_alts_QodenIntangibleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Qoden Intangible [Member]</link:label>
    <link:label id="lab_alts_QodenIntangibleMember_documentation_en-US" xlink:label="lab_alts_QodenIntangibleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Qoden Intangible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_QodenIntangibleMember" xlink:href="alts-20241228.xsd#alts_QodenIntangibleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_QodenIntangibleMember" xlink:to="lab_alts_QodenIntangibleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_b667871e-1fe7-4923-8cd0-327b9787f4ce_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_d7a3cff2-f723-432d-a837-aaf586258036_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrExpirationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date</link:label>
    <link:label id="lab_ecd_TrdArrExpirationDate_label_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrExpirationDate" xlink:to="lab_ecd_TrdArrExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dda31bcc-78cd-4be0-a364-e7d2facb8816_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">INVESTING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_StockIssuedDuringPeriodValuePrepaidInterest_bc6aa560-8297-4b41-b109-04441767f2b4_terseLabel_en-US" xlink:label="lab_alts_StockIssuedDuringPeriodValuePrepaidInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued for prepaid interest</link:label>
    <link:label id="lab_alts_StockIssuedDuringPeriodValuePrepaidInterest_label_en-US" xlink:label="lab_alts_StockIssuedDuringPeriodValuePrepaidInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Prepaid Interest</link:label>
    <link:label id="lab_alts_StockIssuedDuringPeriodValuePrepaidInterest_documentation_en-US" xlink:label="lab_alts_StockIssuedDuringPeriodValuePrepaidInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Prepaid Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockIssuedDuringPeriodValuePrepaidInterest" xlink:href="alts-20241228.xsd#alts_StockIssuedDuringPeriodValuePrepaidInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_StockIssuedDuringPeriodValuePrepaidInterest" xlink:to="lab_alts_StockIssuedDuringPeriodValuePrepaidInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_NetConsideration_e61463c2-f437-401b-b4fa-2b66a35b79dd_totalLabel_en-US" xlink:label="lab_alts_NetConsideration" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net consideration</link:label>
    <link:label id="lab_alts_NetConsideration_label_en-US" xlink:label="lab_alts_NetConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Consideration</link:label>
    <link:label id="lab_alts_NetConsideration_documentation_en-US" xlink:label="lab_alts_NetConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NetConsideration" xlink:href="alts-20241228.xsd#alts_NetConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_NetConsideration" xlink:to="lab_alts_NetConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_281920ab-df59-4d93-b64c-48a5d3f26541_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_7f384ee8-25db-42fe-814d-cd35943c2e54_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current - operating</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockSharesIssued1_b3ff2e57-3932-4f42-930f-ad877b38a518_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares issued upon exchange of convertible preferred stock (in shares)</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockSharesIssued1_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion of Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockSharesIssued1" xlink:to="lab_us-gaap_ConversionOfStockSharesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_SpyrTechnologiesIncMember_ad76b412-5666-4581-98b8-705b54323900_terseLabel_en-US" xlink:label="lab_alts_SpyrTechnologiesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SPYR Technologies Inc.</link:label>
    <link:label id="lab_alts_SpyrTechnologiesIncMember_label_en-US" xlink:label="lab_alts_SpyrTechnologiesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SPYR Technologies Inc. [Member]</link:label>
    <link:label id="lab_alts_SpyrTechnologiesIncMember_documentation_en-US" xlink:label="lab_alts_SpyrTechnologiesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">SPYR Technologies Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SpyrTechnologiesIncMember" xlink:href="alts-20241228.xsd#alts_SpyrTechnologiesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_SpyrTechnologiesIncMember" xlink:to="lab_alts_SpyrTechnologiesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_SeriesQConvertiblePreferredStockMember_3fa2b91a-5b4c-4c01-b968-fbd77bd8aba7_verboseLabel_en-US" xlink:label="lab_alts_SeriesQConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Convertible Preferred stock, series Q - par value $0.001 per share, 2,000,000 authorized, 925,212 and 0 shares issued and outstanding at December&#160;28, 2024 and December&#160;30, 2023, respectively</link:label>
    <link:label id="lab_alts_SeriesQConvertiblePreferredStockMember_c468e4a4-9b75-4046-b559-5d29d60336c0_terseLabel_en-US" xlink:label="lab_alts_SeriesQConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series Q Convertible Preferred Stock</link:label>
    <link:label id="lab_alts_SeriesQConvertiblePreferredStockMember_label_en-US" xlink:label="lab_alts_SeriesQConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series Q Convertible Preferred Stock [Member]</link:label>
    <link:label id="lab_alts_SeriesQConvertiblePreferredStockMember_documentation_en-US" xlink:label="lab_alts_SeriesQConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series Q Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesQConvertiblePreferredStockMember" xlink:href="alts-20241228.xsd#alts_SeriesQConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_SeriesQConvertiblePreferredStockMember" xlink:to="lab_alts_SeriesQConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_cd0adf78-c10f-47fd-80a3-57092a6f1748_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net operating loss</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_PotentialMarketExclusivityPeriod_973dbcc1-ffd2-4f78-9c32-66a3405ed96d_terseLabel_en-US" xlink:label="lab_alts_PotentialMarketExclusivityPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Potential market exclusivity period (in years)</link:label>
    <link:label id="lab_alts_PotentialMarketExclusivityPeriod_label_en-US" xlink:label="lab_alts_PotentialMarketExclusivityPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Potential Market Exclusivity Period</link:label>
    <link:label id="lab_alts_PotentialMarketExclusivityPeriod_documentation_en-US" xlink:label="lab_alts_PotentialMarketExclusivityPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Potential Market Exclusivity Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PotentialMarketExclusivityPeriod" xlink:href="alts-20241228.xsd#alts_PotentialMarketExclusivityPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_PotentialMarketExclusivityPeriod" xlink:to="lab_alts_PotentialMarketExclusivityPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DisposalGroupIncludingDiscontinuedOperationTotalOperatingIncomeExpensesFromDiscontinuedOperations_cb59e956-21e9-4a8e-8ff1-b0785cdf6c7d_negatedTerseLabel_en-US" xlink:label="lab_alts_DisposalGroupIncludingDiscontinuedOperationTotalOperatingIncomeExpensesFromDiscontinuedOperations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses from discontinued operations</link:label>
    <link:label id="lab_alts_DisposalGroupIncludingDiscontinuedOperationTotalOperatingIncomeExpensesFromDiscontinuedOperations_label_en-US" xlink:label="lab_alts_DisposalGroupIncludingDiscontinuedOperationTotalOperatingIncomeExpensesFromDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Total Operating Income (Expenses) From Discontinued Operations</link:label>
    <link:label id="lab_alts_DisposalGroupIncludingDiscontinuedOperationTotalOperatingIncomeExpensesFromDiscontinuedOperations_documentation_en-US" xlink:label="lab_alts_DisposalGroupIncludingDiscontinuedOperationTotalOperatingIncomeExpensesFromDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Total Operating Income (Expenses) From Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalGroupIncludingDiscontinuedOperationTotalOperatingIncomeExpensesFromDiscontinuedOperations" xlink:href="alts-20241228.xsd#alts_DisposalGroupIncludingDiscontinuedOperationTotalOperatingIncomeExpensesFromDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DisposalGroupIncludingDiscontinuedOperationTotalOperatingIncomeExpensesFromDiscontinuedOperations" xlink:to="lab_alts_DisposalGroupIncludingDiscontinuedOperationTotalOperatingIncomeExpensesFromDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidInsurance_2e299e28-d617-4c85-93df-d7fb30f929bd_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid insurance</link:label>
    <link:label id="lab_us-gaap_PrepaidInsurance_label_en-US" xlink:label="lab_us-gaap_PrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidInsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidInsurance" xlink:to="lab_us-gaap_PrepaidInsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_A12DebenturesMaturingJune302025Member_4a0dc520-88eb-4d46-96f8-788bec6783c8_terseLabel_en-US" xlink:label="lab_alts_A12DebenturesMaturingJune302025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">12% Debentures Maturing June 30, 2025</link:label>
    <link:label id="lab_alts_A12DebenturesMaturingJune302025Member_label_en-US" xlink:label="lab_alts_A12DebenturesMaturingJune302025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">12% Debentures Maturing June 30, 2025 [Member]</link:label>
    <link:label id="lab_alts_A12DebenturesMaturingJune302025Member_documentation_en-US" xlink:label="lab_alts_A12DebenturesMaturingJune302025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">12% Debentures Maturing June 30, 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_A12DebenturesMaturingJune302025Member" xlink:href="alts-20241228.xsd#alts_A12DebenturesMaturingJune302025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_A12DebenturesMaturingJune302025Member" xlink:to="lab_alts_A12DebenturesMaturingJune302025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_45401f0c-7941-4434-b75c-a6f659caf3dd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_258d4131-0432-4388-8f9c-a19e9654ac07_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_BiotechnologyMember_a9f795cf-d2ba-45b7-92d9-a99960b8ce45_terseLabel_en-US" xlink:label="lab_alts_BiotechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Biotech</link:label>
    <link:label id="lab_alts_BiotechnologyMember_label_en-US" xlink:label="lab_alts_BiotechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Biotechnology [Member]</link:label>
    <link:label id="lab_alts_BiotechnologyMember_documentation_en-US" xlink:label="lab_alts_BiotechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Biotechnology.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BiotechnologyMember" xlink:href="alts-20241228.xsd#alts_BiotechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_BiotechnologyMember" xlink:to="lab_alts_BiotechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c6179472-a3d8-4121-8b29-adf3b89efb02_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_204561a1-5aad-44e4-9024-e7d76212cd34_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions_81719384-e7af-44c2-93d4-9d6bc2e28f2f_terseLabel_en-US" xlink:label="lab_alts_DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of potential additions</link:label>
    <link:label id="lab_alts_DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions_label_en-US" xlink:label="lab_alts_DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Original Issue Discount, Number Of Potential Additions</link:label>
    <link:label id="lab_alts_DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions_documentation_en-US" xlink:label="lab_alts_DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Original Issue Discount, Number Of Potential Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions" xlink:href="alts-20241228.xsd#alts_DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions" xlink:to="lab_alts_DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_472e3da7-68fa-46c6-9807-65c83daea07d_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Equity attributable to ALT5 Sigma Corporation shareholders</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_e9b2ee3d-f8a2-43c2-96f6-582e3dbbc900_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_027975bd-4457-4fa6-b7bf-a36ba6121dae_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_46a10149-1cfc-411f-8ee2-f7927955194b_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_46fbd499-93f8-45f9-8eff-bd30dfd75e69_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Deposits and Other Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Other Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProFormaMember_3841f254-7f1a-4ea1-91e1-8f22d9c3a368_terseLabel_en-US" xlink:label="lab_srt_ProFormaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proforma</link:label>
    <link:label id="lab_srt_ProFormaMember_label_en-US" xlink:label="lab_srt_ProFormaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pro Forma [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProFormaMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProFormaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProFormaMember" xlink:to="lab_srt_ProFormaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_d76f9354-d896-4003-b891-644af9631c72_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Options authorized for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_d70c6735-c26c-4d0e-bafd-ac9b854ca56b_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_3d46a953-d932-4a7c-bd55-ebc88c2f78a4_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_923df4a3-3c10-4985-abfb-6d333db26a64_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued litigation/legal</link:label>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Estimated Litigation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveCurrent" xlink:to="lab_us-gaap_LitigationReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_NovalkAppsSAALLPShortTermDemandAdvanceMember_a4336db0-0185-4ad5-8368-f2e04aafd8cb_terseLabel_en-US" xlink:label="lab_alts_NovalkAppsSAALLPShortTermDemandAdvanceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Novalk Apps SAA, LLP</link:label>
    <link:label id="lab_alts_NovalkAppsSAALLPShortTermDemandAdvanceMember_label_en-US" xlink:label="lab_alts_NovalkAppsSAALLPShortTermDemandAdvanceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novalk Apps SAA LLP Short-Term Demand Advance [Member]</link:label>
    <link:label id="lab_alts_NovalkAppsSAALLPShortTermDemandAdvanceMember_documentation_en-US" xlink:label="lab_alts_NovalkAppsSAALLPShortTermDemandAdvanceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Novalk Apps SAA LLP Short-Term Demand Advance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NovalkAppsSAALLPShortTermDemandAdvanceMember" xlink:href="alts-20241228.xsd#alts_NovalkAppsSAALLPShortTermDemandAdvanceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_NovalkAppsSAALLPShortTermDemandAdvanceMember" xlink:to="lab_alts_NovalkAppsSAALLPShortTermDemandAdvanceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_ConvertiblePreferredStockSharesIssuableUponConversion_6aebad0e-3785-49fb-a559-09673541ebb9_terseLabel_en-US" xlink:label="lab_alts_ConvertiblePreferredStockSharesIssuableUponConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issuable upon conversion (in shares)</link:label>
    <link:label id="lab_alts_ConvertiblePreferredStockSharesIssuableUponConversion_label_en-US" xlink:label="lab_alts_ConvertiblePreferredStockSharesIssuableUponConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Preferred Stock, Shares Issuable Upon Conversion</link:label>
    <link:label id="lab_alts_ConvertiblePreferredStockSharesIssuableUponConversion_documentation_en-US" xlink:label="lab_alts_ConvertiblePreferredStockSharesIssuableUponConversion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Convertible Preferred Stock, Shares Issuable Upon Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ConvertiblePreferredStockSharesIssuableUponConversion" xlink:href="alts-20241228.xsd#alts_ConvertiblePreferredStockSharesIssuableUponConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_ConvertiblePreferredStockSharesIssuableUponConversion" xlink:to="lab_alts_ConvertiblePreferredStockSharesIssuableUponConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_097c6fe3-5c12-4c8a-bb53-0cb65436fbda_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining contractual life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DisposalOfAccruedLiabilityCaliforniaStateSalesTax_0ead47af-ed17-4fd3-8f81-f11c457d6885_terseLabel_en-US" xlink:label="lab_alts_DisposalOfAccruedLiabilityCaliforniaStateSalesTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued liabilities - California state sales tax</link:label>
    <link:label id="lab_alts_DisposalOfAccruedLiabilityCaliforniaStateSalesTax_label_en-US" xlink:label="lab_alts_DisposalOfAccruedLiabilityCaliforniaStateSalesTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal of Accrued liability - California state sales tax</link:label>
    <link:label id="lab_alts_DisposalOfAccruedLiabilityCaliforniaStateSalesTax_documentation_en-US" xlink:label="lab_alts_DisposalOfAccruedLiabilityCaliforniaStateSalesTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal of Accrued liability - California state sales tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfAccruedLiabilityCaliforniaStateSalesTax" xlink:href="alts-20241228.xsd#alts_DisposalOfAccruedLiabilityCaliforniaStateSalesTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DisposalOfAccruedLiabilityCaliforniaStateSalesTax" xlink:to="lab_alts_DisposalOfAccruedLiabilityCaliforniaStateSalesTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_9961c2d6-6580-4795-aff1-393ea228e71b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill expected to be deductible for tax purposes</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_ba6d0396-5b57-4319-802d-b8b5f2d47135_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_4e558a07-a768-442b-bd8f-5a501485dce1_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_VM7CorporationMember_2469c3dd-9023-4f69-9be8-016f00a5cb12_terseLabel_en-US" xlink:label="lab_alts_VM7CorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">VM7 Corporation</link:label>
    <link:label id="lab_alts_VM7CorporationMember_label_en-US" xlink:label="lab_alts_VM7CorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">V M 7 Corporation [Member]</link:label>
    <link:label id="lab_alts_VM7CorporationMember_documentation_en-US" xlink:label="lab_alts_VM7CorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">VM7 Corporation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_VM7CorporationMember" xlink:href="alts-20241228.xsd#alts_VM7CorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_VM7CorporationMember" xlink:to="lab_alts_VM7CorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_StockConversion1Member_2a3c24d1-ed12-42b6-ab7e-5c42c5045c67_terseLabel_en-US" xlink:label="lab_alts_StockConversion1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Conversion 1</link:label>
    <link:label id="lab_alts_StockConversion1Member_label_en-US" xlink:label="lab_alts_StockConversion1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Conversion 1 [Member]</link:label>
    <link:label id="lab_alts_StockConversion1Member_documentation_en-US" xlink:label="lab_alts_StockConversion1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Conversion 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockConversion1Member" xlink:href="alts-20241228.xsd#alts_StockConversion1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_StockConversion1Member" xlink:to="lab_alts_StockConversion1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_950eb84f-383c-4b17-a2d8-2266edd8c9e8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_3719f326-fbd1-46e9-a315-2c41bc8c6af9_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Software</link:label>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_label_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer Software, Intangible Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:to="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_SeriesA1ConvertiblePreferredStockMember_d7f1796f-3e97-4f1a-b760-13b8feb145a9_verboseLabel_en-US" xlink:label="lab_alts_SeriesA1ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Convertible preferred stock, series A-1 - par value $0.001 per share 2,000,000 authorized, 23,480 and 193,730 shares issued and outstanding at December&#160;28, 2024 and December&#160;30, 2023, respectively</link:label>
    <link:label id="lab_alts_SeriesA1ConvertiblePreferredStockMember_c94bce5e-c921-4563-87f2-8a0feee4ae82_terseLabel_en-US" xlink:label="lab_alts_SeriesA1ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series A1 Convertible Preferred Stock</link:label>
    <link:label id="lab_alts_SeriesA1ConvertiblePreferredStockMember_label_en-US" xlink:label="lab_alts_SeriesA1ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series A-1 Convertible Preferred Stock [Member]</link:label>
    <link:label id="lab_alts_SeriesA1ConvertiblePreferredStockMember_documentation_en-US" xlink:label="lab_alts_SeriesA1ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series A-1 Convertible Preferred Stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesA1ConvertiblePreferredStockMember" xlink:href="alts-20241228.xsd#alts_SeriesA1ConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_SeriesA1ConvertiblePreferredStockMember" xlink:to="lab_alts_SeriesA1ConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_e320e44a-2016-48a5-a97a-8ab102156b4b_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">CASH AND CASH EQUIVALENTS, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_efaf1d2f-5f29-4dad-89db-017c915955ef_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">CASH AND CASH EQUIVALENTS, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_344744b9-9f50-48ea-9a8d-8aa673228ecb_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">CASH AND CASH EQUIVALENTS, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_fe7a9152-2a77-44b9-bcfd-4d21238698a0_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining contractual life, exercisable (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_NotesReceivableTerm_50057004-d1cf-496d-ae45-4dbc4f80ad5c_terseLabel_en-US" xlink:label="lab_alts_NotesReceivableTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term of notes receivable (in years)</link:label>
    <link:label id="lab_alts_NotesReceivableTerm_label_en-US" xlink:label="lab_alts_NotesReceivableTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Receivable, Term</link:label>
    <link:label id="lab_alts_NotesReceivableTerm_documentation_en-US" xlink:label="lab_alts_NotesReceivableTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Notes Receivable, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NotesReceivableTerm" xlink:href="alts-20241228.xsd#alts_NotesReceivableTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_NotesReceivableTerm" xlink:to="lab_alts_NotesReceivableTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_009f7c71-b258-41c9-a3a3-212c93ff5e47_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_1cab3ea3-43bf-41e3-8d39-c63d0bae8fb0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of options, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_cb97d25f-2e06-4bb1-bb74-ff26f89d98e4_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_464c5047-1253-47b1-920f-fd543af75e09_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_RevisedDiscountAmount_e999d02c-d772-47ab-baf2-19a9931a9283_terseLabel_en-US" xlink:label="lab_alts_RevisedDiscountAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revised discount amount</link:label>
    <link:label id="lab_alts_RevisedDiscountAmount_label_en-US" xlink:label="lab_alts_RevisedDiscountAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revised Discount Amount</link:label>
    <link:label id="lab_alts_RevisedDiscountAmount_documentation_en-US" xlink:label="lab_alts_RevisedDiscountAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revised Discount Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RevisedDiscountAmount" xlink:href="alts-20241228.xsd#alts_RevisedDiscountAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_RevisedDiscountAmount" xlink:to="lab_alts_RevisedDiscountAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_85842c43-0a65-4769-9dd2-728566e27c50_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_AssetAcquisitionConsiderationCashPayable_f9f90cc1-28e3-4c6a-9c2c-e0edb4429d31_terseLabel_en-US" xlink:label="lab_alts_AssetAcquisitionConsiderationCashPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash consideration portion to be paid</link:label>
    <link:label id="lab_alts_AssetAcquisitionConsiderationCashPayable_label_en-US" xlink:label="lab_alts_AssetAcquisitionConsiderationCashPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Consideration, Cash Payable</link:label>
    <link:label id="lab_alts_AssetAcquisitionConsiderationCashPayable_documentation_en-US" xlink:label="lab_alts_AssetAcquisitionConsiderationCashPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Consideration, Cash Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AssetAcquisitionConsiderationCashPayable" xlink:href="alts-20241228.xsd#alts_AssetAcquisitionConsiderationCashPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_AssetAcquisitionConsiderationCashPayable" xlink:to="lab_alts_AssetAcquisitionConsiderationCashPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_faed7795-c2b7-474a-aae3-5250531e758c_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss before benefit from income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f74660eb-e4bc-48e6-bc66-8113cb12f171_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss after provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_OwnersOfALT5SubsidiaryMember_2f5e0846-7a13-4d71-9df9-def1b24027ca_terseLabel_en-US" xlink:label="lab_alts_OwnersOfALT5SubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Owners of ALT5 Subsidiary</link:label>
    <link:label id="lab_alts_OwnersOfALT5SubsidiaryMember_label_en-US" xlink:label="lab_alts_OwnersOfALT5SubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Owners Of ALT5 Subsidiary [Member]</link:label>
    <link:label id="lab_alts_OwnersOfALT5SubsidiaryMember_documentation_en-US" xlink:label="lab_alts_OwnersOfALT5SubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Owners Of ALT5 Subsidiary</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OwnersOfALT5SubsidiaryMember" xlink:href="alts-20241228.xsd#alts_OwnersOfALT5SubsidiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_OwnersOfALT5SubsidiaryMember" xlink:to="lab_alts_OwnersOfALT5SubsidiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_MarketableSecuritiesSharesOutstanding_87a5c4b3-39dc-4be3-8c3b-d98fca2a01ee_periodStartLabel_en-US" xlink:label="lab_alts_MarketableSecuritiesSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_alts_MarketableSecuritiesSharesOutstanding_3f3800e0-8099-44c3-a62a-bf3e89ae0245_periodEndLabel_en-US" xlink:label="lab_alts_MarketableSecuritiesSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_alts_MarketableSecuritiesSharesOutstanding_label_en-US" xlink:label="lab_alts_MarketableSecuritiesSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Securities, Shares Outstanding</link:label>
    <link:label id="lab_alts_MarketableSecuritiesSharesOutstanding_documentation_en-US" xlink:label="lab_alts_MarketableSecuritiesSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Marketable Securities, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_MarketableSecuritiesSharesOutstanding" xlink:href="alts-20241228.xsd#alts_MarketableSecuritiesSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_MarketableSecuritiesSharesOutstanding" xlink:to="lab_alts_MarketableSecuritiesSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_054ed66d-7566-4a1c-8545-fee390dd9c27_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Gain on Sale of Recycling Subsidiaries</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_dbcf3877-1b48-46b2-9e0a-1d7ef1bd18c9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Discontinued Operations in Consolidated Statements of Operations and Cash Flows</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesAuthorized_cc8e9c7a-d470-4c44-888c-217bef42e190_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesAuthorized_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesAuthorized" xlink:to="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c3ddc245-d7ca-436b-b022-3fc6e2ce58dd_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_30d93b62-64c4-44c9-b499-0e055bea628d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities_e93f0ab2-4f31-491f-b5c3-c436b59a02d2_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities_416c35da-9305-4aab-9c9e-da6e74896c2f_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities and Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_9dd5cb30-5557-42fb-b580-12d585d3440e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a057ae6c-907f-45e7-ad9c-99c3720c899a_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_f5e30f77-ca83-48a6-876b-2a424085fe94_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_bc72fd13-559b-4e0c-a881-6536edf7b0c0_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_df3f60fb-d721-41d0-8c25-a9268b1af733_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debentures</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_5d26b599-0b9b-41c2-9569-81f207a35ebb_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_2d89f804-9270-4d4f-a8d8-2b34a3eb67f8_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share, diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_0ee618df-de32-4110-bc5a-95eddeda1221_netLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Earnings per basic diluted share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_ee52cf32-0682-4cd0-85e5-551dfb81a429_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net (loss) income per share, diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_NotePayableToLiveVentureIncorporatedMember_55da8417-b573-4c75-b11c-f12dc6627d20_terseLabel_en-US" xlink:label="lab_alts_NotePayableToLiveVentureIncorporatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Note Payable To Live Venture Incorporated</link:label>
    <link:label id="lab_alts_NotePayableToLiveVentureIncorporatedMember_label_en-US" xlink:label="lab_alts_NotePayableToLiveVentureIncorporatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note Payable To Live Venture Incorporated [Member]</link:label>
    <link:label id="lab_alts_NotePayableToLiveVentureIncorporatedMember_documentation_en-US" xlink:label="lab_alts_NotePayableToLiveVentureIncorporatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Note Payable To Live Venture Incorporated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NotePayableToLiveVentureIncorporatedMember" xlink:href="alts-20241228.xsd#alts_NotePayableToLiveVentureIncorporatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_NotePayableToLiveVentureIncorporatedMember" xlink:to="lab_alts_NotePayableToLiveVentureIncorporatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_0829443d-09ef-4767-82b0-31942e83a17c_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_ad476235-9ead-4ee9-8cb9-01733f749088_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_29108d98-964f-4c43-bb61-7b63be42b406_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_b37a1b26-b2b0-483e-b94e-a1f071699446_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Current tax expense</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_38543b29-6802-4499-a96b-99d7b901a13e_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicShareAbstract_207b930c-cb18-4acf-8a79-7dbdd37009dd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicShareAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicShareAbstract" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DigitalAssetsAndOtherReceivablesPolicyPolicyTextBlock_2466338b-4d3d-4c21-9baa-9aa0061710dc_terseLabel_en-US" xlink:label="lab_alts_DigitalAssetsAndOtherReceivablesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Digital Assets and other Receivables</link:label>
    <link:label id="lab_alts_DigitalAssetsAndOtherReceivablesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_alts_DigitalAssetsAndOtherReceivablesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Digital Assets And Other Receivables, Policy [Policy Text Block]</link:label>
    <link:label id="lab_alts_DigitalAssetsAndOtherReceivablesPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_alts_DigitalAssetsAndOtherReceivablesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Digital Assets And Other Receivables, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DigitalAssetsAndOtherReceivablesPolicyPolicyTextBlock" xlink:href="alts-20241228.xsd#alts_DigitalAssetsAndOtherReceivablesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DigitalAssetsAndOtherReceivablesPolicyPolicyTextBlock" xlink:to="lab_alts_DigitalAssetsAndOtherReceivablesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_b1ce08c2-8708-413a-843c-bdb7ac39a3e8_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible preferred stock/Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_GeoTraqIncMember_0dcca21b-0e98-4aba-8784-b34f2746f634_terseLabel_en-US" xlink:label="lab_alts_GeoTraqIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GeoTraq Inc.</link:label>
    <link:label id="lab_alts_GeoTraqIncMember_label_en-US" xlink:label="lab_alts_GeoTraqIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geo Traq Inc [Member]</link:label>
    <link:label id="lab_alts_GeoTraqIncMember_documentation_en-US" xlink:label="lab_alts_GeoTraqIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GeoTraq Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_GeoTraqIncMember" xlink:href="alts-20241228.xsd#alts_GeoTraqIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_GeoTraqIncMember" xlink:to="lab_alts_GeoTraqIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_StockConversion2Member_edf0e62f-3fdb-4324-9195-bc6e3fa8d2fc_terseLabel_en-US" xlink:label="lab_alts_StockConversion2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Conversion 2</link:label>
    <link:label id="lab_alts_StockConversion2Member_label_en-US" xlink:label="lab_alts_StockConversion2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Conversion 2 [Member]</link:label>
    <link:label id="lab_alts_StockConversion2Member_documentation_en-US" xlink:label="lab_alts_StockConversion2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Conversion 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockConversion2Member" xlink:href="alts-20241228.xsd#alts_StockConversion2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_StockConversion2Member" xlink:to="lab_alts_StockConversion2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares_a87ee7ff-2a74-43b2-a7c0-b103964f23e0_terseLabel_en-US" xlink:label="lab_alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted shares issued (in shares)</link:label>
    <link:label id="lab_alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares_label_en-US" xlink:label="lab_alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable, Shares</link:label>
    <link:label id="lab_alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares_documentation_en-US" xlink:label="lab_alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares" xlink:href="alts-20241228.xsd#alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares" xlink:to="lab_alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_9e0da9b1-8552-4858-a7ec-33bb9bfe5a96_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate purchase price</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Consideration Received Per Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_d80bce5d-5138-492d-89ff-ac6c21f0fec5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermNotesPayable_2936dae0-3f4a-43fa-9ce0-22c36aa9bbca_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes payable</link:label>
    <link:label id="lab_us-gaap_LongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermNotesPayable" xlink:to="lab_us-gaap_LongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_fa629a1d-876c-4f66-8a48-f69b0d7deff5_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_3c0e5902-84a5-43c2-a7f9-411c27dbf89b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preliminary calculation of gain on sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_d02c0420-a79a-41ea-b274-33242e7eb8cc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_5935acbb-e682-4b20-bec7-d35e56c7a774_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_7d4d2500-723b-4b47-a699-ec4dc5cdb232_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income:</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_67cd3a37-f9a8-4c55-9a78-7b880a0a6b0d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cancelled/expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_88eb14b8-4a85-4632-9f2a-f5d8c8c9f5f5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shareholders' Equity and Share-Based Payments [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_TotalGuaranteedConsideration_1cd76524-ddd5-40ae-a827-1637bb73a7aa_terseLabel_en-US" xlink:label="lab_alts_TotalGuaranteedConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total minimum consideration</link:label>
    <link:label id="lab_alts_TotalGuaranteedConsideration_label_en-US" xlink:label="lab_alts_TotalGuaranteedConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Guaranteed Consideration</link:label>
    <link:label id="lab_alts_TotalGuaranteedConsideration_documentation_en-US" xlink:label="lab_alts_TotalGuaranteedConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total Guaranteed Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_TotalGuaranteedConsideration" xlink:href="alts-20241228.xsd#alts_TotalGuaranteedConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_TotalGuaranteedConsideration" xlink:to="lab_alts_TotalGuaranteedConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_87310cf5-2e0e-449a-8190-e99d117145ff_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8cc15b7a-30e4-49fa-8c35-5814b40e2c6d_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_031f9699-f038-47c8-abb7-ac228f5bf711_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of intangible assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_16761307-8198-43d8-a0e9-32d906508ac9_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_RelatedPartyTransactionConsultingAgreementTerm_e29b2a1b-795e-4acd-8ffb-cad88deb62d2_terseLabel_en-US" xlink:label="lab_alts_RelatedPartyTransactionConsultingAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term of consulting agreement (in years)</link:label>
    <link:label id="lab_alts_RelatedPartyTransactionConsultingAgreementTerm_label_en-US" xlink:label="lab_alts_RelatedPartyTransactionConsultingAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction, Consulting Agreement, Term</link:label>
    <link:label id="lab_alts_RelatedPartyTransactionConsultingAgreementTerm_documentation_en-US" xlink:label="lab_alts_RelatedPartyTransactionConsultingAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Related Party Transaction, Consulting Agreement, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RelatedPartyTransactionConsultingAgreementTerm" xlink:href="alts-20241228.xsd#alts_RelatedPartyTransactionConsultingAgreementTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_RelatedPartyTransactionConsultingAgreementTerm" xlink:to="lab_alts_RelatedPartyTransactionConsultingAgreementTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_2cfdae9c-8692-4486-9067-25f260bb632e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_0bd4e690-34b0-40c8-aaee-4e1073cedb2b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation , number of additional shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_4ee2742e-e55f-4d13-b3ff-197c19126d09_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_NoteReceivableFaceAmount_64585d9f-3e39-49ef-9481-2b3600f40bce_terseLabel_en-US" xlink:label="lab_alts_NoteReceivableFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Note receivable face amount</link:label>
    <link:label id="lab_alts_NoteReceivableFaceAmount_label_en-US" xlink:label="lab_alts_NoteReceivableFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note Receivable Face Amount</link:label>
    <link:label id="lab_alts_NoteReceivableFaceAmount_documentation_en-US" xlink:label="lab_alts_NoteReceivableFaceAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Note receivable face amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NoteReceivableFaceAmount" xlink:href="alts-20241228.xsd#alts_NoteReceivableFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_NoteReceivableFaceAmount" xlink:to="lab_alts_NoteReceivableFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_875574fd-9ffb-42b3-a9c5-56eec5875aa7_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c4494166-cf96-475c-ab45-3d77fe707a3e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_30f3d0f0-1daa-436d-a1e9-4aae2edd9206_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Securities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:to="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_27c9cde5-41de-443a-b460-b4466117423a_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_16123bdf-3863-424d-af84-3bfb24615ca8_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal Entity</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_7ab8af84-287f-47d2-b895-6e0da6e6b1f0_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Interest (expense) income, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_4d11189c-2c43-4257-a7fd-4363ac9a5926_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest (expense) income, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income (Expense), Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_37fe3d80-d986-4c2c-983c-759afb0a1345_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Recycling Subsidiaries</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_fb252e35-ac87-492d-8371-f6fc6e100062_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_fe5bac7a-39ae-404d-8861-cd7487b9e2eb_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_f2eb95f9-a3c2-49cb-b726-5d503a854d38_negatedLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_4afcb17a-1ba8-4e34-94ab-a4d99f089152_verboseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net income per share from discontinued operations, basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_e3bcf352-2d5f-47fc-a586-a2458d518848_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic income per share from discontinued operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_f8e45c89-ea48-4e2f-997c-3db2e785b1f6_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_SeriesA1PreferredStockMember_9ab11feb-957a-47eb-8047-5f9390b370aa_netLabel_en-US" xlink:label="lab_alts_SeriesA1PreferredStockMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Series A-1 Preferred</link:label>
    <link:label id="lab_alts_SeriesA1PreferredStockMember_label_en-US" xlink:label="lab_alts_SeriesA1PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series A-1 Preferred Stock [Member]</link:label>
    <link:label id="lab_alts_SeriesA1PreferredStockMember_documentation_en-US" xlink:label="lab_alts_SeriesA1PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series A-1 Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesA1PreferredStockMember" xlink:href="alts-20241228.xsd#alts_SeriesA1PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_SeriesA1PreferredStockMember" xlink:to="lab_alts_SeriesA1PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_39266a65-16ac-4a87-a55e-caef55b7da25_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DisposalOfInventory_0cf63500-5dda-4a2e-8b2b-005c2055cf1e_terseLabel_en-US" xlink:label="lab_alts_DisposalOfInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_alts_DisposalOfInventory_label_en-US" xlink:label="lab_alts_DisposalOfInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal of Inventory</link:label>
    <link:label id="lab_alts_DisposalOfInventory_documentation_en-US" xlink:label="lab_alts_DisposalOfInventory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal of Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfInventory" xlink:href="alts-20241228.xsd#alts_DisposalOfInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DisposalOfInventory" xlink:to="lab_alts_DisposalOfInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_Main270LLCLitigationMember_920d83dd-5484-46e8-97fa-8a1995710df0_terseLabel_en-US" xlink:label="lab_alts_Main270LLCLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Main / 270, LLC Litigation</link:label>
    <link:label id="lab_alts_Main270LLCLitigationMember_label_en-US" xlink:label="lab_alts_Main270LLCLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Main / 270, LLC Litigation [Member]</link:label>
    <link:label id="lab_alts_Main270LLCLitigationMember_documentation_en-US" xlink:label="lab_alts_Main270LLCLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Main / 270, LLC Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Main270LLCLitigationMember" xlink:href="alts-20241228.xsd#alts_Main270LLCLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_Main270LLCLitigationMember" xlink:to="lab_alts_Main270LLCLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_97aa124f-fdac-48ad-bb02-18b09e415154_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ce5ba3e5-44d5-4e1d-8dd9-5812c7acf14c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities, Mezzanine Equity, and Stockholders' Equity (Deficit)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DisposalOfIntangibleAssets_8a79b24f-3f8a-4898-92a0-d5bf5d90fb5b_terseLabel_en-US" xlink:label="lab_alts_DisposalOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_alts_DisposalOfIntangibleAssets_label_en-US" xlink:label="lab_alts_DisposalOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal of Intangible assets</link:label>
    <link:label id="lab_alts_DisposalOfIntangibleAssets_documentation_en-US" xlink:label="lab_alts_DisposalOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal of Intangible assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfIntangibleAssets" xlink:href="alts-20241228.xsd#alts_DisposalOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DisposalOfIntangibleAssets" xlink:to="lab_alts_DisposalOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_32729887-91b8-44da-b102-e60b29c86471_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_UniversalLifeInsurancePolicyPolicyTwoMember_a7f523b2-576e-414f-9a85-2f900baa30e4_terseLabel_en-US" xlink:label="lab_alts_UniversalLifeInsurancePolicyPolicyTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2nd policy</link:label>
    <link:label id="lab_alts_UniversalLifeInsurancePolicyPolicyTwoMember_label_en-US" xlink:label="lab_alts_UniversalLifeInsurancePolicyPolicyTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Universal Life Insurance Policy, Policy Two [Member]</link:label>
    <link:label id="lab_alts_UniversalLifeInsurancePolicyPolicyTwoMember_documentation_en-US" xlink:label="lab_alts_UniversalLifeInsurancePolicyPolicyTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Universal Life Insurance Policy, Policy Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_UniversalLifeInsurancePolicyPolicyTwoMember" xlink:href="alts-20241228.xsd#alts_UniversalLifeInsurancePolicyPolicyTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_UniversalLifeInsurancePolicyPolicyTwoMember" xlink:to="lab_alts_UniversalLifeInsurancePolicyPolicyTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_90604941-0eaf-41e1-a88c-fe8c6814caf6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowance for bad debts</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPayment_503f50ac-c725-4155-92ca-28dbaa6e8a31_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Installment</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPayment_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Periodic Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPayment" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_SECComplaintMember_5022f476-c886-4595-aa80-dbf21c6cb365_terseLabel_en-US" xlink:label="lab_alts_SECComplaintMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Complaint</link:label>
    <link:label id="lab_alts_SECComplaintMember_label_en-US" xlink:label="lab_alts_SECComplaintMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Complaint [Member]</link:label>
    <link:label id="lab_alts_SECComplaintMember_documentation_en-US" xlink:label="lab_alts_SECComplaintMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">SEC Complaint</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SECComplaintMember" xlink:href="alts-20241228.xsd#alts_SECComplaintMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_SECComplaintMember" xlink:to="lab_alts_SECComplaintMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_AuditorAbstract_label_en-US" xlink:label="lab_alts_AuditorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor [Abstract]</link:label>
    <link:label id="lab_alts_AuditorAbstract_documentation_en-US" xlink:label="lab_alts_AuditorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Auditor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AuditorAbstract" xlink:href="alts-20241228.xsd#alts_AuditorAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_AuditorAbstract" xlink:to="lab_alts_AuditorAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_StockConversion3Member_50a03ebe-8a20-4bee-b749-c7363fa5785e_terseLabel_en-US" xlink:label="lab_alts_StockConversion3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Conversion 3</link:label>
    <link:label id="lab_alts_StockConversion3Member_label_en-US" xlink:label="lab_alts_StockConversion3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Conversion 3 [Member]</link:label>
    <link:label id="lab_alts_StockConversion3Member_documentation_en-US" xlink:label="lab_alts_StockConversion3Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Conversion 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockConversion3Member" xlink:href="alts-20241228.xsd#alts_StockConversion3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_StockConversion3Member" xlink:to="lab_alts_StockConversion3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_7b8713e4-c514-4847-8edb-cb00296911e2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule Of Property Plant And Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_15c57920-1693-491b-8d7d-d7d80a52a569_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_229210df-859f-4e3d-a401-bd3a22808dc7_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_8a24045c-c764-41ad-9d3c-57dc44d3117d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right of use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_7a6566de-4ef0-43e8-b3a8-9281309eb592_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Right of use asset - operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9b62cdcb-683e-4e63-85d2-7b88609f26e1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ab571165-7466-48b8-af8c-980aadabb766_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_64ba0e91-7d3e-4dcb-9834-7aa35e525d1f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_OtherCommitmentsNumberOfLandlordsOriginallyPurportedToBeLiableFor_361c0d2d-306f-4912-82bb-15f0eb754a5d_terseLabel_en-US" xlink:label="lab_alts_OtherCommitmentsNumberOfLandlordsOriginallyPurportedToBeLiableFor" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of landlords originally purported to be covered under company's guarantee or commitment</link:label>
    <link:label id="lab_alts_OtherCommitmentsNumberOfLandlordsOriginallyPurportedToBeLiableFor_label_en-US" xlink:label="lab_alts_OtherCommitmentsNumberOfLandlordsOriginallyPurportedToBeLiableFor" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitments, Number Of Landlords Originally Purported To Be Liable For</link:label>
    <link:label id="lab_alts_OtherCommitmentsNumberOfLandlordsOriginallyPurportedToBeLiableFor_documentation_en-US" xlink:label="lab_alts_OtherCommitmentsNumberOfLandlordsOriginallyPurportedToBeLiableFor" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Commitments, Number Of Landlords Originally Purported To Be Liable For</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherCommitmentsNumberOfLandlordsOriginallyPurportedToBeLiableFor" xlink:href="alts-20241228.xsd#alts_OtherCommitmentsNumberOfLandlordsOriginallyPurportedToBeLiableFor"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_OtherCommitmentsNumberOfLandlordsOriginallyPurportedToBeLiableFor" xlink:to="lab_alts_OtherCommitmentsNumberOfLandlordsOriginallyPurportedToBeLiableFor" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_716d535d-c601-4e66-ba4d-f7cbd7615522_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price Range</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_StockPurchaseAgreementMember_3e5f1dda-2c37-4dcf-8994-f337531721cd_terseLabel_en-US" xlink:label="lab_alts_StockPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Purchase Agreement</link:label>
    <link:label id="lab_alts_StockPurchaseAgreementMember_label_en-US" xlink:label="lab_alts_StockPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Purchase Agreement [Member]</link:label>
    <link:label id="lab_alts_StockPurchaseAgreementMember_documentation_en-US" xlink:label="lab_alts_StockPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Purchase Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockPurchaseAgreementMember" xlink:href="alts-20241228.xsd#alts_StockPurchaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_StockPurchaseAgreementMember" xlink:to="lab_alts_StockPurchaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_f3386b88-d9f1-4b9e-836f-574512c6a555_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_80bac998-a199-4582-9033-1c9104d9bec5_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings (Loss) per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDiscontinuedOperationsMember_835fdd36-670e-4f5e-9e66-a2fe446c8d73_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discontinued operations</link:label>
    <link:label id="lab_us-gaap_SegmentDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDiscontinuedOperationsMember" xlink:to="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_2d45b0b6-3316-4442-992a-6f6e68ede564_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_e358dd44-aba1-4d52-a470-70967dc41c78_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_907ce08b-cf89-4d3a-91ee-45f02ea3f70e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_A2023EquityIncentivePlanMember_4869ebfb-7327-4148-bf67-9560aa526d39_terseLabel_en-US" xlink:label="lab_alts_A2023EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023 Plan</link:label>
    <link:label id="lab_alts_A2023EquityIncentivePlanMember_label_en-US" xlink:label="lab_alts_A2023EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2023 Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_alts_A2023EquityIncentivePlanMember_documentation_en-US" xlink:label="lab_alts_A2023EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2023 Equity Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_A2023EquityIncentivePlanMember" xlink:href="alts-20241228.xsd#alts_A2023EquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_A2023EquityIncentivePlanMember" xlink:to="lab_alts_A2023EquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_6952fb02-c025-44bf-abe9-6cf921bfa403_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">LESS CASH OF DISCONTINUED OPERATIONS, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForLoanLeaseAndOtherLosses_14098566-c35f-4936-9727-de7346ab875e_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForLoanLeaseAndOtherLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Bad debt expense</link:label>
    <link:label id="lab_us-gaap_ProvisionForLoanLeaseAndOtherLosses_label_en-US" xlink:label="lab_us-gaap_ProvisionForLoanLeaseAndOtherLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Provision for Loan, Lease, and Other Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForLoanLeaseAndOtherLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses" xlink:to="lab_us-gaap_ProvisionForLoanLeaseAndOtherLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dd757b11-8be9-41eb-80e6-6d04af1c529d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_b7884485-6e4e-4bfc-b23c-77e0c731ab17_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ef3191f9-3ae1-4b4b-ba44-452a617f3cb4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Name</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_RelatedPartyTransactionShortTermAdvancesMember_14a3c41d-7f76-416a-b931-23a962dbdcd0_terseLabel_en-US" xlink:label="lab_alts_RelatedPartyTransactionShortTermAdvancesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short Term Advances</link:label>
    <link:label id="lab_alts_RelatedPartyTransactionShortTermAdvancesMember_label_en-US" xlink:label="lab_alts_RelatedPartyTransactionShortTermAdvancesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction, Short Term Advances [Member]</link:label>
    <link:label id="lab_alts_RelatedPartyTransactionShortTermAdvancesMember_documentation_en-US" xlink:label="lab_alts_RelatedPartyTransactionShortTermAdvancesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Related Party Transaction, Short Term Advances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RelatedPartyTransactionShortTermAdvancesMember" xlink:href="alts-20241228.xsd#alts_RelatedPartyTransactionShortTermAdvancesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_RelatedPartyTransactionShortTermAdvancesMember" xlink:to="lab_alts_RelatedPartyTransactionShortTermAdvancesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_NorthYorkLTDMember_6529e470-94a0-47d0-92e6-e7a38b07b552_terseLabel_en-US" xlink:label="lab_alts_NorthYorkLTDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">North York LTD</link:label>
    <link:label id="lab_alts_NorthYorkLTDMember_label_en-US" xlink:label="lab_alts_NorthYorkLTDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">North York LTD [Member]</link:label>
    <link:label id="lab_alts_NorthYorkLTDMember_documentation_en-US" xlink:label="lab_alts_NorthYorkLTDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">North York LTD</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NorthYorkLTDMember" xlink:href="alts-20241228.xsd#alts_NorthYorkLTDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_NorthYorkLTDMember" xlink:to="lab_alts_NorthYorkLTDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRelatedPartyDebt_df440302-6cb2-45e5-af00-279c23bade55_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRelatedPartyDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from the issuance of related party note payable</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRelatedPartyDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRelatedPartyDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Related Party Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="lab_us-gaap_ProceedsFromRelatedPartyDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_RelatedPartyTransactionConsultingAgreementContingentlyTenderedFunds_f81df445-1412-4294-bb4d-3ff1a31de70b_terseLabel_en-US" xlink:label="lab_alts_RelatedPartyTransactionConsultingAgreementContingentlyTenderedFunds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingently tendered funds in counsel's trust account</link:label>
    <link:label id="lab_alts_RelatedPartyTransactionConsultingAgreementContingentlyTenderedFunds_label_en-US" xlink:label="lab_alts_RelatedPartyTransactionConsultingAgreementContingentlyTenderedFunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction, Consulting Agreement, Contingently Tendered Funds</link:label>
    <link:label id="lab_alts_RelatedPartyTransactionConsultingAgreementContingentlyTenderedFunds_documentation_en-US" xlink:label="lab_alts_RelatedPartyTransactionConsultingAgreementContingentlyTenderedFunds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Related Party Transaction, Consulting Agreement, Contingently Tendered Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RelatedPartyTransactionConsultingAgreementContingentlyTenderedFunds" xlink:href="alts-20241228.xsd#alts_RelatedPartyTransactionConsultingAgreementContingentlyTenderedFunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_RelatedPartyTransactionConsultingAgreementContingentlyTenderedFunds" xlink:to="lab_alts_RelatedPartyTransactionConsultingAgreementContingentlyTenderedFunds" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</link:label>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_label_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:to="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_ThirdPartyExchangeForBrokerageServicesMember_642b62b1-6154-4954-8828-af5355e9767a_terseLabel_en-US" xlink:label="lab_alts_ThirdPartyExchangeForBrokerageServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Third-Party Exchange For Brokerage Services</link:label>
    <link:label id="lab_alts_ThirdPartyExchangeForBrokerageServicesMember_label_en-US" xlink:label="lab_alts_ThirdPartyExchangeForBrokerageServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Third-Party Exchange For Brokerage Services [Member]</link:label>
    <link:label id="lab_alts_ThirdPartyExchangeForBrokerageServicesMember_documentation_en-US" xlink:label="lab_alts_ThirdPartyExchangeForBrokerageServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Third-Party Exchange For Brokerage Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ThirdPartyExchangeForBrokerageServicesMember" xlink:href="alts-20241228.xsd#alts_ThirdPartyExchangeForBrokerageServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_ThirdPartyExchangeForBrokerageServicesMember" xlink:to="lab_alts_ThirdPartyExchangeForBrokerageServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermNotesPayable_f0989372-a898-4b4a-8999-5c4bac140b8f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related party notes payable</link:label>
    <link:label id="lab_us-gaap_OtherLongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_OtherLongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermNotesPayable" xlink:to="lab_us-gaap_OtherLongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_d5d8f6cb-5377-4b04-a774-62013ceedaab_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, and Marketable Securities [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_2dc8c0fc-9482-4262-beeb-70454e8bab89_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Gross Profit (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_f07ca245-3478-4797-ab58-72e2bff0bc0f_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income per share from discontinued operations, diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_dd200898-402b-445f-862a-743948df3be9_verboseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Diluted income per share from discontinued operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_edc944e0-8083-48c2-9e2c-e490c2a4861d_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_c2757bc2-1612-475a-aaf9-2697fa849885_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsDisclosureTextBlock_eee6d8eb-940c-40d5-8e13-aca27f31ffd1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deposits and other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_OtherAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_4c06b3ec-0031-4f11-a649-d48ea4da19df_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInAuctionMarketPreferredSecuritiesSharesOutstandingRollForward_f14ccbae-ebee-4a12-ad0c-add4b651e0f4_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInAuctionMarketPreferredSecuritiesSharesOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable Securities, Shares [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInAuctionMarketPreferredSecuritiesSharesOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInAuctionMarketPreferredSecuritiesSharesOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Movement in Auction Market Preferred Securities, Shares Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInAuctionMarketPreferredSecuritiesSharesOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MovementInAuctionMarketPreferredSecuritiesSharesOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInAuctionMarketPreferredSecuritiesSharesOutstandingRollForward" xlink:to="lab_us-gaap_MovementInAuctionMarketPreferredSecuritiesSharesOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionLineItems_388b6a53-3bf8-4504-96b3-36e35572d1d1_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionLineItems" xlink:to="lab_us-gaap_AssetAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentAssetsTextBlock_14209296-569e-43f7-9e71-38ccdfc66ead_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaids and other current assets</link:label>
    <link:label id="lab_us-gaap_OtherCurrentAssetsTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Current Assets [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCurrentAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentAssetsTextBlock" xlink:to="lab_us-gaap_OtherCurrentAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_SoinTherapeuticsMember_f478ab5a-0afb-4479-85f9-8813bae7a2c2_terseLabel_en-US" xlink:label="lab_alts_SoinTherapeuticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soin Therapeutics</link:label>
    <link:label id="lab_alts_SoinTherapeuticsMember_label_en-US" xlink:label="lab_alts_SoinTherapeuticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soin Therapeutics [Member]</link:label>
    <link:label id="lab_alts_SoinTherapeuticsMember_documentation_en-US" xlink:label="lab_alts_SoinTherapeuticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Soin Therapeutics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SoinTherapeuticsMember" xlink:href="alts-20241228.xsd#alts_SoinTherapeuticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_SoinTherapeuticsMember" xlink:to="lab_alts_SoinTherapeuticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes_c17c2124-e1c5-4697-8adb-e37a4399e5df_totalLabel_en-US" xlink:label="lab_alts_IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss before provision of income taxes, Total</link:label>
    <link:label id="lab_alts_IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes_label_en-US" xlink:label="lab_alts_IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations Before Provision (Benefit) Of Income Taxes</link:label>
    <link:label id="lab_alts_IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes_documentation_en-US" xlink:label="lab_alts_IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations Before Provision (Benefit) Of Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes" xlink:href="alts-20241228.xsd#alts_IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes" xlink:to="lab_alts_IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_527a6d3b-6a95-4c16-afff-de496294ebaf_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2de2fc60-ba06-4cbd-96a9-30a595b2e698_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Changes in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DebtInstrumentCovenantPeriodAxis_b03bd930-05bd-4661-aae1-f57efbea1ea6_terseLabel_en-US" xlink:label="lab_alts_DebtInstrumentCovenantPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant Period [Axis]</link:label>
    <link:label id="lab_alts_DebtInstrumentCovenantPeriodAxis_label_en-US" xlink:label="lab_alts_DebtInstrumentCovenantPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant Period [Axis]</link:label>
    <link:label id="lab_alts_DebtInstrumentCovenantPeriodAxis_documentation_en-US" xlink:label="lab_alts_DebtInstrumentCovenantPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentCovenantPeriodAxis" xlink:href="alts-20241228.xsd#alts_DebtInstrumentCovenantPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DebtInstrumentCovenantPeriodAxis" xlink:to="lab_alts_DebtInstrumentCovenantPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_PatentsAndDomainsMember_852225b4-62cf-4135-87ac-3344fc4b13ba_terseLabel_en-US" xlink:label="lab_alts_PatentsAndDomainsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Patents and domains</link:label>
    <link:label id="lab_alts_PatentsAndDomainsMember_label_en-US" xlink:label="lab_alts_PatentsAndDomainsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Patents And Domains [Member]</link:label>
    <link:label id="lab_alts_PatentsAndDomainsMember_documentation_en-US" xlink:label="lab_alts_PatentsAndDomainsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Patents and domains.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PatentsAndDomainsMember" xlink:href="alts-20241228.xsd#alts_PatentsAndDomainsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_PatentsAndDomainsMember" xlink:to="lab_alts_PatentsAndDomainsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_ffff744f-99f2-4146-a953-0bb31d7902b5_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset acquisition, shares issued, fair value</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:to="lab_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashContributionExpense_94392e90-8285-4a30-b04c-f89fb0bbf591_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashContributionExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncash expense for consulting services</link:label>
    <link:label id="lab_us-gaap_NoncashContributionExpense_label_en-US" xlink:label="lab_us-gaap_NoncashContributionExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncash Contribution Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashContributionExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashContributionExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashContributionExpense" xlink:to="lab_us-gaap_NoncashContributionExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_dc68c0c1-3a2e-476d-ab88-abf1c93f805d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company tendered, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_cbee9b27-5325-4bce-8081-c624b306f3b1_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Company tendered (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_3645ac1a-0438-4fcf-bf59-956316681e77_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrent_912a55ee-e872-4539-ba22-fe59c14d34de_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_IsaacConsultingAgreementMember_1deecc9f-d4bf-4af8-be48-79c0f1a8d202_terseLabel_en-US" xlink:label="lab_alts_IsaacConsultingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Isaac Consulting Agreement</link:label>
    <link:label id="lab_alts_IsaacConsultingAgreementMember_label_en-US" xlink:label="lab_alts_IsaacConsultingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Isaac Consulting Agreement [Member]</link:label>
    <link:label id="lab_alts_IsaacConsultingAgreementMember_documentation_en-US" xlink:label="lab_alts_IsaacConsultingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Isaac Consulting Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IsaacConsultingAgreementMember" xlink:href="alts-20241228.xsd#alts_IsaacConsultingAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_IsaacConsultingAgreementMember" xlink:to="lab_alts_IsaacConsultingAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_7fcce487-b7ef-41b0-878c-a2c4f04bc0ab_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_f66c8e36-a599-4c53-bf9d-fc5b4857f128_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_4ae4d8c1-0ffc-4bb8-b8ca-3346350bd1c3_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_478d5ee2-a45b-4a3a-904a-4ab2421ae872_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_LegacyUnaffiliatedThirdPartyNotesMember_b5462c35-2411-43de-9989-f84f1dd8e8a8_terseLabel_en-US" xlink:label="lab_alts_LegacyUnaffiliatedThirdPartyNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unaffiliated third-party</link:label>
    <link:label id="lab_alts_LegacyUnaffiliatedThirdPartyNotesMember_label_en-US" xlink:label="lab_alts_LegacyUnaffiliatedThirdPartyNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legacy Unaffiliated Third Party Notes [Member]</link:label>
    <link:label id="lab_alts_LegacyUnaffiliatedThirdPartyNotesMember_documentation_en-US" xlink:label="lab_alts_LegacyUnaffiliatedThirdPartyNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Legacy Unaffiliated Third Party Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LegacyUnaffiliatedThirdPartyNotesMember" xlink:href="alts-20241228.xsd#alts_LegacyUnaffiliatedThirdPartyNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_LegacyUnaffiliatedThirdPartyNotesMember" xlink:to="lab_alts_LegacyUnaffiliatedThirdPartyNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DigitalAssetsAndOtherPayablesPolicyPolicyTextBlock_1c3d03eb-06c9-41eb-87f0-77f77a102023_terseLabel_en-US" xlink:label="lab_alts_DigitalAssetsAndOtherPayablesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Digital Assets and other Payables</link:label>
    <link:label id="lab_alts_DigitalAssetsAndOtherPayablesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_alts_DigitalAssetsAndOtherPayablesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Digital Assets And Other Payables, Policy [Policy Text Block]</link:label>
    <link:label id="lab_alts_DigitalAssetsAndOtherPayablesPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_alts_DigitalAssetsAndOtherPayablesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Digital Assets And Other Payables, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DigitalAssetsAndOtherPayablesPolicyPolicyTextBlock" xlink:href="alts-20241228.xsd#alts_DigitalAssetsAndOtherPayablesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DigitalAssetsAndOtherPayablesPolicyPolicyTextBlock" xlink:to="lab_alts_DigitalAssetsAndOtherPayablesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_InvestorOneMember_0ebe71a7-48c4-439a-8f6e-9d8e2056297b_terseLabel_en-US" xlink:label="lab_alts_InvestorOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investor one</link:label>
    <link:label id="lab_alts_InvestorOneMember_label_en-US" xlink:label="lab_alts_InvestorOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investor One [Member]</link:label>
    <link:label id="lab_alts_InvestorOneMember_documentation_en-US" xlink:label="lab_alts_InvestorOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Investor One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_InvestorOneMember" xlink:href="alts-20241228.xsd#alts_InvestorOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_InvestorOneMember" xlink:to="lab_alts_InvestorOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_2de707cb-fa51-4923-ba11-a6e39c866219_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_f767238f-7489-489d-84ea-bd6271fbb332_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_47a538dd-920a-4318-8ea1-bdc573324000_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Damages sought value</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:to="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_dbbfa816-d0bf-48df-bb36-fb5456ce615d_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_e82d5628-b041-4aba-88c0-befc74683c06_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_689351fe-bcb9-46c6-940a-c3a7f36d9364_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt conversion, converted (in shares)</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Conversion, Converted Instrument, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_bbefc4e9-bd22-4eab-bfd7-c5ba39fa027e_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_6313c712-bdf8-4760-838b-b28df50ffd9c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_8e7cda6f-062c-4471-818a-f80eb79d4fbb_negatedLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_d1490619-7c20-45e9-b9fb-2b4b67a1fc2e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_15fed42e-c612-44f0-a5f2-eef9e68b0ff6_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_OtherSignificantNoncashTransactionInterestObligationsMember_d446e005-d3da-406a-998d-0785b878b3a8_terseLabel_en-US" xlink:label="lab_alts_OtherSignificantNoncashTransactionInterestObligationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued for interest obligations</link:label>
    <link:label id="lab_alts_OtherSignificantNoncashTransactionInterestObligationsMember_label_en-US" xlink:label="lab_alts_OtherSignificantNoncashTransactionInterestObligationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Significant Noncash Transaction, Interest Obligations [Member]</link:label>
    <link:label id="lab_alts_OtherSignificantNoncashTransactionInterestObligationsMember_documentation_en-US" xlink:label="lab_alts_OtherSignificantNoncashTransactionInterestObligationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Significant Noncash Transaction, Interest Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherSignificantNoncashTransactionInterestObligationsMember" xlink:href="alts-20241228.xsd#alts_OtherSignificantNoncashTransactionInterestObligationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_OtherSignificantNoncashTransactionInterestObligationsMember" xlink:to="lab_alts_OtherSignificantNoncashTransactionInterestObligationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityUnitPurchaseAgreementsMember_c992ce03-c852-402f-bd16-12c27e1d87f7_terseLabel_en-US" xlink:label="lab_us-gaap_EquityUnitPurchaseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Unit Purchase Agreements</link:label>
    <link:label id="lab_us-gaap_EquityUnitPurchaseAgreementsMember_label_en-US" xlink:label="lab_us-gaap_EquityUnitPurchaseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Unit Purchase Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityUnitPurchaseAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityUnitPurchaseAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityUnitPurchaseAgreementsMember" xlink:to="lab_us-gaap_EquityUnitPurchaseAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_fd65fd2a-9b40-4c1c-9db2-d96f3ac1e6d6_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unsecured Debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_InvestorTwoAndInvestorThreeMember_d343bfa8-f6af-4026-9f76-3dd12e0200f3_terseLabel_en-US" xlink:label="lab_alts_InvestorTwoAndInvestorThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other two investors</link:label>
    <link:label id="lab_alts_InvestorTwoAndInvestorThreeMember_label_en-US" xlink:label="lab_alts_InvestorTwoAndInvestorThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investor Two And Investor Three [Member]</link:label>
    <link:label id="lab_alts_InvestorTwoAndInvestorThreeMember_documentation_en-US" xlink:label="lab_alts_InvestorTwoAndInvestorThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Investor Two And Investor Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_InvestorTwoAndInvestorThreeMember" xlink:href="alts-20241228.xsd#alts_InvestorTwoAndInvestorThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_InvestorTwoAndInvestorThreeMember" xlink:to="lab_alts_InvestorTwoAndInvestorThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable_e197c2ab-75ed-419c-b409-9cd912c0e6fc_terseLabel_en-US" xlink:label="lab_alts_StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued in lieu of notes payable obligation</link:label>
    <link:label id="lab_alts_StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable_label_en-US" xlink:label="lab_alts_StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Issued In Lieu Of Notes Payable</link:label>
    <link:label id="lab_alts_StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable_documentation_en-US" xlink:label="lab_alts_StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Issued In Lieu Of Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable" xlink:href="alts-20241228.xsd#alts_StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable" xlink:to="lab_alts_StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_4fe275c9-7a5e-4175-9544-7eafd8cac1db_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Income (Loss) Before Provision of Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DisposalGroupIncludingDiscontinuedOperationsTotalOtherIncomeLossNet_bed0ea59-f0ac-48fa-a8be-e115d99b6ac7_terseLabel_en-US" xlink:label="lab_alts_DisposalGroupIncludingDiscontinuedOperationsTotalOtherIncomeLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total other expense, net</link:label>
    <link:label id="lab_alts_DisposalGroupIncludingDiscontinuedOperationsTotalOtherIncomeLossNet_label_en-US" xlink:label="lab_alts_DisposalGroupIncludingDiscontinuedOperationsTotalOtherIncomeLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Total Other Income (Loss), Net</link:label>
    <link:label id="lab_alts_DisposalGroupIncludingDiscontinuedOperationsTotalOtherIncomeLossNet_documentation_en-US" xlink:label="lab_alts_DisposalGroupIncludingDiscontinuedOperationsTotalOtherIncomeLossNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total other loss, net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalGroupIncludingDiscontinuedOperationsTotalOtherIncomeLossNet" xlink:href="alts-20241228.xsd#alts_DisposalGroupIncludingDiscontinuedOperationsTotalOtherIncomeLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DisposalGroupIncludingDiscontinuedOperationsTotalOtherIncomeLossNet" xlink:to="lab_alts_DisposalGroupIncludingDiscontinuedOperationsTotalOtherIncomeLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_10ceb33e-0777-462c-be8a-52cd1b1c0ff9_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_731b134e-4daa-4ab1-a39d-d4db747cd9ec_verboseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income tax provision</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operation, Tax Effect of Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:to="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_e23d5c54-d909-40a4-8033-592ba1f386da_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_50201208-d383-4e8f-830a-b5d81d98fa7a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_WestervilleSquareLitigationMember_bfc8fea8-a0ab-4bda-ac86-4b71fbbaca77_terseLabel_en-US" xlink:label="lab_alts_WestervilleSquareLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Westerville Square Litigation</link:label>
    <link:label id="lab_alts_WestervilleSquareLitigationMember_label_en-US" xlink:label="lab_alts_WestervilleSquareLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Westerville Square Litigation [Member]</link:label>
    <link:label id="lab_alts_WestervilleSquareLitigationMember_documentation_en-US" xlink:label="lab_alts_WestervilleSquareLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Westerville Square Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_WestervilleSquareLitigationMember" xlink:href="alts-20241228.xsd#alts_WestervilleSquareLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_WestervilleSquareLitigationMember" xlink:to="lab_alts_WestervilleSquareLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_7f2dae90-af6e-4645-b0c3-25f4eb8ae8c9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount owed by company</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_Section174Expenses_0290a402-b734-4617-893b-43f425cf443c_terseLabel_en-US" xlink:label="lab_alts_Section174Expenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Section 174 expenses</link:label>
    <link:label id="lab_alts_Section174Expenses_label_en-US" xlink:label="lab_alts_Section174Expenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Section 174 Expenses</link:label>
    <link:label id="lab_alts_Section174Expenses_documentation_en-US" xlink:label="lab_alts_Section174Expenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Section 174 Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Section174Expenses" xlink:href="alts-20241228.xsd#alts_Section174Expenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_Section174Expenses" xlink:to="lab_alts_Section174Expenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_e44b9f76-231c-4f7e-896c-65d9d84c08a3_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_994d1bd1-4b84-4e0c-83e4-67ff5a844e43_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSegmentAllocationTable_4ab282e6-3904-4659-9b88-7a2ad2d3edcd_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSegmentAllocationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination, Segment Allocation [Table]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSegmentAllocationTable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSegmentAllocationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Segment Allocation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationSegmentAllocationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable" xlink:to="lab_us-gaap_BusinessCombinationSegmentAllocationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_5322a8d7-a742-4b59-8561-c919722db347_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_306b49ef-8056-4872-b303-67f395edc88f_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying value of disposition transaction</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Disposition of Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSignificantNoncashTransactionNameDomain_bf2b5b27-e4f4-46db-9c2d-0c3a9e07fb22_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSignificantNoncashTransactionNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Significant Noncash Transaction, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherSignificantNoncashTransactionNameDomain_label_en-US" xlink:label="lab_us-gaap_OtherSignificantNoncashTransactionNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Significant Noncash Transaction, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSignificantNoncashTransactionNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherSignificantNoncashTransactionNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionNameDomain" xlink:to="lab_us-gaap_OtherSignificantNoncashTransactionNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockMember_31d86f84-9cd2-415c-8b5b-961260fdf585_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred Stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockMember_label_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockMember" xlink:to="lab_us-gaap_PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_34914def-cb05-4a88-a1a5-722d51bd3458_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total long-term notes payable, related parties</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_6795c70a-bf54-4ec8-aa1d-1572e6397064_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total long-term notes payable, related parties</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ba7dae6a-116d-4aad-9a5f-52810efdf88c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule Of Segment Reporting Information By Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_UnaffiliatedThirdPartyMember_6c008c9e-072b-4fa4-8b19-9d585c87296c_terseLabel_en-US" xlink:label="lab_alts_UnaffiliatedThirdPartyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unaffiliated Third Party</link:label>
    <link:label id="lab_alts_UnaffiliatedThirdPartyMember_label_en-US" xlink:label="lab_alts_UnaffiliatedThirdPartyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unaffiliated Third Party [Member]</link:label>
    <link:label id="lab_alts_UnaffiliatedThirdPartyMember_documentation_en-US" xlink:label="lab_alts_UnaffiliatedThirdPartyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Unaffiliated Third Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_UnaffiliatedThirdPartyMember" xlink:href="alts-20241228.xsd#alts_UnaffiliatedThirdPartyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_UnaffiliatedThirdPartyMember" xlink:to="lab_alts_UnaffiliatedThirdPartyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DiscontinuedInvestingActivities_8d6155e7-5f7f-464f-9322-0684f90510b4_terseLabel_en-US" xlink:label="lab_alts_DiscontinuedInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">DISCONTINUED INVESTING ACTIVITIES:</link:label>
    <link:label id="lab_alts_DiscontinuedInvestingActivities_label_en-US" xlink:label="lab_alts_DiscontinuedInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">DISCONTINUED INVESTING ACTIVITIES:</link:label>
    <link:label id="lab_alts_DiscontinuedInvestingActivities_documentation_en-US" xlink:label="lab_alts_DiscontinuedInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">DISCONTINUED INVESTING ACTIVITIES:</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DiscontinuedInvestingActivities" xlink:href="alts-20241228.xsd#alts_DiscontinuedInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DiscontinuedInvestingActivities" xlink:to="lab_alts_DiscontinuedInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_46250ed8-3980-498f-b493-cd89a6369376_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_de8374a0-e33a-49c5-b086-25ac89a08783_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">(Loss) income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_AccruedExpensesAssetAcquisitionCurrent_0f80a1ab-0451-44c8-9824-64f2c6610c88_terseLabel_en-US" xlink:label="lab_alts_AccruedExpensesAssetAcquisitionCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued Qoden payments</link:label>
    <link:label id="lab_alts_AccruedExpensesAssetAcquisitionCurrent_label_en-US" xlink:label="lab_alts_AccruedExpensesAssetAcquisitionCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Expenses, Asset Acquisition, Current</link:label>
    <link:label id="lab_alts_AccruedExpensesAssetAcquisitionCurrent_documentation_en-US" xlink:label="lab_alts_AccruedExpensesAssetAcquisitionCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Expenses, Asset Acquisition, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AccruedExpensesAssetAcquisitionCurrent" xlink:href="alts-20241228.xsd#alts_AccruedExpensesAssetAcquisitionCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_AccruedExpensesAssetAcquisitionCurrent" xlink:to="lab_alts_AccruedExpensesAssetAcquisitionCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_61db651d-664d-42db-b7fb-42b5de60e0cf_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_eae2ee81-3a2d-4f3f-ba9f-fdd994f031c3_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_AssetAcquisitionEquityInstrumentsIssuableValidConversionPeriod_550679ac-9f74-4a43-977d-6232bd0dfad2_terseLabel_en-US" xlink:label="lab_alts_AssetAcquisitionEquityInstrumentsIssuableValidConversionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset acquisition, trailing period (in years)</link:label>
    <link:label id="lab_alts_AssetAcquisitionEquityInstrumentsIssuableValidConversionPeriod_label_en-US" xlink:label="lab_alts_AssetAcquisitionEquityInstrumentsIssuableValidConversionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Equity Instruments Issuable, Valid Conversion Period</link:label>
    <link:label id="lab_alts_AssetAcquisitionEquityInstrumentsIssuableValidConversionPeriod_documentation_en-US" xlink:label="lab_alts_AssetAcquisitionEquityInstrumentsIssuableValidConversionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Equity Instruments Issuable, Valid Conversion Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AssetAcquisitionEquityInstrumentsIssuableValidConversionPeriod" xlink:href="alts-20241228.xsd#alts_AssetAcquisitionEquityInstrumentsIssuableValidConversionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_AssetAcquisitionEquityInstrumentsIssuableValidConversionPeriod" xlink:to="lab_alts_AssetAcquisitionEquityInstrumentsIssuableValidConversionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_ba83f11f-cb3e-42af-bd2b-c85de978c2e3_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_4bff00b2-54ce-4532-a35b-69a80aa46e07_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cancelled/expired (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_cf59b21e-7810-4e62-a2bb-49650c836433_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_CommonStockSharesOutstandingPercentage_4f2fffa8-ba51-4609-aaec-ace9aa29e094_terseLabel_en-US" xlink:label="lab_alts_CommonStockSharesOutstandingPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding (as percent)</link:label>
    <link:label id="lab_alts_CommonStockSharesOutstandingPercentage_label_en-US" xlink:label="lab_alts_CommonStockSharesOutstandingPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Outstanding, Percentage</link:label>
    <link:label id="lab_alts_CommonStockSharesOutstandingPercentage_documentation_en-US" xlink:label="lab_alts_CommonStockSharesOutstandingPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Outstanding, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_CommonStockSharesOutstandingPercentage" xlink:href="alts-20241228.xsd#alts_CommonStockSharesOutstandingPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_CommonStockSharesOutstandingPercentage" xlink:to="lab_alts_CommonStockSharesOutstandingPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_4a5b9764-a699-4a6b-8055-b4a6328f93d8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_60aff828-1b1e-4325-8dd5-a302d313420b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt Payable to Related Parties</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_c3e20116-c393-4b56-9f05-6e02a2d64b7f_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Penalty awarded</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="lab_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_b0be2106-2b7a-4075-865c-d9c4bb097caf_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Present value of payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DebtInstrumentNumberOfDebenturesRepaid_5582fd03-b6e2-4616-a25f-00e26ceee230_terseLabel_en-US" xlink:label="lab_alts_DebtInstrumentNumberOfDebenturesRepaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of debentures repaid</link:label>
    <link:label id="lab_alts_DebtInstrumentNumberOfDebenturesRepaid_label_en-US" xlink:label="lab_alts_DebtInstrumentNumberOfDebenturesRepaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Number Of Debentures Repaid</link:label>
    <link:label id="lab_alts_DebtInstrumentNumberOfDebenturesRepaid_documentation_en-US" xlink:label="lab_alts_DebtInstrumentNumberOfDebenturesRepaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Number Of Debentures Repaid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentNumberOfDebenturesRepaid" xlink:href="alts-20241228.xsd#alts_DebtInstrumentNumberOfDebenturesRepaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DebtInstrumentNumberOfDebenturesRepaid" xlink:to="lab_alts_DebtInstrumentNumberOfDebenturesRepaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockNameDomain_ed296b41-f7af-4f61-9400-d62d6423e585_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of Stock, Name</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockNameDomain_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion of Stock, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockNameDomain" xlink:to="lab_us-gaap_ConversionOfStockNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_14896f71-7ea0-4840-bf5f-0a5c019709c5_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss_d35f27e8-829e-4e06-a278-bc6f01dc7843_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized loss on marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss_4da89cc3-ddac-4060-8258-323f3607d96c_negatedLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Unrealized loss on marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss_c19125a1-8374-40e3-abcb-7b863af05a73_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Unrealized loss on marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Security, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_8c6bcb74-ac68-4c8c-98fd-60b530497168_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_e797f775-2155-43d4-a487-bdb416ac04ba_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_NonConvertibleDebentureBigAndSmallDebentureMember_70786aca-1a4c-4bff-a408-cdf08ba7be2d_terseLabel_en-US" xlink:label="lab_alts_NonConvertibleDebentureBigAndSmallDebentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debentures</link:label>
    <link:label id="lab_alts_NonConvertibleDebentureBigAndSmallDebentureMember_label_en-US" xlink:label="lab_alts_NonConvertibleDebentureBigAndSmallDebentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Convertible Debenture, Big and Small Debenture [Member]</link:label>
    <link:label id="lab_alts_NonConvertibleDebentureBigAndSmallDebentureMember_documentation_en-US" xlink:label="lab_alts_NonConvertibleDebentureBigAndSmallDebentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non-Convertible Debenture, Big and Small Debenture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NonConvertibleDebentureBigAndSmallDebentureMember" xlink:href="alts-20241228.xsd#alts_NonConvertibleDebentureBigAndSmallDebentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_NonConvertibleDebentureBigAndSmallDebentureMember" xlink:to="lab_alts_NonConvertibleDebentureBigAndSmallDebentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_IcgNoteMember_a5f460d8-953d-46dc-aba5-b5b44809d4f6_terseLabel_en-US" xlink:label="lab_alts_IcgNoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ICG Note</link:label>
    <link:label id="lab_alts_IcgNoteMember_label_en-US" xlink:label="lab_alts_IcgNoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ICG Note [Member]</link:label>
    <link:label id="lab_alts_IcgNoteMember_documentation_en-US" xlink:label="lab_alts_IcgNoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">ICG Note Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IcgNoteMember" xlink:href="alts-20241228.xsd#alts_IcgNoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_IcgNoteMember" xlink:to="lab_alts_IcgNoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_LiveNoteMember_d250dccc-79cc-4cc2-90dc-a05341022a6e_terseLabel_en-US" xlink:label="lab_alts_LiveNoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Live Note</link:label>
    <link:label id="lab_alts_LiveNoteMember_label_en-US" xlink:label="lab_alts_LiveNoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Live Note [Member]</link:label>
    <link:label id="lab_alts_LiveNoteMember_documentation_en-US" xlink:label="lab_alts_LiveNoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Live Note</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LiveNoteMember" xlink:href="alts-20241228.xsd#alts_LiveNoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_LiveNoteMember" xlink:to="lab_alts_LiveNoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtCurrent_d49794b4-484e-48e1-98f4-93798c21d341_verboseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Convertible debentures</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtCurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtCurrent" xlink:to="lab_us-gaap_ConvertibleDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_b788a3ae-c6b4-4284-9a40-da1b1d3713bf_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_10916a62-5c0b-450b-9d62-c419748e588b_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, number of shares issued in transaction (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_aad9ea1c-cb76-4c3d-85c6-778acec202c3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_5d052420-dbbb-4584-8581-aac457417fc8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized losses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Unrealized Currency Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:to="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DepositsAndOtherAssetsNoncurrent_6dac1460-baca-437b-9bcb-7e971c4d8f6b_terseLabel_en-US" xlink:label="lab_alts_DepositsAndOtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deposits and other assets</link:label>
    <link:label id="lab_alts_DepositsAndOtherAssetsNoncurrent_f13fc4f1-b24d-4ef7-b28a-89bf0e727175_verboseLabel_en-US" xlink:label="lab_alts_DepositsAndOtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total deposits and other assets</link:label>
    <link:label id="lab_alts_DepositsAndOtherAssetsNoncurrent_label_en-US" xlink:label="lab_alts_DepositsAndOtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deposits And Other Assets Noncurrent</link:label>
    <link:label id="lab_alts_DepositsAndOtherAssetsNoncurrent_documentation_en-US" xlink:label="lab_alts_DepositsAndOtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deposits and other assets noncurrent.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DepositsAndOtherAssetsNoncurrent" xlink:href="alts-20241228.xsd#alts_DepositsAndOtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DepositsAndOtherAssetsNoncurrent" xlink:to="lab_alts_DepositsAndOtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_451893ce-138a-483f-af18-c92c840ab1cc_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-vested shares associated with stock option awards (in shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_4639fbf2-e4b6-4fe7-9eb0-ce600719ce4a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_34b7d892-8fae-40f7-968d-687e26a7243b_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Initial principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_4419b7cb-da00-4a62-88c9-1f1bb61f760c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from short-term demand advances</link:label>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DebtInstrumentCovenantPeriodPeriodTwoMember_b5566ba9-9245-4d8e-9f2d-ce83ddc0f3c6_terseLabel_en-US" xlink:label="lab_alts_DebtInstrumentCovenantPeriodPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">November 01, 2024 to January 29, 2025</link:label>
    <link:label id="lab_alts_DebtInstrumentCovenantPeriodPeriodTwoMember_label_en-US" xlink:label="lab_alts_DebtInstrumentCovenantPeriodPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant Period, Period Two [Member]</link:label>
    <link:label id="lab_alts_DebtInstrumentCovenantPeriodPeriodTwoMember_documentation_en-US" xlink:label="lab_alts_DebtInstrumentCovenantPeriodPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant Period, Period Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentCovenantPeriodPeriodTwoMember" xlink:href="alts-20241228.xsd#alts_DebtInstrumentCovenantPeriodPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DebtInstrumentCovenantPeriodPeriodTwoMember" xlink:to="lab_alts_DebtInstrumentCovenantPeriodPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_552928ff-a25a-473b-a5ab-dff7d4caecc3_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Technology Intangibles</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_971725dd-d86a-433f-bfa2-cb895743945a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_85adb8b7-0242-4263-98e1-39268f310c17_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_MarketableSecurityWriteOffShares_e196469a-71d6-46fc-9cf5-2b72c5015782_negatedTerseLabel_en-US" xlink:label="lab_alts_MarketableSecurityWriteOffShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Write-off marketable securities (in shares)</link:label>
    <link:label id="lab_alts_MarketableSecurityWriteOffShares_label_en-US" xlink:label="lab_alts_MarketableSecurityWriteOffShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Security, Write-Off, Shares</link:label>
    <link:label id="lab_alts_MarketableSecurityWriteOffShares_documentation_en-US" xlink:label="lab_alts_MarketableSecurityWriteOffShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Marketable Security, Write-Off, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_MarketableSecurityWriteOffShares" xlink:href="alts-20241228.xsd#alts_MarketableSecurityWriteOffShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_MarketableSecurityWriteOffShares" xlink:to="lab_alts_MarketableSecurityWriteOffShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_11bdfa9a-2621-4fd0-90e4-d353ac85669c_verboseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Notes Payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_b76d7989-712c-4082-bc38-b6897c7b1be5_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Note</link:label>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable, Other Payables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:to="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_ClassOfWarrantOrRightExercisePeriod_34b3aece-2c35-4384-a9f0-241c680dd377_terseLabel_en-US" xlink:label="lab_alts_ClassOfWarrantOrRightExercisePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of days required to exercise initial tranche (in days)</link:label>
    <link:label id="lab_alts_ClassOfWarrantOrRightExercisePeriod_label_en-US" xlink:label="lab_alts_ClassOfWarrantOrRightExercisePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Exercise Period</link:label>
    <link:label id="lab_alts_ClassOfWarrantOrRightExercisePeriod_documentation_en-US" xlink:label="lab_alts_ClassOfWarrantOrRightExercisePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Exercise Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ClassOfWarrantOrRightExercisePeriod" xlink:href="alts-20241228.xsd#alts_ClassOfWarrantOrRightExercisePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_ClassOfWarrantOrRightExercisePeriod" xlink:to="lab_alts_ClassOfWarrantOrRightExercisePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_fdd77cf6-b4d0-4f6b-b249-40449f59d719_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_FintechMember_7f3b075d-acf0-43c6-8720-d9b0429fb7ef_terseLabel_en-US" xlink:label="lab_alts_FintechMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fintech</link:label>
    <link:label id="lab_alts_FintechMember_label_en-US" xlink:label="lab_alts_FintechMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fintech [Member]</link:label>
    <link:label id="lab_alts_FintechMember_documentation_en-US" xlink:label="lab_alts_FintechMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fintech</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_FintechMember" xlink:href="alts-20241228.xsd#alts_FintechMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_FintechMember" xlink:to="lab_alts_FintechMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_label_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:to="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_9cf46f45-f772-49eb-98e3-95c4d3fca9ad_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1abfc2c5-18b3-4206-b738-e193e229810a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of changes in exchange rate on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_878a34c4-9b47-4606-929c-c3000d33b01e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Related party notes issued for shared services</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_terseLabel_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_label_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:to="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_StockIssuedDuringPeriodSharesIssuedInLieuOfNotesPayable_b96af6f5-3fc8-4203-b06a-9224dd327864_terseLabel_en-US" xlink:label="lab_alts_StockIssuedDuringPeriodSharesIssuedInLieuOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued in lieu of notes payable obligation (in shares)</link:label>
    <link:label id="lab_alts_StockIssuedDuringPeriodSharesIssuedInLieuOfNotesPayable_label_en-US" xlink:label="lab_alts_StockIssuedDuringPeriodSharesIssuedInLieuOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Issued In Lieu Of Notes Payable</link:label>
    <link:label id="lab_alts_StockIssuedDuringPeriodSharesIssuedInLieuOfNotesPayable_documentation_en-US" xlink:label="lab_alts_StockIssuedDuringPeriodSharesIssuedInLieuOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Issued In Lieu Of Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockIssuedDuringPeriodSharesIssuedInLieuOfNotesPayable" xlink:href="alts-20241228.xsd#alts_StockIssuedDuringPeriodSharesIssuedInLieuOfNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_StockIssuedDuringPeriodSharesIssuedInLieuOfNotesPayable" xlink:to="lab_alts_StockIssuedDuringPeriodSharesIssuedInLieuOfNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_OtherSignificantNoncashTransactionIntangibleAssetsMember_b749c849-a56d-4cdf-ab2c-c3c6e9a4ce35_terseLabel_en-US" xlink:label="lab_alts_OtherSignificantNoncashTransactionIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock issued for intangible assets</link:label>
    <link:label id="lab_alts_OtherSignificantNoncashTransactionIntangibleAssetsMember_label_en-US" xlink:label="lab_alts_OtherSignificantNoncashTransactionIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Significant Noncash Transaction, Intangible Assets [Member]</link:label>
    <link:label id="lab_alts_OtherSignificantNoncashTransactionIntangibleAssetsMember_documentation_en-US" xlink:label="lab_alts_OtherSignificantNoncashTransactionIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Significant Noncash Transaction, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherSignificantNoncashTransactionIntangibleAssetsMember" xlink:href="alts-20241228.xsd#alts_OtherSignificantNoncashTransactionIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_OtherSignificantNoncashTransactionIntangibleAssetsMember" xlink:to="lab_alts_OtherSignificantNoncashTransactionIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_3a6352de-6dfe-4784-adb5-f238d30e679d_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2c6a53d3-76a5-418a-a28f-62d7efaf9334_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_NonConvertibleDebentureSmallDebentureMember_d46c1a63-e596-4d25-bd38-f3bf18611721_terseLabel_en-US" xlink:label="lab_alts_NonConvertibleDebentureSmallDebentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Small Debenture</link:label>
    <link:label id="lab_alts_NonConvertibleDebentureSmallDebentureMember_label_en-US" xlink:label="lab_alts_NonConvertibleDebentureSmallDebentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Convertible Debenture, Small Debenture [Member]</link:label>
    <link:label id="lab_alts_NonConvertibleDebentureSmallDebentureMember_documentation_en-US" xlink:label="lab_alts_NonConvertibleDebentureSmallDebentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non-Convertible Debenture, Small Debenture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NonConvertibleDebentureSmallDebentureMember" xlink:href="alts-20241228.xsd#alts_NonConvertibleDebentureSmallDebentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_NonConvertibleDebentureSmallDebentureMember" xlink:to="lab_alts_NonConvertibleDebentureSmallDebentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_SoinTherapeuticsLLCMember_a97827c3-1f20-491b-80df-ef3a8c096e0d_terseLabel_en-US" xlink:label="lab_alts_SoinTherapeuticsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soin Therapeutics LLC</link:label>
    <link:label id="lab_alts_SoinTherapeuticsLLCMember_label_en-US" xlink:label="lab_alts_SoinTherapeuticsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soin Therapeutics LLC [Member]</link:label>
    <link:label id="lab_alts_SoinTherapeuticsLLCMember_documentation_en-US" xlink:label="lab_alts_SoinTherapeuticsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Soin Therapeutics L L C [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SoinTherapeuticsLLCMember" xlink:href="alts-20241228.xsd#alts_SoinTherapeuticsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_SoinTherapeuticsLLCMember" xlink:to="lab_alts_SoinTherapeuticsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_b6d9b002-d82b-4cab-a103-a4bc9d1c5c73_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash acquired in ALT5 Subsidiary acquisition</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_label_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredFromAcquisition" xlink:to="lab_us-gaap_CashAcquiredFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares_5e50eccb-f7fc-4095-93c8-e56a9bafbd89_terseLabel_en-US" xlink:label="lab_alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Securities received (in shares)</link:label>
    <link:label id="lab_alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares_label_en-US" xlink:label="lab_alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncash Or Part Noncash Divestiture, Consideration Received, Shares</link:label>
    <link:label id="lab_alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares_documentation_en-US" xlink:label="lab_alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Noncash Or Part Noncash Divestiture, Consideration Received, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares" xlink:href="alts-20241228.xsd#alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares" xlink:to="lab_alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsPayable_1c75eb5a-11c4-49ed-bed8-bf54fb56c96e_verboseLabel_en-US" xlink:label="lab_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsPayable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Digital assets payable</link:label>
    <link:label id="lab_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsPayable_label_en-US" xlink:label="lab_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Digital Assets Payable</link:label>
    <link:label id="lab_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsPayable_documentation_en-US" xlink:label="lab_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Digital Assets Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsPayable" xlink:href="alts-20241228.xsd#alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsPayable" xlink:to="lab_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPrepaidExpenseCurrent_73f0d48f-c384-43db-8b6f-d24c88224136_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid other</link:label>
    <link:label id="lab_us-gaap_OtherPrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPrepaidExpenseCurrent" xlink:to="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfInterestInPartnershipUnit_e996b46d-7f1e-4d87-bff1-ca7270f448d5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfInterestInPartnershipUnit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfInterestInPartnershipUnit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfInterestInPartnershipUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale of Interest in Partnership Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfInterestInPartnershipUnit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfInterestInPartnershipUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfInterestInPartnershipUnit" xlink:to="lab_us-gaap_ProceedsFromSaleOfInterestInPartnershipUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_fb9b6c60-f21f-455c-a479-10c74d466dd4_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net (loss) income, basic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_207a75ba-a855-4bc9-a781-ba2459eb8a56_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock, Class of Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock, Class of Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</link:label>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:to="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_092c1d95-d5d9-407c-b072-19923a41ced1_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_8b188217-c92d-4d74-855f-15f98eb7c47e_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_fcccbfcb-b288-413a-b6ce-aef90d167d4a_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance_055427cb-5f8a-48cf-8956-ad4f0d397cb6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating loss carryforwards, valuation allowance</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:to="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c22fad3e-78a5-48f6-8257-ef77959b1f7b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_e0c54099-05c8-40ae-ad55-4d4221d73e4e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_8de6b7fe-094f-4bbc-a192-308b3a0ebf38_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies (Note 21)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_0bc0bb13-040b-4780-8651-13b888bd0b2e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_e2bc75d1-891b-40f9-85a7-2576d7381c5c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_c49aab53-ba95-44ae-9ee7-e56d16dc192e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Reconciliation of Income Tax Benefit (Provision) with the Federal Statutory Tax Rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_72778dd3-b2eb-48c8-831f-be0ebbbd57fd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule Of Related Party Transactions By Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance_5d3e5ae1-405f-4565-a3ee-48e722d38855_totalLabel_en-US" xlink:label="lab_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred tax assets (liabilities)</link:label>
    <link:label id="lab_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance_label_en-US" xlink:label="lab_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets Liabilities Gross Before Valuation Allowance</link:label>
    <link:label id="lab_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance_documentation_en-US" xlink:label="lab_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred tax assets liabilities gross before valuation allowance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance" xlink:href="alts-20241228.xsd#alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance" xlink:to="lab_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a52b96de-efaa-421b-94c6-e6546fe6612a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_OperatingExpensesFromDiscontinuedOperationsAbstract_15243af0-b90b-490e-bddb-e412bf4156d1_terseLabel_en-US" xlink:label="lab_alts_OperatingExpensesFromDiscontinuedOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses from discontinued operations:</link:label>
    <link:label id="lab_alts_OperatingExpensesFromDiscontinuedOperationsAbstract_label_en-US" xlink:label="lab_alts_OperatingExpensesFromDiscontinuedOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses From Discontinued Operations [Abstract]</link:label>
    <link:label id="lab_alts_OperatingExpensesFromDiscontinuedOperationsAbstract_documentation_en-US" xlink:label="lab_alts_OperatingExpensesFromDiscontinuedOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Expenses From Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OperatingExpensesFromDiscontinuedOperationsAbstract" xlink:href="alts-20241228.xsd#alts_OperatingExpensesFromDiscontinuedOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_OperatingExpensesFromDiscontinuedOperationsAbstract" xlink:to="lab_alts_OperatingExpensesFromDiscontinuedOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_ba411984-5d73-4b14-9f49-09d273b0989d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_TotalDisposalOfAssets_e5e01d85-7d89-4cef-98be-2c7cb34d8f0c_totalLabel_en-US" xlink:label="lab_alts_TotalDisposalOfAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total disposal of assets</link:label>
    <link:label id="lab_alts_TotalDisposalOfAssets_label_en-US" xlink:label="lab_alts_TotalDisposalOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Disposal of Assets</link:label>
    <link:label id="lab_alts_TotalDisposalOfAssets_documentation_en-US" xlink:label="lab_alts_TotalDisposalOfAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total Disposal of Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_TotalDisposalOfAssets" xlink:href="alts-20241228.xsd#alts_TotalDisposalOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_TotalDisposalOfAssets" xlink:to="lab_alts_TotalDisposalOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DisposalOfLeaseLiability_e8de80d4-dc11-42cc-89f5-381417f56f14_terseLabel_en-US" xlink:label="lab_alts_DisposalOfLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_alts_DisposalOfLeaseLiability_label_en-US" xlink:label="lab_alts_DisposalOfLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal of Lease Liability</link:label>
    <link:label id="lab_alts_DisposalOfLeaseLiability_documentation_en-US" xlink:label="lab_alts_DisposalOfLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal of Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfLeaseLiability" xlink:href="alts-20241228.xsd#alts_DisposalOfLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DisposalOfLeaseLiability" xlink:to="lab_alts_DisposalOfLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_AssetAcquisitionConsiderationPeriodicCashPayment_83df6e78-992e-4967-8a92-fc02a53e1ab8_terseLabel_en-US" xlink:label="lab_alts_AssetAcquisitionConsiderationPeriodicCashPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Monthly cash payments to be made</link:label>
    <link:label id="lab_alts_AssetAcquisitionConsiderationPeriodicCashPayment_label_en-US" xlink:label="lab_alts_AssetAcquisitionConsiderationPeriodicCashPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Consideration, Periodic Cash Payment</link:label>
    <link:label id="lab_alts_AssetAcquisitionConsiderationPeriodicCashPayment_documentation_en-US" xlink:label="lab_alts_AssetAcquisitionConsiderationPeriodicCashPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Consideration, Periodic Cash Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AssetAcquisitionConsiderationPeriodicCashPayment" xlink:href="alts-20241228.xsd#alts_AssetAcquisitionConsiderationPeriodicCashPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_AssetAcquisitionConsiderationPeriodicCashPayment" xlink:to="lab_alts_AssetAcquisitionConsiderationPeriodicCashPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilities_00906c11-19de-4224-bf19-93779412d481_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Due to related parties</link:label>
    <link:label id="lab_us-gaap_OtherLiabilities_label_en-US" xlink:label="lab_us-gaap_OtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilities" xlink:to="lab_us-gaap_OtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesAbstract_cb3bbe71-33b6-46bd-887d-75ba18660419_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract" xlink:to="lab_us-gaap_MarketableSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_4a37d7ea-d2e0-42f3-8fae-c137f5b693c0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Purchase Price Allocation of Purchase for ALT5 Subsidiary to Acquired Identifiable Assets, Liabilities Assumed and Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_da45f38b-b5bf-4f17-89d3-d3e3506b3404_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued for consulting agreement (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_50a8130d-5c0f-4f91-bb7e-81f4d1d65b59_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued for consulting agreement (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Issued for Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_ExercisePriceRangeOneMember_6774fc3f-389c-4792-a0e8-1bc424179161_terseLabel_en-US" xlink:label="lab_alts_ExercisePriceRangeOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">$5.70 to $9.90</link:label>
    <link:label id="lab_alts_ExercisePriceRangeOneMember_label_en-US" xlink:label="lab_alts_ExercisePriceRangeOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price Range One [Member]</link:label>
    <link:label id="lab_alts_ExercisePriceRangeOneMember_documentation_en-US" xlink:label="lab_alts_ExercisePriceRangeOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exercise price range one.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ExercisePriceRangeOneMember" xlink:href="alts-20241228.xsd#alts_ExercisePriceRangeOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_ExercisePriceRangeOneMember" xlink:to="lab_alts_ExercisePriceRangeOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_604ce9e1-f19e-4747-96d4-c7f12622d4d8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_BusinessAcquisitionConsiderationTrancheTwoMember_3f094d44-66c9-48d1-ab31-0d492536a42b_terseLabel_en-US" xlink:label="lab_alts_BusinessAcquisitionConsiderationTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Consideration, Tranche Two</link:label>
    <link:label id="lab_alts_BusinessAcquisitionConsiderationTrancheTwoMember_label_en-US" xlink:label="lab_alts_BusinessAcquisitionConsiderationTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Consideration, Tranche Two [Member]</link:label>
    <link:label id="lab_alts_BusinessAcquisitionConsiderationTrancheTwoMember_documentation_en-US" xlink:label="lab_alts_BusinessAcquisitionConsiderationTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Acquisition, Consideration, Tranche Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessAcquisitionConsiderationTrancheTwoMember" xlink:href="alts-20241228.xsd#alts_BusinessAcquisitionConsiderationTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_BusinessAcquisitionConsiderationTrancheTwoMember" xlink:to="lab_alts_BusinessAcquisitionConsiderationTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityTableTextBlock_063cc468-7317-4db3-b7df-4551f910a0fc_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Series S Convertible Preferred Stock Outstanding</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityTableTextBlock" xlink:to="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_ee18516b-c846-4ee1-8196-c503dd343ada_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_0500170c-74f9-424a-9f75-603102dee607_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_OtherSignificantNoncashTransactionConsultingServicesMember_9f5ce09b-e8f3-435d-b9cd-b8570ae63899_terseLabel_en-US" xlink:label="lab_alts_OtherSignificantNoncashTransactionConsultingServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued for consulting services</link:label>
    <link:label id="lab_alts_OtherSignificantNoncashTransactionConsultingServicesMember_label_en-US" xlink:label="lab_alts_OtherSignificantNoncashTransactionConsultingServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Significant Noncash Transaction, Consulting Services [Member]</link:label>
    <link:label id="lab_alts_OtherSignificantNoncashTransactionConsultingServicesMember_documentation_en-US" xlink:label="lab_alts_OtherSignificantNoncashTransactionConsultingServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Significant Noncash Transaction, Consulting Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherSignificantNoncashTransactionConsultingServicesMember" xlink:href="alts-20241228.xsd#alts_OtherSignificantNoncashTransactionConsultingServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_OtherSignificantNoncashTransactionConsultingServicesMember" xlink:to="lab_alts_OtherSignificantNoncashTransactionConsultingServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_1c21ffa2-4778-4f94-986a-b28b78fdcecb_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_02a7fbd0-10e8-4f88-b644-81fe3966fee5_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Write-off marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_8ba27c79-d257-4170-8d52-4474b9da249c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Write off of marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Security, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments" xlink:to="lab_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_cad01d51-8393-4684-8608-67f2a3e2a1c3_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_4737da3e-9601-4c63-abe7-a0f335df5bc4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_51dfa439-7ec7-4e58-aeee-8021466dd16f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_7bf715a1-9ab9-4e6e-8af5-a99a870603a1_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_OtherCommitmentsNumberOfLandlordsCompanyIsNoLongerLiableFor_6cb596bc-825b-41f3-b041-7ad40929db86_terseLabel_en-US" xlink:label="lab_alts_OtherCommitmentsNumberOfLandlordsCompanyIsNoLongerLiableFor" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of landlords company is no longer liable for</link:label>
    <link:label id="lab_alts_OtherCommitmentsNumberOfLandlordsCompanyIsNoLongerLiableFor_label_en-US" xlink:label="lab_alts_OtherCommitmentsNumberOfLandlordsCompanyIsNoLongerLiableFor" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitments, Number Of Landlords Company Is No Longer Liable For</link:label>
    <link:label id="lab_alts_OtherCommitmentsNumberOfLandlordsCompanyIsNoLongerLiableFor_documentation_en-US" xlink:label="lab_alts_OtherCommitmentsNumberOfLandlordsCompanyIsNoLongerLiableFor" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Commitments, Number Of Landlords Company Is No Longer Liable For</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherCommitmentsNumberOfLandlordsCompanyIsNoLongerLiableFor" xlink:href="alts-20241228.xsd#alts_OtherCommitmentsNumberOfLandlordsCompanyIsNoLongerLiableFor"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_OtherCommitmentsNumberOfLandlordsCompanyIsNoLongerLiableFor" xlink:to="lab_alts_OtherCommitmentsNumberOfLandlordsCompanyIsNoLongerLiableFor" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c8958308-9e78-4ebc-8015-c0eac8b45917_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_LitigationSettlementAmountAwardedToOtherPartyNumberOfPeriodicPayments_8111343f-a14b-4998-9527-2cf896455545_terseLabel_en-US" xlink:label="lab_alts_LitigationSettlementAmountAwardedToOtherPartyNumberOfPeriodicPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of quarterly payments</link:label>
    <link:label id="lab_alts_LitigationSettlementAmountAwardedToOtherPartyNumberOfPeriodicPayments_label_en-US" xlink:label="lab_alts_LitigationSettlementAmountAwardedToOtherPartyNumberOfPeriodicPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party, Number of Periodic Payments</link:label>
    <link:label id="lab_alts_LitigationSettlementAmountAwardedToOtherPartyNumberOfPeriodicPayments_documentation_en-US" xlink:label="lab_alts_LitigationSettlementAmountAwardedToOtherPartyNumberOfPeriodicPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party, Number of Periodic Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LitigationSettlementAmountAwardedToOtherPartyNumberOfPeriodicPayments" xlink:href="alts-20241228.xsd#alts_LitigationSettlementAmountAwardedToOtherPartyNumberOfPeriodicPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_LitigationSettlementAmountAwardedToOtherPartyNumberOfPeriodicPayments" xlink:to="lab_alts_LitigationSettlementAmountAwardedToOtherPartyNumberOfPeriodicPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_6ca98d71-6fe5-4147-ac04-34858d8c044a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average lease term (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_f59199de-0dfd-4ffb-80c5-14b08228c677_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_b035d1b0-861c-43b5-8bd5-4a5d0c5c19db_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_LegalFeesMember_e9748eee-59b3-4909-a638-fb96b1087bf5_terseLabel_en-US" xlink:label="lab_alts_LegalFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal Fees</link:label>
    <link:label id="lab_alts_LegalFeesMember_label_en-US" xlink:label="lab_alts_LegalFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Fees [Member]</link:label>
    <link:label id="lab_alts_LegalFeesMember_documentation_en-US" xlink:label="lab_alts_LegalFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Legal Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LegalFeesMember" xlink:href="alts-20241228.xsd#alts_LegalFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_LegalFeesMember" xlink:to="lab_alts_LegalFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_ConversionOfStockCommencementPeriod_a2ea4938-adff-4b8e-934a-62ceeb4a4b3b_terseLabel_en-US" xlink:label="lab_alts_ConversionOfStockCommencementPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of stock, commencement period (in years)</link:label>
    <link:label id="lab_alts_ConversionOfStockCommencementPeriod_label_en-US" xlink:label="lab_alts_ConversionOfStockCommencementPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion Of Stock, Commencement Period</link:label>
    <link:label id="lab_alts_ConversionOfStockCommencementPeriod_documentation_en-US" xlink:label="lab_alts_ConversionOfStockCommencementPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Conversion Of Stock, Commencement Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ConversionOfStockCommencementPeriod" xlink:href="alts-20241228.xsd#alts_ConversionOfStockCommencementPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_ConversionOfStockCommencementPeriod" xlink:to="lab_alts_ConversionOfStockCommencementPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_BusinessAcquisitionConsiderationTrancheThreeMember_8aafdded-f168-46e2-bab0-f5c0f41078cf_terseLabel_en-US" xlink:label="lab_alts_BusinessAcquisitionConsiderationTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Consideration, Tranche Three</link:label>
    <link:label id="lab_alts_BusinessAcquisitionConsiderationTrancheThreeMember_label_en-US" xlink:label="lab_alts_BusinessAcquisitionConsiderationTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Consideration, Tranche Three [Member]</link:label>
    <link:label id="lab_alts_BusinessAcquisitionConsiderationTrancheThreeMember_documentation_en-US" xlink:label="lab_alts_BusinessAcquisitionConsiderationTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Acquisition, Consideration, Tranche Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessAcquisitionConsiderationTrancheThreeMember" xlink:href="alts-20241228.xsd#alts_BusinessAcquisitionConsiderationTrancheThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_BusinessAcquisitionConsiderationTrancheThreeMember" xlink:to="lab_alts_BusinessAcquisitionConsiderationTrancheThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_SubscriptionsReceivableMember_02c605ad-be0e-4040-88ed-6b78bb6448c6_terseLabel_en-US" xlink:label="lab_alts_SubscriptionsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subscriptions Receivable</link:label>
    <link:label id="lab_alts_SubscriptionsReceivableMember_label_en-US" xlink:label="lab_alts_SubscriptionsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subscriptions Receivable [Member]</link:label>
    <link:label id="lab_alts_SubscriptionsReceivableMember_documentation_en-US" xlink:label="lab_alts_SubscriptionsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Subscriptions Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SubscriptionsReceivableMember" xlink:href="alts-20241228.xsd#alts_SubscriptionsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_SubscriptionsReceivableMember" xlink:to="lab_alts_SubscriptionsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_StockIssuedDuringPeriodSharesWarrantsExercised_9099dfd3-415c-46db-aec5-0e613b3c7e34_terseLabel_en-US" xlink:label="lab_alts_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued for warrants exercised (in shares)</link:label>
    <link:label id="lab_alts_StockIssuedDuringPeriodSharesWarrantsExercised_label_en-US" xlink:label="lab_alts_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Warrants Exercised</link:label>
    <link:label id="lab_alts_StockIssuedDuringPeriodSharesWarrantsExercised_documentation_en-US" xlink:label="lab_alts_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Warrants Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:href="alts-20241228.xsd#alts_StockIssuedDuringPeriodSharesWarrantsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:to="lab_alts_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_69c99deb-fe7e-4529-bc74-e4759c9eb3db_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share from continuing operations, diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_59d33637-4a56-4c9e-bd95-72d852ebf4ae_netLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Diluted (loss) per share from continuing operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_BusinessCombinationConsiderationTransferredLiabilitiesIncurredTerm_f2ed2807-63fd-45aa-9d50-fe0d3688e8f3_terseLabel_en-US" xlink:label="lab_alts_BusinessCombinationConsiderationTransferredLiabilitiesIncurredTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term of unsecured notes entered into (in years)</link:label>
    <link:label id="lab_alts_BusinessCombinationConsiderationTransferredLiabilitiesIncurredTerm_label_en-US" xlink:label="lab_alts_BusinessCombinationConsiderationTransferredLiabilitiesIncurredTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred, Term</link:label>
    <link:label id="lab_alts_BusinessCombinationConsiderationTransferredLiabilitiesIncurredTerm_documentation_en-US" xlink:label="lab_alts_BusinessCombinationConsiderationTransferredLiabilitiesIncurredTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessCombinationConsiderationTransferredLiabilitiesIncurredTerm" xlink:href="alts-20241228.xsd#alts_BusinessCombinationConsiderationTransferredLiabilitiesIncurredTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_BusinessCombinationConsiderationTransferredLiabilitiesIncurredTerm" xlink:to="lab_alts_BusinessCombinationConsiderationTransferredLiabilitiesIncurredTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_1d30521b-ba84-4be3-a003-8de07e084610_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_b32783e9-385c-455c-bc66-75605d427435_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of revenues</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_ScheduleOfOperatingLeaseRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock_2fc8f240-1aea-4d39-a265-4fd7751a92b0_terseLabel_en-US" xlink:label="lab_alts_ScheduleOfOperatingLeaseRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Company's Right of Use Assets and Lease Liabilities</link:label>
    <link:label id="lab_alts_ScheduleOfOperatingLeaseRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_alts_ScheduleOfOperatingLeaseRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Operating Lease Right Of Use Assets And Lease Liabilities [Table Text Block]</link:label>
    <link:label id="lab_alts_ScheduleOfOperatingLeaseRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock_documentation_en-US" xlink:label="lab_alts_ScheduleOfOperatingLeaseRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule Of Operating Lease Right Of Use Assets And Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ScheduleOfOperatingLeaseRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock" xlink:href="alts-20241228.xsd#alts_ScheduleOfOperatingLeaseRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_ScheduleOfOperatingLeaseRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock" xlink:to="lab_alts_ScheduleOfOperatingLeaseRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_2b18715c-1813-41a0-8955-603851867538_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a1652158-7bde-47b0-aa66-e8dddae0dae6_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsSvcCstMember" xlink:to="lab_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_SeriesVPreferredStockMember_7efa380a-72bc-4fcb-982a-3e6f12585270_terseLabel_en-US" xlink:label="lab_alts_SeriesVPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series V Preferred</link:label>
    <link:label id="lab_alts_SeriesVPreferredStockMember_label_en-US" xlink:label="lab_alts_SeriesVPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series V Preferred Stock [Member]</link:label>
    <link:label id="lab_alts_SeriesVPreferredStockMember_documentation_en-US" xlink:label="lab_alts_SeriesVPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series V Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesVPreferredStockMember" xlink:href="alts-20241228.xsd#alts_SeriesVPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_SeriesVPreferredStockMember" xlink:to="lab_alts_SeriesVPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ed581e4f-1dfe-4557-83d5-4fcfc3d19db8_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5c451141-1079-4935-bfc0-b4be68e4df51_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4e65f961-62f3-4758-914c-b2e00b0622fd_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments_35456f05-5f5e-4d04-97ce-f5fffb563b5c_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Mark-to-market</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Security, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments" xlink:to="lab_us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5e93c53e-b711-43a3-93e7-20782c3e5938_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1491805d-da0d-4733-b1b3-11feeee7e167_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c1b65689-2766-4111-b1e0-187d48f42c15_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_2d1087c1-ec1c-4a1d-9cbc-fee8e64681be_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets (liabilities):</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of Deferred Tax Assets and Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_ConversionOfStockPeriodFollowingClosing_57b9481c-5a18-4b98-bd42-57be4ecab838_terseLabel_en-US" xlink:label="lab_alts_ConversionOfStockPeriodFollowingClosing" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of stock, period after closing (in years)</link:label>
    <link:label id="lab_alts_ConversionOfStockPeriodFollowingClosing_label_en-US" xlink:label="lab_alts_ConversionOfStockPeriodFollowingClosing" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion Of Stock, Period Following Closing</link:label>
    <link:label id="lab_alts_ConversionOfStockPeriodFollowingClosing_documentation_en-US" xlink:label="lab_alts_ConversionOfStockPeriodFollowingClosing" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Conversion Of Stock, Period Following Closing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ConversionOfStockPeriodFollowingClosing" xlink:href="alts-20241228.xsd#alts_ConversionOfStockPeriodFollowingClosing"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_ConversionOfStockPeriodFollowingClosing" xlink:to="lab_alts_ConversionOfStockPeriodFollowingClosing" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DrSoinMember_216d17bf-a73e-4227-b6d2-c6b4407eb864_terseLabel_en-US" xlink:label="lab_alts_DrSoinMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dr. Soin</link:label>
    <link:label id="lab_alts_DrSoinMember_label_en-US" xlink:label="lab_alts_DrSoinMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dr. Soin [Member]</link:label>
    <link:label id="lab_alts_DrSoinMember_documentation_en-US" xlink:label="lab_alts_DrSoinMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Dr. Soin [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DrSoinMember" xlink:href="alts-20241228.xsd#alts_DrSoinMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DrSoinMember" xlink:to="lab_alts_DrSoinMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_285ff4b8-e446-4267-96f5-e2e76bdb6f30_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_f22c8144-16f4-4cf0-a40e-3ad7990abed3_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net (loss) income from continuing operations, diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_70c0afb9-e60a-4edd-a622-9344d416734f_verboseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrivatePlacementMember_1fb302fb-66f4-4479-82d3-e1f58b851957_terseLabel_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Private Placement</link:label>
    <link:label id="lab_us-gaap_PrivatePlacementMember_label_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Private Placement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrivatePlacementMember" xlink:to="lab_us-gaap_PrivatePlacementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_MezzanineEquityAbstract_7a954398-c832-48cf-9c18-a4c2d261fae0_terseLabel_en-US" xlink:label="lab_alts_MezzanineEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Mezzanine equity</link:label>
    <link:label id="lab_alts_MezzanineEquityAbstract_label_en-US" xlink:label="lab_alts_MezzanineEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Mezzanine equity [Abstract]</link:label>
    <link:label id="lab_alts_MezzanineEquityAbstract_documentation_en-US" xlink:label="lab_alts_MezzanineEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Mezzanine equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_MezzanineEquityAbstract" xlink:href="alts-20241228.xsd#alts_MezzanineEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_MezzanineEquityAbstract" xlink:to="lab_alts_MezzanineEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateAndOtherMember_c6eb5904-f0d7-4e92-9304-7bd15f6f29f4_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corporate and other</link:label>
    <link:label id="lab_us-gaap_CorporateAndOtherMember_label_en-US" xlink:label="lab_us-gaap_CorporateAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate Segment and Other Operating Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateAndOtherMember" xlink:to="lab_us-gaap_CorporateAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_4067848b-16ca-4201-a656-53ee49b3758d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of shares of common stock to legacy equity holders</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_f5c63411-fdec-4862-8ad0-11ff770157e7_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification of Series S S-1 Preferred Stock to permanent equity</link:label>
    <link:label id="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_e1140bf4-2096-4b13-84df-6150fbe51226_verboseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Reclassification to permanent equity</link:label>
    <link:label id="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_eb9c65bf-26a3-4f42-9e12-5e931308ec6c_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Reclassification to permanent equity</link:label>
    <link:label id="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_label_en-US" xlink:label="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassifications of Temporary to Permanent Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:to="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_584f6ee7-90cb-4d82-9d34-f4d2b03254fd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of options, exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_392dca66-e05d-4cb6-85c1-57a8dbf69680_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_ed4cdc29-19e5-4d12-99dc-1ed4008105fa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_018ad977-6cc7-46ec-b280-e27d178443d3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Prepaids and Other Current Assets</link:label>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DiscontinuedOperatingActivities_85bead47-9fa9-46e2-b5f9-9bb2e6ad675b_terseLabel_en-US" xlink:label="lab_alts_DiscontinuedOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">DISCONTINUED OPERATING ACTIVITIES:</link:label>
    <link:label id="lab_alts_DiscontinuedOperatingActivities_label_en-US" xlink:label="lab_alts_DiscontinuedOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">DISCONTINUED OPERATING ACTIVITIES:</link:label>
    <link:label id="lab_alts_DiscontinuedOperatingActivities_documentation_en-US" xlink:label="lab_alts_DiscontinuedOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">DISCONTINUED OPERATING ACTIVITIES:</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DiscontinuedOperatingActivities" xlink:href="alts-20241228.xsd#alts_DiscontinuedOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DiscontinuedOperatingActivities" xlink:to="lab_alts_DiscontinuedOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DisposalOfAccountsReceivable_e3dce0ab-b526-44b7-96ee-93d6f66c7df3_terseLabel_en-US" xlink:label="lab_alts_DisposalOfAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_alts_DisposalOfAccountsReceivable_label_en-US" xlink:label="lab_alts_DisposalOfAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal of Accounts receivable</link:label>
    <link:label id="lab_alts_DisposalOfAccountsReceivable_documentation_en-US" xlink:label="lab_alts_DisposalOfAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal of Accounts receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfAccountsReceivable" xlink:href="alts-20241228.xsd#alts_DisposalOfAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DisposalOfAccountsReceivable" xlink:to="lab_alts_DisposalOfAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableCurrent_ad8deb47-ce37-4c10-ac37-b44ea4938256_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableCurrent" xlink:to="lab_us-gaap_NotesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_b1011e85-7439-49fc-8040-6b6bfbb0db93_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Due to Soin</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_30d921fb-4105-46fb-ac40-9f541395ba40_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1a087f28-afcd-40d9-9697-3e36e5fdadd9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Computation of Basic and Diluted Net Loss per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CryptoAssetUnrealizedGainLossOperating_9cba6f0e-cdde-48aa-b96b-096248de83e2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CryptoAssetUnrealizedGainLossOperating" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Unrealized gain on digital assets</link:label>
    <link:label id="lab_us-gaap_CryptoAssetUnrealizedGainLossOperating_label_en-US" xlink:label="lab_us-gaap_CryptoAssetUnrealizedGainLossOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Crypto Asset, Unrealized Gain (Loss), Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CryptoAssetUnrealizedGainLossOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetUnrealizedGainLossOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CryptoAssetUnrealizedGainLossOperating" xlink:to="lab_us-gaap_CryptoAssetUnrealizedGainLossOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_0bb7cf78-07a4-4d31-8de7-d4ed385afa77_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating income from discontinued operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_e24e58ca-5b73-4d0e-b092-f476e705a878_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax refunds received, net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassAMember_519e9a87-1964-48c8-9aaf-56df4d2147d2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Class A</link:label>
    <link:label id="lab_us-gaap_CommonClassAMember_label_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Class A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassAMember" xlink:to="lab_us-gaap_CommonClassAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DeferredTaxAssetsInterest_e8afc3fe-fb3f-453a-bb33-0828c1ed78e5_terseLabel_en-US" xlink:label="lab_alts_DeferredTaxAssetsInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Section 163(j) interest</link:label>
    <link:label id="lab_alts_DeferredTaxAssetsInterest_label_en-US" xlink:label="lab_alts_DeferredTaxAssetsInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets Interest</link:label>
    <link:label id="lab_alts_DeferredTaxAssetsInterest_documentation_en-US" xlink:label="lab_alts_DeferredTaxAssetsInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred tax assets interest.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DeferredTaxAssetsInterest" xlink:href="alts-20241228.xsd#alts_DeferredTaxAssetsInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DeferredTaxAssetsInterest" xlink:to="lab_alts_DeferredTaxAssetsInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_947c65eb-3303-4d15-bff0-28cebbef8425_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series A-1 preferred converted for legal settlement (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_WestervilleSquareMember_3b9b7e86-f719-4dcb-8bfe-656d2d40c67c_terseLabel_en-US" xlink:label="lab_alts_WestervilleSquareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Westerville Square</link:label>
    <link:label id="lab_alts_WestervilleSquareMember_label_en-US" xlink:label="lab_alts_WestervilleSquareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Westerville Square [Member]</link:label>
    <link:label id="lab_alts_WestervilleSquareMember_documentation_en-US" xlink:label="lab_alts_WestervilleSquareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Westerville Square [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_WestervilleSquareMember" xlink:href="alts-20241228.xsd#alts_WestervilleSquareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_WestervilleSquareMember" xlink:to="lab_alts_WestervilleSquareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_SoinIntangiblesMember_fe7cc71f-2573-48a4-ab42-3a05e80676c1_terseLabel_en-US" xlink:label="lab_alts_SoinIntangiblesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soin intangibles</link:label>
    <link:label id="lab_alts_SoinIntangiblesMember_label_en-US" xlink:label="lab_alts_SoinIntangiblesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soin Intangibles [Member]</link:label>
    <link:label id="lab_alts_SoinIntangiblesMember_documentation_en-US" xlink:label="lab_alts_SoinIntangiblesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Soin Intangibles [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SoinIntangiblesMember" xlink:href="alts-20241228.xsd#alts_SoinIntangiblesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_SoinIntangiblesMember" xlink:to="lab_alts_SoinIntangiblesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_NumberOfTradingDaysBeforeBoardApproval_3cf6568c-a8c4-4a58-b189-bb54bfaba777_terseLabel_en-US" xlink:label="lab_alts_NumberOfTradingDaysBeforeBoardApproval" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of trading days prior to court approval (in days)</link:label>
    <link:label id="lab_alts_NumberOfTradingDaysBeforeBoardApproval_label_en-US" xlink:label="lab_alts_NumberOfTradingDaysBeforeBoardApproval" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Trading Days Before Board Approval</link:label>
    <link:label id="lab_alts_NumberOfTradingDaysBeforeBoardApproval_documentation_en-US" xlink:label="lab_alts_NumberOfTradingDaysBeforeBoardApproval" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Trading Days Before Board Approval</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NumberOfTradingDaysBeforeBoardApproval" xlink:href="alts-20241228.xsd#alts_NumberOfTradingDaysBeforeBoardApproval"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_NumberOfTradingDaysBeforeBoardApproval" xlink:to="lab_alts_NumberOfTradingDaysBeforeBoardApproval" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_67e08f96-cf8e-438a-8257-96da381513e8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_2ebbd536-ef53-464f-9ae7-a31ec664f2a1_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total goodwill and other intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Including Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_SOINAgreementConvertibleTrancheThreeMember_f635b8f9-2be3-4a16-b1ee-4f5e68559817_terseLabel_en-US" xlink:label="lab_alts_SOINAgreementConvertibleTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soin Agreement Convertible Tranche Three</link:label>
    <link:label id="lab_alts_SOINAgreementConvertibleTrancheThreeMember_label_en-US" xlink:label="lab_alts_SOINAgreementConvertibleTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SOIN Agreement, Convertible Tranche Three [Member]</link:label>
    <link:label id="lab_alts_SOINAgreementConvertibleTrancheThreeMember_documentation_en-US" xlink:label="lab_alts_SOINAgreementConvertibleTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">SOIN Agreement, Convertible Tranche Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SOINAgreementConvertibleTrancheThreeMember" xlink:href="alts-20241228.xsd#alts_SOINAgreementConvertibleTrancheThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_SOINAgreementConvertibleTrancheThreeMember" xlink:to="lab_alts_SOINAgreementConvertibleTrancheThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialGuaranteeInsuranceContractsPremiumsReceivableAccretionOfDiscountOnPremiumReceivable_29a915d5-83ec-4d1b-bf5f-3e015f13e728_negatedLabel_en-US" xlink:label="lab_us-gaap_FinancialGuaranteeInsuranceContractsPremiumsReceivableAccretionOfDiscountOnPremiumReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accretion of note receivable discount</link:label>
    <link:label id="lab_us-gaap_FinancialGuaranteeInsuranceContractsPremiumsReceivableAccretionOfDiscountOnPremiumReceivable_label_en-US" xlink:label="lab_us-gaap_FinancialGuaranteeInsuranceContractsPremiumsReceivableAccretionOfDiscountOnPremiumReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Guarantee Insurance Contracts, Premiums Receivable, Adjustment, Accretion of Discount on Premium Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumsReceivableAccretionOfDiscountOnPremiumReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialGuaranteeInsuranceContractsPremiumsReceivableAccretionOfDiscountOnPremiumReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumsReceivableAccretionOfDiscountOnPremiumReceivable" xlink:to="lab_us-gaap_FinancialGuaranteeInsuranceContractsPremiumsReceivableAccretionOfDiscountOnPremiumReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_31e83391-628b-4495-b404-01b305938d78_verboseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income from discontinued operations</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_ea045256-1c69-484d-9a48-3f694c576bcf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Gain on sale of ARCA</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:to="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_3588cd31-57b4-46d4-a62a-dd3194cba108_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_1838a6ad-7749-4fd1-8516-2737663cad05_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, outstanding shares (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_77db6fb4-e27a-4453-8105-446d13e604e4_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_463b16d1-5aec-448a-b966-426802e533b4_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_e339bd6c-10ca-4dfe-b880-2a5588c47eb2_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_0093272d-8cf3-4355-b0d6-b1bc368085c8_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_ShareholdersEquityTable_38a992ee-028f-4766-abfc-8207e6771509_terseLabel_en-US" xlink:label="lab_alts_ShareholdersEquityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shareholders Equity [Table]</link:label>
    <link:label id="lab_alts_ShareholdersEquityTable_label_en-US" xlink:label="lab_alts_ShareholdersEquityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shareholders Equity [Table]</link:label>
    <link:label id="lab_alts_ShareholdersEquityTable_documentation_en-US" xlink:label="lab_alts_ShareholdersEquityTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stockholders equity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ShareholdersEquityTable" xlink:href="alts-20241228.xsd#alts_ShareholdersEquityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_ShareholdersEquityTable" xlink:to="lab_alts_ShareholdersEquityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_d501da47-6c4e-4f3f-8315-1e6314f353f0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_b2c0383a-972a-43f0-8750-8355ea88c07f_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Long term - operating</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestReceivable_a68ccc1b-0231-49f9-b90d-0cb04f5ba758_terseLabel_en-US" xlink:label="lab_us-gaap_InterestReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued receivables</link:label>
    <link:label id="lab_us-gaap_InterestReceivable_label_en-US" xlink:label="lab_us-gaap_InterestReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestReceivable" xlink:to="lab_us-gaap_InterestReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_9a334523-5538-41cf-90a9-dd1284749dc8_verboseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Warrants and rights outstanding, term (in years)</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants and Rights Outstanding, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_EffectiveIncomeTaxRateReconciliationPermanentDifferences_eee8f023-6d0f-4217-8214-e4f3f690847f_negatedLabel_en-US" xlink:label="lab_alts_EffectiveIncomeTaxRateReconciliationPermanentDifferences" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Permanent differences</link:label>
    <link:label id="lab_alts_EffectiveIncomeTaxRateReconciliationPermanentDifferences_label_en-US" xlink:label="lab_alts_EffectiveIncomeTaxRateReconciliationPermanentDifferences" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation Permanent Differences</link:label>
    <link:label id="lab_alts_EffectiveIncomeTaxRateReconciliationPermanentDifferences_documentation_en-US" xlink:label="lab_alts_EffectiveIncomeTaxRateReconciliationPermanentDifferences" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective income tax rate reconciliation permanent differences.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_EffectiveIncomeTaxRateReconciliationPermanentDifferences" xlink:href="alts-20241228.xsd#alts_EffectiveIncomeTaxRateReconciliationPermanentDifferences"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_EffectiveIncomeTaxRateReconciliationPermanentDifferences" xlink:to="lab_alts_EffectiveIncomeTaxRateReconciliationPermanentDifferences" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_TotalConsiderations_7cf1cada-38d8-4ecb-af09-19a96597a41f_totalLabel_en-US" xlink:label="lab_alts_TotalConsiderations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total consideration</link:label>
    <link:label id="lab_alts_TotalConsiderations_label_en-US" xlink:label="lab_alts_TotalConsiderations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Considerations</link:label>
    <link:label id="lab_alts_TotalConsiderations_documentation_en-US" xlink:label="lab_alts_TotalConsiderations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total Considerations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_TotalConsiderations" xlink:href="alts-20241228.xsd#alts_TotalConsiderations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_TotalConsiderations" xlink:to="lab_alts_TotalConsiderations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRentCurrentAndNoncurrent_3d52b397-08d8-4018-91a3-0ce2fe777586_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRentCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued rent</link:label>
    <link:label id="lab_us-gaap_AccruedRentCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRentCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Rent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRentCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedRentCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRentCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedRentCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableMember_62d376fe-8462-4636-9f81-6c6d85b9afc7_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loan</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_label_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loans Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableMember" xlink:to="lab_us-gaap_LoansPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_98f92e64-10b7-41af-94fb-f200eaa5df5d_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of preferred converted to common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Preferred Stock, Shares Issued upon Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_49255aeb-3ddf-4764-b2cf-6618f101ab0a_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_12d5d5bb-3b1d-4245-a231-16fe96d29974_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule Of Finite Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Asset, Finite-Lived [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_430aeaeb-7bca-4251-ba35-e79111fd8733_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Debentures Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_e8e3eab8-4f50-4bf0-865d-8802f1714313_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice_5580f15d-fd98-46f0-a916-90f0ac802093_terseLabel_en-US" xlink:label="lab_alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Per share value of the restricted shares issued (in usd per share)</link:label>
    <link:label id="lab_alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice_label_en-US" xlink:label="lab_alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction, Consulting Agreement, Convertible Debt, Conversion Price</link:label>
    <link:label id="lab_alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice_documentation_en-US" xlink:label="lab_alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Related Party Transaction, Consulting Agreement, Convertible Debt, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice" xlink:href="alts-20241228.xsd#alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice" xlink:to="lab_alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_17d92861-33e7-424e-a02c-5d855b5e3f1c_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregated consideration received on transaction</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_CommonShareEquivalentsMember_937bb692-e76e-4032-9b11-87a138b23958_verboseLabel_en-US" xlink:label="lab_alts_CommonShareEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common Shares Equivalent</link:label>
    <link:label id="lab_alts_CommonShareEquivalentsMember_e0f59d93-79e3-419e-9dc7-2047dc865f13_terseLabel_en-US" xlink:label="lab_alts_CommonShareEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Share Equivalent</link:label>
    <link:label id="lab_alts_CommonShareEquivalentsMember_label_en-US" xlink:label="lab_alts_CommonShareEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Share Equivalents [Member]</link:label>
    <link:label id="lab_alts_CommonShareEquivalentsMember_documentation_en-US" xlink:label="lab_alts_CommonShareEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Share Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_CommonShareEquivalentsMember" xlink:href="alts-20241228.xsd#alts_CommonShareEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_CommonShareEquivalentsMember" xlink:to="lab_alts_CommonShareEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DebtInstrumentOriginalIssueDiscountExpansionAxis_370abb2d-ddc6-408b-9055-7cd5d64c322f_terseLabel_en-US" xlink:label="lab_alts_DebtInstrumentOriginalIssueDiscountExpansionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Original Issue Discount, Expansion [Axis]</link:label>
    <link:label id="lab_alts_DebtInstrumentOriginalIssueDiscountExpansionAxis_label_en-US" xlink:label="lab_alts_DebtInstrumentOriginalIssueDiscountExpansionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Original Issue Discount, Expansion [Axis]</link:label>
    <link:label id="lab_alts_DebtInstrumentOriginalIssueDiscountExpansionAxis_documentation_en-US" xlink:label="lab_alts_DebtInstrumentOriginalIssueDiscountExpansionAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Original Issue Discount, Expansion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionAxis" xlink:href="alts-20241228.xsd#alts_DebtInstrumentOriginalIssueDiscountExpansionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionAxis" xlink:to="lab_alts_DebtInstrumentOriginalIssueDiscountExpansionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_e29a77ba-666a-4e5f-85b3-e0d35adc3544_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_7cd8c496-2c88-4382-8fc8-3bdaa417c81d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock issued for property and equipment (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Purchase of Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_236d65dc-5fbe-447f-85cf-84703cd5b1d7_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Damages awarded plus interest and attorney fees</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:to="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DebenturesMember_96674176-a70f-45aa-a9e6-960f06a237a0_terseLabel_en-US" xlink:label="lab_alts_DebenturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debentures</link:label>
    <link:label id="lab_alts_DebenturesMember_label_en-US" xlink:label="lab_alts_DebenturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debentures [Member]</link:label>
    <link:label id="lab_alts_DebenturesMember_documentation_en-US" xlink:label="lab_alts_DebenturesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debentures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebenturesMember" xlink:href="alts-20241228.xsd#alts_DebenturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DebenturesMember" xlink:to="lab_alts_DebenturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_5fb415aa-8d72-4a3d-aeff-3a8a49bfe787_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_GainOnSaleNetOfCash_9cf983e3-f753-4d74-a919-1d47cbe24fc2_negatedTerseLabel_en-US" xlink:label="lab_alts_GainOnSaleNetOfCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Gain on sale of ARCA, net of cash</link:label>
    <link:label id="lab_alts_GainOnSaleNetOfCash_label_en-US" xlink:label="lab_alts_GainOnSaleNetOfCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain on Sale, Net of Cash</link:label>
    <link:label id="lab_alts_GainOnSaleNetOfCash_documentation_en-US" xlink:label="lab_alts_GainOnSaleNetOfCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gain on Sale, Net of Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_GainOnSaleNetOfCash" xlink:href="alts-20241228.xsd#alts_GainOnSaleNetOfCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_GainOnSaleNetOfCash" xlink:to="lab_alts_GainOnSaleNetOfCash" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_Mr.TonyIsaacMember_67fec0f0-f10b-470e-a314-992af4b68765_terseLabel_en-US" xlink:label="lab_alts_Mr.TonyIsaacMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Mr. Tony Isaac</link:label>
    <link:label id="lab_alts_Mr.TonyIsaacMember_label_en-US" xlink:label="lab_alts_Mr.TonyIsaacMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Mr. Tony Isaac [Member]</link:label>
    <link:label id="lab_alts_Mr.TonyIsaacMember_documentation_en-US" xlink:label="lab_alts_Mr.TonyIsaacMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Mr. Tony Isaac</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Mr.TonyIsaacMember" xlink:href="alts-20241228.xsd#alts_Mr.TonyIsaacMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_Mr.TonyIsaacMember" xlink:to="lab_alts_Mr.TonyIsaacMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_7170d9fd-b302-4b0d-88b5-83f08ce577f4_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Receivables and Allowance for Doubtful Accounts</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_cde2b6c4-5314-4b26-97dc-a4c925cdbf50_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_24570d6e-c3a4-4d84-bd45-07c7ddeff9d6_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_61ae950b-f0a6-46c3-97dc-79924a1770ca_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business acquisition, proforma net income</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_ApplianceSmartIncMember_1136bfed-22db-4bc5-a243-f62a7388ec79_terseLabel_en-US" xlink:label="lab_alts_ApplianceSmartIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Appliance Smart, Inc.</link:label>
    <link:label id="lab_alts_ApplianceSmartIncMember_label_en-US" xlink:label="lab_alts_ApplianceSmartIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Appliance Smart Inc [Member]</link:label>
    <link:label id="lab_alts_ApplianceSmartIncMember_documentation_en-US" xlink:label="lab_alts_ApplianceSmartIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">ApplianceSmart, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ApplianceSmartIncMember" xlink:href="alts-20241228.xsd#alts_ApplianceSmartIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_ApplianceSmartIncMember" xlink:to="lab_alts_ApplianceSmartIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_Mr.SullivanMember_953bda64-980f-480f-ab59-c2a60b539c96_terseLabel_en-US" xlink:label="lab_alts_Mr.SullivanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Mr. Sullivan</link:label>
    <link:label id="lab_alts_Mr.SullivanMember_label_en-US" xlink:label="lab_alts_Mr.SullivanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Mr. Sullivan [Member]</link:label>
    <link:label id="lab_alts_Mr.SullivanMember_documentation_en-US" xlink:label="lab_alts_Mr.SullivanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Mr. Sullivan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Mr.SullivanMember" xlink:href="alts-20241228.xsd#alts_Mr.SullivanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_Mr.SullivanMember" xlink:to="lab_alts_Mr.SullivanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_ca31141d-381d-4af9-8b22-b2f3839ddfd1_terseLabel_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investing cash flows used in discontinued operations</link:label>
    <link:label id="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_4316520f-3e03-45b6-b8b8-9f1dc679b21d_totalLabel_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities from discontinued operations</link:label>
    <link:label id="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Investing Activities, Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:to="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_5f0dd655-1708-4672-b1aa-9e636259ec8d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_9bda1713-23e1-4742-b115-b2bb60935dc7_terseLabel_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing cash flows used in discontinued operations</link:label>
    <link:label id="lab_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Financing Activities, Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" xlink:to="lab_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionOriginalDebtAmount1_b0302a15-8d78-4335-8e56-f97b63f23ebb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionOriginalDebtAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt conversion, converted amount</link:label>
    <link:label id="lab_us-gaap_DebtConversionOriginalDebtAmount1_label_en-US" xlink:label="lab_us-gaap_DebtConversionOriginalDebtAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Conversion, Original Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionOriginalDebtAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionOriginalDebtAmount1" xlink:to="lab_us-gaap_DebtConversionOriginalDebtAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_9deb53ee-389a-41d6-abd6-3f1a7cb186e9_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_label_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableTypeDomain" xlink:to="lab_us-gaap_ReceivableTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_8df5de07-9fad-439f-9191-8bda3efa9329_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_965de508-649b-45dc-b403-5faa20cba0ef_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business acquisition, shares issued, fair value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_7aee53fe-beb4-420b-9d42-4f3b93ef9949_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Diluted</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_ReclassificationsOfTemporaryToPermanentEquityShares_3f4fb273-98a7-4f51-81c0-50b3b6c238a2_terseLabel_en-US" xlink:label="lab_alts_ReclassificationsOfTemporaryToPermanentEquityShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification to permanent equity (in shares)</link:label>
    <link:label id="lab_alts_ReclassificationsOfTemporaryToPermanentEquityShares_label_en-US" xlink:label="lab_alts_ReclassificationsOfTemporaryToPermanentEquityShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassifications Of Temporary To Permanent Equity, Shares</link:label>
    <link:label id="lab_alts_ReclassificationsOfTemporaryToPermanentEquityShares_documentation_en-US" xlink:label="lab_alts_ReclassificationsOfTemporaryToPermanentEquityShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reclassifications Of Temporary To Permanent Equity, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ReclassificationsOfTemporaryToPermanentEquityShares" xlink:href="alts-20241228.xsd#alts_ReclassificationsOfTemporaryToPermanentEquityShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_ReclassificationsOfTemporaryToPermanentEquityShares" xlink:to="lab_alts_ReclassificationsOfTemporaryToPermanentEquityShares" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet_14e89752-cc0b-4a61-8f2b-f2359035474c_negatedTerseLabel_en-US" xlink:label="lab_alts_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_alts_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet_label_en-US" xlink:label="lab_alts_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other (Income) Expense, Net</link:label>
    <link:label id="lab_alts_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet_documentation_en-US" xlink:label="lab_alts_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other (Income) Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" xlink:href="alts-20241228.xsd#alts_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" xlink:to="lab_alts_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_LiveVentureIncorporatedMember_6c64092f-475b-48ca-a38a-874313b0b2bd_terseLabel_en-US" xlink:label="lab_alts_LiveVentureIncorporatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Live Venture Incorporated</link:label>
    <link:label id="lab_alts_LiveVentureIncorporatedMember_label_en-US" xlink:label="lab_alts_LiveVentureIncorporatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Live Venture Incorporated [Member]</link:label>
    <link:label id="lab_alts_LiveVentureIncorporatedMember_documentation_en-US" xlink:label="lab_alts_LiveVentureIncorporatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Live Venture Incorporated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LiveVentureIncorporatedMember" xlink:href="alts-20241228.xsd#alts_LiveVentureIncorporatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_LiveVentureIncorporatedMember" xlink:to="lab_alts_LiveVentureIncorporatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DebtInstrumentOriginalIssueDiscountExpansionOneMember_24ca1028-6b88-4078-9b58-68b477cf23b4_terseLabel_en-US" xlink:label="lab_alts_DebtInstrumentOriginalIssueDiscountExpansionOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">OID expansion one</link:label>
    <link:label id="lab_alts_DebtInstrumentOriginalIssueDiscountExpansionOneMember_label_en-US" xlink:label="lab_alts_DebtInstrumentOriginalIssueDiscountExpansionOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Original Issue Discount, Expansion One [Member]</link:label>
    <link:label id="lab_alts_DebtInstrumentOriginalIssueDiscountExpansionOneMember_documentation_en-US" xlink:label="lab_alts_DebtInstrumentOriginalIssueDiscountExpansionOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Original Issue Discount, Expansion One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionOneMember" xlink:href="alts-20241228.xsd#alts_DebtInstrumentOriginalIssueDiscountExpansionOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionOneMember" xlink:to="lab_alts_DebtInstrumentOriginalIssueDiscountExpansionOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_b6daf426-4180-4ea4-9cf3-b2fb409a5926_verboseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_023321d3-c547-4094-8645-42aca65bc2b2_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_a8331fce-47fb-4eec-8b5a-d1f8809246a5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_47cb0b16-f186-4eef-b85d-2058fc972bf1_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant excise and granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_5bf885bf-d4a3-4f2c-b06e-322ad576ede6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_d21ccf6b-4a34-4e69-9609-c72dadd10cd0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total rent and common area expenses</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dfdaff81-aa7e-41a7-b3d0-bd8c2083f672_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CASH AND CASH EQUIVALENTS OF CONTINUING OPERATIONS, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_db7a888a-0590-42c1-bc07-f84658f1e556_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_ArticlesOfIncorporationMember_503962f9-4f9f-4a0f-b5e3-c7917bab2ede_terseLabel_en-US" xlink:label="lab_alts_ArticlesOfIncorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Articles of Incorporation</link:label>
    <link:label id="lab_alts_ArticlesOfIncorporationMember_label_en-US" xlink:label="lab_alts_ArticlesOfIncorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Articles Of Incorporation [Member]</link:label>
    <link:label id="lab_alts_ArticlesOfIncorporationMember_documentation_en-US" xlink:label="lab_alts_ArticlesOfIncorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Articles of incorporation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ArticlesOfIncorporationMember" xlink:href="alts-20241228.xsd#alts_ArticlesOfIncorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_ArticlesOfIncorporationMember" xlink:to="lab_alts_ArticlesOfIncorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_b82e062c-ec04-45a4-9819-d75a5a63c013_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_8f5eb977-18cd-4716-9e40-52ffa02cd697_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_257c65a1-2ec3-454f-bf81-09092945d434_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net (loss) income from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_f5f24b65-1d85-4450-8be9-bf6875d15681_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Net loss from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketingRelatedIntangibleAssetsMember_b02f6366-fdb7-4411-bc09-35e35d5f2a9b_terseLabel_en-US" xlink:label="lab_us-gaap_MarketingRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Domain Name and Marketing</link:label>
    <link:label id="lab_us-gaap_MarketingRelatedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_MarketingRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketing-Related Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingRelatedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketingRelatedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketingRelatedIntangibleAssetsMember" xlink:to="lab_us-gaap_MarketingRelatedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_976537b0-f8e7-4662-85ff-ef8a29bd0751_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_A15DebenturesMaturingJune302025Member_3c0ae275-69e7-48fc-9180-a5afe59a340c_terseLabel_en-US" xlink:label="lab_alts_A15DebenturesMaturingJune302025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">15% Debentures Maturing June 30, 2025</link:label>
    <link:label id="lab_alts_A15DebenturesMaturingJune302025Member_label_en-US" xlink:label="lab_alts_A15DebenturesMaturingJune302025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">15% Debentures Maturing June 30, 2025 [Member]</link:label>
    <link:label id="lab_alts_A15DebenturesMaturingJune302025Member_documentation_en-US" xlink:label="lab_alts_A15DebenturesMaturingJune302025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">15% Debentures Maturing June 30, 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_A15DebenturesMaturingJune302025Member" xlink:href="alts-20241228.xsd#alts_A15DebenturesMaturingJune302025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_A15DebenturesMaturingJune302025Member" xlink:to="lab_alts_A15DebenturesMaturingJune302025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_AssetAcquisitionConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare_0aa9a664-0c5b-4469-ab45-35e87ca73c73_terseLabel_en-US" xlink:label="lab_alts_AssetAcquisitionConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset acquisition, shares issued, fair value (in usd per share)</link:label>
    <link:label id="lab_alts_AssetAcquisitionConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare_label_en-US" xlink:label="lab_alts_AssetAcquisitionConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Consideration Transferred, Equity Interests Issued and Issuable Per Share</link:label>
    <link:label id="lab_alts_AssetAcquisitionConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare_documentation_en-US" xlink:label="lab_alts_AssetAcquisitionConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Consideration Transferred, Equity Interests Issued and Issuable Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AssetAcquisitionConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare" xlink:href="alts-20241228.xsd#alts_AssetAcquisitionConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_AssetAcquisitionConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare" xlink:to="lab_alts_AssetAcquisitionConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DebtInstrumentNumberOfDebenturesIssued_9746cf6b-4084-4b8e-9b94-8f84df3d35a5_terseLabel_en-US" xlink:label="lab_alts_DebtInstrumentNumberOfDebenturesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of debentures issued</link:label>
    <link:label id="lab_alts_DebtInstrumentNumberOfDebenturesIssued_label_en-US" xlink:label="lab_alts_DebtInstrumentNumberOfDebenturesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Number Of Debentures Issued</link:label>
    <link:label id="lab_alts_DebtInstrumentNumberOfDebenturesIssued_documentation_en-US" xlink:label="lab_alts_DebtInstrumentNumberOfDebenturesIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Number Of Debentures Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentNumberOfDebenturesIssued" xlink:href="alts-20241228.xsd#alts_DebtInstrumentNumberOfDebenturesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DebtInstrumentNumberOfDebenturesIssued" xlink:to="lab_alts_DebtInstrumentNumberOfDebenturesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_NetCashProvidedByOperatingActivitiesContinuingOperations_26b8680c-802c-46ec-9efe-4a1ee49d07e2_terseLabel_en-US" xlink:label="lab_alts_NetCashProvidedByOperatingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash provided by operating activities</link:label>
    <link:label id="lab_alts_NetCashProvidedByOperatingActivitiesContinuingOperations_label_en-US" xlink:label="lab_alts_NetCashProvidedByOperatingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by Operating Activities, Continuing Operations</link:label>
    <link:label id="lab_alts_NetCashProvidedByOperatingActivitiesContinuingOperations_documentation_en-US" xlink:label="lab_alts_NetCashProvidedByOperatingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net Cash Provided by Operating Activities, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NetCashProvidedByOperatingActivitiesContinuingOperations" xlink:href="alts-20241228.xsd#alts_NetCashProvidedByOperatingActivitiesContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_NetCashProvidedByOperatingActivitiesContinuingOperations" xlink:to="lab_alts_NetCashProvidedByOperatingActivitiesContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_44d7e0a6-22cc-4d8f-85f5-e3c5544ba9d9_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Convertible preferred stock/Preferred stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_a337a91a-f043-4c96-89ea-8a8b7888c86d_periodStartLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_2b73ad2b-eefb-4b3a-8e45-70e91a251fa9_periodEndLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_4f049220-fc10-439a-8349-136d981476b9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, outstanding shares (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_BigWarrantMember_92e128bc-3fb5-4c93-a435-e2e49b389479_terseLabel_en-US" xlink:label="lab_alts_BigWarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Big Warrant</link:label>
    <link:label id="lab_alts_BigWarrantMember_label_en-US" xlink:label="lab_alts_BigWarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Big Warrant [Member]</link:label>
    <link:label id="lab_alts_BigWarrantMember_documentation_en-US" xlink:label="lab_alts_BigWarrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Big Warrant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BigWarrantMember" xlink:href="alts-20241228.xsd#alts_BigWarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_BigWarrantMember" xlink:to="lab_alts_BigWarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_bf7bfc91-1184-455a-af87-875e266697e2_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_af4562c8-df3b-4db2-aad4-94bbf08ff522_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_40d1337a-98d2-4fc2-8e66-53edf9f8c695_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_50f5de04-7f3a-40fc-81de-dd29f1035daf_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stock issued for property and equipment</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Purchase of Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_29bb6afb-544d-4d0d-8eb7-6a081a3c3318_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock equivalents received (in shares)</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_0ca5c789-09b9-4fb9-be66-b24513395713_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_LitigationSettlementAmountAwardedToOtherPartyPeriodicPayments_d941a07d-3312-48af-9abf-63ec0fda4370_terseLabel_en-US" xlink:label="lab_alts_LitigationSettlementAmountAwardedToOtherPartyPeriodicPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Quarterly payment amounts</link:label>
    <link:label id="lab_alts_LitigationSettlementAmountAwardedToOtherPartyPeriodicPayments_label_en-US" xlink:label="lab_alts_LitigationSettlementAmountAwardedToOtherPartyPeriodicPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party, Periodic Payments</link:label>
    <link:label id="lab_alts_LitigationSettlementAmountAwardedToOtherPartyPeriodicPayments_documentation_en-US" xlink:label="lab_alts_LitigationSettlementAmountAwardedToOtherPartyPeriodicPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party, Periodic Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LitigationSettlementAmountAwardedToOtherPartyPeriodicPayments" xlink:href="alts-20241228.xsd#alts_LitigationSettlementAmountAwardedToOtherPartyPeriodicPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_LitigationSettlementAmountAwardedToOtherPartyPeriodicPayments" xlink:to="lab_alts_LitigationSettlementAmountAwardedToOtherPartyPeriodicPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_f1eb2b48-f204-44a4-9365-013a4cdebcbd_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total debentures</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount_0411dd59-2839-442c-843a-e51121c8c543_terseLabel_en-US" xlink:label="lab_alts_DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receivable with imputed interest, net amount</link:label>
    <link:label id="lab_alts_DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount_label_en-US" xlink:label="lab_alts_DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Present Value Of Discount Recorded As Offset To The Principal Amount</link:label>
    <link:label id="lab_alts_DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount_documentation_en-US" xlink:label="lab_alts_DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Present Value Of Discount Recorded As Offset To The Principal Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount" xlink:href="alts-20241228.xsd#alts_DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount" xlink:to="lab_alts_DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_NumberOfAgreementsToBePurchased_a11cdcdf-4352-4655-a6e9-e15eb84f81b0_terseLabel_en-US" xlink:label="lab_alts_NumberOfAgreementsToBePurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unaffiliated third-part investors</link:label>
    <link:label id="lab_alts_NumberOfAgreementsToBePurchased_label_en-US" xlink:label="lab_alts_NumberOfAgreementsToBePurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Agreements To Be Purchased</link:label>
    <link:label id="lab_alts_NumberOfAgreementsToBePurchased_documentation_en-US" xlink:label="lab_alts_NumberOfAgreementsToBePurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Agreements To Be Purchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NumberOfAgreementsToBePurchased" xlink:href="alts-20241228.xsd#alts_NumberOfAgreementsToBePurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_NumberOfAgreementsToBePurchased" xlink:to="lab_alts_NumberOfAgreementsToBePurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_77c97225-7dc4-49b3-a9f3-deedb20cb800_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_81dabb50-81a9-4ccd-a40f-a290c0ffb635_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, issued shares (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_SaleOfStockUnitCompositionNumberOfWarrantsIssuedInEachUnit_5be92156-7b46-4950-b930-86caa3a761d8_terseLabel_en-US" xlink:label="lab_alts_SaleOfStockUnitCompositionNumberOfWarrantsIssuedInEachUnit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of warrants in each unit (in shares)</link:label>
    <link:label id="lab_alts_SaleOfStockUnitCompositionNumberOfWarrantsIssuedInEachUnit_label_en-US" xlink:label="lab_alts_SaleOfStockUnitCompositionNumberOfWarrantsIssuedInEachUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Unit Composition, Number Of Warrants Issued In Each unit</link:label>
    <link:label id="lab_alts_SaleOfStockUnitCompositionNumberOfWarrantsIssuedInEachUnit_documentation_en-US" xlink:label="lab_alts_SaleOfStockUnitCompositionNumberOfWarrantsIssuedInEachUnit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale of Stock, Unit Composition, Number Of Warrants Issued In Each unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SaleOfStockUnitCompositionNumberOfWarrantsIssuedInEachUnit" xlink:href="alts-20241228.xsd#alts_SaleOfStockUnitCompositionNumberOfWarrantsIssuedInEachUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_SaleOfStockUnitCompositionNumberOfWarrantsIssuedInEachUnit" xlink:to="lab_alts_SaleOfStockUnitCompositionNumberOfWarrantsIssuedInEachUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_ef5a3cfa-19a7-419d-88fb-f92a6efc31a6_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_5934e53f-d665-4c70-823f-52942a8b0d13_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Availability under revolving credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsReceivable_cc3e4a6e-7b82-4240-a2b4-ca9741980e89_verboseLabel_en-US" xlink:label="lab_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsReceivable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Digital assets receivable</link:label>
    <link:label id="lab_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsReceivable_label_en-US" xlink:label="lab_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Digital Assets Receivable</link:label>
    <link:label id="lab_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsReceivable_documentation_en-US" xlink:label="lab_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Digital Assets Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsReceivable" xlink:href="alts-20241228.xsd#alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsReceivable" xlink:to="lab_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DisposalOfOtherAssets_8495215e-36ce-4627-90b2-14a9cdadaa5d_terseLabel_en-US" xlink:label="lab_alts_DisposalOfOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_alts_DisposalOfOtherAssets_label_en-US" xlink:label="lab_alts_DisposalOfOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal of Other Assets</link:label>
    <link:label id="lab_alts_DisposalOfOtherAssets_documentation_en-US" xlink:label="lab_alts_DisposalOfOtherAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal of Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfOtherAssets" xlink:href="alts-20241228.xsd#alts_DisposalOfOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DisposalOfOtherAssets" xlink:to="lab_alts_DisposalOfOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_RelatedPartyTransactionConsultingAgreementNumberOfLifeInsurancePoliciesAssigned_f094bea1-c943-42d9-9081-f33c94202a68_terseLabel_en-US" xlink:label="lab_alts_RelatedPartyTransactionConsultingAgreementNumberOfLifeInsurancePoliciesAssigned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Universal life insurance policies assigned</link:label>
    <link:label id="lab_alts_RelatedPartyTransactionConsultingAgreementNumberOfLifeInsurancePoliciesAssigned_label_en-US" xlink:label="lab_alts_RelatedPartyTransactionConsultingAgreementNumberOfLifeInsurancePoliciesAssigned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction, Consulting Agreement, Number Of Life Insurance Policies Assigned</link:label>
    <link:label id="lab_alts_RelatedPartyTransactionConsultingAgreementNumberOfLifeInsurancePoliciesAssigned_documentation_en-US" xlink:label="lab_alts_RelatedPartyTransactionConsultingAgreementNumberOfLifeInsurancePoliciesAssigned" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Related Party Transaction, Consulting Agreement, Number Of Life Insurance Policies Assigned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RelatedPartyTransactionConsultingAgreementNumberOfLifeInsurancePoliciesAssigned" xlink:href="alts-20241228.xsd#alts_RelatedPartyTransactionConsultingAgreementNumberOfLifeInsurancePoliciesAssigned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_RelatedPartyTransactionConsultingAgreementNumberOfLifeInsurancePoliciesAssigned" xlink:to="lab_alts_RelatedPartyTransactionConsultingAgreementNumberOfLifeInsurancePoliciesAssigned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_739b7684-bd7b-4b70-818a-7ce3cd757ed4_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_ReclassificationOfTemporaryToCurrentLiabilities_f5e9af2a-d416-4aeb-ae54-fd4e5964ded7_terseLabel_en-US" xlink:label="lab_alts_ReclassificationOfTemporaryToCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification to current liabilities</link:label>
    <link:label id="lab_alts_ReclassificationOfTemporaryToCurrentLiabilities_fcc53705-9d30-4255-926d-7979e6e580c5_negatedTerseLabel_en-US" xlink:label="lab_alts_ReclassificationOfTemporaryToCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Reclassification to current liabilities</link:label>
    <link:label id="lab_alts_ReclassificationOfTemporaryToCurrentLiabilities_label_en-US" xlink:label="lab_alts_ReclassificationOfTemporaryToCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification of Temporary to Current Liabilities</link:label>
    <link:label id="lab_alts_ReclassificationOfTemporaryToCurrentLiabilities_documentation_en-US" xlink:label="lab_alts_ReclassificationOfTemporaryToCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reclassification of Temporary to Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ReclassificationOfTemporaryToCurrentLiabilities" xlink:href="alts-20241228.xsd#alts_ReclassificationOfTemporaryToCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_ReclassificationOfTemporaryToCurrentLiabilities" xlink:to="lab_alts_ReclassificationOfTemporaryToCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_ConversionOfStockAmountConvertible_f9222861-f546-4322-b021-962de4463179_terseLabel_en-US" xlink:label="lab_alts_ConversionOfStockAmountConvertible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of stock, amount converted</link:label>
    <link:label id="lab_alts_ConversionOfStockAmountConvertible_label_en-US" xlink:label="lab_alts_ConversionOfStockAmountConvertible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion Of Stock, Amount Convertible</link:label>
    <link:label id="lab_alts_ConversionOfStockAmountConvertible_documentation_en-US" xlink:label="lab_alts_ConversionOfStockAmountConvertible" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Conversion Of Stock, Amount Convertible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ConversionOfStockAmountConvertible" xlink:href="alts-20241228.xsd#alts_ConversionOfStockAmountConvertible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_ConversionOfStockAmountConvertible" xlink:to="lab_alts_ConversionOfStockAmountConvertible" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_05bc9356-8252-45a0-8551-59e2584b08b9_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_7836fb71-f6fb-447c-8bb2-5fba7784cf76_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyMember_82287cb6-889e-42c4-b3ac-09be93174299_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyMember_label_en-US" xlink:label="lab_us-gaap_RelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyMember" xlink:to="lab_us-gaap_RelatedPartyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_TotalDisposalOfLiability_28e4d1e8-daba-44d2-9c3a-4075819139b0_totalLabel_en-US" xlink:label="lab_alts_TotalDisposalOfLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total disposal of liabilities</link:label>
    <link:label id="lab_alts_TotalDisposalOfLiability_label_en-US" xlink:label="lab_alts_TotalDisposalOfLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Disposal of Liability</link:label>
    <link:label id="lab_alts_TotalDisposalOfLiability_documentation_en-US" xlink:label="lab_alts_TotalDisposalOfLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total Disposal of Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_TotalDisposalOfLiability" xlink:href="alts-20241228.xsd#alts_TotalDisposalOfLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_TotalDisposalOfLiability" xlink:to="lab_alts_TotalDisposalOfLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_NoncashRecognitionOfNewLeases_89111b87-757c-4542-a087-c35bbcd1f9ff_terseLabel_en-US" xlink:label="lab_alts_NoncashRecognitionOfNewLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncash recognition of new leases</link:label>
    <link:label id="lab_alts_NoncashRecognitionOfNewLeases_label_en-US" xlink:label="lab_alts_NoncashRecognitionOfNewLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncash recognition of new leases</link:label>
    <link:label id="lab_alts_NoncashRecognitionOfNewLeases_documentation_en-US" xlink:label="lab_alts_NoncashRecognitionOfNewLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Noncash recognition of new leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NoncashRecognitionOfNewLeases" xlink:href="alts-20241228.xsd#alts_NoncashRecognitionOfNewLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_NoncashRecognitionOfNewLeases" xlink:to="lab_alts_NoncashRecognitionOfNewLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_8366a65a-d74e-4aa4-bb5c-ea58745fa8e2_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Change in deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_82cd2d9d-1548-4aea-8a20-14b63587ecb8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Non-cash fair value adjustment of deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_c1b96e34-2b27-4e42-a1c6-09bee8907356_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax (benefit) provision</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_c88474fd-9259-4f07-a532-72989dd16ec5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_CryptocurrencyExchangeSoftwareIntangibleMember_9ddccf98-742e-49fa-afde-d2dd1b83dad1_terseLabel_en-US" xlink:label="lab_alts_CryptocurrencyExchangeSoftwareIntangibleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Qoden intangible</link:label>
    <link:label id="lab_alts_CryptocurrencyExchangeSoftwareIntangibleMember_label_en-US" xlink:label="lab_alts_CryptocurrencyExchangeSoftwareIntangibleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cryptocurrency Exchange Software Intangible [Member]</link:label>
    <link:label id="lab_alts_CryptocurrencyExchangeSoftwareIntangibleMember_documentation_en-US" xlink:label="lab_alts_CryptocurrencyExchangeSoftwareIntangibleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cryptocurrency Exchange Software Intangible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_CryptocurrencyExchangeSoftwareIntangibleMember" xlink:href="alts-20241228.xsd#alts_CryptocurrencyExchangeSoftwareIntangibleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_CryptocurrencyExchangeSoftwareIntangibleMember" xlink:to="lab_alts_CryptocurrencyExchangeSoftwareIntangibleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_f72346fb-e846-40da-8855-4c88238428b5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_SoinAgreementConvertibleTrancheOneMember_93ee550a-8043-4784-a0eb-aeb645feac0d_terseLabel_en-US" xlink:label="lab_alts_SoinAgreementConvertibleTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soin Agreement Convertible Tranche One</link:label>
    <link:label id="lab_alts_SoinAgreementConvertibleTrancheOneMember_label_en-US" xlink:label="lab_alts_SoinAgreementConvertibleTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soin Agreement Convertible Tranche One [Member]</link:label>
    <link:label id="lab_alts_SoinAgreementConvertibleTrancheOneMember_documentation_en-US" xlink:label="lab_alts_SoinAgreementConvertibleTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Soin Agreement Convertible Tranche One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SoinAgreementConvertibleTrancheOneMember" xlink:href="alts-20241228.xsd#alts_SoinAgreementConvertibleTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_SoinAgreementConvertibleTrancheOneMember" xlink:to="lab_alts_SoinAgreementConvertibleTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_dd511b62-ccfb-42c1-be81-6e5c08696d87_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_5cac5b69-f0bc-48ad-98bf-bc33bc0e58c0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion price (in usd per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_773f5e17-9891-4ffa-817a-99df0bfbb013_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis_614aaa05-2cc3-498d-a0e4-c2a34909c208_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Conversion Description</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Conversion Description [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:to="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_9852d987-cf10-4211-8669-e6656f748f00_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_b908de4c-9b56-4747-908d-348354623114_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total debentures</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_8cbee888-329d-423d-afe6-0a4d729e9319_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Total</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_da50d829-c48c-4abc-a9e5-002c9c2c6ff4_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Outstanding aggregate obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:to="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_6eff1a5a-8958-4f35-841c-bf4d36c899c0_verboseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Mergers and Acquisitions</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_FixedDepositAgreementMember_2ce65914-f11d-4ade-900d-f1f602376c6f_terseLabel_en-US" xlink:label="lab_alts_FixedDepositAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fixed Deposit Agreement</link:label>
    <link:label id="lab_alts_FixedDepositAgreementMember_label_en-US" xlink:label="lab_alts_FixedDepositAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fixed Deposit Agreement [Member]</link:label>
    <link:label id="lab_alts_FixedDepositAgreementMember_documentation_en-US" xlink:label="lab_alts_FixedDepositAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fixed Deposit Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_FixedDepositAgreementMember" xlink:href="alts-20241228.xsd#alts_FixedDepositAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_FixedDepositAgreementMember" xlink:to="lab_alts_FixedDepositAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_bab6ce59-1e96-4636-88ce-a67022cb9328_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants exercised</link:label>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_label_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Warrant Exercises</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:to="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForCommissions_b8c64bdc-7b96-43be-97ac-7bd9567a3a5d_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForCommissions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for close</link:label>
    <link:label id="lab_us-gaap_PaymentsForCommissions_label_en-US" xlink:label="lab_us-gaap_PaymentsForCommissions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Commissions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForCommissions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForCommissions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForCommissions" xlink:to="lab_us-gaap_PaymentsForCommissions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis_b42dd325-3f83-4a46-8547-8dcd812bf896_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Significant Noncash Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis_label_en-US" xlink:label="lab_us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Significant Noncash Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis" xlink:to="lab_us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_4397261a-7276-4938-87a6-4aae41adb5d4_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_PlatformOperatorCryptoAssetHeldForUserCurrent_6d80b68f-d7ef-4913-bfd0-87073b39061f_terseLabel_en-US" xlink:label="lab_alts_PlatformOperatorCryptoAssetHeldForUserCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Digital assets receivable</link:label>
    <link:label id="lab_alts_PlatformOperatorCryptoAssetHeldForUserCurrent_label_en-US" xlink:label="lab_alts_PlatformOperatorCryptoAssetHeldForUserCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Platform Operator, Crypto Asset, Held-for-User, Current</link:label>
    <link:label id="lab_alts_PlatformOperatorCryptoAssetHeldForUserCurrent_documentation_en-US" xlink:label="lab_alts_PlatformOperatorCryptoAssetHeldForUserCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Platform Operator, Crypto Asset, Held-for-User, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PlatformOperatorCryptoAssetHeldForUserCurrent" xlink:href="alts-20241228.xsd#alts_PlatformOperatorCryptoAssetHeldForUserCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_PlatformOperatorCryptoAssetHeldForUserCurrent" xlink:to="lab_alts_PlatformOperatorCryptoAssetHeldForUserCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_SeriesIConvertiblePreferredStockMember_f7234ed2-8ff2-42d5-8796-16bf8b473767_verboseLabel_en-US" xlink:label="lab_alts_SeriesIConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Convertible preferred stock, series I - par value $0.001 per share, 2,000,000 authorized, 17,000 and 0 shares issued and outstanding at December&#160;28, 2024 and December&#160;30, 2023, respectively</link:label>
    <link:label id="lab_alts_SeriesIConvertiblePreferredStockMember_2abb977d-4d7b-47cd-8072-8f8dbe2ef1af_terseLabel_en-US" xlink:label="lab_alts_SeriesIConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series I Convertible Preferred Stock</link:label>
    <link:label id="lab_alts_SeriesIConvertiblePreferredStockMember_label_en-US" xlink:label="lab_alts_SeriesIConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series I Convertible Preferred Stock [Member]</link:label>
    <link:label id="lab_alts_SeriesIConvertiblePreferredStockMember_documentation_en-US" xlink:label="lab_alts_SeriesIConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series I Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesIConvertiblePreferredStockMember" xlink:href="alts-20241228.xsd#alts_SeriesIConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_SeriesIConvertiblePreferredStockMember" xlink:to="lab_alts_SeriesIConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_125f29f7-5736-402b-89c3-bf8c40107263_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price, lower range limit (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_NotesPayableWithLiveVenturesAndICGMember_bd14ebf0-d2d6-4e91-b84b-443b99a02e9d_terseLabel_en-US" xlink:label="lab_alts_NotesPayableWithLiveVenturesAndICGMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes Payable With Live Ventures and ICG</link:label>
    <link:label id="lab_alts_NotesPayableWithLiveVenturesAndICGMember_label_en-US" xlink:label="lab_alts_NotesPayableWithLiveVenturesAndICGMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable With Live Ventures and ICG [Member]</link:label>
    <link:label id="lab_alts_NotesPayableWithLiveVenturesAndICGMember_documentation_en-US" xlink:label="lab_alts_NotesPayableWithLiveVenturesAndICGMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Notes Payable With Live Ventures and ICG</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NotesPayableWithLiveVenturesAndICGMember" xlink:href="alts-20241228.xsd#alts_NotesPayableWithLiveVenturesAndICGMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_NotesPayableWithLiveVenturesAndICGMember" xlink:to="lab_alts_NotesPayableWithLiveVenturesAndICGMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DigitalAssetLiabilityCurrentCashDeposits_c65679b4-4d6e-4f6f-86a7-42211c8bab71_terseLabel_en-US" xlink:label="lab_alts_DigitalAssetLiabilityCurrentCashDeposits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Digital assets, cash deposits</link:label>
    <link:label id="lab_alts_DigitalAssetLiabilityCurrentCashDeposits_label_en-US" xlink:label="lab_alts_DigitalAssetLiabilityCurrentCashDeposits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Digital Asset, Liability, Current, Cash Deposits</link:label>
    <link:label id="lab_alts_DigitalAssetLiabilityCurrentCashDeposits_documentation_en-US" xlink:label="lab_alts_DigitalAssetLiabilityCurrentCashDeposits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Digital Asset, Liability, Current, Cash Deposits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DigitalAssetLiabilityCurrentCashDeposits" xlink:href="alts-20241228.xsd#alts_DigitalAssetLiabilityCurrentCashDeposits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DigitalAssetLiabilityCurrentCashDeposits" xlink:to="lab_alts_DigitalAssetLiabilityCurrentCashDeposits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_0c68107f-9983-40b9-bcb6-70b336aff66e_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_NotesPayableRelatedPartiesMember_0057d86e-2f33-44b4-9c30-d46811cac6c7_terseLabel_en-US" xlink:label="lab_alts_NotesPayableRelatedPartiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes Payable Related Parties</link:label>
    <link:label id="lab_alts_NotesPayableRelatedPartiesMember_label_en-US" xlink:label="lab_alts_NotesPayableRelatedPartiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable Related Parties [Member]</link:label>
    <link:label id="lab_alts_NotesPayableRelatedPartiesMember_documentation_en-US" xlink:label="lab_alts_NotesPayableRelatedPartiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Notes payable, related parties.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NotesPayableRelatedPartiesMember" xlink:href="alts-20241228.xsd#alts_NotesPayableRelatedPartiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_NotesPayableRelatedPartiesMember" xlink:to="lab_alts_NotesPayableRelatedPartiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_6d4acbf0-b39e-46c9-9fa4-79c4cf98d92a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_07133201-7b29-4944-a9b6-8a1b58fe4031_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_6cf98407-8f8b-44cd-b4fc-1a13e0017aaf_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Original issue discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_24df8f61-d555-4539-a8c9-51b58a090a49_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_321006b1-a243-4242-b5c7-4b16343dd25d_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_bb4cddf9-6415-496c-a52f-56d6611bac93_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less implied interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_SeriesGConvertiblePreferredStockMember_f149e17d-978d-4ab9-812e-26aa4f642d71_verboseLabel_en-US" xlink:label="lab_alts_SeriesGConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Series G Convertible Preferred Shares</link:label>
    <link:label id="lab_alts_SeriesGConvertiblePreferredStockMember_b9fcc761-02e1-4321-ac1c-7d3091a46bf7_terseLabel_en-US" xlink:label="lab_alts_SeriesGConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series G Convertible Preferred Stock</link:label>
    <link:label id="lab_alts_SeriesGConvertiblePreferredStockMember_label_en-US" xlink:label="lab_alts_SeriesGConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series G Convertible Preferred Stock [Member]</link:label>
    <link:label id="lab_alts_SeriesGConvertiblePreferredStockMember_documentation_en-US" xlink:label="lab_alts_SeriesGConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series G Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesGConvertiblePreferredStockMember" xlink:href="alts-20241228.xsd#alts_SeriesGConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_SeriesGConvertiblePreferredStockMember" xlink:to="lab_alts_SeriesGConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_df44f985-25a2-493b-92f6-c18141354755_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation, number of shares available for grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aee30c09-8c82-4434-a079-d137101f938f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_9c57c43c-1fb4-4952-90a9-2d01a469cc8c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_c8e8c8ab-8af0-4556-a9fc-dd3569e65979_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share based compensation (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_1229832c-ab26-4220-b743-ef2c81a1f4a9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_cf8e4d99-3fd5-4a39-a8c3-9ba299bd9017_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated useful life of intangible assets (in years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_6445142f-b734-4937-9917-156bcc805a23_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare_f2c3330b-0f38-4656-8750-be4dd8df2158_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible preferred stock, par value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_b3468370-2f04-47e3-bfa6-4f6bee0c45d2_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_QodenTechnologiesLLCMember_af2f4b72-84f9-44e2-8cef-51a9f7f7ecf7_terseLabel_en-US" xlink:label="lab_alts_QodenTechnologiesLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Qoden Technologies, LLC</link:label>
    <link:label id="lab_alts_QodenTechnologiesLLCMember_label_en-US" xlink:label="lab_alts_QodenTechnologiesLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Qoden Technologies, LLC [Member]</link:label>
    <link:label id="lab_alts_QodenTechnologiesLLCMember_documentation_en-US" xlink:label="lab_alts_QodenTechnologiesLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Qoden Technologies, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_QodenTechnologiesLLCMember" xlink:href="alts-20241228.xsd#alts_QodenTechnologiesLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_QodenTechnologiesLLCMember" xlink:to="lab_alts_QodenTechnologiesLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_f63bc9dd-8f7f-475a-9fcd-6be7441c1a09_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Trade and Other Receivables</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_Alt5SigmaInc.Member_15a674af-b4e9-4dc7-86ed-188f82c279f3_terseLabel_en-US" xlink:label="lab_alts_Alt5SigmaInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Alt 5 Sigma, Inc.</link:label>
    <link:label id="lab_alts_Alt5SigmaInc.Member_label_en-US" xlink:label="lab_alts_Alt5SigmaInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alt 5 Sigma, Inc. [Member]</link:label>
    <link:label id="lab_alts_Alt5SigmaInc.Member_documentation_en-US" xlink:label="lab_alts_Alt5SigmaInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Alt 5 Sigma, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Alt5SigmaInc.Member" xlink:href="alts-20241228.xsd#alts_Alt5SigmaInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_Alt5SigmaInc.Member" xlink:to="lab_alts_Alt5SigmaInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_2302924e-859a-4bb5-8e81-16ae5aa5f3f7_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_15baebdf-c803-4d39-b39b-b3797a032318_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recently Issued Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_ClassOfWarrantPricePerShare_2d342d8f-fcb9-4ce0-b01b-6762ae36d9f0_terseLabel_en-US" xlink:label="lab_alts_ClassOfWarrantPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant price per share (in usd per share)</link:label>
    <link:label id="lab_alts_ClassOfWarrantPricePerShare_label_en-US" xlink:label="lab_alts_ClassOfWarrantPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class Of Warrant Price Per Share</link:label>
    <link:label id="lab_alts_ClassOfWarrantPricePerShare_documentation_en-US" xlink:label="lab_alts_ClassOfWarrantPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class Of Warrant Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ClassOfWarrantPricePerShare" xlink:href="alts-20241228.xsd#alts_ClassOfWarrantPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_ClassOfWarrantPricePerShare" xlink:to="lab_alts_ClassOfWarrantPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_daacaf44-bef1-4fa2-aedc-d88d89f5ffaa_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c01169bf-cbd1-49bf-8b1a-774cd2d0c187_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_666aa236-043e-4e04-9d93-f0abec4999db_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_77f84908-71b3-40fb-a7d8-b10ee5e1434a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_7d681539-daf0-4a0c-8806-7d43a22143f7_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_0acbc1a4-e49c-4b6a-bc0d-0e4d7da3edf1_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net income from discontinued operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_938aa81c-ed01-4d6e-addb-e89aea5d33e9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income from discontinued operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOperatingActivitiesSegmentAxis_0ac90efd-9db4-4df0-8c95-e67a90a718d3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Activities [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementOperatingActivitiesSegmentAxis_label_en-US" xlink:label="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Activities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:to="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_32b86df5-72d5-4df1-b63d-1c24c497e6d9_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_d3d7b55e-553f-41e6-a21e-fbbee6287c3a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_04fe2253-a706-4a73-b4af-371b9fae92fc_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_70e1590d-5969-4c1f-8795-4260dd66fb5f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt interest rate (as percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_f00fab60-ad2f-48f0-823a-af291b45965a_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Debt interest rate (as percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_63bdb951-3359-4a89-9def-7be0ec673da7_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental cash flow disclosures:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_SkyBridgeAmericasMember_915baa00-273b-4012-963f-c08d96e2e202_terseLabel_en-US" xlink:label="lab_alts_SkyBridgeAmericasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SA</link:label>
    <link:label id="lab_alts_SkyBridgeAmericasMember_label_en-US" xlink:label="lab_alts_SkyBridgeAmericasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sky Bridge Americas [Member]</link:label>
    <link:label id="lab_alts_SkyBridgeAmericasMember_documentation_en-US" xlink:label="lab_alts_SkyBridgeAmericasMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sky Bridge Americas.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SkyBridgeAmericasMember" xlink:href="alts-20241228.xsd#alts_SkyBridgeAmericasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_SkyBridgeAmericasMember" xlink:to="lab_alts_SkyBridgeAmericasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DeferredTaxAssetsLeaseLiability_8ceb1af0-8069-4834-9567-574cbfd52caa_terseLabel_en-US" xlink:label="lab_alts_DeferredTaxAssetsLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liability</link:label>
    <link:label id="lab_alts_DeferredTaxAssetsLeaseLiability_label_en-US" xlink:label="lab_alts_DeferredTaxAssetsLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets Lease Liability</link:label>
    <link:label id="lab_alts_DeferredTaxAssetsLeaseLiability_documentation_en-US" xlink:label="lab_alts_DeferredTaxAssetsLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred tax assets lease liability.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DeferredTaxAssetsLeaseLiability" xlink:href="alts-20241228.xsd#alts_DeferredTaxAssetsLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DeferredTaxAssetsLeaseLiability" xlink:to="lab_alts_DeferredTaxAssetsLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_4326deb6-2e74-4101-a01f-3aa60e1e8903_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net (loss) income, diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_CashDisposal_a1324144-cd28-4cbc-82a4-c1338c485399_terseLabel_en-US" xlink:label="lab_alts_CashDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_alts_CashDisposal_label_en-US" xlink:label="lab_alts_CashDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Disposal</link:label>
    <link:label id="lab_alts_CashDisposal_documentation_en-US" xlink:label="lab_alts_CashDisposal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_CashDisposal" xlink:href="alts-20241228.xsd#alts_CashDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_CashDisposal" xlink:to="lab_alts_CashDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_9e29877e-ad1e-43ab-be39-9b64663f17c4_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other (expense) income, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_RealizedGainLossOnExchangeTransactions_17316108-c1f9-49a4-82ff-c963aab8c545_terseLabel_en-US" xlink:label="lab_alts_RealizedGainLossOnExchangeTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Realized gain on exchange transactions</link:label>
    <link:label id="lab_alts_RealizedGainLossOnExchangeTransactions_label_en-US" xlink:label="lab_alts_RealizedGainLossOnExchangeTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Realized Gain (Loss) On Exchange Transactions</link:label>
    <link:label id="lab_alts_RealizedGainLossOnExchangeTransactions_documentation_en-US" xlink:label="lab_alts_RealizedGainLossOnExchangeTransactions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Realized Gain (Loss) On Exchange Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RealizedGainLossOnExchangeTransactions" xlink:href="alts-20241228.xsd#alts_RealizedGainLossOnExchangeTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_RealizedGainLossOnExchangeTransactions" xlink:to="lab_alts_RealizedGainLossOnExchangeTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_A2024EquityIncentivePlanMember_783638b8-2913-41e3-b88c-142184f5126d_terseLabel_en-US" xlink:label="lab_alts_A2024EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024 Plan</link:label>
    <link:label id="lab_alts_A2024EquityIncentivePlanMember_label_en-US" xlink:label="lab_alts_A2024EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2024 Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_alts_A2024EquityIncentivePlanMember_documentation_en-US" xlink:label="lab_alts_A2024EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2024 Equity Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_A2024EquityIncentivePlanMember" xlink:href="alts-20241228.xsd#alts_A2024EquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_A2024EquityIncentivePlanMember" xlink:to="lab_alts_A2024EquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_b4362499-dfaf-4827-bb41-f6cc054f8d28_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_80834312-f167-4c6e-8156-db6d4614f626_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_8ee168b8-c4c3-4b38-b36d-06093bea1a6b_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating loss</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_2a59bdc7-3b23-42e2-a8d6-4a8ecd57b8e7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating loss</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_4a374a84-bd0c-4006-9dbb-228be205d388_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_a27b3ee9-6f83-4c31-8d4b-095c61aeb6f0_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities, mezzanine equity, and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_Mr.JonIsaacMember_851fd77f-bb87-4493-a364-22f0d4ac7e29_terseLabel_en-US" xlink:label="lab_alts_Mr.JonIsaacMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Mr. Jon Isaac</link:label>
    <link:label id="lab_alts_Mr.JonIsaacMember_label_en-US" xlink:label="lab_alts_Mr.JonIsaacMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Mr. Jon Isaac [Member]</link:label>
    <link:label id="lab_alts_Mr.JonIsaacMember_documentation_en-US" xlink:label="lab_alts_Mr.JonIsaacMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Mr. Jon Isaac</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Mr.JonIsaacMember" xlink:href="alts-20241228.xsd#alts_Mr.JonIsaacMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_Mr.JonIsaacMember" xlink:to="lab_alts_Mr.JonIsaacMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_8560ffd6-2c80-4391-b03e-5dcb6d303f4e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_SeriesAConvertiblePreferredStockMember_fb39d8bc-5c2f-4312-8fe4-51a0d8a6e462_terseLabel_en-US" xlink:label="lab_alts_SeriesAConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series A Convertible Preferred Stock</link:label>
    <link:label id="lab_alts_SeriesAConvertiblePreferredStockMember_label_en-US" xlink:label="lab_alts_SeriesAConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series A Convertible Preferred Stock [Member]</link:label>
    <link:label id="lab_alts_SeriesAConvertiblePreferredStockMember_documentation_en-US" xlink:label="lab_alts_SeriesAConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series A Convertible Preferred Stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesAConvertiblePreferredStockMember" xlink:href="alts-20241228.xsd#alts_SeriesAConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_SeriesAConvertiblePreferredStockMember" xlink:to="lab_alts_SeriesAConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_RecyclingSegmentMember_f62cbd6e-8bfa-4f4c-99bc-bba03187f2c6_verboseLabel_en-US" xlink:label="lab_alts_RecyclingSegmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Recycling Segment</link:label>
    <link:label id="lab_alts_RecyclingSegmentMember_a214d835-2664-4e44-8a13-f0ade3985ae7_terseLabel_en-US" xlink:label="lab_alts_RecyclingSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discontinue operations</link:label>
    <link:label id="lab_alts_RecyclingSegmentMember_label_en-US" xlink:label="lab_alts_RecyclingSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recycling Segment [Member]</link:label>
    <link:label id="lab_alts_RecyclingSegmentMember_documentation_en-US" xlink:label="lab_alts_RecyclingSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Recycling Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RecyclingSegmentMember" xlink:href="alts-20241228.xsd#alts_RecyclingSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_RecyclingSegmentMember" xlink:to="lab_alts_RecyclingSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_NumberOfAcquiredIntangibleAssets_d0370d07-73d1-4ac0-9c17-bf114506e01c_terseLabel_en-US" xlink:label="lab_alts_NumberOfAcquiredIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of pending patents</link:label>
    <link:label id="lab_alts_NumberOfAcquiredIntangibleAssets_label_en-US" xlink:label="lab_alts_NumberOfAcquiredIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Acquired Intangible Assets</link:label>
    <link:label id="lab_alts_NumberOfAcquiredIntangibleAssets_documentation_en-US" xlink:label="lab_alts_NumberOfAcquiredIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Acquired Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NumberOfAcquiredIntangibleAssets" xlink:href="alts-20241228.xsd#alts_NumberOfAcquiredIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_NumberOfAcquiredIntangibleAssets" xlink:to="lab_alts_NumberOfAcquiredIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c7373b0f-cdf4-4b63-9a98-6a793193da40_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_AmortizationOfRightOfUseAssets_3dae702b-0396-414e-9318-1a8f8445c22e_terseLabel_en-US" xlink:label="lab_alts_AmortizationOfRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_alts_AmortizationOfRightOfUseAssets_label_en-US" xlink:label="lab_alts_AmortizationOfRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_alts_AmortizationOfRightOfUseAssets_documentation_en-US" xlink:label="lab_alts_AmortizationOfRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AmortizationOfRightOfUseAssets" xlink:href="alts-20241228.xsd#alts_AmortizationOfRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_AmortizationOfRightOfUseAssets" xlink:to="lab_alts_AmortizationOfRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted_1fd041a8-7ac0-47a7-8893-edbb27bf34f3_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income from discontinued operations, diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_c18c4038-164f-4e42-aa8d-203a23caa53a_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Future Maturities of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_NovalkAppsSAALLPMember_5bbbea29-8dfe-4e5d-9da5-00ed45696aa8_terseLabel_en-US" xlink:label="lab_alts_NovalkAppsSAALLPMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Novalk Apps SAA, LLP</link:label>
    <link:label id="lab_alts_NovalkAppsSAALLPMember_label_en-US" xlink:label="lab_alts_NovalkAppsSAALLPMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novalk Apps SAA, LLP [Member]</link:label>
    <link:label id="lab_alts_NovalkAppsSAALLPMember_documentation_en-US" xlink:label="lab_alts_NovalkAppsSAALLPMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Novalk Apps SAA, LLP</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NovalkAppsSAALLPMember" xlink:href="alts-20241228.xsd#alts_NovalkAppsSAALLPMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_NovalkAppsSAALLPMember" xlink:to="lab_alts_NovalkAppsSAALLPMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_c8e673ed-cbc4-4b6f-aa6f-11491914e523_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right of use assets and liabilities upon commencement of operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromNotesPayable_5ae339ec-da69-4f23-9c44-69d07edc7299_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of notes payable</link:label>
    <link:label id="lab_us-gaap_ProceedsFromNotesPayable_fab4b1e7-ab12-4a05-9de1-bb3d0efa6b9b_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromNotesPayable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from note payable</link:label>
    <link:label id="lab_us-gaap_ProceedsFromNotesPayable_label_en-US" xlink:label="lab_us-gaap_ProceedsFromNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromNotesPayable" xlink:to="lab_us-gaap_ProceedsFromNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_43c2c3fe-197b-492d-abd2-6c0102104bb4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Deficit</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_5c7a07d2-18b7-42d7-b8aa-2357cbbdbb12_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate principal amount</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_34bc4bf2-cc65-4cfc-ac5e-d2d13cbacee3_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_e49fc01b-1631-4e4d-8074-280809145c12_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property Plant And Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_f8f2a5dc-5d01-46f2-a707-69cd91c926ce_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_73522beb-89af-4b0d-800d-6c2271c6e92f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_1e409de6-4b4a-4a38-b720-177cde8ea2a9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_8f45d88b-f5d4-4bb3-9ee4-a86b3f769f23_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare_5e6b213f-d511-4052-bcf4-2836a73b43bb_terseLabel_en-US" xlink:label="lab_alts_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business acquisition, shares issued, fair value (in usd per share)</link:label>
    <link:label id="lab_alts_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare_label_en-US" xlink:label="lab_alts_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Per Share</link:label>
    <link:label id="lab_alts_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare_documentation_en-US" xlink:label="lab_alts_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare" xlink:href="alts-20241228.xsd#alts_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare" xlink:to="lab_alts_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_OtherSignificantNoncashTransactionLiabilityObligationsMember_2d581939-508a-44f2-8bb2-4f8ddfd3f77f_terseLabel_en-US" xlink:label="lab_alts_OtherSignificantNoncashTransactionLiabilityObligationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued for liability obligations</link:label>
    <link:label id="lab_alts_OtherSignificantNoncashTransactionLiabilityObligationsMember_label_en-US" xlink:label="lab_alts_OtherSignificantNoncashTransactionLiabilityObligationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Significant Noncash Transaction, Liability Obligations [Member]</link:label>
    <link:label id="lab_alts_OtherSignificantNoncashTransactionLiabilityObligationsMember_documentation_en-US" xlink:label="lab_alts_OtherSignificantNoncashTransactionLiabilityObligationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Significant Noncash Transaction, Liability Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherSignificantNoncashTransactionLiabilityObligationsMember" xlink:href="alts-20241228.xsd#alts_OtherSignificantNoncashTransactionLiabilityObligationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_OtherSignificantNoncashTransactionLiabilityObligationsMember" xlink:to="lab_alts_OtherSignificantNoncashTransactionLiabilityObligationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_UniversalLifeInsurancePolicyPolicyOneMember_58f62872-d58f-44e7-8aa8-01294f72f8a6_terseLabel_en-US" xlink:label="lab_alts_UniversalLifeInsurancePolicyPolicyOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">1st policy</link:label>
    <link:label id="lab_alts_UniversalLifeInsurancePolicyPolicyOneMember_label_en-US" xlink:label="lab_alts_UniversalLifeInsurancePolicyPolicyOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Universal Life Insurance Policy, Policy One [Member]</link:label>
    <link:label id="lab_alts_UniversalLifeInsurancePolicyPolicyOneMember_documentation_en-US" xlink:label="lab_alts_UniversalLifeInsurancePolicyPolicyOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Universal Life Insurance Policy, Policy One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_UniversalLifeInsurancePolicyPolicyOneMember" xlink:href="alts-20241228.xsd#alts_UniversalLifeInsurancePolicyPolicyOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_UniversalLifeInsurancePolicyPolicyOneMember" xlink:to="lab_alts_UniversalLifeInsurancePolicyPolicyOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_d177484b-0428-40bc-a9a1-669da4db6d47_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_9f92e9c8-44bc-45a4-9bf0-4cdb80dc17af_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_StockIssuedDuringPeriodSharesPrepaidInterest_93c758f8-e3c8-4e69-b42b-0db00959a99d_terseLabel_en-US" xlink:label="lab_alts_StockIssuedDuringPeriodSharesPrepaidInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued for prepaid interest (in shares)</link:label>
    <link:label id="lab_alts_StockIssuedDuringPeriodSharesPrepaidInterest_label_en-US" xlink:label="lab_alts_StockIssuedDuringPeriodSharesPrepaidInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Prepaid Interest</link:label>
    <link:label id="lab_alts_StockIssuedDuringPeriodSharesPrepaidInterest_documentation_en-US" xlink:label="lab_alts_StockIssuedDuringPeriodSharesPrepaidInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Prepaid Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockIssuedDuringPeriodSharesPrepaidInterest" xlink:href="alts-20241228.xsd#alts_StockIssuedDuringPeriodSharesPrepaidInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_StockIssuedDuringPeriodSharesPrepaidInterest" xlink:to="lab_alts_StockIssuedDuringPeriodSharesPrepaidInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_PromissoryNoteMember_d6ca5864-59c9-43c0-8773-e2cf73975e1e_terseLabel_en-US" xlink:label="lab_alts_PromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Promissory Note</link:label>
    <link:label id="lab_alts_PromissoryNoteMember_label_en-US" xlink:label="lab_alts_PromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Promissory Note [Member]</link:label>
    <link:label id="lab_alts_PromissoryNoteMember_documentation_en-US" xlink:label="lab_alts_PromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Promissory Note</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PromissoryNoteMember" xlink:href="alts-20241228.xsd#alts_PromissoryNoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_PromissoryNoteMember" xlink:to="lab_alts_PromissoryNoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_PercentageOfNetDollarReceivedToBeIssuedToDebentureHoldersOnAProRataBasis_0040df18-98d0-494e-a139-13302940985b_terseLabel_en-US" xlink:label="lab_alts_PercentageOfNetDollarReceivedToBeIssuedToDebentureHoldersOnAProRataBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net dollar issued to debentures holders on a pro rata basis (as percent)</link:label>
    <link:label id="lab_alts_PercentageOfNetDollarReceivedToBeIssuedToDebentureHoldersOnAProRataBasis_label_en-US" xlink:label="lab_alts_PercentageOfNetDollarReceivedToBeIssuedToDebentureHoldersOnAProRataBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage Of Net Dollar Received To Be Issued To Debenture Holders On A Pro Rata Basis</link:label>
    <link:label id="lab_alts_PercentageOfNetDollarReceivedToBeIssuedToDebentureHoldersOnAProRataBasis_documentation_en-US" xlink:label="lab_alts_PercentageOfNetDollarReceivedToBeIssuedToDebentureHoldersOnAProRataBasis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage Of Net Dollar Received To Be Issued To Debenture Holders On A Pro Rata Basis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PercentageOfNetDollarReceivedToBeIssuedToDebentureHoldersOnAProRataBasis" xlink:href="alts-20241228.xsd#alts_PercentageOfNetDollarReceivedToBeIssuedToDebentureHoldersOnAProRataBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_PercentageOfNetDollarReceivedToBeIssuedToDebentureHoldersOnAProRataBasis" xlink:to="lab_alts_PercentageOfNetDollarReceivedToBeIssuedToDebentureHoldersOnAProRataBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSignificantNoncashTransactionsTable_1b5e453c-1cd7-4287-ad04-72c19f20e881_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSignificantNoncashTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_OtherSignificantNoncashTransactionsTable_label_en-US" xlink:label="lab_us-gaap_OtherSignificantNoncashTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Significant Noncash Transactions [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSignificantNoncashTransactionsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherSignificantNoncashTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionsTable" xlink:to="lab_us-gaap_OtherSignificantNoncashTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_4509668d-8336-4ad6-bcd3-e8216d498b7e_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in reserve for uncollectible accounts</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_9c9f7aea-ead9-46a0-a1b4-9ed69673a135_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</link:label>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:to="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_fe2e5550-5171-461c-9062-d51fb073a79d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business acquisition, proforma revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_7928e74e-93cc-43ae-88cd-d419a5ac4825_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">U.S. statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_5e179954-cb0a-4b22-a124-fccb091ac5fa_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Principal outstanding balance</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_49f50eba-2808-4975-bd65-20f3c046471d_netLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Total notes payable, related parties</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_4aa7ea40-cf52-4508-9a4e-7562ffb6ecb5_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Write off of VM7 note receivable</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_cb70e789-cdf4-4cf4-9183-5e694cf9da07_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Impairment of carrying value</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_547ec238-a4f0-4992-aa50-2a315adef4ac_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_36b825bc-5421-4484-960a-d03a7b2ea148_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Components of Net Deferred Tax Assets (Liabilities)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockTextBlock_44c6bb86-8e4b-4d36-8a11-8797fdfb0943_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred Stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockTextBlock_label_en-US" xlink:label="lab_us-gaap_PreferredStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockTextBlock" xlink:to="lab_us-gaap_PreferredStockTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionTable_89d248ad-446f-4d0e-8d93-0428666472ba_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionTable" xlink:to="lab_us-gaap_AssetAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_1b1ca514-bfcf-40a8-a374-3082f6a8df34_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_4d1147e2-4ba1-487d-b37a-c118fc7b4f28_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share from continuing operations, basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_c763b6a9-097c-4239-807b-8f259883665e_netLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Basic (loss) income per share from continuing operations (in usd per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_d717f9b5-9a02-474b-b9b7-2de9fdb32ca9_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DeferredTaxLiabilitiesRightOfUseAssets_45c802b2-c910-4ad1-8f7f-c50061d6a267_negatedLabel_en-US" xlink:label="lab_alts_DeferredTaxLiabilitiesRightOfUseAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_alts_DeferredTaxLiabilitiesRightOfUseAssets_label_en-US" xlink:label="lab_alts_DeferredTaxLiabilitiesRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Right-of-use Assets</link:label>
    <link:label id="lab_alts_DeferredTaxLiabilitiesRightOfUseAssets_documentation_en-US" xlink:label="lab_alts_DeferredTaxLiabilitiesRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Right-of-use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DeferredTaxLiabilitiesRightOfUseAssets" xlink:href="alts-20241228.xsd#alts_DeferredTaxLiabilitiesRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DeferredTaxLiabilitiesRightOfUseAssets" xlink:to="lab_alts_DeferredTaxLiabilitiesRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_ALT5SubsidiaryMember_2cd4432b-7070-46bd-8a11-3f9646dcb9c5_terseLabel_en-US" xlink:label="lab_alts_ALT5SubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ALT5 Subsidiary</link:label>
    <link:label id="lab_alts_ALT5SubsidiaryMember_label_en-US" xlink:label="lab_alts_ALT5SubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ALT5 Subsidiary [Member]</link:label>
    <link:label id="lab_alts_ALT5SubsidiaryMember_documentation_en-US" xlink:label="lab_alts_ALT5SubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">ALT5 Subsidiary</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ALT5SubsidiaryMember" xlink:href="alts-20241228.xsd#alts_ALT5SubsidiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_ALT5SubsidiaryMember" xlink:to="lab_alts_ALT5SubsidiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_2eead13a-1624-4414-b283-2e7a1a5c0303_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Domestic Tax Jurisdiction</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Domestic Tax Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfRelatedPartyDebt_4fc3d842-d5dd-4633-b328-bfe6a82d9998_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments on related party note</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfRelatedPartyDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Related Party Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="lab_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_PaymentFromBuyer_4ae0801e-1993-4b59-8417-5c0bb9980df5_terseLabel_en-US" xlink:label="lab_alts_PaymentFromBuyer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payment from buyer</link:label>
    <link:label id="lab_alts_PaymentFromBuyer_label_en-US" xlink:label="lab_alts_PaymentFromBuyer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment from Buyer</link:label>
    <link:label id="lab_alts_PaymentFromBuyer_documentation_en-US" xlink:label="lab_alts_PaymentFromBuyer" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payment from Buyer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PaymentFromBuyer" xlink:href="alts-20241228.xsd#alts_PaymentFromBuyer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_PaymentFromBuyer" xlink:to="lab_alts_PaymentFromBuyer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation_b5757d4b-987b-42f4-9c7f-88b33c5b8a3c_verboseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income tax provision for discontinued operations</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operation, Tax Effect of Gain (Loss) from Disposal of Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation" xlink:to="lab_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_e6cfbac5-9b7b-4a7b-9ffc-2d8697ee16b0_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument term (in months)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_97dea565-0f85-4b91-93aa-d5c2d3250c88_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument term (in years)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_33f33c19-8e1a-46a0-a1b2-9b19f8b4b4b4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable, Trade</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_LegacySubsidiaryFixedDepositsMember_d0294dfc-da20-4f24-9d37-7061aa4337e9_terseLabel_en-US" xlink:label="lab_alts_LegacySubsidiaryFixedDepositsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legacy subsidiary fixed deposits</link:label>
    <link:label id="lab_alts_LegacySubsidiaryFixedDepositsMember_label_en-US" xlink:label="lab_alts_LegacySubsidiaryFixedDepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legacy Subsidiary Fixed Deposits [Member]</link:label>
    <link:label id="lab_alts_LegacySubsidiaryFixedDepositsMember_documentation_en-US" xlink:label="lab_alts_LegacySubsidiaryFixedDepositsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Legacy Subsidiary Fixed Deposits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LegacySubsidiaryFixedDepositsMember" xlink:href="alts-20241228.xsd#alts_LegacySubsidiaryFixedDepositsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_LegacySubsidiaryFixedDepositsMember" xlink:to="lab_alts_LegacySubsidiaryFixedDepositsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_0bdd4f6f-4e51-4b3d-a26f-089d50c3d395_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_cdbc34da-d158-4eca-9cc1-47e2e60c2acf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_5ed8a4e2-bc06-4a37-9d92-e421bef1f87b_verboseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Principal balance on notes outstanding</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Receivable, Excluding Accrued Interest, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:to="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_9b52dcd8-ea44-43fb-8300-f1dd51a81ec0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_645d9956-0c26-4447-9353-d4c934ec2d82_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesAbstract_de568818-5db5-4b41-a8a2-dff5ea874b0e_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:label id="lab_us-gaap_ReceivablesAbstract_label_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesAbstract" xlink:to="lab_us-gaap_ReceivablesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_03ec1e98-7d4c-4386-85b3-6f08ab954e1b_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net (loss) income from continuing operations, basic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_2ba88cde-1b35-4e45-b612-2ec81128f62d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impact of sale of ARCA Recycling and Canada</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Disposition of Business, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfIssuedAndOutstandingShares_588f41bd-c45c-4001-a77b-203316d474be_terseLabel_en-US" xlink:label="lab_alts_BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfIssuedAndOutstandingShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of shares acquired</link:label>
    <link:label id="lab_alts_BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfIssuedAndOutstandingShares_label_en-US" xlink:label="lab_alts_BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfIssuedAndOutstandingShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Percentage Of Issued And Outstanding Shares</link:label>
    <link:label id="lab_alts_BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfIssuedAndOutstandingShares_documentation_en-US" xlink:label="lab_alts_BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfIssuedAndOutstandingShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Percentage Of Issued And Outstanding Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfIssuedAndOutstandingShares" xlink:href="alts-20241228.xsd#alts_BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfIssuedAndOutstandingShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfIssuedAndOutstandingShares" xlink:to="lab_alts_BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfIssuedAndOutstandingShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_67049234-2323-4602-a23e-eec1b910e7a0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_bcf55dde-70db-4c3d-96b4-ce28d54b587f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssued1_6a8bcbd0-99b1-47ee-8e63-f678f3fd48da_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock issued</link:label>
    <link:label id="lab_us-gaap_StockIssued1_label_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssued1" xlink:to="lab_us-gaap_StockIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_502ffa04-0f89-49df-a8f1-65d1e6ec5d56_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_0a0920cf-faeb-476c-b98a-7b4a8ad2eed9_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_SeriesQPreferredStockMember_02d8fdec-db9f-4ba8-9990-642dbb505ec0_terseLabel_en-US" xlink:label="lab_alts_SeriesQPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series Q Preferred</link:label>
    <link:label id="lab_alts_SeriesQPreferredStockMember_label_en-US" xlink:label="lab_alts_SeriesQPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series Q Preferred Stock [Member]</link:label>
    <link:label id="lab_alts_SeriesQPreferredStockMember_documentation_en-US" xlink:label="lab_alts_SeriesQPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series Q Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesQPreferredStockMember" xlink:href="alts-20241228.xsd#alts_SeriesQPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_SeriesQPreferredStockMember" xlink:to="lab_alts_SeriesQPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_A10ConvertiblePromissoryNoteMember_4f35ff49-4215-4491-847e-f1741d48706d_terseLabel_en-US" xlink:label="lab_alts_A10ConvertiblePromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">10% Convertible Promissory Note</link:label>
    <link:label id="lab_alts_A10ConvertiblePromissoryNoteMember_label_en-US" xlink:label="lab_alts_A10ConvertiblePromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">10% Convertible Promissory Note [Member]</link:label>
    <link:label id="lab_alts_A10ConvertiblePromissoryNoteMember_documentation_en-US" xlink:label="lab_alts_A10ConvertiblePromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">10% Convertible Promissory Note</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_A10ConvertiblePromissoryNoteMember" xlink:href="alts-20241228.xsd#alts_A10ConvertiblePromissoryNoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_A10ConvertiblePromissoryNoteMember" xlink:to="lab_alts_A10ConvertiblePromissoryNoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_LiveVenturesIncorporatedMember_0b285f6a-fe85-4114-81ee-fce9484b7885_terseLabel_en-US" xlink:label="lab_alts_LiveVenturesIncorporatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Live Ventures Incorporated</link:label>
    <link:label id="lab_alts_LiveVenturesIncorporatedMember_label_en-US" xlink:label="lab_alts_LiveVenturesIncorporatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Live Ventures Incorporated [Member]</link:label>
    <link:label id="lab_alts_LiveVenturesIncorporatedMember_documentation_en-US" xlink:label="lab_alts_LiveVenturesIncorporatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Live Ventures Incorporated.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LiveVenturesIncorporatedMember" xlink:href="alts-20241228.xsd#alts_LiveVenturesIncorporatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_LiveVenturesIncorporatedMember" xlink:to="lab_alts_LiveVenturesIncorporatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_ContinuingOperationsAndDiscontinuedOperationsMember_57b91716-6eb4-42f2-8424-bca0f1d22cf8_terseLabel_en-US" xlink:label="lab_alts_ContinuingOperationsAndDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Continuing and Discontinued Operation</link:label>
    <link:label id="lab_alts_ContinuingOperationsAndDiscontinuedOperationsMember_label_en-US" xlink:label="lab_alts_ContinuingOperationsAndDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Continuing Operations And Discontinued Operations [Member]</link:label>
    <link:label id="lab_alts_ContinuingOperationsAndDiscontinuedOperationsMember_documentation_en-US" xlink:label="lab_alts_ContinuingOperationsAndDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Continuing Operations And Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ContinuingOperationsAndDiscontinuedOperationsMember" xlink:href="alts-20241228.xsd#alts_ContinuingOperationsAndDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_ContinuingOperationsAndDiscontinuedOperationsMember" xlink:to="lab_alts_ContinuingOperationsAndDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DisposalOfDebt_d4858cac-b921-4504-9c24-07a72dc50e76_terseLabel_en-US" xlink:label="lab_alts_DisposalOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_alts_DisposalOfDebt_label_en-US" xlink:label="lab_alts_DisposalOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal of Debt</link:label>
    <link:label id="lab_alts_DisposalOfDebt_documentation_en-US" xlink:label="lab_alts_DisposalOfDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfDebt" xlink:href="alts-20241228.xsd#alts_DisposalOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DisposalOfDebt" xlink:to="lab_alts_DisposalOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue_5865e407-4d87-43c7-acd7-aa0e60b679a9_verboseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accrued guarantees</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue_dedf6105-8b4a-4121-9927-372c4ff5bc9d_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Guarantor obligations, current carrying value</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Guarantor Obligations, Current Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:to="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_c6667484-94b1-4343-adff-7e86b7575f34_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_8070ca11-731e-4596-8436-5988482b4bfa_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_a5801c34-3c09-461b-9b4e-d25ab522a17f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_5b9ba48c-dd66-4d2f-b6d3-5e2a26206329_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign rate differential</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_ccd3a3e5-0396-42d3-adf4-5910f906db30_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_ab5486e5-f8ca-40bf-93da-5e63989e0ffc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_IncreaseDecreaseInDigitalAssetsReceivable_43e532e5-9a39-43c7-8e6b-6d20552b4b55_negatedTerseLabel_en-US" xlink:label="lab_alts_IncreaseDecreaseInDigitalAssetsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Digital assets receivable</link:label>
    <link:label id="lab_alts_IncreaseDecreaseInDigitalAssetsReceivable_label_en-US" xlink:label="lab_alts_IncreaseDecreaseInDigitalAssetsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Digital Assets Receivable</link:label>
    <link:label id="lab_alts_IncreaseDecreaseInDigitalAssetsReceivable_documentation_en-US" xlink:label="lab_alts_IncreaseDecreaseInDigitalAssetsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Digital Assets Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IncreaseDecreaseInDigitalAssetsReceivable" xlink:href="alts-20241228.xsd#alts_IncreaseDecreaseInDigitalAssetsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_IncreaseDecreaseInDigitalAssetsReceivable" xlink:to="lab_alts_IncreaseDecreaseInDigitalAssetsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DebtInstrumentOriginalIssueDiscountExpansionDomain_b9f0c654-a6e3-45fd-906a-ece01436a972_terseLabel_en-US" xlink:label="lab_alts_DebtInstrumentOriginalIssueDiscountExpansionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Original Issue Discount, Expansion [Domain]</link:label>
    <link:label id="lab_alts_DebtInstrumentOriginalIssueDiscountExpansionDomain_label_en-US" xlink:label="lab_alts_DebtInstrumentOriginalIssueDiscountExpansionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Original Issue Discount, Expansion [Domain]</link:label>
    <link:label id="lab_alts_DebtInstrumentOriginalIssueDiscountExpansionDomain_documentation_en-US" xlink:label="lab_alts_DebtInstrumentOriginalIssueDiscountExpansionDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Original Issue Discount, Expansion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionDomain" xlink:href="alts-20241228.xsd#alts_DebtInstrumentOriginalIssueDiscountExpansionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionDomain" xlink:to="lab_alts_DebtInstrumentOriginalIssueDiscountExpansionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockConvertibleConversionRatio_a5fc343e-93a8-4fde-b69f-eb74fc9db261_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockConvertibleConversionRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, conversion ratio</link:label>
    <link:label id="lab_us-gaap_PreferredStockConvertibleConversionRatio_34af277f-77af-40f9-bc74-72803d5bfbb1_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockConvertibleConversionRatio" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, conversion ratio (as percent)</link:label>
    <link:label id="lab_us-gaap_PreferredStockConvertibleConversionRatio_label_en-US" xlink:label="lab_us-gaap_PreferredStockConvertibleConversionRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleConversionRatio" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleConversionRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockConvertibleConversionRatio" xlink:to="lab_us-gaap_PreferredStockConvertibleConversionRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_TotalGainOnSale_9ea0562c-5589-4ce6-9b43-4ae0f0f0d16a_totalLabel_en-US" xlink:label="lab_alts_TotalGainOnSale" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total gain on sale</link:label>
    <link:label id="lab_alts_TotalGainOnSale_label_en-US" xlink:label="lab_alts_TotalGainOnSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Gain on Sale</link:label>
    <link:label id="lab_alts_TotalGainOnSale_documentation_en-US" xlink:label="lab_alts_TotalGainOnSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total Gain on Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_TotalGainOnSale" xlink:href="alts-20241228.xsd#alts_TotalGainOnSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_TotalGainOnSale" xlink:to="lab_alts_TotalGainOnSale" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_SeriesMPreferredStockMember_e40181b7-d940-4c92-b20f-3fda6909097a_netLabel_en-US" xlink:label="lab_alts_SeriesMPreferredStockMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, series M - par value $0.001 per share, 3,200 authorized, 3,200 and 0 shares issued and outstanding at December&#160;28, 2024 and December&#160;30, 2023, respectively</link:label>
    <link:label id="lab_alts_SeriesMPreferredStockMember_dfd8c13c-7919-4a2c-be7b-524c108439de_terseLabel_en-US" xlink:label="lab_alts_SeriesMPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series M Preferred Stock</link:label>
    <link:label id="lab_alts_SeriesMPreferredStockMember_39ae9006-0c6f-4fd8-ad9b-3fb33c3c2bca_verboseLabel_en-US" xlink:label="lab_alts_SeriesMPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Series M Preferred</link:label>
    <link:label id="lab_alts_SeriesMPreferredStockMember_label_en-US" xlink:label="lab_alts_SeriesMPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series M Preferred Stock [Member]</link:label>
    <link:label id="lab_alts_SeriesMPreferredStockMember_documentation_en-US" xlink:label="lab_alts_SeriesMPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series M Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesMPreferredStockMember" xlink:href="alts-20241228.xsd#alts_SeriesMPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_SeriesMPreferredStockMember" xlink:to="lab_alts_SeriesMPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_fed93b6a-fc57-4ed7-bd29-3eb5749ad282_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_12adc557-00a6-4d8c-80ec-81b7c14972de_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_a2dc9d90-701e-4fa7-9cf3-420ee9fc6f2b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued for consulting agreement</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Issued for Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_6c26aec7-9f7a-404b-b311-48fab0e31328_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Prepaid Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_e79be523-3472-4a6c-8795-562bd3bb14a9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share based compensation</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_752151d6-904e-43f3-84e1-2f136840b74a_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share price (in usd per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_7d320765-cad0-48f1-acec-28a5fa17e45d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible preferred stock/Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1e2b9ad9-826a-4bd8-8514-0e8fa70a0a0f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued for equity financing (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_NonConvertibleDebentureBigDebentureMember_81b9299b-e5e7-4ca4-95f8-c3186b9c8479_terseLabel_en-US" xlink:label="lab_alts_NonConvertibleDebentureBigDebentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Big Debenture</link:label>
    <link:label id="lab_alts_NonConvertibleDebentureBigDebentureMember_label_en-US" xlink:label="lab_alts_NonConvertibleDebentureBigDebentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Convertible Debenture, Big Debenture [Member]</link:label>
    <link:label id="lab_alts_NonConvertibleDebentureBigDebentureMember_documentation_en-US" xlink:label="lab_alts_NonConvertibleDebentureBigDebentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non-Convertible Debenture, Big Debenture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NonConvertibleDebentureBigDebentureMember" xlink:href="alts-20241228.xsd#alts_NonConvertibleDebentureBigDebentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_NonConvertibleDebentureBigDebentureMember" xlink:to="lab_alts_NonConvertibleDebentureBigDebentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_1a3d6d5e-a2b8-46da-a241-efa9ff07cfcf_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_e0f230af-0d9e-4b01-bd71-38e91b7e49f8_terseLabel_en-US" xlink:label="lab_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities, Current</link:label>
    <link:label id="lab_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_documentation_en-US" xlink:label="lab_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:href="alts-20241228.xsd#alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:to="lab_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_A12DebenturesMaturingJune302024Member_19223119-3c8f-4e44-b89e-247910cf8f70_terseLabel_en-US" xlink:label="lab_alts_A12DebenturesMaturingJune302024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">12% Debentures Maturing June 30, 2024</link:label>
    <link:label id="lab_alts_A12DebenturesMaturingJune302024Member_label_en-US" xlink:label="lab_alts_A12DebenturesMaturingJune302024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">12% Debentures Maturing June 30, 2024 [Member]</link:label>
    <link:label id="lab_alts_A12DebenturesMaturingJune302024Member_documentation_en-US" xlink:label="lab_alts_A12DebenturesMaturingJune302024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">12% Debentures Maturing June 30, 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_A12DebenturesMaturingJune302024Member" xlink:href="alts-20241228.xsd#alts_A12DebenturesMaturingJune302024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_A12DebenturesMaturingJune302024Member" xlink:to="lab_alts_A12DebenturesMaturingJune302024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_629f6b94-ec3e-40cf-843e-21c0221c0f52_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cost of revenues</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Costs of Goods Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_SeriesVConvertiblePreferredStockMember_3d188574-9a18-4757-a0c1-a1ec2ce2bb9e_verboseLabel_en-US" xlink:label="lab_alts_SeriesVConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Convertible preferred stock, series V - par value $0.001 per share, 125,000 authorized, 5,000 shares and 0 issued and outstanding at December&#160;28, 2024 and December&#160;30, 2023, respectively</link:label>
    <link:label id="lab_alts_SeriesVConvertiblePreferredStockMember_1a3c64b4-a48d-4dec-ad5c-f8afca878836_terseLabel_en-US" xlink:label="lab_alts_SeriesVConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series V Convertible Preferred Stock</link:label>
    <link:label id="lab_alts_SeriesVConvertiblePreferredStockMember_label_en-US" xlink:label="lab_alts_SeriesVConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series V Convertible Preferred Stock [Member]</link:label>
    <link:label id="lab_alts_SeriesVConvertiblePreferredStockMember_documentation_en-US" xlink:label="lab_alts_SeriesVConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series V Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesVConvertiblePreferredStockMember" xlink:href="alts-20241228.xsd#alts_SeriesVConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_SeriesVConvertiblePreferredStockMember" xlink:to="lab_alts_SeriesVConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DisposalOfPropertyPlantAndEquipment_437f0d3c-8ba7-44f1-bbfa-5b24c43bcbcf_terseLabel_en-US" xlink:label="lab_alts_DisposalOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_alts_DisposalOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_alts_DisposalOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal of Property, Plant and Equipment</link:label>
    <link:label id="lab_alts_DisposalOfPropertyPlantAndEquipment_documentation_en-US" xlink:label="lab_alts_DisposalOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal of Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfPropertyPlantAndEquipment" xlink:href="alts-20241228.xsd#alts_DisposalOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DisposalOfPropertyPlantAndEquipment" xlink:to="lab_alts_DisposalOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_5c24cb0a-5264-498c-a7de-143ab440cfb4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_SoinAgreementConvertibleTrancheTwoMember_5149812a-8144-4a01-9e19-bf6bd395fbfe_terseLabel_en-US" xlink:label="lab_alts_SoinAgreementConvertibleTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soin Agreement Convertible Tranche Two</link:label>
    <link:label id="lab_alts_SoinAgreementConvertibleTrancheTwoMember_label_en-US" xlink:label="lab_alts_SoinAgreementConvertibleTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soin Agreement Convertible Tranche Two [Member]</link:label>
    <link:label id="lab_alts_SoinAgreementConvertibleTrancheTwoMember_documentation_en-US" xlink:label="lab_alts_SoinAgreementConvertibleTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Soin Agreement Convertible Tranche Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SoinAgreementConvertibleTrancheTwoMember" xlink:href="alts-20241228.xsd#alts_SoinAgreementConvertibleTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_SoinAgreementConvertibleTrancheTwoMember" xlink:to="lab_alts_SoinAgreementConvertibleTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_a46a6b23-2003-4bb4-af9e-eb659ccd2b9a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_f1318ca2-1ede-483a-9f24-5d72682310c5_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible preferred stock/Preferred stock, par value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_db2bf115-7bcc-4b7c-9922-1c36caea5318_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_192e0d3c-9a31-4134-bd9d-923ec0a2750f_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_7bb0401f-9c01-4d27-8eff-e0a41c6067de_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:to="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_BusinessCombinationConsiderationTransferredBeneficialConversionFeatureValue_4d550024-4596-4ed5-98fb-8edf988e6179_terseLabel_en-US" xlink:label="lab_alts_BusinessCombinationConsiderationTransferredBeneficialConversionFeatureValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Beneficial conversion feature</link:label>
    <link:label id="lab_alts_BusinessCombinationConsiderationTransferredBeneficialConversionFeatureValue_label_en-US" xlink:label="lab_alts_BusinessCombinationConsiderationTransferredBeneficialConversionFeatureValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Beneficial Conversion Feature, Value</link:label>
    <link:label id="lab_alts_BusinessCombinationConsiderationTransferredBeneficialConversionFeatureValue_documentation_en-US" xlink:label="lab_alts_BusinessCombinationConsiderationTransferredBeneficialConversionFeatureValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Beneficial Conversion Feature, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessCombinationConsiderationTransferredBeneficialConversionFeatureValue" xlink:href="alts-20241228.xsd#alts_BusinessCombinationConsiderationTransferredBeneficialConversionFeatureValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_BusinessCombinationConsiderationTransferredBeneficialConversionFeatureValue" xlink:to="lab_alts_BusinessCombinationConsiderationTransferredBeneficialConversionFeatureValue" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_GainLossOnWriteOffOfNotesReceivable_79f5793d-0d77-4569-bcd7-af41a06cca7d_negatedTerseLabel_en-US" xlink:label="lab_alts_GainLossOnWriteOffOfNotesReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Write off of SPYR note receivable</link:label>
    <link:label id="lab_alts_GainLossOnWriteOffOfNotesReceivable_f210f424-3c16-4992-97f1-8b47f3223cdc_negatedLabel_en-US" xlink:label="lab_alts_GainLossOnWriteOffOfNotesReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Impairment charge related to note receivable</link:label>
    <link:label id="lab_alts_GainLossOnWriteOffOfNotesReceivable_label_en-US" xlink:label="lab_alts_GainLossOnWriteOffOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Write-Off Of Notes Receivable</link:label>
    <link:label id="lab_alts_GainLossOnWriteOffOfNotesReceivable_documentation_en-US" xlink:label="lab_alts_GainLossOnWriteOffOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Write-Off Of Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_GainLossOnWriteOffOfNotesReceivable" xlink:href="alts-20241228.xsd#alts_GainLossOnWriteOffOfNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_GainLossOnWriteOffOfNotesReceivable" xlink:to="lab_alts_GainLossOnWriteOffOfNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_d04db774-794b-44d4-96df-82866d8832cc_terseLabel_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating cash flows provided by discontinued operations</link:label>
    <link:label id="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Operating Activities, Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:to="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_cd9370fd-167f-45c5-87a9-398302b51379_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_f9fade56-e6c4-41a7-af54-4edae41b2b34_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_d6fe61ad-9714-4a62-95f6-825f0ee8babe_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_IsaacCapitalGroupNoteMember_7598d9a4-a15c-4182-9882-84a344342f43_terseLabel_en-US" xlink:label="lab_alts_IsaacCapitalGroupNoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Isaac Capital Group</link:label>
    <link:label id="lab_alts_IsaacCapitalGroupNoteMember_label_en-US" xlink:label="lab_alts_IsaacCapitalGroupNoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Isaac Capital Group Note [Member]</link:label>
    <link:label id="lab_alts_IsaacCapitalGroupNoteMember_documentation_en-US" xlink:label="lab_alts_IsaacCapitalGroupNoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Isaac Capital Group Note</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IsaacCapitalGroupNoteMember" xlink:href="alts-20241228.xsd#alts_IsaacCapitalGroupNoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_IsaacCapitalGroupNoteMember" xlink:to="lab_alts_IsaacCapitalGroupNoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_d33f7038-63ff-4335-80c7-34b573b0f8fb_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_dc130b7d-898d-4387-9f2d-d89c11f07c72_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuritiesPurchasedUnderAgreementsToResellAllowanceForCreditLossRollForward_36074693-ce54-4c7a-885e-628b1a507e34_terseLabel_en-US" xlink:label="lab_us-gaap_SecuritiesPurchasedUnderAgreementsToResellAllowanceForCreditLossRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable Securities, Value [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_SecuritiesPurchasedUnderAgreementsToResellAllowanceForCreditLossRollForward_label_en-US" xlink:label="lab_us-gaap_SecuritiesPurchasedUnderAgreementsToResellAllowanceForCreditLossRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Securities Purchased under Agreements to Resell, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesPurchasedUnderAgreementsToResellAllowanceForCreditLossRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecuritiesPurchasedUnderAgreementsToResellAllowanceForCreditLossRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuritiesPurchasedUnderAgreementsToResellAllowanceForCreditLossRollForward" xlink:to="lab_us-gaap_SecuritiesPurchasedUnderAgreementsToResellAllowanceForCreditLossRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_ARCAAndSubsidiariesMember_ae2c7582-7bcd-4b01-a693-6d40cceff9af_terseLabel_en-US" xlink:label="lab_alts_ARCAAndSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ARCA And Subsidiaries</link:label>
    <link:label id="lab_alts_ARCAAndSubsidiariesMember_label_en-US" xlink:label="lab_alts_ARCAAndSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ARCA And Subsidiaries [Member]</link:label>
    <link:label id="lab_alts_ARCAAndSubsidiariesMember_documentation_en-US" xlink:label="lab_alts_ARCAAndSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">ARCA And Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ARCAAndSubsidiariesMember" xlink:href="alts-20241228.xsd#alts_ARCAAndSubsidiariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_ARCAAndSubsidiariesMember" xlink:to="lab_alts_ARCAAndSubsidiariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_1dbe885f-ec5d-41bd-a813-c404d3db1d58_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income before provision for income taxes from discontinued operations</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_34df1824-767f-450e-8a29-af4a25663a4c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_ConversionOfStockSharesForfeited_d2c8325a-b5e1-48b1-8a9b-bb5cf9c5aa89_terseLabel_en-US" xlink:label="lab_alts_ConversionOfStockSharesForfeited" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible preferred stock, forfeited (in shares)</link:label>
    <link:label id="lab_alts_ConversionOfStockSharesForfeited_label_en-US" xlink:label="lab_alts_ConversionOfStockSharesForfeited" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion of Stock, Shares Forfeited</link:label>
    <link:label id="lab_alts_ConversionOfStockSharesForfeited_documentation_en-US" xlink:label="lab_alts_ConversionOfStockSharesForfeited" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Conversion of Stock, Shares Forfeited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ConversionOfStockSharesForfeited" xlink:href="alts-20241228.xsd#alts_ConversionOfStockSharesForfeited"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_ConversionOfStockSharesForfeited" xlink:to="lab_alts_ConversionOfStockSharesForfeited" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2f72079a-cbce-4d79-a0ed-2a53d5266fe6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_29f2ed80-7776-4df2-8b47-6e5e3a570446_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_3b3b6d10-3c21-42f2-a60b-f2c22a7d71da_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_ShareholdersEquityLineItems_303735f6-16bc-457b-b671-9c0f8fd93932_terseLabel_en-US" xlink:label="lab_alts_ShareholdersEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shareholders Equity [Line Items]</link:label>
    <link:label id="lab_alts_ShareholdersEquityLineItems_label_en-US" xlink:label="lab_alts_ShareholdersEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shareholders Equity [Line Items]</link:label>
    <link:label id="lab_alts_ShareholdersEquityLineItems_documentation_en-US" xlink:label="lab_alts_ShareholdersEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Shareholders equity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ShareholdersEquityLineItems" xlink:href="alts-20241228.xsd#alts_ShareholdersEquityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_ShareholdersEquityLineItems" xlink:to="lab_alts_ShareholdersEquityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_NotePayableToIsaacCapitalGroupMember_1bb82504-61b5-4124-b004-384779e8073f_terseLabel_en-US" xlink:label="lab_alts_NotePayableToIsaacCapitalGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Note Payable To Isaac Capital Group</link:label>
    <link:label id="lab_alts_NotePayableToIsaacCapitalGroupMember_label_en-US" xlink:label="lab_alts_NotePayableToIsaacCapitalGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Note Payable To Isaac Capital Group [Member]</link:label>
    <link:label id="lab_alts_NotePayableToIsaacCapitalGroupMember_documentation_en-US" xlink:label="lab_alts_NotePayableToIsaacCapitalGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Note Payable To Isaac Capital Group</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NotePayableToIsaacCapitalGroupMember" xlink:href="alts-20241228.xsd#alts_NotePayableToIsaacCapitalGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_NotePayableToIsaacCapitalGroupMember" xlink:to="lab_alts_NotePayableToIsaacCapitalGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_af138941-3805-4b4c-a201-82754c51a81e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_52309189-172c-4e75-a53e-2e3df5365a43_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes payable converted to common stock</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Conversion, Converted Instrument, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_368f5af5-65f7-4a4d-9935-e01141daf895_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_1d1b3eb6-c051-47c1-bb26-e32f4e9dbc57_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_OtherLegacyNotesPayableMember_548db070-ede9-47f5-b40b-509614dd3b51_terseLabel_en-US" xlink:label="lab_alts_OtherLegacyNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_alts_OtherLegacyNotesPayableMember_label_en-US" xlink:label="lab_alts_OtherLegacyNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Legacy Notes Payable [Member]</link:label>
    <link:label id="lab_alts_OtherLegacyNotesPayableMember_documentation_en-US" xlink:label="lab_alts_OtherLegacyNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Legacy Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherLegacyNotesPayableMember" xlink:href="alts-20241228.xsd#alts_OtherLegacyNotesPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_OtherLegacyNotesPayableMember" xlink:to="lab_alts_OtherLegacyNotesPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_fcb1397a-4836-4fe3-a578-7a68af56e4dd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current tax expense:</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_8f1b5b18-b82d-4c8e-be30-730a46c5d396_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_IsaacCapitalGroupShortTermDemandAdvanceMember_45f3ce07-f69a-41ef-92c1-bb56ebf335a6_terseLabel_en-US" xlink:label="lab_alts_IsaacCapitalGroupShortTermDemandAdvanceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Isaac Capital Group Short-Term Demand Advance</link:label>
    <link:label id="lab_alts_IsaacCapitalGroupShortTermDemandAdvanceMember_label_en-US" xlink:label="lab_alts_IsaacCapitalGroupShortTermDemandAdvanceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Isaac Capital Group Short-Term Demand Advance [Member]</link:label>
    <link:label id="lab_alts_IsaacCapitalGroupShortTermDemandAdvanceMember_documentation_en-US" xlink:label="lab_alts_IsaacCapitalGroupShortTermDemandAdvanceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Isaac Capital Group Short-Term Demand Advance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IsaacCapitalGroupShortTermDemandAdvanceMember" xlink:href="alts-20241228.xsd#alts_IsaacCapitalGroupShortTermDemandAdvanceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_IsaacCapitalGroupShortTermDemandAdvanceMember" xlink:to="lab_alts_IsaacCapitalGroupShortTermDemandAdvanceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_ec8b65b9-509d-478c-a3d1-b566326fffa7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecurities_791a8645-9d52-406d-8082-1a9db670970c_periodStartLabel_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_MarketableSecurities_52f10b25-5418-4bfb-8840-a408cd7f3efa_periodEndLabel_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_MarketableSecurities_label_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecurities" xlink:to="lab_us-gaap_MarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_IsaacCapitalGroupLLCICGMember_a1ffd1da-fba5-473e-80e5-2672d50320f0_terseLabel_en-US" xlink:label="lab_alts_IsaacCapitalGroupLLCICGMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ICG</link:label>
    <link:label id="lab_alts_IsaacCapitalGroupLLCICGMember_label_en-US" xlink:label="lab_alts_IsaacCapitalGroupLLCICGMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Isaac Capital Group LLC (&#8220;ICG&#8221;) [Member]</link:label>
    <link:label id="lab_alts_IsaacCapitalGroupLLCICGMember_documentation_en-US" xlink:label="lab_alts_IsaacCapitalGroupLLCICGMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Isaac Capital Group LLC (&#8220;ICG&#8221;)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IsaacCapitalGroupLLCICGMember" xlink:href="alts-20241228.xsd#alts_IsaacCapitalGroupLLCICGMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_IsaacCapitalGroupLLCICGMember" xlink:to="lab_alts_IsaacCapitalGroupLLCICGMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_79d6559e-b824-439a-9655-1e245f4c0fe6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivablesTextBlock_85e2bef3-8f63-4df9-bfe6-3c8ead35abcd_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivablesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes receivable</link:label>
    <link:label id="lab_us-gaap_FinancingReceivablesTextBlock_label_en-US" xlink:label="lab_us-gaap_FinancingReceivablesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Receivables [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivablesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivablesTextBlock" xlink:to="lab_us-gaap_FinancingReceivablesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_ff6009e8-879c-4377-a4da-66582f657135_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_cb604bf3-774b-411a-91f3-d0eea41bb310_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b0646708-0576-479b-af98-aca815e3d58c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_OperatingLeasesFutureMinimumPaymentsDue1_f899641d-838c-4956-ae40-f5d04d6ca286_terseLabel_en-US" xlink:label="lab_alts_OperatingLeasesFutureMinimumPaymentsDue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Future lease payments</link:label>
    <link:label id="lab_alts_OperatingLeasesFutureMinimumPaymentsDue1_label_en-US" xlink:label="lab_alts_OperatingLeasesFutureMinimumPaymentsDue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases Future Minimum Payments Due1</link:label>
    <link:label id="lab_alts_OperatingLeasesFutureMinimumPaymentsDue1_documentation_en-US" xlink:label="lab_alts_OperatingLeasesFutureMinimumPaymentsDue1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Leases Future Minimum Payments Due1.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OperatingLeasesFutureMinimumPaymentsDue1" xlink:href="alts-20241228.xsd#alts_OperatingLeasesFutureMinimumPaymentsDue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_OperatingLeasesFutureMinimumPaymentsDue1" xlink:to="lab_alts_OperatingLeasesFutureMinimumPaymentsDue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BeneficialOwnerMember_fef4bd23-f175-41bd-8686-35fed358a92a_terseLabel_en-US" xlink:label="lab_us-gaap_BeneficialOwnerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Record and beneficial owner</link:label>
    <link:label id="lab_us-gaap_BeneficialOwnerMember_label_en-US" xlink:label="lab_us-gaap_BeneficialOwnerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Beneficial Owner [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BeneficialOwnerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BeneficialOwnerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BeneficialOwnerMember" xlink:to="lab_us-gaap_BeneficialOwnerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_ExercisePriceRangeTwoMember_b04ce6a7-72a5-4dfb-8334-f7e9d5f07de3_terseLabel_en-US" xlink:label="lab_alts_ExercisePriceRangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">$3.54 to $5.25</link:label>
    <link:label id="lab_alts_ExercisePriceRangeTwoMember_label_en-US" xlink:label="lab_alts_ExercisePriceRangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price Range Two [Member]</link:label>
    <link:label id="lab_alts_ExercisePriceRangeTwoMember_documentation_en-US" xlink:label="lab_alts_ExercisePriceRangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exercise price range two.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ExercisePriceRangeTwoMember" xlink:href="alts-20241228.xsd#alts_ExercisePriceRangeTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_ExercisePriceRangeTwoMember" xlink:to="lab_alts_ExercisePriceRangeTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_StockIssuedDuringPeriodValueWarrantsExercised_303d7d5e-5b92-41b8-b184-ce2602e79c56_terseLabel_en-US" xlink:label="lab_alts_StockIssuedDuringPeriodValueWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued for warrants exercised</link:label>
    <link:label id="lab_alts_StockIssuedDuringPeriodValueWarrantsExercised_label_en-US" xlink:label="lab_alts_StockIssuedDuringPeriodValueWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Warrants Exercised</link:label>
    <link:label id="lab_alts_StockIssuedDuringPeriodValueWarrantsExercised_documentation_en-US" xlink:label="lab_alts_StockIssuedDuringPeriodValueWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Warrants Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockIssuedDuringPeriodValueWarrantsExercised" xlink:href="alts-20241228.xsd#alts_StockIssuedDuringPeriodValueWarrantsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_StockIssuedDuringPeriodValueWarrantsExercised" xlink:to="lab_alts_StockIssuedDuringPeriodValueWarrantsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_20f7db5b-7c2f-4855-ba5a-ac77eb324c48_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_94442a91-e6a8-4130-ab3c-96ff3eb1f19e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price Range</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DebtInstrumentCovenantPeriodPeriodOneMember_c5487978-1296-4613-9b98-b6d56b4e2aaa_terseLabel_en-US" xlink:label="lab_alts_DebtInstrumentCovenantPeriodPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">August 20, 2024 to October 31, 2024</link:label>
    <link:label id="lab_alts_DebtInstrumentCovenantPeriodPeriodOneMember_label_en-US" xlink:label="lab_alts_DebtInstrumentCovenantPeriodPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant Period, Period One [Member]</link:label>
    <link:label id="lab_alts_DebtInstrumentCovenantPeriodPeriodOneMember_documentation_en-US" xlink:label="lab_alts_DebtInstrumentCovenantPeriodPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant Period, Period One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentCovenantPeriodPeriodOneMember" xlink:href="alts-20241228.xsd#alts_DebtInstrumentCovenantPeriodPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DebtInstrumentCovenantPeriodPeriodOneMember" xlink:to="lab_alts_DebtInstrumentCovenantPeriodPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_9b17f1f2-69dd-44c9-8807-b3bfb7944c2e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average discount rate (as percent)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_338ee256-d391-46b1-b29b-13653f835612_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSegmentAllocationLineItems_7612081d-daa2-487b-9252-7ea5f438255d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSegmentAllocationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination Segment Allocation [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSegmentAllocationLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSegmentAllocationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination Segment Allocation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationSegmentAllocationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems" xlink:to="lab_us-gaap_BusinessCombinationSegmentAllocationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_1fe141b2-df34-4f17-a790-7407b0ef494d_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_3a84902d-4c60-48c7-8c67-ddbf4bc24602_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_83f89d9c-598a-4bb0-8685-f3d599a5b686_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_7405cab7-9d0c-4bbe-b222-363edf40b749_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_b100bacd-edc5-49d5-a898-acabd68e47f7_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_ad03e4e2-5d81-444c-b1af-cd91cbc18a82_netLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_JanOneMember_1dbbcf4f-bf30-44d5-b3c5-71eb9f1ce95a_terseLabel_en-US" xlink:label="lab_alts_JanOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Janone</link:label>
    <link:label id="lab_alts_JanOneMember_label_en-US" xlink:label="lab_alts_JanOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">JanOne [Member]</link:label>
    <link:label id="lab_alts_JanOneMember_documentation_en-US" xlink:label="lab_alts_JanOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">JanOne</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_JanOneMember" xlink:href="alts-20241228.xsd#alts_JanOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_JanOneMember" xlink:to="lab_alts_JanOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_4a0bd467-f41c-4a3b-a9ba-dc2c04491cf7_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_1937c659-827d-4f34-a0ac-6a562d944af1_terseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_475c2991-2f59-4ef2-9106-728e05231f4c_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_43329686-eb62-47df-83c3-41e81f90c944_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_SeriesIPreferredStockMember_44d84470-55c3-4049-81c3-6e7c6aadb445_terseLabel_en-US" xlink:label="lab_alts_SeriesIPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series I Preferred</link:label>
    <link:label id="lab_alts_SeriesIPreferredStockMember_label_en-US" xlink:label="lab_alts_SeriesIPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series I Preferred Stock [Member]</link:label>
    <link:label id="lab_alts_SeriesIPreferredStockMember_documentation_en-US" xlink:label="lab_alts_SeriesIPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series I Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesIPreferredStockMember" xlink:href="alts-20241228.xsd#alts_SeriesIPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_SeriesIPreferredStockMember" xlink:to="lab_alts_SeriesIPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_cb51fe9c-4ec7-429f-89fa-cac934829971_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued for equity financing</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_f9988c97-8458-4f5e-a671-7a29a1e37df0_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued for equity financing</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_f0c51455-88b8-42fb-a40d-1697b9098a62_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag_900ef8db-91cf-4a6c-bc4d-077216e3764d_terseLabel_en-US" xlink:label="lab_alts_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Excess of book value over assets disposed, extensible list</link:label>
    <link:label id="lab_alts_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag_label_en-US" xlink:label="lab_alts_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Not Discontinued Operation Gain (Loss) On Disposal, Statement Of Income Extensible List Not Disclosed Flag</link:label>
    <link:label id="lab_alts_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag_documentation_en-US" xlink:label="lab_alts_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal Group Not Discontinued Operation Gain (Loss) On Disposal, Statement Of Income Extensible List Not Disclosed Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:href="alts-20241228.xsd#alts_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:to="lab_alts_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4e5553c8-57af-49df-92f4-df18fe91be4b_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_f90c8a88-51a6-42e4-98de-5c2f5386fe1f_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_b71d5ced-e326-4782-bb5e-fcc6acf8cd98_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value $0.001 per share, 200,000,000 shares authorized, 15,417,693 and 2,827,410 shares issued and outstanding at December&#160;28, 2024 and at December&#160;30, 2023, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_87590123-b7fa-4be3-99ba-54796ed00a19_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_label_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_03ecbac7-c0c3-4262-a53c-098cd4800d9c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock issued for acquisition of Alt5 Subsidiary and Qoden assets</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_Plan2016Member_7c2493f0-bf92-4292-8ae4-2ec30d66ea84_terseLabel_en-US" xlink:label="lab_alts_Plan2016Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2016 Plan</link:label>
    <link:label id="lab_alts_Plan2016Member_label_en-US" xlink:label="lab_alts_Plan2016Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan2016 [Member]</link:label>
    <link:label id="lab_alts_Plan2016Member_documentation_en-US" xlink:label="lab_alts_Plan2016Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Plan 2016.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Plan2016Member" xlink:href="alts-20241228.xsd#alts_Plan2016Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_Plan2016Member" xlink:to="lab_alts_Plan2016Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSignificantNoncashTransactionsLineItems_f89ac2ad-9ee4-49d8-8213-1fb136079ee8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSignificantNoncashTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherSignificantNoncashTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherSignificantNoncashTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Significant Noncash Transactions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSignificantNoncashTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherSignificantNoncashTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionsLineItems" xlink:to="lab_us-gaap_OtherSignificantNoncashTransactionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_017b9a1e-0c13-475b-bffe-ba296324ed3e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock issued for acquisition of Alt5 Subsidiary and Qoden assets (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_7d5afb58-19a1-4c0b-a229-5fec3e86b860_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_c941afcd-f531-4eb8-b800-b3095173309d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a96c1c2f-61c9-4441-a685-1b9074ef0ddd_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">FINANCING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_a4bc642f-8b1e-4d66-b055-c941007a4bd4_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_d66265d9-5639-4498-a52e-da7a92a72900_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share, basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_d4435b64-48e2-4df8-8fef-bf9de58790ab_netLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Net (loss) income per share, basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_12195455-53c1-4bad-9237-3f389d0bf130_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic (loss) income per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_616dcc9f-d4b5-4d54-a67d-7fdbe72b20c6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from equity financings, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_49e660c3-0573-41ff-a9a8-f7dffe8207cf_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash payment for operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_NumberOfConsultants_939be5a9-6315-431d-b228-d7cc894d8228_terseLabel_en-US" xlink:label="lab_alts_NumberOfConsultants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of consultants</link:label>
    <link:label id="lab_alts_NumberOfConsultants_label_en-US" xlink:label="lab_alts_NumberOfConsultants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Consultants</link:label>
    <link:label id="lab_alts_NumberOfConsultants_documentation_en-US" xlink:label="lab_alts_NumberOfConsultants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Consultants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NumberOfConsultants" xlink:href="alts-20241228.xsd#alts_NumberOfConsultants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_NumberOfConsultants" xlink:to="lab_alts_NumberOfConsultants" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_ReclassificationOfTemporaryToCurrentLiabilitiesShares_004dae5e-0d09-4ef0-97fc-70a3455b7bd1_terseLabel_en-US" xlink:label="lab_alts_ReclassificationOfTemporaryToCurrentLiabilitiesShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification to current liabilities (in shares)</link:label>
    <link:label id="lab_alts_ReclassificationOfTemporaryToCurrentLiabilitiesShares_label_en-US" xlink:label="lab_alts_ReclassificationOfTemporaryToCurrentLiabilitiesShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification of Temporary to Current Liabilities, Shares</link:label>
    <link:label id="lab_alts_ReclassificationOfTemporaryToCurrentLiabilitiesShares_documentation_en-US" xlink:label="lab_alts_ReclassificationOfTemporaryToCurrentLiabilitiesShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reclassification of Temporary to Current Liabilities, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ReclassificationOfTemporaryToCurrentLiabilitiesShares" xlink:href="alts-20241228.xsd#alts_ReclassificationOfTemporaryToCurrentLiabilitiesShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_ReclassificationOfTemporaryToCurrentLiabilitiesShares" xlink:to="lab_alts_ReclassificationOfTemporaryToCurrentLiabilitiesShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_b2d72f99-416c-4906-b7b7-3be949dbee72_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Intangibles</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_309f5613-710c-4ec6-89c0-f70e33d03269_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_6a50612a-40bb-4f44-937f-4e6105d6c99a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_1bcb6a14-12fe-4551-bb29-eca84135ec1e_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible preferred stock, series S - par value $0.001 per share 200,000 authorized, 100,000 shares issued and outstanding at December&#160;28, 2024 and December&#160;30, 2023</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_7aa2d753-9bd2-4429-81ac-d60b5003e463_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_4ada3378-5c34-4329-a1d6-b994f90ab324_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_e719c817-7df1-4afd-a58f-d981bb965a7c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation expense, net of estimated forfeitures</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_5961cdb4-a9ad-4d88-8d64-8e190121b951_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_PreFundedWarrantsMember_d0a3aa2e-b903-4a85-9876-63b68c001bfe_terseLabel_en-US" xlink:label="lab_alts_PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-Funded Warrants Member</link:label>
    <link:label id="lab_alts_PreFundedWarrantsMember_label_en-US" xlink:label="lab_alts_PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-Funded Warrants [Member]</link:label>
    <link:label id="lab_alts_PreFundedWarrantsMember_documentation_en-US" xlink:label="lab_alts_PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pre-Funded Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PreFundedWarrantsMember" xlink:href="alts-20241228.xsd#alts_PreFundedWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_PreFundedWarrantsMember" xlink:to="lab_alts_PreFundedWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_03c8a6bb-b7c2-46e6-b318-430d60d3dbbd_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Payments on short term notes payable</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_30fab483-13a8-4d2c-8eba-f26bf951435f_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments on notes payable</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_fb944772-936f-4766-b99a-07c4b32986d0_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_9cb23f50-eabe-48bb-b064-977c77bd2454_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant offering and exercise price (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentOperatingActivitiesDomain_81a3659e-cc18-4c2f-ba1e-731bc63ea121_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Activities [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentOperatingActivitiesDomain_label_en-US" xlink:label="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Activities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain" xlink:to="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_5837b19d-e722-443b-a912-07a48bb0612a_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_OtherSignificantNoncashTransactionBusinessAcquisitionMember_dd552328-50fe-4512-85e6-66fe755abf00_terseLabel_en-US" xlink:label="lab_alts_OtherSignificantNoncashTransactionBusinessAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock issued for the acquisition of Alt5 Subsidiary</link:label>
    <link:label id="lab_alts_OtherSignificantNoncashTransactionBusinessAcquisitionMember_label_en-US" xlink:label="lab_alts_OtherSignificantNoncashTransactionBusinessAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Significant Noncash Transaction, Business Acquisition [Member]</link:label>
    <link:label id="lab_alts_OtherSignificantNoncashTransactionBusinessAcquisitionMember_documentation_en-US" xlink:label="lab_alts_OtherSignificantNoncashTransactionBusinessAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Significant Noncash Transaction, Business Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherSignificantNoncashTransactionBusinessAcquisitionMember" xlink:href="alts-20241228.xsd#alts_OtherSignificantNoncashTransactionBusinessAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_OtherSignificantNoncashTransactionBusinessAcquisitionMember" xlink:to="lab_alts_OtherSignificantNoncashTransactionBusinessAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DeferredTaxLiabilitiesInstallmentSale_0947586d-b7f4-4141-8ec3-00dcc8e11ae0_negatedTerseLabel_en-US" xlink:label="lab_alts_DeferredTaxLiabilitiesInstallmentSale" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Installment sale</link:label>
    <link:label id="lab_alts_DeferredTaxLiabilitiesInstallmentSale_label_en-US" xlink:label="lab_alts_DeferredTaxLiabilitiesInstallmentSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities Installment Sale</link:label>
    <link:label id="lab_alts_DeferredTaxLiabilitiesInstallmentSale_documentation_en-US" xlink:label="lab_alts_DeferredTaxLiabilitiesInstallmentSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities Installment Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DeferredTaxLiabilitiesInstallmentSale" xlink:href="alts-20241228.xsd#alts_DeferredTaxLiabilitiesInstallmentSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DeferredTaxLiabilitiesInstallmentSale" xlink:to="lab_alts_DeferredTaxLiabilitiesInstallmentSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferred_2301c8a8-959a-4212-ac57-53843d3a9097_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset acquisition, total consideration</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferred_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:to="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_758a7a75-a3c2-4543-9126-2b804847559c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_RecyclingSegmentAndTechnologySegmentMember_49d4b3aa-6ae5-4775-a0e1-145bb8bdd4fc_terseLabel_en-US" xlink:label="lab_alts_RecyclingSegmentAndTechnologySegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recycling Segment and Technology Segment</link:label>
    <link:label id="lab_alts_RecyclingSegmentAndTechnologySegmentMember_label_en-US" xlink:label="lab_alts_RecyclingSegmentAndTechnologySegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recycling Segment And Technology Segment [Member]</link:label>
    <link:label id="lab_alts_RecyclingSegmentAndTechnologySegmentMember_documentation_en-US" xlink:label="lab_alts_RecyclingSegmentAndTechnologySegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Recycling Segment And Technology Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RecyclingSegmentAndTechnologySegmentMember" xlink:href="alts-20241228.xsd#alts_RecyclingSegmentAndTechnologySegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_RecyclingSegmentAndTechnologySegmentMember" xlink:to="lab_alts_RecyclingSegmentAndTechnologySegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_0930628a-9ec8-4455-97e6-41d7a0050f5b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock Options Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_a4289649-aed6-47c2-9d4c-73fef8a8bb7e_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_49897a46-7898-4e53-baaa-939ed3e980be_netLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Sale of Recycling Subsidiaries</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_70944b85-080c-4b9d-92d2-a45864c7b99a_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_a26b0e17-eb4f-46a6-b24f-3d3b7c548d40_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series A-1 preferred converted for legal settlement</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_8d1d407a-ca88-48c1-93a5-f01fa1de116d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DiscontinuedFinancingActivities_3c6b2fe3-44f9-4fe3-a7fc-e79b366919b7_terseLabel_en-US" xlink:label="lab_alts_DiscontinuedFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">DISCONTINUED FINANCING ACTIVITIES:</link:label>
    <link:label id="lab_alts_DiscontinuedFinancingActivities_label_en-US" xlink:label="lab_alts_DiscontinuedFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">DISCONTINUED FINANCING ACTIVITIES:</link:label>
    <link:label id="lab_alts_DiscontinuedFinancingActivities_documentation_en-US" xlink:label="lab_alts_DiscontinuedFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">DISCONTINUED FINANCING ACTIVITIES:</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DiscontinuedFinancingActivities" xlink:href="alts-20241228.xsd#alts_DiscontinuedFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DiscontinuedFinancingActivities" xlink:to="lab_alts_DiscontinuedFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_282d94cd-08a4-414c-a003-cbb8ecbafb28_verboseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_907c5dde-f77f-4701-87bf-fff9e0df5cc6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_c85c0618-8901-42b8-b207-fbf6ac4a7ad3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DebtInstrumentOriginalIssueDiscountExpansionTwoMember_c3c11f26-ec35-4aae-a967-6ac9ef461f12_terseLabel_en-US" xlink:label="lab_alts_DebtInstrumentOriginalIssueDiscountExpansionTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">OID expansion two</link:label>
    <link:label id="lab_alts_DebtInstrumentOriginalIssueDiscountExpansionTwoMember_label_en-US" xlink:label="lab_alts_DebtInstrumentOriginalIssueDiscountExpansionTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Original Issue Discount, Expansion Two [Member]</link:label>
    <link:label id="lab_alts_DebtInstrumentOriginalIssueDiscountExpansionTwoMember_documentation_en-US" xlink:label="lab_alts_DebtInstrumentOriginalIssueDiscountExpansionTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Original Issue Discount, Expansion Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionTwoMember" xlink:href="alts-20241228.xsd#alts_DebtInstrumentOriginalIssueDiscountExpansionTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionTwoMember" xlink:to="lab_alts_DebtInstrumentOriginalIssueDiscountExpansionTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract_402bc05e-9a92-4be3-9ac2-718515f72316_terseLabel_en-US" xlink:label="lab_alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other expense from discontinued operations</link:label>
    <link:label id="lab_alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract_label_en-US" xlink:label="lab_alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Income (Expense) From Discontinued Operations [Abstract]</link:label>
    <link:label id="lab_alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract_documentation_en-US" xlink:label="lab_alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Income (Expense) From Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract" xlink:href="alts-20241228.xsd#alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract" xlink:to="lab_alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</link:label>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_label_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:to="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_DebtInstrumentCovenantPeriodPeriodThreeMember_d20c4901-80e1-45bc-9bce-a3740ddb1810_terseLabel_en-US" xlink:label="lab_alts_DebtInstrumentCovenantPeriodPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">January 30, 2025 till Repayment</link:label>
    <link:label id="lab_alts_DebtInstrumentCovenantPeriodPeriodThreeMember_label_en-US" xlink:label="lab_alts_DebtInstrumentCovenantPeriodPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant Period, Period Three [Member]</link:label>
    <link:label id="lab_alts_DebtInstrumentCovenantPeriodPeriodThreeMember_documentation_en-US" xlink:label="lab_alts_DebtInstrumentCovenantPeriodPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant Period, Period Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentCovenantPeriodPeriodThreeMember" xlink:href="alts-20241228.xsd#alts_DebtInstrumentCovenantPeriodPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_DebtInstrumentCovenantPeriodPeriodThreeMember" xlink:to="lab_alts_DebtInstrumentCovenantPeriodPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_413cfb36-217b-482d-a7ef-15e99ea7a493_netLabel_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, series B - par value $0.001 per share, 34,250 authorized, 34,207 and 0 shares issued and outstanding at December&#160;28, 2024 and December&#160;30, 2023, respectively</link:label>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_7581c313-9832-4955-b185-c3a08ff0c138_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series B Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_127a2892-d11c-4a7c-bace-266807aa40e8_verboseLabel_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Series B Preferred</link:label>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series B Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesBPreferredStockMember" xlink:to="lab_us-gaap_SeriesBPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_5d159ece-d905-4fd6-af66-4e8fc699abeb_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_LegacySubsidiaryLoanMember_880e0c26-f856-48a1-8f50-7ea2c60612a3_terseLabel_en-US" xlink:label="lab_alts_LegacySubsidiaryLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legacy subsidiary loan</link:label>
    <link:label id="lab_alts_LegacySubsidiaryLoanMember_label_en-US" xlink:label="lab_alts_LegacySubsidiaryLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legacy Subsidiary Loan [Member]</link:label>
    <link:label id="lab_alts_LegacySubsidiaryLoanMember_documentation_en-US" xlink:label="lab_alts_LegacySubsidiaryLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Legacy Subsidiary Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LegacySubsidiaryLoanMember" xlink:href="alts-20241228.xsd#alts_LegacySubsidiaryLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_LegacySubsidiaryLoanMember" xlink:to="lab_alts_LegacySubsidiaryLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_6e46311b-d653-40c9-a5e8-6796aa10fc14_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_cce897aa-15c1-4842-9f95-50426b090be5_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_99e4373b-192e-43bd-b0d1-b7a85abfa965_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Canada</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_BusinessAcquisitionConsiderationTrancheOneMember_aa0f563f-62e7-4cbf-9f8b-e6cd7bdbeea3_terseLabel_en-US" xlink:label="lab_alts_BusinessAcquisitionConsiderationTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Consideration, Tranche One</link:label>
    <link:label id="lab_alts_BusinessAcquisitionConsiderationTrancheOneMember_label_en-US" xlink:label="lab_alts_BusinessAcquisitionConsiderationTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Consideration, Tranche One [Member]</link:label>
    <link:label id="lab_alts_BusinessAcquisitionConsiderationTrancheOneMember_documentation_en-US" xlink:label="lab_alts_BusinessAcquisitionConsiderationTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Acquisition, Consideration, Tranche One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessAcquisitionConsiderationTrancheOneMember" xlink:href="alts-20241228.xsd#alts_BusinessAcquisitionConsiderationTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_BusinessAcquisitionConsiderationTrancheOneMember" xlink:to="lab_alts_BusinessAcquisitionConsiderationTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_OtherCommitmentsAndLitigationCasesMember_aa8c1ad3-3742-492b-8d16-af52ad97cee3_terseLabel_en-US" xlink:label="lab_alts_OtherCommitmentsAndLitigationCasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Commitments And Litigation Cases</link:label>
    <link:label id="lab_alts_OtherCommitmentsAndLitigationCasesMember_label_en-US" xlink:label="lab_alts_OtherCommitmentsAndLitigationCasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitments And Litigation Cases [Member]</link:label>
    <link:label id="lab_alts_OtherCommitmentsAndLitigationCasesMember_documentation_en-US" xlink:label="lab_alts_OtherCommitmentsAndLitigationCasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Commitments And Litigation Cases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherCommitmentsAndLitigationCasesMember" xlink:href="alts-20241228.xsd#alts_OtherCommitmentsAndLitigationCasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_OtherCommitmentsAndLitigationCasesMember" xlink:to="lab_alts_OtherCommitmentsAndLitigationCasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_0d731b3b-2d5e-4f97-ac60-1a010a12fe02_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_3ddb3e9d-7036-4b66-9adb-47af85905de3_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_585f329a-730e-4bef-91c6-fb1df1336657_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic_2983e775-79b1-4c30-8641-604b47e9d01b_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income from discontinued operations, basic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_7fae8c99-f7ac-43e9-b235-01e18b147f9d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_1a9f5e73-0250-4ca2-8890-85dcbac26fc8_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shared expenses with another company</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction, Purchases from Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_3e4ac1ae-23f8-4cb1-9c4a-766338a9895c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_NumberOfUnaffiliatedThirdPartyInvestors_8a2072b7-ea36-417a-b612-2d1220c1ede9_terseLabel_en-US" xlink:label="lab_alts_NumberOfUnaffiliatedThirdPartyInvestors" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number Of unaffiliated third-party investors</link:label>
    <link:label id="lab_alts_NumberOfUnaffiliatedThirdPartyInvestors_label_en-US" xlink:label="lab_alts_NumberOfUnaffiliatedThirdPartyInvestors" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Unaffiliated Third-Party Investors</link:label>
    <link:label id="lab_alts_NumberOfUnaffiliatedThirdPartyInvestors_documentation_en-US" xlink:label="lab_alts_NumberOfUnaffiliatedThirdPartyInvestors" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Unaffiliated Third-Party Investors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NumberOfUnaffiliatedThirdPartyInvestors" xlink:href="alts-20241228.xsd#alts_NumberOfUnaffiliatedThirdPartyInvestors"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_NumberOfUnaffiliatedThirdPartyInvestors" xlink:to="lab_alts_NumberOfUnaffiliatedThirdPartyInvestors" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_aa60e47b-e3fe-4c68-afa3-22dacd4063fa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value Adjustments for Shares of Series B and Series M Preferred Stock</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_7d6332a4-1a1b-4300-96f1-02d4ac1a3bd0_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_789e5ebf-a06a-4f1e-9388-13e00424ded3_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total prepaids and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_8069f289-6439-4914-8bf4-e52e186e4b53_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Statement Reclassification</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_7ba29671-d3c6-4779-b6f5-13951e8b80ab_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_AlixpartnersLLCLitigationMember_707b07ad-0476-4748-b1b7-4b65e879d360_terseLabel_en-US" xlink:label="lab_alts_AlixpartnersLLCLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Alixpartners, LLC Litigation</link:label>
    <link:label id="lab_alts_AlixpartnersLLCLitigationMember_label_en-US" xlink:label="lab_alts_AlixpartnersLLCLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alixpartners, LLC Litigation [Member]</link:label>
    <link:label id="lab_alts_AlixpartnersLLCLitigationMember_documentation_en-US" xlink:label="lab_alts_AlixpartnersLLCLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Alixpartners, LLC Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AlixpartnersLLCLitigationMember" xlink:href="alts-20241228.xsd#alts_AlixpartnersLLCLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_AlixpartnersLLCLitigationMember" xlink:to="lab_alts_AlixpartnersLLCLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_IncreaseDecreaseInDigitalAssetsPayable_d572e101-6fcd-4ac2-8ff3-34b2a351d7f5_terseLabel_en-US" xlink:label="lab_alts_IncreaseDecreaseInDigitalAssetsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Digital assets payable</link:label>
    <link:label id="lab_alts_IncreaseDecreaseInDigitalAssetsPayable_label_en-US" xlink:label="lab_alts_IncreaseDecreaseInDigitalAssetsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Digital Assets Payable</link:label>
    <link:label id="lab_alts_IncreaseDecreaseInDigitalAssetsPayable_documentation_en-US" xlink:label="lab_alts_IncreaseDecreaseInDigitalAssetsPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Digital Assets Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IncreaseDecreaseInDigitalAssetsPayable" xlink:href="alts-20241228.xsd#alts_IncreaseDecreaseInDigitalAssetsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_IncreaseDecreaseInDigitalAssetsPayable" xlink:to="lab_alts_IncreaseDecreaseInDigitalAssetsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_CurrentAssetsCurrentLiabilitiesNet_f4b35b2b-fe84-494f-a9dc-a4ee1d725745_negatedTerseLabel_en-US" xlink:label="lab_alts_CurrentAssetsCurrentLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Net negative working capital</link:label>
    <link:label id="lab_alts_CurrentAssetsCurrentLiabilitiesNet_label_en-US" xlink:label="lab_alts_CurrentAssetsCurrentLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Assets (Current Liabilities), Net</link:label>
    <link:label id="lab_alts_CurrentAssetsCurrentLiabilitiesNet_documentation_en-US" xlink:label="lab_alts_CurrentAssetsCurrentLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net working capital.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_CurrentAssetsCurrentLiabilitiesNet" xlink:href="alts-20241228.xsd#alts_CurrentAssetsCurrentLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_CurrentAssetsCurrentLiabilitiesNet" xlink:to="lab_alts_CurrentAssetsCurrentLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_fb8e9067-e4ab-4ed7-ab8f-54b1b161f219_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_55d76c99-bb86-4e37-923c-b823d06c2a45_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_8f593b9c-a330-4060-94bc-29b8d31c7202_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_1612927b-557b-443c-884d-c9fb8fd5ef42_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionDomain" xlink:to="lab_us-gaap_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_30415505-ea41-411c-9fcf-f911d0a28cde_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price, upper range limit (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_CommonStockConversionValidConversionPeriod_2b546705-5d27-4e2b-b517-f7b2af2c753b_terseLabel_en-US" xlink:label="lab_alts_CommonStockConversionValidConversionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trailing quarterly basis, period (in years)</link:label>
    <link:label id="lab_alts_CommonStockConversionValidConversionPeriod_label_en-US" xlink:label="lab_alts_CommonStockConversionValidConversionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock Conversion, Valid Conversion Period</link:label>
    <link:label id="lab_alts_CommonStockConversionValidConversionPeriod_documentation_en-US" xlink:label="lab_alts_CommonStockConversionValidConversionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock Conversion, Valid Conversion Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_CommonStockConversionValidConversionPeriod" xlink:href="alts-20241228.xsd#alts_CommonStockConversionValidConversionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_CommonStockConversionValidConversionPeriod" xlink:to="lab_alts_CommonStockConversionValidConversionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_LiveVenturesAndICGNotesMember_d11b34ec-700b-41ba-9b7f-e9e15002b63a_terseLabel_en-US" xlink:label="lab_alts_LiveVenturesAndICGNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Live Ventures and ICG Notes</link:label>
    <link:label id="lab_alts_LiveVenturesAndICGNotesMember_label_en-US" xlink:label="lab_alts_LiveVenturesAndICGNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Live Ventures And ICG Notes [Member]</link:label>
    <link:label id="lab_alts_LiveVenturesAndICGNotesMember_documentation_en-US" xlink:label="lab_alts_LiveVenturesAndICGNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Live Ventures And ICG Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LiveVenturesAndICGNotesMember" xlink:href="alts-20241228.xsd#alts_LiveVenturesAndICGNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_LiveVenturesAndICGNotesMember" xlink:to="lab_alts_LiveVenturesAndICGNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_e2d5e78c-e5f1-47f5-bda4-90f67a989d9c_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_OtherSignificantNoncashTransactionPropertyAndEquipmentMember_3017537f-eb62-4b32-8d0a-c8f18f7b26f8_terseLabel_en-US" xlink:label="lab_alts_OtherSignificantNoncashTransactionPropertyAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued for property and equipment</link:label>
    <link:label id="lab_alts_OtherSignificantNoncashTransactionPropertyAndEquipmentMember_label_en-US" xlink:label="lab_alts_OtherSignificantNoncashTransactionPropertyAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Significant Noncash Transaction, Property And Equipment [Member]</link:label>
    <link:label id="lab_alts_OtherSignificantNoncashTransactionPropertyAndEquipmentMember_documentation_en-US" xlink:label="lab_alts_OtherSignificantNoncashTransactionPropertyAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Significant Noncash Transaction, Property And Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherSignificantNoncashTransactionPropertyAndEquipmentMember" xlink:href="alts-20241228.xsd#alts_OtherSignificantNoncashTransactionPropertyAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_OtherSignificantNoncashTransactionPropertyAndEquipmentMember" xlink:to="lab_alts_OtherSignificantNoncashTransactionPropertyAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f46afc17-6898-4544-a1d5-233fdc0a7bd8_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_TrusteesMain270LlcMember_2d1373b2-f46a-4a03-8d5f-8210863a984a_terseLabel_en-US" xlink:label="lab_alts_TrusteesMain270LlcMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trustees Main/270, LLC</link:label>
    <link:label id="lab_alts_TrusteesMain270LlcMember_label_en-US" xlink:label="lab_alts_TrusteesMain270LlcMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trustees Main/270, LLC [Member]</link:label>
    <link:label id="lab_alts_TrusteesMain270LlcMember_documentation_en-US" xlink:label="lab_alts_TrusteesMain270LlcMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Trustees Main/270, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_TrusteesMain270LlcMember" xlink:href="alts-20241228.xsd#alts_TrusteesMain270LlcMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_TrusteesMain270LlcMember" xlink:to="lab_alts_TrusteesMain270LlcMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_d755d609-4bbe-4488-96ed-4bece08a7ec7_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash payment tendered for contingent liability</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment for Contingent Consideration Liability, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_370667f6-db5f-4bde-b9a6-b49518ddfd11_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Income Tax Provision (Benefit)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_alts_Plan2011Member_5493d7b0-9f4c-44a4-9e7a-a2c239a6ee29_terseLabel_en-US" xlink:label="lab_alts_Plan2011Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2011 Plan</link:label>
    <link:label id="lab_alts_Plan2011Member_label_en-US" xlink:label="lab_alts_Plan2011Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan2011 [Member]</link:label>
    <link:label id="lab_alts_Plan2011Member_documentation_en-US" xlink:label="lab_alts_Plan2011Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Plan 2011.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Plan2011Member" xlink:href="alts-20241228.xsd#alts_Plan2011Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_alts_Plan2011Member" xlink:to="lab_alts_Plan2011Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>alts-20241228_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:2830d163-e030-49d1-a620-63415283e8e5,g:d25a092d-1f61-4617-aa79-df61d6af7f3a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.alt5sigma.com/role/Cover" xlink:type="simple" xlink:href="alts-20241228.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ef09b708-71ad-494a-ab45-8ad883678225" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_DocumentType_ef09b708-71ad-494a-ab45-8ad883678225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_19f51cc1-84d0-4532-940b-ddf47bef57b0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_DocumentAnnualReport_19f51cc1-84d0-4532-940b-ddf47bef57b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_8ab3a4e1-9bda-482e-8023-332d5534ba8c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_CurrentFiscalYearEndDate_8ab3a4e1-9bda-482e-8023-332d5534ba8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_99e1cabc-aed7-4a2b-aabf-87eb2af3ba8f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_DocumentPeriodEndDate_99e1cabc-aed7-4a2b-aabf-87eb2af3ba8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_454d59a8-15a3-461f-9b74-21cc53ca420f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_DocumentTransitionReport_454d59a8-15a3-461f-9b74-21cc53ca420f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_352f2afb-8536-4846-ab45-63981d0684bd" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_EntityFileNumber_352f2afb-8536-4846-ab45-63981d0684bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_6fa397e7-c600-41ff-a5f5-84185ffad94d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_EntityRegistrantName_6fa397e7-c600-41ff-a5f5-84185ffad94d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_09be6978-b4db-4894-a938-39bc218813bb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_EntityIncorporationStateCountryCode_09be6978-b4db-4894-a938-39bc218813bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_dda85148-ef46-43fa-9b55-c7e8e365045f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_EntityTaxIdentificationNumber_dda85148-ef46-43fa-9b55-c7e8e365045f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_3243faf7-5387-4aee-a780-7a6d0b33cd9c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_EntityAddressAddressLine1_3243faf7-5387-4aee-a780-7a6d0b33cd9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_6032064d-5af4-4c3f-8f48-596d6bce5022" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_EntityAddressCityOrTown_6032064d-5af4-4c3f-8f48-596d6bce5022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_24f4dd5b-bd22-4c58-ac49-b587bf7dfdd0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_EntityAddressStateOrProvince_24f4dd5b-bd22-4c58-ac49-b587bf7dfdd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_92fc087a-6e4c-4579-a3cf-4fd1b09a8037" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_EntityAddressPostalZipCode_92fc087a-6e4c-4579-a3cf-4fd1b09a8037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_45e175d1-14ea-489c-a461-50399256cfeb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_CityAreaCode_45e175d1-14ea-489c-a461-50399256cfeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_1e7d28a7-961f-4c92-8162-f1253f57d491" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_LocalPhoneNumber_1e7d28a7-961f-4c92-8162-f1253f57d491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_5f215fce-1a55-4fe9-8590-9d920ec5963d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_Security12bTitle_5f215fce-1a55-4fe9-8590-9d920ec5963d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_cf7a0bd9-b65e-4d13-9990-af770c13feae" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_TradingSymbol_cf7a0bd9-b65e-4d13-9990-af770c13feae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_d88bf279-2a33-416d-b08c-cc22fc866f68" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_SecurityExchangeName_d88bf279-2a33-416d-b08c-cc22fc866f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_a089500c-7c2f-48b2-be1d-573c775d40c8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_a089500c-7c2f-48b2-be1d-573c775d40c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_10423700-c1b6-46d8-b8eb-f3a688592cb9" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_EntityVoluntaryFilers_10423700-c1b6-46d8-b8eb-f3a688592cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_781fc861-3266-4f3e-a30a-585bf3276a2f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_EntityCurrentReportingStatus_781fc861-3266-4f3e-a30a-585bf3276a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_5ae82834-5f0a-4886-a20c-4b56c659bd25" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_EntityInteractiveDataCurrent_5ae82834-5f0a-4886-a20c-4b56c659bd25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_3091fceb-af09-4dc7-aecb-403e99193446" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_EntityFilerCategory_3091fceb-af09-4dc7-aecb-403e99193446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_de07eb83-af45-4e98-9a06-4d71eeb3280f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_EntitySmallBusiness_de07eb83-af45-4e98-9a06-4d71eeb3280f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_ed4cf825-a8c0-4a9e-b3dc-2b7445574104" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_EntityEmergingGrowthCompany_ed4cf825-a8c0-4a9e-b3dc-2b7445574104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_64eb1dcb-4d72-437e-a011-9979e5a3bf96" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_IcfrAuditorAttestationFlag_64eb1dcb-4d72-437e-a011-9979e5a3bf96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_b2df58c3-66ea-41aa-9288-2b0c3a134235" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_b2df58c3-66ea-41aa-9288-2b0c3a134235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_392db9c8-088f-4cd1-a72b-712f58848bfe" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_EntityShellCompany_392db9c8-088f-4cd1-a72b-712f58848bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_5fb42e9c-a111-4753-8396-9e3c36e0c134" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_EntityPublicFloat_5fb42e9c-a111-4753-8396-9e3c36e0c134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_3d04f57c-9966-4022-9765-24e54d347727" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_3d04f57c-9966-4022-9765-24e54d347727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b3a4ee40-fdab-483d-93a7-30da2dbbc04d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_AmendmentFlag_b3a4ee40-fdab-483d-93a7-30da2dbbc04d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_dc0a64b7-d9e7-4baa-adae-03786bb1f38b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_EntityCentralIndexKey_dc0a64b7-d9e7-4baa-adae-03786bb1f38b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_785ee7de-f777-4a0a-add7-623410236367" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_DocumentFiscalYearFocus_785ee7de-f777-4a0a-add7-623410236367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_56dc8d6a-fdf2-414d-9fb9-d02dc79d156b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e0c26bc9-c39d-46d8-aabb-b48a01fb0822" xlink:to="loc_dei_DocumentFiscalPeriodFocus_56dc8d6a-fdf2-414d-9fb9-d02dc79d156b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/AuditInformation" xlink:type="simple" xlink:href="alts-20241228.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_alts_AuditorAbstract_09d4f648-bf6b-4378-8dc4-73639fc861a0" xlink:href="alts-20241228.xsd#alts_AuditorAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_ac66ddbf-b728-4a20-ac4d-45d3bf010f2f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_AuditorAbstract_09d4f648-bf6b-4378-8dc4-73639fc861a0" xlink:to="loc_dei_AuditorFirmId_ac66ddbf-b728-4a20-ac4d-45d3bf010f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_c9e05528-0fe2-4015-a51c-2bf99e83ebf3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_AuditorAbstract_09d4f648-bf6b-4378-8dc4-73639fc861a0" xlink:to="loc_dei_AuditorName_c9e05528-0fe2-4015-a51c-2bf99e83ebf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_4635c09c-7e5e-4b4c-aa6c-d2e2688d5313" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_AuditorAbstract_09d4f648-bf6b-4378-8dc4-73639fc861a0" xlink:to="loc_dei_AuditorLocation_4635c09c-7e5e-4b4c-aa6c-d2e2688d5313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="alts-20241228.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_12f2fa22-6aeb-492d-8275-900fc808059b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_84b4f5f5-64ff-449d-b943-0f5b3d9fc00a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_12f2fa22-6aeb-492d-8275-900fc808059b" xlink:to="loc_us-gaap_StatementTable_84b4f5f5-64ff-449d-b943-0f5b3d9fc00a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0354fc9c-09f4-4b0d-8818-ee2c9c91f560" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_84b4f5f5-64ff-449d-b943-0f5b3d9fc00a" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0354fc9c-09f4-4b0d-8818-ee2c9c91f560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_3b3c8a36-afa0-4182-9340-4ce2cd258732" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0354fc9c-09f4-4b0d-8818-ee2c9c91f560" xlink:to="loc_us-gaap_RelatedPartyDomain_3b3c8a36-afa0-4182-9340-4ce2cd258732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_c516f072-f03f-44c6-b0b0-555552feb5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3b3c8a36-afa0-4182-9340-4ce2cd258732" xlink:to="loc_us-gaap_RelatedPartyMember_c516f072-f03f-44c6-b0b0-555552feb5bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_997617e2-f03d-4d85-8fec-e88ac5c34c51" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_84b4f5f5-64ff-449d-b943-0f5b3d9fc00a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_997617e2-f03d-4d85-8fec-e88ac5c34c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_de6455b3-2784-4b22-a659-cf3d486e3f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_997617e2-f03d-4d85-8fec-e88ac5c34c51" xlink:to="loc_us-gaap_ClassOfStockDomain_de6455b3-2784-4b22-a659-cf3d486e3f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesA1ConvertiblePreferredStockMember_997f5235-4f28-4e50-92cf-2808532c22b2" xlink:href="alts-20241228.xsd#alts_SeriesA1ConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_de6455b3-2784-4b22-a659-cf3d486e3f7c" xlink:to="loc_alts_SeriesA1ConvertiblePreferredStockMember_997f5235-4f28-4e50-92cf-2808532c22b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_d7c3ee5d-4656-4c04-acbb-42ca71034d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_de6455b3-2784-4b22-a659-cf3d486e3f7c" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_d7c3ee5d-4656-4c04-acbb-42ca71034d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesIConvertiblePreferredStockMember_e8a1b9fe-1ca9-4417-8475-385f2e07e8db" xlink:href="alts-20241228.xsd#alts_SeriesIConvertiblePreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_de6455b3-2784-4b22-a659-cf3d486e3f7c" xlink:to="loc_alts_SeriesIConvertiblePreferredStockMember_e8a1b9fe-1ca9-4417-8475-385f2e07e8db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesMPreferredStockMember_309fe8b1-cb7c-4a7e-b888-b79bb99859f4" xlink:href="alts-20241228.xsd#alts_SeriesMPreferredStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_de6455b3-2784-4b22-a659-cf3d486e3f7c" xlink:to="loc_alts_SeriesMPreferredStockMember_309fe8b1-cb7c-4a7e-b888-b79bb99859f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesQConvertiblePreferredStockMember_48c32dcc-ef87-46b6-8012-554435554a08" xlink:href="alts-20241228.xsd#alts_SeriesQConvertiblePreferredStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_de6455b3-2784-4b22-a659-cf3d486e3f7c" xlink:to="loc_alts_SeriesQConvertiblePreferredStockMember_48c32dcc-ef87-46b6-8012-554435554a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesSConvertiblePreferredStockMember_abbbdeea-18d0-4445-a7ec-90e3727272cf" xlink:href="alts-20241228.xsd#alts_SeriesSConvertiblePreferredStockMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_de6455b3-2784-4b22-a659-cf3d486e3f7c" xlink:to="loc_alts_SeriesSConvertiblePreferredStockMember_abbbdeea-18d0-4445-a7ec-90e3727272cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesVConvertiblePreferredStockMember_07aa0227-ab8a-40ef-ad04-3c2276b7133a" xlink:href="alts-20241228.xsd#alts_SeriesVConvertiblePreferredStockMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_de6455b3-2784-4b22-a659-cf3d486e3f7c" xlink:to="loc_alts_SeriesVConvertiblePreferredStockMember_07aa0227-ab8a-40ef-ad04-3c2276b7133a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b61933c7-ef72-4dcf-ba4c-d6d2ddc9c007" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_84b4f5f5-64ff-449d-b943-0f5b3d9fc00a" xlink:to="loc_us-gaap_StatementLineItems_b61933c7-ef72-4dcf-ba4c-d6d2ddc9c007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_46af28fd-ae05-4de2-988b-b6dd3d2a4104" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b61933c7-ef72-4dcf-ba4c-d6d2ddc9c007" xlink:to="loc_us-gaap_AssetsAbstract_46af28fd-ae05-4de2-988b-b6dd3d2a4104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cb047196-734b-4e19-abc7-1498fd8acc2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_46af28fd-ae05-4de2-988b-b6dd3d2a4104" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cb047196-734b-4e19-abc7-1498fd8acc2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_0cb9352c-4718-4562-8ae5-030329e99819" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_46af28fd-ae05-4de2-988b-b6dd3d2a4104" xlink:to="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_0cb9352c-4718-4562-8ae5-030329e99819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PlatformOperatorCryptoAssetHeldForUserCurrent_b58061d6-7159-44bf-8d6d-6966caa40be3" xlink:href="alts-20241228.xsd#alts_PlatformOperatorCryptoAssetHeldForUserCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_46af28fd-ae05-4de2-988b-b6dd3d2a4104" xlink:to="loc_alts_PlatformOperatorCryptoAssetHeldForUserCurrent_b58061d6-7159-44bf-8d6d-6966caa40be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2cc7858d-9e95-4a66-aea7-5cbc444e5412" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_46af28fd-ae05-4de2-988b-b6dd3d2a4104" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2cc7858d-9e95-4a66-aea7-5cbc444e5412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_fc38f417-3900-49a1-b77c-fd6623fee9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_46af28fd-ae05-4de2-988b-b6dd3d2a4104" xlink:to="loc_us-gaap_AssetsCurrent_fc38f417-3900-49a1-b77c-fd6623fee9b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_02ace519-2004-409e-bfe4-0b7912d3529f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_46af28fd-ae05-4de2-988b-b6dd3d2a4104" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_02ace519-2004-409e-bfe4-0b7912d3529f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_6c00d4f2-adcc-47d2-b275-94d6e75fbc4e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_46af28fd-ae05-4de2-988b-b6dd3d2a4104" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_6c00d4f2-adcc-47d2-b275-94d6e75fbc4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f4430662-9f11-4aa9-ad75-6ec0f0a01a80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_46af28fd-ae05-4de2-988b-b6dd3d2a4104" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f4430662-9f11-4aa9-ad75-6ec0f0a01a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_243fe15c-fc31-4b54-8fea-305aa5ff74ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_46af28fd-ae05-4de2-988b-b6dd3d2a4104" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_243fe15c-fc31-4b54-8fea-305aa5ff74ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DepositsAndOtherAssetsNoncurrent_87e3355c-c02e-4ec9-973a-3fd172c73401" xlink:href="alts-20241228.xsd#alts_DepositsAndOtherAssetsNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_46af28fd-ae05-4de2-988b-b6dd3d2a4104" xlink:to="loc_alts_DepositsAndOtherAssetsNoncurrent_87e3355c-c02e-4ec9-973a-3fd172c73401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0461cc4d-a1e6-4afe-9ac1-6d6b6f045472" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_46af28fd-ae05-4de2-988b-b6dd3d2a4104" xlink:to="loc_us-gaap_Goodwill_0461cc4d-a1e6-4afe-9ac1-6d6b6f045472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_4f483dcf-089d-4b0d-9ab4-23b9583436a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_46af28fd-ae05-4de2-988b-b6dd3d2a4104" xlink:to="loc_us-gaap_Assets_4f483dcf-089d-4b0d-9ab4-23b9583436a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3661d527-c568-469c-bcfa-734cd894819e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b61933c7-ef72-4dcf-ba4c-d6d2ddc9c007" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3661d527-c568-469c-bcfa-734cd894819e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3661d527-c568-469c-bcfa-734cd894819e" xlink:to="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_0afb7cdc-c096-4176-a02b-1efcd1fa53d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:to="loc_us-gaap_AccountsPayableCurrent_0afb7cdc-c096-4176-a02b-1efcd1fa53d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_1b8391e9-6632-4045-8d60-832590fdcff3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_1b8391e9-6632-4045-8d60-832590fdcff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DigitalAssetLiabilityCurrent_ddec5de4-8983-4a81-b4c9-2d58ca46834e" xlink:href="alts-20241228.xsd#alts_DigitalAssetLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:to="loc_alts_DigitalAssetLiabilityCurrent_ddec5de4-8983-4a81-b4c9-2d58ca46834e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_e6cb3d69-a020-4e26-9357-dbabb091bd0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_e6cb3d69-a020-4e26-9357-dbabb091bd0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtCurrent_29d2dd64-7972-494f-b39f-b237dcf3c148" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:to="loc_us-gaap_ConvertibleDebtCurrent_29d2dd64-7972-494f-b39f-b237dcf3c148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_e8100562-0831-482f-8dff-7c7bf36ad47c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_e8100562-0831-482f-8dff-7c7bf36ad47c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_9e86f350-ad24-437e-888f-1ff8c7bad84a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:to="loc_us-gaap_NotesPayableCurrent_9e86f350-ad24-437e-888f-1ff8c7bad84a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_0cb52030-2bb5-484c-993b-083b179ecb1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:to="loc_us-gaap_LiabilitiesCurrent_0cb52030-2bb5-484c-993b-083b179ecb1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d7c31e3f-bf29-4714-9577-efc855748079" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d7c31e3f-bf29-4714-9577-efc855748079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermNotesPayable_cf1941ec-5ba8-4a91-8ca9-0b83912f7b34" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLongTermNotesPayable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:to="loc_us-gaap_OtherLongTermNotesPayable_cf1941ec-5ba8-4a91-8ca9-0b83912f7b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_259aa54d-1e6a-45bb-9b97-1c402d185642" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermNotesPayable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:to="loc_us-gaap_LongTermNotesPayable_259aa54d-1e6a-45bb-9b97-1c402d185642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_aa1508be-c680-4427-8a9c-cc934e442d90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_aa1508be-c680-4427-8a9c-cc934e442d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_edc11238-f6f6-4dfa-b875-df7cbd86d59e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_edc11238-f6f6-4dfa-b875-df7cbd86d59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_531e263a-a13f-4796-895c-5925f9888162" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_0a2d7fa5-e2d9-41d5-aee9-2e6e2c5c0da0" xlink:to="loc_us-gaap_Liabilities_531e263a-a13f-4796-895c-5925f9888162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_5bad8fd9-b08b-4d9b-971c-3875c52cf45e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3661d527-c568-469c-bcfa-734cd894819e" xlink:to="loc_us-gaap_CommitmentsAndContingencies_5bad8fd9-b08b-4d9b-971c-3875c52cf45e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_MezzanineEquityAbstract_bbe62772-5c8a-4648-b696-dbc57a818d62" xlink:href="alts-20241228.xsd#alts_MezzanineEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3661d527-c568-469c-bcfa-734cd894819e" xlink:to="loc_alts_MezzanineEquityAbstract_bbe62772-5c8a-4648-b696-dbc57a818d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_3695b6be-d822-48cf-9b7a-4f9be51b89f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_MezzanineEquityAbstract_bbe62772-5c8a-4648-b696-dbc57a818d62" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_3695b6be-d822-48cf-9b7a-4f9be51b89f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_1b048cae-5964-4af3-b3f5-1e12137fbade" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3661d527-c568-469c-bcfa-734cd894819e" xlink:to="loc_us-gaap_StockholdersEquityAbstract_1b048cae-5964-4af3-b3f5-1e12137fbade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_4feaf0ae-a40a-40ec-87f4-f735a362b23e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1b048cae-5964-4af3-b3f5-1e12137fbade" xlink:to="loc_us-gaap_PreferredStockValue_4feaf0ae-a40a-40ec-87f4-f735a362b23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_6be80438-3918-4037-b12c-9dbbfbf580b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1b048cae-5964-4af3-b3f5-1e12137fbade" xlink:to="loc_us-gaap_CommonStockValue_6be80438-3918-4037-b12c-9dbbfbf580b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_47ad8843-f622-4675-8da6-80b28c1309c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1b048cae-5964-4af3-b3f5-1e12137fbade" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_47ad8843-f622-4675-8da6-80b28c1309c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3bc866c6-9fd1-4837-b760-9c025c80bc94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1b048cae-5964-4af3-b3f5-1e12137fbade" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3bc866c6-9fd1-4837-b760-9c025c80bc94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c5b8a7e8-3f08-4364-84b3-5a679fab355a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1b048cae-5964-4af3-b3f5-1e12137fbade" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c5b8a7e8-3f08-4364-84b3-5a679fab355a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8f681063-61af-4196-b140-6fb69d56130c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1b048cae-5964-4af3-b3f5-1e12137fbade" xlink:to="loc_us-gaap_StockholdersEquity_8f681063-61af-4196-b140-6fb69d56130c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_6eb051b5-21eb-4a27-bf8d-b199468ca946" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1b048cae-5964-4af3-b3f5-1e12137fbade" xlink:to="loc_us-gaap_MinorityInterest_6eb051b5-21eb-4a27-bf8d-b199468ca946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1f6fea79-7234-41bb-990f-2e9a5a55def9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1b048cae-5964-4af3-b3f5-1e12137fbade" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1f6fea79-7234-41bb-990f-2e9a5a55def9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_5ca7a305-0c5f-4179-95e8-32ed778edb94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3661d527-c568-469c-bcfa-734cd894819e" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_5ca7a305-0c5f-4179-95e8-32ed778edb94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="alts-20241228.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_b611eece-bc71-48bb-8ff7-5bda41144e16" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_588968d3-1202-4752-8f0d-5f539fce2c99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b611eece-bc71-48bb-8ff7-5bda41144e16" xlink:to="loc_us-gaap_StatementTable_588968d3-1202-4752-8f0d-5f539fce2c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b98b78b6-fb3a-436b-a691-23d314d51b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_588968d3-1202-4752-8f0d-5f539fce2c99" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b98b78b6-fb3a-436b-a691-23d314d51b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c088e001-ceed-4e69-b62e-66f570e953cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b98b78b6-fb3a-436b-a691-23d314d51b1f" xlink:to="loc_us-gaap_ClassOfStockDomain_c088e001-ceed-4e69-b62e-66f570e953cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesA1ConvertiblePreferredStockMember_da3c2ecd-735d-409a-82be-a143f288e760" xlink:href="alts-20241228.xsd#alts_SeriesA1ConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_c088e001-ceed-4e69-b62e-66f570e953cc" xlink:to="loc_alts_SeriesA1ConvertiblePreferredStockMember_da3c2ecd-735d-409a-82be-a143f288e760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_20c545d2-6784-4408-bed0-aae7ebf8e9ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_c088e001-ceed-4e69-b62e-66f570e953cc" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_20c545d2-6784-4408-bed0-aae7ebf8e9ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesIConvertiblePreferredStockMember_a07df097-ab93-4640-b413-42617eb06d08" xlink:href="alts-20241228.xsd#alts_SeriesIConvertiblePreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_c088e001-ceed-4e69-b62e-66f570e953cc" xlink:to="loc_alts_SeriesIConvertiblePreferredStockMember_a07df097-ab93-4640-b413-42617eb06d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesMPreferredStockMember_7cdd78e0-65bc-420e-be8e-539ca7cfdeef" xlink:href="alts-20241228.xsd#alts_SeriesMPreferredStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_c088e001-ceed-4e69-b62e-66f570e953cc" xlink:to="loc_alts_SeriesMPreferredStockMember_7cdd78e0-65bc-420e-be8e-539ca7cfdeef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesQConvertiblePreferredStockMember_8d4160a6-870f-493f-af63-652e8e7958f4" xlink:href="alts-20241228.xsd#alts_SeriesQConvertiblePreferredStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_c088e001-ceed-4e69-b62e-66f570e953cc" xlink:to="loc_alts_SeriesQConvertiblePreferredStockMember_8d4160a6-870f-493f-af63-652e8e7958f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesSConvertiblePreferredStockMember_83d150e7-3aba-4f6f-b8f5-333d1f1a0b57" xlink:href="alts-20241228.xsd#alts_SeriesSConvertiblePreferredStockMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_c088e001-ceed-4e69-b62e-66f570e953cc" xlink:to="loc_alts_SeriesSConvertiblePreferredStockMember_83d150e7-3aba-4f6f-b8f5-333d1f1a0b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesVConvertiblePreferredStockMember_cdf20542-b1ab-49ed-bea4-d7d1d779a63e" xlink:href="alts-20241228.xsd#alts_SeriesVConvertiblePreferredStockMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_c088e001-ceed-4e69-b62e-66f570e953cc" xlink:to="loc_alts_SeriesVConvertiblePreferredStockMember_cdf20542-b1ab-49ed-bea4-d7d1d779a63e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6fe4b312-d06e-4d57-b44b-be860cc6e787" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_588968d3-1202-4752-8f0d-5f539fce2c99" xlink:to="loc_us-gaap_StatementLineItems_6fe4b312-d06e-4d57-b44b-be860cc6e787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_3e5ff5b5-a3c3-4002-8b40-3e128947b5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6fe4b312-d06e-4d57-b44b-be860cc6e787" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_3e5ff5b5-a3c3-4002-8b40-3e128947b5b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_e1ecd259-1d97-4b42-ba83-c03b139d17c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6fe4b312-d06e-4d57-b44b-be860cc6e787" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_e1ecd259-1d97-4b42-ba83-c03b139d17c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_30e367d7-96b2-4bad-be39-3bcc315de3a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6fe4b312-d06e-4d57-b44b-be860cc6e787" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_30e367d7-96b2-4bad-be39-3bcc315de3a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_26a8ac29-02c8-44f0-a7e6-ba128c6a330e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6fe4b312-d06e-4d57-b44b-be860cc6e787" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_26a8ac29-02c8-44f0-a7e6-ba128c6a330e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1f3cc578-1b4b-4fff-8c1f-701233f92e92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6fe4b312-d06e-4d57-b44b-be860cc6e787" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1f3cc578-1b4b-4fff-8c1f-701233f92e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_7893e02e-0636-4e86-baa1-41c1006f8746" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6fe4b312-d06e-4d57-b44b-be860cc6e787" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_7893e02e-0636-4e86-baa1-41c1006f8746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_3b30a1b4-9415-4909-80a5-7b7b31f29639" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6fe4b312-d06e-4d57-b44b-be860cc6e787" xlink:to="loc_us-gaap_PreferredStockSharesIssued_3b30a1b4-9415-4909-80a5-7b7b31f29639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_e6425141-4a15-4070-88ed-f84f65f06c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6fe4b312-d06e-4d57-b44b-be860cc6e787" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_e6425141-4a15-4070-88ed-f84f65f06c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_b8d22ba6-6590-423f-b3f4-bab9ff339e34" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6fe4b312-d06e-4d57-b44b-be860cc6e787" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_b8d22ba6-6590-423f-b3f4-bab9ff339e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_d10e0849-d32f-415c-a880-b17156a35d75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6fe4b312-d06e-4d57-b44b-be860cc6e787" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_d10e0849-d32f-415c-a880-b17156a35d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_e08c6144-2108-47a4-9cb1-f63acd2821e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6fe4b312-d06e-4d57-b44b-be860cc6e787" xlink:to="loc_us-gaap_CommonStockSharesIssued_e08c6144-2108-47a4-9cb1-f63acd2821e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_5a74e6ca-37b6-48a9-b92b-576517b8a247" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6fe4b312-d06e-4d57-b44b-be860cc6e787" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_5a74e6ca-37b6-48a9-b92b-576517b8a247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="alts-20241228.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_21c72f70-105d-4e5e-b19f-dee5435f05a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2df1aa37-803a-4d69-b9b6-32ae0ca52a15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_21c72f70-105d-4e5e-b19f-dee5435f05a2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2df1aa37-803a-4d69-b9b6-32ae0ca52a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_e8f178d8-ab87-412c-954e-0124145f099e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_21c72f70-105d-4e5e-b19f-dee5435f05a2" xlink:to="loc_us-gaap_CostOfRevenue_e8f178d8-ab87-412c-954e-0124145f099e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_3e7bb1b8-de04-4bbe-a312-cd8d975e0c27" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_21c72f70-105d-4e5e-b19f-dee5435f05a2" xlink:to="loc_us-gaap_GrossProfit_3e7bb1b8-de04-4bbe-a312-cd8d975e0c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_bbebf1ad-d688-4994-b086-2c2b6ef3ba74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_21c72f70-105d-4e5e-b19f-dee5435f05a2" xlink:to="loc_us-gaap_OperatingExpensesAbstract_bbebf1ad-d688-4994-b086-2c2b6ef3ba74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_75ff6c12-5562-41e3-8676-78292df6b992" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_bbebf1ad-d688-4994-b086-2c2b6ef3ba74" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_75ff6c12-5562-41e3-8676-78292df6b992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_ff5010d3-94b3-4396-ae2a-c2b774064607" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_bbebf1ad-d688-4994-b086-2c2b6ef3ba74" xlink:to="loc_us-gaap_AssetImpairmentCharges_ff5010d3-94b3-4396-ae2a-c2b774064607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_3ce760e8-029d-4841-97b4-83579bf02184" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_bbebf1ad-d688-4994-b086-2c2b6ef3ba74" xlink:to="loc_us-gaap_OperatingExpenses_3ce760e8-029d-4841-97b4-83579bf02184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_46326a1a-090f-40c4-8e9d-4701429b99f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_21c72f70-105d-4e5e-b19f-dee5435f05a2" xlink:to="loc_us-gaap_OperatingIncomeLoss_46326a1a-090f-40c4-8e9d-4701429b99f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_74ed39c4-d3bc-477f-9167-fd62a10f895b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_21c72f70-105d-4e5e-b19f-dee5435f05a2" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_74ed39c4-d3bc-477f-9167-fd62a10f895b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_251651e2-a8fb-4c04-9574-0b2e597f4e89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_74ed39c4-d3bc-477f-9167-fd62a10f895b" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_251651e2-a8fb-4c04-9574-0b2e597f4e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RealizedGainLossOnExchangeTransactions_fa1e6330-0cbb-4d9c-bc34-3d05811d60dc" xlink:href="alts-20241228.xsd#alts_RealizedGainLossOnExchangeTransactions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_74ed39c4-d3bc-477f-9167-fd62a10f895b" xlink:to="loc_alts_RealizedGainLossOnExchangeTransactions_fa1e6330-0cbb-4d9c-bc34-3d05811d60dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_1998e25a-0bec-4e16-84ed-c9aa5279bd87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_74ed39c4-d3bc-477f-9167-fd62a10f895b" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_1998e25a-0bec-4e16-84ed-c9aa5279bd87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ec38d704-a7b2-461b-a4dc-cabbca89cb53" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_74ed39c4-d3bc-477f-9167-fd62a10f895b" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ec38d704-a7b2-461b-a4dc-cabbca89cb53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_b928b10a-3064-48aa-b043-844fed4a4a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_74ed39c4-d3bc-477f-9167-fd62a10f895b" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_b928b10a-3064-48aa-b043-844fed4a4a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5e5fd5cf-48fd-4312-ba04-7621371379c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_74ed39c4-d3bc-477f-9167-fd62a10f895b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5e5fd5cf-48fd-4312-ba04-7621371379c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1747adb0-d782-45b7-a3e9-c9df03ecf64c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_74ed39c4-d3bc-477f-9167-fd62a10f895b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1747adb0-d782-45b7-a3e9-c9df03ecf64c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_f248c477-4556-43e7-82bb-6f644b680a91" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_74ed39c4-d3bc-477f-9167-fd62a10f895b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_f248c477-4556-43e7-82bb-6f644b680a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_8f2e0f76-3745-45e0-be2f-64f868d9724a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_74ed39c4-d3bc-477f-9167-fd62a10f895b" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_8f2e0f76-3745-45e0-be2f-64f868d9724a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation_346ba220-0d57-4400-bca8-e8799b708741" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_74ed39c4-d3bc-477f-9167-fd62a10f895b" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation_346ba220-0d57-4400-bca8-e8799b708741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_ee0af3c4-b2bf-41d1-a5cd-260535e6b941" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_74ed39c4-d3bc-477f-9167-fd62a10f895b" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_ee0af3c4-b2bf-41d1-a5cd-260535e6b941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f1604de5-3ccf-4a79-9147-9ef72bcf8348" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_74ed39c4-d3bc-477f-9167-fd62a10f895b" xlink:to="loc_us-gaap_NetIncomeLoss_f1604de5-3ccf-4a79-9147-9ef72bcf8348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e7622f0e-6455-46af-8855-32acde3d7f50" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_74ed39c4-d3bc-477f-9167-fd62a10f895b" xlink:to="loc_us-gaap_EarningsPerShareAbstract_e7622f0e-6455-46af-8855-32acde3d7f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_902d377e-c7e6-4a1d-bc2b-d789f83e429b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e7622f0e-6455-46af-8855-32acde3d7f50" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_902d377e-c7e6-4a1d-bc2b-d789f83e429b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_3c630b01-e852-493f-96f2-b2b6e896aae7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e7622f0e-6455-46af-8855-32acde3d7f50" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_3c630b01-e852-493f-96f2-b2b6e896aae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_0c1f3502-9c74-4ef0-a9d0-6b9ac3a10286" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e7622f0e-6455-46af-8855-32acde3d7f50" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_0c1f3502-9c74-4ef0-a9d0-6b9ac3a10286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_0742528d-f353-497e-96e1-84080aaa62b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e7622f0e-6455-46af-8855-32acde3d7f50" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_0742528d-f353-497e-96e1-84080aaa62b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_7f144a7a-b520-49a5-b253-dcb1b1f81d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e7622f0e-6455-46af-8855-32acde3d7f50" xlink:to="loc_us-gaap_EarningsPerShareBasic_7f144a7a-b520-49a5-b253-dcb1b1f81d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_fb6b7eb1-ac9c-466e-9e0b-0fe158f33c63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e7622f0e-6455-46af-8855-32acde3d7f50" xlink:to="loc_us-gaap_EarningsPerShareDiluted_fb6b7eb1-ac9c-466e-9e0b-0fe158f33c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c868a793-5500-4a88-b62b-904ae94440b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e7622f0e-6455-46af-8855-32acde3d7f50" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c868a793-5500-4a88-b62b-904ae94440b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a20280ce-3ec3-4fb4-9ef5-427e727fea0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c868a793-5500-4a88-b62b-904ae94440b5" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a20280ce-3ec3-4fb4-9ef5-427e727fea0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4d4c30cf-8e98-49b1-81ee-f3760a466f05" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c868a793-5500-4a88-b62b-904ae94440b5" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4d4c30cf-8e98-49b1-81ee-f3760a466f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="alts-20241228.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_c711a536-84ca-4547-bb76-15c5ea44c830" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_df964fa3-0467-4cf4-9486-e519c6360246" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c711a536-84ca-4547-bb76-15c5ea44c830" xlink:to="loc_us-gaap_StatementTable_df964fa3-0467-4cf4-9486-e519c6360246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_db69a13c-4777-4abd-912f-5feea6f3f53e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_df964fa3-0467-4cf4-9486-e519c6360246" xlink:to="loc_us-gaap_StatementClassOfStockAxis_db69a13c-4777-4abd-912f-5feea6f3f53e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0709bbe8-8f03-400d-a05e-12b1239f284e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_db69a13c-4777-4abd-912f-5feea6f3f53e" xlink:to="loc_us-gaap_ClassOfStockDomain_0709bbe8-8f03-400d-a05e-12b1239f284e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesA1PreferredStockMember_41d833e4-e001-40d7-991a-813489946d3f" xlink:href="alts-20241228.xsd#alts_SeriesA1PreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0709bbe8-8f03-400d-a05e-12b1239f284e" xlink:to="loc_alts_SeriesA1PreferredStockMember_41d833e4-e001-40d7-991a-813489946d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesS1PreferredMember_1df53d3c-7d24-4415-8e7f-69c7c4185eb7" xlink:href="alts-20241228.xsd#alts_SeriesS1PreferredMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0709bbe8-8f03-400d-a05e-12b1239f284e" xlink:to="loc_alts_SeriesS1PreferredMember_1df53d3c-7d24-4415-8e7f-69c7c4185eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_0d9baccb-acb6-43bd-8f34-0694fce34826" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0709bbe8-8f03-400d-a05e-12b1239f284e" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_0d9baccb-acb6-43bd-8f34-0694fce34826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesIPreferredStockMember_647e4cba-8eb3-442a-b8a6-47d0ded506c9" xlink:href="alts-20241228.xsd#alts_SeriesIPreferredStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0709bbe8-8f03-400d-a05e-12b1239f284e" xlink:to="loc_alts_SeriesIPreferredStockMember_647e4cba-8eb3-442a-b8a6-47d0ded506c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesMPreferredStockMember_c7dee9ab-44ab-4ed3-8845-a08a85ea61a9" xlink:href="alts-20241228.xsd#alts_SeriesMPreferredStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0709bbe8-8f03-400d-a05e-12b1239f284e" xlink:to="loc_alts_SeriesMPreferredStockMember_c7dee9ab-44ab-4ed3-8845-a08a85ea61a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesQPreferredStockMember_147b6a90-56dd-47d8-9b26-4d1a939599f0" xlink:href="alts-20241228.xsd#alts_SeriesQPreferredStockMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0709bbe8-8f03-400d-a05e-12b1239f284e" xlink:to="loc_alts_SeriesQPreferredStockMember_147b6a90-56dd-47d8-9b26-4d1a939599f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesVPreferredStockMember_5529e920-91e3-4bd1-ab32-9a9b87b4dd9e" xlink:href="alts-20241228.xsd#alts_SeriesVPreferredStockMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0709bbe8-8f03-400d-a05e-12b1239f284e" xlink:to="loc_alts_SeriesVPreferredStockMember_5529e920-91e3-4bd1-ab32-9a9b87b4dd9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_d2e03619-2fae-4117-a411-43e0b6866c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0709bbe8-8f03-400d-a05e-12b1239f284e" xlink:to="loc_us-gaap_CommonClassAMember_d2e03619-2fae-4117-a411-43e0b6866c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_80d320b4-a91b-4d66-ba93-76918b71e021" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_df964fa3-0467-4cf4-9486-e519c6360246" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_80d320b4-a91b-4d66-ba93-76918b71e021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_afdb6f8a-a086-4664-b789-17e4ef530982" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_80d320b4-a91b-4d66-ba93-76918b71e021" xlink:to="loc_us-gaap_EquityComponentDomain_afdb6f8a-a086-4664-b789-17e4ef530982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_8c089abc-fb58-49f3-b08b-f7d9c91671a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_afdb6f8a-a086-4664-b789-17e4ef530982" xlink:to="loc_us-gaap_PreferredStockMember_8c089abc-fb58-49f3-b08b-f7d9c91671a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4f0563bd-6041-4c5a-8316-d546e1690b55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_afdb6f8a-a086-4664-b789-17e4ef530982" xlink:to="loc_us-gaap_CommonStockMember_4f0563bd-6041-4c5a-8316-d546e1690b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f2e4599b-8fb4-4af6-88f8-0dec99f88bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_afdb6f8a-a086-4664-b789-17e4ef530982" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f2e4599b-8fb4-4af6-88f8-0dec99f88bcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9c378cd4-e5da-4a37-b135-190fa4bb7502" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_afdb6f8a-a086-4664-b789-17e4ef530982" xlink:to="loc_us-gaap_RetainedEarningsMember_9c378cd4-e5da-4a37-b135-190fa4bb7502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9f2bba40-f24a-48e2-8c12-78423ecf3bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_afdb6f8a-a086-4664-b789-17e4ef530982" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9f2bba40-f24a-48e2-8c12-78423ecf3bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_9e6ad6bb-2a1c-4966-979b-9c84811d028f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_afdb6f8a-a086-4664-b789-17e4ef530982" xlink:to="loc_us-gaap_NoncontrollingInterestMember_9e6ad6bb-2a1c-4966-979b-9c84811d028f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_ef3e387e-8a90-474d-bf6a-ae880625350f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_df964fa3-0467-4cf4-9486-e519c6360246" xlink:to="loc_us-gaap_AssetAcquisitionAxis_ef3e387e-8a90-474d-bf6a-ae880625350f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_0f7d2676-4f02-49f3-8579-5fd5645618b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_ef3e387e-8a90-474d-bf6a-ae880625350f" xlink:to="loc_us-gaap_AssetAcquisitionDomain_0f7d2676-4f02-49f3-8579-5fd5645618b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_QodenTechnologiesLLCMember_ea8c83a4-4dd8-477c-a8b7-ee017eb373b7" xlink:href="alts-20241228.xsd#alts_QodenTechnologiesLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_0f7d2676-4f02-49f3-8579-5fd5645618b1" xlink:to="loc_alts_QodenTechnologiesLLCMember_ea8c83a4-4dd8-477c-a8b7-ee017eb373b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_87fe3223-db68-4b6b-a610-1c9f68d7d4b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_df964fa3-0467-4cf4-9486-e519c6360246" xlink:to="loc_us-gaap_StatementLineItems_87fe3223-db68-4b6b-a610-1c9f68d7d4b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_87fe3223-db68-4b6b-a610-1c9f68d7d4b5" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_22d7c2a1-7771-4003-bbc0-699ff04d44f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_22d7c2a1-7771-4003-bbc0-699ff04d44f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0631fd4b-1bae-4878-ab69-fe5934eeea40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0631fd4b-1bae-4878-ab69-fe5934eeea40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_5d3c9604-8b79-4a27-b12f-8e303963c7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_5d3c9604-8b79-4a27-b12f-8e303963c7cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_d812e26f-3c0f-4d28-a9a1-2928f5dc72a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_d812e26f-3c0f-4d28-a9a1-2928f5dc72a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_73bc8d75-9fba-4e98-b9c8-a1b24d36d18b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_73bc8d75-9fba-4e98-b9c8-a1b24d36d18b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_5b5f5cde-d259-49d6-844d-5228b31f8291" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_5b5f5cde-d259-49d6-844d-5228b31f8291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AdjustmentToAdditionalPaidInCapitalReclassificationsOfTemporaryToLiability_4b79bfe4-bf8a-4b30-9f91-56c6ae476b80" xlink:href="alts-20241228.xsd#alts_AdjustmentToAdditionalPaidInCapitalReclassificationsOfTemporaryToLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_alts_AdjustmentToAdditionalPaidInCapitalReclassificationsOfTemporaryToLiability_4b79bfe4-bf8a-4b30-9f91-56c6ae476b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_82bfadc4-c2e4-4885-85c9-f6cb210884c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_82bfadc4-c2e4-4885-85c9-f6cb210884c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_29811f70-efe9-47b1-bded-5394ea06f36e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_29811f70-efe9-47b1-bded-5394ea06f36e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9c9c0d15-89f4-4fa6-b5f2-b0c73c09a19b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9c9c0d15-89f4-4fa6-b5f2-b0c73c09a19b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_94f6d0a4-e680-4bf8-85df-265e2c484b44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_94f6d0a4-e680-4bf8-85df-265e2c484b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_e7ca3f6b-fb10-43b1-904a-577d51bba679" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_e7ca3f6b-fb10-43b1-904a-577d51bba679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_5bd662ad-3253-4929-95cc-85a184180f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_5bd662ad-3253-4929-95cc-85a184180f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_b90e29c3-89aa-4ad2-82ab-44b082cb7715" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_b90e29c3-89aa-4ad2-82ab-44b082cb7715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_81e04bcc-e6ae-4509-a9ae-0cedf27be7df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_81e04bcc-e6ae-4509-a9ae-0cedf27be7df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockIssuedDuringPeriodSharesIssuedInLieuOfNotesPayable_81e74c8b-342a-4556-9ba6-3888c7c97d84" xlink:href="alts-20241228.xsd#alts_StockIssuedDuringPeriodSharesIssuedInLieuOfNotesPayable"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_alts_StockIssuedDuringPeriodSharesIssuedInLieuOfNotesPayable_81e74c8b-342a-4556-9ba6-3888c7c97d84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable_95a656a5-c662-4c6b-86d0-36c42381d336" xlink:href="alts-20241228.xsd#alts_StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_alts_StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable_95a656a5-c662-4c6b-86d0-36c42381d336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_56d9cf1e-9895-477b-b4c3-82fadecb7712" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_56d9cf1e-9895-477b-b4c3-82fadecb7712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_fece43e9-eb89-4eaa-86ca-8cc7c8e7e92b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_fece43e9-eb89-4eaa-86ca-8cc7c8e7e92b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_1c091dc6-465e-4ae4-a964-ab5a28193722" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_1c091dc6-465e-4ae4-a964-ab5a28193722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_ec74eb8e-0d2a-438b-a2cf-edbde60c3b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_ec74eb8e-0d2a-438b-a2cf-edbde60c3b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockIssuedDuringPeriodSharesPrepaidInterest_c48b43e6-cde6-41cd-acf4-9ccdd37d850d" xlink:href="alts-20241228.xsd#alts_StockIssuedDuringPeriodSharesPrepaidInterest"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_alts_StockIssuedDuringPeriodSharesPrepaidInterest_c48b43e6-cde6-41cd-acf4-9ccdd37d850d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockIssuedDuringPeriodValuePrepaidInterest_0ab9bcaa-2da1-493c-9e0b-70417ca2f858" xlink:href="alts-20241228.xsd#alts_StockIssuedDuringPeriodValuePrepaidInterest"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_alts_StockIssuedDuringPeriodValuePrepaidInterest_0ab9bcaa-2da1-493c-9e0b-70417ca2f858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockIssuedDuringPeriodSharesWarrantsExercised_47d52a17-81dc-44a6-b15d-eb993995a7c3" xlink:href="alts-20241228.xsd#alts_StockIssuedDuringPeriodSharesWarrantsExercised"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_alts_StockIssuedDuringPeriodSharesWarrantsExercised_47d52a17-81dc-44a6-b15d-eb993995a7c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockIssuedDuringPeriodValueWarrantsExercised_6519791a-ab90-4eb9-a9c9-8ecff3ce1efd" xlink:href="alts-20241228.xsd#alts_StockIssuedDuringPeriodValueWarrantsExercised"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_alts_StockIssuedDuringPeriodValueWarrantsExercised_6519791a-ab90-4eb9-a9c9-8ecff3ce1efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7fc3ac17-94dd-4321-8c18-6604064310c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7fc3ac17-94dd-4321-8c18-6604064310c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_54b3e95b-ea42-4cf8-9995-79ae37687531" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_ProfitLoss_54b3e95b-ea42-4cf8-9995-79ae37687531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_5a5d7dc4-e292-47c7-9455-2729ae153856" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_5a5d7dc4-e292-47c7-9455-2729ae153856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8521c0ff-3752-4218-bcd3-b4db6e6df66e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8521c0ff-3752-4218-bcd3-b4db6e6df66e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d636c3d7-1a96-47a4-bd8b-032b8be32cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9d17fb2a-af07-4696-8c83-22920e1d8289" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d636c3d7-1a96-47a4-bd8b-032b8be32cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="alts-20241228.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_ba21c9cf-d2a8-4a9b-bcb1-061c95eb1652" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_23c6049a-c742-4956-8705-eed4dc4c55bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ba21c9cf-d2a8-4a9b-bcb1-061c95eb1652" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_23c6049a-c742-4956-8705-eed4dc4c55bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_14e3e660-0549-407d-9372-91a67e7a8146" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_23c6049a-c742-4956-8705-eed4dc4c55bd" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_14e3e660-0549-407d-9372-91a67e7a8146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_52e9de22-11c9-4bd6-8e51-8b7fa7d5f09c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_23c6049a-c742-4956-8705-eed4dc4c55bd" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_52e9de22-11c9-4bd6-8e51-8b7fa7d5f09c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_82093c89-76c4-4a3b-835b-bdb33a060187" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_52e9de22-11c9-4bd6-8e51-8b7fa7d5f09c" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_82093c89-76c4-4a3b-835b-bdb33a060187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_61919478-a60a-4ef8-a682-01e053e1c096" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_52e9de22-11c9-4bd6-8e51-8b7fa7d5f09c" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_61919478-a60a-4ef8-a682-01e053e1c096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumsReceivableAccretionOfDiscountOnPremiumReceivable_1eaffd1f-068e-4aaf-9e1e-01c101e1d76a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialGuaranteeInsuranceContractsPremiumsReceivableAccretionOfDiscountOnPremiumReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_52e9de22-11c9-4bd6-8e51-8b7fa7d5f09c" xlink:to="loc_us-gaap_FinancialGuaranteeInsuranceContractsPremiumsReceivableAccretionOfDiscountOnPremiumReceivable_1eaffd1f-068e-4aaf-9e1e-01c101e1d76a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_bf46a04d-0e69-4d4d-a8b9-3ceba14a1ff3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_52e9de22-11c9-4bd6-8e51-8b7fa7d5f09c" xlink:to="loc_us-gaap_ShareBasedCompensation_bf46a04d-0e69-4d4d-a8b9-3ceba14a1ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses_05caceef-5471-4fc1-9307-dc749313ccac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForLoanLeaseAndOtherLosses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_52e9de22-11c9-4bd6-8e51-8b7fa7d5f09c" xlink:to="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses_05caceef-5471-4fc1-9307-dc749313ccac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashContributionExpense_b12e6cae-31c0-42be-a5d8-59ce2b6fa2c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashContributionExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_52e9de22-11c9-4bd6-8e51-8b7fa7d5f09c" xlink:to="loc_us-gaap_NoncashContributionExpense_b12e6cae-31c0-42be-a5d8-59ce2b6fa2c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_4acd6421-7397-4a54-a9b6-d5dd296a1885" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_52e9de22-11c9-4bd6-8e51-8b7fa7d5f09c" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_4acd6421-7397-4a54-a9b6-d5dd296a1885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_ade318a0-93b0-43b5-8f2b-e101a81e3415" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_52e9de22-11c9-4bd6-8e51-8b7fa7d5f09c" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_ade318a0-93b0-43b5-8f2b-e101a81e3415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_GainLossOnWriteOffOfNotesReceivable_b1e09a6e-db09-4e3a-86d4-eba7264f5b2c" xlink:href="alts-20241228.xsd#alts_GainLossOnWriteOffOfNotesReceivable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_52e9de22-11c9-4bd6-8e51-8b7fa7d5f09c" xlink:to="loc_alts_GainLossOnWriteOffOfNotesReceivable_b1e09a6e-db09-4e3a-86d4-eba7264f5b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_ced848f9-9b34-4fc0-8d30-5ae9d8029907" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_52e9de22-11c9-4bd6-8e51-8b7fa7d5f09c" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_ced848f9-9b34-4fc0-8d30-5ae9d8029907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_0c1b5b6e-53b8-45b4-8aaf-5f2a09346d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_52e9de22-11c9-4bd6-8e51-8b7fa7d5f09c" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_0c1b5b6e-53b8-45b4-8aaf-5f2a09346d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CryptoAssetUnrealizedGainLossOperating_9e08c207-acd1-45b6-9d6a-2e6ae3096b31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetUnrealizedGainLossOperating"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_52e9de22-11c9-4bd6-8e51-8b7fa7d5f09c" xlink:to="loc_us-gaap_CryptoAssetUnrealizedGainLossOperating_9e08c207-acd1-45b6-9d6a-2e6ae3096b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_773a4d1e-4ef0-4b07-a03a-d56713303bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_52e9de22-11c9-4bd6-8e51-8b7fa7d5f09c" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_773a4d1e-4ef0-4b07-a03a-d56713303bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39f49d90-0503-4109-90e0-5878dc291238" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_52e9de22-11c9-4bd6-8e51-8b7fa7d5f09c" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39f49d90-0503-4109-90e0-5878dc291238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ecada3f3-0d20-40f6-8c79-4b1537d28c24" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39f49d90-0503-4109-90e0-5878dc291238" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ecada3f3-0d20-40f6-8c79-4b1537d28c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IncreaseDecreaseInDigitalAssetsReceivable_ba06f65f-0b20-406d-b9ed-028217ce6f61" xlink:href="alts-20241228.xsd#alts_IncreaseDecreaseInDigitalAssetsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39f49d90-0503-4109-90e0-5878dc291238" xlink:to="loc_alts_IncreaseDecreaseInDigitalAssetsReceivable_ba06f65f-0b20-406d-b9ed-028217ce6f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3469d04c-ea05-41c6-adf9-e5800b3f53e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39f49d90-0503-4109-90e0-5878dc291238" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3469d04c-ea05-41c6-adf9-e5800b3f53e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_ee2c76fb-717c-4a78-ba92-4cbfbbea1ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39f49d90-0503-4109-90e0-5878dc291238" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_ee2c76fb-717c-4a78-ba92-4cbfbbea1ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4380d3bb-dd97-44a0-853f-e504b84587a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39f49d90-0503-4109-90e0-5878dc291238" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4380d3bb-dd97-44a0-853f-e504b84587a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IncreaseDecreaseInDigitalAssetsPayable_20bf61f8-2957-4443-bc64-b12990111d70" xlink:href="alts-20241228.xsd#alts_IncreaseDecreaseInDigitalAssetsPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39f49d90-0503-4109-90e0-5878dc291238" xlink:to="loc_alts_IncreaseDecreaseInDigitalAssetsPayable_20bf61f8-2957-4443-bc64-b12990111d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_c9000d03-25cf-4cc8-b2da-68a20213d912" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39f49d90-0503-4109-90e0-5878dc291238" xlink:to="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_c9000d03-25cf-4cc8-b2da-68a20213d912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5fdf6162-3527-4b36-ae01-11e0c3e49ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_23c6049a-c742-4956-8705-eed4dc4c55bd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5fdf6162-3527-4b36-ae01-11e0c3e49ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ff820d98-66bc-4fd5-9016-fac579b04564" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_23c6049a-c742-4956-8705-eed4dc4c55bd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ff820d98-66bc-4fd5-9016-fac579b04564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_f813cc75-9a11-42d0-956b-147eaf403a95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ff820d98-66bc-4fd5-9016-fac579b04564" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_f813cc75-9a11-42d0-956b-147eaf403a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_d5767906-7db5-4ac0-a254-3ba9e8cab7c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ff820d98-66bc-4fd5-9016-fac579b04564" xlink:to="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_d5767906-7db5-4ac0-a254-3ba9e8cab7c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_88c492d5-57c3-4b76-825c-75a20af3c429" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ff820d98-66bc-4fd5-9016-fac579b04564" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_88c492d5-57c3-4b76-825c-75a20af3c429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c31c0730-83d3-44ab-8fa1-89794d4a275e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_23c6049a-c742-4956-8705-eed4dc4c55bd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c31c0730-83d3-44ab-8fa1-89794d4a275e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_72d106c9-4023-4a91-bce8-856ce4b9f5e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c31c0730-83d3-44ab-8fa1-89794d4a275e" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_72d106c9-4023-4a91-bce8-856ce4b9f5e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt_32400cf8-7b82-410d-b52a-bae32f172ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c31c0730-83d3-44ab-8fa1-89794d4a275e" xlink:to="loc_us-gaap_RepaymentsOfRelatedPartyDebt_32400cf8-7b82-410d-b52a-bae32f172ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt_f389a3d8-7b88-4ecb-bc92-2d4e0cc7ed80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c31c0730-83d3-44ab-8fa1-89794d4a275e" xlink:to="loc_us-gaap_ProceedsFromRelatedPartyDebt_f389a3d8-7b88-4ecb-bc92-2d4e0cc7ed80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_e0f3f5ec-9a38-43bb-a015-8fed434f4102" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c31c0730-83d3-44ab-8fa1-89794d4a275e" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_e0f3f5ec-9a38-43bb-a015-8fed434f4102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_90c51e09-43f5-4edd-a470-c92531b23b76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c31c0730-83d3-44ab-8fa1-89794d4a275e" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_90c51e09-43f5-4edd-a470-c92531b23b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_8e0f794c-e76d-4cfa-9b55-32fb1fab55f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c31c0730-83d3-44ab-8fa1-89794d4a275e" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_8e0f794c-e76d-4cfa-9b55-32fb1fab55f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_11af6fb7-0bc0-4c68-9ef8-64a5479dc272" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c31c0730-83d3-44ab-8fa1-89794d4a275e" xlink:to="loc_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_11af6fb7-0bc0-4c68-9ef8-64a5479dc272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d842a181-8451-4a84-b04f-0756c4b1de03" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c31c0730-83d3-44ab-8fa1-89794d4a275e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d842a181-8451-4a84-b04f-0756c4b1de03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1f4586a1-2fe8-4a1e-bf42-576141804175" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_23c6049a-c742-4956-8705-eed4dc4c55bd" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1f4586a1-2fe8-4a1e-bf42-576141804175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_57cbc889-d2b7-4fae-b3f0-e19cb9cfa741" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_23c6049a-c742-4956-8705-eed4dc4c55bd" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_57cbc889-d2b7-4fae-b3f0-e19cb9cfa741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1e48f780-4bf4-4516-823c-4ada2ba56fef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_23c6049a-c742-4956-8705-eed4dc4c55bd" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1e48f780-4bf4-4516-823c-4ada2ba56fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_5d29bc8f-0ee5-4025-b7bb-0908f42a8f08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_23c6049a-c742-4956-8705-eed4dc4c55bd" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_5d29bc8f-0ee5-4025-b7bb-0908f42a8f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a9eba936-425a-4b70-9eb3-5e74f44668c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_23c6049a-c742-4956-8705-eed4dc4c55bd" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a9eba936-425a-4b70-9eb3-5e74f44668c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_7bace045-06db-458b-901b-889b8ccf3c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_23c6049a-c742-4956-8705-eed4dc4c55bd" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_7bace045-06db-458b-901b-889b8ccf3c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NoncashRecognitionOfNewLeases_659495e7-77d1-48c4-9408-baeff90fbc45" xlink:href="alts-20241228.xsd#alts_NoncashRecognitionOfNewLeases"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_7bace045-06db-458b-901b-889b8ccf3c4d" xlink:to="loc_alts_NoncashRecognitionOfNewLeases_659495e7-77d1-48c4-9408-baeff90fbc45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_0546cd67-f2ae-45f8-a720-f95409832dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_7bace045-06db-458b-901b-889b8ccf3c4d" xlink:to="loc_us-gaap_InterestPaidNet_0546cd67-f2ae-45f8-a720-f95409832dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_70416b69-8cab-4251-905f-824ffa426132" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_7bace045-06db-458b-901b-889b8ccf3c4d" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_70416b69-8cab-4251-905f-824ffa426132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_06a1a182-d99d-4b8c-883b-9782cab19c74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_23c6049a-c742-4956-8705-eed4dc4c55bd" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_06a1a182-d99d-4b8c-883b-9782cab19c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSignificantNoncashTransactionsTable_82e23335-4158-442e-8c02-d2946f778f48" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherSignificantNoncashTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_06a1a182-d99d-4b8c-883b-9782cab19c74" xlink:to="loc_us-gaap_OtherSignificantNoncashTransactionsTable_82e23335-4158-442e-8c02-d2946f778f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis_0a28dbcf-9f82-45af-b76d-6a57263e717e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionsTable_82e23335-4158-442e-8c02-d2946f778f48" xlink:to="loc_us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis_0a28dbcf-9f82-45af-b76d-6a57263e717e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSignificantNoncashTransactionNameDomain_97a6d4c2-05ac-41d0-81b6-217487b96e95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherSignificantNoncashTransactionNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis_0a28dbcf-9f82-45af-b76d-6a57263e717e" xlink:to="loc_us-gaap_OtherSignificantNoncashTransactionNameDomain_97a6d4c2-05ac-41d0-81b6-217487b96e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherSignificantNoncashTransactionBusinessAcquisitionMember_4df44924-cf90-49c3-829d-1c45e65621c0" xlink:href="alts-20241228.xsd#alts_OtherSignificantNoncashTransactionBusinessAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionNameDomain_97a6d4c2-05ac-41d0-81b6-217487b96e95" xlink:to="loc_alts_OtherSignificantNoncashTransactionBusinessAcquisitionMember_4df44924-cf90-49c3-829d-1c45e65621c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherSignificantNoncashTransactionConsultingServicesMember_47357d71-4c76-4099-8e57-5efb9ee68ec0" xlink:href="alts-20241228.xsd#alts_OtherSignificantNoncashTransactionConsultingServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionNameDomain_97a6d4c2-05ac-41d0-81b6-217487b96e95" xlink:to="loc_alts_OtherSignificantNoncashTransactionConsultingServicesMember_47357d71-4c76-4099-8e57-5efb9ee68ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherSignificantNoncashTransactionLiabilityObligationsMember_d5333d73-e6dc-481b-9e61-b5340c9844b5" xlink:href="alts-20241228.xsd#alts_OtherSignificantNoncashTransactionLiabilityObligationsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionNameDomain_97a6d4c2-05ac-41d0-81b6-217487b96e95" xlink:to="loc_alts_OtherSignificantNoncashTransactionLiabilityObligationsMember_d5333d73-e6dc-481b-9e61-b5340c9844b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherSignificantNoncashTransactionInterestObligationsMember_a347be99-5d9a-4174-a874-8f3de9d78b04" xlink:href="alts-20241228.xsd#alts_OtherSignificantNoncashTransactionInterestObligationsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionNameDomain_97a6d4c2-05ac-41d0-81b6-217487b96e95" xlink:to="loc_alts_OtherSignificantNoncashTransactionInterestObligationsMember_a347be99-5d9a-4174-a874-8f3de9d78b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherSignificantNoncashTransactionPropertyAndEquipmentMember_105a8da0-d386-4e39-83e6-9f07f57f12f1" xlink:href="alts-20241228.xsd#alts_OtherSignificantNoncashTransactionPropertyAndEquipmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionNameDomain_97a6d4c2-05ac-41d0-81b6-217487b96e95" xlink:to="loc_alts_OtherSignificantNoncashTransactionPropertyAndEquipmentMember_105a8da0-d386-4e39-83e6-9f07f57f12f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherSignificantNoncashTransactionIntangibleAssetsMember_8fa6ea66-e984-4788-959d-c75f957fce00" xlink:href="alts-20241228.xsd#alts_OtherSignificantNoncashTransactionIntangibleAssetsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionNameDomain_97a6d4c2-05ac-41d0-81b6-217487b96e95" xlink:to="loc_alts_OtherSignificantNoncashTransactionIntangibleAssetsMember_8fa6ea66-e984-4788-959d-c75f957fce00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSignificantNoncashTransactionsLineItems_bcf5db8e-88d0-463e-b4ca-cb27849468a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherSignificantNoncashTransactionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionsTable_82e23335-4158-442e-8c02-d2946f778f48" xlink:to="loc_us-gaap_OtherSignificantNoncashTransactionsLineItems_bcf5db8e-88d0-463e-b4ca-cb27849468a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1_d0363ba2-b159-44c6-b707-b3c10c75cae9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssued1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionsLineItems_bcf5db8e-88d0-463e-b4ca-cb27849468a7" xlink:to="loc_us-gaap_StockIssued1_d0363ba2-b159-44c6-b707-b3c10c75cae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_bc40d75e-09d9-49dc-b21d-6617218b5df4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionsLineItems_bcf5db8e-88d0-463e-b4ca-cb27849468a7" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_bc40d75e-09d9-49dc-b21d-6617218b5df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/BackgroundandBasisofPresentation" xlink:type="simple" xlink:href="alts-20241228.xsd#BackgroundandBasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/BackgroundandBasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_efe9fac4-ce4e-4954-8ac2-3f64bc1e46fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_b71efd9f-89fe-4218-9dcb-2a8b1fa76b93" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_efe9fac4-ce4e-4954-8ac2-3f64bc1e46fb" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_b71efd9f-89fe-4218-9dcb-2a8b1fa76b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="alts-20241228.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_19bab1ff-3ce5-49f1-b1ca-9b5ff65c0c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_875b2bba-0622-4f8b-90b4-0ed914a8a7eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_19bab1ff-3ce5-49f1-b1ca-9b5ff65c0c0e" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_875b2bba-0622-4f8b-90b4-0ed914a8a7eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/MergersandAcquisitions" xlink:type="simple" xlink:href="alts-20241228.xsd#MergersandAcquisitions"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/MergersandAcquisitions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e5347345-afb3-46a0-b5b7-8da1261181b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_ad87ccc8-0560-49db-8a90-2df1fa24b454" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e5347345-afb3-46a0-b5b7-8da1261181b0" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_ad87ccc8-0560-49db-8a90-2df1fa24b454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/SaleofRecyclingSubsidiaries" xlink:type="simple" xlink:href="alts-20241228.xsd#SaleofRecyclingSubsidiaries"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/SaleofRecyclingSubsidiaries" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_9c367aac-0e4d-4edd-aaf6-37fc5395f2c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_f0cf48bb-e32f-42aa-8904-7992ec8f3fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_9c367aac-0e4d-4edd-aaf6-37fc5395f2c6" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_f0cf48bb-e32f-42aa-8904-7992ec8f3fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/DiscontinuedOperations" xlink:type="simple" xlink:href="alts-20241228.xsd#DiscontinuedOperations"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/DiscontinuedOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_df06a7b0-963b-4375-a872-b9ef1685b672" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_b61a4d5d-a2be-4c40-b01e-b18ebccc2411" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_df06a7b0-963b-4375-a872-b9ef1685b672" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_b61a4d5d-a2be-4c40-b01e-b18ebccc2411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/Prepaidsandothercurrentassets" xlink:type="simple" xlink:href="alts-20241228.xsd#Prepaidsandothercurrentassets"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/Prepaidsandothercurrentassets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_4a5fd3f1-9f05-48a5-959e-67fc5c58e1b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsTextBlock_e2b2f801-cf8e-49f5-aa0e-9c414ebce7dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCurrentAssetsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_4a5fd3f1-9f05-48a5-959e-67fc5c58e1b1" xlink:to="loc_us-gaap_OtherCurrentAssetsTextBlock_e2b2f801-cf8e-49f5-aa0e-9c414ebce7dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/PropertyandEquipment" xlink:type="simple" xlink:href="alts-20241228.xsd#PropertyandEquipment"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/PropertyandEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2d834ad7-57e0-45ab-9de4-cc11ba0498c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_f57d83e5-f36f-4b4b-96e3-32cd34b54f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2d834ad7-57e0-45ab-9de4-cc11ba0498c6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_f57d83e5-f36f-4b4b-96e3-32cd34b54f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/Leases" xlink:type="simple" xlink:href="alts-20241228.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_e2358fb6-429b-4007-9a1c-9f5ed15dedf2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_1be36ba6-8a06-416c-96eb-69c11fdc4de3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e2358fb6-429b-4007-9a1c-9f5ed15dedf2" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_1be36ba6-8a06-416c-96eb-69c11fdc4de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/Notesreceivable" xlink:type="simple" xlink:href="alts-20241228.xsd#Notesreceivable"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/Notesreceivable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_62f95a3a-cfd4-4028-900d-44be1270123b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablesTextBlock_255417ca-0638-4077-9fdf-5c4c0c8219aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivablesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_62f95a3a-cfd4-4028-900d-44be1270123b" xlink:to="loc_us-gaap_FinancingReceivablesTextBlock_255417ca-0638-4077-9fdf-5c4c0c8219aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/Intangibleassets" xlink:type="simple" xlink:href="alts-20241228.xsd#Intangibleassets"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/Intangibleassets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_257a4efc-ff9c-4a2a-b594-982524e9a4f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_6dd49f10-3c65-4a7e-8a0a-c19f8bb80328" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_257a4efc-ff9c-4a2a-b594-982524e9a4f5" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_6dd49f10-3c65-4a7e-8a0a-c19f8bb80328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/MarketableSecurities" xlink:type="simple" xlink:href="alts-20241228.xsd#MarketableSecurities"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/MarketableSecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesAbstract_57dd1680-40ba-4e0c-993c-15e01f7ffa1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_28822635-fb27-440d-9b81-f239c37579b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_57dd1680-40ba-4e0c-993c-15e01f7ffa1e" xlink:to="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_28822635-fb27-440d-9b81-f239c37579b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/Depositsandotherassets" xlink:type="simple" xlink:href="alts-20241228.xsd#Depositsandotherassets"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/Depositsandotherassets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_f156ddfc-6403-4080-a4dc-5c9df408d9c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsDisclosureTextBlock_2fbec031-fbd1-4887-a3ba-5ca5da5e5e29" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_f156ddfc-6403-4080-a4dc-5c9df408d9c3" xlink:to="loc_us-gaap_OtherAssetsDisclosureTextBlock_2fbec031-fbd1-4887-a3ba-5ca5da5e5e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/Accruedliabilities" xlink:type="simple" xlink:href="alts-20241228.xsd#Accruedliabilities"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/Accruedliabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_3b33055a-cebc-44bb-8f8c-eef2426b1316" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_192d52f0-dbf4-4944-a235-423e431afdcf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_3b33055a-cebc-44bb-8f8c-eef2426b1316" xlink:to="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_192d52f0-dbf4-4944-a235-423e431afdcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/Debentures" xlink:type="simple" xlink:href="alts-20241228.xsd#Debentures"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/Debentures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_fb87f9d0-4419-47c7-957d-7444750f939b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_c6a8edd6-4727-48ab-aef0-9af4bfc7c4c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fb87f9d0-4419-47c7-957d-7444750f939b" xlink:to="loc_us-gaap_LongTermDebtTextBlock_c6a8edd6-4727-48ab-aef0-9af4bfc7c4c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/LongTermDebt" xlink:type="simple" xlink:href="alts-20241228.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_02587638-fa82-4050-8afd-cd12cf9f0af7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_6ecf507f-8c77-4a79-99d0-e4fb2594e761" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_02587638-fa82-4050-8afd-cd12cf9f0af7" xlink:to="loc_us-gaap_LongTermDebtTextBlock_6ecf507f-8c77-4a79-99d0-e4fb2594e761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/RelatedPartyDebt" xlink:type="simple" xlink:href="alts-20241228.xsd#RelatedPartyDebt"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/RelatedPartyDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_611063a1-e323-4a40-9525-3b95ccfeca75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_fadb0c47-502a-4f0b-ba2a-d10d82a6e08a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_611063a1-e323-4a40-9525-3b95ccfeca75" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_fadb0c47-502a-4f0b-ba2a-d10d82a6e08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/PreferredStock" xlink:type="simple" xlink:href="alts-20241228.xsd#PreferredStock"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/PreferredStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_eb11a034-39b1-4754-946e-40cbc5ab7c49" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockTextBlock_e2f604cf-d490-443e-a43a-870f05c8eebe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_eb11a034-39b1-4754-946e-40cbc5ab7c49" xlink:to="loc_us-gaap_PreferredStockTextBlock_e2f604cf-d490-443e-a43a-870f05c8eebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/StockholdersEquity" xlink:type="simple" xlink:href="alts-20241228.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_c35f2948-8f0d-4896-868e-2b17411774c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_23841395-105b-42c3-b396-0547952d993e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_c35f2948-8f0d-4896-868e-2b17411774c0" xlink:to="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_23841395-105b-42c3-b396-0547952d993e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/Incometaxes" xlink:type="simple" xlink:href="alts-20241228.xsd#Incometaxes"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/Incometaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d728ea0f-b921-4433-9c92-f9afdd7e4597" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_dd1a0d98-71da-4e64-bff0-062c8d636bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d728ea0f-b921-4433-9c92-f9afdd7e4597" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_dd1a0d98-71da-4e64-bff0-062c8d636bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/Relatedparties" xlink:type="simple" xlink:href="alts-20241228.xsd#Relatedparties"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/Relatedparties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_e44a315c-8ac3-4406-923b-1a7b826bb742" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_e91af360-c80b-4c07-9b8a-1a98d9960cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_e44a315c-8ac3-4406-923b-1a7b826bb742" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_e91af360-c80b-4c07-9b8a-1a98d9960cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="alts-20241228.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9e750288-e8b6-4472-ab33-1b7ec8fff982" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7ebaea2d-f50c-4b15-b86d-4b70cc391df9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9e750288-e8b6-4472-ab33-1b7ec8fff982" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7ebaea2d-f50c-4b15-b86d-4b70cc391df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/EarningsLosspershare" xlink:type="simple" xlink:href="alts-20241228.xsd#EarningsLosspershare"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/EarningsLosspershare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b6d6c5ae-36fd-44c3-a8e0-89794cea62a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_35ddf475-0775-4f3c-9735-8bbf4429d94b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b6d6c5ae-36fd-44c3-a8e0-89794cea62a2" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_35ddf475-0775-4f3c-9735-8bbf4429d94b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/Segmentinformation" xlink:type="simple" xlink:href="alts-20241228.xsd#Segmentinformation"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/Segmentinformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ae814939-b314-46d1-8d1b-7e526eddd802" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_1b1de0d5-736f-473a-af31-b5b877e85896" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ae814939-b314-46d1-8d1b-7e526eddd802" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_1b1de0d5-736f-473a-af31-b5b877e85896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/Subsequentevents" xlink:type="simple" xlink:href="alts-20241228.xsd#Subsequentevents"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/Subsequentevents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_72923d0e-6d35-4bc9-98cb-2f5bc15bd21d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_2761dd31-cee3-4ffc-829d-56a11e845676" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_72923d0e-6d35-4bc9-98cb-2f5bc15bd21d" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_2761dd31-cee3-4ffc-829d-56a11e845676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="alts-20241228.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1b21f254-7276-4fca-9402-a4465951098d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_2618478d-d74b-4e30-8323-3351b060811b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b21f254-7276-4fca-9402-a4465951098d" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_2618478d-d74b-4e30-8323-3351b060811b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_d459c5f7-02cf-478d-9f43-affb99a51dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b21f254-7276-4fca-9402-a4465951098d" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_d459c5f7-02cf-478d-9f43-affb99a51dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_a73f1ef0-d72b-4f7f-a419-ac0c032d5826" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b21f254-7276-4fca-9402-a4465951098d" xlink:to="loc_us-gaap_UseOfEstimates_a73f1ef0-d72b-4f7f-a419-ac0c032d5826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_60518206-198f-4e54-95d0-89fa9691dbe6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b21f254-7276-4fca-9402-a4465951098d" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_60518206-198f-4e54-95d0-89fa9691dbe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_f58a3b2b-5857-4e0a-b7cc-5b9e1990bd64" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b21f254-7276-4fca-9402-a4465951098d" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_f58a3b2b-5857-4e0a-b7cc-5b9e1990bd64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DigitalAssetsAndOtherReceivablesPolicyPolicyTextBlock_17c8d298-7b7c-4fe5-961b-fa7276ca0662" xlink:href="alts-20241228.xsd#alts_DigitalAssetsAndOtherReceivablesPolicyPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b21f254-7276-4fca-9402-a4465951098d" xlink:to="loc_alts_DigitalAssetsAndOtherReceivablesPolicyPolicyTextBlock_17c8d298-7b7c-4fe5-961b-fa7276ca0662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_706ff950-7930-4779-acc7-14a751d892af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b21f254-7276-4fca-9402-a4465951098d" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_706ff950-7930-4779-acc7-14a751d892af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_dedff1b6-219a-4db9-afcc-3a87680794b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b21f254-7276-4fca-9402-a4465951098d" xlink:to="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_dedff1b6-219a-4db9-afcc-3a87680794b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DigitalAssetsAndOtherPayablesPolicyPolicyTextBlock_7e87b517-7694-4ae4-aab2-2ecc6c552813" xlink:href="alts-20241228.xsd#alts_DigitalAssetsAndOtherPayablesPolicyPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b21f254-7276-4fca-9402-a4465951098d" xlink:to="loc_alts_DigitalAssetsAndOtherPayablesPolicyPolicyTextBlock_7e87b517-7694-4ae4-aab2-2ecc6c552813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_4cfcae79-07d5-484c-9606-a886e365d002" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b21f254-7276-4fca-9402-a4465951098d" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_4cfcae79-07d5-484c-9606-a886e365d002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_1cbdff74-3a22-419d-91d0-39145df20fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b21f254-7276-4fca-9402-a4465951098d" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_1cbdff74-3a22-419d-91d0-39145df20fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_a65f6442-a977-4661-a21e-905259c752a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b21f254-7276-4fca-9402-a4465951098d" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_a65f6442-a977-4661-a21e-905259c752a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_8c10ab29-2e2d-4821-a6f5-e2b8b791f45f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b21f254-7276-4fca-9402-a4465951098d" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_8c10ab29-2e2d-4821-a6f5-e2b8b791f45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_843d3c2d-f084-4788-80a0-44bd67e89187" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b21f254-7276-4fca-9402-a4465951098d" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_843d3c2d-f084-4788-80a0-44bd67e89187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_e231ac95-7370-4839-8f63-ab9450cbc88f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b21f254-7276-4fca-9402-a4465951098d" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_e231ac95-7370-4839-8f63-ab9450cbc88f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_deec29d7-c991-41f5-81d2-800e4053ca49" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b21f254-7276-4fca-9402-a4465951098d" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_deec29d7-c991-41f5-81d2-800e4053ca49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_bcde78c9-22bd-4400-85c0-5742ec0f195c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1b21f254-7276-4fca-9402-a4465951098d" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_bcde78c9-22bd-4400-85c0-5742ec0f195c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="alts-20241228.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a7bfc5b6-3c38-4f4e-8956-bca8d86cb280" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_14bafd40-bb53-41ae-a055-bbab3be1af56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a7bfc5b6-3c38-4f4e-8956-bca8d86cb280" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_14bafd40-bb53-41ae-a055-bbab3be1af56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/MergersandAcquisitionsTables" xlink:type="simple" xlink:href="alts-20241228.xsd#MergersandAcquisitionsTables"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/MergersandAcquisitionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d19f96d3-5872-4835-ad1a-130c5c6027c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_da045ce2-ea84-4abb-af71-e8cb652981d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d19f96d3-5872-4835-ad1a-130c5c6027c3" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_da045ce2-ea84-4abb-af71-e8cb652981d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_3433dd2c-8fe6-4a76-ba4a-74ad86126bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d19f96d3-5872-4835-ad1a-130c5c6027c3" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_3433dd2c-8fe6-4a76-ba4a-74ad86126bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_e9ee0f97-14f0-4c98-9140-b7075c68e2fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d19f96d3-5872-4835-ad1a-130c5c6027c3" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_e9ee0f97-14f0-4c98-9140-b7075c68e2fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesTables" xlink:type="simple" xlink:href="alts-20241228.xsd#SaleofRecyclingSubsidiariesTables"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_acda41bd-f1b1-46e0-87da-1f482eb397f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_3b533081-5f4e-401f-8b13-f4f9e56d51e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_acda41bd-f1b1-46e0-87da-1f482eb397f4" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_3b533081-5f4e-401f-8b13-f4f9e56d51e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/DiscontinuedOperationsTables" xlink:type="simple" xlink:href="alts-20241228.xsd#DiscontinuedOperationsTables"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/DiscontinuedOperationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_8486ebce-cee0-4756-bc66-27938cb26ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_113f8a94-fe48-486b-8627-9b83b1a6789b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_8486ebce-cee0-4756-bc66-27938cb26ccf" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_113f8a94-fe48-486b-8627-9b83b1a6789b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/PrepaidsandothercurrentassetsTables" xlink:type="simple" xlink:href="alts-20241228.xsd#PrepaidsandothercurrentassetsTables"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/PrepaidsandothercurrentassetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_e27486f7-3d83-43c9-b020-97f584d40ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_cf3f4126-cf3f-453c-b322-61cfe4fda570" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_e27486f7-3d83-43c9-b020-97f584d40ab3" xlink:to="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_cf3f4126-cf3f-453c-b322-61cfe4fda570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/PropertyandEquipmentTables" xlink:type="simple" xlink:href="alts-20241228.xsd#PropertyandEquipmentTables"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/PropertyandEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_05872066-a212-4301-8031-9490d08007d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_0a2d217f-d5a8-4694-afd4-bc0e1d389ae3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_05872066-a212-4301-8031-9490d08007d3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_0a2d217f-d5a8-4694-afd4-bc0e1d389ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/LeasesTables" xlink:type="simple" xlink:href="alts-20241228.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_8b35aaa8-dce1-45ec-93f3-ce8aeda441b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ScheduleOfOperatingLeaseRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock_73ad6d38-bb55-4da2-bb2a-20d4e226041a" xlink:href="alts-20241228.xsd#alts_ScheduleOfOperatingLeaseRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8b35aaa8-dce1-45ec-93f3-ce8aeda441b5" xlink:to="loc_alts_ScheduleOfOperatingLeaseRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock_73ad6d38-bb55-4da2-bb2a-20d4e226041a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_8f667b6e-e96f-467a-bc75-5448bc163af0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8b35aaa8-dce1-45ec-93f3-ce8aeda441b5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_8f667b6e-e96f-467a-bc75-5448bc163af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/IntangibleassetsTables" xlink:type="simple" xlink:href="alts-20241228.xsd#IntangibleassetsTables"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/IntangibleassetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b1d2259e-78ea-4f31-a0bb-a50d4f07c965" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_9ff19061-2f04-4a34-a618-2dfe38618d44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b1d2259e-78ea-4f31-a0bb-a50d4f07c965" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_9ff19061-2f04-4a34-a618-2dfe38618d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/MarketableSecuritiesTables" xlink:type="simple" xlink:href="alts-20241228.xsd#MarketableSecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/MarketableSecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesAbstract_4edad5f0-1610-46f8-94c9-7d108e867898" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_a342a1e3-afc8-4347-a461-84daa7f762e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_4edad5f0-1610-46f8-94c9-7d108e867898" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_a342a1e3-afc8-4347-a461-84daa7f762e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/DepositsandotherassetsTables" xlink:type="simple" xlink:href="alts-20241228.xsd#DepositsandotherassetsTables"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/DepositsandotherassetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_3c304de1-a063-415d-a680-832f8f449672" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_6d446cce-8152-4ea2-a6be-060e74f5cb1a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_3c304de1-a063-415d-a680-832f8f449672" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_6d446cce-8152-4ea2-a6be-060e74f5cb1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/AccruedliabilitiesTables" xlink:type="simple" xlink:href="alts-20241228.xsd#AccruedliabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/AccruedliabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_e3e1e63f-40c3-410c-aedf-e8e06d565083" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_29fb0ac0-48a6-43a4-848c-2970122303f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_e3e1e63f-40c3-410c-aedf-e8e06d565083" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_29fb0ac0-48a6-43a4-848c-2970122303f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/DebenturesTables" xlink:type="simple" xlink:href="alts-20241228.xsd#DebenturesTables"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/DebenturesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ea1d83e9-8a60-48ff-a5a2-f449b9f3541e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_f3d44a78-8c38-47c2-847a-28fc75df9797" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ea1d83e9-8a60-48ff-a5a2-f449b9f3541e" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_f3d44a78-8c38-47c2-847a-28fc75df9797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="alts-20241228.xsd#LongTermDebtTables"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_fc9ea66d-285a-4bda-a93a-5290eea0e376" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_bd4da8da-22e9-48ea-a3bb-042ad801b150" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fc9ea66d-285a-4bda-a93a-5290eea0e376" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_bd4da8da-22e9-48ea-a3bb-042ad801b150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/RelatedPartyDebtTables" xlink:type="simple" xlink:href="alts-20241228.xsd#RelatedPartyDebtTables"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/RelatedPartyDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_877a0b3e-9f7a-4784-8b7a-a41e228b2867" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_7c1251cc-0cd8-4e82-8d33-278c4da6ae59" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_877a0b3e-9f7a-4784-8b7a-a41e228b2867" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_7c1251cc-0cd8-4e82-8d33-278c4da6ae59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_d1bbccfb-939b-4a83-bd39-218f9b321047" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_877a0b3e-9f7a-4784-8b7a-a41e228b2867" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_d1bbccfb-939b-4a83-bd39-218f9b321047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/PreferredStockTables" xlink:type="simple" xlink:href="alts-20241228.xsd#PreferredStockTables"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/PreferredStockTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_dfd670e0-c666-42ec-8c40-3c7c6ba1ba80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock_2e6bf1b8-8e17-41b5-b062-14cef5e37f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_dfd670e0-c666-42ec-8c40-3c7c6ba1ba80" xlink:to="loc_us-gaap_TemporaryEquityTableTextBlock_2e6bf1b8-8e17-41b5-b062-14cef5e37f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="alts-20241228.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_d1bd8092-f572-48c9-9691-f537c39cdab2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_e30a86a8-357c-4a86-afb1-f8fb38f36443" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_d1bd8092-f572-48c9-9691-f537c39cdab2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_e30a86a8-357c-4a86-afb1-f8fb38f36443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_a1161a1a-7a76-4989-ae29-47a2680af9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_d1bd8092-f572-48c9-9691-f537c39cdab2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_a1161a1a-7a76-4989-ae29-47a2680af9a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/IncometaxesTables" xlink:type="simple" xlink:href="alts-20241228.xsd#IncometaxesTables"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/IncometaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d6c4a4c7-59bc-49d5-b8a4-b17768696e82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_aa2e9d43-a155-4140-8e10-a3943435d8a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d6c4a4c7-59bc-49d5-b8a4-b17768696e82" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_aa2e9d43-a155-4140-8e10-a3943435d8a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_e8aae0c8-760a-4a44-b7e4-6abc94f82cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d6c4a4c7-59bc-49d5-b8a4-b17768696e82" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_e8aae0c8-760a-4a44-b7e4-6abc94f82cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_e5aec6e1-3932-4e4c-8804-d71b4cae22a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d6c4a4c7-59bc-49d5-b8a4-b17768696e82" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_e5aec6e1-3932-4e4c-8804-d71b4cae22a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_f72be931-5f59-4295-8419-e8530b234d81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d6c4a4c7-59bc-49d5-b8a4-b17768696e82" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_f72be931-5f59-4295-8419-e8530b234d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/EarningsLosspershareTables" xlink:type="simple" xlink:href="alts-20241228.xsd#EarningsLosspershareTables"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/EarningsLosspershareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_aa2198b4-4f15-4794-a0bd-a54147716ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_48e452a8-7635-4a65-a8df-4e3cd7bf8cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_aa2198b4-4f15-4794-a0bd-a54147716ae7" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_48e452a8-7635-4a65-a8df-4e3cd7bf8cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/SegmentinformationTables" xlink:type="simple" xlink:href="alts-20241228.xsd#SegmentinformationTables"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/SegmentinformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_585a0f33-fe8b-4c16-b4c7-8249b3ce127d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_3364b641-8283-495f-9ae4-b958c7e55e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_585a0f33-fe8b-4c16-b4c7-8249b3ce127d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_3364b641-8283-495f-9ae4-b958c7e55e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/BackgroundandBasisofPresentationDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#BackgroundandBasisofPresentationDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/BackgroundandBasisofPresentationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3bce8f3c-97fd-4ab8-b592-28a348ad7b62" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_8d485b8a-a0be-40f3-904e-0af665c491d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3bce8f3c-97fd-4ab8-b592-28a348ad7b62" xlink:to="loc_us-gaap_NumberOfOperatingSegments_8d485b8a-a0be-40f3-904e-0af665c491d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PotentialMarketExclusivityPeriod_87ed0268-5c75-43a6-a017-4b27c271cc20" xlink:href="alts-20241228.xsd#alts_PotentialMarketExclusivityPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3bce8f3c-97fd-4ab8-b592-28a348ad7b62" xlink:to="loc_alts_PotentialMarketExclusivityPeriod_87ed0268-5c75-43a6-a017-4b27c271cc20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_b681ed66-78aa-473a-80d4-a418eb714070" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3bce8f3c-97fd-4ab8-b592-28a348ad7b62" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_b681ed66-78aa-473a-80d4-a418eb714070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3f4a8f4a-eff2-4316-b74c-db60d8052f89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3bce8f3c-97fd-4ab8-b592-28a348ad7b62" xlink:to="loc_us-gaap_AssetsCurrent_3f4a8f4a-eff2-4316-b74c-db60d8052f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_bd3fedef-9f94-4b6b-8a24-8abdd5fe485a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3bce8f3c-97fd-4ab8-b592-28a348ad7b62" xlink:to="loc_us-gaap_LiabilitiesCurrent_bd3fedef-9f94-4b6b-8a24-8abdd5fe485a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_CurrentAssetsCurrentLiabilitiesNet_d1da509f-125f-43db-9c0c-e80aa61ae039" xlink:href="alts-20241228.xsd#alts_CurrentAssetsCurrentLiabilitiesNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3bce8f3c-97fd-4ab8-b592-28a348ad7b62" xlink:to="loc_alts_CurrentAssetsCurrentLiabilitiesNet_d1da509f-125f-43db-9c0c-e80aa61ae039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NetCashProvidedByOperatingActivitiesContinuingOperations_1fd35c0c-a057-4329-954e-a59724c1e0bc" xlink:href="alts-20241228.xsd#alts_NetCashProvidedByOperatingActivitiesContinuingOperations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3bce8f3c-97fd-4ab8-b592-28a348ad7b62" xlink:to="loc_alts_NetCashProvidedByOperatingActivitiesContinuingOperations_1fd35c0c-a057-4329-954e-a59724c1e0bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6f980ebb-5e89-49d7-be42-82892b5cd9b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1e0b48ff-29b5-4883-9ee8-949bd5d2f1ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6f980ebb-5e89-49d7-be42-82892b5cd9b4" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1e0b48ff-29b5-4883-9ee8-949bd5d2f1ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_8f146d1d-8fa9-458b-9b6a-8e2b941ed732" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1e0b48ff-29b5-4883-9ee8-949bd5d2f1ca" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_8f146d1d-8fa9-458b-9b6a-8e2b941ed732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_1f28f6ba-aaa7-4736-a810-c60838185133" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_8f146d1d-8fa9-458b-9b6a-8e2b941ed732" xlink:to="loc_us-gaap_ReceivableTypeDomain_1f28f6ba-aaa7-4736-a810-c60838185133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SubscriptionsReceivableMember_711b393d-a61d-4214-b2b4-41c3b03f3764" xlink:href="alts-20241228.xsd#alts_SubscriptionsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_1f28f6ba-aaa7-4736-a810-c60838185133" xlink:to="loc_alts_SubscriptionsReceivableMember_711b393d-a61d-4214-b2b4-41c3b03f3764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e019a22c-911a-417f-a3f9-c1c8d4b3748a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1e0b48ff-29b5-4883-9ee8-949bd5d2f1ca" xlink:to="loc_srt_RangeAxis_e019a22c-911a-417f-a3f9-c1c8d4b3748a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_693b5bdc-f2a4-49df-acf7-9f4eaec715ec" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e019a22c-911a-417f-a3f9-c1c8d4b3748a" xlink:to="loc_srt_RangeMember_693b5bdc-f2a4-49df-acf7-9f4eaec715ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_89ce2931-7372-4a8b-a65a-65c1091e0266" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_693b5bdc-f2a4-49df-acf7-9f4eaec715ec" xlink:to="loc_srt_MinimumMember_89ce2931-7372-4a8b-a65a-65c1091e0266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4ac1e68f-e274-402e-ad05-6aaefab05d53" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_693b5bdc-f2a4-49df-acf7-9f4eaec715ec" xlink:to="loc_srt_MaximumMember_4ac1e68f-e274-402e-ad05-6aaefab05d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b5c7dec6-62f7-4270-9bb1-b1f173794714" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1e0b48ff-29b5-4883-9ee8-949bd5d2f1ca" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b5c7dec6-62f7-4270-9bb1-b1f173794714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d06c60aa-1349-4982-8f31-4fb3b7550e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b5c7dec6-62f7-4270-9bb1-b1f173794714" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d06c60aa-1349-4982-8f31-4fb3b7550e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingRelatedIntangibleAssetsMember_a0b4ef8e-aa1b-4669-84b3-ca0fa979260e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketingRelatedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d06c60aa-1349-4982-8f31-4fb3b7550e1b" xlink:to="loc_us-gaap_MarketingRelatedIntangibleAssetsMember_a0b4ef8e-aa1b-4669-84b3-ca0fa979260e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_ce646169-20fe-4976-a809-7402fcd2bd9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d06c60aa-1349-4982-8f31-4fb3b7550e1b" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_ce646169-20fe-4976-a809-7402fcd2bd9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_6c02ca1c-c01f-4f6a-bee3-0ee527babc62" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d06c60aa-1349-4982-8f31-4fb3b7550e1b" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_6c02ca1c-c01f-4f6a-bee3-0ee527babc62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_49c97ea1-2152-4d0a-acd5-8a35741f042e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d06c60aa-1349-4982-8f31-4fb3b7550e1b" xlink:to="loc_us-gaap_CustomerRelationshipsMember_49c97ea1-2152-4d0a-acd5-8a35741f042e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7d596e25-88e4-4e63-9fc3-86cba65c62f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1e0b48ff-29b5-4883-9ee8-949bd5d2f1ca" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7d596e25-88e4-4e63-9fc3-86cba65c62f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PlatformOperatorCryptoAssetHeldForUserCurrent_ca7982a6-4574-4b49-983d-41062303fdf3" xlink:href="alts-20241228.xsd#alts_PlatformOperatorCryptoAssetHeldForUserCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7d596e25-88e4-4e63-9fc3-86cba65c62f3" xlink:to="loc_alts_PlatformOperatorCryptoAssetHeldForUserCurrent_ca7982a6-4574-4b49-983d-41062303fdf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_0f5cc42f-c516-4150-9625-519498d53e54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7d596e25-88e4-4e63-9fc3-86cba65c62f3" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_0f5cc42f-c516-4150-9625-519498d53e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_e5009573-8cb7-4219-b931-2746da143aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7d596e25-88e4-4e63-9fc3-86cba65c62f3" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_e5009573-8cb7-4219-b931-2746da143aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_8db3dcbe-1e59-4566-a5e6-7257b664f82b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7d596e25-88e4-4e63-9fc3-86cba65c62f3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_8db3dcbe-1e59-4566-a5e6-7257b664f82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DigitalAssetLiabilityCurrent_cdb379cf-4e53-45c0-963a-261f901184c9" xlink:href="alts-20241228.xsd#alts_DigitalAssetLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7d596e25-88e4-4e63-9fc3-86cba65c62f3" xlink:to="loc_alts_DigitalAssetLiabilityCurrent_cdb379cf-4e53-45c0-963a-261f901184c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DigitalAssetLiabilityCurrentDigitalAssets_a8668c97-4813-4c80-97df-aed02cd0bf31" xlink:href="alts-20241228.xsd#alts_DigitalAssetLiabilityCurrentDigitalAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7d596e25-88e4-4e63-9fc3-86cba65c62f3" xlink:to="loc_alts_DigitalAssetLiabilityCurrentDigitalAssets_a8668c97-4813-4c80-97df-aed02cd0bf31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DigitalAssetLiabilityCurrentCashDeposits_8be427cf-0287-4418-a023-9a7490eb664e" xlink:href="alts-20241228.xsd#alts_DigitalAssetLiabilityCurrentCashDeposits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7d596e25-88e4-4e63-9fc3-86cba65c62f3" xlink:to="loc_alts_DigitalAssetLiabilityCurrentCashDeposits_8be427cf-0287-4418-a023-9a7490eb664e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_38c55702-62f3-4054-b601-4f48d3db6720" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7d596e25-88e4-4e63-9fc3-86cba65c62f3" xlink:to="loc_us-gaap_NumberOfReportableSegments_38c55702-62f3-4054-b601-4f48d3db6720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesScheduleofTradeandOtherReceivablesDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#SummaryofSignificantAccountingPoliciesScheduleofTradeandOtherReceivablesDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesScheduleofTradeandOtherReceivablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_390c3ed8-a2a8-4067-ab1b-659f9c8912cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_799a79df-b401-4430-8236-f1c6d3916fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_390c3ed8-a2a8-4067-ab1b-659f9c8912cd" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_799a79df-b401-4430-8236-f1c6d3916fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_ebf4dacf-16bd-4fbc-87e4-2474e2da9ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_390c3ed8-a2a8-4067-ab1b-659f9c8912cd" xlink:to="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_ebf4dacf-16bd-4fbc-87e4-2474e2da9ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/MergersandAcquisitionsQodenDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#MergersandAcquisitionsQodenDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/MergersandAcquisitionsQodenDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e9b17620-5a79-4cfe-82ca-70bb22d7029b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionTable_43709e97-682a-48f0-b902-97dd5c753180" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e9b17620-5a79-4cfe-82ca-70bb22d7029b" xlink:to="loc_us-gaap_AssetAcquisitionTable_43709e97-682a-48f0-b902-97dd5c753180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_54dbc365-1019-41ce-b9c0-7a13abf04a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionTable_43709e97-682a-48f0-b902-97dd5c753180" xlink:to="loc_us-gaap_AssetAcquisitionAxis_54dbc365-1019-41ce-b9c0-7a13abf04a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_776c1de6-6e4d-4bf6-bc9a-9ed8c883c8e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_54dbc365-1019-41ce-b9c0-7a13abf04a4e" xlink:to="loc_us-gaap_AssetAcquisitionDomain_776c1de6-6e4d-4bf6-bc9a-9ed8c883c8e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_QodenTechnologiesLLCMember_ad8b62ae-c963-4e76-8431-a16643a51a5f" xlink:href="alts-20241228.xsd#alts_QodenTechnologiesLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_776c1de6-6e4d-4bf6-bc9a-9ed8c883c8e5" xlink:to="loc_alts_QodenTechnologiesLLCMember_ad8b62ae-c963-4e76-8431-a16643a51a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0b13b003-66fa-4480-8fd2-1be024a6e842" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionTable_43709e97-682a-48f0-b902-97dd5c753180" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0b13b003-66fa-4480-8fd2-1be024a6e842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_549fc595-2240-4487-bacb-2efabde72edc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0b13b003-66fa-4480-8fd2-1be024a6e842" xlink:to="loc_us-gaap_RelatedPartyDomain_549fc595-2240-4487-bacb-2efabde72edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_7db59620-da15-4f54-8edc-19a153f5d88c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_549fc595-2240-4487-bacb-2efabde72edc" xlink:to="loc_us-gaap_RelatedPartyMember_7db59620-da15-4f54-8edc-19a153f5d88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_eb372728-4a86-4b89-98af-878bee2720aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionTable_43709e97-682a-48f0-b902-97dd5c753180" xlink:to="loc_us-gaap_StatementClassOfStockAxis_eb372728-4a86-4b89-98af-878bee2720aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8ec3c2dd-6a72-4588-a489-2660e872d7da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_eb372728-4a86-4b89-98af-878bee2720aa" xlink:to="loc_us-gaap_ClassOfStockDomain_8ec3c2dd-6a72-4588-a489-2660e872d7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesQConvertiblePreferredStockMember_0067db02-0c5d-46dd-bb1a-bc5c842640b0" xlink:href="alts-20241228.xsd#alts_SeriesQConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_8ec3c2dd-6a72-4588-a489-2660e872d7da" xlink:to="loc_alts_SeriesQConvertiblePreferredStockMember_0067db02-0c5d-46dd-bb1a-bc5c842640b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionLineItems_35fb1833-203f-423f-b03c-c587d99781df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionTable_43709e97-682a-48f0-b902-97dd5c753180" xlink:to="loc_us-gaap_AssetAcquisitionLineItems_35fb1833-203f-423f-b03c-c587d99781df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred_f12507b0-f020-4bcf-8dc6-97e7c9fc98a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_35fb1833-203f-423f-b03c-c587d99781df" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferred_f12507b0-f020-4bcf-8dc6-97e7c9fc98a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_ea42711f-faa8-4e6f-95d5-3f5bdfdb8bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_35fb1833-203f-423f-b03c-c587d99781df" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_ea42711f-faa8-4e6f-95d5-3f5bdfdb8bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares_1b7edab4-a0d7-49bd-a4ac-7a621cae4a7e" xlink:href="alts-20241228.xsd#alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_35fb1833-203f-423f-b03c-c587d99781df" xlink:to="loc_alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares_1b7edab4-a0d7-49bd-a4ac-7a621cae4a7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AssetAcquisitionConsiderationCashPayable_453407b7-5955-4721-af61-fa86bc03ecfd" xlink:href="alts-20241228.xsd#alts_AssetAcquisitionConsiderationCashPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_35fb1833-203f-423f-b03c-c587d99781df" xlink:to="loc_alts_AssetAcquisitionConsiderationCashPayable_453407b7-5955-4721-af61-fa86bc03ecfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AssetAcquisitionConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare_0f1556a9-0200-4311-b70b-f4da7befc775" xlink:href="alts-20241228.xsd#alts_AssetAcquisitionConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_35fb1833-203f-423f-b03c-c587d99781df" xlink:to="loc_alts_AssetAcquisitionConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare_0f1556a9-0200-4311-b70b-f4da7befc775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AssetAcquisitionEquityInstrumentsIssuableValidConversionPeriod_e95f7e62-a366-4495-b3b0-748c37a093cd" xlink:href="alts-20241228.xsd#alts_AssetAcquisitionEquityInstrumentsIssuableValidConversionPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_35fb1833-203f-423f-b03c-c587d99781df" xlink:to="loc_alts_AssetAcquisitionEquityInstrumentsIssuableValidConversionPeriod_e95f7e62-a366-4495-b3b0-748c37a093cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AssetAcquisitionConsiderationPeriodicCashPayment_eeb6b817-d791-4712-ae10-2ba8f0792eea" xlink:href="alts-20241228.xsd#alts_AssetAcquisitionConsiderationPeriodicCashPayment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_35fb1833-203f-423f-b03c-c587d99781df" xlink:to="loc_alts_AssetAcquisitionConsiderationPeriodicCashPayment_eeb6b817-d791-4712-ae10-2ba8f0792eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/MergersandAcquisitionsALT5Details" xlink:type="simple" xlink:href="alts-20241228.xsd#MergersandAcquisitionsALT5Details"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/MergersandAcquisitionsALT5Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_88f4c853-0e88-424b-95c1-12e652577ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bb47750d-4003-499c-8493-6f47de1af980" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_88f4c853-0e88-424b-95c1-12e652577ef1" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bb47750d-4003-499c-8493-6f47de1af980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_da8186d6-6e83-4ef3-b2d3-5e3c8c8d69ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bb47750d-4003-499c-8493-6f47de1af980" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_da8186d6-6e83-4ef3-b2d3-5e3c8c8d69ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_da454633-d99f-40f5-9c94-dbea90c5b76b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_da8186d6-6e83-4ef3-b2d3-5e3c8c8d69ee" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_da454633-d99f-40f5-9c94-dbea90c5b76b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Alt5SigmaInc.Member_a495e0ef-250f-4251-9349-8bb9753812df" xlink:href="alts-20241228.xsd#alts_Alt5SigmaInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_da454633-d99f-40f5-9c94-dbea90c5b76b" xlink:to="loc_alts_Alt5SigmaInc.Member_a495e0ef-250f-4251-9349-8bb9753812df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_6b51851f-56a8-4bdd-9a8e-b92396b8f1a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bb47750d-4003-499c-8493-6f47de1af980" xlink:to="loc_us-gaap_StatementClassOfStockAxis_6b51851f-56a8-4bdd-9a8e-b92396b8f1a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d0409e2b-8601-425b-991e-d86f89a878a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_6b51851f-56a8-4bdd-9a8e-b92396b8f1a9" xlink:to="loc_us-gaap_ClassOfStockDomain_d0409e2b-8601-425b-991e-d86f89a878a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_f90e1007-accc-4b52-8430-fa76d899484c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d0409e2b-8601-425b-991e-d86f89a878a0" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_f90e1007-accc-4b52-8430-fa76d899484c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesMPreferredStockMember_c38120ae-00ff-460b-97f6-9ac6bdd4273a" xlink:href="alts-20241228.xsd#alts_SeriesMPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d0409e2b-8601-425b-991e-d86f89a878a0" xlink:to="loc_alts_SeriesMPreferredStockMember_c38120ae-00ff-460b-97f6-9ac6bdd4273a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_9fc02a8a-24af-41f7-a4a4-de3dcd912ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bb47750d-4003-499c-8493-6f47de1af980" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_9fc02a8a-24af-41f7-a4a4-de3dcd912ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_eb6c6acb-8b79-4162-8043-74a38990a1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fc02a8a-24af-41f7-a4a4-de3dcd912ee0" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_eb6c6acb-8b79-4162-8043-74a38990a1e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfIssuedAndOutstandingShares_8f8ca827-8d73-48ff-8649-399c82093971" xlink:href="alts-20241228.xsd#alts_BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfIssuedAndOutstandingShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fc02a8a-24af-41f7-a4a4-de3dcd912ee0" xlink:to="loc_alts_BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfIssuedAndOutstandingShares_8f8ca827-8d73-48ff-8649-399c82093971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_75e96bde-89e9-4a33-ba8d-1b14e0195bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fc02a8a-24af-41f7-a4a4-de3dcd912ee0" xlink:to="loc_us-gaap_SharePrice_75e96bde-89e9-4a33-ba8d-1b14e0195bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_4a564a4c-fbab-445d-80de-8dfb4a78cd1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fc02a8a-24af-41f7-a4a4-de3dcd912ee0" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_4a564a4c-fbab-445d-80de-8dfb4a78cd1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a6dda6a0-5dfa-44ed-a052-260afe1c36d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fc02a8a-24af-41f7-a4a4-de3dcd912ee0" xlink:to="loc_us-gaap_Goodwill_a6dda6a0-5dfa-44ed-a052-260afe1c36d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_442a156c-1b44-4229-b3d7-a4d23975fb23" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fc02a8a-24af-41f7-a4a4-de3dcd912ee0" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_442a156c-1b44-4229-b3d7-a4d23975fb23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6d0b7a96-9a9f-4fa7-88f5-81871e658a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9fc02a8a-24af-41f7-a4a4-de3dcd912ee0" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6d0b7a96-9a9f-4fa7-88f5-81871e658a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofFairValueAdjustmentsforSharesofSeriesBandSeriesMPreferredStockDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#MergersandAcquisitionsScheduleofFairValueAdjustmentsforSharesofSeriesBandSeriesMPreferredStockDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofFairValueAdjustmentsforSharesofSeriesBandSeriesMPreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_512b7a91-f9f4-40f3-a657-117ce9f87186" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationTable_e98e7979-f551-418f-82ad-e854d0991eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationSegmentAllocationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_512b7a91-f9f4-40f3-a657-117ce9f87186" xlink:to="loc_us-gaap_BusinessCombinationSegmentAllocationTable_e98e7979-f551-418f-82ad-e854d0991eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_443515bf-89d9-4f2c-9893-c37875a82db5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable_e98e7979-f551-418f-82ad-e854d0991eb2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_443515bf-89d9-4f2c-9893-c37875a82db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_907957f2-fd4b-47c9-9b4c-058d58088cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_443515bf-89d9-4f2c-9893-c37875a82db5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_907957f2-fd4b-47c9-9b4c-058d58088cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Alt5SigmaInc.Member_86e2abd6-25d5-46d4-8b84-a9c3697b67fc" xlink:href="alts-20241228.xsd#alts_Alt5SigmaInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_907957f2-fd4b-47c9-9b4c-058d58088cb5" xlink:to="loc_alts_Alt5SigmaInc.Member_86e2abd6-25d5-46d4-8b84-a9c3697b67fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_4ea36f97-757d-4630-ae54-31f406ea4d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable_e98e7979-f551-418f-82ad-e854d0991eb2" xlink:to="loc_us-gaap_StatementClassOfStockAxis_4ea36f97-757d-4630-ae54-31f406ea4d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f5349fe2-ef68-4c58-93bb-f60409c1f49e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4ea36f97-757d-4630-ae54-31f406ea4d0f" xlink:to="loc_us-gaap_ClassOfStockDomain_f5349fe2-ef68-4c58-93bb-f60409c1f49e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_366b2f0e-05ff-421c-a354-ec9b1c1d2ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_f5349fe2-ef68-4c58-93bb-f60409c1f49e" xlink:to="loc_us-gaap_CommonStockMember_366b2f0e-05ff-421c-a354-ec9b1c1d2ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_7eaabde2-5e08-40b5-811b-ddf06a234c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_f5349fe2-ef68-4c58-93bb-f60409c1f49e" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_7eaabde2-5e08-40b5-811b-ddf06a234c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_bafe9aa4-1a9b-4cd5-9cb2-8f8571729664" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationSegmentAllocationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable_e98e7979-f551-418f-82ad-e854d0991eb2" xlink:to="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_bafe9aa4-1a9b-4cd5-9cb2-8f8571729664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_1100dae3-29c3-46a7-adc7-e978d6d4314d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_bafe9aa4-1a9b-4cd5-9cb2-8f8571729664" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_1100dae3-29c3-46a7-adc7-e978d6d4314d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_83913ba3-1e40-4b24-86a6-2c91bfae9bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_bafe9aa4-1a9b-4cd5-9cb2-8f8571729664" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_83913ba3-1e40-4b24-86a6-2c91bfae9bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_caca9329-db48-4167-945b-876e5bac19b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationTable_66c75166-bb02-4c63-9297-6188efa5f737" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationSegmentAllocationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_caca9329-db48-4167-945b-876e5bac19b8" xlink:to="loc_us-gaap_BusinessCombinationSegmentAllocationTable_66c75166-bb02-4c63-9297-6188efa5f737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4aab2deb-1b28-4e32-8a2d-f0bcccbea1a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable_66c75166-bb02-4c63-9297-6188efa5f737" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4aab2deb-1b28-4e32-8a2d-f0bcccbea1a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87b166ad-b734-46d9-af16-d212e7f19221" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4aab2deb-1b28-4e32-8a2d-f0bcccbea1a4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87b166ad-b734-46d9-af16-d212e7f19221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Alt5SigmaInc.Member_2f4b4e1c-5444-4e56-a72a-c050dd7941a3" xlink:href="alts-20241228.xsd#alts_Alt5SigmaInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87b166ad-b734-46d9-af16-d212e7f19221" xlink:to="loc_alts_Alt5SigmaInc.Member_2f4b4e1c-5444-4e56-a72a-c050dd7941a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_QodenTechnologiesLLCMember_b539e029-546b-4e36-9a77-9ac971d95a45" xlink:href="alts-20241228.xsd#alts_QodenTechnologiesLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87b166ad-b734-46d9-af16-d212e7f19221" xlink:to="loc_alts_QodenTechnologiesLLCMember_b539e029-546b-4e36-9a77-9ac971d95a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8da80c1c-c6ac-42c2-83cf-5ada1f6db120" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable_66c75166-bb02-4c63-9297-6188efa5f737" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8da80c1c-c6ac-42c2-83cf-5ada1f6db120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fdd1b29d-5765-493d-8e3c-70d2abb36211" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_8da80c1c-c6ac-42c2-83cf-5ada1f6db120" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fdd1b29d-5765-493d-8e3c-70d2abb36211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_5702570a-7a0a-400a-aa4d-3f92ad3ea535" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fdd1b29d-5765-493d-8e3c-70d2abb36211" xlink:to="loc_us-gaap_CustomerRelationshipsMember_5702570a-7a0a-400a-aa4d-3f92ad3ea535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_62e68ec6-2fc0-4fb8-a67d-99787f3815e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fdd1b29d-5765-493d-8e3c-70d2abb36211" xlink:to="loc_us-gaap_TradeNamesMember_62e68ec6-2fc0-4fb8-a67d-99787f3815e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_8b4c3345-303d-463f-b555-84f8b5c75abf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fdd1b29d-5765-493d-8e3c-70d2abb36211" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_8b4c3345-303d-463f-b555-84f8b5c75abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationSegmentAllocationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable_66c75166-bb02-4c63-9297-6188efa5f737" xlink:to="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_96e6d5ab-ed5b-47fa-9aec-2c360a333699" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_96e6d5ab-ed5b-47fa-9aec-2c360a333699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_1f967c01-4a42-42a0-ad64-773e7f305da7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_1f967c01-4a42-42a0-ad64-773e7f305da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_133ebdf8-e5d1-4f31-b360-6cf1a14968d6" xlink:href="alts-20241228.xsd#alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:to="loc_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent_133ebdf8-e5d1-4f31-b360-6cf1a14968d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsPayable_c8ba7408-ae09-4167-8383-41026c42c204" xlink:href="alts-20241228.xsd#alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:to="loc_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsPayable_c8ba7408-ae09-4167-8383-41026c42c204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_b9e93f95-18df-46f5-bced-2fdb6e8a53f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_b9e93f95-18df-46f5-bced-2fdb6e8a53f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_3ac12d42-5230-41f4-a2ef-bb5857831347" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_3ac12d42-5230-41f4-a2ef-bb5857831347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_271098e5-c66a-414f-bce0-fa1bdce68ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_271098e5-c66a-414f-bce0-fa1bdce68ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_dadd4f1b-8bce-4975-a724-f896625b8838" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_dadd4f1b-8bce-4975-a724-f896625b8838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a4107923-e8f1-4785-ae4c-9f891879e609" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a4107923-e8f1-4785-ae4c-9f891879e609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsReceivable_fa2da656-c025-4946-9206-ed774faba567" xlink:href="alts-20241228.xsd#alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsReceivable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:to="loc_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsReceivable_fa2da656-c025-4946-9206-ed774faba567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_de10d6db-6db3-4066-9abf-96e064794a81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_de10d6db-6db3-4066-9abf-96e064794a81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_c496a5b5-f0f0-4858-b9a5-f2169fb98158" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_c496a5b5-f0f0-4858-b9a5-f2169fb98158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7096fba2-8670-46c9-8811-bac59a587220" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7096fba2-8670-46c9-8811-bac59a587220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_55d6fd49-a098-4412-8990-fefeb743d47b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_4729dd25-a03c-4549-8cb8-335a4bfa3efd" xlink:to="loc_us-gaap_Goodwill_55d6fd49-a098-4412-8990-fefeb743d47b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofProformaInformationDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#MergersandAcquisitionsScheduleofProformaInformationDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofProformaInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_f0b7e267-322f-4378-aa33-273daf5dd305" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationTable_f6c401e2-f1a8-4bf3-aa5f-0ff4783ee109" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationSegmentAllocationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_f0b7e267-322f-4378-aa33-273daf5dd305" xlink:to="loc_us-gaap_BusinessCombinationSegmentAllocationTable_f6c401e2-f1a8-4bf3-aa5f-0ff4783ee109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_721f9271-a60d-4c6c-80e4-0ab46fb7e218" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable_f6c401e2-f1a8-4bf3-aa5f-0ff4783ee109" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_721f9271-a60d-4c6c-80e4-0ab46fb7e218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a816e77d-c12c-42af-8193-6f9923535397" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_721f9271-a60d-4c6c-80e4-0ab46fb7e218" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a816e77d-c12c-42af-8193-6f9923535397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Alt5SigmaInc.Member_f9484482-9a23-40c6-b4e5-e3b4db384a50" xlink:href="alts-20241228.xsd#alts_Alt5SigmaInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a816e77d-c12c-42af-8193-6f9923535397" xlink:to="loc_alts_Alt5SigmaInc.Member_f9484482-9a23-40c6-b4e5-e3b4db384a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_dc18adc5-4093-42b4-8737-4d9be3adb56c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable_f6c401e2-f1a8-4bf3-aa5f-0ff4783ee109" xlink:to="loc_srt_StatementScenarioAxis_dc18adc5-4093-42b4-8737-4d9be3adb56c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_0e20039f-aa34-4934-8e4a-a297dc18110a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_dc18adc5-4093-42b4-8737-4d9be3adb56c" xlink:to="loc_srt_ScenarioUnspecifiedDomain_0e20039f-aa34-4934-8e4a-a297dc18110a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScenarioAdjustmentMember_7bacf69a-7c40-423b-8841-d12993e8ec3c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScenarioAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_0e20039f-aa34-4934-8e4a-a297dc18110a" xlink:to="loc_us-gaap_ScenarioAdjustmentMember_7bacf69a-7c40-423b-8841-d12993e8ec3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProFormaMember_5f5e580c-8a44-4473-847b-dc0e9f842a0b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProFormaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_0e20039f-aa34-4934-8e4a-a297dc18110a" xlink:to="loc_srt_ProFormaMember_5f5e580c-8a44-4473-847b-dc0e9f842a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_a3547209-6382-47b0-9c49-31334997a91b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationSegmentAllocationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable_f6c401e2-f1a8-4bf3-aa5f-0ff4783ee109" xlink:to="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_a3547209-6382-47b0-9c49-31334997a91b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b6043a86-4b1d-462c-b8b4-b1c4e4be5889" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_a3547209-6382-47b0-9c49-31334997a91b" xlink:to="loc_us-gaap_Revenues_b6043a86-4b1d-462c-b8b4-b1c4e4be5889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_2718a079-2c6e-4f3f-93bc-5a2ada250ada" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_a3547209-6382-47b0-9c49-31334997a91b" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_2718a079-2c6e-4f3f-93bc-5a2ada250ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a973e043-43a4-4b3e-8d65-7933bd3e81ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_a3547209-6382-47b0-9c49-31334997a91b" xlink:to="loc_us-gaap_NetIncomeLoss_a973e043-43a4-4b3e-8d65-7933bd3e81ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_103cd46d-c10c-48a9-a858-51b33add0dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_a3547209-6382-47b0-9c49-31334997a91b" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_103cd46d-c10c-48a9-a858-51b33add0dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a22bcbfa-3ea7-4ff8-b161-0ee15ea94003" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_a3547209-6382-47b0-9c49-31334997a91b" xlink:to="loc_us-gaap_EarningsPerShareBasic_a22bcbfa-3ea7-4ff8-b161-0ee15ea94003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_cc7f05f7-12bc-4c74-bcb7-04ea45157381" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationLineItems_a3547209-6382-47b0-9c49-31334997a91b" xlink:to="loc_us-gaap_EarningsPerShareDiluted_cc7f05f7-12bc-4c74-bcb7-04ea45157381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#MergersandAcquisitionsSoinPharmaceuticalsDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_f9fa8947-ebd8-4ef2-883b-6e063628d153" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_236a3e51-fd00-42bc-ba8a-563632a765c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_f9fa8947-ebd8-4ef2-883b-6e063628d153" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_236a3e51-fd00-42bc-ba8a-563632a765c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_770aeb8c-4729-42bd-b36c-ae843317d19d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_236a3e51-fd00-42bc-ba8a-563632a765c3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_770aeb8c-4729-42bd-b36c-ae843317d19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b3ddab29-c50a-4833-be8d-47f2c4b28eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_770aeb8c-4729-42bd-b36c-ae843317d19d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b3ddab29-c50a-4833-be8d-47f2c4b28eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SoinTherapeuticsLLCMember_9dbf21c0-a3ca-4bdd-8306-d5bfa3add54c" xlink:href="alts-20241228.xsd#alts_SoinTherapeuticsLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b3ddab29-c50a-4833-be8d-47f2c4b28eb8" xlink:to="loc_alts_SoinTherapeuticsLLCMember_9dbf21c0-a3ca-4bdd-8306-d5bfa3add54c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_d4cb9c31-a870-42fa-800e-59457db3ed3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_236a3e51-fd00-42bc-ba8a-563632a765c3" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_d4cb9c31-a870-42fa-800e-59457db3ed3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_106d902f-5f77-4e55-b666-0ecaf7c60a44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_d4cb9c31-a870-42fa-800e-59457db3ed3a" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_106d902f-5f77-4e55-b666-0ecaf7c60a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessAcquisitionConsiderationTrancheOneMember_210b8973-7460-4fce-8a3f-90bfff0da2a0" xlink:href="alts-20241228.xsd#alts_BusinessAcquisitionConsiderationTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_106d902f-5f77-4e55-b666-0ecaf7c60a44" xlink:to="loc_alts_BusinessAcquisitionConsiderationTrancheOneMember_210b8973-7460-4fce-8a3f-90bfff0da2a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessAcquisitionConsiderationTrancheTwoMember_315938a3-6ccd-421a-b968-40d5c5d3b537" xlink:href="alts-20241228.xsd#alts_BusinessAcquisitionConsiderationTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_106d902f-5f77-4e55-b666-0ecaf7c60a44" xlink:to="loc_alts_BusinessAcquisitionConsiderationTrancheTwoMember_315938a3-6ccd-421a-b968-40d5c5d3b537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessAcquisitionConsiderationTrancheThreeMember_6787a632-c70f-4deb-82b0-b9b7dadcc41c" xlink:href="alts-20241228.xsd#alts_BusinessAcquisitionConsiderationTrancheThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_106d902f-5f77-4e55-b666-0ecaf7c60a44" xlink:to="loc_alts_BusinessAcquisitionConsiderationTrancheThreeMember_6787a632-c70f-4deb-82b0-b9b7dadcc41c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SoinAgreementConvertibleTrancheOneMember_ddb365a2-2f21-4bac-867e-89054ae09ce4" xlink:href="alts-20241228.xsd#alts_SoinAgreementConvertibleTrancheOneMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_106d902f-5f77-4e55-b666-0ecaf7c60a44" xlink:to="loc_alts_SoinAgreementConvertibleTrancheOneMember_ddb365a2-2f21-4bac-867e-89054ae09ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SoinAgreementConvertibleTrancheTwoMember_1517f79c-6a8f-4c2e-a73c-9012772bd416" xlink:href="alts-20241228.xsd#alts_SoinAgreementConvertibleTrancheTwoMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_106d902f-5f77-4e55-b666-0ecaf7c60a44" xlink:to="loc_alts_SoinAgreementConvertibleTrancheTwoMember_1517f79c-6a8f-4c2e-a73c-9012772bd416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SOINAgreementConvertibleTrancheThreeMember_c139236d-ae29-463d-9232-7e5ba69137ea" xlink:href="alts-20241228.xsd#alts_SOINAgreementConvertibleTrancheThreeMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_106d902f-5f77-4e55-b666-0ecaf7c60a44" xlink:to="loc_alts_SOINAgreementConvertibleTrancheThreeMember_c139236d-ae29-463d-9232-7e5ba69137ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_a88180e4-eec3-4513-86f9-a6621fb604cd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_236a3e51-fd00-42bc-ba8a-563632a765c3" xlink:to="loc_srt_CounterpartyNameAxis_a88180e4-eec3-4513-86f9-a6621fb604cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18671b8f-1742-46aa-9592-669b59ba3b79" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_a88180e4-eec3-4513-86f9-a6621fb604cd" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18671b8f-1742-46aa-9592-669b59ba3b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DrSoinMember_b61f1901-532a-4fa3-ad25-ea6a22ce1c17" xlink:href="alts-20241228.xsd#alts_DrSoinMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18671b8f-1742-46aa-9592-669b59ba3b79" xlink:to="loc_alts_DrSoinMember_b61f1901-532a-4fa3-ad25-ea6a22ce1c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_88974e98-acc1-42bb-934d-237eba7c3da8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_236a3e51-fd00-42bc-ba8a-563632a765c3" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_88974e98-acc1-42bb-934d-237eba7c3da8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_47af7462-dc4a-46ee-9b14-7e2323964e86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_88974e98-acc1-42bb-934d-237eba7c3da8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_47af7462-dc4a-46ee-9b14-7e2323964e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_8afd94de-280b-4aad-86bb-0065f0643c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_47af7462-dc4a-46ee-9b14-7e2323964e86" xlink:to="loc_us-gaap_SubsequentEventMember_8afd94de-280b-4aad-86bb-0065f0643c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_fc13078b-417b-4791-8899-4d174e675cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_236a3e51-fd00-42bc-ba8a-563632a765c3" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_fc13078b-417b-4791-8899-4d174e675cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_b7649488-c1a9-4604-953f-910bf4a58e68" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc13078b-417b-4791-8899-4d174e675cf8" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_b7649488-c1a9-4604-953f-910bf4a58e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NumberOfTranches_7dc683a4-4d70-49eb-a0f6-9c414ce1df1a" xlink:href="alts-20241228.xsd#alts_NumberOfTranches"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc13078b-417b-4791-8899-4d174e675cf8" xlink:to="loc_alts_NumberOfTranches_7dc683a4-4d70-49eb-a0f6-9c414ce1df1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_419dba9f-251b-451d-bda8-dc919fc49d18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc13078b-417b-4791-8899-4d174e675cf8" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_419dba9f-251b-451d-bda8-dc919fc49d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_8a60d29e-8ff7-4f83-8420-18e552fa51b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc13078b-417b-4791-8899-4d174e675cf8" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_8a60d29e-8ff7-4f83-8420-18e552fa51b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_7ad0b9ea-c4fc-4db7-ac9f-399b0ef23985" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc13078b-417b-4791-8899-4d174e675cf8" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_7ad0b9ea-c4fc-4db7-ac9f-399b0ef23985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesNarrativeDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#SaleofRecyclingSubsidiariesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_ab96a6a7-7774-4c15-be28-ef9d9a880801" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_746e0311-113e-4f34-8388-3774bb29cae2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_ab96a6a7-7774-4c15-be28-ef9d9a880801" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_746e0311-113e-4f34-8388-3774bb29cae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_af0808a6-6dcd-4cf5-803e-2c57b375123c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_746e0311-113e-4f34-8388-3774bb29cae2" xlink:to="loc_srt_CounterpartyNameAxis_af0808a6-6dcd-4cf5-803e-2c57b375123c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bcfe41d5-8091-45c3-b35a-c6dd5c8e4fa2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_af0808a6-6dcd-4cf5-803e-2c57b375123c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bcfe41d5-8091-45c3-b35a-c6dd5c8e4fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_VM7CorporationMember_d65b4a64-6748-4cba-8ad9-3737f4192519" xlink:href="alts-20241228.xsd#alts_VM7CorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bcfe41d5-8091-45c3-b35a-c6dd5c8e4fa2" xlink:to="loc_alts_VM7CorporationMember_d65b4a64-6748-4cba-8ad9-3737f4192519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_752fe73a-d23b-4cd8-88b6-9820d97090ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_746e0311-113e-4f34-8388-3774bb29cae2" xlink:to="loc_us-gaap_TypeOfArrangementAxis_752fe73a-d23b-4cd8-88b6-9820d97090ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_be752534-f53a-4083-b3d8-7c7919423a25" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_752fe73a-d23b-4cd8-88b6-9820d97090ad" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_be752534-f53a-4083-b3d8-7c7919423a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockPurchaseAgreementMember_0618290c-af02-498b-a795-91cdccb854c2" xlink:href="alts-20241228.xsd#alts_StockPurchaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_be752534-f53a-4083-b3d8-7c7919423a25" xlink:to="loc_alts_StockPurchaseAgreementMember_0618290c-af02-498b-a795-91cdccb854c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_593212a1-de0e-4856-afc2-479f4fa611e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_746e0311-113e-4f34-8388-3774bb29cae2" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_593212a1-de0e-4856-afc2-479f4fa611e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_2b2b1499-b6c7-41ad-9ebf-4f71e5473a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_593212a1-de0e-4856-afc2-479f4fa611e9" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_2b2b1499-b6c7-41ad-9ebf-4f71e5473a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_bbe08809-2089-44c9-bf4b-71735d855b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_2b2b1499-b6c7-41ad-9ebf-4f71e5473a5c" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_bbe08809-2089-44c9-bf4b-71735d855b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_52945589-8d7d-4618-8b3a-12591a9b903c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_746e0311-113e-4f34-8388-3774bb29cae2" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_52945589-8d7d-4618-8b3a-12591a9b903c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2a824948-0b3b-46b3-95a5-508f01d43e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_52945589-8d7d-4618-8b3a-12591a9b903c" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2a824948-0b3b-46b3-95a5-508f01d43e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ARCAAndSubsidiariesMember_cf05eb50-8698-4486-ad13-0aa8806db8ad" xlink:href="alts-20241228.xsd#alts_ARCAAndSubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2a824948-0b3b-46b3-95a5-508f01d43e4c" xlink:to="loc_alts_ARCAAndSubsidiariesMember_cf05eb50-8698-4486-ad13-0aa8806db8ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c185e28c-2186-4098-a9a9-646c4a1eeec7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_746e0311-113e-4f34-8388-3774bb29cae2" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c185e28c-2186-4098-a9a9-646c4a1eeec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount_a5e1eb5b-d81b-4849-8e9e-f90cab2219f4" xlink:href="alts-20241228.xsd#alts_DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c185e28c-2186-4098-a9a9-646c4a1eeec7" xlink:to="loc_alts_DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount_a5e1eb5b-d81b-4849-8e9e-f90cab2219f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForCommissions_a2f65735-8f18-45d8-8036-c85af2a40b65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForCommissions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c185e28c-2186-4098-a9a9-646c4a1eeec7" xlink:to="loc_us-gaap_PaymentsForCommissions_a2f65735-8f18-45d8-8036-c85af2a40b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RevisedDiscountAmount_eb5c7ac2-57b0-457d-92a9-bd37776a371e" xlink:href="alts-20241228.xsd#alts_RevisedDiscountAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c185e28c-2186-4098-a9a9-646c4a1eeec7" xlink:to="loc_alts_RevisedDiscountAmount_eb5c7ac2-57b0-457d-92a9-bd37776a371e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeInterestEarningAsset_9d0a829d-5ecf-4f0c-9abc-72d1ec404f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeInterestEarningAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c185e28c-2186-4098-a9a9-646c4a1eeec7" xlink:to="loc_us-gaap_InterestIncomeInterestEarningAsset_9d0a829d-5ecf-4f0c-9abc-72d1ec404f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_efa0414c-3dd1-47cf-bbc9-8616b0aeaccb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c185e28c-2186-4098-a9a9-646c4a1eeec7" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_efa0414c-3dd1-47cf-bbc9-8616b0aeaccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag_2ca5d5cb-3f5c-4770-8d15-0b0cda6c6fa2" xlink:href="alts-20241228.xsd#alts_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c185e28c-2186-4098-a9a9-646c4a1eeec7" xlink:to="loc_alts_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag_2ca5d5cb-3f5c-4770-8d15-0b0cda6c6fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_c63d3138-e3f3-4fbd-b064-d3bfa1b1ba9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c185e28c-2186-4098-a9a9-646c4a1eeec7" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_c63d3138-e3f3-4fbd-b064-d3bfa1b1ba9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_41273bd5-f820-4fa1-8260-a6fd8671e105" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_554d3de5-9541-435d-9124-e1b8a38379ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_41273bd5-f820-4fa1-8260-a6fd8671e105" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_554d3de5-9541-435d-9124-e1b8a38379ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_8b397562-ba7c-4078-aace-37547658d39c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_554d3de5-9541-435d-9124-e1b8a38379ea" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_8b397562-ba7c-4078-aace-37547658d39c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_a55933ae-7270-4f70-88c5-bab6e0af2d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_8b397562-ba7c-4078-aace-37547658d39c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_a55933ae-7270-4f70-88c5-bab6e0af2d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_53bd185a-ca80-4d8a-948b-327e5fb8fa56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_a55933ae-7270-4f70-88c5-bab6e0af2d2d" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_53bd185a-ca80-4d8a-948b-327e5fb8fa56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_da8b40d7-ef70-473a-94f4-9715da9f4ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_554d3de5-9541-435d-9124-e1b8a38379ea" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_da8b40d7-ef70-473a-94f4-9715da9f4ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d429e662-98ba-4063-acb0-744d1ab4b040" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_da8b40d7-ef70-473a-94f4-9715da9f4ee1" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d429e662-98ba-4063-acb0-744d1ab4b040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ARCAAndSubsidiariesMember_d0a82a75-36bb-467d-84d7-9b17c68107f2" xlink:href="alts-20241228.xsd#alts_ARCAAndSubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d429e662-98ba-4063-acb0-744d1ab4b040" xlink:to="loc_alts_ARCAAndSubsidiariesMember_d0a82a75-36bb-467d-84d7-9b17c68107f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_554d3de5-9541-435d-9124-e1b8a38379ea" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_TotalGuaranteedConsideration_75c00566-bc25-4cae-a5e3-94e54ea883f9" xlink:href="alts-20241228.xsd#alts_TotalGuaranteedConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_TotalGuaranteedConsideration_75c00566-bc25-4cae-a5e3-94e54ea883f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PaymentFromBuyer_4869cb6a-6b8b-48dc-8d86-f1695a0589ef" xlink:href="alts-20241228.xsd#alts_PaymentFromBuyer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_PaymentFromBuyer_4869cb6a-6b8b-48dc-8d86-f1695a0589ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NetConsideration_09ce55ad-dc54-4bf7-bd77-171969469eea" xlink:href="alts-20241228.xsd#alts_NetConsideration"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_NetConsideration_09ce55ad-dc54-4bf7-bd77-171969469eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfAccountsPayable_a4cb96b9-7d8d-484d-90a5-18e0d45c6d2a" xlink:href="alts-20241228.xsd#alts_DisposalOfAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_DisposalOfAccountsPayable_a4cb96b9-7d8d-484d-90a5-18e0d45c6d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfAccruedLiability_5e191186-b663-469d-9e22-61afc38d21f8" xlink:href="alts-20241228.xsd#alts_DisposalOfAccruedLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_DisposalOfAccruedLiability_5e191186-b663-469d-9e22-61afc38d21f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfAccruedLiabilityCaliforniaStateSalesTax_e7d39b92-a347-4fb4-aa21-10d11c848be6" xlink:href="alts-20241228.xsd#alts_DisposalOfAccruedLiabilityCaliforniaStateSalesTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_DisposalOfAccruedLiabilityCaliforniaStateSalesTax_e7d39b92-a347-4fb4-aa21-10d11c848be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfLeaseLiability_7394db35-1923-41d8-9805-ce401247370a" xlink:href="alts-20241228.xsd#alts_DisposalOfLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_DisposalOfLeaseLiability_7394db35-1923-41d8-9805-ce401247370a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfDebt_c05cc51c-42ac-4f7a-b294-0160ed0fe38e" xlink:href="alts-20241228.xsd#alts_DisposalOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_DisposalOfDebt_c05cc51c-42ac-4f7a-b294-0160ed0fe38e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_df47c0f2-3dfb-4e12-a7ba-dbdb750348d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_df47c0f2-3dfb-4e12-a7ba-dbdb750348d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_TotalDisposalOfLiability_16b5817d-07f2-4241-a3a5-2e89e2c5a73d" xlink:href="alts-20241228.xsd#alts_TotalDisposalOfLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_TotalDisposalOfLiability_16b5817d-07f2-4241-a3a5-2e89e2c5a73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_TotalConsiderations_2dced91a-4d0f-4ae2-8194-b68fb803384f" xlink:href="alts-20241228.xsd#alts_TotalConsiderations"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_TotalConsiderations_2dced91a-4d0f-4ae2-8194-b68fb803384f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_CashDisposal_7af38e31-e574-4470-a4ad-d06a38634069" xlink:href="alts-20241228.xsd#alts_CashDisposal"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_CashDisposal_7af38e31-e574-4470-a4ad-d06a38634069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfAccountsReceivable_823af8f8-986f-4d1f-9493-1a6294da390e" xlink:href="alts-20241228.xsd#alts_DisposalOfAccountsReceivable"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_DisposalOfAccountsReceivable_823af8f8-986f-4d1f-9493-1a6294da390e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfInventory_4eafb7ee-d371-402b-9de6-684f157f68a7" xlink:href="alts-20241228.xsd#alts_DisposalOfInventory"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_DisposalOfInventory_4eafb7ee-d371-402b-9de6-684f157f68a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfPropertyPlantAndEquipment_51fe3a14-c3dd-4ee7-b093-b0df4222f33d" xlink:href="alts-20241228.xsd#alts_DisposalOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_DisposalOfPropertyPlantAndEquipment_51fe3a14-c3dd-4ee7-b093-b0df4222f33d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfIntangibleAssets_06a7bd99-a397-493f-af7d-6f1a5410b19a" xlink:href="alts-20241228.xsd#alts_DisposalOfIntangibleAssets"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_DisposalOfIntangibleAssets_06a7bd99-a397-493f-af7d-6f1a5410b19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfRightOfUseAssets_33a6bc70-2b8f-4f49-ab52-366743ddd43d" xlink:href="alts-20241228.xsd#alts_DisposalOfRightOfUseAssets"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_DisposalOfRightOfUseAssets_33a6bc70-2b8f-4f49-ab52-366743ddd43d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalOfOtherAssets_2e7096fb-4b09-4dd8-b51f-360b8f702348" xlink:href="alts-20241228.xsd#alts_DisposalOfOtherAssets"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_DisposalOfOtherAssets_2e7096fb-4b09-4dd8-b51f-360b8f702348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_TotalDisposalOfAssets_8aa0437c-e12a-4f8e-a718-a826796b4d10" xlink:href="alts-20241228.xsd#alts_TotalDisposalOfAssets"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_TotalDisposalOfAssets_8aa0437c-e12a-4f8e-a718-a826796b4d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_TotalGainOnSale_4a69336e-44e0-4988-bc9f-7feac44af69d" xlink:href="alts-20241228.xsd#alts_TotalGainOnSale"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_cd716d1a-153b-4276-96f8-8bec5196e4a9" xlink:to="loc_alts_TotalGainOnSale_4a69336e-44e0-4988-bc9f-7feac44af69d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_be3ff3b1-e652-42c0-a013-815655d0de56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9d5ce94d-0a2a-4977-84f4-3a2552d517f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_be3ff3b1-e652-42c0-a013-815655d0de56" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9d5ce94d-0a2a-4977-84f4-3a2552d517f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_554380a5-9b57-4e0e-95f3-fb7f44257bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9d5ce94d-0a2a-4977-84f4-3a2552d517f9" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_554380a5-9b57-4e0e-95f3-fb7f44257bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_85110004-66e3-4aaf-8592-18d7d2c78567" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_554380a5-9b57-4e0e-95f3-fb7f44257bc8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_85110004-66e3-4aaf-8592-18d7d2c78567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_3211c533-1264-455d-8ecf-e57408ee86db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_85110004-66e3-4aaf-8592-18d7d2c78567" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_3211c533-1264-455d-8ecf-e57408ee86db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_37c4bb5e-c45a-4317-8435-a2c1f6d05d17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9d5ce94d-0a2a-4977-84f4-3a2552d517f9" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_37c4bb5e-c45a-4317-8435-a2c1f6d05d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8177d096-7f31-492e-a88b-4d87e217313e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_37c4bb5e-c45a-4317-8435-a2c1f6d05d17" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8177d096-7f31-492e-a88b-4d87e217313e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ARCAAndSubsidiariesMember_0f210800-8a47-4366-be27-5446f1a54ae4" xlink:href="alts-20241228.xsd#alts_ARCAAndSubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8177d096-7f31-492e-a88b-4d87e217313e" xlink:to="loc_alts_ARCAAndSubsidiariesMember_0f210800-8a47-4366-be27-5446f1a54ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a1b00151-2b11-42e9-96bf-e4b75cbd6255" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9d5ce94d-0a2a-4977-84f4-3a2552d517f9" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a1b00151-2b11-42e9-96bf-e4b75cbd6255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6715414d-3f38-4a47-b3f5-7edd95dfb356" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a1b00151-2b11-42e9-96bf-e4b75cbd6255" xlink:to="loc_us-gaap_SegmentDomain_6715414d-3f38-4a47-b3f5-7edd95dfb356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RecyclingSegmentMember_a9ebae33-2ed5-4a93-98ab-9a54b92e146f" xlink:href="alts-20241228.xsd#alts_RecyclingSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6715414d-3f38-4a47-b3f5-7edd95dfb356" xlink:to="loc_alts_RecyclingSegmentMember_a9ebae33-2ed5-4a93-98ab-9a54b92e146f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_95d78dde-a071-431f-bbd8-cc9f7ac003ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_9d5ce94d-0a2a-4977-84f4-3a2552d517f9" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_95d78dde-a071-431f-bbd8-cc9f7ac003ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_c7d87493-efec-477d-9814-668ee1c2151c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_95d78dde-a071-431f-bbd8-cc9f7ac003ed" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_c7d87493-efec-477d-9814-668ee1c2151c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_4321c6d5-23f5-4eb2-b2f5-ef2b9e509c02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_95d78dde-a071-431f-bbd8-cc9f7ac003ed" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_4321c6d5-23f5-4eb2-b2f5-ef2b9e509c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_cbe5ec33-ba63-4dbe-93ce-d9a155fe4e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_95d78dde-a071-431f-bbd8-cc9f7ac003ed" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_cbe5ec33-ba63-4dbe-93ce-d9a155fe4e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OperatingExpensesFromDiscontinuedOperationsAbstract_6cb04e0e-a81f-4730-b5a0-a2511e7ecc85" xlink:href="alts-20241228.xsd#alts_OperatingExpensesFromDiscontinuedOperationsAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_95d78dde-a071-431f-bbd8-cc9f7ac003ed" xlink:to="loc_alts_OperatingExpensesFromDiscontinuedOperationsAbstract_6cb04e0e-a81f-4730-b5a0-a2511e7ecc85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_9d3921ae-2617-4e0d-9309-9f25221e9c88" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_OperatingExpensesFromDiscontinuedOperationsAbstract_6cb04e0e-a81f-4730-b5a0-a2511e7ecc85" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_9d3921ae-2617-4e0d-9309-9f25221e9c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_7a5b6794-6d4a-4920-ba33-8c3371b2df1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_OperatingExpensesFromDiscontinuedOperationsAbstract_6cb04e0e-a81f-4730-b5a0-a2511e7ecc85" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_7a5b6794-6d4a-4920-ba33-8c3371b2df1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalGroupIncludingDiscontinuedOperationTotalOperatingIncomeExpensesFromDiscontinuedOperations_ed282ac8-9de2-4421-a5fc-7dabb7aa4d35" xlink:href="alts-20241228.xsd#alts_DisposalGroupIncludingDiscontinuedOperationTotalOperatingIncomeExpensesFromDiscontinuedOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_OperatingExpensesFromDiscontinuedOperationsAbstract_6cb04e0e-a81f-4730-b5a0-a2511e7ecc85" xlink:to="loc_alts_DisposalGroupIncludingDiscontinuedOperationTotalOperatingIncomeExpensesFromDiscontinuedOperations_ed282ac8-9de2-4421-a5fc-7dabb7aa4d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_d82512c5-8087-4907-a6d8-be12289c4b54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_OperatingExpensesFromDiscontinuedOperationsAbstract_6cb04e0e-a81f-4730-b5a0-a2511e7ecc85" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_d82512c5-8087-4907-a6d8-be12289c4b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract_3deb7479-68ba-47cf-b460-71dec3ba54ed" xlink:href="alts-20241228.xsd#alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_95d78dde-a071-431f-bbd8-cc9f7ac003ed" xlink:to="loc_alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract_3deb7479-68ba-47cf-b460-71dec3ba54ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_a2474d65-c3e2-4db2-86f0-b69f37bffc29" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract_3deb7479-68ba-47cf-b460-71dec3ba54ed" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense_a2474d65-c3e2-4db2-86f0-b69f37bffc29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet_2dd721d4-99f8-403f-9418-00f52545f8fa" xlink:href="alts-20241228.xsd#alts_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract_3deb7479-68ba-47cf-b460-71dec3ba54ed" xlink:to="loc_alts_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet_2dd721d4-99f8-403f-9418-00f52545f8fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DisposalGroupIncludingDiscontinuedOperationsTotalOtherIncomeLossNet_b3e2eaef-50a6-45f0-9852-5ed210c87487" xlink:href="alts-20241228.xsd#alts_DisposalGroupIncludingDiscontinuedOperationsTotalOtherIncomeLossNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract_3deb7479-68ba-47cf-b460-71dec3ba54ed" xlink:to="loc_alts_DisposalGroupIncludingDiscontinuedOperationsTotalOtherIncomeLossNet_b3e2eaef-50a6-45f0-9852-5ed210c87487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_07c9e263-c069-4da1-be83-e51e0c2aa920" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract_3deb7479-68ba-47cf-b460-71dec3ba54ed" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_07c9e263-c069-4da1-be83-e51e0c2aa920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_d1ea3263-6eb8-4503-a977-dcd037fe7f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract_3deb7479-68ba-47cf-b460-71dec3ba54ed" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_d1ea3263-6eb8-4503-a977-dcd037fe7f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_a4979b81-df76-448c-a1a7-fd9e10f39264" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract_3deb7479-68ba-47cf-b460-71dec3ba54ed" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_a4979b81-df76-448c-a1a7-fd9e10f39264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_ece57db6-16ca-4d77-bcde-a06c04e350d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_32557b2b-1e64-40e1-8d5c-0959dd1d4682" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_ece57db6-16ca-4d77-bcde-a06c04e350d8" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_32557b2b-1e64-40e1-8d5c-0959dd1d4682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_642dcedb-a66e-44c6-a436-630949356c26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_32557b2b-1e64-40e1-8d5c-0959dd1d4682" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_642dcedb-a66e-44c6-a436-630949356c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_2ae77460-74d7-4733-9739-78a30d0c77b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_642dcedb-a66e-44c6-a436-630949356c26" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_2ae77460-74d7-4733-9739-78a30d0c77b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_5b6f3b29-f0d1-4b55-93e1-0b3cb12b61d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_2ae77460-74d7-4733-9739-78a30d0c77b6" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_5b6f3b29-f0d1-4b55-93e1-0b3cb12b61d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a54507a8-78ef-4b8e-b314-1f1fb37da0de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_32557b2b-1e64-40e1-8d5c-0959dd1d4682" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a54507a8-78ef-4b8e-b314-1f1fb37da0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_11a375bd-c981-41d3-9295-05d4014719c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a54507a8-78ef-4b8e-b314-1f1fb37da0de" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_11a375bd-c981-41d3-9295-05d4014719c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ARCAAndSubsidiariesMember_85ff439f-b76e-4975-833a-27f44413fa09" xlink:href="alts-20241228.xsd#alts_ARCAAndSubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_11a375bd-c981-41d3-9295-05d4014719c7" xlink:to="loc_alts_ARCAAndSubsidiariesMember_85ff439f-b76e-4975-833a-27f44413fa09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_803626f4-aa1e-49ac-a363-9f054a62a5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_32557b2b-1e64-40e1-8d5c-0959dd1d4682" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_803626f4-aa1e-49ac-a363-9f054a62a5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f6080acc-d574-47c5-8bbc-62e989bbbee7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_803626f4-aa1e-49ac-a363-9f054a62a5d8" xlink:to="loc_us-gaap_SegmentDomain_f6080acc-d574-47c5-8bbc-62e989bbbee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RecyclingSegmentMember_a025f163-9ad9-409d-9114-7ca553d7fcce" xlink:href="alts-20241228.xsd#alts_RecyclingSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f6080acc-d574-47c5-8bbc-62e989bbbee7" xlink:to="loc_alts_RecyclingSegmentMember_a025f163-9ad9-409d-9114-7ca553d7fcce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2bf7ec8f-efec-4380-b0d6-c387c3d37eac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_32557b2b-1e64-40e1-8d5c-0959dd1d4682" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2bf7ec8f-efec-4380-b0d6-c387c3d37eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DiscontinuedOperatingActivities_230b81c3-394b-4d9c-b183-2db4f409c213" xlink:href="alts-20241228.xsd#alts_DiscontinuedOperatingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2bf7ec8f-efec-4380-b0d6-c387c3d37eac" xlink:to="loc_alts_DiscontinuedOperatingActivities_230b81c3-394b-4d9c-b183-2db4f409c213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_95a66e8a-6f25-44f2-a4d4-3f2a05413d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_DiscontinuedOperatingActivities_230b81c3-394b-4d9c-b183-2db4f409c213" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_95a66e8a-6f25-44f2-a4d4-3f2a05413d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_013aaf91-6a65-40b2-bac0-cf58001da482" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_DiscontinuedOperatingActivities_230b81c3-394b-4d9c-b183-2db4f409c213" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_013aaf91-6a65-40b2-bac0-cf58001da482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_6a296c31-ae11-43c9-88d8-0f1c0a5d7a80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_DiscontinuedOperatingActivities_230b81c3-394b-4d9c-b183-2db4f409c213" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_6a296c31-ae11-43c9-88d8-0f1c0a5d7a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AmortizationOfRightOfUseAssets_f984deb2-db04-4a16-88fa-e6e4bdff4e9a" xlink:href="alts-20241228.xsd#alts_AmortizationOfRightOfUseAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_DiscontinuedOperatingActivities_230b81c3-394b-4d9c-b183-2db4f409c213" xlink:to="loc_alts_AmortizationOfRightOfUseAssets_f984deb2-db04-4a16-88fa-e6e4bdff4e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_GainOnSaleNetOfCash_d058a836-6d98-44bb-83b9-f488f7e72d1c" xlink:href="alts-20241228.xsd#alts_GainOnSaleNetOfCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_DiscontinuedOperatingActivities_230b81c3-394b-4d9c-b183-2db4f409c213" xlink:to="loc_alts_GainOnSaleNetOfCash_d058a836-6d98-44bb-83b9-f488f7e72d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7cba04d7-2af8-4b8b-baee-04a988fea6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_DiscontinuedOperatingActivities_230b81c3-394b-4d9c-b183-2db4f409c213" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7cba04d7-2af8-4b8b-baee-04a988fea6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_4fec7db6-7a6c-477e-8bad-3eb5261a1217" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7cba04d7-2af8-4b8b-baee-04a988fea6b8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_4fec7db6-7a6c-477e-8bad-3eb5261a1217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_8e5664a0-80ec-4bac-904b-1d6bc10e586e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7cba04d7-2af8-4b8b-baee-04a988fea6b8" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_8e5664a0-80ec-4bac-904b-1d6bc10e586e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_7b8c0c4b-b18c-460f-bab4-107a242b8c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7cba04d7-2af8-4b8b-baee-04a988fea6b8" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_7b8c0c4b-b18c-460f-bab4-107a242b8c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_bbf09092-ef5b-4399-9789-631259f4afb6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7cba04d7-2af8-4b8b-baee-04a988fea6b8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_bbf09092-ef5b-4399-9789-631259f4afb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_8b6c9a1a-90c2-4799-80d9-7fb7d35c7723" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7cba04d7-2af8-4b8b-baee-04a988fea6b8" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_8b6c9a1a-90c2-4799-80d9-7fb7d35c7723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_3cefb376-dec5-4cfd-a2f3-4d0353990e33" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7cba04d7-2af8-4b8b-baee-04a988fea6b8" xlink:to="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_3cefb376-dec5-4cfd-a2f3-4d0353990e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4c641221-d6b6-40cb-bc9d-ff6c7e89df8a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7cba04d7-2af8-4b8b-baee-04a988fea6b8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4c641221-d6b6-40cb-bc9d-ff6c7e89df8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DiscontinuedInvestingActivities_8b03dc27-37d7-48d2-ac7f-a0f2c8086d16" xlink:href="alts-20241228.xsd#alts_DiscontinuedInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2bf7ec8f-efec-4380-b0d6-c387c3d37eac" xlink:to="loc_alts_DiscontinuedInvestingActivities_8b03dc27-37d7-48d2-ac7f-a0f2c8086d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7fcd2b87-b98f-4940-9332-d66880d45059" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_DiscontinuedInvestingActivities_8b03dc27-37d7-48d2-ac7f-a0f2c8086d16" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7fcd2b87-b98f-4940-9332-d66880d45059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_20424bfa-226c-467a-9b40-71f76ebcfcd3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_DiscontinuedInvestingActivities_8b03dc27-37d7-48d2-ac7f-a0f2c8086d16" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_20424bfa-226c-467a-9b40-71f76ebcfcd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_2ff722bc-db2b-477e-a978-b997b53730ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_DiscontinuedInvestingActivities_8b03dc27-37d7-48d2-ac7f-a0f2c8086d16" xlink:to="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_2ff722bc-db2b-477e-a978-b997b53730ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DiscontinuedFinancingActivities_a2e1d5bb-2dbd-4568-8ae2-077818e5d22c" xlink:href="alts-20241228.xsd#alts_DiscontinuedFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2bf7ec8f-efec-4380-b0d6-c387c3d37eac" xlink:to="loc_alts_DiscontinuedFinancingActivities_a2e1d5bb-2dbd-4568-8ae2-077818e5d22c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_168c1d37-1044-495a-8ab5-bb4a623d573f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_DiscontinuedFinancingActivities_a2e1d5bb-2dbd-4568-8ae2-077818e5d22c" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_168c1d37-1044-495a-8ab5-bb4a623d573f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt_8e494708-e3cc-4eb8-b688-62dc03df68cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_DiscontinuedFinancingActivities_a2e1d5bb-2dbd-4568-8ae2-077818e5d22c" xlink:to="loc_us-gaap_RepaymentsOfRelatedPartyDebt_8e494708-e3cc-4eb8-b688-62dc03df68cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_03a9abe3-0859-4d90-80e4-4ace032b13ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_DiscontinuedFinancingActivities_a2e1d5bb-2dbd-4568-8ae2-077818e5d22c" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_03a9abe3-0859-4d90-80e4-4ace032b13ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_8645d956-fc8c-4d5f-82e2-360f6da49ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_DiscontinuedFinancingActivities_a2e1d5bb-2dbd-4568-8ae2-077818e5d22c" xlink:to="loc_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations_8645d956-fc8c-4d5f-82e2-360f6da49ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_892c3252-c6b9-4ef0-8453-47d1c3434a58" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_DiscontinuedFinancingActivities_a2e1d5bb-2dbd-4568-8ae2-077818e5d22c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_892c3252-c6b9-4ef0-8453-47d1c3434a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_d347b01c-aac7-47b7-8e72-4684232cd2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2bf7ec8f-efec-4380-b0d6-c387c3d37eac" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_d347b01c-aac7-47b7-8e72-4684232cd2ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cb6b3d98-adc4-4f3d-8ef3-c6bdcb75bbeb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2bf7ec8f-efec-4380-b0d6-c387c3d37eac" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cb6b3d98-adc4-4f3d-8ef3-c6bdcb75bbeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_159048f7-d807-48cd-97f9-910098880374" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2bf7ec8f-efec-4380-b0d6-c387c3d37eac" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_159048f7-d807-48cd-97f9-910098880374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_b69ea704-7b35-4b26-bcb4-edaa67c948ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2bf7ec8f-efec-4380-b0d6-c387c3d37eac" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_b69ea704-7b35-4b26-bcb4-edaa67c948ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/PrepaidsandothercurrentassetsDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#PrepaidsandothercurrentassetsDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/PrepaidsandothercurrentassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_48de2edd-15a9-4a8b-9615-6227f463f8aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_e7317835-c54c-4a52-8210-1beb8ceba98f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidInsurance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_48de2edd-15a9-4a8b-9615-6227f463f8aa" xlink:to="loc_us-gaap_PrepaidInsurance_e7317835-c54c-4a52-8210-1beb8ceba98f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_85ae8f11-d27b-440b-8f3a-84e99fada391" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_48de2edd-15a9-4a8b-9615-6227f463f8aa" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent_85ae8f11-d27b-440b-8f3a-84e99fada391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_637901bc-6e2c-4947-88ea-a497d0b12961" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_48de2edd-15a9-4a8b-9615-6227f463f8aa" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_637901bc-6e2c-4947-88ea-a497d0b12961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#PropertyandEquipmentScheduleofPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f5a9031f-62c7-4c96-b5e2-b8534f7f2685" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ead949dc-dacc-432c-b26b-b121543a39f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f5a9031f-62c7-4c96-b5e2-b8534f7f2685" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ead949dc-dacc-432c-b26b-b121543a39f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c1dc4a7d-fc30-4558-89a3-177671914742" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ead949dc-dacc-432c-b26b-b121543a39f1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c1dc4a7d-fc30-4558-89a3-177671914742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_dcf83149-3829-4401-a90f-0749a554284a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c1dc4a7d-fc30-4558-89a3-177671914742" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_dcf83149-3829-4401-a90f-0749a554284a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetUnderConstructionMember_c53c38e3-e7fb-4713-b0c2-47c25c5085af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetUnderConstructionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_dcf83149-3829-4401-a90f-0749a554284a" xlink:to="loc_us-gaap_AssetUnderConstructionMember_c53c38e3-e7fb-4713-b0c2-47c25c5085af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d01ca818-edd3-4030-bbe2-d4c929bda9f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ead949dc-dacc-432c-b26b-b121543a39f1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d01ca818-edd3-4030-bbe2-d4c929bda9f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3691bad6-1218-41ae-b438-9bd5bec74994" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d01ca818-edd3-4030-bbe2-d4c929bda9f1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3691bad6-1218-41ae-b438-9bd5bec74994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/PropertyandEquipmentNarrativeDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#PropertyandEquipmentNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/PropertyandEquipmentNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ed47f022-e604-4b86-a193-61a84f024ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_ff96f82a-4e97-4ee2-8474-2aa8cef85ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ed47f022-e604-4b86-a193-61a84f024ad6" xlink:to="loc_us-gaap_Depreciation_ff96f82a-4e97-4ee2-8474-2aa8cef85ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/LeasesScheduleofCompanysRightofUseAssetsandLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#LeasesScheduleofCompanysRightofUseAssetsandLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/LeasesScheduleofCompanysRightofUseAssetsandLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c897deae-4bce-4793-a86e-8e0e710dd465" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_798b3c8d-437b-4412-ac2e-5d725d637bed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c897deae-4bce-4793-a86e-8e0e710dd465" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_798b3c8d-437b-4412-ac2e-5d725d637bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_d26b0772-5b01-486f-92c5-33393125297d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c897deae-4bce-4793-a86e-8e0e710dd465" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_d26b0772-5b01-486f-92c5-33393125297d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_256de533-9f7f-4294-b9c0-d10faa2c01c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c897deae-4bce-4793-a86e-8e0e710dd465" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_256de533-9f7f-4294-b9c0-d10faa2c01c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_1a9a1cc7-2806-475e-8010-f2e0768ec401" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1e2ef9d5-97da-444c-8ac3-759e751c7834" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1a9a1cc7-2806-475e-8010-f2e0768ec401" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1e2ef9d5-97da-444c-8ac3-759e751c7834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_7396f86a-3fb2-4996-9e6b-43ac7d0a5632" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1a9a1cc7-2806-475e-8010-f2e0768ec401" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_7396f86a-3fb2-4996-9e6b-43ac7d0a5632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_3680c43b-226b-4046-8b54-c40caac10509" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1a9a1cc7-2806-475e-8010-f2e0768ec401" xlink:to="loc_us-gaap_OperatingLeasePayments_3680c43b-226b-4046-8b54-c40caac10509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_896310a4-8782-4520-a38f-a97a98a64fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1a9a1cc7-2806-475e-8010-f2e0768ec401" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_896310a4-8782-4520-a38f-a97a98a64fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d56608fe-9c2f-4a8a-8432-a1f744c7f2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_97c2ed57-55bd-4a0a-b412-1b476cbcad34" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d56608fe-9c2f-4a8a-8432-a1f744c7f2b1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_97c2ed57-55bd-4a0a-b412-1b476cbcad34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d1a241ac-8c3b-4de6-b8f4-44e810e98d23" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d56608fe-9c2f-4a8a-8432-a1f744c7f2b1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d1a241ac-8c3b-4de6-b8f4-44e810e98d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_cc31d423-4812-40e2-8309-abd75b2c537a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d56608fe-9c2f-4a8a-8432-a1f744c7f2b1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_cc31d423-4812-40e2-8309-abd75b2c537a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_485777de-5f5d-4c60-860a-c81f336dcf44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d56608fe-9c2f-4a8a-8432-a1f744c7f2b1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_485777de-5f5d-4c60-860a-c81f336dcf44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_98a85794-50f9-47bf-b8fd-88d766d8e195" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d56608fe-9c2f-4a8a-8432-a1f744c7f2b1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_98a85794-50f9-47bf-b8fd-88d766d8e195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_bbe9787c-a69a-45b9-a802-3d15d65bd897" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d56608fe-9c2f-4a8a-8432-a1f744c7f2b1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_bbe9787c-a69a-45b9-a802-3d15d65bd897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c00e5b6a-af0c-480e-9f1c-9499d9c901df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d56608fe-9c2f-4a8a-8432-a1f744c7f2b1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c00e5b6a-af0c-480e-9f1c-9499d9c901df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_d185a0af-1960-417b-b83f-9aac9bbf2f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d56608fe-9c2f-4a8a-8432-a1f744c7f2b1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_d185a0af-1960-417b-b83f-9aac9bbf2f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_44a23887-2544-4537-8a5a-c081846e6b62" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d56608fe-9c2f-4a8a-8432-a1f744c7f2b1" xlink:to="loc_us-gaap_OperatingLeaseLiability_44a23887-2544-4537-8a5a-c081846e6b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/NotesreceivableDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#NotesreceivableDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/NotesreceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_fea83909-cc49-49e3-b776-8847852c900f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_6974f17c-d295-45b7-a2b9-ff6f41cce1f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_fea83909-cc49-49e3-b776-8847852c900f" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_6974f17c-d295-45b7-a2b9-ff6f41cce1f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_70f1eb20-9402-4089-853b-149dfd180a6b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_6974f17c-d295-45b7-a2b9-ff6f41cce1f6" xlink:to="loc_srt_CounterpartyNameAxis_70f1eb20-9402-4089-853b-149dfd180a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c358bfc3-a25d-4b3c-bc77-4c25fef01421" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_70f1eb20-9402-4089-853b-149dfd180a6b" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c358bfc3-a25d-4b3c-bc77-4c25fef01421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SpyrTechnologiesIncMember_87357f14-5617-444d-980c-f8a19a0a04b9" xlink:href="alts-20241228.xsd#alts_SpyrTechnologiesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c358bfc3-a25d-4b3c-bc77-4c25fef01421" xlink:to="loc_alts_SpyrTechnologiesIncMember_87357f14-5617-444d-980c-f8a19a0a04b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_VM7CorporationMember_7916dc41-2b4e-4196-be22-96ff7678a02d" xlink:href="alts-20241228.xsd#alts_VM7CorporationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c358bfc3-a25d-4b3c-bc77-4c25fef01421" xlink:to="loc_alts_VM7CorporationMember_7916dc41-2b4e-4196-be22-96ff7678a02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e1eedf72-6755-44fb-b907-047fa6ebd6ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_6974f17c-d295-45b7-a2b9-ff6f41cce1f6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e1eedf72-6755-44fb-b907-047fa6ebd6ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a27f566b-f089-45be-9e72-1f421e8fa92c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e1eedf72-6755-44fb-b907-047fa6ebd6ef" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a27f566b-f089-45be-9e72-1f421e8fa92c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_GeoTraqIncMember_0e351bb0-24e2-4e40-b494-8fda96e9cb96" xlink:href="alts-20241228.xsd#alts_GeoTraqIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a27f566b-f089-45be-9e72-1f421e8fa92c" xlink:to="loc_alts_GeoTraqIncMember_0e351bb0-24e2-4e40-b494-8fda96e9cb96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_8f434206-de67-4594-a43d-33b9815053da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_6974f17c-d295-45b7-a2b9-ff6f41cce1f6" xlink:to="loc_us-gaap_TypeOfArrangementAxis_8f434206-de67-4594-a43d-33b9815053da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_475c468d-2d6e-48c6-aacd-809813a4210a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_8f434206-de67-4594-a43d-33b9815053da" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_475c468d-2d6e-48c6-aacd-809813a4210a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockPurchaseAgreementMember_13db7949-7212-4a9f-8896-0590d08f1f7e" xlink:href="alts-20241228.xsd#alts_StockPurchaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_475c468d-2d6e-48c6-aacd-809813a4210a" xlink:to="loc_alts_StockPurchaseAgreementMember_13db7949-7212-4a9f-8896-0590d08f1f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c096b956-353c-4d7b-aff0-5b036c306453" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_6974f17c-d295-45b7-a2b9-ff6f41cce1f6" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c096b956-353c-4d7b-aff0-5b036c306453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NotesReceivableTerm_b4661982-1f95-4fa5-9b1a-f302937971ee" xlink:href="alts-20241228.xsd#alts_NotesReceivableTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c096b956-353c-4d7b-aff0-5b036c306453" xlink:to="loc_alts_NotesReceivableTerm_b4661982-1f95-4fa5-9b1a-f302937971ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NoteReceivableFaceAmount_f127874b-94f0-4a6a-a604-4dca98e19234" xlink:href="alts-20241228.xsd#alts_NoteReceivableFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c096b956-353c-4d7b-aff0-5b036c306453" xlink:to="loc_alts_NoteReceivableFaceAmount_f127874b-94f0-4a6a-a604-4dca98e19234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NoteReceivableStatedInterestRate_a22138f5-7142-4feb-a656-3624e072e1d2" xlink:href="alts-20241228.xsd#alts_NoteReceivableStatedInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c096b956-353c-4d7b-aff0-5b036c306453" xlink:to="loc_alts_NoteReceivableStatedInterestRate_a22138f5-7142-4feb-a656-3624e072e1d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_bf0b3f17-ebb6-4aff-bc45-e97ba7925fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c096b956-353c-4d7b-aff0-5b036c306453" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_bf0b3f17-ebb6-4aff-bc45-e97ba7925fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable_e869d94a-1ad1-4967-8ad0-d792fbcb274c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c096b956-353c-4d7b-aff0-5b036c306453" xlink:to="loc_us-gaap_InterestReceivable_e869d94a-1ad1-4967-8ad0-d792fbcb274c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_GainLossOnWriteOffOfNotesReceivable_37a81316-fe21-4d3d-a430-9e554c65e736" xlink:href="alts-20241228.xsd#alts_GainLossOnWriteOffOfNotesReceivable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c096b956-353c-4d7b-aff0-5b036c306453" xlink:to="loc_alts_GainLossOnWriteOffOfNotesReceivable_37a81316-fe21-4d3d-a430-9e554c65e736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeInterestEarningAsset_531678d2-849a-4917-bdf0-4c46cb6f46cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeInterestEarningAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c096b956-353c-4d7b-aff0-5b036c306453" xlink:to="loc_us-gaap_InterestIncomeInterestEarningAsset_531678d2-849a-4917-bdf0-4c46cb6f46cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_c60724c4-605b-4fb9-a874-320c4e593b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c096b956-353c-4d7b-aff0-5b036c306453" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_c60724c4-605b-4fb9-a874-320c4e593b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForCommissions_f8037a7d-aab3-44d0-919a-61a55d31aec8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForCommissions"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c096b956-353c-4d7b-aff0-5b036c306453" xlink:to="loc_us-gaap_PaymentsForCommissions_f8037a7d-aab3-44d0-919a-61a55d31aec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RevisedDiscountAmount_80a39c2e-a0f8-488c-80bd-bc3fcf272819" xlink:href="alts-20241228.xsd#alts_RevisedDiscountAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c096b956-353c-4d7b-aff0-5b036c306453" xlink:to="loc_alts_RevisedDiscountAmount_80a39c2e-a0f8-488c-80bd-bc3fcf272819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_2bede758-3179-468e-825a-e24a0ea75fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c096b956-353c-4d7b-aff0-5b036c306453" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_2bede758-3179-468e-825a-e24a0ea75fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/IntangibleassetsScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#IntangibleassetsScheduleofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/IntangibleassetsScheduleofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fbad1ed4-4bbd-4fcf-b780-34e1beffe3b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_70f6f3b6-a8d1-4e7c-9255-0d58531cd57e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fbad1ed4-4bbd-4fcf-b780-34e1beffe3b3" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_70f6f3b6-a8d1-4e7c-9255-0d58531cd57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c7788a11-129c-423d-9c9c-5ad76a50e4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_70f6f3b6-a8d1-4e7c-9255-0d58531cd57e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c7788a11-129c-423d-9c9c-5ad76a50e4bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1b3e9b7-ab25-4152-ad9d-0d341228ea2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c7788a11-129c-423d-9c9c-5ad76a50e4bf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1b3e9b7-ab25-4152-ad9d-0d341228ea2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SoinIntangiblesMember_9390545d-8c89-4d1b-a5ac-63810ecf5cd3" xlink:href="alts-20241228.xsd#alts_SoinIntangiblesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1b3e9b7-ab25-4152-ad9d-0d341228ea2c" xlink:to="loc_alts_SoinIntangiblesMember_9390545d-8c89-4d1b-a5ac-63810ecf5cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_CryptocurrencyExchangeSoftwareIntangibleMember_1185cdf4-76d9-4ba4-97f7-2dd1d981fc44" xlink:href="alts-20241228.xsd#alts_CryptocurrencyExchangeSoftwareIntangibleMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1b3e9b7-ab25-4152-ad9d-0d341228ea2c" xlink:to="loc_alts_CryptocurrencyExchangeSoftwareIntangibleMember_1185cdf4-76d9-4ba4-97f7-2dd1d981fc44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PatentsAndDomainsMember_fcac0095-a6e2-45b5-b17a-b2cb6a591631" xlink:href="alts-20241228.xsd#alts_PatentsAndDomainsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1b3e9b7-ab25-4152-ad9d-0d341228ea2c" xlink:to="loc_alts_PatentsAndDomainsMember_fcac0095-a6e2-45b5-b17a-b2cb6a591631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_0e1ae506-6b63-4f57-9238-cc7204d2098b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1b3e9b7-ab25-4152-ad9d-0d341228ea2c" xlink:to="loc_us-gaap_TradeNamesMember_0e1ae506-6b63-4f57-9238-cc7204d2098b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3e169dad-27c6-408e-bca9-d167ca90dbfa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1b3e9b7-ab25-4152-ad9d-0d341228ea2c" xlink:to="loc_us-gaap_CustomerRelationshipsMember_3e169dad-27c6-408e-bca9-d167ca90dbfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_6d0e9d02-f5c1-47f2-ba69-5dbd95100307" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1b3e9b7-ab25-4152-ad9d-0d341228ea2c" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_6d0e9d02-f5c1-47f2-ba69-5dbd95100307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fe6eeea3-9f3c-4a88-a01a-de28c9e2ee50" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_70f6f3b6-a8d1-4e7c-9255-0d58531cd57e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fe6eeea3-9f3c-4a88-a01a-de28c9e2ee50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_8b46495e-7fa6-4a04-b0b3-4e60d2dbe652" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fe6eeea3-9f3c-4a88-a01a-de28c9e2ee50" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_8b46495e-7fa6-4a04-b0b3-4e60d2dbe652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1861e453-04bb-4148-a25c-89f8144490b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fe6eeea3-9f3c-4a88-a01a-de28c9e2ee50" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1861e453-04bb-4148-a25c-89f8144490b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7b436ddb-9cf2-4295-8875-34aacc610662" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_fe6eeea3-9f3c-4a88-a01a-de28c9e2ee50" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7b436ddb-9cf2-4295-8875-34aacc610662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/IntangibleassetsNarrativeDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#IntangibleassetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/IntangibleassetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_82e57952-26be-4430-ba42-0eabbc103597" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9d839578-c9c2-4c5c-8d41-1892ddf73bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_82e57952-26be-4430-ba42-0eabbc103597" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9d839578-c9c2-4c5c-8d41-1892ddf73bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_6ca70ba3-9a01-4597-a37c-1c8d46afd087" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9d839578-c9c2-4c5c-8d41-1892ddf73bd4" xlink:to="loc_us-gaap_AssetAcquisitionAxis_6ca70ba3-9a01-4597-a37c-1c8d46afd087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_e91292a9-7560-4600-a9ca-78acd9128e50" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_6ca70ba3-9a01-4597-a37c-1c8d46afd087" xlink:to="loc_us-gaap_AssetAcquisitionDomain_e91292a9-7560-4600-a9ca-78acd9128e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_QodenTechnologiesLLCMember_727e86ec-e3f5-4a72-9761-4830464d2d64" xlink:href="alts-20241228.xsd#alts_QodenTechnologiesLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_e91292a9-7560-4600-a9ca-78acd9128e50" xlink:to="loc_alts_QodenTechnologiesLLCMember_727e86ec-e3f5-4a72-9761-4830464d2d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f5b40cbb-f5c7-48d7-a38f-95255bb1b4e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9d839578-c9c2-4c5c-8d41-1892ddf73bd4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f5b40cbb-f5c7-48d7-a38f-95255bb1b4e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_eed44eda-8bb5-4571-a8c5-9122d3329c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f5b40cbb-f5c7-48d7-a38f-95255bb1b4e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_eed44eda-8bb5-4571-a8c5-9122d3329c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_QodenIntangibleMember_827beac7-b215-4563-9284-e808e49506cf" xlink:href="alts-20241228.xsd#alts_QodenIntangibleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_eed44eda-8bb5-4571-a8c5-9122d3329c5f" xlink:to="loc_alts_QodenIntangibleMember_827beac7-b215-4563-9284-e808e49506cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_9067301c-026a-4ac7-9942-1e3a2aa66c53" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_eed44eda-8bb5-4571-a8c5-9122d3329c5f" xlink:to="loc_us-gaap_TradeNamesMember_9067301c-026a-4ac7-9942-1e3a2aa66c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_a1e2fd52-0df0-4e37-bc17-dafe16059e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_eed44eda-8bb5-4571-a8c5-9122d3329c5f" xlink:to="loc_us-gaap_CustomerRelationshipsMember_a1e2fd52-0df0-4e37-bc17-dafe16059e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_60c2c59f-f128-4274-986a-fc86621de46a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_eed44eda-8bb5-4571-a8c5-9122d3329c5f" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_60c2c59f-f128-4274-986a-fc86621de46a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SoinIntangiblesMember_fbdd2d65-639e-4fb1-a8ea-a135d42fffea" xlink:href="alts-20241228.xsd#alts_SoinIntangiblesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_eed44eda-8bb5-4571-a8c5-9122d3329c5f" xlink:to="loc_alts_SoinIntangiblesMember_fbdd2d65-639e-4fb1-a8ea-a135d42fffea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_34da2c1e-d4aa-4fae-b744-dc46c1f5b14e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9d839578-c9c2-4c5c-8d41-1892ddf73bd4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_34da2c1e-d4aa-4fae-b744-dc46c1f5b14e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d193cb4b-ed72-434a-9d58-0111c65066ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_34da2c1e-d4aa-4fae-b744-dc46c1f5b14e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d193cb4b-ed72-434a-9d58-0111c65066ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ALT5SubsidiaryMember_aab359ff-07f5-437d-a15c-afa1dd3b68f5" xlink:href="alts-20241228.xsd#alts_ALT5SubsidiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d193cb4b-ed72-434a-9d58-0111c65066ad" xlink:to="loc_alts_ALT5SubsidiaryMember_aab359ff-07f5-437d-a15c-afa1dd3b68f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4b2b1c8e-d46e-4cdd-957e-0500d331ee56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9d839578-c9c2-4c5c-8d41-1892ddf73bd4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4b2b1c8e-d46e-4cdd-957e-0500d331ee56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_4c9a3605-6027-4509-bcc2-6ee10250e9e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4b2b1c8e-d46e-4cdd-957e-0500d331ee56" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_4c9a3605-6027-4509-bcc2-6ee10250e9e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_6603f4bb-b58d-45da-acc8-f1a83e7bdf6b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4b2b1c8e-d46e-4cdd-957e-0500d331ee56" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_6603f4bb-b58d-45da-acc8-f1a83e7bdf6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NumberOfAcquiredIntangibleAssets_b50d31e8-8e43-4066-b50d-14b3dbf07c0f" xlink:href="alts-20241228.xsd#alts_NumberOfAcquiredIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4b2b1c8e-d46e-4cdd-957e-0500d331ee56" xlink:to="loc_alts_NumberOfAcquiredIntangibleAssets_b50d31e8-8e43-4066-b50d-14b3dbf07c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#MarketableSecuritiesScheduleofMarketableSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesAbstract_9d84864e-eca2-41a3-b93e-d5dcbe67f057" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_a078be66-73ab-4153-a81a-5584f34265c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_9d84864e-eca2-41a3-b93e-d5dcbe67f057" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_a078be66-73ab-4153-a81a-5584f34265c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_5da5142d-8825-4d15-af3e-48b800f7f8e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a078be66-73ab-4153-a81a-5584f34265c7" xlink:to="loc_us-gaap_StatementClassOfStockAxis_5da5142d-8825-4d15-af3e-48b800f7f8e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_002a9e5f-f603-4339-a027-28c2d6772833" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_5da5142d-8825-4d15-af3e-48b800f7f8e1" xlink:to="loc_us-gaap_ClassOfStockDomain_002a9e5f-f603-4339-a027-28c2d6772833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesGConvertiblePreferredStockMember_ec7921ad-ca4e-4507-86a5-339bb2d3f765" xlink:href="alts-20241228.xsd#alts_SeriesGConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_002a9e5f-f603-4339-a027-28c2d6772833" xlink:to="loc_alts_SeriesGConvertiblePreferredStockMember_ec7921ad-ca4e-4507-86a5-339bb2d3f765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_CommonShareEquivalentsMember_8feb02c7-19f7-44d1-9f84-1e85a8938e59" xlink:href="alts-20241228.xsd#alts_CommonShareEquivalentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_002a9e5f-f603-4339-a027-28c2d6772833" xlink:to="loc_alts_CommonShareEquivalentsMember_8feb02c7-19f7-44d1-9f84-1e85a8938e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_7233cc31-766d-4d7e-8c99-488f49a04094" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a078be66-73ab-4153-a81a-5584f34265c7" xlink:to="loc_us-gaap_ClassOfStockLineItems_7233cc31-766d-4d7e-8c99-488f49a04094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInAuctionMarketPreferredSecuritiesSharesOutstandingRollForward_2918a559-7a83-4591-b5ad-782ac3e8b455" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MovementInAuctionMarketPreferredSecuritiesSharesOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_7233cc31-766d-4d7e-8c99-488f49a04094" xlink:to="loc_us-gaap_MovementInAuctionMarketPreferredSecuritiesSharesOutstandingRollForward_2918a559-7a83-4591-b5ad-782ac3e8b455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_MarketableSecuritiesSharesOutstanding_5442303b-e379-4ecf-8805-b304a2f43193" xlink:href="alts-20241228.xsd#alts_MarketableSecuritiesSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInAuctionMarketPreferredSecuritiesSharesOutstandingRollForward_2918a559-7a83-4591-b5ad-782ac3e8b455" xlink:to="loc_alts_MarketableSecuritiesSharesOutstanding_5442303b-e379-4ecf-8805-b304a2f43193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares_42fd2382-c647-4175-a5c8-82619cfd988f" xlink:href="alts-20241228.xsd#alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInAuctionMarketPreferredSecuritiesSharesOutstandingRollForward_2918a559-7a83-4591-b5ad-782ac3e8b455" xlink:to="loc_alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares_42fd2382-c647-4175-a5c8-82619cfd988f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_MarketableSecurityWriteOffShares_2a4d859e-4306-4009-957d-285065aa7642" xlink:href="alts-20241228.xsd#alts_MarketableSecurityWriteOffShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInAuctionMarketPreferredSecuritiesSharesOutstandingRollForward_2918a559-7a83-4591-b5ad-782ac3e8b455" xlink:to="loc_alts_MarketableSecurityWriteOffShares_2a4d859e-4306-4009-957d-285065aa7642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_MarketableSecuritiesSharesOutstanding_c5fd4bc2-8b93-45c4-a2c0-d5a1ac7357e4" xlink:href="alts-20241228.xsd#alts_MarketableSecuritiesSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInAuctionMarketPreferredSecuritiesSharesOutstandingRollForward_2918a559-7a83-4591-b5ad-782ac3e8b455" xlink:to="loc_alts_MarketableSecuritiesSharesOutstanding_c5fd4bc2-8b93-45c4-a2c0-d5a1ac7357e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesPurchasedUnderAgreementsToResellAllowanceForCreditLossRollForward_9b2a1fff-a6e5-4dcf-aeb2-7b014c4bbcad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecuritiesPurchasedUnderAgreementsToResellAllowanceForCreditLossRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_7233cc31-766d-4d7e-8c99-488f49a04094" xlink:to="loc_us-gaap_SecuritiesPurchasedUnderAgreementsToResellAllowanceForCreditLossRollForward_9b2a1fff-a6e5-4dcf-aeb2-7b014c4bbcad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_37f5fc5e-da39-4cd7-90ea-4f5e7aa5b391" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesPurchasedUnderAgreementsToResellAllowanceForCreditLossRollForward_9b2a1fff-a6e5-4dcf-aeb2-7b014c4bbcad" xlink:to="loc_us-gaap_MarketableSecurities_37f5fc5e-da39-4cd7-90ea-4f5e7aa5b391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_cef71c5a-0477-4996-9186-17bba8658f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesPurchasedUnderAgreementsToResellAllowanceForCreditLossRollForward_9b2a1fff-a6e5-4dcf-aeb2-7b014c4bbcad" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_cef71c5a-0477-4996-9186-17bba8658f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments_c689ba9c-04c9-48e9-99bb-0dd6e093af47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesPurchasedUnderAgreementsToResellAllowanceForCreditLossRollForward_9b2a1fff-a6e5-4dcf-aeb2-7b014c4bbcad" xlink:to="loc_us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments_c689ba9c-04c9-48e9-99bb-0dd6e093af47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_fef61475-f064-42d1-8b29-b6e33318898a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesPurchasedUnderAgreementsToResellAllowanceForCreditLossRollForward_9b2a1fff-a6e5-4dcf-aeb2-7b014c4bbcad" xlink:to="loc_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_fef61475-f064-42d1-8b29-b6e33318898a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_33e41871-aeca-4de1-9f33-922e6d198297" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesPurchasedUnderAgreementsToResellAllowanceForCreditLossRollForward_9b2a1fff-a6e5-4dcf-aeb2-7b014c4bbcad" xlink:to="loc_us-gaap_MarketableSecurities_33e41871-aeca-4de1-9f33-922e6d198297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/MarketableSecuritiesNarrativeDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#MarketableSecuritiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/MarketableSecuritiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesAbstract_0f3689da-17ac-425f-806c-fb2056a43b94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_0295c986-b1ac-4429-b3af-b11b72893cef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_0f3689da-17ac-425f-806c-fb2056a43b94" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_0295c986-b1ac-4429-b3af-b11b72893cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2329efc4-1315-4cb4-a0aa-0f57c517056b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_0295c986-b1ac-4429-b3af-b11b72893cef" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2329efc4-1315-4cb4-a0aa-0f57c517056b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_67d2eb69-3709-4d24-aba5-178dd17939c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2329efc4-1315-4cb4-a0aa-0f57c517056b" xlink:to="loc_us-gaap_ClassOfStockDomain_67d2eb69-3709-4d24-aba5-178dd17939c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesGConvertiblePreferredStockMember_25bd5f9b-2b03-4aee-b781-ae0c456692c6" xlink:href="alts-20241228.xsd#alts_SeriesGConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_67d2eb69-3709-4d24-aba5-178dd17939c6" xlink:to="loc_alts_SeriesGConvertiblePreferredStockMember_25bd5f9b-2b03-4aee-b781-ae0c456692c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_CommonShareEquivalentsMember_8caf8c8e-489b-4940-bfcf-cc15018b5a11" xlink:href="alts-20241228.xsd#alts_CommonShareEquivalentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_67d2eb69-3709-4d24-aba5-178dd17939c6" xlink:to="loc_alts_CommonShareEquivalentsMember_8caf8c8e-489b-4940-bfcf-cc15018b5a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_d83cad25-891d-4f37-8d37-3553a343d133" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_0295c986-b1ac-4429-b3af-b11b72893cef" xlink:to="loc_us-gaap_ClassOfStockLineItems_d83cad25-891d-4f37-8d37-3553a343d133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleConversionRatio_1b9added-d210-4d3e-b637-e8c90f787c12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleConversionRatio"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d83cad25-891d-4f37-8d37-3553a343d133" xlink:to="loc_us-gaap_PreferredStockConvertibleConversionRatio_1b9added-d210-4d3e-b637-e8c90f787c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares_c73b1677-8936-4342-ab08-69539a993062" xlink:href="alts-20241228.xsd#alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d83cad25-891d-4f37-8d37-3553a343d133" xlink:to="loc_alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares_c73b1677-8936-4342-ab08-69539a993062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ConvertiblePreferredStockSharesIssuableUponConversion_b5c8d412-0c7d-411b-8728-a5b0c69c7a62" xlink:href="alts-20241228.xsd#alts_ConvertiblePreferredStockSharesIssuableUponConversion"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d83cad25-891d-4f37-8d37-3553a343d133" xlink:to="loc_alts_ConvertiblePreferredStockSharesIssuableUponConversion_b5c8d412-0c7d-411b-8728-a5b0c69c7a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_b7343b13-a298-4c89-8ec4-60f1e49d59c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d83cad25-891d-4f37-8d37-3553a343d133" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_b7343b13-a298-4c89-8ec4-60f1e49d59c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_481f89aa-23e3-4a3f-a3f0-92b3674baae7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_d83cad25-891d-4f37-8d37-3553a343d133" xlink:to="loc_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_481f89aa-23e3-4a3f-a3f0-92b3674baae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/DepositsandotherassetsDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#DepositsandotherassetsDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/DepositsandotherassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_abce551d-d6b5-4d7b-9d91-47deb603f330" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_bb969c0c-8b89-4c8d-9567-cf9ae6b55f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_abce551d-d6b5-4d7b-9d91-47deb603f330" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_bb969c0c-8b89-4c8d-9567-cf9ae6b55f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DepositsAndOtherAssetsNoncurrent_e9affbd0-218c-4c7b-85d2-71791f7b5c77" xlink:href="alts-20241228.xsd#alts_DepositsAndOtherAssetsNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_abce551d-d6b5-4d7b-9d91-47deb603f330" xlink:to="loc_alts_DepositsAndOtherAssetsNoncurrent_e9affbd0-218c-4c7b-85d2-71791f7b5c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/AccruedliabilitiesDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#AccruedliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/AccruedliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_b739fd92-469a-410b-ab27-88d764bf40a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_175e6a2a-109a-4272-befb-3bf62213ca0a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_b739fd92-469a-410b-ab27-88d764bf40a3" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_175e6a2a-109a-4272-befb-3bf62213ca0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_324e955b-60a9-44a7-8466-66af9bb534d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_b739fd92-469a-410b-ab27-88d764bf40a3" xlink:to="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_324e955b-60a9-44a7-8466-66af9bb534d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_ab01b406-db73-4906-a83f-c175ba05900f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_b739fd92-469a-410b-ab27-88d764bf40a3" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_ab01b406-db73-4906-a83f-c175ba05900f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_17bfdeb6-86e0-4828-9535-c6207931be9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_b739fd92-469a-410b-ab27-88d764bf40a3" xlink:to="loc_us-gaap_InterestPayableCurrent_17bfdeb6-86e0-4828-9535-c6207931be9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AccruedExpensesAssetAcquisitionCurrent_15620e4a-de58-446f-b299-53bc9ffb309b" xlink:href="alts-20241228.xsd#alts_AccruedExpensesAssetAcquisitionCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_b739fd92-469a-410b-ab27-88d764bf40a3" xlink:to="loc_alts_AccruedExpensesAssetAcquisitionCurrent_15620e4a-de58-446f-b299-53bc9ffb309b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_d3b9cd2a-1fa0-4895-983a-0a3094fe3ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_b739fd92-469a-410b-ab27-88d764bf40a3" xlink:to="loc_us-gaap_LitigationReserveCurrent_d3b9cd2a-1fa0-4895-983a-0a3094fe3ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_41cccf6b-dbb4-4608-93fd-c4dd8ffec17e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_b739fd92-469a-410b-ab27-88d764bf40a3" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_41cccf6b-dbb4-4608-93fd-c4dd8ffec17e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_0875cf63-92bf-4d03-a3e8-a15c3df50993" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_b739fd92-469a-410b-ab27-88d764bf40a3" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_0875cf63-92bf-4d03-a3e8-a15c3df50993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/DebenturesScheduleofDebenturesOutstandingDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#DebenturesScheduleofDebenturesOutstandingDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/DebenturesScheduleofDebenturesOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ef8dcf6d-9e22-48e6-9668-c78517b47456" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1f44652e-baf5-45b6-a7ba-aa3632e0e4bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ef8dcf6d-9e22-48e6-9668-c78517b47456" xlink:to="loc_us-gaap_DebtInstrumentTable_1f44652e-baf5-45b6-a7ba-aa3632e0e4bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e8f99403-bd4c-46a8-8c94-bcddd82db050" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1f44652e-baf5-45b6-a7ba-aa3632e0e4bc" xlink:to="loc_us-gaap_DebtInstrumentAxis_e8f99403-bd4c-46a8-8c94-bcddd82db050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6e2e8694-6814-4e76-ba57-d4d7a0c11aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_e8f99403-bd4c-46a8-8c94-bcddd82db050" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6e2e8694-6814-4e76-ba57-d4d7a0c11aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_A15DebenturesMaturingJune302025Member_ce400952-6200-4fa5-a09d-2ef6efbdd6f7" xlink:href="alts-20241228.xsd#alts_A15DebenturesMaturingJune302025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6e2e8694-6814-4e76-ba57-d4d7a0c11aeb" xlink:to="loc_alts_A15DebenturesMaturingJune302025Member_ce400952-6200-4fa5-a09d-2ef6efbdd6f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0e4b2633-14ee-4f71-a9cc-bc8b19bb3dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1f44652e-baf5-45b6-a7ba-aa3632e0e4bc" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_0e4b2633-14ee-4f71-a9cc-bc8b19bb3dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ac001357-e9ee-40e1-8a3e-c2d955cfcf88" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0e4b2633-14ee-4f71-a9cc-bc8b19bb3dfd" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ac001357-e9ee-40e1-8a3e-c2d955cfcf88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebenturesMember_75d1232a-127c-4069-b8aa-4cf55c9ab781" xlink:href="alts-20241228.xsd#alts_DebenturesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ac001357-e9ee-40e1-8a3e-c2d955cfcf88" xlink:to="loc_alts_DebenturesMember_75d1232a-127c-4069-b8aa-4cf55c9ab781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_dd69b3f8-0329-4ed1-9aa1-e6d9063e45ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1f44652e-baf5-45b6-a7ba-aa3632e0e4bc" xlink:to="loc_us-gaap_DebtInstrumentLineItems_dd69b3f8-0329-4ed1-9aa1-e6d9063e45ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_52735770-fa66-4b05-9b82-8a9281d26976" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dd69b3f8-0329-4ed1-9aa1-e6d9063e45ac" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_52735770-fa66-4b05-9b82-8a9281d26976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_5aeb4538-d310-43c4-b783-e862e9fcd68b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dd69b3f8-0329-4ed1-9aa1-e6d9063e45ac" xlink:to="loc_us-gaap_LongTermDebt_5aeb4538-d310-43c4-b783-e862e9fcd68b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/DebenturesNarrativeDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#DebenturesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/DebenturesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_640e3a49-67a8-4f48-8ad7-2d92c0835424" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2fbd2e41-ef12-4a87-b165-fc73ac18f1e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_640e3a49-67a8-4f48-8ad7-2d92c0835424" xlink:to="loc_us-gaap_DebtInstrumentTable_2fbd2e41-ef12-4a87-b165-fc73ac18f1e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ef475652-85c1-4a54-afb4-62aec9126c34" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2fbd2e41-ef12-4a87-b165-fc73ac18f1e3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ef475652-85c1-4a54-afb4-62aec9126c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_62659b77-7629-430c-a459-4d0c84201042" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ef475652-85c1-4a54-afb4-62aec9126c34" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_62659b77-7629-430c-a459-4d0c84201042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebenturesMember_b58e45f2-110f-4972-a4db-c29e1b11beb7" xlink:href="alts-20241228.xsd#alts_DebenturesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_62659b77-7629-430c-a459-4d0c84201042" xlink:to="loc_alts_DebenturesMember_b58e45f2-110f-4972-a4db-c29e1b11beb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_dd7abf1f-4d9c-4607-9394-3f8da33650c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2fbd2e41-ef12-4a87-b165-fc73ac18f1e3" xlink:to="loc_us-gaap_DebtInstrumentAxis_dd7abf1f-4d9c-4607-9394-3f8da33650c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e1992029-a0f8-44f4-9442-525f93d7a61e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_dd7abf1f-4d9c-4607-9394-3f8da33650c4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e1992029-a0f8-44f4-9442-525f93d7a61e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_A12DebenturesMaturingJune302024Member_c85d2c4c-428c-4f82-8bca-4e672e50e36f" xlink:href="alts-20241228.xsd#alts_A12DebenturesMaturingJune302024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e1992029-a0f8-44f4-9442-525f93d7a61e" xlink:to="loc_alts_A12DebenturesMaturingJune302024Member_c85d2c4c-428c-4f82-8bca-4e672e50e36f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_A12DebenturesMaturingJune302025Member_ed8a90a5-28e8-4663-b18a-ffe803add1cc" xlink:href="alts-20241228.xsd#alts_A12DebenturesMaturingJune302025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e1992029-a0f8-44f4-9442-525f93d7a61e" xlink:to="loc_alts_A12DebenturesMaturingJune302025Member_ed8a90a5-28e8-4663-b18a-ffe803add1cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c6384e1b-51b3-426d-b227-ece28ccde95d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2fbd2e41-ef12-4a87-b165-fc73ac18f1e3" xlink:to="loc_us-gaap_DebtInstrumentLineItems_c6384e1b-51b3-426d-b227-ece28ccde95d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentNumberOfDebenturesIssued_14b099f0-e86a-4bc2-a3d1-4f31e44c5a01" xlink:href="alts-20241228.xsd#alts_DebtInstrumentNumberOfDebenturesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c6384e1b-51b3-426d-b227-ece28ccde95d" xlink:to="loc_alts_DebtInstrumentNumberOfDebenturesIssued_14b099f0-e86a-4bc2-a3d1-4f31e44c5a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0f63311c-3cea-442c-9ae9-506dbf7a9865" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c6384e1b-51b3-426d-b227-ece28ccde95d" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0f63311c-3cea-442c-9ae9-506dbf7a9865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentNumberOfDebenturesRepaid_3d51883f-28cc-40cd-acb8-19b28fb63eac" xlink:href="alts-20241228.xsd#alts_DebtInstrumentNumberOfDebenturesRepaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c6384e1b-51b3-426d-b227-ece28ccde95d" xlink:to="loc_alts_DebtInstrumentNumberOfDebenturesRepaid_3d51883f-28cc-40cd-acb8-19b28fb63eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_e5e5d182-93c4-4789-9d27-7c9d23d9446b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c6384e1b-51b3-426d-b227-ece28ccde95d" xlink:to="loc_us-gaap_RepaymentsOfDebt_e5e5d182-93c4-4789-9d27-7c9d23d9446b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#LongTermDebtScheduleofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d0104c9e-f114-4c8f-afcd-09929edbf927" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_fc1a5334-1441-49ae-b0f7-209e4c2deb74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d0104c9e-f114-4c8f-afcd-09929edbf927" xlink:to="loc_us-gaap_DebtInstrumentTable_fc1a5334-1441-49ae-b0f7-209e4c2deb74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a0ae9a44-2741-45c2-8bc6-b014a9898bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fc1a5334-1441-49ae-b0f7-209e4c2deb74" xlink:to="loc_us-gaap_DebtInstrumentAxis_a0ae9a44-2741-45c2-8bc6-b014a9898bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_93ab529c-267a-4bf5-b517-5de97c5c83c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a0ae9a44-2741-45c2-8bc6-b014a9898bb5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_93ab529c-267a-4bf5-b517-5de97c5c83c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LegacySubsidiaryFixedDepositsMember_7bebebf6-2105-4f20-9c31-f921a712abd4" xlink:href="alts-20241228.xsd#alts_LegacySubsidiaryFixedDepositsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_93ab529c-267a-4bf5-b517-5de97c5c83c5" xlink:to="loc_alts_LegacySubsidiaryFixedDepositsMember_7bebebf6-2105-4f20-9c31-f921a712abd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LegacySubsidiaryLoanMember_dbd628a4-7a28-48c8-8b1d-297b9628cb9a" xlink:href="alts-20241228.xsd#alts_LegacySubsidiaryLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_93ab529c-267a-4bf5-b517-5de97c5c83c5" xlink:to="loc_alts_LegacySubsidiaryLoanMember_dbd628a4-7a28-48c8-8b1d-297b9628cb9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LegacyUnaffiliatedThirdPartyNotesMember_e9dbd67c-f3c8-4d74-ab30-337fb502f9a7" xlink:href="alts-20241228.xsd#alts_LegacyUnaffiliatedThirdPartyNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_93ab529c-267a-4bf5-b517-5de97c5c83c5" xlink:to="loc_alts_LegacyUnaffiliatedThirdPartyNotesMember_e9dbd67c-f3c8-4d74-ab30-337fb502f9a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherLegacyNotesPayableMember_f401d42c-8c93-49de-a939-0cd4f4d59086" xlink:href="alts-20241228.xsd#alts_OtherLegacyNotesPayableMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_93ab529c-267a-4bf5-b517-5de97c5c83c5" xlink:to="loc_alts_OtherLegacyNotesPayableMember_f401d42c-8c93-49de-a939-0cd4f4d59086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_63e529d7-c2ee-4010-b3b4-d18c84417b13" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fc1a5334-1441-49ae-b0f7-209e4c2deb74" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_63e529d7-c2ee-4010-b3b4-d18c84417b13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_60715338-149a-4718-a50a-a203e4b5428b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_63e529d7-c2ee-4010-b3b4-d18c84417b13" xlink:to="loc_us-gaap_RelatedPartyDomain_60715338-149a-4718-a50a-a203e4b5428b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_a3869915-a252-48c6-82ec-41812b8a7c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_60715338-149a-4718-a50a-a203e4b5428b" xlink:to="loc_us-gaap_RelatedPartyMember_a3869915-a252-48c6-82ec-41812b8a7c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_be58825c-fb4f-465a-a7f7-654526ca5707" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fc1a5334-1441-49ae-b0f7-209e4c2deb74" xlink:to="loc_us-gaap_DebtInstrumentLineItems_be58825c-fb4f-465a-a7f7-654526ca5707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6f9e0ffa-d053-4087-a3e4-8763e56a1bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_be58825c-fb4f-465a-a7f7-654526ca5707" xlink:to="loc_us-gaap_LongTermDebt_6f9e0ffa-d053-4087-a3e4-8763e56a1bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_24e81878-94e7-4e3d-9433-93a038bf0364" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_be58825c-fb4f-465a-a7f7-654526ca5707" xlink:to="loc_us-gaap_LongTermDebtCurrent_24e81878-94e7-4e3d-9433-93a038bf0364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_a3064ff6-f65a-4ece-9d22-a99c74f8894f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_be58825c-fb4f-465a-a7f7-654526ca5707" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_a3064ff6-f65a-4ece-9d22-a99c74f8894f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#LongTermDebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_07a33c1c-d7c6-4494-b97c-1c809aee1817" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_4a168a33-0ea2-45da-8e71-98ce4e069570" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_07a33c1c-d7c6-4494-b97c-1c809aee1817" xlink:to="loc_us-gaap_DebtInstrumentTable_4a168a33-0ea2-45da-8e71-98ce4e069570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_396a8110-4e6b-4463-af65-3d32d429a0e2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4a168a33-0ea2-45da-8e71-98ce4e069570" xlink:to="loc_dei_LegalEntityAxis_396a8110-4e6b-4463-af65-3d32d429a0e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b43775e9-076d-43b6-b7d0-fab71d780846" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_396a8110-4e6b-4463-af65-3d32d429a0e2" xlink:to="loc_dei_EntityDomain_b43775e9-076d-43b6-b7d0-fab71d780846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ALT5SubsidiaryMember_37878230-c9e8-431f-bc4a-6279c075d920" xlink:href="alts-20241228.xsd#alts_ALT5SubsidiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_b43775e9-076d-43b6-b7d0-fab71d780846" xlink:to="loc_alts_ALT5SubsidiaryMember_37878230-c9e8-431f-bc4a-6279c075d920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_873fc338-17eb-4dca-a0df-7fddf626efb7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4a168a33-0ea2-45da-8e71-98ce4e069570" xlink:to="loc_us-gaap_DebtInstrumentAxis_873fc338-17eb-4dca-a0df-7fddf626efb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4b888866-21a6-4cb4-9f16-ee4acc1a5934" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_873fc338-17eb-4dca-a0df-7fddf626efb7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4b888866-21a6-4cb4-9f16-ee4acc1a5934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LegacySubsidiaryFixedDepositsMember_3d397696-7d8a-4e15-a58b-a37b5ac1dd69" xlink:href="alts-20241228.xsd#alts_LegacySubsidiaryFixedDepositsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4b888866-21a6-4cb4-9f16-ee4acc1a5934" xlink:to="loc_alts_LegacySubsidiaryFixedDepositsMember_3d397696-7d8a-4e15-a58b-a37b5ac1dd69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LegacySubsidiaryLoanMember_50d0ef76-cbbe-466f-9dde-1026b92e7e70" xlink:href="alts-20241228.xsd#alts_LegacySubsidiaryLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4b888866-21a6-4cb4-9f16-ee4acc1a5934" xlink:to="loc_alts_LegacySubsidiaryLoanMember_50d0ef76-cbbe-466f-9dde-1026b92e7e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IcgNoteMember_9a73051f-848f-4ff3-9349-3b4a77a0c519" xlink:href="alts-20241228.xsd#alts_IcgNoteMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4b888866-21a6-4cb4-9f16-ee4acc1a5934" xlink:to="loc_alts_IcgNoteMember_9a73051f-848f-4ff3-9349-3b4a77a0c519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LiveNoteMember_762edea2-1ba8-4f7a-84bc-8fb451dc965f" xlink:href="alts-20241228.xsd#alts_LiveNoteMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4b888866-21a6-4cb4-9f16-ee4acc1a5934" xlink:to="loc_alts_LiveNoteMember_762edea2-1ba8-4f7a-84bc-8fb451dc965f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NonConvertibleDebentureBigAndSmallDebentureMember_7bc97ebb-8228-43ab-8380-c1a5aa22a86d" xlink:href="alts-20241228.xsd#alts_NonConvertibleDebentureBigAndSmallDebentureMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4b888866-21a6-4cb4-9f16-ee4acc1a5934" xlink:to="loc_alts_NonConvertibleDebentureBigAndSmallDebentureMember_7bc97ebb-8228-43ab-8380-c1a5aa22a86d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NonConvertibleDebentureBigDebentureMember_cf8aa52b-d105-4c16-a886-73e26be293dd" xlink:href="alts-20241228.xsd#alts_NonConvertibleDebentureBigDebentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_NonConvertibleDebentureBigAndSmallDebentureMember_7bc97ebb-8228-43ab-8380-c1a5aa22a86d" xlink:to="loc_alts_NonConvertibleDebentureBigDebentureMember_cf8aa52b-d105-4c16-a886-73e26be293dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NonConvertibleDebentureSmallDebentureMember_0e35ffea-9cc7-4d19-8785-355e43162cce" xlink:href="alts-20241228.xsd#alts_NonConvertibleDebentureSmallDebentureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_NonConvertibleDebentureBigAndSmallDebentureMember_7bc97ebb-8228-43ab-8380-c1a5aa22a86d" xlink:to="loc_alts_NonConvertibleDebentureSmallDebentureMember_0e35ffea-9cc7-4d19-8785-355e43162cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_FixedDepositAgreementMember_3dd5ea00-d1fb-4255-ae20-a33b9f536932" xlink:href="alts-20241228.xsd#alts_FixedDepositAgreementMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4b888866-21a6-4cb4-9f16-ee4acc1a5934" xlink:to="loc_alts_FixedDepositAgreementMember_3dd5ea00-d1fb-4255-ae20-a33b9f536932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PromissoryNoteMember_75142141-512e-4165-824b-ad52e9684caa" xlink:href="alts-20241228.xsd#alts_PromissoryNoteMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4b888866-21a6-4cb4-9f16-ee4acc1a5934" xlink:to="loc_alts_PromissoryNoteMember_75142141-512e-4165-824b-ad52e9684caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a1b7bc84-88ed-4460-970a-01c001c496c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4a168a33-0ea2-45da-8e71-98ce4e069570" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a1b7bc84-88ed-4460-970a-01c001c496c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_806875b0-0284-4a8e-956e-8ed3c022d4af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a1b7bc84-88ed-4460-970a-01c001c496c6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_806875b0-0284-4a8e-956e-8ed3c022d4af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_FixedDepositAgreementMember_ccb565c4-33c8-439d-9636-b25054ca43a6" xlink:href="alts-20241228.xsd#alts_FixedDepositAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_806875b0-0284-4a8e-956e-8ed3c022d4af" xlink:to="loc_alts_FixedDepositAgreementMember_ccb565c4-33c8-439d-9636-b25054ca43a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_a5414d68-ceae-459a-ad1d-b928a4f6f360" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_806875b0-0284-4a8e-956e-8ed3c022d4af" xlink:to="loc_us-gaap_LoansPayableMember_a5414d68-ceae-459a-ad1d-b928a4f6f360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PromissoryNoteMember_b13bb4ba-882d-44a8-820a-4cf5cf621787" xlink:href="alts-20241228.xsd#alts_PromissoryNoteMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_806875b0-0284-4a8e-956e-8ed3c022d4af" xlink:to="loc_alts_PromissoryNoteMember_b13bb4ba-882d-44a8-820a-4cf5cf621787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_65af83df-4f7e-4e2a-a759-c0279d65d254" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_806875b0-0284-4a8e-956e-8ed3c022d4af" xlink:to="loc_us-gaap_UnsecuredDebtMember_65af83df-4f7e-4e2a-a759-c0279d65d254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_57a7c283-90ea-4b35-83df-750ca7770f54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4a168a33-0ea2-45da-8e71-98ce4e069570" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_57a7c283-90ea-4b35-83df-750ca7770f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_721ef67c-387b-4771-8c3b-cecf5dbd635a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_57a7c283-90ea-4b35-83df-750ca7770f54" xlink:to="loc_us-gaap_RelatedPartyDomain_721ef67c-387b-4771-8c3b-cecf5dbd635a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_b77b3b21-a638-4126-9fc3-d9d19220bfeb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_721ef67c-387b-4771-8c3b-cecf5dbd635a" xlink:to="loc_us-gaap_RelatedPartyMember_b77b3b21-a638-4126-9fc3-d9d19220bfeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_cd481475-20d9-491f-9ebe-f96f9ad07416" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4a168a33-0ea2-45da-8e71-98ce4e069570" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_cd481475-20d9-491f-9ebe-f96f9ad07416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_30caede6-e5d2-433b-b56d-350bc31bf116" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_cd481475-20d9-491f-9ebe-f96f9ad07416" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_30caede6-e5d2-433b-b56d-350bc31bf116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NotesPayableWithLiveVenturesAndICGMember_ba252b40-72bb-44bd-bb14-accb229fc451" xlink:href="alts-20241228.xsd#alts_NotesPayableWithLiveVenturesAndICGMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_30caede6-e5d2-433b-b56d-350bc31bf116" xlink:to="loc_alts_NotesPayableWithLiveVenturesAndICGMember_ba252b40-72bb-44bd-bb14-accb229fc451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_16e1ee39-b2f4-4475-9527-3020d221c0d0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4a168a33-0ea2-45da-8e71-98ce4e069570" xlink:to="loc_srt_CounterpartyNameAxis_16e1ee39-b2f4-4475-9527-3020d221c0d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_98811ac9-9e9f-4edc-a2c8-579548f202e1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_16e1ee39-b2f4-4475-9527-3020d221c0d0" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_98811ac9-9e9f-4edc-a2c8-579548f202e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_InvestorOneMember_85579789-5ec7-43d8-b18c-82cb6ef070bc" xlink:href="alts-20241228.xsd#alts_InvestorOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_98811ac9-9e9f-4edc-a2c8-579548f202e1" xlink:to="loc_alts_InvestorOneMember_85579789-5ec7-43d8-b18c-82cb6ef070bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_InvestorTwoAndInvestorThreeMember_5bbe0523-284d-4546-994d-39696de6c1df" xlink:href="alts-20241228.xsd#alts_InvestorTwoAndInvestorThreeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_98811ac9-9e9f-4edc-a2c8-579548f202e1" xlink:to="loc_alts_InvestorTwoAndInvestorThreeMember_5bbe0523-284d-4546-994d-39696de6c1df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ALT5SubsidiaryMember_972ae398-24b4-4cae-9044-26cf2027e748" xlink:href="alts-20241228.xsd#alts_ALT5SubsidiaryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_98811ac9-9e9f-4edc-a2c8-579548f202e1" xlink:to="loc_alts_ALT5SubsidiaryMember_972ae398-24b4-4cae-9044-26cf2027e748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SkyBridgeAmericasMember_4434c0fa-9b69-4806-9e96-65829a4cd5fc" xlink:href="alts-20241228.xsd#alts_SkyBridgeAmericasMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_98811ac9-9e9f-4edc-a2c8-579548f202e1" xlink:to="loc_alts_SkyBridgeAmericasMember_4434c0fa-9b69-4806-9e96-65829a4cd5fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_UnaffiliatedThirdPartyMember_f3c15fda-28ed-4012-b4ac-625b213ee98c" xlink:href="alts-20241228.xsd#alts_UnaffiliatedThirdPartyMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_98811ac9-9e9f-4edc-a2c8-579548f202e1" xlink:to="loc_alts_UnaffiliatedThirdPartyMember_f3c15fda-28ed-4012-b4ac-625b213ee98c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_6e70ef4d-78e9-4fa8-81f7-fd0aa98d2b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4a168a33-0ea2-45da-8e71-98ce4e069570" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_6e70ef4d-78e9-4fa8-81f7-fd0aa98d2b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_92d8e33c-a5f1-4989-8ff9-0c80a0e4b205" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_6e70ef4d-78e9-4fa8-81f7-fd0aa98d2b5b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_92d8e33c-a5f1-4989-8ff9-0c80a0e4b205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_eae40666-22cf-4137-ad21-d9e7dc646656" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_92d8e33c-a5f1-4989-8ff9-0c80a0e4b205" xlink:to="loc_us-gaap_WarrantMember_eae40666-22cf-4137-ad21-d9e7dc646656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BigWarrantMember_bc4bb237-3593-4e5d-852f-d66ea3651e3d" xlink:href="alts-20241228.xsd#alts_BigWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantMember_eae40666-22cf-4137-ad21-d9e7dc646656" xlink:to="loc_alts_BigWarrantMember_bc4bb237-3593-4e5d-852f-d66ea3651e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SmallWarrantMember_1284d1f4-be89-4186-9b98-2a56b7095a45" xlink:href="alts-20241228.xsd#alts_SmallWarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantMember_eae40666-22cf-4137-ad21-d9e7dc646656" xlink:to="loc_alts_SmallWarrantMember_1284d1f4-be89-4186-9b98-2a56b7095a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionAxis_31e75380-8572-4463-ad43-2755898d08b1" xlink:href="alts-20241228.xsd#alts_DebtInstrumentOriginalIssueDiscountExpansionAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4a168a33-0ea2-45da-8e71-98ce4e069570" xlink:to="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionAxis_31e75380-8572-4463-ad43-2755898d08b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionDomain_ac0dc18b-fdf1-453b-95a9-ab53d5c26ec9" xlink:href="alts-20241228.xsd#alts_DebtInstrumentOriginalIssueDiscountExpansionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionAxis_31e75380-8572-4463-ad43-2755898d08b1" xlink:to="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionDomain_ac0dc18b-fdf1-453b-95a9-ab53d5c26ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionOneMember_b0ff8448-a613-4f28-b3d4-28b170be4baf" xlink:href="alts-20241228.xsd#alts_DebtInstrumentOriginalIssueDiscountExpansionOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionDomain_ac0dc18b-fdf1-453b-95a9-ab53d5c26ec9" xlink:to="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionOneMember_b0ff8448-a613-4f28-b3d4-28b170be4baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionTwoMember_0b324932-4ec7-4ae9-89bf-26c2289ec1c2" xlink:href="alts-20241228.xsd#alts_DebtInstrumentOriginalIssueDiscountExpansionTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionDomain_ac0dc18b-fdf1-453b-95a9-ab53d5c26ec9" xlink:to="loc_alts_DebtInstrumentOriginalIssueDiscountExpansionTwoMember_0b324932-4ec7-4ae9-89bf-26c2289ec1c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentCovenantPeriodAxis_1adcebde-0e26-4f38-b7db-bb83f9e20e2d" xlink:href="alts-20241228.xsd#alts_DebtInstrumentCovenantPeriodAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4a168a33-0ea2-45da-8e71-98ce4e069570" xlink:to="loc_alts_DebtInstrumentCovenantPeriodAxis_1adcebde-0e26-4f38-b7db-bb83f9e20e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentCovenantPeriodDomain_119d889d-7d53-48a2-a95b-8e61855e5625" xlink:href="alts-20241228.xsd#alts_DebtInstrumentCovenantPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_DebtInstrumentCovenantPeriodAxis_1adcebde-0e26-4f38-b7db-bb83f9e20e2d" xlink:to="loc_alts_DebtInstrumentCovenantPeriodDomain_119d889d-7d53-48a2-a95b-8e61855e5625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentCovenantPeriodPeriodOneMember_4d0a5c4a-9c9f-4f2a-96f9-d952515cf8dd" xlink:href="alts-20241228.xsd#alts_DebtInstrumentCovenantPeriodPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_DebtInstrumentCovenantPeriodDomain_119d889d-7d53-48a2-a95b-8e61855e5625" xlink:to="loc_alts_DebtInstrumentCovenantPeriodPeriodOneMember_4d0a5c4a-9c9f-4f2a-96f9-d952515cf8dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentCovenantPeriodPeriodTwoMember_ee2d45ff-9418-471f-9e1d-237451d86677" xlink:href="alts-20241228.xsd#alts_DebtInstrumentCovenantPeriodPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_DebtInstrumentCovenantPeriodDomain_119d889d-7d53-48a2-a95b-8e61855e5625" xlink:to="loc_alts_DebtInstrumentCovenantPeriodPeriodTwoMember_ee2d45ff-9418-471f-9e1d-237451d86677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentCovenantPeriodPeriodThreeMember_6b10ba35-981e-4231-ba61-f359217104e6" xlink:href="alts-20241228.xsd#alts_DebtInstrumentCovenantPeriodPeriodThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_DebtInstrumentCovenantPeriodDomain_119d889d-7d53-48a2-a95b-8e61855e5625" xlink:to="loc_alts_DebtInstrumentCovenantPeriodPeriodThreeMember_6b10ba35-981e-4231-ba61-f359217104e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_34f54b07-3f0d-428f-bbfb-a78e2e9dac47" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4a168a33-0ea2-45da-8e71-98ce4e069570" xlink:to="loc_srt_LitigationCaseAxis_34f54b07-3f0d-428f-bbfb-a78e2e9dac47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_06c661d4-9576-49a7-bcd1-daf84b07364f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_34f54b07-3f0d-428f-bbfb-a78e2e9dac47" xlink:to="loc_srt_LitigationCaseTypeDomain_06c661d4-9576-49a7-bcd1-daf84b07364f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SkybridgeLitigationMember_dce8b1e4-77c0-4dfa-902e-29537e2ae6f3" xlink:href="alts-20241228.xsd#alts_SkybridgeLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_06c661d4-9576-49a7-bcd1-daf84b07364f" xlink:to="loc_alts_SkybridgeLitigationMember_dce8b1e4-77c0-4dfa-902e-29537e2ae6f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_cb2f8bae-9fb6-43a3-8fd9-61092e7981ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4a168a33-0ea2-45da-8e71-98ce4e069570" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_cb2f8bae-9fb6-43a3-8fd9-61092e7981ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_e0af46da-7e62-4b65-a584-3937437ec0cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_cb2f8bae-9fb6-43a3-8fd9-61092e7981ec" xlink:to="loc_us-gaap_LossContingencyNatureDomain_e0af46da-7e62-4b65-a584-3937437ec0cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LegalFeesMember_c56b4c00-a6df-4732-b880-a8bdf802916a" xlink:href="alts-20241228.xsd#alts_LegalFeesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_e0af46da-7e62-4b65-a584-3937437ec0cf" xlink:to="loc_alts_LegalFeesMember_c56b4c00-a6df-4732-b880-a8bdf802916a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ec257606-fa33-4a0f-a14a-37b37cf361dd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4a168a33-0ea2-45da-8e71-98ce4e069570" xlink:to="loc_srt_RangeAxis_ec257606-fa33-4a0f-a14a-37b37cf361dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b6de4071-8502-4fc0-8b42-c6942df8847c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ec257606-fa33-4a0f-a14a-37b37cf361dd" xlink:to="loc_srt_RangeMember_b6de4071-8502-4fc0-8b42-c6942df8847c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f8605c88-9cf3-4fc8-a267-0700f8d9555e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b6de4071-8502-4fc0-8b42-c6942df8847c" xlink:to="loc_srt_MinimumMember_f8605c88-9cf3-4fc8-a267-0700f8d9555e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cb3e23f1-157d-4581-a001-537f0df98f97" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b6de4071-8502-4fc0-8b42-c6942df8847c" xlink:to="loc_srt_MaximumMember_cb3e23f1-157d-4581-a001-537f0df98f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_4a168a33-0ea2-45da-8e71-98ce4e069570" xlink:to="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_c7a99894-d533-4e00-8edb-29ff3c0701c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_c7a99894-d533-4e00-8edb-29ff3c0701c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ccbb6dea-6698-49e1-8e4d-b58d8262fdcd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ccbb6dea-6698-49e1-8e4d-b58d8262fdcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_825a36f3-560b-4f4d-98bc-10e39a6d747e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_us-gaap_LongTermDebt_825a36f3-560b-4f4d-98bc-10e39a6d747e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_70146f8f-5d1d-47cf-a7ed-3d326d32d943" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_70146f8f-5d1d-47cf-a7ed-3d326d32d943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1_c75a508c-5b0f-4090-9480-ba1b4a45a145" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionOriginalDebtAmount1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_us-gaap_DebtConversionOriginalDebtAmount1_c75a508c-5b0f-4090-9480-ba1b4a45a145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_e42db3f7-0966-462a-bd89-a61d1d928578" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_e42db3f7-0966-462a-bd89-a61d1d928578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_4dcdca44-1d2f-43f9-9cf8-b40ad4063638" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_4dcdca44-1d2f-43f9-9cf8-b40ad4063638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_1fbec6a0-bbb3-42a0-ae01-db2c1e40d72f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_1fbec6a0-bbb3-42a0-ae01-db2c1e40d72f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NumberOfUnaffiliatedThirdPartyInvestors_706d2490-f55a-4d58-a1e1-5424b8f94244" xlink:href="alts-20241228.xsd#alts_NumberOfUnaffiliatedThirdPartyInvestors"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_alts_NumberOfUnaffiliatedThirdPartyInvestors_706d2490-f55a-4d58-a1e1-5424b8f94244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_4ebc5393-21b7-44f2-a87a-d2c1fe16287e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_4ebc5393-21b7-44f2-a87a-d2c1fe16287e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_daba3b09-f151-4497-b049-143fa79c3df3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_daba3b09-f151-4497-b049-143fa79c3df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions_7583b74b-938b-45d0-9a1a-00fcd44d0eb6" xlink:href="alts-20241228.xsd#alts_DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_alts_DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions_7583b74b-938b-45d0-9a1a-00fcd44d0eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8a650446-58ba-433e-a68c-87322c7ab713" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8a650446-58ba-433e-a68c-87322c7ab713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ClassOfWarrantOrRightExercisePeriod_fcff8db5-ae69-4d7c-b8e9-7d6ec05006b4" xlink:href="alts-20241228.xsd#alts_ClassOfWarrantOrRightExercisePeriod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_alts_ClassOfWarrantOrRightExercisePeriod_fcff8db5-ae69-4d7c-b8e9-7d6ec05006b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PercentageOfNetDollarReceivedToBeIssuedToDebentureHoldersOnAProRataBasis_807bd5ba-65b2-4f74-a44e-49e7f79c2e14" xlink:href="alts-20241228.xsd#alts_PercentageOfNetDollarReceivedToBeIssuedToDebentureHoldersOnAProRataBasis"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_alts_PercentageOfNetDollarReceivedToBeIssuedToDebentureHoldersOnAProRataBasis_807bd5ba-65b2-4f74-a44e-49e7f79c2e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockIssuedDuringPeriodSharesWarrantsExercised_ddede734-f5c7-4a7d-a937-5a14fbc1eccf" xlink:href="alts-20241228.xsd#alts_StockIssuedDuringPeriodSharesWarrantsExercised"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_alts_StockIssuedDuringPeriodSharesWarrantsExercised_ddede734-f5c7-4a7d-a937-5a14fbc1eccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_d547a220-9560-485a-9102-aa1834c3ee84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c75a919c-caac-49fe-86d6-8e70baec56e1" xlink:to="loc_us-gaap_DebtInstrumentTerm_d547a220-9560-485a-9102-aa1834c3ee84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofLongTermDebtPayabletoRelatedPartiesDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#RelatedPartyDebtScheduleofLongTermDebtPayabletoRelatedPartiesDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofLongTermDebtPayabletoRelatedPartiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b68912d7-f450-4c23-847b-ede5f72e5f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_794cab1a-12e7-4b4b-88e1-92380d993181" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b68912d7-f450-4c23-847b-ede5f72e5f8a" xlink:to="loc_us-gaap_DebtInstrumentTable_794cab1a-12e7-4b4b-88e1-92380d993181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_74523088-a4f4-4537-b6db-01e2fc574e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_794cab1a-12e7-4b4b-88e1-92380d993181" xlink:to="loc_us-gaap_DebtInstrumentAxis_74523088-a4f4-4537-b6db-01e2fc574e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_08bd893b-c75f-4652-83d3-c46df675743a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_74523088-a4f4-4537-b6db-01e2fc574e2e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_08bd893b-c75f-4652-83d3-c46df675743a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IsaacCapitalGroupNoteMember_57508e79-0b2c-45e2-bfaf-4c1450697444" xlink:href="alts-20241228.xsd#alts_IsaacCapitalGroupNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_08bd893b-c75f-4652-83d3-c46df675743a" xlink:to="loc_alts_IsaacCapitalGroupNoteMember_57508e79-0b2c-45e2-bfaf-4c1450697444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NotePayableToIsaacCapitalGroupMember_1a979798-2816-4dc1-9a19-858574dc87c8" xlink:href="alts-20241228.xsd#alts_NotePayableToIsaacCapitalGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_08bd893b-c75f-4652-83d3-c46df675743a" xlink:to="loc_alts_NotePayableToIsaacCapitalGroupMember_1a979798-2816-4dc1-9a19-858574dc87c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NotePayableToLiveVentureIncorporatedMember_bc6ef691-50a2-4db8-8781-f41d90fea214" xlink:href="alts-20241228.xsd#alts_NotePayableToLiveVentureIncorporatedMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_08bd893b-c75f-4652-83d3-c46df675743a" xlink:to="loc_alts_NotePayableToLiveVentureIncorporatedMember_bc6ef691-50a2-4db8-8781-f41d90fea214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IsaacCapitalGroupShortTermDemandAdvanceMember_93587faf-3e0e-4558-82ee-2264936d1841" xlink:href="alts-20241228.xsd#alts_IsaacCapitalGroupShortTermDemandAdvanceMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_08bd893b-c75f-4652-83d3-c46df675743a" xlink:to="loc_alts_IsaacCapitalGroupShortTermDemandAdvanceMember_93587faf-3e0e-4558-82ee-2264936d1841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NovalkAppsSAALLPShortTermDemandAdvanceMember_e4ee6dac-b832-4324-b9c4-bb8e7f959db8" xlink:href="alts-20241228.xsd#alts_NovalkAppsSAALLPShortTermDemandAdvanceMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_08bd893b-c75f-4652-83d3-c46df675743a" xlink:to="loc_alts_NovalkAppsSAALLPShortTermDemandAdvanceMember_e4ee6dac-b832-4324-b9c4-bb8e7f959db8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_279e8b09-a1fc-43b9-9bf8-b652947781f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_794cab1a-12e7-4b4b-88e1-92380d993181" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_279e8b09-a1fc-43b9-9bf8-b652947781f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4b45c0b5-eb23-4236-8471-35b9d857f0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_279e8b09-a1fc-43b9-9bf8-b652947781f7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4b45c0b5-eb23-4236-8471-35b9d857f0c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_6966cfb1-498f-4570-a979-c4a449846f38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4b45c0b5-eb23-4236-8471-35b9d857f0c1" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_6966cfb1-498f-4570-a979-c4a449846f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_10b80061-3671-4662-912b-a8bd29cf8acd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_794cab1a-12e7-4b4b-88e1-92380d993181" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_10b80061-3671-4662-912b-a8bd29cf8acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_4d6c1c81-83f1-4dde-9e62-7bbc4bbfa9da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_10b80061-3671-4662-912b-a8bd29cf8acd" xlink:to="loc_us-gaap_RelatedPartyDomain_4d6c1c81-83f1-4dde-9e62-7bbc4bbfa9da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_3da0326f-3185-477e-89c9-882289c5fbc0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_4d6c1c81-83f1-4dde-9e62-7bbc4bbfa9da" xlink:to="loc_us-gaap_RelatedPartyMember_3da0326f-3185-477e-89c9-882289c5fbc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f64afe6e-aa47-4c50-9ff4-2612e280270d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_794cab1a-12e7-4b4b-88e1-92380d993181" xlink:to="loc_us-gaap_DebtInstrumentLineItems_f64afe6e-aa47-4c50-9ff4-2612e280270d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_239a08d5-99a5-4c28-a52e-eca597a1769f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f64afe6e-aa47-4c50-9ff4-2612e280270d" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_239a08d5-99a5-4c28-a52e-eca597a1769f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_5ec50ddc-99b0-4a9c-b31c-027f29d2315a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f64afe6e-aa47-4c50-9ff4-2612e280270d" xlink:to="loc_us-gaap_LongTermDebtCurrent_5ec50ddc-99b0-4a9c-b31c-027f29d2315a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_90d086f4-c6e5-49bd-934c-e1e085de9dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f64afe6e-aa47-4c50-9ff4-2612e280270d" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_90d086f4-c6e5-49bd-934c-e1e085de9dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_09d594de-cf6f-47ba-84f3-4c387bbd6dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f64afe6e-aa47-4c50-9ff4-2612e280270d" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_09d594de-cf6f-47ba-84f3-4c387bbd6dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofFutureMaturitiesofLongTermDebtDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#RelatedPartyDebtScheduleofFutureMaturitiesofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofFutureMaturitiesofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1842f467-2ed3-4812-be64-1288318bd39f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_31c6c5f1-b6ab-4a0b-a989-c6f8b6613b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1842f467-2ed3-4812-be64-1288318bd39f" xlink:to="loc_us-gaap_DebtInstrumentTable_31c6c5f1-b6ab-4a0b-a989-c6f8b6613b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_557e62b1-b952-4f59-a888-d05ac36c8be6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_31c6c5f1-b6ab-4a0b-a989-c6f8b6613b3a" xlink:to="loc_us-gaap_DebtInstrumentAxis_557e62b1-b952-4f59-a888-d05ac36c8be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4aa52832-7087-4d9c-b3ee-4df6503cdece" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_557e62b1-b952-4f59-a888-d05ac36c8be6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4aa52832-7087-4d9c-b3ee-4df6503cdece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NotesPayableRelatedPartiesMember_d50fb3a8-3934-4e59-89a8-4cbbf3ec6f34" xlink:href="alts-20241228.xsd#alts_NotesPayableRelatedPartiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4aa52832-7087-4d9c-b3ee-4df6503cdece" xlink:to="loc_alts_NotesPayableRelatedPartiesMember_d50fb3a8-3934-4e59-89a8-4cbbf3ec6f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1f1fb263-7a30-462e-9a2a-9e155815d594" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_31c6c5f1-b6ab-4a0b-a989-c6f8b6613b3a" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1f1fb263-7a30-462e-9a2a-9e155815d594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_51262bd6-7437-43c1-9759-12fb71332e07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1f1fb263-7a30-462e-9a2a-9e155815d594" xlink:to="loc_us-gaap_RelatedPartyDomain_51262bd6-7437-43c1-9759-12fb71332e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_e5b64a68-54d9-449a-a5c6-f28364e6bc2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_51262bd6-7437-43c1-9759-12fb71332e07" xlink:to="loc_us-gaap_RelatedPartyMember_e5b64a68-54d9-449a-a5c6-f28364e6bc2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b60394f9-696c-4998-92d6-17b395777ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_31c6c5f1-b6ab-4a0b-a989-c6f8b6613b3a" xlink:to="loc_us-gaap_DebtInstrumentLineItems_b60394f9-696c-4998-92d6-17b395777ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_16f09f0b-0b9f-42c0-af3a-3e0346090f99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b60394f9-696c-4998-92d6-17b395777ed8" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_16f09f0b-0b9f-42c0-af3a-3e0346090f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_a0cfce76-9f6f-47ee-88b1-8b549026b133" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b60394f9-696c-4998-92d6-17b395777ed8" xlink:to="loc_us-gaap_LongTermDebt_a0cfce76-9f6f-47ee-88b1-8b549026b133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#RelatedPartyDebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_21966ab0-ba30-4db7-9098-3a471af84f87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_3cdd38b3-8e96-455d-84f1-05c624bf9434" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_21966ab0-ba30-4db7-9098-3a471af84f87" xlink:to="loc_us-gaap_DebtInstrumentTable_3cdd38b3-8e96-455d-84f1-05c624bf9434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a5fc1635-cb03-40a3-bdcf-f1d196a2237f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3cdd38b3-8e96-455d-84f1-05c624bf9434" xlink:to="loc_us-gaap_DebtInstrumentAxis_a5fc1635-cb03-40a3-bdcf-f1d196a2237f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_23697c27-5f4e-4db8-9cc1-819da2b4d846" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a5fc1635-cb03-40a3-bdcf-f1d196a2237f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_23697c27-5f4e-4db8-9cc1-819da2b4d846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IcgNoteMember_fc64aaec-da79-4e91-a9bd-8a1b155e0966" xlink:href="alts-20241228.xsd#alts_IcgNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_23697c27-5f4e-4db8-9cc1-819da2b4d846" xlink:to="loc_alts_IcgNoteMember_fc64aaec-da79-4e91-a9bd-8a1b155e0966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IsaacCapitalGroupShortTermDemandAdvanceMember_60487df9-f7b3-4071-a7b3-698ee0d5e15b" xlink:href="alts-20241228.xsd#alts_IsaacCapitalGroupShortTermDemandAdvanceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_23697c27-5f4e-4db8-9cc1-819da2b4d846" xlink:to="loc_alts_IsaacCapitalGroupShortTermDemandAdvanceMember_60487df9-f7b3-4071-a7b3-698ee0d5e15b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LiveNoteMember_3f798a6e-4ee3-4c3f-bcc1-213a34f5c808" xlink:href="alts-20241228.xsd#alts_LiveNoteMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_23697c27-5f4e-4db8-9cc1-819da2b4d846" xlink:to="loc_alts_LiveNoteMember_3f798a6e-4ee3-4c3f-bcc1-213a34f5c808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_A10ConvertiblePromissoryNoteMember_05c7641f-89f0-4fff-bc3f-8819a385b1da" xlink:href="alts-20241228.xsd#alts_A10ConvertiblePromissoryNoteMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_23697c27-5f4e-4db8-9cc1-819da2b4d846" xlink:to="loc_alts_A10ConvertiblePromissoryNoteMember_05c7641f-89f0-4fff-bc3f-8819a385b1da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Mr.JonIsaacMember_3bda5c94-5f23-484e-bde4-e2cfcd3fb012" xlink:href="alts-20241228.xsd#alts_Mr.JonIsaacMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_23697c27-5f4e-4db8-9cc1-819da2b4d846" xlink:to="loc_alts_Mr.JonIsaacMember_3bda5c94-5f23-484e-bde4-e2cfcd3fb012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3fea437f-51f0-45ca-a2f1-465bdce0f5fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3cdd38b3-8e96-455d-84f1-05c624bf9434" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3fea437f-51f0-45ca-a2f1-465bdce0f5fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f853b0b8-590e-490a-8a01-eca584d089cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3fea437f-51f0-45ca-a2f1-465bdce0f5fc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f853b0b8-590e-490a-8a01-eca584d089cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_078027d6-84de-4215-9bb3-ec441acd72fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f853b0b8-590e-490a-8a01-eca584d089cd" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_078027d6-84de-4215-9bb3-ec441acd72fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_29f65bd2-8e39-4601-bf9f-76277116f37c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3cdd38b3-8e96-455d-84f1-05c624bf9434" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_29f65bd2-8e39-4601-bf9f-76277116f37c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_f19625b7-3e80-440a-8208-e2668323a1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_29f65bd2-8e39-4601-bf9f-76277116f37c" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_f19625b7-3e80-440a-8208-e2668323a1a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IcgNoteMember_5c87ee1b-a854-4936-a856-70860953ee5e" xlink:href="alts-20241228.xsd#alts_IcgNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_f19625b7-3e80-440a-8208-e2668323a1a8" xlink:to="loc_alts_IcgNoteMember_5c87ee1b-a854-4936-a856-70860953ee5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LiveVentureIncorporatedMember_2b2d9414-31e5-4ff1-a4cb-1e5d1671a47b" xlink:href="alts-20241228.xsd#alts_LiveVentureIncorporatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_f19625b7-3e80-440a-8208-e2668323a1a8" xlink:to="loc_alts_LiveVentureIncorporatedMember_2b2d9414-31e5-4ff1-a4cb-1e5d1671a47b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IsaacConsultingAgreementMember_2e88221d-97f2-4915-94d6-365e041dc80c" xlink:href="alts-20241228.xsd#alts_IsaacConsultingAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_f19625b7-3e80-440a-8208-e2668323a1a8" xlink:to="loc_alts_IsaacConsultingAgreementMember_2e88221d-97f2-4915-94d6-365e041dc80c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RelatedPartyTransactionShortTermAdvancesMember_be1aca24-b6ec-405e-a51a-8ef047ed6c27" xlink:href="alts-20241228.xsd#alts_RelatedPartyTransactionShortTermAdvancesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_f19625b7-3e80-440a-8208-e2668323a1a8" xlink:to="loc_alts_RelatedPartyTransactionShortTermAdvancesMember_be1aca24-b6ec-405e-a51a-8ef047ed6c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5cdd70fa-59d6-4a64-9e21-fda759c48e81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3cdd38b3-8e96-455d-84f1-05c624bf9434" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5cdd70fa-59d6-4a64-9e21-fda759c48e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_20bfd83a-d019-48cf-8792-3a7e2a9bb6f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5cdd70fa-59d6-4a64-9e21-fda759c48e81" xlink:to="loc_us-gaap_RelatedPartyDomain_20bfd83a-d019-48cf-8792-3a7e2a9bb6f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_4a3e8701-a34b-4019-a024-f395774c217c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_20bfd83a-d019-48cf-8792-3a7e2a9bb6f9" xlink:to="loc_us-gaap_RelatedPartyMember_4a3e8701-a34b-4019-a024-f395774c217c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_4e9a82c6-cfd8-4de3-9539-4f1d2962b40e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3cdd38b3-8e96-455d-84f1-05c624bf9434" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_4e9a82c6-cfd8-4de3-9539-4f1d2962b40e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8424d235-3a36-4f54-bd2e-da95c8cbef2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_4e9a82c6-cfd8-4de3-9539-4f1d2962b40e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8424d235-3a36-4f54-bd2e-da95c8cbef2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityUnitPurchaseAgreementsMember_eab69690-0ae0-4d3e-89e2-71c9c3f4476b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityUnitPurchaseAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8424d235-3a36-4f54-bd2e-da95c8cbef2c" xlink:to="loc_us-gaap_EquityUnitPurchaseAgreementsMember_eab69690-0ae0-4d3e-89e2-71c9c3f4476b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_214a3802-2064-49d1-a808-8811c2c81463" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3cdd38b3-8e96-455d-84f1-05c624bf9434" xlink:to="loc_srt_CounterpartyNameAxis_214a3802-2064-49d1-a808-8811c2c81463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_973f2bcc-dbc4-4309-84a8-2b86fc3dd581" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_214a3802-2064-49d1-a808-8811c2c81463" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_973f2bcc-dbc4-4309-84a8-2b86fc3dd581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Mr.JonIsaacMember_611cc267-d143-4ffd-9700-a040a80fe4c2" xlink:href="alts-20241228.xsd#alts_Mr.JonIsaacMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_973f2bcc-dbc4-4309-84a8-2b86fc3dd581" xlink:to="loc_alts_Mr.JonIsaacMember_611cc267-d143-4ffd-9700-a040a80fe4c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NovalkAppsSAALLPMember_19728f62-13de-478d-90e1-413e00cecee7" xlink:href="alts-20241228.xsd#alts_NovalkAppsSAALLPMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_973f2bcc-dbc4-4309-84a8-2b86fc3dd581" xlink:to="loc_alts_NovalkAppsSAALLPMember_19728f62-13de-478d-90e1-413e00cecee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Mr.TonyIsaacMember_192f9a75-19ab-4560-ad7c-172ac6b8dfb0" xlink:href="alts-20241228.xsd#alts_Mr.TonyIsaacMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_973f2bcc-dbc4-4309-84a8-2b86fc3dd581" xlink:to="loc_alts_Mr.TonyIsaacMember_192f9a75-19ab-4560-ad7c-172ac6b8dfb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_0c547b82-33ac-4421-878a-4c43a26b2813" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3cdd38b3-8e96-455d-84f1-05c624bf9434" xlink:to="loc_us-gaap_DebtInstrumentLineItems_0c547b82-33ac-4421-878a-4c43a26b2813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_dcba790a-214d-48e9-a07d-5434fe4a0323" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c547b82-33ac-4421-878a-4c43a26b2813" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_dcba790a-214d-48e9-a07d-5434fe4a0323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_6aab8f69-9d37-49b9-a849-92157dcc1b88" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c547b82-33ac-4421-878a-4c43a26b2813" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_6aab8f69-9d37-49b9-a849-92157dcc1b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1_c5fbc429-3eb4-4c72-87cc-ceb1e160045a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionOriginalDebtAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c547b82-33ac-4421-878a-4c43a26b2813" xlink:to="loc_us-gaap_DebtConversionOriginalDebtAmount1_c5fbc429-3eb4-4c72-87cc-ceb1e160045a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_d922ef1e-f8fa-4614-baf1-d8f7aa736264" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c547b82-33ac-4421-878a-4c43a26b2813" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_d922ef1e-f8fa-4614-baf1-d8f7aa736264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_a89b6c73-98b3-40c0-9d96-a73827698590" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c547b82-33ac-4421-878a-4c43a26b2813" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_a89b6c73-98b3-40c0-9d96-a73827698590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_c3574da1-8e7b-454c-b897-d020e78e6e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c547b82-33ac-4421-878a-4c43a26b2813" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_c3574da1-8e7b-454c-b897-d020e78e6e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_85bce256-a4b4-4a57-b3de-78679d35a92a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c547b82-33ac-4421-878a-4c43a26b2813" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_85bce256-a4b4-4a57-b3de-78679d35a92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RelatedPartyTransactionConsultingAgreementTerm_d800a62b-3a82-4477-9f96-f7238842d588" xlink:href="alts-20241228.xsd#alts_RelatedPartyTransactionConsultingAgreementTerm"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c547b82-33ac-4421-878a-4c43a26b2813" xlink:to="loc_alts_RelatedPartyTransactionConsultingAgreementTerm_d800a62b-3a82-4477-9f96-f7238842d588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_a3c9a7cf-d290-48e9-82b9-6991f39ed052" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c547b82-33ac-4421-878a-4c43a26b2813" xlink:to="loc_us-gaap_DebtInstrumentTerm_a3c9a7cf-d290-48e9-82b9-6991f39ed052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice_53eb37c6-b81e-4a3c-acac-f43868c2e3bd" xlink:href="alts-20241228.xsd#alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c547b82-33ac-4421-878a-4c43a26b2813" xlink:to="loc_alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice_53eb37c6-b81e-4a3c-acac-f43868c2e3bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_1ff58e3a-5de9-48a2-889e-2d0a98e13263" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c547b82-33ac-4421-878a-4c43a26b2813" xlink:to="loc_us-gaap_ShortTermBorrowings_1ff58e3a-5de9-48a2-889e-2d0a98e13263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/PreferredStockSeriesA1ConvertiblePreferredStockDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#PreferredStockSeriesA1ConvertiblePreferredStockDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/PreferredStockSeriesA1ConvertiblePreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f054f61a-88c8-4dc9-b572-cbfed02aca92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_0d412d94-be11-4e7b-85ce-3ed02aa3c758" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f054f61a-88c8-4dc9-b572-cbfed02aca92" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_0d412d94-be11-4e7b-85ce-3ed02aa3c758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6d59ca42-556e-48da-bab2-308a72e5ef75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_0d412d94-be11-4e7b-85ce-3ed02aa3c758" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6d59ca42-556e-48da-bab2-308a72e5ef75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d0ce5810-8f9d-4769-ba27-b40e98cef331" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6d59ca42-556e-48da-bab2-308a72e5ef75" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d0ce5810-8f9d-4769-ba27-b40e98cef331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_GeoTraqIncMember_b73bd98c-9f43-4e5b-adb3-c36c312c4bf1" xlink:href="alts-20241228.xsd#alts_GeoTraqIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d0ce5810-8f9d-4769-ba27-b40e98cef331" xlink:to="loc_alts_GeoTraqIncMember_b73bd98c-9f43-4e5b-adb3-c36c312c4bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_b67be714-7e5d-4368-afdc-a8f8c6b63047" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_0d412d94-be11-4e7b-85ce-3ed02aa3c758" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_b67be714-7e5d-4368-afdc-a8f8c6b63047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_9ad537f6-c364-4c45-a3a8-8da1279100b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_b67be714-7e5d-4368-afdc-a8f8c6b63047" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_9ad537f6-c364-4c45-a3a8-8da1279100b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesAConvertiblePreferredStockMember_df933a23-cb89-4e3f-aca3-73bba99ead5e" xlink:href="alts-20241228.xsd#alts_SeriesAConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_9ad537f6-c364-4c45-a3a8-8da1279100b7" xlink:to="loc_alts_SeriesAConvertiblePreferredStockMember_df933a23-cb89-4e3f-aca3-73bba99ead5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesA1ConvertiblePreferredStockMember_24d4a2ca-6965-47d5-b0cb-c466ea0e87c4" xlink:href="alts-20241228.xsd#alts_SeriesA1ConvertiblePreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_9ad537f6-c364-4c45-a3a8-8da1279100b7" xlink:to="loc_alts_SeriesA1ConvertiblePreferredStockMember_24d4a2ca-6965-47d5-b0cb-c466ea0e87c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_c5c8e5bd-2e9c-41ed-b2d4-f58283c1c701" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_0d412d94-be11-4e7b-85ce-3ed02aa3c758" xlink:to="loc_us-gaap_ClassOfStockLineItems_c5c8e5bd-2e9c-41ed-b2d4-f58283c1c701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_082f825f-37d9-49b8-95c7-56857e220ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c5c8e5bd-2e9c-41ed-b2d4-f58283c1c701" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_082f825f-37d9-49b8-95c7-56857e220ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_1dad5f8d-b7fe-4e94-8334-f5597620bb36" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c5c8e5bd-2e9c-41ed-b2d4-f58283c1c701" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_1dad5f8d-b7fe-4e94-8334-f5597620bb36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessCombinationConsiderationTransferredBeneficialConversionFeatureValue_5f788c98-da8b-495a-8164-617c93401002" xlink:href="alts-20241228.xsd#alts_BusinessCombinationConsiderationTransferredBeneficialConversionFeatureValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c5c8e5bd-2e9c-41ed-b2d4-f58283c1c701" xlink:to="loc_alts_BusinessCombinationConsiderationTransferredBeneficialConversionFeatureValue_5f788c98-da8b-495a-8164-617c93401002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessCombinationConsiderationTransferredLiabilitiesIncurredTerm_e608692e-e15a-4455-933a-aba73424f0bd" xlink:href="alts-20241228.xsd#alts_BusinessCombinationConsiderationTransferredLiabilitiesIncurredTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c5c8e5bd-2e9c-41ed-b2d4-f58283c1c701" xlink:to="loc_alts_BusinessCombinationConsiderationTransferredLiabilitiesIncurredTerm_e608692e-e15a-4455-933a-aba73424f0bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_deb3dbce-b7ba-4eff-8667-16cf7b3205cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c5c8e5bd-2e9c-41ed-b2d4-f58283c1c701" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_deb3dbce-b7ba-4eff-8667-16cf7b3205cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleConversionRatio_7acb0495-51fa-4ba8-a03d-2ee7a1ee8bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleConversionRatio"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c5c8e5bd-2e9c-41ed-b2d4-f58283c1c701" xlink:to="loc_us-gaap_PreferredStockConvertibleConversionRatio_7acb0495-51fa-4ba8-a03d-2ee7a1ee8bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_e3107ca7-d1bc-40b9-9811-70be46aa9e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c5c8e5bd-2e9c-41ed-b2d4-f58283c1c701" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_e3107ca7-d1bc-40b9-9811-70be46aa9e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_091cacc8-814c-4ac5-95a5-dd0160d5a3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c5c8e5bd-2e9c-41ed-b2d4-f58283c1c701" xlink:to="loc_us-gaap_ConversionOfStockSharesIssued1_091cacc8-814c-4ac5-95a5-dd0160d5a3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ConversionOfStockSharesForfeited_cbe2abd7-69b8-40b6-9f02-9cc143957d5b" xlink:href="alts-20241228.xsd#alts_ConversionOfStockSharesForfeited"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c5c8e5bd-2e9c-41ed-b2d4-f58283c1c701" xlink:to="loc_alts_ConversionOfStockSharesForfeited_cbe2abd7-69b8-40b6-9f02-9cc143957d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_0106ac0b-d496-4b0e-8fca-39480c8bbe40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c5c8e5bd-2e9c-41ed-b2d4-f58283c1c701" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_0106ac0b-d496-4b0e-8fca-39480c8bbe40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/PreferredStockSeriesBPreferredStockDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#PreferredStockSeriesBPreferredStockDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/PreferredStockSeriesBPreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7f048f59-1159-4651-8e41-57a70d3ac2ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_038767ba-3976-4e77-ab59-217b7c5f8940" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7f048f59-1159-4651-8e41-57a70d3ac2ae" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_038767ba-3976-4e77-ab59-217b7c5f8940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_afcefc94-5de2-49a8-a8cd-836f3c95fc1c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_038767ba-3976-4e77-ab59-217b7c5f8940" xlink:to="loc_srt_CounterpartyNameAxis_afcefc94-5de2-49a8-a8cd-836f3c95fc1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2b0285f5-1b00-4e8b-b1cb-f505a11b1e7d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_afcefc94-5de2-49a8-a8cd-836f3c95fc1c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2b0285f5-1b00-4e8b-b1cb-f505a11b1e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OwnersOfALT5SubsidiaryMember_40b4e505-0da1-4b70-ab59-6391de034baa" xlink:href="alts-20241228.xsd#alts_OwnersOfALT5SubsidiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2b0285f5-1b00-4e8b-b1cb-f505a11b1e7d" xlink:to="loc_alts_OwnersOfALT5SubsidiaryMember_40b4e505-0da1-4b70-ab59-6391de034baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_396595d3-0f14-4dcc-96f7-3cc5e24597ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_038767ba-3976-4e77-ab59-217b7c5f8940" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_396595d3-0f14-4dcc-96f7-3cc5e24597ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_83f70dde-05c0-42e7-9a01-94555b79b0b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_396595d3-0f14-4dcc-96f7-3cc5e24597ee" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_83f70dde-05c0-42e7-9a01-94555b79b0b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Alt5SigmaInc.Member_a1c9a740-a30e-4619-80ac-835f5d0a613d" xlink:href="alts-20241228.xsd#alts_Alt5SigmaInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_83f70dde-05c0-42e7-9a01-94555b79b0b8" xlink:to="loc_alts_Alt5SigmaInc.Member_a1c9a740-a30e-4619-80ac-835f5d0a613d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_eac831e3-1c3e-4e6e-845e-a23b05e335b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_038767ba-3976-4e77-ab59-217b7c5f8940" xlink:to="loc_us-gaap_StatementClassOfStockAxis_eac831e3-1c3e-4e6e-845e-a23b05e335b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d9c7f9d0-adf6-4105-89fe-3bf55d9e06bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_eac831e3-1c3e-4e6e-845e-a23b05e335b9" xlink:to="loc_us-gaap_ClassOfStockDomain_d9c7f9d0-adf6-4105-89fe-3bf55d9e06bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_14da29c9-0756-4cb8-abbb-c24e340adf5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d9c7f9d0-adf6-4105-89fe-3bf55d9e06bd" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_14da29c9-0756-4cb8-abbb-c24e340adf5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_48da4bc6-b841-4f08-9e88-4394520cc068" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_038767ba-3976-4e77-ab59-217b7c5f8940" xlink:to="loc_us-gaap_ClassOfStockLineItems_48da4bc6-b841-4f08-9e88-4394520cc068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_950ef034-7561-4094-8394-149e31149180" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_48da4bc6-b841-4f08-9e88-4394520cc068" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_950ef034-7561-4094-8394-149e31149180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_90372057-b146-481a-b5ef-1aa5a5cdc73d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_48da4bc6-b841-4f08-9e88-4394520cc068" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_90372057-b146-481a-b5ef-1aa5a5cdc73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_fdf1c734-4e5a-4775-9d43-46432a153807" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_48da4bc6-b841-4f08-9e88-4394520cc068" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_fdf1c734-4e5a-4775-9d43-46432a153807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/PreferredStockSeriesIConvertiblePreferredStockDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#PreferredStockSeriesIConvertiblePreferredStockDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/PreferredStockSeriesIConvertiblePreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f340ad57-ee4b-4d2a-9ee1-c088630f445a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_cd412062-7dc5-402a-bca6-7959cf1e71b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f340ad57-ee4b-4d2a-9ee1-c088630f445a" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_cd412062-7dc5-402a-bca6-7959cf1e71b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0d7436a6-e2c4-4a8f-85da-c828dd20592c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_cd412062-7dc5-402a-bca6-7959cf1e71b6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0d7436a6-e2c4-4a8f-85da-c828dd20592c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_40ac5b99-abf2-41e8-8bd5-15f584eb3330" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0d7436a6-e2c4-4a8f-85da-c828dd20592c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_40ac5b99-abf2-41e8-8bd5-15f584eb3330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Alt5SigmaInc.Member_6c6afd48-0eb2-45a4-b7c5-a305f7206755" xlink:href="alts-20241228.xsd#alts_Alt5SigmaInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_40ac5b99-abf2-41e8-8bd5-15f584eb3330" xlink:to="loc_alts_Alt5SigmaInc.Member_6c6afd48-0eb2-45a4-b7c5-a305f7206755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b6cbe439-329f-418a-aee4-570ea19829d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_cd412062-7dc5-402a-bca6-7959cf1e71b6" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b6cbe439-329f-418a-aee4-570ea19829d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_7061a74d-3855-4b50-8cfd-5a762c2280b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b6cbe439-329f-418a-aee4-570ea19829d9" xlink:to="loc_us-gaap_ClassOfStockDomain_7061a74d-3855-4b50-8cfd-5a762c2280b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesIConvertiblePreferredStockMember_4e51c545-a5a7-424e-9f04-7adf020b93cd" xlink:href="alts-20241228.xsd#alts_SeriesIConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7061a74d-3855-4b50-8cfd-5a762c2280b3" xlink:to="loc_alts_SeriesIConvertiblePreferredStockMember_4e51c545-a5a7-424e-9f04-7adf020b93cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_7fc8971f-4b9b-4c23-8099-287516f5c0e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_cd412062-7dc5-402a-bca6-7959cf1e71b6" xlink:to="loc_us-gaap_ClassOfStockLineItems_7fc8971f-4b9b-4c23-8099-287516f5c0e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_3d4796ff-5f4c-455e-a1ab-88eb9c588567" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_7fc8971f-4b9b-4c23-8099-287516f5c0e7" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_3d4796ff-5f4c-455e-a1ab-88eb9c588567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NumberOfConsultants_bd14d9de-efaf-4668-ac0f-679026abd182" xlink:href="alts-20241228.xsd#alts_NumberOfConsultants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_7fc8971f-4b9b-4c23-8099-287516f5c0e7" xlink:to="loc_alts_NumberOfConsultants_bd14d9de-efaf-4668-ac0f-679026abd182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleConversionRatio_f1d6947b-750a-4738-a3d5-2b5d72505cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleConversionRatio"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_7fc8971f-4b9b-4c23-8099-287516f5c0e7" xlink:to="loc_us-gaap_PreferredStockConvertibleConversionRatio_f1d6947b-750a-4738-a3d5-2b5d72505cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_CommonStockConversionValidConversionPeriod_8e11a816-a068-46de-bc19-518125838049" xlink:href="alts-20241228.xsd#alts_CommonStockConversionValidConversionPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_7fc8971f-4b9b-4c23-8099-287516f5c0e7" xlink:to="loc_alts_CommonStockConversionValidConversionPeriod_8e11a816-a068-46de-bc19-518125838049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_e53d95b0-12ad-4b5e-a2db-eab211f9b2fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_7fc8971f-4b9b-4c23-8099-287516f5c0e7" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_e53d95b0-12ad-4b5e-a2db-eab211f9b2fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/PreferredStockSeriesMPreferredStockDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#PreferredStockSeriesMPreferredStockDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/PreferredStockSeriesMPreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_04c2ded3-1395-4183-bce5-32efd77172f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_c4c61965-31b7-48b7-a53b-796f47284deb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_04c2ded3-1395-4183-bce5-32efd77172f8" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_c4c61965-31b7-48b7-a53b-796f47284deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e67a3277-e84b-46b2-9177-7cb7beacd8b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_c4c61965-31b7-48b7-a53b-796f47284deb" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e67a3277-e84b-46b2-9177-7cb7beacd8b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2621afd8-4f3f-47e5-9a1f-1a374fcf413f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e67a3277-e84b-46b2-9177-7cb7beacd8b5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2621afd8-4f3f-47e5-9a1f-1a374fcf413f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Alt5SigmaInc.Member_fae79eb4-34d0-4416-9e1a-e07ea77e228c" xlink:href="alts-20241228.xsd#alts_Alt5SigmaInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2621afd8-4f3f-47e5-9a1f-1a374fcf413f" xlink:to="loc_alts_Alt5SigmaInc.Member_fae79eb4-34d0-4416-9e1a-e07ea77e228c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_13a5efce-bbc8-4ca6-a404-fb8b0844cdac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_c4c61965-31b7-48b7-a53b-796f47284deb" xlink:to="loc_us-gaap_StatementClassOfStockAxis_13a5efce-bbc8-4ca6-a404-fb8b0844cdac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8c158395-fedc-4b0d-8409-cf7482d2e207" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_13a5efce-bbc8-4ca6-a404-fb8b0844cdac" xlink:to="loc_us-gaap_ClassOfStockDomain_8c158395-fedc-4b0d-8409-cf7482d2e207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesMPreferredStockMember_af436c2b-4f4b-46bc-bb2d-1dbc4919ed74" xlink:href="alts-20241228.xsd#alts_SeriesMPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_8c158395-fedc-4b0d-8409-cf7482d2e207" xlink:to="loc_alts_SeriesMPreferredStockMember_af436c2b-4f4b-46bc-bb2d-1dbc4919ed74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_40d41acc-2264-49bc-a213-a678bae53095" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_c4c61965-31b7-48b7-a53b-796f47284deb" xlink:to="loc_us-gaap_ClassOfStockLineItems_40d41acc-2264-49bc-a213-a678bae53095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_3423c47e-f1c3-4ffe-a64c-9c9e9209c903" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_40d41acc-2264-49bc-a213-a678bae53095" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_3423c47e-f1c3-4ffe-a64c-9c9e9209c903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_3d0fce8c-15ea-4525-ad94-2b8899e77edf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_40d41acc-2264-49bc-a213-a678bae53095" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_3d0fce8c-15ea-4525-ad94-2b8899e77edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/PreferredStockSeriesQConvertiblePreferredStockDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#PreferredStockSeriesQConvertiblePreferredStockDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/PreferredStockSeriesQConvertiblePreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_1dd702e5-60e4-46a8-8480-b4074550e46c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_2eb53b59-986b-49e0-be3f-8695941da866" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1dd702e5-60e4-46a8-8480-b4074550e46c" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_2eb53b59-986b-49e0-be3f-8695941da866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_aff001f0-2d96-411a-8998-bc8ee557a256" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_2eb53b59-986b-49e0-be3f-8695941da866" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_aff001f0-2d96-411a-8998-bc8ee557a256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a3d219b-560a-4047-8950-883b695239cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_aff001f0-2d96-411a-8998-bc8ee557a256" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a3d219b-560a-4047-8950-883b695239cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_QodenTechnologiesLLCMember_01850654-c3c7-43fa-979a-36169ba81d83" xlink:href="alts-20241228.xsd#alts_QodenTechnologiesLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a3d219b-560a-4047-8950-883b695239cb" xlink:to="loc_alts_QodenTechnologiesLLCMember_01850654-c3c7-43fa-979a-36169ba81d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_06557518-1619-4e37-a345-ed1e68ed0243" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_2eb53b59-986b-49e0-be3f-8695941da866" xlink:to="loc_us-gaap_StatementClassOfStockAxis_06557518-1619-4e37-a345-ed1e68ed0243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_18c5b162-8566-4d15-9e76-9bddb4afc56e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_06557518-1619-4e37-a345-ed1e68ed0243" xlink:to="loc_us-gaap_ClassOfStockDomain_18c5b162-8566-4d15-9e76-9bddb4afc56e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesQConvertiblePreferredStockMember_bd497516-4889-4e08-b4f5-08fa67742618" xlink:href="alts-20241228.xsd#alts_SeriesQConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_18c5b162-8566-4d15-9e76-9bddb4afc56e" xlink:to="loc_alts_SeriesQConvertiblePreferredStockMember_bd497516-4889-4e08-b4f5-08fa67742618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_0b7dfab3-3e18-4ccb-9ef2-2c71737998e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_2eb53b59-986b-49e0-be3f-8695941da866" xlink:to="loc_us-gaap_ClassOfStockLineItems_0b7dfab3-3e18-4ccb-9ef2-2c71737998e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8a474f89-d820-4bde-99d8-f540b123d2dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0b7dfab3-3e18-4ccb-9ef2-2c71737998e7" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8a474f89-d820-4bde-99d8-f540b123d2dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_2a070d05-6f91-4f95-b7b6-0e2fb722f3a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0b7dfab3-3e18-4ccb-9ef2-2c71737998e7" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_2a070d05-6f91-4f95-b7b6-0e2fb722f3a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare_89dce91f-2708-4b05-82c3-fcd564d35fce" xlink:href="alts-20241228.xsd#alts_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0b7dfab3-3e18-4ccb-9ef2-2c71737998e7" xlink:to="loc_alts_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare_89dce91f-2708-4b05-82c3-fcd564d35fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_be19d40c-15cb-45d2-ab0f-ad0164c2299f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0b7dfab3-3e18-4ccb-9ef2-2c71737998e7" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_be19d40c-15cb-45d2-ab0f-ad0164c2299f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/PreferredStockSeriesVConvertiblePreferredStockDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#PreferredStockSeriesVConvertiblePreferredStockDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/PreferredStockSeriesVConvertiblePreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_9398a485-243b-4c91-b090-5757e93843b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_81fa6220-587d-47c1-b0ee-302afec4e29a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9398a485-243b-4c91-b090-5757e93843b2" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_81fa6220-587d-47c1-b0ee-302afec4e29a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_794001a6-84a9-476b-a7c8-3752a6d46df1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_81fa6220-587d-47c1-b0ee-302afec4e29a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_794001a6-84a9-476b-a7c8-3752a6d46df1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2540c90c-4c4e-40dd-a73d-57c08ae25b06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_794001a6-84a9-476b-a7c8-3752a6d46df1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2540c90c-4c4e-40dd-a73d-57c08ae25b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NorthYorkLTDMember_102355d4-a7f5-4f7c-ae0d-9f8dabb1bae0" xlink:href="alts-20241228.xsd#alts_NorthYorkLTDMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2540c90c-4c4e-40dd-a73d-57c08ae25b06" xlink:to="loc_alts_NorthYorkLTDMember_102355d4-a7f5-4f7c-ae0d-9f8dabb1bae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_UnaffiliatedThirdPartyMember_a913f5f8-a503-4864-a71d-e236bbe2146f" xlink:href="alts-20241228.xsd#alts_UnaffiliatedThirdPartyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2540c90c-4c4e-40dd-a73d-57c08ae25b06" xlink:to="loc_alts_UnaffiliatedThirdPartyMember_a913f5f8-a503-4864-a71d-e236bbe2146f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_86c0af51-9f3d-42a9-a55f-6d0cc628cc4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_81fa6220-587d-47c1-b0ee-302afec4e29a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_86c0af51-9f3d-42a9-a55f-6d0cc628cc4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0a2a5bad-8cdb-4da0-8207-ab696cf961a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_86c0af51-9f3d-42a9-a55f-6d0cc628cc4f" xlink:to="loc_us-gaap_ClassOfStockDomain_0a2a5bad-8cdb-4da0-8207-ab696cf961a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesVConvertiblePreferredStockMember_dc8d3edb-17f3-49e7-a2df-1b3f94417140" xlink:href="alts-20241228.xsd#alts_SeriesVConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0a2a5bad-8cdb-4da0-8207-ab696cf961a9" xlink:to="loc_alts_SeriesVConvertiblePreferredStockMember_dc8d3edb-17f3-49e7-a2df-1b3f94417140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_f0ab866b-1569-4479-bcfe-cf6ec5990c91" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_81fa6220-587d-47c1-b0ee-302afec4e29a" xlink:to="loc_us-gaap_ClassOfStockLineItems_f0ab866b-1569-4479-bcfe-cf6ec5990c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_f53082c2-1363-428c-bfa7-7f55787939f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f0ab866b-1569-4479-bcfe-cf6ec5990c91" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_f53082c2-1363-428c-bfa7-7f55787939f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_f6e8a844-4652-4ca6-b517-3681a549cb6c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f0ab866b-1569-4479-bcfe-cf6ec5990c91" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_f6e8a844-4652-4ca6-b517-3681a549cb6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#PreferredStockSeriesSConvertiblePreferredStockDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_0b4e4ef8-9951-46a7-ab26-e06f588b1684" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_852ba34a-a8e3-421b-bb1e-ce66d7e56a10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0b4e4ef8-9951-46a7-ab26-e06f588b1684" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_852ba34a-a8e3-421b-bb1e-ce66d7e56a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_32a13746-0a26-4986-928f-d547ccdc99c6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_852ba34a-a8e3-421b-bb1e-ce66d7e56a10" xlink:to="loc_srt_CounterpartyNameAxis_32a13746-0a26-4986-928f-d547ccdc99c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c136cece-cb5f-4163-97f5-331e90ec0b0c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_32a13746-0a26-4986-928f-d547ccdc99c6" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c136cece-cb5f-4163-97f5-331e90ec0b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DrSoinMember_18cd987b-c748-4b82-8e3a-c0a76e2dfd83" xlink:href="alts-20241228.xsd#alts_DrSoinMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c136cece-cb5f-4163-97f5-331e90ec0b0c" xlink:to="loc_alts_DrSoinMember_18cd987b-c748-4b82-8e3a-c0a76e2dfd83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_1cfb9ce4-33d9-47c7-9b4e-079dea2b3c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_852ba34a-a8e3-421b-bb1e-ce66d7e56a10" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_1cfb9ce4-33d9-47c7-9b4e-079dea2b3c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_8566b3f4-a174-42a4-b514-686a81317d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_1cfb9ce4-33d9-47c7-9b4e-079dea2b3c4b" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_8566b3f4-a174-42a4-b514-686a81317d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockConversion1Member_8c046de4-13eb-46cd-9f24-e5d95dbff9ba" xlink:href="alts-20241228.xsd#alts_StockConversion1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_8566b3f4-a174-42a4-b514-686a81317d8c" xlink:to="loc_alts_StockConversion1Member_8c046de4-13eb-46cd-9f24-e5d95dbff9ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockConversion2Member_f39665ab-8c74-4cc4-8ff1-511f6ff9a16d" xlink:href="alts-20241228.xsd#alts_StockConversion2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_8566b3f4-a174-42a4-b514-686a81317d8c" xlink:to="loc_alts_StockConversion2Member_f39665ab-8c74-4cc4-8ff1-511f6ff9a16d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockConversion3Member_184cc4e4-ddae-4bf0-a277-5c3a3b89329b" xlink:href="alts-20241228.xsd#alts_StockConversion3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_8566b3f4-a174-42a4-b514-686a81317d8c" xlink:to="loc_alts_StockConversion3Member_184cc4e4-ddae-4bf0-a277-5c3a3b89329b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b94ff653-7055-4772-a793-a5773304c679" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_852ba34a-a8e3-421b-bb1e-ce66d7e56a10" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b94ff653-7055-4772-a793-a5773304c679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_87244270-8358-438e-a8c2-171b811f1188" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b94ff653-7055-4772-a793-a5773304c679" xlink:to="loc_us-gaap_RelatedPartyDomain_87244270-8358-438e-a8c2-171b811f1188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_84633782-e104-4666-bc1a-70829a085c86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_87244270-8358-438e-a8c2-171b811f1188" xlink:to="loc_us-gaap_RelatedPartyMember_84633782-e104-4666-bc1a-70829a085c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a4854731-ac3e-44bd-8993-db9a1a504b41" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_852ba34a-a8e3-421b-bb1e-ce66d7e56a10" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a4854731-ac3e-44bd-8993-db9a1a504b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c9d94a0c-3f9c-4d5e-a7b7-17a3ebd1fc34" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a4854731-ac3e-44bd-8993-db9a1a504b41" xlink:to="loc_us-gaap_ClassOfStockDomain_c9d94a0c-3f9c-4d5e-a7b7-17a3ebd1fc34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesSConvertiblePreferredStockMember_04b0ea25-d6d0-4fc1-bb5e-23afe2079bdd" xlink:href="alts-20241228.xsd#alts_SeriesSConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_c9d94a0c-3f9c-4d5e-a7b7-17a3ebd1fc34" xlink:to="loc_alts_SeriesSConvertiblePreferredStockMember_04b0ea25-d6d0-4fc1-bb5e-23afe2079bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9a1d6549-693e-4b43-a974-d87b5f89ff77" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_852ba34a-a8e3-421b-bb1e-ce66d7e56a10" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9a1d6549-693e-4b43-a974-d87b5f89ff77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22e8fdee-36ea-4d0d-8ce3-f5d5ab9ca5cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9a1d6549-693e-4b43-a974-d87b5f89ff77" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22e8fdee-36ea-4d0d-8ce3-f5d5ab9ca5cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SoinTherapeuticsMember_c095c52e-87d8-42d5-abaf-5a9bcde15f7f" xlink:href="alts-20241228.xsd#alts_SoinTherapeuticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22e8fdee-36ea-4d0d-8ce3-f5d5ab9ca5cc" xlink:to="loc_alts_SoinTherapeuticsMember_c095c52e-87d8-42d5-abaf-5a9bcde15f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_6059ea33-a007-4693-aa16-f35334f4a08b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_852ba34a-a8e3-421b-bb1e-ce66d7e56a10" xlink:to="loc_us-gaap_ClassOfStockLineItems_6059ea33-a007-4693-aa16-f35334f4a08b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_f092dafb-7313-45cb-9009-10fd4966645b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6059ea33-a007-4693-aa16-f35334f4a08b" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_f092dafb-7313-45cb-9009-10fd4966645b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_148d3e0a-08c4-4b25-9970-191a8e5ab846" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6059ea33-a007-4693-aa16-f35334f4a08b" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_148d3e0a-08c4-4b25-9970-191a8e5ab846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ConversionOfStockAmountConvertible_db5872c2-5e55-48c4-9d24-b1d41a2efd2c" xlink:href="alts-20241228.xsd#alts_ConversionOfStockAmountConvertible"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6059ea33-a007-4693-aa16-f35334f4a08b" xlink:to="loc_alts_ConversionOfStockAmountConvertible_db5872c2-5e55-48c4-9d24-b1d41a2efd2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ConversionOfStockCommencementPeriod_b3fdd76a-22b8-42fd-b29d-8d8ad4896e25" xlink:href="alts-20241228.xsd#alts_ConversionOfStockCommencementPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6059ea33-a007-4693-aa16-f35334f4a08b" xlink:to="loc_alts_ConversionOfStockCommencementPeriod_b3fdd76a-22b8-42fd-b29d-8d8ad4896e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ConversionOfStockPeriodFollowingClosing_9ad58b00-6a23-4aab-aab2-37b64854614a" xlink:href="alts-20241228.xsd#alts_ConversionOfStockPeriodFollowingClosing"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6059ea33-a007-4693-aa16-f35334f4a08b" xlink:to="loc_alts_ConversionOfStockPeriodFollowingClosing_9ad58b00-6a23-4aab-aab2-37b64854614a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PercentageOfGrossRevenue_e18ca459-4e49-4a74-9730-9637b6c287f3" xlink:href="alts-20241228.xsd#alts_PercentageOfGrossRevenue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6059ea33-a007-4693-aa16-f35334f4a08b" xlink:to="loc_alts_PercentageOfGrossRevenue_e18ca459-4e49-4a74-9730-9637b6c287f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_CommonStockSharesOutstandingPercentage_43e3af71-736f-4922-ba1d-f049cc1ee855" xlink:href="alts-20241228.xsd#alts_CommonStockSharesOutstandingPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6059ea33-a007-4693-aa16-f35334f4a08b" xlink:to="loc_alts_CommonStockSharesOutstandingPercentage_43e3af71-736f-4922-ba1d-f049cc1ee855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ReclassificationOfTemporaryToCurrentLiabilities_7391a9a0-1ede-4345-8edd-e8ffc6349e7c" xlink:href="alts-20241228.xsd#alts_ReclassificationOfTemporaryToCurrentLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6059ea33-a007-4693-aa16-f35334f4a08b" xlink:to="loc_alts_ReclassificationOfTemporaryToCurrentLiabilities_7391a9a0-1ede-4345-8edd-e8ffc6349e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_636a2ca3-94de-483c-8043-d9d2aafed206" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6059ea33-a007-4693-aa16-f35334f4a08b" xlink:to="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_636a2ca3-94de-483c-8043-d9d2aafed206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleConversionRatio_e8980e50-b72e-4e69-bfab-f0a7bfbd1dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleConversionRatio"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6059ea33-a007-4693-aa16-f35334f4a08b" xlink:to="loc_us-gaap_PreferredStockConvertibleConversionRatio_e8980e50-b72e-4e69-bfab-f0a7bfbd1dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_bd4c876d-8082-4393-bd5c-d2e472710856" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6059ea33-a007-4693-aa16-f35334f4a08b" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_bd4c876d-8082-4393-bd5c-d2e472710856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/PreferredStockScheduleofSeriesSConvertiblePreferredStockOutstandingDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#PreferredStockScheduleofSeriesSConvertiblePreferredStockOutstandingDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/PreferredStockScheduleofSeriesSConvertiblePreferredStockOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b74e12f9-0a44-4e6d-806a-8a9f4745912d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_fa0db615-5f16-4c35-a0b2-37b3af6d6540" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b74e12f9-0a44-4e6d-806a-8a9f4745912d" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_fa0db615-5f16-4c35-a0b2-37b3af6d6540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2597a45f-6487-49f2-b9b7-2833ee8611f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_fa0db615-5f16-4c35-a0b2-37b3af6d6540" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2597a45f-6487-49f2-b9b7-2833ee8611f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a684042a-f022-4600-b665-7fbfb0b4d92c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2597a45f-6487-49f2-b9b7-2833ee8611f9" xlink:to="loc_us-gaap_ClassOfStockDomain_a684042a-f022-4600-b665-7fbfb0b4d92c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesSConvertiblePreferredStockMember_cb37ca0d-bf4b-427e-8584-a01b84d7158f" xlink:href="alts-20241228.xsd#alts_SeriesSConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a684042a-f022-4600-b665-7fbfb0b4d92c" xlink:to="loc_alts_SeriesSConvertiblePreferredStockMember_cb37ca0d-bf4b-427e-8584-a01b84d7158f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_ac6561d4-91a1-47a0-92c1-e06f4f945910" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_fa0db615-5f16-4c35-a0b2-37b3af6d6540" xlink:to="loc_us-gaap_ClassOfStockLineItems_ac6561d4-91a1-47a0-92c1-e06f4f945910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a0c6a91d-6013-464d-afb1-b82ee863ca3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ac6561d4-91a1-47a0-92c1-e06f4f945910" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a0c6a91d-6013-464d-afb1-b82ee863ca3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_044830c5-ab1f-4f6c-9c62-6cd6b6da5673" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a0c6a91d-6013-464d-afb1-b82ee863ca3b" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_044830c5-ab1f-4f6c-9c62-6cd6b6da5673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_3756c996-215b-4a52-ad49-b24b5181c8e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a0c6a91d-6013-464d-afb1-b82ee863ca3b" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_3756c996-215b-4a52-ad49-b24b5181c8e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ReclassificationsOfTemporaryToPermanentEquityShares_f28e3add-d783-4d44-a85b-6b135903df2c" xlink:href="alts-20241228.xsd#alts_ReclassificationsOfTemporaryToPermanentEquityShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a0c6a91d-6013-464d-afb1-b82ee863ca3b" xlink:to="loc_alts_ReclassificationsOfTemporaryToPermanentEquityShares_f28e3add-d783-4d44-a85b-6b135903df2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_792d6434-eba7-422e-8db4-a322b9d1f90d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a0c6a91d-6013-464d-afb1-b82ee863ca3b" xlink:to="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_792d6434-eba7-422e-8db4-a322b9d1f90d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ReclassificationOfTemporaryToCurrentLiabilitiesShares_a091ba5b-6fc9-42de-aff5-ae206ed8cf45" xlink:href="alts-20241228.xsd#alts_ReclassificationOfTemporaryToCurrentLiabilitiesShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a0c6a91d-6013-464d-afb1-b82ee863ca3b" xlink:to="loc_alts_ReclassificationOfTemporaryToCurrentLiabilitiesShares_a091ba5b-6fc9-42de-aff5-ae206ed8cf45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ReclassificationOfTemporaryToCurrentLiabilities_f3fecd03-ec51-4134-8427-521c2f6223e0" xlink:href="alts-20241228.xsd#alts_ReclassificationOfTemporaryToCurrentLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a0c6a91d-6013-464d-afb1-b82ee863ca3b" xlink:to="loc_alts_ReclassificationOfTemporaryToCurrentLiabilities_f3fecd03-ec51-4134-8427-521c2f6223e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_f2c52dc5-28fe-4c65-8b16-2d8d68f9d325" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a0c6a91d-6013-464d-afb1-b82ee863ca3b" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_f2c52dc5-28fe-4c65-8b16-2d8d68f9d325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_df2b3c37-de20-4616-942c-c619b80191d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a0c6a91d-6013-464d-afb1-b82ee863ca3b" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_df2b3c37-de20-4616-942c-c619b80191d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/StockholdersEquityCommonStockDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#StockholdersEquityCommonStockDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/StockholdersEquityCommonStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_372e3eb9-344f-44d7-a671-db3ffe72e5cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ShareholdersEquityTable_3b1fa5cf-6d09-447e-80fb-ece4e6dfc1c6" xlink:href="alts-20241228.xsd#alts_ShareholdersEquityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_372e3eb9-344f-44d7-a671-db3ffe72e5cd" xlink:to="loc_alts_ShareholdersEquityTable_3b1fa5cf-6d09-447e-80fb-ece4e6dfc1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_9dc3cd23-2998-406d-b878-67a09749e7ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityTable_3b1fa5cf-6d09-447e-80fb-ece4e6dfc1c6" xlink:to="loc_us-gaap_TypeOfArrangementAxis_9dc3cd23-2998-406d-b878-67a09749e7ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6f62fef8-76a6-4d99-b506-24da0d7ce94d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_9dc3cd23-2998-406d-b878-67a09749e7ba" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6f62fef8-76a6-4d99-b506-24da0d7ce94d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ArticlesOfIncorporationMember_7377db79-1762-4470-9211-ac22b4f768e7" xlink:href="alts-20241228.xsd#alts_ArticlesOfIncorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6f62fef8-76a6-4d99-b506-24da0d7ce94d" xlink:to="loc_alts_ArticlesOfIncorporationMember_7377db79-1762-4470-9211-ac22b4f768e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ShareholdersEquityLineItems_ba221a47-224f-496e-9f81-8c32467aa2b0" xlink:href="alts-20241228.xsd#alts_ShareholdersEquityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityTable_3b1fa5cf-6d09-447e-80fb-ece4e6dfc1c6" xlink:to="loc_alts_ShareholdersEquityLineItems_ba221a47-224f-496e-9f81-8c32467aa2b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_a81c10a6-b86f-4644-9a34-a37f3b001019" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_ba221a47-224f-496e-9f81-8c32467aa2b0" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_a81c10a6-b86f-4644-9a34-a37f3b001019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_f82162c0-8ea8-4f84-9b8b-a060b077e7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_ba221a47-224f-496e-9f81-8c32467aa2b0" xlink:to="loc_us-gaap_CommonStockSharesIssued_f82162c0-8ea8-4f84-9b8b-a060b077e7a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_47f6d3f5-6986-43ad-af72-24988340e2e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_ba221a47-224f-496e-9f81-8c32467aa2b0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_47f6d3f5-6986-43ad-af72-24988340e2e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#StockholdersEquityEquityOfferingsDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_d84bf1e8-03ff-4169-b484-888112e2fc9a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ShareholdersEquityTable_8c6b37b2-aa72-4d29-b310-9651eaaefe3d" xlink:href="alts-20241228.xsd#alts_ShareholdersEquityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_d84bf1e8-03ff-4169-b484-888112e2fc9a" xlink:to="loc_alts_ShareholdersEquityTable_8c6b37b2-aa72-4d29-b310-9651eaaefe3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_17316731-c03b-406b-89f9-94b1311d0dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityTable_8c6b37b2-aa72-4d29-b310-9651eaaefe3d" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_17316731-c03b-406b-89f9-94b1311d0dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_77000ee9-9b0f-4e5b-9f9c-1dbd26028600" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_17316731-c03b-406b-89f9-94b1311d0dd6" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_77000ee9-9b0f-4e5b-9f9c-1dbd26028600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_1287af6d-ac22-4fb2-a905-b7c88787c85f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_77000ee9-9b0f-4e5b-9f9c-1dbd26028600" xlink:to="loc_us-gaap_PrivatePlacementMember_1287af6d-ac22-4fb2-a905-b7c88787c85f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityUnitPurchaseAgreementsMember_4ffbf3b6-7d46-40b7-a860-cca6dee3b022" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityUnitPurchaseAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_77000ee9-9b0f-4e5b-9f9c-1dbd26028600" xlink:to="loc_us-gaap_EquityUnitPurchaseAgreementsMember_4ffbf3b6-7d46-40b7-a860-cca6dee3b022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ThirdPartyExchangeForBrokerageServicesMember_8980f8da-0a4c-48b0-b845-c1894b40a61d" xlink:href="alts-20241228.xsd#alts_ThirdPartyExchangeForBrokerageServicesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_77000ee9-9b0f-4e5b-9f9c-1dbd26028600" xlink:to="loc_alts_ThirdPartyExchangeForBrokerageServicesMember_8980f8da-0a4c-48b0-b845-c1894b40a61d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_22a21111-1d50-4cee-97c4-5b50a85824cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityTable_8c6b37b2-aa72-4d29-b310-9651eaaefe3d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_22a21111-1d50-4cee-97c4-5b50a85824cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_5283ae28-28aa-47d3-b634-2f11dcaa1dec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_22a21111-1d50-4cee-97c4-5b50a85824cf" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_5283ae28-28aa-47d3-b634-2f11dcaa1dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PreFundedWarrantsMember_c9716912-8bb3-41f7-a7ce-346da96137e0" xlink:href="alts-20241228.xsd#alts_PreFundedWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_5283ae28-28aa-47d3-b634-2f11dcaa1dec" xlink:to="loc_alts_PreFundedWarrantsMember_c9716912-8bb3-41f7-a7ce-346da96137e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_4cb38026-161d-4414-ada6-d9dc14bbed19" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityTable_8c6b37b2-aa72-4d29-b310-9651eaaefe3d" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_4cb38026-161d-4414-ada6-d9dc14bbed19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_014661ae-1b92-4aa8-8896-ec3cd6ea58e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_4cb38026-161d-4414-ada6-d9dc14bbed19" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_014661ae-1b92-4aa8-8896-ec3cd6ea58e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IcgNoteMember_b633b716-8d76-4b47-a47d-15eee0b755f8" xlink:href="alts-20241228.xsd#alts_IcgNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_014661ae-1b92-4aa8-8896-ec3cd6ea58e7" xlink:to="loc_alts_IcgNoteMember_b633b716-8d76-4b47-a47d-15eee0b755f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IsaacConsultingAgreementMember_7489caea-3075-4fa8-aa3a-205e513d8ded" xlink:href="alts-20241228.xsd#alts_IsaacConsultingAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_014661ae-1b92-4aa8-8896-ec3cd6ea58e7" xlink:to="loc_alts_IsaacConsultingAgreementMember_7489caea-3075-4fa8-aa3a-205e513d8ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NorthYorkLTDMember_fd03af4c-b614-4528-ae43-afe18120c83c" xlink:href="alts-20241228.xsd#alts_NorthYorkLTDMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_014661ae-1b92-4aa8-8896-ec3cd6ea58e7" xlink:to="loc_alts_NorthYorkLTDMember_fd03af4c-b614-4528-ae43-afe18120c83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f91f8f42-801d-47a7-a340-01ce185584b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityTable_8c6b37b2-aa72-4d29-b310-9651eaaefe3d" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f91f8f42-801d-47a7-a340-01ce185584b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_ea80eff1-ce60-4297-b0b3-3fe3578065da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f91f8f42-801d-47a7-a340-01ce185584b9" xlink:to="loc_us-gaap_RelatedPartyDomain_ea80eff1-ce60-4297-b0b3-3fe3578065da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_e9599664-0efc-4057-9076-f6d329f2a5a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_ea80eff1-ce60-4297-b0b3-3fe3578065da" xlink:to="loc_us-gaap_RelatedPartyMember_e9599664-0efc-4057-9076-f6d329f2a5a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_9ab78ec7-c317-4ca0-88c7-d94ebc0fb72a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityTable_8c6b37b2-aa72-4d29-b310-9651eaaefe3d" xlink:to="loc_srt_CounterpartyNameAxis_9ab78ec7-c317-4ca0-88c7-d94ebc0fb72a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4036f8a6-bbc8-4608-9dab-bd28777f2533" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_9ab78ec7-c317-4ca0-88c7-d94ebc0fb72a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4036f8a6-bbc8-4608-9dab-bd28777f2533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Mr.JonIsaacMember_816b3a36-04d7-41bf-a1c8-ece9480b079d" xlink:href="alts-20241228.xsd#alts_Mr.JonIsaacMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4036f8a6-bbc8-4608-9dab-bd28777f2533" xlink:to="loc_alts_Mr.JonIsaacMember_816b3a36-04d7-41bf-a1c8-ece9480b079d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_UnaffiliatedThirdPartyMember_98fc0882-f48c-4176-a520-0229f3897191" xlink:href="alts-20241228.xsd#alts_UnaffiliatedThirdPartyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4036f8a6-bbc8-4608-9dab-bd28777f2533" xlink:to="loc_alts_UnaffiliatedThirdPartyMember_98fc0882-f48c-4176-a520-0229f3897191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_96c25663-5a57-4440-9cce-adb8a93ac274" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityTable_8c6b37b2-aa72-4d29-b310-9651eaaefe3d" xlink:to="loc_us-gaap_DebtInstrumentAxis_96c25663-5a57-4440-9cce-adb8a93ac274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0c15e4e0-5b6e-4a58-aa85-679ec4375d29" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_96c25663-5a57-4440-9cce-adb8a93ac274" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0c15e4e0-5b6e-4a58-aa85-679ec4375d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IcgNoteMember_da3e1e3a-d824-4528-a3ed-ab7c2fa8643b" xlink:href="alts-20241228.xsd#alts_IcgNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0c15e4e0-5b6e-4a58-aa85-679ec4375d29" xlink:to="loc_alts_IcgNoteMember_da3e1e3a-d824-4528-a3ed-ab7c2fa8643b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NonConvertibleDebentureBigAndSmallDebentureMember_5790140e-9d27-4865-a210-c42f7558fed1" xlink:href="alts-20241228.xsd#alts_NonConvertibleDebentureBigAndSmallDebentureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0c15e4e0-5b6e-4a58-aa85-679ec4375d29" xlink:to="loc_alts_NonConvertibleDebentureBigAndSmallDebentureMember_5790140e-9d27-4865-a210-c42f7558fed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PromissoryNoteMember_898c66a1-f021-4d3e-80e9-86c1af2ccc6e" xlink:href="alts-20241228.xsd#alts_PromissoryNoteMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0c15e4e0-5b6e-4a58-aa85-679ec4375d29" xlink:to="loc_alts_PromissoryNoteMember_898c66a1-f021-4d3e-80e9-86c1af2ccc6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_A10ConvertiblePromissoryNoteMember_eacde7e6-f3ff-4d4b-93ed-4478c2474e22" xlink:href="alts-20241228.xsd#alts_A10ConvertiblePromissoryNoteMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0c15e4e0-5b6e-4a58-aa85-679ec4375d29" xlink:to="loc_alts_A10ConvertiblePromissoryNoteMember_eacde7e6-f3ff-4d4b-93ed-4478c2474e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7d573546-7973-4277-b49c-061cf25f4aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityTable_8c6b37b2-aa72-4d29-b310-9651eaaefe3d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7d573546-7973-4277-b49c-061cf25f4aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c80ee933-84a3-4a54-8f53-f4778b039edf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7d573546-7973-4277-b49c-061cf25f4aeb" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c80ee933-84a3-4a54-8f53-f4778b039edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PromissoryNoteMember_d5296e80-9c92-4480-82bc-3198bfb590cf" xlink:href="alts-20241228.xsd#alts_PromissoryNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c80ee933-84a3-4a54-8f53-f4778b039edf" xlink:to="loc_alts_PromissoryNoteMember_d5296e80-9c92-4480-82bc-3198bfb590cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_f4da6a93-b654-4e48-a98d-4b0074b7ff93" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c80ee933-84a3-4a54-8f53-f4778b039edf" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_f4da6a93-b654-4e48-a98d-4b0074b7ff93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a64d71e7-d4f2-431f-9c5f-e6f9a75d7dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityTable_8c6b37b2-aa72-4d29-b310-9651eaaefe3d" xlink:to="loc_us-gaap_AwardTypeAxis_a64d71e7-d4f2-431f-9c5f-e6f9a75d7dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d62aa19-5903-44e1-937d-a521f45f7ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a64d71e7-d4f2-431f-9c5f-e6f9a75d7dbc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d62aa19-5903-44e1-937d-a521f45f7ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_713099b0-e459-44ee-9e13-e40dd69e86b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d62aa19-5903-44e1-937d-a521f45f7ae9" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_713099b0-e459-44ee-9e13-e40dd69e86b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_ad94603e-a6f2-4170-badf-b460efae7ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityTable_8c6b37b2-aa72-4d29-b310-9651eaaefe3d" xlink:to="loc_us-gaap_StatementClassOfStockAxis_ad94603e-a6f2-4170-badf-b460efae7ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b1f2dd03-e2bf-4834-916f-8c048f3acdbe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ad94603e-a6f2-4170-badf-b460efae7ce4" xlink:to="loc_us-gaap_ClassOfStockDomain_b1f2dd03-e2bf-4834-916f-8c048f3acdbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_922da69e-7deb-4bd8-a439-6923d369c6bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_b1f2dd03-e2bf-4834-916f-8c048f3acdbe" xlink:to="loc_us-gaap_CommonStockMember_922da69e-7deb-4bd8-a439-6923d369c6bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SeriesVConvertiblePreferredStockMember_6cd3e91e-d219-45ab-835e-3d37262107fc" xlink:href="alts-20241228.xsd#alts_SeriesVConvertiblePreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_b1f2dd03-e2bf-4834-916f-8c048f3acdbe" xlink:to="loc_alts_SeriesVConvertiblePreferredStockMember_6cd3e91e-d219-45ab-835e-3d37262107fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c5eba3c1-d2de-4a46-828c-de4d9b1e09fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityTable_8c6b37b2-aa72-4d29-b310-9651eaaefe3d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c5eba3c1-d2de-4a46-828c-de4d9b1e09fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5704d3c8-77c9-496a-990a-11318cafdb90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c5eba3c1-d2de-4a46-828c-de4d9b1e09fe" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5704d3c8-77c9-496a-990a-11318cafdb90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Alt5SigmaInc.Member_16903778-8692-4139-965c-d3c315a3e079" xlink:href="alts-20241228.xsd#alts_Alt5SigmaInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5704d3c8-77c9-496a-990a-11318cafdb90" xlink:to="loc_alts_Alt5SigmaInc.Member_16903778-8692-4139-965c-d3c315a3e079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_1c2030d2-3600-4f47-9366-c0ec718599c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityTable_8c6b37b2-aa72-4d29-b310-9651eaaefe3d" xlink:to="loc_us-gaap_PlanNameAxis_1c2030d2-3600-4f47-9366-c0ec718599c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_bb4785dc-c7da-49f1-92de-f8452e3b229b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_1c2030d2-3600-4f47-9366-c0ec718599c5" xlink:to="loc_us-gaap_PlanNameDomain_bb4785dc-c7da-49f1-92de-f8452e3b229b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_A2023EquityIncentivePlanMember_ac8b61b3-8871-4d25-ab55-cf7531a1834a" xlink:href="alts-20241228.xsd#alts_A2023EquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_bb4785dc-c7da-49f1-92de-f8452e3b229b" xlink:to="loc_alts_A2023EquityIncentivePlanMember_ac8b61b3-8871-4d25-ab55-cf7531a1834a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:href="alts-20241228.xsd#alts_ShareholdersEquityLineItems"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityTable_8c6b37b2-aa72-4d29-b310-9651eaaefe3d" xlink:to="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_1584e80e-26f5-48aa-89fa-8a1e31d114ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_1584e80e-26f5-48aa-89fa-8a1e31d114ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_3196900b-c02a-49e2-b396-42ee634170bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_3196900b-c02a-49e2-b396-42ee634170bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_cd4e393b-af19-4fdb-9be0-e4d52e0cd471" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_cd4e393b-af19-4fdb-9be0-e4d52e0cd471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfInterestInPartnershipUnit_092ab43d-6ff4-4ace-b0d6-caca6778c672" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfInterestInPartnershipUnit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_ProceedsFromSaleOfInterestInPartnershipUnit_092ab43d-6ff4-4ace-b0d6-caca6778c672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_b0b19916-67a2-4707-abf8-0f87cc64614a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_b0b19916-67a2-4707-abf8-0f87cc64614a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_24a7a018-76e8-48ba-834c-3570e4fbd585" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_24a7a018-76e8-48ba-834c-3570e4fbd585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_d34ff796-e786-41fa-971b-8c9e450a2d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_d34ff796-e786-41fa-971b-8c9e450a2d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NumberOfAgreementsToBePurchased_c1711ecd-47ad-45ba-892a-9cc90ffa82f3" xlink:href="alts-20241228.xsd#alts_NumberOfAgreementsToBePurchased"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_alts_NumberOfAgreementsToBePurchased_c1711ecd-47ad-45ba-892a-9cc90ffa82f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_85d067d7-6822-4f46-be6b-73081b670854" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_85d067d7-6822-4f46-be6b-73081b670854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_9f5d841d-373b-4939-8c8f-0be1dfe91fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_9f5d841d-373b-4939-8c8f-0be1dfe91fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SaleOfStockUnitCompositionNumberOfCommonSharesInEachUnit_cf5fcddf-a779-4bb9-9ce6-af05b045b032" xlink:href="alts-20241228.xsd#alts_SaleOfStockUnitCompositionNumberOfCommonSharesInEachUnit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_alts_SaleOfStockUnitCompositionNumberOfCommonSharesInEachUnit_cf5fcddf-a779-4bb9-9ce6-af05b045b032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SaleOfStockUnitCompositionNumberOfWarrantsIssuedInEachUnit_4927fa2a-cbef-4fab-99fa-8fd4ba7e539e" xlink:href="alts-20241228.xsd#alts_SaleOfStockUnitCompositionNumberOfWarrantsIssuedInEachUnit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_alts_SaleOfStockUnitCompositionNumberOfWarrantsIssuedInEachUnit_4927fa2a-cbef-4fab-99fa-8fd4ba7e539e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ClassOfWarrantPricePerShare_539bda34-ad9b-4f45-9102-a7f0cafb9f33" xlink:href="alts-20241228.xsd#alts_ClassOfWarrantPricePerShare"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_alts_ClassOfWarrantPricePerShare_539bda34-ad9b-4f45-9102-a7f0cafb9f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_6c7031a6-b9b0-4573-885c-dbc4ea3f6339" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_6c7031a6-b9b0-4573-885c-dbc4ea3f6339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RelatedPartyTransactionConsultingAgreementTerm_23a96660-7d88-4206-8488-6571ff9e0a88" xlink:href="alts-20241228.xsd#alts_RelatedPartyTransactionConsultingAgreementTerm"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_alts_RelatedPartyTransactionConsultingAgreementTerm_23a96660-7d88-4206-8488-6571ff9e0a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares_58aa2b1d-4f12-49d6-adff-566d145bf676" xlink:href="alts-20241228.xsd#alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares_58aa2b1d-4f12-49d6-adff-566d145bf676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1_d5c5dd4b-4f4a-4037-a86e-947ea45e7f55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionOriginalDebtAmount1"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_DebtConversionOriginalDebtAmount1_d5c5dd4b-4f4a-4037-a86e-947ea45e7f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_3866f05e-95f4-4645-90bb-182658c0886d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_3866f05e-95f4-4645-90bb-182658c0886d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_43190825-8382-462c-bc90-571019acd3fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_43190825-8382-462c-bc90-571019acd3fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockIssuedDuringPeriodSharesPrepaidInterest_e349e540-ff5e-425b-ad24-f4512f26c335" xlink:href="alts-20241228.xsd#alts_StockIssuedDuringPeriodSharesPrepaidInterest"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_alts_StockIssuedDuringPeriodSharesPrepaidInterest_e349e540-ff5e-425b-ad24-f4512f26c335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_StockIssuedDuringPeriodSharesWarrantsExercised_b7bcd931-92e4-4dec-9978-45e6f86c1358" xlink:href="alts-20241228.xsd#alts_StockIssuedDuringPeriodSharesWarrantsExercised"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_alts_StockIssuedDuringPeriodSharesWarrantsExercised_b7bcd931-92e4-4dec-9978-45e6f86c1358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e8c35a93-d379-4c32-9fdc-32c107e52e94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e8c35a93-d379-4c32-9fdc-32c107e52e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_f8485a00-4d6f-408f-9b55-c4090353791b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_990c658c-cca7-4d76-a8d1-895733b6fb88" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_f8485a00-4d6f-408f-9b55-c4090353791b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#StockholdersEquityEquityIncentivesDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f5a25735-358a-4e42-a2c5-13164e4b3e76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ShareholdersEquityTable_26520993-b29f-4827-8f2f-d926b21a5e82" xlink:href="alts-20241228.xsd#alts_ShareholdersEquityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f5a25735-358a-4e42-a2c5-13164e4b3e76" xlink:to="loc_alts_ShareholdersEquityTable_26520993-b29f-4827-8f2f-d926b21a5e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_1270bb9d-e6fc-4e65-a62c-bea41f43b914" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityTable_26520993-b29f-4827-8f2f-d926b21a5e82" xlink:to="loc_us-gaap_PlanNameAxis_1270bb9d-e6fc-4e65-a62c-bea41f43b914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_c5d4148b-cc34-453d-89d1-6c6f837de91f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_1270bb9d-e6fc-4e65-a62c-bea41f43b914" xlink:to="loc_us-gaap_PlanNameDomain_c5d4148b-cc34-453d-89d1-6c6f837de91f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_A2024EquityIncentivePlanMember_d00840f2-ccf2-4115-9f90-8edded1a58eb" xlink:href="alts-20241228.xsd#alts_A2024EquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_c5d4148b-cc34-453d-89d1-6c6f837de91f" xlink:to="loc_alts_A2024EquityIncentivePlanMember_d00840f2-ccf2-4115-9f90-8edded1a58eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_A2023EquityIncentivePlanMember_248f8c7c-0622-4658-a730-cf4c6d1ba5eb" xlink:href="alts-20241228.xsd#alts_A2023EquityIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_c5d4148b-cc34-453d-89d1-6c6f837de91f" xlink:to="loc_alts_A2023EquityIncentivePlanMember_248f8c7c-0622-4658-a730-cf4c6d1ba5eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Plan2016Member_ab7f427e-6de5-4e94-b572-c5d6d076e0ce" xlink:href="alts-20241228.xsd#alts_Plan2016Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_c5d4148b-cc34-453d-89d1-6c6f837de91f" xlink:to="loc_alts_Plan2016Member_ab7f427e-6de5-4e94-b572-c5d6d076e0ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Plan2011Member_46a64224-ced1-4dc2-8bbf-fe6c2a97274f" xlink:href="alts-20241228.xsd#alts_Plan2011Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_c5d4148b-cc34-453d-89d1-6c6f837de91f" xlink:to="loc_alts_Plan2011Member_46a64224-ced1-4dc2-8bbf-fe6c2a97274f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1bfc053a-dbe9-4435-bcc0-abc9b4ec23c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityTable_26520993-b29f-4827-8f2f-d926b21a5e82" xlink:to="loc_us-gaap_AwardTypeAxis_1bfc053a-dbe9-4435-bcc0-abc9b4ec23c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2ccbf68c-49ea-4b96-810b-5755e04c294f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1bfc053a-dbe9-4435-bcc0-abc9b4ec23c3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2ccbf68c-49ea-4b96-810b-5755e04c294f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a9321536-5c49-422f-b227-6f855f83ae9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2ccbf68c-49ea-4b96-810b-5755e04c294f" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a9321536-5c49-422f-b227-6f855f83ae9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_6dc09372-7590-441a-b9bd-7a2515fcab94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2ccbf68c-49ea-4b96-810b-5755e04c294f" xlink:to="loc_us-gaap_EmployeeStockOptionMember_6dc09372-7590-441a-b9bd-7a2515fcab94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_35740d51-2a4d-4afb-ac8a-f0d25a86098b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityTable_26520993-b29f-4827-8f2f-d926b21a5e82" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_35740d51-2a4d-4afb-ac8a-f0d25a86098b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_0e6fa5bf-b282-4c1e-829c-785e38b33b86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_35740d51-2a4d-4afb-ac8a-f0d25a86098b" xlink:to="loc_us-gaap_RelatedPartyDomain_0e6fa5bf-b282-4c1e-829c-785e38b33b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_ac9a41b3-ad1d-4961-a3fa-da3d86c5ee9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_0e6fa5bf-b282-4c1e-829c-785e38b33b86" xlink:to="loc_us-gaap_RelatedPartyMember_ac9a41b3-ad1d-4961-a3fa-da3d86c5ee9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ShareholdersEquityLineItems_8921b5d6-ad93-4f20-90e8-5f081ad921c3" xlink:href="alts-20241228.xsd#alts_ShareholdersEquityLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityTable_26520993-b29f-4827-8f2f-d926b21a5e82" xlink:to="loc_alts_ShareholdersEquityLineItems_8921b5d6-ad93-4f20-90e8-5f081ad921c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4c0f9aa1-8b2e-4eb5-a657-ead90d47b382" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_8921b5d6-ad93-4f20-90e8-5f081ad921c3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4c0f9aa1-8b2e-4eb5-a657-ead90d47b382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_26ae6308-69bb-4c48-8093-4cd1709e3fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_8921b5d6-ad93-4f20-90e8-5f081ad921c3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_26ae6308-69bb-4c48-8093-4cd1709e3fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_e76230c4-607b-4b83-8b1c-695f6c43840e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_8921b5d6-ad93-4f20-90e8-5f081ad921c3" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_e76230c4-607b-4b83-8b1c-695f6c43840e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_481d42ee-3202-43d2-9a6c-ff4b40432d28" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_8921b5d6-ad93-4f20-90e8-5f081ad921c3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_481d42ee-3202-43d2-9a6c-ff4b40432d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a7834c56-ef11-4622-bbb3-bb78a52a14e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_8921b5d6-ad93-4f20-90e8-5f081ad921c3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a7834c56-ef11-4622-bbb3-bb78a52a14e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_e1f159c1-4632-48cc-85c5-44c6d490aa8b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_8921b5d6-ad93-4f20-90e8-5f081ad921c3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_e1f159c1-4632-48cc-85c5-44c6d490aa8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_ec9d16b3-b2a2-454f-9d34-ac62c554f0de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_8921b5d6-ad93-4f20-90e8-5f081ad921c3" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_ec9d16b3-b2a2-454f-9d34-ac62c554f0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_11156199-bafa-415f-8260-d190400ecce6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_ShareholdersEquityLineItems_8921b5d6-ad93-4f20-90e8-5f081ad921c3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_11156199-bafa-415f-8260-d190400ecce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#StockholdersEquityScheduleofStockOptionsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_7e35fe19-5466-494e-be93-78d3ccfcbbe1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2f792715-e16f-4e89-8291-9d8434e13db7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_7e35fe19-5466-494e-be93-78d3ccfcbbe1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2f792715-e16f-4e89-8291-9d8434e13db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5a09c542-c925-4481-b455-8ef24b8967d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2f792715-e16f-4e89-8291-9d8434e13db7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5a09c542-c925-4481-b455-8ef24b8967d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_068bfd88-148e-4dfe-9e55-a0de915de4e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2f792715-e16f-4e89-8291-9d8434e13db7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_068bfd88-148e-4dfe-9e55-a0de915de4e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_debe4048-e2aa-4e28-8fac-0289e2647a45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2f792715-e16f-4e89-8291-9d8434e13db7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_debe4048-e2aa-4e28-8fac-0289e2647a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_59b3b0cf-d024-46be-940a-e555a1a33448" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2f792715-e16f-4e89-8291-9d8434e13db7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_59b3b0cf-d024-46be-940a-e555a1a33448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_6847b636-cd9c-4e50-bb1d-ae0e19bf16a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_7e35fe19-5466-494e-be93-78d3ccfcbbe1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_6847b636-cd9c-4e50-bb1d-ae0e19bf16a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0300363f-754e-4898-8717-f40c71dc8276" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_7e35fe19-5466-494e-be93-78d3ccfcbbe1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0300363f-754e-4898-8717-f40c71dc8276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f3ef2011-1378-407f-8317-9c9a06c531de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0300363f-754e-4898-8717-f40c71dc8276" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f3ef2011-1378-407f-8317-9c9a06c531de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_e4e114c4-f0f9-4f5b-bf61-5717d739c0b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0300363f-754e-4898-8717-f40c71dc8276" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_e4e114c4-f0f9-4f5b-bf61-5717d739c0b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_eb79c333-880a-45f7-9a3a-76b39a73f0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0300363f-754e-4898-8717-f40c71dc8276" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_eb79c333-880a-45f7-9a3a-76b39a73f0eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d6802c94-e28c-457a-a684-800a6f9c76d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0300363f-754e-4898-8717-f40c71dc8276" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d6802c94-e28c-457a-a684-800a6f9c76d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_cdd10106-03e2-4f5c-b6ec-e390299caaca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_7e35fe19-5466-494e-be93-78d3ccfcbbe1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_cdd10106-03e2-4f5c-b6ec-e390299caaca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AggregateIntrinsicValueAbstract_1bc2d122-d226-4248-abe7-6a9e1e23404e" xlink:href="alts-20241228.xsd#alts_AggregateIntrinsicValueAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_7e35fe19-5466-494e-be93-78d3ccfcbbe1" xlink:to="loc_alts_AggregateIntrinsicValueAbstract_1bc2d122-d226-4248-abe7-6a9e1e23404e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_5d2991c6-c899-4224-83c5-7773488456c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_AggregateIntrinsicValueAbstract_1bc2d122-d226-4248-abe7-6a9e1e23404e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_5d2991c6-c899-4224-83c5-7773488456c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_6423e569-1023-494d-aaf2-c9bebc6b21f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_alts_AggregateIntrinsicValueAbstract_1bc2d122-d226-4248-abe7-6a9e1e23404e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_6423e569-1023-494d-aaf2-c9bebc6b21f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_01807129-e2a3-4ff8-99ca-9582ee628edd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_7e35fe19-5466-494e-be93-78d3ccfcbbe1" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_01807129-e2a3-4ff8-99ca-9582ee628edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_9ab87286-a000-4009-8384-e770a9925642" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_7e35fe19-5466-494e-be93-78d3ccfcbbe1" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_9ab87286-a000-4009-8384-e770a9925642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/StockholdersEquityScheduleofExercisePriceforStockOptionsOutstandingandExercisableOutstandingDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#StockholdersEquityScheduleofExercisePriceforStockOptionsOutstandingandExercisableOutstandingDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/StockholdersEquityScheduleofExercisePriceforStockOptionsOutstandingandExercisableOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_1e5f4908-a0dd-4ab2-8698-b0c22cc5a033" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_927fcbb7-05e5-4376-9f02-c99b5ec64155" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_1e5f4908-a0dd-4ab2-8698-b0c22cc5a033" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_927fcbb7-05e5-4376-9f02-c99b5ec64155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_cf55943e-d34c-4ff2-b499-01f9fcab4140" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_927fcbb7-05e5-4376-9f02-c99b5ec64155" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_cf55943e-d34c-4ff2-b499-01f9fcab4140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_db1e2c54-f9a7-4e98-9902-58123ccb449e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_cf55943e-d34c-4ff2-b499-01f9fcab4140" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_db1e2c54-f9a7-4e98-9902-58123ccb449e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ExercisePriceRangeOneMember_a5ba38b6-899a-453e-a8c0-08aabf4f7018" xlink:href="alts-20241228.xsd#alts_ExercisePriceRangeOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_db1e2c54-f9a7-4e98-9902-58123ccb449e" xlink:to="loc_alts_ExercisePriceRangeOneMember_a5ba38b6-899a-453e-a8c0-08aabf4f7018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ExercisePriceRangeTwoMember_ec7d7208-2605-409d-8f29-9fbd2ca480e6" xlink:href="alts-20241228.xsd#alts_ExercisePriceRangeTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_db1e2c54-f9a7-4e98-9902-58123ccb449e" xlink:to="loc_alts_ExercisePriceRangeTwoMember_ec7d7208-2605-409d-8f29-9fbd2ca480e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_f8f93d5f-bf2b-4a47-b4d5-aaf116669a96" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_927fcbb7-05e5-4376-9f02-c99b5ec64155" xlink:to="loc_us-gaap_ClassOfStockLineItems_f8f93d5f-bf2b-4a47-b4d5-aaf116669a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_97cc0e51-f3f5-41b7-99be-81567815ada7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f8f93d5f-bf2b-4a47-b4d5-aaf116669a96" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_97cc0e51-f3f5-41b7-99be-81567815ada7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_8cf34cf9-e694-4e88-ab51-bfb16c304133" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f8f93d5f-bf2b-4a47-b4d5-aaf116669a96" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_8cf34cf9-e694-4e88-ab51-bfb16c304133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_a0c724ff-458c-47d8-9de3-8a1375298aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f8f93d5f-bf2b-4a47-b4d5-aaf116669a96" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_a0c724ff-458c-47d8-9de3-8a1375298aa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_cec8c539-47dc-46ee-91f2-e7f2234e9347" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_f8f93d5f-bf2b-4a47-b4d5-aaf116669a96" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_cec8c539-47dc-46ee-91f2-e7f2234e9347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/IncometaxesNarrativeDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#IncometaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/IncometaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_fe7a3139-bbf5-4f9d-895b-a92f0cce948e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_5e92a8e3-08ed-4117-aaf0-e7dcf592f4d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fe7a3139-bbf5-4f9d-895b-a92f0cce948e" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_5e92a8e3-08ed-4117-aaf0-e7dcf592f4d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_14baf174-42fc-4ef6-94bd-c6d0d1284cba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_5e92a8e3-08ed-4117-aaf0-e7dcf592f4d8" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_14baf174-42fc-4ef6-94bd-c6d0d1284cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_f2d0cebf-df3e-42c1-9e1d-d532ecb50df1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_14baf174-42fc-4ef6-94bd-c6d0d1284cba" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_f2d0cebf-df3e-42c1-9e1d-d532ecb50df1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_25a19bc3-514f-4d75-ac12-b6b3ce51ae49" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f2d0cebf-df3e-42c1-9e1d-d532ecb50df1" xlink:to="loc_us-gaap_DomesticCountryMember_25a19bc3-514f-4d75-ac12-b6b3ce51ae49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_48bc24d5-fe81-44ec-860c-13025f2ca881" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f2d0cebf-df3e-42c1-9e1d-d532ecb50df1" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_48bc24d5-fe81-44ec-860c-13025f2ca881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_c8d24fcc-2ea9-4797-bc1f-97d3ccb198ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_5e92a8e3-08ed-4117-aaf0-e7dcf592f4d8" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_c8d24fcc-2ea9-4797-bc1f-97d3ccb198ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_c0933081-0e02-40fe-a86d-c371803112f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_c8d24fcc-2ea9-4797-bc1f-97d3ccb198ba" xlink:to="loc_us-gaap_OperatingLossCarryforwards_c0933081-0e02-40fe-a86d-c371803112f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_dcd2f444-0498-43b4-9956-35a70e02177c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_c8d24fcc-2ea9-4797-bc1f-97d3ccb198ba" xlink:to="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_dcd2f444-0498-43b4-9956-35a70e02177c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeTaxProvisionBenefitDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#IncometaxesScheduleofIncomeTaxProvisionBenefitDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeTaxProvisionBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a8ce5385-59e7-4e5a-b37f-c9ac3f2add44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_051b2ccd-4f1f-4f5b-8465-f58ca04dacba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a8ce5385-59e7-4e5a-b37f-c9ac3f2add44" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_051b2ccd-4f1f-4f5b-8465-f58ca04dacba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_6be2ac91-5213-4b2a-8774-6f9523909e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_051b2ccd-4f1f-4f5b-8465-f58ca04dacba" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_6be2ac91-5213-4b2a-8774-6f9523909e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_9ec79e01-2dc5-4169-8fb7-8400de7da920" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_6be2ac91-5213-4b2a-8774-6f9523909e8d" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_9ec79e01-2dc5-4169-8fb7-8400de7da920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentContinuingOperationsMember_5bbcdf96-c189-4573-9f0e-14c36818d746" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentContinuingOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_9ec79e01-2dc5-4169-8fb7-8400de7da920" xlink:to="loc_us-gaap_SegmentContinuingOperationsMember_5bbcdf96-c189-4573-9f0e-14c36818d746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_c6679d30-2b58-47f7-8552-915715bc8676" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_9ec79e01-2dc5-4169-8fb7-8400de7da920" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_c6679d30-2b58-47f7-8552-915715bc8676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_bbea0285-9e6a-4009-8213-6aa3424be8ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_051b2ccd-4f1f-4f5b-8465-f58ca04dacba" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_bbea0285-9e6a-4009-8213-6aa3424be8ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_fb7ca665-974e-4d34-aac9-3f3018b063c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_bbea0285-9e6a-4009-8213-6aa3424be8ea" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_fb7ca665-974e-4d34-aac9-3f3018b063c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_58800811-ac24-4045-9d64-7b9440ae8bb3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_bbea0285-9e6a-4009-8213-6aa3424be8ea" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_58800811-ac24-4045-9d64-7b9440ae8bb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_da246c9f-93dd-4259-8756-9db1ff3316a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_58800811-ac24-4045-9d64-7b9440ae8bb3" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_da246c9f-93dd-4259-8756-9db1ff3316a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_bd744e1a-e153-44a0-ba83-19b5a3985076" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_58800811-ac24-4045-9d64-7b9440ae8bb3" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_bd744e1a-e153-44a0-ba83-19b5a3985076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_170eefbe-797b-4950-8e6f-05413587ee82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_58800811-ac24-4045-9d64-7b9440ae8bb3" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_170eefbe-797b-4950-8e6f-05413587ee82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_b3406a2d-4148-4496-8759-1ff92d9f3143" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_58800811-ac24-4045-9d64-7b9440ae8bb3" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_b3406a2d-4148-4496-8759-1ff92d9f3143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_10d4e7cd-5c95-419c-8710-621313b89497" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_bbea0285-9e6a-4009-8213-6aa3424be8ea" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_10d4e7cd-5c95-419c-8710-621313b89497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ProvisionBenefitOfIncomeTaxes_b1f2db3b-5aef-4697-8f38-6d97d94bb282" xlink:href="alts-20241228.xsd#alts_ProvisionBenefitOfIncomeTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_bbea0285-9e6a-4009-8213-6aa3424be8ea" xlink:to="loc_alts_ProvisionBenefitOfIncomeTaxes_b1f2db3b-5aef-4697-8f38-6d97d94bb282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/IncometaxesScheduleofReconciliationofIncomeTaxBenefitProvisionwiththeFederalStatutoryTaxRateDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#IncometaxesScheduleofReconciliationofIncomeTaxBenefitProvisionwiththeFederalStatutoryTaxRateDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/IncometaxesScheduleofReconciliationofIncomeTaxBenefitProvisionwiththeFederalStatutoryTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ea8a408a-ba38-4749-a313-96852f4dfa41" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_18629d43-9035-4f8b-9bed-befe60a9f13f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ea8a408a-ba38-4749-a313-96852f4dfa41" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_18629d43-9035-4f8b-9bed-befe60a9f13f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_84213088-3e52-4487-91d1-b2948a368564" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_18629d43-9035-4f8b-9bed-befe60a9f13f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_84213088-3e52-4487-91d1-b2948a368564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_3c56b7af-2be1-428f-865c-784878f25999" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_18629d43-9035-4f8b-9bed-befe60a9f13f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_3c56b7af-2be1-428f-865c-784878f25999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_5af02055-c369-49e5-91f2-4ac1fcea90e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_18629d43-9035-4f8b-9bed-befe60a9f13f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_5af02055-c369-49e5-91f2-4ac1fcea90e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_EffectiveIncomeTaxRateReconciliationPermanentDifferences_abb5f377-11f3-46c4-999c-439b383efe51" xlink:href="alts-20241228.xsd#alts_EffectiveIncomeTaxRateReconciliationPermanentDifferences"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_18629d43-9035-4f8b-9bed-befe60a9f13f" xlink:to="loc_alts_EffectiveIncomeTaxRateReconciliationPermanentDifferences_abb5f377-11f3-46c4-999c-439b383efe51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_320fe468-1600-48f9-a31e-02394013afb1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_18629d43-9035-4f8b-9bed-befe60a9f13f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_320fe468-1600-48f9-a31e-02394013afb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_73972722-c842-4847-b8ff-40a59ea1459e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_18629d43-9035-4f8b-9bed-befe60a9f13f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_73972722-c842-4847-b8ff-40a59ea1459e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_06f372fc-cb42-4233-b462-df7e9284e85f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_18629d43-9035-4f8b-9bed-befe60a9f13f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_06f372fc-cb42-4233-b462-df7e9284e85f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_19e49cff-84ac-4d29-a5ce-cf3305d07fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_18629d43-9035-4f8b-9bed-befe60a9f13f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_19e49cff-84ac-4d29-a5ce-cf3305d07fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeLossBeforeProvisionofIncomeTaxesDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#IncometaxesScheduleofIncomeLossBeforeProvisionofIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeLossBeforeProvisionofIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_25ae117f-3223-4b70-a849-20deb651c47c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_77fdf3a7-51f2-4c29-9332-bcce74957c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_25ae117f-3223-4b70-a849-20deb651c47c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_77fdf3a7-51f2-4c29-9332-bcce74957c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_4872b667-4330-4620-8b05-9d4b2bb30f02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_25ae117f-3223-4b70-a849-20deb651c47c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_4872b667-4330-4620-8b05-9d4b2bb30f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes_cfa5c2c8-a218-49d9-a045-d8363b4a5220" xlink:href="alts-20241228.xsd#alts_IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_25ae117f-3223-4b70-a849-20deb651c47c" xlink:to="loc_alts_IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes_cfa5c2c8-a218-49d9-a045-d8363b4a5220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_754cdc96-2a23-427d-9936-a7911be2ec30" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_54f031c1-b4ce-447a-8bb2-278efc7bc52c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_754cdc96-2a23-427d-9936-a7911be2ec30" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_54f031c1-b4ce-447a-8bb2-278efc7bc52c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_9d7464e2-8e09-449c-b71e-9ffc77bebc12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_54f031c1-b4ce-447a-8bb2-278efc7bc52c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_9d7464e2-8e09-449c-b71e-9ffc77bebc12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_63048ae1-0215-4fdf-8030-eb8a51cc5a27" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_54f031c1-b4ce-447a-8bb2-278efc7bc52c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_63048ae1-0215-4fdf-8030-eb8a51cc5a27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_636dc83d-57f3-4d22-9ec1-c65b8f2a326c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_54f031c1-b4ce-447a-8bb2-278efc7bc52c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_636dc83d-57f3-4d22-9ec1-c65b8f2a326c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Section174Expenses_89820063-b76c-4b86-a5f9-ff1fa07cc506" xlink:href="alts-20241228.xsd#alts_Section174Expenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_54f031c1-b4ce-447a-8bb2-278efc7bc52c" xlink:to="loc_alts_Section174Expenses_89820063-b76c-4b86-a5f9-ff1fa07cc506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_d64fd958-2dd0-4fa2-90cb-5ec9d58c62db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_54f031c1-b4ce-447a-8bb2-278efc7bc52c" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_d64fd958-2dd0-4fa2-90cb-5ec9d58c62db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_f3c8b4c6-a4f7-4b70-bb26-21a8c9e92fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_54f031c1-b4ce-447a-8bb2-278efc7bc52c" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_f3c8b4c6-a4f7-4b70-bb26-21a8c9e92fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DeferredTaxAssetsLeaseLiability_e834fd07-ca9e-400c-bee0-4ca7e1ced07d" xlink:href="alts-20241228.xsd#alts_DeferredTaxAssetsLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_54f031c1-b4ce-447a-8bb2-278efc7bc52c" xlink:to="loc_alts_DeferredTaxAssetsLeaseLiability_e834fd07-ca9e-400c-bee0-4ca7e1ced07d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_69c257b4-b1cd-492a-9f97-7ebd55c6bf84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_54f031c1-b4ce-447a-8bb2-278efc7bc52c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_69c257b4-b1cd-492a-9f97-7ebd55c6bf84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_f59afd1c-4d27-4efe-bf62-0ef7462cf8a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_54f031c1-b4ce-447a-8bb2-278efc7bc52c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_f59afd1c-4d27-4efe-bf62-0ef7462cf8a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_5653ac71-f57b-448f-a863-6a3de9f51683" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_54f031c1-b4ce-447a-8bb2-278efc7bc52c" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_5653ac71-f57b-448f-a863-6a3de9f51683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DeferredTaxLiabilitiesRightOfUseAssets_6c09c4c0-c8b3-421c-94d8-e244cb6f5ff0" xlink:href="alts-20241228.xsd#alts_DeferredTaxLiabilitiesRightOfUseAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_54f031c1-b4ce-447a-8bb2-278efc7bc52c" xlink:to="loc_alts_DeferredTaxLiabilitiesRightOfUseAssets_6c09c4c0-c8b3-421c-94d8-e244cb6f5ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DeferredTaxLiabilitiesInstallmentSale_402dd860-c7fa-4525-ab30-c078e169da2f" xlink:href="alts-20241228.xsd#alts_DeferredTaxLiabilitiesInstallmentSale"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_54f031c1-b4ce-447a-8bb2-278efc7bc52c" xlink:to="loc_alts_DeferredTaxLiabilitiesInstallmentSale_402dd860-c7fa-4525-ab30-c078e169da2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_189e7632-ec93-4cb4-a950-cce26ed4880e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_54f031c1-b4ce-447a-8bb2-278efc7bc52c" xlink:to="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_189e7632-ec93-4cb4-a950-cce26ed4880e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DeferredTaxAssetsInterest_a5f988f9-6aff-4453-89d0-810f88186259" xlink:href="alts-20241228.xsd#alts_DeferredTaxAssetsInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_54f031c1-b4ce-447a-8bb2-278efc7bc52c" xlink:to="loc_alts_DeferredTaxAssetsInterest_a5f988f9-6aff-4453-89d0-810f88186259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance_b7dc97b1-f006-4952-af1d-49866670198f" xlink:href="alts-20241228.xsd#alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_54f031c1-b4ce-447a-8bb2-278efc7bc52c" xlink:to="loc_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance_b7dc97b1-f006-4952-af1d-49866670198f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_76b010b2-2dc0-4187-b572-dfeee81a3498" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_754cdc96-2a23-427d-9936-a7911be2ec30" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_76b010b2-2dc0-4187-b572-dfeee81a3498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_8779aad2-85cf-4b26-abdb-cfc1460b9a80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_754cdc96-2a23-427d-9936-a7911be2ec30" xlink:to="loc_us-gaap_DeferredTaxLiabilities_8779aad2-85cf-4b26-abdb-cfc1460b9a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/RelatedpartiesDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#RelatedpartiesDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/RelatedpartiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_25397a49-b6bf-43cf-8d92-45043ac51557" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c51f330d-87f3-437b-9ac8-bdee24198e75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_25397a49-b6bf-43cf-8d92-45043ac51557" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c51f330d-87f3-437b-9ac8-bdee24198e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_aa866be8-debe-4fd1-ba27-34fe969df846" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c51f330d-87f3-437b-9ac8-bdee24198e75" xlink:to="loc_srt_CounterpartyNameAxis_aa866be8-debe-4fd1-ba27-34fe969df846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d3f303f0-ac65-4d21-ae5b-8e3e1a778181" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_aa866be8-debe-4fd1-ba27-34fe969df846" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d3f303f0-ac65-4d21-ae5b-8e3e1a778181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LiveVenturesIncorporatedMember_7f318188-a430-4816-807b-a9c9cbd4aab2" xlink:href="alts-20241228.xsd#alts_LiveVenturesIncorporatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d3f303f0-ac65-4d21-ae5b-8e3e1a778181" xlink:to="loc_alts_LiveVenturesIncorporatedMember_7f318188-a430-4816-807b-a9c9cbd4aab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Mr.JonIsaacMember_bc36ccbc-8796-4b92-96cd-2a95ff324cc0" xlink:href="alts-20241228.xsd#alts_Mr.JonIsaacMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d3f303f0-ac65-4d21-ae5b-8e3e1a778181" xlink:to="loc_alts_Mr.JonIsaacMember_bc36ccbc-8796-4b92-96cd-2a95ff324cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NovalkAppsSAALLPMember_6ae5a0b9-c53f-40ff-8eaf-fd6af482d599" xlink:href="alts-20241228.xsd#alts_NovalkAppsSAALLPMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d3f303f0-ac65-4d21-ae5b-8e3e1a778181" xlink:to="loc_alts_NovalkAppsSAALLPMember_6ae5a0b9-c53f-40ff-8eaf-fd6af482d599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Mr.TonyIsaacMember_37bfa781-bca4-4fd9-aaf2-76f75e2b043b" xlink:href="alts-20241228.xsd#alts_Mr.TonyIsaacMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d3f303f0-ac65-4d21-ae5b-8e3e1a778181" xlink:to="loc_alts_Mr.TonyIsaacMember_37bfa781-bca4-4fd9-aaf2-76f75e2b043b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_f463c40d-dabc-4746-b7a5-643579d5c564" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c51f330d-87f3-437b-9ac8-bdee24198e75" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_f463c40d-dabc-4746-b7a5-643579d5c564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_ab084aec-4349-47df-95b3-0186e01e6e45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_f463c40d-dabc-4746-b7a5-643579d5c564" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_ab084aec-4349-47df-95b3-0186e01e6e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NotesPayableWithLiveVenturesAndICGMember_6ba5a46f-b88a-4a58-9b7e-1f283eb13c1f" xlink:href="alts-20241228.xsd#alts_NotesPayableWithLiveVenturesAndICGMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_ab084aec-4349-47df-95b3-0186e01e6e45" xlink:to="loc_alts_NotesPayableWithLiveVenturesAndICGMember_6ba5a46f-b88a-4a58-9b7e-1f283eb13c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IsaacConsultingAgreementMember_528f997d-b13f-4bc5-9cff-5f4d4c062525" xlink:href="alts-20241228.xsd#alts_IsaacConsultingAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_ab084aec-4349-47df-95b3-0186e01e6e45" xlink:to="loc_alts_IsaacConsultingAgreementMember_528f997d-b13f-4bc5-9cff-5f4d4c062525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IcgNoteMember_14b1e21b-6f32-4ef8-bd91-cf36e2f447aa" xlink:href="alts-20241228.xsd#alts_IcgNoteMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_ab084aec-4349-47df-95b3-0186e01e6e45" xlink:to="loc_alts_IcgNoteMember_14b1e21b-6f32-4ef8-bd91-cf36e2f447aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RelatedPartyTransactionShortTermAdvancesMember_7a68754e-0559-45b6-b3d3-07396579b0f2" xlink:href="alts-20241228.xsd#alts_RelatedPartyTransactionShortTermAdvancesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_ab084aec-4349-47df-95b3-0186e01e6e45" xlink:to="loc_alts_RelatedPartyTransactionShortTermAdvancesMember_7a68754e-0559-45b6-b3d3-07396579b0f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_48e945d4-0c78-4511-887f-fb4e37807467" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c51f330d-87f3-437b-9ac8-bdee24198e75" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_48e945d4-0c78-4511-887f-fb4e37807467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_d24dc26a-546b-45da-ad12-ce2ee909f8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_48e945d4-0c78-4511-887f-fb4e37807467" xlink:to="loc_us-gaap_RelatedPartyDomain_d24dc26a-546b-45da-ad12-ce2ee909f8a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_969293dd-764f-48e6-8e07-247b1f38cc57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_d24dc26a-546b-45da-ad12-ce2ee909f8a5" xlink:to="loc_us-gaap_RelatedPartyMember_969293dd-764f-48e6-8e07-247b1f38cc57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BeneficialOwnerMember_bfa56d1f-5b50-4cbc-9f98-69010dfa2719" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BeneficialOwnerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_d24dc26a-546b-45da-ad12-ce2ee909f8a5" xlink:to="loc_us-gaap_BeneficialOwnerMember_bfa56d1f-5b50-4cbc-9f98-69010dfa2719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3a806e61-58bf-4fa4-aa40-b5d369e9ab30" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c51f330d-87f3-437b-9ac8-bdee24198e75" xlink:to="loc_us-gaap_DebtInstrumentAxis_3a806e61-58bf-4fa4-aa40-b5d369e9ab30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c498ef53-9303-4eaa-b7a2-113300f30772" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_3a806e61-58bf-4fa4-aa40-b5d369e9ab30" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c498ef53-9303-4eaa-b7a2-113300f30772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LiveVenturesAndICGNotesMember_153ff960-1817-4cea-a3ee-d8b34affe625" xlink:href="alts-20241228.xsd#alts_LiveVenturesAndICGNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c498ef53-9303-4eaa-b7a2-113300f30772" xlink:to="loc_alts_LiveVenturesAndICGNotesMember_153ff960-1817-4cea-a3ee-d8b34affe625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IsaacConsultingAgreementMember_24b8dffe-1deb-4998-8769-647521888f1a" xlink:href="alts-20241228.xsd#alts_IsaacConsultingAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c498ef53-9303-4eaa-b7a2-113300f30772" xlink:to="loc_alts_IsaacConsultingAgreementMember_24b8dffe-1deb-4998-8769-647521888f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_A10ConvertiblePromissoryNoteMember_8e2547bd-7957-4f11-9909-ec13bbffd400" xlink:href="alts-20241228.xsd#alts_A10ConvertiblePromissoryNoteMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c498ef53-9303-4eaa-b7a2-113300f30772" xlink:to="loc_alts_A10ConvertiblePromissoryNoteMember_8e2547bd-7957-4f11-9909-ec13bbffd400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IsaacCapitalGroupShortTermDemandAdvanceMember_c34f1457-2a5e-433b-a233-7aa57bc42c73" xlink:href="alts-20241228.xsd#alts_IsaacCapitalGroupShortTermDemandAdvanceMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c498ef53-9303-4eaa-b7a2-113300f30772" xlink:to="loc_alts_IsaacCapitalGroupShortTermDemandAdvanceMember_c34f1457-2a5e-433b-a233-7aa57bc42c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d79e2125-082b-4c3c-92bd-544f62b0fce0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c51f330d-87f3-437b-9ac8-bdee24198e75" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d79e2125-082b-4c3c-92bd-544f62b0fce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_43c04b59-ab26-4e61-99c6-a7844f691267" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d79e2125-082b-4c3c-92bd-544f62b0fce0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_43c04b59-ab26-4e61-99c6-a7844f691267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PromissoryNoteMember_a0e8ea2d-9aa4-4e76-b7ae-9754ee7eab02" xlink:href="alts-20241228.xsd#alts_PromissoryNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_43c04b59-ab26-4e61-99c6-a7844f691267" xlink:to="loc_alts_PromissoryNoteMember_a0e8ea2d-9aa4-4e76-b7ae-9754ee7eab02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_718c01fe-cd52-46d9-9682-218863a22a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_43c04b59-ab26-4e61-99c6-a7844f691267" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_718c01fe-cd52-46d9-9682-218863a22a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f554b47e-ac68-4916-9c80-859ad6f25607" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c51f330d-87f3-437b-9ac8-bdee24198e75" xlink:to="loc_srt_ProductOrServiceAxis_f554b47e-ac68-4916-9c80-859ad6f25607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_06666c15-b413-48c4-adc0-3c30f74908ee" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_f554b47e-ac68-4916-9c80-859ad6f25607" xlink:to="loc_srt_ProductsAndServicesDomain_06666c15-b413-48c4-adc0-3c30f74908ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_UniversalLifeInsurancePolicyPolicyOneMember_a7be70af-be4a-41ca-a953-606bbbe0b9e4" xlink:href="alts-20241228.xsd#alts_UniversalLifeInsurancePolicyPolicyOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_06666c15-b413-48c4-adc0-3c30f74908ee" xlink:to="loc_alts_UniversalLifeInsurancePolicyPolicyOneMember_a7be70af-be4a-41ca-a953-606bbbe0b9e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_UniversalLifeInsurancePolicyPolicyTwoMember_86dd4690-8564-4aca-a457-e970bf5e9bb6" xlink:href="alts-20241228.xsd#alts_UniversalLifeInsurancePolicyPolicyTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_06666c15-b413-48c4-adc0-3c30f74908ee" xlink:to="loc_alts_UniversalLifeInsurancePolicyPolicyTwoMember_86dd4690-8564-4aca-a457-e970bf5e9bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_ee3fc3f3-e278-42c2-a185-ec32ba3b07ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c51f330d-87f3-437b-9ac8-bdee24198e75" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_ee3fc3f3-e278-42c2-a185-ec32ba3b07ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_72f0f149-61ff-41a5-bb65-602f2c3e11d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_ee3fc3f3-e278-42c2-a185-ec32ba3b07ff" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_72f0f149-61ff-41a5-bb65-602f2c3e11d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_7d7e1af0-7b3f-4d75-9f09-3d359895343c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_72f0f149-61ff-41a5-bb65-602f2c3e11d5" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_7d7e1af0-7b3f-4d75-9f09-3d359895343c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_23dec12c-8bf4-45e3-9845-87975537aed5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_72f0f149-61ff-41a5-bb65-602f2c3e11d5" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_23dec12c-8bf4-45e3-9845-87975537aed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_76af8e91-ad9f-4fdd-8945-643bfbcdc25f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c51f330d-87f3-437b-9ac8-bdee24198e75" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_76af8e91-ad9f-4fdd-8945-643bfbcdc25f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8509b5a7-bec5-414f-936f-d37354f0f7c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_76af8e91-ad9f-4fdd-8945-643bfbcdc25f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8509b5a7-bec5-414f-936f-d37354f0f7c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ARCAAndSubsidiariesMember_58843dc1-ee01-44de-ae60-fbf514ebf4ab" xlink:href="alts-20241228.xsd#alts_ARCAAndSubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8509b5a7-bec5-414f-936f-d37354f0f7c4" xlink:to="loc_alts_ARCAAndSubsidiariesMember_58843dc1-ee01-44de-ae60-fbf514ebf4ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_8581d295-02b0-42e6-bbbb-a3cd74e71e73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c51f330d-87f3-437b-9ac8-bdee24198e75" xlink:to="loc_us-gaap_CreditFacilityAxis_8581d295-02b0-42e6-bbbb-a3cd74e71e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b455b1be-f5ab-4fe9-bef6-f621f7ca3466" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_8581d295-02b0-42e6-bbbb-a3cd74e71e73" xlink:to="loc_us-gaap_CreditFacilityDomain_b455b1be-f5ab-4fe9-bef6-f621f7ca3466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_0c99083c-d09e-48a7-9ac9-8b17502cf6df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_b455b1be-f5ab-4fe9-bef6-f621f7ca3466" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_0c99083c-d09e-48a7-9ac9-8b17502cf6df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_bee4ac81-34e9-4853-809e-94e0c178f7ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c51f330d-87f3-437b-9ac8-bdee24198e75" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_bee4ac81-34e9-4853-809e-94e0c178f7ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e15d9064-7acf-40ed-ae78-4907037ed8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bee4ac81-34e9-4853-809e-94e0c178f7ad" xlink:to="loc_us-gaap_SegmentDomain_e15d9064-7acf-40ed-ae78-4907037ed8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RecyclingSegmentAndTechnologySegmentMember_1492fe1c-dd3a-4c8d-8b07-0a1088fdbfcf" xlink:href="alts-20241228.xsd#alts_RecyclingSegmentAndTechnologySegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e15d9064-7acf-40ed-ae78-4907037ed8dc" xlink:to="loc_alts_RecyclingSegmentAndTechnologySegmentMember_1492fe1c-dd3a-4c8d-8b07-0a1088fdbfcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f1670017-490d-4de3-a24c-dd6d995a1dfe" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c51f330d-87f3-437b-9ac8-bdee24198e75" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f1670017-490d-4de3-a24c-dd6d995a1dfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_4360878b-f66c-4da5-8e85-b6d1c00bf483" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f1670017-490d-4de3-a24c-dd6d995a1dfe" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_4360878b-f66c-4da5-8e85-b6d1c00bf483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_JanOneMember_cd6f57bf-2018-4c5d-a65c-11ba521cdc5d" xlink:href="alts-20241228.xsd#alts_JanOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4360878b-f66c-4da5-8e85-b6d1c00bf483" xlink:to="loc_alts_JanOneMember_cd6f57bf-2018-4c5d-a65c-11ba521cdc5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_50904271-2087-40df-9045-db2e3f368e19" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c51f330d-87f3-437b-9ac8-bdee24198e75" xlink:to="loc_dei_LegalEntityAxis_50904271-2087-40df-9045-db2e3f368e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8a16420c-441a-46c8-ad16-5e0c7a5d2ee3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_50904271-2087-40df-9045-db2e3f368e19" xlink:to="loc_dei_EntityDomain_8a16420c-441a-46c8-ad16-5e0c7a5d2ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_IsaacCapitalGroupLLCICGMember_bdc83442-226d-4d89-9432-a9ebe849dffe" xlink:href="alts-20241228.xsd#alts_IsaacCapitalGroupLLCICGMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_8a16420c-441a-46c8-ad16-5e0c7a5d2ee3" xlink:to="loc_alts_IsaacCapitalGroupLLCICGMember_bdc83442-226d-4d89-9432-a9ebe849dffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c51f330d-87f3-437b-9ac8-bdee24198e75" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_3f18a783-1fc1-4b11-89b5-d999d01e6b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_3f18a783-1fc1-4b11-89b5-d999d01e6b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetRentableArea_560e6c06-49a1-40a7-8355-6bdc623b6872" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetRentableArea"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_NetRentableArea_560e6c06-49a1-40a7-8355-6bdc623b6872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_42f5dcc0-5474-4ea2-9b94-ddbd61735779" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_OperatingLeaseExpense_42f5dcc0-5474-4ea2-9b94-ddbd61735779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRentCurrentAndNoncurrent_a7c604b2-92c2-4f0a-9284-84481718c68b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedRentCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_AccruedRentCurrentAndNoncurrent_a7c604b2-92c2-4f0a-9284-84481718c68b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_99c75ae1-e2ee-4cdb-b5c2-d227c5cf366a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_99c75ae1-e2ee-4cdb-b5c2-d227c5cf366a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b6a785df-e87c-495e-88a1-5dcbbae4a50f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b6a785df-e87c-495e-88a1-5dcbbae4a50f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment_96649cd4-6933-418b-bd59-5444ccda5e75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPayment_96649cd4-6933-418b-bd59-5444ccda5e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_ac121f4b-00c4-48e4-b6e1-cc1c19fd152f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_ac121f4b-00c4-48e4-b6e1-cc1c19fd152f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_9a450293-06b7-4b9b-92e7-a79420c06d09" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_9a450293-06b7-4b9b-92e7-a79420c06d09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RelatedPartyTransactionConsultingAgreementTerm_d54c4b01-397b-4ced-bd9c-f470ffeeb7b4" xlink:href="alts-20241228.xsd#alts_RelatedPartyTransactionConsultingAgreementTerm"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_alts_RelatedPartyTransactionConsultingAgreementTerm_d54c4b01-397b-4ced-bd9c-f470ffeeb7b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RelatedPartyTransactionConsultingAgreementNumberOfLifeInsurancePoliciesAssigned_cc757d39-9c95-445d-947f-f723e2b120d7" xlink:href="alts-20241228.xsd#alts_RelatedPartyTransactionConsultingAgreementNumberOfLifeInsurancePoliciesAssigned"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_alts_RelatedPartyTransactionConsultingAgreementNumberOfLifeInsurancePoliciesAssigned_cc757d39-9c95-445d-947f-f723e2b120d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueOfLifeInsurance_e9e419b7-75d5-490f-b44f-a65f6dabaddb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashSurrenderValueOfLifeInsurance"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_CashSurrenderValueOfLifeInsurance_e9e419b7-75d5-490f-b44f-a65f6dabaddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RelatedPartyTransactionConsultingAgreementContingentlyTenderedFunds_ebf30732-4557-4e1f-9c89-138a1ba30c09" xlink:href="alts-20241228.xsd#alts_RelatedPartyTransactionConsultingAgreementContingentlyTenderedFunds"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_alts_RelatedPartyTransactionConsultingAgreementContingentlyTenderedFunds_ebf30732-4557-4e1f-9c89-138a1ba30c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares_a33648ba-0c5b-4813-932b-f587278b0fdf" xlink:href="alts-20241228.xsd#alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares_a33648ba-0c5b-4813-932b-f587278b0fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NumberOfTradingDaysBeforeBoardApproval_8dc582ed-3624-412f-945f-d45312c4fbbd" xlink:href="alts-20241228.xsd#alts_NumberOfTradingDaysBeforeBoardApproval"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_alts_NumberOfTradingDaysBeforeBoardApproval_8dc582ed-3624-412f-945f-d45312c4fbbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice_b9f129cf-ee80-4d46-8b7c-f03555363543" xlink:href="alts-20241228.xsd#alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice_b9f129cf-ee80-4d46-8b7c-f03555363543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_5576ee97-d51a-4bd0-b929-a3b5f1874843" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_5576ee97-d51a-4bd0-b929-a3b5f1874843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_958c7728-c64f-409f-ab9f-df5d0f627ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_ShortTermBorrowings_958c7728-c64f-409f-ab9f-df5d0f627ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_60a9f227-e961-4de8-9e61-641ae23f8a28" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_60a9f227-e961-4de8-9e61-641ae23f8a28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_97fba758-8529-43fa-9b6c-75bbc1637547" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_97fba758-8529-43fa-9b6c-75bbc1637547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_90c5d506-c27c-4e24-be09-b0fad22f563d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_90c5d506-c27c-4e24-be09-b0fad22f563d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_dd083b5d-4ec5-43fe-ae50-65f5d9a8760c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_dd083b5d-4ec5-43fe-ae50-65f5d9a8760c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_32635e19-55f0-4974-aee5-d40cfada387c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5e022ccc-5b89-4e2f-a9e5-6a039b0eabe7" xlink:to="loc_us-gaap_OtherLiabilities_32635e19-55f0-4974-aee5-d40cfada387c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9cde4aec-ed17-4af5-9d38-3e3895b3e5d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_ba0d1c78-014f-4d06-ac16-594c85151b68" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9cde4aec-ed17-4af5-9d38-3e3895b3e5d3" xlink:to="loc_us-gaap_LossContingenciesTable_ba0d1c78-014f-4d06-ac16-594c85151b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_4c7b0508-c13e-4501-bfb5-9a047205367c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_ba0d1c78-014f-4d06-ac16-594c85151b68" xlink:to="loc_srt_LitigationCaseAxis_4c7b0508-c13e-4501-bfb5-9a047205367c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b616d20c-b2c4-4138-aebf-d903cb267430" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_4c7b0508-c13e-4501-bfb5-9a047205367c" xlink:to="loc_srt_LitigationCaseTypeDomain_b616d20c-b2c4-4138-aebf-d903cb267430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SECComplaintMember_64fb199c-f9fa-4e47-9006-dfe48ad5e582" xlink:href="alts-20241228.xsd#alts_SECComplaintMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b616d20c-b2c4-4138-aebf-d903cb267430" xlink:to="loc_alts_SECComplaintMember_64fb199c-f9fa-4e47-9006-dfe48ad5e582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SkybridgeLitigationMember_1947241b-5ceb-4edf-a20a-1dc315dd575e" xlink:href="alts-20241228.xsd#alts_SkybridgeLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b616d20c-b2c4-4138-aebf-d903cb267430" xlink:to="loc_alts_SkybridgeLitigationMember_1947241b-5ceb-4edf-a20a-1dc315dd575e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AlixpartnersLLCLitigationMember_822426b8-bd8c-4a2d-80a1-7fde0fd787d8" xlink:href="alts-20241228.xsd#alts_AlixpartnersLLCLitigationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b616d20c-b2c4-4138-aebf-d903cb267430" xlink:to="loc_alts_AlixpartnersLLCLitigationMember_822426b8-bd8c-4a2d-80a1-7fde0fd787d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Main270LLCLitigationMember_7e0e63dd-3849-44a6-be32-094d564259db" xlink:href="alts-20241228.xsd#alts_Main270LLCLitigationMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b616d20c-b2c4-4138-aebf-d903cb267430" xlink:to="loc_alts_Main270LLCLitigationMember_7e0e63dd-3849-44a6-be32-094d564259db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_WestervilleSquareLitigationMember_d8c4afa2-3855-4da3-81c2-386aaa8898b4" xlink:href="alts-20241228.xsd#alts_WestervilleSquareLitigationMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b616d20c-b2c4-4138-aebf-d903cb267430" xlink:to="loc_alts_WestervilleSquareLitigationMember_d8c4afa2-3855-4da3-81c2-386aaa8898b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherCommitmentsAndLitigationCasesMember_335fd752-71e0-4eec-b3ec-10d48d75d98d" xlink:href="alts-20241228.xsd#alts_OtherCommitmentsAndLitigationCasesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b616d20c-b2c4-4138-aebf-d903cb267430" xlink:to="loc_alts_OtherCommitmentsAndLitigationCasesMember_335fd752-71e0-4eec-b3ec-10d48d75d98d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_5d869c6c-8432-484a-afc0-b27da228ff70" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_ba0d1c78-014f-4d06-ac16-594c85151b68" xlink:to="loc_srt_CounterpartyNameAxis_5d869c6c-8432-484a-afc0-b27da228ff70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c5a3ce4-271a-48d7-a55e-298918644d46" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_5d869c6c-8432-484a-afc0-b27da228ff70" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c5a3ce4-271a-48d7-a55e-298918644d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_SkyBridgeAmericasMember_8e4ef081-0002-481f-a200-67f39825a415" xlink:href="alts-20241228.xsd#alts_SkyBridgeAmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c5a3ce4-271a-48d7-a55e-298918644d46" xlink:to="loc_alts_SkyBridgeAmericasMember_8e4ef081-0002-481f-a200-67f39825a415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_AlixpartnersLLCMember_5edc46c8-beff-435d-a41c-c1825f5aabdd" xlink:href="alts-20241228.xsd#alts_AlixpartnersLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c5a3ce4-271a-48d7-a55e-298918644d46" xlink:to="loc_alts_AlixpartnersLLCMember_5edc46c8-beff-435d-a41c-c1825f5aabdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_TrusteesMain270LlcMember_66d0c37c-d629-4e2f-9470-4dfcd0524f8c" xlink:href="alts-20241228.xsd#alts_TrusteesMain270LlcMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c5a3ce4-271a-48d7-a55e-298918644d46" xlink:to="loc_alts_TrusteesMain270LlcMember_66d0c37c-d629-4e2f-9470-4dfcd0524f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_WestervilleSquareMember_5e69aa3e-0d3d-49fc-beaa-d8e514ce33ec" xlink:href="alts-20241228.xsd#alts_WestervilleSquareMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c5a3ce4-271a-48d7-a55e-298918644d46" xlink:to="loc_alts_WestervilleSquareMember_5e69aa3e-0d3d-49fc-beaa-d8e514ce33ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_UnaffiliatedThirdPartyMember_cb9d4720-39a2-4545-b521-95354151cbbd" xlink:href="alts-20241228.xsd#alts_UnaffiliatedThirdPartyMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c5a3ce4-271a-48d7-a55e-298918644d46" xlink:to="loc_alts_UnaffiliatedThirdPartyMember_cb9d4720-39a2-4545-b521-95354151cbbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_Mr.SullivanMember_fa937b86-75a5-4f8f-ac63-5a8e664eca35" xlink:href="alts-20241228.xsd#alts_Mr.SullivanMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c5a3ce4-271a-48d7-a55e-298918644d46" xlink:to="loc_alts_Mr.SullivanMember_fa937b86-75a5-4f8f-ac63-5a8e664eca35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_c9a18ca1-6f35-4894-bba6-1ec06b4ebaf1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_ba0d1c78-014f-4d06-ac16-594c85151b68" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_c9a18ca1-6f35-4894-bba6-1ec06b4ebaf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_9d5bf6bb-a4e9-441c-96dc-353c6b9407c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_c9a18ca1-6f35-4894-bba6-1ec06b4ebaf1" xlink:to="loc_us-gaap_LossContingencyNatureDomain_9d5bf6bb-a4e9-441c-96dc-353c6b9407c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LegalFeesMember_7b5d8a99-2155-4c16-bea5-f8ef7c6f2166" xlink:href="alts-20241228.xsd#alts_LegalFeesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_9d5bf6bb-a4e9-441c-96dc-353c6b9407c6" xlink:to="loc_alts_LegalFeesMember_7b5d8a99-2155-4c16-bea5-f8ef7c6f2166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8b683a02-7b3f-4545-95ad-5f12793666f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_ba0d1c78-014f-4d06-ac16-594c85151b68" xlink:to="loc_us-gaap_DebtInstrumentAxis_8b683a02-7b3f-4545-95ad-5f12793666f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b209632b-1eb2-4061-b3b7-4bc0ff1f9fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8b683a02-7b3f-4545-95ad-5f12793666f0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b209632b-1eb2-4061-b3b7-4bc0ff1f9fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_PromissoryNoteMember_ea8fd04f-1e19-4a55-9a02-1ccea93c5333" xlink:href="alts-20241228.xsd#alts_PromissoryNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b209632b-1eb2-4061-b3b7-4bc0ff1f9fc1" xlink:to="loc_alts_PromissoryNoteMember_ea8fd04f-1e19-4a55-9a02-1ccea93c5333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3e3ef649-e64e-4a01-841a-ea7d08151387" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_ba0d1c78-014f-4d06-ac16-594c85151b68" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3e3ef649-e64e-4a01-841a-ea7d08151387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f84bb40d-2252-483a-8ad8-5421a1adccc3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3e3ef649-e64e-4a01-841a-ea7d08151387" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f84bb40d-2252-483a-8ad8-5421a1adccc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_GeoTraqIncMember_7e3dccee-e6a1-4d94-8626-2cc510ca7957" xlink:href="alts-20241228.xsd#alts_GeoTraqIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f84bb40d-2252-483a-8ad8-5421a1adccc3" xlink:to="loc_alts_GeoTraqIncMember_7e3dccee-e6a1-4d94-8626-2cc510ca7957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_ec268977-a757-4ca2-b9c5-62f501dd1e31" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_ba0d1c78-014f-4d06-ac16-594c85151b68" xlink:to="loc_dei_LegalEntityAxis_ec268977-a757-4ca2-b9c5-62f501dd1e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_06b9941a-cc94-4050-a3b4-a18785768417" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_ec268977-a757-4ca2-b9c5-62f501dd1e31" xlink:to="loc_dei_EntityDomain_06b9941a-cc94-4050-a3b4-a18785768417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ApplianceSmartIncMember_68ed091a-c51a-4c08-b4df-87a129cad9f9" xlink:href="alts-20241228.xsd#alts_ApplianceSmartIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_06b9941a-cc94-4050-a3b4-a18785768417" xlink:to="loc_alts_ApplianceSmartIncMember_68ed091a-c51a-4c08-b4df-87a129cad9f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_15a39001-50aa-47e0-ae7b-31e31a7c4406" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_ba0d1c78-014f-4d06-ac16-594c85151b68" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_15a39001-50aa-47e0-ae7b-31e31a7c4406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_4753b739-403d-401c-b833-270d44bc87ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_15a39001-50aa-47e0-ae7b-31e31a7c4406" xlink:to="loc_us-gaap_RelatedPartyDomain_4753b739-403d-401c-b833-270d44bc87ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_5ecf8de1-8eb2-4af8-8c20-b7f54f270242" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_4753b739-403d-401c-b833-270d44bc87ab" xlink:to="loc_us-gaap_RelatedPartyMember_5ecf8de1-8eb2-4af8-8c20-b7f54f270242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_ba0d1c78-014f-4d06-ac16-594c85151b68" xlink:to="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LossContingencyNumberOfExecutiveOfficersNamedInComplaint_85c4c6e8-a664-404c-b6c5-efd934475c7f" xlink:href="alts-20241228.xsd#alts_LossContingencyNumberOfExecutiveOfficersNamedInComplaint"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_alts_LossContingencyNumberOfExecutiveOfficersNamedInComplaint_85c4c6e8-a664-404c-b6c5-efd934475c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_96e1a915-6c0f-4b51-b1d1-9d0e1f80a601" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_96e1a915-6c0f-4b51-b1d1-9d0e1f80a601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LitigationSettlementAmountAwardedToOtherPartyNumberOfPeriodicPayments_f6791096-1900-4eca-9c4f-6017662e999b" xlink:href="alts-20241228.xsd#alts_LitigationSettlementAmountAwardedToOtherPartyNumberOfPeriodicPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_alts_LitigationSettlementAmountAwardedToOtherPartyNumberOfPeriodicPayments_f6791096-1900-4eca-9c4f-6017662e999b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_LitigationSettlementAmountAwardedToOtherPartyPeriodicPayments_ad7ec5c3-09d6-4d9e-afe2-eceb0ba401b6" xlink:href="alts-20241228.xsd#alts_LitigationSettlementAmountAwardedToOtherPartyPeriodicPayments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_alts_LitigationSettlementAmountAwardedToOtherPartyPeriodicPayments_ad7ec5c3-09d6-4d9e-afe2-eceb0ba401b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_a1da4c5e-ae26-4cad-993d-1447ff881591" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_a1da4c5e-ae26-4cad-993d-1447ff881591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_9bbba3e8-a1c2-47ce-bdb4-ffc4f809735d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_9bbba3e8-a1c2-47ce-bdb4-ffc4f809735d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_05921929-5855-4b35-ade9-851ce275009e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_05921929-5855-4b35-ade9-851ce275009e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_8dee4d75-6b1f-4964-8344-3c4859d273d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_8dee4d75-6b1f-4964-8344-3c4859d273d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1_b0e1f6c8-3ae9-4da5-ad29-8a74882e6ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionOriginalDebtAmount1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_us-gaap_DebtConversionOriginalDebtAmount1_b0e1f6c8-3ae9-4da5-ad29-8a74882e6ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_58f8ff58-8b35-4617-84bc-eab1e443736b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_58f8ff58-8b35-4617-84bc-eab1e443736b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_de8706a8-1cb9-4788-9733-f8d8dea1f922" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_de8706a8-1cb9-4788-9733-f8d8dea1f922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_bb86fa77-abf2-49b0-808b-d81c7387ea2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_bb86fa77-abf2-49b0-808b-d81c7387ea2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_NumberOfTranches_6ded67d4-7fdd-4853-8801-770a5b43a8f6" xlink:href="alts-20241228.xsd#alts_NumberOfTranches"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_alts_NumberOfTranches_6ded67d4-7fdd-4853-8801-770a5b43a8f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_5ba22989-2572-4a73-bd74-4eab9767b11b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_5ba22989-2572-4a73-bd74-4eab9767b11b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b95659cf-26e8-49de-9e93-91b382697568" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b95659cf-26e8-49de-9e93-91b382697568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherCommitmentsNumberOfLandlordsOriginallyPurportedToBeLiableFor_2afe9742-dd33-4720-a8a6-6f09bdbe3b8c" xlink:href="alts-20241228.xsd#alts_OtherCommitmentsNumberOfLandlordsOriginallyPurportedToBeLiableFor"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_alts_OtherCommitmentsNumberOfLandlordsOriginallyPurportedToBeLiableFor_2afe9742-dd33-4720-a8a6-6f09bdbe3b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OperatingLeasesFutureMinimumPaymentsDue1_43a8f546-1979-4d7a-837a-ad24b5be9289" xlink:href="alts-20241228.xsd#alts_OperatingLeasesFutureMinimumPaymentsDue1"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_alts_OperatingLeasesFutureMinimumPaymentsDue1_43a8f546-1979-4d7a-837a-ad24b5be9289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_OtherCommitmentsNumberOfLandlordsCompanyIsNoLongerLiableFor_1ab9902d-fa67-4a98-a508-6e4bb0b7d4af" xlink:href="alts-20241228.xsd#alts_OtherCommitmentsNumberOfLandlordsCompanyIsNoLongerLiableFor"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ecd581b8-1224-4af2-8abd-aa084e771b3c" xlink:to="loc_alts_OtherCommitmentsNumberOfLandlordsCompanyIsNoLongerLiableFor_1ab9902d-fa67-4a98-a508-6e4bb0b7d4af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/EarningsLosspershareScheduleofComputationofBasicandDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#EarningsLosspershareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/EarningsLosspershareScheduleofComputationofBasicandDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b1b1a711-9869-4618-a9c7-fa296c95db41" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract_ae89fd62-6a8d-419c-83ef-8c0fea566436" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b1b1a711-9869-4618-a9c7-fa296c95db41" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract_ae89fd62-6a8d-419c-83ef-8c0fea566436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_8c8d878b-1d10-45cd-8305-f34feca03289" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract_ae89fd62-6a8d-419c-83ef-8c0fea566436" xlink:to="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_8c8d878b-1d10-45cd-8305-f34feca03289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_656f80a2-c30c-4b7c-9989-e6bf293af6a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract_ae89fd62-6a8d-419c-83ef-8c0fea566436" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_656f80a2-c30c-4b7c-9989-e6bf293af6a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_1be1d112-0b3c-4ddf-87e7-19725616fedf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract_ae89fd62-6a8d-419c-83ef-8c0fea566436" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_1be1d112-0b3c-4ddf-87e7-19725616fedf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_30f87f2d-818d-4670-b7f7-262d2e778501" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract_ae89fd62-6a8d-419c-83ef-8c0fea566436" xlink:to="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_30f87f2d-818d-4670-b7f7-262d2e778501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_61ec2bc2-581a-4891-afb2-5166aa10b90a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract_ae89fd62-6a8d-419c-83ef-8c0fea566436" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_61ec2bc2-581a-4891-afb2-5166aa10b90a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_0a889ca8-081c-420b-8e78-86c7ea1e0df6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract_ae89fd62-6a8d-419c-83ef-8c0fea566436" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_0a889ca8-081c-420b-8e78-86c7ea1e0df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicShareAbstract_566bdb54-9993-48d3-97b2-f701d23dee82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicShareAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b1b1a711-9869-4618-a9c7-fa296c95db41" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicShareAbstract_566bdb54-9993-48d3-97b2-f701d23dee82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic_5680498d-7615-49eb-a970-2b4f85aafd25" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicShareAbstract_566bdb54-9993-48d3-97b2-f701d23dee82" xlink:to="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic_5680498d-7615-49eb-a970-2b4f85aafd25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9dc41754-80ce-402c-8ee2-5472660d3314" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicShareAbstract_566bdb54-9993-48d3-97b2-f701d23dee82" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9dc41754-80ce-402c-8ee2-5472660d3314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_a11e1fbd-e38b-4405-b962-a1a0a5ad3b56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicShareAbstract_566bdb54-9993-48d3-97b2-f701d23dee82" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_a11e1fbd-e38b-4405-b962-a1a0a5ad3b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted_abc77c13-3f37-45f2-9805-16a3965f8c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicShareAbstract_566bdb54-9993-48d3-97b2-f701d23dee82" xlink:to="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted_abc77c13-3f37-45f2-9805-16a3965f8c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d2c9aa68-5e8d-4db1-be14-94967dd2709a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicShareAbstract_566bdb54-9993-48d3-97b2-f701d23dee82" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d2c9aa68-5e8d-4db1-be14-94967dd2709a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_af66206a-8b7d-4489-8cbd-e5118b5505f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicShareAbstract_566bdb54-9993-48d3-97b2-f701d23dee82" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_af66206a-8b7d-4489-8cbd-e5118b5505f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_82a9b7ef-f2a2-4ef2-b031-098ef4326853" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b1b1a711-9869-4618-a9c7-fa296c95db41" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_82a9b7ef-f2a2-4ef2-b031-098ef4326853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_7664c9d7-fb46-4ade-bb24-b3729cacd21a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_82a9b7ef-f2a2-4ef2-b031-098ef4326853" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_7664c9d7-fb46-4ade-bb24-b3729cacd21a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f0573db5-2fbb-4bcd-bc28-e09ac6c9e17f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_82a9b7ef-f2a2-4ef2-b031-098ef4326853" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f0573db5-2fbb-4bcd-bc28-e09ac6c9e17f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_d0ea3764-3799-44e0-8914-13bd59662437" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_82a9b7ef-f2a2-4ef2-b031-098ef4326853" xlink:to="loc_us-gaap_EarningsPerShareBasic_d0ea3764-3799-44e0-8914-13bd59662437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_a2ba9ed4-8e1e-425a-b5c6-69849027b8bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b1b1a711-9869-4618-a9c7-fa296c95db41" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_a2ba9ed4-8e1e-425a-b5c6-69849027b8bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_1d63a0df-b221-4b80-a826-36ca49464ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_a2ba9ed4-8e1e-425a-b5c6-69849027b8bd" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_1d63a0df-b221-4b80-a826-36ca49464ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_94b1a8ac-5081-4ffb-a2fa-f1704a287d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_a2ba9ed4-8e1e-425a-b5c6-69849027b8bd" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_94b1a8ac-5081-4ffb-a2fa-f1704a287d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8d94952a-320f-407c-949b-41e6faae84ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_a2ba9ed4-8e1e-425a-b5c6-69849027b8bd" xlink:to="loc_us-gaap_EarningsPerShareDiluted_8d94952a-320f-407c-949b-41e6faae84ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/EarningsLosspershareNarrativeDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#EarningsLosspershareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/EarningsLosspershareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7a83a726-a166-4d5f-92fb-f17b85387f15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_746adbc9-334a-458d-bb31-cfc63c6649d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7a83a726-a166-4d5f-92fb-f17b85387f15" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_746adbc9-334a-458d-bb31-cfc63c6649d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/SegmentinformationNarrativeDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#SegmentinformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/SegmentinformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_f7aaebfb-82e5-4101-85a4-9e204428badf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_2a597ff3-732a-45bb-84d6-829ed0c11ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f7aaebfb-82e5-4101-85a4-9e204428badf" xlink:to="loc_us-gaap_NumberOfReportableSegments_2a597ff3-732a-45bb-84d6-829ed0c11ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/SegmentinformationScheduleofSegmentInformationDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#SegmentinformationScheduleofSegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/SegmentinformationScheduleofSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_1064cdc1-a775-4803-afc2-189c5d8a8263" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_309c7d72-7f1d-4dde-94fb-53b7300bf459" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_1064cdc1-a775-4803-afc2-189c5d8a8263" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_309c7d72-7f1d-4dde-94fb-53b7300bf459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b981e062-cd78-4094-ae0a-6b74a8fac616" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_309c7d72-7f1d-4dde-94fb-53b7300bf459" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b981e062-cd78-4094-ae0a-6b74a8fac616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6de0c085-1cd2-4174-86d5-1ab4cbe57af7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b981e062-cd78-4094-ae0a-6b74a8fac616" xlink:to="loc_us-gaap_SegmentDomain_6de0c085-1cd2-4174-86d5-1ab4cbe57af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_FintechMember_e7339430-62be-468f-9a38-6bc66fbbcba0" xlink:href="alts-20241228.xsd#alts_FintechMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6de0c085-1cd2-4174-86d5-1ab4cbe57af7" xlink:to="loc_alts_FintechMember_e7339430-62be-468f-9a38-6bc66fbbcba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BiotechnologyMember_22cebe16-4ebc-4d4c-99eb-8e7c75abf7a4" xlink:href="alts-20241228.xsd#alts_BiotechnologyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6de0c085-1cd2-4174-86d5-1ab4cbe57af7" xlink:to="loc_alts_BiotechnologyMember_22cebe16-4ebc-4d4c-99eb-8e7c75abf7a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember_d82e65c6-c4d1-4c35-8c16-df4d5114747f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6de0c085-1cd2-4174-86d5-1ab4cbe57af7" xlink:to="loc_us-gaap_CorporateAndOtherMember_d82e65c6-c4d1-4c35-8c16-df4d5114747f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RecyclingSegmentMember_dc439d1b-b891-45af-a202-c5055e53133b" xlink:href="alts-20241228.xsd#alts_RecyclingSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6de0c085-1cd2-4174-86d5-1ab4cbe57af7" xlink:to="loc_alts_RecyclingSegmentMember_dc439d1b-b891-45af-a202-c5055e53133b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_59173380-a279-4490-bc93-eb8bc90340b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_309c7d72-7f1d-4dde-94fb-53b7300bf459" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_59173380-a279-4490-bc93-eb8bc90340b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_a1101097-2c90-4565-925d-2eb4882d6e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_59173380-a279-4490-bc93-eb8bc90340b6" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_a1101097-2c90-4565-925d-2eb4882d6e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_2800d228-03ee-4c3b-9fe8-8cafa746206e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_a1101097-2c90-4565-925d-2eb4882d6e4c" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_2800d228-03ee-4c3b-9fe8-8cafa746206e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ContinuingOperationsAndDiscontinuedOperationsMember_8e142e6a-4716-4cd7-8f71-a4c274be7dcc" xlink:href="alts-20241228.xsd#alts_ContinuingOperationsAndDiscontinuedOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_a1101097-2c90-4565-925d-2eb4882d6e4c" xlink:to="loc_alts_ContinuingOperationsAndDiscontinuedOperationsMember_8e142e6a-4716-4cd7-8f71-a4c274be7dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_21636b3a-5bc2-4c86-9d7d-b3fa732de7ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_309c7d72-7f1d-4dde-94fb-53b7300bf459" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_21636b3a-5bc2-4c86-9d7d-b3fa732de7ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e689ed51-55a5-4288-9b9d-cb998b2841df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_21636b3a-5bc2-4c86-9d7d-b3fa732de7ae" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e689ed51-55a5-4288-9b9d-cb998b2841df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_a5863d54-5bcf-496b-be1e-d61f7284a02d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_21636b3a-5bc2-4c86-9d7d-b3fa732de7ae" xlink:to="loc_us-gaap_GrossProfit_a5863d54-5bcf-496b-be1e-d61f7284a02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e021a549-f73c-483e-8d18-bd55888043fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_21636b3a-5bc2-4c86-9d7d-b3fa732de7ae" xlink:to="loc_us-gaap_OperatingIncomeLoss_e021a549-f73c-483e-8d18-bd55888043fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_a0bd3d66-e2a6-4ac2-b65a-a39278aec12f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_21636b3a-5bc2-4c86-9d7d-b3fa732de7ae" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_a0bd3d66-e2a6-4ac2-b65a-a39278aec12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_4220448f-66e8-4d56-98d8-d6945d3682d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_21636b3a-5bc2-4c86-9d7d-b3fa732de7ae" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_4220448f-66e8-4d56-98d8-d6945d3682d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ec10df8d-a6c6-4e68-921e-cf1caa6fe6dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_21636b3a-5bc2-4c86-9d7d-b3fa732de7ae" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ec10df8d-a6c6-4e68-921e-cf1caa6fe6dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.alt5sigma.com/role/SegmentinformationScheduleofBalanceSheetInformationDetails" xlink:type="simple" xlink:href="alts-20241228.xsd#SegmentinformationScheduleofBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://www.alt5sigma.com/role/SegmentinformationScheduleofBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_1fddaee1-ccab-41ff-bc39-6241104e5ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_27218ae9-a3d3-442a-9d7a-c0c3b454ed08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_1fddaee1-ccab-41ff-bc39-6241104e5ba0" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_27218ae9-a3d3-442a-9d7a-c0c3b454ed08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3232f3c9-25ad-4d23-920e-20f325f63711" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_27218ae9-a3d3-442a-9d7a-c0c3b454ed08" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3232f3c9-25ad-4d23-920e-20f325f63711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_664c59cd-7434-4994-9eab-78ee2c59e957" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3232f3c9-25ad-4d23-920e-20f325f63711" xlink:to="loc_us-gaap_SegmentDomain_664c59cd-7434-4994-9eab-78ee2c59e957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_FintechMember_63d5596f-f247-4ff3-b1ea-a66c766c5f29" xlink:href="alts-20241228.xsd#alts_FintechMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_664c59cd-7434-4994-9eab-78ee2c59e957" xlink:to="loc_alts_FintechMember_63d5596f-f247-4ff3-b1ea-a66c766c5f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_BiotechnologyMember_0c3d5151-a31f-4c3f-b439-9336f109e872" xlink:href="alts-20241228.xsd#alts_BiotechnologyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_664c59cd-7434-4994-9eab-78ee2c59e957" xlink:to="loc_alts_BiotechnologyMember_0c3d5151-a31f-4c3f-b439-9336f109e872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember_c58a0c81-ec1a-47b1-9dc8-8e955162e8b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_664c59cd-7434-4994-9eab-78ee2c59e957" xlink:to="loc_us-gaap_CorporateAndOtherMember_c58a0c81-ec1a-47b1-9dc8-8e955162e8b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_RecyclingSegmentMember_0ba317cc-ebf9-44e8-bee4-bf5bfc5982f7" xlink:href="alts-20241228.xsd#alts_RecyclingSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_664c59cd-7434-4994-9eab-78ee2c59e957" xlink:to="loc_alts_RecyclingSegmentMember_0ba317cc-ebf9-44e8-bee4-bf5bfc5982f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_cb857321-6d6c-4b55-9dcf-2658e5ac42de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_27218ae9-a3d3-442a-9d7a-c0c3b454ed08" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_cb857321-6d6c-4b55-9dcf-2658e5ac42de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_4638500b-7eda-495a-9dfd-275dbb4851d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_cb857321-6d6c-4b55-9dcf-2658e5ac42de" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_4638500b-7eda-495a-9dfd-275dbb4851d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_240060b3-48ed-41ee-811f-5d91b38585d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_4638500b-7eda-495a-9dfd-275dbb4851d2" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_240060b3-48ed-41ee-811f-5d91b38585d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_alts_ContinuingOperationsAndDiscontinuedOperationsMember_84fb9b51-d1d4-4058-8ef8-6975dcb05128" xlink:href="alts-20241228.xsd#alts_ContinuingOperationsAndDiscontinuedOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_4638500b-7eda-495a-9dfd-275dbb4851d2" xlink:to="loc_alts_ContinuingOperationsAndDiscontinuedOperationsMember_84fb9b51-d1d4-4058-8ef8-6975dcb05128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_66718cc7-205a-48ef-a003-430abe428ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_27218ae9-a3d3-442a-9d7a-c0c3b454ed08" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_66718cc7-205a-48ef-a003-430abe428ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_f4c5b00b-5597-4583-8973-af279a2e6351" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_66718cc7-205a-48ef-a003-430abe428ad9" xlink:to="loc_us-gaap_Assets_f4c5b00b-5597-4583-8973-af279a2e6351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_fe3616b0-1f08-4ffe-bdf1-d19c55db8a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_66718cc7-205a-48ef-a003-430abe428ad9" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_fe3616b0-1f08-4ffe-bdf1-d19c55db8a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrExpirationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>alts-20241228_g1.jpg
<TEXT>
begin 644 alts-20241228_g1.jpg
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M;X+G);_W/?DQH_U-?J2^)'R>H4[:XU*A1CLTX7&(QSG'@HV@
M         9.L^/:5^)_ZLD[AN-MU&Z<G.<*DEG_R4F]V[JPO86:5O*-Q*M.%
M).5.*\'HEF67^Y%&TJ*UG1ELX<HN$5)K82QPECK6402M[NG.FFY3BVG+FWLI
M_-7LX/S8;)*=G=P2_C;3V</:J2:>Y)_NF_:>SL[F5&BN<CSL*<XN>T\Y>,//
ML)*5O<TZFTY*<5G93J2\'PG[]S7'J*NC>/ZK^)_ZHU@
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MOZ4?B>K6*D$]G1KZ*XO%-+_)H6%W"_LZ5S3C*,*BRE+BBP
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M0JNBTOGPI1FY8XO=E/TY-0R^4WD"[]5?W(TJ7_''T(Z
M:RFNLQ:&@U[:C&C0U:ZA3C\V*C'<=O1KJ33>L73<=Z>S'<>]Z+S[9N_RQ'>F
M\^V;O\L1WHO/MF[_ "Q'>B\^V;OW1/(Z-=PBHQUBZ27!*,?@>T]%J]U4*]QJ
M-Q7YF6W&,TL9Q@UC&N-(JTIW5Q;ZC<454;JRA%+&<?Z(=,L[Z]T^A<RU>ZC*
MI#::2CA%A:-=*3DM8NDY<7LQWGO>B\^V;O\ +$=Z+S[9N_RQ/):-=R6):Q=-
M9SOC$][TWGVS=_EB1U]"KW-&5&MJUU.G+=*+C'>;,5LQ270L'H
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M_P#8[^4FD?78?EE\"CK6NZ9<Z3<T:-W&=2<,1CLO>_<;UMXM2]1=A(
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M;BYPYN"@E&6-V4\?L<PL*<%'9G53A'9B]O>H[MW[(I\H_$[?\52[36
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M'?V7V3J?Z'^QW]E]DZG^A_L\^4$(S@JVGW]&,YJ"G4I))-O=TFN
M            177BM;U)=A3Y/>0[/[M&;I-M4K1N7!9B[F<6\\,5$^PO2M;J
M<I.4,JI4A4:RGLM-IK>]^[9.YT+KN>VA&*VJ$8R?A_.DL;L^C(E:U)VSI.AO
MC4<HMR6].IG^TFG;-7=&=*FL02CF6&E'?PZ4^!7JT;FE.K5IQ>-IRR\.7"7O
M7#"X] I=W58[49U$LX>=GK><=?\ X[RGK/=?,T7<+$.?H]*?A975[3Z
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MFW4A3\-XS)<6]V!S=O*IC9IN<7YLIX7^,?L9NON"LJ$*>SB%U2CA=&_@;
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M^1#N:A_)I?D0[FH?R*7Y$.YJ'\FE^1#N:A_)I?D1ZK>BFFJ---<&HHE
%   /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>alts-20241228_g10.jpg
<TEXT>
begin 644 alts-20241228_g10.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &% 7L# 2(  A$! Q$!_\0
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MF%_Z*]D\X]>2?R'D>7V ]ZK&>$_3=VL>Y7B D7.VR8+-PU@J1%<?:*$2&_*
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M"Y41IT*<8"OJ]:>Z<^F:H-;-M-:VSP=V74?F:OE[BW*ZPD36Y,F0X\VPF<>
MR?J -@9('([FMKYH/5NCMV_$&[HZUZAC:PN5I:?T]+2'U1W@4CVCI</N%P)S
MT@\@]J6P?0T$&HUW+\1VW.T5[BV?5VJ&+-<I3'M+,9;+SBUM@D=0\M"N,BJV
M>#>'K)O<Y+IF71G3PL:!=8,V'<?+<F$C"R[,6</ ]74&QT$8Q3@WJNCNA_&9
MHS5]PL%ZN6GV--/Q79%KMCLP)=4X>E)" >:6"RNW^YNE=TK)]+:3OL._6\++
M:G8CG5T+_>K2>4J^1 -.<* P.<U\_56W5ULMOB W'LNAM1P;!JF1;V+79(Q7
M;IK@0</2REL%;:.P/2.L@<=S7'M?H?7^JO[K6G8]ROEGMKUHCW*P3$IG1XS<
MM')\I4E1<.2,*"CS\ *6#Z'!8/:HQU[XEMLMK[\[9=5:O@V6YM-I>7'D)<RE
M"AD*)"2/TU"G@PU;JO?75%ZW.U$N9 M\.$SIR!:U/*+*Y#7^ZY'2#A1*P #Z
M<T[_ !2:<N6X>I- :!B6IXV2_P!Q+NH+FS&ZNB&R.H,J<Q[O6K //:K+<$ZZ
M4U7:=;6&%>['.;N5JFMAV-*9ST.(/J,XI7KCM5MBV>WQX,&.W%AQVTM-,M)Z
M4MI' 2!\.*[* **QFLT 45BLT 4444 5"WBPW1U#M#M8+]IHQ1<?I!B/F6SY
MB.A07U<9'/NBIIJM_CU'5L8D9X^EHO\ ,Y4H%85>/7=WW>AVQXSS^UY_UZV/
MC^W403E=E('K[ ?]:H#'2?=/'I7D['\QM0"0?T5I2*LL(CQ][IN#A5E(^< C
M_P"ZA7CYW5QD?0G_ '$_ZU5YAQLC.,8[BNGR!^]-0T3%HG=?C_W82DX^A,__
M  )_UJ2Y'X1#=Y'4ELV-)&<'Z/./Z=0O*B80<#'V4C.Q <DC]%5HWC!,F&1^
M$GWKBNJ:/T"5CU^CN,?]NDV7^$_WHCGI2+ 3GG]KLX_^NHE?LK,AH]:.L&F_
M<]&M.)4(Y*#CZOQK-NB_E7P3;_Y4O>M:CTKT]P<#]K3_ *]:O_A1M\4(]U6G
M<9[FV'_7JN*M.(8\Y"VU(6#E*B,"DI49(>2"CK;SG-2G9SN#B6;'X5/>X/%*
MCIW !/2+:>1_VZG_ &9\>>OMP["F3*79_:D'#B6XA&/NZJ^;FH[5$=9#\4]+
MHY*:5=F=;2]+ZJ80W)2PR\KRU^8KI1S\:GE&,K1]5QXJ-;%/'T?_ -V_MK(\
M4NMP<_M=]T8_ZU0;8I3DR$ATE*^H Y0<TJI.?M-9VS-2;'=N-N&[NTQ;V-86
M&S7]B"[Y[#4IEP(2OXE*7 %#CLK(IUQO$WK&%';CL-6MEEI 0VVW$Z4I X
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M->+\3!"D_6%4X-5@Q^Q-CGC<W*PKI-HR">/8_P#:I(>\>&Z++I3^T_3\H/\
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M:T.@*KMXZV0[LB$=_P!M(O\ ,Y5B/2J^^. $[+\=_I2-_,Y0M#D^=JK>$#D
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MYJ=/A]U0N%J.79T^2E:BIUI+X/<#D9'(X]?E45'<.4;DV_(D..NNI3YI>'O
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M+AM %&>.5?"H?AZ3A(0?. >![<Y(^^IF\6:$(W<+RB<B$UG/IRKM4'W35<>
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M@DX?2ZWTJ&>M)]T9^=3)HJ[>>$-J<0EWI[D\+SGD5?K6W@-TIK):757B9!?
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M8T98A8RHV80(X@]6<^S^4GRLYYST=/>E^DK2RDJT[;2GV4@QFCF!_N<^X/\
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M$W.L7D/:77I)2D:<RI4%:BHY4'N5G/UJN'=K<Q=[9+@R4J5'E-*8<"5%)*5
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M'W<YX^--/<#=72>UEF<NFK=0P+%"2"H+EO!*E_\ \4]U?<#0#L/ -4L\97B
MV^LNY>VUEG:DCL733FI6IMUC%"RJ*R6CA9XP1R.V:<<GQ;ZXW@+D#8O;N5>(
MZR4#5>IDJB6U'^4A)PIWX]Q]]5'\2O@GW*G;AZ=OVM-<V:\7_6EU;MRWHT1Q
MM##GEY!Z0G'2  !B@/J7HC6UDW$TW!U!IR>W=+--05QY;0(2X,XR 0#2]4:^
M'/:V9LQL_IW1L^:Q<9=K9+3DJ.DI0X2HG(!Y]:DJ@"BBB@"BBB@"BBB@"BBB
M@-5=JK)O?=?#:[N(L;A1+;/U;";;\](A2'W$HY4VE\-)(4/4)7FK-J[?F[52
M[>&XP[%NQKJ[6"X;FMHA-,/ZHE:2<@HA00ELE*BEY!6XH-@J/3DX&* N+8Y<
M2?:8DJ!CV)YEMQC""@>6I(*?=/;@CC'%=U(VCID>XZ5M$N),=N,5^&PZS,?_
M ,(^A3:2EQ7 ]Y0()X[FEF@,8H]#6:QZ&@*@:2_QFVM?\QVOZUBK?CM50-)?
MXS;6O^8[7]:Q5OQVJ60C-%%%02%%%% >:P#7S9\0N@Y\+>W5Y;N3$L7B<'HB
M75M)$5?DIRDA2^!E(5E72#FOI0H9J,M3>&S;?5UZGW>[:2@3;C/(5*?<1R\0
M !U?'L._PKDZG"\\-*/>\%\1CX7U+SR5VFO[_F5OT3NQNAX5-,6B+K[32=;[
M<>2@L:LTLSE^*A0!'M# SGO]8$Y^)JV&VFZND]VM/M7O25]AWRW.)!*XSF5-
MG]ZM!]Y"A\"!2W:M/6^R66-:841MFW1F4QVHR4CH2V!@)Q\,>E5\W*\%MLE7
MM[5^U=[D[6:Y'Y02K6,P9:OWK\?ZI!^(Y^1[5U1512/$R3<YN;=V66HJI>G/
M%KJO9Z>QIWQ!Z8_8^M2PTQK.SH4]:9?P4O RT3^;Y#M5G[)J:U:CLS-VM-PC
MW.VO(\QN5%<#C:TXSP14E!6HJ&8OC!VBF7Y%E9U@RY=''@PF((C_ %]95TCC
MHX&>,]JF1!ZD@CL>: SBM2D$'[*WK4#Y41!&&\^TT37=I3<&)@LVH+6#(@W9
M/NEE2><*/[PXY^%5EV?3=-]=:WFQ7F[,1K8_,^E;E'C*PJ<M(",)^*/=S]_S
MJ[]SA1[A;Y,66VEV*\@H=;6/=4D]P:A+8S1NGH.N]PGHULB,OP+TIB(IM !9
M;\I!*4_+)S7G9L.K+!KCO\GV'AGB3P=#U$);RBEI=+T[T_X9-=HMD:T068<-
ME$>,P@-MMMC"4I'8 5VXK5O&#6]>@E2H^1;<FV^X5&>_^\FE-E- 2KSJZ<[;
M[?**H+3C,5Q\EY:%=*>E"20#@\]OC4EE0'K5$_'9?5^(N^6W8K1#0N-Y@R/I
MF^7/J_O:TLM-KPEPCNLD_5^8^/$D#K_!Y[_:)U+M1:="V^Z.+U'9V''ID=V,
MXVA"5.JP0XH!*NX[$U;M,Z.LX2\VH_)8/^FOFOX)_P 'YIO6.D(NN=7W5V[V
M^ZL+0Q;(BG8:XZTN%)476W!U @=L"K,J_!Z;/C_ QM11OFSJ*8G_ .^IV*[E
MDP\@]EI/V$5GJ!'ZJK1_Y/G;1O/L]WUK%/H6M3RN/SJK4^ ;2+?^Y]=;B1E>
MA;U(X<?G!H3N(GX1*W;<R=G;U*U(;2-:1K>HV(S'NB4,NHZRR,CJ^==6E/$+
MX?/#GMI CV&[VI+DIMMU5FTT3,E29); 5AM!)R3P2<"JR>.?P-7K2VGVM8V'
M4]VU)8K)!<<N"]4W3VB0T2XD)2Q[@X.<G[JL%X ?"6_LEHV?<=86>RRM0SY"
M),.>P$ON-QRA)">HI]TYYXIV".V/N-XB/$(G_P S-,Q]G]*/<)O>IT^=<G4?
MOFHX^KD'@G\].C0'@;T/9+VG4FM95PW/U=U=:KKJATOH2OXH9^HD?<:L<A.!
M\ZVJ"3QCQ68C*&F&D---IZ4(;2$I2/@ .!58?$U8-U=9ZZT>=+[>1[O:=+W=
MN[(G.WZ/']LPV4EL-J'4@@GN:M)10"/I.X72Z6&'+O5J%DNCK85(@"0F0&%?
MO?,3PK[12Q110!1110!1110!1110!1110')=''FK?*<CEL/I:46R[GH"L''5
MCG&<9QZ5\YMWM>[>:]UA>+Q>K]ME)NMLCMM7!M5SND<SUH22IHM-=*9(!'2$
MJ![]/K7TB6,CBJ,;T0=R96Z.O'-$B6(L!V.TJ%IBUP'GUER,LMNN>8GJ*@ZE
M(5DC"%Y&2* N9H2>W=-&V.:RAIMF1 CO(0RT6D)"FDD!*%8*0 > 0"!P:7:0
M]$"XC2%E%W2IN["#']L0M04H/>6GS 2  3U9YI1NEUBV6W2I\Y]$:'%;4\\\
MX<)0A(R23\,"@.NL>AJ-=.^)/;35=LNEQM6K8,J#;(XERY)"VVVFB<!94H $
M9^&:7MO]U])[I09,O2M[CWAF,L-O^3D*:41D!25 %.1R,B@*V:2_QFVM?\QV
MOZUBK?CM50-(D'\)MK3!S_YCL_UK%6_':I9",T445!(4444 4444 5@BLT4
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M2%VL6D^TI:/99;^L$_/&*5_QYG_X$MT?Y <_52A9:6BJM?CSO_P);H_R O\
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M3/!U?-3;>ZPU7LSJNU-VQ=L!O=E:BS/;&683RS^1\S ("5YZ0H ]) ["@+9
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/% %%%% %%%% %%%% ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>alts-20241228_g11.jpg
<TEXT>
begin 644 alts-20241228_g11.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $O @<# 2(  A$! Q$!_\0
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MS" QB&(S" QB,PA (0A (0A (0A (0A (0A (0A (0A (0A (0A (0A (0A
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M0<HLWTJ/SV:0_09W[8BL@Y1M6Z>C5JV_<W0JU(=AA#L,>[>^A;?HG_E5K/\
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M<HVK=/1JU;?N;H5:D.PPAV&/=O?0MOT3_P JM9_I$A]A<;$C&NWHG_E5K/\
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MD(0@$(1B PKP3%(=2JYJ)L\[45[7X=+ZKJE;%T2$E+2,Y16NOF*6&4J"F"@
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M[T+Y+\L8RRA8?>&.8C&^GRCRQX\:>+$VZ_\ &&LGK*PFK]49O*$X1N]S 8_
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M+:02&%<>8W4D ]H2(L"-.EI?E'A<5;3W-,SDSNIFN#G7E1W% CBAO>^]C\7
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MRA <H1V9\W.BOWY%UOZ(Y[(V;;#Y V3-+,G_ )D9]IC63?GR+K?T1SV1>[9
MT<->T,V>[H^,53:^+U/?F^XB[O-S7= *>K7_ )J.:1V1S'B_KX6DNX_9[X7'
MUCV6Y!S&8PD$#CY(S&@.LD(0@$8[(S&(#RVINI=O:1V74;KNF=-/H=/2E4Q,
M!I3A0"H)'>I!)XGLBE>UG>6R7J'>DM_"#<=1H5X2DFPMNHT:7F&9DR[J XT%
M+0@@C=5D \1G$7QJU)DJU(.R=0E&)^4= "V)EL.-KXYXI.08I)K-J+J@_M$7
M'8VG&C5AWTU2I*5FG)RH(2'F$+1A*'EG"4J[T[J>>Z(D9KV>OV&*WL[2RJY;
MNBE1F*I5 VF>JLW/,O\ =+R2K=2I3CB1D9[!%N$\HUKT;:QUOTUJUY3,_H)9
MM+8M%MM^Y)>D/]S3K4H>^#J #]\1@$A6"GA&P^R[GE+TM.CU^0*C)5.3:G6=
M_P +<<0% 'S\<'SB,LXNQ[NZA"$12,'E^<>V,Q@\OSCVP&LWHVO' U[_ )Z8
M_7%10?:1\8;5#UEJ'OUQ?CHVO' U[_GIC]<5%!]I'QAM4/66H>_7%A)1U"$(
MR8N*_ 5Z(_H7V1_%BTJ]6Y#W"8_GH7X"O1']"^R/XL6E7JW(>X3&,LH2L_,M
M2K2G7W$,M)QE;B@E(]),=#<]Z2M$MZI3\F&ZQ-RS"W6J?+3#8=F5 $AM))QD
M\N,0;TCLPY*[&&I;S+BV74R\IA;:BE0_CS'(B(OL/HP]);CLFWJM-5B]DS4_
M3I>:>#5P*2G?6TE2L#<X#*C@1%?)5MH-QUFY9BH[)5<4W<'4_#*G9NGD3VYP
M;ZWCWQ&1C,2OI/M.7'=-V4JW:EHA7K(HZDJ:^%)Z?DS+2B4H[T;J#D#@ ,1X
M\]%3HZ>!K%\D>0W"H_\ \(S]RJT>_P LWS_^X5?L01;IJMTYU80W/RSBU' 2
MAY))/D S'V9R(UG:D[+UJ;,NU-L[(M"I7"^BL7$E,TFKU-4R"$*3C P,<^,;
M,$#"!Z!!6M+I4?GLTA^@SOVQ%9!RBS?2H_/9I#]!G?MB*R#E&U;IZ-6K;]S=
M"K4AV&$.PQ[M[Z%M^B?^56L_TB0^PN-B9_WQKLZ)_P"56L_TB0^PN-B1C0,?
MJU:N<X_5JUEK,V?OESK;ZY3'L5$SQ#&S]\N=;?7*8]BHF>.;;P\57J\[!Z9'
ME]5/FOO'ZFG?<+CU$>7U4^:^\?J:=]PN/"P_STZP_2<I3[L*>*/I=]3H^VJ)
MX\L0/L*>*/I=]3H^VJ)X\L=/AZ:<V80A%"$(0&.PQQ/(>D>V.788X'D/2/;
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MI44!2#P())SN\1YXMNG..,9RQAF$(1%(P>7YQ[8S&#R_./; :S>C:\<#7O\
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M,1(=X6[I/M^Z6B;MNO-34Y3']^FW!3LM3M)FQQ2<'"@#VI/ CB.(S%:?X,]
M=%U6Q?%L61=^T#1)PN-TY^06:I)4O=/>M=61X63R6. XGLBPVQ/HW7K6JFH>
MH]P6ZS9,Q?,ZU,RUJ2Z0D4Z7;20C?2G@%JR20.7YXRM$PF22=!+;OM[3B7IN
ML<K1ZU<-/?7+M3[24O\ =C"".J?6%#O7%#B<>GG$O(2$I   'D@DX!S&%NH;
M0I:E )2,DDX $2ZQ#D3P,07)[:&D]4U?8TSIMPN56YWI@R@33Y5;\NEX E2"
MZD%.0 <GD,<3'6UC:6TWUK=N_2JQ]0Y%-\S5/FY.4<:WP@/=6I)+;F-U923Q
MW2?-G$5JTKT<VCJ+95OZ7R[%K:)T.FA;,U=<I,-3%1JB\DK<9/A;R@>*N'#M
MQ"(Y\SLF7:;V5ZU,W4C6'1I]JB:FR*"9R0"0)6O,8[]EY'@E2APX^%PY$ Q&
MNB6F!UMM=ZJZ54RDZ&2D[U](O.5;H)753,[V'FY:8<X(1@D )X)R>&1'OMAN
M\KPFKXU5LJJ7G-:DVK;$ZS+TVZ)L96XZH$NL=9DA>[CRG!X9BWS+"6,A"$H!
M)4=T8R3S,,N79+W=#I[8U)TULVCVM0I?N:D4F61*RS1.2$)',GM).23VDF/1
M9 [89Q'%>""?)!65.(0!O*"<D 9.,D\A$,[0NO$_I7.6I;ELT)NY;WNR;7*4
MFGS$P)>6 ;3ONNO.<PA*>/#B>,0MM+7;<5\T&M:67!4J5I_?=5JZ9FP52E5<
M0)U$NM*D./O!.&U*.<(YE0 [.->KA?IMT6/5=*MH6\ZG8NKMIU!ZK4>\)YU<
MPU.H>(3]X* "I"A@;B>([,8(B6O'(R7+V:-IZH:P.U.DW=1J;;M:EI]V1DGJ
M?4DS$I6%-)*GC*DX4L-@=\H I'+.8]-:^R]:UDZZU74ZW)B=HLU5Y4L5.BR3
M@1(3CI.1,+;QX8\W;QYYS'FS]LLW%0+RMB]K^N*BUJ;M>D+I%MR-N4\R<I*,
M.COW5;W?*6I)_P!I/.+3@8$93:_)(R G$.4"0(\7JQJY;6C-H.W/=<\JGT5J
M89EW9D(*^K+BPA*B!QW03D^0 F(KVF\,XS$7[0FS_:FT58DQ;=RRH*T_?9"H
ML@=TR+X!PXTKF/..1' Q7K:_VGJ:;5L=RUKY<I^G]5K[M+N2[;85UK\FAMLK
MZII:0=U2R1WPX^2/EV6=1+HT]ONWK-N2KW#<DI?QF:E;U/K,VB<G*-3V4[P=
MFG<[V7=Y.$<DCF<B+$7,GCK.I5UL7^SH[J90J8_JE)R2Q8^JTU0D5$N2C9SW
MY4DX4@?C*Y$C(S@FV6AF@(TJF:Y7ZU<$W>=]7 MM56N&?;2VIU*!AMEIM("6
MFDCDE./+$K]0AQ:'BV"XD$)41DISS /9G'&/W$1+,PA""D(0@$(0@$8S D#M
MCRFIFI=NZ1V35;LNBH(IM&IS9<>>7Q)/)*$CFI2C@ #F3 S>FFIE$K+NO.'"
M$)*U$>0 D_[!&O6=VI[POY$SJA-ZR432/3:GUAR2D;=;DV9VI5-IEPI=4XA6
M5[Z]T@)&  0>T$_MJ'M,:Y4FT*?KB]/T.T-.YFI2\O3K,J#(<GZC).+ ZU2Q
MG"RG*@E/$ 1\4G(:"WM,U?4?0[2)C5&]Y"I(74+;FG%2:I4+))F42SV$JR1P
MP",GD.$,INE^RSVS]MCZ=[157J-%MR8GY2LR+0F%2%6EBPZZR>3J 3WR>(/Y
MQ';4S9DMB@:\S.JM#?G:)59Z47+52G2#@;DZBL\G7D8XK&.SF<'G$:[/FDM\
MWCK=4=<=2:!+6345TH42C6M*NI<<E94**BN86G@5DD\.P>@1:Q(QF+/*;D93
M##8 3CMC.0(<!$7:E[3VEND-PR-#O"]*91*O.X#,D\I2W2"< J2@'=!)&"K$
M178ZA:Y65I=<EM4.Z:XS1ZA<;ZI>FI?!"'5IQG*_!3Q*1Q/-0BO^U+M>SNGF
MH4Y95#N6WK*-'IS-6JU<N-M3Y4AQ2@W+RLND@NN$)))S@1.^MVB5I;1&GTS;
M=S2J9N1F$AZ5FVP ]*N8[QYI7,*&?SCA%*[?T^NRE:BR^D.I-O4ZXKR9DUIL
M+52>H_PBE,LVK(1,#EO(' %?@D]H(,2(OR[F7.':4NN_\*'69V_]$ZY5-.]4
M:+3F6Y^6NFEJ;DZ[3E$]6ZIK.=W.<'R8P>V+-[.6@U5TQG;KNF[ZVS<=^79,
M-S%5G91CJ)9 ;3NMM,H[$I':>)C[M#=!9C32HUFYKDN%Z\KZKB6VZA6G64L(
M2RWP;89:3P;;3QX#M,3 3B,LLF,7G,  Y1@D1D*!.,Q$FMFJU;TGG:579B0I
MJ=.)5I]ZY*U,3"^Z))*0 T&64I)65$__ .<XQEE:[W5\7K3;"LNN735'3\%4
MB3=G9A3??'<;25*"?*>&/3%5K-VV;VFKYM.7NBPJ52;3NF155I>98K*53=,I
MXR1-SR580VWC''/$G R>$0)0I^O:#5[X<OBO3U[[,EX*J$C(S-.J:IR7D&)Q
M>\ER80$YR<GA^(0K&",'TNC&R&J^;9NVVK!U<HMPZ.5B=1(U2<13EN5=3#*D
MJ$DB85WO5@8 (X<20 <QE3%IYY(N!KKL_6;M/67(,51:V)AA3<_1[AIB@F:E
M%G"DN-+\BAC@>!X'F 1*5%III-+DY)4R_.JEVD-&9FE;[KNZ,;ZU=JCC),*)
M1I6WZ1)4R2;ZJ3DF&Y9AO.=UM"0E(SY@!'W#@#F($=+>=W4JP[7JEQ5N9[CI
M-,EU34R^4D[B$C).!'=9X1\\VPS.RSLN^TA]AU)0XVZD*0M)&""#P((\L8Z+
MJ@35/:]MBV= Y+4NTYJ3N26K$PS3Z4IQ_J6.Z73N@3"C^"2CB5YX@ Q5N^=H
MVS=;K+F-*M4;F<NBH3M9899O2R:0XBDT.<*@)=/7*4>L(7D$_C \/+'>Z\;/
M<QLM5&M79:EM(O?1*MNAV[-/GTEQ$KQ_])EA^+N\\CP>1X'A+&G>RXW><U;U
M:GZRTSI5*S35?M^P9"B)IC3#FZ%,&;![YQ:.>%?C<8RCO*/FL[95U2NJZK(>
MUDU!IUUT"QYONZDRU.D2U,3LRE)0V[-.GB=U)/+GV^6+=A(&8PWX/+'ICE!8
M(0A (0A (0A (0A (0A (0A (CS6S6VVM"++F+BN69*6@>JE9-@;\S.OGP&6
M4<U*)_1VQ(<5RVP-EMW7:E4>X;:JBZ%J+:KAFZ%/*5EE2\[W5.H.1@D#"L9!
M\T21 5VZG?\ "PN"EZ1:S:7U/2VJ5UM=2LRN=U=<XV\D$A1&!NJQC(&>/ XR
M#$;4.[DZ*:PUQO:@I=6U!O2D4]N5LK>EQ-R%3:\$!E&""\X<96H$C*L\1QDO
M9+N&=USVF:O7=:JFB1U5LQHT^CV:6#+-2C92.MFD9/WU2SGEG P>6,7MJUFT
M.OU*F5"I4J3GIZEN%Z1F)AD+<EED8*D*/%)QY(RM$)'S5^V$="Z]I!8UR52X
MI)B@5&[ZJNM_%N3.6:0VO.XP/\X \0.6 .PQ9I*=W/G@E&[&87N1%G!UQ+22
MI:@A(&23P  YQ3[;0O2M:L:3U>E:-7;2KA>IKN]<M#HL^DU&8DA^$;:6@DH/
M A6 20>'+!^GI%:KJ+3-.:8;?9F3I\J9'QN?H:B*JB4WN*6L\$MD9WE#)' <
MLF(6T4LJP-1=J*P*]L[T%VA6=:,BKXR7$VE;3,^IQ *)4@_A'0"=XGM/FC&(
MBKDM_AYPZO3RE4_:LK%N3.DTM*Z(6+IC*[SEQ/2[*ZF)Q;/WQ&Z2!N([[+BS
MQ()\@B0MG/3J5VVM*9DZR&9O!-L5R:I]#NJ2?=DOA.6"L%X;F-X' XXS@X[(
MD35GH][7U$U23=%*K,_:=(JYW;KH=)66F:T@'>2#NG""2!O''$>?C%G;;MBF
M6C19*D4:1EZ;2Y)M+,M*2R-QMI"1@!($7MS2.3K=.-,[:TFM64MNU*1+T:CR
MHPW+RZ<<>U2CS4H]I/&/3DX@3@$QP6HE!*0<C\V8%F%O)!2DJ 4KP03S]$5M
M3MD434-NY+4TW+;VJ\@N>EI2W:VPXTE;DLK!4I:1@(6.*%$@'(!Q$:5S5N=U
M4U.J=%?HB[$U]LQ,XJU*55JDZ:75F7."7@$X2\O=!PGED\R. B^V;;:UKKM6
MOG3-#NF&U);LVN9N&W)]]18JB\)2XD(6?P2]T$8P!G!YA42(ORDGD]1LXV?9
M^U7HU=^GVI$S56M3Y:MS52J;%2>5W?29E3AZMV5WN*6TC=3@9!W>/,&+#Z*:
M!UHVC2Y+6IBW[]K]LSJT4.NKENLF#+)_!+<*QX?#../GR>,?!H=I76KYNV7U
M<U6L.CVAJ-+=9*2+5'FUK4F54D)/=!SNN*SO;I/(''9F+()3@8C+W2.8!NC@
M,#S1GD(=D>&U/U3EM,TT S-%JU615Z@B0WJ9+=:F5!!)=>.0$-@ Y)C%7LYB
M89986X\XEMM(RI2S@)'E)[(UVZO7M3IZS]0:[:]%N&^=(JU<+\G?3LR\[W9+
M[FZGKJ:%#<##92>(XY&#@8,<*GKG>LMJ]5].-8:C+S.AMSU*=EI.Z'))26IM
MIY(4RRU-(7NH;05#=<.>((.1P$C[,5LWOLYZB36B\U*+OO2RHE^:HUPL!+AI
MH4.L<EYQ.2!O!6?(2H$<%8%^&]UO9$UJVI<VGUGO6QIM:,IM":!7JGKJ/*S+
MH0ND3*B"I$PK&4)':HX(([""#<[0[9AT_P!#4/3UKVTU2JM.,I;FIAR87-.I
M',M(<<)(0#G@, QZ/2;1*T-%9"K25G4I-'DZG.KJ#\NVXI2 XKF$ ^ GR)'
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MP77%+6<JQV)'^:D <SS),20!B+VM#&(]1(Q&8P!C,9@R(0A (0A (0A (0A
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& 0A" __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>alts-20241228_g12.jpg
<TEXT>
begin 644 alts-20241228_g12.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $\ 8X# 2(  A$! Q$!_\0
M'@ !  (" P$! 0            <( 08"!0D$ PK_Q !:$  ! P,# @,$ PD-
M P8-!0 ! @,$  4&!Q$2""$3,4$)%")1%3)A%ADC.$)QE=+3%Q@D,U)65W5V
M@92RM"5BD34V0U-R="8G-SESA)*AHJ2SP=0H1E6"L?_$ !L! 0$  P$! 0
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M;<F4IOQ R76U(YE.XWVY;[;C>H$RWHHFY-TFX3HPG+&([V./P7E7E4!2DO\
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M^OX12AO\@*ERN*4\=_\ [5RJ[NY$K"E*4**4I0"E*4 I2E *4I0"E*4 I2E
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MD(N;)0J.X^8[;P5RVX*>!:"O(K'$=ZVI-C@)4E0A1PI*DJ20TD%)2.*2.WF
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MEJNJPE]ZV.J4HLJ_W%*"C\^WG6ZZ49G@=_L[5HP*Z6J;:[,PU%1&M3@4W%:
MXMH 'D-D[#\U5A]H1=]/$V!RWJ%M&HP=A.<C&/O9A\U?]+Q^IL%=N7S[5O\
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MIK?C&-KD/>X7?![[[K!F)2M2"ZB)(+K/%12?R-_3TKTHP=,Q&'V)-P=EO3Q
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M&2!Y]Q7IV1N/E7F-[4:W2M']=M(-;K8VL.V^6VB2IIM.Q+#H6 ?F5-E2>_H
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M-B?FI(]:B30?3S5+*NH&YZPZG8Q9,!D(Q_[G8-AM$T37WTJ?2\M^2^GX5$<
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M5'>H37_674'6K',IF1+399."W21,LEND,J\2*I11NV_OMS(\-/F!7M(6QO\
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M4E945@@#5/9]:N91>M"L#P2PL"'.AV"YK1/N>/R%0?$\0F$?'2\ M*5*7X@
M'/<!)04DJLCULI*.DO5X@['[FIO_ -,UKWL[D<NC/2I6_<6M0_\ F'J^/+.]
MU(Z$:NF5+EE2;E9J_-UOAVMT6+>=R6H\//C<PI=SQ\V[WY*BA%O?#ONONFRD
M\B[MXGO7Q!6VWA?#MR^*NOM\#5-#$?WV\8HX\&;=XQ8MDE*2Z'3[^4@O'9*V
M]@T/-"NZ^8[5(J!L#^>LGR-?8T".KA;]3OHF:(5YQ9NYF/*3&<?M<E3*7S)W
MC%:0\"4)C_"L @J<^))2GX:IMKYKDPK7/#_I7*+/*FXC?IO)R%:);3=O:*6@
MTE]*E$OK"TJ*BR0"G8  ]Z]"R-_SUUSF-VI]:UNVV&XM9Y*4N.@E1^TD=ZU-
M51G7I\D';;Y.YZ+@/$M-PK5O4ZBFY^S))*2C[T7%O,9=&[=Y%N YME>J>,VS
M(<3R;&)MJ?G1PX^Y9Y:"N.VT43$)2IX%+BG_ (FU$$)1V4E9^*MAMUMU119H
MR)MZQ5=U$:.)#K-JDI8+XD[OJ0DODA"H_P * 22ESXB5)^&M]BPV8;:&H[3;
M#2?)#: E(_N%?36S&]O:W.%5=-SDZ2:C?">7;O=E?X$<7&WZI+8D>X7C%6G2
MU<?!,BUR5 ++G^S^6SPW"&]P]M]=6Q1P':NP,+/_ *441<L>^CC/4H(,!_Q?
M<_=-@GEXNWB^]?$5;<?"^';E\5;O2LCY$=QK?J<F)%$B\8NN0$6WQRW;)(0I
M25*^D>(+Q("T\?!!_BR#S*]^WYBW:JFVE*KUB?O_ +I*2'!:I7A>\F2#%64^
M/OX:8_)*T[[J<(4E24CB9(I0$=WZW:GNNJ-FO.+1F_&G%*9UJDNGPBSM"&Z7
MT_$AWNZ?):>R0@]Z^NW0=0@[#]_NN.NM!4,R1'MSZ%* 96)? EX\2I[@ILG?
M@@*"N1(4-YI0'E?[56%;+EBUE^[K/[1)SBRPH'NF,6=2XP6Y(?<$V867%+);
M*$-!OONC@O<JW%6'Z,,+AX3I)><:T7U4QG,[;&?N+W*279Z(,MUQ!A#BAQ"D
MM>$E9=1^6X2I!0.0-A\YZ>M--2[W],99@F/Y%=/!3']\N=O;>=\-))2CDH$[
M J5L/M-=EI]H_A&E0FC#L4M&,B:4&3]%0T,>-PWX\N(&^W([?+<T!\ZX>H)N
MBRBYXZ+=[^^4H5;W_%$0Q-F4%7B[%P2=U*5MQ+?P@!7Q5\D*!J<E,/WJ\8PL
MA-K]Y\*UR!R*2KZ2X;O=O$''P-]_#[\_$W%2'2@(HOU@U7NE@E0D7;"7G7[<
M^PM$ZQR78[DA4D>&5-^\?$S[MR0I&^Y<(4"$_">B7T^^[S9;\+%],HX1)EN0
M5'$4^(TWX2?<N:@L;K0\%*<4G8*3Q"0A0Y&=*4!HKL'4,W"*INZ8Z(8N3"Y"
M%6U\N*@B.D/-H/C;!XO\U)604A!2DI*@5'L<3BY>P^@Y'.L\MKW-M*A;(;K!
M,KQ'/$6.;BMFR@M )\PI*R20H ;32@%*4H!2E* 4I2@%*4H!6#6:XJ4$^?K0
M#EL0"16>0WVW[U2?/NH[+\MZL]+[/B,U4/2YG)I..W"8RO\ Y;GMQ7''T)[?
M$PP0E!4#L7.8&_'MHTS7[4Y%PN6L:<WE)QJ#JC]PZ<'3%:]P<M@?$<N%1'B>
M\$GQ.?+L>VVW:BR-B2?:T_B9Y!_6EN_U J6.AW\4;2/^S</_ "53_P!IWU?:
M89GHYF>D]JO,M_-K=>H\=^$NVOH0E;$C\+LZ4\#ML>X/?MMO6R]+WM'M"-,N
MGK3S%+_D\^->K198T.8PBRRG$MNH3LH!24$*[^H.U >AE*J']]:Z<?YW7']
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M]:N7[P7I[_HGQS_#J_6J?DUF@( _>"]/?]$^.?X=7ZU85T#=/@23^Y/CF_\
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M)(4.WF#W!%2\D ]Z @+]X+T]_P!$^.?X=7ZU/W@O3W_1/CG^'5^M4_UC>J"
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M*'%09 'X,$=CQVW'G55D1Y.Y0@#OZ^5<MJ)&PVK-1%%*4J@4I2@%*4H!2E*
M4I2@.*E<0:@+/>N?1?3C4)S#+_F+<2ZQW$L3'VXKKT2"ZK?BV_(0DH;4=O(G
MM^5M4U919EY!CMSM:+A,M2YL9R,)]N<#<F.5I*?$:400E:=]P=CL0*HA@688
MSTEXM?\ 07J!M-M1B3\>5,M65)@%47*8Y)4ZA](!)G#<#S*E'CL=^)5 =!U"
MYUJ=8M39]_5J#&LU_B,3\AMN-2KLVK'I>--*#,:,I@#^%2ISA)Y;DH  &WPU
MO3_2XM_-]$M5].],']+,Y>O;<G)[<U-:3!@P%-J$M+S*%<2MQ("4%I())',
MCMN?1UT]VN7H=@LK4'#&95QLDR9+Q=K)8R'[C9[<X^5Q&5J4"4K2C@>/Y/;R
M([6S\)/RJK!-\AKLG;T]*Y$@#O6MZAZ@X_I7A]SRC*+I'LUBMS)>DS)*MDI
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>alts-20241228_g13.jpg
<TEXT>
begin 644 alts-20241228_g13.jpg
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M8K*8EE*+0,?ORU:J[E74S,24G:64IIIH-((F+E"4LIL57))-XD$>&IV,&_\
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M'6<@:6=>D2;PU-JW)TJF J$QBZA561QUL[FUAJ6Q51,Q90X=S,TTH<Y*O?\
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M8[]">X0PZUCI%-0WXNXA)6 $J6K-QOZ1PUZH9=0VCL34S,2[LLII)<#10ZX
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M">S77CIOC:I&%ESCQ'-H<0?ZJ1NMO.F[M[8:>-L'S#[#[#*&\NHL$J( UUS
M[AOZXKWBC9US:YA=T#FTYLV4)!%S8WWB^I^>&55L*3265)!0,J>DAQK+E &M
M["YWPQ:IAYR6YTW1T%Y% C*03KQZKP@.L%I:DFQL;$C='7!!!!!!!!!!!'*E
M9C>POV0L8+^VZB_CS'RB8^HUOR3WGXS&4$,[:\RF8V:XB:5Y*I4@Z7XB*R4+
M"3"VE)/.D'<%HWGK'9;KA7F\)RK;"6$+2VN^B!=1TX?[H;TW0 *@J7R%" ;J
M4X-UP";=?^<=DWAL+87EN;;AS=U'7X(94WAM"9A*U*"'TGI%*,PM>]K6/?>\
M:T]2F^: 6XD7%K<T2JP&EM1P_;$;8N2W+3"TH<2MQ*,P"6S:]S:Q/5U:F&LS
MS5=D'Y2<<ND))"<IM?=N.I%HC?'FS)FK4M:5JSLE!3F0S8V.EQKUZV[HISB?
M#$YA>J/R<VTL!"R$.E)"7$\"#W0CP0000000001[&^!)^XACW\HT_JK433RH
M\+N5?:-+N@H4A5/:1E*A<$+7;3^-T0^=G[CCJ06DD!0%RHBYA2E,)FF^ZA*4
MV RY#N-]+]6F^-*>PY)S[DP4K4^""3S9 R7XCKB(<>;.TY%N!"6FW3F#25YE
MK2-+F^[>3$.5W"9EJ@A?-,AM1""VE5CW&_H/KB,,28.+:IA+[:4*0O/=+A(%
MR3W6!/'47B,Z]@U]#I+:4))MF2%Z"XN>&H_RAK5&@/R)Z60YMP2?BZX2E)RJ
M(ZHX@@@@@@@@@@A9P7]MU%_'F/E$Q]1K?DGO/QF,H(;NT!'.8-JZ;7NR=+7O
MJ(@!;"F2%(G0TI71R;[>L?LC3"5S"U%]3EE '19W=5@/BM"U+R3<U*)R**;$
M@ERV[B3?=PWZQP_0VIE#A0X7F%J)NI*K$BV@ /JZX3)O"*5A:W"6RL:*RW4K
M?<;_ .+PV:KAWQ1M9""LOW3E4HJ)MN OPT^&(CQOA(,.$&X07"  "$@GB .&
MD,.8PXOW1EDI6@D#H A0%]P.\"W5ZHW)S"STO3%))6H*%LYWWUL1;3LMQB,\
M5;'6*S2YIN=ETOH=78)<OE^<<-T59VI;"YK"07-TQ+LQ+ ].7RE2F^T'[X:=
M\1&1K'$$$$$$$$$>QO@2?N(8]_*-/ZJU%O-JN$4U?$S,\6KJ1+H2'!O%BK3M
MWPVT87:F,PF6TYM.FD"Y[+6U^"$.N;/S-(=YAQE02#=I-[I&F\#C$8UF@O41
MX%;A"202 G+H#T;=G?OAA8OK\Q,+4I!&8I*4IRYEKM]\2-PB+<1X82E3<RML
MMWN;+1=:S;I? 1ZX8-6PV)[IFX<) %D D Z6M;=NW[B+PVSA0O%]7--*;4"G
MR"1Q&^QZ]W\!F8NP%)J0^^A.;+8E9L =. MP_;$'XBPXJ3F\H.JB;6!.;U#O
MAMN-EM1!X&,((((((((((6<%_;=1?QYCY1,?4:WY)[S\9C*.+@&U]81<:6_D
MO4KG3FM_IB(9+![LZEQURXN-"H@ #KL-8S5A":= N'$)3E*B+&^^V[^.V.^7
MD'&4@INIK+D 2+))''KC5=EDI*BXM2<Q.4HWW[/1"?/52884ME#O,,)2"1>R
ME$CB?FAH51Y;J0J^0YNB7/*WBXL.)C1<I0G9$]-22%<V7$]*R3IFZ[?Q>-%6
MSM+F2880KI#<L $ZG7L[^Z.,28(?EY.4"<[9*"I82D=>I_WPTZW@R9J206T@
MV0$J4EQ)UX$ZPS:ULD9F)%;@"BM.BBE()2. _P!QBFFW7DKN2C\S5Z#=ITDJ
M<DUI 0LZDE*AHE79NBKU0IDU2IMV5G&'):8:-EM.IRJ2>T1K00000001[&^!
M)^XACW\HT_JK47_K=)1.OI<*[+2D#4VOO^>$&:P^MH%*4:;K$7![8:M=IDW3
MPMMBZKV%[%%U<3<\(CC%UYR26S-M)7E5JZA-CWG^M:V@B$*KAPKFW&BX'>=;
M#KCB0+J45"PMPL-+7AMUS#:Y>74E:F<BU6+3:PI:B>)ZM+:0T7:(E9#@84$.
M+%@&_O1O/\?[M>:PLIUM;?E9B5-H2.@/2!>YX^B&#B;"B/%$])HV)5D!L1H+
M@'OZXC>=V?R3A=4\YTG;J" 1<6XCJW[NR(KVD;.I6EU!Q4D\N82XV'RI:,MM
M.D+D '7XXBR8EBVOH@VW=+?'24D;XX@@@@@@@A9P7]MU%_'F/E$Q]1K?DGO/
MQF!1LDF**[:=MV,'.6!0Z)A_'U2HF&*;4:-)5.BKI$XVV779Q31#CAE5(4T^
ME2@A?.!*U(2$D923=;%"%.8?GTIOF+9M87.^(N9D9EKG$J?64!(4"-R->KB8
MWVGIQDE1<;5IJ-4Z<(Q-2GIAH<Y*92-#E((!OH81*J'E+6ZI*TW!(4@V">P7
M'?"#.32G5@%"@;Y@3K8=GJA#J$BI164-$.:%)0+:7X>F%[ =*2\;J2K*!S91
M;11ZSIU_'#Z,@RE*4I9L=P6===PM"'7\,>-$K(7S@&Y1TMZH8<]2>8#S(EBI
M*NH;N'5"*_20TM2SG"-.%R.W=#!V@4!B>E5MN-9@Y=-E ZZ;^W3A%;=K7)YH
MN.Z>Z%RRI282/<9QM.K74=VHX$12#:5LPK.S*L^(U1M*FUW4S--7YMT=E]Q[
M(9\$$$$$$>QO@2?N(8]_*-/ZJU'H/4JC+RKI;=<"%9<PN+Z:PDKQ-+(25)>S
M9=2+'3JA"KF)$3'.%"EV!&JAJ>X1%^*ZE+*869HYVR"G0$ 7OK;KB%*_*K4O
M.S-EE*F^<Z?1S'.$I'H%S#?J;2I-Y"E.J>075!M8 5<H)W]X.^$@M+==*E%2
MGUEPE22"FWKWZ]W9!*4Q3TGSB>="T#*C*3T;@A0M>X_BT,[%.")AI*T-*4H.
M#H@G0?ZUM]^$1A5\,3;#+K 5,LL:ISHU4+[AKI<::^N(:Q_(S\S,AK.ZTMH<
MT4*3=0N;BPTL-=_P1$%9DGW5K2K.XZ%$YSFRIUX7W#Y^N$M5,?F0I/,J2X+Y
M4@$E>NX=9UA.>E'&;9DD$]FZ.F""""""%G!?VW47\>8^43'U&M^2>\_&8%:I
M,4FV[4I4[RVL$MSM*DF6'FZ4[3W6FF7'ZFMF9=<=YU"I]@J3+]%2%!AXH*U*
M N (NA4TYZ=,"^],-!3;@;.B2X>[7OA/6KFG%AQL*.ELOD]T:LP^MI16VRI*
M=VX_L^*$IR8==39;91?<%;AV=D(_.-K4XAT!PE0Z0&HMQ^*%6ETV76H MYDC
M?QAP2=(EY%@K;!!UZ0'&-.=J@IZE..,DL(M=P?>DQL)J:9AE;:2EPY0H=O?"
M/,U%EU0\8E0,ER !K;O]<)51I;,XPKFDK&;1.EP3VQ'>*\/!!4A>=3AO9 T&
M_?:(MK6&5H9=RJ4@VW7*2.LC33_.(^QS@^CXUIKE-JDBB>8<)!2ZF]B0-1VV
MXQ0_;YR=:GL=G?&FW34*(^L\V^&U!3%[V0YP[,U]8ALBT$$$$$>QO@2?N(8]
M_*-/ZJU%M]LM733ZRTVM\-H7+ V*\@\HW).[^##"&*6)0-WF"E)2"I&^_<#:
M_?"35*Z\Z4 3"E)6=!DT N;;CV#6\-VKNNNRLP7WB[DLA*%JWG>3?X+=D1/7
M,1JF954NVD(:6L)OO4JRB";G=KN/7'51'W?'&)5I[GFPM:#G3<E*ATK6WVA^
MX?PS39MA)<N)C($JLWT";ZWZKVO;A"^WAJ60A2G+#,=^3U:0VZ[),2CJ[I#V
M_5"#JF]M.W?\$1Y6:&V@3#R1J"%E.4FUN)('^<1CB_!4K7DJ<;DPM93=]QN7
M*PHZV-AIZ.R(LJ^Q*:=*6$TJ=05*4YG1(N*"TVTOT=1:&54=EKS$JZ)FG3<F
MI1!;?FI!Q(0> N4C3<.KMB-Y^AH>FG$-O!;J"4A+;85>QL>\=\-RJX.FI9E<
MPE(+8.A"2 H:ZCKZO1#;6VI"B%"Q'",8((((6<%_;=1?QYCY1,?4:WY)[S\9
M@5Y,45Y1,E1U\LW"R7Z;7EU*;?PWEE)>6"V:NEJ>?6'&GC*N%@29LZZ$O-<X
ME5CH+F\51N:>_;?ETAFHF$/\XEM=U9BDW'5H?V0VY];LJ%+4><4X2,Z$E9N=
MV@U'HCB2!2TREYW,EQ!S!0&B1PWFZK\8;^(*S+-%>58LFYRJ%Q8PTYS%+3"E
M+44DD:@)N1&W1-H!6WD/-H= N5 '00OR>+RXJ[K]LR0$@Z:_MA4<K[<[*.L.
M--NMY3HM/[.)O#6EZ@9$GF $H"MP3IKV6C=:G%U!)ND:]$@(OIN_B\.3#5+=
M=N2T0$=($Z"&MBNA/3;SI"$%T*MG4C0#OB*L7TM,A+/+4"5#^HDV[KF(CJ<^
MPS.W-TH!L.B3NXD[^N$'&TI(XUH$W39]MB::6V4K:=3?-U'N!''O&Z/.[:UL
MTFMG.)7Y10+D@XLJEGA>Q3ORG_6'Q6ACP0001[&^!)^XACW\HT_JK46VVSX3
MJ=>K#3DDUF;\7"2YEO8@DZ_!$&5#!V(*<^\6VYA60G,74$BXW93PZ]UH:U0E
M:VT\MQ;#\N]8$YSS@)[+GUPVI[&M69>6TN6=6$)4W<M]&]K:$]^^&U5%SE14
M%O(;9"E)4+I5<$$7 UW'?#GP[36FEMF6";HS72<UA??OX7)A\TJ6G4S8YMHI
M:6K4M"^FZ\2"SANIUC.S(RQFE@ *4#9*1Q)439(':1"=4<-8=DU?\:5%RKS"
M+DR=%3T+Z^4\O3OR@PVGL62,BZK[$X5I$D4W"7Z@E<\_H=+EPY;CL3#?F-IV
M,U-K:EZU,4\*T0FF-(E@E6HM[FE-AV\+PU:EB''<^'5NXNQ"E9(2%"I/#7JM
MFWV&^&#6]H>TZE3#IE,=8F;EVD%(0S5'EMKN;DY5$@'KOU0T)W;'C:9:<8Q-
M3</8P;5HM>(,/2<P"CB2I"$.9M3]]>Y-H1:U6-C^)65/5[ E1P:IQ YJ?P?.
MK?9"2";F4FB1<$7)0XF]K 7B'<<\E>=Q?+SM>V4XAI>U&G2K)>FI*C)5+U>5
M;&]3U/=/.\3<M<X-#KH3%;IB77+.+;<2I#B%%*DJ%BD@Z@@[CV1UP000LX+^
MVZB_CS'RB8^HUOR3WGXS')W&//7E2UZF2W+WV92RL28HE9Q"J1S]-EFD&4#:
MYQ00MI:GD%.9S(AP!M94%D FQ$7MQO66\/X3J=1?6$-2[6=:CP%Q\\1"_BYF
MDXB*4.9F9A:G @ V;)&EM?ONEIUB$W$F-&I%3#<LLO.3<V6V<NN5(%E Z[K@
MB$R9KOB[(?Y]2W2D@J2D$)OP2+V&[=^V(YK^*9>52XZ]-NNV!N"G4JMW]D1+
M7-IBV7"GGLK:@3F4HW UXGXH2J7MC1(.E G"XML '->Y]'I$.:A[9N?=R)?"
M<UO<P.-^T[NV)#H&T-QUI3@F%*0;YBL:'??CNTAT26+F%E "]YZ*[<-.V%^2
MQ.VETM,.FY!S*3Q/&')1,9OR2R K.VO^MJ+QTS572GG#-.!Q+@'3'WH/$$;H
M:6*F6'Y-Q*'@<P.1Q5CIWF*M[4I)V0+\R)E;>3,4$$I]1ONB*:;C1R8G1+.O
M@*>%LQ3H@@$7M?=H8TMMF!FL6;/IMLI3XRTD3#/03FS 7!''=I;J,45=06W%
M)(L4FQ';&,$$$>QO@2?N(8]_*-/ZJU'H=42TEE2G"!8?!$>XC=:5SH0@65O.
M7U&\17B&5\8"TJ%D[PH#AOB(L7H2P'@TT'U9;W4- -;VM$.UO%3DFKFO))7D
MT;O8[R+GXH7,)8F<J;C"F[A94%!)20-;VOU#]HBP&"*.S)TE-=KLVN7I(5E8
M;:T=G%C>EN_WH^^7N'?&Y6\?/55"):54U)4AL9VY.7)#?>H[UGM,([;5U(G.
M< 0Z2!8Z*MOM&F^9!V8YWFU)%[B^MANN?6(<,M*86J$@W+<XJ2G<UE//)]RO
M?0WWC6&C7<)KD9DMNA2Y=-P'&[%M:3QS<3#0K^$)6:0HRS:BJWN:0+E1.^XW
MQ&.*L%/3A<8EI5.<G*5E-DVU/H(B"L9X??8DYN4=9*V4DV6C<>L_QNWQ %:;
M?PI5F:M1Y^;E*G*J2ZQ-R[BT.)6!Y:7$V*5#L-XE*6VEX4Y2!1A_:\]+4+&R
MCS%-VH2K(;0\N_1;J[:4@/().7QE(#B-"K.+Q!&TC9MB'91C*I87Q/3UTVKR
M*PEQI1"DK21=#C:QHMM:2%)6FX4""##8@@A9P7]MU%_'F/E$Q]1K?DGO/QF.
M5>28K+B+$FWOV1]$H2<&X47@%VH*=1B1,H_,."02A2BAUS-[@^%9<HRY5*((
M-@J))Y4*II/)YVA*DF5OS2*-,+:;;-E*4$D@ GCI'FCA/E>RF(-G%:K]4FRT
MJ7;E6[JZ;B70L%02.%@"H'_6[(<6R7;!4=K&,$U&6=5+T2GRR2T'2,X6N]S:
M_E=0.X&\2QB3'!I\F6FU)RIZ.I%SZ;_Q>(1Q9M/D)9<QX_.#J4"H'-?2UK]G
M&("QKMUD\ZU2RD-I1=(3IF!S'A?4;M(B^8VXJ#ZSE4?=-Z0-$WL0-==+PKTC
ME"2DNZDN(>:"57TOJ+]G5$V8$Y55+>RRZ:F$)5K>8LDIU MK;??MW1-%!VWR
M-22VJ64A)5:ZW% *2#NT)N./IA_87QL[-S$OT$EIT90HFY2+G72);IE29:EW
MWU77E S $6&;C;T?#'+U984A(6Z6[:A(58]T(F(J\V\QE2[S2VU%:1Q2>'\=
ML5_VFL&J-O!MX G5>;12NOT:166MMSN&ZBI3:0E 405E0(-^ X>GX8=;.-4U
MO#)9<<;1,MI*7"HI'#MTX#X(J%CVGM25>F"TXEQ+BU*NDA5M>L;X;4$$$>QO
M@2?N(8]_*-/ZJU%[<95$2;H22=4"WK,1O5*[T"[H!8@$C6_^Z(SQ3BL)4ZEN
MY0#JKJ/HB%,;8^6RET)44I(Z:Q8:1 E6JK<Q-N)+C;6=>< D D'?QWG=$C[#
MVVL18M$O-3)E:)3Y=RIU6:18<S*-#,HI_P!96B$C^LH=4.RM;87,>UXOS26I
M.GV#,I(MKNW+,)OD; &ZPM<G>;F% 8M9I[TNMJ9S-+ 6E5M%&'WA!ZGXTQG*
MX=KF(?L2B<LJ67S87F=-LK5R0 H@Z$WN;#?:-O:MAD4"I3S6%&I.=I%%0IF<
M>9GVWISGDZN*?:N%HM>UDIR@#MB-9"O//K!*E+ &:YOQXP_J+B93%(4U,**&
ME]-4NK4.D<>PVN8Y\?E_%UO2N7F]%9%GI(U^&\)]0F43;1"T(UL,RDA*3??H
M(A?:1L]?>2?%6RX"JZ&U'1O?O(TL>V*9;9\..4R96XO*#<I4PE>6XL=>WCZX
MA%_.VLWT2>!.Z+#X&G7>4?L4JF ZFKQO&^!*<]6,*3KA"GYFFM KG*62>DL(
M22^RG4IRN)&A%JW%-KQQ!"S@O[;J+^/,?*)CZC6_)/>?C,<V@RC33=$>\H%0
M1L8QA[J&!X@M.<C07($?-I69J9ID_5J:U,+$IXTX%(&@40I20;=T6JY(>,&:
M7@&:D*8E#4XB<4]4'WDZ93HVE/6HA.G5:&YM\Y2DZBIS-$PS..,J:7E>G$@=
M$@:I1V@[S\?"N%4Q'5*PX7)Z??FEWS7<63KUPG9C'%X+P D&%RA8UK.'G0N2
MGW6@-Z";I/H,6$V3\K!JCN)177)F66A-DOMHYU .@W#4:7X&T6SP!RDZ7BR1
M=;IM2EIM*@-&[%Q5@=%).NG=#QF<5U*JR7.<RL2X&5+@ N"#J +ZP@3.)W@C
M+,.\\XE2CJJY"23E! X@:#NXQ&^),5O2\Z[+S24B52D^ZYP%E6NX:)L!U]T0
MIC^L*:;FD-KYPJ%PNP!&^^8<+VMP^*(#G,:SDI,K,H^49@4KM;4=1]!MZ8:D
M_.N3SZEND%9.^-2"""/8WP)/W$,>_E&G]5:BS^V_'#-.Q8:2VLKFA*-NE .X
M*4JQ^"(DKF+FY9A == !U*0K>3NU^&\0IM&VB+9EWE2_E W ;5E*>_CNXQ4?
M'6U&H,U%TOFZ 5+4UG -^!2+G?KJ>J(J<VGO2TXX\AUYQ2]4YE#*>-];\1QB
M;=F.TB>IG)>VJXI* IZ;K-%H)47KKYA2GYAQ-KBURTSK_J]\-?"NUH5284J:
M6&6LN7,7$Z\=4YM-.KC$J81VBM522FI=.6ISC2P)26;?24K2?*6,IWWX7[=8
MZJYM.F9JN..N-N,N)<262ARQ:*+9;'CE(OZ!#U8QI,8UQ1.5BK3$NU/U%TS4
MU,H(2,QT4H"YWE)TZX>N$</8HQ2^W_)G#E4J*7E^YN,,.*8=UMFYPV1IK>YT
MM!,XE%'GIF2G'1-3$LM4NXZR\%ME0)!RJ'E:@FXW\+PJR.-676T*9NA838JS
M$%-M?5\\=B\9%*BIY*N;(OF20 ;[SOWWCF;KJ'I1;?-79-[W.5)'?%:]L6$Y
M>M>/<VWS\QE/,O7"@D=6_?Q],5#Q/0G:5.N(YE0;%\A41JFY%]\//DNXFF,(
M\HG9M4Y=91S=?DV74@GW1EUT-.H-M2%-K6D@;PHB&KM5PVU@W:9B_#[/\U2:
MQ.2"-;]%I]:!K87T3#5@A9P7]MU%_'F/E$Q]1K?DGO/QF,H(@[EO5J8P[R4]
MI=2E5\V_+4LK2NU[>Z(O\%X^>G'SLK,XOJ[TDD-RSLPIU* 19.8W(T[3Z(<6
M'L4S6SK"4V).8<EJO5 !E24J"&@399'WJM3:(^6LK4I2B2HFY)WF,8(((((!
M'?+3CTF\EUAUQEU)N%MJ*5#TB)%I7*0VA4J43*#$<Q-2H5FYJ;"7;G_M$9OA
MAQTSE+S[C83/L+;= (YQBRDDGB4G=Z#&W6=NS-=9<;=<4I9-TJ2D D]MSIP]
M41]5<>3,XN90ITJ;<RD@ZW(%K$]WQ"&2MPK423K&$$$$$>QO@2?N(8]_*-/Z
MJU"SRRMK36"N4#,4]Q2?<Z'*3002,QS+>!(![$_#$25K:;*U8HF/&6RM:BM"
M+ZWR[CW"^^(2VI8\91+S"$+;+JDA(2E6JB1UQ4[&$Q,NU!\) 0T3T3>Q( XG
MC#3*B=Y-HG[8%*JQQL3VT8$ESFJRI"3Q93F+=)]5.<<\8;3UGQ:8><MO/-6&
ML0&5*1H"=-Q$*%'Q'/4.:;F)1]3;C>XW,.6G[5JF',LZEN<9-Q9RX*;G4@W^
M>']AC:2Q/--L<WXOS?2NI>8 [K6L-+VBV_)XY8TWLWV4X[PB_,2\\9J7;=HL
MG/-J?84\MU*)AI0!%D+:4I1U&J21JJ&O7=H.%J_,R3N'L-G#1YM2YR03.+?E
MN=^\4P%ISH3:^A4K>+&PM&O+XP9YMG*&U!9)7;,+@<-.V'%3L2-S,J&U):4I
M9W 6M_ B;=BN%,/XY<G:=-SBV*@IA3DD@6+2W1O2JYWD;NT1$VUO!XP_-3<N
M"R@))2M#B2""+[KC=?U?!%'MKM,$K57WF&$-RQ425)4%9;_$-.';"YR/\-,U
M[;WANJU'W.@844O%-7F!<):DY$&8621J,RD(;%N+B8B;%5=?Q/B2KUF:MXS4
M9MV<=MNSN+4L_"J$J"%G!?VW47\>8^43'U&M^2>\_&8R@BOGA /Z&^UC_8R_
ME$1\[BE$DP*<4M1*CF)XF,8(((((((((-T<A1$&8QQ!!!!!'L;X$G[B&/?RC
M3^JM16_PPU1<IW*IDN;40'L*2[2@#O!=?_RBG=!VI5&ARZ4-E;BVF>::S+)2
MG6Y)&XWTO"%6\85&N3K\P\[D"U9@VCR4]@A&6\MP64HJ';&$.C9AM&K.R?'M
M#Q?0'TR]7I$RF98*TYFUVT4VX+C,VM)4A2>*5*'&)2V];**-4Z.-K6S1H.;.
MJJ\E,[2VSF?PO/+%U2,P-_-%6;F7=RTV'E#6!2+$B &T9H>6T04**2+&XAV4
M':+/4I*DN(;FTDI)2ZVDA5N!-KV],/"F[9*;GRSV&I>80H=+)..LG7?:T/&7
MVTX6:E$*;PV4*1K951<"1KI<VOZ?1"S1.4+A^3=0IW"TD9=65*R9YTJ(ZP.'
M7$Q;.-N& INILS4M6)G#SS"@0W.CGT=H"D $C?O'JB:-JV)<';;J(I&'JHW.
M5*70EIJ<<3S?/K(OS2P;V)U"5'0^2=;1YO;1<-U:I8Y3AN2ILU,U9^8$NS3V
M&BX\X\56#:$)3=2B38 0_P#:9.R/)RV85+9%2IAF;QY75MN8XJ4JL.-R2&U9
MF:.TX#9658#CZDZ%82@$A!BMY43>\<00LX+^VZB_CS'RB8^HUOR3WGXS&4$5
M\\(!_0WVL?[&7\HB/G:.\P00000000000000000")&H6Q2K8GH^"'Z+.253J
M.*ZG,TJ5IS:RAR7>9+5@ZM8"$Y@Z%"Q-A8DB]H=[?(VVAN-NO@4 2;=KS9KT
MJ&2<BG"D*S^4&TEPC@G6/2CP--#G,-;+=IU(J#09GI#%:I68;"PH)<1+-I4,
MPT.H.HT,53\,O_2HI?Y,RORS\4.@@@@A];(MLN(]C5>>J5!>8<8FV3*5&E5!
MH/R-2EE>4Q,LG1Q!]8-BD@@&)7<V4[.>4(X9S975Y7 V+GQF<V?8GG0TPZOB
M*;4'"$+!-@&9@H6-P4OA"..]G&)]F=;=H^*Z!4,/5-LD&6J,NII1[4W%E)W$
M*3<$$:PW2@@V(L8XL;7@CD*(%KFT9)6M&J201Q!C8:G9ID70ZM(TUOU18#8I
MLHVI3<B,6NS<M@; PZ,SB3%[WB=/>;U*D("O=)E1W!+"5*S$;B1$FX]Y3N$)
M.FSM,V43<R,<.ROB+FT:LRXEYV9945!QB5%R94*!RAU1+JTZ%2.-*YA+B'W$
MNY@X%$*"]][ZWCKA9P;0&\4XGI='=J4K1VYZ:;EU3\]GYB7"E 9UY$J58=@)
M[(D6A<F/%F*9[$C%(?I+[5$JC]*<=G*BU*%]QHG,6T.$%0ME)ZLZ084IWDT8
MXV<3-.KE8E:>9.5J<HQ-(DJDS,.RKBG4C*ZA"B4%*R$*ON40(^C9OR3WGXXR
M@BOGA /Z&^UC_8ROE$1\[92;G0^J#*>HP93U&#*>HP93U&#*>HP93U&#*>HP
M93U&#*>HP93U&#*>HP93U&#*>HP93U&#*>HP93U&#*>HP93U&)?V!XLP11ZF
MD[0Z[CJE25+7X[1%X,5+\Y+S:BD.+//:)NE"-4ZW2+Q)>.=INQ=& :Q)X.QK
MMG<K:D<[(RM:5(B16_E#=W>;.:W-E2;IUW"+V>!>J,U5MD.T>>GGW)J<F<4<
MZ\^\K,MQ:I5LJ43Q)))BK7AEQ?E3TJVO_)F5^6?BAV4]1@RGJ,&4]1@RGJ,&
M4]1@RGJ,<I*D\#ZHE[!'*LVBX-H*<.OU1C%F%4IR)P]BV3;JT@@< VV^%%JV
M\<V4ZZPNJVF[#L:)<.)=D=2PE..D*5.X$KRDL@@ 63*SB70 =YLYW6C!6S_8
M!6W2:;M5Q3AU"DDI;Q#A /)0=X!<EIA1-]UPV(Q=V&;)DN*".45ALHOT2O#5
M9!(X7 EB ?28!L8V.2;)<FN4#(3=LQ#-'PG4WG%6&@'/(:2"3UFW;&;4ER;L
M,H2M^?VCXZF4JS<TQ*2=%EUV/DJ4I<PNQZQ8QW(Y45(P4I)V8;*,,8+FV\Q:
MK=30JNU1LG[Y+LS=I"AP4AH$6W[[Q-CO:9BW:=6U5?%N(*GB.HD%*9BI3*GB
MVF_DH!-D)ZDI  X"&U=75\$#BW'3=>91M:YC'*>HQVRK[LF^V\RM33S:@M"T
MZ%*@;@@]A$6EP=C;D^RM E7JQBS;3*U^;29JJBF"G^+KG'0GQA2"KI%*B@:J
MU( O#1VA[1Z%6=H--D\ XHQS5,.5&;EYFI)QBXR'IB;,R%J59GHJ%PE5U:YK
M]D?12WY)[S\9C*"&]C_#V',58.JU)Q=+2<YAN;9YN>8J"@EA;=P;+)( %P.,
M5[')9Y)5PG^26S^YX>--?61R.2QR2CNPEL_/'29:^LCI=Y,?)$9%W,,;/$#=
MTIQD?_\ 6,5<FCD@(!*L-[.D@"]S.L[OSL=*N3IR.4>50=FR>^H,?6QC['CD
M;?@39I[X2_UL8^Q]Y&?X&V9^^,O];!['WD9_@;9G[XR_UL'L?>1G^!MF7OC+
M_6P>Q]Y&?X&V9>^,O];!['WD9_@;9E[XR_UL'L?>1G^!MF7OC+_6P>Q]Y&?X
M&V9>^,O];!['WD9_@;9E[XR_UL'L?>1G^!MF7OC+_6P>Q]Y&?X&V9>^,O];!
M['WD9_@;9E[XR_UL'L?>1G^!MF7OC+_6P>Q]Y&?X&V9>^,O];!['WD9_@;9G
M[Y2_UL'L?>1G^!MF?OE+_6Q-&PG!.RG!-#J,MLHE</RM*=F@Y-HP\^AYLOY
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MI#]$J<Q)3  =964*RJS#0D;_ $1H0001[&^!)^XACW\HT_JK4>B[KB6T$J(
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M)&73+,M*1[E=1)4$CJW$]9,2AM%VQ2DC+NI=G&F1J$E.ENN^H[!ZXK57MN[
MFUI:YJ81J"I*"H#@=^_=\,1U6]I,S4,X0AL%2<N=&9)W[^_MA 5B>=*@4N%
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M$$$$>QO@2?N(8]_*-/ZJU&/+)VNL;/N5J_(/.B5,UA65=:4DBZU)=F+W!W@
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M&ZNX6UM'0_0F$3H3S:0I1"M59E9QJ"=>K6PT^&.Q%!8K:T.NK<#)LM#CW0!
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MA/-$>ZEPJL H[P.))_;&W,R04A332$+*-5*43SBCJ#J8ZES$O($LK;#W$AL
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M7\I1XW)A+F0TA#B4I96LJS-I%\MQ8:GCK;2&I5*&'&RU:[3=@2E&^^_X_5"
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MA)-E'+FN+$=8)MU6TO#.:Q4^GQ=T2J)9EMM2 D(!*@>)&Y/'0>F\,NMXP?\
M&7D_S#:3<J*+E1MIQA@3NTY+3JTN3" X3E3<:'>+_!"IA?:5+Y0/&6M+)N4[
MB2=3_'&)BPMM-E9=;:!--/*L.@D6S'JU^*)BPOCMJ8*5J4E+E@E0$2'2JRS,
M %#B%"_]7^.N''3JH$= A-[9AT876Y]"T#.-%=D)58ERW<I0E:%"_;I#(Q$
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M&^/:-06Y83:I92ZC-+;)RI4<V1 MO)!&AW)M?C$@UW&#--IA3,A >+73*+I
MMO%['=_'&(6Q1M"%3=*6@I(N=2JUM>CT1O'48BRLXQ8E)L.HR%W7I*!R\<IT
MN-]Q<:PB26UB6E)A?22LK< NL^4.M/=O^>)/P5MPE9F8:0Q,*<F+E24K.O\
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,@@@@@@@@@@@@C__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>alts-20241228_g14.jpg
<TEXT>
begin 644 alts-20241228_g14.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #I ;D# 2(  A$! Q$!_\0
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MI7[T4]6:(N7*2EME#16>2$= *VPA'L4>2:7<)MDXO\1I3S;?UXWAU:\8!?\
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M.*W--.G4M>+1K1>;C#EN-?5!^&=V Q.1N'SFM]VU'*^IZO.8,:YH\8[FU7M
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M-%2B4I^45VZ:;BRW5J4GIWBH]+205TZ:6!:2X=V#6>5R=B\?DUM--<,V4M?
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MTI7];]W6LGTY*5#/LHS5CX((-QH5LX97X_\ 8_IJI<%X+4.9]E6OXXKQPNU
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M=;*A*Q"5@=C7^LA_S8W/WM ^EI?9 UE\6-S][0/I:(E*I)!W]D#67Q8W/WM
M^EI?9 UE\6-S][0/I:(E*@ =_9 UE\6-S][0/I:P=?ZR/_-C<S_^;P/I:(M*
M@ <#76L.?^UA<N?_ +VM_P!+2^OK6'Q7W+WK;_I:(]*@+ Y^OO6'Q7W+WM ^
MEI?7WK#XL+E[V@?2T1J5&Y%D#@ZZU>>O#"Y>]H'TM+Z_-8CIPPN?O:W_ $M$
M>E4W860./K[UAW\+[G[VM_TM+Z^]8?%A<_>T#Z6B/2J-PL@<_7WK#XL+E[V@
M?2TOK[UA\6%R][0/I:(U*INPL@<_7YK ?\U]R][6_P"EK'U]ZP^*^Y>]K?\
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8WWVGE  \E;FU*3SZXSFG>O#??7N@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>alts-20241228_g15.jpg
<TEXT>
begin 644 alts-20241228_g15.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !( ;D# 2(  A$! Q$!_\0
M'0 !  (" P$!              8' P@! @4$"?_$ %@0  $# P$$ @T&"04-
M"0    $" P0 !1$&!Q(A,0@3%!<B05%487&1E:/1TA465I/3U!@C)C)&@862
MH20T0D2R)3,U-D524V)S=)3!\$-59')V@Z2T\?_$ !P! 0 " P$! 0
M       !! (#!08'"/_$ #T1  $"! (&!0H%! ,       $  @,$!1&1T086
M(3%24P<2%1=!%$-$46%Q@9*AHA,B5+'P(S,TP7+A\?_:  P# 0 "$0,1 #\
MW^VEZZN^F[XS&@.-H94R%G>;"CDDC_E45&US4PY2(_ZV!7V;:N&J6!_X9/\
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M6.:O0J;*/8'.@M!]RF/;>U*!DR8P_P#8%16[=*6?8;\NV7%:HB$.,LJN#L-
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M<%I25) 2 "..,FISI?3T72>G+9982EJBV^,W&;4X<J4$C&2?">=4*EI-.,A
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M.2G6>5X'+7_>\_HIGS^BM@>U1IOQ#VBO?7':GTUXA[17OIW3U?FLQ.2:SRO
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5B)2E*(E*4HB4I2B)2E*(E*4HB__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>alts-20241228_g16.jpg
<TEXT>
begin 644 alts-20241228_g16.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHK\E/\ @K7_ ,$YOV)OV4/@NNO?"G1?BIX@^,GQ9\80>%?A
M-X9;XX^(T@O/$&H2-MFD1+P!+6W7?/)@! L:H2F\$ 'ZUT5^6/[0'[.?C/\
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M/^&[/VC_ /I&S\2__ RVH ^G**^8_P#ANS]H_P#Z1L_$O_P,MJ/^&[/VC_\
MI&S\2_\ P,MJ /IRBOF/_ANS]H__ *1L_$O_ ,#+:C_ANS]H_P#Z1L_$O_P,
MMJ /IRBOF/\ X;L_:/\ ^D;/Q+_\#+:C_ANS]H__ *1L_$O_ ,#+:@#Z<HKY
MC_X;L_:/_P"D;/Q+_P# RVH_X;L_:/\ ^D;/Q+_\#+:@#Z<HKYC_ .&[/VC_
M /I&S\2__ RVH_X;L_:/_P"D;/Q+_P# RVH ^G**^8_^&[/VC_\ I&S\2_\
MP,MJ/^&[/VC_ /I&S\2__ RVH ^G**^8_P#ANS]H_P#Z1L_$O_P,MJ/^&[/V
MC_\ I&S\2_\ P,MJ /IRBOF/_ANS]H__ *1L_$O_ ,#+:C_ANS]H_P#Z1L_$
MO_P,MJ /IRBOF/\ X;L_:/\ ^D;/Q+_\#+:C_ANS]H__ *1L_$O_ ,#+:@#Z
M<HKYC_X;L_:/_P"D;/Q+_P# RVH_X;L_:/\ ^D;/Q+_\#+:@#Z<HKYC_ .&[
M/VC_ /I&S\2__ RVH_X;L_:/_P"D;/Q+_P# RVH ^G**^8_^&[/VC_\ I&S\
M2_\ P,MJ/^&[/VC_ /I&S\2__ RVH ^G**^8_P#ANS]H_P#Z1L_$O_P,MJ/^
M&[/VC_\ I&S\2_\ P,MJ /IRBOF/_ANS]H__ *1L_$O_ ,#+:C_ANS]H_P#Z
M1L_$O_P,MJ /IRBOF/\ X;L_:/\ ^D;/Q+_\#+:C_ANS]H__ *1L_$O_ ,#+
M:@#Z<HKYC_X;L_:/_P"D;/Q+_P# RVH_X;L_:/\ ^D;/Q+_\#+:@#Z<HKYC_
M .&[/VC_ /I&S\2__ RVH_X;L_:/_P"D;/Q+_P# RVH ^G**^8_^&[/VC_\
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MQ+_\#+:@#Z<HKYC_ .&[/VC_ /I&S\2__ RVH_X;L_:/_P"D;/Q+_P# RVH
M^G**^8_^&[/VC_\ I&S\2_\ P,MJ/^&[/VC_ /I&S\2__ RVH ^G**^8_P#A
MNS]H_P#Z1L_$O_P,MJ/^&[/VC_\ I&S\2_\ P,MJ /IRBOF/_ANS]H__ *1L
M_$O_ ,#+:C_ANS]H_P#Z1L_$O_P,MJ /IRBOF/\ X;L_:/\ ^D;/Q+_\#+:C
M_ANS]H__ *1L_$O_ ,#+:@#Z<HKYC_X;L_:/_P"D;/Q+_P# RVKJOV:?VS-4
M^/7Q5\0?!SQ?\ O$/@37/#^D0:C<6FO7,3L\4SE4P$Z9QF@#W*BBB@ HHHH
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M,O\ P2F_Y-WUO_L>[_\ ]%6]?35 !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?-/P
MO_Y2G_%+_LFFB?\ HUZ^EJ^:?A?_ ,I3_BE_V331/_1KT ?2U%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\R_\ !*;_ )-W
MUO\ ['N__P#15O7TU7S+_P $IO\ DW?6_P#L>[__ -%6]?35 !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %?-/PO\ ^4I_Q2_[)IHG_HUZ^EJ^:?A?_P I3_BE_P!D
MTT3_ -&O0!]+4444 %%%% !1110 4444 %%%% !1110 5^#WA3]I_P#X)F_M
MI:)\0_VM/^"FOQM^*/B'Q-XD\5ZVO@^Q^'__  DD]G\'/"UK?3V.GW#KI -O
M97#M:M=/+.&>7*-Y>QF,G[PU^2?_  3V_:+^ O\ P11^$?Q3_8%_:_\ A)XP
MTKQ)8?$K7]7\&KHGPYU#58?B?I5[(&LI+*:U@DAFN&B\NV>&5U\LHJL0%?8
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M,?#'_0:@_P"^J^<O^"5-E92?L\:T7M(FQXZOP,Q@X'E6_%?3/]G:?_SXP_\
M?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C
M#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\
MSXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V
M=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_
M 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#S
MXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_
M ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V
M=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:
M@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_
MT&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ
M_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A
M,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@
M_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#
M'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?
M#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X
M3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?
MH4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SX
MP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_
M //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=
MI_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?
MH4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\
M^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I
M_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]
MG:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^
MJN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#
M'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3
M'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X
M3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_O
MJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'
M_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\
MA,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/
M_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0
M!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP
M_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:
M?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_
M9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H
M4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP
M_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9
MVG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN
M?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_O
MJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@
M_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\
MA,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[Z
MH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[
MZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!
MJ#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A
M,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !7S3\+_ /E*?\4O^R::)_Z->OI:OFGX7_\ *4_XI?\
M9--$_P#1KT ?2U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110!\R_\$IO^3=];_P"Q[O\ _P!%6]?35?,O_!*;_DW?6_\ L>[_
M /\ 15O7TU0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+?\ "#Z1_P _-[_X%M7S[_P2F_Y-WUO_ +'N_P#_ $5;U]-4 8__  @^D?\
M/S>_^!;4?\(/I'_/S>_^!;5L44 8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@
M6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\
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M #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\
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M(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH **** "BBB@ HHHH **** "OFGX7_\ *4_XI?\ 9--$_P#1KU]+5\T_"_\
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M#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M0!L45C_\(/I'_/S>_P#@6U'_  @^D?\
M/S>_^!;4 ;%%8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;4 ;%%8__"#Z1_S\
MWO\ X%M1_P (/I'_ #\WO_@6U &Q16/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\
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MZ1_S\WO_ (%M0!L45C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;4 ;%%8_\
MP@^D?\_-[_X%M1_P@^D?\_-[_P"!;4 ;%%8__"#Z1_S\WO\ X%M1_P (/I'_
M #\WO_@6U &Q16/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U &Q16/_P@^D?\
M_-[_ .!;4?\ "#Z1_P _-[_X%M0!L45C_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_
M (%M0!L45C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;4 ;%%8_\ P@^D?\_-
M[_X%M1_P@^D?\_-[_P"!;4 ;%%8__"#Z1_S\WO\ X%M1_P (/I'_ #\WO_@6
MU &Q16/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U &Q16/_P@^D?\_-[_ .!;
M4?\ "#Z1_P _-[_X%M0!L45C_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M0!L4
M5C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;4 ;%%8_\ P@^D?\_-[_X%M1_P
M@^D?\_-[_P"!;4 ;%%8__"#Z1_S\WO\ X%M1_P (/I'_ #\WO_@6U &Q16/_
M ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U &Q16/_P@^D?\_-[_ .!;4?\ "#Z1
M_P _-[_X%M0!L45C_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M0!L45C_\(/I'
M_/S>_P#@6U'_  @^D?\ /S>_^!;4 ;%%8_\ P@^D?\_-[_X%M1_P@^D?\_-[
M_P"!;4 ;%%8__"#Z1_S\WO\ X%M1_P (/I'_ #\WO_@6U &Q16/_ ,(/I'_/
MS>_^!;4?\(/I'_/S>_\ @6U &Q16/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X
M%M0!L45C_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M0!L45C_\(/I'_/S>_P#@
M6U'_  @^D?\ /S>_^!;4 ;%%8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;4 ;
M%%8__"#Z1_S\WO\ X%M1_P (/I'_ #\WO_@6U &Q16/_ ,(/I'_/S>_^!;4?
M\(/I'_/S>_\ @6U &Q16/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M0!L45C
M_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M0!L5\T_"_P#Y2G_%+_LFFB?^C7KW
M[_A!](_Y^;W_ ,"VKYZ^#^GPZ9_P5$^*%G;O(RK\-=%(,CECS*YZF@#Z=HHH
MH **** "BBB@ HHHH *_+'_@KI_P5<_X*'^"/VAOB-^R=_P3(\ ^#X9_@C\(
M9OB'\8O'OC5/-^PV:V[7*6EG 3L>5H%5@65][2;<1B-G;]*_BW\7OA?\!?AW
MJ?Q<^-'C[2O"_AC18DEU;7M;O%M[6T1I%C5I)'("@NZJ,]V K\9/^"MGA;_@
MFK^VW\8-6_:A_8X_X+K_  O^#_CWQ9X"F\%_$:S?Q?!-I?B_19(VC,%R(Y0R
M'RV\LDK(K+''A49-Y /J;]BC_@J?^U?XH_;D^%?[)7[4GPXT9_#7QJ_9UT+Q
MQ\-_&VE;8[F[U-=&M;G5XKB)&VI&9FN2@V(4V(!O60>7^C%?CK_P0C_9<_95
M\&_M6:7\6OB9_P %A/!?[2OQET#X<CPI\.?#'AC78Y+7PMH-O&BNMM&9"[[8
MUV9"1JJR2EE=I-Z_L50 5ROQL^"/PG_:.^%NK_!/XY>!;'Q+X4U^%(M8T/4D
M+07:)(LJJX!!(#HC=>JBNJHH Y'XR? 3X+_M#?"K4?@=\<?ACHWBKPCJMNL%
M_P"'];LEGMI40@H=K=&5E5E<8964,I! -<9^R=^P!^QO^PU::M;?LI_ #1/!
MTFO/&VM7UGYL]W?",$1I+<W#R3.B9.U"^U<G &37L-% '%^+_P!GSX3^/?C/
MX/\ C_XO\-O?>)_ -KJ,/A&[EOIO*TXWT:17,JP!Q$TS1((Q*REU1Y%4J)'#
M>>_M'?\ !-']B/\ :T^)-M\6OC]\#XM<UV'3X=/NYX]<O[.'5;*&8SQ6FH6]
MK/'#J4"2DNL-TDJ DX&"0?=J* &PPPV\*6]O$L<:*%1$7 4#@  =!3J** "B
MBB@#YE_X)3?\F[ZW_P!CW?\ _HJWKZ:KYE_X)3?\F[ZW_P!CW?\ _HJWKZ:H
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5O7TU0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[OP5XK^S?!?X40KX+2UBL8''B7Q@&2?4K@3M&9DBL(S#9A$94>>2ZW;C$FT
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M?_$T?\-M_LH?]%ST/_OZW_Q-'UG#?SK[T'^K^??] E7_ ,%S_P CU.BO+/\
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M/^BYZ'_W];_XFC_AMO\ 90_Z+GH?_?UO_B:Z/K.&_G7WH\'_ %?S[_H$J_\
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M]7\^_P"@2K_X+G_D>IT5Y9_PVW^RA_T7/0_^_K?_ !-'_#;?[*'_ $7/0_\
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MZ:_BCPQ8:N^G2MEK4W-O',8B2!DKOV]!TKIZ;###;PI;V\2QQHH5$1<!0.
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M)_\ B:^C:*/J&"_Y]K[@_P!=.+?^@ZK_ .!L^<O^'6?[*?\ SX:__P"#D_\
MQ-'_  ZS_93_ .?#7_\ P<G_ .)KZ-HH^H8+_GVON#_73BW_ *#JO_@;/G+_
M (=9_LI_\^&O_P#@Y/\ \31_PZS_ &4_^?#7_P#P<G_XFOHVBCZA@O\ GVON
M#_73BW_H.J_^!L^<O^'6?[*?_/AK_P#X.3_\31_PZS_93_Y\-?\ _!R?_B:^
MC:*/J&"_Y]K[@_UTXM_Z#JO_ (&SX9^,/[ GPV^"_P 0;?Q2_P -_%7BGX?W
MEF([Z+0+HRZCI%R#_K=@&9H6'7NISR, -1\#?L2?"GX[?$O3A\-OACXQ\/\
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MU]&T4?4,%_S[7W!_KIQ;_P!!U7_P-GSE_P .L_V4_P#GPU__ ,')_P#B:/\
MAUG^RG_SX:__ .#D_P#Q-?1M%'U#!?\ /M?<'^NG%O\ T'5?_ V?.7_#K/\
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M8RE9)*RU;NWU;>K=V?.7_#K/]E/_ )\-?_\ !R?_ (FC_AUG^RG_ ,^&O_\
M@Y/_ ,37T;15_4,%_P ^U]QR_P"NG%O_ $'5?_ V?.7_  ZS_93_ .?#7_\
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MPU__ ,')_P#B:/\ AUG^RG_SX:__ .#D_P#Q-?1M%'U#!?\ /M?<'^NG%O\
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M &GK/]HCQ=_P4_\ B;\5;.UT>\L6\(^*89Q:2-.@43$O?3#<F,CY._45^B5
M!1110 4444 %%%% !1110 4444 ?,O\ P2F_Y-WUO_L>[_\ ]%6]?35?,O\
MP2F_Y-WUO_L>[_\ ]%6]?35 !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?-/PO_Y2
MG_%+_LFFB?\ HUZ^EJ^:?A?_ ,I3_BE_V331/_1KT ?2U%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\R_\ !*;_ )-WUO\
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M #ZZS_X,_P#[&C_AWY^SW_SZZS_X,_\ [&CFQ_:/XA[;C/\ Y]4?_ IG7?\
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M #ZZS_X,_P#[&C_AWY^SW_SZZS_X,_\ [&CFQ_:/XA[;C/\ Y]4?_ IG7?\
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M?X5R/_#OS]GO_GUUG_P9_P#V-'_#OS]GO_GUUG_P9_\ V-'-C^T?Q#VW&?\
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MXW^%'_#57[.__16=)_[^-_A7(_\ #OS]GO\ Y]=9_P#!G_\ 8T?\._/V>_\
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MB@ HHHH ^9?^"4W_ ";OK?\ V/=__P"BK>OIJOF7_@E-_P F[ZW_ -CW?_\
MHJWKZ:H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ KYI^%_P#RE/\ BE_V331/_1KU
M]+5\T_"__E*?\4O^R::)_P"C7H ^EJ*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#YE_X)3?\F[ZW_P!CW?\ _HJWKZ:KYE_X
M)3?\F[ZW_P!CW?\ _HJWKZ:H **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KYI^%_\
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MY1\Z:2V26ZD;S%$49@^5S,-H![#1110 4444 ?,O_!*;_DW?6_\ L>[_ /\
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MPG_/R/WH/9U.S+=%5/[?T+_H-6G_ ($K_C1_;^A?]!JT_P# E?\ &CZWA/\
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M?T+_ *#5I_X$K_C1_;^A?]!JT_\  E?\:/K>$_Y^1^]![.IV9;HJI_;^A?\
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MVYFO_/U_<O\ (\F_X9ED_P"AH7_OS1_PS+)_T-"_]^:]9HH_XAGP-_T!1_\
M I__ "0?VYFO_/U_<O\ (\F_X9ED_P"AH7_OS1_PS+)_T-"_]^:]9HH_XAGP
M-_T!1_\  I__ "0?VYFO_/U_<O\ (\F_X9ED_P"AH7_OS1_PS+)_T-"_]^:]
M9HH_XAGP-_T!1_\  I__ "0?VYFO_/U_<O\ (\F_X9ED_P"AH7_OS1_PS+)_
MT-"_]^:]9HH_XAGP-_T!1_\  I__ "0?VYFO_/U_<O\ (\F_X9ED_P"AH7_O
MS1_PS+)_T-"_]^:]9HH_XAGP-_T!1_\  I__ "0?VYFO_/U_<O\ (\F_X9ED
M_P"AH7_OS1_PS+)_T-"_]^:]9HH_XAGP-_T!1_\  I__ "0?VYFO_/U_<O\
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M(9\#?] 4?_ I_P#R0?VYFO\ S]?W+_(\F_X9ED_Z&A?^_-'_  S+)_T-"_\
M?FO6:*/^(9\#?] 4?_ I_P#R0?VYFO\ S]?W+_(\F_X9ED_Z&A?^_-'_  S+
M)_T-"_\ ?FO6:*/^(9\#?] 4?_ I_P#R0?VYFO\ S]?W+_(\F_X9ED_Z&A?^
M_-'_  S+)_T-"_\ ?FO6:*/^(9\#?] 4?_ I_P#R0?VYFO\ S]?W+_(\F_X9
MED_Z&A?^_-'_  S+)_T-"_\ ?FO6:*/^(9\#?] 4?_ I_P#R0?VYFO\ S]?W
M+_(\F_X9ED_Z&A?^_-'_  S+)_T-"_\ ?FO6:*/^(9\#?] 4?_ I_P#R0?VY
MFO\ S]?W+_(\F_X9ED_Z&A?^_-'_  S+)_T-"_\ ?FO6:*/^(9\#?] 4?_ I
M_P#R0?VYFO\ S]?W+_(\F_X9ED_Z&A?^_-(?V9G R?%"@#J3#7K5<Q\;/%\O
MP]^#7B[Q]#IT=X^A^&+_ %!+29RJ3F&WDD",1R VW!(YYI2\,^!^5\N"C?\
MQ3_^2!9YFM]:K^Y?Y'E_@WX6:=KLDVJCQ9:PV]O>E+4SE<W 0\O@GA2>GXUV
M7P\N/$6F:C>?#JS\0V;+8#SK%RGF"2!CG@@_PDX.?6OSI_9B_:^_X+3_ +77
MP!\+?M*_!S_@F-\ )O"_C'2UU#19=0^*%U!,T)9E!>,H2ARIXKT7]E;]MO\
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M?VX_^C__ /R;U/\ ^.5^KE% 'Y1_\.&?VX_^C_\ _P F]3_^.4?\.&?VX_\
MH_\ _P#)O4__ (Y7ZN44 ?E'_P .&?VX_P#H_P#_ /)O4_\ XY1_PX9_;C_Z
M/_\ _)O4_P#XY7ZN44 ?E'_PX9_;C_Z/_P#_ ";U/_XY1_PX9_;C_P"C_P#_
M ,F]3_\ CE?JY10!^4?_  X9_;C_ .C_ /\ \F]3_P#CE'_#AG]N/_H__P#\
MF]3_ /CE?JY10!^4?_#AG]N/_H__ /\ )O4__CE'_#AG]N/_ */_ /\ R;U/
M_P".5^KE% 'Y1_\ #AG]N/\ Z/\ _P#R;U/_ ..4?\.&?VX_^C__ /R;U/\
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M_P#Y-ZG_ /'*_5RB@#\H_P#APS^W'_T?_P#^3>I__'*/^'#/[<?_ $?_ /\
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M ";U/_XY7ZN44 ?E'_PX9_;C_P"C_P#_ ,F]3_\ CE'_  X9_;C_ .C_ /\
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M (Y1_P .&?VX_P#H_P#_ /)O4_\ XY7ZN44 ?E'_ ,.&?VX_^C__ /R;U/\
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M0-$_\&L/_P 57R[_ ,.AOAQ_T5_6_P#P!AH_X=#?#C_HK^M_^ ,-<OU7)_\
MH(?_ ( SK^M9W_T#K_P-'U%_PLOX<?\ 10-$_P#!K#_\51_PLOX<?]% T3_P
M:P__ !5?+O\ PZ&^''_17];_ / &&C_AT-\./^BOZW_X PT?5<G_ .@A_P#@
M##ZUG?\ T#K_ ,#1]1?\++^''_10-$_\&L/_ ,51_P ++^''_10-$_\ !K#_
M /%5\N_\.AOAQ_T5_6__  !AH_X=#?#C_HK^M_\ @##1]5R?_H(?_@##ZUG?
M_0.O_ T?47_"R_AQ_P!% T3_ ,&L/_Q5'_"R_AQ_T4#1/_!K#_\ %5\N_P##
MH;X<?]%?UO\ \ 8:/^'0WPX_Z*_K?_@##1]5R?\ Z"'_ . ,/K6=_P#0.O\
MP-'U%_PLOX<?]% T3_P:P_\ Q5'_  LOX<?]% T3_P &L/\ \57R[_PZ&^''
M_17];_\  &&C_AT-\./^BOZW_P" ,-'U7)_^@A_^ ,/K6=_] Z_\#1]1?\++
M^''_ $4#1/\ P:P__%4?\++^''_10-$_\&L/_P 57R[_ ,.AOAQ_T5_6_P#P
M!AH_X=#?#C_HK^M_^ ,-'U7)_P#H(?\ X P^M9W_ - Z_P# T?47_"R_AQ_T
M4#1/_!K#_P#%4?\ "R_AQ_T4#1/_  :P_P#Q5?+O_#H;X<?]%?UO_P  8:/^
M'0WPX_Z*_K?_ ( PT?5<G_Z"'_X P^M9W_T#K_P-'U%_PLOX<?\ 10-$_P#!
MK#_\51_PLOX<?]% T3_P:P__ !5?+O\ PZ&^''_17];_ / &&C_AT-\./^BO
MZW_X PT?5<G_ .@A_P#@##ZUG?\ T#K_ ,#1]1?\++^''_10-$_\&L/_ ,51
M_P ++^''_10-$_\ !K#_ /%5\N_\.AOAQ_T5_6__  !AH_X=#?#C_HK^M_\
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M_P"#6'_XJOEW_AT-\./^BOZW_P" ,-'_  Z&^''_ $5_6_\ P!AKS_JN3_\
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M%E_#C_HH&B?^#6'_ .*H_P"%E_#C_HH&B?\ @UA_^*KY=_X=#?#C_HK^M_\
M@##1_P .AOAQ_P!%?UO_ , 8:/JN3_\ 00__  !A]:SO_H'7_@:/J+_A9?PX
M_P"B@:)_X-8?_BJ/^%E_#C_HH&B?^#6'_P"*KY=_X=#?#C_HK^M_^ ,-'_#H
M;X<?]%?UO_P!AH^JY/\ ]!#_ / &'UK._P#H'7_@:/J+_A9?PX_Z*!HG_@UA
M_P#BJ/\ A9?PX_Z*!HG_ (-8?_BJ^7?^'0WPX_Z*_K?_ ( PT?\ #H;X<?\
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M%E_#C_HH&B?^#6'_ .*H_P"%E_#C_HH&B?\ @UA_^*KY=_X=#?#C_HK^M_\
M@##1_P .AOAQ_P!%?UO_ , 8:/JN3_\ 00__  !A]:SO_H'7_@:/J+_A9?PX
M_P"B@:)_X-8?_BJ/^%E_#C_HH&B?^#6'_P"*KY=_X=#?#C_HK^M_^ ,-'_#H
M;X<?]%?UO_P!AH^JY/\ ]!#_ / &'UK._P#H'7_@:/J+_A9?PX_Z*!HG_@UA
M_P#BJ/\ A9?PX_Z*!HG_ (-8?_BJ^7?^'0WPX_Z*_K?_ ( PT?\ #H;X<?\
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M@84/8JI//<B@#[JHKXLT#X7?\%HO$6A67B"S_:]^&Z0WUI'<1++X>C#!74,
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M/&OP_P#!/Q'TN+1/'GA>RU:TANX[F*WOH ZI*ARK 'OV/J"0<@D'75550J@
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M 4444 %%%% !7D'@WP+XNL/VT_&GQ O-!GCT74/!^G6MEJ+ >7+-&[%T'/4
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MS%\%_$O[0'QJ\40Z-X6\):3+J.M:C-SLB0?=5>KR.Q5$0?,[NJJ"6 K\S/\
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M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7XE?M7_%G]D'X]?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[&>EZM<>,M;7XSWO[3-AJ\WB^T)2023V'V,D[4G-P8A&CS?:E. Q,0K]P/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KYQ_8X_P"2N>-/^!?^E#5]'5\X_L<?\E<\:?\
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M5JWQ$^']O%/XP\+6PE\_3HY!&59F9 CX\V,-L9MC.%;:>* /4**** "BBB@
MHHHH **** "BBB@ HHKA_P!H?]I+X(_LH?#27XP_M">/K?PUX;AU"UL9=5NK
M>:5%N+F988$VPH[9>1U4'&!GD@<T =Q15;6M8TWP]H]WK^LW0@L[&VDN+N=@
M2(XD4LS$#). ">*\RTK]N3]DG5_V5H?VW8OCSH-M\*+C3VOH?&^IS-9V;0"8
MP[OWZHX)E4QJI7<S$*H)(! /5J*^4_@!_P %O_\ @E?^T]\4M-^"WP<_:]TB
M[\3:W*(M"TW6-$U+2/[4D)PJ6LFH6T,=RS'A5B9BQX4$U]64 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX5>"]1^(GQ$\16^DZ)I-N9]2U*[)$=O&" 68@'C)%>*_\/6/^"=O_1VOA/\
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MO2OIOX?_ /!1?]B#XJ^--.^'?P[_ &D_#FK:WJUP(--TVTG<R7$A!(505'.
M:^!?^"2?_!#S]C_XI_\ !-SX/_$/XV^!O%]CXLU;PC'/KMI+J\UHT4YDD!!A
M9 8^ .#7UG\%/^"+O[$'P ^*VA_&7X=Z%XCBUOP]?"[TV2[\0O+&L@! W(5^
M88)XH ^L:_!3]I;X@?!;]O)/VOO^"A5E^U%X"T'XC?#SQII-E^RW8ZOXQL8+
M^"'P;*UX]S;0R2K(RZC<S78C&!DOZ=?V6_;CTW]HO7/V0OB)X<_9'L;2;XE:
MKX6NM/\ !SWVHK:16UY<+Y*W)E;A3"':8>IB [UX]^R#_P $9OV!OV?/V7/
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MEXF^"WPY^%9T/X8^%_$$-OJ<5_KE_.DVH:E-:3(R(4BC2W7<.=B.,8S7,?\
M!0G_ ()*:%&GPK_:1_X)?_LX?#3P1\7?A%\4-/\ $%G%H6B66@1:_I1#0ZAI
MMQ-;PKE)87ZMG 5U&"YKH/<.4^+/PZ_;S_X)W_\ !2GXR_MX?!']B2/]HGP-
M\;-/T$:D?#OB.VLO%/@\Z;9BU:VABN5/VRUE*B010D'=MW8V OUG_!-?]H#]
M@+]J;]O'XH?'/X4_#3XD?";]H&_\&6-E\5/A-\1]!;1+R:S@G'D:H]G\R7$@
M9UA^TK(6".@95\Q2T7B[X,_\%8/V'?VL/B3\:/V+O OAGX\?"[XM:W'X@O\
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ML%_M+_%WPEH/PN^$_@'5O&_Q(M?%?B2UL+;5M7U*UDTO3-/!N'7,T5O<W%V
M,_)*,]A7Z:Z/I=IH>D6NB6 806=LD$(9LD(BA1D]S@"OAG]A3_@E%X:U/6/B
M]^TO_P %,?V;?AMXU^*/Q:^*E_KBP^(=#L=>30-#C6.VTS389KB)P!'!&,[,
M9W*#G97JJ]M3\WGR\SY=NA4_X-X/VDXOB-^QUK7[(OB#XCZ;XH\2_LW>,;SP
M#<ZYI>H1W,&KZ/;R-_9&H121LRM#): 1(03G[*W2H/\ @V-_Y1&>%/\ L>/%
MO_I^O:Z'X>?\$X_%O[(O_!7"Q_:?_8T^%WA'PU\&/B'\,7\/?%OPIH$5OI<5
MCJMG*\VGZG;V<**DC,&^SL%QM#RN<EJZ_P#X(H_L@_&;]AC]@#0?V=OCW9:?
M;^)=/\3:_?7,6EWXN81%=ZI<W,)$@ !)CE3(['(IDGUC7@?[?'_(HZ!_V$I?
M_1=>^5X'^WQ_R*.@?]A*7_T70![7X._Y%'2O^P;!_P"BUK1K.\'?\BCI7_8-
M@_\ 1:UHT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %?./[''_)7/&G_  +_ -*&KZ.KYQO/V+/'_P#;M]K&
MC_$VVL_MES)(1"DJ'#,6 )4C.,T ?1U%?./_  QQ\7/^BT?^1+C_ .*H_P"&
M./BY_P!%H_\ (EQ_\50!]'45\X_\,<?%S_HM'_D2X_\ BJ/^&./BY_T6C_R)
M<?\ Q5 'T=17SC_PQQ\7/^BT?^1+C_XJC_ACCXN?]%H_\B7'_P 50!]'45\X
M_P##''Q<_P"BT?\ D2X_^*H_X8X^+G_1:/\ R)<?_%4 ?1U%?./_  QQ\7/^
MBT?^1+C_ .*H_P"&./BY_P!%H_\ (EQ_\50!]'45\X_\,<?%S_HM'_D2X_\
MBJ/^&./BY_T6C_R)<?\ Q5 'T=17SC_PQQ\7/^BT?^1+C_XJC_ACCXN?]%H_
M\B7'_P 50!]'45\X_P##''Q<_P"BT?\ D2X_^*H_X8X^+G_1:/\ R)<?_%4
M?1U%?./_  QQ\7/^BT?^1+C_ .*H_P"&./BY_P!%H_\ (EQ_\50!]'45\X_\
M,<?%S_HM'_D2X_\ BJ/^&./BY_T6C_R)<?\ Q5 'T=17SC_PQQ\7/^BT?^1+
MC_XJC_ACCXN?]%H_\B7'_P 50!]'45\X_P##''Q<_P"BT?\ D2X_^*H_X8X^
M+G_1:/\ R)<?_%4 ?1U%?./_  QQ\7/^BT?^1+C_ .*H_P"&./BY_P!%H_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
144 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>alts-20241228_g17.jpg
<TEXT>
begin 644 alts-20241228_g17.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $  8X# 2(  A$! Q$!_\0
M&P !  ,! 0$!              0%!@," 0?_Q !6$  ! P,! P<&" <,"00#
M   !  (#! 41!A(A,1,4%19!4=$B559ADY0R5'&!D9+2TR,S-4)24Z$'%R0E
M<G1U@I6BL;,T-C=E@Z.RP?!#1$5&8J3A_\0 %0$! 0
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MOI'U?XX$-8P9()#?A8#B!V[)[E[K:*:X5CZJIT?5/D>S9=BX1!IW%H. _&T
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MI$])5U$E.^32M>3!"8!_&;/+C.,M?Y?E@XWYR@\,?9'QAXUI<<'<,UK0>!/
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MU<],R1RZ6M3XGM>PTD0VFG(W, 5'<X+U>+95VRMGT])3U,3HY6%TGP2"._\
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M3M;]_:<8'[/F3F,C9Y)FV6$.:[:R"<N .[&_CC_OWJ-<]":8@M-9+':8&/9
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MJIZE:6]';5[HSP3J5I;T=M7NC/!!;\ZI_P!?%]<+$1N;U5MSMH;/6#.<[O\
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M<6M)P?(X;E<-U!IIN]MWM(^2IC\56:IU%8YM(WB**\VY\CZ*5K6-JF$N)8<
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M3]9US'N' T-/N/=D,QE :TM:\:UK2QSBUKA0P$$C&?S/6KOI_3.R&]+VG &
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M=;U@X8/,8,.SW>0K\ZBTZ]H#[S:W;NVJC/\ W42X7ZRR4^*2\V<2D_"?41$
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7[+0W/<,+TB("(B B(@(B("(B B(@_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>alts-20241228_g2.jpg
<TEXT>
begin 644 alts-20241228_g2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #\ @(# 2(  A$! Q$!_\0
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MI!T*@1"-R?2+[XM*E6'JFVVAUI*,'2%K\1;0Q7C.,S<7)4UV?F42[*U%Q5[
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MOZ&Y^C39@?\ TAH__FOQCQ7;F0EZ7M-5I25;#,LT[A0V#<)%AE&Q^F^HF_\
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M/=%O2:-M)3:DB;E:/-+F4$@!4N'$WS2;IO:+K,YI/4=FLU["8EW8["VIN2J
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MB-K6T AG:?8FM;-NM@L^4LK3BWC#27$ISMF4C_F<<5.,G?S^YZN)BJBA-/\
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M4B1;<Q $+*3<@$YQ8;-2$T_5PXQ3&)Y: J\F\.B0!G<<;:P\BBRI;0?*W!T
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M+ZRHNZEU9)&2GJR<DMJM\'\C7(^:$I3VJ@'9B=F%;Q!I#EDE*[]!:UV_=VU
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MV %[L]9/O"%K;-D])/FC[0[89S[86L&R?X1_6 #=GK)]X0;L]9/O"$9]L&<
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M3#C*@C3(W]7'MAE^H34XM9F)EU]10&2IQ6(E S"2>5X6[5I]]@R[L_-.,%.
MMK?44E/*U[6R$3"$,[HFI6K[-;+S9V5HL].ON,,2RW7FVPZI*;9)(U/>.^*]
MT@LJ(T(RB6U/3*'2ZB8<0XM(0I:38E.0MZLA$-S)A7J$0E8@OZ<@F19/X8W-
M&I+;TC++5L;.5,%L'?MOJ <.E\AEG&%D%$2;(_#'K>R>Q4O5=GI&=<J-29<<
M18I9F,*1;%H+=D<RVL[T\9JJTE;VF<EJ0DM-J5L?-/-N8DH69A0+BL1T/9I;
MLC*S;)3./I#1EPE9 94JY;S\TGLTCTRF;#RL^AD.SU0L0M64QH02<LLLQ'FU
M2;W-4FV<2EA+ZT8EFZCTB+D\XJ[V-8\N=]64=S)FS\D'UNA5,=J=BBP9648,
MSQ_%I[(F;44U,FS+I&SS]#65&ZWW2K>9:6_YI'-CJ<FJ.S06^^S@+8!87AO=
M1&<6_P H.S[=%E9)3<Y.3)<<4DB9=QVL <LHEIZK97_W5))RC?R9B TKL$*0
MT2L=$*S M?7/2$A1YWAR43OIMEM1(2MP(-M;$B*J[9=+'VOKQW,U**,$A>/9
M&;7A<3<"96 D&W1]N8]L-OTMOR&>4C969;P[RSZIE1#%CU;6-A&@G=DFF%S"
M$5"H86UMI ,Q?(G.^4,S>R[35(J+B9Z>LSO+(+W1-@3F+1>SL9WQG>C[SST-
M&W Y<(@5I!3)*OS$34K)!]0B%65$R2OXA%8[1/ENJ]>4;>3,]!!!'6>:?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>alts-20241228_g3.jpg
<TEXT>
begin 644 alts-20241228_g3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $% 8D# 2(  A$! Q$!_\0
M'@   0,% 0$               0%!P$" P8("0K_Q !D$  ! P,!! 0(!P@)
M#PD)   !  (#! 41!@<2(3$305%A" D4(C)Q@9$5(T)TH;&S,S92<G:2P=$6
M.$-38H*3PM(7)#1497.#A**CLK3#T^$E)BA$8V1UA908&2<U1F:5I/'_Q  <
M 0$  04! 0               0(%!@<(! /_Q  _$0 "  0!"00&!PD! 0
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M)"T=1*Q+%;?_ )':^SR=GU+*@!"$( 0A" $(0@!"$( 0A" $(0@!"$( 0A"
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MX +1;7!IROU5!>:..Z^4U=1TNZZ!S(>DW-PN<'#(]'//J3M-J+5C0##I5KW
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MN!/XY*J1>7-X^>_^2_XJGEK?PW_R06(%Y%RH.92(5K>/GO\ Y,(-<P<Y)/S
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M]U+.P31M?](4@TNT'4E%*X6^[3TSW#H\R2;OF]GG$C"QSZYN3#(^X/HJ]YP
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(YS/FX(=Q_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>alts-20241228_g4.jpg
<TEXT>
begin 644 alts-20241228_g4.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "K 6\# 2(  A$! Q$!_\0
M'0   00# 0$               $%!@<"! @#"?_$ %L0  $"!0(" P8/"0H.
M P    $" P $!081!R$2,1-!LR(W46%ULA05%B,G,C4V<7)S=(&QM @7)"4F
M,T)VTC1%56-E@Y&AP<)&4E-45F2"DI.4HJ/1X4-$8O_$ !8! 0$!
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M0 &\.-MS+4Y0I%;*N-LLH&X(W W&\!K6I=C%T,SJF9:9E'9.8,L^S-(X5H6
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MB?GZ9+34XQ@-O.(RH8.1_0=_%&=-M*E4MYEZ6DFT/L-J9;>4,K2A2N)203N
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MM.OEI_[,8"PH2 <H# 0/33W4O;RTOLT1/8@6F?NK>WEI?9HB>P!!!! $$$$
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M,Q#I?4^R&TK#-R4A S@]',(&_C\<.='ONWJ_.&4IE:D9Z9X2OH9=Y*E\(YG
M@'^"$'*%@$(R(;*E;5)K#S+T]39:<=9W;6^T%E.^>OJSOB'2$@*FUH&+OTL
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M5(ITS9M:#\M+(:<X4H(R!@_I0]??"J(_P,KG^XC]J \-0??G8'E![L%1.TD
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;;@8QB%Y0"<(\$)P)WVYQE! 8\"?!&4$$!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>alts-20241228_g5.jpg
<TEXT>
begin 644 alts-20241228_g5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "I 'X# 2(  A$! Q$!_\0
M'0   @(# 0$!              8%!P$#! (("?_$ $D0  $# P,"! ,#" 8%
M#0    $" P0 !1$&$B$3,0<4(D$R46$5<9$((S9T@9*TT187,U)5<T)#H;'P
M)"8T-6)D<G6"I++!\?_$ !4! 0$                    !_\0 %1$! 0
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)_*O>:H*B@__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>alts-20241228_g6.jpg
<TEXT>
begin 644 alts-20241228_g6.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #] 44# 2(  A$! Q$!_\0
M'@   @(" P$!              @!!P8) @0% PK_Q !K$  ! @4" P,$"0P*
M# H(!P ! @, ! 4&$0<2""$Q$R)!"111=146(S(W.&&SM!<8)#,T0EAQ<G:!
ML38Y0W-T=Y2RP]$9)2A$4F*1EJ'2T]0F*35&4U56A)7!14AD96>%AK6BHZ3$
MU>'C_\0 %@$! 0$                   $"_\0 )1$! 0$  @$$ @(# 0
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M3_T=R%D/[5-*?Q<,?1DP#*:%? M87J&1^81&<Q@VA7P+6%ZAD?F$1G, 1!Y
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M42F)J3;OLBS./%J7*G D!E6X=\$*VCQ,9U=>C4Q=.J-7K[\XTW2:C:;UN+:
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M1UY_[AF/WM7ZC'W2<YCX3P*I1](!42VH #QY& 63R;'Q6:+ZRJ7TI<-'"Y<
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M>TKGGFWE+IC=PT9^:9IJ"3M#+06EM*@/OMI/RPW5AREP25J4UBZ9Z3J=P(:
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MK)7<X\*;*_[C%26%7).N^4)E'Y*Z)NZFDV"\DS4ZPVTML^=([@"&6ACQZ'K
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MOJ+C_H&/I#<:FI-NFLT6@S99JBBIF8>6D2S3"!V;A&$SX1N<!Y9F59,J>XG
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MPD6U-W7:M2K5#EI2S*19M-EI:Y:&[.NMJO=U"^_,M(Y!T.8/,Y]]\L&#P<*
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MFPW+2[*;;D2&VT)"4I!*"3@ #)),-5)2[$G*M2TLTAB7:0&VVFD!*$) P$I
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MA162$8QRQG/..A2-+M7K5M:KV11M)[T-F7=YL_=*INCLJG@^#E[S-0.U*/\
M!W<\=8W*;1Z(,03&F::T)OVNT*2T_J^D^HHTSH#\U/4(RE)EA53,/ 9\X).P
MIR#R3SZ8AHN&'0;4FV>#VW:*[;'FMU2-X>SJ:/59A,JI;"'DG"E85L)"3@$'
M_3#[$1. (EFDZ*SJ)H[J/K9.*KE>I%*MV8IDNB5I=(9J/G1<*YAIQYUUW8D
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32E$DQDP&(F+MOJB,01,$$U__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>alts-20241228_g7.jpg
<TEXT>
begin 644 alts-20241228_g7.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $* 8$# 2(  A$! Q$!_\0
M'@ !  $$ P$!              8!!P@) @0% PK_Q !?$  ! P,# @,#!@4)
M$@L)   ! @,$  41!A(A!S$($T$4(E$)%2,R87$6=8&SM"0W.$)2<Y&RT1<E
M*#,T-39%56)R=)*5H;'2TR9#4U9C=H*#A)3!&"=&5V2%D^'P_\0 ' $!  (#
M 0$!              $'! 4& @,(_\0 0!$  @$# 04#"04&!04       $"
M P01!082(3%!47&Q!Q,4%30U88&1%C)3<J$B)#-2P>%#1&*BT51SDK+P_]H
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M8ZR%H;P!N6$X_;<9/W]QF'WOK]\PIO<R58"NT6V\R+%YS,K+RGVXY>2HME(
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MD\'%""T=SZ[PM;6QV &F;8W,=9?MCTA[>9K2+A[.L;<#8O<TH@ J&"#\:O\
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MQ^J/[VLO,4Q0%GNDNMH6E=#PK9>YL@S&5+"0(TN0L-Y]T..J;^D7CNH  D\
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MEXA"6T)4-OEK3R=QSG/I6-'27QD>(7Q6:Q^:=*:+TX7HC(5*F-SKA"AQ6R2
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M%\Z_WGYU2U$6I:64F+'9V%2DI*CN84<X[$=CQ69#6]1AEQK-9)S@MUX=?"-
M\,U@NMGTCJZ[/1;E)3+>5<H\=U86$[1@A"0!BKM?@]?_ /G4[_Y!G^2I,D<5
M\WVO-:6C) 4DC([C-:FK6J5INI4>9/F^T@PEN_@EZ6:KU?>I#O4ZXKN\RY+<
MD1VG(@VR'W%N;$CR^<DJ  SVP>U57\F]H:>W<8]LU]>53H:@TZ%B,M+#A 4
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M/*CZ5#]1^&^[ZHB1HLZZVEZ+:[E(N$!AV(ZI#X>E!Y;<@!8)2 D) 01SA1[
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;2&@PLEY2DAL*RE"4DX ![8J9TI0D4I2@/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>alts-20241228_g8.jpg
<TEXT>
begin 644 alts-20241228_g8.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" (1 7X# 2(  A$! Q$!_\0
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M6TK("P"<'!^D5B(E.(:<;2LI0YCF![<'M6=<;I<-1SDNS'G9DA0"$E1Y''L
M%8#K2FU%"@4J!(*5#!!KEUZL7/32DW%<9YP:5"2CJ:+HLMR(\AYLX6@\@K /
M?[]7J8ZD<R2M ROB4!7K>6<X]WTUC*.!BK<D>VJ[G)QTYV,K"Y*J&%&J445
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MX\JQBPM*>100/?BKT2GD-+;2XI*%?.2%$ _6/;5VDJ44_6B]UMV__4:VGV/
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MF_E#E)2E7NS^RCK#[L3?Y==)2@"KV_(U954T KK)K=ZP:>>A6](C3'7>:YB
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M)](1Q 7[>/T5U@^!+3QVOW(&<_U;C=__ +-72OJMU33M:M132>=GE9>[P_\
M95@HOZDCI(>P^^/XZ^9WQ#)SOSN0?9]DMS_+':^F)7E]\?QU\T?B$DN?;PW(
M8*STOLFN:N('M]+=KCTU%YU>-C8)?3;-M5;KJJ:&U/AM*8Z5K4DA15@J&//'
M;L??7K:+5;G671,N"V%J4&PVR$G)SYJR1@>W(_T4G2Z2>PXX[=JS[5=%6\2
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M2?N$]^Y3'Y+Z^3SJBI2C[35>I1E1DX5%AK^?8WRIQC34LY;_ )O[F&"../\
M30A7K=^X]];JRVMV07E^C)>PTK"7 H9)[#CCS5[A]%:J4E"7G$H2M* <87YC
MZZ2MZE.FJDEA2X]_<TO&,H]))2)*BPM:T_M5+[*^_@G^.M]=IUZN&E("I<]J
M1;F7"AE@O)4ZV>^<I^</K-)Q#66^7-/SL<<]_K^JLYUJ QS"'7I!Z:2A92$
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M 1BNOCOC6_4-^@LZ.<GLQ+A=+/$::N\9J8_,MY3Z1U&G"D-,JY@(<4HY(PH
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M('62[)7QY+(7D?M4X'D,#%>FI=!6;5LJP2;G&+SUBG)N4 I<4@-/I0I 5A)
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MMRU_*U+IFX:-E.2;<]&2&6GF.82MI9^4\T#YQ.!V\L8 G$*K5$]Q5: ****
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MD D>X (["M7*L,:5JR$S/2FZ)$%]2?36T.<?E6?+U0/]%*ZM%(_7K"^Y[_\
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M2ES@4P?C)O+%FVVM,QZ>]&0W?(I$1A7!V<L(>*64+Z3A0I) >Y #CT<E0 -
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MMA37%U)*BE25#BI1R!Z^/T]+<7PSNEU# 9AWQY4AY9:882B%%477GD_*,,I
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M5\FTSBWJ!?25&\ON6U/3C\VPR.FA,=WT,)$#"H@2%YX!!_2$'O:#Z\GF% 4
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M7B4V]TD&-5N/6'5S6Y^&FM)N36PC;7^UE;64J']M"_40S^D#R\QM]D=Y-O\
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M2^2N([#D0.U 9&C-)QM%646N)(G2VDNN/*D7*6N2^XM:U+4I3BR2<E78>0&
M*WH[4 8KRD2FXC3CKRTMM-I*UK4<!( )))^@#- 7*=" HGL!3$>(3<37$&S7
M!&V:K9>A%:7"N_H"_2KI:)#BT!A\1TJ 6V '0X@E+@!"T9X*2<+?O=>'J-M[
M0&D[S.7J*65MR%626(LB,4LI?0VW(((;DN)(6PD@H=*% ^J%$;;P\;"';J=>
M=67>5Z5J>_N/O20TUT6V4NOEU6$E(<RM6'"AU;O24I:&U<"<@>6P&PTS23[V
MJ-9.L3M9R)<QX+@K=;BMI?4@*<Z!<6@/N(:;YK!).//)45/O5J4A-5)P* "<
M4G-9ZA-JM+S$&XVF#?YB'&+2B[O<&7Y?$EI! (4H%7'(1ZV,X]F<36FYMDT8
MTEF3);?NKZVV(EJ9=3Z1)><Y=%M*2>W,H4 I6$^J>_:HLZ(VXU5XB->WJ?K"
M9=;/IZS7YUY%L=(ELA\L]-;<&0^SR#/=84.FVXTYW;<PH!(&9I?;S7OB.U_=
M9>Y<5VRZ;MR[A;'K*D.PYC!=990MAF2VLA^,M'/DM("7$J;4<+0$HF)&;2RP
MAM "4I& ![!0VT D>]/85Z 8% 5HHHH HHHH HHJA/>@*UK+_>OB*TS)WHK\
MP1F5/%B,D*<<"020D$C)P#V]OL[UH=S=SK-MCIU5RN\V+&<=46(3$J0&!,D\
M%*0PE9[!:N) SVJ.FU.MYWBEN'Q_:+VO2NIK$HF!J;3R%/VZYVUY1ZD65&=4
M0W(:6"%-+45MN(0ZA2FW"E0&IN4J]^+_ '&BR['.CHT58+BP_;)<=#77@O()
M5Z>EXMJ6B0I*VULI3S94EMQJ0A"SD2ST)HNW[?:3MFG;4%B! :#39<5R6KN2
MI2C[RHE7; &<  5[:5TO%TK9(MMCK=D)9&5R9*@MY]P]UNN* '):U$J4<#)/
MD*W- %6.*X@?2<55:N*2?.HZ;Y>)AO3^HXVB-/,HDW*5)8CS+@%=8,L.K<9=
M]&0VL%^4RH(4N-E+@0OJ!*@DX MWWW0UK/T[.D;:.Q)MF8EKL5Y>:CR572TS
MNLVD*Z*2DJ:XJPLIPM*7$.()3DTM-D-G9.B8J[O?Y[\_4TMR8X^$/.(B->D2
MNNX6XW46VTXXH(4YP44E840<*.;-D?#];MJ7YUSRTN\RT>CER&_)Z*&,-GIA
M+KJRH=1+CB2>Z.LI"<)\W= P*  ,"J<O/Z*KFF]W8W@L6V^G[HX_,$F]HC/*
M@V:$0[.F/I96ZEIED E3A2@J P?5258(2< *+6-SFP[)+9L\NV1M02&UMVM-
MW6H1W)/ E"5I20M2<CN$>MC./*HW:7T)KK?K6UUF:_;DZ?LL%Z3;Y-HB/O,.
MQW516FW$1Y25CJ,N)45\D(2E25IS\J@I1HK!L'KS=K>2)K6[ZUFMZ.8D"X0'
M(5R1+9G1W TZR8O)"@P"6SU,<5-JY=)9;=PF9;;24A) Q@8&/=[J \X,-N#%
M9CLIX,LH2VA.2<) P!D]SV%9%%8TR:U!:ZCRTMH*DH"EJ"1R4H)2,GVDD >\
MD =Z ODO(8:6MQQ+:$)*E*6< #WD^ZHO;Z:AW.UW>[?IW19MDK1M\4I,2_V]
M G1I'%I77AS,.!+8)2OBOUFUA10H!:4A:?WPW*OV\.NK-I70T:XO6;K28:KO
M F."%<5<G(LR/*92 5QVEI"'%(6'&^8<;Y<2E4A-C-I6-F]OX>FV;I(N_36M
MYR5(:9:*G%X*\):0A."H$Y(Y**E*42230%NRNS5MVBTPW#BEQVXR(\5,Y]4I
MYYLK982TE#(<42VTA*>*$#R3C.3DTX@&!B@# P*K0!1110!1110!5JC@4*\O
M]5('=O=RW[6:7=N+L65>9ZUKCQ+7;65OOOOAEQ[CQ0"I*0AM2U*P>*03@]@0
M//>'>&S[56%<BX<Y<]]MTQ+='<"'GPCB'%\O[6VV%I4MT^J@')]@I ;'H&\M
MBBW?4UI%P8M$E]FUW:8ZS(=D()6S(CNJ;'3D-I4CLZG*'@EMS 6DTA-B=II>
M[5^M&[MX=C-0[N&KZE$)#[?I;BTX 2EQSE'"4I#3A;*F9C0;64(R14MXD1F&
MPAIEM#32$A"$(2$I2D>0 '8 >Z@*0H;$&(S'CM-L,-(2VVTTD)0A*1@)2!V
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MG[O+M@M"'5(?@6Y4EJ4)04EPI;=6CD&!S2XRXT\5M*Y)0L(4MNIHE(/F,T
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M$]AWJ+.DO!I=-3^'C3ND=33!IN\IA6F%.<MCQ+C;$1E_#8(&.0=E/>KDI*
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MLUEKB=:).I]0)B15,6%IYN''C1DK#21U25J62XM2B<#N ![2 [-%%% %%%%
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M%U:?50\M*1@$#L$@?>K=#15F&<15#Z>NY_.K$VY_4"1]T9OY0Y2HH#0C0]E
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M]4=\9'LQDU(K;3?/0&[ZYR-$ZOM.J%00@R1;)(=+(43Q*L>6<'\% ; ;;6L
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MRYT9#;R$.J*0X.0QZJ%+0 K]MDD 8I1L'.X<D^6;4W_*KJR%HZ5;DA,6;#C
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M'<=Z3.C/%$]J9^U,1]IM?Q(,UU+:;E,BPDQVDE1!<61**@D'.2 3V\JYS,[
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ML;E+3]CEO"3 U;:V8Y'02!TFW)J5(1V]5*DI(& 0,8H!2C74']T"P_PFRO\
M9*1.^6M83^S.O4)UQ9)2U6&>E++>XDB2I9,=P<0T8J0LGV))&?+-.MS?_P#H
MFZO_ $SM'^WTA=^%/_:1W"S'W,; T_<#RF:PM;C(_0[GZ8A,U2E)]Z4I)([
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M'8TT6_&Q#F^S%KM4O4";/I]GF9S,>U1Y$R024\>C(>2KT8@!7K-IY]QA0P*
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+ 4444 4444!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>alts-20241228_g9.jpg
<TEXT>
begin 644 alts-20241228_g9.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $< D@# 2(  A$! Q$!_\0
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M(85/2BSF&MMTA'+NY(#PSN"^7))0* W+D7N!%N<.W/3&6ITQ+BH\9:P''0@
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MEXM.-C&4JRX"M0^4I.X!/2H[9[*^M=7W;03EZ=3H^!9D7://79M1O7*:XB3
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MB7VTNAF6RS:9#J4J* L86E.#R4.E8M^FR=G/]\UU_P !ROS: W$/R35FTO\
M8;C_ '?(_P LUJI^FR=G,C'U377_  '*_-JWV7TJW9V@MRTN:ENN7)3SJ?ZA
MR?DJ42/VOLH#=3%*T[_39.SG^^:Z_P" Y7YM/TV3LY_OFNO^ Y7YM ;BTJ/^
M!_'/27:$T.C5NBYC\ZR+D.10[(C+CJ[Q&-PVK /F.=2!0"E*4 J-.TG$>G<"
MM;,Q[+]4,@VUQ35N)6.]6GQ)/@\9VD;\)R3MP 3R,EU&7:7C1IG C6T>6Q+D
ML/6]39;@H"W22H $ D @$@G/+ .<C(H#4SA'K74/#?@1K1BV(EQ-,L3X#T+6
M=MCR>_=;>G1HCKQ1)0H@I83NV=T-J&CD'<%F>NQ\G21TW?I&E;\]=5RI:9$^
M)(ML6&N,\2X-RNXCLA:G G<5*!/3IYV'LT7#4EY[/NI#I"-;-/ZJ;N\A,=$Z
MTQVXJ70EA2DK9B]R@D@E!.04J^43LQ5^[)7&'6W%NWZA?U<Y;I(@JBQPY;[4
M[ #$PAWUN*0XZYWI:*6_C4X0K?X<XS0&PH'*J$<OI%8QQ,U7*T3P\U-?X;,:
M1,MEN?EL-3'TL,N.(02E+CBB A). 5$C YUK9I+MHZIOVHH=N.BF[F\;:X^[
M:K8M0GR)*&)#BTQ]RBTXT%QRR' LI65!05SQ0')Z,[_B2U7_ '[WO\<BMN*T
M_P#1>RESN 6HI+L9V&X]K*\.*CO8WM$NH)0K'+(Z''LK<"@%*4H"AZ&O+;65
MM>U7VL..^G[?JGZS%R-[C31Q7*^Z"6TP8Z#:.\W-_95+3(V]X,^K9VG&1ZDJ
M^2:\JN+TC2UI[0/'BY<9+;)U9P13J>(Q]3=I"E3OATVUI3$K#:FUI:3'3)05
M=Z$[EI!03XD@4;G-S;/,U8WI_P"I^SV9TQ)? C;M.O7 0DW+NMHW[RM+N0TY
M_8V=QZUS/ VXVDR'?JP^JM24VUOY7UF"O #I^5W7<]X#S[G^Q?*N>0Q?H^J;
M99K]-8G=IN>P'>'.M6 /@RRVC"BB/*4$I:[P-"6DA;+IRXGQ$J!'!!4U+5J0
M:23\%.VC<KCT90Y:N9 5ZTFW[BH+*TIF !D1\]ZC!&X8 V2]&=;W;5PNXAPG
M]2#6+S&N;DVO4(7O^$B$M?JC.Y6=_7.3UZFMOZTW]%Y)TW+X/:Z>T? ?M>E5
MZUN*K5!E@AZ/&*&N[0L*4H[@.1RI1]];BK7M\B?F!- <,Y;R8SWJR$.2 A1:
M0XO:E2L<@2 < G&3@U"W9BXTZSXOP-2/ZOT.K1I@SMD(+>=494=S*VG$A;2/
M"&RD;CA15NRA'(5D'%6#Q=G7*$KAU?-)6B"EDB4C4EGE3'%N[N10IIYL!..6
M""<\ZP+0I[2%\E1Y=SU5PY7:6+F]&ELL:;GH><;9D*:<[M1E$ J"%%)((&1G
M/.@-CZ5QI=R>8(^<&OI2L#ESH"PZZ5J)&E[B=)-VQW4?=?J%-Y6XF'WF?_K2
MV"L)Q^YYU \K4':CB7^WVE5OX1*>FLOO(<$NZ[4AHMY!\&<GO$_<-8+I_P!)
M ]JNT0;K9^!^N[A;)ST=B++95%V/+?<4VR$DN#Y:T* ^:NG?>W1>8VKX%RD\
M"->1Q:[9<9$AI:HNX,I?99=<Y.=$.-E)]Y'44!M9PO.N3I\_7":T^SJ /K&-
M,N/KB=SRV<W@%[L[L\L=,5F5:;S/2%W*WJN(?X#Z]:,!R4S*RN)\4N,TEY\'
MXS]HVM*CY8/+-;/\+]>QN)_#[3FKH4=V)#O=O9N#+$C'>-H<0%!*L<LC/E0&
M4UB7%B#\)\,]60_@<ZA[^U2F_@E*]IF$M*PSG(QN.!U'6LMK#^+_ *M]:W6(
MFL2Y,-5GEAYF @KD.([E>0VD$$JQT% :/< M2:DX;<+>*LNS6F1*MJ;"]<X^
MHX#,L24RF6TCN B2DE.Q3KR4)#/,MJ5XP0$SQV2)&D)E[UE/T]JF5>;I+EO*
MGQY=MB17'@B0XAN8I;,5DN=Z % J*N2QYY)Q_L92;M-X>:ZMMGA1=.:@BOM1
MV'9EHC-M-O\ <%*5O(BI:#I&T$@JWX(YI"AG).RQQEXB\2]2ZAMNLW+1(-G9
M[B<W:[4[$%ON"7U(5'+CCSB9 +8"PML!(Z$D\@!LIBL#X]C^LAQ"_O>N/Y*[
M74X^<1KSPQT ]>K#!M]QN0DL,H8N<Q$5HI4H[SO6M *@D$A.X9/*M:=6]KN_
MZ[T#Q8MC6C'+O&9TQ)>CQ[6E;4YEM>6%.R6GB VG:YWX .0A)^4: E3T>/[#
M+A5]JC^/=K8JM=?1X?L,N%7VJ/X]VMBJ 4I2@%*4H!2E* 4I2@%*4H!2E6/6
MFMK)P\TU<=1:DN3%HLEO;[Z5-D9"&49 RK'O('TT!35NN=/Z$MR;AJ6]VZP6
M];@9$NZ2T1VBLY(3N60-QP<#W&HVN?%[@+>KK%NUQUIH"=<HNPQYDFYPW'6M
MB^\1L6593M7XACSYUB.H.VMV8=4PTP[WQ$TE=XJ5AU+$]OOT)6 1N"5H(!P2
M,^\U&.G.T+V2V.(6L94J^\/Q;7T0/5%+MS102EIP.;!W7+!(SRH#=2R7:#?K
M7%N5MEQY]OE-I>8E17 XT\@C*5H4.2DD8((KO5KS:.W/V<H#$2VVWB=IJ/';
M"(\>+&*D(0.B4)2$X Z  <JV$2<@_/0'U2E* 5"?:K@64:&C7F_Z+TUK&V6N
M2EQQ&HWG4)CEPAE!92W'>4M:EK2C:$CY76ILJ%.UVR\SP9NMR9N+D0PG8JC'
M,CN6I(5+824*(COG>02&R&U8<*3@^0&7<"Y]MN7"/2LJT6B)8;8[ ;5'ML!+
MB6(Z>?@0'&VUX']LA)]U<'$/6ECO&D>(%B@W6'+O%MLTI4V"R^E;T<*CN%)6
M@'*<UQ]GAR%(X':,5;4!$ VMH,([X/;48( WAIH*^<-H_BBH8XB=DV,Y:.+U
MQNNH)R[)>VIEW1!MTAZ*\F1DO@N.)7@I24; E"4A25G?N(% 7OT</["WA;]K
MW?RI^ME*UK]'#S[%W"S[7._E3U;*4 I2E *4I0"E*4 JA^2:K5#\DT!^>GTC
M8QVTN*GVQ:_)F:UNK9'TC?[-/BG]L&OR9FM;J =*4I0"E*4![G>B _8>0OMW
M/_RD5NU6DOH?_P!AY"^W<_\ RD5NU0"E*4 J(NTV[-GZ#@:6MFH#INY:MN;5
MA8EMP7I3A+C;JUI1W3K9;\#2U*<*L)0E?(DBI=J+^T@K1\;A9/G:WM=VNEE@
MO-2!\!1Y#L^.[NVH>8+!#B%)*CXTD8!.>1.0,7[/EE@63A?J^P--%URVW6?#
MFPK?!E1'$.=V@E"$R)#ZR5(4A2%API4'$$ '-1OZ/Q+2(6K!N;?D(CVIE+L4
ML%IB,EI_N(;W=,-#UQD%:7RK<25-^+EBKK>K_H?3'95U;(TA8]0VBQQ[@W%<
M<N@N-MF/R'9,="YKKQ_5:TA3J5+<&5*2TM(SBNIV#M;C6+6LE-*E.LI$"0E3
M]VN<[N"X)*3')G'(6CN@HJ; 2H.HR,IH#;)UAN2PMIUM+C:TE*D+&0H'J"/,
M&NG&L5NA.LNQX,=AUEH1VUM-)24-9!V)(').0/".7NKO_M:P:5QCTG U]]1L
MFZH8O@:[Y3;B%);2.[4[M+A&T*[M"UX)^2DGW4! 7HSP!P2U7C]^][_')K;>
MM&O1Z<8-!Z.X0ZI@W[6VG++,5K.\NICW&[QX[BD*>3M6$K6#@X.#T-;0_HC>
M%&<?7-T=GV?5!$_I* D2E1V.T=PG/3B;HX_]H(G])0=HSA0>G$W1W^,$3^DH
M"0STKR_F2]36/MN\=;MP>M\/5'&M,]AA&GKXK;;O@4Q(JGY).YOXU,@1D#XP
M>%Q7(]1OX>T;PH*#CB;HX_\ :")_25YO7[46FN+':QXUZ1@\2+9PL;F7-B^Q
M>*<&YLI6XVW#CL&W(<[QL*;<4YWIVN_*CCPG&4@=BVQK%%X6ZKL=AGR979MN
M$U3W$35TA.+Q:+J5H+D>&-HRV'4QD@]TYR=4<GK7>O!<G_6V&K +<U9%M'@6
M81S]5#P+9C)NGRL!1$4'[#R=76-P^+6E+SH^\<5&I=ALL+1[RK:_P:;N#"8N
MM"E24&>ZC*=RE%WO<]RYGN!XCU'+*UUIC3(TPMS55EU..*;B&HR'KDP?K4%W
M: Y&\:MG==[D9[C^QT\QSP!MSZ.&3J*9P^XF/ZM@QK7JAW7UT7=(4+[#'DD-
M=XA'B5X0<@<S\]?/I%DNS-+\(K8)3[$6Y<0(4.6AF;)B!YE427N;6Y&^-"3@
M?(R>0P*PWT>O$30G"SAYQ!L%^XJV"XR8^MKD&[M=;S':=N;>&@)7B=)4%X)W
M D'R)KL]NCC)HC4\3@PC3VN;%<Y,7B%!DO"TZDC,NLM"++!<+P60RD%0'>*Y
M D9ZT!BH[/\ I$=8*#_VQU;^97RUV>=&LI4&[:TV"HK(3K#5H!4HY43X.I.2
M:RU/%.TX&-=O?_&*WU7ZZ=J_?V]_\8K?0&"Z)T=#X>=K3@E'L;CL*/<W[JF8
MPS?[U-0^E$,E 6B> D 'F-N3GKY5Z+I&4IKSHF\4-/,]J3@3<+CK.*NVPY-V
M+TRY:\B7=F/NA$))*" SN/+*CXN0'.MTT=HSA3@#ZYNCL_WP1/Z2@-'NR>!^
MASX7GS^&])__ #254B\3DCX2U;@?_875 '^'TU"_9AXDZ1L_ +AM"G:JL<*6
MQ>=+N.QY%S8;<;0W<I*G%*25Y 2D@G/0$$\C6?<1N+6AY%QU06=9:>=#NB]2
M1VRB[1U;W5WP.(0,+YJ4C*@!S(YCE0&0:V'Q_%/V_">M?_DD:MC>Q_\ L7>%
M'][,#\2FM2=9<5]$/R.)7=:QT^YZQ<=7J9*+K'/>!VS1T-%/CY[U@I3CJ00.
M=;%=CGBWHB3P"X4:<8UCI]_4'U/08_P4U=6%2^\2P"I'=!>_< #D8R,'V4!L
M74:=HB\R;1PJNR(-U=LUPN;D>T19<>$Y+>2[*>3'3W3;;C:M^7.2MXVGQ'(!
M!DH'-8+QN:TVOAC?W-6VN9=[ PR)$F-;8[KTKP*"TK92U\8'$J 4E2/$DC(Q
MB@(Y[*FF(N@U:WTH)<=V[6FX1VIK3,&9&.2P-CV9$E_O$N)&X+04@X4"D$5%
MG8:BL1=?ZK:[EP%B &H;(4R7K7%]=>Q#N'=1VLS-P+F5J<5M4<D')5E=@U)H
M"P]GOBE<M$Z9U8U!A6]V9<)%W:N$*X7-Y;!45"4]^J'%)2$IWI)VC 16+=AS
MB"G4_$#5UO;>DSFFH84'S>;O.:;[N6XR!B<=OQH0'D% !#:PE62": W)G6Z+
M=8KL69':EQG!M6R^@+0L9Z%)!!Z5@?'2VQ(W!KB5):C--R9&GI_?/(; 6[MB
M.A.X@95@$XSTS4AJ5@5!W$_C)I+6'"[BY9[;=D.3;/8KBU)#R%-(SW4AG*5*
M "AWK3C?+]L@^XD"T>CQ_89<*OM4?Q[M;%5J]Z/S5]BM_8ZX6L2KS;X[Z+60
MIIV6VA23W[O(@JR*V$^KS37[X+7]_-?G4!?:58OJ\TU^^"U_?S7YU/J\TWR_
MW06OGT_5K7YU 7VE6 ZYTX>E_M?WZU^=6J>H?2C\)87KMOM$;4EUOV'VX$,6
M-[NYKS94G:E:=Q*2M."I(./9RQ0&Y=*\Q&/3!:F?<G,M<'D./6])5-;3.F*,
M0#.2Z/5,I ((YXZ5(_#'TLNAKMHE=^UWIR]:9[R:J/'7:[?(GPW$ )P?6%(0
M-Y5O!0 <;1S]@&^E*COACQ[T1Q3T+:-66:^1V[9=&N^81/=0P^$[BGQMJ5E)
MR#]&*AOCGVHM:Z?XTV#A]PRM^C+\]/L;UY>FZ@O"HS+7=O=WW86V2,D$$ \^
MOLH#9UZZPXSBFWI3#2QU2MU(/W":,W:$^ZEMJ6PXXKHE#J23]&:\[M=\,-;\
M3=3SM1ZIX,\ ;W?)H2)$^7J5]3KFU 0DDX'1(2/F%<.@.%&M>&.H+9?]-\&N
M -KOMN!]7N4?4KZ7D$H*%*!P>92I0/ST!Z15KKZ0L#]!KQ6^U/\ YS=6#@KV
MG=<7CCA=.'?$ZWZ*L2V-/-WZ/-T[>526W N260VI:\ *\"R1U P>AKM=OW5=
MDN/8\XIL1KS;Y#RK3A+;4MM2C\<WR "LGI0$5_ -L^IJVJ^#(6XZ+U4LGU5O
MY2;W#"3TZ@$@>S-9LO3=H%UUNV+5 "$:ZNK:1ZHWA*1IHJ 'AY#//'MK!SJ&
MTC3-N!ND($:*U4@YDHY%5\AE(Z]2 2/;6;KU+9E776Z_A>"4KUU=5I/K*,*2
M=-;<CGS&>6?;RH#7CCE:($?L=//M08K3_P!37#Y?>MQT)5N4^YN5D#.3YGJ:
M]0T=#\]>77'&^6V5V.'F6;A$<>.FN'R.[0^@JW)?<W#&<Y'F.H\Z]-+=J2TW
M1Y3$*YPYCP!46X\A#B@,]< DT!<Z50'(Y56@%0YVL[<_<."]T[J<[$88D17Y
M;*)$)A,J,B0VI]I:YB%,A/=A:O%C.S!."09CJ">UM$T<K2-IFZXTC<=0V2',
M!^$[6^VT]9W7-K29&Y;B-H^,(WY.WZ<T!F?9[5;W."VCEVI4I=M5;FC&5-6P
MMTM\]N5,)2T>70MI"<8QRJ\\50/K9:O]OP/,_$.5U>#:[>[PLTN;3(ER[8+<
MRB(_/6VM];*4!*"M39*%':!S23G&<DUK_P 2KSQY"^-#S.FX)LBK,RU96+G<
MFQ"0PE4Q,E84WEPR%LEMPA0VIPA.?.@,@]'#^PMX6_:]W\J?K92M:_1P_L+N
M%O+_ )N=_*GZV4H!2N&2I;;+JVVRZM*24MI."H@' Y],U WU^.+J>7Z'.^G'
MG]4EL_I* G^E:\CM#<5C.5#'9VOWK(:#Q3]4EM^224YSWGM!KNP>.'%B7-C,
M/]GN^1&774(<D+U';5):25 *60',D 9.!S.* GFE?*.8)KZH!5#\DU6J'Y)H
M#\]/I&_V:?%/[8-?DS-:W5LCZ1O]FGQ3^V#7Y,S6MU *4I0"E*4![G>A_P#V
M'D+[=S_\I%;M5I+Z'_\ 8>0OMW/_ ,I%;M4 I2E *C3M*(A.<"-<)N#4]^&J
MVN!QNV)2I\CEC 40G&<;MQV[=V[PYJ2ZCSM"N/L\%-9N1Y5RA/(MSBDR+.DJ
ME-XZE"005<LY2DA1&0GF10$8=C_6%GF\ +E?;*8#,1J7)>[Y5OA6J'W@9;4?
M[%/=% )"5.9SE*@?D5<>RCQCUMQ8AZ@.M;?;;?)MZV UZ@ZT0\'%/G>D-ONY
M:*$-;%JVE1#G+E7:X$-VK5_";4TRX7>+J6VWJ;+D3&E6J5;8,<*:0EQEN/,W
M.(;\)<.[(W.N8  Q6)=C#3?U*R]71(XC1K6_%M4N%#;DQY+@96W(*'BZU#C;
MFW$!&W<'""A?,9Q0&T?45%.K>S/HK7&NI>IK[&D7+UR'ZE+M3SN84D=TXSO6
MC&2KNG5HZXP0<9&:E7=@=#7PEW=@8(Z>1H#R2T;V?>&]P[ _&[6,G1MI>U/:
M+K?&8%U6Q\?&0TZ@-)0<\@D$@>S\-CA\&N'KL:,\=*Z0=3W33AD-19GJ1WH"
M=Y"E=\8ZCE#0^RB2%EW]3%%2[H$?^C2[0W/_ )YU%^/;K%H-PWLQ)*9;_<!E
MI\..:G2^\$K;#6[X0&$A:BGNU3<;9: +<!N:- 8?]8GA^U(+1T=;F@V L^OM
M)*T]WC<72T=I2WG]7! W*)'J. #6'<6N$NB+'HA3T+3-CM\@38<?<]'=[\!<
MI&4+*#L[]:2HME/Q7J^X.?'E-35M]4E;2TAAAM(6&41#;R@QP-Q2T?['+6?B
MW2,6,$AS.^L XVNEKA^MMQY25)N$)D(;G"&@%4MIQ*!&/-M!2"M4/K(7B:,)
M010'HDGL&=GXI_XIM,]!_P E/\]5'8*[/W/^M-IGW?J4_G5/:.GT"OJ@("_0
M%=G[^";3/WH?SJ?H">S[_!-IK[U/YU3[2@(#'8*[/O\ !-IG[T/YU4/8*[/O
M+^M-IG[T/YU3[2@(#'8+[/OGPFTS]Z'^>GZ OL^_P3::^]#_ #U/E* @,=@O
ML_>?";3/WH?SJH>P5V?<<N$VF?O0_P ]3[2@("_0%=G['_%-IG[U/YU/T!79
M]Y_UIM,_>I_.J?:4! 7Z KL_?P3:9^]#^=5ZT7V/N#7#S4\#46F^'5BLU[@+
M+D6?$CE+K*BDI)2<^Q1'TU,=* ^4)VC'X*Q7BJF(KAIJT3VY[L(VF4'F[6E2
MI2D=RO<&0D@ES&=N".>.=996+\34O.</=4HCO3X\A5KDAMZUX]:0KNEX+.<#
MO!U3GSQ0&O78+U/I^[:!U%(M :8BQI#")#[=G@0&04LX(+D,]VZM.T[RHY3D
M>2A5][,W&_77$S5FHK;JR%9F845LR(<NUR&%MR$ET)!8+;[A=:'B!=4E&2$\
MO$0GG[)\B%JW3>H[H[?_ *HA<G8K<JWJLTVW1HVR.EK'<3,J*W$I!<(.U1 .
M,Y)Q#LAZ/AZ0X@WINSB#"T_,M"9%NCLS8\LO,^N.)2ZTXU!CGNQA22E2W"#L
M\N:@-MB-P^8UK;QB[,>A[7PJXQW"1$?O";S:YD]4.Y.]ZQ&<;$B6CN4@#;B0
MZX[DDG*L9P *V2)VU@7'AP*X(\0>1'^YZX^7_57: \L=0=FSAG#[ '"'7S6D
MHB-6WFZV^/<+IWSH7(0X^\E:595M&X)2.0'3'+.:Z_Z'7AHWN,K2T%IW(WB9
M(=MR@O/ZJ"F]R]BD)YOLY/P:GXT*?^34IZH_^BZX#=?^'+7TP3_9,CH#R_U9
M\ZZ,!E2TI+#SZ06XBA\%);=;V+60UM,G"RTVKG"4KXQYSPW (:)- 1O^ASX=
MJ0GNM)L+E@$*;80Z^\'<_$)5&WC:ZIO<IF/N/KK69.YK9W9^])]GCA?=NT1P
MDL+NE[6_9+U>9++D5N[.O-RX8ANN(+"Q@SH_>@[9X[O>I*FN[ :W*D!P#U1#
MJRTXT&)!$>4I:8:D)= < 6V._P"X4H@R5'XYM\)1$"HQ4:[FAVW4]J[@RIQV
MXE0U3,0^B2S&2>^^#G2I4O8<(F8("FXN8@0&RE7>J<% ;:I]''V<%)!^M7:\
M_P!U2OZ6J_I<?9QYCZU=JQ_=,K^EK9!K[&/FK[H#6W]+B[-_\%=K^^I7]+5/
MTN+LX?P5VO[YE?TM;)TH#6S]+B[.'GPKM?WU*_I:K^EQ=G#^"NU_?4K^EK9*
ME :V_I<79O\ X*[7]]2OZ6J'T<79P_@KM?WU*_I:V3I0&MGZ7%V<.?\ 6KM?
MWU*_I:J/1Q]G#^"NU_?,K^EK9*E :VCT<?9P'_W5VO[ZE?TM4_2X^SC_  5V
MO[YE?TM;)TH#6P>CC[.'\%=K^^97]+68\*^R#PAX*:F5J'0^B(6GKTJ.N*9D
M=YY:BTH@J3A:U#!*4^7E4Q4H"@&!BJTI0"H]X]N6B/PPNK]\B7>7;&7(KKOP
M E2IS!3*:4A]H)YY:6$NG&>39Y'I4A5!_;$OMJ@<%[G:[G%ER1=G6(S18BR'
M6F5!]M9=>+*%E+: G>0<;PDH'-0H#/\ A W9FN&VGQIYJ<S9C%2N*FYMK;DE
M!).YU*P%!9)).0.M<W%4?ULM7_:>9^(<K&NS-ZNWP"T.F(P['CHM;24(=4M:
ML#(R2L)5SZ^( \^?.HYXN=I>/IVV<5[-JFS&TV2T6TQV;Q ?7<2Z])2XVPT\
MRTUEEQ>-^W<K:@@K*-PR!]>CB..Q;PMS_P"KW?RI^MDDK"LXSR]U:V^CB/\
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M5+M0MVK+'K'4W#Q-HT=IE.J)4Q\-R8TB3%;C-M=>\=:D(4E_:0"EL;<J )4
M* R#LXR&97 _1BV4M(;^#FTA# 0$)P2"!L;;3R(/R4)'NKXUUPZTMIO27$2_
M6G3UMMMZNMIFJGW")%0V_+)9627%@96>0YG/05>N#MFFZ=X8::MESC/0IT2
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MC;B!H5XDMG/,W-DUZ?US][3L;1>QO\J(I2E5RR*4I0"E*4 I2E *4I0"E*4
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ME*O?Y_17R=D'#A%_!;AK6E]SAM]J(1N62<\L5E-KA-NI"B@[AT2*1(&6@HC
M'MJYPRF.$J !&>935+Z77)):Z1<E/VUV7FTQU;DA*3NP, >57AU+K64N9"O,
M*/.NC;I+F IH[%JY[_,5<-ZY"BX\2MU1RI:C51V;Y17?@C=[ET<2&]_B*@<>
M8YUVV;*Y>9\&.@-&*P[ZPZRXGFOH$C(_M@#@\NOOKE9BMH8<?=/=M-C<I7L%
M9'PRB*D*<FR4K:2ZYN2@CH,$(_D)5](KQ;;[?*;^$9F39%:AOMDG:,TTWL:8
M"<.)P"KW^?\ +D_34NV"VIM[ W %(Z\ZQ33;;,=M"U.)0!@@GE5YNFH4M-E#
M:TJ_B\S7YOFY,LBS2?DH63=K4$=J\7X1U%IH;>?-7F?FK&'YRGEE:E  ]<UT
M)$];RU*"2H_<JU3)Z]^W 'SFI*:IJ"7RC1IJC5HN\NX-(02VH[D<@D5T65JV
M!UQ6]*B<$]15NB[GW,@$KS@]>E=QUMUUQMI.$MHQG'MJW5!KI+O[FDY*&FF?
M26%KD(3@\N>2.7+G5P#*3@@''+*1SKNPX"6UMI".\4"#N)Y>_P#FKZE)]3=4
M/ @*Y#SSSZ51OE+:6WM'N&1SZ(GXO\+(/$:PNV^4@D,N)?1W9P4*!\_;RS]V
MHNUEIYQ.C;RAQ1<<;M4I)44^087SK8"[$K<6YA(RG!2!D#Z:B_B8LHTCJ/&T
M VR7X4IZ?$+K1HSIJ$:GXV9]N.K+/<:[-Y="#&BK!]KX_P"*35]JQZ%_658/
MM?'_ !2:OE3$(K1[TI[W<Z"T(K&1\,/ _>RZWAK1#TM$A,;AQH%2MW.^.CPC
M/_)7*GH>K8L^IZ[-$[=(]:0CF2<5?+>WEXI(Y#Z.58OI]E;B6'0HI(Y%/MP*
MS&$P\%A:$X!ZCS-=9+;BFO/0C8W)F36F&"2K& GK[JR6W1%[L!.[ED"K):L-
M)0A+9W$>(Y-97;67"E*=@']M[JQ;ERW*3UI]$LIOP7""P&<I*<C/45>HHPG;
MC.3GG7! BJ6,(& .M79ECFK&%'V>RL^R;>H\O]#XI/9\(=2RVIUQ/A">>*^H
M%R]<W([IR-OQM2Z,'K\KKTJLR*J4T]&V;F]N,I',U2S2H10&D[$OM("5)4?$
M/;G-?85KC[DUK[$T'N2[+XXXE(44+2L#J0,YKA$X)>"P2E/7(KA*@,@G Z=*
MZZG D>%73RZ5]JA!))O1KPTF9%&OP:P%X6,#F.9KOLS8LD[L84>61GG6&,+*
MPH#)..6:[#2W&#D')'(@]*ECBN,TX?8T(:WV9@9821L?+9!K@D7N9%R0ZAP=
M>?*L3FSU(2%$$$\_"3^"K=(N+H .XD59AC-M<G\&M53&Q]F93M;7E=MD,0GF
M8LG;EMU:=Z2H'.% ^1Q@^RN"#JYC4;:U%M#$] V/1%G"TJ]WM'F#4=3;B]X@
M7BD$GESQ6!WS4[[,E+C2BT^VK<B2@^)/\X]QK26'5!I+Z7K]_P"9GYOIT7N<
M26+AJ1<!UP+!2GF,'YZC?66I YWB<D;A\H>7OK#Y7%-UX%FZ[65D91+9.&U'
M^V_<G^2K5=]7)>B;R0HX&1G_ &S7WVX5S<9_8YMX-,M]=G!)U]?=$N*D19!]
M75D9S\H?-5JU'Q&A:ZMBE7"(XN6.C@  3CV5A>O;T[=N32U!0Y *'+Z*Q.TH
ME^I!M)<"FUD[TG/7V9KU91&,93@N]>3%<)0M<%W$W0]%>^7NU/J3]RC1;R4^
M\?"+!_SUZP5Y-^BI9[GM3ZF22I3GU%NE95YGX0CUZR5S%W^8]$J2BM(4I2H#
MZ*4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E <4@[67#
M[$G\!KR*<8;=OBHI^+:94I&<9_;K4?NDUZZR!EAW^*?P&O'D+=<NDK:LA9E+
M 43S^R*%=%Z+*49SXKO1)!>7]C)+$Q*A3'Y01X$@M%1 PD'SY_,*QF\/;>]"
MW"4GS5S)K(Y+3T-'J;H(<;YNISD \_/SK%KTZ'$JPG<!^YYUU;:=>YK3T0Z[
M;^2QLIR%> +).1X:RFPQUN!*0"%%0VCJ<^S%8VP4A1"2K<!63VN]KM\=0:0C
MO#C:XKJG_751-:>GX1/)N"Z,IN=H=M+,8/92MQ.X@IP4G/LKCCMMM-$G(YYZ
M5:V[E*N)+CSRGEXYE9S5R@J2YE*B0H#(S7SER2DOE>#XY[K^HNT)6$[B"4XS
MSY 5D,(MO%LI0I6X#EC(-6*WL@85U*NNZLLM<4K<&!R_V^Y52R$4GHB<DD<=
MT@.3Q$@#<&I#P#A ZI\TU+ND=/AMJ.E"<('B!QUSS_U5AC5B=FQTF.E1>9(6
M@)',GS J6--7&$Q:$N*>2A&.>[D4'/R3[QSKGO4;W"A)/]S(MMBK7R9DT5*(
M4=(4V.0QTS6/7FY!<A1!( SY52=J^&ZR>X<,C'7NTDXK!KSJ1R:^IB,TL<\%
M121S]E<SC8T['RUY):K(1[+^F< LGGUP%9_EJJ6A.2LY\>>IJRPT/2$H&TD!
M.%&KPZZRF)W.X@CD-G-9K25'".MEY92BMHN4*(J*R72C*^61[>M7E^7'WI?>
M0TU@ !*< #'0?<JPQ?A68\S%C0W'G\'XI(.3CJ?N5<)MF<CM;;HE,=0 5W"L
M+6,^T>76O/LOCYTRK9E*;Y2+FYJ5A(&UH CF=O4^6*Z\J4)K+BD-+&TX(QUJ
MS(D1XRU-Q0&&U !3:0,*( S]TC-7ZS1'WG KN]K1Z$G;52V$:HZ:<D>'E\7Y
MT8U,:=+906N\ /4]<>\5&W$:V/.:/U$X582+7+Y!/0=PY4]O:36IQQU 6HN<
M_F]U1]Q(L,M&C]4%Q"4-)M,P^('G^IW*RE=&,HI+79?KS8R6MFSVA>>BK!]K
MX_XI-7RK'H7EHJP?:^/^*35\KH3V*T:]*M"5.T%H!M(R1>WE8_\ 95UO+6F7
MI+&$2-)Z#2XH)'PL_@GV^K+JSBM*Z+?W/C6T: 6&$XVT/B_$#S*AC%9E;K47
MU!2CE*N@QUKLV:QPP4#OM^>O/K4BV.P,%M :8*Q^Z\A6_.V.^B-)HLU@L07\
MI'0XY]:S&%9U >)/ER Z5>K;8T1_&EA((YG(K(X$%1(01M& >72L6RU_L0RD
M][V6&V652E8V'G@CEUJZ-6!""7/52IW.-P&*RIFV9*,''F15SB0DE22#E/3%
M9D[Y<ET21LUY,6A6)Q\K^).$]#[*M\OANQ(??=3&2)CX3N<Z'(Z'-2C"@MDD
M)!5GEX:N\73Z9)WJ!'+S%>89TZ^F2*VN3^H@3U&?#6Y'D(+I;Y*4!XDCRW5P
MFTR5G<E)VD<CTJ=WM&--R7RD!*G0EPE/4\L50:,& ,!9/M&0*N2RZ7J2BME^
MG*BB$8%I=2YAUHXY9/M%=]=M+:#M!Y<ZEN1HK8G(9R,?*;3T^BNK+TJA]!;0
M%!0(Z)J:.6GI?.C7AFP?3(E>M:G-I4VDG'3%="39=Z,XV>Y7*I>5I NIP4D)
M(QN0G\(\JX7-&N!&4I"QCS3TJU#)4G]4O@NTY:Y=,@Z?9GP%%E!*\$%7D!TQ
M4<:LTN\PG:4[O/*!GE[*VXD:3:BL*RV <<^7NJ*-3Z5*Y2EI!2#T"1@5L1R8
M2E_H:<[/<?GR:C:CLDA 5E!(R1M\L>^L'U7<VM,V!<R6M:61X4M)_;+\N7EY
MUM-?]%E\. MCDDYRGK4(:_X0R.(MO<L<%]J/<"QW\0/# ==2HY:]Q(SBK>19
MS3]OMZ,?,@J82FC6@\4GI<Q(D,!$/&,-_* SUYFI*T\\%1Q+9DL>JKYX5R5D
M^_I[,U@+G +5MHGICWFVNVI(5A1?&,\^>WR/T5U=?-_44P-,QR^A2/C7B\G:
ML;L$)Q\V#61!Y%$9.U_!S55_&7/R>@WHLI+4OM4ZD<:4E8^HEW)2H*_YQ8]E
M>K]>,GH4%$]HS6>2?UJ.?EL6O9NL.V?N3<_N1RER;8I2E1'D4I2@%*4H!2E*
M 4I2@%*4H!2E* 4I2@%*4H!2E* 4I2@%*4H!2E* XG_L+G\4_@->2.E/5_JB
M,F00EM,USJD<L.*QU]]>M[_V%S^*?P5Y"6>"N=(E$K[MF-)=7N QGXQ7W:Z/
MT6+D[$OLO^3S*32TODOD]"U/S'GEA3A5@J(R5?[8K%)\4(5C]URQBLKD$/1B
M4\SO.X=?:?N5:S;E.NK42<]/F_UUT]2Y1W^"-2V^S%1"6E:CR'\6N]$CX'BY
MC-7H6;XO(\0]PJJK2L [4*',' '2O*4.NB2=G1\VU24E6XI/N\JO$=HJPI(&
M00.0KH0K>M!YI()Z8YUD]N@$HZ9)/+'/YZ].*X[VR.4]H[MK9R.?BP.O,5GF
MFX D!.U(!]IZFK#9[.=N[! . ?94J:+L2.^;*T$H2<G/G6/ES5<=E*RSX3,V
MT7IQ$>.B0X@#PX2G'/YZZFM-,VHEEQ3"4J6L(44G;E7D<>?G62?"7JS*$A(
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M7YDUV@, U'_U[M. ?V!JS_$V\?Z+5?KX:<__ "&K/\3;Q_HM>3LX04%I&?\
M0&K7.40^#["*Q0\<-.X_L#5?^)MX_P!%JWR>,M@>/A@:KZ_O-O __JU\*^2F
MX:1GZ%Y36/<23_6[U5]J9GXA=61OC/I\<C U6/\ L;>/]%JS:ZXLV:ZZ)U#!
MAVS5C\J3;I+#+0T==P5K4TM*1DQ<<R0.=?40UQEM-HDO0WZS+#]KX_XM-7NK
M/HZ.[$TG96'VU-/-0F$+0L8*5!M(((\CG-7BAHBM&O2JMJ=T'H!*%[";T]SS
MC/ZE7RK>6M/O20</M4Z^T9HEG2^G+AJ*1%N[KKS5OBJ?+2#'6D*4$]!G ^FK
MF&U'(@WXV5\B/*J2-0^SCPDAZVF75F1/5;DP8#EQ>>2P7U%ML E*4@C)(-;-
MZ;[.MMG0[<ENZ.3(-P@/38SKMO4EX%E0"DEDG))"AC!YFHE[/>C.)_">]WNX
M*X?:N#MPL[EN9=CP%M*BNJQL=&1T3YXY]*GCA^K75HNR;AJ;3&K;U)?A/0WI
M26W"\V%J RG<,# &0!Y^VNAR<JYRDZYZBORC&X)1X2B=ZQ\'6[/*@VR'."&;
M[E6U^,J.]'[KGE2%$DY/3'(JQ[,UWKQPTMU@MR;C*F3]J3W*(RXZ8\EU85Y@
M$C:>>#UQUJ3]/69F!;[7'1;;S.3&)<0[=VUKD-A?4;MHQCV>TU:N(L2Y75-N
MA1;)<I#,<J<[]3"W#GY.WD.0P,_36)*^R3W+LISJ4HR48_T9T-+?!FK,J7I]
MMAJ,E*%NON@IZ<AC',UEUI=ML):FK<VPTRGY?<@ 9^BL4<L5Q<LJF6+9<(,=
MOY3"(CI<D+QS/(<A\]7?3FGE6*VI'J,U<AX;G"J(YR]WR:BGQ:9E2IO7>F9<
MB0EQ&>2TI\SS%=:6]&E[(RE#>KQ(R<'YZXHP<8;(]5E@']J(COYM=6[1BMA<
MMN)-2\PDN#9#>43@9P$A))^8<ZJ:U)DL%9+IQ?\ (^82N2\QU-N(4003S-7)
MAE;I2^4%OO$ D*&%)^>L0B\6;*&VGW+/JLR G<0-'7?KCF.<6KBCC38WV,JL
MVK&U>23HZ[Y_):^RX-:T3PPYO;>]_L97'95G(4.0JX-;7EX<5G%1VWQ=LR=Q
M-JU8<GI]1]X_T6JGC'9S_P T:K'_ &/N_P#HM5W7%_!9I5M2VXO^I)*\*\.[
M '0BN%AE"5<SN4/VQK V^,%F4G;\&ZJ0/:='W@G\EK[3Q8L/4Q-6#YM&WC_1
M:^JI)[T7&K9Z:B9_N+8))'T5UB^IU"N8 /+F*PSZ[&G]BP(>K"2.1.CKQ_HM
M?3'%C3R(X0N#JI2@.:OJ.O'^BUZ<6SU[=S>DM'WK& XEII]H##9\AY?16&/:
MQD,I+95NP?,FLK>XG:><20(FJQGVZ/NY'Y+6$ZBN]@N.]2+;J<JSD+:TA=T+
M_):J64RGK9#[=E?\)WHUQ=G!94C>#S'/%6Z\6;ODKVH4V<9YC(/TUA4VY288
M_4%OU9(1NSW:])79/S?\FK@C:YOR'DH<TEJY20H@K^I:YD8]V8]59^Y1)<([
M+$:W-;2.MP!C"+VU7D9RH: E \O_ -48K=>M0.!<.]WGM<2=2.:=OMNL;>BG
MX!F7.RRH+7K"K@PX&TJ>;1N44I*L#/(&MOZU*Y.44Y+3-FMMQ6Q2E*]D@I2E
M *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4!3 .:IM&<U]4
MH"F*;1C%5I0%,"F.55I0%-HIM%5I0%  *;15:4!3%,56E 4Q3%5I0%,4Q5:4
M I2E *IBJTH"@Y4Q5:4!0 )&!TJM*4 JA&:K2@/G8*K@56E 4VBFT56E 4VB
MF *K2@* 8ICE5:4!0#%,56E 4Q3%5I0%,56E* IBJTI0%,8IBJTH"F*8JM*
A^0D YKZI2@%*4H!2E* 4I2@%*4H!2E* 4I2@%*4H#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
MB5!.1PT*&@H    -24A$4@   ^X    %" 8   #;C[9B    "7!(67,  $SE
M  !,Y0%USO"5    /DE$051XVNW7H1$   @#L>Z_-$R  (/)WV6!NB9) 0
M ._&C ,   "..P   ' Y[I(D29(D29(D29(D:5L#D&*L[IK&DNL     245.
%1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>image_2.jpg
<TEXT>
begin 644 image_2.jpg
MB5!.1PT*&@H    -24A$4@   O,    %" 8   #(46/Z    "7!(67,  $SE
M  !,Y0%USO"5    -TE$051XVNW6,0T   P"0?R;;@UT)AWNDS/ 1)(,  #P
KWIEA  # F0<  )IG7I(D29(D29(DM5K^GL&OE_,S&P    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>image_3.jpg
<TEXT>
begin 644 image_3.jpg
MB5!.1PT*&@H    -24A$4@   O0    &" 8   "L&0HM    "7!(67,  $SE
M  !,Y0%USO"5    /DE$051XVNW6P0D 0 @$L>V_:0]\6X"'&4@/DQI* @
M+-?O;N@! ,#0 P  AAX  ##T  !P>>@E29(D_=$#VX74F?M=*L0     245.
%1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>image_4.jpg
<TEXT>
begin 644 image_4.jpg
MB5!.1PT*&@H    -24A$4@  !U,   !&" 8   "9DKVK    "7!(67,  $SE
M  !,Y0%USO"5   ##4E$051XVNS901$ , C ,/R;9@*H@ETBH=_. @
M '",!         "7F0H        0S%0       " 8*8"        !#,5
M    ()BI         ,%,!0        AF*@       $ P4P$       ""F0H
M       0S%0       " 8*8"        !#,5        ()BI         ,%,
M!0        AF*@       $ P4P$  +[Q    ___LV:$! " ,P##^?WH<L$H$
M(CFAMC,   # .T<"        @,U,!0        AF*@       $ P4P$
M  ""F0H        0S%0       " 8*8"        !#,5        ()BI
M     ,%,!0        AF*@       $ P4P$       ""F0H        0S%0
M      " 8*8"        !#,5        ()BI        \)L+  #__^S9H0$
M( S ,/Y_>ARP2@0B.:&V,WS@2         "PF:D         P4P%
M"&8J        0#!3 0       (*9"@       !#,5        (!@I@(
M   $,Q4        @F*D         P4P%        "&8J        0#!3 0
M     (*9"@       !#,5        (!@I@(        $,Q4        @F*D
M , +%P  ___LV3$- # ,P+#Q)]V]E18$DPTA;V8     /G,D         'B9
MJ0        #!3 4        (9BH       ! ,%,!        @ID*
M$,Q4        @&"F @        0S%0       ""8J0        #!3 4
M   (9BH       ! ,%,!        @ID*        $,Q4        @&"F @
M      0S%0      @.4"  #___O_?Q2,@E$  0!?4CSN.S&DZ     !)14Y$
$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>image_5.jpg
<TEXT>
begin 644 image_5.jpg
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M8DTMC!FRFZ ]12M% S(7<:YCJW&J"F-4 Q"(A.Y'0(C(9/?4=X'HS!C;OT$
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M$4+Q<;)$!%>0-17L5+44J?XG)N_2I4L+(8-O2ZM?YH=;M<=%Y:--;/-_^RH
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M8N:9SWSF<@P]DS'\IW_ZIXW?&Y%B_CSUJ4]=&FP.Y,M?_O*E$=L/;5O"F,T
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M#GN7OA"=-";*\U 8VTDN9P)(%!?8V&-=& .611-GPN$4IP^NB7W(#MHG-]$
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MLPX BAB%ZM^0R[5PPL "4,07#B0Q#5#/P$%-S-:"E$DA CXZCPP99]1];,;
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MYS([2YAVID:KR8)&"K1^&UX;FS6&6&F=8V ^#HDF<+!2<AE&9=_@UQ9)4JI
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M'<_[D.6&@,JBOA%L"*MXUI"]T/V''*/]+(PA;@073"GSIU*%".+2/ ]AS86
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MN%%&8_2[V C!A7'\?-;S"_P8>[$K2MRM(HQE@11XG#F%L77.DBP"Y%S"F!*
M/?^<G1HCDF;/8S_S]U%D$:P1"?B]=,:8-:4LZ!S"IR"<F$4:RQ#:2^,89&=X
M[94SQO2/O;_5/WOAC#'/",.UGM%S9/. *"B( #;N]0'\ @,81_YK?%_8I15T
MX]YQ3=CO5<T0Q- +AH$)B"0P(1Z;+8F<L'VR9)?-(8RU@D9@Q&T(8X+/:A\,
MIU;[='Q#ON9<@0J[)8P)5%35+?Z>P/_X>^:H2H&M;+"2/5A_C["6V7H\UR:S
MQG9-&.N=9]#+%IMZOEC=+*!,#&J55[*(AB)4]ZHP9N&WLG#&7.5L)X1VMK@0
M$-%(1V',Q.5DM^K0CBDW(M6T=W[ )H0Q0#@K(7:L"&-E(Q3E,$48BR2AN<TA
M'VKF4BQS."2,<6KBV57(>G,^-N(L@QLWU!;X1L!LNI:NS:'8L+'"&!O"'F7@
M8.SY8O7:M.ED8-"FC;2>2QC3B("932_WXOCWSEN8ZY(%,#92]%@7QC@M &M+
M]!G*+CB(PE@MYG.6A\H_<9Y[!\YS+ #.[+LB8_=2V<\YA3%-)#:G9[\*8ZV(
MMGI>#05P.=-H3.D_^\-8<0:^1L@HQ>D9YBA#@K24W3AWLP\A"VI[)JN7KQ'/
MU&4C$:K;$L8*D6&.3A7&UA'#6L*8!D\K,Q;'%"Z=&ARC)%J\GS.&I^#%30AC
M@M(B"2UCJD=\R_ ;$H.-8ZM\.\*(Z(@0%,E+./3GN.>5,Z[X)42-+.-K;-N$
M,.:YS(_X;Z4T]JK"F/*'YA<\+WM&0!/LQBZI,$&L$'#$3^5_"9H9$M*B[V@O
M[1'-;- J?K\FNS>6K8T9@.LV?9.))XBC5F.K8I99O/@_+:(_.V]XU4L0,+L+
MV[<^8URG".>%D(SO*&"R%@S+.55%"&S=P_P62!'/BD;V#=D<@5ZP"CNA/-T4
M&V7^QP F4?%S!Z#,(8P5HG1=8:Q5462WA3$^_M":X2,-C:\ @HC?9>Y9DS%[
MDE\5R[UM2QCS3#W!HV2USV7+9(39*^LU]N0G/_FH3%'X)HYE_,PVA3%^2:\<
M..S8FU/;$L8$8_>.E>B)]3+1XW>M\[K$IRQ-O$&K\HX]%-?"+XIS'/9IW=]>
M&><Z?%2$-%P2_J'%F^$2E>-D?]P[CI5[\X4V)8QIGM4Z$K2S:6%,($X1=+(,
M7ES7G%E/^T$8*TU #(S9FJ/L>YT]"%O&SPI:6\?'V)/"F [KU;5V+ZF//1 ]
ME0@N)&\<6)-)FE]+&)LKNV#;PIB)!4RO6[?:]R]_^<OOB-9DC.(!I9DP1C!I
MI;N/R?H#A#/G^U 8VZPPQMA)>QXKC $X<:/=I#"F9$#VWIRZ2$0C/6KRF1C.
MF6^1BH2*33LXHE\+23-6&#.OE>_(RC*N L!])Y8(*>,F>FA.80S1I(1*5IX%
M2)"E5R)&-UW"<E5RY5@3QM[WOO<M(\M:I+](QF-5&"N_AXSLE;  X'HE@XU]
M%&CJ\@*;RFX4O=6KZ[X-88Q8KHSS?A7&1$KVA#$.G;,<AXC#9S_[V=TY5,KE
M*I.TBO#$$7[:TYZV/&<)68-48N/9%UE#WCLK0U-C91B0B+N)QL[4(@0;+4)9
M!G'M$(E*'>J#N84Q^RU28*\(8^69XEX*VTXM=9D)8\A?\WJO"6,$AAZ987X/
ME2*S9V9V'JY"6"&Y$02BF]FZ&%AHK9?]U>_8-_::,$;(S<YD7E<8\_VQ8RIS
M(2/5C0\R%*[E6_,7[(\$?+XJ J0WAO9#Q-\JC>\=LUZ(P',%OA9A+/(+"+(>
M <;/[&4=EWXCY&Q#&"MB72O@AS^&J)]R_@HB+HJ2L'[!16QV*=_O]V4^M$@U
MV#V>L4Q<X3\,->N#GX7O&9L]6>]1YDLOJ_M0&-N.,#9FS?3.DRH-]HREX<P]
M 0]1\+0V8FG/;0ECY4R\WOO" _:MN1I;7&<!R2*K>9433CAAAP^J-&44*;8E
MC-FK>QB:\-4+K-F6,"9H)<ZY<EEO,HU:K2X'6,_7."^57&=O6V*2@$MCR?^)
MGX$M8SE.># + (#1ZS5&F(7=6X('C%_V#3Y8O'>KU.5<PIB&SX W-BV,P2KE
MF07ZQ>>WG_?*5AYD8:PT-J4UKK2!@C?-F>AG^]Y4_F)/"V,V9O5$ATHRM(CR
M=82Q+&/,O6+F22V,S95=L&UAK)!?HOK7!3;N 9P#AW5?QO,ULE**R@1D !(A
M+A-L#/E(H#D4QK8KC.D#T=E3A+$(E#8IC&DB#J,C#637XH!U(S,A]DE+E&6?
M./;1#B 5IY3&&+IL)F7C&"N,>38$PES"&.=#B:*L3)Z-<DYAK'7.6+D7VQ@)
M'02NTDYS]KM,G[GJ.A]T80SHX=QEZU*IEKU6DG+;PI@FPJY5!M9%>+9^>H*Q
MZ.GLN];8JF>J]!KQW[RR'W(($=GPU% $V]S"6#D[:;\*8[)'>B5$B$EC1'B9
M&*+/(]:H'4R1HJW2O^LT-C$K"0?+U<Z._:_&?W,V$81(E3H27RG%XX\__JCR
M>)SSH;,TYQ;&D Q^;R\)8X@+<Z$N,6*L9+"N*XPAE_3[;@IC1+#H:'NWWF\B
MB.(:RGRM3#R$C^UG[&W)NM/'4;BR'I6?UGHV?[<N[S9T1,'<5X8W9-=$H1U>
ML0_VQA"_T"LG1]!8-2M"@&44D=CNN8)]-81Z)%>M)_N M68OBAD5!-VA\X-@
M9.<,;4L8(XSV2M7!F5."RV#_>+X[WZ8$!EISY3Q')"A^J-78@7B$ XXCGO^4
M83^99G-D3^_FM1^%L;DN-E=6":P^=+:K8*,AXI3O6Y?!Q%-9H^Q,+5[X>WQ2
MM%W;$,:,E[4S%.".(X/EYO1)!>^6W\?/U&M,2;1HXV&!&)2\#6%,'PFPZ*UM
M&*Y7N6,;PICG[(D\RL&V @X$A,3^-B\)_-F:9G,%'[3N90VQ\U%,% !3BT:"
M%[)*/^[-?XOW=M^>*,=GPLG!5G&/@26R<R7G%,9PSCBU30ICDD&*D&W="@"J
M.7"X8^B<V&-!&#-WKG_]ZZ?Z@#V^'B,<0_P<SF)3Y12W+HS97'JB5YE,!(Q6
M-"X#-C5Z50<R<)G8X8R'# CNYS/&:N&$4]^+;!YSZ2>3O8"-L<*819-%NUC$
M(K"&&@."E#D4QK8KC$UMNR&, 6H.(XVV \@I(!98C"5O$" ]1\K9(O%@V5:&
MV1QMRAECLBSB!@$<])S)'JF?E=VQ7I4NFE,84\8D.RL0V<GAL<G%^0.T>;Z#
MWO:B,,:N(*<ST,(.<@I;AZ,?2\*8!HMP\C+[90PYZ:W&#L62<75YB;C^YQ)#
MXAF:QAG)%HF[30ICVVB;%,:0E2WAV'6I2UUJ>8;<4(-)8FEQXU$+8^RD*-ZY
MFXRV0DK6>VXD8I2[[46SKML$X90J$AQZ?8L$K>T/+",#8YO"V*IMD\*8YDR>
M^AP9XS558,Z$,6.O+.%N"F-*!L7, D)@+P.@B%M# 9>9Z(>0VN^$^6Y=$6_(
M3H4-LK/KAL[ @[M;&>J%.&R56QK3LK-SB"ISD50BT8<R.Q!8]3G(^(5H?[-Y
M>^*))VY-&!.H,[0>^&MCQX(H&7UX7$$1H?EP)2.!+] JYR6@QQY=[TWZVY$,
M0P29 *,AX?Q0&-L?PAAN9V@L\3>]$J;V)[Q"C2_XX&P0/%MC+[@C.]]RG##V
M?P   /__PBN;-0  ,!M)1$%4[-T%N'5%U0=P_$Q4#$SL[N[$[FZP6PSL%CM0
M00QLQ<("$SNQ$!5%L1O$%A-;C/,]O^,S..^<F=FS3]Q[W_?.>I[]\'+O/7O/
MF3VSXO]?:\W7)HO(-[_YS<F%+WSAR7;;;5>]7O>ZUTW^_.<_3Y8EO__][R<7
MO>A%C[__,Y_YS,GO?O>[XW___.<_?W*&,YQABS$\^]G/GGXNENM?__J3$Y_X
MQ-DQG^]\YYM\__O?7WBL7__ZUR?G.M>YJO/SUK>^=?+7O_ZU>(]K7O.:V7&>
M__SGG_SH1S]:RIQ^[6M?FYSUK&<MCO$=[WC'Y.]___O,YXX[[KC)U:YVM<F)
M3G2B+?[^M*<][>3'/_YQ\7G?_>YW)Q>YR$4F__=__S?SK$M>\I*3AS_\X9-3
MG>I46_S\6<]ZUN1/?_K3\<^]\I6O///<\.R?__SGV>=^YSO?F5S@ A?(/O=2
ME[K4Y->__O5DSSWWG)SRE*?<XG?/><YS)G_YRU]F[G?9RUYV<L(3GC [9Q>\
MX 4GO_WM;R<;29[QC&=,3G:RDTW'=Z4K76EF_NY\YSM7U^(\<MWK7G=FCE[[
MVM=._OG/?\[\[7O>\Y[)24]ZTBW^]E[WNM?D'__X1_49WND)3G""+3[WJ4]]
M:G+,,<?,W,^Z&[H?L?]/<I*39-^M<?[G/_^9_MW=[W[WF6=_\(,?//[WRY;M
MXO_Y]K>_7=RT!O7VM[]]X0?^[6]_FYSM;&>K/N>\YSWO=%)+?V>A'7C@@:.>
M^^]__WORB4]\8N9>%M/UKG>]R9G/?.:9WU&4CW[THY<RT9[_I2]]:>89)S_Y
MR:?C&A(*D]+*S=<YSWG.P6?_X <_F-SA#G?(*JOT?COLL$-6$9WB%*>8O.0E
M+YG>DS(ZQSG.,3-?-[_YS;=X]F]^\YOIALH]:\<==YQ\X0M?J([]%[_X1?;=
MQ._O,I>YS!:?H0P^^<E/SOSMZ4]_^LFG/_WIP;G^XQ__.'GRDY\\\WESQZ!L
M)+%//OSA#Q?G9Z>==IHJD%4+!7?&,YYQ9FW?[6YW&_RL-?*8QSRF^'XY!:5U
M_<4O?G%F37.2*.Q@I.-U:@W?]:YWK8[G*U_YRA;W]&\.PJJ$8V</Y_;'XQ__
M^"W^]K###IOYOAS,CWSD(Z.?R[%Y\(,?G-TG3WG*4Z9_PX"_^<UOGOD;3K.Y
M;Q7[^)&/?.3,?>QM#M&AAQXZ.?6I3[W%[QC,6]WJ5I-M73[SF<]D;1T[*.!)
MA;U(]UI8]Z]XQ2N6,B8.=VYMA'?&^=O:A%Y_P0M>D U^.)&+Z#Z.96ZNSG.>
M\U3?"1UF?P5'.KUN<8M;3'[UJU\M=1[LVQO>\(8S@<X>>^Q1_=P?_O"'K ]R
MK6M=:Y0N6$OY^,<_/KG"%:ZPQ7CY"]9V^O/;W_[VDY_][&>C[GW%*UZQ:'L!
M&F]\XQN;WL=-;WK3JE]FO^^UUUY+G1OZ_R$/><C,L_AK_)S8WW[4HQXU7:LM
M?JK[LJ&?_>QG)T<??7336-[PAC=,SG[VLT^?=^UK7WORH0]]:/+$)SYQ9B^]
MYC6O&?0E'O:PA\U\IUO?^M93.[M6\M2G/G40S,I=P>Z6!&CQK6]]:SH/5[WJ
M58__'("#;ALC3WC"$V:>O_WVVT^>][SG-=_C<8][W,P]@&@M:Z4D=#';%]]3
M'!8#<ZE\]:M?G=SL9C>KSBT@YF4O>]G,9P%$\[RK?FTW8]OVV6>?&?#/_XO7
MAT ,:_LN=[G+#  2XM(7O>A%6>"P50XZZ*#)I2]]Z1G[2E<M0^R;&O#I>NA#
M'[H%F/GYSW]^&M_4/F-OO_.=[\P^<Y===IGKO=%/ ,J<W.E.=RH"D>$RYJ'8
M/8[';WG+6\[$=>]ZU[NF]A;^XF? ->LD!^:%."G6>2Z X-#[<S_KBH]E#1U[
M[+%SO5^8A['FUF< 00\__/"%UI X*%VC\276;P5*<Y\= R2RPQM)U]@[? OK
M-O7=T@ON4/,]K#M^8/R9F]SD)I-##CEDYN=7N<I5IMAH*G1'"@BG_@HR9!&Q
M7FOX5XC7CSCBB,%[(<Z..NJHZ;X50P8")"?6B7D(:YT?&Y,68@4Q0SR.E[_\
MY3/W7 MB;.^]]YZ<[G2G*\X/ N][W_M>]1YK08PA#D]SFM,4_7OO)B=THG><
MPX=JQ!CA@\, <\^\SWWN,\5ZXY\]_>E//_X='G#  3/O.'YVB1@C]E$.HW#1
M<6QE^FQ^X[9 C"'_ D8G[DC7%9(6Z=B)L?_IB)Q-Y?.'."+G%[[O?>_;-H@Q
M7_+5KWYU5<E[N0  +_0ZU[E.\6_& G/NEP/%!/WWN,<]LLZIQ0WX&$M44(""
M<R22 !\IY;MSFM:#& ORKW_]:QI <GQ++&WXWAQ\ACTEOC@#8X@Q3BA"+O<<
M8TC_/B51 </Q_=/LF4Z,;5YBC/SPAS^<7/[RE]_B,PSN Q[P@"FIPPC%O[-F
MW__^]U?'8X^DBOYB%[O8U "L-S&&7 =>Q7]WIC.=:2[0%."> [:0-*]\Y2N7
M2HQQHA[QB$?,W.?<YS[W]/X(OQPY)-@L!?"=&%L=,69,G,[<GKS<Y2XW=7P[
M,?9? =CF;+/K0A>ZT" Y8NV7?!WV[DUO>M/2YH /L/_^^\]DZUWB$I>89BQV
M8NQGH_1V#9@$: C:AX2]N>UM;UOUB^=9HX*&4N#@Y_1NFFG+1T*: H/"S]BF
M(;W"AC_VL8_=(CL26-%JEWRWLYSE+-//"8+X;_SRU!8,^3(;A1A;MH@?XDS4
M]$(J[K???@L38^S*&!NR"F+LHQ_]Z P #L0I 4=$IOI][WO?ZA[B"[_^]:_O
MQ-B*B+%O?.,;DQO=Z$8S,1."N]6'VW???;.^L)^]^]WO7F@/\=]O<YO;S)!.
M[#.[N*@@K]C1TER)*20 Q,^BK\34M3FVMS_P@0\TC4$B8.I+B!?2K'781 Z$
M)/>___VGL5MM3,#FUC'!"M)U(;;Q>?$9'RF0;7RADKSE+6\Y_F]C\&S(9O,!
MD$W>#5!V$7G:TYXVC;=R<T*?2@!<U#^#EY0(E[4DQDIB?97(P;4@Q@@@-_5A
MXXMOI]JJ).)HX&W\&9B/]9@F<K,K/_WI3]><&(/M("=S%3OQM>NNNTY^\I.?
M%._SRU_^<NKSQ@FUQOWE+W^YN!ZLPY <Q>> 7<9_*V$U]47$I2D0OVIB#"[*
M+ZP1^1*AAY(+5TV,&6>-X%$1PQ;DA!^<8C[A4A4VM*?AT6EEF.L:U[C&S#M\
MZ4M?>KQ=,&\E?],%>ZL]6ZR8VZ,O?.$+IWI;DGKJ2\!\MV9BC/T*A!\;FNY?
M_Z;#EDWH;,W$V).>]*1LP8[*NN KV9_ILV%0VP0Q!D *P6\M>$&FF)!<X!:<
M;8#$6".3.L6!;+%1&=W<LRBD,5E LC(H_'C>D$P"149R+8DQSY0U TR0S1$6
M6:@@>^ #'UA4?.8ES88V[Q;\&&(,L X<J65QYC)4 XD7,O!L/%G5LGHZ,=:)
ML2"R6ZSM]'/6*>?WGO>\YQ9[Q5H9*F,6X*=M H"<N6SC%N&@7_SB%Y\"R#+"
M@3,R14/VZQAB3&98JD/-,S!QK CB<F05 WCPP0<OE1CCN.^VVV[9TGKS+>LS
M#50",2"P'2M''GGD5+]9.YQ.&;(( 6->).MX,Q!C0"P@;&X_LA<<YF4 2=L*
M,>:^,N5S\X6T_]C'/E;]/%!7\%*RP_;VO%G.J0BD[(?T.3*ZAP"F3HS-SD?.
M3XCMC8##^J@)@"+-J$\O%<LU4 SX >P$1$CB0$H!V/AY.:%O@1NIK;4V!"IQ
M(+WSSCL/^JCT@<K?.,#Q_7????<B !N+S&B!LJ 2L>*]>6X\/OZ[:JG-2(P%
MTB#U2^)W--9.YN(K]O9M;WO;NA)C"+ [WO&.6]P3&,M.#@% I0QGEWBFM;*>
M_W/UJU]]IG(@S+$]C:Q+GR'CFE_5<N6JC'T><)+^;<L>(NQ$3K^;F]9QL>^Y
MS]?&16]*N$Q!7#$;/[Q5Q,@WN,$-LLDX\_B!J8A%4__9N(?T2JMMS8T]WJ.?
M^]SGLL1LFCV?VM?6ZBR@5USM&_1Z"CQ)MBGM47JA5H$1_))2%5LJ\),XT2+X
MMO88'SV IW1)K0J!74KUGUAJR)]7%<V>(6C9R45$W&8MYKKI2+A<1.\%D3PN
M87"C$F,IZ=FJ5Q[TH ?-Z&=Z/7VG*G_-<_IY.C?,KXKI&']*05-Q"M"V]#[$
MM'',+4G;>A3WI+&5)-&<#[=J8DQ,,E2!ZF*O<X1"$.^<_YCJ '-0LBOV84A"
M5R49DT/BPS16]RZ0\JFLFACS;DH^45Q9,@32KYH8@QW!<VJ5H*4J(KJS1(ZJ
MNAW2?_:HN4[WB/6?WA?&'^XG/JH1CFQ-;5X]%R:1/I=]D2B1%F=(?,G=;VLB
MQG36"#I!LJ.U&7]_>$"M4G,S$F//?>YSL^\7=BRNQ!NE)*IK584*:TJ,>4%#
M6;$F)U0J,&@46FDLLJA:G1"&@>.>,V(,*& V!_Z&,<G(:!'C 8*GG\?,&P.&
M?2V(,4929E,,;FA3EF;0&*\Q869SC*V?Q4;'LRBZ,<289R"XTH4?&R'OP,8$
M^@/B@>BAA-P8.(G(#^-/E6DGQM:>&!-\>S_V\WH38X%82C-3C$756+Q&E;%[
M3@O)EX*F\3X>(XCRN.HQK"/.3G!FQQ!C@,ZT#9I]Z7YC@S)E^#%Q&(,0H6U1
MB1CC,(Y95XBJM'+4G'*<[5=.=0Y4$$@A[\:(=\1@IZT9P_,Z,5:?.P!4*3 '
MNK_WO>_=*H'E51%CLA&!-KGY$@#4LCEC @=YGKN'=S$O*9_Z$$"75%?RI5K:
ML*TE,48'JT!:M&7G*HDQ I1(_: T*W,(T >6IKHO#4",K1:@ RL$92UD&B*6
M?Y/ZPS>^\8VG6?DQ,&X<"("6X-,>2K/I?:\A4!=8&=JVFB\50Y*EXF HM'.L
M 4!K38P!O1!_?-.UD%I%RKWO?>_!MCHMQ!B"=DQKN2%B3$QICH9:8*8VR#UB
MLB!4E@^1 CG0.LY S;7$RHGUE]I8,4I,-.?:D(YI9VE><I]?%%SG]Z;WE0G>
M*O>[W_VRGZ^-"]&2@J622KWW,3ZSOS6O:<(F8&\9?@?R*O6?/4MR[*)G]!@[
M/9:KMN+S6U,Y@%W%6NT<(81"*SC+9J;D ]V9QO<(I5++0OLLK<Q*+WO3?FL1
M^C'U)Q&F@%"^0R"6_']IC?DY&Q@#N7SF(;*4CF8'$0S+(%;-&3N9VF?O;]%J
MM""JDTKM-3<:,39&Q-XI.< _3GT&N )<:FB.^&^URC5)!J4JG)3\5=D!!Q0?
MQFL,9H"DR\W;*HDQ?JA$CJ&6II(W2LE/L?#I4G 9-E/R=W6/"#&IF"$&\U_\
MXA?/V$;)!3E2>Y7$F+B*/U0['@;AU1)_K9(8XY?1#Z5Q6GLUPKY&4$F":?'-
M[:ETK::DF-]['V&MBY-JZP]V)":L"7\RQ6S%RK#8>.]ZMH2HW#Y;*V+,]Q%O
MSGO^%]L0$Y#L?5KIQ^<;BF$V&S$F7LOM#44$[#[B+/T]_V25R=EK0HQQ.&4]
M#YUMQ>&(-X;/E?J44F*M[9PP\;G*",]4L1# K5)I-L>Y)=/00DB#30O&BR7
MYAPQ-M3:;2PQ9AQI%8T-&L:1FQ]!1]K'UKUC)S\FAEJ)L0#$Y$!O8^)<:)N"
MP/$L]T#&,7@VJ])VBH0"%MCV,\;6EQBCC&2 JAB*@8KU),8X=X*F]',I,<)1
MS65LYL:3 XVL2YFS8P29R[F*[\/9=MY63.RU$F-(294!Z=_:BT/ 42YH3 -@
M 2]@)$B)&#,V07BK6#/I=PSGBP5PU/UR:\#^KK7%R*V''#CJ_7'*-IIL)&+,
M/)=:^PBLM!59=G_LK9T8LW]S23_TGXSHUK$YT+H41 J20Q7G(H1G>GY"V!=
MA(U"C/%UK&, 9DO2T'H28WSFFF_+!M$Y-2>>[X5P+A%C=+)[U$ M 01P-UX_
M@)_47O&-@-5IU81J!I6-0) 8J )HONI5KVJ:"_YX"LA96P+$VMCY)]Z%1"X)
M77RT%+SF#[;$'VM%C+&+@NC;W>YVS=4<BXIS,M)*JM!*>2PYAR#(M3AG@\=D
MM-:(,7;"OX%FM19II7T;5VSQYZR-&FC!A\A52P5=3/>7R(!TGE-]+E9)/]^)
ML?^*Q,=TO\9G68G_QMAH %7.#O*%EW'>IC@XU7_\67'&(C:6Y"I.0K5A":\
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M5:NY2MN<K?>]M1"DG\6BI39=8J:8B#-/=$=,O)EC_F5)OWJ7?/E:0BO@6\4
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M^A@I+G8U+M]CZ-S77+P X*KY\VR*\4EP:;5/]+'J$',SUN]$CO(YXO;Q_-=
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3_5I:TJ/Y!     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Mar. 25, 2025</div></th>
<th class="th"><div>Jul. 01, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 28,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-19621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ALT5 Sigma Corporation<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">41-1454591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">325 E. Warm Springs Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Las Vegas<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NV<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">89119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">997-5968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ALTS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,078,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000862861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_AuditorAbstract', window );"><strong>Auditor [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">6849<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Hudgens CPA, PLLC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Houston, Texas<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_AuditorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Auditor</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_AuditorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 7,177<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsAndOtherReceivablesNetCurrent', window );">Trade and other receivables, net</a></td>
<td class="nump">2,530<span></span>
</td>
<td class="nump">266<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_PlatformOperatorCryptoAssetHeldForUserCurrent', window );">Digital assets receivable</a></td>
<td class="nump">23,776<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,518<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">35,001<span></span>
</td>
<td class="nump">346<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">1,170<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use assets</a></td>
<td class="nump">121<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">34,430<span></span>
</td>
<td class="nump">17,846<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">286<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DepositsAndOtherAssetsNoncurrent', window );">Deposits and other assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">11,714<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">82,436<span></span>
</td>
<td class="nump">18,487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">3,231<span></span>
</td>
<td class="nump">2,272<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">2,553<span></span>
</td>
<td class="nump">3,633<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DigitalAssetLiabilityCurrent', window );">Digital assets payable</a></td>
<td class="nump">30,918<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertible debentures</a></td>
<td class="nump">563<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">40,937<span></span>
</td>
<td class="nump">5,905<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes, net</a></td>
<td class="nump">1,041<span></span>
</td>
<td class="nump">639<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Notes payable</a></td>
<td class="nump">11,570<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other noncurrent liabilities</a></td>
<td class="nump">108<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">53,769<span></span>
</td>
<td class="nump">7,285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Note 21)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.001 per share, 200,000,000 shares authorized, 15,417,693 and 2,827,410 shares issued and outstanding at December&#160;28, 2024 and at December&#160;30, 2023, respectively</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid in capital</a></td>
<td class="nump">62,207<span></span>
</td>
<td class="nump">47,323<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(56,879)<span></span>
</td>
<td class="num">(50,634)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(2,317)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Equity attributable to ALT5 Sigma Corporation shareholders</a></td>
<td class="nump">20,886<span></span>
</td>
<td class="num">(3,308)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest</a></td>
<td class="nump">3,925<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">24,811<span></span>
</td>
<td class="num">(3,308)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, mezzanine equity, and stockholders' equity</a></td>
<td class="nump">82,436<span></span>
</td>
<td class="nump">18,487<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=alts_SeriesA1ConvertiblePreferredStockMember', window );">Convertible preferred stock, series A-1 - par value $0.001 per share 2,000,000 authorized, 23,480 and 193,730 shares issued and outstanding at December&#160;28, 2024 and December&#160;30, 2023, respectively</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Preferred stock, series B - par value $0.001 per share, 34,250 authorized, 34,207 and 0 shares issued and outstanding at December&#160;28, 2024 and December&#160;30, 2023, respectively</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="nump">8,552<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=alts_SeriesIConvertiblePreferredStockMember', window );">Convertible preferred stock, series I - par value $0.001 per share, 2,000,000 authorized, 17,000 and 0 shares issued and outstanding at December&#160;28, 2024 and December&#160;30, 2023, respectively</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=alts_SeriesMPreferredStockMember', window );">Preferred stock, series M - par value $0.001 per share, 3,200 authorized, 3,200 and 0 shares issued and outstanding at December&#160;28, 2024 and December&#160;30, 2023, respectively</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=alts_SeriesQConvertiblePreferredStockMember', window );">Convertible Preferred stock, series Q - par value $0.001 per share, 2,000,000 authorized, 925,212 and 0 shares issued and outstanding at December&#160;28, 2024 and December&#160;30, 2023, respectively</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="nump">1,321<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=alts_SeriesSConvertiblePreferredStockMember', window );">Convertible preferred stock, series S - par value $0.001 per share, 200,000 authorized, 100,000 and 100,000 shares issued and outstanding at December&#160;28, 2024 and December&#160;30, 2023, respectively</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_MezzanineEquityAbstract', window );"><strong>Mezzanine equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Convertible preferred stock, series S - par value $0.001 per share 200,000 authorized, 100,000 shares issued and outstanding at December&#160;28, 2024 and December&#160;30, 2023</a></td>
<td class="nump">3,856<span></span>
</td>
<td class="nump">14,510<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="nump">7,993<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=alts_SeriesVConvertiblePreferredStockMember', window );">Convertible preferred stock, series V - par value $0.001 per share, 125,000 authorized, 5,000 shares and 0 issued and outstanding at December&#160;28, 2024 and December&#160;30, 2023, respectively</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Due to Soin</a></td>
<td class="nump">2,850<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Notes payable</a></td>
<td class="nump">812<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermNotesPayable', window );">Related party notes payable</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 707<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DepositsAndOtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deposits and other assets noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DepositsAndOtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DigitalAssetLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Digital Asset, Liability, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DigitalAssetLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_MezzanineEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Mezzanine equity [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_MezzanineEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_PlatformOperatorCryptoAssetHeldForUserCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Platform Operator, Crypto Asset, Held-for-User, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_PlatformOperatorCryptoAssetHeldForUserCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndOtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsAndOtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term notes classified as other, payable after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 43: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 44: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 45: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 46: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 47: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 48: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.E.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=alts_SeriesA1ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=alts_SeriesA1ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=alts_SeriesIConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=alts_SeriesIConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=alts_SeriesMPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=alts_SeriesMPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=alts_SeriesQConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=alts_SeriesQConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=alts_SeriesSConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=alts_SeriesSConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=alts_SeriesVConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=alts_SeriesVConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued shares (in shares)</a></td>
<td class="nump">15,417,693<span></span>
</td>
<td class="nump">2,827,410<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding shares (in shares)</a></td>
<td class="nump">15,417,693<span></span>
</td>
<td class="nump">2,827,410<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=alts_SeriesA1ConvertiblePreferredStockMember', window );">Series A1 Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Convertible preferred stock/Preferred stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Convertible preferred stock/Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Convertible preferred stock/Preferred stock, shares issued (in shares)</a></td>
<td class="nump">23,480<span></span>
</td>
<td class="nump">193,730<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Convertible preferred stock/Preferred stock, outstanding (in shares)</a></td>
<td class="nump">23,480<span></span>
</td>
<td class="nump">193,730<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Convertible preferred stock/Preferred stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Convertible preferred stock/Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">34,250<span></span>
</td>
<td class="nump">34,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Convertible preferred stock/Preferred stock, shares issued (in shares)</a></td>
<td class="nump">34,207<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Convertible preferred stock/Preferred stock, outstanding (in shares)</a></td>
<td class="nump">34,207<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=alts_SeriesIConvertiblePreferredStockMember', window );">Series I Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Convertible preferred stock/Preferred stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Convertible preferred stock/Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Convertible preferred stock/Preferred stock, shares issued (in shares)</a></td>
<td class="nump">17,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Convertible preferred stock/Preferred stock, outstanding (in shares)</a></td>
<td class="nump">17,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=alts_SeriesMPreferredStockMember', window );">Series M Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Convertible preferred stock/Preferred stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Convertible preferred stock/Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">3,200<span></span>
</td>
<td class="nump">3,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Convertible preferred stock/Preferred stock, shares issued (in shares)</a></td>
<td class="nump">3,200<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Convertible preferred stock/Preferred stock, outstanding (in shares)</a></td>
<td class="nump">3,200<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=alts_SeriesQConvertiblePreferredStockMember', window );">Series Q Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Convertible preferred stock/Preferred stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Convertible preferred stock/Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Convertible preferred stock/Preferred stock, shares issued (in shares)</a></td>
<td class="nump">925,212<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Convertible preferred stock/Preferred stock, outstanding (in shares)</a></td>
<td class="nump">925,212<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=alts_SeriesSConvertiblePreferredStockMember', window );">Series S Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Convertible preferred stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Convertible preferred stock, shares authorized (in shares)</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Convertible preferred stock, shares issued (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Convertible preferred stock/Preferred stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Convertible preferred stock/Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Convertible preferred stock/Preferred stock, shares issued (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Convertible preferred stock/Preferred stock, outstanding (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=alts_SeriesVConvertiblePreferredStockMember', window );">Series V Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Convertible preferred stock/Preferred stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Convertible preferred stock/Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">125,000<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Convertible preferred stock/Preferred stock, shares issued (in shares)</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Convertible preferred stock/Preferred stock, outstanding (in shares)</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=alts_SeriesA1ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=alts_SeriesA1ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=alts_SeriesIConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=alts_SeriesIConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=alts_SeriesMPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=alts_SeriesMPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=alts_SeriesQConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=alts_SeriesQConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=alts_SeriesSConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=alts_SeriesSConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=alts_SeriesVConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=alts_SeriesVConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 12,532<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenues</a></td>
<td class="nump">6,238<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">6,294<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">13,856<span></span>
</td>
<td class="nump">4,746<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,100<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">13,856<span></span>
</td>
<td class="nump">19,846<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(7,562)<span></span>
</td>
<td class="num">(19,846)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest (expense) income, net</a></td>
<td class="num">(879)<span></span>
</td>
<td class="nump">2,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_RealizedGainLossOnExchangeTransactions', window );">Realized gain on exchange transactions</a></td>
<td class="nump">374<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized loss on marketable securities</a></td>
<td class="num">(1,058)<span></span>
</td>
<td class="num">(926)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="num">(161)<span></span>
</td>
<td class="nump">998<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other (expense) income, net</a></td>
<td class="num">(1,724)<span></span>
</td>
<td class="nump">2,322<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before benefit from income taxes</a></td>
<td class="num">(9,286)<span></span>
</td>
<td class="num">(17,524)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="num">(3,041)<span></span>
</td>
<td class="num">(429)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Net loss from continuing operations</a></td>
<td class="num">(6,245)<span></span>
</td>
<td class="num">(17,095)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax', window );">Income from discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation', window );">Income tax provision for discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">971<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Net income from discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,283<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (6,245)<span></span>
</td>
<td class="num">$ (7,812)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>(Loss) income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Net loss per share from continuing operations, basic (in usd per share)</a></td>
<td class="num">$ (0.56)<span></span>
</td>
<td class="num">$ (4.27)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Net loss per share from continuing operations, diluted (in usd per share)</a></td>
<td class="num">(0.56)<span></span>
</td>
<td class="num">(4.27)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare', window );">Net income per share from discontinued operations, basic (in usd per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2.32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare', window );">Net income per share from discontinued operations, diluted (in usd per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2.09<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic (in usd per share)</a></td>
<td class="num">(0.56)<span></span>
</td>
<td class="num">(1.95)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted (in usd per share)</a></td>
<td class="num">$ (0.56)<span></span>
</td>
<td class="num">$ (1.95)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">11,148,493<span></span>
</td>
<td class="nump">4,005,334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">11,148,493<span></span>
</td>
<td class="nump">4,444,361<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_RealizedGainLossOnExchangeTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Realized Gain (Loss) On Exchange Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_RealizedGainLossOnExchangeTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) on gain (loss) not previously recognized resulting from the disposal of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 17: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income (expense) classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Qoden Technologies, LLC</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid in Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Accumulated Other Comprehensive Deficit</div></th>
<th class="th"><div>Noncontrolling Interest</div></th>
<th class="th">
<div>Series A-1 Preferred </div>
<div>Preferred Stock</div>
</th>
<th class="th">
<div>Series S-1 Preferred </div>
<div>Preferred Stock</div>
</th>
<th class="th"><div>Series B Preferred</div></th>
<th class="th">
<div>Series B Preferred </div>
<div>Preferred Stock</div>
</th>
<th class="th">
<div>Series I Preferred </div>
<div>Preferred Stock</div>
</th>
<th class="th"><div>Series M Preferred</div></th>
<th class="th">
<div>Series M Preferred </div>
<div>Preferred Stock</div>
</th>
<th class="th">
<div>Series Q Preferred </div>
<div>Preferred Stock</div>
</th>
<th class="th">
<div>Series Q Preferred </div>
<div>Preferred Stock </div>
<div>Qoden Technologies, LLC</div>
</th>
<th class="th">
<div>Series V Preferred </div>
<div>Preferred Stock</div>
</th>
<th class="th"><div>Common Class A</div></th>
<th class="th">
<div>Common Class A </div>
<div>Common Stock</div>
</th>
<th class="th">
<div>Common Class A </div>
<div>Additional Paid in Capital</div>
</th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222,588<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">$ 2,307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 45,748<span></span>
</td>
<td class="num">$ (42,822)<span></span>
</td>
<td class="num">$ (621)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,150,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other comprehensive loss</a></td>
<td class="nump">621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock issued for equity financing (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">779,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common stock issued for equity financing</a></td>
<td class="nump">793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">792<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share based compensation</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Series A-1 preferred converted for legal settlement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">547,069<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27,353)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Series A-1 preferred converted for legal settlement</a></td>
<td class="nump">510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Series A-1 Preferred forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,505)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Common stock issued for warrants exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">481,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_StockIssuedDuringPeriodValueWarrantsExercised', window );">Common stock issued for warrants exercised</a></td>
<td class="nump">259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(7,812)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,812)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193,730<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 30, 2023</a></td>
<td class="num">$ (3,308)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">47,323<span></span>
</td>
<td class="num">(50,634)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 30, 2023</a></td>
<td class="nump">2,827,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,957,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock issued for equity financing (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,030,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common stock issued for equity financing</a></td>
<td class="nump">$ 1,033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">1,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_AdjustmentToAdditionalPaidInCapitalReclassificationsOfTemporaryToLiability', window );">Reclassification of Series S S-1 Preferred Stock to liability</a></td>
<td class="num">(339)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(339)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationsOfTemporaryToPermanentEquity', window );">Reclassification of Series S S-1 Preferred Stock to permanent equity</a></td>
<td class="nump">7,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share based compensation</a></td>
<td class="nump">1,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Series A-1 preferred converted for legal settlement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,055,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(170,250)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Common stock issued for consulting agreement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">477,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Common stock issued for consulting agreement</a></td>
<td class="nump">1,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">1,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_StockIssuedDuringPeriodSharesIssuedInLieuOfNotesPayable', window );">Common stock issued in lieu of notes payable obligation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,031,595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable', window );">Common stock issued in lieu of notes payable obligation</a></td>
<td class="nump">2,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Stock issued for acquisition of Alt5 Subsidiary and Qoden assets (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,207<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">925,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,799,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Stock issued for acquisition of Alt5 Subsidiary and Qoden assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,552<span></span>
</td>
<td class="nump">$ 8,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,447<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 7,447<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets', window );">Stock issued for property and equipment (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets', window );">Stock issued for property and equipment</a></td>
<td class="nump">1,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_StockIssuedDuringPeriodSharesPrepaidInterest', window );">Common stock issued for prepaid interest (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_StockIssuedDuringPeriodValuePrepaidInterest', window );">Common stock issued for prepaid interest</a></td>
<td class="nump">380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Common stock issued for warrants exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">290,908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_StockIssuedDuringPeriodValueWarrantsExercised', window );">Common stock issued for warrants exercised</a></td>
<td class="nump">497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency adjustment</a></td>
<td class="num">(2,317)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,317)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(2,320)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,245)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 28, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,480<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">34,207<span></span>
</td>
<td class="nump">34,207<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
<td class="nump">3,200<span></span>
</td>
<td class="nump">3,200<span></span>
</td>
<td class="nump">925,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 28, 2024</a></td>
<td class="nump">$ 24,811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 62,207<span></span>
</td>
<td class="num">$ (56,879)<span></span>
</td>
<td class="num">$ (2,317)<span></span>
</td>
<td class="nump">$ 3,925<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,552<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 28, 2024</a></td>
<td class="nump">15,417,693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,417,693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_AdjustmentToAdditionalPaidInCapitalReclassificationsOfTemporaryToLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment To Additional Paid in Capital, Reclassifications of Temporary To Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_AdjustmentToAdditionalPaidInCapitalReclassificationsOfTemporaryToLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_StockIssuedDuringPeriodSharesIssuedInLieuOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Issued In Lieu Of Notes Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_StockIssuedDuringPeriodSharesIssuedInLieuOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_StockIssuedDuringPeriodSharesPrepaidInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Prepaid Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_StockIssuedDuringPeriodSharesPrepaidInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_StockIssuedDuringPeriodSharesWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_StockIssuedDuringPeriodSharesWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Issued In Lieu Of Notes Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_StockIssuedDuringPeriodValuePrepaidInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Prepaid Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_StockIssuedDuringPeriodValuePrepaidInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_StockIssuedDuringPeriodValueWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_StockIssuedDuringPeriodValueWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationsOfTemporaryToPermanentEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationsOfTemporaryToPermanentEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 43: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 44: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 45: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 46: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 47: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 48: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Net (loss) income from continuing operations</a></td>
<td class="num">$ (6,245)<span></span>
</td>
<td class="num">$ (17,095)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">3,402<span></span>
</td>
<td class="nump">1,452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Change in reserve for uncollectible accounts</a></td>
<td class="nump">254<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialGuaranteeInsuranceContractsPremiumsReceivableAccretionOfDiscountOnPremiumReceivable', window );">Accretion of note receivable discount</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,223)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation expense</a></td>
<td class="nump">1,657<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForLoanLeaseAndOtherLosses', window );">Bad debt expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashContributionExpense', window );">Noncash expense for consulting services</a></td>
<td class="nump">271<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Related party notes issued for shared services</a></td>
<td class="nump">800<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Write off of VM7 note receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_GainLossOnWriteOffOfNotesReceivable', window );">Write off of SPYR note receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized loss on marketable securities</a></td>
<td class="nump">1,058<span></span>
</td>
<td class="nump">926<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of right-of-use assets</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CryptoAssetUnrealizedGainLossOperating', window );">Unrealized gain on digital assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Change in deferred income taxes</a></td>
<td class="num">(3,229)<span></span>
</td>
<td class="nump">444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">1,876<span></span>
</td>
<td class="num">(367)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_IncreaseDecreaseInDigitalAssetsReceivable', window );">Digital assets receivable</a></td>
<td class="num">(14,694)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">780<span></span>
</td>
<td class="nump">320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">1,648<span></span>
</td>
<td class="num">(1,052)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_IncreaseDecreaseInDigitalAssetsPayable', window );">Digital assets payable</a></td>
<td class="nump">14,155<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations', window );">Operating cash flows provided by discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,319<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">1,777<span></span>
</td>
<td class="nump">1,463<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired in ALT5 Subsidiary acquisition</a></td>
<td class="nump">5,853<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations', window );">Investing cash flows used in discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(155)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">5,853<span></span>
</td>
<td class="num">(155)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from issuance of notes payable</a></td>
<td class="nump">7,237<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Payments on related party note</a></td>
<td class="num">(248)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from the issuance of related party note payable</a></td>
<td class="nump">603<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from equity financings, net</a></td>
<td class="nump">851<span></span>
</td>
<td class="nump">792<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Warrants exercised</a></td>
<td class="nump">497<span></span>
</td>
<td class="nump">259<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Payments on short term notes payable</a></td>
<td class="num">(2,847)<span></span>
</td>
<td class="num">(274)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations', window );">Financing cash flows used in discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,212)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">6,093<span></span>
</td>
<td class="num">(1,435)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Effect of changes in exchange rate on cash and cash equivalents</a></td>
<td class="num">(6,551)<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</a></td>
<td class="nump">7,172<span></span>
</td>
<td class="num">(110)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">CASH AND CASH EQUIVALENTS, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations', window );">LESS CASH OF DISCONTINUED OPERATIONS, end of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS OF CONTINUING OPERATIONS, end of period</a></td>
<td class="nump">7,177<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow disclosures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_NoncashRecognitionOfNewLeases', window );">Noncash recognition of new leases</a></td>
<td class="nump">121<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">296<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income tax refunds received, net</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSignificantNoncashTransactionsLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Notes payable converted to common stock</a></td>
<td class="nump">1,660<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis=alts_OtherSignificantNoncashTransactionBusinessAcquisitionMember', window );">Stock issued for the acquisition of Alt5 Subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSignificantNoncashTransactionsLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Stock issued</a></td>
<td class="nump">16,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis=alts_OtherSignificantNoncashTransactionConsultingServicesMember', window );">Common stock issued for consulting services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSignificantNoncashTransactionsLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Stock issued</a></td>
<td class="nump">853<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis=alts_OtherSignificantNoncashTransactionLiabilityObligationsMember', window );">Common stock issued for liability obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSignificantNoncashTransactionsLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Stock issued</a></td>
<td class="nump">367<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis=alts_OtherSignificantNoncashTransactionInterestObligationsMember', window );">Common stock issued for interest obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSignificantNoncashTransactionsLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Stock issued</a></td>
<td class="nump">380<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis=alts_OtherSignificantNoncashTransactionPropertyAndEquipmentMember', window );">Common stock issued for property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSignificantNoncashTransactionsLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Stock issued</a></td>
<td class="nump">1,170<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis=alts_OtherSignificantNoncashTransactionIntangibleAssetsMember', window );">Preferred stock issued for intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSignificantNoncashTransactionsLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Stock issued</a></td>
<td class="nump">$ 1,321<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_GainLossOnWriteOffOfNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Write-Off Of Notes Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_GainLossOnWriteOffOfNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_IncreaseDecreaseInDigitalAssetsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Digital Assets Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_IncreaseDecreaseInDigitalAssetsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_IncreaseDecreaseInDigitalAssetsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Digital Assets Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_IncreaseDecreaseInDigitalAssetsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_NoncashRecognitionOfNewLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash recognition of new leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_NoncashRecognitionOfNewLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; attributable to disposal group, including, but not limited to, discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of financing activities of discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of investing activities of discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetUnrealizedGainLossOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) from remeasurement of crypto asset, classified as operating. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476167/350-60-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetUnrealizedGainLossOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialGuaranteeInsuranceContractsPremiumsReceivableAccretionOfDiscountOnPremiumReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accretion of the discount for premiums receivable on financial guarantee insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)(4)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477363/944-310-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialGuaranteeInsuranceContractsPremiumsReceivableAccretionOfDiscountOnPremiumReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashContributionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash charitable contributions made by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashContributionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSignificantNoncashTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSignificantNoncashTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForLoanLeaseAndOtherLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related loan transactions, lease transactions, credit loss from transactions other than loan and lease transactions, and other loss based on assessment of uncollectability from the counterparty to reduce the account to their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-11B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForLoanLeaseAndOtherLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis=alts_OtherSignificantNoncashTransactionBusinessAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis=alts_OtherSignificantNoncashTransactionBusinessAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis=alts_OtherSignificantNoncashTransactionConsultingServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis=alts_OtherSignificantNoncashTransactionConsultingServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis=alts_OtherSignificantNoncashTransactionLiabilityObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis=alts_OtherSignificantNoncashTransactionLiabilityObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis=alts_OtherSignificantNoncashTransactionInterestObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis=alts_OtherSignificantNoncashTransactionInterestObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis=alts_OtherSignificantNoncashTransactionPropertyAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis=alts_OtherSignificantNoncashTransactionPropertyAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis=alts_OtherSignificantNoncashTransactionIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis=alts_OtherSignificantNoncashTransactionIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Background and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Background and Basis of Presentation</a></td>
<td class="text">Background and Basis of Presentation<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements include the accounts of ALT5 Sigma Corporation, a Nevada corporation, and its subsidiaries (collectively, the &#8220;Company&#8221; or &#8220;ALT5&#8221;). Effective July 15, 2024, the Company changed its corporate name from &#8220;JanOne Inc.&#8221; to &#8220;ALT5 Sigma Corporation,&#8221; and also changed its Nasdaq common stock ticker symbol from &#8220;JAN&#8221; to &#8220;ALTS&#8221;. The corporate name change was effected through a parent/subsidiary short-form merger of ALT5 Sigma Corporation, the Company&#8217;s wholly-owned Nevada subsidiary formed solely for the purpose of effectuating the name change), whereby it merged with and into the Company, with the Company being the surviving entity, albeit with its new name.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had three operating segments &#8211; Fintech, Biotechnology, and Corporate and Other. In connection with the sale of ARCA Recycling, Inc. (&#8220;ARCA Recycling&#8221;), the accounts for the Recycling segment have been presented as discontinued operations in the accompanying consolidated financial statements (See Note 4).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Fintech</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 15, 2024, the Company acquired ALT5 Sigma, Inc. (&#8220;ALT5 Subsidiary&#8221;). ALT5 Subsidiary is a fintech company that provides next generation blockchain-powered technologies to enable a migration to a new global financial paradigm. ALT5 Subsidiary, through its respective subsidiaries, offers two main platforms to its customers: &#8220;ALT5 Pay&#8221; and &#8220;ALT5 Prime.&#8221; ALT5 Pay is a crypto-currency payment gateway that enables registered and approved global merchants to accept and make crypto-currency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay&#8217;s checkout widgets and APIs. Merchants have the option to convert to fiat currency (US Dollars, Canadian Dollars, Euros, and British Pounds Sterling) automatically or to receive their payment in digital assets (see Note 3).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Biotechnology</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During September 2019, ALT5 Sigma Corporation, through its biotechnology segment, broadened its business perspectives to become a pharmaceutical company focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. Effective December 28, 2022, the Company acquired Soin Therapeutics LLC, a Delaware limited liability company (&#8220;STLLC&#8221;), and its product, a patent-pending, novel formulation of low-dose naltrexone, (&#8220;JAN123&#8221;). The product is being developed for the treatment of Complex Regional Pain Syndrome (CRPS), an indication that causes severe, chronic pain generally affecting the arms or legs. At present, there are no truly effective treatments for CRPS. Because of the relatively small number of patients afflicted with CRPS, the FDA has granted Orphan Drug Designation for any product approved for treatment of CRPS. This designation will provide the Company with tax credits for its clinical trials, exemption of user fees, and the potential of seven years of market exclusivity following approval. In addition, development of orphan drugs currently also involves smaller trials and quicker times to approval, given the limited number of patients available to study. However, there can be no assurance that the product will receive FDA approval or that it will result in material sales. In that regard, we have previously announced our intention to capitalize a subsidiary with certain of our biotechnology assets, acquire an additional biotechnology asset, and then engage in a financing of that subsidiary. The short-term intended result of that series of transactions would be for us to own a controlling interest in that subsidiary, but to decouple it from us so that it would operate on a stand-alone basis.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Recycling</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Recycling Subsidiaries constituted the Company&#8217;s Recycling segment and provided turnkey recycling services for electric utility energy efficiency programs in the United States. ARCA Recycling and ARCA Canada recycled major household appliances in North America by providing turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs. Connexx provided call center services for ARCA Recycling and ARCA Canada. On March 9, 2023, retroactive to March 1, 2023, the Company entered into a Stock Purchase Agreement (the &#8220;Recycling Purchase Agreement&#8221; with VM7 Corporation (&#8220;VM7&#8221;), under which it agreed to acquire all of the outstanding equity interests of the Recycling Subsidiaries. The principal of VM7 is Virland A. Johnson, our Chief Financial Officer. The sale of all of the outstanding equity interests of the Recycling Subsidiaries to VM7 under the Recycling Purchase Agreement was consummated simultaneously with the execution of the Recycling Purchase Agreement (see Note 4). The Company&#8217;s Board of Directors unanimously approved the Recycling Purchase Agreement and the Disposition Transaction. In connection with the disposition of the Recycling Subsidiaries, accounts for the Recycling segment have been presented as discontinued operations in the accompanying consolidated financial statements (See Note 4).</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Corporate and Other</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Corporate and Other segment consists of certain corporate general and administrative costs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports on a 52- or 53-week fiscal year. The Company's 2024 fiscal year (&#8220;2024&#8221;) ended on December&#160;28, 2024, and our fiscal year (&#8220;2022&#8221;) ended on December&#160;30, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Going concern</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying financial statements have been prepared under the assumption that the Company will continue as a going concern. Such assumption contemplates the realization of assets and satisfaction of liabilities in the normal course of business, however, the issues described below raise substantial doubt about the Company&#8217;s ability to do so.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company currently faces a challenging competitive environment and is focused on improving its overall profitability, which includes managing expenses. The Company reported a net loss from continuing operations of approximately $6.2 million for the year ended December&#160;28, 2024, and net loss from continuing operations of approximately $17.1 million for the fiscal year ended December&#160;30, 2023. Additionally, as of December&#160;28, 2024, the Company has total current assets of approximately $35.0 million and total current liabilities of approximately $40.9 million resulting in a net negative working capital of approximately $5.9 million. Cash provided by operations was approximately $1.0 million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company intends to raise funds to support future development of JAN 123 and JAN 101 and through a combination of cash flows derived from its acquisition of ALT5 (see Note 3), capital raises, and/or structured arrangements. However, the success of such funding cannot be assured. We currently expect that the biotechnology subsidiary transaction discussed above will allow us to finance our Phase III clinical trial for JAN123. No assurance can be given any financing obtained may not further dilute or otherwise impair the ownership interest of our existing stockholders or our ownership interest in the to-be-effectuated biotechnology subsidiary. The short-term intended result of that transaction would be for us to own a controlling interest in that subsidiary, but to decouple it from us so that it would operate on a stand-alone basis.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Statement Reclassification</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain account balances from prior periods have been reclassified in these consolidated financial statements to conform to current period classifications.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumption that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant estimates made in connection with the accompanying consolidated financial statements include the fair values in connection with the GeoTraq promissory note, analysis of other intangibles and long-lived assets for impairment, valuation allowance against deferred tax assets, lease terminations, and estimated useful lives for intangible assets and property and equipment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Instruments</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments consist primarily of cash equivalents, trade and other receivables, notes receivables, and obligations under accounts payable, accrued expenses and notes payable. The carrying amounts of cash equivalents, trade receivables and other receivables, accounts payable, accrued expenses and short-term notes payable approximate fair value because of the short maturity of these instruments. The fair value of the long-term debt is calculated based on interest rates available for debt with terms and maturities similar to the Company&#8217;s existing debt arrangements, unless quoted market prices were </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">available (Level 2 inputs). The carrying amounts of long-term debt at December&#160;28, 2024 and December&#160;30, 2023 approximate fair value. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of highly liquid investments with a maturity of three months or less at the time of purchase. Fair value of cash equivalents approximates carrying value.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Digital Assets and other Receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">s</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Digital assets and other receivables are the Company&#8217;s digital assets and its customer prepayments in the form of digital assets. The Company holds all digital assets in secure non-custodial wallets through the wallet services from Fireblocks. As of December&#160;28, 2024, the outstanding balance of digital assets and other receivables was approximately $23.8 million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Receivables and Allowance for Doubtful Accounts</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company carries unsecured other receivables at the original invoice amount less an estimate made for doubtful accounts based on a monthly review of all outstanding amounts. Management determines the allowance for doubtful accounts by regularly evaluating receivables based on current economic conditions. The Company writes off receivables when it deems them to be uncollectible. The Company records recoveries of receivables previously written off when payment is received. The Company considers a receivable to be past due if any portion of the receivable balance is outstanding for more than ninety days. The Company does not charge interest on past due receivables. The Company had no allowance for doubtful accounts for the years ended December&#160;28, 2024 and December&#160;30, 2023.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table details the Company's trade and other receivables as of December&#160;28, 2024 and December&#160;30, 2023 (in $000&#8217;s):</span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.393%"><tr><td style="width:1.0%"></td><td style="width:57.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.162%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.162%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.165%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other receivables</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">266&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade and other receivables, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,530&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">266&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;28, 2024, other receivables includes approximately $2.2&#160;million in subscriptions receivable (see Note 18).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s intangible assets consist of customer relationship intangibles, favorable leases, trade names, licenses for the use of internet domain names, Universal Resource Locators, or URL&#8217;s, software, patents, and marketing and technology related intangibles. Upon acquisition, estimates are made in valuing acquired intangible assets, which include but are not limited to, future expected cash flows from customer contracts, customer lists, and estimating cash flows from projects when completed; tradename and market position, as well as assumptions about the period of time that customer relationships will continue; and discount rates. Management's estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from the assumptions used in determining the fair values. All intangible assets are capitalized at their original cost and amortized over their estimated useful lives as follows: domain name and marketing &#8211; 3-to-20 years; software &#8211; 3-to-5 years; technology intangibles &#8211; 7 years; customer relationships &#8211; 7-to-15 years.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Digital Assets and other Payables</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Digital assets and other payables are liabilities that represent the Company&#8217;s obligation to deliver the settlement of transactions in the form of digital assets and or cash. The Company safeguards these digital assets and cash for customers and is obligated to safeguard them from loss, theft, or other misuse. The Company recognizes digital assets and other payables, on initial recognition and at each reporting date, at fair value of the digital assets. Any loss, theft, or other misuse would impact the measurement of digital assets and other payables. As of December&#160;28, 2024, the outstanding balance of digital assets and other payables was approximately $30.9 million, of which approximately $23.8 million was digital assets and $7.1 million was cash deposits.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognition applies to the Company&#8217;s Fintech segment only, as the Company&#8217;s Biotech segment has not recognized revenue to date. Revenue is recognized under Topic 606 in a manner that reasonably reflects the delivery of its services and products to customers in return for expected consideration and includes the following elements:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Executed contracts with the Company&#8217;s customers that it believes are legally enforceable;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Identification of performance obligations in the respective contract;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Determination of the transaction price for each performance obligation in the respective contract;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Allocation of the transaction price to each performance obligation; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Recognition of revenue only when the Company satisfies each performance obligation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fintech Revenue</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The five elements above, as applied to each of the Fintech segment's revenue categories, is summarized below:</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Product sales &#8211; revenue is recognized at the time of sale of equipment to the customer.</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Service sales &#8211; revenue is recognized based on when the service has been provided to the customer.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s service is comprised of a single performance obligation to buy and sell or convert digital assets to currencies. That is, the Company is the counter party to all transactions between customers and liquidity providers and presents revenue for the fees earned on a net basis.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is acting as principal in all transactions, and control the digital assets being provided before it is transferred to the buyer, and has risk related to the digital assets, and is responsible for the fulfillment of the digital asset transactions. The Company sets the price for the digital assets by aggregating prices from several liquidity providers and displays them on the Company&#8217;s platform. As a result, the Company acts as a price discovery service and acts as a principal facilitating the ability for a customer to purchase or sell digital assets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers its performance obligation satisfied, and recognizes revenue, at the point in time the transaction is processed. Contracts with customers are usually open-ended and can be terminated by either party without a termination penalty. Therefore, contracts are defined at the transaction level and do not extend beyond the service already provided.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company charges a fee at the transaction level. The transaction price, represented by the trading fee, is calculated based on volume and varies depending on payment type and the value of the transaction. Digital asset purchases or sale transactions executed by a customer on the Company&#8217;s platform is based on tiered pricing that is driven primarily by transaction volume processed for a specific historical period. The Company has concluded that this volume-based pricing approach does not constitute a future material right since the discount is within a range typically offered to a class of customers with similar volume. The transaction fee is collected from the customer at the time the transaction is executed. In certain instances, the transaction fee can be collected in digital assets, with revenue measured based on the amount of digital assets received and the fair value of the digital assets at the time of the transaction. The Company also marks up or down the digital asset prices and earns revenue from the spread between the buying and selling price. The Company also earns a fee from transfers of currencies and or digital assets. The transfer fees are nominal and are set to offset the fees associated with banking and or blockchain mining fees.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Biotechnology Revenue</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company currently generates no revenue from its Biotechnology segment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Discontinued Operations Revenue</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 9, 2023, retroactive to March 1, 2023, the Company entered into the Recycling Purchase Agreement with VM7, under which VM7 agreed to acquire all of the outstanding equity interests of the Recycling Subsidiaries. As discussed </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">previously, the accounts for the Recycling segment have been presented as discontinued operations in the accompanying consolidated financial statements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC Topic 820, &#8220;Fair Value Measurements and Disclosures,&#8221; requires disclosure of the fair value of financial instruments held by the Company. ASC Topic 825, &#8220;Financial Instruments,&#8221; defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The three levels of valuation hierarchy are defined as follows: Level 1 - inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets. Level 2 &#8211; to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. Level 3 &#8211; inputs to the valuation methodology are unobservable and significant to the fair value measurement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes using the asset and liability method. The asset and liability method requires recognition of deferred tax assets and liabilities for expected future tax consequences of temporary differences that currently exist between tax bases and financial reporting bases of the Company's assets and liabilities. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is provided on deferred taxes if it is determined that it is more likely than not that the asset will not be realized. The Company recognizes penalties and interest accrued related to income tax liabilities in the provision for income taxes in its Consolidated Statements of Income.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant management judgment is required to determine the amount of benefit to be recognized in relation to an uncertain tax position. The Company uses a two-step process to evaluate tax positions. The first step requires an entity to determine whether it is more likely than not (greater than 50% chance) that the tax position will be sustained. The second step requires an entity to recognize in the financial statements the benefit of a tax position that meets the more-likely-than-not recognition criterion. The amounts ultimately paid upon resolution of issues raised by taxing authorities may differ materially from the amounts accrued and may materially impact the financial statements of the Company in future periods.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company from time to time grants stock options to employees, non-employees and Company executives and directors. Such awards are valued based on the grant date fair-value of the instruments. The value of each award is amortized on a straight-line basis over the vesting period.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings Per Share</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share is calculated in accordance with ASC 260, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;. Under ASC 260 basic earnings per share is computed using the weighted average number of common shares outstanding during the period except that it does not include unvested restricted stock subject to cancellation. Diluted earnings per share is computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of warrants, options, restricted shares and convertible preferred stock. The dilutive effect of outstanding restricted shares, options and warrants is reflected in diluted earnings per share by application of the treasury stock method. Convertible preferred stock is reflected on an if-converted basis.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Reporting</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC Topic 280, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; requires use of the &#8220;management approach&#8221; model for segment reporting. The management approach model is based on the way a Company&#8217;s management organizes segments within the Company for making operating decisions and assessing performance. The Company determined it had three reportable segments. The Recycling segment has been presented as discontinued operations (see Note 23).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains cash balances at banks in Nevada and Minnesota. The account is insured by the Federal Deposit Insurance Corporation up to $250,000. At times, balances may exceed federally insured limits.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update ("ASU") 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures ("ASU 2023-07"). ASU 2023-07 requires, among other updates, enhanced disclosures about significant segment expenses that are regularly provided to the CODM, as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and requires retrospective adoption. Early adoption is permitted. The Company is evaluating the impact of this guidance on its consolidated financial statements and related disclosures.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU No. 2023-08, Intangibles&#8212;Goodwill and Other&#8212;Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets. The amendments in ASU No. 2023-08 are intended to improve the accounting for certain crypto assets by requiring an entity to measure those crypto assets at fair value each reporting period with changes in fair value recognized in net income. The amendments also improve the information provided to investors about an entity&#8217;s crypto asset holdings by requiring disclosure about significant holdings, contractual sale restrictions, and changes during the reporting period. The amendments are effective for all entities for fiscal years beginning after December 15, 2024, including interim periods within those fiscal years. The Company is evaluating the impact of this guidance on its consolidated financial statements and related disclosures.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures ("ASU 2023-09"). ASU 2023-09 requires enhanced annual disclosures regarding the rate reconciliation and income taxes paid information. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, and may be adopted on a prospective or retrospective basis. Early adoption is permitted. The Company is evaluating the impact of this guidance on its consolidated financial statements and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Mergers and Acquisitions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Mergers and Acquisitions</a></td>
<td class="text">Mergers and Acquisitions<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Qoden</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 8, 2024, the Company acquired the Qodex Cryptocurrency Exchange Software platform and other related assets from Qoden Technologies, LLC, a provider of technology solutions for the blockchain industry. The purchase price was $2.2 million, consisting of $2.0 million, or 771,010 shares, of the Company&#8217;s Series Q Convertible Preferred Stock and $0.2 million in cash. The Series Q Convertible Stock was valued at $2.594 per share on the date issued, and is subject to a mandatory eight-calendar-quarter leak-out, such that no more than twelve-and-one-half percent of the shares may be converted into shares of the Company&#8217;s common stock on a trailing quarterly basis over a period of two years, and are subject to vesting provisions. The $0.2 million in cash is payable in increments of $10,000 per month for 24 months, commencing on the first day of the month following closing. The acquisition was determined to be an asset acquisition for accounting purposes.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">ALT5</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;14, 2024, the Company acquired its ALT5 Subsidiary, which is a fintech company that provides next generation blockchain-powered technologies to enable a migration to a new global financial paradigm. ALT5 Subsidiary, through its respective subsidiaries, offers two main platforms to its customers: &#8220;ALT5 Pay&#8221; and &#8220;ALT5 Prime.&#8221; ALT5 Pay is a crypto-currency payment gateway that enables registered and approved global merchants to accept and make crypto-currency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay&#8217;s checkout widgets and APIs. Merchants have the option to convert to fiat currency (US Dollars, Canadian Dollars, Euros, and British Pounds Sterling) automatically or to receive their payment in digital assets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As consideration under the acquisition, the Company issued 1,799,100 shares of its common stock to the legacy equity holders of the capital stock of ALT5 Subsidiary. Those shares represented approximately 19.9% of the Company's then-issued and outstanding shares of common stock. Each of the shares of the Company's newly-issued common stock was valued at $4.14, which was the Nasdaq Historical NOCP on Thursday, May 9, 2024, the day immediately prior to the date on which the agreement was executed. The Company also issued 34,207 shares of its newly-designated Series B Preferred </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock (the &#8220;Series B Stock&#8221;) to the legacy equity holders of the capital stock of ALT5. In connection with the closing of the acquisition of ALT5 Subsidiary, the Company also issued 3,200 shares of its newly-designated Series M Preferred Stock (the &#8220;Series M Stock&#8221;) to two entities that acted as finders for the transaction.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the purchase price components outlined above was $16.0 million due to fair value adjustments for the shares of Series B Stock and Series M Stock, as detailed below (in $000&#8217;s):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.293%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series B preferred stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total purchase price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the preliminary purchase price allocation, the Company recognized goodwill of approximately $11.7 million, which is calculated as the excess of both the consideration exchanged and liabilities assumed as compared to the fair value of the identifiable assets acquired. The values assigned to the assets acquired and liabilities assumed are based on their estimates of fair value available as of May&#160;10, 2024, as calculated by an independent third-party firm. Because the transaction was considered a stock purchase for tax purposes, none of the goodwill arising from the acquisition will be deductible for tax purposes. During the thirteen weeks ended September&#160;28, 2024, the Company recorded a noncash fair value adjustment related to deferred tax liabilities and other liabilities acquired in the aggregate amount of approximately $7.9 million, which was recorded to goodwill. The table below outlines the purchase price allocation of the purchase for ALT5 Subsidiary to the acquired identifiable assets, liabilities assumed and goodwill (in $000&#8217;s):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.515%"><tr><td style="width:1.0%"></td><td style="width:66.874%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total purchase price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,866&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Digital assets payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,763&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities assumed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,509&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48,509&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,853&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Digital assets receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subtotal intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,450&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36,795&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,714&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proforma Information</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents selected proforma information for the Company for the years ended December&#160;28, 2024 and December&#160;30, 2023, assuming that the acquisition had occurred on January 1, 2023 (the beginning of the Company&#8217;s 2023 fiscal year), pursuant to ASC 805-10-50 (in $000&#8217;s). This proforma information does not purport to represent what the </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">actual results of operations of the Company would have been had the acquisition occurred on that date, nor does it purport to predict the results of operations for future periods.</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended<br/>December 28, 2024</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As Reported</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Proforma</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ALT5 Sigma Corporation (1)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ALT5 Subsidiary (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Adjustments (3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,532&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,918&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,450&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,245)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,343)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,517)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per basic common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.56)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per basic diluted share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended<br/>December 30, 2023</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As Reported</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Proforma</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ALT5 Sigma Corporation (4)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ALT5 Subsidiary (5)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Adjustments (3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,812)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,148)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,601)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per basic common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.95)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per basic diluted share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.95)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.65)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">ALT5 Sigma Corporation for the year ended December&#160;28, 2024. Includes ALT5 Subsidiary from May 15, 2024 through December&#160;28, 2024.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">ALT5 Subsidiary from December 31, 2023 through the acquisition date of May&#160;14, 2024.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Reflects adjustments for amortization expense of definite-lived intangible assets has been adjusted based on the preliminary fair value at the acquisition date..</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">ALT5 Sigma Corporation for the year ended December&#160;30, 2023.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    ALT5 Subsidiary for the year ended December&#160;30, 2023.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Soin Pharmaceuticals</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January&#160;24, 2024, the Company, Amol Soin (&#8220;Dr. Soin&#8221;), and Soin Therapeutics LLC, a wholly-owned subsidiary of the Company that we had acquired from Dr. Soin, entered into an amendment (the &#8220;Soin Amendment&#8221;) to the parties&#8217; Agreement and Plan of Merger that was dated as of December 28, 2022 (the &#8220;Soin Agreement&#8221;). With reference to the Soin Agreement, the parties to the Soin Amendment agreed that the $3.0 million convertible tranche (the first of the three original conversion tranches under the Soin Agreement) would be payable to Dr. Soin in cash rather than through his conversion of shares of the Series S Convertible Preferred Stock (the &#8220;Soin Preferred&#8221;) that constituted the consideration under the Soin Agreement. We tendered the first $0.1 million amended tranche cash payment to Dr. Soin in March 2024; the second amended tranche cash payment to Dr. Soin, also in the amount of $0.1 million, was due on July 1, 2024; and the third amended tranche cash payment to Dr. Soin, in the amount of $2.8 million, was due on December 31, 2024. During the pendency of the amended cash tranche period, Dr. Soin agreed that he would not convert any of his shares of Soin Preferred. After we have tendered the second and third amended tranche cash payments to Dr. Soin, his conversion rights for the second and third original conversion tranches will remain convertible under the original provisions of the Soin Agreement and the related Certificate of Designation for the Soin Preferred. If we do not tender the second and third amended tranche cash payments to Dr. Soin, we agreed that we will transfer to him the membership interests of Soin Therapeutics LLC, and he will transfer to us the shares of Soin Preferred for cancellation. During the year ended December&#160;28, 2024, we tendered an aggregate of $150,000 to Dr. Soin and during February 2025, we tendered an additional $350,000.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Soin Amendment, the Company reclassified the $3.0 million convertible tranche, originally valued at approximately $2.7 million on our balance sheet, from mezzanine equity to current liabilities, and reclassified the $10.0 million convertible tranche, originally valued at approximately $8.0 million on our balance sheet, to permanent equity. As of December&#160;28, 2024, the outstanding balance in mezzanine equity relates to the $17.0 million convertible tranche originally valued at approximately $3.9 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/805/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Sale of Recycling Subsidiaries<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Sale of Recycling Subsidiaries</a></td>
<td class="text">Sale of Recycling Subsidiaries<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 9, 2023, the Company entered into a Stock Purchase Agreement (the &#8220;Recycling Purchase Agreement&#8221;) with VM7 Corporation, a Delaware corporation (&#8220;VM7&#8221;), under which it agreed to acquire all of the outstanding equity interests of the Recycling Subsidiaries, consisting of: (a) ARCA Recycling, (b) ARCA Canada, and (c) Connexx. The principal of VM7 is Virland A. Johnson, our Chief Financial Officer. The sale of all of the outstanding equity interests of the Recycling Subsidiaries to VM7 under the Recycling Purchase Agreement was consummated simultaneously with the execution of the Recycling Purchase Agreement. The Recycling Purchase Agreement is retroactive to March 1, 2023 (see Note 4).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation, factoring in the discount rate that the Company used, yielded a present value of approximately $6.0 million, which, in addition to the $3,000 paid at close, comprised the approximately 6.0 million of net consideration. The amount of the revised discount amount, or approximately $18.0 million, was recorded as an offset to the principal amount of the Note, and was to have been accreted ratably to interest income over the term of the Note. During the year ended December&#160;30, 2023, approximately $720,000 of the discount was recorded as interest income. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of fiscal 2023, VM7 determined that, after expending significant amounts of time and resources, it was unable to obtain sufficient equity or debt financing to continue the operations of the Recycling Subsidiaries. Accordingly, the Company was advised that the operations of the Recycling Subsidiaries were wound down and, ultimately, ceased. For a variety of related reasons, the Company determined fully to impair the $5.3 million carrying value of the Disposition Transaction on its balance sheet and determined not to exercise any of its remedies under the Recycling Purchase Agreement so that it could maintain its focus on its clinical-stage biopharmaceutical activities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary calculation of the gain on sale was approximately $15.8 million. The following table details the final calculation of the gain on sale of the Recycling Subsidiaries, as shown on the income statement (in $000&#8217;s):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.151%"><tr><td style="width:1.0%"></td><td style="width:82.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.824%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total minimum consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment from buyer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net consideration</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,026&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,323&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities - California state sales tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(604)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total disposal of liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,320&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total consideration</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,884&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total disposal of assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,244&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total gain on sale</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,102&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>Discontinued Operations<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;30, 2023, the Company discontinued operations of its Recycling segment as follows:</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 9, 2023, the Company executed a Recycling Purchase Agreement with VM7, under which, as of March 1, 2023, it agreed to acquire all of the outstanding equity interests of the Recycling Subsidiaries, consisting of (a) ARCA Recycling, </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) ARCA Canada, and (c) Connexx. The principal of VM7 is Virland A. Johnson, our Chief Financial Officer. The sale of all of the outstanding equity interests of the Recycling Subsidiaries to VM7 under the Recycling Purchase Agreement was consummated simultaneously with the execution of the Recycling Purchase Agreement (See Note 4).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the provisions of ASC 205-20, the Company has not included in the results of continuing operations the results of operations of the discontinued operations in the consolidated statements of operations and comprehensive income (loss). The results of operations for these entities for the year ended December&#160;28, 2024 and December&#160;30, 2023, respectively, have been reflected as discontinued operations in the consolidated statements of operations and comprehensive income (loss) and consist of the following (in $000&#8217;s):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,795&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(197)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses from discontinued operations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain on sale of ARCA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12,102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,635)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,438&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense from discontinued operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other expense, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(184)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before provision for income taxes from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,254&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income from discontinued operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,283&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the provisions of ASC 205-20, the Company has separately reported the cash flow activity of the discontinued operations in the consolidated statements of cash flows. The cash flow activity from discontinued operations for the year ended December&#160;28, 2024 and December&#160;30, 2023 have been reflected as discontinued operations in the consolidated statements of cash flows and consist of the following (in $000&#8217;s):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DISCONTINUED OPERATING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain on sale of ARCA, net of cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12,248)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities from discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,319&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DISCONTINUED INVESTING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchase of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities from discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(155)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DISCONTINUED FINANCING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from note payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments on related party note</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments on notes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,336)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities from discontinued operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,212)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effect of changes in exchange rate on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DECREASE IN CASH AND CASH EQUIVALENTS</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CASH AND CASH EQUIVALENTS, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CASH AND CASH EQUIVALENTS, end of period</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205-20/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Discontinued Operations</a></td>
<td class="text">Sale of Recycling Subsidiaries<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 9, 2023, the Company entered into a Stock Purchase Agreement (the &#8220;Recycling Purchase Agreement&#8221;) with VM7 Corporation, a Delaware corporation (&#8220;VM7&#8221;), under which it agreed to acquire all of the outstanding equity interests of the Recycling Subsidiaries, consisting of: (a) ARCA Recycling, (b) ARCA Canada, and (c) Connexx. The principal of VM7 is Virland A. Johnson, our Chief Financial Officer. The sale of all of the outstanding equity interests of the Recycling Subsidiaries to VM7 under the Recycling Purchase Agreement was consummated simultaneously with the execution of the Recycling Purchase Agreement. The Recycling Purchase Agreement is retroactive to March 1, 2023 (see Note 4).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation, factoring in the discount rate that the Company used, yielded a present value of approximately $6.0 million, which, in addition to the $3,000 paid at close, comprised the approximately 6.0 million of net consideration. The amount of the revised discount amount, or approximately $18.0 million, was recorded as an offset to the principal amount of the Note, and was to have been accreted ratably to interest income over the term of the Note. During the year ended December&#160;30, 2023, approximately $720,000 of the discount was recorded as interest income. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of fiscal 2023, VM7 determined that, after expending significant amounts of time and resources, it was unable to obtain sufficient equity or debt financing to continue the operations of the Recycling Subsidiaries. Accordingly, the Company was advised that the operations of the Recycling Subsidiaries were wound down and, ultimately, ceased. For a variety of related reasons, the Company determined fully to impair the $5.3 million carrying value of the Disposition Transaction on its balance sheet and determined not to exercise any of its remedies under the Recycling Purchase Agreement so that it could maintain its focus on its clinical-stage biopharmaceutical activities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary calculation of the gain on sale was approximately $15.8 million. The following table details the final calculation of the gain on sale of the Recycling Subsidiaries, as shown on the income statement (in $000&#8217;s):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.151%"><tr><td style="width:1.0%"></td><td style="width:82.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.824%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total minimum consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment from buyer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net consideration</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,026&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,323&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities - California state sales tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(604)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total disposal of liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,320&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total consideration</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,884&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total disposal of assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,244&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total gain on sale</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,102&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>Discontinued Operations<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;30, 2023, the Company discontinued operations of its Recycling segment as follows:</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 9, 2023, the Company executed a Recycling Purchase Agreement with VM7, under which, as of March 1, 2023, it agreed to acquire all of the outstanding equity interests of the Recycling Subsidiaries, consisting of (a) ARCA Recycling, </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) ARCA Canada, and (c) Connexx. The principal of VM7 is Virland A. Johnson, our Chief Financial Officer. The sale of all of the outstanding equity interests of the Recycling Subsidiaries to VM7 under the Recycling Purchase Agreement was consummated simultaneously with the execution of the Recycling Purchase Agreement (See Note 4).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the provisions of ASC 205-20, the Company has not included in the results of continuing operations the results of operations of the discontinued operations in the consolidated statements of operations and comprehensive income (loss). The results of operations for these entities for the year ended December&#160;28, 2024 and December&#160;30, 2023, respectively, have been reflected as discontinued operations in the consolidated statements of operations and comprehensive income (loss) and consist of the following (in $000&#8217;s):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,795&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(197)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses from discontinued operations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain on sale of ARCA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12,102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,635)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,438&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense from discontinued operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other expense, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(184)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before provision for income taxes from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,254&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income from discontinued operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,283&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the provisions of ASC 205-20, the Company has separately reported the cash flow activity of the discontinued operations in the consolidated statements of cash flows. The cash flow activity from discontinued operations for the year ended December&#160;28, 2024 and December&#160;30, 2023 have been reflected as discontinued operations in the consolidated statements of cash flows and consist of the following (in $000&#8217;s):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DISCONTINUED OPERATING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain on sale of ARCA, net of cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12,248)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities from discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,319&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DISCONTINUED INVESTING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchase of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities from discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(155)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DISCONTINUED FINANCING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from note payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments on related party note</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments on notes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,336)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities from discontinued operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,212)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effect of changes in exchange rate on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DECREASE IN CASH AND CASH EQUIVALENTS</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CASH AND CASH EQUIVALENTS, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CASH AND CASH EQUIVALENTS, end of period</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205-20/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaids and other current assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCurrentAssetsTextBlock', window );">Prepaids and other current assets</a></td>
<td class="text">Prepaids and other current assets<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaids and other current assets as of December&#160;28, 2024 and December&#160;30, 2023 consist of the following (in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"><tr><td style="width:1.0%"></td><td style="width:67.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.120%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.123%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid insurance</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total prepaids and other current assets</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,518&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text">Property and Equipment<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment as of December&#160;28, 2024 and December&#160;30, 2023 consist of the following (in $000&#8217;s):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"><tr><td style="width:1.0%"></td><td style="width:65.006%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.235%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.239%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Projects under construction</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,170&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,170&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded no depreciation expense from continuing operations for the years ended December&#160;28, 2024 and December&#160;30, 2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with its acquisition of ALT5 Subsidiary (see Note 3), the Company leases commercial office space. These assets and properties are leased under noncancelable agreements that expire at various future dates. The agreements, which have been classified as operating leases, provide for minimum rent and require the Company to pay all insurance, taxes, and other maintenance costs. As a result, the Company recognizes assets and liabilities for leases with lease terms greater than 12 months. The amounts recognized reflect the present value of remaining lease payments for all leases. The discount rate used is an estimate of the Company&#8217;s blended incremental borrowing rate based on information available associated with each subsidiary&#8217;s debt outstanding at lease commencement. In considering the lease asset value, the Company considers fixed and variable payment terms, prepayments and options to extend, terminate or purchase. Renewal, termination, or purchase options affect the lease term used for determining lease asset value only if the option is reasonably certain to be exercised.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table details the Company&#8217;s right of use assets and lease liabilities as of December&#160;28, 2024 and December&#160;30, 2023 (in $000&#8217;s):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.636%"><tr><td style="width:1.0%"></td><td style="width:65.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.336%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.337%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right of use asset - operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current - operating</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long term - operating</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;28, 2024, the weighted average remaining lease term for operating leases is 4.9 years. The Company&#8217;s weighted average discount rate for operating leases is 12.8%. No cash payments for operating leases were made during the years ended December&#160;28, 2024 and December&#160;30, 2023. Additionally, the Company recognized approximately $123,000 in right of use assets and liabilities upon commencement of operating leases during the year ended December&#160;28, 2024.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total present value of future lease payments of operating leases as of September&#160;28, 2024 (in $000&#8217;s): </span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.809%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Twelve months ended:</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2029</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">170&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less implied interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Present value of payments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">123&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes receivable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivablesTextBlock', window );">Notes receivable</a></td>
<td class="text">Notes receivable <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">SPYR Note</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;24, 2022, the Company entered into an Asset Purchase Agreement with SPYR Technologies Inc. (&#8220;SPYR&#8221;), pursuant to which the Company sold to SPYR substantially all of the assets and none of the specified liabilities of GeoTraq. In connection with the Purchase Agreement, SPYR delivered to the Company a five-year Promissory Note in the initial principal amount of $12.6 million. The Promissory Note bears simple interest at the rate of 8.0% per annum, provides quarterly interest payments due on the first day of each calendar quarter, and may be prepaid at any time without penalty. Interest payments may be remitted in either restricted shares of common stock or restricted shares of Series G Convertible Preferred Stock of SPYR, or in cash. The Promissory Note matures on May 24, 2027. The Company had received restricted shares of Series G Convertible Preferred Stock of SPYR equivalent to approximately 26,253,900,000 shares of its common stock during the year ended December&#160;28, 2024, and 922,442,000 shares of SPYR's common stock during the year ended December&#160;30, 2023. As of December&#160;30, 2023, the Company had no accrued receivables related to the Promissory Note.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;30, 2023, the Company performed a qualitative analysis of the SPYR note receivable and concluded that, due to a number of triggering factors, it was probable that SPYR would be unable to fulfill its obligation to repay the principal amount under the promissory note on or before the maturity date. Consequently, the Company recorded an impairment charge of approximately $9.8&#160;million for the fiscal year ended December&#160;30, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal years ended December&#160;28, 2024 and December&#160;30, 2023, approximately $0 and $806,000, respectively, of the discount was recorded as interest income. As of December&#160;28, 2024 and December&#160;30, 2023, no principal balance on the Note was outstanding.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">VM7 Note</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 9, 2023, the Company entered into a Stock Purchase Agreement (the &#8220;Recycling Purchase Agreement&#8221;) with VM7 Corporation, a Delaware corporation (&#8220;VM7&#8221;), under which it agreed to acquire all of the outstanding equity interests of the Recycling Subsidiaries, consisting of: (a) ARCA Recycling, (b) ARCA Canada, and (c) Connexx. The principal of VM7 is Virland A. Johnson, our Chief Financial Officer. The sale of all of the outstanding equity interests of the Recycling Subsidiaries to VM7 under the Recycling Purchase Agreement was consummated simultaneously with the execution of the Recycling Purchase Agreement. The Recycling Purchase Agreement is retroactive to March 1, 2023 (see Note 4).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation, factoring in the discount rate that the Company used, yielded a present value of approximately $6.0 million, which, in addition to the $3,000 paid at close, comprised the approximately 6.0 million of net consideration. The amount of the revised discount amount, or approximately $18.0 million, was recorded as an offset to the principal amount of the Note, and was to have been accreted ratably to interest income over the term of the Note. During the year ended December&#160;30, 2023, approximately $720,000 of the discount was recorded as interest income. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of fiscal 2023, VM7 determined that, after expending significant amounts of time and resources, it was unable to obtain sufficient equity or debt financing to continue the operations of the Recycling Subsidiaries. Accordingly, the Company was advised that the operations of the Recycling Subsidiaries were wound down and, ultimately, ceased. For a variety of related reasons, the Company determined fully to impair the $5.3 million carrying value of the Disposition Transaction on its balance sheet and determined not to exercise any of its remedies under the Recycling Purchase Agreement so that it could maintain its focus on its clinical-stage biopharmaceutical activities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivablesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481933/310-10-55-12A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-42<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 44<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-44<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/310-10/tableOfContent<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/310-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivablesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible assets</a></td>
<td class="text">Intangible assets<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets as of consist of the following (in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soin intangibles</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19,293&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19,293&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Qoden intangible</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patents and domains</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,925&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total intangible assets</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39,283&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19,297&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,853)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,451)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total intangible assets, net</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,430&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,846&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible amortization expense for continuing operations was approximately $3.4&#160;million and $1.5 million, respectively, for the fiscal years ended December&#160;28, 2024 and December&#160;30, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Qoden Intangible Assets</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 8, 2024, the Company acquired the Qodex Cryptocurrency Exchange Software platform and other related assets from Qoden Technologies, LLC, a provider of technology solutions for the blockchain industry. The Company will amortize the intangible assets over a two-year period (see Note 3).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ALT5 Subsidiary Intangible Assets</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;14, 2024, the Company acquired its ALT5 Subsidiary, which is a fintech company that provides next generation blockchain-powered technologies to enable a migration to a new global financial paradigm. As part of the acquisition, the Company acquired trade names, customer relationships, and developed technology, which will be amortized over a period of seven years, 10 years, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">five</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> years, respectively (see Note 3). </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Soin Intangible Assets</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective as of December 28, 2022, the Company acquired Soin Therapeutics LLC, a Delaware limited liability company (&#8220;STLLC&#8221;), and its product, a patent-pending, novel formulation of low-dose naltrexone. The assets acquired by the Company consist of 1) three pending patents related to the methods of using low-dose Naltrexone to treat chronic pain, 2) final formula for Naltrexone, and 3) orphan drug designation as approved by the FDA. The Company reviewed the assets acquired and determined that no in-process research and development costs were acquired as part of the transaction, and, thus, all assets acquired represent intellectual property and should be capitalized. The Company will amortize the intangible assets ratably over a 10-year period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/985-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Marketable Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock', window );">Marketable Securities</a></td>
<td class="text">Marketable Securities<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities consist of the following (in $000&#8217;s, except shares):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.666%"><tr><td style="width:1.0%"></td><td style="width:45.921%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.145%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Series G Convertible Preferred Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Common Shares Equivalent</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Amount </span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning balance, December 31, 2022</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30,000,000</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">315&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities received</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,224</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">922,442,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mark-to-market</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(926)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning balance, December 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,224</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">952,442,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">286</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities received</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,876</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,253,900,000</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">518&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mark-to-market</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(370)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Write-off marketable securities</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(43,100)</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(27,206,342,000)</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(434)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance, December 28, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities reflect shares of SPYR stock received by the Company in connection with the sale of GeoTraq. Quarterly interest payments may be remitted in either restricted shares of common stock or restricted shares of Series G Convertible Preferred Stock of SPYR, or in cash. Shares of Series G Convertible Preferred Stock are convertible into the SPYR&#8217;s common shares at a ratio of 1:100,000. Shares held are marked to fair market value as of each balance sheet date, with the resulting change recorded as an unrealized gain or loss. For the year ended December&#160;28, 2024, the Company received 33,876 shares of Series G Convertible Preferred Stock, which are convertible into approximately 26,253,900,000 shares of SPYR&#8217;s common stock. For the year ended December&#160;30, 2023, the Company received 9,224 shares of Series G Convertible Preferred Stock, which are convertible into approximately 922,442,000 shares of SPYR&#8217;s common stock. Unrealized loss was approximately $1.1 million and $926,000 for the years ended December&#160;28, 2024 and December&#160;30, 2023, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;28, 2024, the Company was notified that SPYR Technologies, Inc. (&#8220;SPYR&#8221;) had ceased operations, and that no future quarterly interest payments on the promissory note, which may be remitted in either restricted shares of common stock or restricted shares of Series G Convertible Preferred Stock of SPYR, or in cash, would be made. Consequently, the Company recorded a full write-off of approximately $434,000 of its Series G Convertible Preferred shares of SPYR.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/320/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deposits and other assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsDisclosureTextBlock', window );">Deposits and other assets</a></td>
<td class="text">Deposits and other assets<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deposits and other assets consist of the following (in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deposits and other assets</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total deposits and other assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">Accrued liabilities</a></td>
<td class="text">Accrued liabilities<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities of continuing consist of the following (in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation and benefits</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">204&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued guarantees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued taxes</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">362&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued Qoden payments</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued litigation/legal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">730&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,553&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,633&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debentures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Debentures</a></td>
<td class="text">Debentures<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debentures outstanding as of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;28, 2024 and December&#160;30, 2023 consisted for the following (in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate of 15%, maturity date of June 30, 2025</span></div></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">563&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total debentures</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">563&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ALT5 Subsidiary issued 39 debentures over a period from October 2018 through September 2019. The debentures bear interest at 12% per annum and mature as of June&#160;30, 2024 or June&#160;30, 2025. During the year ended December&#160;28, 2024, ALT5 Subsidiary repaid 33 of the debentures in the amount of approximately $1.1 million.</span></div> Long-Term Debt<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt as of December&#160;28, 2024 and December&#160;30, 2023 consisted of the following (in $000&#8217;s):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legacy subsidiary fixed deposits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legacy subsidiary loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unaffiliated third-party</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total notes payable, related parties</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,570&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total long-term notes payable, related parties</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,570&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Legacy Subsidiary Fixed Deposits</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;28, 2024, ALT5 Subsidiary entered into several Corporate Fixed Deposit Agreements with otherwise unaffiliated third-parties, pursuant to which the Company became obligated for an aggregate of $4.7 million, as set forth in the respective agreements. Each obligation bears interest at a rate of 13% or 15% per annum, and has a maturity date range of March&#160;18, 2026 to March&#160;13, 2027. During the year ended December&#160;28, 2024, several of these unaffiliated third-parties agreed to convert their respective investments into Future Equity Agreements for shares of the Company&#8217;s subsidiary, Alyea Therapeutic and, consequently, approximately $475,000 of these deposits were reclassified as non-controlling interest. As of December&#160;28, 2024, the outstanding aggregate obligations totaled approximately $4.2 million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Legacy Subsidiary Loan</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 10, 2023, ALT5 Subsidiary entered into an extension agreement for a Bitcoin promissory note with an otherwise unaffiliated third-party. The Bitcoin promissory note is denominated in Bitcoin and, thus, is adjusted to its fair value each period. Pursuant to the terms of an extension agreement, the maturity date is August&#160;29, 2025. The promissory note bears interest at 15% per annum. As of December&#160;28, 2024, the outstanding balance of the note was approximately $3.8 million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Unaffiliated Third-Party Loans</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">ICG Note</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 7, 2024, the Company amended its outstanding related party promissory obligations (the &#8220;ICG Note&#8221;) in favor of Isaac Capital Group LLC (&#8220;ICG&#8221;) to add a convertibility provision. In accordance with Nasdaq Rules, the per-share conversion price was set at $0.61, subject to standard adjustments for (i) stock dividends and splits, (ii) subsequent rights offerings, and (iii) pro rata distributions. The Company&#8217;s board of directors provided its approvals of the amendments on February 7, 2024. On March 6, 2024, ICG entered into a Note Purchase Agreement with an otherwise unaffiliated third party, under which the third party acquired the ICG Note. The terms and conditions of the ICG Note were not modified in connection with its acquisition by the third party. The principal amount of the ICG Note on the date of acquisition was approximately $1.2 million. During the year ended December&#160;28, 2024, the third party converted $548,900 of the Company&#8217;s obligations under the ICG Note into 900,000 shares of the Company&#8217;s common stock. As of December&#160;28, 2024, the amount outstanding on the ICG Note was approximately $0.7 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Live Note</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 7, 2024, the Company amended its outstanding related party promissory obligations (the &#8220;Live Note&#8221;) in favor of Live Ventures Incorporated (&#8220;Live&#8221;) to add a convertibility provision. In accordance with Nasdaq Rules, the per-share conversion price for each obligation, as amended, was set at $0.61, subject to standard adjustments for (i) stock dividends and splits, (ii) subsequent rights offerings, and (iii) pro rata distributions. The Company&#8217;s board of directors provided its final approvals of the amendments on February 7, 2024. On March 6, 2024, Live entered into a Note Purchase Agreement with another otherwise unaffiliated third party, under which the third party acquired the Live Note. The terms and conditions of the acquired Live Note were not modified in connection with its acquisition by the third party. The principal amount of the Live Note on the date of acquisition was approximately $1.0 million. During the year ended </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;28, 2024, the third party converted $243,900 of the Company&#8217;s obligations under the Live Note into 400,000 shares of the Company&#8217;s common stock. As of December&#160;28, 2024, the amount outstanding on the Live Note was approximately $0.8 million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Skybridge Obligation</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;10, 2024, Skybridge Americas, Inc. (&#8220;SA&#8221;) sold its judgment to an otherwise unaffiliated third party for the face value of the judgment and the interest accrued thereon through that date (an aggregate of $433,920), plus accrued legal fees (in the amount of $18,124) to which SA was entitled in accordance with the terms of the underlying agreement with the Company and with the judgment. The purchaser agreed to forbear from enforcing the judgment, subject to the Company&#8217;s repayment or his conversion thereof. In connection with the third-party&#8217;s forbearance, the Company issued its promissory note to such person in the initial principal amount of $147,956, which bears interest at the rate of 10% per annum, and, as with the underlying judgment, is convertible into shares of the Company&#8217;s common stock at a fixed per-share conversion price of $2.60 (see Note 21).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;23, 2024, pursuant to the terms of the agreement, the unaffiliated third party converted the obligation, plus accrued interest under the agreements, in the amount of approximately $691,000, into 265,842 shares of the Company&#8217;s common stock (see Note 18). As of December&#160;28, 2024, there was no balance outstanding.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Big/Small Debentures</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August&#160;20, 2024, the Company entered into three Purchase Agreements with three otherwise unaffiliated third-party investors (the &#8220;Investors&#8221;), pursuant to which (1) one Investor agreed to purchase a unit (the &#8220;Unit&#8221;), consisting of (i) a non-convertible debenture in the principal amount of up to approximately $1.8 million (the &#8220;Big Debenture&#8221;), and (ii) a warrant (the &#8220;Big Warrant&#8221;) for the purchase of up to 400,000 shares of the Company&#8217;s Common Stock and (2) the two other Investors each agreed to purchase a Unit, consisting of (i) a non-convertible debenture in the principal amount of up to $404,454 (the &#8220;Small Debenture&#8221;, and, together with the Big Debenture, the &#8220;Debentures&#8221;) and (ii) a warrant (the &#8220;Small Warrant&#8221;, and, together with the Big Warrant, the &#8220;Warrants&#8221;) for the purchase of up 90,909 shares of Common Stock.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Debentures are unsecured and subordinated to any existing or future debt.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Debentures bear interest at a rate of (i) 1% per month from and after August 20, 2024 (&#8220;Original Issue Date&#8221;) through and including October 31, 2024, (ii) 3% per month from and after November 1, 2024 through and including January 29, 2025, and (iii) 4% per month from and after January 30, 2025 through and including the date of repayment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Big Debenture was issued with an original issue discount (an &#8220;OID&#8221;) initially of $171,000, which OID can be expanded with up to two potential additions, the first in the amount of $171,000 and, thereafter, in the amount of $342,000, which OIDs will increase the principal amount owing on the Big Debenture.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the original OID, the initial principal amount owing under the Big Debenture is approximately $1.3 million; if, expanded, the principal amount would increase to approximately $1.4 million and, thereafter, potentially to approximately $1.8 million. The first potential increase in the Big Debenture OID would occur if the initial principal amount and interest accrued thereon is not paid in full on or before October 31, 2024. The second potential increase in the OID would occur if the initial principal amount (including the first potential increase in the OID) and interest accrued thereon is not paid in full on or before January 29, 2025.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Small Debentures were issued with an OID initially of $38,863, which OID can be expanded with up to two potential additions, the first in the amount of $38,863 and, thereafter, in the amount of $77,728, which OIDs will increase the principal amount owing on the Small Debentures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the original OID, the initial principal amount owing under a Small Debenture is $288,864; if, expanded, the principal amount would increase to $327,726 and, thereafter, potentially to $404,454.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The first potential increase in the Small Debenture OID would occur if the initial principal amount and interest accrued thereon is not paid in full on or before October 31, 2024.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The second potential increase in the OID would occur if the initial principal amount (including the first potential increase in the OID) and interest accrued thereon is not paid in full on or before January 29, 2025.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of November&#160;1, 2024, the first of the two additional OIDs was effective.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final maturity date for each of the Debentures is April 28, 2025.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Big Warrant is exercisable, at an exercise price of $1.71 per share, as follows: (i) 100,000 shares of Common Stock as of Original Issue Date, (ii) contingently for an additional 100,000 shares of Common Stock as of October 31, 2024, if, as of such date, the Company has not repaid in full its obligations under the Big Debenture, and (iii) contingently for an </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">additional 200,000 shares of Common Stock as of January 29, 2025, if, as of such date, the Company has not repaid in full its obligations under the Big Debenture.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Small Warrant is exercisable, at an exercise price of $1.71 per share, as follows: (i) 22,727 shares of Common Stock as of Original Issue Date, (ii) contingently for an additional 22,727 shares of Common Stock as of October 31, 2024, if, as of such date, the Company has not repaid in full its obligations under the Small Debenture, and (iii) 45,455 shares of Common Stock as of January 29, 2025, if, as of such date, the Company has not repaid in full its obligations under the Small Debenture.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of November 1, 2024, the contingent second tranche of the Warrants vested.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Investor is required to exercise the initial tranche of each Warrant within 15 days of the Original Issue Date.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the vesting of each contingent tranche of a Warrant vest, each Investor shall exercise such vested, contingent tranche within 15 days of the vesting of such contingent tranche.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company consummates any equity or debt financing before satisfying in full its obligations under the Debentures, then 50% of every net dollar received by the Company from any such financing transaction shall be paid by the Company to the holders of the Debentures, on a pro rata basis, as a mandatory pre-payment thereof.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event the Company has repaid all sums owing under a Debenture to the Investor, except for an amount equal to any non-conditional OID, the Company has the right, not the obligation, to exercise the vested portion of the Warrant held by the Debenture holder through a set-off of any or all such unpaid OID, on a dollar-for-dollar basis.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Warrants also feature a &#8220;cashless&#8221; exercise provision.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In lieu of making the cash payment otherwise contemplated to be made to the Company upon exercise of a Warrant in payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the net number of shares of Common Stock determined according to a formula set forth in the Warrant. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of the year ended December&#160;28, 2024, the non-affiliated Investor exercised the Big Warrant for a total of 200,000 shares of the Company&#8217;s common stock, and the other two non-affiliated Investors exercised the Small Warrant for a total of 90,908 shares (see Note 18). Additionally, during the fourth quarter of the year ended December&#160;28, 2024, these unaffiliated third-parties agreed to convert a portion their respective investment into Future Equity Agreements of the Company&#8217;s subsidiary, Alyea Therapeutics and, consequently, approximately $1.3 million was reclassified as non-controlling interest. As of December&#160;28, 2024, the outstanding balance due on the debentures was approximately $500,000, consisting of principal and accrued interest.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Corporate Fixed Deposit Agreement</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;19, 2024, ALT5 Subsidiary and an investor entered into a 12-month Corporate Fixed Deposit Agreement, pursuant to which ALT5 Subsidiary borrowed $1.5 million at an interest rate of 12% per annum, payable monthly, calculated on the then-unpaid principal amount.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon maturity, ALT5 Subsidiary is obligated to repay the principal amount in full and any accrued and unpaid interest.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal may be repaid in full, but not in part, with a pre-payment penalty equivalent to three month&#8217;s of interest. As of December&#160;28, 2024, the outstanding balance was $1.5 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-Term Debt</a></td>
<td class="text">Debentures<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debentures outstanding as of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;28, 2024 and December&#160;30, 2023 consisted for the following (in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate of 15%, maturity date of June 30, 2025</span></div></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">563&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total debentures</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">563&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ALT5 Subsidiary issued 39 debentures over a period from October 2018 through September 2019. The debentures bear interest at 12% per annum and mature as of June&#160;30, 2024 or June&#160;30, 2025. During the year ended December&#160;28, 2024, ALT5 Subsidiary repaid 33 of the debentures in the amount of approximately $1.1 million.</span></div> Long-Term Debt<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt as of December&#160;28, 2024 and December&#160;30, 2023 consisted of the following (in $000&#8217;s):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legacy subsidiary fixed deposits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legacy subsidiary loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unaffiliated third-party</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total notes payable, related parties</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,570&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total long-term notes payable, related parties</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,570&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Legacy Subsidiary Fixed Deposits</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;28, 2024, ALT5 Subsidiary entered into several Corporate Fixed Deposit Agreements with otherwise unaffiliated third-parties, pursuant to which the Company became obligated for an aggregate of $4.7 million, as set forth in the respective agreements. Each obligation bears interest at a rate of 13% or 15% per annum, and has a maturity date range of March&#160;18, 2026 to March&#160;13, 2027. During the year ended December&#160;28, 2024, several of these unaffiliated third-parties agreed to convert their respective investments into Future Equity Agreements for shares of the Company&#8217;s subsidiary, Alyea Therapeutic and, consequently, approximately $475,000 of these deposits were reclassified as non-controlling interest. As of December&#160;28, 2024, the outstanding aggregate obligations totaled approximately $4.2 million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Legacy Subsidiary Loan</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 10, 2023, ALT5 Subsidiary entered into an extension agreement for a Bitcoin promissory note with an otherwise unaffiliated third-party. The Bitcoin promissory note is denominated in Bitcoin and, thus, is adjusted to its fair value each period. Pursuant to the terms of an extension agreement, the maturity date is August&#160;29, 2025. The promissory note bears interest at 15% per annum. As of December&#160;28, 2024, the outstanding balance of the note was approximately $3.8 million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Unaffiliated Third-Party Loans</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">ICG Note</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 7, 2024, the Company amended its outstanding related party promissory obligations (the &#8220;ICG Note&#8221;) in favor of Isaac Capital Group LLC (&#8220;ICG&#8221;) to add a convertibility provision. In accordance with Nasdaq Rules, the per-share conversion price was set at $0.61, subject to standard adjustments for (i) stock dividends and splits, (ii) subsequent rights offerings, and (iii) pro rata distributions. The Company&#8217;s board of directors provided its approvals of the amendments on February 7, 2024. On March 6, 2024, ICG entered into a Note Purchase Agreement with an otherwise unaffiliated third party, under which the third party acquired the ICG Note. The terms and conditions of the ICG Note were not modified in connection with its acquisition by the third party. The principal amount of the ICG Note on the date of acquisition was approximately $1.2 million. During the year ended December&#160;28, 2024, the third party converted $548,900 of the Company&#8217;s obligations under the ICG Note into 900,000 shares of the Company&#8217;s common stock. As of December&#160;28, 2024, the amount outstanding on the ICG Note was approximately $0.7 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Live Note</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 7, 2024, the Company amended its outstanding related party promissory obligations (the &#8220;Live Note&#8221;) in favor of Live Ventures Incorporated (&#8220;Live&#8221;) to add a convertibility provision. In accordance with Nasdaq Rules, the per-share conversion price for each obligation, as amended, was set at $0.61, subject to standard adjustments for (i) stock dividends and splits, (ii) subsequent rights offerings, and (iii) pro rata distributions. The Company&#8217;s board of directors provided its final approvals of the amendments on February 7, 2024. On March 6, 2024, Live entered into a Note Purchase Agreement with another otherwise unaffiliated third party, under which the third party acquired the Live Note. The terms and conditions of the acquired Live Note were not modified in connection with its acquisition by the third party. The principal amount of the Live Note on the date of acquisition was approximately $1.0 million. During the year ended </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;28, 2024, the third party converted $243,900 of the Company&#8217;s obligations under the Live Note into 400,000 shares of the Company&#8217;s common stock. As of December&#160;28, 2024, the amount outstanding on the Live Note was approximately $0.8 million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Skybridge Obligation</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;10, 2024, Skybridge Americas, Inc. (&#8220;SA&#8221;) sold its judgment to an otherwise unaffiliated third party for the face value of the judgment and the interest accrued thereon through that date (an aggregate of $433,920), plus accrued legal fees (in the amount of $18,124) to which SA was entitled in accordance with the terms of the underlying agreement with the Company and with the judgment. The purchaser agreed to forbear from enforcing the judgment, subject to the Company&#8217;s repayment or his conversion thereof. In connection with the third-party&#8217;s forbearance, the Company issued its promissory note to such person in the initial principal amount of $147,956, which bears interest at the rate of 10% per annum, and, as with the underlying judgment, is convertible into shares of the Company&#8217;s common stock at a fixed per-share conversion price of $2.60 (see Note 21).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;23, 2024, pursuant to the terms of the agreement, the unaffiliated third party converted the obligation, plus accrued interest under the agreements, in the amount of approximately $691,000, into 265,842 shares of the Company&#8217;s common stock (see Note 18). As of December&#160;28, 2024, there was no balance outstanding.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Big/Small Debentures</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August&#160;20, 2024, the Company entered into three Purchase Agreements with three otherwise unaffiliated third-party investors (the &#8220;Investors&#8221;), pursuant to which (1) one Investor agreed to purchase a unit (the &#8220;Unit&#8221;), consisting of (i) a non-convertible debenture in the principal amount of up to approximately $1.8 million (the &#8220;Big Debenture&#8221;), and (ii) a warrant (the &#8220;Big Warrant&#8221;) for the purchase of up to 400,000 shares of the Company&#8217;s Common Stock and (2) the two other Investors each agreed to purchase a Unit, consisting of (i) a non-convertible debenture in the principal amount of up to $404,454 (the &#8220;Small Debenture&#8221;, and, together with the Big Debenture, the &#8220;Debentures&#8221;) and (ii) a warrant (the &#8220;Small Warrant&#8221;, and, together with the Big Warrant, the &#8220;Warrants&#8221;) for the purchase of up 90,909 shares of Common Stock.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Debentures are unsecured and subordinated to any existing or future debt.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Debentures bear interest at a rate of (i) 1% per month from and after August 20, 2024 (&#8220;Original Issue Date&#8221;) through and including October 31, 2024, (ii) 3% per month from and after November 1, 2024 through and including January 29, 2025, and (iii) 4% per month from and after January 30, 2025 through and including the date of repayment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Big Debenture was issued with an original issue discount (an &#8220;OID&#8221;) initially of $171,000, which OID can be expanded with up to two potential additions, the first in the amount of $171,000 and, thereafter, in the amount of $342,000, which OIDs will increase the principal amount owing on the Big Debenture.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the original OID, the initial principal amount owing under the Big Debenture is approximately $1.3 million; if, expanded, the principal amount would increase to approximately $1.4 million and, thereafter, potentially to approximately $1.8 million. The first potential increase in the Big Debenture OID would occur if the initial principal amount and interest accrued thereon is not paid in full on or before October 31, 2024. The second potential increase in the OID would occur if the initial principal amount (including the first potential increase in the OID) and interest accrued thereon is not paid in full on or before January 29, 2025.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Small Debentures were issued with an OID initially of $38,863, which OID can be expanded with up to two potential additions, the first in the amount of $38,863 and, thereafter, in the amount of $77,728, which OIDs will increase the principal amount owing on the Small Debentures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the original OID, the initial principal amount owing under a Small Debenture is $288,864; if, expanded, the principal amount would increase to $327,726 and, thereafter, potentially to $404,454.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The first potential increase in the Small Debenture OID would occur if the initial principal amount and interest accrued thereon is not paid in full on or before October 31, 2024.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The second potential increase in the OID would occur if the initial principal amount (including the first potential increase in the OID) and interest accrued thereon is not paid in full on or before January 29, 2025.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of November&#160;1, 2024, the first of the two additional OIDs was effective.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final maturity date for each of the Debentures is April 28, 2025.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Big Warrant is exercisable, at an exercise price of $1.71 per share, as follows: (i) 100,000 shares of Common Stock as of Original Issue Date, (ii) contingently for an additional 100,000 shares of Common Stock as of October 31, 2024, if, as of such date, the Company has not repaid in full its obligations under the Big Debenture, and (iii) contingently for an </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">additional 200,000 shares of Common Stock as of January 29, 2025, if, as of such date, the Company has not repaid in full its obligations under the Big Debenture.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Small Warrant is exercisable, at an exercise price of $1.71 per share, as follows: (i) 22,727 shares of Common Stock as of Original Issue Date, (ii) contingently for an additional 22,727 shares of Common Stock as of October 31, 2024, if, as of such date, the Company has not repaid in full its obligations under the Small Debenture, and (iii) 45,455 shares of Common Stock as of January 29, 2025, if, as of such date, the Company has not repaid in full its obligations under the Small Debenture.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of November 1, 2024, the contingent second tranche of the Warrants vested.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Investor is required to exercise the initial tranche of each Warrant within 15 days of the Original Issue Date.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the vesting of each contingent tranche of a Warrant vest, each Investor shall exercise such vested, contingent tranche within 15 days of the vesting of such contingent tranche.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company consummates any equity or debt financing before satisfying in full its obligations under the Debentures, then 50% of every net dollar received by the Company from any such financing transaction shall be paid by the Company to the holders of the Debentures, on a pro rata basis, as a mandatory pre-payment thereof.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event the Company has repaid all sums owing under a Debenture to the Investor, except for an amount equal to any non-conditional OID, the Company has the right, not the obligation, to exercise the vested portion of the Warrant held by the Debenture holder through a set-off of any or all such unpaid OID, on a dollar-for-dollar basis.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Warrants also feature a &#8220;cashless&#8221; exercise provision.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In lieu of making the cash payment otherwise contemplated to be made to the Company upon exercise of a Warrant in payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the net number of shares of Common Stock determined according to a formula set forth in the Warrant. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of the year ended December&#160;28, 2024, the non-affiliated Investor exercised the Big Warrant for a total of 200,000 shares of the Company&#8217;s common stock, and the other two non-affiliated Investors exercised the Small Warrant for a total of 90,908 shares (see Note 18). Additionally, during the fourth quarter of the year ended December&#160;28, 2024, these unaffiliated third-parties agreed to convert a portion their respective investment into Future Equity Agreements of the Company&#8217;s subsidiary, Alyea Therapeutics and, consequently, approximately $1.3 million was reclassified as non-controlling interest. As of December&#160;28, 2024, the outstanding balance due on the debentures was approximately $500,000, consisting of principal and accrued interest.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Corporate Fixed Deposit Agreement</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;19, 2024, ALT5 Subsidiary and an investor entered into a 12-month Corporate Fixed Deposit Agreement, pursuant to which ALT5 Subsidiary borrowed $1.5 million at an interest rate of 12% per annum, payable monthly, calculated on the then-unpaid principal amount.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon maturity, ALT5 Subsidiary is obligated to repay the principal amount in full and any accrued and unpaid interest.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal may be repaid in full, but not in part, with a pre-payment penalty equivalent to three month&#8217;s of interest. As of December&#160;28, 2024, the outstanding balance was $1.5 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Related Party Debt</a></td>
<td class="text">Related Party Debt<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt payable to related parties (see Note 20) as of December&#160;28, 2024 and December&#160;30, 2023 consisted of the following (in $000&#8217;s):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Isaac Capital Group</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">707&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Isaac Capital Group, 10% interest rate, matures December 31, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Live Ventures Incorporated, 10% interest rate, matures December 31, 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Isaac Capital Group short-term demand advance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Novalk Apps SAA, LLP  short-term demand advance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total notes payable, related parties</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">812&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">707&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(812)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total long-term notes payable, related parties</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">707&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total future maturities of long-term debt to related parties is as follows (in $000&#8217;s):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.052%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Twelve months ending September 30,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total future maturities of long-term debt, related parties</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">812&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Isaac Capital Group LLC</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;7, 2024, the Company amended its outstanding related party promissory obligations (the &#8220;ICG Note&#8221;) in favor of ICG to add a convertibility provision. In accordance with Nasdaq Rules, the per-share conversion price was set at $0.61, subject to standard adjustments for (i) stock dividends and splits, (ii) subsequent rights offerings, and (iii) pro rata distributions. The Company&#8217;s board of directors provided its approvals of the amendments on February&#160;7, 2024. On March&#160;6, 2024, ICG entered into a Note Purchase Agreement with an otherwise unaffiliated third party, under which the third party acquired the ICG Note. The terms and conditions of the ICG Note were not modified in connection with its acquisition by the third party. The principal amount of the ICG Note on the date of acquisition was approximately $1.2 million. As of December&#160;28, 2024, the third party converted $183,000 of the Company&#8217;s obligation under the ICG Note into 300,000 shares of the Company&#8217;s common stock. As of December&#160;28, 2024, the amount outstanding on the ICG Note was approximately $0.3 million (see Note 20).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;18, 2024, ICG made a short-term demand advance to the Company in the amount of $100,000. The advance bears interest at a rate of 10% per annum until repaid. As of December&#160;28, 2024, the principal amount outstanding was $48,000 (see Note 20).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Live Ventures Incorporated</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;7, 2024, the Company amended its outstanding related party promissory obligations (the &#8220;Live Note&#8221;) in favor of Live Ventures to add a convertibility provision. In accordance with Nasdaq Rules, the per-share conversion price for each obligation, as amended, was set at $0.61, subject to standard adjustments for (i) stock dividends and splits, (ii) subsequent rights offerings, and (iii) pro rata distributions. The Company&#8217;s board of directors provided its final approvals of the amendments on February&#160;7, 2024. On March&#160;6, 2024, Live Ventures entered into a Note Purchase Agreement with another otherwise unaffiliated third party, under which under which the third party acquired the Live Note. The terms and conditions of the acquired Live Note were not modified in connection with its acquisition by the third party. The principal amount of the Live Note on the date of acquisition was approximately $1.0 million. As of December&#160;28, 2024, the third party converted $183,000 of the Company&#8217;s obligation under the Live Note into 300,000 shares of the Company&#8217;s common stock. As of December&#160;28, 2024, the amount outstanding on the Live Note was approximately $0.3 million (see Note 20).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Jon Isaac</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;4, 2024, the Company entered into a two-year Consulting Agreement with Jon Isaac, pursuant to which he will provide to the Company (the &#8220;Services&#8221;): (i) strategic financial advice, including growth strategies, capital allocation, and financial restructuring; (ii) sales and business development advice, including for the acquisition of new clients and new products through networking, referrals, and marketing efforts for our prospective products; (iii) in-depth research and </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">market intelligence on specific industries, sectors, and market trends; (iv) financial models and financial analysis to support strategic decision-making; (v) assistance, through site visits, in the preparation of new client offers and bids for proposed projects; (vi) weekly update calls with management to align on progress of objectives and goals; (vii) enhanced non-confidential materials; (viii) business risk management support; and (ix) other services to which the Company and he may agree that will be memorialized in writing if, when, and as needed during the two-year term. In connection with the Consulting Agreement, the Company entered into a a two-year, straight 10% convertible promissory note in the initial principal amount of $500,000, and a per-share conversion price equivalent to the per-share value of the restricted common stock that he was granted ($1.16). The maturity date of the promissory note is March&#160;4, 2026. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;23, 2024, pursuant to the terms of his Consulting Agreement, Mr. Isaac converted the principal and accrued interest on the convertible promissory note, in the amount of approximately $540,000, into 465,753 shares of the Company&#8217;s common stock. As of December&#160;28, 2024, there was no principal balance outstanding on the promissory note (see Note 20).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Novalk Apps SAA, LLP</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;28, 2024 and June&#160;3, 2024, Novalk Apps SAA, LLP (&#8220;Novalk&#8221;) made short-term demand advances in the amount of $120,000 and $100,000, respectively, to the Company. The advances bears interest at a rate of 10% per annum until repaid. As of December&#160;28, 2024, the principal amount outstanding was $110,000 (see Note 20).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Tony Isaac</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During June&#160;3, 2024, Tony Isaac made a number of short-term demand advances in the aggregate amount of $62,000 to the Company. The advances bears interest at a rate of 10% per annum until repaid. As of December&#160;28, 2024, the principal amount outstanding was fully repaid (see Note 20).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockTextBlock', window );">Preferred Stock</a></td>
<td class="text">Preferred Stock<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Series A-1 Convertible Preferred Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">History</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August&#160;18, 2017, the Company acquired GeoTraq by way of merger. In connection with this transaction, the Company tendered to the owners of GeoTraq $200,000, issued to them an aggregate of 288,588 shares (number of shares specific &#8211; not rounded) of the Company&#8217;s Series A Convertible Preferred Stock valued at $12.3 million, including the beneficial conversion feature of $2.6 million, and entered into one-year unsecured promissory notes in the aggregate principal amount of $800,000.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The &#8220;Conversion Ratio&#8221; per share of the Series A-1 Convertible Preferred Stock in connection with any conversion shall be at a ratio of 20:1, one share of Series A-1 Convertible Preferred Stock, if and when converted into shares of Common Stock, shall convert into twenty shares Common Stock. Each holder shall have the right, exercisable at any time and from time to time (unless otherwise prohibited by law, rule, or regulation, or as restricted below), to convert any or all of such holder&#8217;s shares of Series A-1 Convertible Preferred Stock into shares of Common Stock at the Conversion Ratio.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;28, 2024 and December&#160;30, 2023, 0 and 27,353 shares of the Company&#8217;s Series A-1 Convertible Preferred Stock were converted into 0 and 547,069 shares, respectively, of the Company&#8217;s common stock. Additionally, during the year ended December&#160;28, 2024, 0 shares of the Company&#8217;s Series A-1 Convertible Preferred Stock were forfeited. As of December&#160;28, 2024 and December&#160;30, 2023, there were 23,480 and 193,730 shares, respectively, of Series A-1 Convertible Preferred Stock outstanding.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company cannot declare, pay or set aside any dividends on shares of any other class or series of our capital stock unless (in addition to the obtaining of any consents required by our Articles of Incorporation) the holders of the Series A Convertible Preferred Stock then outstanding shall first receive, or simultaneously receive, a dividend in the aggregate amount of one dollar, regardless of the number of then-issued and outstanding shares of Series A Convertible Preferred Stock. Any remaining dividends allocated by the Board of Directors shall be distributed in an equal amount per share to the holders of outstanding common stock and Series A-1 Convertible Preferred Stock (on an as-if-converted to common stock basis pursuant to the Conversion Ratio as defined below).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voting Rights</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each holder of a share of Series A Convertible Preferred Stock has a number of votes as is determined by multiplying (i) the number of shares of Series A Preferred Stock held by such holder, and (ii) 17. The holders of Series A-1 Convertible Preferred Stock vote together with all other classes and series of common and preferred stock of the Company as a single class on all actions to be taken by the common stockholders of the Company, except to the extent that voting as a separate class or series is required by law.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redemption</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series A-1 Convertible Preferred Stock has no redemption rights by the Company, or any other entity.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preemptive Rights</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Series A-1 Convertible Preferred Stock and holders of ALT5 Sigma Corporation&#8217;s common stock are not entitled to any preemptive, subscription, or similar rights in respect of any securities of the Company, except as set forth in the Amended and Restated Series A-1 Certificate of Designation or in any other document agreed to by ALT5 Sigma Corporation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Protective Provisions</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Without first obtaining the affirmative approval of a majority of the holders of the shares of Series A-1 Convertible Preferred Stock, the Company may not directly or indirectly (i) increase or decrease (other than by redemption or conversion) the total number of authorized shares of Series A-1 Convertible Preferred Stock; (ii) effect an exchange, reclassification, or cancellation of all or a part of the Series A-1 Convertible Preferred Stock, but excluding a stock split or </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reverse stock split or combination of the common stock or preferred stock; (iii) effect an exchange, or create a right of exchange, of all or part of the shares of another class of shares into shares of Series A-1 Convertible Preferred Stock; or (iv) alter or change the rights, preferences or privileges of the shares of Series A-1 Convertible Preferred Stock so as to affect adversely the shares of such series, including the rights set forth in this Designation; provided, however, that we may, without any vote of the holders of shares of the Series A-1 Convertible Preferred Stock, make technical, corrective, administrative or similar changes to the Amended and Restated Series A-1 Certificate of Designation that do not, individually or in the aggregate, materially adversely affect the rights or preferences of the holders of shares of the Series A-1 Convertible Preferred Stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Series B Preferred Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">History</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;15, 2024 the Company acquired acquired its ALT5 Subsidiary by way of merger (see Note 3). the Company tendered to the owners of ALT5 Subsidiary 34,250 shares of the Company&#8217;s Series B Preferred Stock valued at approximately $8.6 million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series B Preferred Stock are not be convertible into any class or series of capital stock of the Company. As of the year ended December&#160;28, 2024, 34,207 shares of Series B Preferred Stock were outstanding.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company shall not declare, pay, or set aside any dividends on shares of Series B Preferred Stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voting Rights</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as required by the General Corporation Law of the State of Nevada, the Series B Preferred Stock shall not have any voting rights.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redemption</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series B Preferred Stock has no redemption rights by ALT5 Sigma Corporation, or any other entity.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preemptive Rights</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of Series B Preferred Stock and holders of Common Stock are not be entitled to any preemptive, subscription, or similar rights in respect of any securities of the Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Protective Provisions</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Without first obtaining the affirmative approval of a majority of the holders of the shares of Series B Preferred Stock, the Company may not directly or indirectly (i) increase or decrease (other than by redemption or conversion) the total number of authorized shares of Series B Preferred Stock; (ii) effect an exchange, reclassification, or cancellation of all or a part of the Series B Preferred Stock, but excluding a stock split or reverse stock split or combination of the common stock or preferred stock; (iii) effect an exchange, or create a right of exchange, of all or part of the shares of another class of shares into shares of Series B Preferred Stock; (iv) permit the convertibility, whether mandatory or permissible, of some or all of the then-outstanding shares of Series B Preferred Stock, or (v) alter or change the rights, preferences or privileges of the shares of Series B Preferred Stock so as to affect adversely the shares of such series, including the rights set forth in this Designation; provided, however, that we may, without any vote of the holders of shares of the Series B Preferred Stock, </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">make technical, corrective, administrative or similar changes that do not, individually or in the aggregate, materially adversely affect the rights or preferences of the holders of shares of the Series B Preferred Stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Series I Convertible Preferred Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">History</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with its acquisition of ALT5 Subsidiary (see Note 3), on December&#160;2, 2024, the Company tendered 17,000 shares of Series I Convertible Preferred Stock to two consultants of ALT5 Subsidiary.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series I Convertible Preferred Stock is subject to a mandatory eight-calendar-quarter leak-out, such that no more than twelve-and-one-half percent of the shares may be converted into shares of the Company&#8217;s common stock on a trailing quarterly basis over a period of two years, and are subject to vesting provisions. The conversion ratio per share of the Series I Convertible Preferred Stock shall be one hundred shares of the Company&#8217;s common stock for each share of Series </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I Convertible Preferred Stock subject to certain adjustments. As of the year ended December&#160;28, 2024, 17,000 shares of Series I Convertible Preferred Stock were outstanding.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Original Issue Date, the holders of this series of Preferred Stock shall be entitled to receive dividends on an as-converted into-Common Stock basis contemporaneously with the declaration and payment to the holders of Common Stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voting Rights</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as required by the General Corporation Law of the State of Nevada, the Series I Convertible Preferred Stock shall not have any voting rights.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redemption</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Certificate of Designation for the Series I Convertible Preferred Stock does not provide any redemption rights by ALT5 Sigma Corporation, or any other entity.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preemptive Rights</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Certificate of Designation for the Series I Convertible Preferred Stock does not provide the holders thereof with any preemptive, subscription, or similar rights in respect of any securities of the Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Protective Provisions</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Certificate of Designation for the Series I Convertible Preferred Stock does not provide the holders thereof with any protective provisions in their favor for so long as shares of such series remain outstanding.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Series M Preferred Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">History</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with its acquisition of ALT5 Subsidiary (see Note 3), the Company issued 3,200 shares of Series M Preferred Stock to two entities that acted as finders for the transaction.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series M Preferred Stock shall not be convertible into any class or series of capital stock of the Company. As of the year ended December&#160;28, 2024, 3,200 shares of Series M Preferred Stock were outstanding.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company shall not declare, pay, or set aside any dividends on shares of Series M Preferred Stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voting Rights</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as required by the General Corporation Law of the State of Nevada, the Series M Preferred Stock shall not have any voting rights.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redemption</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series M Preferred Stock has no redemption rights by ALT5 Sigma Corporation, or any other entity.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preemptive Rights</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of Series M Preferred Stock and holders of Common Stock shall not be entitled to any preemptive, subscription, or similar rights in respect of any securities of the Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Protective Provisions</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Without first obtaining the affirmative approval of a majority of the holders of the shares of Series M Preferred Stock, the Company may not directly or indirectly (i) increase or decrease (other than by redemption or conversion) the total number of authorized shares of Series M Preferred Stock; (ii) effect an exchange, reclassification, or cancellation of all or a part of </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Series M Preferred Stock, but excluding a stock split or reverse stock split or combination of the common stock or preferred stock; (iii) effect an exchange, or create a right of exchange, of all or part of the shares of another class of shares into shares of Series M Preferred Stock; (iv) permit the convertibility, whether mandatory or permissible, of some or all of the then-outstanding shares of Series M Preferred Stock, or (v) alter or change the rights, preferences or privileges of the shares of Series M Preferred Stock so as to affect adversely the shares of such series, including the rights set forth in this Designation; provided, however, that we may, without any vote of the holders of shares of the Series M Preferred Stock, make technical, corrective, administrative or similar changes that do not, individually or in the aggregate, materially adversely affect the rights or preferences of the holders of shares of the Series M Preferred Stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Series Q Convertible Preferred Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">History</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;6, 2024 acquired the Qodex Cryptocurrency Exchange Software platform and other related assets from Qoden Technologies, LLC by way of an asset purchase agreement (see Note 3). The Company tendered to the owners of Qoden Technologies, LLC 771,010 shares of the Company&#8217;s Series Q Convertible Preferred Stock valued at approximately $1.3 million. Additionally, the Company tendered and additional 154,202 shares of the Company&#8217;s Series Q Convertible Preferred Stock to a third-party contractor to act as a consultant in implementing and enhancing the platform.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series Q Convertible Preferred Stock was valued at $2.594 per share on the date issued, and is subject to a mandatory eight-calendar-quarter leak-out, such that no more than twelve-and-one-half percent of the shares may be converted into shares of the Company&#8217;s common stock on a trailing quarterly basis over a period of two years, and are subject to vesting provisions. The conversion ratio per share of the Series Q Convertible Preferred Stock shall be one share of the Company&#8217;s common stock for each share of Series Q Convertible Preferred Stock subject to certain adjustments. As of the year ended December&#160;28, 2024, 925,212 shares of Series Q Convertible Preferred Stock were outstanding.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Original Issue Date, holders of Series Q Convertible Preferred Stock shall not be entitled to receive any dividends.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voting Rights</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as required by the General Corporation Law of the State of Nevada, the Series Q Convertible Preferred Stock shall not have any voting rights.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redemption</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series Q Convertible Preferred Stock has no redemption rights by ALT5 Sigma Corporation, or any other entity.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preemptive Rights</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of Series Q Convertible Preferred Stock and holders of Common Stock shall not be entitled to any preemptive, subscription, or similar rights in respect of any securities of the Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Protective Provisions</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Without first obtaining the affirmative approval of a majority of the holders of the shares of Series Q Convertible Preferred Stock, the Company may not directly or indirectly (i) increase or decrease (other than by redemption or conversion) the total number of authorized shares of Series Q Convertible Preferred Stock; (ii) effect an exchange, reclassification, or cancellation of all or a part of the Series Q Convertible Preferred Stock, but excluding a stock split or reverse stock split or combination of the common stock or preferred stock; (iii) effect an exchange, or create a right of exchange, of all or part of the shares of another class of shares into shares of Series Q Preferred Stock; (iv) permit the convertibility, whether mandatory or permissible, of some or all of the then-outstanding shares of Series B Preferred Stock, or (v) alter or change the rights, preferences or privileges of the shares of Series Q Convertible Preferred Stock so as to affect adversely the shares of such series, including the rights set forth in this Designation; provided, however, that we may, without any vote of the holders of shares of the Series Q Convertible Preferred Stock, make technical, corrective, administrative or similar </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">changes that do not, individually or in the aggregate, materially adversely affect the rights or preferences of the holders of shares of the Series Q Convertible Preferred Stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Series V Convertible Preferred Stock</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">History</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;4, 2024, entered into an Asset Purchase Agreement for the purchase of specified assets of an unaffiliated third-party (see Note 18). In connection with this transaction, the Company tendered 5,000 shares of the Company's Series V Convertible Preferred Stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The conversion ratio per share of the Series V Convertible Preferred Stock in connection with any Conversion shall be at a ratio of 1:1, meaning every one share of Series V Convertible Preferred Stock, if and when converted into shares of Common Stock, shall convert into one share of Common Stock. Each Holder shall have the right, exercisable at any time and from time to time, unless otherwise prohibited by law, rule, or regulation, to convert any or all of such Holder&#8217;s shares of Series V Convertible Preferred Stock into shares of Common Stock at the Conversion Ratio. As of the year ended December&#160;28, 2024, 5,000 shares of Series Q Convertible Preferred Stock were outstanding.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares of Series V Convertible Preferred Stock do not have dividend rights.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voting Rights</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Holder of each share of Series V Convertible Preferred Stock shall have such number of votes as is determined by multiplying (a) the number of shares of Series V Convertible Preferred Stock held by such Holder by (b) one. Such voting calculation is hereby authorized by the Company and the Company acknowledges such calculation may result in the total number of possible votes cast by the Series V Convertible Preferred Stock Holders and all other classes of the Company&#8217;s Common Stock in any given voting matter exceeding the total aggregate number of shares that this Company shall have authority to issue.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redemption</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series V Convertible Preferred Stock has no redemption rights by ALT5 Sigma Corporation, or any other entity.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preemptive Rights</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of Series V Convertible Preferred Stock and holders of Common Stock shall not be entitled to any preemptive, subscription, or similar rights in respect of any securities of the Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Protective Provisions</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Without first obtaining the affirmative approval of a majority of the holders of the shares of Series V Convertible Preferred Stock, the Company may not directly or indirectly (i) increase or decrease (other than by redemption or conversion) the total number of authorized shares of Series V Convertible Preferred Stock; (ii) effect an exchange, reclassification, or cancellation of all or a part of the Series V Convertible Preferred Stock, but excluding a stock split or reverse stock split or combination of the common stock or preferred stock; (iii) effect an exchange, or create a right of exchange, of all or part of the shares of another class of shares into shares of Series V Preferred Stock; (iv) permit the convertibility, whether mandatory or permissible, of some or all of the then-outstanding shares of Series V Preferred Stock, or (v) alter or change the rights, preferences or privileges of the shares of Series V Convertible Preferred Stock so as to affect adversely the shares of such series, including the rights set forth in this Designation; provided, however, that we may, without any vote of the holders of shares of the Series V Convertible Preferred Stock, make technical, corrective, administrative or similar </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">changes that do not, individually or in the aggregate, materially adversely affect the rights or preferences of the holders of shares of the Series V Convertible Preferred Stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Series S Convertible Preferred Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">History</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 28, 2022 the Company acquired Soin Therapeutics by way of merger. In connection with this transaction, with a potential value of up to $30 million, the Company tendered 100,000 shares of the Company's Series S Convertible Preferred Stock. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Initially, Dr. Soin was entitled to convert up to three million dollars of value of the Series S Stock into shares of the Company&#8217;s common stock commencing one year from the closing and may also convert up to an additional $10 million of value of the Series S Stock into shares of the Company's common stock from and after the sooner of (y) the issuance by the FDA of New Drug Approval for low-dose naltrexone for treating pain or (z) 10 years from the closing. Further, during the 10-year period following the closing, Dr. Soin may convert up to an additional $17 million of value at a rate of five percent of the gross revenues that the Company receives in connection with sales or license revenue from the product.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Soin further agreed to certain restrictions on the maximum number of shares of Series S Stock that he may ultimately keep or that he may convert into shares of our common stock or sell into the public markets at any given time: (i) Dr. Soin may not convert shares of Series S Stock into shares of the Company's common stock in an amount such that, upon any such conversion, he beneficially own shares of the Company's common stock in excess of 4.99% of the Company's then-outstanding common stock and (ii) during the five-year period that commences on the date that Dr. Soin is first eligible to convert any shares of Series S Stock into shares of the Company's common stock, he will not dispose of any of such shares into the public markets in an amount that exceeds five percent of the daily trading volume of the Company's common stock during any trading day.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares of Series S Convertible Preferred Stock are convertible into the Company&#8217;s common shares at a ratio of 1:1. During the year ended December&#160;28, 2024, in connection with the amended agreement disclosed in Note 3, the Company reclassified approximately $2.7&#160;million from mezzanine equity to current liabilities, and approximately $8.0&#160;million from mezzanine equity to permanent equity (see Note 3). As of December&#160;28, 2024 and December&#160;30, 2023, there were 100,000 shares of Series S Convertible Preferred Stock outstanding, as reflected in the following (dollars in $000&#8217;s):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Series S Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance, December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,510&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance, December 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100,000</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100000</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,510</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassification to permanent equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,993)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassification to current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,661)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance, December 28, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,856&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares of Series S Convertible Preferred Stock do not have dividend rights.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voting Rights</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Holder of each share of Series S Convertible Preferred Stock shall have one vote for such share. With respect to any stockholder vote, the Holder shall have full voting rights and powers equal to the voting rights and powers of the Common Stock stockholders, and shall be entitled to notice of any stockholders' meeting in accordance with the Bylaws of the Company, and shall be entitled to vote, together with Common Stock stockholders, with respect to any question upon which the Common Stock stockholders have the right to vote. The Holders of Series S Convertible Preferred Stock shall vote together with all other classes and series of common and preferred stock of the Company as a single class on all actions to be taken by the Common Stock stockholders, except to the extent that voting as a separate class or series is required by law.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redemption</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series S Convertible Preferred Stock has no redemption rights by ALT5 Sigma Corporation, or any other entity.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preemptive Rights</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Series S Convertible Preferred Stock and holders of ALT5 Sigma Corporation common stock are not entitled to any preemptive, subscription, or similar rights in respect of any securities of ALT5 Sigma Corporation, except as set forth in the Amended and Restated Series A-1 Certificate of Designation or in any other document agreed to by ALT5 Sigma Corporation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Protective Provisions</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Without first obtaining the affirmative approval of a majority of the holders of the shares of Series S Convertible Preferred Stock, the Company may not directly or indirectly (i) increase or decrease (other than by redemption or conversion) the total number of authorized shares of Series S Convertible Preferred Stock; (ii) effect an exchange, reclassification, or cancellation of all or a part of the Series S Convertible Preferred Stock, but excluding a stock split or reverse stock split or combination of the common stock or preferred stock; (iii) effect an exchange, or create a right of exchange, of all or part of the shares of another class of shares into shares of Series S Convertible Preferred Stock; (iv) issue additional shares of Series S Convertible Preferred Stock other than in connection with the merger agreement, or (v) alter or change the rights, preferences or privileges of the shares of Series S Convertible Preferred Stock so as to affect adversely the shares of such series, including the rights set forth in this Designation; provided, however, that we may, without any vote of the holders of shares of the Series S Convertible Preferred Stock, make technical, corrective, administrative or similar changes to the Amended and Restated Series S Certificate of Designation that do not, individually or in the aggregate, materially adversely affect the rights or preferences of the holders of shares of the Series S Convertible Preferred Stock.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders&#8217; Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">Stockholders&#8217; Equity</a></td>
<td class="text">Stockholders&#8217; Equity<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The Company's Articles of Incorporation authorize 200,000,000 shares of common stock that may be issued from time to time having such rights, powers, preferences and designations as the Board of Directors may determine. As of December&#160;28, 2024, and December&#160;30, 2023, there were 15,417,687 and 4,957,647</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares, respectively, of common stock issued and outstanding.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Equity Offerings:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;22, 2023, the Company entered into a Securities Purchase Agreement with certain institutional investors for the sale by the Company in a registered direct offering of 361,000 shares of the Company&#8217;s common stock, par value $0.001 per share, at a purchase price per share of Common Stock of $1.17. The offering closed on March&#160;24, 2023. The aggregate gross proceeds for the sale of the shares of Common Stock were approximately $422,000, before deducting the placement agent fees and related expenses. The Company utilized the net proceeds for working capital and general corporate purposes.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August&#160;18, 2023, the Company entered into a Securities Purchase Agreement with a certain institutional investor for the sale by the Company in a registered direct offering of: (i) 418,000 shares of the Company&#8217;s common stock, par value $0.001 per share, at an offering price of $0.8811 per share and (ii) pre-funded warrants exercisable for up to 481,348 shares of Common Stock to the Investor at an offering price equal to $0.8801 per pre-funded Warrant. In connection with the Securities Purchase Agreement, during the year ended December&#160;28, 2024, the Company issued 27,738 shares of its common stock to three third-parties in exchange for brokerage services.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;23, 2024, the Company entered into Unit Purchase Agreements with two otherwise unaffiliated third-party investors, pursuant to which each Investor agreed to purchase 408,163 units of securities from the Company, at a price per Unit of $0.7350, for an aggregate purchase price of $300,000 per investor for an aggregate price of $600,000. Each Unit consists of one share of the Company&#8217;s common stock and one warrant to purchase an additional share of common stock. The per-Unit price is allocated as follows: $0.61 per share of common stock and $0.125 per Warrant. The Warrant has a three-year term and will be immediately exercisable. Each Warrant is exercisable at $0.61 per share. The Company utilized the proceeds from the Unit Purchases for its working capital needs. Further, the Company issued an additional 81,632 shares of its common stock to another party in exchange for brokerage services rendered.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;4, 2024, the Company entered into a two-year Consulting Agreement (the &#8220;Consulting Agreement&#8221;) with Jon Isaac, pursuant to which he will provide a variety of services to the Company. In connection with the Consulting Agreement, the Company issued to Mr. Isaac 200,000 restricted shares of its common stock (see Note 20).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;22, 2024, pursuant to the terms and conditions of a promissory note, the Company converted $183,000 of obligations into 300,000 shares of the Company&#8217;s common stock (see Note 20).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;25, 2024, pursuant to the terms and conditions of a promissory note, the Company converted $183,000 of obligations into 300,000 shares of the Company&#8217;s common stock (see Note 20).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;10, 2024, pursuant to the terms and conditions of a promissory note, the Company converted $60,900 of obligations into 100,000 shares of the Company&#8217;s common stock (see Note 20).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;12, 2024, pursuant to the terms and conditions of a promissory note, the Company converted $60,900 of obligations into 100,000 shares of the Company&#8217;s common stock (see Note 20).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;1, 2024, the Company entered into a Securities Purchase Agreement with two institutional investors for the sale by the Company of 79,782 units of the Company&#8217;s securities at a purchase price of $3.775 per unit, each unit consisting of one share of the Company&#8217;s common stock and one common stock purchase warrant for the purchase of an additional share of Common Stock. Each three-year warrant is exercisable immediately at an exercise price of $3.63 per share. The gross proceeds were approximately $300,000, before deducting related expenses.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;4, 2024, the Company entered into an Asset Purchase Agreement for the purchase of specified assets of an unaffiliated third-party. For the purchase of the assets, the Company (i) issued 300,000 restricted shares of its common stock, (ii) issued 5,000 shares of its Series V Convertible Preferred Stock, and (iii) granted a three-year warrant for the purchase of up to 125,000 shares of its common stock at an exercise price of $1.25 per share.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;15, 2024, the Company acquired ALT5 Subsidiary. As consideration under the acquisition, the Company issued 1,799,100 shares of its common stock to the legacy equity holders of the capital stock of ALT5 (see Note 3).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;3, 2024, the Company entered into a six-month marketing agreement with a non-affiliated third-party, pursuant to which the third-party will provide a variety of marketing-related services to the Company. In connection with the marketing agreement, the Company issued to the third-party 47,923 shares of its common stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;6, 2024, the Company entered into a one-year consulting agreement with a non-affiliated third-party, pursuant to which the third party will provide a variety of finance and investor-related services to the Company. In connection with the marketing agreement, the Company issued to the third-party 150,000 shares of its common stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;18, 2024, the Company entered into a six-month marketing agreement with a non-affiliated third-party, pursuant to which the third-party will provide a variety of marketing-related services to the Company. In connection with the marketing agreement, the Company issued to the third-party 20,000 shares of its common stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During October 2024, the Company issued 225,000 shares of its common stock as prepayment of one year&#8217;s interest on its Bitcoin loan.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Big/Small Debenture (see Note 15), on October&#160;18, 2024, the Company issued an additional 25,000 shares of its common stock to another party in exchange for brokerage services rendered.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of the fiscal year ended December&#160;28, 2024, the Company issued 290,908 shares of its common stock related to the exercise of warrants under Big/Small Debenture (see Note 15).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July&#160;1, 2024, the Company entered into a one-year consulting agreement with a non-affiliated third-party, pursuant to which the third-party will provide a variety of communication-related consulting services to the Company. In connection with the marketing agreement, on December&#160;3, 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company issued to the third-party 60,000 shares of its common stock.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;23, 2024, pursuant to the terms of his Consulting Agreement, Mr. Isaac converted the existing obligation on the convertible promissory note, in the amount of approximately $540,000, into 465,753 shares of the Company&#8217;s common stock (see Note 16).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;23, 2024, pursuant to the terms of the judgment and forbearance agreements, a non-affiliated third-party converted the existing obligation plus accrued interest due under the agreements, in the amount of approximately $691,000, into 265,842 shares of the Company&#8217;s common stock (see Note 15).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;28, 2024, the Company issued an aggregate of 341,175 shares of its common stock to four individuals under the Company&#8217;s 2023 Equity Incentive Plan. The aggregate value of the shares at issuance was approximately $1.3 million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Equity Incentives</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The Company&#8217;s 2024 Plan, which was adopted by the Board in November 2024 and approved by the stockholders at the 2024 annual meeting of stockholders, replaces the 2023 Plan, which replaced the 2016 Plan, which replaced the 2011 Plan. Under the 2024 Plan, the maximum aggregate number of shares, which may be subject to or delivered under Awards granted under the Plan is 2,800,000 shares. Awards may be in the form of a Stock Award, Option, Stock Appreciation Right, Stock Unit, or Other Stock-based Award granted in accordance with the terms of the respective Plan. During the year ended December&#160;28, 2024, there were no grants under the 2024 Plan.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s 2023 Plan, which was adopted by the Board in August 2023 and approved by the stockholders at the 2023 Annual Meeting of Stockholders, replaces the 2016 Plan, which replaced the 2011 Plan. Under the 2023 Plan, the maximum aggregate number of shares, which may be subject to or delivered under Awards granted under the Plan is two million (2,000,000) shares. Awards may be in the form of a Stock Award, Option, Stock Appreciation Right, Stock Unit, or Other Stock-based Award granted in accordance with the terms of the respective Plan. During the year ended December&#160;28, 2024, the Company recognized $1.2 million and in share-based compensation expense related to the 908,852 RSU&#8217;s that were awarded and immediately vested, as well as 295,000 shares of the Company&#8217;s common stock issued (see above).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s 2016 Plan authorizes the granting of awards in any of the following forms: (i) incentive stock options, (ii) nonqualified stock options, (iii) restricted stock awards, and (iv) restricted stock units, and expires on the earlier of October&#160;28, 2026, or the date that all shares reserved under the 2016 Plan are issued or no longer available. On November&#160;4, 2020, the Company amended the 2016 Plan to increase the issuance of common shares from 400,000 to 800,000. The vesting period is determined by the Board of Directors at the time of the stock option grant. As of December&#160;28, 2024 and December&#160;30, 2023, 100,000 options were outstanding under the 2016 Plan.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s 2011 Plan authorizes the granting of awards in any of the following forms: (i) stock options, (ii) stock appreciation rights, and (iii) other share-based awards, including but not limited to, restricted stock, restricted stock units or performance shares, and expired on the earlier of May&#160;12, 2021, or the date that all shares reserved under the 2011 Plan are issued or no longer available. As of December&#160;28, 2024 and December&#160;30, 2023, 8,000 and 14,000 options, respectively, were outstanding under the 2011 Plan. No additional awards will be granted under the 2011 Plan.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity for the fiscal years ended December&#160;28, 2024, and December&#160;30, 2023 (Aggregate Intrinsic Value in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Options <br/>Outstanding </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate<br/>Intrinsic<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cancelled/expired</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,000)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.1</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cancelled/expired</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,000)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 28, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercisable at December 28, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.8</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exercise price for stock options outstanding and exercisable outstanding at December&#160;28, 2024 is as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.447%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercisable</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Options</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercise Price ($)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Options</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercise Price ($)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42,000</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$5.70 to $9.90</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,000</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$5.70 to $9.90</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$3.54 to $5.25</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$3.54 to $5.25</span></div></td></tr><tr><td colspan="3" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108,000</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,000</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized share-based compensation expense related to equity incentive awards of approximately $1.7 million and approximately $14,000 for the fiscal years ended December&#160;28, 2024, and December&#160;30, 2023, respectively. As of December&#160;28, 2024, the Company had no unrecognized share-based compensation expense, and there were no non-vested shares associated with stock option awards.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income taxes</a></td>
<td class="text">Income taxes<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For fiscal years ended December&#160;28, 2024, and December&#160;30, 2023, the Company recorded an income tax benefit from continuing operations of approximately $3.0 million and an income tax benefit of $0.4&#160;million, respectively, and an income tax provision from discontinued operations of $0 and approximately $1.0 million, respectively, which consisted of the following (in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current tax expense:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(44)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current tax expense</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">188&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax (benefit) provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total (benefit) provision of income taxes</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,041)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">542&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the Company's income tax benefit (provision) with the federal statutory tax rate for the fiscal years ended December&#160;28, 2024, and December&#160;30, 2023, respectively, is shown below:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Years Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. statutory rate</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.0&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.0&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign rate differential</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Permanent differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Impact of sale of ARCA Recycling and Canada</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-4.4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-25.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.2&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-0.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-7.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) before provision of income taxes was derived from the following sources for fiscal years December&#160;28, 2024 and December&#160;30, 2023, respectively, as shown below (in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Years Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12,825)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,613)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Canada</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(657)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9,286)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,270)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net deferred tax assets (liabilities) as of December&#160;28, 2024 and December&#160;30, 2023, respectively, are as follows (in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets (liabilities):</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allowance for bad debts</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 174 expenses</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,586&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,360&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax credits</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangibles</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,909)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,747)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment sale</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 163(j) interest</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,878&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,134&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,919)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,773)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net deferred tax liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,041)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(639)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;28, 2024, the Company has net operating loss carryforwards of approximately $19.5 million for federal income tax purposes, and approximately $11.8 million for state income tax purposes, which will be available to offset future taxable income. Due to recent tax legislation, the federal net operating losses are eligible for indefinite carryforward, limited by certain taxable income limitations. State net operating losses begin to expire in 2032. The Company evaluates all available evidence to determine if a valuation allowance is needed to reduce its deferred tax assets. During the fourth quarter of fiscal year 2023, management concluded that a valuation allowance is necessary for the state net operating loss carryforward and a portion of the federal net operating loss carryforward. Due to the 2023 sale of ARCA Canada (as part of the Recycling Subsidiaries transaction), the valuation allowance was released. The Company has recorded a valuation allowance of approximately $2.9 million as of December&#160;28, 2024, and December&#160;30, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company annually conducts an analysis of its uncertain tax positions and has concluded that it has no uncertain tax positions as of December&#160;28, 2024. The Company&#8217;s policy is to record uncertain tax positions as a component of income tax expense.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files U.S. and state income tax returns in jurisdictions with differing statutes of limitations. The 2021 through 2024 tax years remain subject to selection for examination as of December&#160;28, 2024. None of the Company&#8217;s income tax returns are currently under audit.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related parties</a></td>
<td class="text">Related parties<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Shared Services</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tony Isaac, the Company&#8217;s President, is the father of Jon Isaac, President and Chief Executive Officer of Live Ventures and managing member of ICG. Tony Isaac and Richard Butler, Board of Directors members of the Company, are members of the Board of Directors of Live Ventures. The Company also shares certain executive, accounting and legal services with Live Ventures. The total services shared were approximately $144,000 and approximately $203,000 for fiscal years ending December&#160;28, 2024 and December&#160;30, 2023, respectively. Customer Connexx rented approximately 9,900 square feet of office space from Live Ventures in Las Vegas, Nevada. Effective August 2023, due to the winding down of operations of the Recycling Subsidiaries, the Company ceased leasing office space in the Las Vegas, Nevada facility. The total rent and common area expenses for Connexx at the Las Vegas, Nevada office were approximately $17,000 and approximately $103,000 for fiscal years ending December&#160;28, 2024 and December&#160;30, 2023, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During Q4 2023, operations of the Recycling Subsidiaries were wound down and, ultimately, ceased. See Note 4. Consequently, outstanding liabilities for shared rent and services for the Recycling Subsidiaries reverted to the Company. As such, the Company has recorded a liability in the amount of approximately $258,000, which was offset against the gain on sale of the Recycling Subsidiaries.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Notes with Live Ventures and ICG</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;7, 2024, the Company entered into a promissory notes with each of Live Ventures and ICG. The initial principal amount of each note is $300,000, with an interest rate of 10% per annum. Pursuant to an amendment to each note, $100,000 of principal, and accrued interest thereon, is due on September&#160;7, 2024 for each note, and the balance of each note is due on December&#160;31, 2024. At the Company&#8217;s option, the obligation under each note is convertible after the six-month anniversary thereof at a per-share conversion price of $0.61, subject to standard adjustments for (i) stock dividends and splits, (ii) subsequent rights offerings, and (iii) pro rata distributions. The Company&#8217;s board of directors approved the issuance of the two notes on February&#160;7, 2024. As of December&#160;28, 2024, the principal balances outstanding on each of the promissory notes was $327,000.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Isaac Consulting Agreement</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;4, 2024, the Company entered into a two-year Consulting Agreement with Jon Isaac, pursuant to which he will provide to the Company (the &#8220;Services&#8221;): (i) strategic financial advice, including growth strategies, capital allocation, and financial restructuring; (ii) sales and business development advice, including for the acquisition of new clients and new products through networking, referrals, and marketing efforts for our prospective products; (iii) in-depth research and market intelligence on specific industries, sectors, and market trends; (iv) financial models and financial analysis to support strategic decision-making; (v) assistance, through site visits, in the preparation of new client offers and bids for proposed projects; (vi) weekly update calls with management to align on progress of objectives and goals; (vii) enhanced non-confidential materials; (viii) business risk management support; and (ix) other services to which the Company and he may agree that will be memorialized in writing if, when, and as needed during the two-year term.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As compensation for the Services, the Company (i) assigned to him two universal life insurance policies that relate to the life of one of the founders of our now-disposed legacy recycling business (as of March 4, 2024, the first policy had an accumulated value/surrender value of approximately $3,854 and the second had an accumulated value/surrender value of approximately $468); (ii) agreed to tender to him funds in our Canadian counsel&#8217;s trust account in the event that the prospective Order of the Court of Appeal for Ontario Canada in the matter styled, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amtim Capital Inc. and Appliance Recycling Centers of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case No. COA-23-CV-0156, became the final Order of the Court, which amount we received during the reporting period and tendered to Mr. Isaac $220,000; (iii) issued to him 200,000 restricted shares of our common stock with the per-share value being the average of the Nasdaq Historical NOCP closing price during the five trading days prior to our board approving the Consulting Agreement, which shares were awarded from our 2023 Equity Incentive Plan; and (iv) issued to him a two-year, straight 10.0% convertible promissory note in the initial principal amount of $500,000, with an interest rate of 10.0% and a per-share conversion price equivalent to the per-share value of the restricted common stock that he was granted ($1.16). The maturity date of the promissory note is March&#160;4, 2026. The value of the restricted shares was $232,000 on the date issued. As of December&#160;28, 2024, there was no principal balance outstanding on the promissory note.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Short-Term Advances</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;18, 2024, ICG made a short-term demand advance to the Company in the amount of $100,000. The advance bears interest at a rate of 10% per annum until repaid. As of December&#160;28, 2024, the principal amount outstanding was $48,000.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;28, 2024 and June&#160;3, 2024, Novalk made short-term demand advances in the amount of $120,000 and $100,000, respectively, to the Company. Juan Yunis, an employee of Live Ventures, is the managing member of Novalk. The advances bears interest at a rate of 10% per annum until repaid. As of December&#160;28, 2024, the principal amount outstanding was $110,000.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During June&#160;3, 2024, Tony Isaac made a number of short-term demand advances in the aggregate amount of $62,000 to the Company. The advances bears interest at a rate of 10% per annum until repaid. As of December&#160;28, 2024, the Company had repaid the advance in full (see Note 20).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Sale of Recycling Subsidiaries</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 9, 2023, the Company entered into a Stock Purchase Agreement (the &#8220;Recycling Purchase Agreement&#8221;) with VM7 Corporation, a Delaware corporation (&#8220;VM7&#8221;), under which it agreed to acquire all of the outstanding equity interests of the Recycling Subsidiaries consisting of: (a) ARCA Recycling, Inc., (b) ARCA Canada, and (c) Connexx. The principal of VM7 is Virland A. Johnson, our Chief Financial Officer. The sale of all of the outstanding equity interests of the Recycling Subsidiaries to VM7 under the Recycling Purchase Agreement was consummated simultaneously with the execution of the Recycling Agreement. The Company's Board of Directors unanimously approved the Recycling Purchase Agreement and the Disposition Transaction. The Recycling Purchase Agreement is retroactively effective as of March 1, 2023. During the fourth quarter of fiscal 2023, VM7 determined that, after expending significant amounts of time and resources, it was unable to obtain sufficient equity or debt financing to continue the operations of the Recycling Subsidiaries. Accordingly, the Company was advised that the operations of the Recycling Subsidiaries were wound down and, ultimately, ceased. Because the Company did not receive all of the economic benefits of the Disposition Transaction and understands that it will not receive any future benefits of the Disposition Transaction, the Company determined to fully impair the $5.3&#160;million carrying value of the Disposition Transaction on its balance sheet. The Company also determined not to exercise any of its remedies under the Recycling Purchase Agreement so that the Company could maintain its focus on its clinical-stage biopharmaceutical activities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ICG Note</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August&#160;28, 2019, ARCA Recycling entered into and delivered to ICG a secured revolving line of credit promissory note, whereby ICG agreed to provide ARCA Recycling with a $2.5 million revolving credit facility (the &#8220;ICG Note&#8221;). Jon Isaac is the manager and sole member of ICG, and the son of Tony Isaac, the President of ALT5 Sigma Corporation and, previously, ARCA Recycling. ICG is a record and beneficial owner of 13.6% of the outstanding common stock of the Company. The ICG Note was originally a component of the sale of the Recycling Subsidiaries in March 2023; however, because of the winding down of operations of the Recycling Subsidiaries during Q4 2023, and because the ICG Note was guaranteed by the Company, it recorded a liability in the amount of approximately $690,000 for the principal balance due on the note, which was offset against the gain on sale of the Recycling Subsidiaries (see Note 4). Additionally, effective February 2024, the ICG Note was amended to reflect the Company as co-maker on the ICG Note (see Note 20). The ICG Note matures in March 2026, and bears interest at 8.75% per annum. Monthly payments on the note are approximately $24,767. As of December&#160;28, 2024 and December&#160;30, 2023, the balance outstanding was $0 and $706,000, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">SEC Complaint</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 2, 2021, the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) filed a civil complaint (the &#8220;SEC Complaint&#8221;) in the United States District Court for the District of Nevada naming the Company and one of its executive officers, Virland Johnson, the Company's Chief Financial Officer, as defendants (collectively, the &#8220;Defendants&#8221;). Pursuant to an agreed-upon Order of the Court, on May 28, 2024, the Company settled its litigation with the SEC. The Settlement Agreement provided, in pertinent part: &#8220;Without admitting or denying the allegations of the complaint (except as provided herein in paragraph 12 and except as to personal and subject matter jurisdiction, which [the Company] admits), [the Company] hereby consents to the entry of the final Judgment in the form attached hereto (the &#8220;Final Judgment&#8221;) and </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">incorporated by reference herein, which, among other things: &#8220;(a) permanently restrains and enjoins [the Company] from violation of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder [15 U.S.C. &#167; 78j(b) and 17 C.F.R. &#167;&#167; 240.10b-5]; and (c)[sic] orders [the Company] to pay a civil penalty in the amount of $250,000 under Section 21(d)(3) of the Exchange Act [15 U.S.C. &#167; 78u(d)(3)).&#8221; The SEC has agreed to accept four quarterly payments from the Company, each in the amount of $62,500. The Settlement Agreement is attached to the Order as Exhibit 1, both of which documents may be viewed at https://ecf.nvd.uscourts.gov/doc1/115110470966.</span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SEC Complaint's remaining allegations relate to financial, disclosure and reporting violations against the executive officer under Section 10(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Rule 10b-5. The SEC Complaint also alleges various claims against the executive officer under Sections 13(a), 13(b)(2)(A), 13(b)(2)(B) and 13(b)(5) of the Exchange Act and Rules 12b-20, 13a-1, 13a-13, 13a-14, 13b2-1, and 13b2-2. The SEC continues to seek a permanent injunction, civil penalties, and an officer-and-director bar against the executive officer. The foregoing is only a general summary of the SEC Complaint, which may be accessed on the SEC&#8217;s website at https://www.sec.gov/litigation/litreleases/2021/lr25155.htm.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Skybridge</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 29, 2016, the Company served a Minnesota state court complaint for breach of contract on Skybridge Americas, Inc. (&#8220;SA&#8221;), the Company&#8217;s primary call center vendor throughout 2015 and most of 2016. On April 10 2024, subsequent to the conclusion of litigation at the trial court and appellate court levels, SA sold its judgment to an otherwise unaffiliated third party for the face value of the judgment and the interest accrued thereon through that date (an aggregate of $433,920), plus accrued legal fees (in the amount of $18,124) to which SA was entitled in accordance with the terms of the underlying agreement with the Company and with the judgment. The purchaser agreed to forbear from enforcing the judgment, subject to the Company&#8217;s repayment or his conversion thereof. In connection with the third-party&#8217;s forbearance, the Company issued its promissory note to such person in the initial principal amount of $147,956, which bears interest at the rate of 10% per annum, and, as with the underlying judgment, is convertible into shares of the Company&#8217;s common stock at a fixed per-share conversion price of $2.60. On December&#160;23, 2024, pursuant to the terms of the agreement, the unaffiliated third party converted the obligation, plus accrued interest under the agreements, in the amount of approximately $691,000, into 265,842 shares of the Company&#8217;s common stock (see Note 18). As of December&#160;28, 2024, there was no balance outstanding.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">GeoTraq</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or about April&#160;9, 2021, GeoTraq, Gregg Sullivan, Tony Isaac, and the Company, among others, resolved all of the claims that related to, among other items, the Company's acquisition of GeoTraq in August 2017, all post-acquisition activities, and Mr. Sullivan&#8217;s post-acquisition employment relationship with GeoTraq (all of such claims, the &#8220;GeoTraq Matters&#8221;). The resolution was effectuated through the parties&#8217; execution and delivery of a Settlement Agreement and Mutual Agreement of Claims (the &#8220;GeoTraq Settlement Agreement&#8221;). </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The parties to the Settlement Agreement released and forever discharged one another from any and all known and unknown claims that were asserted or could have been asserted arising out of the GeoTraq Litigation Matters. The accrued liability for payments due to Mr. Sullivan is $0 and $510,000 as of December&#160;28, 2024 and December&#160;30, 2023, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Alixpartners, LLC</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;19, 2022, Alixpartners, LLC filed a complaint in the Supreme Court of the State of New York, County of New York, styled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Alixpartners, LLC, plaintiff/petitioner, against JanOne Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Index No. 653877/2022. Plaintiff alleged the breach of an agreement and sought damages in the amount of approximately $345,000. The Company denied that obligation. After extensive negotiations, the parties reached a settlement, pursuant to which the Company agreed to pay to Alixpartners the sum of $125,000 in two tranches and to provide a confession of judgment in its favor in the amount of approximately $450,000, which represented the amount sought in the complaint plus interest thereon. The confession of judgment will be null and void and the complaint will be dismissed with prejudice upon the Company tendering both tranches timely. The Company tendered both settlement payments in May 2023, and the complaint was subsequently dismissed.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sieggreen</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In a matter pending in the United States District Court for the District Of Nevada, Case No. 2:21-cv-01517-CDS-EJY, styled as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sieggreen, Individually and On Behalf of All Others Similarly Situated, Plaintiff, v. Live Ventures Incorporated, </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jon Isaac, and Virland A. Johnson, Defendants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company was added as a defendant on March 6, 2023, and was served on March 23, 2023. Plaintiff has alleged causes of action against the Company for (i) violation of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder and (ii) violation of Section 10(b) of the Securities Exchange Act of 1934 and Rules 10b-5(a) and 10b-5(c) promulgated thereunder. In June 2023 the Company filed a Motion to Dismiss, regarding which, as of the date of these financial statements, the Court has not ruled. The Company strongly disputes and denies all of the allegations contained therein and will continue to defend itself vigorously against the claims.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Main/270</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a defendant in an action filed on April 11, 2022, in the U.S. District Court Southern District of Ohio, Eastern Division, styled, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trustees Main/270, LLC, Plaintiff, vs ApplianceSmart, Inc. and JANONE, Inc., Defendant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case no.: 2:22-cv-01938-ALM-EPD. The Company was a guarantor of the lease between the Plaintiff and ApplianceSmart, Inc. Plaintiff alleged a cause of action against the Company in respect of the guaranty and seeks approximately $90,000 therefor. Plaintiff also seeks approximately $1,420,000 against ApplianceSmart and the Company on a joint and several basis. The Company does not believe that it is obligated to Plaintiff in that amount and the parties continue to negotiate a potential settlement.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Westerville Square</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In an attempt to recover payments due under a lease, in 2022, Westerville Square, Inc., as the landlord, initiated a civil action against the Company, styled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Westerville Square, Inc. v. Appliance Recycling Centers Of America, Inc., et al., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the Court of Common Pleas of Franklin County, Ohio, Case No. 19 CV 8627. The case was stayed during the bankruptcy proceedings of ApplianceSmart, Inc., and was reinstated on June 7, 2021. The landlord is currently seeking $120,000, which amount is disputed by the Company. Effective June 4, 2023, the parties settled the matter, pursuant to which settlement the Company tendered the sum of $110,000 to the landlord, the parties entered into a Settlement Agreement and Release, and the case was dismissed with prejudice.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Commitments</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2017, the Company disposed of its retail appliance segment and sold ApplianceSmart to Live Ventures, a related party. In connection with that sale, as of January&#160;1, 2022, the Company accrued an aggregate amount of future real property lease payments of approximately $767,000 which represented amounts guaranteed or which may have been owed under certain lease agreements to three third party landlords in which the Company either remained the counterparty, was a guarantor, or had agreed to remain contractually liable under the lease (&#8220;ApplianceSmart Leases&#8221;). A final decree was issued by the court on February 28, 2022, upon the full satisfaction of the Plan, at which time ApplianceSmart emerged from Chapter 11. During the year ended December&#160;28, 2024, the Company reversed approximately $637,000 of the accrual, as the Company is no longer liable for two of these guarantees upon ApplianceSmart's emergence from bankruptcy. As of December&#160;28, 2024, a balance of approximately $130,000 remains as an accrued liability due to an ongoing dispute concerning one of the leases. The Company and Live Ventures have agreed to divide in half between them any ultimate balance owing thereunder and any attorneys&#8217; fees expended in relation thereto.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is party from time to time to other ordinary course disputes that we do not believe to be material to our financial condition as of December&#160;28, 2024.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) per share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings (Loss) per share</a></td>
<td class="text">Earnings (Loss) per share<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per share is calculated using the weighted average number of shares of common stock outstanding during the applicable period. Basic weighted average common shares outstanding do not include shares of restricted stock that have not yet vested, although such shares are included as outstanding shares in the Company&#8217;s Consolidated Balance Sheet. Diluted net earnings per share is computed using the weighted average number of common shares outstanding, and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the additional common shares issuable with respect to restricted share awards, stock options and convertible preferred stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the computation of basic and diluted net loss per share (in $000&#8217;s, except per share data):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the Years Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">Continuing Operations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Basic and diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net (loss) income from continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6,245)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(17,095)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11,148,493</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,005,334</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic and diluted (loss) income per share from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(0.56)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4.27)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">Discontinued Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income from discontinued operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11,148,493</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,005,334</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic income per share from discontinued operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.32&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income from discontinued operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11,148,493</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,444,361</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Diluted income per share from discontinued operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.09&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Basic and diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net (loss) income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6,245)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7,812)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11,148,493</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,005,334</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic and diluted (loss) income per share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(0.56)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1.95)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div>Potentially dilutive securities totaling approximately 9.0&#160;million and 3.9&#160;million shares, respectively, were excluded from the calculation of diluted net earnings (loss) per share for the years ended December&#160;28, 2024 and December&#160;30, 2023 because the effects were anti-dilutive based on the application of the treasury stock method.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment information</a></td>
<td class="text">Segment information<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates within targeted markets through three reportable segments for continuing operations: Fintech, Biotech, and Corporate and Other. Due the sale of Company&#8217;s Recycling segment during March 2023, it is being presented as discontinued operations for the years ended December&#160;28, 2024 and December&#160;30, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present our segment information (in $000&#8217;s): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the Years Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fintech</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biotech</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,795&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,532&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,795&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fintech</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biotech</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(197)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Gross profit</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,294&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(197)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating loss</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fintech</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biotech</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,148)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,531)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,319)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(18,315)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,438&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Operating loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,562)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,562)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9,408)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fintech</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biotech</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,086&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,402&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,548&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest (expense) income, net</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fintech</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(499)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biotech</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(380)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(181)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Interest (expense) income, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(879)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,069&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net loss after provision for income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fintech</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biotech</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,086)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,532)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,628)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15,563)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total net loss after provision for income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,245)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,812)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of <br/>December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of <br/>December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fintech</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biotech</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,926&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,846&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discontinue operations</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82,436&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,487&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill and other intangible Assets</span></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fintech</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30,385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biotech</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,755&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,846&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discontinued operations</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total goodwill and other intangible Assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46,144&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,846&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent events</a></td>
<td class="text">Subsequent events<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated subsequent events through the filing of this Form 10-K, and determined that there have been no events that have occurred that would require adjustments to disclosures in its consolidated financial statements other than as discussed below:</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="num">$ (6,245)<span></span>
</td>
<td class="num">$ (7,812)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management and Strategy Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on our subsidiary-level information technology professionals to continuously monitor and update our IT networks and infrastructure. Their role is to prevent, detect, address, and mitigate risks related to unauthorized access, misuse, </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">malware, and other security threats. To safeguard our data and business processes, as well as those of our subsidiaries, we invest in industry-standard security technologies to defend against cyber risks.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To further strengthen our cybersecurity efforts, with our subsidiary&#8217;s assistance, we are establishing an &#8220;IT Steering Committee&#8221; composed of IT professionals from our subsidiary. This committee will meet quarterly to discuss cybersecurity threats, emerging attack methods, and best practices.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal year 2024, our crypto-processing subsidiary engaged an external consultant to conduct a cybersecurity risk assessment of our business operations. This assessment examined both internal and external threats to our systems and data handling processes, providing a structured framework for evaluating, prioritizing, and enhancing our cybersecurity initiatives. On a going-forward basis, in collaboration with our Audit Committee, management will determine and implement appropriate measures based on these findings.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our cybersecurity risk management program, we are working with our crypto-processing subsidiary to develop a cyber training curriculum for our employees. The training may cover topics such as phishing awareness, cybersecurity best practices, and e-mail security.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite our commitment to cybersecurity, no system can fully eliminate technology risks. As of now, we are unaware of any cybersecurity incidents that have had, or are reasonably likely to have, a material impact on our business or operations. However, the increasing volume and sophistication of cyberattacks&#8212;including data breaches, ransomware, and similar threats&#8212;pose ongoing risks. Incidents that occur could result in reputational, competitive, operational, or financial harm, as well as regulatory consequences. For a more detailed discussion of how cybersecurity threats may affect our business strategy, operations, or financial condition, see Item 1A, &#8220;Risk Factors,&#8221; which is incorporated by reference into Item 1C.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on our subsidiary-level information technology professionals to continuously monitor and update our IT networks and infrastructure. Their role is to prevent, detect, address, and mitigate risks related to unauthorized access, misuse, </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">malware, and other security threats. To safeguard our data and business processes, as well as those of our subsidiaries, we invest in industry-standard security technologies to defend against cyber risks.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To further strengthen our cybersecurity efforts, with our subsidiary&#8217;s assistance, we are establishing an &#8220;IT Steering Committee&#8221; composed of IT professionals from our subsidiary. This committee will meet quarterly to discuss cybersecurity threats, emerging attack methods, and best practices.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we collect, use, store, and digitally transmit confidential, sensitive, proprietary, and personal information. The secure maintenance of this information and our information technology systems are important to our operations and business strategy. The Audit Committee, which is composed solely of independent directors, has been designated by our Board to review and discuss with management the Company&#8217;s risk assessment and risk management policies, including the steps that management has taken to monitor and control related cybersecurity risks and exposures. Management updates the Audit Committee and the Board as necessary about significant cybersecurity occurrences and measures the Company is taking to prevent the same.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">The Audit Committee, which is composed solely of independent directors, has been designated by our Board to review and discuss with management the Company&#8217;s risk assessment and risk management policies, including the steps that management has taken to monitor and control related cybersecurity risks and exposures. Management updates the Audit Committee and the Board as necessary about significant cybersecurity occurrences and measures the Company is taking to prevent the same.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">Management updates the Audit Committee and the Board as necessary about significant cybersecurity occurrences and measures the Company is taking to prevent the same.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we collect, use, store, and digitally transmit confidential, sensitive, proprietary, and personal information. The secure maintenance of this information and our information technology systems are important to our operations and business strategy. The Audit Committee, which is composed solely of independent directors, has been designated by our Board to review and discuss with management the Company&#8217;s risk assessment and risk management policies, including the steps that management has taken to monitor and control related cybersecurity risks and exposures. Management updates the Audit Committee and the Board as necessary about significant cybersecurity occurrences and measures the Company is taking to prevent the same.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text">The Audit Committee, which is composed solely of independent directors, has been designated by our Board to review and discuss with management the Company&#8217;s risk assessment and risk management policies, including the steps that management has taken to monitor and control related cybersecurity risks and exposures.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock', window );">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our cybersecurity risk management program, we are working with our crypto-processing subsidiary to develop a cyber training curriculum for our employees. The training may cover topics such as phishing awareness, cybersecurity best practices, and e-mail security.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text">The Audit Committee, which is composed solely of independent directors, has been designated by our Board to review and discuss with management the Company&#8217;s risk assessment and risk management policies, including the steps that management has taken to monitor and control related cybersecurity risks and exposures.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div>The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Financial Statement Reclassification</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Statement Reclassification</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain account balances from prior periods have been reclassified in these consolidated financial statements to conform to current period classifications.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumption that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant estimates made in connection with the accompanying consolidated financial statements include the fair values in connection with the GeoTraq promissory note, analysis of other intangibles and long-lived assets for impairment, valuation allowance against deferred tax assets, lease terminations, and estimated useful lives for intangible assets and property and equipment.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Financial Instruments</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Instruments</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments consist primarily of cash equivalents, trade and other receivables, notes receivables, and obligations under accounts payable, accrued expenses and notes payable. The carrying amounts of cash equivalents, trade receivables and other receivables, accounts payable, accrued expenses and short-term notes payable approximate fair value because of the short maturity of these instruments. The fair value of the long-term debt is calculated based on interest rates available for debt with terms and maturities similar to the Company&#8217;s existing debt arrangements, unless quoted market prices were </span></div>available (Level 2 inputs). The carrying amounts of long-term debt at December&#160;28, 2024 and December&#160;30, 2023 approximate fair value.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of highly liquid investments with a maturity of three months or less at the time of purchase. Fair value of cash equivalents approximates carrying value.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DigitalAssetsAndOtherReceivablesPolicyPolicyTextBlock', window );">Digital Assets and other Receivables</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Digital Assets and other Receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">s</span></div>Digital assets and other receivables are the Company&#8217;s digital assets and its customer prepayments in the form of digital assets. The Company holds all digital assets in secure non-custodial wallets through the wallet services from Fireblocks.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Other Receivables and Allowance for Doubtful Accounts</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Receivables and Allowance for Doubtful Accounts</span></div>The Company carries unsecured other receivables at the original invoice amount less an estimate made for doubtful accounts based on a monthly review of all outstanding amounts. Management determines the allowance for doubtful accounts by regularly evaluating receivables based on current economic conditions. The Company writes off receivables when it deems them to be uncollectible. The Company records recoveries of receivables previously written off when payment is received. The Company considers a receivable to be past due if any portion of the receivable balance is outstanding for more than ninety days. The Company does not charge interest on past due receivables.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible Assets</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s intangible assets consist of customer relationship intangibles, favorable leases, trade names, licenses for the use of internet domain names, Universal Resource Locators, or URL&#8217;s, software, patents, and marketing and technology related intangibles. Upon acquisition, estimates are made in valuing acquired intangible assets, which include but are not limited to, future expected cash flows from customer contracts, customer lists, and estimating cash flows from projects when completed; tradename and market position, as well as assumptions about the period of time that customer relationships will continue; and discount rates. Management's estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from the assumptions used in determining the fair values. All intangible assets are capitalized at their original cost and amortized over their estimated useful lives as follows: domain name and marketing &#8211; 3-to-20 years; software &#8211; 3-to-5 years; technology intangibles &#8211; 7 years; customer relationships &#8211; 7-to-15 years.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DigitalAssetsAndOtherPayablesPolicyPolicyTextBlock', window );">Digital Assets and other Payables</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Digital Assets and other Payables</span></div>Digital assets and other payables are liabilities that represent the Company&#8217;s obligation to deliver the settlement of transactions in the form of digital assets and or cash. The Company safeguards these digital assets and cash for customers and is obligated to safeguard them from loss, theft, or other misuse. The Company recognizes digital assets and other payables, on initial recognition and at each reporting date, at fair value of the digital assets. Any loss, theft, or other misuse would impact the measurement of digital assets and other payables.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognition applies to the Company&#8217;s Fintech segment only, as the Company&#8217;s Biotech segment has not recognized revenue to date. Revenue is recognized under Topic 606 in a manner that reasonably reflects the delivery of its services and products to customers in return for expected consideration and includes the following elements:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Executed contracts with the Company&#8217;s customers that it believes are legally enforceable;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Identification of performance obligations in the respective contract;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Determination of the transaction price for each performance obligation in the respective contract;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Allocation of the transaction price to each performance obligation; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Recognition of revenue only when the Company satisfies each performance obligation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fintech Revenue</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The five elements above, as applied to each of the Fintech segment's revenue categories, is summarized below:</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Product sales &#8211; revenue is recognized at the time of sale of equipment to the customer.</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Service sales &#8211; revenue is recognized based on when the service has been provided to the customer.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s service is comprised of a single performance obligation to buy and sell or convert digital assets to currencies. That is, the Company is the counter party to all transactions between customers and liquidity providers and presents revenue for the fees earned on a net basis.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is acting as principal in all transactions, and control the digital assets being provided before it is transferred to the buyer, and has risk related to the digital assets, and is responsible for the fulfillment of the digital asset transactions. The Company sets the price for the digital assets by aggregating prices from several liquidity providers and displays them on the Company&#8217;s platform. As a result, the Company acts as a price discovery service and acts as a principal facilitating the ability for a customer to purchase or sell digital assets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers its performance obligation satisfied, and recognizes revenue, at the point in time the transaction is processed. Contracts with customers are usually open-ended and can be terminated by either party without a termination penalty. Therefore, contracts are defined at the transaction level and do not extend beyond the service already provided.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company charges a fee at the transaction level. The transaction price, represented by the trading fee, is calculated based on volume and varies depending on payment type and the value of the transaction. Digital asset purchases or sale transactions executed by a customer on the Company&#8217;s platform is based on tiered pricing that is driven primarily by transaction volume processed for a specific historical period. The Company has concluded that this volume-based pricing approach does not constitute a future material right since the discount is within a range typically offered to a class of customers with similar volume. The transaction fee is collected from the customer at the time the transaction is executed. In certain instances, the transaction fee can be collected in digital assets, with revenue measured based on the amount of digital assets received and the fair value of the digital assets at the time of the transaction. The Company also marks up or down the digital asset prices and earns revenue from the spread between the buying and selling price. The Company also earns a fee from transfers of currencies and or digital assets. The transfer fees are nominal and are set to offset the fees associated with banking and or blockchain mining fees.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Biotechnology Revenue</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company currently generates no revenue from its Biotechnology segment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Discontinued Operations Revenue</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 9, 2023, retroactive to March 1, 2023, the Company entered into the Recycling Purchase Agreement with VM7, under which VM7 agreed to acquire all of the outstanding equity interests of the Recycling Subsidiaries. As discussed </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">previously, the accounts for the Recycling segment have been presented as discontinued operations in the accompanying consolidated financial statements.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC Topic 820, &#8220;Fair Value Measurements and Disclosures,&#8221; requires disclosure of the fair value of financial instruments held by the Company. ASC Topic 825, &#8220;Financial Instruments,&#8221; defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The three levels of valuation hierarchy are defined as follows: Level 1 - inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets. Level 2 &#8211; to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. Level 3 &#8211; inputs to the valuation methodology are unobservable and significant to the fair value measurement.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes using the asset and liability method. The asset and liability method requires recognition of deferred tax assets and liabilities for expected future tax consequences of temporary differences that currently exist between tax bases and financial reporting bases of the Company's assets and liabilities. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is provided on deferred taxes if it is determined that it is more likely than not that the asset will not be realized. The Company recognizes penalties and interest accrued related to income tax liabilities in the provision for income taxes in its Consolidated Statements of Income.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant management judgment is required to determine the amount of benefit to be recognized in relation to an uncertain tax position. The Company uses a two-step process to evaluate tax positions. The first step requires an entity to determine whether it is more likely than not (greater than 50% chance) that the tax position will be sustained. The second step requires an entity to recognize in the financial statements the benefit of a tax position that meets the more-likely-than-not recognition criterion. The amounts ultimately paid upon resolution of issues raised by taxing authorities may differ materially from the amounts accrued and may materially impact the financial statements of the Company in future periods.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company from time to time grants stock options to employees, non-employees and Company executives and directors. Such awards are valued based on the grant date fair-value of the instruments. The value of each award is amortized on a straight-line basis over the vesting period.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings Per Share</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share is calculated in accordance with ASC 260, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;. Under ASC 260 basic earnings per share is computed using the weighted average number of common shares outstanding during the period except that it does not include unvested restricted stock subject to cancellation. Diluted earnings per share is computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of warrants, options, restricted shares and convertible preferred stock. The dilutive effect of outstanding restricted shares, options and warrants is reflected in diluted earnings per share by application of the treasury stock method. Convertible preferred stock is reflected on an if-converted basis.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Reporting</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC Topic 280, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; requires use of the &#8220;management approach&#8221; model for segment reporting. The management approach model is based on the way a Company&#8217;s management organizes segments within the Company for making operating decisions and assessing performance. The Company determined it had three reportable segments. The Recycling segment has been presented as discontinued operations (see Note 23).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains cash balances at banks in Nevada and Minnesota. The account is insured by the Federal Deposit Insurance Corporation up to $250,000. At times, balances may exceed federally insured limits.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Pronouncements</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update ("ASU") 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures ("ASU 2023-07"). ASU 2023-07 requires, among other updates, enhanced disclosures about significant segment expenses that are regularly provided to the CODM, as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and requires retrospective adoption. Early adoption is permitted. The Company is evaluating the impact of this guidance on its consolidated financial statements and related disclosures.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU No. 2023-08, Intangibles&#8212;Goodwill and Other&#8212;Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets. The amendments in ASU No. 2023-08 are intended to improve the accounting for certain crypto assets by requiring an entity to measure those crypto assets at fair value each reporting period with changes in fair value recognized in net income. The amendments also improve the information provided to investors about an entity&#8217;s crypto asset holdings by requiring disclosure about significant holdings, contractual sale restrictions, and changes during the reporting period. The amendments are effective for all entities for fiscal years beginning after December 15, 2024, including interim periods within those fiscal years. The Company is evaluating the impact of this guidance on its consolidated financial statements and related disclosures.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures ("ASU 2023-09"). ASU 2023-09 requires enhanced annual disclosures regarding the rate reconciliation and income taxes paid information. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, and may be adopted on a prospective or retrospective basis. Early adoption is permitted. The Company is evaluating the impact of this guidance on its consolidated financial statements and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DigitalAssetsAndOtherPayablesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Digital Assets And Other Payables, Policy</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DigitalAssetsAndOtherPayablesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DigitalAssetsAndOtherReceivablesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Digital Assets And Other Receivables, Policy</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DigitalAssetsAndOtherReceivablesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478898/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478609/920-350-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478609/920-350-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478609/920-350-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483504/205-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 36<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-36<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481569/310-20-50-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-15<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-11B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Trade and Other Receivables</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table details the Company's trade and other receivables as of December&#160;28, 2024 and December&#160;30, 2023 (in $000&#8217;s):</span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.393%"><tr><td style="width:1.0%"></td><td style="width:57.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.162%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.162%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.165%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other receivables</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">266&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade and other receivables, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,530&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">266&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Mergers and Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Fair Value Adjustments for Shares of Series B and Series M Preferred Stock</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the purchase price components outlined above was $16.0 million due to fair value adjustments for the shares of Series B Stock and Series M Stock, as detailed below (in $000&#8217;s):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.293%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series B preferred stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total purchase price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Purchase Price Allocation of Purchase for ALT5 Subsidiary to Acquired Identifiable Assets, Liabilities Assumed and Goodwill</a></td>
<td class="text">The table below outlines the purchase price allocation of the purchase for ALT5 Subsidiary to the acquired identifiable assets, liabilities assumed and goodwill (in $000&#8217;s):<div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.515%"><tr><td style="width:1.0%"></td><td style="width:66.874%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total purchase price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,866&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Digital assets payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,763&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities assumed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,509&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48,509&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,853&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Digital assets receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subtotal intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,450&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36,795&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,714&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Business Acquisition, Pro Forma Information</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents selected proforma information for the Company for the years ended December&#160;28, 2024 and December&#160;30, 2023, assuming that the acquisition had occurred on January 1, 2023 (the beginning of the Company&#8217;s 2023 fiscal year), pursuant to ASC 805-10-50 (in $000&#8217;s). This proforma information does not purport to represent what the </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">actual results of operations of the Company would have been had the acquisition occurred on that date, nor does it purport to predict the results of operations for future periods.</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended<br/>December 28, 2024</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As Reported</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Proforma</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ALT5 Sigma Corporation (1)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ALT5 Subsidiary (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Adjustments (3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,532&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,918&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,450&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,245)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,343)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,517)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per basic common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.56)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per basic diluted share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended<br/>December 30, 2023</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As Reported</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Proforma</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ALT5 Sigma Corporation (4)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ALT5 Subsidiary (5)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Adjustments (3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,812)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,148)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,601)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per basic common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.95)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per basic diluted share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.95)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.65)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">ALT5 Sigma Corporation for the year ended December&#160;28, 2024. Includes ALT5 Subsidiary from May 15, 2024 through December&#160;28, 2024.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">ALT5 Subsidiary from December 31, 2023 through the acquisition date of May&#160;14, 2024.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Reflects adjustments for amortization expense of definite-lived intangible assets has been adjusted based on the preliminary fair value at the acquisition date..</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">ALT5 Sigma Corporation for the year ended December&#160;30, 2023.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    ALT5 Subsidiary for the year ended December&#160;30, 2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Sale of Recycling Subsidiaries (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Schedule of Gain on Sale of Recycling Subsidiaries</a></td>
<td class="text">The following table details the final calculation of the gain on sale of the Recycling Subsidiaries, as shown on the income statement (in $000&#8217;s):<div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.151%"><tr><td style="width:1.0%"></td><td style="width:82.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.824%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total minimum consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment from buyer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net consideration</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,026&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,323&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities - California state sales tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(604)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total disposal of liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,320&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total consideration</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,884&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total disposal of assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,244&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total gain on sale</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,102&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>The results of operations for these entities for the year ended December&#160;28, 2024 and December&#160;30, 2023, respectively, have been reflected as discontinued operations in the consolidated statements of operations and comprehensive income (loss) and consist of the following (in $000&#8217;s):<div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,795&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(197)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses from discontinued operations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain on sale of ARCA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12,102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,635)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,438&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense from discontinued operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other expense, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(184)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before provision for income taxes from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,254&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income from discontinued operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,283&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>The cash flow activity from discontinued operations for the year ended December&#160;28, 2024 and December&#160;30, 2023 have been reflected as discontinued operations in the consolidated statements of cash flows and consist of the following (in $000&#8217;s):<div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DISCONTINUED OPERATING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain on sale of ARCA, net of cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12,248)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities from discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,319&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DISCONTINUED INVESTING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchase of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities from discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(155)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DISCONTINUED FINANCING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from note payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments on related party note</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments on notes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,336)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities from discontinued operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,212)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effect of changes in exchange rate on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DECREASE IN CASH AND CASH EQUIVALENTS</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CASH AND CASH EQUIVALENTS, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CASH AND CASH EQUIVALENTS, end of period</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-3A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-4A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-4B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5D<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3A<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Schedule of Discontinued Operations in Consolidated Statements of Operations and Cash Flows</a></td>
<td class="text">The following table details the final calculation of the gain on sale of the Recycling Subsidiaries, as shown on the income statement (in $000&#8217;s):<div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.151%"><tr><td style="width:1.0%"></td><td style="width:82.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.824%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total minimum consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment from buyer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net consideration</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,026&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,323&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities - California state sales tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(604)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total disposal of liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,320&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total consideration</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,884&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total disposal of assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,244&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total gain on sale</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,102&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>The results of operations for these entities for the year ended December&#160;28, 2024 and December&#160;30, 2023, respectively, have been reflected as discontinued operations in the consolidated statements of operations and comprehensive income (loss) and consist of the following (in $000&#8217;s):<div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,795&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(197)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses from discontinued operations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain on sale of ARCA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12,102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,635)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,438&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense from discontinued operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other expense, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(184)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before provision for income taxes from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,254&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income from discontinued operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,283&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>The cash flow activity from discontinued operations for the year ended December&#160;28, 2024 and December&#160;30, 2023 have been reflected as discontinued operations in the consolidated statements of cash flows and consist of the following (in $000&#8217;s):<div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DISCONTINUED OPERATING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income from discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain on sale of ARCA, net of cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12,248)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities from discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,319&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DISCONTINUED INVESTING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchase of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities from discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(155)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DISCONTINUED FINANCING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceeds from note payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments on related party note</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments on notes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,336)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities from discontinued operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,212)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effect of changes in exchange rate on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DECREASE IN CASH AND CASH EQUIVALENTS</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CASH AND CASH EQUIVALENTS, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CASH AND CASH EQUIVALENTS, end of period</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-3A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-4A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-4B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5D<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3A<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaids and other current assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Schedule of Prepaids and Other Current Assets</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaids and other current assets as of December&#160;28, 2024 and December&#160;30, 2023 consist of the following (in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"><tr><td style="width:1.0%"></td><td style="width:67.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.120%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.123%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid insurance</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total prepaids and other current assets</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,518&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment as of December&#160;28, 2024 and December&#160;30, 2023 consist of the following (in $000&#8217;s):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"><tr><td style="width:1.0%"></td><td style="width:65.006%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.235%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.239%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Projects under construction</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,170&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,170&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ScheduleOfOperatingLeaseRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock', window );">Schedule of Company's Right of Use Assets and Lease Liabilities</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table details the Company&#8217;s right of use assets and lease liabilities as of December&#160;28, 2024 and December&#160;30, 2023 (in $000&#8217;s):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.636%"><tr><td style="width:1.0%"></td><td style="width:65.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.336%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.337%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right of use asset - operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current - operating</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long term - operating</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Total Present Value of Future Lease Payments of Operating Leases</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total present value of future lease payments of operating leases as of September&#160;28, 2024 (in $000&#8217;s): </span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.809%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Twelve months ended:</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2029</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">170&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less implied interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Present value of payments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">123&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_ScheduleOfOperatingLeaseRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Operating Lease Right Of Use Assets And Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_ScheduleOfOperatingLeaseRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Intangible Assets</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets as of consist of the following (in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soin intangibles</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19,293&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19,293&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Qoden intangible</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patents and domains</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,925&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total intangible assets</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39,283&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19,297&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,853)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,451)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total intangible assets, net</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,430&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,846&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Marketable Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Schedule of Marketable Securities</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities consist of the following (in $000&#8217;s, except shares):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.666%"><tr><td style="width:1.0%"></td><td style="width:45.921%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.145%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Series G Convertible Preferred Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Common Shares Equivalent</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Amount </span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning balance, December 31, 2022</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30,000,000</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">315&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities received</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,224</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">922,442,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mark-to-market</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(926)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning balance, December 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,224</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">952,442,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">286</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities received</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,876</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,253,900,000</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">518&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mark-to-market</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(370)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Write-off marketable securities</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(43,100)</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(27,206,342,000)</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(434)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance, December 28, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deposits and other assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock', window );">Schedule of Deposits and Other Assets</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deposits and other assets consist of the following (in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deposits and other assets</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total deposits and other assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities of continuing consist of the following (in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation and benefits</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">204&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued guarantees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued taxes</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">362&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued Qoden payments</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued litigation/legal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">730&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,553&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,633&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debentures (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Debentures Outstanding</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debentures outstanding as of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;28, 2024 and December&#160;30, 2023 consisted for the following (in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate of 15%, maturity date of June 30, 2025</span></div></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">563&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total debentures</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">563&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt as of December&#160;28, 2024 and December&#160;30, 2023 consisted of the following (in $000&#8217;s):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legacy subsidiary fixed deposits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legacy subsidiary loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unaffiliated third-party</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total notes payable, related parties</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,570&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total long-term notes payable, related parties</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,570&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-8<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-6<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-Term Debt</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debentures outstanding as of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;28, 2024 and December&#160;30, 2023 consisted for the following (in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate of 15%, maturity date of June 30, 2025</span></div></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">563&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total debentures</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">563&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt as of December&#160;28, 2024 and December&#160;30, 2023 consisted of the following (in $000&#8217;s):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legacy subsidiary fixed deposits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legacy subsidiary loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unaffiliated third-party</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total notes payable, related parties</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,570&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total long-term notes payable, related parties</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,570&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-8<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-6<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Long-Term Debt Payable to Related Parties</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt payable to related parties (see Note 20) as of December&#160;28, 2024 and December&#160;30, 2023 consisted of the following (in $000&#8217;s):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Isaac Capital Group</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">707&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Isaac Capital Group, 10% interest rate, matures December 31, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Live Ventures Incorporated, 10% interest rate, matures December 31, 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Isaac Capital Group short-term demand advance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Novalk Apps SAA, LLP  short-term demand advance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total notes payable, related parties</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">812&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">707&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(812)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total long-term notes payable, related parties</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">707&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Future Maturities of Long-term Debt</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total future maturities of long-term debt to related parties is as follows (in $000&#8217;s):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.052%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Twelve months ending September 30,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total future maturities of long-term debt, related parties</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">812&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityTableTextBlock', window );">Schedule of Series S Convertible Preferred Stock Outstanding</a></td>
<td class="text">As of December&#160;28, 2024 and December&#160;30, 2023, there were 100,000 shares of Series S Convertible Preferred Stock outstanding, as reflected in the following (dollars in $000&#8217;s):<div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Series S Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance, December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,510&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance, December 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100,000</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100000</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,510</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassification to permanent equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,993)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassification to current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,661)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance, December 28, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,856&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders&#8217; Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Options Activity</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity for the fiscal years ended December&#160;28, 2024, and December&#160;30, 2023 (Aggregate Intrinsic Value in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Options <br/>Outstanding </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate<br/>Intrinsic<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cancelled/expired</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,000)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.1</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cancelled/expired</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,000)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 28, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercisable at December 28, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.8</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Schedule of Exercise Price for Stock Options Outstanding and Exercisable Outstanding</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exercise price for stock options outstanding and exercisable outstanding at December&#160;28, 2024 is as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.447%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercisable</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Options</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercise Price ($)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Options</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercise Price ($)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42,000</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$5.70 to $9.90</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,000</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$5.70 to $9.90</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$3.54 to $5.25</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$3.54 to $5.25</span></div></td></tr><tr><td colspan="3" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108,000</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,000</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Income Tax Provision (Benefit)</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For fiscal years ended December&#160;28, 2024, and December&#160;30, 2023, the Company recorded an income tax benefit from continuing operations of approximately $3.0 million and an income tax benefit of $0.4&#160;million, respectively, and an income tax provision from discontinued operations of $0 and approximately $1.0 million, respectively, which consisted of the following (in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current tax expense:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(44)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current tax expense</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">188&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax (benefit) provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total (benefit) provision of income taxes</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,041)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">542&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation of Income Tax Benefit (Provision) with the Federal Statutory Tax Rate</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the Company's income tax benefit (provision) with the federal statutory tax rate for the fiscal years ended December&#160;28, 2024, and December&#160;30, 2023, respectively, is shown below:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Years Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. statutory rate</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.0&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.0&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign rate differential</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Permanent differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Impact of sale of ARCA Recycling and Canada</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-4.4&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-25.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.2&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-0.1&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-7.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income (Loss) Before Provision of Income Taxes</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) before provision of income taxes was derived from the following sources for fiscal years December&#160;28, 2024 and December&#160;30, 2023, respectively, as shown below (in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Years Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12,825)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,613)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Canada</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(657)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9,286)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,270)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Components of Net Deferred Tax Assets (Liabilities)</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net deferred tax assets (liabilities) as of December&#160;28, 2024 and December&#160;30, 2023, respectively, are as follows (in $000&#8217;s):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets (liabilities):</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allowance for bad debts</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 174 expenses</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,586&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,360&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax credits</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangibles</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,909)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,747)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Installment sale</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 163(j) interest</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,878&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,134&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,919)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,773)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net deferred tax liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,041)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(639)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) per share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted Net Loss per Share</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the computation of basic and diluted net loss per share (in $000&#8217;s, except per share data):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the Years Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">Continuing Operations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Basic and diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net (loss) income from continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6,245)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(17,095)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11,148,493</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,005,334</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic and diluted (loss) income per share from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(0.56)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4.27)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">Discontinued Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income from discontinued operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11,148,493</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,005,334</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic income per share from discontinued operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.32&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income from discontinued operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11,148,493</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,444,361</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Diluted income per share from discontinued operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.09&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Basic and diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net (loss) income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6,245)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7,812)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11,148,493</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,005,334</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic and diluted (loss) income per share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(0.56)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1.95)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 28, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Information</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present our segment information (in $000&#8217;s): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the Years Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 28, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fintech</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biotech</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,795&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,532&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,795&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fintech</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biotech</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(197)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Gross profit</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,294&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(197)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating loss</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fintech</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biotech</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,148)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,531)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,319)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(18,315)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,438&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Operating loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,562)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,562)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9,408)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fintech</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biotech</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,086&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,402&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,548&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest (expense) income, net</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fintech</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(499)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biotech</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(380)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(181)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Interest (expense) income, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(879)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,069&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net loss after provision for income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fintech</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biotech</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,086)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,532)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,628)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15,563)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total net loss after provision for income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,245)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,812)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of <br/>December 28, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of <br/>December 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fintech</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biotech</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,926&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,846&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discontinue operations</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82,436&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,487&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill and other intangible Assets</span></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fintech</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30,385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biotech</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,755&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,846&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discontinued operations</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total goodwill and other intangible Assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46,144&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,846&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Background and Basis of Presentation (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 28, 2024 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_PotentialMarketExclusivityPeriod', window );">Potential market exclusivity period (in years)</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Net loss from continuing operations</a></td>
<td class="nump">$ 6,245<span></span>
</td>
<td class="nump">$ 17,095<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="nump">35,001<span></span>
</td>
<td class="nump">346<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="nump">40,937<span></span>
</td>
<td class="nump">$ 5,905<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_CurrentAssetsCurrentLiabilitiesNet', window );">Net negative working capital</a></td>
<td class="nump">5,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_NetCashProvidedByOperatingActivitiesContinuingOperations', window );">Cash provided by operating activities</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_CurrentAssetsCurrentLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net working capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_CurrentAssetsCurrentLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_NetCashProvidedByOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Cash Provided by Operating Activities, Continuing Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_NetCashProvidedByOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_PotentialMarketExclusivityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Potential Market Exclusivity Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_PotentialMarketExclusivityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 28, 2024 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_PlatformOperatorCryptoAssetHeldForUserCurrent', window );">Digital assets receivable</a></td>
<td class="nump">$ 23,776<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">2,530<span></span>
</td>
<td class="nump">266<span></span>
</td>
<td class="nump">$ 106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DigitalAssetLiabilityCurrent', window );">Digital assets payable</a></td>
<td class="nump">30,918<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DigitalAssetLiabilityCurrentDigitalAssets', window );">Digital assets</a></td>
<td class="nump">23,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DigitalAssetLiabilityCurrentCashDeposits', window );">Digital assets, cash deposits</a></td>
<td class="nump">$ 7,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology Intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life of intangible assets (in years)</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Domain Name and Marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life of intangible assets (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life of intangible assets (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life of intangible assets (in years)</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Domain Name and Marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life of intangible assets (in years)</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life of intangible assets (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life of intangible assets (in years)</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=alts_SubscriptionsReceivableMember', window );">Subscriptions Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DigitalAssetLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Digital Asset, Liability, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DigitalAssetLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DigitalAssetLiabilityCurrentCashDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Digital Asset, Liability, Current, Cash Deposits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DigitalAssetLiabilityCurrentCashDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DigitalAssetLiabilityCurrentDigitalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Digital Asset, Liability, Current, Digital Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DigitalAssetLiabilityCurrentDigitalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_PlatformOperatorCryptoAssetHeldForUserCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Platform Operator, Crypto Asset, Held-for-User, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_PlatformOperatorCryptoAssetHeldForUserCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_MarketingRelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_MarketingRelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=alts_SubscriptionsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=alts_SubscriptionsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Trade and Other Receivables (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">$ 2,530<span></span>
</td>
<td class="nump">$ 266<span></span>
</td>
<td class="nump">$ 106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsAndOtherReceivablesNetCurrent', window );">Trade and other receivables, net</a></td>
<td class="nump">$ 2,530<span></span>
</td>
<td class="nump">$ 266<span></span>
</td>
<td class="nump">$ 106<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndOtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsAndOtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Mergers and Acquisitions - Qoden (Details) - Qoden Technologies, LLC<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th">
<div>Nov. 08, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Asset acquisition, total consideration</a></td>
<td class="nump">$ 2,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable', window );">Asset acquisition, shares issued, fair value</a></td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_AssetAcquisitionConsiderationCashPayable', window );">Cash consideration portion to be paid</a></td>
<td class="nump">$ 200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_AssetAcquisitionEquityInstrumentsIssuableValidConversionPeriod', window );">Asset acquisition, trailing period (in years)</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_AssetAcquisitionConsiderationPeriodicCashPayment', window );">Monthly cash payments to be made</a></td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=alts_QodenTechnologiesLLCMember', window );">Series Q Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares', window );">Restricted shares issued (in shares) | shares</a></td>
<td class="nump">771,010<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_AssetAcquisitionConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare', window );">Asset acquisition, shares issued, fair value (in usd per share) | $ / shares</a></td>
<td class="nump">$ 2.594<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_AssetAcquisitionConsiderationCashPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Consideration, Cash Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_AssetAcquisitionConsiderationCashPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_AssetAcquisitionConsiderationPeriodicCashPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Consideration, Periodic Cash Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_AssetAcquisitionConsiderationPeriodicCashPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable, Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_AssetAcquisitionConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Consideration Transferred, Equity Interests Issued and Issuable Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_AssetAcquisitionConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_AssetAcquisitionEquityInstrumentsIssuableValidConversionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Equity Instruments Issuable, Valid Conversion Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_AssetAcquisitionEquityInstrumentsIssuableValidConversionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479908/805-50-55-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480060/805-50-25-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of acquirer's equity interest issued and issuable as part of consideration transferred in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480060/805-50-25-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=alts_QodenTechnologiesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=alts_QodenTechnologiesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=alts_SeriesQConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=alts_SeriesQConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Mergers and Acquisitions - ALT5 (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 15, 2024</div></th>
<th class="th"><div>Sep. 28, 2024</div></th>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
<th class="th"><div>May 09, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,714<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Non-cash fair value adjustment of deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,229<span></span>
</td>
<td class="num">$ (444)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member', window );">Alt 5 Sigma, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Company tendered, shares (in shares)</a></td>
<td class="nump">1,799,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfIssuedAndOutstandingShares', window );">Percentage of shares acquired</a></td>
<td class="nump">19.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Business acquisition, shares issued, fair value</a></td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">11,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill expected to be deductible for tax purposes</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Non-cash fair value adjustment of deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member', window );">Alt 5 Sigma, Inc. | Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Company tendered, shares (in shares)</a></td>
<td class="nump">34,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Business acquisition, shares issued, fair value</a></td>
<td class="nump">$ 8,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member', window );">Alt 5 Sigma, Inc. | Series M Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Company tendered, shares (in shares)</a></td>
<td class="nump">3,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfIssuedAndOutstandingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Percentage Of Issued And Outstanding Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfIssuedAndOutstandingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=alts_SeriesMPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=alts_SeriesMPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Mergers and Acquisitions - Schedule of Fair Value Adjustments for Shares of Series B and Series M Preferred Stock (Details) - Alt 5 Sigma, Inc.<br> $ in Thousands</strong></div></th>
<th class="th">
<div>May 15, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSegmentAllocationLineItems', window );"><strong>Business Combination Segment Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Business acquisition, shares issued, fair value</a></td>
<td class="nump">$ 16,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total purchase price</a></td>
<td class="nump">16,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member', window );">Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSegmentAllocationLineItems', window );"><strong>Business Combination Segment Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Business acquisition, shares issued, fair value</a></td>
<td class="nump">7,448<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member', window );">Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSegmentAllocationLineItems', window );"><strong>Business Combination Segment Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Business acquisition, shares issued, fair value</a></td>
<td class="nump">$ 8,552<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSegmentAllocationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSegmentAllocationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Mergers and Acquisitions - Schedule of Purchase Price Allocation of Purchase for ALT5 Subsidiary to Acquired Identifiable Assets, Liabilities Assumed and Goodwill (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>May 15, 2024</div></th>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSegmentAllocationLineItems', window );"><strong>Business Combination Segment Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Total goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,714<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member', window );">Alt 5 Sigma, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSegmentAllocationLineItems', window );"><strong>Business Combination Segment Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total purchase price</a></td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">7,866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsPayable', window );">Digital assets payable</a></td>
<td class="nump">16,763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt', window );">Debt</a></td>
<td class="nump">7,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="nump">32,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration</a></td>
<td class="nump">48,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="nump">5,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="nump">2,917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsReceivable', window );">Digital assets receivable</a></td>
<td class="nump">9,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">18,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other</a></td>
<td class="nump">493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="nump">36,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Total goodwill</a></td>
<td class="nump">11,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member', window );">Alt 5 Sigma, Inc. | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSegmentAllocationLineItems', window );"><strong>Business Combination Segment Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">13,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member', window );">Alt 5 Sigma, Inc. | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSegmentAllocationLineItems', window );"><strong>Business Combination Segment Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">2,675<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member', window );">Alt 5 Sigma, Inc. | Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSegmentAllocationLineItems', window );"><strong>Business Combination Segment Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">$ 1,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Digital Assets Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Digital Assets Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSegmentAllocationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSegmentAllocationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Mergers and Acquisitions - Schedule of Proforma Information (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSegmentAllocationLineItems', window );"><strong>Business Combination Segment Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">$ 12,532<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="num">$ (6,245)<span></span>
</td>
<td class="num">$ (7,812)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net (loss) income per share, basic (in usd per share)</a></td>
<td class="num">$ (0.56)<span></span>
</td>
<td class="num">$ (1.95)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per basic diluted share (in usd per share)</a></td>
<td class="num">$ (0.56)<span></span>
</td>
<td class="num">$ (1.95)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=us-gaap_ScenarioAdjustmentMember', window );">Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSegmentAllocationLineItems', window );"><strong>Business Combination Segment Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="num">$ (1,343)<span></span>
</td>
<td class="num">$ (2,148)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ProFormaMember', window );">Proforma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSegmentAllocationLineItems', window );"><strong>Business Combination Segment Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">15,450<span></span>
</td>
<td class="nump">7,145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="num">$ (7,517)<span></span>
</td>
<td class="num">$ (6,601)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net (loss) income per share, basic (in usd per share)</a></td>
<td class="num">$ (0.11)<span></span>
</td>
<td class="num">$ (1.65)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per basic diluted share (in usd per share)</a></td>
<td class="num">$ (0.11)<span></span>
</td>
<td class="num">$ (1.65)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member', window );">Alt 5 Sigma, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSegmentAllocationLineItems', window );"><strong>Business Combination Segment Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Business acquisition, proforma revenue</a></td>
<td class="nump">$ 2,918<span></span>
</td>
<td class="nump">$ 7,145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Business acquisition, proforma net income</a></td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 3,359<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSegmentAllocationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSegmentAllocationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=us-gaap_ScenarioAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=us-gaap_ScenarioAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ProFormaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ProFormaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Mergers and Acquisitions - Soin Pharmaceuticals (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 24, 2024 </div>
<div>USD ($) </div>
<div>tranche</div>
</th>
<th class="th">
<div>Dec. 28, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 28, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 28, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=alts_DrSoinMember', window );">Dr. Soin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Payments for legal settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=alts_DrSoinMember', window );">Dr. Soin | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Payments for legal settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_SoinTherapeuticsLLCMember', window );">Soin Therapeutics LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_NumberOfTranches', window );">Number of tranches | tranche</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_SoinTherapeuticsLLCMember', window );">Soin Therapeutics LLC | Business Acquisition, Consideration, Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities', window );">Cash payment tendered for contingent liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_SoinTherapeuticsLLCMember', window );">Soin Therapeutics LLC | Business Acquisition, Consideration, Tranche Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_SoinTherapeuticsLLCMember', window );">Soin Therapeutics LLC | Business Acquisition, Consideration, Tranche Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_SoinTherapeuticsLLCMember', window );">Soin Therapeutics LLC | Soin Agreement Convertible Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Business acquisition, shares issued, fair value</a></td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="nump">$ 2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_SoinTherapeuticsLLCMember', window );">Soin Therapeutics LLC | Soin Agreement Convertible Tranche Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Business acquisition, shares issued, fair value</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_SoinTherapeuticsLLCMember', window );">Soin Therapeutics LLC | Soin Agreement Convertible Tranche Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Business acquisition, shares issued, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_NumberOfTranches">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Tranches</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_NumberOfTranches</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479668/805-30-25-5<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, made soon after acquisition date of business combination, to settle contingent consideration liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=alts_DrSoinMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=alts_DrSoinMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=alts_SoinTherapeuticsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=alts_SoinTherapeuticsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=alts_BusinessAcquisitionConsiderationTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=alts_BusinessAcquisitionConsiderationTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=alts_BusinessAcquisitionConsiderationTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=alts_BusinessAcquisitionConsiderationTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=alts_BusinessAcquisitionConsiderationTrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=alts_BusinessAcquisitionConsiderationTrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=alts_SoinAgreementConvertibleTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=alts_SoinAgreementConvertibleTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=alts_SoinAgreementConvertibleTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=alts_SoinAgreementConvertibleTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=alts_SOINAgreementConvertibleTrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=alts_SOINAgreementConvertibleTrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Sale of Recycling Subsidiaries - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 09, 2023</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Carrying value of disposition transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag', window );">Excess of book value over assets disposed, extensible list</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">gain on sale<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Sale of Recycling Subsidiaries | ARCA And Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Preliminary calculation of gain on sale</a></td>
<td class="nump">$ 15,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=alts_VM7CorporationMember', window );">VM7 Corporation | Stock Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount', window );">Receivable with imputed interest, net amount</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForCommissions', window );">Cash paid for close</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_RevisedDiscountAmount', window );">Revised discount amount</a></td>
<td class="nump">$ 18,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeInterestEarningAsset', window );">Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 720<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operations, Present Value Of Discount Recorded As Offset To The Principal Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Not Discontinued Operation Gain (Loss) On Disposal, Statement Of Income Extensible List Not Disclosed Flag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:tokenItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_RevisedDiscountAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revised Discount Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_RevisedDiscountAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeInterestEarningAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income from interest-earning asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph a<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph b<br> -Subparagraph (1)<br> -Publisher SEC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeInterestEarningAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for commissions during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=alts_ARCAAndSubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=alts_ARCAAndSubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=alts_VM7CorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=alts_VM7CorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=alts_StockPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=alts_StockPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Sale of Recycling Subsidiaries - Schedule of Gain on Sale of Recycling Subsidiaries (Details) - Sale of Recycling Subsidiaries - ARCA And Subsidiaries<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 09, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_TotalGuaranteedConsideration', window );">Total minimum consideration</a></td>
<td class="nump">$ 6,023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_PaymentFromBuyer', window );">Payment from buyer</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_NetConsideration', window );">Net consideration</a></td>
<td class="nump">6,026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DisposalOfAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">5,323<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DisposalOfAccruedLiability', window );">Accrued liabilities</a></td>
<td class="nump">1,857<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DisposalOfAccruedLiabilityCaliforniaStateSalesTax', window );">Accrued liabilities - California state sales tax</a></td>
<td class="nump">6,320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DisposalOfLeaseLiability', window );">Lease liabilities</a></td>
<td class="nump">5,285<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DisposalOfDebt', window );">Debt</a></td>
<td class="nump">2,139<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(604)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_TotalDisposalOfLiability', window );">Total disposal of liabilities</a></td>
<td class="nump">20,320<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_TotalConsiderations', window );">Total consideration</a></td>
<td class="nump">26,346<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_CashDisposal', window );">Cash</a></td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DisposalOfAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">4,884<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DisposalOfInventory', window );">Inventory</a></td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DisposalOfPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">2,767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DisposalOfIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">732<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DisposalOfRightOfUseAssets', window );">Right-of-use assets</a></td>
<td class="nump">5,075<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DisposalOfOtherAssets', window );">Other assets</a></td>
<td class="nump">574<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_TotalDisposalOfAssets', window );">Total disposal of assets</a></td>
<td class="nump">14,244<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_TotalGainOnSale', window );">Total gain on sale</a></td>
<td class="nump">$ 12,102<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_CashDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Disposal</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_CashDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DisposalOfAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal of Accounts Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DisposalOfAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DisposalOfAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal of Accounts receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DisposalOfAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DisposalOfAccruedLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal of Accrued liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DisposalOfAccruedLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DisposalOfAccruedLiabilityCaliforniaStateSalesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal of Accrued liability - California state sales tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DisposalOfAccruedLiabilityCaliforniaStateSalesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DisposalOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal of Debt</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DisposalOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DisposalOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal of Intangible assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DisposalOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DisposalOfInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal of Inventory</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DisposalOfInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DisposalOfLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal of Lease Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DisposalOfLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DisposalOfOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal of Other Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DisposalOfOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DisposalOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal of Property, Plant and Equipment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DisposalOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DisposalOfRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal of Right-of-use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DisposalOfRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_NetConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Consideration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_NetConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_PaymentFromBuyer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment from Buyer</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_PaymentFromBuyer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_TotalConsiderations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total Considerations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_TotalConsiderations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_TotalDisposalOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total Disposal of Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_TotalDisposalOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_TotalDisposalOfLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total Disposal of Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_TotalDisposalOfLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_TotalGainOnSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total Gain on Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_TotalGainOnSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_TotalGuaranteedConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total Guaranteed Consideration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_TotalGuaranteedConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-15<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-17A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=alts_ARCAAndSubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=alts_ARCAAndSubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations - Schedule of Discontinued Operations in Consolidated Statements of Operations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_OperatingExpensesFromDiscontinuedOperationsAbstract', window );"><strong>Operating expenses from discontinued operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax', window );">Gain on sale of ARCA</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (10,254)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract', window );"><strong>Other expense from discontinued operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Net income from discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,283<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember', window );">Discontinued operations | ARCA And Subsidiaries | Recycling Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,795<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold', window );">Cost of revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,992<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss', window );">Gross profit</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(197)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_OperatingExpensesFromDiscontinuedOperationsAbstract', window );"><strong>Operating expenses from discontinued operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,467<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax', window );">Gain on sale of ARCA</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(12,102)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DisposalGroupIncludingDiscontinuedOperationTotalOperatingIncomeExpensesFromDiscontinuedOperations', window );">Total operating expenses from discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(10,635)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss', window );">Operating income from discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,438<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract', window );"><strong>Other expense from discontinued operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense', window );">Interest expense, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(181)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet', window );">Other expense, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DisposalGroupIncludingDiscontinuedOperationsTotalOtherIncomeLossNet', window );">Total other expense, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(184)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax', window );">Income before provision for income taxes from discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation', window );">Income tax provision</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">971<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Net income from discontinued operations</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 9,283<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Other (Income) Expense, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DisposalGroupIncludingDiscontinuedOperationTotalOperatingIncomeExpensesFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Total Operating Income (Expenses) From Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DisposalGroupIncludingDiscontinuedOperationTotalOperatingIncomeExpensesFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DisposalGroupIncludingDiscontinuedOperationsTotalOtherIncomeLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total other loss, net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DisposalGroupIncludingDiscontinuedOperationsTotalOtherIncomeLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_OperatingExpensesFromDiscontinuedOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Expenses From Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_OperatingExpensesFromDiscontinuedOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Income (Expense) From Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gross profit attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section S99<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480781/205-20-S99-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-6<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=alts_ARCAAndSubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=alts_ARCAAndSubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=alts_RecyclingSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=alts_RecyclingSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations - Schedule of Discontinued Operations in the Consolidated Statements of Cash Flows (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DiscontinuedOperatingActivities', window );"><strong>DISCONTINUED OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Net income from discontinued operations</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 9,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">3,402<span></span>
</td>
<td class="nump">1,452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">1,876<span></span>
</td>
<td class="num">(367)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations', window );">Operating cash flows provided by discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,319<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">1,777<span></span>
</td>
<td class="nump">1,463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DiscontinuedInvestingActivities', window );"><strong>DISCONTINUED INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations', window );">Net cash used in investing activities from discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(155)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DiscontinuedFinancingActivities', window );"><strong>DISCONTINUED FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from note payable</a></td>
<td class="nump">7,237<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Payments on related party note</a></td>
<td class="num">(248)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Payments on notes payable</a></td>
<td class="nump">2,847<span></span>
</td>
<td class="nump">274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations', window );">Financing cash flows used in discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,212)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">6,093<span></span>
</td>
<td class="num">(1,435)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Effect of changes in exchange rate on cash and cash equivalents</a></td>
<td class="num">(6,551)<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">DECREASE IN CASH AND CASH EQUIVALENTS</a></td>
<td class="nump">7,172<span></span>
</td>
<td class="num">(110)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">CASH AND CASH EQUIVALENTS, beginning of period</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">CASH AND CASH EQUIVALENTS, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember', window );">Discontinued operations | ARCA And Subsidiaries | Recycling Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DiscontinuedOperatingActivities', window );"><strong>DISCONTINUED OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Net income from discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_AmortizationOfRightOfUseAssets', window );">Amortization of right-of-use assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_GainOnSaleNetOfCash', window );">Gain on sale of ARCA, net of cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(12,248)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,932<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,837<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations', window );">Operating cash flows provided by discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,319<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,319<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DiscontinuedInvestingActivities', window );"><strong>DISCONTINUED INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(123)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations', window );">Net cash used in investing activities from discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(155)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DiscontinuedFinancingActivities', window );"><strong>DISCONTINUED FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from note payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,162<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Payments on related party note</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Payments on notes payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations', window );">Financing cash flows used in discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,212)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,212)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Effect of changes in exchange rate on cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">DECREASE IN CASH AND CASH EQUIVALENTS</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(53)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">CASH AND CASH EQUIVALENTS, beginning of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">CASH AND CASH EQUIVALENTS, end of period</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_AmortizationOfRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization of right-of-use assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_AmortizationOfRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DiscontinuedFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>DISCONTINUED FINANCING ACTIVITIES:</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DiscontinuedFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DiscontinuedInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>DISCONTINUED INVESTING ACTIVITIES:</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DiscontinuedInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DiscontinuedOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>DISCONTINUED OPERATING ACTIVITIES:</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DiscontinuedOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_GainOnSaleNetOfCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain on Sale, Net of Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_GainOnSaleNetOfCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of financing activities of discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of investing activities of discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=alts_ARCAAndSubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=alts_ARCAAndSubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=alts_RecyclingSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=alts_RecyclingSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Prepaids and other current assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Prepaid insurance</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPrepaidExpenseCurrent', window );">Prepaid other</a></td>
<td class="nump">1,517<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total prepaids and other current assets</a></td>
<td class="nump">$ 1,518<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment - Schedule of Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">$ 1,170<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AssetUnderConstructionMember', window );">Projects under construction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">$ 1,170<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AssetUnderConstructionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AssetUnderConstructionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Company's Right of Use Assets and Lease Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use asset - operating leases</a></td>
<td class="nump">$ 121<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current - operating</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long term - operating</a></td>
<td class="nump">$ 113<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average lease term (in years)</a></td>
<td class="text">4 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate (as percent)</a></td>
<td class="nump">12.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash payment for operating leases</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right of use assets and liabilities upon commencement of operating leases</a></td>
<td class="nump">$ 123,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Total Present Value of Future Lease Payments of Operating Leases (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 28, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2028</a></td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2029</a></td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total</a></td>
<td class="nump">170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less implied interest</a></td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of payments</a></td>
<td class="nump">$ 123<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes receivable (Details) - USD ($)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 09, 2023</div></th>
<th class="th"><div>May 24, 2022</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_GainLossOnWriteOffOfNotesReceivable', window );">Impairment charge related to note receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 9,780,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Principal balance on notes outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Carrying value of disposition transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_GeoTraqIncMember', window );">GeoTraq Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_NoteReceivableFaceAmount', window );">Note receivable face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_NoteReceivableStatedInterestRate', window );">Note receivable interest rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeInterestEarningAsset', window );">Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 806,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=alts_SpyrTechnologiesIncMember', window );">SPYR Technologies Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_NotesReceivableTerm', window );">Term of notes receivable (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1', window );">Common stock equivalents received (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,253,900<span></span>
</td>
<td class="nump">922,442<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestReceivable', window );">Accrued receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=alts_VM7CorporationMember', window );">VM7 Corporation | Stock Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeInterestEarningAsset', window );">Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 720,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForCommissions', window );">Cash paid for close</a></td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_RevisedDiscountAmount', window );">Revised discount amount</a></td>
<td class="nump">$ 18,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_GainLossOnWriteOffOfNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Write-Off Of Notes Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_GainLossOnWriteOffOfNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_NoteReceivableFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Note receivable face amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_NoteReceivableFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_NoteReceivableStatedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Note receivable interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_NoteReceivableStatedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_NotesReceivableTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Notes Receivable, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_NotesReceivableTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_RevisedDiscountAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revised Discount Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_RevisedDiscountAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 40<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481628/310-20-40-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest, after allowance for credit loss, of financing receivable. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeInterestEarningAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income from interest-earning asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph a<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph b<br> -Subparagraph (1)<br> -Publisher SEC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeInterestEarningAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477802/946-310-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued as [noncash or part noncash] consideration for a business or asset acquired. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for commissions during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=alts_GeoTraqIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=alts_GeoTraqIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=alts_SpyrTechnologiesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=alts_SpyrTechnologiesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=alts_VM7CorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=alts_VM7CorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=alts_StockPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=alts_StockPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible assets - Schedule of Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total intangible assets</a></td>
<td class="nump">$ 39,283<span></span>
</td>
<td class="nump">$ 19,297<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less accumulated amortization</a></td>
<td class="num">(4,853)<span></span>
</td>
<td class="num">(1,451)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total intangible assets, net</a></td>
<td class="nump">34,430<span></span>
</td>
<td class="nump">17,846<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=alts_SoinIntangiblesMember', window );">Soin intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total intangible assets</a></td>
<td class="nump">19,293<span></span>
</td>
<td class="nump">19,293<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=alts_CryptocurrencyExchangeSoftwareIntangibleMember', window );">Qoden intangible</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total intangible assets</a></td>
<td class="nump">1,536<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=alts_PatentsAndDomainsMember', window );">Patents and domains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total intangible assets</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total intangible assets</a></td>
<td class="nump">2,675<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total intangible assets</a></td>
<td class="nump">13,925<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total intangible assets</a></td>
<td class="nump">$ 1,850<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478859/928-340-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=alts_SoinIntangiblesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=alts_SoinIntangiblesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=alts_CryptocurrencyExchangeSoftwareIntangibleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=alts_CryptocurrencyExchangeSoftwareIntangibleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=alts_PatentsAndDomainsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=alts_PatentsAndDomainsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 28, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Nov. 08, 2024</div></th>
<th class="th"><div>May 14, 2024</div></th>
<th class="th">
<div>Dec. 28, 2022 </div>
<div>patent</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible amortization expense | $</a></td>
<td class="nump">$ 3.4<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names | ALT5 Subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life of intangible assets (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships | ALT5 Subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life of intangible assets (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology | ALT5 Subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life of intangible assets (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=alts_SoinIntangiblesMember', window );">Soin intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life of intangible assets (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_NumberOfAcquiredIntangibleAssets', window );">Number of pending patents | patent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=alts_QodenTechnologiesLLCMember', window );">Qoden Technologies, LLC | Qoden intangible</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life of intangible assets (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_NumberOfAcquiredIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Acquired Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_NumberOfAcquiredIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=alts_ALT5SubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=alts_ALT5SubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=alts_SoinIntangiblesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=alts_SoinIntangiblesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=alts_QodenTechnologiesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=alts_QodenTechnologiesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=alts_QodenIntangibleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=alts_QodenIntangibleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities - Schedule of Marketable Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesPurchasedUnderAgreementsToResellAllowanceForCreditLossRollForward', window );"><strong>Marketable Securities, Value [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Beginning balance</a></td>
<td class="nump">$ 286<span></span>
</td>
<td class="nump">$ 315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Securities received</a></td>
<td class="nump">518<span></span>
</td>
<td class="nump">897<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments', window );">Mark-to-market</a></td>
<td class="num">(370)<span></span>
</td>
<td class="num">(926)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments', window );">Write-off marketable securities</a></td>
<td class="num">(434)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Ending balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 286<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=alts_SeriesGConvertiblePreferredStockMember', window );">Series G Convertible Preferred Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInAuctionMarketPreferredSecuritiesSharesOutstandingRollForward', window );"><strong>Marketable Securities, Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_MarketableSecuritiesSharesOutstanding', window );">Beginning balance (in shares)</a></td>
<td class="nump">9,224<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares', window );">Securities received (in shares)</a></td>
<td class="nump">33,876<span></span>
</td>
<td class="nump">9,224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_MarketableSecurityWriteOffShares', window );">Write-off marketable securities (in shares)</a></td>
<td class="num">(43,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_MarketableSecuritiesSharesOutstanding', window );">Ending balance (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,224<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=alts_CommonShareEquivalentsMember', window );">Common Shares Equivalent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInAuctionMarketPreferredSecuritiesSharesOutstandingRollForward', window );"><strong>Marketable Securities, Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_MarketableSecuritiesSharesOutstanding', window );">Beginning balance (in shares)</a></td>
<td class="nump">952,442,000<span></span>
</td>
<td class="nump">30,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares', window );">Securities received (in shares)</a></td>
<td class="nump">26,253,900,000<span></span>
</td>
<td class="nump">922,442,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_MarketableSecurityWriteOffShares', window );">Write-off marketable securities (in shares)</a></td>
<td class="num">(27,206,342,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_MarketableSecuritiesSharesOutstanding', window );">Ending balance (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">952,442,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_MarketableSecuritiesSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Marketable Securities, Shares Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_MarketableSecuritiesSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_MarketableSecurityWriteOffShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Marketable Security, Write-Off, Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_MarketableSecurityWriteOffShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash Or Part Noncash Divestiture, Consideration Received, Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInAuctionMarketPreferredSecuritiesSharesOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInAuctionMarketPreferredSecuritiesSharesOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesPurchasedUnderAgreementsToResellAllowanceForCreditLossRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesPurchasedUnderAgreementsToResellAllowanceForCreditLossRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=alts_SeriesGConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=alts_SeriesGConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=alts_CommonShareEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=alts_CommonShareEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 28, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 30, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized loss on marketable securities | $</a></td>
<td class="nump">$ 1,058<span></span>
</td>
<td class="nump">$ 926<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments', window );">Write off of marketable securities | $</a></td>
<td class="nump">$ 434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=alts_SeriesGConvertiblePreferredStockMember', window );">Series G Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionRatio', window );">Preferred stock, conversion ratio</a></td>
<td class="nump">0.00001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares', window );">Securities received (in shares)</a></td>
<td class="nump">33,876<span></span>
</td>
<td class="nump">9,224<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=alts_CommonShareEquivalentsMember', window );">Common Share Equivalent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares', window );">Securities received (in shares)</a></td>
<td class="nump">26,253,900,000<span></span>
</td>
<td class="nump">922,442,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ConvertiblePreferredStockSharesIssuableUponConversion', window );">Shares issuable upon conversion (in shares)</a></td>
<td class="nump">26,253,900,000<span></span>
</td>
<td class="nump">922,442,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_ConvertiblePreferredStockSharesIssuableUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible Preferred Stock, Shares Issuable Upon Conversion</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_ConvertiblePreferredStockSharesIssuableUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash Or Part Noncash Divestiture, Consideration Received, Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common shares issuable upon conversion for each share of preferred stock to be converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=alts_SeriesGConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=alts_SeriesGConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=alts_CommonShareEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=alts_CommonShareEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Deposits and other assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Deposits and other assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DepositsAndOtherAssetsNoncurrent', window );">Total deposits and other assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DepositsAndOtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deposits and other assets noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DepositsAndOtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Compensation and benefits</a></td>
<td class="nump">$ 204<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsCurrentCarryingValue', window );">Accrued guarantees</a></td>
<td class="nump">309<span></span>
</td>
<td class="nump">3,049<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Accrued taxes</a></td>
<td class="nump">362<span></span>
</td>
<td class="nump">102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">789<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_AccruedExpensesAssetAcquisitionCurrent', window );">Accrued Qoden payments</a></td>
<td class="nump">109<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationReserveCurrent', window );">Accrued litigation/legal</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">397<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">730<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Total accrued liabilities</a></td>
<td class="nump">$ 2,553<span></span>
</td>
<td class="nump">$ 3,633<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_AccruedExpensesAssetAcquisitionCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Expenses, Asset Acquisition, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_AccruedExpensesAssetAcquisitionCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsCurrentCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current carrying amount of the liability for the freestanding or embedded guarantor's obligations under the guarantee or each group of similar guarantees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsCurrentCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debentures - Schedule of Debentures Outstanding (Details) - Debentures - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debentures</a></td>
<td class="nump">$ 563<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_A15DebenturesMaturingJune302025Member', window );">15% Debentures Maturing June 30, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (as percent)</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debentures</a></td>
<td class="nump">$ 563<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=alts_DebenturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=alts_DebenturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_A15DebenturesMaturingJune302025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_A15DebenturesMaturingJune302025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debentures - Narrative (Details) - Debentures<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 28, 2024 </div>
<div>USD ($) </div>
<div>debenture</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>debenture</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DebtInstrumentNumberOfDebenturesIssued', window );">Number of debentures issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DebtInstrumentNumberOfDebenturesRepaid', window );">Number of debentures repaid</a></td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt | $</a></td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=alts_DebenturesMember', window );">12% Debentures Maturing June 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (as percent)</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=alts_DebenturesMember', window );">12% Debentures Maturing June 30, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (as percent)</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DebtInstrumentNumberOfDebenturesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Number Of Debentures Issued</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DebtInstrumentNumberOfDebenturesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DebtInstrumentNumberOfDebenturesRepaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Number Of Debentures Repaid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DebtInstrumentNumberOfDebenturesRepaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=alts_DebenturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=alts_DebenturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_A12DebenturesMaturingJune302024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_A12DebenturesMaturingJune302024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_A12DebenturesMaturingJune302025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_A12DebenturesMaturingJune302025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt - Schedule of Long-Term Debt (Details) - Related Party - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt, Total</a></td>
<td class="nump">$ 11,570<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less current portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term notes payable, related parties</a></td>
<td class="nump">11,570<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_LegacySubsidiaryFixedDepositsMember', window );">Legacy subsidiary fixed deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt, Total</a></td>
<td class="nump">4,247<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_LegacySubsidiaryLoanMember', window );">Legacy subsidiary loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt, Total</a></td>
<td class="nump">3,782<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_LegacyUnaffiliatedThirdPartyNotesMember', window );">Unaffiliated third-party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt, Total</a></td>
<td class="nump">3,508<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_OtherLegacyNotesPayableMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt, Total</a></td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_LegacySubsidiaryFixedDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_LegacySubsidiaryFixedDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_LegacySubsidiaryLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_LegacySubsidiaryLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_LegacyUnaffiliatedThirdPartyNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_LegacyUnaffiliatedThirdPartyNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_OtherLegacyNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_OtherLegacyNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 23, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 19, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 20, 2024 </div>
<div>USD ($) </div>
<div>addition </div>
<div>investor </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 10, 2024 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 22, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 28, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 28, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 07, 2024 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ClassOfWarrantOrRightExercisePeriod', window );">Number of days required to exercise initial tranche (in days)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_PercentageOfNetDollarReceivedToBeIssuedToDebentureHoldersOnAProRataBasis', window );">Net dollar issued to debentures holders on a pro rata basis (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=alts_BigWarrantMember', window );">Big Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant offering and exercise price (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=alts_BigWarrantMember', window );">Big Warrant | August 20, 2024 to October 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant excise and granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=alts_BigWarrantMember', window );">Big Warrant | November 01, 2024 to January 29, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant excise and granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=alts_BigWarrantMember', window );">Big Warrant | January 30, 2025 till Repayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant excise and granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=alts_SmallWarrantMember', window );">Small Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant offering and exercise price (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=alts_SmallWarrantMember', window );">Small Warrant | August 20, 2024 to October 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant excise and granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=alts_SmallWarrantMember', window );">Small Warrant | November 01, 2024 to January 29, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant excise and granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=alts_SmallWarrantMember', window );">Small Warrant | January 30, 2025 till Repayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant excise and granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=alts_InvestorOneMember', window );">Investor one | Big Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant excise and granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=alts_InvestorTwoAndInvestorThreeMember', window );">Other two investors | Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant excise and granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=alts_SkyBridgeAmericasMember', window );">SA | Skybridge Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded plus interest and attorney fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 433,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=alts_SkyBridgeAmericasMember', window );">SA | Skybridge Litigation | Legal Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded plus interest and attorney fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding aggregate obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,570,000<span></span>
</td>
<td class="nump">$ 11,570,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party | Big Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Common stock issued for warrants exercised (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party | Small Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Common stock issued for warrants exercised (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_LegacySubsidiaryFixedDepositsMember', window );">Legacy subsidiary fixed deposits | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding aggregate obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,247,000<span></span>
</td>
<td class="nump">4,247,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_LegacySubsidiaryLoanMember', window );">Legacy subsidiary loan | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding aggregate obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,782,000<span></span>
</td>
<td class="nump">$ 3,782,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_LegacySubsidiaryLoanMember', window );">Legacy subsidiary loan | Loan | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding aggregate obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,800,000<span></span>
</td>
<td class="nump">$ 3,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_IcgNoteMember', window );">ICG Note | Promissory Note | Related Party | Notes Payable With Live Ventures and ICG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Debt conversion, converted amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 548,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt conversion, converted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal outstanding balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_LiveNoteMember', window );">Live Note | Promissory Note | Related Party | Notes Payable With Live Ventures and ICG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Debt conversion, converted amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 243,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt conversion, converted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal outstanding balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_NonConvertibleDebentureBigAndSmallDebentureMember', window );">Debentures | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Common stock issued for warrants exercised (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">290,908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_NonConvertibleDebentureBigAndSmallDebentureMember', window );">Debentures | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding aggregate obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Debt conversion, converted amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_NonConvertibleDebentureBigAndSmallDebentureMember', window );">Debentures | Unsecured Debt | August 20, 2024 to October 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_NonConvertibleDebentureBigAndSmallDebentureMember', window );">Debentures | Unsecured Debt | November 01, 2024 to January 29, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_NonConvertibleDebentureBigAndSmallDebentureMember', window );">Debentures | Unsecured Debt | January 30, 2025 till Repayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_NonConvertibleDebentureBigDebentureMember', window );">Big Debenture | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding aggregate obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_NumberOfUnaffiliatedThirdPartyInvestors', window );">Number Of unaffiliated third-party investors | investor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 171,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions', window );">Number of potential additions | addition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_NonConvertibleDebentureBigDebentureMember', window );">Big Debenture | Unsecured Debt | OID expansion one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding aggregate obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_NonConvertibleDebentureBigDebentureMember', window );">Big Debenture | Unsecured Debt | OID expansion two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding aggregate obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">342,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_NonConvertibleDebentureBigDebentureMember', window );">Big Debenture | Unsecured Debt | Investor one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_NonConvertibleDebentureSmallDebentureMember', window );">Small Debenture | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding aggregate obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">288,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions', window );">Number of potential additions | addition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_NonConvertibleDebentureSmallDebentureMember', window );">Small Debenture | Unsecured Debt | OID expansion one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding aggregate obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 327,726<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_NonConvertibleDebentureSmallDebentureMember', window );">Small Debenture | Unsecured Debt | OID expansion two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding aggregate obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">404,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_NonConvertibleDebentureSmallDebentureMember', window );">Small Debenture | Unsecured Debt | Other two investors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 404,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_FixedDepositAgreementMember', window );">Fixed Deposit Agreement | Fixed Deposit Agreement | ALT5 Subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding aggregate obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term (in months)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_PromissoryNoteMember', window );">Promissory Note | Skybridge Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 147,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_PromissoryNoteMember', window );">Promissory Note | Unaffiliated Third Party | Skybridge Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Debt conversion, converted amount</a></td>
<td class="nump">$ 691,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt conversion, converted (in shares) | shares</a></td>
<td class="nump">265,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=alts_ALT5SubsidiaryMember', window );">ALT5 Subsidiary | Legacy subsidiary fixed deposits | Fixed Deposit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,700,000<span></span>
</td>
<td class="nump">4,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Outstanding aggregate obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,200,000<span></span>
</td>
<td class="nump">$ 4,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Debt conversion, converted amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 475,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=alts_ALT5SubsidiaryMember', window );">ALT5 Subsidiary | Legacy subsidiary fixed deposits | Fixed Deposit Agreement | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=alts_ALT5SubsidiaryMember', window );">ALT5 Subsidiary | Legacy subsidiary fixed deposits | Fixed Deposit Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_ClassOfWarrantOrRightExercisePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant or Right, Exercise Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_ClassOfWarrantOrRightExercisePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Original Issue Discount, Number Of Potential Additions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_NumberOfUnaffiliatedThirdPartyInvestors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Unaffiliated Third-Party Investors</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_NumberOfUnaffiliatedThirdPartyInvestors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_PercentageOfNetDollarReceivedToBeIssuedToDebentureHoldersOnAProRataBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Net Dollar Received To Be Issued To Debenture Holders On A Pro Rata Basis</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_PercentageOfNetDollarReceivedToBeIssuedToDebentureHoldersOnAProRataBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_StockIssuedDuringPeriodSharesWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_StockIssuedDuringPeriodSharesWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionOriginalDebtAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionOriginalDebtAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=alts_BigWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=alts_BigWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DebtInstrumentCovenantPeriodAxis=alts_DebtInstrumentCovenantPeriodPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DebtInstrumentCovenantPeriodAxis=alts_DebtInstrumentCovenantPeriodPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DebtInstrumentCovenantPeriodAxis=alts_DebtInstrumentCovenantPeriodPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DebtInstrumentCovenantPeriodAxis=alts_DebtInstrumentCovenantPeriodPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DebtInstrumentCovenantPeriodAxis=alts_DebtInstrumentCovenantPeriodPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DebtInstrumentCovenantPeriodAxis=alts_DebtInstrumentCovenantPeriodPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=alts_SmallWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=alts_SmallWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=alts_InvestorOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=alts_InvestorOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=alts_InvestorTwoAndInvestorThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=alts_InvestorTwoAndInvestorThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=alts_SkyBridgeAmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=alts_SkyBridgeAmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=alts_SkybridgeLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=alts_SkybridgeLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=alts_LegalFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=alts_LegalFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_LegacySubsidiaryFixedDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_LegacySubsidiaryFixedDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_LegacySubsidiaryLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_LegacySubsidiaryLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_IcgNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_IcgNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=alts_PromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=alts_PromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=alts_NotesPayableWithLiveVenturesAndICGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=alts_NotesPayableWithLiveVenturesAndICGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_LiveNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_LiveNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_NonConvertibleDebentureBigAndSmallDebentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_NonConvertibleDebentureBigAndSmallDebentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_NonConvertibleDebentureBigDebentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_NonConvertibleDebentureBigDebentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DebtInstrumentOriginalIssueDiscountExpansionAxis=alts_DebtInstrumentOriginalIssueDiscountExpansionOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DebtInstrumentOriginalIssueDiscountExpansionAxis=alts_DebtInstrumentOriginalIssueDiscountExpansionOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DebtInstrumentOriginalIssueDiscountExpansionAxis=alts_DebtInstrumentOriginalIssueDiscountExpansionTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DebtInstrumentOriginalIssueDiscountExpansionAxis=alts_DebtInstrumentOriginalIssueDiscountExpansionTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_NonConvertibleDebentureSmallDebentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_NonConvertibleDebentureSmallDebentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_FixedDepositAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_FixedDepositAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=alts_FixedDepositAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=alts_FixedDepositAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=alts_ALT5SubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=alts_ALT5SubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_PromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_PromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=alts_UnaffiliatedThirdPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=alts_UnaffiliatedThirdPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=alts_ALT5SubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=alts_ALT5SubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Related Party Debt - Schedule of Long-Term Debt Payable to Related Parties (Details) - Related Party - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less current portion</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term notes payable, related parties</a></td>
<td class="nump">11,570<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total notes payable, related parties</a></td>
<td class="nump">812<span></span>
</td>
<td class="nump">707<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less current portion</a></td>
<td class="num">(812)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term notes payable, related parties</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">707<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_IsaacCapitalGroupNoteMember', window );">Isaac Capital Group | Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total notes payable, related parties</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">707<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_NotePayableToIsaacCapitalGroupMember', window );">Note Payable To Isaac Capital Group | Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total notes payable, related parties</a></td>
<td class="nump">$ 327<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (as percent)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_NotePayableToLiveVentureIncorporatedMember', window );">Note Payable To Live Venture Incorporated | Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total notes payable, related parties</a></td>
<td class="nump">$ 327<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (as percent)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_IsaacCapitalGroupShortTermDemandAdvanceMember', window );">Isaac Capital Group Short-Term Demand Advance | Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total notes payable, related parties</a></td>
<td class="nump">$ 48<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_NovalkAppsSAALLPShortTermDemandAdvanceMember', window );">Novalk Apps SAA, LLP | Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total notes payable, related parties</a></td>
<td class="nump">$ 110<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_IsaacCapitalGroupNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_IsaacCapitalGroupNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_NotePayableToIsaacCapitalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_NotePayableToIsaacCapitalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_NotePayableToLiveVentureIncorporatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_NotePayableToLiveVentureIncorporatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_IsaacCapitalGroupShortTermDemandAdvanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_IsaacCapitalGroupShortTermDemandAdvanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_NovalkAppsSAALLPShortTermDemandAdvanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_NovalkAppsSAALLPShortTermDemandAdvanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Related Party Debt - Schedule of Future Maturities of Long Term Debt (Details) - Related Party - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt, Total</a></td>
<td class="nump">$ 11,570<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_NotesPayableRelatedPartiesMember', window );">Notes Payable Related Parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2025</a></td>
<td class="nump">812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-Term Debt, Total</a></td>
<td class="nump">$ 812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_NotesPayableRelatedPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_NotesPayableRelatedPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Debt - Narrative (Details) - Related Party - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 23, 2024</div></th>
<th class="th"><div>Sep. 18, 2024</div></th>
<th class="th"><div>Jul. 01, 2024</div></th>
<th class="th"><div>Jun. 06, 2024</div></th>
<th class="th"><div>Jun. 03, 2024</div></th>
<th class="th"><div>May 28, 2024</div></th>
<th class="th"><div>Apr. 18, 2024</div></th>
<th class="th"><div>Mar. 04, 2024</div></th>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Feb. 07, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=alts_IsaacConsultingAgreementMember', window );">Isaac Consulting Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_RelatedPartyTransactionConsultingAgreementTerm', window );">Term of consulting agreement (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=alts_IsaacConsultingAgreementMember', window );">Isaac Consulting Agreement | Mr. Jon Isaac</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal outstanding balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_RelatedPartyTransactionConsultingAgreementTerm', window );">Term of consulting agreement (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice', window );">Per share value of the restricted shares issued (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=alts_RelatedPartyTransactionShortTermAdvancesMember', window );">Short Term Advances | Novalk Apps SAA, LLP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term demand advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Total debentures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=alts_RelatedPartyTransactionShortTermAdvancesMember', window );">Short Term Advances | Mr. Tony Isaac</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term demand advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal outstanding balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 707<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_IcgNoteMember', window );">ICG Note | Note | ICG Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Debt conversion, converted amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal outstanding balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_IcgNoteMember', window );">ICG Note | Note | ICG Note | Equity Unit Purchase Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt conversion, converted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_IsaacCapitalGroupShortTermDemandAdvanceMember', window );">Isaac Capital Group Short-Term Demand Advance | Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal outstanding balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_IsaacCapitalGroupShortTermDemandAdvanceMember', window );">Isaac Capital Group Short-Term Demand Advance | Note | ICG Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal outstanding balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term demand advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_LiveNoteMember', window );">Live Note | Note | Live Venture Incorporated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Debt conversion, converted amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal outstanding balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_LiveNoteMember', window );">Live Note | Note | Live Venture Incorporated | Equity Unit Purchase Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt conversion, converted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_A10ConvertiblePromissoryNoteMember', window );">10% Convertible Promissory Note | Isaac Consulting Agreement | Mr. Jon Isaac</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_RelatedPartyTransactionConsultingAgreementTerm', window );">Term of consulting agreement (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=alts_A10ConvertiblePromissoryNoteMember', window );">10% Convertible Promissory Note | Note | Isaac Consulting Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Debt conversion, converted amount</a></td>
<td class="nump">$ 540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt conversion, converted (in shares)</a></td>
<td class="nump">465,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Consulting Agreement, Convertible Debt, Conversion Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_RelatedPartyTransactionConsultingAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Consulting Agreement, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_RelatedPartyTransactionConsultingAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionOriginalDebtAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionOriginalDebtAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=alts_IsaacConsultingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=alts_IsaacConsultingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=alts_Mr.JonIsaacMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=alts_Mr.JonIsaacMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=alts_RelatedPartyTransactionShortTermAdvancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=alts_RelatedPartyTransactionShortTermAdvancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=alts_NovalkAppsSAALLPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=alts_NovalkAppsSAALLPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=alts_Mr.TonyIsaacMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=alts_Mr.TonyIsaacMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_IcgNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_IcgNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=alts_IcgNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=alts_IcgNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EquityUnitPurchaseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EquityUnitPurchaseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_IsaacCapitalGroupShortTermDemandAdvanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_IsaacCapitalGroupShortTermDemandAdvanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_LiveNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_LiveNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=alts_LiveVentureIncorporatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=alts_LiveVentureIncorporatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_A10ConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_A10ConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred Stock - Series A-1 Convertible Preferred Stock (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Aug. 18, 2017 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 28, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 30, 2023 </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=alts_SeriesA1ConvertiblePreferredStockMember', window );">Series A1 Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionRatio', window );">Preferred stock, conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Number of preferred converted to common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">27,353<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Number of shares issued upon exchange of convertible preferred stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">547,069<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ConversionOfStockSharesForfeited', window );">Convertible preferred stock, forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,480<span></span>
</td>
<td class="nump">193,730<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_GeoTraqIncMember', window );">GeoTraq Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Business acquisition, shares issued, fair value | $</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Company tendered, shares (in shares)</a></td>
<td class="nump">288,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_BusinessCombinationConsiderationTransferredLiabilitiesIncurredTerm', window );">Term of unsecured notes entered into (in years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Aggregate principal amount | $</a></td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_GeoTraqIncMember', window );">GeoTraq Inc. | Series A Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Business acquisition, shares issued, fair value | $</a></td>
<td class="nump">12,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_BusinessCombinationConsiderationTransferredBeneficialConversionFeatureValue', window );">Beneficial conversion feature | $</a></td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_BusinessCombinationConsiderationTransferredBeneficialConversionFeatureValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Beneficial Conversion Feature, Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_BusinessCombinationConsiderationTransferredBeneficialConversionFeatureValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_BusinessCombinationConsiderationTransferredLiabilitiesIncurredTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Liabilities Incurred, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_BusinessCombinationConsiderationTransferredLiabilitiesIncurredTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_ConversionOfStockSharesForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion of Stock, Shares Forfeited</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_ConversionOfStockSharesForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479668/805-30-25-5<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common shares issuable upon conversion for each share of preferred stock to be converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=alts_SeriesA1ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockByUniqueDescriptionAxis=alts_SeriesA1ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=alts_GeoTraqIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=alts_GeoTraqIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=alts_SeriesAConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockByUniqueDescriptionAxis=alts_SeriesAConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Preferred Stock - Series B Preferred Stock (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>May 15, 2024</div></th>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,207<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member', window );">Alt 5 Sigma, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Company tendered, shares (in shares)</a></td>
<td class="nump">1,799,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Business acquisition, shares issued, fair value</a></td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member', window );">Alt 5 Sigma, Inc. | Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Company tendered, shares (in shares)</a></td>
<td class="nump">34,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Business acquisition, shares issued, fair value</a></td>
<td class="nump">$ 8,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=alts_OwnersOfALT5SubsidiaryMember', window );">Owners of ALT5 Subsidiary | Alt 5 Sigma, Inc. | Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Company tendered, shares (in shares)</a></td>
<td class="nump">34,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=alts_OwnersOfALT5SubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=alts_OwnersOfALT5SubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred Stock - Series I Convertible Preferred Stock (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 02, 2024 </div>
<div>consultant </div>
<div>shares</div>
</th>
<th class="th">
<div>May 15, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 28, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 30, 2023 </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=alts_SeriesIConvertiblePreferredStockMember', window );">Series I Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionRatio', window );">Preferred stock, conversion ratio (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_CommonStockConversionValidConversionPeriod', window );">Trailing quarterly basis, period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member', window );">Alt 5 Sigma, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Company tendered, shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,799,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_NumberOfConsultants', window );">Number of consultants | consultant</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member', window );">Alt 5 Sigma, Inc. | Series I Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Company tendered, shares (in shares)</a></td>
<td class="nump">17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_CommonStockConversionValidConversionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock Conversion, Valid Conversion Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_CommonStockConversionValidConversionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_NumberOfConsultants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Consultants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_NumberOfConsultants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common shares issuable upon conversion for each share of preferred stock to be converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=alts_SeriesIConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=alts_SeriesIConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Preferred Stock - Series M Preferred Stock (Details) - shares<br></strong></div></th>
<th class="th"><div>May 15, 2024</div></th>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=alts_SeriesMPreferredStockMember', window );">Series M Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,200<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member', window );">Alt 5 Sigma, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Company tendered, shares (in shares)</a></td>
<td class="nump">1,799,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member', window );">Alt 5 Sigma, Inc. | Series M Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Company tendered, shares (in shares)</a></td>
<td class="nump">3,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=alts_SeriesMPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=alts_SeriesMPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Preferred Stock - Series Q Convertible Preferred Stock (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th"><div>Nov. 06, 2024</div></th>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=alts_SeriesQConvertiblePreferredStockMember', window );">Series Q Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare', window );">Business acquisition, shares issued, fair value (in usd per share)</a></td>
<td class="nump">$ 2.594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">925,212<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_QodenTechnologiesLLCMember', window );">Qoden Technologies, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Company tendered, shares (in shares)</a></td>
<td class="nump">771,010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_QodenTechnologiesLLCMember', window );">Qoden Technologies, LLC | Series Q Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Company tendered, shares (in shares)</a></td>
<td class="nump">154,202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Business acquisition, shares issued, fair value</a></td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=alts_SeriesQConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=alts_SeriesQConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=alts_QodenTechnologiesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=alts_QodenTechnologiesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Preferred Stock - Series V Convertible Preferred Stock (Details) - Series V Convertible Preferred Stock - shares<br></strong></div></th>
<th class="th"><div>May 04, 2024</div></th>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_UnaffiliatedThirdPartyMember', window );">Unaffiliated Third Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Company tendered, shares (in shares)</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=alts_SeriesVConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=alts_SeriesVConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=alts_UnaffiliatedThirdPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=alts_UnaffiliatedThirdPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred Stock - Series S Convertible Preferred Stock (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 28, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 28, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 30, 2023 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationsOfTemporaryToPermanentEquity', window );">Reclassification to permanent equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=alts_SeriesSConvertiblePreferredStockMember', window );">Series S</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ReclassificationOfTemporaryToCurrentLiabilities', window );">Reclassification to current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationsOfTemporaryToPermanentEquity', window );">Reclassification to permanent equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionRatio', window );">Preferred stock, conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding shares (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=alts_SeriesSConvertiblePreferredStockMember', window );">Series S | Soin Therapeutics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Issuance of shares of common stock to legacy equity holders</a></td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Company tendered, shares (in shares) | shares</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=alts_DrSoinMember', window );">Dr. Soin | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_CommonStockSharesOutstandingPercentage', window );">Common stock, shares outstanding (as percent)</a></td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=alts_DrSoinMember', window );">Dr. Soin | Stock Conversion 1 | Related Party | Series S</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ConversionOfStockAmountConvertible', window );">Conversion of stock, amount converted</a></td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ConversionOfStockCommencementPeriod', window );">Conversion of stock, commencement period (in years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=alts_DrSoinMember', window );">Dr. Soin | Stock Conversion 2 | Related Party | Series S</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ConversionOfStockAmountConvertible', window );">Conversion of stock, amount converted</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=alts_DrSoinMember', window );">Dr. Soin | Stock Conversion 3 | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_PercentageOfGrossRevenue', window );">Percentage of gross revenue</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=alts_DrSoinMember', window );">Dr. Soin | Stock Conversion 3 | Related Party | Series S</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ConversionOfStockAmountConvertible', window );">Conversion of stock, amount converted</a></td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ConversionOfStockPeriodFollowingClosing', window );">Conversion of stock, period after closing (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_CommonStockSharesOutstandingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Shares Outstanding, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_CommonStockSharesOutstandingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_ConversionOfStockAmountConvertible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion Of Stock, Amount Convertible</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_ConversionOfStockAmountConvertible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_ConversionOfStockCommencementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion Of Stock, Commencement Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_ConversionOfStockCommencementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_ConversionOfStockPeriodFollowingClosing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion Of Stock, Period Following Closing</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_ConversionOfStockPeriodFollowingClosing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_PercentageOfGrossRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of Gross Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_PercentageOfGrossRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_ReclassificationOfTemporaryToCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Temporary to Current Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_ReclassificationOfTemporaryToCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common shares issuable upon conversion for each share of preferred stock to be converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationsOfTemporaryToPermanentEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationsOfTemporaryToPermanentEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=alts_SeriesSConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=alts_SeriesSConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=alts_SoinTherapeuticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=alts_SoinTherapeuticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=alts_DrSoinMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=alts_DrSoinMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=alts_StockConversion1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockByUniqueDescriptionAxis=alts_StockConversion1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=alts_StockConversion2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockByUniqueDescriptionAxis=alts_StockConversion2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=alts_StockConversion3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockByUniqueDescriptionAxis=alts_StockConversion3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred Stock - Schedule of Series S Convertible Preferred Stock Outstanding (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 28, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationsOfTemporaryToPermanentEquity', window );">Reclassification to permanent equity</a></td>
<td class="num">$ (7,993)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=alts_SeriesSConvertiblePreferredStockMember', window );">Series S Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance (in shares) | shares</a></td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance</a></td>
<td class="nump">$ 14,510<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ReclassificationsOfTemporaryToPermanentEquityShares', window );">Reclassification to permanent equity (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationsOfTemporaryToPermanentEquity', window );">Reclassification to permanent equity</a></td>
<td class="num">$ (7,993)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ReclassificationOfTemporaryToCurrentLiabilitiesShares', window );">Reclassification to current liabilities (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ReclassificationOfTemporaryToCurrentLiabilities', window );">Reclassification to current liabilities</a></td>
<td class="num">$ (2,661)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) | shares</a></td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance</a></td>
<td class="nump">$ 3,856<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_ReclassificationOfTemporaryToCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Temporary to Current Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_ReclassificationOfTemporaryToCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_ReclassificationOfTemporaryToCurrentLiabilitiesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Temporary to Current Liabilities, Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_ReclassificationOfTemporaryToCurrentLiabilitiesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_ReclassificationsOfTemporaryToPermanentEquityShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassifications Of Temporary To Permanent Equity, Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_ReclassificationsOfTemporaryToPermanentEquityShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationsOfTemporaryToPermanentEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationsOfTemporaryToPermanentEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.E.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=alts_SeriesSConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=alts_SeriesSConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders' Equity - Common Stock (Details) - shares<br></strong></div></th>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued shares (in shares)</a></td>
<td class="nump">15,417,693<span></span>
</td>
<td class="nump">2,827,410<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding shares (in shares)</a></td>
<td class="nump">15,417,693<span></span>
</td>
<td class="nump">2,827,410<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=alts_ArticlesOfIncorporationMember', window );">Articles of Incorporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued shares (in shares)</a></td>
<td class="nump">15,417,687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,957,647<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_ShareholdersEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shareholders equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_ShareholdersEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=alts_ArticlesOfIncorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=alts_ArticlesOfIncorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Equity Offerings (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 23, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 03, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 18, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 18, 2024 </div>
<div>shares</div>
</th>
<th class="th"><div>Jul. 01, 2024</div></th>
<th class="th">
<div>Jun. 06, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 03, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 15, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 01, 2024 </div>
<div>USD ($) </div>
<div>investor </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 12, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 10, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 25, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 22, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 04, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 23, 2024 </div>
<div>USD ($) </div>
<div>investor </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 18, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 22, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 28, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 28, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 30, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common stock issued for equity financing | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,033,000<span></span>
</td>
<td class="nump">$ 793,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member', window );">Alt 5 Sigma, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Company tendered (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,799,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | 2023 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Common stock issued for consulting agreement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">908,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Common stock issued for consulting agreement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_StockIssuedDuringPeriodSharesPrepaidInterest', window );">Common stock issued for prepaid interest (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party | 2023 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Common stock issued for consulting agreement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock issued for equity financing (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">341,175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common stock issued for equity financing | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party | Debentures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Common stock issued for warrants exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">290,908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=alts_IcgNoteMember', window );">ICG Note | Related Party | ICG Note | Promissory Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Debt conversion, converted amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,900<span></span>
</td>
<td class="nump">$ 60,900<span></span>
</td>
<td class="nump">$ 183,000<span></span>
</td>
<td class="nump">$ 183,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=alts_IcgNoteMember', window );">ICG Note | Related Party | ICG Note | Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Debt conversion, converted amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 183,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=alts_IsaacConsultingAgreementMember', window );">Isaac Consulting Agreement | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Common stock issued for consulting agreement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_RelatedPartyTransactionConsultingAgreementTerm', window );">Term of consulting agreement (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares', window );">Restricted shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=alts_IsaacConsultingAgreementMember', window );">Isaac Consulting Agreement | Related Party | 10% Convertible Promissory Note | Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Debt conversion, converted amount | $</a></td>
<td class="nump">$ 540,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt conversion, converted (in shares)</a></td>
<td class="nump">465,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=alts_IsaacConsultingAgreementMember', window );">Isaac Consulting Agreement | Related Party | Mr. Jon Isaac</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_RelatedPartyTransactionConsultingAgreementTerm', window );">Term of consulting agreement (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares', window );">Restricted shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=alts_IsaacConsultingAgreementMember', window );">Isaac Consulting Agreement | Related Party | Mr. Jon Isaac | 10% Convertible Promissory Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_RelatedPartyTransactionConsultingAgreementTerm', window );">Term of consulting agreement (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=alts_NorthYorkLTDMember', window );">North York LTD | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant offering and exercise price (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and rights outstanding, term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=alts_NorthYorkLTDMember', window );">North York LTD | Related Party | Series V Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=alts_NorthYorkLTDMember', window );">North York LTD | Related Party | Restricted Stock Units (RSUs) | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">418,000<span></span>
</td>
<td class="nump">361,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.8811<span></span>
</td>
<td class="nump">$ 1.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfInterestInPartnershipUnit', window );">Proceeds from sale of common stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 422,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Common stock issued for consulting agreement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement | Pre-Funded Warrants Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant excise and granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">481,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant offering and exercise price (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.8801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EquityUnitPurchaseAgreementsMember', window );">Equity Unit Purchase Agreements | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,782<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">408,163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EquityUnitPurchaseAgreementsMember', window );">Equity Unit Purchase Agreements | ICG Note | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.7350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant offering and exercise price (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_NumberOfAgreementsToBePurchased', window );">Unaffiliated third-part investors | investor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Aggregate purchase price | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Aggregated consideration received on transaction | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_SaleOfStockUnitCompositionNumberOfCommonSharesInEachUnit', window );">Number of common shares in each unit (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_SaleOfStockUnitCompositionNumberOfWarrantsIssuedInEachUnit', window );">Number of warrants in each unit (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ClassOfWarrantPricePerShare', window );">Warrant price per share (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and rights outstanding, term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EquityUnitPurchaseAgreementsMember', window );">Equity Unit Purchase Agreements | ICG Note | Related Party | ICG Note | Promissory Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt conversion, converted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EquityUnitPurchaseAgreementsMember', window );">Equity Unit Purchase Agreements | ICG Note | Related Party | ICG Note | Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt conversion, converted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=alts_ThirdPartyExchangeForBrokerageServicesMember', window );">Third-Party Exchange For Brokerage Services | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable, Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_ClassOfWarrantPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Price Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_ClassOfWarrantPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_NumberOfAgreementsToBePurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Agreements To Be Purchased</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_NumberOfAgreementsToBePurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_RelatedPartyTransactionConsultingAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Consulting Agreement, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_RelatedPartyTransactionConsultingAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_SaleOfStockUnitCompositionNumberOfCommonSharesInEachUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Unit Composition, Number Of Common Shares In Each Unit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_SaleOfStockUnitCompositionNumberOfCommonSharesInEachUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_SaleOfStockUnitCompositionNumberOfWarrantsIssuedInEachUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Unit Composition, Number Of Warrants Issued In Each unit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_SaleOfStockUnitCompositionNumberOfWarrantsIssuedInEachUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_ShareholdersEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shareholders equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_ShareholdersEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_StockIssuedDuringPeriodSharesPrepaidInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Prepaid Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_StockIssuedDuringPeriodSharesPrepaidInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_StockIssuedDuringPeriodSharesWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_StockIssuedDuringPeriodSharesWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionOriginalDebtAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionOriginalDebtAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfInterestInPartnershipUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proceeds from the sale of an interest in a unit of partnership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfInterestInPartnershipUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedPerTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=alts_Alt5SigmaInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=alts_A2023EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=alts_A2023EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_NonConvertibleDebentureBigAndSmallDebentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_NonConvertibleDebentureBigAndSmallDebentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=alts_IcgNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=alts_IcgNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_IcgNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_IcgNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=alts_PromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=alts_PromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=alts_IsaacConsultingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=alts_IsaacConsultingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_A10ConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_A10ConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=alts_Mr.JonIsaacMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=alts_Mr.JonIsaacMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=alts_NorthYorkLTDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=alts_NorthYorkLTDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=alts_SeriesVConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=alts_SeriesVConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=alts_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=alts_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EquityUnitPurchaseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EquityUnitPurchaseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=alts_ThirdPartyExchangeForBrokerageServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=alts_ThirdPartyExchangeForBrokerageServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Equity Incentives (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 18, 2024</div></th>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Nov. 04, 2020</div></th>
<th class="th"><div>Nov. 03, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108,000<span></span>
</td>
<td class="nump">114,000<span></span>
</td>
<td class="nump">110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Common stock issued for consulting agreement (in shares)</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="nump">$ 14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation expense, net of estimated forfeitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Non-vested shares associated with stock option awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=alts_A2024EquityIncentivePlanMember', window );">2024 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Options authorized for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Share-based compensation, number of shares available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=alts_A2023EquityIncentivePlanMember', window );">2023 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Options authorized for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=alts_A2023EquityIncentivePlanMember', window );">2023 Plan | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Common stock issued for consulting agreement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=alts_A2023EquityIncentivePlanMember', window );">2023 Plan | Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Common stock issued for consulting agreement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">908,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=alts_Plan2016Member', window );">2016 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Options authorized for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=alts_Plan2011Member', window );">2011 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ShareholdersEquityLineItems', window );"><strong>Shareholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Share-based compensation , number of additional shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_ShareholdersEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shareholders equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_ShareholdersEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=alts_A2024EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=alts_A2024EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=alts_A2023EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=alts_A2023EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=alts_Plan2016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=alts_Plan2016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=alts_Plan2011Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=alts_Plan2011Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Stock Options Activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Options Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">114,000<span></span>
</td>
<td class="nump">110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Cancelled/expired (in shares)</a></td>
<td class="num">(6,000)<span></span>
</td>
<td class="num">(6,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">108,000<span></span>
</td>
<td class="nump">114,000<span></span>
</td>
<td class="nump">110,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable (in shares)</a></td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (in usd per share)</a></td>
<td class="nump">$ 5.68<span></span>
</td>
<td class="nump">$ 6.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Cancelled/expired (in usd per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance (in usd per share)</a></td>
<td class="nump">5.03<span></span>
</td>
<td class="nump">$ 5.68<span></span>
</td>
<td class="nump">$ 6.27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable (in usd per share)</a></td>
<td class="nump">$ 3.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_AggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options outstanding</a></td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options exercisable</a></td>
<td class="nump">$ 68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life (in years)</a></td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">6 years 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual life, exercisable (in years)</a></td>
<td class="text">5 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_AggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_AggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Exercise Price for Stock Options Outstanding and Exercisable Outstanding (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 28, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of options, outstanding (in shares)</a></td>
<td class="nump">108,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of options, exercisable (in shares)</a></td>
<td class="nump">60,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=alts_ExercisePriceRangeOneMember', window );">$5.70 to $9.90</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of options, outstanding (in shares)</a></td>
<td class="nump">42,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price, lower range limit (in usd per share) | $ / shares</a></td>
<td class="nump">$ 5.70<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of options, exercisable (in shares)</a></td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price, upper range limit (in usd per share) | $ / shares</a></td>
<td class="nump">$ 9.90<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=alts_ExercisePriceRangeTwoMember', window );">$3.54 to $5.25</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of options, outstanding (in shares)</a></td>
<td class="nump">66,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price, lower range limit (in usd per share) | $ / shares</a></td>
<td class="nump">$ 3.54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of options, exercisable (in shares)</a></td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price, upper range limit (in usd per share) | $ / shares</a></td>
<td class="nump">$ 5.25<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=alts_ExercisePriceRangeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=alts_ExercisePriceRangeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=alts_ExercisePriceRangeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=alts_ExercisePriceRangeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income taxes - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsValuationAllowance', window );">Operating loss carryforwards, valuation allowance</a></td>
<td class="nump">$ 2.9<span></span>
</td>
<td class="nump">$ 2.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">19.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">$ 11.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes - Schedule of Income Tax Provision (Benefit) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="num">$ (3,041)<span></span>
</td>
<td class="num">$ (429)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current tax expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="num">(102)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(44)<span></span>
</td>
<td class="nump">98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">334<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current tax expense</a></td>
<td class="nump">188<span></span>
</td>
<td class="nump">98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax (benefit) provision</a></td>
<td class="num">(3,229)<span></span>
</td>
<td class="nump">444<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_ProvisionBenefitOfIncomeTaxes', window );">Total (benefit) provision of income taxes</a></td>
<td class="num">(3,041)<span></span>
</td>
<td class="nump">542<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember', window );">Continuing Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="num">(3,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember', window );">Discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_ProvisionBenefitOfIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Provision (Benefit) Of Income Taxes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_ProvisionBenefitOfIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes - Schedule of Reconciliation of Income Tax Benefit (Provision) with the Federal Statutory Tax Rate (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>Reconciliation of provision for income taxes with federal statutory rate</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">U.S. statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State tax rate</a></td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign rate differential</a></td>
<td class="nump">4.40%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_EffectiveIncomeTaxRateReconciliationPermanentDifferences', window );">Permanent differences</a></td>
<td class="num">(6.70%)<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness', window );">Impact of sale of ARCA Recycling and Canada</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(4.40%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">12.90%<span></span>
</td>
<td class="num">(25.70%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">32.70%<span></span>
</td>
<td class="num">(7.30%)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_EffectiveIncomeTaxRateReconciliationPermanentDifferences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation permanent differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_EffectiveIncomeTaxRateReconciliationPermanentDifferences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.1.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to disposition of a business not qualifying as a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes - Schedule of Income (Loss) Before Provision of Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United States</a></td>
<td class="num">$ (12,825)<span></span>
</td>
<td class="num">$ (6,613)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Canada</a></td>
<td class="nump">3,539<span></span>
</td>
<td class="num">(657)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes', window );">Loss before provision of income taxes, Total</a></td>
<td class="num">$ (9,286)<span></span>
</td>
<td class="num">$ (7,270)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Continuing Operations Before Provision (Benefit) Of Income Taxes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income taxes - Schedule of Components of Net Deferred Tax Assets (Liabilities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Deferred tax assets (liabilities):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">$ 152<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Allowance for bad debts</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation', window );">Accrued compensation</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_Section174Expenses', window );">Section 174 expenses</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses', window );">Prepaid expenses</a></td>
<td class="num">(128)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss</a></td>
<td class="nump">7,586<span></span>
</td>
<td class="nump">5,360<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DeferredTaxAssetsLeaseLiability', window );">Lease liability</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credits</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Share-based compensation</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Intangibles</a></td>
<td class="num">(6,909)<span></span>
</td>
<td class="num">(3,747)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DeferredTaxLiabilitiesRightOfUseAssets', window );">Right-of-use assets</a></td>
<td class="num">(33)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DeferredTaxLiabilitiesInstallmentSale', window );">Installment sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses', window );">Unrealized losses</a></td>
<td class="nump">794<span></span>
</td>
<td class="nump">327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DeferredTaxAssetsInterest', window );">Section 163(j) interest</a></td>
<td class="nump">138<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance', window );">Total deferred tax assets (liabilities)</a></td>
<td class="nump">1,878<span></span>
</td>
<td class="nump">2,134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(2,919)<span></span>
</td>
<td class="num">(2,773)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liabilities</a></td>
<td class="num">$ (1,041)<span></span>
</td>
<td class="num">$ (639)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DeferredTaxAssetsInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DeferredTaxAssetsInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DeferredTaxAssetsLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DeferredTaxAssetsLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets liabilities gross before valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DeferredTaxLiabilitiesInstallmentSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities Installment Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DeferredTaxLiabilitiesInstallmentSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_DeferredTaxLiabilitiesRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Right-of-use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_DeferredTaxLiabilitiesRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_Section174Expenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Section 174 Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_Section174Expenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses on foreign currency transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 18, 2024</div></th>
<th class="th"><div>Jul. 01, 2024</div></th>
<th class="th"><div>Jun. 06, 2024</div></th>
<th class="th">
<div>Jun. 03, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>May 28, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 18, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 04, 2024 </div>
<div>USD ($) </div>
<div>trading_day </div>
<div>insurance_policy </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 07, 2024 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>May 24, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 28, 2024 </div>
<div>USD ($) </div>
<div>ft&#178; </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th">
<div>Aug. 28, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Impairment of carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 5,320,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsCurrentCarryingValue', window );">Guarantor obligations, current carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,049,000<span></span>
</td>
<td class="nump">309,000<span></span>
</td>
<td class="nump">3,049,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Sale of Recycling Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Impairment of carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedRentCurrentAndNoncurrent', window );">Accrued rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">258,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">258,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party | Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal outstanding balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">707,000<span></span>
</td>
<td class="nump">812,000<span></span>
</td>
<td class="nump">707,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party | Isaac Capital Group Short-Term Demand Advance | Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal outstanding balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">48,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=alts_NotesPayableWithLiveVenturesAndICGMember', window );">Notes Payable With Live Ventures and ICG | Related Party | Live Ventures and ICG Notes | Promissory Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Initial principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal outstanding balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 327,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=alts_IsaacConsultingAgreementMember', window );">Isaac Consulting Agreement | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_RelatedPartyTransactionConsultingAgreementTerm', window );">Term of consulting agreement (in years)</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares', window );">Restricted shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=alts_IsaacConsultingAgreementMember', window );">Isaac Consulting Agreement | Related Party | 10% Convertible Promissory Note | Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Initial principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=alts_IcgNoteMember', window );">ICG Note | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsCurrentCarryingValue', window );">Guarantor obligations, current carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 690,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 690,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Due to related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 706,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 706,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=alts_IcgNoteMember', window );">ICG Note | Related Party | Isaac Capital Group Short-Term Demand Advance | Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal outstanding balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term demand advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=alts_IcgNoteMember', window );">ICG Note | Record and beneficial owner | Discontinued operations | ARCA And Subsidiaries | Recycling Segment and Technology Segment | Janone | ICG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Common stock, shares outstanding, ownership (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=alts_IcgNoteMember', window );">ICG Note | Record and beneficial owner | Discontinued operations | ARCA And Subsidiaries | Revolving Credit Facility | Recycling Segment and Technology Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Availability under revolving credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=alts_IcgNoteMember', window );">ICG Note | Record and beneficial owner | Note | Discontinued operations | ARCA And Subsidiaries | Recycling Segment and Technology Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=alts_LiveVenturesIncorporatedMember', window );">Live Ventures Incorporated | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty', window );">Shared expenses with another company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 144,000<span></span>
</td>
<td class="nump">$ 203,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetRentableArea', window );">Rented office space (in sqft) | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Total rent and common area expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="nump">$ 103,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=alts_Mr.JonIsaacMember', window );">Mr. Jon Isaac | Isaac Consulting Agreement | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal outstanding balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_RelatedPartyTransactionConsultingAgreementTerm', window );">Term of consulting agreement (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_RelatedPartyTransactionConsultingAgreementNumberOfLifeInsurancePoliciesAssigned', window );">Universal life insurance policies assigned | insurance_policy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_RelatedPartyTransactionConsultingAgreementContingentlyTenderedFunds', window );">Contingently tendered funds in counsel's trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 220,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares', window );">Restricted shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_NumberOfTradingDaysBeforeBoardApproval', window );">Number of trading days prior to court approval (in days) | trading_day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice', window );">Per share value of the restricted shares issued (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=alts_Mr.JonIsaacMember', window );">Mr. Jon Isaac | Isaac Consulting Agreement | Related Party | 1st policy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashSurrenderValueOfLifeInsurance', window );">Cash surrender value of life insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=alts_Mr.JonIsaacMember', window );">Mr. Jon Isaac | Isaac Consulting Agreement | Related Party | 2nd policy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashSurrenderValueOfLifeInsurance', window );">Cash surrender value of life insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=alts_Mr.JonIsaacMember', window );">Mr. Jon Isaac | Isaac Consulting Agreement | Related Party | 10% Convertible Promissory Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_RelatedPartyTransactionConsultingAgreementTerm', window );">Term of consulting agreement (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=alts_NovalkAppsSAALLPMember', window );">Novalk Apps SAA, LLP | Short Term Advances | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term demand advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Total debentures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=alts_Mr.TonyIsaacMember', window );">Mr. Tony Isaac | Short Term Advances | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term demand advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable, Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_NumberOfTradingDaysBeforeBoardApproval">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Trading Days Before Board Approval</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_NumberOfTradingDaysBeforeBoardApproval</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_RelatedPartyTransactionConsultingAgreementContingentlyTenderedFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Consulting Agreement, Contingently Tendered Funds</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_RelatedPartyTransactionConsultingAgreementContingentlyTenderedFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Consulting Agreement, Convertible Debt, Conversion Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_RelatedPartyTransactionConsultingAgreementNumberOfLifeInsurancePoliciesAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Consulting Agreement, Number Of Life Insurance Policies Assigned</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_RelatedPartyTransactionConsultingAgreementNumberOfLifeInsurancePoliciesAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_RelatedPartyTransactionConsultingAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Consulting Agreement, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_RelatedPartyTransactionConsultingAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRentCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for contractual rent under lease arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRentCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashSurrenderValueOfLifeInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts which could be received based on the terms of the insurance contract upon surrendering life policies owned by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashSurrenderValueOfLifeInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsCurrentCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current carrying amount of the liability for the freestanding or embedded guarantor's obligations under the guarantee or each group of similar guarantees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsCurrentCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetRentableArea">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net rentable area for properties owned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetRentableArea</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_IsaacCapitalGroupShortTermDemandAdvanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_IsaacCapitalGroupShortTermDemandAdvanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=alts_NotesPayableWithLiveVenturesAndICGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=alts_NotesPayableWithLiveVenturesAndICGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_LiveVenturesAndICGNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_LiveVenturesAndICGNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=alts_PromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=alts_PromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=alts_IsaacConsultingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=alts_IsaacConsultingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_A10ConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_A10ConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=alts_IcgNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=alts_IcgNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_BeneficialOwnerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_BeneficialOwnerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_SegmentDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=alts_ARCAAndSubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=alts_ARCAAndSubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=alts_RecyclingSegmentAndTechnologySegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=alts_RecyclingSegmentAndTechnologySegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=alts_JanOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=alts_JanOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=alts_IsaacCapitalGroupLLCICGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=alts_IsaacCapitalGroupLLCICGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=alts_LiveVenturesIncorporatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=alts_LiveVenturesIncorporatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=alts_Mr.JonIsaacMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=alts_Mr.JonIsaacMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=alts_UniversalLifeInsurancePolicyPolicyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=alts_UniversalLifeInsurancePolicyPolicyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=alts_UniversalLifeInsurancePolicyPolicyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=alts_UniversalLifeInsurancePolicyPolicyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=alts_NovalkAppsSAALLPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=alts_NovalkAppsSAALLPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=alts_RelatedPartyTransactionShortTermAdvancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=alts_RelatedPartyTransactionShortTermAdvancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=alts_Mr.TonyIsaacMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=alts_Mr.TonyIsaacMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 23, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>May 28, 2024 </div>
<div>USD ($) </div>
<div>payment</div>
</th>
<th class="th">
<div>Apr. 10, 2024 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 04, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 19, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 28, 2024 </div>
<div>USD ($) </div>
<div>guarantee </div>
<div>tranche</div>
</th>
<th class="th">
<div>Dec. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 02, 2021 </div>
<div>officer</div>
</th>
<th class="th">
<div>Dec. 30, 2017 </div>
<div>landlord</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=alts_Mr.SullivanMember', window );">Mr. Sullivan | GeoTraq Inc. | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent', window );">Accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 510,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=alts_SECComplaintMember', window );">SEC Complaint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_LossContingencyNumberOfExecutiveOfficersNamedInComplaint', window );">Number of executive officers named in complaint | officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Penalty awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_LitigationSettlementAmountAwardedToOtherPartyNumberOfPeriodicPayments', window );">Number of quarterly payments | payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_LitigationSettlementAmountAwardedToOtherPartyPeriodicPayments', window );">Quarterly payment amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=alts_SkybridgeLitigationMember', window );">Skybridge Litigation | Promissory Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 147,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=alts_SkybridgeLitigationMember', window );">Skybridge Litigation | SA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded plus interest and attorney fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 433,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=alts_SkybridgeLitigationMember', window );">Skybridge Litigation | SA | Legal Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded plus interest and attorney fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=alts_SkybridgeLitigationMember', window );">Skybridge Litigation | Unaffiliated Third Party | Promissory Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Debt conversion, converted amount</a></td>
<td class="nump">$ 691,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt conversion, converted (in shares) | shares</a></td>
<td class="nump">265,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=alts_AlixpartnersLLCLitigationMember', window );">Alixpartners, LLC Litigation | Alixpartners, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Penalty awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded plus interest and attorney fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Damages sought value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 345,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_NumberOfTranches', window );">Number of tranches | tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=alts_Main270LLCLitigationMember', window );">Main / 270, LLC Litigation | Trustees Main/270, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Damages sought value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=alts_Main270LLCLitigationMember', window );">Main / 270, LLC Litigation | Trustees Main/270, LLC | Appliance Smart, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Damages sought value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,420,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=alts_WestervilleSquareLitigationMember', window );">Westerville Square Litigation | Westerville Square</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Damages sought value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Payments for legal settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=alts_OtherCommitmentsAndLitigationCasesMember', window );">Other Commitments And Litigation Cases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_OtherCommitmentsNumberOfLandlordsOriginallyPurportedToBeLiableFor', window );">Number of landlords originally purported to be covered under company's guarantee or commitment | landlord</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_OtherCommitmentsNumberOfLandlordsCompanyIsNoLongerLiableFor', window );">Number of landlords company is no longer liable for | guarantee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=alts_OtherCommitmentsAndLitigationCasesMember', window );">Other Commitments And Litigation Cases | Appliance Smart, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent', window );">Accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 130,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Amount owed by company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 767,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_alts_OperatingLeasesFutureMinimumPaymentsDue1', window );">Future lease payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 637,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_LitigationSettlementAmountAwardedToOtherPartyNumberOfPeriodicPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Amount Awarded to Other Party, Number of Periodic Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_LitigationSettlementAmountAwardedToOtherPartyNumberOfPeriodicPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_LitigationSettlementAmountAwardedToOtherPartyPeriodicPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Amount Awarded to Other Party, Periodic Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_LitigationSettlementAmountAwardedToOtherPartyPeriodicPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_LossContingencyNumberOfExecutiveOfficersNamedInComplaint">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Executive Officers Named In Complaint</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_LossContingencyNumberOfExecutiveOfficersNamedInComplaint</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_NumberOfTranches">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Tranches</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_NumberOfTranches</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_OperatingLeasesFutureMinimumPaymentsDue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Leases Future Minimum Payments Due1.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_OperatingLeasesFutureMinimumPaymentsDue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_OtherCommitmentsNumberOfLandlordsCompanyIsNoLongerLiableFor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Commitments, Number Of Landlords Company Is No Longer Liable For</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_OtherCommitmentsNumberOfLandlordsCompanyIsNoLongerLiableFor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_alts_OtherCommitmentsNumberOfLandlordsOriginallyPurportedToBeLiableFor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Commitments, Number Of Landlords Originally Purported To Be Liable For</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">alts_OtherCommitmentsNumberOfLandlordsOriginallyPurportedToBeLiableFor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>alts_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479613/805-30-35-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479668/805-30-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionOriginalDebtAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionOriginalDebtAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483359/720-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 27<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482395/460-10-55-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=alts_Mr.SullivanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=alts_Mr.SullivanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=alts_GeoTraqIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=alts_GeoTraqIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=alts_SECComplaintMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=alts_SECComplaintMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=alts_SkybridgeLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=alts_SkybridgeLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=alts_PromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=alts_PromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=alts_SkyBridgeAmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=alts_SkyBridgeAmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=alts_LegalFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=alts_LegalFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=alts_UnaffiliatedThirdPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=alts_UnaffiliatedThirdPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=alts_AlixpartnersLLCLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=alts_AlixpartnersLLCLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=alts_AlixpartnersLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=alts_AlixpartnersLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=alts_Main270LLCLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=alts_Main270LLCLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=alts_TrusteesMain270LlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=alts_TrusteesMain270LlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=alts_ApplianceSmartIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=alts_ApplianceSmartIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=alts_WestervilleSquareLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=alts_WestervilleSquareLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=alts_WestervilleSquareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=alts_WestervilleSquareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=alts_OtherCommitmentsAndLitigationCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=alts_OtherCommitmentsAndLitigationCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) per share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract', window );"><strong>Continuing Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic', window );">Net (loss) income from continuing operations, basic</a></td>
<td class="num">$ (6,245)<span></span>
</td>
<td class="num">$ (17,095)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding, diluted (in shares)</a></td>
<td class="nump">11,148,493<span></span>
</td>
<td class="nump">4,444,361<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic (loss) income per share from continuing operations (in usd per share)</a></td>
<td class="num">$ (0.56)<span></span>
</td>
<td class="num">$ (4.27)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted', window );">Net (loss) income from continuing operations, diluted</a></td>
<td class="num">$ (6,245)<span></span>
</td>
<td class="num">$ (17,095)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding, basic (in shares)</a></td>
<td class="nump">11,148,493<span></span>
</td>
<td class="nump">4,005,334<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Diluted (loss) per share from continuing operations (in usd per share)</a></td>
<td class="num">$ (0.56)<span></span>
</td>
<td class="num">$ (4.27)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicShareAbstract', window );"><strong>Discontinued Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic', window );">Net income from discontinued operations, basic</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 9,283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding, basic (in shares)</a></td>
<td class="nump">11,148,493<span></span>
</td>
<td class="nump">4,005,334<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare', window );">Basic income per share from discontinued operations (in usd per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2.32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted', window );">Net income from discontinued operations, diluted</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 9,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding, diluted (in shares)</a></td>
<td class="nump">11,148,493<span></span>
</td>
<td class="nump">4,444,361<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare', window );">Diluted income per share from discontinued operations (in usd per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2.09<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net (loss) income, basic</a></td>
<td class="num">$ (6,245)<span></span>
</td>
<td class="num">$ (7,812)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding, basic (in shares)</a></td>
<td class="nump">11,148,493<span></span>
</td>
<td class="nump">4,005,334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (loss) income per share (in usd per share)</a></td>
<td class="num">$ (0.56)<span></span>
</td>
<td class="num">$ (1.95)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net (loss) income, diluted</a></td>
<td class="num">$ (6,245)<span></span>
</td>
<td class="num">$ (7,812)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding, diluted (in shares)</a></td>
<td class="nump">11,148,493<span></span>
</td>
<td class="nump">4,444,361<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net (loss) income per share, diluted (in usd per share)</a></td>
<td class="num">$ (0.56)<span></span>
</td>
<td class="num">$ (1.95)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 17: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from continuing operations available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) from continuing operations available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from discontinued operations available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) from discontinued operations available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) per share - Narrative (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares excluded from earnings per share calculation (in shares)</a></td>
<td class="nump">9.0<span></span>
</td>
<td class="nump">3.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 28, 2024 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information - Schedule of Segment Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 12,532<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">6,294<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(7,562)<span></span>
</td>
<td class="num">(19,846)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">3,402<span></span>
</td>
<td class="nump">1,452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest (expense) income, net</a></td>
<td class="num">(879)<span></span>
</td>
<td class="nump">2,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss after provision for income taxes</a></td>
<td class="num">(9,286)<span></span>
</td>
<td class="num">(17,524)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=alts_ContinuingOperationsAndDiscontinuedOperationsMember', window );">Continuing and Discontinued Operation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">12,532<span></span>
</td>
<td class="nump">3,795<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">6,294<span></span>
</td>
<td class="num">(197)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(7,562)<span></span>
</td>
<td class="num">(9,408)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">3,402<span></span>
</td>
<td class="nump">1,548<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest (expense) income, net</a></td>
<td class="num">(879)<span></span>
</td>
<td class="nump">2,069<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss after provision for income taxes</a></td>
<td class="num">(6,245)<span></span>
</td>
<td class="num">(7,812)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=alts_FintechMember', window );">Fintech</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">12,532<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">6,294<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="nump">905<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,316<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest (expense) income, net</a></td>
<td class="num">(499)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss after provision for income taxes</a></td>
<td class="nump">469<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=alts_BiotechnologyMember', window );">Biotech</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(2,148)<span></span>
</td>
<td class="num">(1,531)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,086<span></span>
</td>
<td class="nump">1,452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest (expense) income, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss after provision for income taxes</a></td>
<td class="num">(2,086)<span></span>
</td>
<td class="num">(1,532)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember', window );">Corporate and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(6,319)<span></span>
</td>
<td class="num">(18,315)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest (expense) income, net</a></td>
<td class="num">(380)<span></span>
</td>
<td class="nump">2,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss after provision for income taxes</a></td>
<td class="num">(4,628)<span></span>
</td>
<td class="num">(15,563)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=alts_RecyclingSegmentMember', window );">Discontinue operations | Discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,795<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(197)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,438<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest (expense) income, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(181)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss after provision for income taxes</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 9,283<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income (expense) classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=alts_ContinuingOperationsAndDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=alts_ContinuingOperationsAndDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=alts_FintechMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=alts_FintechMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=alts_BiotechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=alts_BiotechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=alts_RecyclingSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=alts_RecyclingSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment information - Schedule of Balance Sheet Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 28, 2024</div></th>
<th class="th"><div>Dec. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">$ 82,436<span></span>
</td>
<td class="nump">$ 18,487<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=alts_ContinuingOperationsAndDiscontinuedOperationsMember', window );">Continuing and Discontinued Operation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">82,436<span></span>
</td>
<td class="nump">18,487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Total goodwill and other intangible Assets</a></td>
<td class="nump">46,144<span></span>
</td>
<td class="nump">17,846<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=alts_FintechMember', window );">Fintech</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">64,217<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Total goodwill and other intangible Assets</a></td>
<td class="nump">30,385<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=alts_BiotechnologyMember', window );">Biotech</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">16,926<span></span>
</td>
<td class="nump">17,846<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Total goodwill and other intangible Assets</a></td>
<td class="nump">15,755<span></span>
</td>
<td class="nump">17,846<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember', window );">Corporate and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">1,293<span></span>
</td>
<td class="nump">641<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Total goodwill and other intangible Assets</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=alts_RecyclingSegmentMember', window );">Discontinue operations | Discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Total goodwill and other intangible Assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after impairment and amortization, of goodwill, indefinite-lived, and finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=alts_ContinuingOperationsAndDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=alts_ContinuingOperationsAndDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=alts_FintechMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=alts_FintechMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=alts_BiotechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=alts_BiotechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=alts_RecyclingSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=alts_RecyclingSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>150
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( #V%?%I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( #V%?%I];,=,\P   "L"   1
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MS,1J)[A<%'*Y>!]=?_C=A%UG[-[^,^/5-^.K8%W!K[NH/P%02P,$%     @
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M3@H\W/[O#;#"Q([A[8N_ 5!+ P04    "  ]A7Q:^\SL;RX'  !>+@  &
M 'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;+6:;7.B2!2%_TJ7.[4U4Q4C-&IT
M-K'*F&0W.TDF&S.9FIW:#RUTE K0;M/DY=_O!50DU5QAJYT/HR#W2#^AVW/@
M'K\(^10O.%?D-0RB^*2U4&KYN=.)W04/67PHECR"3QZ%#)F"33GOQ$O)F9<5
MA4&'6E:_$S(_:HV.LWVW<G0L$A7X$;^5)$["D,FW4QZ(EY.6W5KON//G"Y7N
MZ(R.EVS.IUQ]6]Y*V.IL5#P_Y%'LBXA(_GC2&MN?SYRCM" [XL'G+_'6>Y(.
M92;$4[IQZ9VTK/2,>,!=E4HP>'GF$QX$J1*<Q[\KT=;F.]/"[?=K]8ML\#"8
M&8OY1 3??4\M3EJ#%O'X(TL"=2=>_N"K ?52/5<$<?8_><F/[3DMXB:Q$N&J
M&,X@]*/\E;VN0&P5.'9% 5T5T'<%=K>BP%D5.'4+NJN";D8F'TK&X8PI-CJ6
MXH7(]&A02]]D,+-J&+X?I7_WJ9+PJ0]U:C01SUR2-ODV/2,?/WPB'X@?D6L_
M"."/$A]W%'Q%>F#'7<F=YG*T0LZFY%I$:A&3\\CC7EF@ ^>V.4&Z/L%3BBJ>
M<?>0T,$!H1;M:DYH@I=?,PGEO:R\IRD_P\O_3()#8MFZ;R^-QMG@=C(]!\7]
M<SR+E81+_A\=X5RAJU=(UX'/\9*Y_*0%$SWF\IFW1K_^8O>MWW1T3(J=&1(K
MD>MNR'4Q]=&9<!-8;Q2Y?UMR'3:\W+;:7W1\T*JF? R)E?CT-GQZ]?B,HRAA
M ;GC2R&5#A2NHV2BPSM!JYJ",B16 M7?@.JC YPD4J:<+OS8!4X_.)/I8D5@
M^=1>5[A:NVW3-AWHB*&%38D9$BL1.]H0.ZIW:=URZ0L/I;5#:;V85Z[F:'U3
M:(;$2M &&VB#FNN59."2,I-3/2=QK4<6Q-I)B98UI65(K$1KN*$U1$=X'BE?
MO<&<##BY2<(9ESI*N(9E66U[V*>VCA1:VI24(;$2*=LJ')M5A]4=G_NIBX!+
M[(:%VLFX0VA\==\C4W\>,C(1$BY-EEZE.GJX4%-\IM3*_+8<KUV'WV7D%H,^
M(%,%*QH1$E DD9)O\.KIH>+J-P]:@&A18X"&U,H :0&0U@%XSU[)I0=+G/_H
MNQE%9.KND.S:;;O;Z_:&VLF+%S>F9TBM3*]( #9JD]?TQIX'ZO'!^@VY@N/(
MUTA_S>&2#NV1\T/RG<F03)?2C^8QN1/,T[(TF@A,J959%IG QEW]>Y:3= OF
M\+UXT:UCISODKEA,'OB<Z8+O!*]M#&X?6<$NPH*-N_SWX#:KWZT4SW[DZJ]"
M7+-BY3,:'$RIE;$5T<'&W?Y[;+<B5I A_O:7U3\7N.)@:-M#+3>C\<&46IE;
M$2!LW/=G\W(L.:O&A L<650+R6A<,*56AE0$!AMW^5<BS:.W"Q%A'GB'R'!X
MU.X-^]I BI<VIK6/O& 7@<'&W?Z]KR KB$=BTX^S3V3*W43"5:9%ABM-1!B"
M=YDJX3X=D _6H6799,DD>6:!_EX(+M@8Y#[B!"WB!,53 .13#QP#F;Z%,Q'H
M^.T0@!@QU=Z8-1H:3*F5*16A@>*V?GU]D?-7=\&B.:\,73N$;L;3L_%?6EY&
M,X(IM3*O(B/06AGA.P^"]E,$=@QF*(MA:?/(91PG^K5MA^:-T&(S&@Y,J96Q
M%>& U@H'#R* $,ID?D=$:A_$[%"J@&74_9M2*\,JW#^MY?[7-W3SNVO94@9N
M-M%#PQ5_<*WUQZL:4]N']:>%]:>UK/]EI+C,G[JF-W/9&J.6&JY81<VH\S>E
M5J96.']:R_EGTY%,("S-A=2:C1TZ-R)J,]?E( ,B7BZHI6?4_YM2*],K_#_%
M[?N*WC1D04!.DQ@^CO7S$]>I>CB%ES6&M8\<0(L<0'$+OX)U'G(Y3U>SWT%!
M+2 YA4L6Z:^Y__GX *]KC&T?@8 6@8#B-OYR<G%'QHGG*R')6"D.T3R[*7D1
ML+F6&JY73<VH^S>E5FY'*-R_@YOWS6.J"S]BD>M# LWN!67[SJ7,;HC##T/>
MI?,S9:EO6L"_IA(F7M>X06$?(<$I0H)3Z\G"= &N%YNO.V2J81E-"*;4RK"*
MA.#42@BWR2SP79BD@FF]!Z[2N!W&:%A8J?4RM;3#[GE$^X='QYUG'9FM'J%:
M(:!\7V*Z8'!&Y&NB8%V+TL2NI66V>2A7ZV^-#PX]&O2[Q1A7)/:1!)PB"3BX
M;Q_#<N7ERUC%8K]#H'K*&;7^IM3*F KK[]2R_A, )6&AOXP\_DJ^</T:A4M9
M\&_0IX.^]H$=7MR8VCZLOU-8?P>W[%L_D47'T 7LU#K8'6)5?2]X66-B^[#[
M3F'WG9H-0RMBJ[ZA:F:XW,4/+3&CGM^46DZLL]60F]KXK+$Y)F[:6I#WYF[V
M;IJGQUG+<*<X/.^\OF9I"HA)P!^AU#H\@LD@\V;F?$.)9=;>.Q-*B3![N^#,
MXS(] #Y_%$*M-](OV+24C_X#4$L#!!0    ( #V%?%I<#"%H-@(  *H%   8
M    >&PO=V]R:W-H965T<R]S:&5E=#(N>&ULC93;CML@$(9?!5&I5U'L.(=F
M4]M2#ETETFX5[?9P4?6"V!,;K0$7\#K[]@7LN*F46'MC&)CY^08S$]9"OJ@<
M0*,3*[B*<*YUN? \E>3 B!J*$KC9.0K)B#:FS#Q52B"I"V*%%_C^S&.$<AR'
M;FTOXU!4NJ <]A*IBC$BWU90B#K"(WQ>>*)9KNV"%X<ER> 9]/=R+XWE=2HI
M9< 5%1Q).$9X.5JL9M;?.?R@4*N+.;*9'(1XL<8NC;!O@:" 1%L%8H976$-1
M6"&#\:?5Q-V1-O!R?E:_=[F;7 Y$P5H4/VFJ\PC/,4KA2*I"/XEZ"VT^4ZN7
MB$*Y+ZH;W]$=1DFEM&!ML"%@E#<C.;7W<!DPOQ$0M &!XVX.<I0;HDD<2E$C
M:;V-FIVX5%VT@:/<_I1G+<TN-7$Z7E8IU6C'F]]K[BGTM)&UFU[22JP:B>"&
MQ"A CX+K7*$O/(7T?P'/\'10P1EJ%?0J;B 9HF ^0($?3'KTQEV28Z<W[DM2
M2/1K>5!:FH?P^UJ6C<;DNH8MCH4J20(1-J]?@7P%''_\,)KYGWL()QWAI$^]
M([RGDJ'=YAI>O\!L/KGKX9AV'--W<7PE#*Y!]$=OJS0S]8K6^^4 [1\>UCU$
MLXYH]BZB!Y'<?)_]"EMARX@/T#<X$74-R;NH'P8R<UU"H4147#>EU*UVC6C9
MU-\_]Z:+/1*947,%!1Q-J#_\9&Y,-IVA,;0H734>A#:U[::Y::8@K8/9/PJA
MSX8]H&O/\5]02P,$%     @ /85\6LAZ$E]+"0  FC@  !@   !X;"]W;W)K
M<VAE971S+W-H965T,RYX;6S%6VUSF[@6_BL:;V=?9IP:20AP;^(9U\F]VYF^
M9.OLWL_$5F*F@+P@DJ:_?B5,+(->L#?L]D,;&Q\=GB/IZ'ET!.>/K/A2;BCE
MX&N6YN7%:,/Y]LUD4JXV-(O+UVQ+<_'+'2NRF(NOQ?VDW!8T7M>-LG2"/"^8
M9'&2CV;G];7K8G;.*IXF.;TN0%EE65P\O:4I>[P8P='SA<_)_8;+"Y/9^3:^
MITO*?]]>%^+;9.]EG60T+Q.6@X+>78SF\,TB\&6#VN*/A#Z6!Y^!#.66L2_R
MR[OUQ<B3B&A*5URZB,6?![J@:2H]"1Q_-DY'^WO*AH>?G[W_MPY>!',;EW3!
MTO\G:[ZY&$4CL*9W<97RS^SQ5]H$1*2_%4O+^G_PV-AZ(["J2LZRIK% D"7Y
M[F_\M>F(@P;0MS1 30-T; /<-,!UH#MD=5B7,8]GYP5[!(6T%M[DA[IOZM8B
MFB27P[CDA?@U$>WX;/'IX_+3^W>7\YNK2_!V_G[^<7$%EK]>7=TLP1GX?7D)
M?G[U"W@%DAS<;%A5QOFZ/)]P<6?9?K)J[O)V=Q=DN<LE7;T&*!H#Y"'?T'QQ
M1'/LU<UQN_E$Q+L/&NV#1K4_;/$W+TO*C6'LVOGF=C*EWI3;>$4O1B)G2EH\
MT-'LQQ]@X/W'%-1 SEHAXGV(V.5]MHC+#1"#!5;R _VS2A[BE.;FJ'>NPMJ5
MS/N'60C#\'SR<!B-;D3V%BV(_AZB[X1X4\1K6F-D?$,+L2BLJ$!YF])R#'+*
M34AW'H,#$(A@KX/48!0$9JQDCY4XL5XF]PF/4Q#7,^< J@DDT>^/PS#HH-2M
M/#/&8(\Q<&*\+N@V3M: ?A5K?$G+@ZY=544A!K^!;\(<:&@@@5$'LFX46N9
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MT?PMMGR!Q;OL1;#'F+$XS+YNB;<A- W@OS_%,7M92-\M*]\EG/\/4$L#!!0
M   ( #V%?%K6AC%32@8  "D<   8    >&PO=V]R:W-H965T<R]S:&5E=#4N
M>&ULK5G;;N)($/V5%CM:9:0$W.T;9 D2@<Q.I"1$(3/SL-H'!S=@C2^LNR'9
M_?HM7["-^Y(P(@_!-E7E<[JKZU33P]<D_<G6E'+T%H4QN^JL.=]<]GILL::1
MQ[K)AL;PS3))(X_#;;KJL4U*/3]WBL(>,0RG%WE!W!D-\V>/Z6B8;'D8Q/0Q
M16P;15[Z[S4-D]>K#N[L'SP%JS7/'O1&PXVWHG/*OVT>4[CK55'\(*(Q"Y(8
MI71YU1GCRXEI90ZYQ?> OK+&-<JHO"3)S^SFUK_J&!DB&M(%ST)X\+&C$QJ&
M623 \4\9M%.],W-L7N^C?\G) YD7C]%)$OX(?+Z^ZO0[R*=+;QORI^3U*RT)
MV5F\11*R_#]Z+6V-#EIL&4^BTAD01$%<?'IOY4 T'+"C<""E VD[6 H'LW0P
M<Z(%LIS6U./>:)@FKRC-K"%:=I&/3>X-;((XF\8Y3^'; /SX:#)[F,_N;J?C
MYYLIFC_#Q_W-P_,<S;Z@V>/-T_CY%@S0^&&*)K/[QZ>;KS</\]OO-^AN-I^C
M"_1M/D5GGSZC3RB(T?,ZV3(O]MFPQP%:]H+>HH1Q7< @"AB8H/LDYFN&;F*?
M^H<!>L"I(D;VQ*Z)-N*4+KJ(],\1,8@E 33Y@+MIY.ZF!HY9C;.9QS,5\6[C
M11)1-.<>I[ *./IK_,)X"EG\MVRTBF"6/%BVM"_9QEO0JPZL74;3'>V,?O\-
M.\8?,J8G"G; VZIX6[KHHR>ZH_&62E.B\'1SSZS<[" -;),,>[LF>M'*J"P.
M(-D5)%L+:9(PCI(E%"$UM"*"TWBI0\Q^"YEHI$#F5,@<+;(_TX0QM$F39<!E
MJ!P)JH'50B4:*5"Y%2I7F[JS#4T]'L0K1-] /1AEES)P[BE3]D3!#OCV*[Y]
M[2S,05. [3E:T1B8APA*&O)\*+Y!MF(SV:E&0C80?6$"L-FWG=8TB5:6:SGR
MF1I4R =:Y+?1Q@O2O+PLUEZZDN,;:!*DP"9:8!L;BC3"1BTUAA;><\)A-!,A
MG:1R87QH%&5F@[YJ''%#%;$6:IWS(2Q)*4 LO/G"M9UV]9*9Z1"2&B'1KTJ^
MIBFH;B8KTO58^I]H09XJVB';6CVQ5J1 /CF%N!R=E4GSN:1^CF(JK95EP(.!
M[[N#]O2(5H38JDRO10^_IWI>&/Q'?;2"1AI!MTK?8$'&*XJ@@,3,RUM8>5I9
M B#3;9=XB9$*<BV*6*^*W^)T#SI+^0PT]/4_*?=>0HH876S3@ >*Q2HJX04V
M[+9>RLP&1+42:M'$>M5LK@1U.HBR>($=W$8H6@T&?07 6C^Q5J[V=2^'^?'\
M=26 72*D@FA&3$(4D&L)Q'H-O,M2X(7"-I'"1TRA(4'+-(E*U(A[;XI4$'4-
MYK@OU&V)&7;M!KU#X+4"XG<DL,*WQRU%*2K<A6E80CI(S"PRD&,DM0X2O0X^
MP.X\7V/YB"Y@WQ/$VTQK2FE4E 8B:MV%0RR[!5IFAEUC8"M@UYI(])I8#FT.
MV@]8B1OJQ3NP105L]QL2$VP06Y$,I-9(HE6E9C) 4[T+\M\>(*>/@D_>AR^:
M#%RL %]+'M%+7I8EP2\.N:AJ F;1!):IJ0!="Q_1"]\^M:6HQ)V<-'\E9FX?
M*TH:J06.V-J&Z2RK:?NRBV#\$(,>6=X[$:U6'ML[G2K:(?%:'XE>'ZMR4W'6
M%)[S[$>Q8('.H&_9,K_V^2P=I^+-@^9<&5W;,9I_[:HJ<[*ZQ%5,<"VS1"^S
M1_+T@W#+82E]D&GQ[FR_<0Q5F9>&:ZW/1*_/C>+08JLH$T?.JRC/0@'IB]1(
MUU0MTUK B5[ ?X'9D3/Y_OZW-&EQ,Q3";];";WY0^"N$QTU+&?[())1ZX:ZJ
M(3#KAL#4-P0R.L?-1?F"X^J'S$E#I^X63/V.^D?^DS]@]W:06[!7@R2,H&'(
MX<.&:,L9]V(?ZHA4,\R3[K=/%>UP+!J_5NN;C^LJ*POV\MD3>PB,L=6W!F9[
MRD1+RS!LTU2T>&;=<)CZAF/:R#<=5'''K((J6EKP9SKMAJ[7.'2):+K*SZ(8
M),TVYL4Q1?6T..^ZQI>3_%BH]7R,+\?YZ4^O#E,<HMU[Z2J(&0KI$D(:71<:
MB;0XERIN>++)CW9>$LZ3*+]<4\^G:68 WR^3A.]OLA=4IX.C_P%02P,$%
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M;\#E-VF\RUXB>X[3--YFEQM*EC01 OS[51RGAQOQ \?W$(?_ U!+ P04
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MBM0S$;'0(;#Z3T)7CL<HERV04I>M9S==(TS4S('_L\.C[R:/M( A>^=;@C+
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MSOL2$[5_8[\E$I PVY6)87$5B. /B.A2G8%  4[4?),-$&C.%O0+1K;P;IY
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M30,J1X' (#CMR-X:3$)]H9LP'HA-(^V.*1#GX:U,2=P"%Z"$28-)UPO287U
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MN!$H516=U\NN+NC:<%^"*A<4H ,>M6*62)BW!%%N)#X "-<)S?JG)GM*M#:
M%'H!NVMJMKRE\FL^$+C1J@G9*I";[A$RP5AH?$MDFC M_? 1KUS49B4(%AT<
MK^O-WU;M:.&$GKA.9Y)(&^6\L&;*%J)4SK%L9*)\#,H,D&,0?R,@?@U5."5.
M#6$JU!:TOV-N9?('.UJJSB=-Y>T0^Q;:U>["4Z]S^@MVV1%A*XL=7USI!9P(
M&*7JLJM9/"CZ UJ-^!:(3>'$5-TH4S-\)#.\450 YPA" 1:R+!Y>IE:.+%[F
MX?[YC^?S\V<O/>@ J2""\S&@/N1/E&\"9H*(OOB]LP0-Q.:K9@$B%W,+@#)
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M'&JPE6!W?*==:61&ZY8'QBG"#EHT&9 O(1/[-MPP0+8:?#/35R0]8IJ"C>4
MM8-3TXU\?(1#7-DRKU,=91&5-*F7M]^7Y(!L%W@?@]NKX_ /[^0V,5AW&C 6
M_:>>SW5(VS^GR+)/5.?/,TTZ7'B8+F=O'X1MF6./]<RX:V,KI!F<J82C4W0K
MQ!_9&S8-*KDDP8H*P?N%WVR_=2LE(5"X*]5$<U/.,ZR*2U"A0L%O()0<ZJ1W
ML1 -!,L5FQI[(ZY]+&=:'EF5G%BPDPGY (1L'*NA^#]10NG')^<7CU@H2DT]
MB"A 5S0I!L91(RT'E(:J*%P( QKI/3W5<B6.8[F?$/14BE'_:)H&[KA5T_1^
M8R@OXP@IK$J:^8.NN.WU3B8^J++1.;;15]91U,^ =5LR70_F3V:3V6R&^+EE
M+P@52H"08R8#2>F5G$GN.5S&DXD\35)*!O6!HH-J\*ZFLXVEH$\X_@'HP ')
M'$TJS/45F&SG-6DX>\RWEKS;PUBNN;Q^&^3WD80CU?BV+UMVI@]/+J^_G#SB
MZTYGSR8C6O0PZ=JC%\6'#876_:N-GWN9B3NS>I4<'P\_>41%IO0Q:>6$'#.)
M-$>='0.&AZ',4PU*0S(PF>?M4233FTFI4M$/T^_WW:]^?O=Q,)/)D5=HDN:Q
MNX 4KT!8N$G#Q/$ET/XUPI"3\G1!V(&+.29U/(8U1)_:"FRTR7QSR0IX@LN2
MCB[T"N+,P>.2 NTT8'7^)%9M4XID-NE]U6 T_M11CV-[,U4:6F?30(JJQ&-P
M"$1OC8;/G#F2'6G;_82.,.M?7V!'*2$KFUY\N^J,Q$16DK%O>V<S9G^9/' _
MII\]ZW4&:I#$'S3_R4X#W9]/LO%MSZ9X_O)?UE:<HM U/*P>OKARNRUD)DQ,
M/KSN%BTKP\63V>E3TH=,M[C3-JC7BFW+3H@)A6ZJ]'K0'GAAJK:5WB\ENJ)Q
M>74[WA:3Q5+NZ/O]PDKI5&3)5!10>2%UN&LX3[@W<AAB0>E7<XF"0<\V#--:
M&MDP(8O>PYB;.CE.II&?K)"&;Z^G\D:9=5'G$R;]#%B& +\]Q9'* /VL0GQH
M.>*6OB5.$\G<S8UQ4S8^$M"^]U7@?5R=WE-Q:H$P%K$\]V<558P/+3FB^<+;
M_-C_=-T4P?]^,BRQ!J_S[/&8U^E7'O4VWP^]S?>]>4M^134-,3QW+^0 7)48
M3,Z )+NA(93!,&-?3^):0";$PUO_FI%_/$GY_R)8XIB\;C,3;=V>S0ZA\W^B
MP1[[?8VS['=1-MJM^-=?O(R<R4^DI*?I!V8NY7=5^N7RZS0?E5M1P%CK);;.
MIL^>G,C@0?P ^\V_LK*P;6LW_.=:*\1NM #?+RWBU/"!+D@_N_/F_P%02P,$
M%     @ /85\6GVCR1@M#@  '"<  !D   !X;"]W;W)K<VAE971S+W-H965T
M,3 N>&ULK5II<^,V$OTK**\W:U?1LDA)ECU7E8])95*9B1-/DMK:V@\0"4G(
M4(0&("U[?OV^;A 42<G.))LO-@^@T>?K@WJU,?:36RI5BH=57KC7!\NR7+\X
M/77I4JVD&YBU*O!F;NQ*EKBUBU.WMDIFO&F5GR;#X=GI2NKBX,TK?G9KW[PR
M59GK0MU:X:K52MK'*Y6;S>N#^" \^%DOEB4].'WS:BT7ZDZ5OZQO+>Y.&RJ9
M7JG":5,(J^:O#R[C%U=C6L\+?M5JXUK7@B29&?.);MYEKP^&Q)#*55H2!8E_
M]^I:Y3D1 AN?:YH'S9&TL7T=J'_+LD.6F73JVN2_Z:Q<OCXX/Q"9FLLJ+W\V
MF^]4+<^$Z*4F=_Q7;.JUPP.15JXTJWHS.%CIPO^7#[4>OF9#4F](F&]_$'-Y
M(TOYYI4U&V%I-:C1!8O*N\&<+L@H=Z7%6XU]Y9OWRBZ4=4(6F;A,/U?::=*6
M>W5:@CJM.4UK2E>>4O($I3@1[TU1+IUX6V0JZQ(X!5L-;TG@[2IYEN*-2@<B
M.8]$,DS&S] ;-;*.F-[H"7I7E<,3Y\2U6<UT(4G02%PZ!]]OR1ZQ,KXWNBC%
MKZHH*ZN$]P!RH_]<SEQIX4S_W:<BS\!X/P,48"_<6J;J]0$BR"E[KP[>?/./
M^&SX\AGQQHUXX^>H_RE3_C5*XB>3J4+\6(@/YEZM9LJ*VCJ1*)>*]+J6Q2-"
M#7NLRO@A[7D0U_9Q79JTLE85Z:-X^Y N9;%0XL[,RXV$AM>Y+ EC^%"#C18Q
MCV>@(LE"3LRM6=4<?%3ILC"Y66CE(O'##]>PF5A;<Z\S[#-S488%C\*9O/+<
M@SQS-,M-^@GGZT+H(D.,V<>!^(@7Z\KBL<.%U:D2&^G$83)($'=YSHZ1@HQV
MI2X6= C>#;?O0'PZC:-A/!1N"8G &#&R5<LW_SA/XNE+)^Z4!=_B)[PH[I4M
M]2Q7XA9HI"PI[0YZ^L1J.!QN#P>K(I5NZ3G=2\)O)*[O95Z1XDKB<7(Q%FNH
MA;D2H$0\9="LT,YAF?=W[0#,L]\!EJ(TT.8*#V5I[*-@8#M)9:[PQ)Y\KJ0M
M02Y7\M,)8#["OG0)HCBM,&)E< AN<,Q&Y??J!'1.3*%.EC*?$Q\I0BIHQBL*
M9SV*F2+MDBQ@'*%GPLLGE)B:U0JR.):9X%T@*G5.IJDYS!\)KR$7?-62?T!G
M)F-Z&R,>E;3.BTYJ:<E^K[R%V9\H^3BO\WW6(+6MY:,D];,[I58A997,]F$\
MC(;#(2M_1=#('IB,_8V+6 :$ [N3-\M<6U?".(]![+ O1_:D=6EN &(+SY'<
MQB:;/5,0&TF"(L^01F$%#I[.2F)"IJFI"B]F9=?&*0AY^</'"07W>QP?CY\-
M; T)>?E=-7,ZT\CGD=@L=<H:D9"CH! D"7DC>T<=H$X4ZJ$4"U4HZS%U&Y G
M:[-1C!RM""=A5,$ZAE_J1;V+W;1 WE_D9B9S.E-"F;A:2RLSO5@-=GDLE]94
MBR4+ .]:*ZX*R/Q^B?9Q.R?X(S>ANJ;!)N:$=OK$C#4O!#ED,GS)!]U*]L\D
M?LE^U7EE4<H,PMNPVBLK96P\:< 1#D4^)!:(T8VLE><50$PO@$"L(_;=-6D5
M-[42P!0A:\FLPLIJ7?*ZE?RDGCK($7:19+ 9*5>QS1L> SL-0G-T8HFV='RN
M4V\/$$&MZ(WC!.7:!1-:Y]4"2MQH./)OQER3TP,%/-!;T=:<C^RE2C\!6*@2
M6A#P<QJZ?0</?=](MY3WGDVS#LY0PP==SC4TUHAY],N=N$$$<<!?RP*^@<!H
MGKRMK*F1X,HB1!#5MPB.#$!-* (QCH6L8&](!A0$K'AU694J[;F )H*6("E<
M3Y>PA<];<$+G$T<6_!W$E4]%LEUVM"/-0[.(H^G%110/ARTT9 =LHY^W!@!Y
M(2&M L7R42Q-GI$3USB2RC7S5./EO!\9!"A @7",55R@%)Q^R<4>-,17D#V^
M&%S\LP?*_W)T5YS43+-AJ]*5N" GV++>9GL@WDH@1#<3[-!%?.>/@7!'ZEZ>
M&P\(LCP$T2LB\T&Z3'X6WR%@C"7;B0\_7M\2UGY<5A;O  @$=A=MK"/PU7!1
MJ(4%1BW@[=VD34);/H<MN+"*(9]/50\JK: TC\\-;.;.!(N.QE$RG/;,Z:4$
M-.I%P25/G=^O=LJ"(SJS!I9F$;^JL>7XK[O#0+PKR%.+NF/BB.75/NF$S>UD
MLNM)O8S1%AV2]QWY*<G??XWD[_=(OJ%<48(YRAL$G"C5N8:D_, J"&4@ZH7"
M21;5FVLN$<?L4D'27D%(V0RE#".F[V]!> ;X]:5B?+:M!T4&*H1$6YHR^QUI
MPP-NX&&KC*XQ.8:Z4D;"9W@4.3AV1NVT. +:'*+$"-AY_((4OXV10S&-QN/S
M+?%UHU2_X#R:3!+QT9 O](0]%/$9ER^_-&B%W;E&?0$K]U<#%TTJ=W$,(&D6
MA?Y"&<J8; /MD+1=3#F,X\%T6TDW=00B-JU"#\!DU4-*#1PHS$QPS@ZTJKJQ
M\"B4:SE#3<C. #2N5IX25R765TGE7L.#()P(:82+#M]_A.+'.PLO9ZKPW"VI
MWMJGN4#-2=.$K*[\P "5G:00%J_M-_<P><T(O>+R;!@@2W;4-'NDFH\<?8UJ
MG5"I7&J;G4!<@ "J2]1$5RJ5E5/]&& ?#LHD#FL7:0S-/BL?FH(Q0KE?-!IK
MK(L:BL&"V[4^7/ *%*:9RJK4=RU]L@-Q4]E0.Q#WI4+'MU'J$^"5)@OPYG7I
MN\]D;_M)/F<S%@$<<IF^-PR;!A.VRT)<$"L=@S7M:.=I4P@7=19 &J!Z3<@5
M%=9[?'PZN.B[.&F\819,!!UZ#RO9YC[0:[AQ^U!I&WH[L#4/]=46GAM';238
M=?5HO\L6K1C>@SS/H\BE[SBV[5)R-J6'EC)#^[AI='YV)FXZ-52S"<2F9R-Q
MHV8E%I[%H_K4??R.DF@RO*@7=%%B?,ZOKLDU)M'Y9+1ESU=UGL/H(I[V.6F]
MOXB&YPER)NJ<A6X!Q77='7C_HFIXJ=>.5#&*+I*)^(CN1(E"KL!L$IU-)Y#G
M'F9>M_L>Q#@8&Y+E2I9 [YP3GT=CK/B1O7-\$731AZ 1='8QJ5\V!@0W*"[C
M,?*LX=DN!)DW4ZZ^_]75H!-^G@JJZ[!-M[:%M!8B,=QSLUU'[PT4V E>=JSF
MZ<@CVRCR=O1 (,L=)%E*Q&7*-3YCZ/>RJ,B]8[_=EPLS-$M%T2I=^E,$7CK7
MCFI#8O(X(@=VE2RXC[B\NQ;GP\E)/#R!HG=\GN*4!@#[5)$9:G1-Z7'-MR5-
M58WX;T0J*YR-QU7NIP:M'JK+M-B8*L]\YS,C3"05[-1C+96PWJAB):2VGB/=
M80CL9#KUG.QG@2PXKW@&ZN<GP.=OO;[^#7WY62]U.#\K(DK7K3*G\2T/0FC)
M):2AX[V2CN+C'7PZ2HX[-(Y&Q[7O?E $V?>JJ!A7$-ZC!!<4IN?T8,+A0*MT
M@11/BX[.HF0\.:9"**;;.!J-1W1[-(TF\?08/8@E_W \I*%Q4=IT&3PNP\KA
M8')V["_B>.^.3.=4]#^YY6]4V'B/PB9?IS!VV^0E%X7Q>-+\[RH,\!LGQ/LH
M&DTNZ$F"5>?'7IEGP_T:Z.LL'ERPUG%Q-ODZG?6V;%UC1PEM5'D*5*B72?.*
MIDU]?7%APD74I :@,!3:0X6]<1^!+6 %Q E4^B'I>\9Y9ZPV8"O]K.:$IFZG
M-4 184O])92TJ.4<DT"5H@M=JI-<W_LQ:2\E(/-Z;/ 4J2)L%9F= KY=$NW"
M*S$]&+3\[4]9(8#XP#MG7W]?M?/. &YOX1TKF:J*1R].O)W/ZXE=P/MDWZ R
M$I<KDWL21W7/>&,]S= M^HD/+T&VLW+-A[CP-6&#CAF=J=E0<>^VS/<PF3%V
MHQB+FXSK':0^+Z)^5-DPU::1+ R=<0':Z6F)D\OPJM_-4P&/XJ9./>*RF3J0
M$+>YY-K/?[>I>:)N,;1.>-?W[63/X8%H.'P@?J,1 />,JDA58*:[.FHSV%W2
M",I3DFR;R0]'K58Y;7W#H(8DQ8*C[32\UCC"2R$(+,JQPA=TV,3?ANL]KC57
MZW)X7*?.F6H*2; 9#-3,\N'82Z^^H@EFRN^MH\!+=U)5=]9WSW[+V=%TLV!K
M9M(,%:FE+AD7=UO;IZ2#E2 /Q5'XY.;U=HCDT^B8?8Y>U_IE@</,LJ>,]Q(E
M/ ?52S^D0(M"H^:O)!'50Y^Z,VKZH38_D??/BH=IWU=YJ-O&?G(>6K\_<^CN
M><G@?.]Y?>@>=UI.WSBG3:0'#OCDP(:OA:*MVMH.CO?>WZC\"U-I @M0)']J
M#7TZSC 0EW/ZLL9P<M^S:3 ":^>/-..ZJNDYL:4/>JT95)_RLS'&S8-5_%VD
M';A;[VRV;S^@-='2<=S&U*$/OR9B<_J>H#QD^:E@.]OT-?9N3NK*#.O:*^S_
M5M=&=<R)6Q::9R5SQ;/@I?:SC14[$O5W_/4$9BVWAMV35L#.<@^YRO6G@1TQ
M6?H4?*O<-Y0=AWVN#&)A&C^BW-,,*O@#Y<1_H6P# /&8>>K?JIGU27:83'9)
M91G7"K#TX<@3>G*"W$T'.^.:G,9H<UV[^A\EAZAQ,>#&]A- ;]Z2;$>*%/2F
MHLHS)R4*_KE,Y-/T2GWY(E&<JC IIR])_.6H;$\5O.UV68V'?P>OYRTB^WFE
M9DVA%*+I<\TI?UC:D]GK4JC]!280@Q%VY/7!UR3NPWCZ!ZGY:P0:;8==@WT_
M;3EM_6)I154+_2Z+0 K8[7^\U#QM?OIUZ7_QM%WN?S>&; 5VG,C5'%N'@^GD
MP"-<N"G-FG__-#-E:59\N502;DP+\'YN3!ENZ(#F!W%O_@=02P,$%     @
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MX^'QX2!5>OT2;!,ONPL;<'6.CR7^J[ 3 _Q>6%QSNA?9H/_W<_$?4$L#!!0
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M; ^3K?GY^V"GDP@['4$9&.+!@UTYX<@9^)CGKJ5B2X]8F[0,F_K:2PSPP]?
M07^>1( AF;2H>LEM'0Y+O?+*K]4A!MUPMK?TD*,"1<AUR_Z%2J+RN3XX(P(E
MQ<?R?J<6"XHA*=$IK/-#I$(LI>>2FT<HWIP.6=H6*@;&MR8]L:)L=8EJC_FS
M<ZT6,BH0GG!)K:*!#X2B1=!=]Z@/2_0 6T'I.<%QB@LB@558H98Y:N"?![_
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MZ# "TW;@[8?3=>AZ)]I1#QU>2_K1@L8OH/FIIF0N/_P&W<^@\3]02P,$%
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MONI?,S#-KF@.3M=A/I?:T;0'L:3UBL8;T'VAM=L=?(!V8:=_ %!+ P04
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MIR.6*H@Y78N,0="S>BG@_QRB%RD=R(+M#X?#G_YQFL339_KPZ1:RFR2OBEH
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M8Z(+ [R$9%)010$;9+/1,<XZEQ58<4OA9Y9PG5]P$%+-EN2W/QHG/6XP-T
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M_:C4JMTA<HW]OZ5OXKIM(,.]M<CL_2+?RI#8A70G%*IUFQ"J XH$7,[SL(
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M ._G"M#/_L %_.>.+_\#4$L#!!0    ( #V%?%JQ]YX#G@\   (Y   9
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M;_@:$C@9#H.%4 'N*4.)*: \D=5?\;0!IE/[-2CKE#Q&8G@X:9#8;-"!A=?
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M8GD GL\,/*TO>('VJ]_5OP%02P,$%     @ /85\6AQ(LAZ'$@  W&,  !D
M  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL[5U;<]NV$OXK&)^<UIZA94FV
M8^<ZXR1-DYFF3>.>].',>8!(2$)#$@Q 6E9__=E=@'>*HAW;=9H^M)$H8K$W
M['Z[(.&G*Z4_F:40*;N,PM@\VUFF:?+XX,#X2Q%Q,U*)B.&7N=(13^&K7AR8
M1 L>T* H/)B.QP\/(B[CG>=/Z=I[_?RIRM)0QN*]9B:+(J[7+T2H5L]V)COY
MA0]RL4SQPL'SIPE?B'.1_B=YK^';04$ED)&(C50QTV+^;.=L\OC%$=Y/-WR4
M8F4JGQE*,E/J$WYY&SS;&2-#(A1^BA0X_',A7HHP1$+ QF='<Z>8$@=6/^?4
M7Y/L(,N,&_%2A;_+(%T^VSG=88&8\RQ,/ZC5&^'D.49ZO@H-_9^M[+T3N-G/
M3*HB-Q@XB&1L_^673@^5 :?C#0.F;L"4^+83$9>O>,J?/]5JQ33>#=3P XE*
MHX$Y&:-1SE,-OTH8ESY_#TH06HN G:?*__3T( 6B^-.![PB\L 2F&PA,INR=
MBM.E83_$@0CJ! Z FX*E:<[2BVDOQ5?"'['IJ<>FX^E1#[W#0L1#HG>X@=X/
MGS.9KME_SV8FU> %_^L2TI(XZB:!*^.Q2;@OGNV ZQNA+\3.\^_^-7DX?M+#
MX%'!X%$?]2$VN!(!=BZT%(:=[4_82Q5?")W*62A8\[8W$MQ+K]DO,3O+%N!K
M;$):GYQX+%T*&!LE/%[#R@$-XK ?A?I-\\]LMF8KOF9JSB*A%T*/V-N8^2J.
MW5);R70)%*1AH/#8<+I:IYD*\!:DF2JZKE:QT 9)YI,\@+CBC>$_)HW)BCLC
MQF$M+Q9:+'@J<,#T]-0[/CUE9LG!-FPWSJ*9T/B+NV(2X<NY]-EW_SJ=3B9/
M6*Q2IE6&_KJ']U48HUM.GIA"A[T:O. A<L93]F R'1W" @U#$E7&?I@%,EX0
M[9F(!<PO>8A: FH4TN:"IYDF$1Y,1P_+P3P.F(A34H^,06P5B_VUX)IEL1%^
MAM<3K2+0"YH/I %&94Q3E9I)-# A$YB31R!K2O.<6IV.G%3$QV\P#,6>CI]4
MKG[@8#2Z# I+0)^DS%Q; SU,MMT"C5]1 E -0U 0ZI SC9.23<>/)Q[*74X[
M;$I0_9P4N%J*V$V4YGIT_@#$P-H1S.Z&6";<S?;6= 466.<CJK>/V _<7[*E
M"@.K%1BZY!>"]*(Q"7A,7 KM2\.1010,'1Y2&3$V!\O9;S@-_KN;Q:$PP!=0
MT"MIT'9J*6<2&8>U%O*5QW06"M"(ADRXR$)N5Q1\Y0:N0&"3/MV-67;/0]*Y
M.#@YW@=LXI+("MX+5R_5,MBL&Y6)XMKE5/>D$7N5Z7P]H"\;AA$@8!#M!:W7
M/.*3DHJKAV.Z>NBQ,?TP/?$.CP\KD_>MW2UBK&"%-5W$SG)\=.*-'SYRTWBH
MX400?@C7WJ99?:L&8YWD+ @D&@GT#D."NO";9$<I;TXT@&QS@4X$W!#!P;I&
M1Q26"'P].K5:F3PZ]$X.QYNU,I YP(8F!8*@$7 +>2$#4(>A.)2G!Y_'&*0#
MX8<PE\<23DYL *5R _>35P?%4!M(G-K(X5$"!H-Q6>$X8@Q^5!E<YHE,(2Z2
MI9A;?+L0J[BS69&49BG 6C2<(PO.8B NX))S*1&6)Y(\ U']T$[Q-O:53A3%
MLGB/"-D%9YK1LU=+*0:PBJI<J)E+#8E:@\U [Q0!C(P @O)8J,R$Z_(G7BBH
MG1S*E( Q-E AJ!D-NN ZL+'(<EKF4F1GWV5B=(8&9XT TB<9>&.,;$9.MZ49
M03[E<Q?U</H7"O@ASP5E^P!63)DP HE1;Y;9I8NH &Q29KLR93EC5FQ0Y;VZ
M:DFP@4Z\JVA.;O;E?+\,(A1X*Q2A8@ 8E&3:9!RX<KPTHR-&<2@E -;E(7S$
M/JH4^:,RR=1R#CIC.R_V<KN$"7C%FA>$&>"BQ(D!:D1V[C5#7Y))N,:Y=^5>
MPPLZ+-V:2H1$J))I+*39E4!N<C*BA5ZQQD"%(\N@OX6@I6VQ!.:T<J6C1#!/
MN=B=)?!B4E"S=JF'5T;J,2 S3.RB1DSD+78U:#CPN91_@D7IG+-JY\8"=V01
M"/@B*<PN+@'V8GZ$)'EAS6LG%@G7N"R; 4O6(PT @1'[( (1)6F.W 9J#QT@
M5D"M&*RM8SEA"HX1*A0!%+B%TFF$U&@8H!SGCV^Z(]H6+M 2%56=_?3;,3N7
MBXC#J")D=B94AMZ.*8%8"NU*0T:3@C7 <=G,^%HF!3B"T"@ALN6RRCC/67E
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M>9_7.V=%O9-WDXM2"+FU[ZF6=96MF;(8HW\HJ>*J OVR9IJ<[GW).[C'C<W
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M$-&>P-@QEHUA\328#MO2R=)L17N4$-:"_U*G9V (8@2,+;X *\72:FNNU2<
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M<=8/PK[RB.)^J^'972O52YYY-WML]=3#]*[B:9NMT32XB(=[[-$H<O( 14*
MM%!.FH+N6RF2'5+D0A:\2.SV@<\Y?X5.H_%V1NY5ZHU8E[;UCWI;__]CU+$5
M'U;G*[NW\CXI%>VE[-Q'>4#\Q"PIUOR.].K*!,1T719(,HPI<:L3I[^09:*@
MH\L4+W;*_T(NSV]R:+G9*S$'RA4DV"9@1>/3 ,EY ?H1T=M]'I;HSW6?KYIM
MJX7"GIA]KH *$'/!>"%- GP\?D_K HO:O9M:'FP.%'52@['U?J!-/P?5Z^)8
M]K Z]WO&L8/.ABJ <C6A]%H[7(N3;^)[,* Y?;$J80_UR,F# EP#@^'^S@@(
MK*#.[=\$:-K]IA^R8/"5?-T1H4Q4'K1JL'L=EK1C>*XJZ]];5?!XY*I@@L)H
M,@ZFX^'7=5?1Y/31BL"+/ZIT:0\M().!@\X!B3:SU9NMP5[\/4!5ZZR"#BI)
M=&51;R-:6HEV/==:[I#:)A=12VTQJ&TVBK]2;>BMK_[$;GEG3Q:/RT91$$%+
MN#]&8G0#[E,)'EGQS+04L<TXGN'X8\0W8)@"CR#9=8;QOWO890]#NL=:O"1&
MR:(;W"GM:C(*ARR'X !6"N\M8KJGQ6V.1L1 X,(-$4[5&C'@.FU[5@N&?*=N
MG19Q%H*,6+AMAIK6T37RB_?<X (/27(A?!?='HHGLG3D9OR,88<I]S1U3Z/)
MWJ>1T^C'V@XM*6U< ZU5>4O=145R(5ONB-B2=L?@IIK_@6==8&U(>ZG(0*,8
M]:VEKR"G0&OL6[/&_+@B-N)Q,.MLMH1^BC]E+UR:U+G=WK&'3S0H8._7MC%R
M-T'CT.E:9Z2W<_R3C[1I ?R]IY1--\_P79C44JH9Q(.\)%$ZM4CRT;X32IH3
M<J?,Q_B5/X<OE%VS[1*U*<)=>!P^&(_N=)3F/ *-0W9ET?BV0>/-/C1^#=Z&
M?R'><"O-10)V$OOW/4[_1]!71W7@5"T+.MC!38Q:);;/L]IP+$),QQTJ*Y?;
MK=JN(J'F#&;CF/UZ\[&&*[TK8_?$4$CWUDA[LPW;20%ZY+AW!I4;?,87VZ7W
MP23G$A3E.CX'C)_N<A^'U>:5'PMBTK[#.K?F1T/8_5-K?CS'PQ$(!&./\F6=
MH]R."8'!N&TMJ"/PY-ONNMT? "/:FV2V2:*E_8;6;<\(VL2U \ .DA1D 0IV
MSZ1UFKI?LW:?$/!P3(K.14;!DMXIV+WME7:B4*TG7;_E!#0@8F4*VAO-^"V7
MF3U:?-_*?';C<K"UZ95;/'8IE[B?G6B!&W'XI,[=K9-1RR"=-(Y<BH!I,W\(
MC"9& -&[!D)+E:)[UR]);47$SMM4+MS1RUJ^C&B9R )BYUM6NUZR\H<&SLX6
M^JV7I/I4O!.IT3=$:A\^'>3:(<N_JM9LJ-K^MAT+/$;!>%E%0LVK$IL ELE<
MVH 0W /N_3O^/$*CZ>C%7#2^C_<-P-,>@-,&JST7BKX&W-&#P?U( -A7>_!A
M-&HC8?N=NOW \!GSG6KO2#AK^Z/^^_FM-?-#!P@EG7'85Y8)2!VHTSO%6 W[
M_?'6SH/9G4IZ-<!.KNHD_J8 >Q=&)NPWJM8!IL>@$@_QTTN7/ W[G5X[QE18
M3ZYOO6\I"4S;K&CW&V(61=;GCMDDC*?P00O$3^!RS/[FE.3&1"'TG"\1:%DF
MTG,/L).)+0!VKN6EBYQ5Q^%DUEHGVD/3C]I%NT94-)@Y.<;A8(CBS.#;F+WN
MOJEQ?^+$RS\,A[&?-R,(;!U7H($[D: #0>MRS6+J$,?2=-YP:4O89OI=7<QY
M>[_V;%T36R?'IP\;-(JMI.-P2HG@^"*\&'C;;MV=3.S=83@>T=TQGM.X+>2M
MNU[U3I,?^HNDQQ1$[GRE*1"<\]YO\*-PVJF\MA];P'T#U^R&H#TO$+=3]XJG
M&!>KXA%ZL.MW^QS<4[&E7MVM&Z,2N\-"16XW))&VPKX7S\];/Q/(A5[2CR&P
M'*R*TOYBH+Y;_][BRO[,H!EN?ZSQENLE!"B6B05,'833\9'-@/ZB5&OZT<%<
ME:7*Z>M*< BW. ">+Y0J_04N4/\*Y?E_ %!+ P04    "  ]A7Q:$QMRXHX'
M  "3$P  &0   'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6RM6&MOXS86_2N$
MFW9M0+'U\B.9)$ FZ6 ':+O!9*;%8K$?:(F..95%EZ3B>'_]GDM*LI4HZ:"[
M7RQ+XKT\]]PG=;%3^G>S%L*RITU1FLO!VMKM^61BLK78<#-66U'BS4KI#;>X
MU0\3L]6"YTYH4TSB,)Q--ER6@ZL+]^Q.7UVHRA:R%'>:F6JSX7K_7A1J=SF(
M!LV#3_)A;>G!Y.IBRQ_$O;!?MG<:=Y-62RXWHC12E4R+U>7@.CI_G])ZM^!7
M*7;FZ#\C2Y9*_4XW'_/+04B 1"$R2QHX+H_B1A0%*0*,/VJ=@W9+$CS^WVC_
MX&R'+4MNQ(TJ?I.Y75\.%@.6BQ6O"OM)[?XN:GNFI"]3A7&_;.?7)LF 996Q
M:E,+ \%&EO[*GVH>C@06X2L"<2T0.]Q^(X?REEM^=:'5CFE:#6WTQYGJI %.
MEN24>ZOQ5D+.7GTL,[41S/(G82XF%AKI^22KI=][Z?@5Z2AF/ZO2K@W[L<Q%
MWE4P 9063]S@>1^_J?%69&,6+P(6AW'ZAKZDM2]Q^I*W[?O,G]BM-%FA3*4%
M^]?UTEB-B/AWG\U>8]JOD;+DW&QY)BX'2 ,C]*,87/WP730+W[V!-VWQIF]I
M_U-_?+LT0]2R%6SF!=L+K@T3Y",&AL5F*73+<L!X>?0X"=WC)&!V+=B-VFQY
MN4?^94J3."^9;'=A2U&*E;1LI=6&90@%65:R?& H&II3VAFF5HQOMUH]2>20
M*/;L)!F'".6B<%E9OJ82<B?A.&U6!H!@ML(E<;$/>@2QQZ-TQ<*AR6&Z!P34
M73PGH1?OPHH.L)YOMEO+;$WV&6DLJ5LY<E:J0%$C>X>RA-8P_.&[11S-WYG1
M.?O@J?^GH_['?NI?LLYN*JU%:9U%X@FUUXAS=F^!D9VP813&(US=-O$[]D'D
ML*M@PS0=L;,%N1QEJ&1)DK9K>A2R:+&@Y;=B)? R=^^&-?&C(R*'21#'9R.6
MIBG[K"SMU+,*;,CCP#LAN3"-".DTC=FUBYXRDX5T/FCHJV/K;Z;/_<-6_P@E
MT:X]X;6]!GQ45NF]$]%$#OJ37_*_1'S7Z](PLU:[$IC@YK_LT2_C^_$18H<V
MIF#[OKEX][:FA.,S/(S&4_PV'G4O<KF"P^!,"1@I<N-[K*55=P(-JB0O-TLR
M^.%T-I[CY6DXCG#Y"+(SEU:&%X*NUY]NKMDGD>VS@F*8.+GA)<]Y&SL0]MO<
MK'GY(. G]LB+RGN14_!S[,2BV"$^C:=NPW_ #QK(XL/F2>RAS,<)0?'N'J(:
MFQ'8A>_$&_&TXP:-5L,KN4_M;NX956DR=_6\WKUTSC>YG7?<_G],[2^EI.+A
MO.VR)(J#13RE-!G.@EF4C!K^DV":G.'A=#ZJ\PY+SH)X,7.+YT$\#_$&-("F
MK2+/N\)68HK+CY.:&R/P:HC,6R+]K!0@G+NU?Y4=N(J;FG[3Q\ZW4''[9R#/
MV766:2K==<TBPJ)IC-\YNVXCCWR^Y#F,7D+#-&DCMY$F?B#N(S:9LH3=U_-@
M-$\/NM.$S2)VI\66RZ,MX:'%"+^@_1=06W<1Q!Q%+IL'T\6,38-D%K*?!$9#
MUEBP1P5NH=#LD<%6"83-,\!8@\E3&BB?@8RBE$7)#$EBD7-R61".67 6H@ZC
MKLY3Q(2;G4_5ZK0RHJ4O0?PT^C^6*#A%L:&2X-*]>=%<OY08X0OY'^Q.MF"/
M^5F*-)T?^)DEPZ\C9*)%/3$6F!:M=!0LY@L6!Q'ZS$_"F//>LC",@[.(4,?!
M?)YX"CO1>>1PEPY-TQC.$HA=]X=I=RY9(Q;+EZ[)N-9[!,>.Z[QO!(G.4#>;
M&<05CKJS',\3E=XJ,!/T#@O1>-%18%P-[Q7WT\,.BU%2&'_DLN!P*[,*R%9P
M'EM5EL92B+D77LN8W59N$;IGT\ +\2!-X8@..AWQ)0?@E')5%-(%D0,I4:M6
MDLI0AZ$ GMBXVK3<LTQHB\/<,S!^A1^AQG7#ZMUS"80EH4822>U:1ARB_+MJ
MU7A-^' AB"#EP(AXE#GU+I+/!0(/)QZH@/MZ TR2[P657\=27M$S:_I*()&I
M":;O'97&1/%'Q37VH/ XZAMUU4,_Q:'4)1#-+D7EMEES^Q86M"&#HVT[C)A7
M>.JP[\.+;94^'HY>=VQ'N T2DG&EM=/=ZWXR1)9L86RC_-#T[ZNED;GDFG(0
M1R)4(9?^(Q]>?992.]8X5E/IZKIU[=XT!X5>X9>I2+-#>QIX+>5[6U-W<UZ6
M%?;9D[L0"0@#3L<+7NPQM+N9 H^J\BB\0;F1_E! ^@G],U=C#G4%1KTNV(^X
M ZWIC1 K9+:G4/%9#:+>4LP/W;T[$S4-JDO 2E*K<-,FF?.B(&F!(E/2L,V^
M(A=,+C._E1NO_>#HYBDWJ@IG6"?K/_L0B\"-5M7#VC=W4NWG+2WH*Q SU?(K
M>@C9>/CZ0ADAGCCRN8Z(UWC[!?8^.R"T_/480R4N\R<<N+Y"?=.,5^BUX[[#
M^.3H0\E&Z ?W.8B\7I76?S-IG[9?G*[]AY;#<O^YZF>N4>@,*O(*HN%X/ATP
M[3\!^1NKMNZSRU)9JS;N[UIPX*,%>+]2RC8WM$'['>[JOU!+ P04    "  ]
MA7Q:DB?&>%P.  #2)P  &0   'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6S%
M6FUOVS@2_BM$KKN7 (YC.Z]MV@)IVKWM8MOFFEX/A\-]H"7:YD8255**X_OU
M]\P,)4N.D\TN=G% D5H6.1S.RS//D'ZY=/XF+(RIU%V>%>'5SJ*JRA<'!R%9
MF%R'H2M-@3<SYW-=X='/#T+IC4YY4IX=3$:CDX-<VV+G]4O^[LJ_?NGJ*K.%
MN?(JU'FN_>J-R=SRU<YXI_GBLYTO*OKBX/7+4L_-M:G^45YY/!VT4E*;FR)8
M5RAO9J]V+L8OWAS1>![PU9IEZ'Q6M).I<S?T\#Y]M3,BA4QFDHHD:/QW:RY-
MEI$@J/$MRMQIEZ2)W<^-]!]X[]C+5 =SZ;)_VK1:O-HYVU&IF>DZJSZ[Y8\F
M[N>8Y"4N"_Q7+67L(08G=:A<'B=#@]P6\K^^BW;H3#@;/3!A$B=,6&]9B+5\
MJRO]^J5W2^5I-*31!]XJSX9RMB"G7%<>;RWF5:\_FTQ7)E6E]I4UX>5!!:'T
MZB") MZ(@,D# L83]<$5U2*H=T5JTKZ  VC3JC1I5'HS>53B6Y,,U>1LH":C
MR=$C\@[;+1ZRO,-?V>(5MKA27[PN@N:0".K?%]-0>3S]9]O&1>S1=K&4+2]"
MJ1/S:@?I$(R_-3NOO__+^&1T_HC21ZW21X])?XI??I, =;W0'H_7T-,F>/[B
MBI5Z'[1.!JI:&'7I\E(7J^__<C89GYX'=84]V=04U4#9P"-F&G^]<C/U$](I
M3FV'*5VDZG)AS4R]NS-)3<FF/LUF6(SG_$S/7S&PQ@P>G.M"SVTQ5[G)IS+H
M_>7?AAW->-AGFT#U5+T!HA@_4&\</6'P6^N1VLZ'*"#0EYVM#!1VO/ENR^Q-
MY:#!6HC267 JD/&"PE8JX)PRS0:Q1)*XNJAH&Z1L9N8Z4Z$Q\M)6BVW"*U=U
MAP7QS=) 7UV6WMU9X(W)5NK9^.AH,!J-6/C&J\GHD%\!F=7,A@025T9C0Z9(
M21_DD1BVR246TGY[..)O#P? UE :1L=L-527##H8<.F*PMS=X75!@=1?_?G@
M.98.WVJR\8RJ!\SHV-V*LT+-O,LWO [3_:P#GN<Z#-1'<ZM3/53O9C-975W4
M<RP>M4IKLA,[;6EE1ZE;%KQ.:;R6#(YN_6R259+1F.MZBH"TVB/H>Y$-[P&]
MR44ZT,">LM",AM[3#D&?V,Q6JZ[??!/NB<MSJBRHAH@)U,F 39([&M/IZ@&Q
M<?&M'C]]R.'C/\?A;VM/L_]^%-\^U;JB_1+AGXIGL-I H1I&A0?1XD. CE$?
M7674T9!,$\RW&B:D$: )H=*B?F;UE&QMHQ%C5K36;M.%7CZBEC>WR%/,C-$3
M_3]4%\BT.EGTHV*A:4;B?$HQWBJQ:D)"YY3?9(G-]#L^(V\,U'(!A%)+3>::
M!62"G@,D@KB>/BK$2-"9>=R<0S;1-LS@W0,:U:="_6"F'CFW4J?BXOYF*%/)
M9K; WK6"OKD-P6%XL99M--3=BL@"OPM*![@!X54B,A);XM/:##R=Q%%=>'8(
M"X@52+0N:&FH@-TCAGC'X]%W"A&%=T6=#]55[4.M(8HT1,R X*6YD>=6](""
MG063A%:+@61%DOA:-BDK45DRKN!"1:@!<U^;LI*HCW;BH.G()T%DN:G.=)&8
M>QN+<M;),Q8YB*)J:[UT):6,N,--,SOG%%)(#N/[HA-74(#:*2)"S[ 'GA/L
MW7Y.1(H,!<_X0%Z6K<T(2#19<9^3(HI@8@SCB/K/1L,3*!GJZ2_(;3(G9Q:5
M.YW^ EPE*TOR[-H]O'3)C4KM+57O5/P?2D0^0&K7T@#$IB2J\D1M.;P-0440
M\V$4AB'&R-4:HD"E[+1FY.C5T-9&TZ;XIFWQY:2Z->(,Q&K=>(.>JZ6+@>ON
M1S[G,Q7R3=03'ZQ#-[HX], & IL\D-&;F:(IN">,Q</(1@BZ"-XP_6+NC>&P
M14Y^T!Z2CIZ0D-C0/D'V=E&<0AUN579214"&:V%&>>G(;QL(IW;I@:P]&9TW
M1(\?Q^=[+Z+7*2WG-D$!*6 52G*=TD!D3Y%D-1MG#K(*59K!5$@375JJ?3K+
M7*(EU"D(UF(H%7V=5%Q-SF,, ?4DM*8UBJX)2"R@<^9*WO#]E1MHU\FWV@;+
M*007%>CN@)@<P"2-GF&#%,L1-_6NGB._3$4=(,10A4.H>G"W0:2:_L:PM<T,
M2\0T<+4G*4TM;"6>Q]"VQ7X*'%G0U@S[>"V+T2=#FAN.5P \I%@4=;Q(:\H$
MLEJ0*.\JH2I/^49KW.YUS)>[U&1APZ9@R-DJ$/]&-M=E"=4[+DRQ(F' ?JYO
MQ.:0J /&5Q3P@]8R,*11MV3/,&CJ&GH6M ;ZOH4ES:/7;"JF@FE*1^P)'PA>
M2/];F&AIS V*85VFA/9@)%DL,DSN30/L&H;B,HCI"/? B>L8J&!X66ONX"X6
M"[FF6- 6X&EL#V@WXQZ#[82%O&V'8FP;6MZ&F^["T6+G$:WN]I3C#J8E$FU>
M=9.(!N,QU_A(J8F7NI*TFW([X6AY^U_.:K7TEN/*SH@(F)@5 (_"&&(4J9"K
MB&:2_-A SN@%_DBD49S0A'Z3N'T@H>0EU\X+(38+FS,\UK%69& N,RK<H?8,
MH:7+;$)TB-7WW TV>,%#R0-%"[4SQY5*'(.\*-QR'X@N3J>N)ED138J\I37Y
M+K.>;0@XLQZEF;4@DI5RL4^2.J^E+[W566T.H"VE YS"SUMHUN'@[/BH+==(
M*$?^^?WRCD[.]B(ZL7N%)LJ<:-=93061>!L,<8EX D,K%/5YP61M,0/888.Q
M_VNR"N!&$;^(Q+^++I]\*DVNN+7VS*8NRM+ >>3\3T4%(NAD1=U(A-Y$$4*U
MR@SH]44.>HTA@L;OBV3(MH$8,%?R^YI<7G+Q8?]<H)^SB58#S S$Q<'#/UWL
M3P[W+[_NC\;')P/$=@(N%ET'V-FB;T-U(Q=<&HH(8V_[80Y<0=+1$_B*=:GX
MC@TLQO[@FX+Z#(6*"FP+N*C_Z_">1 ;(A<4FY.38A\<8C>V7,!E&';9YRY(D
M!*:FT4PC4X -S9X^ZI#J;^I'P*4CZV3JXZ?+*Z"@X_Y0B%5G8S/R(L!76E&]
M"C3$<=20-D)NA,\T4[:5^<:*<2_2 BXU]Q_<,Y,PZL34.]1 -")P,F$?%K\"
MD6G0[';37&MV,> :09P-Y'L(^MUEG!M,IPFSQQC_L^,GD'Q:AZ'O,9H*/FGA
ME5@5MGDK^J;C\YZ7.;.(!0%WY@ Z&K#[;#P<G^P)Y42ZP&.P6AHUV\+NB(1W
M$>M$ICZD0.,H8H23PXET)6(U7D3<\#@=]:)RX>[STDU:ND5A=- +Y-3^%Q0.
M=9'>"IT%\[R M$R-VY6H2<PUB*&&UC2#2@UX0LZ>D8F;I/%>G]NT7F*59M:4
M3QI:QW-#LK7%4W0<1G2PU/97K+(EVCJV8(,?G8DJ3+-7_9.-GVK4K\-&WD<'
M!][(]A_<?-BV70$A%MGLO7]&,KAWE/ 3>+GZ%XHO<SME\C)S*V/NM=7MX>F6
MPTY1N&?E\/\R\W@<71X/@_JF[9S(QNB" G$73S#U'- WISUTC'XB>;1IUS_?
M%NMSGS1.$"5CF$/G60VJMQN:,ZO)"-!R'8]O'CAR:IO Y\T1VR--X#4CV56-
M\52,U_U?MWU;+W1_8-/2"1Q__7"*E3R*;M.68>L9510"X/9[M1LE8WPC8!"/
M)Z0@V:K#B+@!H\H$6T1([ :-D=+4^.;73@I1"*@KD6-7=*)Z3UU\OKQ8#Q\P
ME1FHW6E\(R0H'C0D>\V)JD3(.IZQ+.T?2?;5^HR9$)+3+8I EF#^QE<2/[0M
M5;R2$$'-J=P?LTN8C901F_;';?$VY1W9A6Y#N<Q84%FL;%P=0%1;/A,O&Z1-
MZTMMA?6.6_X:MMURU#" S45V[]#E424;WOV66P'IQSLW:++NHQ(L':]6WNF(
MI=2!1T;<[1WD>.VP!:#8DW@8@>X8*@&;>.HM*4:V3@TAC^6F"-1@$ _4^#">
M74@=$[7E=(PB\"->M."ZM#GX%:MPNV7%)S 4\21B=5.^[0DUA0RWQC$@0/I2
M,ZV:1IW4=>1+!'@M%/JI9^@ JX3.GO$]EYD.:I N=$ 2XMY^D]RGG\V_ >^O
M@^DMG5IJO*N&WG?3@_HO<),$X%R8F5WGQ ,1PD:6UI*R*K:C-C;4O46P\*RF
MJOE4V7U[=4/!,8@C<_'*2BX^.QX>JAR+DI!$>[\BF_4XWT-;P#]2IN%K?-F^
MY9*PHP#MB\ZS[XQ/X$#>&Q8A*1YID9*'G@@3P:V]W]YDN3JC\R0 $P6HY?.L
MI Z-IB2,&II]V!S]SM2Z$APVUXD!D% "<3+R3<N0.2,7.N*3\0*.*^88Q:R/
MTAN5C&++9'3^(#8G29I:]%KN;6Y==BL7.W+.D.!K>'Z#W/*YB3?3E<QO*U!S
MQKFA@K0@8.+#X]:=ZZ7B$LVM7:^D-AMMJM]P?=;:8VG,*H#'+C/]J^GUK4$0
M--Z\0U]?AE//_?.78W5MY[GNEF=)Q!(:6\;B31.+/Z".CK=2<@['"<'U"\DL
M"HT/AR??;:M:O8:I?R4N4=MZG.^LO)U3OT]E@0^D7!$W4'4*Y"-(8QON0ZA\
MKA9N2?=O<J! P!)G_]X[W*8#;Z\GQ1YKT.KM9HY:05TA0FBZZO\8P%:_[Y[O
MY/FHO77=>K'0W!71RR:@_Y ;P0X)/4*T7J0I8Q/Y:M IH^W%R)KD]FS"5VR2
M4][,,KX<ZF(7T1 Z0J:P*OK3-UAP+WBXT][P_TGCGDWB?C8\/>Y= _)OAF#>
M4J_D7JIC0/[=QN9MZ]'@].3T06[_T$UW[XIOL^F)+=_IZ.1^RS?<]AN>@\[O
MK'+CY_QKLL G@Y7\Y*K]MOW!VH7\3FL]7'[M!I,A[8+*S Q31S#/CERS-0^5
M*_E76U-752[GCPN#YLO3 +R?.5@J/M "[<_X7O\/4$L#!!0    ( #V%?%I4
M<>D1B!   -$J   9    >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;*U::W/;
M.++]*RCOW%V[BI9%RO(CKRK'2?9.*HE3\>Q,;4W-!XB$)"04H1"D9/W[>[KQ
M("G+F9J]^\46*:#1[S[=T(NMJ;_9I5*->%B5E7UYM&R:];.S,YLOU4K:D5FK
M"M_,3;V2#1[KQ9E=UTH6O&E5GF7C\<792NKJZ-4+?O>Y?O7"M$VI*_6Y%K9=
MK62]>ZU*LWUYE!Z%%U_T8MG0B[-7+]9RH>Y5\Z_UYQI/9Y%*H5>JLMI4HE;S
MET<WZ;/7Y[2>%_RJU=;V/@N29&;,-WKXN7AY-":&5*GRABA(_-NH6U661 AL
M?/<TC^*1M+'_.5!_Q[)#EIFTZM:4O^FB6;X\NCH2A9K+MFR^F.W_*B_/E.CE
MIK3\5VS=VFEV)/+6-F;E-X.#E:[<?_G@]=#;<#5^8D/F-V3,MSN(N7PC&_GJ
M16VVHJ;5H$8?6%3>#>9T14:Y;VI\J[&O>75K5BO=0,N-%;(JQ*VI&ETM5)5K
M95^<-3B"%I[EGMQK1RY[@ER:B8^@L+3B;56H8DC@#+Q%!K/ X.OLAQ3?J'PD
MLJM$9./L_ ?T)E'@"=.;_"<"BS?:YJ6Q;:W$[S<SV]3PFC\.J<$=<G[X$(JD
M9W8M<_7R"*%B5;U11Z_^_K?T8OS\!R*<1Q'.?T3]K]OL_T%.?-"-7DB.H/NW
MM_ARM2X1ZXVXJ\1-NX"'BHR-DR:B62KQK]']2-RKO*VQ43F*;Q_RI01%P4=9
M#NCCO__M*LO&ST&4/Z7/3\1<EZH04N1ZHTN1QZ..B7"WOF,B[M25.[S2#2C<
M-[)QQFQJG3=8W]:-0 ;C1?&UF8M/:B,+*2J)T%KPMT1;5COFVU2*%FDH1CU
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M;VY9X&T9E#7 _]<2!VO[8@_8W;_G?P%02P,$%     @ /85\6A0O*D^.!
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M.X\=T_I@7&PHE@-%^@S%)(5+TJZV<*%++'\GB%G/*"K=BEJF>QG/L3B$].0
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ME@A^0,)D:S:SL'=CT=H-9>9?7"NA3ZG&J6Q%GM%>HA4(^R)8#FA)95YQV0I
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M[;+4TQ.$2=#G6\[5,3 %^GF<_0902P,$%     @ /85\6MQCO-5# @  B@8
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M%]KT+C<LS,\"I TPSS,A]'%B-^A_/\D?4$L#!!0    ( #V%?%JDQ(TL$0(
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M.]\.<5K[]P=,2/#[!ZW=,0@%QA>M^ 502P,$%     @ /85\6CF<G ,O"0
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M./TD$A6IT10<L^]@ 9 4A!T'ZW<5;@1D8%FK_<:X3&33@5OO)5G+4H53:T*
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M\/DX<+YNP)!A&?#F'1AN2".!HZX!\%3JPG-P;TJ2@0R ','! )_7<KN#SM6
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M*[NFOSWBN*V4_T!'>IK^OLD%_U6/?CC_<91/TJX1T%9J!5-GTZ?G)]Q<%+^
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M3!F,$!()X/M:"+W;H(#F_QKS?P%02P,$%     @ /85\6B%M;U 3!@  JP\
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MV:L7^5EV?H#@(!(<'$*?W=!+JSJ!H&JX4DW+Y/T_!OS[<*)O!N'"&+0&F*S
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MLU+EB@L!3):P4?I95_HE-X50IM4(O\[FQFJZ,[^W]:'+DF_/XN;HQ#2LP&E
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MJ='UX"8 W:R)YF!5Y:6Y4I:$[LV"-BMJ%T#?<Z7L[N *M+LZ^0=02P,$%
M  @ /85\6A-)1H3) @  ( 8  !D   !X;"]W;W)K<VAE971S+W-H965T-#<N
M>&UL?55M3]LP$/XKIX 02!5QD[[35BJP:9.&U@';/DS[X";7U,*Q.]NA\.]W
M=MK0::5?$OM>'C^/+W<9;[1YLBM$!R^E5'82K9Q;C^+89BLLN;W4:U3D66I3
M<D=;4\1V;9#G(:F4<<)8+RZY4-%T'&QS,QWKRDFA<&[ 5F7)S>LU2KV91.UH
M9[@7Q<IY0SP=KWF!#^B^K^>&=G&#DHL2E15:@<'E))JU1]<='Q\"?@C<V+TU
M>"4+K9_\YG,^B9@GA!(SYQ$XO9[Q!J7T0$3CSQ8S:H[TB?OK'?K'H)VT++C%
M&RU_BMRM)M$@@AR7O)+N7F\^X59/U^-E6MKPA$T=FZ819)5UNMPF$X-2J/K-
M7[;WL)<P8.\D)-N$)/"N#PHL;[GCT['1&S ^FM#\(D@-V41.*%^4!V?(*RC/
M36=99BK,00J^$%(X@1;.'_E"HKT8QXY.\'%QMD6[KM&2=]#:"=QIY586/J@<
M\W\!8J+6\$MV_*Z3HXBWF%U",FA!PI+.$;RTT9L&O/0=O#E_#>* JQR">"XM
M_)HMK#/TA?P^I+E&[!Q&]%TSLFN>X22BMK!HGC&:GIVT>^SJ"-].P[=S#'WZ
M0%V85Q)!+V%7JR]OM3I$]RC@8;J'O@(Z,*-:"E4)5?BE%=9YJULA++6D=O:.
M<Z'@E#%V=C)(VOTK>S$"JAF6"S1-W=XL*0N6%&YT27/%\KHUJ18+5+@4SL(I
M!73HF?8;P47%#5<.B57*AI"V6&?8.!U_\?9> FV6-%9!X23/07\PA, MN6J<
MWW2."M;\E:8+G=AF_X?X2R@"NUABP25T&:3#/GPE]0;Z*8/. !ZU(P\_<'DD
MHM7MIEY&JY>F<.A+B/>ZMD13A-EDZ:8KY>H&;JS-^)O57?\67L_..VX*H2Q(
M7%(JN^QW(S#U/*HW3J_##%AH1Q,E+%<TPM'X /(OM7:[C3^@^2E,_P)02P,$
M%     @ /85\6G'\\S<0 P  9P<  !D   !X;"]W;W)K<VAE971S+W-H965T
M-#@N>&ULK55=3]LP%/TK5L802(6D24LK:"OQL6E,(! ?V\.T!S>Y:2P<.[-O
M*/S[73MM**-TTK27Q/:]]]QSG/AX--?FP18 R)Y*J>PX*!"KPS"T:0$EM_NZ
M D617)N2(TW-++25 9[YHE*&<10=A"47*IB,_-JUF8QTC5(HN#;,UF7)S?,)
M2#T?!]U@N7 C9@6ZA7 RJO@,;@'OJVM#L[!%R40)R@JMF(%\'!QW#T]Z+M\G
M?!,PMRMCYI1,M7YPD_-L'$2.$$A(T2%P>CW"*4CI@(C&KP5FT+9TA:OC)?IG
MKYVT3+F%4RV_BPR+<3 ,6 8YKR7>Z/D76.CI.[Q42^N?;-[D)OV I;5%72Z*
MB4$I5//F3XM]6"D81N\4Q(N"V/-N&GF69QSY9&3TG!F736ANX*7Z:B(GE/LH
MMV@H*J@.)V<P!86U <MV[OA4@MT=A4C +ARF"Y"3!B1^!Z0;LTNML+#LD\H@
M>PT0$J.65KRD=1)O1#R#=)_%PPZ+H[BW 2]I928>+WE?)K(S85.I+8EE/XZG
M%@W]$C_7J6VP>NNQW#$YM!5/81S0.;!@'B&8;'_H'D1'&YCV6J:]3>B36SIV
M62V!Z9RM?)RK&BURE0DU6\=X(^9ZQBO@^@6<<=MT3J&<@FF_ :/PRVH2^=6$
MI9J.IT7(&/D#PP+H+>F@.Z0=H=A6%$7;'X9Q=W!D=P_7P+Z%/%<(1 J9X>AW
MH=O_V*%?GJ@*?&;98O5KK6!9U&?]@X3Y/O$1N]/()9W,5MZ6#V^U"1=:S?:H
M2>F2\)\54]%_$7P!,YX^DRU.K<@$.2/+Q1/A9U!I*]#Q[W7BWF!5P9L2J;EB
M26<PC-ND>\7S7$C!'5DLA,GV*FYH"Y-./QJV:5<D@MC\N7]*(VU=Q9^=*73(
M?Z7'<0B" MUNIS^(5@A92W9E#.TYJ[3QCKL,O@:6[>[_I<76LLF+[G7G*UPQ
MOQ+,S%L\D=&UPL8'V]7V%CENS/,EO;F"+KF9"669A)Q*H_T!F;9I;+V9H*Z\
ME4XUDC'[84$W(1B70/%<DZ3%Q#5H[];);U!+ P04    "  ]A7Q:A8XN;!8#
M  !C!P  &0   'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6RM56UOTS 0_BNG
M;$Q#*DN:MFNUM94V!@+$Q+07^(#XX":7QL*Q@WVEV[_G[+19!UV1$%\2^WSW
MW/-<<N?QTMCOKD0DN*^4=I.H)*I/XMAE)5;"'9D:-9\4QE:">&OGL:LMBCP$
M52I.D^0XKH34T70<;%=V.C8+4E+CE06WJ"IA'\Y1F>4DZD9KP[6<E^0-\71<
MBSG>(-W55Y9W<8N2RPJUDT:#Q6(2G75/SOO>/SA\EKAT&VOP2F;&?/>;]_DD
M2CPA5)B11Q#\^HFO42D/Q#1^K#"C-J4/W%ROT=\&[:QE)AR^-NJ+S*F<1*,(
M<BS$0M&U6;[#E9Z!Q\N,<N$)R\8W'4:0+1R9:A7,#"JIF[>X7]5A(V"4/!.0
MK@+2P+M)%%A>"!+3L35+L-Z;T?PB2 W13$YJ_U%NR/*IY#B:?C1Z_NH6;047
M.",XO!4SA>[E."8&]RYQM@(Z;X#29X"Z*5P:3:6#-SK'_"E S*Q::NF:VGFZ
M$_$"LR-(1QU(D[2_ Z_72NT%O-ZS>"SP0KI,&;>P"%_/9HXL_Q;?MJEML/K;
ML7RKG+A:9#B)N!<<VI\830_VNL?)Z0ZF_99I?Q?Z](9;+U\H!%/ TP^TC>E.
MK.U,&0HU<1$<<*,Z$CJ7>@["^8Q<=ZQF:-O: Q\_6GM)L/8@,]R:CC 'G@U
M)?);<9-[I$.I83])DH.]4=H=GKJ7)UM@_X1\KPF9%($5%-1W!R\Z_+LS54D/
MD*^L'Q8:UT$#&!SW(.1)3^'6D%#<E:V\_7"\WSJ$<I(O9^Y_AW]5S$'_1?!'
MG(OL@4?BS,E<\E2$0MXS?HZU<9(\_WXG[0\W%?P1HHS0T.L,1VGK=*=%44@E
MA2=+I;3YJUI8+F&O,TA&K=LG%L%L?J^?-L2EJ\6#'P8=GKTJX'@$R0?=;F<P
M3#8(.<>CREJN.=3&AFF[/GP*K-KJ_R7%_CK)H^YM?15O#+X*[3R,=R9C%IJ:
M&=A:VQODK!F<C^[-]7,I[%QJ!PH+#DV.AH,(;#/2FPV9.HS1F2$>RF%9\BV(
MUCOP>6%8TFKC$[3WZO074$L#!!0    ( #V%?%J^#";,;@,  -8(   9
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M"V6IB_EI0;\-U"Z UI=*V9WA"C0_HO%?4$L#!!0    ( #V%?%KZW9VY< ,
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M>+BHJENJ!D86KN%828/MBWO<8(<)RB[ ]VN)!V$]L F:GC7^!E!+ P04
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MPV=.AR\3O?V3+*9(/TC0@N=SM<RU_]4FT!K4%>#@N$/3%UM$SD&]T>5!X_+
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MZ^QE"M"_:$&Y,@_-T /?&+N0+'CIM!,TE0-*<T%I'BC-AZ*U;6_R0W@$GTO
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M;P3X=8!?ZJZ(2I7GS+!@K.0:E-U-:'906BVC21S/;%5"H^@IIS@37*%:HM+
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M!GJ^D-(\3^QUVWPM!7\ 4$L#!!0    ( #V%?%JAPYO"A04  .@C   9
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M?5#"+*-5\VFNW_N#Y.HN57%R]IGP%>$"X#P!U_'W@@JJWX< OX 'U<>2(B6
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M04#M#<(5VK0U#Z+SQF#8W'8&&]?UQ@W>]LDI0J*/!?3AB@ A2ZG,OZS+T?P
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M G8W"O6:^<9V 5_N%RPF.&B'_0;N=<N >]^QU\-7[0VNA78J1=T=8&>1A/9
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M3>RHG8GF,GE^*[NV/4SJ(6TQZ6'LJ'B(YC3Q<_I4S6%2SVB+B:<Y3#2DR2]
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M%XJ/@^+HA6+WH#>8OOR%RC5^/L)AA2!O&".';'I=,]&BMNUB*30V'SLL\/<
MT@3@_DH(O9^8#M3]<-*_4$L#!!0    ( #V%?%KERF V? (  .4'   9
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M87 =D (6;"7L@]I\@;:>2\>7*V'\EVP:W\O+@.0K8U75@C&#BLMF9=M6ASU
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MLA/H^UQ*L^O8!9J_C.0/4$L#!!0    ( #V%?%IO//VTLP(  ,0'   9
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M!PR_-\.H#AB]#O"/!(SK@/'K@-&1 +\.\$W=5Y5E:CH@BBSF@C\A49;6M/+
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MM B*UE6V=74\NZVSY%G&<R05CS\C^F6K=4WU-.A%9)H8B2O[OE]C4'L'E!:
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MS!QN*$FH* OH[U=<#\SU29F@V5VW^ ]02P,$%     @ /85\6O3V'LL*!
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MCXQ]U3=W\=3Q-"-(82DU!%4_>YA!FFHDQ>-;">I4_U,G-J^?T-\5Q:MB'JF
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M'9,+GB@2P=P@G<Z9F4;*?!U8OJ/%*ENW-!5:BSC;7 (+0:87F/-S(?3K3MI
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M[0+L_4(I\[!QW=T/\^PW4$L#!!0    ( #V%?%HI#"MJ]@(  $T)   9
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M4'M!5)OE:J!X4>XWYUSIW6MYF@*)09@ ?3_ANB&N!V8+V_QE$?T%4$L#!!0
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MIM/A[>J#F]>-:4:;4*AFH9J-:@ZJN:CFH9I$-1_5 E0+*:V>\*HQ-6!/P31
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MG/KO<CJNT>WTO=ZP'=2@!C4P@IJ=]O\*J2QP 40/H7=0&-LX%\7@7126FFL
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M8#1%&JTDC*K%IM3:)/?EB=M?G_SG%!EVI<CP^6&GW_M@5D;+$?O@ODK=+G[
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M\R*6B/P7'8JZHZ&%HIV0+"V#50]20HM__+44XBS ]ZX$>&6 =Q'@.5<"_#+
MOPQPKP0,RH#!K0'#,B ?NEV,/1<NP!+/)IP=$->U%4U?Y.KGT4HO0O6+LI1<
M/24J3LY>E2_ .<1H*5GTAGY%2^ $!'I&"T;WP"59)8 NJ]T%(#%)Q"\36ZI>
M:)8=E2T&18O>E19=#[TP*K<"A32&N ZP5?>K,7CO8YA[K<0 HCYRO![R'&^
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MD6*:6U5X M<3U/B:,?G<T95*7<I&_P!02P,$%     @ /85\6NKCP]B3 P
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MC0D"2HD9++5([^ U+,V'SRJ&(-:P1$E1P1(N!=^BU'1EUG\V^51II0G/*-_
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M*DJ[P;Q?"Z$?)M9!V_HF_P!02P,$%     @ /85\6AY/B1+; @  /@L  !D
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MRD+'VLM:VQ&TUO>=6RKD[4DW<WG!!:8"Y/R44K'LJ"M4?V5._@)02P,$%
M  @ /85\6G@>QHKJ'0  U%T" !D   !X;"]W;W)K<VAE971S+W-H965T.3@N
M>&ULO=UK<]I8@L;QKZ+RSNYV5V5BQ-V]B:O2T?U^G]K:VA<$RS;5-GB$G'2J
MYL.OP,)"& Z0_F??=&."?@=0S!,='3U\^+8H_EC>YWDI_?GX,%]^O+@ORZ??
M+B^7T_O\<;)\OWC*Y]6?W"Z*QTE9_5C<72Z?BGQRL][H\>&RV^D,+Q\GL_G%
M]8?U?4%Q_6'Q7#[,YGE02,OGQ\=)\?WW_&'Q[>.%?+&Y(YK=W9>K.RZO/SQ-
M[O(X+].GH*A^NGQ5;F:/^7PY6\RE(K_]>/%)_BV[ZJPV6#\BF^7?EENWI=5+
M^;)8_+'ZP;SY>-%9/:/\(9^6*V)2_>]K_CE_>%A)U?/X9XU>O(ZYVG#[]D;7
MUB^^>C%?)LO\\^+A'[.;\O[CQ?A"NLEO)\\/9;3X9N3U"QJLO.GB8;G^K_2M
M?FSG0IH^+\O%8[UQ]0P>9_.7_T_^K-^(K0VZ5P<VZ-8;='<WD ]LT*LWZ)VZ
M0;_>H'_J!H-Z@\'.!G+_P ;#>H/AJ2.,Z@U&IVXPKC<8[VYP:#]<U1M<[6S0
M'Q_:<9W-GNN<NNODUYU]\MZ6-[M;?K._#VZRV>'RFSU^<)/-+I=W]WFO>VB3
MS4Z7=_=Z_^ HF]TN[^[WPZ-L=KR\N^?[!W^A-KM>?K/O#_UED3<[7][=^P>?
M6'>S][N[>__@$^MN]GYW=^_W>H<V>?UE7^_]RY>/E?5GDC(I)]<?BL4WJ5@]
MOO)6-]8?;.OMJX^BV7SU&1R71?6GLVJ[\CHN%],_[A</-WFQ_$])_>?SK/PN
M_7USP[^]S8O9_&XI_:+DY63VL/SUPV59#;O:^'):#Q&_#-$],(0LN8MY>;^4
MU/E-?K-G^T2\?>_8]NF1\;L"X+)ZOU[?M.[F3?N]*Q25?/I>ZO;>2=U.MR^E
ML2+]\K=?I>7]I,B7>Y[?YQ.TSD8[J"ABQ9^6[R5Y?$Q1Q4J</YVB:&+%>GZH
M7I'\HNS97#^V^;S:?'CL21BG*$??5E.LN)/ODCPXAEC'D<W;\?K793;_FE>_
MX(7T-^FRE@\/8(L'^/145+NM>^I?2.<4K7.JYAY[\976'9RJ>:=H)[]2_P2M
MTZ^U4W9$( :U_,N>3X:S=G5X9.<\W[W^AO9. J/3W]'>ZU,^!8Y/^$3JR<=^
M=Y)3/FO'9^RB]!SPG->;G0#W.@??2$'P]%[3NK<>HG?HXWD%U6F]R>C_<:H'
M26:9/R[_=\^3_OU%[.\75X=XORV?)M/\XT5U#+?,BZ_YQ?5__)L\[/S7OB0C
M,87$5!+32$PG,8/$3!*S2,PF,8?$7!+S2,PGL8#$0A*+2"PFL83$4A++(*R5
M6?W7S.J+].O/B\?'Q5Q:K@XTWTE/DT+Z.GEXSJ5?9G/I>7DC/>7%2T#^*OWK
M8%J^1)EPH'.CC,04$E-)3",QG<0,$C-)S"(QF\0<$G-)S",QG\0"$@M)+"*Q
MF,22%VR\QE:G<;Y>=]YW.O*'RZ_;&772H[)CCVJERN U508GIXHT6RZ?\QOI
MMCK"SE\.BFYG\\E\.IO?K3)E7Y0(]7.CA,04$E-)3",QG<0,$C-)S"(QF\0<
M$G-)S",QG\0"$@M)+"*QF,02$DM?L-%6ELB=7J_3Z>QDSMO'C:Y:#VN%SO U
M=(;"T/GT4$H#*9[=/4[>2>9\^GY?L@B)<Y.%Q!024TE,(S&=Q P2,TG,(C&;
MQ!P2<TG,(S&?Q (2"TDL(K&8Q!(22TDL@[!62(U>0VJ$GR,:D9E%8@J)J22F
MD9A.8@:)F21FD9A-8@Z)N23FD9A/8@&)A206D5A,8@F)I22605@KL\:OF34^
M-IOW-)E_E\I\7L56?K,^.?1R'FC?@L/?A=JY>45B"HFI)*:1F$YB!HF9+]AP
M>X9@='4E[\X06.2@-HDY).:2F$=B/HD%)!:26$1B,8DE)):26 9AK2BZ>HVB
M*V$41?FR+&;3L@JA]=IX*9W/RJ7T2Q2GR]4*A?7BON!A,M^72T+ZW%PB,87$
M5!+32$PG,8/$3!*S2,PF,8?$7!+S2,PGL8#$0A*+2"PFL83$4A++(*P57G+G
M-;U6%QG"LW\U"<46JBFHIJ*:AFHZJAFH9J*:A6HVJCFHYJ*:AVH^J@6H%J):
MA&HQJB6HEJ):1FGM*-NZ,ED^-BFX=XG?=#%?/C^4J\5]D[LBSQ_S>7ELPE \
MU-D11VH*JJFHIJ&:CFH&JIFH9J&:C6H.JKFHYJ&:CVH!JH6H%J%:C&H)JJ6U
MMCW!?]49CP?=G16 U*CM\.HVX=4],HWX,%G-(0:3HOR^-Y&$VY^=2*2FH)J*
M:AJJZ:AFH)J):A:JV:CFH)J+:AZJ^:@6H%J(:A&JQ:B6H%J*:AFEM7.K*9B0
M^88)&:V80#4%U514TU!-1S4#U4Q4LU#-1C4'U5Q4\U#-1[4 U4)4BU M1K4$
MU5)4RRBM'65-[\2JH_+_:_Y0.-39$4=J2JUM'Q%W!V\NB5/10354TU'-0#43
MU2Q4LU'-0347U3Q4\U$M0+40U2)4BU$M0;44U3)*:V=7TVXA_UB]1378TV1V
M(\WF95Z->SRWT)X+5%-0344U#=5T5#-0S40U"]5L5'-0S44U#]5\5 M0+42U
M"-7B6FO]2WK//Z43=-04U3)*:P=7TY ABRLR6N>]CBV7%UMGIQ-:EH%J*JII
MJ*:CFH%J)JI9J&:CFH-J+JIYJ.:C6H!J(:I%J!:C6H)J*:IEE-;.L*9 0^8;
M-&2T0@/5%%1344U#-1W5#%0S4<U"-1O5'%1S4<U#-1_5 E0+42U"M1C5$E1+
M42VCM':4-;T:\M%B#>X<&-JZ@6H*JJFHIJ&:CFH&JIFH9J&:C6H.JKFHYJ&:
MCVH!JH6H%J%:C&H)JJ7RVY*<[M7;><Z,&K4=7DT3ARRNXCBYX_U8<*&U'*BF
MH)J*:AJJZ:AFH)J):A:JV:CFH)J+:AZJ^:@6H%J(:A&JQ:B6H%I::]O!U>O+
M\FBP&UP_HX2CVY1P=(571O_E+R<1\^<&%JHIJ*:BFH9J.JH9J&:BFH5J-JHY
MJ.:BFH=J/JH%J!:B6H1J,:HEJ);66NL+2U;?0_+F4(L:MIU83==&5]RUL;ML
M0\F_Y//RN=C_/8QB[.Q\0MLT4$U%-0W5=%0S4,U$-0O5;%1S4,U%-0_5?%0+
M4"U$M0C58E1+4"U%M8S2VB'6;4*LBZ_;Z*(U'*BFH)J*:AJJZ:AFH)J):A:J
MV:CFH)J+:AZJ^:@6H%J(:A&JQ:B6H%J*:AFEM:.LJ>'H"J^-/CB#^&U2%)-Y
MN93R/_-B.EL>_ZH4\4!G!QQ:SH%J*JIIJ*:CFH%J)JI9J&:CFH-J+JIYJ.:C
M6H!J(:I%J!:C6E)K[746G:O.N#WYEZ*C9I36CJZF=J.Z*8HN\[,N>8LRE_XE
M[<XJ;OU14"P>JUQ;%-_7]^Q-+N$X9R<7J2FHIJ*:AFHZJAFH9J*:A6HVJCFH
MYJ*:AVH^J@6H%J):A&HQJB6HEJ):1FGM?&NJ.;H#?I81K>% -0755%334$U'
M-0/53%2S4,U&-0?57%3S4,U'M0#50E2+4"U&M0354E3+**T=94U91U=<UJ'D
M7\K5I6!?JRB;+>;OZMNK0[;)X^)Y7AY<H(@6=Z":@FHJJFFHIJ.:@6HFJEFH
M9M?:]J*L8>=J=TF6<]K#W#T/D\>]-RN\O!,?YZ.O-4"U$-4B5(M1+4&U%-4R
M2FNG1E./T15>LWSB!-_!63VT* /5%%1344U#-1W5#%0S4<U"-1O5'%1S4<U#
M-1_5 E0+42U"M1C5$E1+42VCM':H-449W3$_JX<68J":@FHJJFFHIJ.:@6HF
MJEFH9J.:@VHNJGFHYJ-:@&HAJD6H%J-:@FHIJF64UHZRIC:C*Z[-^/%9/;0G
M ]445%-134,U'=4,5#-1S4(U&]4<5'-1S4,U']4"5 M1+4*U&-425$MK[=A<
M<T:-VDJJ7M.3T1/W9)C+R60J?6ZZ"#^]=A'NS"WNBRLQ?FY<H9J":BJJ::BF
MHYJ!:B:J6:AFHYJ#:BZJ>:CFHUJ :B&J1:@6HUJ":BFJ9936#K6F2J,GXS.)
M/;10 ]445%-134,U'=4,5#-1S4(U&]4<5'-1S4,U']4"5 M1+4*U&-425$M1
M+:.T=I1UFR@37N6,ML>+ASH[XEZT[2OKAF];M11T4'7/H-VW@VKHH/J>0>7!
MVU$-=%03U2Q4LU'-0347U3Q4\U$M0+40U2)4BU$M0;44U3)*:\=-4WK1$Y=>
M)'GQ*"UN#\?+]WQ2'$@7M.4"U1144X^\AT.I2NSR?E]MHW9D4WG]_N[-H!_<
MT/CQ)VNB[YJ%:C:J.:CFHIJ':CZJ!:@6HEJ$:C&J):B6HEI&:>T$:KHKJINB
M#Z0H7Y;%;+HZ[?1R*+,YZCEV<"-DSXX?4E-0344U#=5T5#-J;?O JS^ZZO;:
MQUTF.JB%:C:J.:CFHIJ':CZJ!:@6HEJ$:C&J):B6HEI&:>V<:CHH>L(+@\]8
M.%']+'?^??70U1+ V9>'?+=Z27"MEOA9G!UK:&T%JJFHIJ&:CFH&JIFH9J&:
MC6H.JKFHYJ&:CVH!JH6H%J%:C&H)JJ6HEE%:._V:VHK>D%]A@396H)J":BJJ
M::BFHYJ!:B:J6:AFHYJ#:BZJ>:CFHUJ :B&J1:@6HUJ":BFJ9936CK*F2Z,G
M[M+XX6NU:G=[A?^@_W99P&?Q^&<G%5J0@6H:JNFH9J":B6H6JMFHYJ":BVH>
MJOFH%J!:B&H1JL6HEJ!:BFH9I;63JBG(Z FO6A8EU;&38^.W)U*&@]&@MQM5
M: $&JJFHIJ&:CFH&JIFH9J&:C6H.JKFHYJ&:CVH!JH6H%J%:C&H)JJ6HEE%:
M.ZJ: HR>N #CK+-C;O%>LA9S:;W1WOA"6S%034$U%=4T5--1S4 U$]4L5+-1
MS4$U%]4\5/-1+4"U$-4B5(M1+4&U%-4R2FN%7+_ISNAW\)-@?;0Q ]445%-1
M34,U'=4,5#-1S4(U&]4<5'-1S4,U']4"5 M1+4*U&-425$M1+:.T=I0UC1E]
MX67,?^6Z+[%\=J*AQ1FHIJ*:AFHZJAFH9J*:A6HVJCFHYJ*:AVK^D<^3[LL'
MQM[T0DLR4"U"M1C5$E1+42VCM'9Z=9OT$I=D1#]XS9B8/3NZ2$U!-175-%33
M4<U -1/5+%2S4<U!-1?5/%3S^P<Z9';6;07HJ"&J1:@6HUJ":NF^O=7KONW1
MI49M1U!3G-$7]RC\^ FOXY>'[8TNM&T#U1144U%-0S4=U0Q4,U'-0C4;U1Q4
M<U'-0S4?U0)4"U$M0K48U1)42U$MH[1V##;M'=5-_)18'XTR4E-0344U#=5T
M5#-0S40U"]5L5'-0S44U#]5\5 M0+42U"-5B5$M0+46UC-+:4=84?/3%!1]_
MY9086MJ!:@JJJ:BFH9J.:@:JF:AFH9J-:@ZJN:CFH9I_Y/-$=$H,+>A M0C5
M8E1+4"U%M8S2VNG5%'3TA5=-7WN+HKR7_GM1_"$YB7+*=WF)P;-#"ZWG0#45
MU314TU'-0#43U2Q4LU'-0347U3Q4\U$M0+40U2)4BU$M0;44U3)*:P=94\_1
M'_$SBN15WY]134$U%=4T5--1S4 U$]4L5+-1S4$U%]4\5/-1+4"U$-4B5(M1
M+4&U%-4R2FM'6=/?T1?W=\23AWPUH[C^,J]WTOSY\4M>K.]H+5J<S:6RF,R7
MDVDY6\R/KF$D+QO_C&H*JJFHIJ&:CFH&JIFH9J&:C6H.JKFHYJ&:WW];Z"-W
M!WO6,*+5'J@6H5J,:@FJI:B645H[Q9IJC[ZXVN,?DZ)*I[+*K=N\6)\5F]](
M^9]Y,9TM<^FIF$WS=68]+V^DIRK?UMGUZZI$4;JL@VQOCJ$='ZBFH)J*:AJJ
MZ:AFH)J):A:JV:CFH)J+:AZJ^;5VM9UC[[N#W11#NSM0+4*U&-425$M1+:.T
M5HH-FNZ.@?""ZDV*+=?I5<SN[JN;B^=R658_5Z'V3BI7RS_$RSS$0YP;6:BF
MH)J*:AJJZ:AFH)J):A:JV:CFH)J+:AZJ^4<^6'J'EWF@SR-$M0C58E1+4"U%
MM8S2VC'6]'8,Q-?9BY=Y5#_'U3%:OI2RG>O+\NK8K:@>%J^F(O=F&]KJ@6H*
MJJFHIJ&:CFH&JIFH9J&:C6H.JKFHYJ&:CVH!JH6H%J%:C&H)JJ6HEE%:.^^Z
M3=YU\=4@ [3E ]445%-134,U'=4,5#-1S4(U&]4<5'-1S4,U']4"5 M1+4*U
M&-425$M1+:.T=I0UC2$#<6/(3UD-(A[S[*Q#:T%0344U#=5T5#-0S40U"]5L
M5'-0S44U#]7\6MM>#;)G+0@Z9HAJ$:K%J):@6HIJ&:6U,ZRI^ZAN_J7IQZAI
M9EQ/-4KI?%8NI5^B.%VNUH1\7CP^5JEV>!I2./[9>49J"JJIJ*:AFHYJ!JJ9
MJ&:AFHUJ#JJYJ.:AFH]J :J%J!:A6HQJ":JEJ)916COWFFZ0P8"?AD1+05!-
M0345U314TU'-0#43U2Q4LU'-0347U3Q4\U$M0+40U2)4BU$M0;44U3)*:T=9
M4Q0R$!>%_)QI2+1+!-445%-134,U'=4,5#-1S4(U&]4<5'-1S4,UO]:VIR%[
M^XKUT5%#5(M0+4:U!-525,LHK9UB34O(0'CI]G50S+Y.REP*'JHQ5@V->U,)
MK05!-0755%334$U'-0/53%2S4,U&-0?57%3S4,U'M0#50E2+4"U&M0354E3+
M**V=74TMR&#,3R:BK1^HIJ":BFH:JNFH9J":B6H6JMFHYJ":BVH>JOFH%J!:
MB&H1JL6HEJ!:BFH9I;6CK.D&&8B[07[.9"+:#()J"JJIJ*:AFHYJ!JJ9J&:A
MFHUJ#JJYJ.:AFH]J :J%M;8]T=F7QV\F.J,]C^L-Y3>/B]%GEZ!:BFH9I;7R
M:=BT?@S%%^?7RPWK>'J:%-+7R</S#_55B4<Z-Y5034$U%=4T5--1S4 U$]4L
M5+-1S4$U%]4\5/-1+4"UL-;&6VG3>=_IR#NA=-K#8O2Y):B6HEI&:>U,:BH\
MAN(*CYUCII<"Q=<@^J%H0KL[4$U!-175-%334<U -1/5+%2S4<U!-1?5/%3S
M42U M;#6Y$$K=,9C^4TXO3RPW0<ICW:S":W;0+44U3)*:V=3M\DFX370UT&Q
MF.;YS5*Z+1:/TK).JNG64=0JC/9F$%JZ@6H*JJFHIJ&:CFH&JIFH9J&:C6H.
MJKFHYJ&:CVH!JH6H%M7::'L*L-M].[6'CIJ@6HIJ&:6UHZJITQB*ZS2VI_8V
MYYEN%\7AKV\6G'$2#W5V>*$M&JBFHIJ&:CJJ&:AFHIJ%:C:J.:CFHIJ':CZJ
M!:@6HEJ$:C&J):B6#M\VHW1'H]ZXG=(9-6@[NYH:C>JF^#!K9_5Z=505%/G?
MM>?Y315CKUWU;KY:3[$WL80#G)U8I*:@FHIJ&JKIJ&:@FHEJ%JK9J.:@FHMJ
M'JKYJ!:@6HAJ$:K%J):@6HIJ&:6U@ZWIR1CR/1E#M"<#U1144U%-0S4=U0Q4
M,U'-0C4;U1Q4<U'-0S4?U0)4"U$M0K48U1)42U$MH[1VE#4]&4-Q3\;F:R_S
M/]??<[GZVK"[U1W5\=FQV42T# /5%%1344U#-1W5#%0S4<U"-1O5'%1S4<U#
M-1_5 E0+AV^+.OICN=<?[Z[&0,LP4"U!M135,DIK1U53AC$4EV'\I&]H%H]Z
M=HZA]1FHIJ*:AFHZJAFH9J*:A6HVJCFHYJ*:AVH^J@6H%M;:FV6%;]>\H\T8
MJ):@6HIJ&:6U@ZQIQA@*+U>^KF<,5YWQ4O!<3.\G57Y]VJSB6.[VS>\-+;0H
M ]445%-134,U'=4,5#-1S4(U&]4<5'-1S4,U']4"5 M1+4*U&-425$M1+:.T
M=K(U11G#*_[$&-J#@6H*JJFHIJ&:CFH&JIFH9J&:C6H.JKFHYJ&:CVH!JH6H
M%J%:C&H)JJ6HEE%:*\I&3:?&2-RI\5,ZG\1CGIMUJ*:@FHIJ&JKIJ&:@FHEJ
M5JUMGQ$978W&W?8\DHT.ZJ":BVH>JOFH%NS96?W.6![VVGLK1$>-4"U&M035
M4E3+**T=3TV]QDA<KW%\#M'\K$O>HLQ/F4X4#W9V+J'5&JBFHIJ&:CJJ&:AF
MHIJ%:C:J.:CFHIJ':CZJ!:@6HEJ$:C&J):B6HEI&:>V0ZS8AU\6G$T=H0P>J
M*:BFHIJ&:CJJ&:AFHIJ%:C:J.:CFHIJ':CZJ!:@6HEJ$:C&J):B6HEI&:>TH
M:WH\1N(>#[X.43S@V4&'MGF@FHIJ&JKIJ&:@FHEJ5JUM%ZSVWH]&@]VY1+2F
M ]5<5/-0S4>UH-9VEA".>H/=N42T@ /58E1+4"U%M8S2VMG4]'14-T79]),6
MUHM'/3N@2$U!-175-%334<U -1/5K%J[:@74[MD3&QW30347U3Q4\U$MV+.O
M.N^'\FXZD6-&J!:C6H)J*:IEE-9.IZ9L8R2\ OHZG4]N;V</L_49K/)^5MS\
M_6E2E-)L_C6OCJ:*U;FNS>V],806;Z":@FHJJFFHIJ.:@6HFJEFUUNIFV\T@
MM$T#U5Q4\U#-1[7@^(X*T0$C5(M1+4&U%-4R2FL'4%.1,1)79'RZNRORNU61
MX=-FH<7+,=&!CG@Q=W;@H,48J*:BFH9J.JH9J&:BFH5J-JHYJ.:BFH=J/JH%
MM;;=P][K=-[TL(?HJ!&JQ:B6H%J*:AFEM0.J*<88B8LQ7@/J9ET+/[O)B\EZ
M-7J13_/9U^KN17N5^J'@0ILP4$U!-175-%334<U -1/5K%H[]B%GHZ,ZJ.:B
MFH=J/JH%>_;6<&\DD:-&J!:C6H)J*:IEE-:.I*;B8B2NN/!>+Y?:?*M6?=74
M7,HGTWOI>;5N_=C%4FC'!:HIJ*:BFH9J.JH9J&:BFE5KV_-!\FX2H<45J.:B
MFH=J/JH%QW=4B X8H5J,:@FJI:B645H[A)HVBI'P$N&M$/JV^:J1L_('+:9
M-0755%334$U'-0/53%2S:DV8/VC;!*JYJ.:AFH]JP?$=%:(#1J@6HUJ":BFJ
M9936RI]Q4R$Q%E=(;-;5 8N]Q2.=FT6HIJ":BFH:JNFH9J":B6H6JMFHYJ":
MBVH>JOFH%M3:]@+^SGNYN[LD'!TT0K48U1)42U$MH[1V=#7U$F-QO<3K=S.N
MEH(7L[O[ZN;BN5R6U<^S^=T[J<R+QW60?<\GQ?[C)_$09V<66BJ!:BJJ::BF
MHYJ!:B:J64?^2O=>_JKNS2>T0 +57%3S4,U'M>"']U^(/H\(U6)42U M1;6,
MTMJ1U6TB2W@%[U]H1&K_45 L'F?+Y:+XOKYG;[*A'1.HIJ":BFH:JNFH9J":
MB6H6JMFHYJ":BVH>JOFH%J!:B&H1JL6HEJ!:BFH9I;43L.F8&+]<)TS6)8W1
M%@E44U!-134-U714,U#-1#4+U6Q4<U#-134/U7Q4"U M1+4(U6)42U M1;6,
MTMI1UE125#=%!W-*_J5<+6;_6D79;#%_5]\^X6N)Q?#9@49J"JJIJ*:AFHYJ
M!JJ9J&:AFEUKK:4%>Q99.R<^SMWSN'U+[+T3'^>CKS9 M1#5(E2+42U!M135
M,DIK!T?3%C$6MT50LX 'I_[0-@E44U!-134-U714,U#-1#4+U6Q4<U#-134/
MU7Q4"U M1+4(U6)42U M1;6,TMJQUW14C(?\U!_:4X%J"JJIJ*:AFHYJ!JJ9
MJ&:AFHUJ#JJYJ.:AFH]J :J%J!:A6HQJ":JEJ)916CO*FC:+L;C-XB],_:']
M%:BFH)J*:AJJZ:AFH)J):A:JV:CFH)J+:AZJ^:@6H%J(:A&JQ:B6H%I::\>F
MHS-JU'94-2T78W'+1;)NHWV9/53_G-Y/YG>YI"T*Z?=B\4=>3*J?XFK0V31?
MGO(MC.+1SLXOM/ "U514TU!-1S4#U4Q4LU#-1C4'U5Q4\U#-1[4 U4)4BU M
M1K4$U5)4RRBMG7)-C<;XBI];1+LS4$U!-175-%334<U -1/5+%2S4<U!-1?5
M/%3S42U M1#5(E2+42U!M135,DIK1=E5T\AQ)6[DV/D6QOEK0=2FGG"Y?*Z.
MT&;MNMPCTX[B,<_-.E134$U%-0W5=%0S4,U$-0O5;%1S4,U%-0_5?%0+:FU[
MPFLL#WN[WT>"#AJA6HQJ":JEJ)91VDN(72[O\[Q4)N7D^L-C7MSEG_.'AZ4T
M73S/*[Y[L76O5.2WU:N1?\ODB\LW]W^2?_O47=U_V3#7'YXF=[D[*>YF\Z7T
MD-]69.?]Z@M5UJ4>FQ_*Q=/'"_E"^K(HR\7C^N9]/JD.^%8/J/[\=K$H-S^L
M!OBV*/Y8/^WK_P-02P,$%     @ /85\6D:7W)U !P   4H  !D   !X;"]W
M;W)K<VAE971S+W-H965T.3DN>&ULM9Q=;]LV%(;_"N$-6PJTL41_)DL,M)'(
M%5C;($&VBV$7BLW80O7ABG3<#OOQ(V79,F.9MKMW-XTL\SRD<]Z*AV]H7BWS
MXK.<":'(US3)Y'5KIM3\LMV6XYE((WF>ST6FWWG*BS12^F4Q;<MY(:))&90F
M;>IY_78:Q5EK=%7>NRU&5_E")7$F;@LB%VD:%=_>B21?7K?\UOK&73R=*7.C
M/;J:1U-Q+]3#_+;0K]H;RB1.12;C/".%>+INO?4O>:=K LH6O\=B*;>NB?DH
MCWG^V;QX/[EN>69$(A%C91"1_O$L;D22&)(>QY<*VMKT:0*WK]=T5GYX_6$>
M(REN\N2/>*)FUZUABTS$4[1(U%V^_%54'ZAG>.,\D>6_9+EJ.]"-QPNI\K0*
MUB-(XVSU,_I:_2*V OSNG@!:!="7 ?T] 9TJH'-L#]TJH'ML0*\*Z!T;T*\"
M^L<&#*J 09FLU6^W3$T0J6AT5>1+4IC6FF8NROR6T3HC<6:D>*\*_6ZLX]3H
M7N7CS[,\F8A"_DS"+XM8?2-OUA?OL['(C%8D.0N$BN)$OM+O/MP'Y.S'5U=M
MI4=@..UQU=O-JC>ZIS>?D@]YIF:2A-E$3&Q 6P]],WZZ'O\[ZB1^&JMSX@]?
M$^K1;M. W.&!&)\3NC\\."*\XY7AG8;P\)APOPRG#>','?XQ?SXG7K<,]QK"
M^3'AG:9P*Q6=C90Z):^S3TJSJ!"5E-8"^O,WW8B\5R*5?S6,\-V*V&TFFL?P
MI9Q'8W'=TL]9*8IGT1K]](/?]WYI2C42%B!A(1+&D# .@EF"Z6X$TW711Y_F
M9C:21,^04D79),ZFY"S.B#1"DDV/EW=.X*EZ6<'Z)<Q,V<\CWQMZGOZ_\+RM
MA(9F?G>G6=C4S-MIQI"?@(-@5O9ZF^SUG-F[$TFDQ(3<1H7ZUI0K9_BIN4+"
M B0L1,(8$L9!,$L=_8TZ^O#)H(\4#!(6(&$A$L:0, Z"68(9; 0S<#Y.;O(T
MU4L3:>I1$DNYT(\6O=(B8SU#Z&6%F1NB:2&$7@:I0[/$8.=13'L[3^(;YWA.
M50@2%B)A# GC()BED.%&(4.G0LJE"JF*AJ:T.\-/?7X@80$2%B)A# GC()BE
MCHN-.B[@$\X%4C!(6("$A4@80\(X"&8)QO=JZ\-S/U",9-X8(VNBIYET+C(9
ME?Z8^&JN19-DW,A3-5/1!MN+AH&WNVH(FAHVK$&@HV-0&D?1[&1O^5R^,]D/
M62'&^32+_]Z3[=<D$XKD3T1(%:?ETD;7'T\B5@L]GD8M.'L\60O^3HIW5(#L
M,(32&)3&431;++06"W6*Y6.>O7G6.M :6)69))(R'\>E*I:QFE5U:CY?^>G+
MJ)C(0U6IN\^3Y4)WBMP=N2 [#*$T!J5Q%,V62VU\^DZ;;&3,8W*;1%ECVJ$>
M)Y060&DAE,:@-(ZBV0JIG4Z_"Z].?:C9":4%4%H(I3$HC:-HMG!JD]5WNZQK
MCSQ:J%E>E,6+<46,01)E8W%PSH&:L!7-,E:&C>4JU&&%TAB4QE$T6QZUR^H[
M/;F]2QA=S"[21U&8>G9=P3Q'<1(])J(4T+2(#OMH[LY/5D__<,4"-5JA- :E
M<13-UDUMMOINM]7\O7I_Q8*T#&^@M !*"Z$T!J5Q%,U62&VV^D-\Q0)U8*&T
M $H+H30&I7$4S19.[</Z3M?N/U<L4%.VHED5B]=8L4 =5RB-06D<1;.W:]6F
M*W6;KIN9A_Q##FXA<+-.%0.4%D!I(93&H#2.HMF*J9U;ZL-G(@JU9J&T $H+
MH30&I7$4S19.[>)2MXN+W%+@[NID0>V:M_1B=XM" .TUA-(8E,91-%LJM8-+
M#SJX6[.25$4\-A/3:LO!0Q8K2<[N[A_V: /J\$)I 9060FD,2N,HFJV@VN&E
M>(>70AU>*"V TD(HC4%I'$6SA5,[O-3M\'[/+@0W\F3A]'8W%]"F11*TVQ!*
M8U :1]%L3=2V+G7;NM#*!6KBTET3]\(;#GOTI52@3BZ4QJ TCJ+94JF=7'K(
MR?7[>YU<=^S)N8<ZN5!:"*4Q*(VC:+9":B>7XIU<"G5RH;0 2@NA- :E<13-
M%D[MY-+_U<EUTT_6$'1_+9060FF,[GK637]DYPWMNG8[^VN<M47;<5NTW_&]
M/#?QU%Q7-/N;>0WUZ)'M0NCH&)3&430[U[6YVG%OB]7E@[^W?'#'GIQ5J(L*
MI850&H/2.(IF*Z1V43L47CYTH&XIE!9 :2&4QJ TCJ+9PMDZ#L#MJ7[/-((]
M#Z#3.)&^G$1V6S5]M0(Z- :E<13-3G1M?7:<#ME^!VM[%UHTF<3F9I1L-J35
M9>4A64!]THKFVH<&[3"$TAB4QE&TE73:6P?1I**8EF<,22V*1:969[IL[J[.
M,;KQ+X/RN)\7]]_ZEV_+4WW:-69U.-*'J)C&^JF2B">-],X'O18I5N<-K5ZH
M?%X>=_.8*Y6GY>5,1'KV,@WT^T]YKM8O3 >;4Y]&_P)02P,$%     @ /85\
M6H?A?&2Q!   5A<  !H   !X;"]W;W)K<VAE971S+W-H965T,3 P+GAM;+58
M47.C-A#^*QIZTR8S.8/ QG9J>\8):7L/-Y>Y-'?/"JQM)H!\DHB3?U\),!B#
M%9RA+S;(NY_V^[22UCO;4?;,-P "O<91PN?&1HCMM6ER?P,QX0.ZA43^LJ(L
M)D*^LK7)MPQ(D#G%D6E;EFO&)$R,Q2P;NV>+&4U%%"9PSQ!/XYBPMQN(Z&YN
M8&,_\#U<;X0:,!>S+5G# XC'[3V3;V:)$H0Q)#RD"6*PFAM+?.WAJ7+(+'Z$
ML.,'STA1>:+T6;U\">:&I2*""'RA((C\>H%;B"*%)./X58 :Y9S*\?!YC_Y7
M1EZ2>2(<;FGT,PS$9FY,#!3 BJ21^$YW_T!!:*3P?!KQ[!/M"EO+0'[*!8T+
M9QE!'";Y-WDMA#APL$<G'.S"P3YV<$XX.(6#<^2 QR<<AH7#,%,FIY+IX!%!
M%C-&=X@I:XFF'C(Q,V])/TS4NC\()G\-I9]8/ CJ/V]H% #C?Z"[7VDHWM!G
M]"#S*T@C0'2%,A/T;:O6B:.E6BAE=.&!(&'$+Z7YXX.'+CY=HD_(1'Q#&' 4
M)N@Q"06_DH/R^=\-33E) CXSA0Q;36[Z18@W>8CVB1"QC;[21&PXNDL"".H
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MVBN:UQ=:7<>J@L7Z$G;_AY#J_Q 6*./#5&_</TV;X]I-:U)G4)6B6%^+[AE
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MPDS0XUO.U:%A#+0_3-%74$L#!!0    ( #V%?%J.DS,FS (  +4*   :
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M^UCI=A:$6:#?EYRK\\!LT#7(V?]02P,$%     @ /85\6OL"DP3% @  )@<
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M=ICJAPR%"=#[:\[5?F(.:)[&Z"]02P,$%     @ /85\6M[2<] O!   30\
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MNGZ&A?<S++2?@6H.JKFHYJ&:CVH!JH6H%J%:3&G]O'7]#.L[_8S7[G2AE^I
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MD[I8-J2X*>JZ6*P_O)/)3);- ]3W;XNB?OZDF>"A*+^LG][%?P!02P,$%
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M<Z%-:[ME8_XE(*V#.:^$T"?#7C#]G;(_4$L#!!0    ( #V%?%JB<^_,8P8
M '0F   :    >&PO=V]R:W-H965T<R]S:&5E=#$Q,BYX;6RUFEUOVS84AO\*
MX15#"S2U^"'9RAP#C;-N =:M2-;M8MB%:M.V,$GT)#K)AOWX41\1+9$ZBAKE
M)K'E<XY?'E/O(U):W(OTKVS/N40/<91D%Y.]E(?SZ31;[WD<9._$@2?JDZU(
MXT"JM^ENFAU2'FR*I#B:$L?QIG$0)I/EHCCV*5TNQ%%&8<(_I2@[QG&0_G/)
M(W%_,<&3QP,WX6XO\P/3Y>(0[/@MEY\/GU+U;EI7V80Q3[)0)"CEVXO)>WR^
M8GZ>4$3\%O+[[.0URH?R18B_\C?7FXN)DROB$5_+O$2@_MWQ%8^BO)+2\7=5
M=%)_9YYX^OJQ^H=B\&HP7X*,KT3T>[B1^XO)?((V?!L<(WDC[G_DU8#<O-Y:
M1%GQ%]U7L<X$K8^9%'&5K!3$85+^#QZJ1IPD8*\C@50)I)W .A)HE4"+@9;*
MBF%=!3)8+E)QC](\6E7+7Q2]*;+5:,(D_QEO9:H^#56>7-[RG?I1) J3<DKD
MK3U#MVJV;(X11V*+'B.N3R)>7W$9A%'V1L5^OKU"KU^]0:]4#?3K7ARS(-ED
MBZE4ZO+OF*XK)9>E$M*A!!/T421RGZ'ODPW?- M,U;#JL9''L5T2L.(57[]#
M9/X6$8<PBZ#5$]*I4Z130 ZM6TV+>K2GU3?\(%(9)KM&2__X286C:\GC[$];
M\\K:S%X[/]G/LT.PYA<3=39G/+WCD^6WWV#/^<XV\)&*-=K ZC8PJ/KRAM_Q
MY,AM8RP39T5B[C]W:E*XE"RF=Z?BS2BGCF@H<FM%+JCHAU1D&3JD8AM*FZPR
MVSOY0H_XK*7*#.I0Y=6J/%#5+P>>!L4TB90\FR[/^,JSF>NUVV6)POZ<>79U
MLUK=#%1WQ=746(?EW%4G/ KB?%+_6QRPB9T9,BASVEK-(,Q<8E<ZKY7.0:77
MB>1J%DOTFC\H^&7\C3*JM8CY6Y1PZ^\]-SLVG_DMJ680(6['3^[74GU0ZL\*
MV_F/C8*MTIS/R+NPX*6RB4HTDL$#M\X&WU3MD[G7DFV)PC.7,+MP[&B,.*#T
ME;+N,#GFTS6?#5=AMBZ/\ VJ9K)]7L!UAQK;6-6:73B!*7Y!BZ^*C]6*D:HU
M6T%T*\C7VGR5Z?7XO"6,SGRW8Z9J"F.0;KUN7Z7WV+TE2MGJK$.<9B.&X=AO
M^E6!/M>WA?G,F7<(U*C$,"L'^SXVP6@Q?DL4=EF76HU0##-TN/=C"RY-\[=$
M$<?S.^1JIF(8JL_R?VS"\\PCS&U+MX3-YK@#LEA3%L.8_1"J7J_W5F5@YF!?
M&ZE:<YP:T=A_28L'+P &MV*D:LW5E68^@9D/6'R5V6?QEK".2RBB&4Q L/7Z
M>Y7>X^^6J"YE&HD$1F*_N1,3>;[3/H,M05W2-!0)#,7!MDY,_F&*VU>;EJ@N
MJ1J1!$;D<$\G%A8RO^WIEJ@NK9J6!*;ELPR=F$QDGJ'ZR>M.HJE)8&I>AJ++
MRN',H?XU5K7F.#5NR>P%K9R +!_<BI&J-5NAZ4U@>D-6;JYTG?8DA$*:BC1G
M";P6[K5Q<R5KR()"FEMXFGD49EZ_AU.3:6<$GUS+5EMPEC#L4MPA4../PO@;
M[.34)!UQC'T#2U3WU@S52*0P$H>;.87H5VE],B#IR=XM#,AG.3FU+!9M/;:M
M*4\OFIK:-3$I3,R52)7!!9(7\T'(/4^M*L$J@[>81ZK6'+,F+W5?<K,=Q/K@
M5HQ4K=D*C7,*XQSP=FJN8XV3"0II*M+@I? ZM\_;J;E&-61!(4U9&H(4AN 3
MO-VR->Q1W+XHLX7A.<4=>U=40Y'"4!QN[OV4!$.:=W@T)1E,R>&VSBPXI/.V
M5DM4]ZX[T\QD,#.?9>[,).,9\TB;][8P[+H>[1"O$<I@A)YLM2/QN-.>H?^:
M>_#Z$^L8P*\8ZG=C56LV1*.:O>1]5C;JC=:QJC5;<7*K]>OOM4++W4J\&=*]
M <\TFMGS;K<R:$E;*3-#NG??F28E>^XM5]8/3$L(=ACMV,MF&IILY#NNK)^B
MEA"_X\8PTQAE8]]P9?U+3$N(0FK':HEIH+(7O.-:U;8_B5#)-D-\,F][_O3D
M^9V8I[OBL:8,K<4QD>7C+O71\M&I2WR^*IXP:AU_C\_?%P\23769\GFLCT&Z
M"Q46(KY5)9UW,W4&I>4C3N4;*0[%4T)?A)0B+E[N>;#A:1Z@/M\*(1_?Y%]0
M/VBV_!]02P,$%     @ /85\6N+Q[$T3!   T14  !H   !X;"]W;W)K<VAE
M971S+W-H965T,3$S+GAM;+58;8^C-A#^*Q8]57=2NV @0+8)TFVB4U=JU=7F
MKOU0]8,7)@DZP*GM;*Y2?WQM8'D)Q-ETR9>$EYF'9Q[/V&//#I1]Y5L @;YE
M:<[GQE:(W:UI\F@+&>$W= >Y?+.F+"-"WK*-R7<,2%PX9:EI6Y9G9B3)C7!6
M/'M@X8SN19KD\, 0WV<98?_<04H/<P,;+P\>D\U6J =F.-N1#:Q ?-D],'EG
MUBAQDD'.$YHC!NNY\1'?+FQ'.106OR=PX*UKI$)YHO2KNKF/YX:E&$$*D5 0
M1/X]PP+25"%)'G]7H$;]3>78OGY!_U0$+X-Y(AP6-/TCB<5V;@0&BF%-]JEX
MI(>?H0IHHO BFO+B%QTJ6\M T9X+FE7.DD&6Y.4_^58)T7+ [@D'NW*P7^O@
M5 Z%<F;)K AK200)9XP>$%/6$DU=%-H4WC*:)%?#N!),ODVDGPA7L)&#(E"2
MERFAI/T1K62VQ/L4$%VC.Y*2/ *T*K+JOF7W?@F")"G_(#V^K);H_;L/Z)U$
M0I^W=,])'O.9*21']24SJOC<E7SL$WR6$-T@._@!V9;M#K@O7N'N6(6[TW4W
MI3*U/'8MCUW@.6?D>80=92+)-QT!_OQ%FJ-[ 1G_:RC4$ML=QE8%>LMW)(*Y
M(2N0 WL&(_S^.^Q9/PT%/A)81P:GEL'1H8>?J2 I^L@YB,$Q+;W]PEM-',]A
M8+N.-S.?VQ'TK7#@!GYMU:'FUM1<+;4%S>6X[-70R(Q#RX1'Y1.(T6\[8,5(
M#7'6PEXZ.".!=128U I,KIBCDS%E& FL(X-7R^"]*4=+;^],CO:M-#GJU]3\
M5U#;4!H?DC0M\I2*+3 Y5PJ2;Y(G.=.>)N[W*+D>=MTCXGTK[ >N-TP\J(D'
M6N*?)$&(MD.LM(Z7YLU(8)T8IW6,TRN6SW1,&48"Z\B K:83L-Y40)5[.\4\
MU\;^42(.F%G#68A;30J^8@%5X&U&CN4$DV/B?;-3Q)OV 6N7Y? NH:<*2.]Y
M:>J,A=:-L^D/L'/%(L+:[N-B*49"ZTK1]"-8WY"<+2.W/U-[4_MX(1HR.SVA
MXZ99P-I%^*VE-.FSFOB37BD-F&G(-TL\UJ_Q"\ID?A$!#>]!EEJ4B_-I)+1N
MS$WO@/UKEI:V,[E8BI'0NE(TW0C6MR-G2ROHIYT]=8Z3LV_EN?A$:C9=!-:N
MSF^MJVF_R3NFW3<YL3S9S9)OZY?\UFX)T9?-$D?_=K=1S9O!3:[V$Q?O<D="
MZPK2-!HVON9^7]O%7"S%2&A=*5HG'_K6Y5RQ5>[#^5A%H#/ITFHZ#?LU1Q'_
MM\[L_AE$C[3.I"1MML[;U&'GKX1M$EDW*:RECW7CR^6/E>>'Y8V@N^(([HD*
M0;/B<@LD!J8,Y/LUE6UB=:-.]>I3W/ _4$L#!!0    ( #V%?%H2K!33:0,
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MKF[8[.O-S7QF 08 ,#@9('L_Y19D#T#VC@@YFYN'VYL[ WC_A=U/;QXLR!!
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MY@+;R0\H\?O$B?]*99DLJX.:]'I5-]26(H]W()$ ?&(!W'"=&ZB"O9^HHOC
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MQ3I-K\RV^WRB>++]2:+MSRE]_@]02P,$%     @ /85\6B)<<!<I P  6$(
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MX+4IV 80VY1L YAMBK8!U#9EVP!NF\)M +E-Z3: W:9X&T!OKWI[@-Y>]?8
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M)U!+ 0(4 Q0    ( #V%?%I&QTU(E0   ,T    0              "  0
M  !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ /85\6GULQTSS    *P(
M !$              ( !PP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%
M  @ /85\6IE<G",0!@  G"<  !,              ( !Y0$  'AL+W1H96UE
M+W1H96UE,2YX;6Q02P$"% ,4    "  ]A7Q:^\SL;RX'  !>+@  &
M        @($F"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%
M  @ /85\6EP,(6@V @  J@4  !@              ("!B@\  'AL+W=O<FMS
M:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( #V%?%K(>A)?2PD  )HX   8
M              " @?81  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"
M% ,4    "  ]A7Q:(@@19%D%  !7*   &               @(%W&P  >&PO
M=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ /85\6M:&,5-*!@
M*1P  !@              ("!!B$  'AL+W=O<FMS:&5E=',O<VAE970U+GAM
M;%!+ 0(4 Q0    ( #V%?%J6XU70Q1$  %X) 0 8              " @88G
M  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    "  ]A7Q:E$BR
M:J(*  "3.   &               @(&!.0  >&PO=V]R:W-H965T<R]S:&5E
M=#<N>&UL4$L! A0#%     @ /85\6E'9@VI##0  =2(  !@
M ("!640  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( #V%
M?%J4+W4/F1<  ()'   8              " @=)1  !X;"]W;W)K<VAE971S
M+W-H965T.2YX;6Q02P$"% ,4    "  ]A7Q:?:/)&"T.   <)P  &0
M        @(&A:0  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0
M   ( #V%?%IUJ$U;,@H  $ >   9              " @05X  !X;"]W;W)K
M<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ /85\6I'!=0DQ"@  ,AX
M !D              ("!;H(  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q0
M2P$"% ,4    "  ]A7Q:Y-E5HHT"   :!@  &0              @('6C
M>&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( #V%?%H!O1CW
MGP(  #4&   9              " @9J/  !X;"]W;W)K<VAE971S+W-H965T
M,30N>&UL4$L! A0#%     @ /85\6M%*1N]@!0  "0T  !D
M ("!<)(  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    "  ]
MA7Q:%YK?=N@'  #;$P  &0              @($'F   >&PO=V]R:W-H965T
M<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( #V%?%HC;-.*O 4  #X-   9
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M970R,2YX;6Q02P$"% ,4    "  ]A7Q:L?>> YX/   ".0  &0
M    @(&*P   >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    (
M #V%?%J[QK8#[ @   $<   9              " @5_0  !X;"]W;W)K<VAE
M971S+W-H965T,C,N>&UL4$L! A0#%     @ /85\6AQ(LAZ'$@  W&,  !D
M             ("!@MD  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"
M% ,4    "  ]A7Q:AFE28\4-  "1,@  &0              @(% [   >&PO
M=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( #V%?%H3&W+BC@<
M ),3   9              " @3SZ  !X;"]W;W)K<VAE971S+W-H965T,C8N
M>&UL4$L! A0#%     @ /85\6I(GQGA<#@  TB<  !D              ("!
M 0(! 'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    "  ]A7Q:
M5''I$8@0  #1*@  &0              @(&4$ $ >&PO=V]R:W-H965T<R]S
M:&5E=#(X+GAM;%!+ 0(4 Q0    ( #V%?%J/"V(M&P0  (L+   9
M      " @5,A 0!X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%
M  @ /85\6A0O*D^.!   C@P  !D              ("!I24! 'AL+W=O<FMS
M:&5E=',O<VAE970S,"YX;6Q02P$"% ,4    "  ]A7Q:0R'BRX<"  "G!0
M&0              @(%J*@$ >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+
M 0(4 Q0    ( #V%?%H,>$ED2 (  )L%   9              " @2@M 0!X
M;"]W;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ /85\6MQCO-5#
M @  B@8  !D              ("!IR\! 'AL+W=O<FMS:&5E=',O<VAE970S
M,RYX;6Q02P$"% ,4    "  ]A7Q:I,2-+!$"  #=!   &0
M@($A,@$ >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( #V%
M?%HYG)P#+PD  !(H   9              " @6DT 0!X;"]W;W)K<VAE971S
M+W-H965T,S4N>&UL4$L! A0#%     @ /85\6E+LP:WB%0   48  !D
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M=#0P+GAM;%!+ 0(4 Q0    ( #V%?%H?KR'XH0(   T&   9
M  " @?5I 0!X;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @
M/85\6H2\Z=QW @  Q 4  !D              ("!S6P! 'AL+W=O<FMS:&5E
M=',O<VAE970T,BYX;6Q02P$"% ,4    "  ]A7Q:5)\-J#D#  #F!P  &0
M            @(%[;P$ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4
M Q0    ( #V%?%J$%$+E]0(  '<&   9              " @>MR 0!X;"]W
M;W)K<VAE971S+W-H965T-#0N>&UL4$L! A0#%     @ /85\6CJ<[T$" P
MYP8  !D              ("!%W8! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX
M;6Q02P$"% ,4    "  ]A7Q:5U!677P"  "W!0  &0              @(%0
M>0$ >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( #V%?%H3
M24:$R0(  " &   9              " @0-\ 0!X;"]W;W)K<VAE971S+W-H
M965T-#<N>&UL4$L! A0#%     @ /85\6G'\\S<0 P  9P<  !D
M     ("! W\! 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( #V%?%HQK^CE[P4  +@/   9              "
M@?6/ 0!X;"]W;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ /85\
M6@Q)JP]& P  Y @  !D              ("!&Y8! 'AL+W=O<FMS:&5E=',O
M<VAE970U-"YX;6Q02P$"% ,4    "  ]A7Q:?T9'GQ8$  !'"P  &0
M        @(&8F0$ >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0
M   ( #V%?%JI*WCPA ,  +\*   9              " @>6= 0!X;"]W;W)K
M<VAE971S+W-H965T-38N>&UL4$L! A0#%     @ /85\6E"[#K'8!0  -2P
M !D              ("!H*$! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q0
M2P$"% ,4    "  ]A7Q:,C:&=7H"  #M!@  &0              @(&OIP$
M>&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4 Q0    ( #V%?%I4S*]2
M. ,  (4)   9              " @6"J 0!X;"]W;W)K<VAE971S+W-H965T
M-3DN>&UL4$L! A0#%     @ /85\6EK_6Y]_!0  %"@  !D
M ("!SZT! 'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6Q02P$"% ,4    "  ]
MA7Q:,ST8S>8"   Y"0  &0              @(&%LP$ >&PO=V]R:W-H965T
M<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0    ( #V%?%JAPYO"A04  .@C   9
M          " @:*V 0!X;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#
M%     @ /85\6F%Q:QY)!   ^A(  !D              ("!7KP! 'AL+W=O
M<FMS:&5E=',O<VAE970V,RYX;6Q02P$"% ,4    "  ]A7Q:YS/X5R &  !L
M.   &0              @('>P $ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM
M;%!+ 0(4 Q0    ( #V%?%I3RN]3H@0  +$8   9              " @37'
M 0!X;"]W;W)K<VAE971S+W-H965T-C4N>&UL4$L! A0#%     @ /85\6G>A
MX=9&!   2@X  !D              ("!#LP! 'AL+W=O<FMS:&5E=',O<VAE
M970V-BYX;6Q02P$"% ,4    "  ]A7Q:YE*$<L@$   /%0  &0
M    @(&+T $ >&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    (
M #V%?%H47AY?U <  ,@I   9              " @8K5 0!X;"]W;W)K<VAE
M971S+W-H965T-C@N>&UL4$L! A0#%     @ /85\6NP5\:1_ @  ? 8  !D
M             ("!E=T! 'AL+W=O<FMS:&5E=',O<VAE970V.2YX;6Q02P$"
M% ,4    "  ]A7Q:Y<I@-GP"  #E!P  &0              @(%+X $ >&PO
M=V]R:W-H965T<R]S:&5E=#<P+GAM;%!+ 0(4 Q0    ( #V%?%IX6.'Z60(
M *@%   9              " @?[B 0!X;"]W;W)K<VAE971S+W-H965T-S$N
M>&UL4$L! A0#%     @ /85\6J!7U,YY @  ;08  !D              ("!
MCN4! 'AL+W=O<FMS:&5E=',O<VAE970W,BYX;6Q02P$"% ,4    "  ]A7Q:
M5N,<END"  !Q"   &0              @($^Z $ >&PO=V]R:W-H965T<R]S
M:&5E=#<S+GAM;%!+ 0(4 Q0    ( #V%?%IO//VTLP(  ,0'   9
M      " @5[K 0!X;"]W;W)K<VAE971S+W-H965T-S0N>&UL4$L! A0#%
M  @ /85\6@DTNJZQ!0  :2<  !D              ("!2.X! 'AL+W=O<FMS
M:&5E=',O<VAE970W-2YX;6Q02P$"% ,4    "  ]A7Q:]/8>RPH$  !.%@
M&0              @($P] $ >&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+
M 0(4 Q0    ( #V%?%JA0\-*] 0  )DG   9              " @7'X 0!X
M;"]W;W)K<VAE971S+W-H965T-S<N>&UL4$L! A0#%     @ /85\6N=(PLXM
M!   @A(  !D              ("!G/T! 'AL+W=O<FMS:&5E=',O<VAE970W
M."YX;6Q02P$"% ,4    "  ]A7Q:OXAAA)X#  "K#0  &0
M@($  @( >&PO=V]R:W-H965T<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0    ( #V%
M?%JG=- K4P(  -@%   9              " @=4% @!X;"]W;W)K<VAE971S
M+W-H965T.# N>&UL4$L! A0#%     @ /85\6BD,*VKV @  30D  !D
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M=#@U+GAM;%!+ 0(4 Q0    ( #V%?%KM:3^.=@0  /D8   9
M  " @1<Q @!X;"]W;W)K<VAE971S+W-H965T.#8N>&UL4$L! A0#%     @
M/85\6A_G!DVH @  L0@  !D              ("!Q#4" 'AL+W=O<FMS:&5E
M=',O<VAE970X-RYX;6Q02P$"% ,4    "  ]A7Q:D#I2T>(-  "<TP  &0
M            @(&C. ( >&PO=V]R:W-H965T<R]S:&5E=#@X+GAM;%!+ 0(4
M Q0    ( #V%?%H!SS-CR@0  $09   9              " @;Q& @!X;"]W
M;W)K<VAE971S+W-H965T.#DN>&UL4$L! A0#%     @ /85\6D"SJE*\ P
M0A4  !D              ("!O4L" 'AL+W=O<FMS:&5E=',O<VAE970Y,"YX
M;6Q02P$"% ,4    "  ]A7Q:FWG[)0H$  !@%P  &0              @(&P
M3P( >&PO=V]R:W-H965T<R]S:&5E=#DQ+GAM;%!+ 0(4 Q0    ( #V%?%IV
MZ51&_P(  -8.   9              " @?%3 @!X;"]W;W)K<VAE971S+W-H
M965T.3(N>&UL4$L! A0#%     @ /85\6NKCP]B3 P  K1$  !D
M     ("!)U<" 'AL+W=O<FMS:&5E=',O<VAE970Y,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( #V%?%IX'L:*ZAT  -1= @ 9              "
M@5]J @!X;"]W;W)K<VAE971S+W-H965T.3@N>&UL4$L! A0#%     @ /85\
M6D:7W)U !P   4H  !D              ("!@(@" 'AL+W=O<FMS:&5E=',O
M<VAE970Y.2YX;6Q02P$"% ,4    "  ]A7Q:A^%\9+$$  !6%P  &@
M        @('WCP( >&PO=V]R:W-H965T<R]S:&5E=#$P,"YX;6Q02P$"% ,4
M    "  ]A7Q: G&Q/6L#   \#0  &@              @('@E ( >&PO=V]R
M:W-H965T<R]S:&5E=#$P,2YX;6Q02P$"% ,4    "  ]A7Q:CI,S)LP"  "U
M"@  &@              @(&#F ( >&PO=V]R:W-H965T<R]S:&5E=#$P,BYX
M;6Q02P$"% ,4    "  ]A7Q:))X,/<8#  #:#P  &@              @(&'
MFP( >&PO=V]R:W-H965T<R]S:&5E=#$P,RYX;6Q02P$"% ,4    "  ]A7Q:
M(C,D;X0#   L"P  &@              @(&%GP( >&PO=V]R:W-H965T<R]S
M:&5E=#$P-"YX;6Q02P$"% ,4    "  ]A7Q:^P*3!,4"   F!P  &@
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M:&5E=#$P.2YX;6Q02P$"% ,4    "  ]A7Q:D.]_*X("  #U!0  &@
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M<F5L<R\N<F5L<U!+ 0(4 Q0    ( #V%?%HY%PP:S0<  -))   /
M      "  9_H @!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  ]A7Q:(EQP
M%RD#  !80@  &@              @ &9\ ( >&PO7W)E;',O=V]R:V)O;VLN
M>&UL+G)E;'-02P$"% ,4    "  ]A7Q:_SZM7H("  #%/P  $P
M    @ 'Z\P( 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     >0!Y %0A  "M
%]@(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>154
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>421</ContextCount>
  <ElementCount>534</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>166</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>18</UnitCount>
  <MyReports>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952151 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952152 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952153 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952154 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952155 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952156 - Disclosure - Background and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/BackgroundandBasisofPresentation</Role>
      <ShortName>Background and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952157 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - Mergers and Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/MergersandAcquisitions</Role>
      <ShortName>Mergers and Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - Sale of Recycling Subsidiaries</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/SaleofRecyclingSubsidiaries</Role>
      <ShortName>Sale of Recycling Subsidiaries</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - Discontinued Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/DiscontinuedOperations</Role>
      <ShortName>Discontinued Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - Prepaids and other current assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/Prepaidsandothercurrentassets</Role>
      <ShortName>Prepaids and other current assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/PropertyandEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - Notes receivable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.alt5sigma.com/role/Notesreceivable</Role>
      <ShortName>Notes receivable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - Intangible assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/Intangibleassets</Role>
      <ShortName>Intangible assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - Marketable Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/MarketableSecurities</Role>
      <ShortName>Marketable Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9952167 - Disclosure - Deposits and other assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/Depositsandotherassets</Role>
      <ShortName>Deposits and other assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9952168 - Disclosure - Accrued liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/Accruedliabilities</Role>
      <ShortName>Accrued liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9952169 - Disclosure - Debentures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/Debentures</Role>
      <ShortName>Debentures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9952170 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/LongTermDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9952171 - Disclosure - Related Party Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/RelatedPartyDebt</Role>
      <ShortName>Related Party Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9952172 - Disclosure - Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/PreferredStock</Role>
      <ShortName>Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9952173 - Disclosure - Stockholders??? Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders??? Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9952174 - Disclosure - Income taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/Incometaxes</Role>
      <ShortName>Income taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9952175 - Disclosure - Related parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/Relatedparties</Role>
      <ShortName>Related parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9952176 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9952177 - Disclosure - Earnings (Loss) per share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/EarningsLosspershare</Role>
      <ShortName>Earnings (Loss) per share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9952178 - Disclosure - Segment information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/Segmentinformation</Role>
      <ShortName>Segment information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9952179 - Disclosure - Subsequent events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/Subsequentevents</Role>
      <ShortName>Subsequent events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure</Role>
      <ShortName>Cybersecurity Risk Management and Strategy Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.alt5sigma.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9955512 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.alt5sigma.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9955513 - Disclosure - Mergers and Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/MergersandAcquisitionsTables</Role>
      <ShortName>Mergers and Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.alt5sigma.com/role/MergersandAcquisitions</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9955514 - Disclosure - Sale of Recycling Subsidiaries (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesTables</Role>
      <ShortName>Sale of Recycling Subsidiaries (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.alt5sigma.com/role/SaleofRecyclingSubsidiaries</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9955515 - Disclosure - Discontinued Operations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/DiscontinuedOperationsTables</Role>
      <ShortName>Discontinued Operations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.alt5sigma.com/role/DiscontinuedOperations</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9955516 - Disclosure - Prepaids and other current assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/PrepaidsandothercurrentassetsTables</Role>
      <ShortName>Prepaids and other current assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.alt5sigma.com/role/Prepaidsandothercurrentassets</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9955517 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/PropertyandEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.alt5sigma.com/role/PropertyandEquipment</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9955518 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.alt5sigma.com/role/Leases</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9955519 - Disclosure - Intangible assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/IntangibleassetsTables</Role>
      <ShortName>Intangible assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.alt5sigma.com/role/Intangibleassets</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9955520 - Disclosure - Marketable Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/MarketableSecuritiesTables</Role>
      <ShortName>Marketable Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.alt5sigma.com/role/MarketableSecurities</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9955521 - Disclosure - Deposits and other assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/DepositsandotherassetsTables</Role>
      <ShortName>Deposits and other assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.alt5sigma.com/role/Depositsandotherassets</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9955522 - Disclosure - Accrued liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/AccruedliabilitiesTables</Role>
      <ShortName>Accrued liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.alt5sigma.com/role/Accruedliabilities</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9955523 - Disclosure - Debentures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/DebenturesTables</Role>
      <ShortName>Debentures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.alt5sigma.com/role/Debentures</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9955524 - Disclosure - Long-Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/LongTermDebtTables</Role>
      <ShortName>Long-Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.alt5sigma.com/role/LongTermDebt</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9955525 - Disclosure - Related Party Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/RelatedPartyDebtTables</Role>
      <ShortName>Related Party Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.alt5sigma.com/role/RelatedPartyDebt</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9955526 - Disclosure - Preferred Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/PreferredStockTables</Role>
      <ShortName>Preferred Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.alt5sigma.com/role/PreferredStock</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9955527 - Disclosure - Stockholders??? Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders??? Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.alt5sigma.com/role/StockholdersEquity</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9955528 - Disclosure - Income taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/IncometaxesTables</Role>
      <ShortName>Income taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.alt5sigma.com/role/Incometaxes</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9955529 - Disclosure - Earnings (Loss) per share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/EarningsLosspershareTables</Role>
      <ShortName>Earnings (Loss) per share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.alt5sigma.com/role/EarningsLosspershare</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9955530 - Disclosure - Segment information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/SegmentinformationTables</Role>
      <ShortName>Segment information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.alt5sigma.com/role/Segmentinformation</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9955531 - Disclosure - Background and Basis of Presentation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/BackgroundandBasisofPresentationDetails</Role>
      <ShortName>Background and Basis of Presentation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.alt5sigma.com/role/BackgroundandBasisofPresentation</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9955532 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9955533 - Disclosure - Summary of Significant Accounting Policies - Schedule of Trade and Other Receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesScheduleofTradeandOtherReceivablesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Trade and Other Receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9955534 - Disclosure - Mergers and Acquisitions - Qoden (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/MergersandAcquisitionsQodenDetails</Role>
      <ShortName>Mergers and Acquisitions - Qoden (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9955535 - Disclosure - Mergers and Acquisitions - ALT5 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/MergersandAcquisitionsALT5Details</Role>
      <ShortName>Mergers and Acquisitions - ALT5 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9955536 - Disclosure - Mergers and Acquisitions - Schedule of Fair Value Adjustments for Shares of Series B and Series M Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofFairValueAdjustmentsforSharesofSeriesBandSeriesMPreferredStockDetails</Role>
      <ShortName>Mergers and Acquisitions - Schedule of Fair Value Adjustments for Shares of Series B and Series M Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9955537 - Disclosure - Mergers and Acquisitions - Schedule of Purchase Price Allocation of Purchase for ALT5 Subsidiary to Acquired Identifiable Assets, Liabilities Assumed and Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails</Role>
      <ShortName>Mergers and Acquisitions - Schedule of Purchase Price Allocation of Purchase for ALT5 Subsidiary to Acquired Identifiable Assets, Liabilities Assumed and Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9955538 - Disclosure - Mergers and Acquisitions - Schedule of Proforma Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofProformaInformationDetails</Role>
      <ShortName>Mergers and Acquisitions - Schedule of Proforma Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9955539 - Disclosure - Mergers and Acquisitions - Soin Pharmaceuticals (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails</Role>
      <ShortName>Mergers and Acquisitions - Soin Pharmaceuticals (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9955540 - Disclosure - Sale of Recycling Subsidiaries - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesNarrativeDetails</Role>
      <ShortName>Sale of Recycling Subsidiaries - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9955541 - Disclosure - Sale of Recycling Subsidiaries - Schedule of Gain on Sale of Recycling Subsidiaries (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails</Role>
      <ShortName>Sale of Recycling Subsidiaries - Schedule of Gain on Sale of Recycling Subsidiaries (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9955542 - Disclosure - Discontinued Operations - Schedule of Discontinued Operations in Consolidated Statements of Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails</Role>
      <ShortName>Discontinued Operations - Schedule of Discontinued Operations in Consolidated Statements of Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9955543 - Disclosure - Discontinued Operations - Schedule of Discontinued Operations in the Consolidated Statements of Cash Flows (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails</Role>
      <ShortName>Discontinued Operations - Schedule of Discontinued Operations in the Consolidated Statements of Cash Flows (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9955544 - Disclosure - Prepaids and other current assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/PrepaidsandothercurrentassetsDetails</Role>
      <ShortName>Prepaids and other current assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.alt5sigma.com/role/PrepaidsandothercurrentassetsTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9955545 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails</Role>
      <ShortName>Property and Equipment - Schedule of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9955546 - Disclosure - Property and Equipment - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/PropertyandEquipmentNarrativeDetails</Role>
      <ShortName>Property and Equipment - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>9955547 - Disclosure - Leases - Schedule of Company's Right of Use Assets and Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/LeasesScheduleofCompanysRightofUseAssetsandLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Schedule of Company's Right of Use Assets and Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>9955548 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>9955549 - Disclosure - Leases - Schedule of Total Present Value of Future Lease Payments of Operating Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails</Role>
      <ShortName>Leases - Schedule of Total Present Value of Future Lease Payments of Operating Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>9955550 - Disclosure - Notes receivable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.alt5sigma.com/role/NotesreceivableDetails</Role>
      <ShortName>Notes receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.alt5sigma.com/role/Notesreceivable</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>9955551 - Disclosure - Intangible assets - Schedule of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/IntangibleassetsScheduleofIntangibleAssetsDetails</Role>
      <ShortName>Intangible assets - Schedule of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>9955552 - Disclosure - Intangible assets - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/IntangibleassetsNarrativeDetails</Role>
      <ShortName>Intangible assets - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>9955553 - Disclosure - Marketable Securities - Schedule of Marketable Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails</Role>
      <ShortName>Marketable Securities - Schedule of Marketable Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>9955554 - Disclosure - Marketable Securities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/MarketableSecuritiesNarrativeDetails</Role>
      <ShortName>Marketable Securities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>9955555 - Disclosure - Deposits and other assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/DepositsandotherassetsDetails</Role>
      <ShortName>Deposits and other assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.alt5sigma.com/role/DepositsandotherassetsTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>9955556 - Disclosure - Accrued liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/AccruedliabilitiesDetails</Role>
      <ShortName>Accrued liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.alt5sigma.com/role/AccruedliabilitiesTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>9955557 - Disclosure - Debentures - Schedule of Debentures Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/DebenturesScheduleofDebenturesOutstandingDetails</Role>
      <ShortName>Debentures - Schedule of Debentures Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>9955558 - Disclosure - Debentures - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/DebenturesNarrativeDetails</Role>
      <ShortName>Debentures - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>9955559 - Disclosure - Long-Term Debt - Schedule of Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/LongTermDebtScheduleofLongTermDebtDetails</Role>
      <ShortName>Long-Term Debt - Schedule of Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>9955560 - Disclosure - Long-Term Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails</Role>
      <ShortName>Long-Term Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>9955561 - Disclosure - Related Party Debt - Schedule of Long-Term Debt Payable to Related Parties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofLongTermDebtPayabletoRelatedPartiesDetails</Role>
      <ShortName>Related Party Debt - Schedule of Long-Term Debt Payable to Related Parties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>9955562 - Disclosure - Related Party Debt - Schedule of Future Maturities of Long Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofFutureMaturitiesofLongTermDebtDetails</Role>
      <ShortName>Related Party Debt - Schedule of Future Maturities of Long Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>9955563 - Disclosure - Related Party Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails</Role>
      <ShortName>Related Party Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>9955564 - Disclosure - Preferred Stock - Series A-1 Convertible Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/PreferredStockSeriesA1ConvertiblePreferredStockDetails</Role>
      <ShortName>Preferred Stock - Series A-1 Convertible Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>9955565 - Disclosure - Preferred Stock - Series B Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/PreferredStockSeriesBPreferredStockDetails</Role>
      <ShortName>Preferred Stock - Series B Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>9955566 - Disclosure - Preferred Stock - Series I Convertible Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/PreferredStockSeriesIConvertiblePreferredStockDetails</Role>
      <ShortName>Preferred Stock - Series I Convertible Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>9955567 - Disclosure - Preferred Stock - Series M Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/PreferredStockSeriesMPreferredStockDetails</Role>
      <ShortName>Preferred Stock - Series M Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>9955568 - Disclosure - Preferred Stock - Series Q Convertible Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/PreferredStockSeriesQConvertiblePreferredStockDetails</Role>
      <ShortName>Preferred Stock - Series Q Convertible Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>9955569 - Disclosure - Preferred Stock - Series V Convertible Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/PreferredStockSeriesVConvertiblePreferredStockDetails</Role>
      <ShortName>Preferred Stock - Series V Convertible Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>9955570 - Disclosure - Preferred Stock - Series S Convertible Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails</Role>
      <ShortName>Preferred Stock - Series S Convertible Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>9955571 - Disclosure - Preferred Stock - Schedule of Series S Convertible Preferred Stock Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/PreferredStockScheduleofSeriesSConvertiblePreferredStockOutstandingDetails</Role>
      <ShortName>Preferred Stock - Schedule of Series S Convertible Preferred Stock Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>9955572 - Disclosure - Stockholders' Equity - Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/StockholdersEquityCommonStockDetails</Role>
      <ShortName>Stockholders' Equity - Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>9955573 - Disclosure - Stockholders' Equity - Equity Offerings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails</Role>
      <ShortName>Stockholders' Equity - Equity Offerings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>9955574 - Disclosure - Stockholders' Equity - Equity Incentives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails</Role>
      <ShortName>Stockholders' Equity - Equity Incentives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>9955575 - Disclosure - Stockholders' Equity - Schedule of Stock Options Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Stock Options Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>9955576 - Disclosure - Stockholders' Equity - Schedule of Exercise Price for Stock Options Outstanding and Exercisable Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/StockholdersEquityScheduleofExercisePriceforStockOptionsOutstandingandExercisableOutstandingDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Exercise Price for Stock Options Outstanding and Exercisable Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>9955577 - Disclosure - Income taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/IncometaxesNarrativeDetails</Role>
      <ShortName>Income taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>9955578 - Disclosure - Income taxes - Schedule of Income Tax Provision (Benefit) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeTaxProvisionBenefitDetails</Role>
      <ShortName>Income taxes - Schedule of Income Tax Provision (Benefit) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>9955579 - Disclosure - Income taxes - Schedule of Reconciliation of Income Tax Benefit (Provision) with the Federal Statutory Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/IncometaxesScheduleofReconciliationofIncomeTaxBenefitProvisionwiththeFederalStatutoryTaxRateDetails</Role>
      <ShortName>Income taxes - Schedule of Reconciliation of Income Tax Benefit (Provision) with the Federal Statutory Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>9955580 - Disclosure - Income taxes - Schedule of Income (Loss) Before Provision of Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeLossBeforeProvisionofIncomeTaxesDetails</Role>
      <ShortName>Income taxes - Schedule of Income (Loss) Before Provision of Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>9955581 - Disclosure - Income taxes - Schedule of Components of Net Deferred Tax Assets (Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails</Role>
      <ShortName>Income taxes - Schedule of Components of Net Deferred Tax Assets (Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>9955582 - Disclosure - Related parties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/RelatedpartiesDetails</Role>
      <ShortName>Related parties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.alt5sigma.com/role/Relatedparties</ParentRole>
      <Position>107</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>9955583 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.alt5sigma.com/role/CommitmentsandContingencies</ParentRole>
      <Position>108</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>9955584 - Disclosure - Earnings (Loss) per share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/EarningsLosspershareScheduleofComputationofBasicandDilutedNetLossPerShareDetails</Role>
      <ShortName>Earnings (Loss) per share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.alt5sigma.com/role/EarningsLosspershareTables</ParentRole>
      <Position>109</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>9955585 - Disclosure - Earnings (Loss) per share - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/EarningsLosspershareNarrativeDetails</Role>
      <ShortName>Earnings (Loss) per share - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.alt5sigma.com/role/EarningsLosspershareTables</ParentRole>
      <Position>110</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>9955586 - Disclosure - Segment information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/SegmentinformationNarrativeDetails</Role>
      <ShortName>Segment information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>111</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>9955587 - Disclosure - Segment information - Schedule of Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/SegmentinformationScheduleofSegmentInformationDetails</Role>
      <ShortName>Segment information - Schedule of Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>112</Position>
    </Report>
    <Report instance="alts-20241228.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>9955588 - Disclosure - Segment information - Schedule of Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.alt5sigma.com/role/SegmentinformationScheduleofBalanceSheetInformationDetails</Role>
      <ShortName>Segment information - Schedule of Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>113</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="alts-20241228.htm">alts-20241228.htm</File>
    <File>alts-20241228.xsd</File>
    <File>alts-20241228_cal.xml</File>
    <File>alts-20241228_def.xml</File>
    <File>alts-20241228_lab.xml</File>
    <File>alts-20241228_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>alts-20241228_g1.jpg</File>
    <File>alts-20241228_g10.jpg</File>
    <File>alts-20241228_g11.jpg</File>
    <File>alts-20241228_g12.jpg</File>
    <File>alts-20241228_g13.jpg</File>
    <File>alts-20241228_g14.jpg</File>
    <File>alts-20241228_g15.jpg</File>
    <File>alts-20241228_g16.jpg</File>
    <File>alts-20241228_g17.jpg</File>
    <File>alts-20241228_g2.jpg</File>
    <File>alts-20241228_g3.jpg</File>
    <File>alts-20241228_g4.jpg</File>
    <File>alts-20241228_g5.jpg</File>
    <File>alts-20241228_g6.jpg</File>
    <File>alts-20241228_g7.jpg</File>
    <File>alts-20241228_g8.jpg</File>
    <File>alts-20241228_g9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1230">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="15">http://xbrl.sec.gov/cyd/2024</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="5">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>157
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "alts-20241228.htm": {
   "nsprefix": "alts",
   "nsuri": "http://www.alt5sigma.com/20241228",
   "dts": {
    "inline": {
     "local": [
      "alts-20241228.htm"
     ]
    },
    "schema": {
     "local": [
      "alts-20241228.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-af-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-af-sub-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "alts-20241228_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "alts-20241228_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "alts-20241228_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "alts-20241228_pre.xml"
     ]
    }
   },
   "keyStandard": 421,
   "keyCustom": 113,
   "axisStandard": 35,
   "axisCustom": 2,
   "memberStandard": 37,
   "memberCustom": 119,
   "hidden": {
    "total": 6,
    "http://xbrl.sec.gov/dei/2024": 4,
    "http://fasb.org/us-gaap/2024": 2
   },
   "contextCount": 421,
   "entityCount": 1,
   "segmentCount": 166,
   "elementCount": 960,
   "unitCount": 18,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 1230,
    "http://xbrl.sec.gov/dei/2024": 37,
    "http://xbrl.sec.gov/cyd/2024": 15,
    "http://xbrl.sec.gov/ecd/2024": 5
   },
   "report": {
    "R1": {
     "role": "http://www.alt5sigma.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.alt5sigma.com/role/AuditInformation",
     "longName": "0000002 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorFirmId",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorFirmId",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS",
     "longName": "9952151 - Statement - CONSOLIDATED BALANCE SHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "longName": "9952152 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-10",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
     "longName": "9952153 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CostOfRevenue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT",
     "longName": "9952154 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)",
     "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-23",
      "name": "us-gaap:PreferredStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-23",
      "name": "us-gaap:PreferredStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "longName": "9952155 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperations",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProvisionForDoubtfulAccounts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.alt5sigma.com/role/BackgroundandBasisofPresentation",
     "longName": "9952156 - Disclosure - Background and Basis of Presentation",
     "shortName": "Background and Basis of Presentation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPolicies",
     "longName": "9952157 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.alt5sigma.com/role/MergersandAcquisitions",
     "longName": "9952158 - Disclosure - Mergers and Acquisitions",
     "shortName": "Mergers and Acquisitions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiaries",
     "longName": "9952159 - Disclosure - Sale of Recycling Subsidiaries",
     "shortName": "Sale of Recycling Subsidiaries",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R12": {
     "role": "http://www.alt5sigma.com/role/DiscontinuedOperations",
     "longName": "9952160 - Disclosure - Discontinued Operations",
     "shortName": "Discontinued Operations",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R13": {
     "role": "http://www.alt5sigma.com/role/Prepaidsandothercurrentassets",
     "longName": "9952161 - Disclosure - Prepaids and other current assets",
     "shortName": "Prepaids and other current assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherCurrentAssetsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherCurrentAssetsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.alt5sigma.com/role/PropertyandEquipment",
     "longName": "9952162 - Disclosure - Property and Equipment",
     "shortName": "Property and Equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.alt5sigma.com/role/Leases",
     "longName": "9952163 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.alt5sigma.com/role/Notesreceivable",
     "longName": "9952164 - Disclosure - Notes receivable",
     "shortName": "Notes receivable",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FinancingReceivablesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FinancingReceivablesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.alt5sigma.com/role/Intangibleassets",
     "longName": "9952165 - Disclosure - Intangible assets",
     "shortName": "Intangible assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.alt5sigma.com/role/MarketableSecurities",
     "longName": "9952166 - Disclosure - Marketable Securities",
     "shortName": "Marketable Securities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.alt5sigma.com/role/Depositsandotherassets",
     "longName": "9952167 - Disclosure - Deposits and other assets",
     "shortName": "Deposits and other assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.alt5sigma.com/role/Accruedliabilities",
     "longName": "9952168 - Disclosure - Accrued liabilities",
     "shortName": "Accrued liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.alt5sigma.com/role/Debentures",
     "longName": "9952169 - Disclosure - Debentures",
     "shortName": "Debentures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R22": {
     "role": "http://www.alt5sigma.com/role/LongTermDebt",
     "longName": "9952170 - Disclosure - Long-Term Debt",
     "shortName": "Long-Term Debt",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R23": {
     "role": "http://www.alt5sigma.com/role/RelatedPartyDebt",
     "longName": "9952171 - Disclosure - Related Party Debt",
     "shortName": "Related Party Debt",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.alt5sigma.com/role/PreferredStock",
     "longName": "9952172 - Disclosure - Preferred Stock",
     "shortName": "Preferred Stock",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PreferredStockTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PreferredStockTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.alt5sigma.com/role/StockholdersEquity",
     "longName": "9952173 - Disclosure - Stockholders\u2019 Equity",
     "shortName": "Stockholders\u2019 Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.alt5sigma.com/role/Incometaxes",
     "longName": "9952174 - Disclosure - Income taxes",
     "shortName": "Income taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.alt5sigma.com/role/Relatedparties",
     "longName": "9952175 - Disclosure - Related parties",
     "shortName": "Related parties",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.alt5sigma.com/role/CommitmentsandContingencies",
     "longName": "9952176 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.alt5sigma.com/role/EarningsLosspershare",
     "longName": "9952177 - Disclosure - Earnings (Loss) per share",
     "shortName": "Earnings (Loss) per share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.alt5sigma.com/role/Segmentinformation",
     "longName": "9952178 - Disclosure - Segment information",
     "shortName": "Segment information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.alt5sigma.com/role/Subsequentevents",
     "longName": "9952179 - Disclosure - Subsequent events",
     "shortName": "Subsequent events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R33": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-421",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-421",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure",
     "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "longName": "9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesTables",
     "longName": "9955512 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.alt5sigma.com/role/MergersandAcquisitionsTables",
     "longName": "9955513 - Disclosure - Mergers and Acquisitions (Tables)",
     "shortName": "Mergers and Acquisitions (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesTables",
     "longName": "9955514 - Disclosure - Sale of Recycling Subsidiaries (Tables)",
     "shortName": "Sale of Recycling Subsidiaries (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R40": {
     "role": "http://www.alt5sigma.com/role/DiscontinuedOperationsTables",
     "longName": "9955515 - Disclosure - Discontinued Operations (Tables)",
     "shortName": "Discontinued Operations (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R41": {
     "role": "http://www.alt5sigma.com/role/PrepaidsandothercurrentassetsTables",
     "longName": "9955516 - Disclosure - Prepaids and other current assets (Tables)",
     "shortName": "Prepaids and other current assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.alt5sigma.com/role/PropertyandEquipmentTables",
     "longName": "9955517 - Disclosure - Property and Equipment (Tables)",
     "shortName": "Property and Equipment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.alt5sigma.com/role/LeasesTables",
     "longName": "9955518 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "alts:ScheduleOfOperatingLeaseRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "alts:ScheduleOfOperatingLeaseRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.alt5sigma.com/role/IntangibleassetsTables",
     "longName": "9955519 - Disclosure - Intangible assets (Tables)",
     "shortName": "Intangible assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.alt5sigma.com/role/MarketableSecuritiesTables",
     "longName": "9955520 - Disclosure - Marketable Securities (Tables)",
     "shortName": "Marketable Securities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.alt5sigma.com/role/DepositsandotherassetsTables",
     "longName": "9955521 - Disclosure - Deposits and other assets (Tables)",
     "shortName": "Deposits and other assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.alt5sigma.com/role/AccruedliabilitiesTables",
     "longName": "9955522 - Disclosure - Accrued liabilities (Tables)",
     "shortName": "Accrued liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.alt5sigma.com/role/DebenturesTables",
     "longName": "9955523 - Disclosure - Debentures (Tables)",
     "shortName": "Debentures (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R49": {
     "role": "http://www.alt5sigma.com/role/LongTermDebtTables",
     "longName": "9955524 - Disclosure - Long-Term Debt (Tables)",
     "shortName": "Long-Term Debt (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R50": {
     "role": "http://www.alt5sigma.com/role/RelatedPartyDebtTables",
     "longName": "9955525 - Disclosure - Related Party Debt (Tables)",
     "shortName": "Related Party Debt (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.alt5sigma.com/role/PreferredStockTables",
     "longName": "9955526 - Disclosure - Preferred Stock (Tables)",
     "shortName": "Preferred Stock (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.alt5sigma.com/role/StockholdersEquityTables",
     "longName": "9955527 - Disclosure - Stockholders\u2019 Equity (Tables)",
     "shortName": "Stockholders\u2019 Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.alt5sigma.com/role/IncometaxesTables",
     "longName": "9955528 - Disclosure - Income taxes (Tables)",
     "shortName": "Income taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.alt5sigma.com/role/EarningsLosspershareTables",
     "longName": "9955529 - Disclosure - Earnings (Loss) per share (Tables)",
     "shortName": "Earnings (Loss) per share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.alt5sigma.com/role/SegmentinformationTables",
     "longName": "9955530 - Disclosure - Segment information (Tables)",
     "shortName": "Segment information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.alt5sigma.com/role/BackgroundandBasisofPresentationDetails",
     "longName": "9955531 - Disclosure - Background and Basis of Presentation (Details)",
     "shortName": "Background and Basis of Presentation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "longName": "9955532 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)",
     "shortName": "Summary of Significant Accounting Policies - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "alts:PlatformOperatorCryptoAssetHeldForUserCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesScheduleofTradeandOtherReceivablesDetails",
     "longName": "9955533 - Disclosure - Summary of Significant Accounting Policies - Schedule of Trade and Other Receivables (Details)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Trade and Other Receivables (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:OtherReceivablesNetCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-35",
      "name": "us-gaap:AccountsAndOtherReceivablesNetCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.alt5sigma.com/role/MergersandAcquisitionsQodenDetails",
     "longName": "9955534 - Disclosure - Mergers and Acquisitions - Qoden (Details)",
     "shortName": "Mergers and Acquisitions - Qoden (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-102",
      "name": "us-gaap:AssetAcquisitionConsiderationTransferred",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-102",
      "name": "us-gaap:AssetAcquisitionConsiderationTransferred",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.alt5sigma.com/role/MergersandAcquisitionsALT5Details",
     "longName": "9955535 - Disclosure - Mergers and Acquisitions - ALT5 (Details)",
     "shortName": "Mergers and Acquisitions - ALT5 (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-106",
      "name": "alts:BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfIssuedAndOutstandingShares",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofFairValueAdjustmentsforSharesofSeriesBandSeriesMPreferredStockDetails",
     "longName": "9955536 - Disclosure - Mergers and Acquisitions - Schedule of Fair Value Adjustments for Shares of Series B and Series M Preferred Stock (Details)",
     "shortName": "Mergers and Acquisitions - Schedule of Fair Value Adjustments for Shares of Series B and Series M Preferred Stock (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-105",
      "name": "us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-110",
      "name": "us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails",
     "longName": "9955537 - Disclosure - Mergers and Acquisitions - Schedule of Purchase Price Allocation of Purchase for ALT5 Subsidiary to Acquired Identifiable Assets, Liabilities Assumed and Goodwill (Details)",
     "shortName": "Mergers and Acquisitions - Schedule of Purchase Price Allocation of Purchase for ALT5 Subsidiary to Acquired Identifiable Assets, Liabilities Assumed and Goodwill (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-106",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofProformaInformationDetails",
     "longName": "9955538 - Disclosure - Mergers and Acquisitions - Schedule of Proforma Information (Details)",
     "shortName": "Mergers and Acquisitions - Schedule of Proforma Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails",
     "longName": "9955539 - Disclosure - Mergers and Acquisitions - Soin Pharmaceuticals (Details)",
     "shortName": "Mergers and Acquisitions - Soin Pharmaceuticals (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-126",
      "name": "us-gaap:PaymentsForLegalSettlements",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-126",
      "name": "us-gaap:PaymentsForLegalSettlements",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesNarrativeDetails",
     "longName": "9955540 - Disclosure - Sale of Recycling Subsidiaries - Narrative (Details)",
     "shortName": "Sale of Recycling Subsidiaries - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-136",
      "name": "us-gaap:GainLossOnDispositionOfAssets1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "alts:DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails",
     "longName": "9955541 - Disclosure - Sale of Recycling Subsidiaries - Schedule of Gain on Sale of Recycling Subsidiaries (Details)",
     "shortName": "Sale of Recycling Subsidiaries - Schedule of Gain on Sale of Recycling Subsidiaries (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-137",
      "name": "alts:TotalGuaranteedConsideration",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-137",
      "name": "alts:TotalGuaranteedConsideration",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails",
     "longName": "9955542 - Disclosure - Discontinued Operations - Schedule of Discontinued Operations in Consolidated Statements of Operations (Details)",
     "shortName": "Discontinued Operations - Schedule of Discontinued Operations in Consolidated Statements of Operations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-138",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails",
     "longName": "9955543 - Disclosure - Discontinued Operations - Schedule of Discontinued Operations in the Consolidated Statements of Cash Flows (Details)",
     "shortName": "Discontinued Operations - Schedule of Discontinued Operations in the Consolidated Statements of Cash Flows (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-35",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.alt5sigma.com/role/PrepaidsandothercurrentassetsDetails",
     "longName": "9955544 - Disclosure - Prepaids and other current assets (Details)",
     "shortName": "Prepaids and other current assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PrepaidInsurance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PrepaidInsurance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.alt5sigma.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails",
     "longName": "9955545 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)",
     "shortName": "Property and Equipment - Schedule of Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-143",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.alt5sigma.com/role/PropertyandEquipmentNarrativeDetails",
     "longName": "9955546 - Disclosure - Property and Equipment - Narrative (Details)",
     "shortName": "Property and Equipment - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "us-gaap:Depreciation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "us-gaap:Depreciation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.alt5sigma.com/role/LeasesScheduleofCompanysRightofUseAssetsandLeaseLiabilitiesDetails",
     "longName": "9955547 - Disclosure - Leases - Schedule of Company's Right of Use Assets and Lease Liabilities (Details)",
     "shortName": "Leases - Schedule of Company's Right of Use Assets and Lease Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R73": {
     "role": "http://www.alt5sigma.com/role/LeasesNarrativeDetails",
     "longName": "9955548 - Disclosure - Leases - Narrative (Details)",
     "shortName": "Leases - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.alt5sigma.com/role/LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails",
     "longName": "9955549 - Disclosure - Leases - Schedule of Total Present Value of Future Lease Payments of Operating Leases (Details)",
     "shortName": "Leases - Schedule of Total Present Value of Future Lease Payments of Operating Leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://www.alt5sigma.com/role/NotesreceivableDetails",
     "longName": "9955550 - Disclosure - Notes receivable (Details)",
     "shortName": "Notes receivable (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "alts:GainLossOnWriteOffOfNotesReceivable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.alt5sigma.com/role/IntangibleassetsScheduleofIntangibleAssetsDetails",
     "longName": "9955551 - Disclosure - Intangible assets - Schedule of Intangible Assets (Details)",
     "shortName": "Intangible assets - Schedule of Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R77": {
     "role": "http://www.alt5sigma.com/role/IntangibleassetsNarrativeDetails",
     "longName": "9955552 - Disclosure - Intangible assets - Narrative (Details)",
     "shortName": "Intangible assets - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R78": {
     "role": "http://www.alt5sigma.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails",
     "longName": "9955553 - Disclosure - Marketable Securities - Schedule of Marketable Securities (Details)",
     "shortName": "Marketable Securities - Schedule of Marketable Securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:MarketableSecurities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-35",
      "name": "us-gaap:MarketableSecurities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R79": {
     "role": "http://www.alt5sigma.com/role/MarketableSecuritiesNarrativeDetails",
     "longName": "9955554 - Disclosure - Marketable Securities - Narrative (Details)",
     "shortName": "Marketable Securities - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:MarketableSecuritiesUnrealizedGainLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-178",
      "name": "alts:ConvertiblePreferredStockSharesIssuableUponConversion",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R80": {
     "role": "http://www.alt5sigma.com/role/DepositsandotherassetsDetails",
     "longName": "9955555 - Disclosure - Deposits and other assets (Details)",
     "shortName": "Deposits and other assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:OtherAssetsNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:OtherAssetsNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R81": {
     "role": "http://www.alt5sigma.com/role/AccruedliabilitiesDetails",
     "longName": "9955556 - Disclosure - Accrued liabilities (Details)",
     "shortName": "Accrued liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://www.alt5sigma.com/role/DebenturesScheduleofDebenturesOutstandingDetails",
     "longName": "9955557 - Disclosure - Debentures - Schedule of Debentures Outstanding (Details)",
     "shortName": "Debentures - Schedule of Debentures Outstanding (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "c-181",
      "name": "us-gaap:LongTermDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-181",
      "name": "us-gaap:LongTermDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R83": {
     "role": "http://www.alt5sigma.com/role/DebenturesNarrativeDetails",
     "longName": "9955558 - Disclosure - Debentures - Narrative (Details)",
     "shortName": "Debentures - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "c-183",
      "name": "alts:DebtInstrumentNumberOfDebenturesIssued",
      "unitRef": "debenture",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-183",
      "name": "alts:DebtInstrumentNumberOfDebenturesIssued",
      "unitRef": "debenture",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R84": {
     "role": "http://www.alt5sigma.com/role/LongTermDebtScheduleofLongTermDebtDetails",
     "longName": "9955559 - Disclosure - Long-Term Debt - Schedule of Long-Term Debt (Details)",
     "shortName": "Long-Term Debt - Schedule of Long-Term Debt (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:LongTermDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-191",
      "name": "us-gaap:LongTermDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R85": {
     "role": "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
     "longName": "9955560 - Disclosure - Long-Term Debt - Narrative (Details)",
     "shortName": "Long-Term Debt - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "c-231",
      "name": "alts:ClassOfWarrantOrRightExercisePeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-231",
      "name": "alts:ClassOfWarrantOrRightExercisePeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R86": {
     "role": "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofLongTermDebtPayabletoRelatedPartiesDetails",
     "longName": "9955561 - Disclosure - Related Party Debt - Schedule of Long-Term Debt Payable to Related Parties (Details)",
     "shortName": "Related Party Debt - Schedule of Long-Term Debt Payable to Related Parties (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:LongTermDebtCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-249",
      "name": "us-gaap:LongTermDebtCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R87": {
     "role": "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofFutureMaturitiesofLongTermDebtDetails",
     "longName": "9955562 - Disclosure - Related Party Debt - Schedule of Future Maturities of Long Term Debt (Details)",
     "shortName": "Related Party Debt - Schedule of Future Maturities of Long Term Debt (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:LongTermDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-251",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R88": {
     "role": "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
     "longName": "9955563 - Disclosure - Related Party Debt - Narrative (Details)",
     "shortName": "Related Party Debt - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "c-336",
      "name": "alts:RelatedPartyTransactionConsultingAgreementTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-252",
      "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R89": {
     "role": "http://www.alt5sigma.com/role/PreferredStockSeriesA1ConvertiblePreferredStockDetails",
     "longName": "9955564 - Disclosure - Preferred Stock - Series A-1 Convertible Preferred Stock (Details)",
     "shortName": "Preferred Stock - Series A-1 Convertible Preferred Stock (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": {
      "contextRef": "c-283",
      "name": "us-gaap:PreferredStockConvertibleConversionRatio",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-283",
      "name": "us-gaap:PreferredStockConvertibleConversionRatio",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R90": {
     "role": "http://www.alt5sigma.com/role/PreferredStockSeriesBPreferredStockDetails",
     "longName": "9955565 - Disclosure - Preferred Stock - Series B Preferred Stock (Details)",
     "shortName": "Preferred Stock - Series B Preferred Stock (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "90",
     "firstAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:PreferredStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-287",
      "name": "us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R91": {
     "role": "http://www.alt5sigma.com/role/PreferredStockSeriesIConvertiblePreferredStockDetails",
     "longName": "9955566 - Disclosure - Preferred Stock - Series I Convertible Preferred Stock (Details)",
     "shortName": "Preferred Stock - Series I Convertible Preferred Stock (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "91",
     "firstAnchor": {
      "contextRef": "c-290",
      "name": "alts:CommonStockConversionValidConversionPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-290",
      "name": "alts:CommonStockConversionValidConversionPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R92": {
     "role": "http://www.alt5sigma.com/role/PreferredStockSeriesMPreferredStockDetails",
     "longName": "9955567 - Disclosure - Preferred Stock - Series M Preferred Stock (Details)",
     "shortName": "Preferred Stock - Series M Preferred Stock (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "92",
     "firstAnchor": {
      "contextRef": "c-16",
      "name": "us-gaap:PreferredStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:PreferredStockSharesIssued",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R93": {
     "role": "http://www.alt5sigma.com/role/PreferredStockSeriesQConvertiblePreferredStockDetails",
     "longName": "9955568 - Disclosure - Preferred Stock - Series Q Convertible Preferred Stock (Details)",
     "shortName": "Preferred Stock - Series Q Convertible Preferred Stock (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "93",
     "firstAnchor": {
      "contextRef": "c-293",
      "name": "alts:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-293",
      "name": "alts:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R94": {
     "role": "http://www.alt5sigma.com/role/PreferredStockSeriesVConvertiblePreferredStockDetails",
     "longName": "9955569 - Disclosure - Preferred Stock - Series V Convertible Preferred Stock (Details)",
     "shortName": "Preferred Stock - Series V Convertible Preferred Stock (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "94",
     "firstAnchor": {
      "contextRef": "c-20",
      "name": "us-gaap:PreferredStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:PreferredStockSharesIssued",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-294",
      "name": "us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R95": {
     "role": "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails",
     "longName": "9955570 - Disclosure - Preferred Stock - Series S Convertible Preferred Stock (Details)",
     "shortName": "Preferred Stock - Series S Convertible Preferred Stock (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "95",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ReclassificationsOfTemporaryToPermanentEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-9",
      "name": "us-gaap:PreferredStockConvertibleConversionRatio",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R96": {
     "role": "http://www.alt5sigma.com/role/PreferredStockScheduleofSeriesSConvertiblePreferredStockOutstandingDetails",
     "longName": "9955571 - Disclosure - Preferred Stock - Schedule of Series S Convertible Preferred Stock Outstanding (Details)",
     "shortName": "Preferred Stock - Schedule of Series S Convertible Preferred Stock Outstanding (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "96",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ReclassificationsOfTemporaryToPermanentEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-304",
      "name": "alts:ReclassificationsOfTemporaryToPermanentEquityShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R97": {
     "role": "http://www.alt5sigma.com/role/StockholdersEquityCommonStockDetails",
     "longName": "9955572 - Disclosure - Stockholders' Equity - Common Stock (Details)",
     "shortName": "Stockholders' Equity - Common Stock (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "97",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockSharesAuthorized",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-306",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R98": {
     "role": "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails",
     "longName": "9955573 - Disclosure - Stockholders' Equity - Equity Offerings (Details)",
     "shortName": "Stockholders' Equity - Equity Offerings (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "98",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-337",
      "name": "alts:StockIssuedDuringPeriodSharesPrepaidInterest",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R99": {
     "role": "http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails",
     "longName": "9955574 - Disclosure - Stockholders' Equity - Equity Incentives (Details)",
     "shortName": "Stockholders' Equity - Equity Incentives (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "99",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-359",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R100": {
     "role": "http://www.alt5sigma.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails",
     "longName": "9955575 - Disclosure - Stockholders' Equity - Schedule of Stock Options Activity (Details)",
     "shortName": "Stockholders' Equity - Schedule of Stock Options Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "100",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-22",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R101": {
     "role": "http://www.alt5sigma.com/role/StockholdersEquityScheduleofExercisePriceforStockOptionsOutstandingandExercisableOutstandingDetails",
     "longName": "9955576 - Disclosure - Stockholders' Equity - Schedule of Exercise Price for Stock Options Outstanding and Exercisable Outstanding (Details)",
     "shortName": "Stockholders' Equity - Schedule of Exercise Price for Stock Options Outstanding and Exercisable Outstanding (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "101",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R102": {
     "role": "http://www.alt5sigma.com/role/IncometaxesNarrativeDetails",
     "longName": "9955577 - Disclosure - Income taxes - Narrative (Details)",
     "shortName": "Income taxes - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "102",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:OperatingLossCarryforwardsValuationAllowance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "us-gaap:OperatingLossCarryforwardsValuationAllowance",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:OperatingLossCarryforwardsValuationAllowance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "us-gaap:OperatingLossCarryforwardsValuationAllowance",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R103": {
     "role": "http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeTaxProvisionBenefitDetails",
     "longName": "9955578 - Disclosure - Income taxes - Schedule of Income Tax Provision (Benefit) (Details)",
     "shortName": "Income taxes - Schedule of Income Tax Provision (Benefit) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "103",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R104": {
     "role": "http://www.alt5sigma.com/role/IncometaxesScheduleofReconciliationofIncomeTaxBenefitProvisionwiththeFederalStatutoryTaxRateDetails",
     "longName": "9955579 - Disclosure - Income taxes - Schedule of Reconciliation of Income Tax Benefit (Provision) with the Federal Statutory Tax Rate (Details)",
     "shortName": "Income taxes - Schedule of Reconciliation of Income Tax Benefit (Provision) with the Federal Statutory Tax Rate (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "104",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R105": {
     "role": "http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeLossBeforeProvisionofIncomeTaxesDetails",
     "longName": "9955580 - Disclosure - Income taxes - Schedule of Income (Loss) Before Provision of Income Taxes (Details)",
     "shortName": "Income taxes - Schedule of Income (Loss) Before Provision of Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "105",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R106": {
     "role": "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails",
     "longName": "9955581 - Disclosure - Income taxes - Schedule of Components of Net Deferred Tax Assets (Liabilities) (Details)",
     "shortName": "Income taxes - Schedule of Components of Net Deferred Tax Assets (Liabilities) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "106",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R107": {
     "role": "http://www.alt5sigma.com/role/RelatedpartiesDetails",
     "longName": "9955582 - Disclosure - Related parties (Details)",
     "shortName": "Related parties (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "107",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-378",
      "name": "us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R108": {
     "role": "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
     "longName": "9955583 - Disclosure - Commitments and Contingencies (Details)",
     "shortName": "Commitments and Contingencies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "108",
     "firstAnchor": {
      "contextRef": "c-388",
      "name": "us-gaap:AccruedLiabilitiesCurrentAndNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-388",
      "name": "us-gaap:AccruedLiabilitiesCurrentAndNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R109": {
     "role": "http://www.alt5sigma.com/role/EarningsLosspershareScheduleofComputationofBasicandDilutedNetLossPerShareDetails",
     "longName": "9955584 - Disclosure - Earnings (Loss) per share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details)",
     "shortName": "Earnings (Loss) per share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "109",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R110": {
     "role": "http://www.alt5sigma.com/role/EarningsLosspershareNarrativeDetails",
     "longName": "9955585 - Disclosure - Earnings (Loss) per share - Narrative (Details)",
     "shortName": "Earnings (Loss) per share - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "110",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true,
      "unique": true
     }
    },
    "R111": {
     "role": "http://www.alt5sigma.com/role/SegmentinformationNarrativeDetails",
     "longName": "9955586 - Disclosure - Segment information - Narrative (Details)",
     "shortName": "Segment information - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "111",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R112": {
     "role": "http://www.alt5sigma.com/role/SegmentinformationScheduleofSegmentInformationDetails",
     "longName": "9955587 - Disclosure - Segment information - Schedule of Segment Information (Details)",
     "shortName": "Segment information - Schedule of Segment Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "112",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-409",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    },
    "R113": {
     "role": "http://www.alt5sigma.com/role/SegmentinformationScheduleofBalanceSheetInformationDetails",
     "longName": "9955588 - Disclosure - Segment information - Schedule of Balance Sheet Information (Details)",
     "shortName": "Segment information - Schedule of Balance Sheet Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "113",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:Assets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-419",
      "name": "us-gaap:Assets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "alts-20241228.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "alts_A10ConvertiblePromissoryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "A10ConvertiblePromissoryNoteMember",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "10% Convertible Promissory Note",
        "label": "10% Convertible Promissory Note [Member]",
        "documentation": "10% Convertible Promissory Note"
       }
      }
     },
     "auth_ref": []
    },
    "alts_A12DebenturesMaturingJune302024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "A12DebenturesMaturingJune302024Member",
     "presentation": [
      "http://www.alt5sigma.com/role/DebenturesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "12% Debentures Maturing June 30, 2024",
        "label": "12% Debentures Maturing June 30, 2024 [Member]",
        "documentation": "12% Debentures Maturing June 30, 2024"
       }
      }
     },
     "auth_ref": []
    },
    "alts_A12DebenturesMaturingJune302025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "A12DebenturesMaturingJune302025Member",
     "presentation": [
      "http://www.alt5sigma.com/role/DebenturesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "12% Debentures Maturing June 30, 2025",
        "label": "12% Debentures Maturing June 30, 2025 [Member]",
        "documentation": "12% Debentures Maturing June 30, 2025"
       }
      }
     },
     "auth_ref": []
    },
    "alts_A15DebenturesMaturingJune302025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "A15DebenturesMaturingJune302025Member",
     "presentation": [
      "http://www.alt5sigma.com/role/DebenturesScheduleofDebenturesOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "15% Debentures Maturing June 30, 2025",
        "label": "15% Debentures Maturing June 30, 2025 [Member]",
        "documentation": "15% Debentures Maturing June 30, 2025"
       }
      }
     },
     "auth_ref": []
    },
    "alts_A2023EquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "A2023EquityIncentivePlanMember",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023 Plan",
        "label": "2023 Equity Incentive Plan [Member]",
        "documentation": "2023 Equity Incentive Plan"
       }
      }
     },
     "auth_ref": []
    },
    "alts_A2024EquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "A2024EquityIncentivePlanMember",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024 Plan",
        "label": "2024 Equity Incentive Plan [Member]",
        "documentation": "2024 Equity Incentive Plan"
       }
      }
     },
     "auth_ref": []
    },
    "alts_ALT5SubsidiaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "ALT5SubsidiaryMember",
     "presentation": [
      "http://www.alt5sigma.com/role/IntangibleassetsNarrativeDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ALT5 Subsidiary",
        "label": "ALT5 Subsidiary [Member]",
        "documentation": "ALT5 Subsidiary"
       }
      }
     },
     "auth_ref": []
    },
    "alts_ARCAAndSubsidiariesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "ARCAAndSubsidiariesMember",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails",
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails",
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesNarrativeDetails",
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ARCA And Subsidiaries",
        "label": "ARCA And Subsidiaries [Member]",
        "documentation": "ARCA And Subsidiaries"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Abstract]",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsAndOtherReceivablesNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsAndOtherReceivablesNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesScheduleofTradeandOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade and other receivables, net",
        "verboseLabel": "Trade and other receivables, net",
        "label": "Accounts and Other Receivables, Net, Current",
        "documentation": "Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "presentation": [
      "http://www.alt5sigma.com/role/NotesreceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r340",
      "r996"
     ]
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivable Type [Axis]",
        "label": "Receivable Type [Axis]",
        "documentation": "Information by type of receivable."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r128"
     ]
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/Accruedliabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued liabilities",
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]",
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r494"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r818"
     ]
    },
    "alts_AccruedExpensesAssetAcquisitionCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "AccruedExpensesAssetAcquisitionCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/AccruedliabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/AccruedliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued Qoden payments",
        "label": "Accrued Expenses, Asset Acquisition, Current",
        "documentation": "Accrued Expenses, Asset Acquisition, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedIncomeTaxesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/AccruedliabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/AccruedliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued taxes",
        "label": "Accrued Income Taxes, Current",
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r177"
     ]
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesAndOtherLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.alt5sigma.com/role/AccruedliabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/AccruedliabilitiesDetails",
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Total accrued liabilities",
        "label": "Accrued Liabilities and Other Liabilities",
        "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued liabilities",
        "label": "Accrued Liabilities",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities."
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "us-gaap_AccruedRentCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedRentCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued rent",
        "label": "Accrued Rent",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for contractual rent under lease arrangements."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r116",
      "r178"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive loss",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32",
      "r129",
      "r226",
      "r624",
      "r661",
      "r662"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Deficit",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r19",
      "r32",
      "r553",
      "r556",
      "r588",
      "r657",
      "r658",
      "r967",
      "r968",
      "r969",
      "r980",
      "r981",
      "r982",
      "r984"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r885"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid in capital",
        "label": "Additional Paid in Capital, Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid in Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r679",
      "r980",
      "r981",
      "r982",
      "r984",
      "r1083",
      "r1140"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "alts_AdjustmentToAdditionalPaidInCapitalReclassificationsOfTemporaryToLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "AdjustmentToAdditionalPaidInCapitalReclassificationsOfTemporaryToLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Reclassification of Series S S-1 Preferred Stock to liability",
        "label": "Adjustment To Additional Paid in Capital, Reclassifications of Temporary To Liability",
        "documentation": "Adjustment To Additional Paid in Capital, Reclassifications of Temporary To Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash provided by operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "alts_AggregateIntrinsicValueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "AggregateIntrinsicValueAbstract",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Intrinsic Value",
        "label": "Aggregate Intrinsic Value [Abstract]",
        "documentation": "Aggregate Intrinsic Value"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table",
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r943"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r856",
      "r867",
      "r877",
      "r910"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r859",
      "r870",
      "r880",
      "r913"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Pension Adjustments Service Cost",
        "label": "Aggregate Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r944"
     ]
    },
    "alts_AlixpartnersLLCLitigationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "AlixpartnersLLCLitigationMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Alixpartners, LLC Litigation",
        "label": "Alixpartners, LLC Litigation [Member]",
        "documentation": "Alixpartners, LLC Litigation"
       }
      }
     },
     "auth_ref": []
    },
    "alts_AlixpartnersLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "AlixpartnersLLCMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Alixpartners, LLC",
        "label": "Alixpartners, LLC [Member]",
        "documentation": "Alixpartners, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r860",
      "r871",
      "r881",
      "r905",
      "r914",
      "r918",
      "r926"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r924"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r486",
      "r492"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for doubtful accounts",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r341",
      "r352"
     ]
    },
    "alts_Alt5SigmaInc.Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "Alt5SigmaInc.Member",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsALT5Details",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofFairValueAdjustmentsforSharesofSeriesBandSeriesMPreferredStockDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofProformaInformationDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesBPreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesIConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesMPreferredStockDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Alt 5 Sigma, Inc.",
        "label": "Alt 5 Sigma, Inc. [Member]",
        "documentation": "Alt 5 Sigma, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfFinancingCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of debt issuance costs",
        "label": "Amortization of Debt Issuance Costs",
        "documentation": "Amount of amortization expense attributable to debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r432",
      "r973",
      "r1091"
     ]
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/IntangibleassetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible amortization expense",
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r367",
      "r374",
      "r794"
     ]
    },
    "alts_AmortizationOfRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "AmortizationOfRightOfUseAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of right-of-use assets",
        "label": "Amortization of right-of-use assets",
        "documentation": "Amortization of right-of-use assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.alt5sigma.com/role/EarningsLosspershareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Potentially dilutive shares excluded from earnings per share calculation (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r288"
     ]
    },
    "alts_ApplianceSmartIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "ApplianceSmartIncMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Appliance Smart, Inc.",
        "label": "Appliance Smart Inc [Member]",
        "documentation": "ApplianceSmart, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://www.alt5sigma.com/role/NotesreceivableDetails",
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesNarrativeDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r544"
     ]
    },
    "alts_ArticlesOfIncorporationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "ArticlesOfIncorporationMember",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Articles of Incorporation",
        "label": "Articles Of Incorporation [Member]",
        "documentation": "Articles of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.alt5sigma.com/role/IntangibleassetsNarrativeDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsQodenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Acquisition [Axis]",
        "label": "Asset Acquisition [Axis]",
        "documentation": "Information by asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r1079"
     ]
    },
    "alts_AssetAcquisitionConsiderationCashPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "AssetAcquisitionConsiderationCashPayable",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsQodenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash consideration portion to be paid",
        "label": "Asset Acquisition, Consideration, Cash Payable",
        "documentation": "Asset Acquisition, Consideration, Cash Payable"
       }
      }
     },
     "auth_ref": []
    },
    "alts_AssetAcquisitionConsiderationPeriodicCashPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "AssetAcquisitionConsiderationPeriodicCashPayment",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsQodenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Monthly cash payments to be made",
        "label": "Asset Acquisition, Consideration, Periodic Cash Payment",
        "documentation": "Asset Acquisition, Consideration, Periodic Cash Payment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetAcquisitionConsiderationTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionConsiderationTransferred",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsQodenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset acquisition, total consideration",
        "label": "Asset Acquisition, Consideration Transferred",
        "documentation": "Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer."
       }
      }
     },
     "auth_ref": [
      "r808",
      "r1080",
      "r1081",
      "r1082"
     ]
    },
    "us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsQodenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset acquisition, shares issued, fair value",
        "label": "Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable",
        "documentation": "Amount of acquirer's equity interest issued and issuable as part of consideration transferred in asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r1080",
      "r1081",
      "r1082"
     ]
    },
    "alts_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsQodenDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted shares issued (in shares)",
        "label": "Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable, Shares",
        "documentation": "Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable, Shares"
       }
      }
     },
     "auth_ref": []
    },
    "alts_AssetAcquisitionConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "AssetAcquisitionConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsQodenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset acquisition, shares issued, fair value (in usd per share)",
        "label": "Asset Acquisition, Consideration Transferred, Equity Interests Issued and Issuable Per Share",
        "documentation": "Asset Acquisition, Consideration Transferred, Equity Interests Issued and Issuable Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetAcquisitionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.alt5sigma.com/role/IntangibleassetsNarrativeDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsQodenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Acquisition [Domain]",
        "label": "Asset Acquisition [Domain]",
        "documentation": "Asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r1079"
     ]
    },
    "alts_AssetAcquisitionEquityInstrumentsIssuableValidConversionPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "AssetAcquisitionEquityInstrumentsIssuableValidConversionPeriod",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsQodenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset acquisition, trailing period (in years)",
        "label": "Asset Acquisition, Equity Instruments Issuable, Valid Conversion Period",
        "documentation": "Asset Acquisition, Equity Instruments Issuable, Valid Conversion Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionLineItems",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsQodenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Line Items]",
        "label": "Asset Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r1079"
     ]
    },
    "us-gaap_AssetAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionTable",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsQodenDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "label": "Asset Acquisition [Table]",
        "documentation": "Disclosure of information about asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r1079"
     ]
    },
    "us-gaap_AssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetImpairmentCharges",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Impairment charges",
        "label": "Asset Impairment Charges",
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r49"
     ]
    },
    "us-gaap_AssetUnderConstructionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetUnderConstructionMember",
     "presentation": [
      "http://www.alt5sigma.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Projects under construction",
        "label": "Asset under Construction [Member]",
        "documentation": "Asset in process of being built."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofBalanceSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "terseLabel": "Total Assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r192",
      "r220",
      "r250",
      "r293",
      "r301",
      "r326",
      "r330",
      "r349",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r546",
      "r550",
      "r564",
      "r616",
      "r713",
      "r785",
      "r786",
      "r818",
      "r835",
      "r1032",
      "r1033",
      "r1096"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/BackgroundandBasisofPresentationDetails",
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "terseLabel": "Current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r228",
      "r250",
      "r349",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r546",
      "r550",
      "r564",
      "r818",
      "r1032",
      "r1033",
      "r1096"
     ]
    },
    "alts_AuditorAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "AuditorAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Abstract]",
        "documentation": "Auditor"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.alt5sigma.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Firm ID",
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r839",
      "r840",
      "r863"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.alt5sigma.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Location",
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r839",
      "r840",
      "r863"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://www.alt5sigma.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Name",
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r839",
      "r840",
      "r863"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r921"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r922"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r458",
      "r459",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r920"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r919"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r918"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r918"
     ]
    },
    "us-gaap_BeneficialOwnerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BeneficialOwnerMember",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Record and beneficial owner",
        "label": "Beneficial Owner [Member]",
        "documentation": "Any person who, directly or indirectly, through any contract, arrangement, understanding, relationship, or otherwise has shares of the entity with 1) voting power which includes the power to vote, or to direct the voting of, such security, and/or 2) investment power which includes the power to dispose, or to direct the disposition of, such security."
       }
      }
     },
     "auth_ref": []
    },
    "alts_BigWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "BigWarrantMember",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Big Warrant",
        "label": "Big Warrant [Member]",
        "documentation": "Big Warrant"
       }
      }
     },
     "auth_ref": []
    },
    "alts_BiotechnologyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "BiotechnologyMember",
     "presentation": [
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofBalanceSheetInformationDetails",
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Biotech",
        "label": "Biotechnology [Member]",
        "documentation": "Biotechnology."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
      "http://www.alt5sigma.com/role/IntangibleassetsNarrativeDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsALT5Details",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofFairValueAdjustmentsforSharesofSeriesBandSeriesMPreferredStockDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofProformaInformationDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails",
      "http://www.alt5sigma.com/role/NotesreceivableDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesA1ConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesBPreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesIConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesMPreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesQConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesVConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition, Acquiree",
        "label": "Business Acquisition, Acquiree [Domain]",
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r539",
      "r803",
      "r804"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
      "http://www.alt5sigma.com/role/IntangibleassetsNarrativeDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsALT5Details",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofFairValueAdjustmentsforSharesofSeriesBandSeriesMPreferredStockDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofProformaInformationDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails",
      "http://www.alt5sigma.com/role/NotesreceivableDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesA1ConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesBPreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesIConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesMPreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesQConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesVConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition",
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r68",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r539",
      "r803",
      "r804"
     ]
    },
    "alts_BusinessAcquisitionConsiderationTrancheOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "BusinessAcquisitionConsiderationTrancheOneMember",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition, Consideration, Tranche One",
        "label": "Business Acquisition, Consideration, Tranche One [Member]",
        "documentation": "Business Acquisition, Consideration, Tranche One"
       }
      }
     },
     "auth_ref": []
    },
    "alts_BusinessAcquisitionConsiderationTrancheThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "BusinessAcquisitionConsiderationTrancheThreeMember",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition, Consideration, Tranche Three",
        "label": "Business Acquisition, Consideration, Tranche Three [Member]",
        "documentation": "Business Acquisition, Consideration, Tranche Three"
       }
      }
     },
     "auth_ref": []
    },
    "alts_BusinessAcquisitionConsiderationTrancheTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "BusinessAcquisitionConsiderationTrancheTwoMember",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition, Consideration, Tranche Two",
        "label": "Business Acquisition, Consideration, Tranche Two [Member]",
        "documentation": "Business Acquisition, Consideration, Tranche Two"
       }
      }
     },
     "auth_ref": []
    },
    "alts_BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfIssuedAndOutstandingShares": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfIssuedAndOutstandingShares",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsALT5Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of shares acquired",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Percentage Of Issued And Outstanding Shares",
        "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Percentage Of Issued And Outstanding Shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of shares of common stock to legacy equity holders",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned",
        "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity."
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsALT5Details",
      "http://www.alt5sigma.com/role/PreferredStockSeriesA1ConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesBPreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesIConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesMPreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesQConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesVConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company tendered, shares (in shares)",
        "verboseLabel": "Company tendered (in shares)",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity."
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsALT5Details",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Line Items]",
        "label": "Business Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r539"
     ]
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition, Pro Forma Information",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate."
       }
      }
     },
     "auth_ref": [
      "r954",
      "r955"
     ]
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsALT5Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill expected to be deductible for tax purposes",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofProformaInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business acquisition, proforma net income",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period."
       }
      }
     },
     "auth_ref": [
      "r537",
      "r538"
     ]
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofProformaInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business acquisition, proforma revenue",
        "label": "Business Acquisition, Pro Forma Revenue",
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period."
       }
      }
     },
     "auth_ref": [
      "r537",
      "r538"
     ]
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]",
        "label": "Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationConsiderationTransferred1",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total consideration",
        "label": "Business Combination, Consideration Transferred",
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r18"
     ]
    },
    "alts_BusinessCombinationConsiderationTransferredBeneficialConversionFeatureValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "BusinessCombinationConsiderationTransferredBeneficialConversionFeatureValue",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/PreferredStockSeriesA1ConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Beneficial conversion feature",
        "label": "Business Combination, Consideration Transferred, Beneficial Conversion Feature, Value",
        "documentation": "Business Combination, Consideration Transferred, Beneficial Conversion Feature, Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsALT5Details",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofFairValueAdjustmentsforSharesofSeriesBandSeriesMPreferredStockDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesA1ConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesBPreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesQConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business acquisition, shares issued, fair value",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1"
     ]
    },
    "alts_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare",
     "presentation": [
      "http://www.alt5sigma.com/role/PreferredStockSeriesQConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business acquisition, shares issued, fair value (in usd per share)",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Per Share",
        "documentation": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesA1ConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate principal amount",
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred",
        "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r72",
      "r540"
     ]
    },
    "alts_BusinessCombinationConsiderationTransferredLiabilitiesIncurredTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurredTerm",
     "presentation": [
      "http://www.alt5sigma.com/role/PreferredStockSeriesA1ConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term of unsecured notes entered into (in years)",
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred, Term",
        "documentation": "Business Combination, Consideration Transferred, Liabilities Incurred, Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount owed by company",
        "label": "Business Combination, Contingent Consideration, Liability",
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r170",
      "r541",
      "r561",
      "r562",
      "r563"
     ]
    },
    "alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities, Current",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total assets acquired",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "documentation": "Amount of assets acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-Term Debt",
        "documentation": "Amount of long-term debt due within one year or within the normal operating cycle, if longer, assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsPayable",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Digital assets payable",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Digital Assets Payable",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Digital Assets Payable"
       }
      }
     },
     "auth_ref": []
    },
    "alts_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsReceivable",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Digital assets receivable",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Digital Assets Receivable",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Digital Assets Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total liabilities assumed",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "documentation": "Amount of liabilities assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofFairValueAdjustmentsforSharesofSeriesBandSeriesMPreferredStockDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total purchase price",
        "terseLabel": "Total purchase price",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_BusinessCombinationSegmentAllocationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationSegmentAllocationLineItems",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofFairValueAdjustmentsforSharesofSeriesBandSeriesMPreferredStockDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofProformaInformationDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination Segment Allocation [Line Items]",
        "label": "Business Combination Segment Allocation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationSegmentAllocationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationSegmentAllocationTable",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofFairValueAdjustmentsforSharesofSeriesBandSeriesMPreferredStockDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofProformaInformationDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination, Segment Allocation [Table]",
        "label": "Business Combination, Segment Allocation [Table]",
        "documentation": "Disclosure of information about goodwill in a business combination."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAcquiredFromAcquisition",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash acquired in ALT5 Subsidiary acquisition",
        "label": "Cash Acquired from Acquisition",
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business)."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r216",
      "r769"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsAndMarketableSecuritiesTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/MarketableSecurities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable Securities",
        "label": "Cash, Cash Equivalents, and Marketable Securities [Text Block]",
        "documentation": "The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r998"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH AND CASH EQUIVALENTS OF CONTINUING OPERATIONS, end of period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r143",
      "r247"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "LESS CASH OF DISCONTINUED OPERATIONS, end of period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; attributable to disposal group, including, but not limited to, discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r143",
      "r247"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "CASH AND CASH EQUIVALENTS, beginning of period",
        "periodStartLabel": "CASH AND CASH EQUIVALENTS, beginning of period",
        "periodEndLabel": "CASH AND CASH EQUIVALENTS, end of period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r143",
      "r247"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS",
        "terseLabel": "DECREASE IN CASH AND CASH EQUIVALENTS",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r143"
     ]
    },
    "alts_CashDisposal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "CashDisposal",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails": {
       "parentTag": "alts_TotalDisposalOfAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash",
        "label": "Cash Disposal",
        "documentation": "Cash Disposal"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing cash flows used in discontinued operations",
        "label": "Cash Provided by (Used in) Financing Activities, Discontinued Operations",
        "documentation": "Amount of cash inflow (outflow) of financing activities of discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investing cash flows used in discontinued operations",
        "totalLabel": "Net cash used in investing activities from discontinued operations",
        "label": "Cash Provided by (Used in) Investing Activities, Discontinued Operations",
        "documentation": "Amount of cash inflow (outflow) of investing activities of discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r143"
     ]
    },
    "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash flows provided by discontinued operations",
        "label": "Cash Provided by (Used in) Operating Activities, Discontinued Operations",
        "documentation": "Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r143"
     ]
    },
    "us-gaap_CashSurrenderValueOfLifeInsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashSurrenderValueOfLifeInsurance",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash surrender value of life insurance",
        "label": "Cash Surrender Value of Life Insurance",
        "documentation": "Carrying amount as of the balance sheet date of amounts which could be received based on the terms of the insurance contract upon surrendering life policies owned by the entity."
       }
      }
     },
     "auth_ref": [
      "r960"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r896"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year",
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r893"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested",
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.alt5sigma.com/role/MarketableSecuritiesNarrativeDetails",
      "http://www.alt5sigma.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsALT5Details",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsQodenDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofFairValueAdjustmentsforSharesofSeriesBandSeriesMPreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockScheduleofSeriesSConvertiblePreferredStockOutstandingDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesBPreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesIConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesMPreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesQConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesVConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r223",
      "r224",
      "r225",
      "r250",
      "r277",
      "r278",
      "r285",
      "r287",
      "r295",
      "r296",
      "r349",
      "r401",
      "r403",
      "r404",
      "r405",
      "r408",
      "r409",
      "r439",
      "r440",
      "r443",
      "r444",
      "r447",
      "r564",
      "r668",
      "r669",
      "r670",
      "r671",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r701",
      "r722",
      "r744",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r948",
      "r974",
      "r985"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.alt5sigma.com/role/MarketableSecuritiesNarrativeDetails",
      "http://www.alt5sigma.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails",
      "http://www.alt5sigma.com/role/PreferredStockScheduleofSeriesSConvertiblePreferredStockOutstandingDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesA1ConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesBPreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesIConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesMPreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesQConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesVConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityScheduleofExercisePriceforStockOptionsOutstandingandExercisableOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Line Items]",
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r223",
      "r224",
      "r225",
      "r295",
      "r439",
      "r440",
      "r442",
      "r443",
      "r444",
      "r446",
      "r447",
      "r668",
      "r669",
      "r670",
      "r671",
      "r801",
      "r948",
      "r974"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Axis]",
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Domain]",
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "alts_ClassOfWarrantOrRightExercisePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "ClassOfWarrantOrRightExercisePeriod",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of days required to exercise initial tranche (in days)",
        "label": "Class of Warrant or Right, Exercise Period",
        "documentation": "Class of Warrant or Right, Exercise Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant offering and exercise price (in usd per share)",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r448"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant excise and granted (in shares)",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r448"
     ]
    },
    "alts_ClassOfWarrantPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "ClassOfWarrantPricePerShare",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant price per share (in usd per share)",
        "label": "Class Of Warrant Price Per Share",
        "documentation": "Class Of Warrant Price Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Commitments and Contingencies (Note 21)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r181",
      "r620",
      "r700"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r390",
      "r391",
      "r761",
      "r1019",
      "r1024"
     ]
    },
    "us-gaap_CommonClassAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonClassAMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Class A",
        "label": "Common Class A [Member]",
        "documentation": "Classification of common stock representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r1140"
     ]
    },
    "alts_CommonShareEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "CommonShareEquivalentsMember",
     "presentation": [
      "http://www.alt5sigma.com/role/MarketableSecuritiesNarrativeDetails",
      "http://www.alt5sigma.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common Shares Equivalent",
        "terseLabel": "Common Share Equivalent",
        "label": "Common Share Equivalents [Member]",
        "documentation": "Common Share Equivalents"
       }
      }
     },
     "auth_ref": []
    },
    "alts_CommonStockConversionValidConversionPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "CommonStockConversionValidConversionPeriod",
     "presentation": [
      "http://www.alt5sigma.com/role/PreferredStockSeriesIConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trailing quarterly basis, period (in years)",
        "label": "Common Stock Conversion, Valid Conversion Period",
        "documentation": "Common Stock Conversion, Valid Conversion Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofFairValueAdjustmentsforSharesofSeriesBandSeriesMPreferredStockDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "verboseLabel": "Common stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r825",
      "r826",
      "r827",
      "r829",
      "r830",
      "r831",
      "r832",
      "r980",
      "r981",
      "r984",
      "r1083",
      "r1138",
      "r1140"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in usd per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.alt5sigma.com/role/StockholdersEquityCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r701"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.alt5sigma.com/role/StockholdersEquityCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, issued shares (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.alt5sigma.com/role/StockholdersEquityCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, outstanding shares (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r121",
      "r701",
      "r719",
      "r1140",
      "r1141"
     ]
    },
    "alts_CommonStockSharesOutstandingPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "CommonStockSharesOutstandingPercentage",
     "presentation": [
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding (as percent)",
        "label": "Common Stock, Shares Outstanding, Percentage",
        "documentation": "Common Stock, Shares Outstanding, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock, par value $0.001 per share, 200,000,000 shares authorized, 15,417,693 and 2,827,410 shares issued and outstanding at December\u00a028, 2024 and at December\u00a030, 2023, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r622",
      "r818"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r902"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r901"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r903"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r900"
     ]
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets (liabilities):",
        "label": "Components of Deferred Tax Assets and Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComputerSoftwareIntangibleAssetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComputerSoftwareIntangibleAssetMember",
     "presentation": [
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Software",
        "label": "Computer Software, Intangible Asset [Member]",
        "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks."
       }
      }
     },
     "auth_ref": [
      "r765",
      "r768",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1011",
      "r1013",
      "r1015",
      "r1016"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration of Credit Risk",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r200"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principles of Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r774"
     ]
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContingentConsiderationByTypeAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent Consideration by Type [Axis]",
        "label": "Contingent Consideration by Type [Axis]",
        "documentation": "Information by type of contingent consideration."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContingentConsiderationTypeDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent Consideration Type [Domain]",
        "label": "Contingent Consideration Type [Domain]",
        "documentation": "Description of contingent payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "alts_ContinuingOperationsAndDiscontinuedOperationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "ContinuingOperationsAndDiscontinuedOperationsMember",
     "presentation": [
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofBalanceSheetInformationDetails",
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Continuing and Discontinued Operation",
        "label": "Continuing Operations And Discontinued Operations [Member]",
        "documentation": "Continuing Operations And Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "alts_ConversionOfStockAmountConvertible": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "ConversionOfStockAmountConvertible",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of stock, amount converted",
        "label": "Conversion Of Stock, Amount Convertible",
        "documentation": "Conversion Of Stock, Amount Convertible"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockByUniqueDescriptionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockByUniqueDescriptionAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/PreferredStockSeriesA1ConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Conversion Description",
        "label": "Stock Conversion Description [Axis]",
        "documentation": "Information by description of stock conversions."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r39",
      "r40"
     ]
    },
    "alts_ConversionOfStockCommencementPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "ConversionOfStockCommencementPeriod",
     "presentation": [
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of stock, commencement period (in years)",
        "label": "Conversion Of Stock, Commencement Period",
        "documentation": "Conversion Of Stock, Commencement Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockNameDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/PreferredStockSeriesA1ConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of Stock, Name",
        "label": "Conversion of Stock, Name [Domain]",
        "documentation": "The unique name of a noncash or part noncash stock conversion."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r39",
      "r40"
     ]
    },
    "alts_ConversionOfStockPeriodFollowingClosing": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "ConversionOfStockPeriodFollowingClosing",
     "presentation": [
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of stock, period after closing (in years)",
        "label": "Conversion Of Stock, Period Following Closing",
        "documentation": "Conversion Of Stock, Period Following Closing"
       }
      }
     },
     "auth_ref": []
    },
    "alts_ConversionOfStockSharesForfeited": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "ConversionOfStockSharesForfeited",
     "presentation": [
      "http://www.alt5sigma.com/role/PreferredStockSeriesA1ConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preferred stock, forfeited (in shares)",
        "label": "Conversion of Stock, Shares Forfeited",
        "documentation": "Conversion of Stock, Shares Forfeited"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockSharesIssued1",
     "presentation": [
      "http://www.alt5sigma.com/role/PreferredStockSeriesA1ConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares issued upon exchange of convertible preferred stock (in shares)",
        "label": "Conversion of Stock, Shares Issued",
        "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r39",
      "r40"
     ]
    },
    "us-gaap_ConvertibleDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Convertible debentures",
        "label": "Convertible Debt, Current",
        "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "alts_ConvertiblePreferredStockSharesIssuableUponConversion": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "ConvertiblePreferredStockSharesIssuableUponConversion",
     "presentation": [
      "http://www.alt5sigma.com/role/MarketableSecuritiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issuable upon conversion (in shares)",
        "label": "Convertible Preferred Stock, Shares Issuable Upon Conversion",
        "documentation": "Convertible Preferred Stock, Shares Issuable Upon Conversion"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "presentation": [
      "http://www.alt5sigma.com/role/PreferredStockSeriesA1ConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of preferred converted to common stock (in shares)",
        "label": "Convertible Preferred Stock, Shares Issued upon Conversion",
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r57",
      "r120",
      "r159",
      "r445"
     ]
    },
    "us-gaap_CorporateAndOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CorporateAndOtherMember",
     "presentation": [
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofBalanceSheetInformationDetails",
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate and other",
        "label": "Corporate Segment and Other Operating Segment [Member]",
        "documentation": "Component of entity providing financial and operational oversight and administrative support considered to be operating segment and operating segment, classified as other. Excludes intersegment elimination and reconciling item."
       }
      }
     },
     "auth_ref": [
      "r988"
     ]
    },
    "us-gaap_CostOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfRevenue",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of revenues",
        "label": "Cost of Revenue",
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r250",
      "r349",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r564",
      "r785",
      "r1032"
     ]
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails",
      "http://www.alt5sigma.com/role/NotesreceivableDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesBPreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails",
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesNarrativeDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name",
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r255",
      "r256",
      "r414",
      "r442",
      "r595",
      "r602",
      "r615",
      "r771",
      "r773"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility",
        "label": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r400",
      "r1030"
     ]
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility",
        "label": "Credit Facility [Domain]",
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r400",
      "r1030",
      "r1031"
     ]
    },
    "us-gaap_CryptoAssetUnrealizedGainLossOperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CryptoAssetUnrealizedGainLossOperating",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Unrealized gain on digital assets",
        "label": "Crypto Asset, Unrealized Gain (Loss), Operating",
        "documentation": "Amount of unrealized gain (loss) from remeasurement of crypto asset, classified as operating. Excludes crypto asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r1017"
     ]
    },
    "alts_CryptocurrencyExchangeSoftwareIntangibleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "CryptocurrencyExchangeSoftwareIntangibleMember",
     "presentation": [
      "http://www.alt5sigma.com/role/IntangibleassetsScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Qoden intangible",
        "label": "Cryptocurrency Exchange Software Intangible [Member]",
        "documentation": "Cryptocurrency Exchange Software Intangible"
       }
      }
     },
     "auth_ref": []
    },
    "alts_CurrentAssetsCurrentLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "CurrentAssetsCurrentLiabilitiesNet",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/BackgroundandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Net negative working capital",
        "label": "Current Assets (Current Liabilities), Net",
        "documentation": "Net working capital."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeTaxProvisionBenefitDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal",
        "label": "Current Federal Tax Expense (Benefit)",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r956",
      "r977",
      "r1073"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentForeignTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeTaxProvisionBenefitDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Current Foreign Tax Expense (Benefit)",
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r956",
      "r977"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeTaxProvisionBenefitDetails": {
       "parentTag": "alts_ProvisionBenefitOfIncomeTaxes",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Current tax expense",
        "label": "Current Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r521",
      "r977"
     ]
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeTaxProvisionBenefitDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State",
        "label": "Current State and Local Tax Expense (Benefit)",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r956",
      "r977",
      "r1073"
     ]
    },
    "us-gaap_CustomerRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CustomerRelationshipsMember",
     "presentation": [
      "http://www.alt5sigma.com/role/IntangibleassetsNarrativeDetails",
      "http://www.alt5sigma.com/role/IntangibleassetsScheduleofIntangibleAssetsDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails",
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer relationships",
        "verboseLabel": "Customer relationships",
        "label": "Customer Relationships [Member]",
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1011",
      "r1013",
      "r1015",
      "r1016"
     ]
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r848",
      "r937"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r848",
      "r937"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r850",
      "r939"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r850",
      "r939"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r852",
      "r941"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r850",
      "r939"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r843",
      "r932"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r844",
      "r933"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r844",
      "r933"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r842",
      "r931"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r842",
      "r931"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r842",
      "r931"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r845",
      "r934"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r847",
      "r936"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r847",
      "r936"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r848",
      "r937"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r851",
      "r940"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r849",
      "r938"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r846",
      "r935"
     ]
    },
    "alts_DebenturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DebenturesMember",
     "presentation": [
      "http://www.alt5sigma.com/role/DebenturesNarrativeDetails",
      "http://www.alt5sigma.com/role/DebenturesScheduleofDebenturesOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debentures",
        "label": "Debentures [Member]",
        "documentation": "Debentures"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes payable converted to common stock",
        "label": "Debt Conversion, Converted Instrument, Amount",
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r40"
     ]
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt conversion, converted (in shares)",
        "label": "Debt Conversion, Converted Instrument, Shares Issued",
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r40"
     ]
    },
    "us-gaap_DebtConversionOriginalDebtAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionOriginalDebtAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt conversion, converted amount",
        "label": "Debt Conversion, Original Debt, Amount",
        "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r40"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Disclosure [Abstract]",
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedPartyDebt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Debt",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r249",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r399",
      "r400",
      "r410",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r426",
      "r433",
      "r434",
      "r436",
      "r573"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
      "http://www.alt5sigma.com/role/DebenturesNarrativeDetails",
      "http://www.alt5sigma.com/role/DebenturesScheduleofDebenturesOutstandingDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/LongTermDebtScheduleofLongTermDebtDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofFutureMaturitiesofLongTermDebtDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofLongTermDebtPayabletoRelatedPartiesDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r110",
      "r111",
      "r176",
      "r180",
      "r257",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r417",
      "r422",
      "r423",
      "r424",
      "r425",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r816",
      "r975",
      "r1020",
      "r1021",
      "r1022",
      "r1090",
      "r1092"
     ]
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofLongTermDebtPayabletoRelatedPartiesDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Principal outstanding balance",
        "netLabel": "Total notes payable, related parties",
        "label": "Long-Term Debt, Gross",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r180",
      "r437"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion price (in usd per share)",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "documentation": "The price per share of the conversion feature embedded in the debt instrument."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r413"
     ]
    },
    "alts_DebtInstrumentCovenantPeriodAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DebtInstrumentCovenantPeriodAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Covenant Period [Axis]",
        "label": "Debt Instrument, Covenant Period [Axis]",
        "documentation": "Debt Instrument, Covenant Period"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DebtInstrumentCovenantPeriodDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DebtInstrumentCovenantPeriodDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Covenant Period [Domain]",
        "label": "Debt Instrument, Covenant Period [Domain]",
        "documentation": "Debt Instrument, Covenant Period"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DebtInstrumentCovenantPeriodPeriodOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DebtInstrumentCovenantPeriodPeriodOneMember",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "August 20, 2024 to October 31, 2024",
        "label": "Debt Instrument, Covenant Period, Period One [Member]",
        "documentation": "Debt Instrument, Covenant Period, Period One"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DebtInstrumentCovenantPeriodPeriodThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DebtInstrumentCovenantPeriodPeriodThreeMember",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "January 30, 2025 till Repayment",
        "label": "Debt Instrument, Covenant Period, Period Three [Member]",
        "documentation": "Debt Instrument, Covenant Period, Period Three"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DebtInstrumentCovenantPeriodPeriodTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DebtInstrumentCovenantPeriodPeriodTwoMember",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "November 01, 2024 to January 29, 2025",
        "label": "Debt Instrument, Covenant Period, Period Two [Member]",
        "documentation": "Debt Instrument, Covenant Period, Period Two"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt face amount",
        "verboseLabel": "Initial principal amount",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r411",
      "r573",
      "r574",
      "r797",
      "r798",
      "r816"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
      "http://www.alt5sigma.com/role/DebenturesNarrativeDetails",
      "http://www.alt5sigma.com/role/DebenturesScheduleofDebenturesOutstandingDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofLongTermDebtPayabletoRelatedPartiesDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt interest rate (as percent)",
        "verboseLabel": "Debt interest rate (as percent)",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r412"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://www.alt5sigma.com/role/DebenturesNarrativeDetails",
      "http://www.alt5sigma.com/role/DebenturesScheduleofDebenturesOutstandingDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/LongTermDebtScheduleofLongTermDebtDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofFutureMaturitiesofLongTermDebtDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofLongTermDebtPayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Line Items]",
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r257",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r417",
      "r422",
      "r423",
      "r424",
      "r425",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r435",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r816",
      "r975",
      "r1090",
      "r1092"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
      "http://www.alt5sigma.com/role/DebenturesNarrativeDetails",
      "http://www.alt5sigma.com/role/DebenturesScheduleofDebenturesOutstandingDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/LongTermDebtScheduleofLongTermDebtDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofFutureMaturitiesofLongTermDebtDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofLongTermDebtPayabletoRelatedPartiesDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r257",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r417",
      "r422",
      "r423",
      "r424",
      "r425",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r816",
      "r975",
      "r1020",
      "r1021",
      "r1022",
      "r1090",
      "r1092"
     ]
    },
    "alts_DebtInstrumentNumberOfDebenturesIssued": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DebtInstrumentNumberOfDebenturesIssued",
     "presentation": [
      "http://www.alt5sigma.com/role/DebenturesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of debentures issued",
        "label": "Debt Instrument, Number Of Debentures Issued",
        "documentation": "Debt Instrument, Number Of Debentures Issued"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DebtInstrumentNumberOfDebenturesRepaid": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DebtInstrumentNumberOfDebenturesRepaid",
     "presentation": [
      "http://www.alt5sigma.com/role/DebenturesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of debentures repaid",
        "label": "Debt Instrument, Number Of Debentures Repaid",
        "documentation": "Debt Instrument, Number Of Debentures Repaid"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DebtInstrumentOriginalIssueDiscountExpansionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DebtInstrumentOriginalIssueDiscountExpansionAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Original Issue Discount, Expansion [Axis]",
        "label": "Debt Instrument, Original Issue Discount, Expansion [Axis]",
        "documentation": "Debt Instrument, Original Issue Discount, Expansion"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DebtInstrumentOriginalIssueDiscountExpansionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DebtInstrumentOriginalIssueDiscountExpansionDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Original Issue Discount, Expansion [Domain]",
        "label": "Debt Instrument, Original Issue Discount, Expansion [Domain]",
        "documentation": "Debt Instrument, Original Issue Discount, Expansion"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DebtInstrumentOriginalIssueDiscountExpansionOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DebtInstrumentOriginalIssueDiscountExpansionOneMember",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OID expansion one",
        "label": "Debt Instrument, Original Issue Discount, Expansion One [Member]",
        "documentation": "Debt Instrument, Original Issue Discount, Expansion One"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DebtInstrumentOriginalIssueDiscountExpansionTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DebtInstrumentOriginalIssueDiscountExpansionTwoMember",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OID expansion two",
        "label": "Debt Instrument, Original Issue Discount, Expansion Two [Member]",
        "documentation": "Debt Instrument, Original Issue Discount, Expansion Two"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of potential additions",
        "label": "Debt Instrument, Original Issue Discount, Number Of Potential Additions",
        "documentation": "Debt Instrument, Original Issue Discount, Number Of Potential Additions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentPeriodicPayment",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Installment",
        "label": "Debt Instrument, Periodic Payment",
        "documentation": "Amount of the required periodic payments including both interest and principal payments."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r83"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://www.alt5sigma.com/role/DebenturesNarrativeDetails",
      "http://www.alt5sigma.com/role/DebenturesScheduleofDebenturesOutstandingDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/LongTermDebtScheduleofLongTermDebtDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofFutureMaturitiesofLongTermDebtDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofLongTermDebtPayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-Term Debt Instruments [Table]",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "Disclosure of information about long-term debt instrument or arrangement."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r57",
      "r60",
      "r82",
      "r158",
      "r160",
      "r257",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r417",
      "r422",
      "r423",
      "r424",
      "r425",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r435",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r816",
      "r975",
      "r1090",
      "r1092"
     ]
    },
    "us-gaap_DebtInstrumentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTerm",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Debt instrument term (in months)",
        "terseLabel": "Debt instrument term (in years)",
        "label": "Debt Instrument, Term",
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentUnamortizedDiscount",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Original issue discount",
        "label": "Debt Instrument, Unamortized Discount",
        "documentation": "Amount, after accumulated amortization, of debt discount."
       }
      }
     },
     "auth_ref": [
      "r1035",
      "r1089",
      "r1090",
      "r1092"
     ]
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]",
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/PrepaidsandothercurrentassetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Prepaids and Other Current Assets",
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]",
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeTaxProvisionBenefitDetails": {
       "parentTag": "alts_ProvisionBenefitOfIncomeTaxes",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeTaxProvisionBenefitDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsALT5Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Change in deferred income taxes",
        "negatedTerseLabel": "Non-cash fair value adjustment of deferred tax liabilities",
        "terseLabel": "Deferred tax (benefit) provision",
        "label": "Deferred Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r206",
      "r977"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income taxes, net",
        "label": "Deferred Income Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r498",
      "r499",
      "r617"
     ]
    },
    "alts_DeferredTaxAssetsInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DeferredTaxAssetsInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Section 163(j) interest",
        "label": "Deferred Tax Assets Interest",
        "documentation": "Deferred tax assets interest."
       }
      }
     },
     "auth_ref": []
    },
    "alts_DeferredTaxAssetsLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DeferredTaxAssetsLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liability",
        "label": "Deferred Tax Assets Lease Liability",
        "documentation": "Deferred tax assets lease liability."
       }
      }
     },
     "auth_ref": []
    },
    "alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred tax assets (liabilities)",
        "label": "Deferred Tax Assets Liabilities Gross Before Valuation Allowance",
        "documentation": "Deferred tax assets liabilities gross before valuation allowance."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1071"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax credits",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1071"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued compensation",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation."
       }
      }
     },
     "auth_ref": [
      "r1071"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r1071"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities."
       }
      }
     },
     "auth_ref": [
      "r1071"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for bad debts",
        "label": "Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r1071"
     ]
    },
    "us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsUnrealizedCurrencyLosses",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized losses",
        "label": "Deferred Tax Assets, Unrealized Currency Losses",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses on foreign currency transactions."
       }
      }
     },
     "auth_ref": [
      "r1071"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r514"
     ]
    },
    "us-gaap_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Net deferred tax liabilities",
        "label": "Deferred Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r1068"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Intangibles",
        "label": "Deferred Tax Liabilities, Intangible Assets",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill."
       }
      }
     },
     "auth_ref": [
      "r1071"
     ]
    },
    "alts_DeferredTaxLiabilitiesInstallmentSale": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DeferredTaxLiabilitiesInstallmentSale",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Installment sale",
        "label": "Deferred Tax Liabilities Installment Sale",
        "documentation": "Deferred Tax Liabilities Installment Sale"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesPrepaidExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesPrepaidExpenses",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses",
        "label": "Deferred Tax Liabilities, Prepaid Expenses",
        "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses."
       }
      }
     },
     "auth_ref": [
      "r1071"
     ]
    },
    "alts_DeferredTaxLiabilitiesRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DeferredTaxLiabilitiesRightOfUseAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Right-of-use assets",
        "label": "Deferred Tax Liabilities, Right-of-use Assets",
        "documentation": "Deferred Tax Liabilities, Right-of-use Assets"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DepositsAndOtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DepositsAndOtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.alt5sigma.com/role/DepositsandotherassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deposits and other assets",
        "verboseLabel": "Total deposits and other assets",
        "label": "Deposits And Other Assets Noncurrent",
        "documentation": "Deposits and other assets noncurrent."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Depreciation",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/PropertyandEquipmentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation expense",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r50"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails",
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "verboseLabel": "Depreciation and amortization",
        "netLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r293",
      "r306",
      "r330",
      "r785",
      "r786"
     ]
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DevelopedTechnologyRightsMember",
     "presentation": [
      "http://www.alt5sigma.com/role/IntangibleassetsNarrativeDetails",
      "http://www.alt5sigma.com/role/IntangibleassetsScheduleofIntangibleAssetsDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Developed technology",
        "terseLabel": "Developed technology",
        "label": "Developed Technology Rights [Member]",
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1011",
      "r1013",
      "r1015",
      "r1016"
     ]
    },
    "alts_DigitalAssetLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DigitalAssetLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Digital assets payable",
        "label": "Digital Asset, Liability, Current",
        "documentation": "Digital Asset, Liability, Current"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DigitalAssetLiabilityCurrentCashDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DigitalAssetLiabilityCurrentCashDeposits",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Digital assets, cash deposits",
        "label": "Digital Asset, Liability, Current, Cash Deposits",
        "documentation": "Digital Asset, Liability, Current, Cash Deposits"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DigitalAssetLiabilityCurrentDigitalAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DigitalAssetLiabilityCurrentDigitalAssets",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Digital assets",
        "label": "Digital Asset, Liability, Current, Digital Assets",
        "documentation": "Digital Asset, Liability, Current, Digital Assets"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DigitalAssetsAndOtherPayablesPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DigitalAssetsAndOtherPayablesPolicyPolicyTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Digital Assets and other Payables",
        "label": "Digital Assets And Other Payables, Policy [Policy Text Block]",
        "documentation": "Digital Assets And Other Payables, Policy"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DigitalAssetsAndOtherReceivablesPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DigitalAssetsAndOtherReceivablesPolicyPolicyTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Digital Assets and other Receivables",
        "label": "Digital Assets And Other Receivables, Policy [Policy Text Block]",
        "documentation": "Digital Assets And Other Receivables, Policy"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DiscontinuedFinancingActivities": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DiscontinuedFinancingActivities",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "DISCONTINUED FINANCING ACTIVITIES:",
        "label": "DISCONTINUED FINANCING ACTIVITIES:",
        "documentation": "DISCONTINUED FINANCING ACTIVITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DiscontinuedInvestingActivities": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DiscontinuedInvestingActivities",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "DISCONTINUED INVESTING ACTIVITIES:",
        "label": "DISCONTINUED INVESTING ACTIVITIES:",
        "documentation": "DISCONTINUED INVESTING ACTIVITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DiscontinuedOperatingActivities": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DiscontinuedOperatingActivities",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "DISCONTINUED OPERATING ACTIVITIES:",
        "label": "DISCONTINUED OPERATING ACTIVITIES:",
        "documentation": "DISCONTINUED OPERATING ACTIVITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income from discontinued operations",
        "negatedTerseLabel": "Gain on sale of ARCA",
        "label": "Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax",
        "documentation": "Amount before tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r93",
      "r95"
     ]
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income before provision for income taxes from discontinued operations",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax",
        "documentation": "Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r92",
      "r93",
      "r94",
      "r95",
      "r101",
      "r133",
      "r1107"
     ]
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.alt5sigma.com/role/EarningsLosspershareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net income per share from discontinued operations, basic (in usd per share)",
        "terseLabel": "Basic income per share from discontinued operations (in usd per share)",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share",
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.alt5sigma.com/role/EarningsLosspershareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income per share from discontinued operations, diluted (in usd per share)",
        "verboseLabel": "Diluted income per share from discontinued operations (in usd per share)",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share",
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income tax provision",
        "label": "Discontinued Operation, Tax Effect of Discontinued Operation",
        "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r93",
      "r94",
      "r95",
      "r101",
      "r105",
      "r500",
      "r526",
      "r528"
     ]
    },
    "us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income tax provision for discontinued operations",
        "label": "Discontinued Operation, Tax Effect of Gain (Loss) from Disposal of Discontinued Operation",
        "documentation": "Amount of tax expense (benefit) on gain (loss) not previously recognized resulting from the disposal of a discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r95",
      "r105",
      "r1074"
     ]
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]",
        "label": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupClassificationAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails",
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails",
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesNarrativeDetails",
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Classification [Axis]",
        "label": "Disposal Group Classification [Axis]",
        "documentation": "Information by disposal group classification."
       }
      }
     },
     "auth_ref": [
      "r212"
     ]
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupClassificationDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails",
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails",
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesNarrativeDetails",
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Classification [Domain]",
        "label": "Disposal Group Classification [Domain]",
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails",
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesNarrativeDetails",
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Recycling Subsidiaries",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r23"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cost of revenues",
        "label": "Disposal Group, Including Discontinued Operation, Costs of Goods Sold",
        "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r213"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling, general and administrative expenses",
        "label": "Disposal Group, Including Discontinued Operation, General and Administrative Expense",
        "documentation": "Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross profit",
        "label": "Disposal Group, Including Discontinued Operation, Gross Profit (Loss)",
        "documentation": "Amount of gross profit attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r213"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense, net",
        "label": "Disposal Group, Including Discontinued Operation, Interest Expense",
        "documentation": "Amount of interest expense attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r30",
      "r102"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating income from discontinued operations",
        "label": "Disposal Group, Including Discontinued Operation, Operating Income (Loss)",
        "documentation": "Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "alts_DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other expense, net",
        "label": "Disposal Group, Including Discontinued Operation, Other (Income) Expense, Net",
        "documentation": "Disposal Group, Including Discontinued Operation, Other (Income) Expense, Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Revenues",
        "label": "Disposal Group, Including Discontinued Operation, Revenue",
        "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r213"
     ]
    },
    "alts_DisposalGroupIncludingDiscontinuedOperationTotalOperatingIncomeExpensesFromDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DisposalGroupIncludingDiscontinuedOperationTotalOperatingIncomeExpensesFromDiscontinuedOperations",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Total operating expenses from discontinued operations",
        "label": "Disposal Group, Including Discontinued Operation, Total Operating Income (Expenses) From Discontinued Operations",
        "documentation": "Disposal Group, Including Discontinued Operation, Total Operating Income (Expenses) From Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivable with imputed interest, net amount",
        "label": "Disposal Group, Including Discontinued Operations, Present Value Of Discount Recorded As Offset To The Principal Amount",
        "documentation": "Disposal Group, Including Discontinued Operations, Present Value Of Discount Recorded As Offset To The Principal Amount"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DisposalGroupIncludingDiscontinuedOperationsTotalOtherIncomeLossNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DisposalGroupIncludingDiscontinuedOperationsTotalOtherIncomeLossNet",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total other expense, net",
        "label": "Disposal Group, Including Discontinued Operations, Total Other Income (Loss), Net",
        "documentation": "Total other loss, net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preliminary calculation of gain on sale",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal",
        "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r381",
      "r973",
      "r1018"
     ]
    },
    "alts_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag": {
     "xbrltype": "tokenItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag",
     "presentation": [
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Excess of book value over assets disposed, extensible list",
        "label": "Disposal Group Not Discontinued Operation Gain (Loss) On Disposal, Statement Of Income Extensible List Not Disclosed Flag",
        "documentation": "Disposal Group Not Discontinued Operation Gain (Loss) On Disposal, Statement Of Income Extensible List Not Disclosed Flag"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Write off of VM7 note receivable",
        "verboseLabel": "Impairment of carrying value",
        "label": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down",
        "documentation": "Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r12",
      "r150"
     ]
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperations",
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiaries"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Sale of Recycling Subsidiaries",
        "verboseLabel": "Discontinued Operations",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r148"
     ]
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails",
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails",
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesNarrativeDetails",
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Name",
        "label": "Disposal Group Name [Domain]",
        "documentation": "Name of disposal group."
       }
      }
     },
     "auth_ref": [
      "r803",
      "r804"
     ]
    },
    "alts_DisposalOfAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DisposalOfAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails": {
       "parentTag": "alts_TotalDisposalOfLiability",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Disposal of Accounts Payable",
        "documentation": "Disposal of Accounts Payable"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DisposalOfAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DisposalOfAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails": {
       "parentTag": "alts_TotalDisposalOfAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable",
        "label": "Disposal of Accounts receivable",
        "documentation": "Disposal of Accounts receivable"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DisposalOfAccruedLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DisposalOfAccruedLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails": {
       "parentTag": "alts_TotalDisposalOfLiability",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued liabilities",
        "label": "Disposal of Accrued liability",
        "documentation": "Disposal of Accrued liability"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DisposalOfAccruedLiabilityCaliforniaStateSalesTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DisposalOfAccruedLiabilityCaliforniaStateSalesTax",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails": {
       "parentTag": "alts_TotalDisposalOfLiability",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued liabilities - California state sales tax",
        "label": "Disposal of Accrued liability - California state sales tax",
        "documentation": "Disposal of Accrued liability - California state sales tax"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DisposalOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DisposalOfDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails": {
       "parentTag": "alts_TotalDisposalOfLiability",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt",
        "label": "Disposal of Debt",
        "documentation": "Disposal of Debt"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DisposalOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DisposalOfIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails": {
       "parentTag": "alts_TotalDisposalOfAssets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets",
        "label": "Disposal of Intangible assets",
        "documentation": "Disposal of Intangible assets"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DisposalOfInventory": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DisposalOfInventory",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails": {
       "parentTag": "alts_TotalDisposalOfAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory",
        "label": "Disposal of Inventory",
        "documentation": "Disposal of Inventory"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DisposalOfLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DisposalOfLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails": {
       "parentTag": "alts_TotalDisposalOfLiability",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities",
        "label": "Disposal of Lease Liability",
        "documentation": "Disposal of Lease Liability"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DisposalOfOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DisposalOfOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails": {
       "parentTag": "alts_TotalDisposalOfAssets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "label": "Disposal of Other Assets",
        "documentation": "Disposal of Other Assets"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DisposalOfPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DisposalOfPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails": {
       "parentTag": "alts_TotalDisposalOfAssets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment",
        "label": "Disposal of Property, Plant and Equipment",
        "documentation": "Disposal of Property, Plant and Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "alts_DisposalOfRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DisposalOfRightOfUseAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails": {
       "parentTag": "alts_TotalDisposalOfAssets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets",
        "label": "Disposal of Right-of-use Assets",
        "documentation": "Disposal of Right-of-use Assets"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Annual Report",
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r839",
      "r840",
      "r863"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Error Correction [Flag]",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r839",
      "r840",
      "r863",
      "r906"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Domestic Tax Jurisdiction",
        "label": "Domestic Tax Jurisdiction [Member]",
        "documentation": "Designated federal jurisdiction entitled to levy and collect income tax in country of domicile. Includes, but is not limited to, national jurisdiction for non-U.S. jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r502"
     ]
    },
    "alts_DrSoinMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "DrSoinMember",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dr. Soin",
        "label": "Dr. Soin [Member]",
        "documentation": "Dr. Soin [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year",
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r895"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "(Loss) income per share:",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.alt5sigma.com/role/EarningsLosspershareScheduleofComputationofBasicandDilutedNetLossPerShareDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofProformaInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per share, basic (in usd per share)",
        "netLabel": "Net (loss) income per share, basic (in usd per share)",
        "verboseLabel": "Basic (loss) income per share (in usd per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r238",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r274",
      "r277",
      "r285",
      "r286",
      "r287",
      "r292",
      "r535",
      "r543",
      "r559",
      "r560",
      "r612",
      "r634",
      "r777"
     ]
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasicAbstract",
     "presentation": [
      "http://www.alt5sigma.com/role/EarningsLosspershareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Basic",
        "label": "Earnings Per Share, Basic [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.alt5sigma.com/role/EarningsLosspershareScheduleofComputationofBasicandDilutedNetLossPerShareDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofProformaInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per share, diluted (in usd per share)",
        "netLabel": "Earnings per basic diluted share (in usd per share)",
        "verboseLabel": "Net (loss) income per share, diluted (in usd per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r238",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r277",
      "r285",
      "r286",
      "r287",
      "r292",
      "r535",
      "r543",
      "r559",
      "r560",
      "r612",
      "r634",
      "r777"
     ]
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDilutedAbstract",
     "presentation": [
      "http://www.alt5sigma.com/role/EarningsLosspershareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Diluted",
        "label": "Earnings Per Share, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings Per Share",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r42",
      "r289"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/EarningsLosspershare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings (Loss) per share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r273",
      "r288",
      "r290",
      "r291"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of changes in exchange rate on cash and cash equivalents",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1088"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofReconciliationofIncomeTaxBenefitProvisionwiththeFederalStatutoryTaxRateDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofReconciliationofIncomeTaxBenefitProvisionwiththeFederalStatutoryTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Effective income tax rate",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r502",
      "r807"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract",
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofReconciliationofIncomeTaxBenefitProvisionwiththeFederalStatutoryTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of provision for income taxes with federal statutory rate",
        "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofReconciliationofIncomeTaxBenefitProvisionwiththeFederalStatutoryTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofReconciliationofIncomeTaxBenefitProvisionwiththeFederalStatutoryTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. statutory rate",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r252",
      "r502",
      "r524",
      "r807"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofReconciliationofIncomeTaxBenefitProvisionwiththeFederalStatutoryTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofReconciliationofIncomeTaxBenefitProvisionwiththeFederalStatutoryTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in valuation allowance",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r507",
      "r807",
      "r978",
      "r1065"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationDispositionOfBusiness",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofReconciliationofIncomeTaxBenefitProvisionwiththeFederalStatutoryTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofReconciliationofIncomeTaxBenefitProvisionwiththeFederalStatutoryTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impact of sale of ARCA Recycling and Canada",
        "label": "Effective Income Tax Rate Reconciliation, Disposition of Business, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to disposition of a business not qualifying as a discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r978",
      "r1065",
      "r1066"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofReconciliationofIncomeTaxBenefitProvisionwiththeFederalStatutoryTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofReconciliationofIncomeTaxBenefitProvisionwiththeFederalStatutoryTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign rate differential",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile."
       }
      }
     },
     "auth_ref": [
      "r503",
      "r506",
      "r807",
      "r978",
      "r1065"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofReconciliationofIncomeTaxBenefitProvisionwiththeFederalStatutoryTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofReconciliationofIncomeTaxBenefitProvisionwiththeFederalStatutoryTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r807",
      "r978",
      "r1065",
      "r1066"
     ]
    },
    "alts_EffectiveIncomeTaxRateReconciliationPermanentDifferences": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "EffectiveIncomeTaxRateReconciliationPermanentDifferences",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofReconciliationofIncomeTaxBenefitProvisionwiththeFederalStatutoryTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofReconciliationofIncomeTaxBenefitProvisionwiththeFederalStatutoryTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Permanent differences",
        "label": "Effective Income Tax Rate Reconciliation Permanent Differences",
        "documentation": "Effective income tax rate reconciliation permanent differences."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofReconciliationofIncomeTaxBenefitProvisionwiththeFederalStatutoryTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofReconciliationofIncomeTaxBenefitProvisionwiththeFederalStatutoryTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State tax rate",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r505",
      "r807",
      "r978",
      "r1065"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/AccruedliabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/AccruedliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation and benefits",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation expense, net of estimated forfeitures",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1064"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Options",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r837"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity",
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r837"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r837"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r946"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Public Float",
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r837"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r837"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r837"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r837"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Voluntary Filers",
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r947"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Footnote",
        "label": "Equity Awards Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table",
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r942"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments",
        "label": "Equity Awards Adjustments [Member]"
       }
      }
     },
     "auth_ref": [
      "r942"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table",
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r942"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity [Abstract]",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r209",
      "r233",
      "r234",
      "r235",
      "r258",
      "r259",
      "r260",
      "r262",
      "r267",
      "r269",
      "r271",
      "r294",
      "r350",
      "r351",
      "r380",
      "r449",
      "r522",
      "r523",
      "r532",
      "r533",
      "r534",
      "r536",
      "r542",
      "r543",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r565",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r575",
      "r578",
      "r588",
      "r633",
      "r657",
      "r658",
      "r659",
      "r679",
      "r744"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Domain]",
        "label": "Investment, Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r346",
      "r347",
      "r348",
      "r531",
      "r950",
      "r951",
      "r952",
      "r1075",
      "r1076",
      "r1077",
      "r1078"
     ]
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding, ownership (as percent)",
        "label": "Equity Method Investment, Ownership Percentage",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r346"
     ]
    },
    "us-gaap_EquityUnitPurchaseAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityUnitPurchaseAgreementsMember",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Unit Purchase Agreements",
        "label": "Equity Unit Purchase Agreements [Member]",
        "documentation": "Contracts and securities that allow the holder to buy equity units from the entity."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r899"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r856",
      "r867",
      "r877",
      "r910"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r853",
      "r864",
      "r874",
      "r907"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "alts_ExercisePriceRangeOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "ExercisePriceRangeOneMember",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityScheduleofExercisePriceforStockOptionsOutstandingandExercisableOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "$5.70 to $9.90",
        "label": "Exercise Price Range One [Member]",
        "documentation": "Exercise price range one."
       }
      }
     },
     "auth_ref": []
    },
    "alts_ExercisePriceRangeTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "ExercisePriceRangeTwoMember",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityScheduleofExercisePriceforStockOptionsOutstandingandExercisableOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "$3.54 to $5.25",
        "label": "Exercise Price Range Two [Member]",
        "documentation": "Exercise price range two."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_FinancialGuaranteeInsuranceContractsPremiumsReceivableAccretionOfDiscountOnPremiumReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialGuaranteeInsuranceContractsPremiumsReceivableAccretionOfDiscountOnPremiumReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accretion of note receivable discount",
        "label": "Financial Guarantee Insurance Contracts, Premiums Receivable, Adjustment, Accretion of Discount on Premium Receivable",
        "documentation": "Amount of accretion of the discount for premiums receivable on financial guarantee insurance contracts."
       }
      }
     },
     "auth_ref": [
      "r653"
     ]
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/NotesreceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Principal balance on notes outstanding",
        "label": "Financing Receivable, Excluding Accrued Interest, after Allowance for Credit Loss",
        "documentation": "Amortized cost excluding accrued interest, after allowance for credit loss, of financing receivable. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r1000"
     ]
    },
    "us-gaap_FinancingReceivablesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancingReceivablesTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/Notesreceivable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes receivable",
        "label": "Financing Receivables [Text Block]",
        "documentation": "The entire disclosure for financing receivable."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r342",
      "r343",
      "r344",
      "r791"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://www.alt5sigma.com/role/IntangibleassetsNarrativeDetails",
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated useful life of intangible assets (in years)",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/IntangibleassetsScheduleofIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IntangibleassetsScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less accumulated amortization",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r218",
      "r354",
      "r373",
      "r794"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/IntangibleassetsNarrativeDetails",
      "http://www.alt5sigma.com/role/IntangibleassetsScheduleofIntangibleAssetsDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails",
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets by Major Class",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r366",
      "r368",
      "r369",
      "r370",
      "r372",
      "r373",
      "r375",
      "r376",
      "r608",
      "r609",
      "r765"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/IntangibleassetsScheduleofIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IntangibleassetsScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total intangible assets",
        "label": "Finite-Lived Intangible Assets, Gross",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r354",
      "r373",
      "r609",
      "r794"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://www.alt5sigma.com/role/IntangibleassetsNarrativeDetails",
      "http://www.alt5sigma.com/role/IntangibleassetsScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite Lived Intangible Assets [Line Items]",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r366",
      "r373",
      "r375",
      "r376",
      "r378",
      "r608",
      "r765",
      "r794"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/IntangibleassetsNarrativeDetails",
      "http://www.alt5sigma.com/role/IntangibleassetsScheduleofIntangibleAssetsDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails",
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r366",
      "r368",
      "r369",
      "r370",
      "r372",
      "r373",
      "r375",
      "r376",
      "r765"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/IntangibleassetsScheduleofIntangibleAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IntangibleassetsScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total intangible assets, net",
        "label": "Finite-Lived Intangible Assets, Net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r608",
      "r1013"
     ]
    },
    "alts_FintechMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "FintechMember",
     "presentation": [
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofBalanceSheetInformationDetails",
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fintech",
        "label": "Fintech [Member]",
        "documentation": "Fintech"
       }
      }
     },
     "auth_ref": []
    },
    "alts_FixedDepositAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "FixedDepositAgreementMember",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed Deposit Agreement",
        "label": "Fixed Deposit Agreement [Member]",
        "documentation": "Fixed Deposit Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r860",
      "r871",
      "r881",
      "r914"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r860",
      "r871",
      "r881",
      "r914"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r860",
      "r871",
      "r881",
      "r914"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r860",
      "r871",
      "r881",
      "r914"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r860",
      "r871",
      "r881",
      "r914"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year",
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnDispositionOfAssets1",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/NotesreceivableDetails",
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Carrying value of disposition transaction",
        "label": "Gain (Loss) on Disposition of Assets",
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee."
       }
      }
     },
     "auth_ref": [
      "r973"
     ]
    },
    "alts_GainLossOnWriteOffOfNotesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "GainLossOnWriteOffOfNotesReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.alt5sigma.com/role/NotesreceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Write off of SPYR note receivable",
        "negatedLabel": "Impairment charge related to note receivable",
        "label": "Gain (Loss) on Write-Off Of Notes Receivable",
        "documentation": "Gain (Loss) on Write-Off Of Notes Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "alts_GainOnSaleNetOfCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "GainOnSaleNetOfCash",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Gain on sale of ARCA, net of cash",
        "label": "Gain on Sale, Net of Cash",
        "documentation": "Gain on Sale, Net of Cash"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Related party notes issued for shared services",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r52",
      "r53"
     ]
    },
    "alts_GeoTraqIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "GeoTraqIncMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
      "http://www.alt5sigma.com/role/NotesreceivableDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesA1ConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GeoTraq Inc.",
        "label": "Geo Traq Inc [Member]",
        "documentation": "GeoTraq Inc."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsALT5Details",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "verboseLabel": "Total goodwill",
        "label": "Goodwill",
        "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r217",
      "r355",
      "r610",
      "r786",
      "r793",
      "r811",
      "r818",
      "r1003",
      "r1004"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit",
        "terseLabel": "Gross profit",
        "label": "Gross Profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r134",
      "r191",
      "r250",
      "r349",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r564",
      "r779",
      "r785",
      "r987",
      "r990",
      "r991",
      "r992",
      "r993",
      "r1032"
     ]
    },
    "us-gaap_GuaranteeObligationsCurrentCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GuaranteeObligationsCurrentCarryingValue",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/AccruedliabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/AccruedliabilitiesDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued guarantees",
        "terseLabel": "Guarantor obligations, current carrying value",
        "label": "Guarantor Obligations, Current Carrying Value",
        "documentation": "The current carrying amount of the liability for the freestanding or embedded guarantor's obligations under the guarantee or each group of similar guarantees."
       }
      }
     },
     "auth_ref": [
      "r398"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICFR Auditor Attestation Flag",
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r839",
      "r840",
      "r863"
     ]
    },
    "alts_IcgNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "IcgNoteMember",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICG Note",
        "label": "ICG Note [Member]",
        "documentation": "ICG Note Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperations",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/BackgroundandBasisofPresentationDetails",
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss from continuing operations",
        "terseLabel": "Net (loss) income from continuing operations",
        "negatedTerseLabel": "Net loss from continuing operations",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r132",
      "r145",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r283",
      "r287",
      "r543"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsAttributableToParentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsAttributableToParentAbstract",
     "presentation": [
      "http://www.alt5sigma.com/role/EarningsLosspershareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Continuing Operations",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeLossBeforeProvisionofIncomeTaxesDetails": {
       "parentTag": "alts_IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeLossBeforeProvisionofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r501"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss before benefit from income taxes",
        "terseLabel": "Net loss after provision for income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r186",
      "r191",
      "r613",
      "r630",
      "r779",
      "r785",
      "r987",
      "r990",
      "r991",
      "r992",
      "r993"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeLossBeforeProvisionofIncomeTaxesDetails": {
       "parentTag": "alts_IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeLossBeforeProvisionofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Canada",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r501"
     ]
    },
    "alts_IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeLossBeforeProvisionofIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeLossBeforeProvisionofIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss before provision of income taxes, Total",
        "label": "Income (Loss) from Continuing Operations Before Provision (Benefit) Of Income Taxes",
        "documentation": "Income (Loss) from Continuing Operations Before Provision (Benefit) Of Income Taxes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.alt5sigma.com/role/EarningsLosspershareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per share from continuing operations, basic (in usd per share)",
        "netLabel": "Basic (loss) income per share from continuing operations (in usd per share)",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r187",
      "r238",
      "r261",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r277",
      "r285",
      "r286",
      "r535",
      "r543",
      "r560",
      "r612",
      "r1108"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.alt5sigma.com/role/EarningsLosspershareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per share from continuing operations, diluted (in usd per share)",
        "netLabel": "Diluted (loss) per share from continuing operations (in usd per share)",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r238",
      "r261",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r277",
      "r285",
      "r286",
      "r287",
      "r543",
      "r560",
      "r612",
      "r1108"
     ]
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicShareAbstract",
     "presentation": [
      "http://www.alt5sigma.com/role/EarningsLosspershareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discontinued Operations",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails",
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income from discontinued operations",
        "terseLabel": "Net income from discontinued operations",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r92",
      "r93",
      "r94",
      "r95",
      "r101",
      "r105",
      "r173"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails",
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails",
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesNarrativeDetails",
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Name",
        "label": "Disposal Group Name [Axis]",
        "documentation": "Information by name of disposal group."
       }
      }
     },
     "auth_ref": [
      "r803",
      "r804"
     ]
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails",
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails",
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesNarrativeDetails",
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails",
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails",
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesNarrativeDetails",
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r23",
      "r29",
      "r87",
      "r96",
      "r97",
      "r98",
      "r99",
      "r100",
      "r104",
      "r106",
      "r107",
      "r151"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Jurisdiction [Axis]",
        "label": "Income Tax Jurisdiction [Axis]",
        "documentation": "Information by income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r246",
      "r502",
      "r503",
      "r511",
      "r518",
      "r807",
      "r1070"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Jurisdiction [Domain]",
        "label": "Income Tax Jurisdiction [Domain]",
        "documentation": "Income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r246",
      "r502",
      "r503",
      "r511",
      "r518",
      "r807",
      "r1070"
     ]
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxContingencyLineItems",
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesNarrativeDetails",
      "http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Contingency [Line Items]",
        "label": "Income Tax Contingency [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxContingencyTable",
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesNarrativeDetails",
      "http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Contingency [Table]",
        "label": "Income Tax Contingency [Table]",
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months."
       }
      }
     },
     "auth_ref": [
      "r1067"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/Incometaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r252",
      "r495",
      "r502",
      "r508",
      "r509",
      "r510",
      "r512",
      "r516",
      "r525",
      "r527",
      "r529",
      "r530",
      "r673",
      "r807"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax benefit",
        "verboseLabel": "Income tax benefit",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r197",
      "r207",
      "r270",
      "r271",
      "r293",
      "r309",
      "r330",
      "r500",
      "r502",
      "r526",
      "r635",
      "r807"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current tax expense:",
        "label": "Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r232",
      "r496",
      "r497",
      "r512",
      "r513",
      "r515",
      "r520",
      "r667"
     ]
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax refunds received, net",
        "label": "Income Taxes Paid, Net",
        "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r246",
      "r517",
      "r518"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and accrued expenses",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and accrued expenses",
        "label": "Increase (Decrease) in Accounts Payable, Trade",
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts receivable",
        "negatedTerseLabel": "Accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "alts_IncreaseDecreaseInDigitalAssetsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "IncreaseDecreaseInDigitalAssetsPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Digital assets payable",
        "label": "Increase (Decrease) In Digital Assets Payable",
        "documentation": "Increase (Decrease) In Digital Assets Payable"
       }
      }
     },
     "auth_ref": []
    },
    "alts_IncreaseDecreaseInDigitalAssetsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "IncreaseDecreaseInDigitalAssetsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Digital assets receivable",
        "label": "Increase (Decrease) In Digital Assets Receivable",
        "documentation": "Increase (Decrease) In Digital Assets Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Inventories",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in assets and liabilities:",
        "verboseLabel": "Changes in assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other assets",
        "negatedTerseLabel": "Other assets",
        "label": "Increase (Decrease) in Other Operating Assets",
        "documentation": "Amount of increase (decrease) in operating assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expense",
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "presentation": [
      "http://www.alt5sigma.com/role/PreferredStockScheduleofSeriesSConvertiblePreferredStockOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r860",
      "r871",
      "r881",
      "r905",
      "r914",
      "r918",
      "r926"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r924"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r841",
      "r930"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r841",
      "r930"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r841",
      "r930"
     ]
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/Intangibleassets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets",
        "label": "Intangible Assets Disclosure [Text Block]",
        "documentation": "The entire disclosure for all or part of the information related to intangible assets."
       }
      }
     },
     "auth_ref": [
      "r365",
      "r377",
      "r379",
      "r764",
      "r765"
     ]
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "presentation": [
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible Assets",
        "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets."
       }
      }
     },
     "auth_ref": [
      "r604",
      "r605",
      "r606",
      "r608",
      "r775",
      "r1005"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets, net",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r366",
      "r1013",
      "r1014"
     ]
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsNetIncludingGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofBalanceSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total goodwill and other intangible Assets",
        "label": "Intangible Assets, Net (Including Goodwill)",
        "documentation": "Amount, after impairment and amortization, of goodwill, indefinite-lived, and finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r1002"
     ]
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Interest (expense) income, net",
        "terseLabel": "Interest (expense) income, net",
        "label": "Interest Income (Expense), Nonoperating",
        "documentation": "Amount of interest income (expense) classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r785",
      "r970",
      "r990"
     ]
    },
    "us-gaap_InterestIncomeInterestEarningAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestIncomeInterestEarningAsset",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/NotesreceivableDetails",
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Interest Income, Interest-Earning Asset",
        "documentation": "Amount of interest income from interest-earning asset."
       }
      }
     },
     "auth_ref": [
      "r957",
      "r958"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest paid",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r241",
      "r244",
      "r245"
     ]
    },
    "us-gaap_InterestPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/AccruedliabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/AccruedliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued interest",
        "label": "Interest Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "us-gaap_InterestReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestReceivable",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/NotesreceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued receivables",
        "label": "Interest Receivable",
        "documentation": "Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable."
       }
      }
     },
     "auth_ref": [
      "r964",
      "r1142"
     ]
    },
    "alts_InvestorOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "InvestorOneMember",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investor one",
        "label": "Investor One [Member]",
        "documentation": "Investor One"
       }
      }
     },
     "auth_ref": []
    },
    "alts_InvestorTwoAndInvestorThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "InvestorTwoAndInvestorThreeMember",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other two investors",
        "label": "Investor Two And Investor Three [Member]",
        "documentation": "Investor Two And Investor Three"
       }
      }
     },
     "auth_ref": []
    },
    "alts_IsaacCapitalGroupLLCICGMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "IsaacCapitalGroupLLCICGMember",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICG",
        "label": "Isaac Capital Group LLC (\u201cICG\u201d) [Member]",
        "documentation": "Isaac Capital Group LLC (\u201cICG\u201d)"
       }
      }
     },
     "auth_ref": []
    },
    "alts_IsaacCapitalGroupNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "IsaacCapitalGroupNoteMember",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofLongTermDebtPayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Isaac Capital Group",
        "label": "Isaac Capital Group Note [Member]",
        "documentation": "Isaac Capital Group Note"
       }
      }
     },
     "auth_ref": []
    },
    "alts_IsaacCapitalGroupShortTermDemandAdvanceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "IsaacCapitalGroupShortTermDemandAdvanceMember",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofLongTermDebtPayabletoRelatedPartiesDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Isaac Capital Group Short-Term Demand Advance",
        "label": "Isaac Capital Group Short-Term Demand Advance [Member]",
        "documentation": "Isaac Capital Group Short-Term Demand Advance"
       }
      }
     },
     "auth_ref": []
    },
    "alts_IsaacConsultingAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "IsaacConsultingAgreementMember",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Isaac Consulting Agreement",
        "label": "Isaac Consulting Agreement [Member]",
        "documentation": "Isaac Consulting Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "alts_JanOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "JanOneMember",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Janone",
        "label": "JanOne [Member]",
        "documentation": "JanOne"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases [Abstract]",
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "alts_LegacySubsidiaryFixedDepositsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "LegacySubsidiaryFixedDepositsMember",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legacy subsidiary fixed deposits",
        "label": "Legacy Subsidiary Fixed Deposits [Member]",
        "documentation": "Legacy Subsidiary Fixed Deposits"
       }
      }
     },
     "auth_ref": []
    },
    "alts_LegacySubsidiaryLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "LegacySubsidiaryLoanMember",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legacy subsidiary loan",
        "label": "Legacy Subsidiary Loan [Member]",
        "documentation": "Legacy Subsidiary Loan"
       }
      }
     },
     "auth_ref": []
    },
    "alts_LegacyUnaffiliatedThirdPartyNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "LegacyUnaffiliatedThirdPartyNotesMember",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unaffiliated third-party",
        "label": "Legacy Unaffiliated Third Party Notes [Member]",
        "documentation": "Legacy Unaffiliated Third Party Notes"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal Entity",
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "alts_LegalFeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "LegalFeesMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal Fees",
        "label": "Legal Fees [Member]",
        "documentation": "Legal Fees"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Total Present Value of Future Lease Payments of Operating Leases",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1094"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.alt5sigma.com/role/LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less implied interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r577"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r110",
      "r111",
      "r112",
      "r115",
      "r116",
      "r117",
      "r118",
      "r250",
      "r349",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r547",
      "r550",
      "r551",
      "r564",
      "r699",
      "r778",
      "r835",
      "r1032",
      "r1096",
      "r1097"
     ]
    },
    "us-gaap_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities:",
        "label": "Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities, mezzanine equity, and stockholders' equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r183",
      "r627",
      "r818",
      "r976",
      "r999",
      "r1087"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities, Mezzanine Equity, and Stockholders' Equity (Deficit)",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/BackgroundandBasisofPresentationDetails",
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "terseLabel": "Current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r215",
      "r250",
      "r349",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r547",
      "r550",
      "r551",
      "r564",
      "r818",
      "r1032",
      "r1096",
      "r1097"
     ]
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Availability under revolving credit facility",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r114"
     ]
    },
    "srt_LitigationCaseAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "LitigationCaseAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Litigation Case [Axis]",
        "label": "Litigation Case [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_LitigationCaseTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "LitigationCaseTypeDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Litigation Case [Domain]",
        "label": "Litigation Case [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LitigationReserveCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LitigationReserveCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/AccruedliabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/AccruedliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued litigation/legal",
        "label": "Estimated Litigation Liability, Current",
        "documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r1025"
     ]
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Penalty awarded",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "documentation": "Amount awarded to other party in judgment or settlement of litigation."
       }
      }
     },
     "auth_ref": []
    },
    "alts_LitigationSettlementAmountAwardedToOtherPartyNumberOfPeriodicPayments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "LitigationSettlementAmountAwardedToOtherPartyNumberOfPeriodicPayments",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of quarterly payments",
        "label": "Litigation Settlement, Amount Awarded to Other Party, Number of Periodic Payments",
        "documentation": "Litigation Settlement, Amount Awarded to Other Party, Number of Periodic Payments"
       }
      }
     },
     "auth_ref": []
    },
    "alts_LitigationSettlementAmountAwardedToOtherPartyPeriodicPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "LitigationSettlementAmountAwardedToOtherPartyPeriodicPayments",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Quarterly payment amounts",
        "label": "Litigation Settlement, Amount Awarded to Other Party, Periodic Payments",
        "documentation": "Litigation Settlement, Amount Awarded to Other Party, Periodic Payments"
       }
      }
     },
     "auth_ref": []
    },
    "alts_LiveNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "LiveNoteMember",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Live Note",
        "label": "Live Note [Member]",
        "documentation": "Live Note"
       }
      }
     },
     "auth_ref": []
    },
    "alts_LiveVentureIncorporatedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "LiveVentureIncorporatedMember",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Live Venture Incorporated",
        "label": "Live Venture Incorporated [Member]",
        "documentation": "Live Venture Incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "alts_LiveVenturesAndICGNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "LiveVenturesAndICGNotesMember",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Live Ventures and ICG Notes",
        "label": "Live Ventures And ICG Notes [Member]",
        "documentation": "Live Ventures And ICG Notes"
       }
      }
     },
     "auth_ref": []
    },
    "alts_LiveVenturesIncorporatedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "LiveVenturesIncorporatedMember",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Live Ventures Incorporated",
        "label": "Live Ventures Incorporated [Member]",
        "documentation": "Live Ventures Incorporated."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LoansPayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LoansPayableMember",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loan",
        "label": "Loans Payable [Member]",
        "documentation": "Borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/LongTermDebtScheduleofLongTermDebtDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofFutureMaturitiesofLongTermDebtDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/DebenturesScheduleofDebenturesOutstandingDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/LongTermDebtScheduleofLongTermDebtDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofFutureMaturitiesofLongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total debentures",
        "totalLabel": "Long-Term Debt, Total",
        "verboseLabel": "Outstanding aggregate obligations",
        "label": "Long-Term Debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r180",
      "r423",
      "r438",
      "r797",
      "r798",
      "r816",
      "r1105"
     ]
    },
    "us-gaap_LongTermDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/LongTermDebtScheduleofLongTermDebtDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtScheduleofLongTermDebtDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofLongTermDebtPayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less current portion",
        "negatedTerseLabel": "Less current portion",
        "label": "Long-Term Debt, Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r221"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofFutureMaturitiesofLongTermDebtDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofFutureMaturitiesofLongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Long-Term Debt, Maturity, Year One",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r257",
      "r428"
     ]
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/LongTermDebtScheduleofLongTermDebtDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtScheduleofLongTermDebtDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofLongTermDebtPayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total long-term notes payable, related parties",
        "verboseLabel": "Total long-term notes payable, related parties",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r222"
     ]
    },
    "us-gaap_LongTermDebtTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/Debentures",
      "http://www.alt5sigma.com/role/LongTermDebt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debentures",
        "verboseLabel": "Long-Term Debt",
        "label": "Long-Term Debt [Text Block]",
        "documentation": "The entire disclosure for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "us-gaap_LongTermNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes payable",
        "label": "Notes Payable, Noncurrent",
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/DebenturesNarrativeDetails",
      "http://www.alt5sigma.com/role/DebenturesScheduleofDebenturesOutstandingDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofLongTermDebtPayabletoRelatedPartiesDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r1020",
      "r1021",
      "r1022"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/DebenturesNarrativeDetails",
      "http://www.alt5sigma.com/role/DebenturesScheduleofDebenturesOutstandingDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofLongTermDebtPayabletoRelatedPartiesDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r51",
      "r1020",
      "r1021",
      "r1022"
     ]
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingency Nature [Axis]",
        "label": "Loss Contingency Nature [Axis]",
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r392",
      "r393",
      "r394",
      "r397",
      "r493",
      "r663",
      "r795",
      "r1026",
      "r1027"
     ]
    },
    "us-gaap_LossContingenciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingenciesLineItems",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Loss Contingencies [Line Items]",
        "label": "Loss Contingencies [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r392",
      "r393",
      "r394",
      "r397",
      "r493",
      "r795",
      "r1026",
      "r1027"
     ]
    },
    "us-gaap_LossContingenciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingenciesTable",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Loss Contingencies [Table]",
        "label": "Loss Contingencies [Table]",
        "documentation": "Disclosure of information about loss contingency. Excludes environmental contingency, warranty, and unconditional purchase obligation."
       }
      }
     },
     "auth_ref": [
      "r392",
      "r393",
      "r394",
      "r397",
      "r493",
      "r795",
      "r1026",
      "r1027"
     ]
    },
    "us-gaap_LossContingencyDamagesAwardedValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingencyDamagesAwardedValue",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Damages awarded plus interest and attorney fees",
        "label": "Loss Contingency, Damages Awarded, Value",
        "documentation": "Amount of damages awarded to the plaintiff in the legal matter."
       }
      }
     },
     "auth_ref": [
      "r1025",
      "r1026",
      "r1027"
     ]
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingencyDamagesSoughtValue",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Damages sought value",
        "label": "Loss Contingency, Damages Sought, Value",
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter."
       }
      }
     },
     "auth_ref": [
      "r1025",
      "r1026",
      "r1027"
     ]
    },
    "us-gaap_LossContingencyNatureDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingencyNatureDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingency, Nature [Domain]",
        "label": "Loss Contingency, Nature [Domain]",
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability."
       }
      }
     },
     "auth_ref": [
      "r392",
      "r393",
      "r394",
      "r397",
      "r493",
      "r663",
      "r795",
      "r1026",
      "r1027"
     ]
    },
    "alts_LossContingencyNumberOfExecutiveOfficersNamedInComplaint": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "LossContingencyNumberOfExecutiveOfficersNamedInComplaint",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of executive officers named in complaint",
        "label": "Loss Contingency, Number Of Executive Officers Named In Complaint",
        "documentation": "Loss Contingency, Number Of Executive Officers Named In Complaint"
       }
      }
     },
     "auth_ref": []
    },
    "alts_Main270LLCLitigationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "Main270LLCLitigationMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Main / 270, LLC Litigation",
        "label": "Main / 270, LLC Litigation [Member]",
        "documentation": "Main / 270, LLC Litigation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecurities",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Marketable Securities",
        "documentation": "Amount of investment in marketable security."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r961"
     ]
    },
    "us-gaap_MarketableSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable Securities [Abstract]",
        "label": "Marketable Securities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mark-to-market",
        "label": "Marketable Security, Gain (Loss)",
        "documentation": "Amount of realized and unrealized gain (loss) on investment in marketable security."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable securities",
        "label": "Marketable Securities, Noncurrent",
        "documentation": "Amount of investment in marketable security, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/MarketableSecuritiesNarrativeDetails",
      "http://www.alt5sigma.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Write-off marketable securities",
        "negatedTerseLabel": "Write off of marketable securities",
        "label": "Marketable Security, Realized Gain (Loss)",
        "documentation": "Amount of realized gain (loss) on investment in marketable security."
       }
      }
     },
     "auth_ref": []
    },
    "alts_MarketableSecuritiesSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "MarketableSecuritiesSharesOutstanding",
     "presentation": [
      "http://www.alt5sigma.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Marketable Securities, Shares Outstanding",
        "documentation": "Marketable Securities, Shares Outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/MarketableSecuritiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Marketable Securities",
        "label": "Marketable Securities [Table Text Block]",
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesUnrealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesUnrealizedGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.alt5sigma.com/role/MarketableSecuritiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized loss on marketable securities",
        "negatedLabel": "Unrealized loss on marketable securities",
        "negatedTerseLabel": "Unrealized loss on marketable securities",
        "label": "Marketable Security, Unrealized Gain (Loss)",
        "documentation": "Amount of unrealized gain (loss) on investment in marketable security."
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "alts_MarketableSecurityWriteOffShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "MarketableSecurityWriteOffShares",
     "presentation": [
      "http://www.alt5sigma.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Write-off marketable securities (in shares)",
        "label": "Marketable Security, Write-Off, Shares",
        "documentation": "Marketable Security, Write-Off, Shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketingRelatedIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketingRelatedIntangibleAssetsMember",
     "presentation": [
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Domain Name and Marketing",
        "label": "Marketing-Related Intangible Assets [Member]",
        "documentation": "Marketing-related asset, including, but not limited to, internet domain name, newspaper mast head, and trademark."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1011",
      "r1013",
      "r1015",
      "r1016"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r393",
      "r394",
      "r395",
      "r396",
      "r454",
      "r493",
      "r563",
      "r603",
      "r655",
      "r656",
      "r663",
      "r691",
      "r692",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r762",
      "r763",
      "r791",
      "r801",
      "r805",
      "r812",
      "r813",
      "r814",
      "r815",
      "r820",
      "r1034",
      "r1098",
      "r1099",
      "r1100",
      "r1101",
      "r1102",
      "r1103"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Mergers and Acquisitions",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r167"
     ]
    },
    "alts_MezzanineEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "MezzanineEquityAbstract",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mezzanine equity",
        "label": "Mezzanine equity [Abstract]",
        "documentation": "Mezzanine equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r393",
      "r394",
      "r395",
      "r396",
      "r454",
      "r493",
      "r563",
      "r603",
      "r655",
      "r656",
      "r663",
      "r691",
      "r692",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r762",
      "r763",
      "r791",
      "r801",
      "r805",
      "r812",
      "r813",
      "r814",
      "r820",
      "r1034",
      "r1098",
      "r1099",
      "r1100",
      "r1101",
      "r1102",
      "r1103"
     ]
    },
    "us-gaap_MinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncontrolling interest",
        "label": "Equity, Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r182",
      "r250",
      "r349",
      "r401",
      "r403",
      "r404",
      "r405",
      "r408",
      "r409",
      "r564",
      "r626",
      "r703"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "us-gaap_MovementInAuctionMarketPreferredSecuritiesSharesOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MovementInAuctionMarketPreferredSecuritiesSharesOutstandingRollForward",
     "presentation": [
      "http://www.alt5sigma.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable Securities, Shares [Roll Forward]",
        "label": "Movement in Auction Market Preferred Securities, Shares Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "alts_Mr.JonIsaacMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "Mr.JonIsaacMember",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mr. Jon Isaac",
        "label": "Mr. Jon Isaac [Member]",
        "documentation": "Mr. Jon Isaac"
       }
      }
     },
     "auth_ref": []
    },
    "alts_Mr.SullivanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "Mr.SullivanMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mr. Sullivan",
        "label": "Mr. Sullivan [Member]",
        "documentation": "Mr. Sullivan"
       }
      }
     },
     "auth_ref": []
    },
    "alts_Mr.TonyIsaacMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "Mr.TonyIsaacMember",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mr. Tony Isaac",
        "label": "Mr. Tony Isaac [Member]",
        "documentation": "Mr. Tony Isaac"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r925"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "alts_NetCashProvidedByOperatingActivitiesContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "NetCashProvidedByOperatingActivitiesContinuingOperations",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/BackgroundandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash provided by operating activities",
        "label": "Net Cash Provided by Operating Activities, Continuing Operations",
        "documentation": "Net Cash Provided by Operating Activities, Continuing Operations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r243"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FINANCING ACTIVITIES:",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r243"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INVESTING ACTIVITIES:",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r144",
      "r145"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OPERATING ACTIVITIES:",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "alts_NetConsideration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "NetConsideration",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails": {
       "parentTag": "alts_TotalConsiderations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net consideration",
        "label": "Net Consideration",
        "documentation": "Net Consideration"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofProformaInformationDetails",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "terseLabel": "Net income",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r145",
      "r188",
      "r213",
      "r230",
      "r231",
      "r235",
      "r250",
      "r261",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r270",
      "r271",
      "r283",
      "r349",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r535",
      "r543",
      "r560",
      "r564",
      "r632",
      "r721",
      "r742",
      "r743",
      "r833",
      "r1032"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/EarningsLosspershareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net (loss) income, basic",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r263",
      "r264",
      "r265",
      "r266",
      "r274",
      "r275",
      "r284",
      "r287",
      "r543"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/EarningsLosspershareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net (loss) income, diluted",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r276",
      "r279",
      "r280",
      "r281",
      "r282",
      "r284",
      "r287"
     ]
    },
    "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/EarningsLosspershareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net (loss) income from continuing operations, basic",
        "label": "Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from continuing operations available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r275",
      "r287"
     ]
    },
    "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/EarningsLosspershareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net (loss) income from continuing operations, diluted",
        "label": "Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) from continuing operations available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r276",
      "r280",
      "r281",
      "r282",
      "r287"
     ]
    },
    "us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/EarningsLosspershareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income from discontinued operations, basic",
        "label": "Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from discontinued operations available to common shareholders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/EarningsLosspershareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income from discontinued operations, diluted",
        "label": "Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) from discontinued operations available to common shareholders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetRentableArea": {
     "xbrltype": "areaItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetRentableArea",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rented office space (in sqft)",
        "label": "Net Rentable Area",
        "documentation": "Net rentable area for properties owned."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recently Issued Accounting Pronouncements",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "alts_NonConvertibleDebentureBigAndSmallDebentureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "NonConvertibleDebentureBigAndSmallDebentureMember",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debentures",
        "label": "Non-Convertible Debenture, Big and Small Debenture [Member]",
        "documentation": "Non-Convertible Debenture, Big and Small Debenture"
       }
      }
     },
     "auth_ref": []
    },
    "alts_NonConvertibleDebentureBigDebentureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "NonConvertibleDebentureBigDebentureMember",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Big Debenture",
        "label": "Non-Convertible Debenture, Big Debenture [Member]",
        "documentation": "Non-Convertible Debenture, Big Debenture"
       }
      }
     },
     "auth_ref": []
    },
    "alts_NonConvertibleDebentureSmallDebentureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "NonConvertibleDebentureSmallDebentureMember",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Small Debenture",
        "label": "Non-Convertible Debenture, Small Debenture [Member]",
        "documentation": "Non-Convertible Debenture, Small Debenture"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r860",
      "r871",
      "r881",
      "r905",
      "r914"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r925"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r925"
     ]
    },
    "us-gaap_NoncashContributionExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncashContributionExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 21.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncash expense for consulting services",
        "label": "Noncash Contribution Expense",
        "documentation": "Noncash charitable contributions made by the entity during the period."
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncash Investing and Financing Items [Abstract]",
        "label": "Noncash Investing and Financing Items [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1",
     "presentation": [
      "http://www.alt5sigma.com/role/NotesreceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock equivalents received (in shares)",
        "label": "Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Shares Issued",
        "documentation": "The number of shares issued as [noncash or part noncash] consideration for a business or asset acquired. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r39",
      "r40"
     ]
    },
    "alts_NoncashOrPartNoncashDivestitureConsiderationReceivedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "NoncashOrPartNoncashDivestitureConsiderationReceivedShares",
     "presentation": [
      "http://www.alt5sigma.com/role/MarketableSecuritiesNarrativeDetails",
      "http://www.alt5sigma.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Securities received (in shares)",
        "label": "Noncash Or Part Noncash Divestiture, Consideration Received, Shares",
        "documentation": "Noncash Or Part Noncash Divestiture, Consideration Received, Shares"
       }
      }
     },
     "auth_ref": []
    },
    "alts_NoncashRecognitionOfNewLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "NoncashRecognitionOfNewLeases",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncash recognition of new leases",
        "label": "Noncash recognition of new leases",
        "documentation": "Noncash recognition of new leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncontrollingInterestMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncontrolling Interest",
        "label": "Noncontrolling Interest [Member]",
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r449",
      "r980",
      "r981",
      "r982",
      "r984",
      "r1140"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other (expense) income, net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income:",
        "label": "Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "alts_NorthYorkLTDMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "NorthYorkLTDMember",
     "presentation": [
      "http://www.alt5sigma.com/role/PreferredStockSeriesVConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "North York LTD",
        "label": "North York LTD [Member]",
        "documentation": "North York LTD"
       }
      }
     },
     "auth_ref": []
    },
    "alts_NotePayableToIsaacCapitalGroupMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "NotePayableToIsaacCapitalGroupMember",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofLongTermDebtPayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Note Payable To Isaac Capital Group",
        "label": "Note Payable To Isaac Capital Group [Member]",
        "documentation": "Note Payable To Isaac Capital Group"
       }
      }
     },
     "auth_ref": []
    },
    "alts_NotePayableToLiveVentureIncorporatedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "NotePayableToLiveVentureIncorporatedMember",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofLongTermDebtPayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Note Payable To Live Venture Incorporated",
        "label": "Note Payable To Live Venture Incorporated [Member]",
        "documentation": "Note Payable To Live Venture Incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "alts_NoteReceivableFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "NoteReceivableFaceAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/NotesreceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Note receivable face amount",
        "label": "Note Receivable Face Amount",
        "documentation": "Note receivable face amount."
       }
      }
     },
     "auth_ref": []
    },
    "alts_NoteReceivableStatedInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "NoteReceivableStatedInterestRate",
     "presentation": [
      "http://www.alt5sigma.com/role/NotesreceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Note receivable interest rate (as percent)",
        "label": "Note Receivable Stated Interest Rate",
        "documentation": "Note receivable interest rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes payable",
        "label": "Notes Payable, Current",
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r111"
     ]
    },
    "us-gaap_NotesPayableOtherPayablesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesPayableOtherPayablesMember",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofLongTermDebtPayabletoRelatedPartiesDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Notes Payable",
        "terseLabel": "Note",
        "label": "Notes Payable, Other Payables [Member]",
        "documentation": "A written promise to pay a note to a third party."
       }
      }
     },
     "auth_ref": []
    },
    "alts_NotesPayableRelatedPartiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "NotesPayableRelatedPartiesMember",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofFutureMaturitiesofLongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes Payable Related Parties",
        "label": "Notes Payable Related Parties [Member]",
        "documentation": "Notes payable, related parties."
       }
      }
     },
     "auth_ref": []
    },
    "alts_NotesPayableWithLiveVenturesAndICGMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "NotesPayableWithLiveVenturesAndICGMember",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes Payable With Live Ventures and ICG",
        "label": "Notes Payable With Live Ventures and ICG [Member]",
        "documentation": "Notes Payable With Live Ventures and ICG"
       }
      }
     },
     "auth_ref": []
    },
    "alts_NotesReceivableTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "NotesReceivableTerm",
     "presentation": [
      "http://www.alt5sigma.com/role/NotesreceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term of notes receivable (in years)",
        "label": "Notes Receivable, Term",
        "documentation": "Notes Receivable, Term"
       }
      }
     },
     "auth_ref": []
    },
    "alts_NovalkAppsSAALLPMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "NovalkAppsSAALLPMember",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Novalk Apps SAA, LLP",
        "label": "Novalk Apps SAA, LLP [Member]",
        "documentation": "Novalk Apps SAA, LLP"
       }
      }
     },
     "auth_ref": []
    },
    "alts_NovalkAppsSAALLPShortTermDemandAdvanceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "NovalkAppsSAALLPShortTermDemandAdvanceMember",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofLongTermDebtPayabletoRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Novalk Apps SAA, LLP",
        "label": "Novalk Apps SAA LLP Short-Term Demand Advance [Member]",
        "documentation": "Novalk Apps SAA LLP Short-Term Demand Advance"
       }
      }
     },
     "auth_ref": []
    },
    "alts_NumberOfAcquiredIntangibleAssets": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "NumberOfAcquiredIntangibleAssets",
     "presentation": [
      "http://www.alt5sigma.com/role/IntangibleassetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of pending patents",
        "label": "Number Of Acquired Intangible Assets",
        "documentation": "Number Of Acquired Intangible Assets"
       }
      }
     },
     "auth_ref": []
    },
    "alts_NumberOfAgreementsToBePurchased": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "NumberOfAgreementsToBePurchased",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unaffiliated third-part investors",
        "label": "Number Of Agreements To Be Purchased",
        "documentation": "Number Of Agreements To Be Purchased"
       }
      }
     },
     "auth_ref": []
    },
    "alts_NumberOfConsultants": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "NumberOfConsultants",
     "presentation": [
      "http://www.alt5sigma.com/role/PreferredStockSeriesIConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of consultants",
        "label": "Number Of Consultants",
        "documentation": "Number Of Consultants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://www.alt5sigma.com/role/BackgroundandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of operating segments",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r786",
      "r989"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.alt5sigma.com/role/SegmentinformationNarrativeDetails",
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segments",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r780",
      "r790",
      "r989"
     ]
    },
    "alts_NumberOfTradingDaysBeforeBoardApproval": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "NumberOfTradingDaysBeforeBoardApproval",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of trading days prior to court approval (in days)",
        "label": "Number Of Trading Days Before Board Approval",
        "documentation": "Number Of Trading Days Before Board Approval"
       }
      }
     },
     "auth_ref": []
    },
    "alts_NumberOfTranches": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "NumberOfTranches",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of tranches",
        "label": "Number Of Tranches",
        "documentation": "Number Of Tranches"
       }
      }
     },
     "auth_ref": []
    },
    "alts_NumberOfUnaffiliatedThirdPartyInvestors": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "NumberOfUnaffiliatedThirdPartyInvestors",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number Of unaffiliated third-party investors",
        "label": "Number Of Unaffiliated Third-Party Investors",
        "documentation": "Number Of Unaffiliated Third-Party Investors"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "alts_OperatingExpensesFromDiscontinuedOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "OperatingExpensesFromDiscontinuedOperationsAbstract",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses from discontinued operations:",
        "label": "Operating Expenses From Discontinued Operations [Abstract]",
        "documentation": "Operating Expenses From Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating loss",
        "terseLabel": "Operating loss",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r779",
      "r987",
      "r990",
      "r991",
      "r992",
      "r993"
     ]
    },
    "us-gaap_OperatingLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total rent and common area expenses",
        "label": "Operating Lease, Expense",
        "documentation": "Amount of operating lease expense. Excludes sublease income."
       }
      }
     },
     "auth_ref": [
      "r1093"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/LeasesScheduleofTotalPresentValueofFutureLeasePaymentsofOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Present value of payments",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r580"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.alt5sigma.com/role/LeasesScheduleofCompanysRightofUseAssetsandLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "verboseLabel": "Current - operating",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r580"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.alt5sigma.com/role/LeasesScheduleofCompanysRightofUseAssetsandLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "verboseLabel": "Long term - operating",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r580"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash payment for operating leases",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r581",
      "r582"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.alt5sigma.com/role/LeasesScheduleofCompanysRightofUseAssetsandLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right of use assets",
        "verboseLabel": "Right of use asset - operating leases",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r973"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.alt5sigma.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average discount rate (as percent)",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r585",
      "r817"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.alt5sigma.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average lease term (in years)",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r584",
      "r817"
     ]
    },
    "alts_OperatingLeasesFutureMinimumPaymentsDue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "OperatingLeasesFutureMinimumPaymentsDue1",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Future lease payments",
        "label": "Operating Leases Future Minimum Payments Due1",
        "documentation": "Operating Leases Future Minimum Payments Due1."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating loss carryforwards",
        "label": "Operating Loss Carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r519"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwardsValuationAllowance",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating loss carryforwards, valuation allowance",
        "label": "Operating Loss Carryforwards, Valuation Allowance",
        "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r1069"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/BackgroundandBasisofPresentation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Background and Basis of Presentation",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r172",
      "r664",
      "r665"
     ]
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/AccruedliabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/AccruedliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Other Accrued Liabilities, Current",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "us-gaap_OtherAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/Depositsandotherassets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deposits and other assets",
        "label": "Other Assets Disclosure [Text Block]",
        "documentation": "The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/DepositsandotherassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deposits and other assets",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r219"
     ]
    },
    "alts_OtherCommitmentsAndLitigationCasesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "OtherCommitmentsAndLitigationCasesMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Commitments And Litigation Cases",
        "label": "Other Commitments And Litigation Cases [Member]",
        "documentation": "Other Commitments And Litigation Cases"
       }
      }
     },
     "auth_ref": []
    },
    "alts_OtherCommitmentsNumberOfLandlordsCompanyIsNoLongerLiableFor": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "OtherCommitmentsNumberOfLandlordsCompanyIsNoLongerLiableFor",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of landlords company is no longer liable for",
        "label": "Other Commitments, Number Of Landlords Company Is No Longer Liable For",
        "documentation": "Other Commitments, Number Of Landlords Company Is No Longer Liable For"
       }
      }
     },
     "auth_ref": []
    },
    "alts_OtherCommitmentsNumberOfLandlordsOriginallyPurportedToBeLiableFor": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "OtherCommitmentsNumberOfLandlordsOriginallyPurportedToBeLiableFor",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of landlords originally purported to be covered under company's guarantee or commitment",
        "label": "Other Commitments, Number Of Landlords Originally Purported To Be Liable For",
        "documentation": "Other Commitments, Number Of Landlords Originally Purported To Be Liable For"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive loss",
        "label": "Other Comprehensive Income (Loss), before Tax",
        "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r237",
      "r565",
      "r566",
      "r571",
      "r611",
      "r633",
      "r967",
      "r968"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency adjustment",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r633"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails": {
       "parentTag": "alts_TotalDisposalOfLiability",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive loss",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax",
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r129",
      "r229",
      "r345"
     ]
    },
    "us-gaap_OtherCurrentAssetsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherCurrentAssetsTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/Prepaidsandothercurrentassets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaids and other current assets",
        "label": "Other Current Assets [Text Block]",
        "documentation": "The entire disclosure for other current assets."
       }
      }
     },
     "auth_ref": []
    },
    "alts_OtherIncomeExpenseFromDiscontinuedOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "OtherIncomeExpenseFromDiscontinuedOperationsAbstract",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other expense from discontinued operations",
        "label": "Other Income (Expense) From Discontinued Operations [Abstract]",
        "documentation": "Other Income (Expense) From Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "alts_OtherLegacyNotesPayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "OtherLegacyNotesPayableMember",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtScheduleofLongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Legacy Notes Payable [Member]",
        "documentation": "Other Legacy Notes Payable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due to related parties",
        "label": "Other Liabilities",
        "documentation": "Amount of liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r179",
      "r618",
      "r695",
      "r696",
      "r835",
      "r1106",
      "r1139"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due to Soin",
        "label": "Other Liabilities, Current",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r818"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other noncurrent liabilities",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "us-gaap_OtherLongTermNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLongTermNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related party notes payable",
        "label": "Other Notes Payable, Noncurrent",
        "documentation": "Amount of long-term notes classified as other, payable after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income, net",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "us-gaap_OtherPrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherPrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/PrepaidsandothercurrentassetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/PrepaidsandothercurrentassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid other",
        "label": "Other Prepaid Expense, Current",
        "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r965",
      "r1001"
     ]
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherReceivablesNetCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesScheduleofTradeandOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other receivables",
        "label": "Other Receivables, Net, Current",
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "alts_OtherSignificantNoncashTransactionBusinessAcquisitionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "OtherSignificantNoncashTransactionBusinessAcquisitionMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock issued for the acquisition of Alt5 Subsidiary",
        "label": "Other Significant Noncash Transaction, Business Acquisition [Member]",
        "documentation": "Other Significant Noncash Transaction, Business Acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "alts_OtherSignificantNoncashTransactionConsultingServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "OtherSignificantNoncashTransactionConsultingServicesMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued for consulting services",
        "label": "Other Significant Noncash Transaction, Consulting Services [Member]",
        "documentation": "Other Significant Noncash Transaction, Consulting Services"
       }
      }
     },
     "auth_ref": []
    },
    "alts_OtherSignificantNoncashTransactionIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "OtherSignificantNoncashTransactionIntangibleAssetsMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock issued for intangible assets",
        "label": "Other Significant Noncash Transaction, Intangible Assets [Member]",
        "documentation": "Other Significant Noncash Transaction, Intangible Assets"
       }
      }
     },
     "auth_ref": []
    },
    "alts_OtherSignificantNoncashTransactionInterestObligationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "OtherSignificantNoncashTransactionInterestObligationsMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued for interest obligations",
        "label": "Other Significant Noncash Transaction, Interest Obligations [Member]",
        "documentation": "Other Significant Noncash Transaction, Interest Obligations"
       }
      }
     },
     "auth_ref": []
    },
    "alts_OtherSignificantNoncashTransactionLiabilityObligationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "OtherSignificantNoncashTransactionLiabilityObligationsMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued for liability obligations",
        "label": "Other Significant Noncash Transaction, Liability Obligations [Member]",
        "documentation": "Other Significant Noncash Transaction, Liability Obligations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherSignificantNoncashTransactionNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherSignificantNoncashTransactionNameDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Significant Noncash Transaction, Name [Domain]",
        "label": "Other Significant Noncash Transaction, Name [Domain]",
        "documentation": "The name of other significant noncash (or part noncash) investing and financing activities required to be supplementally disclosed to enable users of the financial information to fully understand the period cash flows of the Entity in relation to the statements of financial position, income statement, and statement of changes in shareholders' equity. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r39",
      "r40"
     ]
    },
    "alts_OtherSignificantNoncashTransactionPropertyAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "OtherSignificantNoncashTransactionPropertyAndEquipmentMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued for property and equipment",
        "label": "Other Significant Noncash Transaction, Property And Equipment [Member]",
        "documentation": "Other Significant Noncash Transaction, Property And Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherSignificantNoncashTransactionsByUniqueDescriptionAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Significant Noncash Transaction [Axis]",
        "label": "Other Significant Noncash Transaction [Axis]",
        "documentation": "Information by other significant noncash transactions."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r39",
      "r40"
     ]
    },
    "us-gaap_OtherSignificantNoncashTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherSignificantNoncashTransactionsLineItems",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Other Significant Noncash Transactions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherSignificantNoncashTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherSignificantNoncashTransactionsTable",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Other Significant Noncash Transactions [Table]",
        "documentation": "Disclosure of information about other noncash or part noncash transaction."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r39",
      "r40"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r858",
      "r869",
      "r879",
      "r912"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r861",
      "r872",
      "r882",
      "r915"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r861",
      "r872",
      "r882",
      "r915"
     ]
    },
    "alts_OwnersOfALT5SubsidiaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "OwnersOfALT5SubsidiaryMember",
     "presentation": [
      "http://www.alt5sigma.com/role/PreferredStockSeriesBPreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Owners of ALT5 Subsidiary",
        "label": "Owners Of ALT5 Subsidiary [Member]",
        "documentation": "Owners Of ALT5 Subsidiary"
       }
      }
     },
     "auth_ref": []
    },
    "alts_PatentsAndDomainsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "PatentsAndDomainsMember",
     "presentation": [
      "http://www.alt5sigma.com/role/IntangibleassetsScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Patents and domains",
        "label": "Patents And Domains [Member]",
        "documentation": "Patents and domains."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r886"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payables and Accruals [Abstract]",
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentForContingentConsiderationLiabilityInvestingActivities",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash payment tendered for contingent liability",
        "label": "Payment for Contingent Consideration Liability, Investing Activities",
        "documentation": "Amount of cash outflow, made soon after acquisition date of business combination, to settle contingent consideration liability."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "alts_PaymentFromBuyer": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "PaymentFromBuyer",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails": {
       "parentTag": "alts_NetConsideration",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment from buyer",
        "label": "Payment from Buyer",
        "documentation": "Payment from Buyer"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForCommissions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForCommissions",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/NotesreceivableDetails",
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for close",
        "label": "Payments for Commissions",
        "documentation": "The amount of cash paid for commissions during the current period."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForLegalSettlements",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments for legal settlements",
        "label": "Payments for Legal Settlements",
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails": {
       "parentTag": "us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchase of intangible assets",
        "label": "Payments to Acquire Intangible Assets",
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails": {
       "parentTag": "us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r896"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r896"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "alts_PercentageOfGrossRevenue": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "PercentageOfGrossRevenue",
     "presentation": [
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of gross revenue",
        "label": "Percentage of Gross Revenue",
        "documentation": "Percentage of Gross Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "alts_PercentageOfNetDollarReceivedToBeIssuedToDebentureHoldersOnAProRataBasis": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "PercentageOfNetDollarReceivedToBeIssuedToDebentureHoldersOnAProRataBasis",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net dollar issued to debentures holders on a pro rata basis (as percent)",
        "label": "Percentage Of Net Dollar Received To Be Issued To Debenture Holders On A Pro Rata Basis",
        "documentation": "Percentage Of Net Dollar Received To Be Issued To Debenture Holders On A Pro Rata Basis"
       }
      }
     },
     "auth_ref": []
    },
    "alts_Plan2011Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "Plan2011Member",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2011 Plan",
        "label": "Plan2011 [Member]",
        "documentation": "Plan 2011."
       }
      }
     },
     "auth_ref": []
    },
    "alts_Plan2016Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "Plan2016Member",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2016 Plan",
        "label": "Plan2016 [Member]",
        "documentation": "Plan 2016."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063"
     ]
    },
    "alts_PlatformOperatorCryptoAssetHeldForUserCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "PlatformOperatorCryptoAssetHeldForUserCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Digital assets receivable",
        "label": "Platform Operator, Crypto Asset, Held-for-User, Current",
        "documentation": "Platform Operator, Crypto Asset, Held-for-User, Current"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Prior Service Cost",
        "label": "Pension Adjustments Prior Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Service Cost",
        "label": "Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r945"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Benefits Adjustments, Footnote",
        "label": "Pension Benefits Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "alts_PotentialMarketExclusivityPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "PotentialMarketExclusivityPeriod",
     "presentation": [
      "http://www.alt5sigma.com/role/BackgroundandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Potential market exclusivity period (in years)",
        "label": "Potential Market Exclusivity Period",
        "documentation": "Potential Market Exclusivity Period"
       }
      }
     },
     "auth_ref": []
    },
    "alts_PreFundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "PreFundedWarrantsMember",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-Funded Warrants Member",
        "label": "Pre-Funded Warrants [Member]",
        "documentation": "Pre-Funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockConvertibleConversionRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockConvertibleConversionRatio",
     "presentation": [
      "http://www.alt5sigma.com/role/MarketableSecuritiesNarrativeDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesA1ConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesIConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, conversion ratio",
        "verboseLabel": "Preferred stock, conversion ratio (as percent)",
        "label": "Preferred Stock, Convertible, Conversion Ratio",
        "documentation": "Number of common shares issuable upon conversion for each share of preferred stock to be converted."
       }
      }
     },
     "auth_ref": [
      "r441"
     ]
    },
    "us-gaap_PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred Stock",
        "label": "Preferred Stock [Member]",
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company."
       }
      }
     },
     "auth_ref": [
      "r825",
      "r826",
      "r829",
      "r830",
      "r831",
      "r832",
      "r1138",
      "r1140"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preferred stock/Preferred stock, par value (in usd per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r439"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preferred stock/Preferred stock, shares authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r701"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preferred stock/Preferred stock, shares issued (in shares)",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r439"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.alt5sigma.com/role/PreferredStockSeriesA1ConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesBPreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesIConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesMPreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesQConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesVConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Convertible preferred stock/Preferred stock, outstanding (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "terseLabel": "Preferred stock, outstanding shares (in shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r701",
      "r719",
      "r1140",
      "r1141"
     ]
    },
    "us-gaap_PreferredStockTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/PreferredStock"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred Stock",
        "label": "Preferred Stock [Text Block]",
        "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock."
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r621",
      "r818"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.alt5sigma.com/role/PrepaidsandothercurrentassetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.alt5sigma.com/role/PrepaidsandothercurrentassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Total prepaids and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r966"
     ]
    },
    "us-gaap_PrepaidInsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidInsurance",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/PrepaidsandothercurrentassetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/PrepaidsandothercurrentassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid insurance",
        "label": "Prepaid Insurance",
        "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r770",
      "r792",
      "r1001"
     ]
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "presentation": [
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Statement Reclassification",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error."
       }
      }
     },
     "auth_ref": [
      "r959"
     ]
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Private Placement",
        "label": "Private Placement [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ProFormaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProFormaMember",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofProformaInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proforma",
        "label": "Pro Forma [Member]"
       }
      }
     },
     "auth_ref": [
      "r272",
      "r949",
      "r953"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from equity financings, net",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ProceedsFromNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromNotesPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of notes payable",
        "verboseLabel": "Proceeds from note payable",
        "label": "Proceeds from Notes Payable",
        "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromRelatedPartyDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from the issuance of related party note payable",
        "label": "Proceeds from Related Party Debt",
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Securities received",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleOfInterestInPartnershipUnit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleOfInterestInPartnershipUnit",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of common stock",
        "label": "Proceeds from Sale of Interest in Partnership Unit",
        "documentation": "The proceeds from the sale of an interest in a unit of partnership."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ProceedsFromShortTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromShortTermDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from short-term demand advances",
        "label": "Proceeds from Short-Term Debt",
        "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromWarrantExercises",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants exercised",
        "label": "Proceeds from Warrant Exercises",
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants."
       }
      }
     },
     "auth_ref": [
      "r971"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r334",
      "r607",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r654",
      "r767",
      "r802",
      "r819",
      "r820",
      "r821",
      "r823",
      "r824",
      "r1028",
      "r1029",
      "r1037",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131",
      "r1132",
      "r1133",
      "r1134",
      "r1135",
      "r1136",
      "r1137"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]"
       }
      }
     },
     "auth_ref": [
      "r334",
      "r607",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r654",
      "r767",
      "r802",
      "r819",
      "r820",
      "r821",
      "r823",
      "r824",
      "r1028",
      "r1029",
      "r1037",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131",
      "r1132",
      "r1133",
      "r1134",
      "r1135",
      "r1136",
      "r1137"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net loss",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r230",
      "r231",
      "r242",
      "r250",
      "r261",
      "r267",
      "r270",
      "r271",
      "r349",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r535",
      "r543",
      "r545",
      "r548",
      "r549",
      "r560",
      "r564",
      "r613",
      "r631",
      "r678",
      "r721",
      "r742",
      "r743",
      "r809",
      "r810",
      "r834",
      "r969",
      "r1032"
     ]
    },
    "alts_PromissoryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "PromissoryNoteMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Promissory Note",
        "label": "Promissory Note [Member]",
        "documentation": "Promissory Note"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Abstract]",
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r587"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/PropertyandEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and Equipment",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r201",
      "r204",
      "r205"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.alt5sigma.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails",
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property Plant And Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.alt5sigma.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property and equipment, net",
        "terseLabel": "Total property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r587",
      "r614",
      "r629",
      "r818"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/PropertyandEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property and Equipment",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r587"
     ]
    },
    "alts_ProvisionBenefitOfIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "ProvisionBenefitOfIncomeTaxes",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeTaxProvisionBenefitDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total (benefit) provision of income taxes",
        "label": "Provision (Benefit) Of Income Taxes",
        "documentation": "Provision (Benefit) Of Income Taxes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProvisionForDoubtfulAccounts",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in reserve for uncollectible accounts",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r353"
     ]
    },
    "us-gaap_ProvisionForLoanLeaseAndOtherLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProvisionForLoanLeaseAndOtherLosses",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bad debt expense",
        "label": "Provision for Loan, Lease, and Other Losses",
        "documentation": "Amount of expense related loan transactions, lease transactions, credit loss from transactions other than loan and lease transactions, and other loss based on assessment of uncollectability from the counterparty to reduce the account to their net realizable value."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r185",
      "r194"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r886"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r886"
     ]
    },
    "alts_QodenIntangibleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "QodenIntangibleMember",
     "presentation": [
      "http://www.alt5sigma.com/role/IntangibleassetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Qoden intangible",
        "label": "Qoden Intangible [Member]",
        "documentation": "Qoden Intangible"
       }
      }
     },
     "auth_ref": []
    },
    "alts_QodenTechnologiesLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "QodenTechnologiesLLCMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.alt5sigma.com/role/IntangibleassetsNarrativeDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsQodenDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesQConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Qoden Technologies, LLC",
        "label": "Qoden Technologies, LLC [Member]",
        "documentation": "Qoden Technologies, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r393",
      "r394",
      "r395",
      "r396",
      "r452",
      "r454",
      "r482",
      "r483",
      "r484",
      "r493",
      "r563",
      "r600",
      "r601",
      "r603",
      "r655",
      "r656",
      "r663",
      "r691",
      "r692",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r762",
      "r763",
      "r791",
      "r801",
      "r805",
      "r812",
      "r813",
      "r814",
      "r815",
      "r820",
      "r827",
      "r1023",
      "r1034",
      "r1085",
      "r1099",
      "r1100",
      "r1101",
      "r1102",
      "r1103"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r393",
      "r394",
      "r395",
      "r396",
      "r452",
      "r454",
      "r482",
      "r483",
      "r484",
      "r493",
      "r563",
      "r600",
      "r601",
      "r603",
      "r655",
      "r656",
      "r663",
      "r691",
      "r692",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r762",
      "r763",
      "r791",
      "r801",
      "r805",
      "r812",
      "r813",
      "r814",
      "r815",
      "r820",
      "r827",
      "r1023",
      "r1034",
      "r1085",
      "r1099",
      "r1100",
      "r1101",
      "r1102",
      "r1103"
     ]
    },
    "alts_RealizedGainLossOnExchangeTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "RealizedGainLossOnExchangeTransactions",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Realized gain on exchange transactions",
        "label": "Realized Gain (Loss) On Exchange Transactions",
        "documentation": "Realized Gain (Loss) On Exchange Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReceivableTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReceivableTypeDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivable [Domain]",
        "label": "Receivable [Domain]",
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r128"
     ]
    },
    "us-gaap_ReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivables [Abstract]",
        "label": "Receivables [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "alts_ReclassificationOfTemporaryToCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "ReclassificationOfTemporaryToCurrentLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/PreferredStockScheduleofSeriesSConvertiblePreferredStockOutstandingDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification to current liabilities",
        "negatedTerseLabel": "Reclassification to current liabilities",
        "label": "Reclassification of Temporary to Current Liabilities",
        "documentation": "Reclassification of Temporary to Current Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "alts_ReclassificationOfTemporaryToCurrentLiabilitiesShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "ReclassificationOfTemporaryToCurrentLiabilitiesShares",
     "presentation": [
      "http://www.alt5sigma.com/role/PreferredStockScheduleofSeriesSConvertiblePreferredStockOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification to current liabilities (in shares)",
        "label": "Reclassification of Temporary to Current Liabilities, Shares",
        "documentation": "Reclassification of Temporary to Current Liabilities, Shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReclassificationsOfTemporaryToPermanentEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReclassificationsOfTemporaryToPermanentEquity",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.alt5sigma.com/role/PreferredStockScheduleofSeriesSConvertiblePreferredStockOutstandingDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification of Series S S-1 Preferred Stock to permanent equity",
        "verboseLabel": "Reclassification to permanent equity",
        "negatedLabel": "Reclassification to permanent equity",
        "label": "Reclassifications of Temporary to Permanent Equity",
        "documentation": "The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r174"
     ]
    },
    "alts_ReclassificationsOfTemporaryToPermanentEquityShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "ReclassificationsOfTemporaryToPermanentEquityShares",
     "presentation": [
      "http://www.alt5sigma.com/role/PreferredStockScheduleofSeriesSConvertiblePreferredStockOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification to permanent equity (in shares)",
        "label": "Reclassifications Of Temporary To Permanent Equity, Shares",
        "documentation": "Reclassifications Of Temporary To Permanent Equity, Shares"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r853",
      "r864",
      "r874",
      "r907"
     ]
    },
    "alts_RecyclingSegmentAndTechnologySegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "RecyclingSegmentAndTechnologySegmentMember",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recycling Segment and Technology Segment",
        "label": "Recycling Segment And Technology Segment [Member]",
        "documentation": "Recycling Segment And Technology Segment"
       }
      }
     },
     "auth_ref": []
    },
    "alts_RecyclingSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "RecyclingSegmentMember",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails",
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails",
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofBalanceSheetInformationDetails",
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Recycling Segment",
        "terseLabel": "Discontinue operations",
        "label": "Recycling Segment [Member]",
        "documentation": "Recycling Segment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/LongTermDebtScheduleofLongTermDebtDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsQodenDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofFutureMaturitiesofLongTermDebtDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofLongTermDebtPayabletoRelatedPartiesDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party",
        "label": "Related and Nonrelated Parties [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r339",
      "r453",
      "r592",
      "r593",
      "r619",
      "r628",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r718",
      "r720",
      "r749"
     ]
    },
    "us-gaap_RelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/LongTermDebtScheduleofLongTermDebtDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsQodenDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofFutureMaturitiesofLongTermDebtDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofLongTermDebtPayabletoRelatedPartiesDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party",
        "label": "Related Party [Member]",
        "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family."
       }
      }
     },
     "auth_ref": [
      "r253",
      "r254",
      "r592",
      "r593",
      "r594",
      "r595",
      "r619",
      "r628",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r718",
      "r720",
      "r749"
     ]
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction",
        "label": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r592",
      "r593",
      "r1095"
     ]
    },
    "alts_RelatedPartyTransactionConsultingAgreementContingentlyTenderedFunds": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "RelatedPartyTransactionConsultingAgreementContingentlyTenderedFunds",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingently tendered funds in counsel's trust account",
        "label": "Related Party Transaction, Consulting Agreement, Contingently Tendered Funds",
        "documentation": "Related Party Transaction, Consulting Agreement, Contingently Tendered Funds"
       }
      }
     },
     "auth_ref": []
    },
    "alts_RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Per share value of the restricted shares issued (in usd per share)",
        "label": "Related Party Transaction, Consulting Agreement, Convertible Debt, Conversion Price",
        "documentation": "Related Party Transaction, Consulting Agreement, Convertible Debt, Conversion Price"
       }
      }
     },
     "auth_ref": []
    },
    "alts_RelatedPartyTransactionConsultingAgreementNumberOfLifeInsurancePoliciesAssigned": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "RelatedPartyTransactionConsultingAgreementNumberOfLifeInsurancePoliciesAssigned",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Universal life insurance policies assigned",
        "label": "Related Party Transaction, Consulting Agreement, Number Of Life Insurance Policies Assigned",
        "documentation": "Related Party Transaction, Consulting Agreement, Number Of Life Insurance Policies Assigned"
       }
      }
     },
     "auth_ref": []
    },
    "alts_RelatedPartyTransactionConsultingAgreementTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "RelatedPartyTransactionConsultingAgreementTerm",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term of consulting agreement (in years)",
        "label": "Related Party Transaction, Consulting Agreement, Term",
        "documentation": "Related Party Transaction, Consulting Agreement, Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction",
        "label": "Related Party Transaction [Domain]",
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Line Items]",
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r339",
      "r725",
      "r726",
      "r729"
     ]
    },
    "us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionPurchasesFromRelatedParty",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shared expenses with another company",
        "label": "Related Party Transaction, Purchases from Related Party",
        "documentation": "Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party."
       }
      }
     },
     "auth_ref": []
    },
    "alts_RelatedPartyTransactionShortTermAdvancesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "RelatedPartyTransactionShortTermAdvancesMember",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short Term Advances",
        "label": "Related Party Transaction, Short Term Advances [Member]",
        "documentation": "Related Party Transaction, Short Term Advances"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transactions [Abstract]",
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/LongTermDebtScheduleofLongTermDebtDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsQodenDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofFutureMaturitiesofLongTermDebtDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtScheduleofLongTermDebtPayabletoRelatedPartiesDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party",
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r339",
      "r453",
      "r592",
      "r593",
      "r619",
      "r628",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r718",
      "r720",
      "r749",
      "r1095"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/Relatedparties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related parties",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r589",
      "r590",
      "r591",
      "r593",
      "r596",
      "r674",
      "r675",
      "r676",
      "r727",
      "r728",
      "r729",
      "r747",
      "r748"
     ]
    },
    "us-gaap_RepaymentsOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/DebenturesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repayments of debt",
        "label": "Repayments of Debt",
        "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation."
       }
      }
     },
     "auth_ref": [
      "r972"
     ]
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments on short term notes payable",
        "terseLabel": "Payments on notes payable",
        "label": "Repayments of Notes Payable",
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "us-gaap_RepaymentsOfRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfRelatedPartyDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments on related party note",
        "label": "Repayments of Related Party Debt",
        "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails",
      "http://www.alt5sigma.com/role/NotesreceivableDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesBPreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails",
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesNarrativeDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name",
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r255",
      "r256",
      "r414",
      "r442",
      "r595",
      "r602",
      "r615",
      "r772",
      "r773"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r854",
      "r865",
      "r875",
      "r908"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r855",
      "r866",
      "r876",
      "r909"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r862",
      "r873",
      "r883",
      "r916"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Stock Units (RSUs)",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r161",
      "r625",
      "r660",
      "r662",
      "r672",
      "r702",
      "r818"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r209",
      "r258",
      "r259",
      "r260",
      "r262",
      "r267",
      "r269",
      "r271",
      "r350",
      "r351",
      "r380",
      "r522",
      "r523",
      "r532",
      "r533",
      "r534",
      "r536",
      "r542",
      "r543",
      "r552",
      "r554",
      "r555",
      "r557",
      "r558",
      "r575",
      "r578",
      "r657",
      "r659",
      "r679",
      "r1140"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues",
        "verboseLabel": "Revenue",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r189",
      "r190",
      "r293",
      "r302",
      "r303",
      "r324",
      "r330",
      "r334",
      "r336",
      "r337",
      "r450",
      "r451",
      "r607"
     ]
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition",
        "label": "Revenue [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r723",
      "r766",
      "r776"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Revenues",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofProformaInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net revenue",
        "label": "Revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r189",
      "r190",
      "r236",
      "r250",
      "r293",
      "r302",
      "r303",
      "r324",
      "r330",
      "r334",
      "r336",
      "r337",
      "r349",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r564",
      "r613",
      "r785",
      "r1032"
     ]
    },
    "alts_RevisedDiscountAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "RevisedDiscountAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/NotesreceivableDetails",
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revised discount amount",
        "label": "Revised Discount Amount",
        "documentation": "Revised Discount Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevolvingCreditFacilityMember",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revolving Credit Facility",
        "label": "Revolving Credit Facility [Member]",
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right of use assets and liabilities upon commencement of operating leases",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r583",
      "r817"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r925"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r925"
     ]
    },
    "alts_SECComplaintMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "SECComplaintMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Complaint",
        "label": "SEC Complaint [Member]",
        "documentation": "SEC Complaint"
       }
      }
     },
     "auth_ref": []
    },
    "alts_SOINAgreementConvertibleTrancheThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "SOINAgreementConvertibleTrancheThreeMember",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soin Agreement Convertible Tranche Three",
        "label": "SOIN Agreement, Convertible Tranche Three [Member]",
        "documentation": "SOIN Agreement, Convertible Tranche Three"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregated consideration received on transaction",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockConsiderationReceivedPerTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockConsiderationReceivedPerTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate purchase price",
        "label": "Sale of Stock, Consideration Received Per Transaction",
        "documentation": "Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock",
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, number of shares issued in transaction (in shares)",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, price per share (in usd per share)",
        "label": "Sale of Stock, Price Per Share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "alts_SaleOfStockUnitCompositionNumberOfCommonSharesInEachUnit": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "SaleOfStockUnitCompositionNumberOfCommonSharesInEachUnit",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of common shares in each unit (in shares)",
        "label": "Sale of Stock, Unit Composition, Number Of Common Shares In Each Unit",
        "documentation": "Sale of Stock, Unit Composition, Number Of Common Shares In Each Unit"
       }
      }
     },
     "auth_ref": []
    },
    "alts_SaleOfStockUnitCompositionNumberOfWarrantsIssuedInEachUnit": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "SaleOfStockUnitCompositionNumberOfWarrantsIssuedInEachUnit",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of warrants in each unit (in shares)",
        "label": "Sale of Stock, Unit Composition, Number Of Warrants Issued In Each unit",
        "documentation": "Sale of Stock, Unit Composition, Number Of Warrants Issued In Each unit"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScenarioAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScenarioAdjustmentMember",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofProformaInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments",
        "label": "Scenario, Adjustment [Member]",
        "documentation": "Domain member used to indicate figures that are adjustments during a period or as of a point in time. This domain member would never be expected to appear in a relationship group without the \"Scenario, Previously Reported\" Member with the same parent."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofProformaInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Scenario [Domain]",
        "label": "Scenario [Domain]"
       }
      }
     },
     "auth_ref": [
      "r272",
      "r455",
      "r949",
      "r983"
     ]
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "presentation": [
      "http://www.alt5sigma.com/role/NotesreceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts and Financing Receivables [Table]",
        "label": "Accounts and Financing Receivables [Table]",
        "documentation": "Disclosure of information about accounts and financing receivables. Includes, but is not limited to, amount of receivable and allowance for credit loss."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r128",
      "r340",
      "r996"
     ]
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Trade and Other Receivables",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r128"
     ]
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/AccruedliabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accrued Liabilities",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsALT5Details",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "documentation": "Disclosure of information about business combination. Includes, but is not limited to, recognized asset and liability."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r68",
      "r539"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value Adjustments for Shares of Series B and Series M Preferred Stock",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r68"
     ]
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Income Tax Provision (Benefit)",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r1072"
     ]
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/DebenturesTables",
      "http://www.alt5sigma.com/role/LongTermDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Debentures Outstanding",
        "terseLabel": "Schedule of Long-Term Debt",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r57",
      "r60",
      "r82",
      "r158",
      "r160",
      "r797",
      "r799",
      "r979",
      "r1090"
     ]
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDebtTableTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedPartyDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-Term Debt Payable to Related Parties",
        "label": "Schedule of Debt [Table Text Block]",
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Net Deferred Tax Assets (Liabilities)",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1068"
     ]
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsTables",
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Gain on Sale of Recycling Subsidiaries",
        "terseLabel": "Schedule of Discontinued Operations in Consolidated Statements of Operations and Cash Flows",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r23",
      "r29",
      "r87",
      "r96",
      "r97",
      "r98",
      "r99",
      "r100",
      "r104",
      "r106",
      "r107",
      "r151"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/EarningsLosspershareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Computation of Basic and Diluted Net Loss per Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r986"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliation of Income Tax Benefit (Provision) with the Federal Statutory Tax Rate",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r504",
      "r807",
      "r1065"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Axis]",
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r346",
      "r347",
      "r348",
      "r531",
      "r950",
      "r951",
      "r952",
      "r1075",
      "r1076",
      "r1077",
      "r1078"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://www.alt5sigma.com/role/IntangibleassetsNarrativeDetails",
      "http://www.alt5sigma.com/role/IntangibleassetsScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Finite Lived Intangible Assets [Table]",
        "label": "Intangible Asset, Finite-Lived [Table]",
        "documentation": "Disclosure of information about finite-lived intangible asset. Excludes indefinite-lived intangible asset."
       }
      }
     },
     "auth_ref": [
      "r366",
      "r373",
      "r375",
      "r376",
      "r378",
      "r608",
      "r765",
      "r794"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/IntangibleassetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Intangible Assets",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r794",
      "r1012"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Income (Loss) Before Provision of Income Taxes",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r977"
     ]
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedPartyDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Future Maturities of Long-term Debt",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "alts_ScheduleOfOperatingLeaseRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "ScheduleOfOperatingLeaseRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Company's Right of Use Assets and Lease Liabilities",
        "label": "Schedule Of Operating Lease Right Of Use Assets And Lease Liabilities [Table Text Block]",
        "documentation": "Schedule Of Operating Lease Right Of Use Assets And Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfOtherAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfOtherAssetsTableTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/DepositsandotherassetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Deposits and Other Assets",
        "label": "Schedule of Other Assets [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.alt5sigma.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails",
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Property Plant And Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r587"
     ]
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Purchase Price Allocation of Purchase for ALT5 Subsidiary to Acquired Identifiable Assets, Liabilities Assumed and Goodwill",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree."
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Related Party Transactions By Related Party [Table]",
        "label": "Related Party Transaction [Table]",
        "documentation": "Disclosure of information about related party transaction."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r81",
      "r725",
      "r726",
      "r729"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofBalanceSheetInformationDetails",
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Segment Reporting Information By Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r47",
      "r48"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/SegmentinformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Information",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r47",
      "r48"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Exercise Price for Stock Options Outstanding and Exercisable Outstanding",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]",
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock Options Activity",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r22",
      "r163"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://www.alt5sigma.com/role/MarketableSecuritiesNarrativeDetails",
      "http://www.alt5sigma.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails",
      "http://www.alt5sigma.com/role/PreferredStockScheduleofSeriesSConvertiblePreferredStockOutstandingDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesA1ConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesBPreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesIConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesMPreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesQConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesVConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityScheduleofExercisePriceforStockOptionsOutstandingandExercisableOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock, Class of Stock [Table]",
        "label": "Stock, Class of Stock [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r155",
      "r158",
      "r160",
      "r161",
      "r223",
      "r224",
      "r225",
      "r295",
      "r439",
      "r440",
      "r442",
      "r443",
      "r444",
      "r446",
      "r447",
      "r668",
      "r669",
      "r670",
      "r671",
      "r801",
      "r948",
      "r974"
     ]
    },
    "alts_Section174Expenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "Section174Expenses",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "alts_DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofComponentsofNetDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Section 174 expenses",
        "label": "Section 174 Expenses",
        "documentation": "Section 174 Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SecuritiesPurchasedUnderAgreementsToResellAllowanceForCreditLossRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SecuritiesPurchasedUnderAgreementsToResellAllowanceForCreditLossRollForward",
     "presentation": [
      "http://www.alt5sigma.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable Securities, Value [Roll Forward]",
        "label": "Securities Purchased under Agreements to Resell, Allowance for Credit Loss [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r836"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r838"
     ]
    },
    "us-gaap_SegmentContinuingOperationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentContinuingOperationsMember",
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Continuing Operations",
        "label": "Continuing Operations [Member]",
        "documentation": "Component of an entity expected to operate in the foreseeable future."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentDiscontinuedOperationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentDiscontinuedOperationsMember",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails",
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails",
      "http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeTaxProvisionBenefitDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails",
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofBalanceSheetInformationDetails",
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discontinued operations",
        "label": "Discontinued Operations [Member]",
        "documentation": "Component or group of components representing strategic shift that has or will have major effect on operation and financial result, classified as held-for-sale or disposed of by sale or by means other than sale, and business and nonprofit activity on acquisition and upon joint venture formation, classified as held-for-sale."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r88",
      "r89",
      "r90"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails",
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails",
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofBalanceSheetInformationDetails",
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r189",
      "r190",
      "r191",
      "r192",
      "r293",
      "r298",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r314",
      "r315",
      "r316",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r330",
      "r331",
      "r332",
      "r337",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r378",
      "r388",
      "r389",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r782",
      "r785",
      "r786",
      "r793",
      "r822",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131",
      "r1132",
      "r1133",
      "r1134",
      "r1135",
      "r1136",
      "r1137"
     ]
    },
    "us-gaap_SegmentOperatingActivitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentOperatingActivitiesDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeTaxProvisionBenefitDetails",
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofBalanceSheetInformationDetails",
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Activities [Domain]",
        "label": "Operating Activities [Domain]",
        "documentation": "Operations of an entity including continuing and discontinued operations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting [Abstract]",
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/Segmentinformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment information",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r192",
      "r293",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r313",
      "r315",
      "r316",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r334",
      "r335",
      "r337",
      "r780",
      "r783",
      "r784",
      "r785",
      "r787",
      "r789",
      "r790"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofBalanceSheetInformationDetails",
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r333",
      "r336",
      "r781",
      "r782",
      "r788"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling, general and administrative expenses",
        "label": "Selling, General and Administrative Expense",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "alts_SeriesA1ConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "SeriesA1ConvertiblePreferredStockMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.alt5sigma.com/role/PreferredStockSeriesA1ConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Convertible preferred stock, series A-1 - par value $0.001 per share 2,000,000 authorized, 23,480 and 193,730 shares issued and outstanding at December\u00a028, 2024 and December\u00a030, 2023, respectively",
        "terseLabel": "Series A1 Convertible Preferred Stock",
        "label": "Series A-1 Convertible Preferred Stock [Member]",
        "documentation": "Series A-1 Convertible Preferred Stock."
       }
      }
     },
     "auth_ref": []
    },
    "alts_SeriesA1PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "SeriesA1PreferredStockMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Series A-1 Preferred",
        "label": "Series A-1 Preferred Stock [Member]",
        "documentation": "Series A-1 Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "alts_SeriesAConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "SeriesAConvertiblePreferredStockMember",
     "presentation": [
      "http://www.alt5sigma.com/role/PreferredStockSeriesA1ConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series A Convertible Preferred Stock",
        "label": "Series A Convertible Preferred Stock [Member]",
        "documentation": "Series A Convertible Preferred Stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeriesBPreferredStockMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsALT5Details",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofFairValueAdjustmentsforSharesofSeriesBandSeriesMPreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesBPreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Preferred stock, series B - par value $0.001 per share, 34,250 authorized, 34,207 and 0 shares issued and outstanding at December\u00a028, 2024 and December\u00a030, 2023, respectively",
        "terseLabel": "Series B Preferred Stock",
        "verboseLabel": "Series B Preferred",
        "label": "Series B Preferred Stock [Member]",
        "documentation": "Series B preferred stock."
       }
      }
     },
     "auth_ref": [
      "r962",
      "r963",
      "r1036"
     ]
    },
    "alts_SeriesGConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "SeriesGConvertiblePreferredStockMember",
     "presentation": [
      "http://www.alt5sigma.com/role/MarketableSecuritiesNarrativeDetails",
      "http://www.alt5sigma.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Series G Convertible Preferred Shares",
        "terseLabel": "Series G Convertible Preferred Stock",
        "label": "Series G Convertible Preferred Stock [Member]",
        "documentation": "Series G Convertible Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "alts_SeriesIConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "SeriesIConvertiblePreferredStockMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.alt5sigma.com/role/PreferredStockSeriesIConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Convertible preferred stock, series I - par value $0.001 per share, 2,000,000 authorized, 17,000 and 0 shares issued and outstanding at December\u00a028, 2024 and December\u00a030, 2023, respectively",
        "terseLabel": "Series I Convertible Preferred Stock",
        "label": "Series I Convertible Preferred Stock [Member]",
        "documentation": "Series I Convertible Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "alts_SeriesIPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "SeriesIPreferredStockMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series I Preferred",
        "label": "Series I Preferred Stock [Member]",
        "documentation": "Series I Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "alts_SeriesMPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "SeriesMPreferredStockMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsALT5Details",
      "http://www.alt5sigma.com/role/PreferredStockSeriesMPreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Preferred stock, series M - par value $0.001 per share, 3,200 authorized, 3,200 and 0 shares issued and outstanding at December\u00a028, 2024 and December\u00a030, 2023, respectively",
        "terseLabel": "Series M Preferred Stock",
        "verboseLabel": "Series M Preferred",
        "label": "Series M Preferred Stock [Member]",
        "documentation": "Series M Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "alts_SeriesQConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "SeriesQConvertiblePreferredStockMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsQodenDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesQConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Convertible Preferred stock, series Q - par value $0.001 per share, 2,000,000 authorized, 925,212 and 0 shares issued and outstanding at December\u00a028, 2024 and December\u00a030, 2023, respectively",
        "terseLabel": "Series Q Convertible Preferred Stock",
        "label": "Series Q Convertible Preferred Stock [Member]",
        "documentation": "Series Q Convertible Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "alts_SeriesQPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "SeriesQPreferredStockMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series Q Preferred",
        "label": "Series Q Preferred Stock [Member]",
        "documentation": "Series Q Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "alts_SeriesS1PreferredMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "SeriesS1PreferredMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series S-1 Preferred",
        "label": "Series S - 1 Preferred [Member]",
        "documentation": "Series S - 1 Preferred"
       }
      }
     },
     "auth_ref": []
    },
    "alts_SeriesSConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "SeriesSConvertiblePreferredStockMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.alt5sigma.com/role/PreferredStockScheduleofSeriesSConvertiblePreferredStockOutstandingDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Convertible preferred stock, series S - par value $0.001 per share, 200,000 authorized, 100,000 and 100,000 shares issued and outstanding at December\u00a028, 2024 and December\u00a030, 2023, respectively",
        "verboseLabel": "Series S Convertible Preferred Stock",
        "terseLabel": "Series S",
        "label": "Series S Convertible Preferred Stock [Member]",
        "documentation": "Series S Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "alts_SeriesVConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "SeriesVConvertiblePreferredStockMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.alt5sigma.com/role/PreferredStockSeriesVConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Convertible preferred stock, series V - par value $0.001 per share, 125,000 authorized, 5,000 shares and 0 issued and outstanding at December\u00a028, 2024 and December\u00a030, 2023, respectively",
        "terseLabel": "Series V Convertible Preferred Stock",
        "label": "Series V Convertible Preferred Stock [Member]",
        "documentation": "Series V Convertible Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "alts_SeriesVPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "SeriesVPreferredStockMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series V Preferred",
        "label": "Series V Preferred Stock [Member]",
        "documentation": "Series V Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock based compensation expense",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation , number of additional shares authorized (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Options authorized for issuance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r806"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r463"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable (in usd per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r463"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Cancelled/expired (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired."
       }
      }
     },
     "auth_ref": [
      "r1044"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cancelled/expired (in usd per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price of options that were either forfeited or expired."
       }
      }
     },
     "auth_ref": [
      "r1044"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r465"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options outstanding",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options outstanding (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r461",
      "r462"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options Outstanding",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance (in usd per share)",
        "periodEndLabel": "Ending balance (in usd per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r461",
      "r462"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation, number of shares available for grant (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period",
        "documentation": "Number of shares issued under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r458",
      "r459",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in usd per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r465"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r456",
      "r460",
      "r479",
      "r480",
      "r481",
      "r482",
      "r485",
      "r487",
      "r488",
      "r489",
      "r490"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityScheduleofExercisePriceforStockOptionsOutstandingandExercisableOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price Range",
        "label": "Exercise Price Range [Axis]",
        "documentation": "Information by range of option prices pertaining to options granted."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityScheduleofExercisePriceforStockOptionsOutstandingandExercisableOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price Range",
        "label": "Exercise Price Range [Domain]",
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityScheduleofExercisePriceforStockOptionsOutstandingandExercisableOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price, lower range limit (in usd per share)",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityScheduleofExercisePriceforStockOptionsOutstandingandExercisableOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of options, exercisable (in shares)",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable",
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityScheduleofExercisePriceforStockOptionsOutstandingandExercisableOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of options, outstanding (in shares)",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding",
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r165"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityScheduleofExercisePriceforStockOptionsOutstandingandExercisableOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price, upper range limit (in usd per share)",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharePrice",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsALT5Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share price (in usd per share)",
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options exercisable",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining contractual life, exercisable (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-vested shares associated with stock option awards (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares",
        "documentation": "Number of non-vested options outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining contractual life (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders\u2019 Equity",
        "label": "Shareholders' Equity and Share-Based Payments [Text Block]",
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP)."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r162"
     ]
    },
    "alts_ShareholdersEquityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "ShareholdersEquityLineItems",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityCommonStockDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shareholders Equity [Line Items]",
        "label": "Shareholders Equity [Line Items]",
        "documentation": "Shareholders equity."
       }
      }
     },
     "auth_ref": []
    },
    "alts_ShareholdersEquityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "ShareholdersEquityTable",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityCommonStockDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shareholders Equity [Table]",
        "label": "Shareholders Equity [Table]",
        "documentation": "Stockholders equity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermBorrowings",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total debentures",
        "label": "Short-Term Debt",
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r176",
      "r818",
      "r1104"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r248"
     ]
    },
    "alts_SkyBridgeAmericasMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "SkyBridgeAmericasMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SA",
        "label": "Sky Bridge Americas [Member]",
        "documentation": "Sky Bridge Americas."
       }
      }
     },
     "auth_ref": []
    },
    "alts_SkybridgeLitigationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "SkybridgeLitigationMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Skybridge Litigation",
        "label": "Skybridge Litigation [Member]",
        "documentation": "Skybridge Litigation"
       }
      }
     },
     "auth_ref": []
    },
    "alts_SmallWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "SmallWarrantMember",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Small Warrant",
        "label": "Small Warrant [Member]",
        "documentation": "Small Warrant"
       }
      }
     },
     "auth_ref": []
    },
    "alts_SoinAgreementConvertibleTrancheOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "SoinAgreementConvertibleTrancheOneMember",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soin Agreement Convertible Tranche One",
        "label": "Soin Agreement Convertible Tranche One [Member]",
        "documentation": "Soin Agreement Convertible Tranche One"
       }
      }
     },
     "auth_ref": []
    },
    "alts_SoinAgreementConvertibleTrancheTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "SoinAgreementConvertibleTrancheTwoMember",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soin Agreement Convertible Tranche Two",
        "label": "Soin Agreement Convertible Tranche Two [Member]",
        "documentation": "Soin Agreement Convertible Tranche Two"
       }
      }
     },
     "auth_ref": []
    },
    "alts_SoinIntangiblesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "SoinIntangiblesMember",
     "presentation": [
      "http://www.alt5sigma.com/role/IntangibleassetsNarrativeDetails",
      "http://www.alt5sigma.com/role/IntangibleassetsScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soin intangibles",
        "label": "Soin Intangibles [Member]",
        "documentation": "Soin Intangibles [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "alts_SoinTherapeuticsLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "SoinTherapeuticsLLCMember",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soin Therapeutics LLC",
        "label": "Soin Therapeutics LLC [Member]",
        "documentation": "Soin Therapeutics L L C [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "alts_SoinTherapeuticsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "SoinTherapeuticsMember",
     "presentation": [
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soin Therapeutics",
        "label": "Soin Therapeutics [Member]",
        "documentation": "Soin Therapeutics"
       }
      }
     },
     "auth_ref": []
    },
    "alts_SpyrTechnologiesIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "SpyrTechnologiesIncMember",
     "presentation": [
      "http://www.alt5sigma.com/role/NotesreceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SPYR Technologies Inc.",
        "label": "SPYR Technologies Inc. [Member]",
        "documentation": "SPYR Technologies Inc."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State and Local Jurisdiction",
        "label": "State and Local Jurisdiction [Member]",
        "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax."
       }
      }
     },
     "auth_ref": [
      "r502"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsinConsolidatedStatementsofOperationsDetails",
      "http://www.alt5sigma.com/role/DiscontinuedOperationsScheduleofDiscontinuedOperationsintheConsolidatedStatementsofCashFlowsDetails",
      "http://www.alt5sigma.com/role/RelatedpartiesDetails",
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofBalanceSheetInformationDetails",
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r189",
      "r190",
      "r191",
      "r192",
      "r211",
      "r293",
      "r298",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r314",
      "r315",
      "r316",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r330",
      "r331",
      "r332",
      "r337",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r378",
      "r382",
      "r388",
      "r389",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r782",
      "r785",
      "r786",
      "r793",
      "r822",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131",
      "r1132",
      "r1133",
      "r1134",
      "r1135",
      "r1136",
      "r1137"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.alt5sigma.com/role/MarketableSecuritiesNarrativeDetails",
      "http://www.alt5sigma.com/role/MarketableSecuritiesScheduleofMarketableSecuritiesDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsALT5Details",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsQodenDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofFairValueAdjustmentsforSharesofSeriesBandSeriesMPreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockScheduleofSeriesSConvertiblePreferredStockOutstandingDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesBPreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesIConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesMPreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesQConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesVConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r223",
      "r224",
      "r225",
      "r250",
      "r277",
      "r278",
      "r285",
      "r287",
      "r295",
      "r296",
      "r349",
      "r401",
      "r403",
      "r404",
      "r405",
      "r408",
      "r409",
      "r439",
      "r440",
      "r443",
      "r444",
      "r447",
      "r564",
      "r668",
      "r669",
      "r670",
      "r671",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r701",
      "r722",
      "r744",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r948",
      "r974",
      "r985"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r121",
      "r125",
      "r126",
      "r209",
      "r233",
      "r234",
      "r235",
      "r258",
      "r259",
      "r260",
      "r262",
      "r267",
      "r269",
      "r271",
      "r294",
      "r350",
      "r351",
      "r380",
      "r449",
      "r522",
      "r523",
      "r532",
      "r533",
      "r534",
      "r536",
      "r542",
      "r543",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r565",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r575",
      "r578",
      "r588",
      "r633",
      "r657",
      "r658",
      "r659",
      "r679",
      "r744"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r259",
      "r260",
      "r294",
      "r578",
      "r607",
      "r666",
      "r690",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r701",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r720",
      "r723",
      "r724",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r744",
      "r828"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOperatingActivitiesSegmentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOperatingActivitiesSegmentAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/IncometaxesScheduleofIncomeTaxProvisionBenefitDetails",
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofBalanceSheetInformationDetails",
      "http://www.alt5sigma.com/role/SegmentinformationScheduleofSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Activities [Axis]",
        "label": "Operating Activities [Axis]",
        "documentation": "Information by continuing and discontinuing operations."
       }
      }
     },
     "auth_ref": []
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofProformaInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Scenario [Axis]",
        "label": "Scenario [Axis]"
       }
      }
     },
     "auth_ref": [
      "r272",
      "r455",
      "r949",
      "r953",
      "r983"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r259",
      "r260",
      "r294",
      "r339",
      "r578",
      "r607",
      "r666",
      "r690",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r701",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r720",
      "r723",
      "r724",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r744",
      "r828"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r857",
      "r868",
      "r878",
      "r911"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "alts_StockConversion1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "StockConversion1Member",
     "presentation": [
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Conversion 1",
        "label": "Stock Conversion 1 [Member]",
        "documentation": "Stock Conversion 1 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "alts_StockConversion2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "StockConversion2Member",
     "presentation": [
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Conversion 2",
        "label": "Stock Conversion 2 [Member]",
        "documentation": "Stock Conversion 2 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "alts_StockConversion3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "StockConversion3Member",
     "presentation": [
      "http://www.alt5sigma.com/role/PreferredStockSeriesSConvertiblePreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Conversion 3",
        "label": "Stock Conversion 3 [Member]",
        "documentation": "Stock Conversion 3 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssued1",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock issued",
        "label": "Stock Issued",
        "documentation": "The fair value of stock issued in noncash financing activities."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r39",
      "r40"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock issued for acquisition of Alt5 Subsidiary and Qoden assets (in shares)",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r121",
      "r161"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series A-1 preferred converted for legal settlement (in shares)",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r57",
      "r121",
      "r125",
      "r161",
      "r427"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityIncentivesDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued for consulting agreement (in shares)",
        "verboseLabel": "Common stock issued for consulting agreement (in shares)",
        "label": "Stock Issued During Period, Shares, Issued for Services",
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "alts_StockIssuedDuringPeriodSharesIssuedInLieuOfNotesPayable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "StockIssuedDuringPeriodSharesIssuedInLieuOfNotesPayable",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued in lieu of notes payable obligation (in shares)",
        "label": "Stock Issued During Period, Shares, Issued In Lieu Of Notes Payable",
        "documentation": "Stock Issued During Period, Shares, Issued In Lieu Of Notes Payable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued for equity financing (in shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r120",
      "r121",
      "r161",
      "r668",
      "r744",
      "r756"
     ]
    },
    "alts_StockIssuedDuringPeriodSharesPrepaidInterest": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "StockIssuedDuringPeriodSharesPrepaidInterest",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued for prepaid interest (in shares)",
        "label": "Stock Issued During Period, Shares, Prepaid Interest",
        "documentation": "Stock Issued During Period, Shares, Prepaid Interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesPurchaseOfAssets",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock issued for property and equipment (in shares)",
        "label": "Stock Issued During Period, Shares, Purchase of Assets",
        "documentation": "Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share based compensation (in shares)",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r120",
      "r121",
      "r161"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Series A-1 Preferred forfeited (in shares)",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited",
        "documentation": "Number of shares (or other type of equity) forfeited during the period."
       }
      }
     },
     "auth_ref": []
    },
    "alts_StockIssuedDuringPeriodSharesWarrantsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "StockIssuedDuringPeriodSharesWarrantsExercised",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued for warrants exercised (in shares)",
        "label": "Stock Issued During Period, Shares, Warrants Exercised",
        "documentation": "Stock Issued During Period, Shares, Warrants Exercised"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock issued for acquisition of Alt5 Subsidiary and Qoden assets",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "documentation": "Value of stock issued pursuant to acquisitions during the period."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r121",
      "r125",
      "r126",
      "r161"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series A-1 preferred converted for legal settlement",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r121",
      "r125",
      "r126",
      "r161"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued for consulting agreement",
        "label": "Stock Issued During Period, Value, Issued for Services",
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "alts_StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued in lieu of notes payable obligation",
        "label": "Stock Issued During Period, Value, Issued In Lieu Of Notes Payable",
        "documentation": "Stock Issued During Period, Value, Issued In Lieu Of Notes Payable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued for equity financing",
        "verboseLabel": "Common stock issued for equity financing",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r120",
      "r121",
      "r161",
      "r679",
      "r744",
      "r756",
      "r834"
     ]
    },
    "alts_StockIssuedDuringPeriodValuePrepaidInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "StockIssuedDuringPeriodValuePrepaidInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued for prepaid interest",
        "label": "Stock Issued During Period, Value, Prepaid Interest",
        "documentation": "Stock Issued During Period, Value, Prepaid Interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValuePurchaseOfAssets",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock issued for property and equipment",
        "label": "Stock Issued During Period, Value, Purchase of Assets",
        "documentation": "Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share based compensation",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r120",
      "r121",
      "r161"
     ]
    },
    "alts_StockIssuedDuringPeriodValueWarrantsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "StockIssuedDuringPeriodValueWarrantsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued for warrants exercised",
        "label": "Stock Issued During Period, Value, Warrants Exercised",
        "documentation": "Stock Issued During Period, Value, Warrants Exercised"
       }
      }
     },
     "auth_ref": []
    },
    "alts_StockPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "StockPurchaseAgreementMember",
     "presentation": [
      "http://www.alt5sigma.com/role/NotesreceivableDetails",
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Purchase Agreement",
        "label": "Stock Purchase Agreement [Member]",
        "documentation": "Stock Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Equity attributable to ALT5 Sigma Corporation shareholders",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r125",
      "r126",
      "r147",
      "r703",
      "r719",
      "r745",
      "r746",
      "r818",
      "r835",
      "r976",
      "r999",
      "r1087",
      "r1140"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders' equity:",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders' equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r76",
      "r79",
      "r209",
      "r210",
      "r234",
      "r258",
      "r259",
      "r260",
      "r262",
      "r267",
      "r269",
      "r350",
      "r351",
      "r380",
      "r449",
      "r522",
      "r523",
      "r532",
      "r533",
      "r534",
      "r536",
      "r542",
      "r543",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r565",
      "r567",
      "r571",
      "r576",
      "r588",
      "r658",
      "r659",
      "r677",
      "r703",
      "r719",
      "r745",
      "r746",
      "r760",
      "r834",
      "r976",
      "r999",
      "r1087",
      "r1140"
     ]
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders' Equity Note [Abstract]",
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "alts_SubscriptionsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "SubscriptionsReceivableMember",
     "presentation": [
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subscriptions Receivable",
        "label": "Subscriptions Receivable [Member]",
        "documentation": "Subscriptions Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r572",
      "r598"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r572",
      "r598"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.alt5sigma.com/role/MergersandAcquisitionsSoinPharmaceuticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r572",
      "r598"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events [Abstract]",
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/Subsequentevents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r597",
      "r599"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedPartyDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock",
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental cash flow disclosures:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r904"
     ]
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "presentation": [
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Technology Intangibles",
        "label": "Technology-Based Intangible Assets [Member]",
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1011",
      "r1013",
      "r1015",
      "r1016"
     ]
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.alt5sigma.com/role/PreferredStockScheduleofSeriesSConvertiblePreferredStockOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preferred stock, series S - par value $0.001 per share 200,000 authorized, 100,000 shares issued and outstanding at December\u00a028, 2024 and December\u00a030, 2023",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r401",
      "r403",
      "r404",
      "r405",
      "r408",
      "r409",
      "r491",
      "r623"
     ]
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preferred stock, par value (in usd per share)",
        "label": "Temporary Equity, Par or Stated Value Per Share",
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r54"
     ]
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquitySharesAuthorized",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preferred stock, shares authorized (in shares)",
        "label": "Temporary Equity, Shares Authorized",
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquitySharesIssued",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preferred stock, shares issued (in shares)",
        "label": "Temporary Equity, Shares Issued",
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquitySharesOutstanding",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.alt5sigma.com/role/PreferredStockScheduleofSeriesSConvertiblePreferredStockOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preferred stock, shares outstanding (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Temporary Equity, Shares Outstanding",
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "us-gaap_TemporaryEquityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityTableTextBlock",
     "presentation": [
      "http://www.alt5sigma.com/role/PreferredStockTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Series S Convertible Preferred Stock Outstanding",
        "label": "Temporary Equity [Table Text Block]",
        "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r54"
     ]
    },
    "alts_ThirdPartyExchangeForBrokerageServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "ThirdPartyExchangeForBrokerageServicesMember",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Third-Party Exchange For Brokerage Services",
        "label": "Third-Party Exchange For Brokerage Services [Member]",
        "documentation": "Third-Party Exchange For Brokerage Services"
       }
      }
     },
     "auth_ref": []
    },
    "alts_TotalConsiderations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "TotalConsiderations",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails": {
       "parentTag": "alts_TotalGainOnSale",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total consideration",
        "label": "Total Considerations",
        "documentation": "Total Considerations"
       }
      }
     },
     "auth_ref": []
    },
    "alts_TotalDisposalOfAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "TotalDisposalOfAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails": {
       "parentTag": "alts_TotalGainOnSale",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total disposal of assets",
        "label": "Total Disposal of Assets",
        "documentation": "Total Disposal of Assets"
       }
      }
     },
     "auth_ref": []
    },
    "alts_TotalDisposalOfLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "TotalDisposalOfLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails": {
       "parentTag": "alts_TotalConsiderations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total disposal of liabilities",
        "label": "Total Disposal of Liability",
        "documentation": "Total Disposal of Liability"
       }
      }
     },
     "auth_ref": []
    },
    "alts_TotalGainOnSale": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "TotalGainOnSale",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total gain on sale",
        "label": "Total Gain on Sale",
        "documentation": "Total Gain on Sale"
       }
      }
     },
     "auth_ref": []
    },
    "alts_TotalGuaranteedConsideration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "TotalGuaranteedConsideration",
     "crdr": "debit",
     "calculation": {
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails": {
       "parentTag": "alts_NetConsideration",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesScheduleofGainonSaleofRecyclingSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total minimum consideration",
        "label": "Total Guaranteed Consideration",
        "documentation": "Total Guaranteed Consideration"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r896"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r903"
     ]
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "presentation": [
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Receivables and Allowance for Doubtful Accounts",
        "label": "Accounts Receivable [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r193",
      "r195",
      "r196",
      "r994",
      "r995",
      "r997"
     ]
    },
    "us-gaap_TradeNamesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TradeNamesMember",
     "presentation": [
      "http://www.alt5sigma.com/role/IntangibleassetsNarrativeDetails",
      "http://www.alt5sigma.com/role/IntangibleassetsScheduleofIntangibleAssetsDetails",
      "http://www.alt5sigma.com/role/MergersandAcquisitionsScheduleofPurchasePriceAllocationofPurchaseforALT5SubsidiarytoAcquiredIdentifiableAssetsLiabilitiesAssumedandGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trade names",
        "terseLabel": "Trade names",
        "label": "Trade Names [Member]",
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1013",
      "r1014",
      "r1015",
      "r1016"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r924"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r926"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.alt5sigma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r927"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r926"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r926"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r929"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r927"
     ]
    },
    "alts_TrusteesMain270LlcMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "TrusteesMain270LlcMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trustees Main/270, LLC",
        "label": "Trustees Main/270, LLC [Member]",
        "documentation": "Trustees Main/270, LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://www.alt5sigma.com/role/NotesreceivableDetails",
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesNarrativeDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r544"
     ]
    },
    "alts_UnaffiliatedThirdPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "UnaffiliatedThirdPartyMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails",
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails",
      "http://www.alt5sigma.com/role/PreferredStockSeriesVConvertiblePreferredStockDetails",
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unaffiliated Third Party",
        "label": "Unaffiliated Third Party [Member]",
        "documentation": "Unaffiliated Third Party"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r923"
     ]
    },
    "alts_UniversalLifeInsurancePolicyPolicyOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "UniversalLifeInsurancePolicyPolicyOneMember",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "1st policy",
        "label": "Universal Life Insurance Policy, Policy One [Member]",
        "documentation": "Universal Life Insurance Policy, Policy One"
       }
      }
     },
     "auth_ref": []
    },
    "alts_UniversalLifeInsurancePolicyPolicyTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "UniversalLifeInsurancePolicyPolicyTwoMember",
     "presentation": [
      "http://www.alt5sigma.com/role/RelatedpartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2nd policy",
        "label": "Universal Life Insurance Policy, Policy Two [Member]",
        "documentation": "Universal Life Insurance Policy, Policy Two"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnsecuredDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnsecuredDebtMember",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unsecured Debt",
        "label": "Unsecured Debt [Member]",
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.alt5sigma.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r44",
      "r45",
      "r198",
      "r199",
      "r202",
      "r203"
     ]
    },
    "alts_VM7CorporationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "VM7CorporationMember",
     "presentation": [
      "http://www.alt5sigma.com/role/NotesreceivableDetails",
      "http://www.alt5sigma.com/role/SaleofRecyclingSubsidiariesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "VM7 Corporation",
        "label": "V M 7 Corporation [Member]",
        "documentation": "VM7 Corporation [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year",
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r892"
     ]
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantMember",
     "presentation": [
      "http://www.alt5sigma.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant",
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r825",
      "r826",
      "r829",
      "r830",
      "r831",
      "r832"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://www.alt5sigma.com/role/StockholdersEquityEquityOfferingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Warrants and rights outstanding, term (in years)",
        "label": "Warrants and Rights Outstanding, Term",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1084",
      "r1085",
      "r1086"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.alt5sigma.com/role/EarningsLosspershareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in shares)",
        "verboseLabel": "Weighted average common shares outstanding, diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r276",
      "r287"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average common shares outstanding:",
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.alt5sigma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.alt5sigma.com/role/EarningsLosspershareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average common shares outstanding, basic (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r274",
      "r287"
     ]
    },
    "alts_WestervilleSquareLitigationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "WestervilleSquareLitigationMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Westerville Square Litigation",
        "label": "Westerville Square Litigation [Member]",
        "documentation": "Westerville Square Litigation"
       }
      }
     },
     "auth_ref": []
    },
    "alts_WestervilleSquareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.alt5sigma.com/20241228",
     "localname": "WestervilleSquareMember",
     "presentation": [
      "http://www.alt5sigma.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Westerville Square",
        "label": "Westerville Square [Member]",
        "documentation": "Westerville Square [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested",
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "7",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-7"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "8",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-8"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-15"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1D",
   "SubTopic": "20",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-1D"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-5"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13",
   "SubTopic": "20",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-13"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-6"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-7"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-3"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "S99",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480781/205-20-S99-3"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-4"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-2"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-4"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479668/805-30-25-5"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479668/805-30-25-6"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-18"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205-20/tableOfContent"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-11"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-1A"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-1B"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-1C"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3A"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3B"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-4"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-3A"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4A"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4B"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5A"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5D"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3A"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-5"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/805/tableOfContent"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r169": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r170": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479613/805-30-35-1"
  },
  "r171": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r172": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r173": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r174": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-3"
  },
  "r175": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r176": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r177": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r178": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r179": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r180": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r181": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r182": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r183": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r184": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r185": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r186": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r187": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r188": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r189": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r190": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r191": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r192": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r193": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11B"
  },
  "r194": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11B",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11B"
  },
  "r195": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-15"
  },
  "r196": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-6"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-17A"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "36",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/310-10/tableOfContent"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-42"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "44",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-44"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/310-20/tableOfContent"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-4"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-4"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.E.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10A"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.1.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478758/740-323-25-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-4"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(4)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/985-20/tableOfContent"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(b)",
   "SubTopic": "20",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479908/805-50-55-1"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(3)",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483504/205-10-50-1"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "40",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481628/310-20-40-7"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/320/tableOfContent"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476167/350-60-45-2"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-5"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "15",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480123/805-50-15-3"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480060/805-50-25-1"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-1"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-2"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>158
<FILENAME>0001628280-25-015469-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-25-015469-xbrl.zip
M4$L#!!0    ( #V%?%I:$+-[W <  'LG   7    86QT-2TR,#(T,3(R.'AE
M>#,Q,2YH=&WM6FUOVS@2_GZ_@I?@N@E@)Y)CIXF=!LBU7:"XV]VB#; ?#Y0T
MLGBA1"U)V?'^^IT9RF^QD[K[TKK!%F@2D4-R.'SXS$-*5X4O]?55 3*[_L?5
M/[M=\<:D30F5%ZD%Z2$3C5/56/R<@;L3W6YK]=K4,ZO&A1>]J#<0/QM[IR8R
MU'OE-5S/^[DZ#<]7ISS(56*RV?55IB9"9:\.E$RBZ (&_?,HA?[Y^=FE? D1
M9%&:7\)%DE[^+S[ IF@>VC@_T_#JH%15MP :?]@?U'XT59DOAG$4_>N [:ZO
M<E-Y',QBX_!GZ&.S)VG'V)DW]3#N84\>[GU7:C6NACR_@]#5W#PUVMCA8<3_
M1E33S66I]&SXW:TJP8D?82H^F%)6WW6<K%S7@55Y,'3J5T ?<1!^G ;_7V(_
M6E4PGT_<HTF\O2]4HKPXBT_B]1GLYGN*D0?[E9Q_#=:K7*72*U.)]XUUC40O
MO!$?(>6RLZ@G3"Y\ >*CM(FLP'5_NM<P$S>IIYI>%/5^S[S_WS@<>O:73[R_
M=>+O.N+65#/QSDF9=D3*<9CA-*5_<3BX&.T\HUIF&>ZZKH;<#WLOM\XQ%*DJ
MPZ4>=LGH*\TZ/IG/Z\N/OAZI^/)D0&%X)PHY 6%AHF"*%.8+Y<1-5352BP]0
M&XL8J\3WQI8BCKK_$;FQC,5<N11-9B"M  QL)MY "F4"]L5A?!Z->A<=XKL^
M(?3FO[<#\5&-2XED:+'/@/8CZN?%X46O%XTLC)7S%K'/!?'H&%%P^4Q1T-L[
M%/Q;.EQ!7)-R)NXJ,]60C:$3P& #"C*#+E0&DQV.(%4E).[>IO*V 9P!IC_.
MA+C:4I3X9!6B(Y=$45:84C&GL=V&087 <4[:&9F4\@X88(L^'99EZ P.J3F-
MMFR8*HMI$\TJ;(Z>9&#%M%!I(5Q#/Y;MIV"A[80F4"JG,;]2JIXJ7^ $78UD
M2Z-3OS6Z9C*<Y@2;92*9K8;A&:/R[-M!)=%/A>M.$%JN<P<AB>98;5?J5864
M50;&456J&^(JQ-+*HG80A\KJF:@1"H1B0K?62YBV"'$/AL:=D"GJN$,6C48#
MQ*9! /%PCOU)I2M$KLW4S8&[Y#HAJ3#XC5YV5O#GYLYL>/N,(=C?.PC>KJT7
MY:;XY<BU(&M%"Q&)R5'$@3URQ[R8[X2TP+!!&*A$ ^=-0*PF6KF"6I!9B3Q*
M7$K/&294;5R#[8AAK=$!/[4U*618[,01PB4#Q%_ Q-O[M)#5&%@(?F@T6L1G
MLAL/CB!X$0^R\!0>%>G<*N"6^A?$<"MP#O B7W8>*%\;*,>!YOI@%>1H02)C
M9UUW_A"W@_Y^X_9('N\-< <GES$%X@TX#!4N(&?#3Z.K0XDZE8W;O0EES 00
M*>U((0>;QF('R&(3Y9@;T0HJ[H?4_9)55YG9@I8,O38)+^'3:5F;*A4R+/KB
MC%89'[A=DSB5*6D534 %J<"YHJ*>&D?IFS>KXUS/3&H<H$-XU.9&M43,IXV6
ME !P6NS$4@9@BR J5K40_I4 &2)'8WO(=N;D;P_:R3Y!^ZR_">V=:6T#X;L3
MXLY Q\TQ41GA5SI326)^Z1#[)%()U-)F<X AY)5,E%9^1LI@V["TW1B+#+.P
M4]9,5T0N)YC[=D)U@\<LA\M 2B9-C<W8 9:[8ZA0H&A$.]9 3=N(3%#*!T3C
M=E,U<OPSQG2Z3Y@.=/UV(G7#G$8+#GE.US\37"JW13<N=,@.'!T>MTM)AC V
M1'YU0; FIO&/>[!+%I$+:R UGG_Z3"62N<[G70DA$N@/(Y &>)XHS/8)A2VS
MA@7>! H=]EL1R#5;T?@9?$I"P*1I8PD.*UEW2Z^E<1[+Z9IV?NOT2X-)&[L^
M>J1)CKA&IGM@W3J.!S+@>PJZPN![KN#7<?"JD&XA48@C>1] QLF#X]$2^TQH
M=0>ZO;1X8-_YPR'Z+.Q_>R>]P?,YZ?']:3;?.)TEFQ&YKH)W26P$O\^0+1N:
M>.&=1%WLC74+I< %V&59*N\!GD@=B4$M0O690O^XDR.$.#*UHTR OTF=S_<E
M_-(H=)_W8%/QFPEW_/>![DLJA!N->@^#Q:^+T"<ZH*<*$"UMEE\<K*8@[RAM
M!_W'B9N5*U_%SF^G/@N#[1DH7&IL(4"984,'"_Y[%*^MWL4F"#J4I9V@'1P*
M!]>4"!F,$D^FS3M;[_&>N2[8PQ/7#:;_W"*Y=! )P)2(6.++]!9TG9 ]534Q
M>@*40BLY;M\)V)9%H:RUF0'63@L3>%.N01HA^*?HBY/?ES3CBSDRYC"@$H2!
MYX-<VT6"L 7;Q?70LG8PG/\QPAQ0:SD;JHJCRHU&[8")\=Z40WH!/Z%<@KJD
MA1^/%ZJ7[^9/HO!^WEO\G\U';JM/N.K49YMU_8N3R^CQZN@D?K3N3^KVE%T.
M;F-D7"VK5P=G!_,&;;R'O?I>Q.O[D);@87!"7/ZZC<@]#I7'T=*G]P9/_\5A
M'W'(/\5[($UYBZ=[96K38/)?@*Z-T1/3CP13^DXA:_'&D*TQ"'3Y)6CVHST+
MYF,?.G#HOEBXOJ6@O"X4Y.+M/:0-';7%3T%;_AV9ZZ/WX1X*67TC/,=_*#ZG
MS,M/IX:OE_S?T!40ZVKQ@[1IL?8QQ>#1M+;Z@5=M'+^4'(8[]0EL?/*U9!9.
M2M&RB4R07AK_>)/U=$;:ZBFIM5K GXA1R<$GOCAK?X:/WT[YH[O? %!+ P04
M    "  ]A7Q:W;-) =('  !H)P  %P   &%L=#4M,C R-#$R,CAX97@S,3(N
M:'1M[5IK;]NX$OU^?P5O@NTF@.U8CMTD=AH@M^T"W?O815OL?EQ0XLCBC41J
M2<J.[Z^_,T/YD=AIW7VT:; %FD1\#(?#PS.'E"Z+4)57EP5(=?6WR[]WN^*5
MS9H*3!"9 QE B<9K,Q4_*_ WHMMM6[VT]<+I:1'$H#\8B9^MN]$S&>N##B5<
M+>U<GL3GRQ,>Y#*U:G%UJ?1,:/7B0*=GS].+B[Y*+IXGPWX^.+\8G _E($O@
MK)](F?Z2'&!7;![[^+ HX<5!I4VW !I_/!S583+7*A3CI-__YH#;75WFU@0<
MS&'G^&>TL6U)NBD:"[8>)P.T%. V=&6IIV;,\SN(II;-,UM:-S[L\[\)U71S
M6>ER,?[VO:[ B__ 7+RUE33?=KPTONO!Z3PV]/I_@#[B(/PXC_Z?H9U2&UC.
M)QG0)%[?%CK509PFO<'=&>SG>X:1!_>%G'\)+NA<9S)H:\2/C?.-1"^"%>\@
MX[+3_D#87(0"Q#OI4FG =W^X+6$AKK- -8-^_S?-^[^-QZ$7?_K$ASLG_J8C
M?M*NE$:)ZY[XWA;&6],1&<=C@=.5X=GAZ'RR]\QJJ13NOFX)>1@/SG;.-19I
MHW#)QUUJ](5FG_26\_K\H]^-5'+1&U$8WHA"SD XF&F8(Y6%0GMQ;4PC2_$6
M:NL0:T9\9UTEDG[WGR*WCC&9:Y]ADP5()P #J\3W$CNYA7@%&50IN&>'R?/^
M9'#>(?X;$F*O__5^)-[I:261'!W:CN@_(GO/#L\'@_[$P53[X' O<$$R.48T
M7#Q1- P>'1K^(3VN)*Y)M1 WQLY+4%/H1%"XB 9ET05C,?GA"%(;(<U"-":X
M!G &F XY,^)J2U'AD].(DEP293EA*\T<Q^VV&A@$CO<$(6Q2R1M@H*UL>BQ3
MZ P.67):;=DQTP[3*#8SV!T]4>#$O-!9(7Q#/];]Y^"@-4(3J+0O,=]2ZI[K
M4. $?8WD2Z.3W1I=LPJG.<-N2J2+S3 \852>?CVH)!HRN.X$H?4Z=P1E%XO5
M;J->&Z2N*C*.-EG9$&<AEC86M8,XQ-RT$#5"@5!,Z"[+-4Q;A/A[0^-.4)H,
M=ZA%4V(#Q*9% /%PGOW)I"]$7MJY7P)WS75"4F'T&[WL;.#/+YW9\O8)0W#X
MZ"#X_LYZ46Y*SB:^!5DK7HA(;(ZB#MR1/^;%?".D X8-PD"G)7#^!,1J6FI?
M4 ]J5B&/$I?2L\+$6EK?8#]B6&?+B)_:V0P4%GMQA'!1@/B+F'A]FQ723(&%
MX=NFQ!;)J>PFHR.(7B0C%9_BHR;=:R)NR;X@AMN <X07^;+W0/F=@7(<:*D3
M-D&.+4AL[*WOGM_'[6CXN'%[)(\?#7!'O8N$ O$*/(8*%Y"SX<?1U:%$G<G&
M[]^%,F8*B)1VI)B#;>/0 ++83'OF1FP%ANV0RE^SZB8S.R@E0Z]-PFOX=%K6
MIDJ-#(N^>%MJQ0=PWZ1>*RV=I@GH*!4X5QBRU'A*W[Q9/>=Z9E+K 1W"HS=W
MJB5B/FM*20D I\5.K&4 ]HBB8E,+X5\I4$/D:.P/:F]._OJ@G3XF:)\.MZ&]
M-ZUM(7Q_0MP;Z+@Y9EH1?B6>;R4QO_2(?1*I!&KIU!)@"'DM4UWJL"!EL&M8
MVFZ,1899W"EWFFZ(7$XPM^V$Z@:/61Z7@91,EEFGV &6NU,P*%!*1#O60$W;
MB)J@E(^(QNVF:^3X)XSI[#%A.M+UZYDL&^8T6G#(<[H.FN%2^1VZ<:5#]N#H
M^+A;2C*$L2/RJX^"-;5->-B#?;*(7+4&4N/YQ\]4(EWJ?-Z5$".!_C ":8"G
MB4+UF%#8,FM<X&V@T&&_%8%<LQ.-G\"G) 1LEC6.X+"1=7=8K:P/6$[7MLO;
MIU\;3-IH^NB!+CGB&IGN7NO6<3R0 =]3T!4&WW=%OXZC5X7T*XE"',G[ !0G
M#XY'2^P+4>H;*-M+BWOM.[\[1)^$_:_OI#=Z.B<]OD=5RXW36;,9D>LF>-?$
M1O#[!-FRI8E7WDG4Q<$ZOU(*7( FJTJ' /"!U)%:U")4KS3ZQT:.$.+(U)XR
M ?XF=;[<E_!KH]%]WH.-X3<5_OBO ]WG5 C7)>H]#!:_/D*?Z(">:4"TM%E^
M=;":@[RAM!WU'R=N5JY\%;N\G?HD#+9GH'BIL8, I<*.'E;\]R!>6[V+71!T
M*$L[43MX% Z^J1 R&"6>3)MW=M[C/7%=\ A/7->8_G.'Y-)!) !3(F*)+]-;
MT'5B]M1F9LL94 HU<MJ^$W MBT)5EW8!6#LO;.1->0?2",$_1%_T]DV:N,2!
M#VEM=8J0!-?%6)>R]C!>_C%!?J]+N1AKPQ'C3I/66&I#L-687K;/*$^@YFBA
MQ9"*U>OW\+U^?!<?'/Y7RY';ZAY7G02U73<\[UWT'Z[N]Y('Z_X@LR?L<G0;
M(^-K:5X<G!XL.[30&0_J6Y'<W6.$IOO!B7'Y\S896QSK@*-E'\8]3__9X1 Q
MQC]WO*E> :J-T0>FWQ=,UWN%K,4;P['&(-#%EJ#93QY9,!_ZJ(%#]]G"]34%
MY66A(1??K<CIAZ@;_XK,U=&/\8X)@[(5GN/?%9\3YN6]:/]+9/97=+_#HEG\
M6[JLN/.EQ.C!G+7Y-5=M/;]Q',<+\QEL?=^UIA;.2OUU%YDBOS3AX2YW\QD)
MIP_IJ,T"_AZ,2@X^\GE9^S-^Z7;"7]C]'U!+ P04    "  ]A7Q:SP*89:D%
M  "D%@  %P   &%L=#4M,C R-#$R,CAX97@S,C$N:'1M[5AM;]LV$/Z^7W%S
ML#8%+$>2[<:1W0">XV+!NCB(773[-% 297&52)6DXFB_?D=*BI-F:;UV;=)A
M06!((GDOSQV/SW&2ZCP[GJ24Q,??3;YW'#@149E3KB&2E&@:0ZD87\.;F*JW
MX#C-K)DH*LG6J0;?]8?P1LBW[)+4XYKIC!ZW<B8']?ODP"J9A"*NCB<QNP06
MO^BP?G+DQ<0/XWX\&/1'7GA(#XD_&E%O-(I&L?>[U\&E.+U>HW25T1>=G'$G
MI49_,!@6>KQAL4X#SW5_Z-AYQY-$<(W*)"ZN'VL9=R41N49A6A2!YZ,D3:^T
M0S*VYH'UKU.+:J='(A,RV'/MW]B,. G)658%3U<LIPK.Z 8N1$[XTZXB7#F*
M2I;4$Q7[DZ*-J,2^;FK[#U%.QCAM_?%\X\3\*F4AT]#W>]YM#W:S/4+DJ7P@
MXV?SB]7IR]/9='6Z.(/SUQ?+U].S%:P6]WKR6"SW1O"ZM^S->K"<SZSU7G_H
M=A^]W=,E3$\6YZOYR3<%=PORD?L<%B]A]=,<EM.+'Z=G\Z6S^/75_#>8SE9F
MQ'==_U.VP1^ETBRIZD^,Q^ALX!\67WY7#_[6WU,.D>"<1IH)#ANF4] IA2GG
M)<G@@A9":A )3%^MAK!DZYQ@H97XE=@%^V;RD[V1[[OCF<@+PBO[YHV? 0Z_
M%#('SW5^AD1(*SAA*D+!%242*'H?PPF-:!Y2^63/>^Z._5'7U.]!%XC"R1E.
MN#9J2:-2,LW0>\)CF%]%*>%KB@;E.5/*V(/_9F:,QP2D5%*T_*:)M3^MA5TX
M[<)*\ I.%2%1URX]EU0Q$Q6K8Y8RFJ FU*S9)85%DK"(2H.(F=RXC"N%?0^I
MLFCE%;SE8H/6HWE&3D@S%-0%7&NBWX6BE*HDJ 57WMCB31SL%C<(D%@4YL2[
M.;V=9%*TL6-)9$@X5<[B*J,53"-KA4E1XQ1!CX>C\2[9^AR3IB!QC.>KD]%$
M!\/!Q]/7><#\]7JM6U]?^VVDO*/>T,"PPG@T^R8ILZS"_947F4G:ZT26]%W)
M)#5<1)E ;<.^3W#?2/"&^_&SZ^!NT_XZY9L(>T?] <;V:&R2[#\97_]1QI=Q
MK&=Y70*Q?&J"*V/\:N/5!I\PB=$OL)Z8.'?-,,DRP&5H#-9 '"@P\*K;%$9.
M>&2^H\"86=&F<N"L,JO31!2T+KOJO?K3V_4@PB!J$F:T'0Z%C*ET$,Z,%(H&
M[<,X9JK(2!4P;D&QB\:-L%!H+?+ D-Q+4\ZPGC?)8Y.F'M[RWYY;<V"-Q%?'
MK>9FN&>'#G1\=VPPZAVY]P^[/>_>L7])[($UN38;D5$(]8M.O],N:+(C\(LK
M\&[O(I,P[X-3X_+EMI&5&#"-VJ(/I[9U_\G>X'"L["^<4TQ)6!%SAA:BS(2Z
M3J@&HP^X[QKG=X2LR3>;C@6"(#(6@_%^_,C O(\C6NB^&ES?$BCW,*7_D3G>
M/Y<,*WN!I?T./,\^"Y\#6Y=W*OL/<7:?F,L:2SWA%R*C]!;#'WY&\_1 _IB3
MOR;PF%KV@%94F\X&:1T)!4:5*63ZYFXJ*25G*D528$@\!]I<GF#%HX84?"J=
MMY0 M7"A6TVV1T(M!:D[M1L4Q.A&&W'$]$-XID=8JTJ)C^V-VFT> 4V3UG0I
M1KRH\U3M3#&^:KAV/_/J.PE0:!;")21#FW%#6O\1SPT2;$TQH!J1LL@T'!U;
MM^IFB+H&(X$@R2V(I,1WKFU2\#7V;5';_-G7=L&&*5HW= 98@[.QAF@3$-.D
M 2D*;(N5Y9%5@:H-R;1=0\,L:8:&2,%9!%C@ZH;WGSN0$I.E.+>0XI*9%KSI
M7MLL,#FV84A50].J-.06I;P_9YODC8!=&G0)#-DLFIDD4!;XQ=B);?/]"7;S
M5K40RE+C0-*,F$)ZYYYU2S4L2W6W2TB(NZ_4=Y=\Y&JV^:UOB0_L[?1?4$L#
M!!0    ( #V%?%KUA])+H 4  +P6   7    86QT-2TR,#(T,3(R.'AE>#,R
M,BYH=&WM6%%OVS80?M^ON#E8FP*6(RFV8\MN ,]QL&Q=7,3NNCT-M$197"52
M(ZDXVJ_?D9(2IVE:KUV;=%@0&)*./-Y]=SQ^QW&BL_1XG% 2'7\S_M9QX$2$
M14:YAE!2HFD$A6)\#:\CJMZ X]2CIB(O)5LG&GS7[\%K(=^P2U+)-=,I/6[T
MC ^J]_&!762\$E%Y/([8);#H>8N%KD]I-!P,H^Y1M]_K#8^H[[G].![07K??
MCW_W6C@5AU=SE"Y3^KR5,>XDU*P?='NY'FU8I)/ <]WO6G;<\3@67.-B$B=7
MCY6.NYJ(7*,R+?+ \U&3IE?:(2E;\\#ZUZI4-<-#D0H9[+GV;V0D3DPREI;!
MTR7+J()SNH$+D1'^M*T(5XZBDL750,7^HF@C+F)?-Y7]1Z@G99PV_GB^<6)V
ME; 5TW#H=_S;'NQF>XC(4_E QD]G%\NST[/I9'DV/X>7KRX6KR;G2UC.[_7D
ML5CN#>!59]&9=F QFUKKO<.>VW[T=D\6,#F9OUS.3KXJN!N0AVX?YJ>P_&$&
MB\G%]Y/SV<*9__IB]AM,IDLC\5WWH[;!'X72+"ZK3XQ'Z&S@'^6??U=WW^GO
M&8=0<$Y#S02'#=,)Z(3"A/."I'!!<R$UB!@F+Y8]6+!U1K#02OQ*[(1],_C)
MWL#WW=%49#GAI7WS1L\ Q:="9N"YSD\0"VD5QTR%J+BD1 )%[R,XH2'-5E0^
MV?/Z[L@?M$W][K:!*!R<XH!KHQ8T+"33#+TG/(+959@0OJ9H4)8QI8P]^&]&
M1GA,0$(E1<NW3:S\:2QLPUD;?F$R-=HF'?A1)%P)WK8JI@FC,9PR3GC(T.)Y
M'+.02MA_*1E^R?'3'>$S@Y2=7$&!FH1]7U%E4<Q*>,/%!KU"L\VJ*YKB,FW
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MJ_YT=CV@,(B:K%+:B%="1E0Z"&=*<D6#YF$4,96GI P8MZ#82:-:V4IH+;+
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MNN@+!&F@RH9E8^)H N]&!:IK<%=*U!HS0;3O;G*(E!,_AY8>&:?J+@A"^UB
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M]2VX+UB4R/E;5KQ/*/_,7FVT;UZI]#]02P,$%     @ /85\6J\<H1UJJ@,
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M256_DOY]L:N1QNS+=$W^4E396CJ&"93YE;MKERIHO#26-^@;F4B56OZ25N=
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MEWM[P+P^M\"ZQ]NUPT9S"D2/:[;7EEBS FN>!;7SV8I7L F,? 5H(Y![X/L
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MTF6L+\/A?^(Y&.KC5G=LV0-NWU@P]QM+*#"G\E,BL)AUQUVW?./).Y@H9P&
MP($;083."PLLA_>$I])75Q&HPV9U=TXN&'!7615W3Q4$++M<^4HTLZ#8Z7<8
M;$,KO]_LRE>-&?T&E/8K$EI'T]D)D5FB!0Z1 Y_C^;TA?O1D"%?^C 2*3)"4
M/:Q!\*E$(Y@O0A_6:!3,6##CD\SX0[J1%S*?BE7\(*G9K6X7$]X-.*469SCQ
M7>V]-0#MA^SG6,QU$QY,,V>7ZP=@S.?73%E.A&D:>G3D<YN3SU&K6U3I&5CO
M8#RPH:T@ @,R&$@L'['4_C%XAX6S<[]CP4,10B_K-;RWF.=8[^IJB5TPQ.%V
M]P]8 #Y.3\([. D]#.T1ICG0'%D06H=5RV'C8&-R)F?<INM[5:T=>L@A"Z,)
MT]5V/H/D>N#\;*<,/Y=;)VZ0#X$%AR(,@6>Y"ZSH2P\#!.[8XK?<'ULGZ-7B
M29RWW#IF(5/5B3/2:#)&VE1(V^U7O!^YJ@R@4[Y>M^A1\TE$"@_>%P)CV<JL
M!-V(;2T_$H%1+P3&5@L,\MQ=6!RWF&V#P,"V.0[Q&+KMWMRKX%QXY0<WT%QA
M5C $60,__%A# 8D. 0[C"I@OG#Y/D0"J&:?\-N8\Z["2^9.@N[5/I?BQA_/1
M3\0/+)Q \B :+?IAL$@0KWVK[\N[<! _&C\9QRIJ]6ZY'EMA:=.KLA+!3%/'
MZR;=#NN5_?K^RMM*]BH'S6QR;LU*_;">R4C;,*G7S"@"C6Y*6)W.9_KL-\FL
MM,;,U=F&UI$MKEH%EG* I>=L,?+;@-2^],=S<FST$*';U@]-TFWU!J4Z'IH"
MZ]_TMA%*N9]:QYL1PIU%%M,;0=NJ+$'PB#O;/=F;H/DJS0DV2!Y?YMO(6TH<
M,32^$3#:"A9/[@2NOW K\+.V/;R!"H"3'GAK8VN!FX9%L4MFQ# P1N$P4%&8
M&@NE%07*'86EJKX.X60OLPY-8<@*O^6.\>-W CZ-T_%@=1+EY:T(2.5YS+,%
M<]&0Q6UO^#"VJW.8[RQ*MKUC[^<ZE!L/O>296E:.E>JTC%9]6%Z#P0$6AAPW
MA2"F &FXVQ8FQ_J4OTA*M%D0@'[ 2S$B>:_'*=+FZ=)]?!/[R_L>$ >*%A]X
MUY(@]U)$,U&[U"(NH9%FM9DJZ.TPO\M@W/+%O<O'E/9Y5]NUOE<ZV(]JO[Z'
MU;_O<>639>IRF:X+@BU%FCWA#U74=03?9O@04#.5:C@T918Y(M3SVAA!+B^8
M3^R>W\(I2[\UP=Q7E_6?ELM[C\GE''-"SPHFR4) \:K%XPM%:YJ9)C0<Q%U&
M@WB,=(R1=BZHTA_UFLX)]EQ*%<(E6_H^3[9C L"X[V.64"*)W@H9!>XXIM!Y
M7\T!E<9=1+X*KQ,.PR^XP':R[.6H=?^-4NOCI(8JEZA*@L96A#&AEYBZ4Q1(
MHBW)'J%PMR6EOD"&N^- !'K++_JVM[S<9:C$4<US+U!"'S-8<(OR\<G7TS2=
M*('4EJQ__FVO6=\]_&1S/TCGPWRP.VZ1#Y)Y:.LBS8?__%MM;_]3O5FMU*K'
MY1HP8V$)O&X2)!APUXTM2^O=G(K%J2P R,C-H6AECQ;7MK2O<O"(E"FJL8J4
MY,JKN 9^8?T^<!RRY) J\-5>GD<DJZTV 06X"<@"^B5A3(G''AH0,%)0LI3L
MELJNL%T9D.O%7)C\",B6QE<U!S0,//CO""R)FNIB1V4&;#3RY;T CN!PYW4Z
M#LX'T]\U6W^E?#W,-?*$8NHH<'9FN+R^ _+)AFF[P<\[Y=V'/'])=O]75[)P
MQ\)N@'!W+^'QPYW/];W*?LSF\2<_6[ NEYHG;9#J5\NJFDOS:NLNT>  K!2P
M.Z*0X@)(I4M2/B-KY8SY]@!MA.JG^BX1[RX1[T**41^<)9I&FFA.SK_.J2^C
M;]/.NPX-<3&9\K3F@,65'4DMSG' A,:J21_)ZL[GVEZING]0VFL^I+2ED-S(
MS_94\]N7I]OUCZ2*='T$ZY2A_?J@@?]D"O3MZN05U@VD&X4/7U&L]OFGKO]A
M;HOZ50\>V$\.'A@D0!NQ/ICL/F<WH C G_W(W#LV#G#UQ>D$>3N=H%8WJ&'C
M=>OH](MU\=5J7YQ??SF_7MQ9?V8%>9%0M7JE>I!-B<I^O;+;R&8#/<TJDW*7
M;%M(;;@1RI)$>PGBT*P67)KZB3E 7X&J$,YCZFH6KX<;VON<D;2=AZ9-2?X5
MY[*\Y,?^8)>MJVOK9(Z\-X(*U]P(3J6J'S,DUNHISB6:-7[Q =& (;\2O31V
M/I^$?&C5*@L(YI6P4IAWJR$MKH)9)]:>D-L^KFI#'9GSR&>UQT5R(0 W@IB]
M6 "V"@F8'PD(6+L2P8WUE=FA] LIF!]F:U8+,6@@9@ZU&*P74C _4A"0=NG+
M$<*8%S(P/YRVMU?(0/,P@UNN208V"AF8&QF(2#OE?>9:( EM3NT-"E&8'X8K
M1*&1F-G5HK!9B,+\B$) VAF\8G58CX=CZU@$6'@5^85MF".V>TH@FIZY*;*$
MYF<)L9!890F+-&$AF)8@F$9-VP.[A3V0&WL D:::JM-VV8O(M_3Y#5_^C$0X
M+EE76&+('8L*2@?2Q4V.9[C'T@]HNZ7JWHL'!]L#%G J>%7OICI>%K9%;EAX
M;[]PM@S$3%,+U[U"N.9'N#;Q% 3=M^!KLO$5.SD6 C$W;%<(1",QLZ\%XGXA
M$/,C$/?1VGS0BP.#4%$0"-W HY7:Z#V1FFWI.:J]"SYSQ8/(5?T*+D9<3:FP
M,O/#NGBV8R%43<-,K5J-I6I1Z;;IN:R(MO]@,PH1TG9 $I%PP8U_I\+\5JLK
MHU"?I&9A@5PA-O/#G/N-0FZ:B)IXB\1!(39S)#8!:Q,#LS/I083BLQ.-1B[]
M9OZX\-ESQHS[S4).FH>:>O5 R\G#0D[F1DX2UMK4Y!0;8I)T!(.2]7VNY27U
M5FVI'I6,V@AZ\4]LEH(OI,*?B2U:"-3\<.UN$04U$36U..E^6#CLFY[+BFC#
MIBO441C%(Q4F.T497KXXKQ"*9J(F3I8?'A5",4="$=!V01U>3SS5JXY:&1;B
M,"\\MULD=8Q$39PJ/VP7TC _TA"P-G&5\<1>YE/KT:_2AV]A+UQ?!([0?=2I
M;?JESV_Q1(L3+QCI!NN%_,P/DSXE/TVOM"^V=>1@6T<]Z?Y6;.PH9--R)),T
M@*L6_E1^+ A$V[' DU:D'Y2L+\EA)Q>]GL!S3DH4>FI+?X3?X=8W/. $P_1%
M9#Y'G+E[6'A=)J(F:1I7M,W<]%Q61-M$4K93YTH5,C$_C+=7+V2BB:B).\C5
MBA9RFY[+BFC3>WG'UL6=!Z;C0(SHX B .Q.>=<0]#C8EEG>H^V193K9ZZ#T;
M"W<2%[(U/PR\5Y36F8B:1MR9KE:TIMOT7%9$6RQ%24!BT!ZD:S E,J_Q<'-U
M]);VVF/'WCJ!KX[P"/3";<\5KQ9-[<Q$3=S5KE:TM=OT7%9$VZ4O/%N,P 9-
MU1Y_Y5SOY^#^K;"+^KH\,>)3K1=,SU 5"=$<)$0;2:.['_FFML)&>"71U(R+
M[FM%J[M-SV5%M'VY'XBNT%L\Y^S]M#KV@#N16]@)>6+&O2(%:B1JXCK\6M&U
M;M-S61%M7Z6/Y3[E7ZU.-!PR?UR(P_SPW%/BT'1#=B\+0BID02:R /<.P(OW
M5BBMV'@J9$%.9 $@;W^EH_0*SC.&\W:K.Y\[ %H6%KN"\\-RB+7]W<=8[D/(
MNBZ/KZ= KJ?1!&W\:20#ZG7YT:>4X"W_="><< "+(*BDWE+(^UB=O,*Z@72C
M\.$K"H6??^KZ'V9GE_H7QQ;.SSO+G2.O7QKX$]KK\W+7Y^RFS'HA]S\R]XZ-
M ]3UJ5D/A5=.KW?^5(UAVWR*$)#^UTAK5*@#'\16+7,H<Y8.P=KO WK J8*I
M3$N/I^+.&7'FO%AO'*.=GOP*Q-K866VM?T1!*'KC#2WVY/K+F86%PVJUFY"]
MUNM\?/[ZC[YW3LZ_=#H/T6TVYAX3(M^XQWWF+K.DO<VL:#XAM$ZO=RTP188L
MV2L"*RM9[W"3/BQN;-UX\LZS6&#]FWD7'K=./+ORGD*L0=0-A".8+V ^[V#&
MV T?])D[+EG8_[E>_73'2_17[5-\)0J2*^& QU>Q%IMYX^26].,[.$%]]7W%
MNA[X,NH/+!GY&.$-N3VP M['Z&Z)QM,#62-?W@H'YN4!I*T^88<:3'==:=_8
M P;(&,D[[G/'PE$\@'<?UP&N$/=(LC)K*/KZ+;C*8*@[J^_*+G.M7A)='C&?
M.0 _JMS!.4PF>"1D,O1X,LT[&-KG5D_:40!?A]%A--K]&X)J#577+3RPQ8Z[
M8NL=P#:#%RP;ON )&SZLVW5U?7B77I?64'5^=?RHKSMW@9%31I/13GK'XA7X
ML&H>BZ.4P1 1_!:'&"6G"5=,YL[YM'SA66=L;-5V2U:]6F].$P2S_XP$8GM"
M\26B955R)7'/M9M^V::F:(Z%"04[V4;EL2&@SI?#-#L@Y.<S4F7.YT0 M#0A
MH$#7+L19"Z)IK*!%?-AJ]@^'L>Z (VVD%YAB=YP:#V@)L. #P8TX7A !]FR+
M0K04$" >AX\%6.T+L]9L0C> BD4( [ @ !("*>?)X5@1$=[N\B"$Y[%0S58G
M >'5Y&LD$##3$M]A/GP2O)$R_"A3R0;W@<(9KBN'Q!5+GC/F WX.B$H:TR0F
MJ5F])AE'! #!4'@17'!YG]ECJQL%,&Z !RG%<@(?O>+VV'81W9V41"TA_P>
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M2DKBHM\#9(.#@#7)P;OQ*.R),6]?04_"N#ZG4#@Y_8\HNQP)A;09MR1MF",
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M2W"'=JS" _R!U&,Q5WJ\8IUXRHGQ18 83J%QOG/%[X'Q! <7!!1,U 7X 3W
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M3*UR<)B\5K$Z%'FC_BZT1M7V(7(QCF]C,)@_K1]GIO90K^U6ZNEO?@.YYBF
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M-Q U(^O=4?O;^QGK8988$O9[(!@1#P!6M\NQ/S8B8R@=KC9KC)@-/BH,_Z_
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M*^!]DIT,I1J87G'Y#*!_Q/TG8F2;=$A62C8_9@Q< A7FCJEQTMJLUB<8WJK
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M17"##V!;B!A#48 UMF.U G)$2'ZJNCE5.Q,WN8A+VJ;X<S08@Y,%H->? QY
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M;JQTG!0,<E%),$Q@)CLOJZ+%8OY433Z+L]"I@7W&&MAU<_!#0JRU2,?9J$K
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M &=;<Y&8(5$KM5%+I%6&>:9UCL-G3X^4)S9>_).QUH4LTJ91B'].G&I^*:O
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M=68JBSK,Z33D4&2&:H>%[] )Q,LRD3W5=98Q-E*B#"#5?&A(0SBV<'ZCK36
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M=M74CY$P!;=94EIB,B[T8 1>QK'M'7GS3+8M_8GC=M/,2CVH6J@JS85!T')
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M640\;G/N04=RO.-8>/(ZG%J?H%D+/RWMSO0/4.A0LHC NED-F@\#BPM1__#
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M6=#B\FOJFV3\B7HA9R8C3MY"?A:Y?;9ENWAWF_&XSD*&X2(-6^)UDX$4\P>
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M_T%@05Q*$_MXT)=NV=)_F,%\\H6(.\JM&(OU$-$$+'D>GR6H&0EUK?S"-.T
M.,7CYSWJU<#K&2Z@'Z#F2AC<O_B_KQ\170YQ3LXIGB (W( $^!:#\>>G>,_P
MKDEFG1X9KJ5WP6@C//^U]U0F2'-7#.B?G]WX(?Q3//O(4^R_/8'V/WJS1[3H
MDQWO]V !'=[F"D<$I2%DGN5)&#LW7F_'6G:H97]]K&7?@6<YW%KV XX\B'C\
MZ;.'41U0CC!B5NW;<CE(JR[1IW47"V(5<G7A W[0H<$=J7<?=W]M8"/"U]2"
MFP9 ]] 5A&V$E\!.0;8@*<H=]^(PUXQ__5Z140 &L*,>C;*:3/93QKX$PA%<
MDP_ 4#</1R*$_() //+;)P*;DYYUN7J\\9[[1"I=/!Q[#ZT\GC];03(-QI]-
M$IV\H9?>L#Z4#YYB?_3+H45V#[CF+)X?(XGR;1[$GI++</< /7;N-ZIT%.*4
M_Z$-01S!J['4HNOY570"5CG1_Z ^XZ-F#@8S/K7Q-"C_4#H[$9:28*\D]>'.
M85#XB,5/IK?[XO'^VUT7[<('@EC(-3OFVN?KQVUV_+"/%C]AV$8G\7ALS6P0
MV &X1IZK"*AD N9PH64E8);Q3KZ'V]4@<J&8^TE1&XT7[0OJ">"B!&%<X;<S
M(Y0LM:!JN]0@NC!!-)HB""?9-'7X"2Y/[-=Y6<SO"N3:^3O4R8!-9-(3XPTM
MP9K9,>&A1!>@\Y$E7/A.4B'?<X[ OZ2D0O3).NAO8//^^3E[BI3MII1[9IQ&
M"$04L8L&!AT>.XA@6XJI0M4*K418!\3-'FG$9JS:DU_I8F>W-]PQJ!P'R*9O
M:A+ZPIY*%S5W?2;A>E.?G#?,.)_>[J&6N:F:;%11^OP#2PM0Q8":?-4R0+F9
M65*"V6J"%@;J1.BZT)!D!HWQ*?D#'T.2M> @+MY9 6#2E%-#^T/ V@^S\4V#
M>+2_D ]WC+V-\30O/5%/"$]/+\? .]MER8C='1<1XD-)[E!F7T\JOZ&;5@E#
MB!>O]^ZBD[C63U^)6C1IY0H&*O2_YY)(L!(-='KRG3@ZTOO%K*!<B6_?*%H
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MX'3#9JOM\. VB\)5VNIJPW?N?C!9YTC)_S;-.N-QR1?" Z>IY]]V+I[>I9:
MO0XL^++'6ZI>>-^P;UK:._!PVY)DS,DUJQ>7>0ORDT#M,)JI*X025>G"YN*&
M<CH78HO:JFQ7PP:-M-2?G'>QOB+3V4FFK"_[RO]5UM,/8>6$MO;OF&%>.W1/
MO:>YZTI*5\15<*8E'OK.CUK;61O91+K@TQ>G1NT3YY@:D=.XSM] $3Q2 YG\
M4<:)HZ_8\_,/<<HTB3]*PK>.:>[#77;,TA%F@#WDN/Y@<&@%^+59,G6]MQ 8
M=[7TG=&Z3ALNF0M#>%>-*D(61.-4"CQE -2DPV)$I)@7)9-5Y)'*0EKK. 5]
MN+/XUB194N,=ITE$ 7U<58J9N?Y,EK0=34Z2CN0I5<D8SAA9T0NR0FP[@D_E
M[[LL:_7%DLM1?Z,[+U>F-.J_DZ9 ^_S#0H,F74#)%Y@Z,'9;<@@,*L/RD!?&
MZZ3*/O&E>"1GBN_7.5E(?&#YV--&F%00N*^EU)\>*\)!8PEH)"MO+K.OW#;U
M 5&,2BZHZ9](7I'3V=.'')F2VO E. 6]R+6\KR?=+"K@C"OT;^\N/]>GN^[>
M-0A!U$?JJX:1:&\>GL9XK@RW)SACYYZ-QDZ2NM#0T:KLGA*79:9IDS*C(3&R
M:JMA'3-EP'T,$0BY(GQ!*Z66HSAI2"L$9 ,S8\TS8Q#U5#U<6_CN^J*SA<&P
MRJ,6JK\_TV@IY8,$&>HY51_9U0[[*&ZB7[5UYBK8!SM[KY#.+1@*90Q6D>'$
MT>QQEJ2[?^O!#PDGBB:4;"T+5/+,!H6G8%YJS><O$DH4FYSG7V3SB J+Y(I[
M^D37*-%!<.G6_-I$\[&2>KB+ALZY4"B8K4,0R9;(TQIRUQNOB@1L!)H8;U,@
M7MI2])[K@<8!E%94/IX?$:X_@V0$/SD^OX]'6%H>BF6?!-X5S>;-M^0J(B4G
M6=T^C6VYMND/4;-'8A A&2E.$8"%E/8R[<=S0+<0Z<@A;,*E=>GC8] .=E)R
M$@P.?I6+O#!\TSE<T"?8'0V$K=@*ITJ]?8CDN^$-]2G69:40!3G)#M@6U)]T
M+#>?,D'$TSQ>?AIS4.(6D,L511FL<4QIM@A(K@EZ0Y5B@5$0;^:^($3T@T&J
M%6T:4P;10\B""YQ6OR "_$/$.:<Z'$HO:)A=;U *NG^&]C5; 57&A-JB88M5
MX-?,<(1$7-D&((_(;K2[;=]PUL<O-I2ZXCG&),^ O!RL74%8,=6BYPCAO=NI
M%1$@FPR] GUB1M\[=.")0SH.A)K]T-8B*J.@6OK_( T2Y6J9]VVGF8PBS7!4
MS16GPS3+0BI@G ?IO7TA5Y*T*+(@8^O-X-KO,0[.LQ&$,=H*60R9]VWJ]^VP
M[5<ANPM+"5#T4*^"%,48MAMY/W>'NWK40EVS-06S3YLREF2V>=<K<B<<&O(9
MLRQF9ON>R$"#?0QPRW-5D>X%P$?\WGR53H1ENCA[@@I4EXC\6I2>'.O7KKF5
MS@8LO#:\>6VVFJ*UAL1_][QJEM"$:DE\L*QGGQ:8%PP+5ABX_UT/G.=6:CZX
M8:?K5"\AU\4O(F(I6UPV2 G1%Z7G 2N6QE?O+>5\0E"Q.DM8X2:/<DGN^=+M
M&K6![!T<[AK^FVLP(UQ+*/P 5<U6LOBTK* <U8+EG8X8OVS6:Q!7LZ$$V37@
ML.Z#Y) -=WM&LE("(A:=:"Y'^DVC,UGAAN14#_46T[8**X*7@F03DRN8U>!_
M*$LF6C9> M-S[W#G&-SD[D..P"VS)N@C.V=ZRGF3 W3@-?MQE*+WV]=M]7 +
MFS50NB96Y7#GYUV"7KWN-!FO[2[,E<DU$-UMV:C @19)"%0,]Z!J:H#?.>"<
MY/+Y]KU3U3[>^ T"9>H-X%0K,Y^J RG^.*#@)*Y6?"QR^26EJ\-='S]X,PNG
M+*,###G3Z]8(-0L8\'#L:PEJ>W&%$*B>.W!*P.87YT,.40+G(J]\>JX+,J[S
MEK[*6XYY<9_]\=;AX6V?'/&V=^!9#A9O>\HU?/%V&0M":LGPSAP '_\:RH+"
MPX(%U;R-KIOZQ&0?"+(OR#0)<ZQWF( )HR&'2U_V*E-N6H;(R%,>7_5DPN6Y
M+%I&]\!4C+DY!Y\4?D3;'3W51[X3L94LE,YZ,W3#=M@@M<^@IV -99S" XEI
M8^Z#3"(XXS6%N,T&;-Z5S0NN;^% /KE"TV<8:!R[?GUM[B@%^*>WHN/]):%M
M%775F?3CT U;@NHEO37]A>:JRBB=QIP,VNY]F?O!]V-U__)WVJ$/F517I$T[
MG5]5G$,&VI?;^TK_(D#%]1<M!?4B'!,$8R #[Y:2*"#JC+4_R+O@H8GN:[S'
MX7I(/Y.(L2RAT.D'$S6:A4D5ES1MZ4LURS99%1VV-;QP-94_R2\?XF C+\IA
M@1U+PI\;(*"6MF(@P.E/^Q5K2+@]1,1;C57!'!WP>)M6ZB@F91DRU&12UI^$
M\$C)4YDSAHYP%CBOJ\KF^41@68.)3;YJF]GR@H2<DA<<Q:,X1^<R<O8WGY+L
MBPV>"@:#L+=-1A-N8M5Z-X.56OG8'M!AX3ITWTI.\W"7S$2;E>H2YY3(4V8+
MSO5P7#[) K0YJ>/L6WGSV%)=#>(1D?Q9@Y0 #C/RQ?B>I'MW+EB)*^J])AU"
M@&H(ZN%GN='[^#5=P7TP2YKE8%OY!YGY5-S1'[%Q\1_T*HB=\YHZ&(G2 =>B
M]D.*#DW':^::R3>H)=!T^7NJ(B07%EM"^>-6!SSZZXCT-&/)+AVST/B9N&@J
ML Z$?L-+T+GYBWB'T=5E0Y Y_<X<F$"/W565EYL@.*5U&FW0" K*9*QQ7TZT
M:1UQY":-><@LU#>'M4>#$2H_<KM9C/7!3?C+H<5!Y$-,%W&%0BGR;R&9*3LH
M6S,P1#JQEA7J8T1NHGU0VU9)/+J &$EG75W;92.2L46)MLLFY&))<KR9Q[SB
M(9Q0_X7C8"PE+V*F!")?5OZ/JPMRJIOWCA9(A('Q;WB1ZN)EH@S@<.A>$EB'
M.XY?L#FNH22T'L]0,CMV=WY\HK2'-^3J9Y2Y]4-O#ZYH/;6+JMGE%2<NO-NP
M.>13E.TXS8BQXQ*M4[0BK7%F'TBD:9H^54@^&F6P94RN$G@MY@X"[KW1'<NG
M+!RP:&.H6(I'+8X;*B!\DKX@;H2<G*/BV,"5\2,J!4ZG$2M'J=3C,CH/X6UV
M,9?5U'..*H=>ASL)B2/JSXNJN2+AX9AR]0:(]:]#LEEP5"%8'%>\*)R80;?=
ME"4B*40?G1B]N4H^4P^&6Y74#AX"0EWF:>J;3!TCC+ !ZL$?)6AL5Y+BJ5,I
M ?H,$H<\)\GE"2)DT<2N>M-NG %4Q[%KNZAS>A+Q<.6YU-FB(S2:V,.=W(1'
M.=":Z(FU='GDDR9HV,PP<E#?SAQ<9!\5-+]W9PE@!&=A8$PDE*6[LP*IOZPZ
M,I\B6>YXJ2(0++L<O0E^8_CG+IPW:@E8;97W_O.VV?H32&I4_/&2&,E.-DCF
M:%TI@K6H?:7L-IDVC1,/-N?G4BMHX[TQ9D/SN@;B0P]+!'3^K7;DX7<A[Z)$
MB15YC-1',P@$-D>)CH@N]"+WK[3SC_&<F?+E=)JXI0#(-[:E1;[)N<$ZYDG5
M+T^#;HLV!K6X:U<N.HR2,(UP4**+"^XBX':_?0O!P1G)U_-[A'IX#!Z?)DLG
M<WY;KZGK=$L@[NX"E)/G[HA'_017$2,BB]Y,A ^JFD F)@(%7=>L2JJ)4D K
MS5X7#HAI<&5TS@!:@[EE+HIMJ<;7,A@$ZJ_$:_P(KP$CX YW]A*D*7%)O?Z?
M5]^=//DFC'DP9MH*ZYT\/ZAD\_RILG%Y-R2LW0"ANV**PN!1UX9=GK/4+55'
MQ_\UX9Y$Y$!PY6Z<'%'00B;%"D)01MY-8_0O?#SG:MG.NT@;=X/HXVB%/R&9
M"D8$83>*CDV5+XD@%[TSW0:S,M3P'ZUI/;>X=OW89+6EVH\&426I7GN3 6BJ
MCUUDC5XU;54HU:B<Y6FE,W6HV'W6_X[)56">:O$:3.<,MQ%>>?_;'>Y$3TN5
MXY,TZ:7WOM4_863\B%YXC_.]MS/>U/_[W]3,[S^X&%KPK=4,8,MGW+-P#.3)
M 5TU'?/4>B<63,.;H1;VLD[;GT.W^!(,;%IA# B($=1$86(^*H8U$DH6ZS80
M6GX[]&I><.0 \U/E.UI<!G 75I(WFDCV^DW@S4]_L4LO2)A[!L3Y<?$&;'4A
M89L?!@W6Q'/$"S,(7[L__'<REL59CX["Z[Q+L;83HW:X2_IGI*\H+ KM\>!)
M;ZGP8_C216S#U1T.FH$SDW3 [>%@QY2YS@9VHEI"@98U37*P*3CR<.<B@F>J
M'2]NRB !*H)]Y3]!TR4YD;*SUWSRA)XCXLRZ"E-J"U_S4?%"\LMJ]85@<6\,
MG1*H:B1]N%.6ML-,XJKK0V_ ?4-A1#HKR?AQ1P#A35H2$:KG*F';MKS$9GQ/
M"C)@ ) >B5@_&Q=V[ :-MAM7*]J<^BX(O\;5T%I?C?JHY#B1OIE@D-4;37%O
MQ[Z*YT^/?15WX%ENLZ\"]NH7R-(]NVNR=+/:['<O"?J)J>[7LWD0<1<+MI0I
M5&Q=#6A.Z=T,#A66<51_-74=+O;=O]3Q=S=Y.0.8#;&AQ*!2M)[VX,\GH3#X
M61Q] \_.XN"/)P7>HW<ZVIXIVO2?K"S4M$743Q((< ?7*7*!;[P#$Q#?% *W
M30XT4-HZ^&@QOV"FH/P]#VIH=SA4G.,QV"0)&61M36^Y"+#AY)<N 0(FURK!
MTPP]2I8C^3>S6+^=+,!?(BXK6L0G$![^]MG\>N4_E<3:\.W)DZ^C(;SE%4RH
MM"]?_'XN83I<3YX_^@)CD53_%>*AA"K6O.AG?M\-&V<VE@/PU7[# $1&FTW"
M8?_F4Y#(B^.LW]ZLC^$WW)6>A4@[HW8=89FNSU6W*?C4X.F_Z83](MWHXR3_
M!EM;TO-RFE1@\>.PAI5:0U>(JR_+MJEQ]G"^3Z3_EKL4=. _4JX2EOL+-,3A
M8BD^!0G<C$E+.VTC[1C3OFJ=ZXY[_A:7@YEP71E^1D('$*7#E/<L-0_4?1*.
M>J:IYGG7S-AQ(F]Q(G&^TO9""@>9]LW6AY<M,B =TJ!*_T[9,YTL%C@]SM;O
M?=2")G59E=U%2ORJ6<Z+<DNJ?!55YQ32\L_&?VV!U!R+_6+G!<V(O*I*=KV%
MY;1LBX7P QQG^A9G>MK8V:Q3+L 0\/F5@!:!;HZ@[CAGMSIG^[IU;7<( RN5
M-K*LUU4>FQ!NVI-[G-=;G%<MLK(H#I$:NT(;:!/7UY^B*ZE$K=3<JF)0YG=L
MWW.AJC-<+I.K:J04+I9RU!^G_A:GGIM"8\U?! [8$1(B3O=!Y"SQ(3J(9OTD
M!$!#IX5(*C+W)8*<XWS>\GR*-!HEG:A=0?W;F 8-FFE&)AT_)1?+B3)]38+N
M.?G(8RH2/JEGNW<MU095&]\'%-T(77+TMW_OY2(((0$;489?$,/*9Q]Q0W&&
MQ\S,%B6D7$MM<0*W>J=9S=KU5TW[_CB]MQU.5?F*.FL248+""5,R=7 2!"C.
M6.SH[<3D\]1%V@O;8XJF.?\>/@[;+6$.>G\_XF\1B%=<6ZQRDGD;<DYA&ZTM
M4$J5%3XFR 3#C8SWH,QH7;/NKU NF5FKBCJ+(+.C&;G5=69A?XKXPQ02M&5U
M#-)N<R[*FON#RV7@JT[LLU2^R1](][VX],?9^MUK2Y;QN,\K/W8O\*?CQ/QN
M$\/QC" 21@'._0.(G*:@!E9QCJH,/2B:0O\*I<ZY\PD%K14Z882?4,085'A3
MF/,G<8+ M;V[3RXCPQ[B]9'H95TM(..1B_5_9IYGD1-'(QM1&SQ:O -Q])KX
M;N;1* Q2OB&<8U3U*]Q&- 88RCPL.^_';(/VN,0HD6&,.GW&*2]A+[<,CPR1
M],85*>N9U//]6T*OZL5EZ2\E2*(VWY:%'U^GQ+\1:#1+@S 6[F!F>/^:)_PO
MINAMR\Z49Z9S;2C8-BZO_4?KH>()V#4#U@W6 LN!^X<;MJQ1M*%E@(DKC%J\
MKM)(2'RX>.C_E^%8*JS+*G<F:;"NG(K+I(*]W421,-U_K,(<]-@O2N"=*4X@
M=['Y)U^7=M+A#O\\9@V#71,< 7Q?NEX%.<?CO4;A9.FJYFI6X]I0)\S+71_N
MD"<\%3=2]A9";E&)8=4+_G>RY/\0!!-8D'W3,R\C(8I5JH,5XX!G[%4*Q,@^
MB78.,' X*"(Y.W5-(/GG"FWJT@CE<Z_!3WSUS[TJ/_%Q7JUU0%7B)OO%K;["
M +F?6?5Z44GA^>#'./:,Q)Z19\>>D3OP+ >KQ?&SBXI*^<)'4N=H[VQ[4\9)
M;?D#IC-HMR3@]##8=I:3C$9[L7:NNVUS?7==AG=F9,QQN*0&3AQ^HY$[W)%Z
M.QB/X2)G88Z:2Q$H'ASNR'PWUJD+SM*XUR!X3BG!+CQ.^B/S15)B(\BX\C;7
M@4^IR>^-.7MGG9!4B8Z"T\C#8](WRV%'/'W>IZGH'^3.B$L_O8AWB>  ,9 [
M%\HX?YW^@I,U:W\#;C*+$6N%\-;5EJ#)]N5&P<+#7=VOUJ-%33P821@P%FI4
M+=J/2 1FGX?\QA N7>_[^D<:.[X'-[O"<QO.N#C-:(=+[%>J*VZWR5AD(VZ;
M3$))YLX!2<NP67JC-BL@?#]ZY$[]B'0TZ+]TPN]:M>3IHV=?_6(X[]0.SZ6&
MPQP#.<"B7:HJ1VSSHP9-L2M]_MX121XE9HR*'';SO C<'446_W$7S:B#LI3@
M@F>'UX9&&1T38T'B;MQN&]B1!*FJ_&R2GO-K!R"TNMP.TL\5;W><X\\^QQ$-
MF+A@=LK7VMU*?W34]P8^YP 8%WE'L*IUU!R',F)HH=N4-?TQ260?9_;S[UY4
M9K=.4H6<;>C5+>/="Z4?H2P[!Y:!F!7)S8+1WKBB'#:,,.9";+88].S'+)(O
M0;3.F2R*+6]@'!A91!IAC;1#Z,AD V+4V?E\,08D2),=E\EG7R9:%2%]F#;9
MI<2 "%D?4JF<"\M&A\!QNC[[=-7NG$])YK-5,FZANFH-O\S19?H=IB?E%:',
M1T6&-%\0P9N0?HO.$^%S_$54Y D^>3"0JDQ,KA)3K,BQR@G-<^^DD]>=[,OC
M'-_*P:JICPDO"*FO.=?/6%-.?QUGZ'9F:#W4(C.N-E)\E_DT)<M.F&2EMYG<
M?9&"[&V?17J5PB%OX@K!X]&1"3(BR!SDVVVEU+''^?_L\Q\B%!:5<\SEY&=Q
M"_4$?WH648UDKU>3: @=)^T6(E%U1!6[2X4YTC.G W&;[RA.#1V-D?4SM<"Q
M#>:B7): '_;@+J-@*#.4Q]TJK\20FW/7ASK >/LW\Y.U.L[\YY_YWZJ_F3A<
M0HNS\+]$0ZUNL&"82__ZQXU]"]-K9K!I$^8F@7=G@;B'LT3#M@"^5(I%JA]U
MC&5^!R\J&L-_!R!V:FT)T,.<7/E5QQDA=GK^Z<ULAUA(M')2#87C!-Y.H*(I
M/3\Q0VV$*/,//*&0Q%A):C^M"9H^\>7.D*0!:E[WQP3][4RBMJ@ "5;[!SDG
M-/YEJ1$H][UH3^>-0IO.3T[/#<>04LF2\"3;&^Y<#A6*_'1?@J@C9]P!=[%Z
M+QP!T:$ZKHS/OC)B<I]P?Q/!*_A173<.5$=8):M_0\:9 9I YUCIZ-!CGK.@
MYS'S>^O3;9MX6E)ZP7:7U.#1I;W]DQ54P=8*@QV)&]48%,-8)5+'/4[)K4Q)
M5?YK*(LP'\C$]T&Z=@]N(>J#V3V4,K!_/.@XO":*Y\<FBCOP++?=1'&T3[\\
MO6E%V?93W;8&_C94';(F:%YO-8[>0UHLB=(V\.^P<_#/9FKRCH?1Y\]H6M^
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M+X>RXE4>E[?6:;:M\[,GYU+"($KL=YW93R+S[D^?G)IUMT.[NL@[)UT<9CV
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M&'JLXQ#HM4#5Y^@W_D.P=UTY$0#!-:'R06EZM$YR&E[]F5Q8_ZK@PLP?CC-
M2I:O8[QYQ]SCVMX@<BY$/F[>(D6M6W)!9<0(3^HO:7'MK)O(*&F,9VB'H?H2
MMYA=.LJBB]4/H[OQQSEAJ2A!&I^PK-=M#DZ;%<@0[]]R.ZV5&)^D0 )O7].>
M^R7Q[ZEF)),4^YE%QU[?Q1(+EH\9&+.HTKUI%V%2$H@ @-%W* $N*8:P 9P"
M<\LV*2:$&9-<4K;H&J8ZY)5"%Y,:B?>^FNT%-??F6K83@JL>K\G;2&3RQNT1
M_KY7;MF5)"2S:98E,E.3[IE[OSZDH$>"+($%8=5BF^>$57,,E_)'V "TAIOL
M.&68XB\@(8":>EQTI0[G&H4@ #M(9*;S\P*SP>-H)DH5JDG1APCF5CFM/ER7
MLX51L<"?V\D<9[3<3@#,5_8Y6>K^R^=M,VP5#N0GIRR\]4W>AT13%LQI>;C5
M$*(3Q58O_7QUL-LLH[0DP,-0YT-_T;08TBSD"%FGM.+&;JGR 45GB#7L-GY@
MN#7&(7!259SP-'0/,Q@+!C@C%#LG+)'&6=P;GB\;*%+&V[=,9M>S]HUJ(V5*
M69A(8!4.N<K%OX9R];Z2!%>S]HN5+L,:1JOFO%;%3OX^:+5\R.%?'O!W+/G=
M8J\Y.+PF@B^.301WX%D.5HF!B^P@":_RH?;N11&:6G-Q!@[:WG=./2$RB0UT
M!%5?PE3M&,VCTA6FY#U&B="WM0Y^N"-[QHS:BWZW98?62C-+5$,EZJ$C !SX
M,.V0X\!!Z(Q>7>_C#.W2%8<[FB_]FG(?\LVV@M=HEBM.<.7D8CYXQ-(!Q)1D
M8LT2+6O_97_JBJ,:=+G3.:#X%YWO<')\D &;B"":;YV7&ZZ_])3U==S- P_@
MLFR'CC/X&YQCY!5+QDJO3>W;.>LWPEOJ75[)HT2(%NOQ;>&* U0-K^APU\!I
MP9D?J#YDBY7N+W^NY2IG:E9"ZX#3710D(TD5&9R%<-?H;&.';>^)P*[?E;/J
MELJB6V(5,C]1X<,:A U;4D3HF?!&$PKW,"2LO)4?SB_PXAR:,VD[PFGCS0O*
MT'7)@$NAGT&Z<-]I]&K!)3+&-\C+V\+R!$V:Q8Q-M>.Y['R02G=Y7T.TAG'H
MO>P2-/_*%5EL4;)+?2F**R2:68QJI)W?C=+PLVRJ3CSWSAG$0I<)HMO_!"M@
MBA7G7TQS200!%W.S4%=]),O.0Q)S'JT:ML/=XC\[X72# *W-+*HBR1AP/!UY
MD5:_&/S#+%S;-BU"O6KM/\\IY^#W><EL1F0X,FTEHN_2-(PX4 QM'(JZ@#^T
M!P[<_\DD D+!A<[$'AVO?20;#^F Q+=!VC!?A?$UJ<+$S0SY@2PXE()CO<[_
MQ*9MR8QIPR4:,9)D#\YTEB9B\EY7>WOL7$M_0T[I(D"HY8V$;WG=YD,Q0 R>
ME+'IV#<))9O<""[(%$BMYL^^XD-V$2092L"X#BTX&P+D>+-SU9!>AS8LKO(V
MR:N85=JASYB.HN3SJ-2 336T9-(TPR,3A4>RR1J3]K63-TG<','$$DZQ,X+S
M8H7D-%6=DVRJ'#LIQ6RY*9'U8E>3\N*K]V@/ZL@^(3-Y@A.P:UK2>^Z]>ZG9
M>\[-8@UW6SA'YT[3TV3F#G@RSA(/45*[01$[-'@ACVP< R-98.M!U/ 6G 8<
M*>\E"[[A\(WDH*=%AYGTXN'.R*LUU1U7U!0"7]N8<6*;V]%9X$>*;97_<M&0
M^TW>*!4$"!_5HQ$"Z]\J")%#1B!$A<8--?N#%L%/SB*7)A7) XB<./;>0+/J
M6/B^OUPOZ%>"EZRDHX7O>\"Z<J&<S2XR%"4IRY;7<6@!]""U.;,%K>S,"*.!
M 8X,P?"0\XJ\0,C3[)9M*3(G;N,]=#!,<AM_VX)A5/A@T72$?/=BY_)#MGY)
M7PMY&DUG!+YB_'-%81X&- 9Q-*P2$G.(DQ>7<)^+&&\'TD%45[B\)TZ@#;VB
M-OM$9_3>A,6O!U24.K'G7>1W&3<]QB.=:Y?D7/GSQ:;^N/ TTYSR&5L:[WJ#
MZ<\,1C'JA(C=/O3P8R^]/\.5^Y-8NR,"814MM-#V"N(+JWS+K20$M!'>::$A
M)KDZ0> *B\Y"@#+>HT=2CO$YQ'/+QN9\T%:'8X?JQSI4$XG),(,TFGYP?.#4
M979$L\ 3@4GAR A.4@M_6+[!$"5PZ8 \PMN>@#R1BG.<)*P :A_R1T<O<X:/
MSX>RR$TV0?C^\9_!T> Y<BG$ :X$@U?PWX:<45N8J*&,*4FRQ=H5A)0R<!>%
M,I)(&MSVWL)GQ,F@?T?.H%2;-4K# )'3-CY ."F</Q=%-B:OA*F!?UA$<A0?
MC8H$S>F[MZ(^\Q#XKLVF*>2N3)^7RLMP=%=X7RQ*@H7FT35.? *)G"QIQM@J
M^E@';N\"_!]*S#>F(Y4^9'X"U]) 5JR-DWF';0" Q-M1O[CJ2 02'T$ZBS).
M(O(8<T9GU&>4I?"YC(-V<;[I\PGICPG;]3/#K,HE!.6<#[]ZJ()HI$$1[^ZZ
MU85?IBR%EL.MI7EG]L@@>I#1NL%9@G?J\P_\W1/OY?B'Q^!;T@UF34$&*R"0
M_'=YM)'$+B1WP3<9L =.>LIH^7!$%VY]?KCNT \B5\G>S*SE\/^D.U[!G25*
M;7)"2Q0_66D+EK\VGBIV'FH%@A&+P:(;"ZMF*IY,TGEMCVB3(7,]Q+'/R<L-
MV_65[E9Y1.:?LI</XIH(C@*($R"UG2;;UKBVMVUJG ]W[A-7F#"#IF%Q]J"7
MJ!/6&VD\E'@0N!1%BU-N('24/^RZ88:2>4X^=^3=[-%>YNU[B4H?)!))C)/@
M>#^]?:2'BZ2#Y !L5K-\/0DI_^'.^[N/[O4QH#'Q4\:+@N)<,K49P\B<XAII
M[\F&!.^//U[7)4'DU!E11"(M/,KA29SL+TQH2(C9U#4PW43Q6+MD$MDE;A0^
M7FB8M?:KN.=EAY_(5PYWQG_P[@,<@TPH4E"I_1#E$SE\6/A](AD=VWP00N-]
MRNC>0R%Y"UTL<6W,$PDK^TDGV2CW 4X/0F%_5U6T"?DN1N=K2'/M0@QF?E H
M,HF[;[VI**E&C418(N6P]"O2=>DFX%@=>,KSUCE91)0GP);H#MQT\(%/$4P?
MRN%\)FQX"]. /<"Q0,@#]-S2%U!\S"]=^L6'G >[;EJ!7Y8(<[GWM) &[=:O
MY558>MX(^#@+?R=-=NW+KU,"6FXU\2-#/JQEHUWO[UVT$2T5*)#FB*5[8U%M
M%LC;1V%)2=3![8N(H[HWG#Z(V/EO=H^.3BC>LO: DN#UI[J$K_$6;H!DDR($
MJ?8/%D-J7FYC\V'U8V>%1,9V3#J %!"=1':18QV<Q42NCOKXX5J.UX'8F8+\
MT-QM&)N)K-ZTIL;]I#@TU;74E!/]O5P.G*1EZDQT\V#GX-YCMKP1]?T1C![
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M#B)8&4?9'[O]%8-KBP7HNL]'FSYTZ@DJ""=HS.=*&2/@JNF9.,WG+WY1;CO
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M[H%-MDZ@63?6B.Y=0]EX$9ET[]0+%AHBLH_&XQS$,E*NDKR*X!C,P SH6XS
M&$,-*#&!52O&2Y$/E --<F.)(3S<!7/Z&_:K4JA_D1=)ST"P$?@4GX0662?X
MVWJO;%Y DQQLJ_)IG=*%Q'YP]1OV'.SRZ?7D.F(.C)-ELX,U P H^R?\)9KM
M,^9B0M1/FW!-27T^AX[MRVD*=[3235T%E6E8+=Y8#%.*BJLU\8I?I=[B_B*-
M17OI"9GWU-QN],&]-Q=]LVZ55^$_<#]_"5H_PF1F:PGF3M*[RKN>PZ\,#Y1[
M/]L/H?>(NQ*3*)3_41L@Z3QFT5ER-O0Q+YMJV'#-5RG=J:^$V]0V?FV4/H#1
MU7RX1OQU0@N!V3E"L ,$^ZLC!/L./,O!0K#53HXY!BF=BS;[2,XW8[S!8F1,
M=B;=7[#YY&I/K+XR(.XYRGE"=@&J$VC)1NWCB+@X")0+EMWTMF)WM>=D_BFT
M;?UPK;-EKD(,@J%9#XIR8 >Y,,K#1-M'R/(Y7PQ,KSP3?,3*)^2!"2$T:G E
MLU<RF*,L)#F3L"A-;NP_KZI)&YU*-1'@7?R(()J<8#+NS9X$EB)PS=^$8IZF
M:@XX3J'*S#11*!0AA<5<&4>#I'WTL_.C':5(V(5<.E9G!6=9WA;$_DVA0+/N
MK]A:P.U6=O#0ZD7:)M+E!;:2VGO6)\WZ)+B*L4LLH9.:\-GRJ5GBBJJ&DJ5\
MN)?^6G[:NPT:-?U>^->0OT>,<C&T+<(:_'M=-0VE8LLVU0&F[FE(M)1=WO'B
MWC97$ AN6"K*4F1A_%Q%<.>A#FBC&!41-0MVAS=4VJ3:(,VQXK""&MQ)?DJY
M3,)[S[&M\Q,*Y[I);5*.XX#]T5<QC82$L#_F&L!#,>+*&<2N/>=URAZU B3D
MI?V0%[2D=FC0#46^/1I)(V@%_37O,?B-6_GPJ-LZ5LLAGDPD,>Z?@7JUUIC<
MG+/9I^EBB*_ N\,1>(,NBM0K\??N;;9@0&Y)R!T$X%*E\$-=2]W")<QT&0T\
MI?2)-M:1@1,".Z3X.DU'3(A\F6A(2B@2$$<JI(P>PR5T2!PV%M*K3)0+O=1*
M<@2/+*M%I$12^5LUC$UF=0-E63+7L3I3X8\3_<&$W#BFL NWR?DLIA*,BVS%
MZEU9'M>H9DAJH&Q6*N"HQZ64W5@Y#RFWH93N)IMOS0^=>"463BY<+:7"A#@1
MZR(+M JF:RL>PB,$E??/UO"TPGPEJ8JA4Q1"33-%.1#FU]?D)O442!*:N'.P
M.$ *AD8;:L!/RVN3I-?A3N<IMFG5U.>N2%P?G:/\TAN%$%;!ZB@L9>8+&9\'
MF20E+<[Y&AX**YAS1*7AYF]-$IJI/91(*/5.Q="/!I)/=.W=(Z]+U322M+'2
M[C."D4N@G!<<214--2<NH<\#[=A C@V^ F](00+<S%6'X+E?-F41%HZSBK'7
M)-0C@TB@-:EFB55C^>* EXMA1DJH;6@R"6O,*AA:8R(WT#]'+LZS6D&L)P9K
M[-/@1C ;LN%1MH%/@?G%Q=/8.??^%^B"4R W2*L9W5T#$0ZNX9[IX:Y"6T,=
MPWY_#K'B,7<V+ME9.F%J1T5LH"[N/\0]&$0C7'"'NZ#>M(W?["IDQ7Q8H7+!
MU6$5NTE%M:Y22S[:I\S;U?5<"MFX0E-C+,S#MYQH0A\<<]!?)<D@(/;<-&[,
MZC'O;9G/1L<%.60\7J)@D*9 4FS"+"R4S/0-3Z=4;'P"#).:EVQU=0[K0M#4
M<6/N0;E$'*.@8/UU?,2 )6//0=[2T*">(KD(%LL,OR.DE:)Z:R<BN=O0BZ'.
MIT(J(IZ"A'3)JEA8A]R*KBA9/L$/%7^ 3HPD^R K5M*=!*9GW04UM</V7%(2
MXWJY5:"Q9*B':X0#7C0@$8$RVC=.J!D()V+&FFA,KYZ>=S$$$]V[>%0>\$ G
ML%@,F%!^QL'AA2Q)$::S^?C25684Z(XP5! >!NT )Z218H]N?C4I5NQ=!4)N
M&])V'0,)236][*]CY1.6V4I[S1+B[.F')/D0CZ, ^7X8*VP'BR-Z-<)9,RPY
M8/BMF^QM)ZTGHX;&TYPZWX43I0UQ@E&>)&QR[-@.')^Q'S5ALH^0A5\Z-S-4
MCQ*4&0Z8>W-P <8A&_P:7,_^R2,TD4"(1C-HVB5"YVZ6"*;<;-ZR9.(.UT"_
M:V#7NH8<C WK+$2H(\--0UYB3*3N#T+"56IB8S_S%@4U+EO$9 ?_WD_503>N
M_"R#3@0'WK50^WY-[H;G)"@B7"*^4VJIJ"'%0/M5VUP5$H_0MTZBQB&+8QSN
MT#,?C'?MINJT5X[A"4:\V.X*V3#[OBIVC4\93A2FY]*\9?.?H(]K=#JQ-3MD
M'C"PK@6@Y5K4",'$-\UCA"('F.-KCIN -&6P=V&.AJ0)<_WM34_8+>*Q^OP$
M O/?/IL_<_E/)0&,OCUY\O6VO_DI_+>\!4M%X8?LETT5L9I]^>+WF[!TB)X\
M>_35EQB N* 3^\03PN>T6#3JK=B#!(_-%W/GC.['E,&/S66A[3VFSPC5X^[%
M79GZTVW?=#3ROW2;WK6Y?_KHV5<8 >.OIX3;E"7C&*[8-^GLL5^YT4]GVVDX
M)]\RW_PZOVQ: E-(YW"Q?ZH/#TO\]1%+? >>Y;:QQ$<;]AO8, 7#! M6GPAT
M)A4%")8+.+[>_C+]'AU^H5<YEG6.1]/GG]8^<$)J(03*NW =&9"T; ;FN/[7
M$#CEALZMAXJJ)-<B+[CPNG*M2D=PM2/(\1F=O1($@N[\/"49%%_WN QN<1F,
M54^OZTV,_@:7UAA97KGSLJNFS<:&PHCF./8D'R?XLT]P##^VKF4>F4AZ' QV
MG<@2"_G8,B^D43Q2LEN*75-Z9?P$UHSY@5\<A1M?^SCEGW]/!_;D8% ##D++
MS%I=%@96K9WNH1A5O(;@\!(0GC7GW/0:,1TA/6JR.L1V=UP%GW_C6T5;9!#*
M@G>Q,MF8 #(@SA>;LD-EQJ\!<QP/*"2ZCMA$ QVB "%DYY.TG+(.S!8MXA?%
MZ%RXBHZ-@>S/TEWDU7K28G=<*)]]H;#V9*!T;L00E"LB2FH*1W8D_1:420PH
MDP&"Y>AGQ\F[U>A,J0*9Y*UWIHF!=_EQ.C[[=%BO%UP/,XJ:@-6ALP5$AR%Q
MVX-5@111N!1&%$K^7R0>'")DII'M&Z(\FZC?<'[8JKB!2:\5YE9(B4S5+E[X
MK7U<%;>P2<-9&F3^\"=TA9_X?;N&%OBZ/">^OD#[4O@Q;8DH6-J.F6/3'Y$:
MJQ'57N""#/<("V8[+"'LV._N'Y#BY;395M&H@4M02V*$//L5)3'< AK:C*V
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MD^);;>^V!N]Z7/3[\PQPOG (8*1'4)?**5NK E48@0#5!+/J>%0EQI3K0-U
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M0H>E"T*KE1EY/TA@%@,D[_9N#3P,R K-<E3R@(_(HL80>]0517\1#"?"$>Y
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M!AA:1[C=:X7-& XL_MF]D^J?Q+OF_BO>.Q\NZF/!@Z[OX/S*T[+TBPES=M7
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M1P)QG8GMM8)_@-+M&.$CZE,TJ%0S'45*E6$8G3/O\5@[)#&!DO5G2@-BFEL
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M^!"<5[!$;@+XQM?D^P0XQXHW;]S0$N";?I>JG@TY'$5^J9+BO##4171#1=_
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MV\&*LJW L!JD;42'>I_CCB/3\250<E53+I'7I!CRVR]^='/T(6M6V00!PSA
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M+#\1=X<-T%\@EY+[E3F65I%4#,<&JF#]T5!NZ,*Y&*T-PQJQ(+PSAIQLB>%
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MAP^=S6(TVJ-RS Q[GC73BDAILV9LXL[HX4#!,%BU$12UPRH)T8Y2A1'8S@^
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MSQUX0 AAAD5I[V;X&12.#KD:9W#Y:JGF*9!WG)5UY E:>3G3,-%%51SS)#4
M7&)=H#1<^B'RYXD_B?P)C*S"1M"A4=\QX45;O*'%Z]A^U@C/)M:=K!CV]< ,
M4U=-LTK7Q ;CIF'B;@L+"XOF49P4T!T"[<L9$\LUDG6C1 V"(E"$=%4X0")I
MW(39?J0C2&,-)=19!EVW)++2FA(Z(,*BPDY+X4_698&XB7MIYRG6P@08X,N#
M)3+]+O[Y$#A4[?C3'PKKBU8'.P==RLFR,-CYPTG4ZKJ1[A(A@A#5\FH,B*T@
MX,6=#NF*[6(DC</@/0:KP%X@!B8ZD0:.F:FAITQ.TN@MD+X5"@%<4XB8_D*
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M)IBHI)% B=]/4P<T2DY(LC1BBNGDYU.H.(!'JK#.Z,4:S*^PO#.T#;CN.2"
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MIHV17/=@+87C0W I 3,(]U$,2B!W8-I2<A)CV)DZ/71F&X"*$*M ](\%K=1
M#"'?,)M,Q4G1>Y)EJNMT<$/;%@ -2V^-N+J*8<[P\R3R-=D2FN?"P::_5!0+
M>&>4-U=^FQ'SGX/L$JJ5*U^+0>=$L!IE]Y6@XEL,+IJCR,X0N1+C!.'2C&*\
M*H7,YW0ZA0SJKX4/&641?;AZWSD4)"+"622!IR+*B9X!S3FFI*; ;0BGA$B*
M(?<;#Y>$%P2W"IKO#&GXYZQ4AXQ</'H.)#Z3[FEOJ$LX5% 1, #'K-T.(##
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MZ!5.!R3N.,DJ]"\_>_-N'VKY9(=:7H-G^3:H9;_.><]RX]90S=C"/Q[C'S?
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M?@28X.9G9$I:GSKWL77%*+_3_"/R)PQ;O\% MO7$%<G0RGI E)C<1(G3=;5
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MX*%7U(:6N2$->>CRPO1('OI1 *N?F5=?%#,QMLR^-;9\BWFJ,F%__67:\,G
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M*O$M<IG2#:^C&U[7L\PJIG(%B>&7ITG(#W4-/N17S]P<BLH5"EFN@'&=TF<
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M\>'I6!H"B[%@94^N.5:FINLKSDCQGYF'^0N;WZDS,:DQLFS3'ECP(3 1/IO
M;KS+N5Y?I4/P\DH55C=U/ NMP)7+QJ9OO;#/K];0?X:E<RL7^98PMU?EQ5?,
M/JP #-3&K\A"X*\7E65B1/^+ZT4[:>F:P8Q!HZ&-JJS2;.C-9J7/JH8QJ#7T
MT:C6_S]-Q\,6\:UG-]S$% SV1=]EYL\+<P1[O#+'K^:;AW",8@^ %Z7[*LDV
M$F8T.AAAA " V^"(H^PK\,F8BY^"-9G2K$5Y=M&)^MMN!H%O^\BG X.48/4]
MBL$_/IFM..:_*TSKL3!M?W^L*KW.MQ]MY;K[<-]]:#]VNG<;Q5B695]W[WK=
M[YV;]N/MC=)[A#]^W-X]]I3N5^7ZG^V[;[<]I7,'O^A>_^\_N]]O;A]Z_Z7<
M_NNWSN._E0\WMU\[UYW'C])O\L.-,QZ;K@?J&!2P,X-G#;W-RUXQ-;#H8&QU
MJ$OY[=,!/G/JL:OP+Y]#@V;9? G\2Y^#AP4*&+7'2B3$B21^'2B69N.R4>6Z
M)7 0@A<':N<2?O4IYN?:I5ZNQ?ZJ?*G%?V7#H_3+>KV:ZDE;?MZHY[0FO9GZ
MW0=?4[6A2[<F&>E4+L?_ANA$=-J+3LUT3R(ZR;,F*>E$<D=^06YK,BZUFB'9
MFBJ7NMZ4;$U5D+N*=&NJ2>C3:?KV-07IQ/"70?2C:R)ZB4V_;3WQ::Y]+.9@
M1\1TQSG9J24*]'KP+7A8^T)3[ETV8JZ;Z"3SA$G1(U*$I/A"A!"$Z! A!"%^
M$"$$(?Y%A!"$^/WL"7$M2FM[OC/XF94$\#'7>15_UXM)CC:L%8\TS/$_^NZG
MUKUI#17+YG^_-J>6#S\G(K4'@]ED-N:GF9PT-VQD#2Q?(=I$:<-)T_6?F2OP
MXTRF+GMFMF>]L#.B6ST1W>Z6!K\KX>3WDZ9,,D0].J!UEB$2'_YI>X=_D8*_
MI)V Y::9J,)+(E>[-WP>%&M/G)F=A[B=%ED$D A'A"/"$>'H_<E"."(<$8X(
M1[*0A7!$."(<$8YD(0OAZ)UQ),?'TE_A'HW*HX$<75*JE]6$_2S&ICU@JG+#
M!@POH2J&IBIZ6=?WNQDL2+ 7KH]XYS<I==)>^C6V7OJ='Q/R@[+LEWR;I9:N
MZVJUT<CI6O<R?I-U2TW#\'=NE):4ZRD:J:;:?5'!'C>=T-@^N9@C_-D9 UF\
MVS]GEO_6L0?C&=+B'@<3._;RO.+EDYOPX";%>.UZ.;\>Q2EUV.&Z%V^61U+&
MNY5QY9C*N*Z56EJYK (-2!F3,CZN,J[(IHSU\U3&>E[*.%8VBX32#2JYFI]*
MW@Y XZP 2 :!#,)F.9/!(%3.2A[)("0U"+5C&83J60&0# (9A,UR)H-!J)V5
M/))!2&H0ZL<R"/G-+BT" ,D@D$'8+&<R&(3&6<DC&82D!J%Q+(.0XY#+ @"0
M# (9A,UR)H%!:)SI@2X9A!T&H7DD@]#0S@J 9!#((&R6,QD,PID>*E.%SR93
M8)2WF@+1E22?\IZ&46H9JE8MJ[I!!3ZDBX^KBY>!?CA=O*YS*Z66?@[:EB2.
M)&Y)XK3C>S^;K%!$'*NE5J6JUBOK!?\DDR23!93)K8/;UX127Q7*#7/2WTDZ
M<1ZIKC;T=8N9?,PZ":9D""7!3""8:[>!#BR8Z[)7+[5J^OJHR],2O--+$C?R
M]]QDNPS1.*^3;3(.IV\<4LGC.]2B)_#5\.ZT:I3KTHMDZBX$(_Y_Q>I"P!O<
M*H.EYK9CQTO4@V,/ D@H4G,+D7W#J3V&&(*]MU^0DFPIA38>(0>SEL0?X@_Q
MA_A#_"'^$'^(/\0?X@_QA_A#_"'^$'^(/\0?X@_QYWWY0PEE O1) 9KX0_PA
M_A!_LAS=[^@:Q$]MER:2=NR!,V'?'<_[PD:.RQ[-7S&'[\UR?+$6@4;*ZBL2
MZ=,1:7VMA#HGD=9D$NFSF-P1#%WWL'Y*L3QOQH98!*4P7D2EC"S;M >PFSPN
M)Q9#$+*$/#E5W191?^RGW^,1(GM5-/&'^$/\(?X0?X@_Q!_B#_&'^$/\(?X0
M?X@_Q!_B#_&'^$/\.5RGPF(EE-/V(]P^O(+?=.[P1/W-S,7[S; L9RAZ$\*2
M^:^\M)T)FWJI5:\WCS)X]-0E,=7A>)()"NO<_MT<SUB$V>LG:4:IE?D<34+E
M0)"Y,)+T6-\',A50 <V\^C3*!)IS_W[!A.:0]202HK-@W'F/>I*]55H559HA
MB4H[BQXLW ]5^J;'AKP3"[,]$VE./5BH_HSJ XD_Q!_B#_&'^$/\(?X0?X@_
MQ!_B#_&'^$/\(?X0?X@_Q!_B3S;^4$*9 'U2@#Y1_ARKYH&?2'W! ZGKR'E4
MW&EAK=32*I)</B< D8 3?X@_DM7/$'=D-(]9ZF>2F\>Z1.;Q+'JS].![\+CV
MA:9,739BKLN+:FQ<9-"F9<R>S+'B,=\?LPFS_?-IT[)YM.2&LOKF2EG]MN&2
MF^KKKSGQ/7A==R3^[EO],>NQ 7S4M_:HNV^46GI=-:KK16IK0R?WX>4Y51Q2
M12CQA_A#_"'^$'^(/\0?X@_QA_A#_"'^$'^(/\0?X@_QA_A#_*$.- ?L0)-_
MAKQ9:E4K=;5<:U)G&I+0D^;/L4JB$@CIZO&O42Z#'&KKW:$(3)*"B82=^$/\
MH?9"Q>*.;.51>YE*3293>1YMA^)*I2#0&#'+9\/S:3Z4N2HJ1:@77SGX-21Z
MRD#/*.NEEJ96R]6<*J'.N':4:GN)/\0?X@_QA_A#_"'^$'^(/\0?X@_QA_A#
M_"'^$'^(/\0?XL]._IQ<?IQZ*1&@W_/[A ^Y\4'\(?X4I-:$N',6TG,6G6ZN
MG<G$P=<Z@Y^*Q>L->'N;5]-U3=OW%/:+N0/+V[.4HY!%^UE<U3,N#*/"/>(/
M\8?X0_PA_A!_B#_$'^(/\8?X0_PA_A!_B#_$'^(/\8?X0UU@]NL"8XY];_N]
MP#^"I/UMF+-/?1/0*+4J#4TU*@UJ^4+B>-+\R:/ERS:1Y)?88R1R_=)ZI=32
MJ^L]E@@YDB*'))OX0_RA_B[%XLXQ^[OD8Q>K,MG%LVCF<L=\9>QXWOFT;:&R
M].(5YM$]"P(T 9H 38 F0!.@"= $:"DX0X F0!.@"= $:%DY0X F0!.@"=#%
M!S3QA_@C59/WF,.Q2GGU<,R#'<#?5GN]W[O.R/*_.U["$5V1([):J557&YJ^
MNW,[H>?=T4/2+7-=0BK1UK;/-=DDT2/K%QM>_,5<)TZ8ZQ&_)MN9-V%&2HNP
M7BZ1OT5H2&,1SJ)_RA=S;-H#IBHW;, F?>8J1EE5]+)N9*F7[COND+D7OC.]
M0LI[SM@:*KB;@H5I*0O?*_K6F3CWX7PA7EDD2MZ[,]_S31MIDKK8O5EJ:4U#
MK1OK Z/>L]@]&?.+HB!3F=4DX\*>G3&0Q[O]<V;Y;QU[,)XA3>X=%Q_?]GW7
MZL]\LS]FC\Z=8^,+7&<,ZWKJP*L ,7X*DZR5<S/):25;]ALXYZJBC&.J*$T#
M%54NJT"#XZDH8GZ\<C*D4$X1<.B;E1.!X_B:H9*?9MC.=X/X+HU2J,BF%"H$
M#IF40O582J%*?)=&*51E4PHU H=,2J%V+*6P):-,?#^R4JC)IA0:! Z9E$)\
MTX\#*(4F\5T:I5"73"GH6Q*>!([C*X7&D92"KA'?I5$*&YK-O)]2H$2C5$JA
MN54IB(D>^9P_Z-@/3&U6ZVJM4J=#4CG40_,XZF'M,%2OE%K&61V#$@ZWX+"Z
M5MYZ>#.UN_Y)KX+&JJN&3D@]::2FJKNKKI5K;JB[>R?,UDJM:EFM&94,17L$
M5YGAF@JMLE5!Z?D5)A-*3Z, OBI',4P$HUNRV831 F#T,(9?;KO?A(!*-<KK
MO;8E,OMGT??P@0W&IN=9(U@1!Y4S4GKP+'A%3^E=:,H\TZIPJ"B^HXPMLV^-
M 2K4+)'N")W'O3\"- &: %T SA"@"= $: (T 5I6SA"@"= $: (T 5I6SA"@
M"= $: )T\0%]HOQ)=Q*TX:(NGU35'OYGYOD39ON/3AL(@4\SQ_>F->S8U^;4
M\LWQZ@F!UQT]LLG4<4WW[='Y'IX%Q)SR&.52RS#6QUA1AS[Y($4B3_PA_AQW
MLB-Q1TJ#N:'#Y1'LI2:)O3R+_H7[5#Y,F0LO!NXKC-?*Y'$/I!@2E"62RJF:
MJXB*YV1&_A*@"= $Z )PA@!-@"9 $Z )T+)RA@!-@"9 $Z )T+)RA@!-@"9
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MK&=5+NMY%OT@Q/10>"WV>K X>Y%M0:<'9639ICV W5#/!RH/.X_R/0(T 9H
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MWTH_V+9:QQ.6LJI7U_.Z'^G^QYD6[9Z<L-+]0@(T 9H 38"6G#,$: (T 9H
M38"6E3,$: (T 9H 38"6CC/YS#MZIT1D \M+R]5J?M7>)*/%EU'B#_&'^$/\
M(?Y(P1]JCR(S=PHA/>?>9V3J.E-8ZIMBVD.%_3FSIA-F^]1?A&JTSJ.&C@!-
M@"9 %X S!&@"- &: $V EI4S!&@"- &: $V EHXS:2^'5/8_BKV?N8-GTV/=
M4=OSF)_^Y+59:N5XZDKB2.(H*V<(T&<*:.(/\8?X0_PA_DC!'VH;(3-W"B$]
M9])_8=%9X4 U!(4L=*;*_>+5_5#E/@&: $V )D 3H G0!&@"M!2<(4 3H G0
M!&@"M*R<(4 3H$\#T$?L3Y"U**96+K6,<IF:$9! GCQ_4DT7K>S?_GL_F5RT
M *]II9:F:O5UB21H20HM$GWB#_&'^B@4BSN',)S:.]I-72Z[>>X=(/[E#)FM
MF,A+Q5R,1*$6$%1O)6^]%5TO($ 3H G0!&@"- &: $V EH(S!&@"]&D .NV-
M^0R'@^GGD$8.!HU2JZE754 1W9<_YMS9ZOO,G:U5,'EFZ)HD<V=)AY!1)*-(
M@"9 GP.@B3_$'^(/\8?X(P5_J&^%S-PY2-A9>Z>PLRI7V'GF[3;8U+2&B@7(
M<)E'C3;VV? Y%8:=3.$> 9H 38 N &<(T 1H C0!F@ M*V<(T 1H C0!F@ M
M*V<(T 3HTP!T/HTVS+'O[>BR(1*CG2 OFKJ6KE9JZ7J.LV=(&(LOC"?*GSR:
M;&P32'%3>%4>U\^5ZJ66T9#E)C#AAN2:^$/\D:P4@[@CHU7<T$$C#Z/8D,DH
MGD5[C$VE%J^FZYJV[RGL%W,'EL>&U!:#RKG.H]R. $V )D 7@#,$: (T 9H
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M"%[LK6=IV2RA=RF[^OP:AN"'+I<^"Z]BCW+I.0-R+)>NE67+=9'O*DVY])Z
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M9U7#&-0:^FA4Z_^?IM=+X;>>W7 34_.)7?1=9OZ\,$>PQRMS_&J^>0C'*/8
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M^Y/YRM"=/7E"-L'YN<"<M="(^*4+EXTMQEW4H&0 U&,TH%EM=:MOL"H]!U8
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M35XJ.$AZD?'LOT5E%/-:>>JLZ.@QYN.;[X,7?WF;ER&VY]W4DTEKM8R7%;=
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MX,5N!8VG,7$HYC/Q$#5_;"LJR4BADE1B+0J5I*K+OCD4E21_</>>8PO>AXY
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MT[Q)FZI6:.F1+\0+!Q )@M=A)'9,C8'1/1D6O[[SIN%0L1@4[+8=J:2"G83
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M7T&GZ3CX_E*W@#= N(+?7/F.+4*ROV+/$IB).U!7,W!-/9+GY\_8T&1C;$O
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M\>\+<"]\8H(:T4#!2V/<(0&P9#,N*2+<D&!:.J(57\7F\?VN.],%:=I?B #
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MOL,FJ^GF@P=2@.=R.^?*_>JGQ\#4@V[X#O<P\2!TA6;?3/TYY,%^;?R,AX9
M(<"?F[=Y+M>'F*3!=JG9<[]IXH3!_-Z6<I9&P4#+PW3!9K[)G;/\(1=._^!
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M 3KY]NX*;<K-;]KD\O'ZC^O'ZZN'_4#A<N??WJM7I\#*SB'5MV?\625G*AY
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MQH(=:\_,$B8S(@P7*_N5SRR*CF1"D"N.C*:#PG]V I1^'1[UJCV;]A,H^7D
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M=.N1+5>VHSOK:QK]2F/'TS19'PU5LI<F?X>M@BPK)Z:7-IBJ("W.-;#3>>O
MSJ"*;OVYGG[WK4]_"*??>P??7O' 'MVG>3WZ46W<'B;MX-GEG<H*,IVBMUM8
M]?2J$&MH8V]JISX<[.!>=<\I\>3[E3CY%BBM?KW=Z]1'%4DRG4$JZ8,FC';@
M99<1-H.K[KC7&BJ0[%,*FY6<=#B+I,4A8;,M]#HXLE\Y_LRO?-.V6&TF*!0%
M3&C?MPP"MCO@00Z2SH."V3L"6_P/'!J[L.=S;9E6KWXVEZUL\<AUV]IL#4T(
MQIH(?3N?[^E;=VOC;J?>2O&I$V*AKE6EG7'_3<^X!_>G0;W=[-<[&<&\TL]:
M7:"4#4^QX?>,-S8?;LL1C[F3S$RHA-XQ8!XX2$ RFR?ATDK(YAT*3%AM 2ML
M( 9O5[_?'I1<OU]NDD<Q1HPQAF_(&,.W8XRW8(:/YF>429H3E9+B2-OI,=R\
M0[J&[=+GS"I@WB-TPSMLCB@[HL<=F^(?[O[W'M9F3_\,$KZ;D$Z&A:QD,<YC
MKX:WH#^[.L?G^(W9CX[^5T/[EZ\['G/,-<'YP/,];:6OR5/5EOH:,7P<MC0\
M!%*"9S)#0(>Z'E 5?QFN:LJ[8/FZ[(P/[6HCYE_F6ZSC4W CNKMHR.[:O,]
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MSSE511;)(D5*E"W)7&"G8XDJ5ITZ[Z>@)S#. )5T]G!%/!H5XE&^35L1>T:
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M/&1OY3_>39UP[MI/;QV/8$,_>B>6%\(?!1?U'0;U1+R%7LB_CF5:N\/EVB*
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M^%-]L8#8.^'C^'4B)J&'0K&(M9*$HPP>OF,T 9)F<\.7]H(K+3?P,;OW\?6
M,&2G/V+Z&XZ4GK5@+29T"IPYS1@Z0Y09XB^NS@T+U#GT69 S+NUXX*#)ZGJ%
MFNM*W76%:Z#\F4;Y9VH1J2#E5@[A# 9;#%",]0&*O\=.4I>ICEB/V_ $;P<V
MCE2@<_-4-$DK-7]3?365+'G0=3I%H\>)6HK\N^DQJJHS&#Y?,ND'(.W=F:"+
M1W4!</*]XS;\+5 2/G"\IB=8']FK2+"*@SCI1"$GL1:$V.Z_;0ZR/0VXTT].
M"8Z<>IS!IS HS-J?@[:QCW9TRIUC25M:-3<7D2,6X'$'A]<SL:]!FQNKBH<P
M%=!##!43DZ, L? 0%5!L*QLEW\B#5**U6)U^2$ ZT,?ZO3RZ7<^GF#A$YUE=
MBG @Z^BL-^BWAGV-YZQ6GV+ N4VU"][F'"D5"KVC,\_/ B!&>#E;6N,13?.4
MP_4SZOIG[B.K_&H_:2:!_K[TF)@"*M%6VS#T6+CB^)=1P)?RA7*SA<)-\X.&
M*RJ[Z\H/ F+ <03=G# #'JGBQE<$BVK<>$%F$_H.I4?0?6JE7*R)O*>PUL2G
MX19''L%AU\A\&FYQN ;L:(W4I^$6IVO CL9K[*B_S1WAI/JULK%V.3UKN"*/
M-Z+M]WX0T"3EL#*%FR;U"7YM>5G7OO>TIP&^#]S5HY&M\:%DJBVG143;$F+T
M%LR56^3):PO49TJX!:P%HV'0U2/M\\FA+2;@PA&M-7CL%C-P84=K3'D:;C$%
M%W94<LS3\S+YV=(%NYLO6,A"FY!H*B0ZS ^)XH;QVE?'Z4SL?+QY(+4_:C>A
MU":4VH12]T#30S\*<%AS^+8X()3I/O:=I[^PZ16ZW#)-QD#"#+A( Q;-IN<+
M^2&NE&P^%JUDT%*9HO@$7/7!:;FP[GWY0>M=NH<B1G7%,%9MG)^:AA*9,#)P
MVT$;@U9\BUE=SJ0$+OZG$R[\X&GO# LLW5O>PA;4VCUSF*KOD(GEOS'_.K#_
MP@QQ$*3(R0'3;UF0$]W%Y((X7)5<<X$E%)3DSE5W_]'#S !84KZDFATR6N'8
M>R\B^?#^&\>S9?S,@4W0'Q17XUCY$4Z[>)**J8@)G'M3_ =*L.J6RQ!;BN6&
M.VA] 8=[K&^/K;(B"R4G$)($1"80(N%P'N<0:L][&<CC?B,M_W*F1DBJ@V $
M(!B-6OU1=MZ;#) <JY8K?1(EOE"TQ'Q'I0S4&85-3_("*I+I%+$<'MZ=KBS<
MR4+7+"Y#J!7-TLG9 $:,[W<+TK/5=%$$S@WS&  0X_I*^'O&:.1M=6M_E-,P
M@,+4%<[^/MI6')3[Q#?U)]Z,[NS=#J!0.QNHCH^.'HY$MDAQILBHL^[VOS@V
M59L!GGWFW5^G9=-*X!SFT9D/?%B;*[/TX&?+@&=#J?$PC<MF\T2-&IFF!B25
MF407Q]?DU50?@I80(_O>*0K7<?)\? KC!Z*!B-V1>X4GSPC.7$[]TY6DH8:@
M\"M8E:?(2=^=XZ_CO!M9*ZHMDZ:!MMJ23JQ%7@N%? 9OWYHM Z@]!DPYH  ?
MGQ$_P\0_)7^$V%J<4'#!DP?$3SB8Q,/\T<4C,,0G^0OU\;;Q$4M;[WQWRN\-
M?GIG/S">\(0WWS+8+Q9,G)#,=@0]ZFV 5#R3%/@3_PM?@_\]7GHNY5]&M9#
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M[Z;VC@:AJR7I%1J"U&\I,]BI2.WFRV<2D-O&AQ@=2R2Q:J0(N03O^<_B5HZ
M+ZA!4"JR:.G82@LF$4/%WZW?>M#J]/2M!XGT?Z0BM9>S:S[G.7BZ]B^HW>7B
MBV-34-%!!T,94U]5.8;8+RRK<W"X2<6#Y.D]^_>_,=>;&8Q\$$2Q? <@@*,M
MB'Y:6P"(](JD81(F@ (,$9 9-L4])=4A,CHZ&[6S)DA)B,SEZ^5GR9Z@A=JS
MF3YI="Q^%@JT7,/S[UV@(67+8XWOOC_&]1@<<([ABP"4N#.>[ZVG#;JVY%=6
MA[[BB \$2WG1%5U<XT('5]TYX ,PBRMN</2\&S3S76LE\M:+F:HBNUN\1=+,
M91->3L'E=60A'4O'"'SS-]B,Y+<G;],F5E(4Y060"-NJ2ZH%A0ZCT'4P9<'I
M!'<V#]E;^8]W*+M=^^FMXY'<H1^]$^N+>#?&=PDN ''Q%GHA_SH._;8[//R[
M".#_I_+-XNLV?/4F^_G0;(\M_5>=MJG]/&\IL]ONC/0_R5LJ__->9U#?IJS"
MI=X0O#C,X%H0(\ATC"+R4T2ZMQW#G"_$.M%CX\QCW?DO?/!=)J::OD)^>W5K
M-*-2@=:(XO+B6(OI9G")'Q.(3Z0R!RO%=YVI@0=\MU\0(VZ5@,^ZYWT= .-.
MH2H(=6-/?MX&\*OIJ=CC!,R1V:SHW"Z;97CC=DY=TE1X;[OH5&W%,4G+Y#')
M,KB3!X&U<(+B^SL%G(K:B]7IKRBS2^F0-:@PW2(59OT+U-%^/9?>,?:!+/Z6
M!EY-A]]3?-=:ALDT &L%KE_808 U7YS/GB\6@7.S).T1S$0;#==RR&\IR(]A
MB%ZKKXE1<9MI.Y>(7U6ZS-4Z6W9',_J_?1<EPF9=BQ,)"+Q.4;*J4W?]@J17
MLR!9C<"[=TDFO:#!UDJ"8/3B8J"?*P9>G3J?=L?JO*!UZ(7[C<5YZGM>VR"M
M][_0TWTEWJ!AM(.CLY?7U5^!1KY'>O?Q)B&9#,?=0DA&Y;;#H[-A:SS.SL<Z
MV>2&&J6Z/$/7!/I>C8JV79Z^(J);P-5'M7'UU*V4XNJ:FSPTKJX[XFZC:CU<
M?7N9!RI3'Q^==5N#@;D!4]=SD^TS]3W4TK.>$AGXK\'I+H*PUAQK[Y88TB7[
M\] MTQ(9#\_A1QEV=LXAOQ%"')H8J1,T>THI&NDS?FD?SM \.K-:H_Z@7D_^
MIKQP/>GUAF!1JJ_$'E7:'5#/RN+,K:9GY2Y?9HF>E<77JS0JK%@7L$J92.8G
M*GN(*Y"HUV^I AY5I^A2?6$V)9$ZZ&!96YP^WS:P4U?484WT9Z/\=MXB@7[$
MLZ>S?9AG2_A78J B9:+._4?LK<#^6MJN(7+#<Y^*<^R5YG'Q^T5.<M3&6JUV
M!;)S)E%9@/JC?QCWC-$+L0I@,@%@42U@E#3^_LFU']-%" 6O$E#P;WGC)UJG
M8,N/&J#^M<3!Q(@V6+[R>.=,[HI/GNIU+;?!IQEG>_6506/"@.0ILJU!"0A\
M35A=)/'3C24[>*6@QR>M8]V>RV3K+8^6MT6=$QP P+JP?S)/:9Z:!T/&QX4*
M_ &R8K*.0^ 2?Q^;VU1-)]X8R*T[R3&C<-TI;MPT<$HU<.JEX-,T<&H:.#4-
MG)ZE@5-^IZ9=UPX/H\MQL>QLNARK[6D/J,OQHBP&I#H=ZR\]57,+-@;:A=OL
M?9R'?"R:M)[JO\F,<UDM"2?Z 0HI36$2,#@_-8T+! '%#1BO-XNZ=8HN;#%6
M3_W)DNHMX_+V7((X$-QO6C.7;<U<2$\[WIJY<._;;,V\ FBOKC7SRHMX..$#
M(]16,%4++V,DRBDPY[WSXOKR+;5D7F&_[WM+YA6XO5Y+YJAUJ+]2N%T5B;9=
M:CU:W(6OC \##8O5QJ,YPJK?G9+'Q<87GPSYMF(=/GGS!<QY/.K<F]*'[T&(
M3+_;3TC3H:8T?]C3E.8/>]G2_"O%;R6*L8V/(G=VG8)L_@[=J[L[T]$W5W6J
MZGA1/8 2/"^A%KTEMVK<ZN4<0W8NI\[/WD11\R/5H6H_!:LS6!$2R'0+.H_4
ME.JI!?VCLRY/+5C5#32A#Q O1)WLAC?18YI!BNB:IOD%*&TBD4<._:3H0TX\
MC1DMC?@B_[MO!U/BPJ3F^< /\971Z"\YWS"O%\QV&EZL<4%KMFD=#H[.S'ZK
M9PY;@Y&F;1R>K_+FAU4WOU'FRO#HK-<:]^$ O>P!MD/)W5*4;+PD&^%WTY)V
M.^@KV+ U36."KO"6]W=6955.ST6B<0EZ$K9]"M]N^9XJ;?R%T8:F;P>3.\'G
MN@HOB^SDY#!N4!<C5Y!F(#=9+[+;H.,!CBR6PD!R0+L,B>7*J=W8C#$]SA!=
M/3@!%_1N>BNWQP&3^>T5]LG+8U"KRA2O8!^BZ::N&?9G[SIN4UZ=88V.SJR!
M6:$SMK9_< LM6]'+L[ WUG<6T.:S8%B5&*#PZ>]V<!E<D2%#;<_C134''!^=
M89.<;%9N/%VZQ=NP16/:P2Z=L.3PZ41(%O[>TB&5N_Z.FR@ZV0BS)-N:]JH\
M%A[AI.CZYB>)B4^SM_BS\9!*WKT4S%W1%%"EA8R-G@ *J18;=4E;403Y76SJ
M$^A='$Y1+WP/,&+A@9YUY\S_@'=4)@.T^GK 8'1DT *=#Y9CL#ELO2H=!W/7
MYEVN 7KXOS,F-#L*B / V:\Y]G -VZH.;0"_<<G!AFMX;)&$]:,?_.1C5N<.
M30^%]6!U%M@X'IQKV]C3,<#6CSN:2;6*I9\O;V$+' W-43T\W5[!U3=DZKRK
M:U7.;JX:&+Y5SCX"L[@'\'UQSFZ:V^'L(ZLL9_?BN^2L?6T&OO(LE1AX#P\P
M&IE%)XC;U((%>3I;DBOOT0X ,Q8A\!@63)R0TAT0Q5>,.,A#U.ZJ&T+'].7L
MG_RUEP$%.2.4C<CSPG9=-GW_))X+Q8,E2VE4R("5WAN9+:LW*L+=A/P1WL[/
MDN*U%Q]EWZUY_6L!ZB._)$8($7T90<?40F# <2,/NQ5D$.OEC+%AQ>PST0F_
M1+O9!-_D]EIE;+-6T1#>)V>!O!<N[[&OLL9/?G#%@@> YQK(A1UBAZVA58A;
MSB+5V)CP"Z"&T8%@>HJ1'(=W<9>!'J+ F\#_">(:_@K%!O=32G]B-\'2#IX$
M E@Z!$C(:=2[- @6<D3,11(IH;-H4EAT*IE/_)YK_SV3K]?,'"G.#AZ!&;1X
M]+,(08&P1R!>V#'&@5V'=+L8!YYBR[&%BAG.UZ#\3)[+2KG5,4^*<@(B6Z,R
M]:QJC[9=I0*LJ5YGU#('V=)UVCJ/X,0<)QI<$&<3DZD565B$-NO+XYYV],,Z
MTGC<08X[M/HZ"V!&F4N*G92R%5<=(+OQ0;&QH^S\PO="9\JXZ^@'GQZ!$-GD
M'L=8*I3G L=K22C.R9._S($O-\+;,2C#@YSSMHV/2*2$B!-\=;@H'GB01YEY
M;G)B6,KY\$U(#B(=6E*I4(,YK7JXIXPI6X*3C:V<.H?(E;%R%M0Z;O9-#R^5
M(LFDUCY^+^?X0F5.\-[DM)P(0"HPN/$.%'%*^,&1WPDQG\.?D"BP0]&%.GQ;
M"Q/K;DVG'/>1PVGJTY.NK@PNK'FJ@98U\_D?B2.M9LVD#)O=OG[GD0*,5R7^
MH/14>\5L)[.7AK6$X[DWY8!4@D'7++@O-\ML/!1CW$ZUT\PPFD> I5D>&%"\
MOV=3A_O,%(M.,"9Y(B=I[H$<W7%T&ZU$MP+76.P6DQI$0L'D[C+4-](N,P]_
MI4SZTE@L2;JOS.I6112WJH&-00,#RWA@=:M:+S++3&JMJ^P6(Q!#0/?3@%&<
MW;V5QLM*3C%*M1(A%R]ZG9^4RT3%!0=/>;>165*::9B=#ID@>I81KZQX/H_Q
M."C"NYUWN@?H*_/=";? ?@=<^!S:]D1GILC!0B+/#>#Q8 <.XYFM$4(D)]KD
M.AQT>]'2(:SW%<?OXJZJDZ%^S@7=SWD8LH4R8S:A4=*%\?0QW4A=8/UR]JQL
M552-1,V.&>689&E4SCA+I-AFR#6>L=+MG#0E>L4E>OVF1&\G]M*4Z.WJMK=3
MHD>IE]J,3&MW*O>J)YCTD@*2ZB1 BO/@+IR6*XX\<1\%YCU(,S^@:@V6%'-B
M'AQ;84)E1=N*5C(?V,U"&<@:. !=V\5/>3<9L[K(PA$((TLOLG PY@W<EDA6
M)(6IJK3N=K326G^B"PFWSQX(2RJG4A7H-8YG%;B[*DS)+A++>XCO_1W!]Z[Y
M[/C>VS:^=U\4W_L-OLMLDWG@N"+9I+,K^)Z(@)YF7#!;P/<!^K];XZVA>^]%
MT7V8WR_P%:/[KJ@SW?ZSH_MHR^@^>%%T'S?H'FDS(D'!+.'B*Y%'6#U-H9OG
M#=Y"F@)<?4Z:PCJY[&N$.+LOF:L._W=T-ARWAB.-ZSO*/=!AO9*/H$OT7CO[
M('GWFV0?F"888%9[.,P)<>%V6CR99*G$J=<L.>CFI:$_9Z3:-%\F4KWIX6N*
M5)MF7J0Z<<((567\6E)T] 7U#]#&L=7T2!%++(YR(#YO(1YJFOW">.BC/L"I
M1D5MT7"!1R'KI=NM14!-<X!$K4N52D5 4U47&Y=2=%<XD+::;&.:PWSK4U-,
MD:F7V&]-I$2P$=1T#%#IM! =>6/-I#-S*-<$?B9:AN0F)+:-3YI%J%D#_3RY
M,VHDLUXBK_62]0VF.2KP<92*LK5X7OVZIZ]0"K"%TX,-T%]E >"!1?^,/XL;
MC8@B X#&+;(U1+45LL+*L,UZ9$6W4TI6Z.ADO>(':V4Z^C;OL0LZK=DM=9-)
MS:=6@6AUGT<@=C',T,[+X^("<;^YO]G7L7][(GKN\OCA\@9$KF,'3]308:)*
M8(/"J9Q;Q_D+==1=F"L':[]?AG"V,%02)Y()$@+C+P.9(*&CA^HD@!.(6\/Q
MN&56) +ASG+9K3UY$H,9TSW89%I8U)R9KB!V?5A[ZOGX?>DQT>-CX^PFJ[?U
M[*8N6#NA\^L4+F]QE^'J .B?O#.YG:[KA,=.]7J.+H^)O)M*;49^4E/TRE.I
M?U9-<])L.B_+*;VMRC)*[U[?@5RG+E;J#5OCKL;(R:?<?2>YP>8DU]\^R0W(
MP:#7HR9QCEY=)&>L(KF9X]&\ 50VI8MR+ZAO9<G55@L6S2Z&M_HK_?V'0617
M;+Y0*D]-;>5I-5(;;)_41HUTVX"^5O47VS9]X>#&UT!>''C&Y63AT[S$NBJZ
MK6&^>E)X=]\#-K>=J51**M^<U8&;6\=Z1F<KO)JZ7%)$V./5[U&8P1%;PK8Y
M^//WSF+B.Y[A^O:.MNTNO/D<(G_OW+ZYNL?>Q!_8#8!B&3#%-#+[)RT\O\"7
M(H9<2V&-I<_H?R8N8&'6?G54>F6%-1_B;A$S'TNLC+^6<&S>/IP^=1"TS]1*
MPAJOR7BDMTHZL:I[+:PNH,L8<TRJM9&0\CB:X"0\>/!LU-6%^X!6$N<>H@]9
M46Z%G(UBU:[7V;IJ9UG/:T6M5.T0FY:>:*8?J7?*3FK1]."!5"?9Y&SEDLAS
MC@W!-VM<VGK1%I3;T7A[*V-'6Y9U/<J/VTSC;>K04G5H@Z8.;2?VTM2A[>JV
MMU:'9NGKT'H[,QE@E5:44I*MXM1M0%<<4:(OM(Y+JN.$;:YJRHS!*/W9\#TQ
M^B;.#<BD@,M)'Y2+3;DGZV<F=0<KFKS6GPMN]8_.^KV\;*1UTK]3AWCN]&]K
M<'36&_1;PWYAS*5"^K<Y*&=+[#W1X!__6DYO>=M>;XJ@OP'%GH<EHASM5J'Z
M7H*LYNXRQ G+P9);,MR5-%TR-;ROO*Y6$NL\>_6H!7)T,-8W$5^3Q#IZR_ZY
M2&P$QCV0V*A7V&6E"HGMI;G^8=/>H(G.<6MDJO=6-5PM-)0 "O35&@;2^.@,
MK+26J4O(+_8&HEM,F985*B2?QA7L?"UF(N$T'1R*B5,47=M+MV7G_9>3#=CM
M!4&9CW#';E<;) PGX7S:+PEFZM&L0%D <A #LD=-ZC6""K#5=?9N!.::TSVB
MRPU?TI>1&.:D(F&/<*XE7%&$2U-_ON SXN/!1""EOOD/1/K\5RA!^4#,^%%U
M7#VB*'XF'O:P]_(]8[)L)3G9/F#443^4O[ 2FQ+?3L6WYJ#P6U,0T1\1Z2FG
MY#XO()3EO4)A\1!,.:R&+RUF/H7+FW_1(#N?3]MTX3+13<F)^_P1X!-&N;,Q
MQ>,;L:ZA,M];F90:S6K#^V1>2*AWC@[D6](JWC]EQKG1+I,I>^M/TC)[&"]I
MC8KK$-L2-')TEB="!\$]+SCEO;OIH99Q*6;^B@\!L^#U7*.BI%+YS1]4#07W
M<$EQ%_KP] 9/RE>*+@([^T^ +J><24J/9T(?C&<2":2I+/36G:O5R^MPO/$E
M)_.3.:^N6I\$(N',TY0:WJHQB@1I[28O7SGM7"N5RS)$/LR"_Z8".[2,<\X.
MO\;L\*J(':[#\*P79'B+1U^*>..X,F&L3+AZ>>YG(??KY'"_D]?$_B*='[;K
MWWK4P;.B]CDHUC[/9;-=_;U_Y(5C6O6S1P4'N>JGR$7DUR5@.%&6ED5IZ;!M
M98PN;ABPY7 /T-/9N#-JC?H:2/RX^B-B?6*F,58?(B*)87QJ(29F;>(89!NK
M%%T7_[N93??LL!A@W'YEGL=*TUX8N&3AVS? \O?1OM>+/R%KXI&N7 @15Q&R
MRN9L#1D,[R3 V1JVP<8G\$["MW)(O;!K104&,;E0U-X!]'$B"Z]NS#X 3ZB5
M?#QWBUXM2]8>-$]0+P#^ )"O0S?*&2_P,]?A0B^1U"3XV8"X*CXX10E)U(#Y
M%P(MX/\!ZQ+B3@%6$ V&A34\WW!]CP:D/]B.R[LY7\;VDUHJVDG5"HEQW<GE
M@>\ ) .&I6[X363Y*PV[^2ZI7W)EFM1G\.V0O,7!JGFVQAI5?[T5N68O?^#1
MT5F><<6]0\B*:;(1\4=4NJ)!P2D]-3%16"BA-+!8.I04PN-D7CQIN'#0<.6;
M6%6KONY5<'5*K4+EEU/]*L9'9U5/U>_L^JGZG?PN0IJN2?RU7#E0IO/J>.'A
M"$*S1D&H$W]"HJF:OIP;'E=D\^1254.5(A D@KND6[A9+C!::[C.O</5U%9&
M+F8_D5US N0AA#XH4:0Y&,O/J49^QA6OO,V8N8[L-$O+SF=C1_T5O2AW@'!-
MD QZ0;A./YQ^=^</C%7CO9Q>G9*>@L1H\6(V);TEE4%E;0E449NP*'F^4'\H
MX;V#K9Y]TWCOE/1\P;KD$)*L+R>&5)*A%Z7DFAF83.[8=$D=%+30(7-/H,HY
MWI^S>**<K&M8]#W8_3^50_6.# 9GG6-*4[!D>])E^CHA$A:4<!8N[V&_)%(2
MVI<M0! UN%#RZ<,5OIA\-F@<GT=^O\\>R  OA)NCZ!V*KK_!^:78.WE;5GH#
M-,599/)F )AS"E!U[7G(WLI_O)LZX=RUG]XZ'L&&?O1.+"8R/C'#D3*0X*SB
MSNCZ^-=Q\F.[PQ,@%P'\_U2^67S=AJ_>9#_O]=I6OZ?]JM,VM9_G+65VVYV1
M_B=Y2^5_WNL,FDT]_Z;ZA4N](<SBV 4(C)1 G?VB[-TIBI.W'<,$ GBSZK'N
M_!<^^"Z3?YE&=H[G=?.G4:FD3,%\C?^X"=Z<*=(ZRKM_LYB^)GC\D_Y@4X+'
M^0/5;M&_9;$0_4%M;UXIA")A0I"(! K]14+EE<(E%W-^L'O;\> <]!=FFJ-"
MMK1=^ON+,TM"; 43NK$G/V\#'Q2U4W&PR82QV>Q= ;!<-LM(V.V JFSZIL)H
MP%24>HMA\:JP;@D4RH6#T$1(49DOC-!WG:F!1RJ"$!G>.P6BRN;)=ER:]=EQ
M?;#CS#R/T_K7K6,E]:!(Q]@'4OI;&G@U'7Y/J:.HT5V_L,]=C20B18&0 HEF
M>5K:P $-[>XP0QC<D-O.#>-7E6XZ5TPWM-G09DG:+*;)K?H?(TV5E-2D_)HY
MO]CT]-\L\"/RM!3R'!Z=D8>D^^XU4.CK5;9R&@WT,Y.B">=N5J/E3659$1D+
MBIV _0JZVH8%Z!A4\!0'G[3[Z48%FUD7,_J_O;(N?N/.[+6TRM7'W5GL+5U>
MM2(%:T.6^QL?D" 2CW_#YO;5C04:<E.?K9"Z52VWZU;#"JT&LD>X4: H=XL;
M0J]$D+ 2AE15E@=45*0I?ZTHBO64OC6!6P8%]_'WK\%==8&I$:[+IF]$2D0=
M#HN]8!]5L_>W+%L^^<&,.=@,"P<-?,3+X)/<M'4N923-P 2=29_&7[=7JOG]
M!K]_#7IKKE=<!/(W47T.RU KRXYVW2D^P.2FG.RF1M'=NJ*[LP[A@75TUF\/
MLLTE]U_'?7W85XAU.^KR'/1J<WGN( X>J -([[[LZAG;SGDO!WWT7IJ;>"]E
MKB'\G.7?^6M\JK'2&RL]D:>]7T;ZX/F-]"(]18,C!Z"GY&G)YE:UY)784JP[
MKU!I5"2J/8J[9[':G?O]:_;IR,*-QJ=3U:>CGX:W0SZ=$<8N]35Z=?MT-K:D
M=XY>RJ=,Z8ZXIXA>('Q[.^NBPAG4[<X!A6$;8CH48BHDHF?UN&4]:\,.V#*'
MZ-A]54ZU;*7S3OK4AB8RZ9HS O?0-22D&14LUZ:%9U-@+2#!J;_$MS1J^$8L
M5;FP-=7P83=WRM%SEQL=LN*@.^*>XOF+:>$*LE?5PH?6T9G5MK*='??6H]40
MTZ$0TSI:^ 8:E$)%22W<U*KAO3K4\-TAFX.-;3VO&I[/BO/4<+.,&HY3J-JC
MU6KX&VJ/H\Y83#S>S%Q4$./3J35L9B[NQ%Z:F8N[NNUOVYJYV*O,F5>U@DOU
MO*-A!DI_.&Q%%[Y_2FC$/Y"K:UK%#0=[VRHN&@D^QP-2([A$[]!$7T/>I#-V
M;?CZ8&.J8:838N-VWI,N/+B&;UVKW>L5M_EZ_MYCS:8J;6I8O4O;>#^;1BEN
MWTW;9NTI!!2-NY);>IW<A]T[_;=H#H\P0,KX)E<>?95A>!BPDZJ 0;J <?RW
M,LF KPM$#7IM#;V:5/2J2>8OO\&= XG&13>;=6:35YK:9_77*=@L93EF[4;9
M=EU1P023K!YKQ/DTW1ICC1P)UO?S;H!$A>$3O8>#\.[%@BMK=0(<K!'06Q//
MOOB/+.#_POD<6OP9H7]XJ!]NM/LG_&,^7WG"\='9N#TNH _N=MH7*FE8[3JL
M5K'UUF6UHTZ]G:$:5ONZ6.W(/'16.^J69[5;J, Y ,ZXSCC$EU="1];1V4!?
M);FU5B);+-8Z&/XWVBW^U\.$L7ZO3O[WC"<LP_\HV:+;KU/5?,7Y[SO--NM0
M* > +L_<:K1AFSO%5,JPS>'!L\U1>;:YH5=39 &DJR5>IR&^3AW%#BB;XYJ+
MG&NRPU_Z]PV&[P2&UZ 7C#LUUP]M"4%+Y WO2^Z;F,%M!&SBWWIX[8G!UQ,%
M/W V-?R;&93A3#.O#?;7$F>G.A[&DIT')F?<XJ#N^3SP?\%5+YC[5"ROLW(Z
M.:*^GT;@<]?U)[@'/29_Y!N-4&R@H)B)G<RS4W\,@*^+^\+\ODVV/E@QA[[L
MUJN23L'(YEHGVR8'/Q?/"6_1:R6*W=D%L[*UH"SNF?7Q?N[Z3XQ=L> !F)$>
MGM]\[X&%6%) B'GM+VQ7_?["#Q??_,5_,WBKI !U0G*5!HYCZ^C,TXR 7GH5
MJ(O#'B?0,SY4NZI-N )JFU9K1 "5?/]*;*-\5ZAQ3P\G^..4KRV'V-MAZ$\<
M8C:/SN+.2$YNIAM-C<K6UVO@FU<GRI.C9F52[DOP[YQ,(W_!#'/\UJB6%?[9
M [QCU_:O#\ /7#]<!KI\[G&?8Q8 $HAG(3_$Y9)IWGPY8V'_8F%NM4U1:KM8
M5?>R[OH9[XC=OH>U#I>SZ,2"N[YG'ILYB[RIY^.RJ>R#79+FGX#+U\3A%RG%
M(,"%X$1.=-7&#0>A,0O\>WEUF +O@]%KBZSYS72 03>M X0 9/A7+CXG;U<K
M_<FEH!&1">FO/2B<IM+^NQMOOXP&H)YM='36:6>])?QRQ0&3TKNE.2]<V(,3
MXNGH:J> 49(P4Y=;\3JM8I5NU2VJ\@,,8<T=;JRY]3;;87P7W0[-R\G'L_0U
M/-XYDSO<3^B0^ /HDL)&]2)(5L>.9_P-^ <U4QR^"T\.KH9D:+;'EOZKM:;.
M5RVFV':1!6W*JEYD<=B5")^XP/IO$E@?46!52?A]7<G1:W70:1++D[#3SG59
MU[>^3^V8+I9! -=",EZ8FF\W<:IMCEDOEQ=6=S=<WA*EL^,8<+4 K6BC[H0'
MUOIE_QHPYC>=URBT9MH1F6. ",Y Z''N3;_X<-A\+==2M%STI7:R?9 R-6'K
MD%/3B+2A@UI:(*4,\8Q#OB3ZEW8#@W:Q:W-\:M)O]D/,?6(@_6TW5[<I'#*1
M/?>>#)G8IF00$"TG$ZRCLU[6"55>)!2@WE;:>Y70.0\38[; 0RLA2N_H;+QY
M,[AZL.55V0&?_ #^]-9BD*]C6F"&/^JQG<.Q'+;WC\XL*\\YOX?Z<H,ME9EC
M+KI44"T'!ZI:[C3#U+C.-M$NR[E4#Y!0RK'556$VE1R&1V?FJ"XEHK2K>]>5
MT5>+8"4Y<14,&]6HI6X/P5[#5+</;,;@^J;$AH]%6L9)G*_PRO39K1C\$L8;
MY:2HY#,&M;?5[8X/PD=\X!A5)Z==B4A97#$[Z#G:%1/I->BUE RM8Z68?^0D
MTCK7$G0;5>0<6I"E3M#L-A^I53+9[B)\^UTBIF ?2D9O.O.\A% R311*G9ZY
MN9>ZIM*SES H&AIN:'B[ND 9TM509_?HK-_;?+C2RQ)HB0K!->L:/LYF/&\X
M@N,/>\&P>,F;.*Y#Z=DYA0U=T]K+'OWG5(00'T^F1XL2A7^$NGS]XTB;.>&U
M0Y10S0-4< ![L5SXP1/])   ;K-(KH7M_\,[_]&#W;G^8Y.[W>1N'V3NMM$D
M;S?)VTWR=OT2\(_V55L16H$FD;<)$*1554\,L2TP.#-^JS+:U;G,<[F2%Y)X
M.%)J3[N*YM4[.NOJ*L)V*I+P,A?X]ZWU]FA(H9 4DH;;\]%"OZ&%<K2P\\,=
M7D/<D1+#(SOQE449GUVX)M+P=:ZB!"<98,E[-KCX B&C76 738AS]P1D-7S&
M?*9VMAWD*\7GUV#9B:Q0[H.<.H!1F*'DO+KZE6<7- +PB2<^*/#7$^CHZ*R7
MVV/E6:L6=H% FR*;W1,XZ^$U=M397/ <"EZ_!K/F.PM@#4QKEU)GDDWT.7!U
M\+06J4-Q[C*D&8'\0PQQ+3EVL0^NIDGI*]4#&[NF;D3.D3-;P&03!4LVT^J5
M8O+A.?3VT.3Z?#\'+,0DDA#P%?][_N/BW  ,?YJXV&P/\SHN;,^>VHT1METC
M[ .@GQ\Z^,_+V?ME"#L*5[<23C"8^IIM'(KVVEAE6Q>7.>4S&Z"\#K6MQMGP
MRHRRBSOLPFXXGO%@NZ)+MHT]8&W0L%Z9<?;LPH@#_[,G:Y?@H?,P9(OP3WD7
MY_(J]/3:.SHSNTTXJC';]D$.;8SMF,71;YP4KRE8=8EC21J;:+MBB(!\/L62
M"YR]DJ,;4N9#754R>T]\C<FSRZ*F'$8/:_$4'@I&;VKMK*M%;:WL<_< _@R<
M_<*7@W$NH]$I>NP?'9U9W=JTJ1<I>]P%LFFHY3 $2'G"&1^=#=M60S<UB)NM
MU"OS:WW/9GX07_$'^$\(H#CWIE%;1'W)LM7)3H:##[-CZ/:BDEG,RCMV_3 \
M,6X(*/EM5XQ'.P0:"H XIGP:5W(H5.@O@PD\-DM/?M,7+%>H5[83]<HKIT]E
MIOYIAS *6 N ]+ @67K"W])(67AY7(?\]^25"I+LQ#^Q;X  EXO\GV1J&E\J
MQ?/4&J7@I?SO71 7Q-ZRTYN V3]/[1EL]ZWM/MI/(8HE%;<!L<7R_5$;@9@^
M?^XI9[.MG9*3V!1G!=*-OUWB\&A\"O9D[\Q>C+L &=;_6ST+%*P18DE(DRB,
MT&[YCS=V:J+EBV*;OECV_,MUW[CZ_-O7<^/B\L?WRQ_GUY\OO^W\MK]=7G^\
M,JXO8=/?KBZ_?/YP?OWQ@_'I\[?S;Q>?S[\85]?PP=>/WZZO=*14,%E4C!#5
M?<WE2-. (=OKH&G L ]U\4T#AJ8!0]. X7D:,("Q"^1%U5SKMD-\U<W2]KL=
MVE::[7)C\ N8@I_ MM-Y/%)6,PNEW5RYYZ&%H]JZK5$W6^.Q;M/#O6YKV-#B
MZZ#%;&_"72!&L$D&K8&9]5KN$"V^BG2[]9.\]S?IJ,:)'6L0C7#W5J<9"YOV
M]JV=R*YKVLGO$Y^.4$Z#53W@Q/ULU/79IQ.\!AN*VLTWK>2;-M0OV4J^+/^H
MM^6\U3\Z&[>ZHT'3<KZA]8;6GT%?>$EB'QR=#5O=8;;!X=X0>TXZ2#*FOV9"
M2*;@ +MC.?:-XSH+AX6YB2##O<SXN+YC )K[N8_5\B%&DST&MZC.,K,)"L:Q
M&P/A!#,PX-G-$SD"ADOQG)%P92)'$PE]Y9'0[&/[%:"J$-P[:#B\VD#=AU6<
M]>TFA2.;!X37*DFI=V>O:MC]^60"RL)4SFTN'[LMZWC;N1.7MRUT1]QM&Z&*
MB= K-Z$R4D,Q+5E\)H95_F"PS0>&"BJA$:PDT$G15[46P.CHS.QO7)VW.Z[J
MADH.E4KZ+T@E6+JQ(S12DVJT)S)1%O93Y<"-/044N%FLU_QQ?RMB7UZ6R&OX
MY <?_.7-8K9TX3N [D)++[W.T5E_XTJG.@ID:U9O&_S:#A<NQ*\5/=94O#-W
MJL7::[5@T(L(-TW.UR9E98NL^D(!-)"3B F$'^_GKO_$$E]KR:5[=&;MQ R'
M)DUEY]CTIKB%65 [@EJO2F6^8AP[S&$OUY74Z#.KF# %904H 9*")O3*;N_H
MK-<HNX>('#E<M IR](_.!CO1*NBU*:/? S:WG7QW^H$K"Y5R5,IKHHJC3 "X
M$/L'6,LS>OFDU4:YK!5?RFN7%?$%I\IMDGG8*(S5;_X;6Q@^3S/S;@WL]]*H
MB[79[)<2L)C:=V$'P=/,#Q[M8%H]6:\WPF2]OB8SMU$U]Q^QJAKL=2+6^.BL
MW[(&=8VY;M34"CCRA=DA,V3:S],KTU+KLM0SY$%@E<K'DP[K^YVC,VM7/%2-
M?OI<9OM*3"D?;>K7%VUJ]-8U\M7M7\8$;M)I\@'J#3)=$% +=(H59+%;<ZX:
M3?7E0TM:C-)@3ATQHT8)72-F=&<'[/0&!&$3O'_IX#W=Q7N\"O6!"S]<:$D&
M)SF9&T]>:]38'42QK<7P*Z)8'U#,VMCKU*BXU;'EL[>PO5OGQGUU(?SMAZ]^
M\_WIH^.Z0!<QF#DAI?^N[%'K#[!MUKB3;0%4N:ZZT7UW"M76BGQM%=6&V&UJ
MV-ND,U"C,E?'FA_X[U-_=KH,F:C>?&7:<ATL.NV24XB& 'PY^R.,*$.#_".M
M#[=)+]@Y9-F"^[805RJXJ\:-%_=%5=QP8;LN3MLS0KB;5Z;G;I>'*L"] MA6
M(8M!I_'B'C(R56>RFR!34Y?ULB,! @;;^#>;4GK7J\N%W:9?-X;MQ1*^\"9/
M7PC$6C+H'IT-QXVS]A#QIJJSMA+>8%RLVS0@>,EJJH%U_*\3P\$V6BQ<-%IJ
M/6E:GP4\M5B/H2TK6SS0:)_[CR25,K1B)*F@<?8/3>/<</#S88QVWEZ^J.*M
M#T 0\VZ[?]HN;R$;-:BH[)\?8 E4:S3<F(]5NLX]T =?+5Y6RT[=&EX.C\ZZ
M+=.JRQK9H?$^>]@+] L+P[?&@[Q6PY;W^LH4S2V%_3DMU4$U(Z2:L=D$]@\-
MF:K:[W4@TQB1:3BL8;C:2RNG^\!COZ6[V2N]EM>4=LW\CRV!YH 8RUK):95Y
MR;"#9D:GEVTU4CD98M?']A38'PW9-F3[DHE^6LHTC\X&FF&0>T.7.1-VXH$Z
M^S'>YKQ@3$W+6-PQ Y/A;>_)N+-#&GV3;(IA3-3R)5S+GL\#_Q>@R(*Y3\;?
MJF"7-4CB5S^-7T7E_0+'!@J.=8'[C]O95HX& -+%S6#[Y!D##+%=PZ&)4:0"
MS9?!W ]9V*)!/1L=:%#K@2PL:VEGG6:) X4XXUY_G,<[9W)G8-*M<<,,^\%V
M7)H)M/#AYF:@P!NSY6(9T,_H"[Y*V_BPI(<"AB-3N)K(;IW0)5V?XXF$8Q9'
M %MQC!$#=,>47MJDXX'2Z0#H6 *#6J!^WL.'4^/FR9@ [=F.E]H,?X)/_VH;
M5W18[3MO8(<>[IK]FCL!_ARPVNJVC6L%JQGW+N 6 2@Q1-B#,V7881M^/V4+
M%MP#Z1@.H+?.'V$X2!L @"F'TG2)GRU"W9PH!&: VR2@^<M@<6?\M;0#> >2
MS\S!>S>>F!V(@5! X_8MHU0PP*Z)NZ37W-F+HKU,6!C:P1/!&E\4YL I 7V.
M[L;<#VA)V$WQQ29^'"$)_@9W3HEKN,CYCXMS@X]J-HZ!B\SAL'+Q'VSR-'%Q
MP:OE3>A,'3L B6$L N!I'+E/.'KI3OH(BP7,Q5+U:?):[^B;"7+_:0Z8-F-5
M:S,JG86LH?3>)E[]^K?3!YN\G976^8RH:/Q9JV#^6;OL/+/=$:$JWMF>MP04
M>\+K 28 ' #V YCO/H4.0029PM)3.!M06^@0,R.H(.*FJ-Q9<-GKY_^P -@)
MNI!CX^"WKC-Y0E;!N3H02M'J=CP"CPX1RQ;11W#/KVWFN+#P'^VK-EU"1H(&
M#*0B@ )@\R]@WN'4F7#8/#K O:?.#+@\\C#\X1*%"0 I(::N.4\TX49!B;V]
MXV, <6ED],BK[A'PX?+F7VRRP$L)@:]QND<6SGX!"#S!P@IO^QO<DF2NZ5O7
MG @%\X12;1: M:!>@Q2REU-GD;K1[/1(Y8X%7'LX%U#BS5M@S#9.,8S' ?X]
M.?)1J.R=^"?V#2CH +_<GRC(PV>WO1#N?#I%TR4!'^5_<</(.9VN:3%K,AJ9
MLS[KC4?=\;AWP_J6-1F,NK/9X.;_S''G2/[J+I"GF(.X/[T)F/WSU)[!(=_:
M[J/]%*+5H1(64)785'_41M"GH98+F]EL:[#A]#U%CD)X\I90"I^"/=D[LQ?C
M+D#!^?]67]$06ZK<<$4&!]#B%-#_>&.?Y3*\Y\=1_2C!\R_7?>/J\V]?0?>Z
M_/']\L?Y]>?+;SN_[6^7UQ^OC.M+V/2WJ\LOGS^<7W_\8'SZ_.W\V\7G\R_&
MU35\\/7CM^LK'0'NEN#).:&_0&'PUJ@V@/<'\E,V_0[*\]-UK!Z''\!@ &4<
MK+9KEAFZ.QQP31'8-IN>+^2'N'IR%J]8G71S\ORG?!D)6*=D@?(V7%CWOF[N
MM-_![EQ-$>^BY@!3XXH%#\Y$B8P48-T+G2Q'V_%!S?D<VO:DI54-O@<L1(MW
MT2*E$,T^&_Z73-+?X8K%3Z/'2$^ZN'/8S/CXBTV6*.F-R]D,@$._^8)__PD/
M EYRS9;,6%22[OF$4WCH\\5OH!I%.Z/'?CB3.S1%WR\7+@M:QGL?_T*%!VSX
MR<('98DO$*:T'#XK.?6=YM?IS24-1S"@0/?"RPXC_P.3!X17\/$[> S<K,MN
MP3 .!5)P;5"S^,)?J(^%')<>&<YVWL2Y-"SVQN9PC._+ $ <,IJIKCY3+KS2
M4;@+-B;N]5J NEE+<&/7V>BE3X=9#1U+?SKR',:NFM!@'KJ3-QWXW38N@$V
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M?W3D)2SL*A]BR(S?Q;%FN[IUXKWO&P%SOYP HQ236E )'P=/@T<'#("6O'+
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MJ#//EPMACI&Y'JIA&34S%<G9%EW=>)$<3S7!["U?MEGS!7JAS<9 HWEP;OU
M-+A34(([P$OKZ3NGE'^%H[SI#CM[IY.K2. DN0%=J*1?CI]^E&5G2D>F5."Q
MHCBEMU_Y2\0,+U',>WGG^"WCHQTN^#</3DCI [LYA/D:!U%CWIF\8.&O5-7N
M,)[)? 77O&C%PYI_/_]V^>VC[)L9R8(=F,[L^>VW:#-UN<TTMD:GYU^^GG[\
M_B')&$A6R.Y ?E3M2]$OXX8M'C$BA9\H/E!U2K4*D:R;U#:B5D<%<L+Q9(Q#
MOE[LAYM+F' =;N;XL9[=93H^.LMK.D3<%-9+ BSTZSCHBJ8K]1^TCU-76KW<
MX1/BNI/XDDX80+YC&UC:)MSG&&ZE9DRA$Z8\S#[C0NZ&N0X\9LA6EI@;SSW.
MW!4<PY8XF"T[CT;OEAYG599)OS2Z)^<^6APD;2-?U?X*L'\R9,@/(+Q!^?G_
MV7OS[D2.+'WXJ^2I<?^Z:DX*D>RH>NH]E*2RY:Z2-))L3__E$T  Z4HRZ5RD
M4G_Z]]X;$;E L@J)!,(S;0O()99[;SQWQX2I_8MROQ+G50C(9Q**RE<]#_WR
M&?>VA()"@M'Q)<ZQV0508IL)'P%">Y@(E1^P0Q$9I_(1YPNO@KK@YLT6C4@Q
M+Z9*E)V3XAF@Y4U&]ZO5P4IG3NG5S^TEB;4IE$O6 (I)N\4]QL\@;]SO<)MT
MD9H2A,2V0ZMMG/]NM!J5IK23XP^D]H3L&?8NU>V]"T_RHTG8>T:,CUT.,#V7
M#'4Y1UZB0"$^)E1.((IT@*:(H1*O5-1%4:TBO,!Y)HF/;UY3RM??7,I;\QL,
M*3>&%*\P/ZEC3%<:+!F7<7T[6J!:NNJ8$L>JA@A^)VS)>>Z_E/M@UA\A[][,
MZ;>L]864-5\\_RMF+22NO_53..N5^?U,5'12(I72BS1=S'Y>M-<=EV(P]J8H
MRI_GXRG ";>FJ"/CN9&JX;5W!ULZ?4N$_6 $8YJN^U1$FO>3>L^@F3L(%:4D
M#_@P%7S@3 -TI*:IIE@L#KNDP.\Y^1H F["FI;))_,I<K$HI@UV4BICQQ<L
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M"H5L5()GUKJ(A;!?:%ULK5D/9/LCWRSTM575)8(TYQ=B:F]0(NAU6+_V%J6
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M^RT<K+)'J#LTL."E]M\?F^%.^^^/SFNYQ'\?2X2D UBN_&Z]^]0N;RL$:P^
MCB;Y(LUMJX[Z7))?PV:D'?;:85]TW#[KL9^#VY<RPPH:<J7\[E,%.[[MWCJF
MS:=;IJ,9#_YKTI$%2J)9KUJ[IZ,CTPNT0W]-MICQZ+\F6U30 %FU9KMBK&T]
M*0#PUG2TT,/_FG14!?': D*:5>/>G)".#+)JC__6/?XOU.(JVO-_X/2SI,#
M5B0J!@64S5IU5O/9ZSC4@LC21<$!BST9VHVIW9B+XP->$V<UWGUJFO7&;,&
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MO&':=CE$AR$<.$$M+6.U98+200H["U(8;N!%6=&OI0O0'&4!FJV&/[R.SMS
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M=\VL=>J1A$>E^N?"VL)%Q&XD D#2$8F8*3^)D!J\OX=B?0JD,-1X E)O8I;
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MEQV([%48#SBEBZNF%#.J7M+8IP\BUWN:I^@5L[G[NM)G;H;'3A2^>7)H)CL
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MT!'M3QBVZB&&ZOCV?P!O2"4FI3KD*/96NU61A@?YIO/;C@%$QUT1=/'NCH=
MN_UW9(*)8GNU>#CZJ,3;5E8 "G/>7@"N<?\=(0!1K3RMQGOV0?8L"58"%86J
M+)R=QFRKFTQ_$?C9:E=KE'[#QA1S9*H6IRJB+]O7(RY.+-P/TA AJ >X-Z!
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M;J 9>O(RZFZ4JKL^GVR.KQ591;<B*\!8WK(56=%[H]Y$8=SJ\%(T:.Z(!LW
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M6^'/@Z)-O"D#N35B.\C+#@FQ570I>HW87H384D5(YV UPF%H<Z/"I)G6E5L
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M>8"(M898 7QCCE@!+1#K%Q[SE$73>4KM*2L.8IK,G6K'2\O).GR<%:<P4;]
MJODQ3+_DD=J7QV1&7K/XBW[?=:J.=2]/79HM,4,,0PRK"X;5JH <N[%@ )X?
MHP8-VD92,U;,+%+#@S*1U.XCM7(#P"\Y2UD,6)8E=V!6=[+)_[4&;@[ZPA#"
MZ@5ASU=]5RWG2%A&BYE%6+C'$@GK/L(JX\J_X=V,='(5)$K$Q:&."^O*)IN7
MYB-@(6 A8-5;>U<MYPA81HN9!5A-!"P$K)6=DW;;;SL+@-4L%^W/:$HYK-1I
M/#I8.T\'@$PCUN/ZNF[CP%0BSI(2K-[PL.2J]G3&D8V2>*#/_4GY0,A,^<:.
M2>?Z:OH^ +G2!]9)1$RNASQE8YY# Y)Z0^5Q,14Y2B(M<$S>6V\L@KR&NRP1
MV*IN#:J6<]QE:;286<#FUQ;8]EHT/[UT?/ML_>>R0D?4K =J=K(D_+++_M _
MWK?(19*.RT0>;SA/R DT?+KDZ%)$Q;VW14D2;?I>(3RBLP_9$=EQQXBUU$9V
M-%;,+';$,&E(8/<1F+](8 JMWFO?G1R*,>"6\NW)3))/0%"#13#3_K_N9!7$
M"C@3::1^_YH,8PG7[MWN^0!<\Q'7$-<0UZKN1ZA:SA'7C!8S"]<PH!KBVAJN
M!:TF7<"U,J#:99*.BC5L>O>GBJRQP7NVR%=J%E8I0ESCAAR%'%5U)5VUG -'
M><A1QHJ9Q5$8LPPYJCRH"?ZB;<51\"^@#<5000 T!>7?%S&+Z XX-?57G><#
MM7?3:2-0(5 A4-5#6U<MY^T&=1&HC!4S"J@<VT:B0J):(BKXGD.; 1#5T+&A
M@=P 5-VR5*WK3_E8L5-!5O];7-NXMJL(+[:\Q*L\YSQ)B<@D85)"+4LMIS8/
M7,60L"PIMQ_P?I^'&:2U7/<%;\A9.B%.X>KRD,R0S)#,*J_V*Y?UAD,5FGF(
M9B:*&89F#J(9HMDJFKEMOZF=7?#O1H0#@+,DYOTD3[,A&_%EI]>EOKSC$9G;
M3K\L]FH6CK)+WDTUD+60QY#'D,=JHNNKEG7:"!#'C!4S#,<PF#_BV%TX1F\B
M>*3D,9'*;!W'U-5E&EL]64G#USOE^/H#) #4]+E*Y2I\WD/^0OY"_JJM<J]:
MUI&_3!8SC+\P1#_RUUW\Y=X4[#6>(56<+//7*FPM[EY$AQ<"%P*7:=J\:EE'
MX#)9S##@PHC]"%QW 9?W0\"%3BYD+F0N Q5ZU;*.S&6RF*[(1L:Z$=\0&K2L
M5Z\)+66<2*$-8LHCIM86G]V*7C:$9J1:R>)3!7Z<VO-'6%<F49YM?V3)X,M\
M- *[M=XI#M0#6JO'T"[\'*;SHAWPDV[*V9<3UH?$GK+HEDVD*N2%C(Y$?+)8
MJKL4" +;]P';2T$=E[MAN^WTF]P+VC0(O"YONF[HMVF_[W=O6B]^OE9]0*_C
M@@]"<Y,;<&G:/Z![:>E9@T_ADR>0WXB-)3^=_G'6$W(<L<FIB'6J]4-G4)4#
M: 5E+U&-8%77JPP5M^?MP[*+-E*.C\HOE[<MN-58O^Y;@;OY#IBSC=>WO8E:
M;3=XE#=Y+8NZ[DZOVG[=L_U'291OV737;^\[38$5^+M5WE.4TZX-ZFG*Z>[V
M9)A? 0^J,=-,;?(KB&__TTO"?VST+Z@$;_0QM'S'U8&1%+;;E+KW+J.Y\T";
M_9Q0,_523+>F40^]%.BE0"]%3<Q#U;).RZ,&T4UAI)AA"%??HVL0X:J <'=-
M#/V:Q,5JG.4HXHA7B%>(5W51W57+.N*5T6*&X16>[H)X=1=>.4WJVU.\<AWJ
MV@5>722QS*,,ZGO!(Z:WE"%4X6G+2%5UU]A5R[K70*@R5\PPJ,(S6!"JMBUK
M=ELMI]5@428+AY5/@^\('_Z>38B#1(5N*@2JFFCKJF6]V? 1J(P5,PRH\# 6
M!*KO!JH'KM@24N8\/2:_.N2\N;Y>2Z_+BC+2)!TQ&+'CE=.' <=LY#'D,>2Q
MFBC[JF6]V: . IFQ8F8!F8-GN2"0;0,RKT5M;P'( KIRWO#OL=AXEDL_236)
M_?2R3:E]]EH,R!O>+?;MZVO.F<:PA?OER3#'T]M+A^M1)#(D,B2RNFC[JF5]
M>KH>$IF18H81&1[A@D3VW43V(8E/+I)85ZS:K#_#KCN9#*D+J0NIJ^8:O6I9
M1^HR6LPPZL*36I"ZOINZ+I+1*(E))TO"+W-_V/2PXPWDA=XNY"[D+C-T>M6R
MCMQEM)AAW(4GM"!W[7O^L3-B473G#&0A@52&5(949H;&KUK6D<J,%C.,RO 8
M%Z2R_<]!;N:R8^0NY"[DKIKJ]*IE';G+:#'#N O#W"-W/<TL)'J\D+R0O$S2
MZE7+.I*7T6*&D1=&IT?RVIF\WH[&43+14XYK@;VF$.4C1"%$(4351$%7+>OM
MAFLC1!DK9AA$80QZA*CO=E^=2\D75G.IU5D=%FT(F?HA^<I'79Z2-J+5 _KE
MR;^P;)"M*J"W*Y=UI^%0A"MCQ0R#*XQ%CW!UUP$_7D ]9W9^HN,X9?14M1RK
M*V)5X>2: VMUAAQ J\NS6\YC<AY-.(,;X3"& AFH:/4723HNDUM@F#KA^K5(
M9"AX'/+B>.L5%G,"A#'T<R&+U43-5R[K3H-B&'MSQ0QCL5TB&]<@3W__L>P@
M,SXU,_)OC@VM\.:OI)?$3#G.QJ7?K&"^<TUA9N1EU2UH4-96/9S%N9O_2GK
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MK5Q]KW</*T"_V#W0%2Q!<$MBU"K O7B%LP+.P5Z[,,P=!!G,([<&>?#:?Q4
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M-XP]FVX'['O.Y.BXLMW@=8@;O+C'?I4\RN0[E],)_0[_*^A^<N@"$4]9V.K
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M(-2HHK 1O2E.GQ\GC[=7:8+N"9V%3_PJW[K5]1+J<C'!&S!&/#<#ST)Q*4@
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M2<^=1-J1]_*NBNRD_#[#Q<0&6F9O,FI@-;&L* 2'4&( B=XGQW3&U#JG]UU
M?8J&&ZB^G? [JNN7AJN@,(/UDB!D9\$[3_ZUU4*@5HGYUOI_<+GR82M0]]+W
M[L)M6+H^(=+-O[T=A?&<HNE:/W-66P<LDL>Q**N2!6GJ,38A&:VW7H%APHJD
MF2F\M3?R/3Q]BF ;:+^9Z)N1X=5X'L8?JW]\,3T"\N+KLICK<EDB6\,SH0#/
M8@15A*?9*HJ?BLW1ZKH5U?JXZ3:X^A3&-B!'<U6T*4I_CF>3V?"J6'X)[JKP
M (71.9<,"@,#Q6."2%0&34"5UMRPO%T=^GTC]2E.W4/?[:7:S!K\%J;_QD75
MYGLD()LU2$9[Y#QF\D<#44X)#E%S!5B<*BDB%M/:#GP?49]"U@86H*'XN]C8
M):[>4G>K0U%>$E&C+ Y4B@Z"$P6,CB6Q;'@,K1W$^S#UY+1%$,XX*STMZ"P1
M%4J"D),$)C!:HX5GIO5&0!>G+7JSZ[P__^XO(^]<T<U>S ]X>C:9ANFW"^"K
M,[%'IS73=1WVVW"1[N+*>R2K))VV!--+"%$8X-GZ&'U!JUN;[P>#[%-XWRGU
MNE5?TPY$P_DI7IR6/";R$T@<I\6N:PI1Y4*^J,B27)3"P><2R#5EVCFKA.6M
M[=MWX/0I4= I<UJII)-#, I]1D8D#;QV3#*"II@\!U=8CCESF5EK&_/ 0HA'
MV/!NSX%=1;ZA\[\^W134:_J^27O"]Q_HS]]>O/GP_N3ER=L7[XX^O*+?'KUY
M?GSRV]MW+_[QXLW[5_]\\?KD_=Z]"Q\P4O/&AKO.LE'7P\OL\;+OP6S@))?,
M.0-*<B(5=QF<D(("!2$5R]D$;'Y8:Q/$WNXW+MRK7W%,#Q[1RW.43X?CX6Q>
MA_F,RV$&0<OH'$.(1=?S^;04ABCI6R<$URD*;9L?9MX*69_<Y_T8<L-?;J^9
MMML6KT[/PG!:U\;C3V'ZD:;+$O+LR, :$3Q91TWQ>$X<K. 24[(EZN9]K&Y%
MTB?/MBTK&DB^&0M^G4YFL[?321G.!UE+G:.-((2FL R3([=(<. ZT*^2X,RT
MWLM8&W[_WGZ?<7R.+TEYU<>;AC3_UW#^Z?A\-I^<XO0R-5RE3__+M0^8-$$&
MJR3HS O-V!7PJ!F4D!@STHM86GM?.\#LDWW<E2\WV_YUJZV& =UL?E*6< ?&
MZ2BS5Y!KZTIZT37$8#0PAZKXPD/)[?O)K@%XH%&$'X(+NXNXX;;>JD?@BI'#
M\3G1;VGX)^/9,RR3*5Z>(<+9BZ_$6A+Y<!RFWUZ1H&9W]6WP08EZM(@+1W8]
M)PT^6@5%TP]#\C+SUISI<#K-JF>N, ZB9II[D@M7@B3D$JVCR!B8E##R%!S*
MUI51M\#HDYGM"Q_O++_947L-CQ^-)]>QK)QI)KQ43A>@]4'5\S <8N0:-!<E
MU0(2UKP1ZYU@^N3#]I52;339CECDFJ]Q&VWD+DK@3H:ZA4B166 6+$_H>8Z1
ME=:V^QJ [M>U01 JZJ($O;Y5REQZB%E'BCU<D9G1PBT.OSSUR1;OSHB;%2M-
MM=&1]_-\.$L7T#!?(5OU3KZ^U?(.S^J^'P7&]!?FWP8B91$$CV!8IK#8E@).
M6P0II94Z2592ZS/,S<#WR5AWQ;E#Z;9]L?6:.#@7)A3A@%E?'0YGP:GD(1FI
MT;,2O6G=..Q>=W&_S(M%H[/T",;*2&^]SQ"0T[2T9**X;$-N[;/<F7GI2?YU
M1WW?."JPHY3;$_@R=2A,PJ)0@ X5AJ&7R6<C@?P;[2PS28C.CC?>ON7PR'F$
MUCK?3^0'S"D,%)JH9?$0;*99)N8@:!T@2Q<Q2TF6_;%]KW[E4C*)1]9;0+@4
M%I0O"-$C!ZN=B<RC-:9U1[V#Y5+ZGG%X$%L?[OH>AA2-WVX"NC0RSW",=9'Q
MUG-GZQ586&\[DUQ"D*BA8,@FQ(+:M.Z!<@>47MGX@]!K/VT<(#=EK>/98H&Z
MITMPBH08:%G"*'54,1G7_ C[EKFIG4["+%Z_:P]='ZV>T8G>\V@*Q2NJT*M9
MVVJ%NOIF[Y5UT5- VWZ!NQ]7GPQO&[;<<CBFK7;:'(YYAV$T_ _F7\-P7(W!
MR?C%U_0IC#_BAVD8ST*Z, 4V,!9*,I""KMX?4^#JM\*8F+1.4=OMCLAL-UZO
M(O^F=.A*Z)V>H/E]/-U 3*$;2TYI!Q%C!B5\!.)GA%R2$M+$6CC1V(YLAZQ/
M5;3=6)(.--2VI=3=TXY1*,PQ  I#J[^HZ%A&0*<QB=KOE876D?9W$?6IWK8;
MMC342 _3V\9FS"4F0%VOS(D\T-*9R4YJ[T5,*(IH?["WD_3VPZ5XZ]"KUW^)
M[6PR"Z.3<NM'-^*[@62I7O[C0'!#+#.2@T/%P4B=N1=&L^:U5XVGT"<O\G$X
M?J/5[B-RI%W7YMN0U="R%$PDP1NB_MZ,!CG1NLB,@"02K8M$28@B,C!9>O*X
MZM)X$)KO.H$>9Q%ZQ?*#$.1QCJ,<'[W_Q\O7)_]J>O+DZJ&='C*Y WNC\R3U
M]L,P^_1V.OD\I*<]^_;[K/89O]R .*+0ZO/%J2/NE+$L4W25:R?%K 5X3/6^
M\^@IZ"XIRN:IGZW1[5TD>W4#X,W0X'*\@?9*JGK98+0<ZYWO&H)&3C&"#U99
M9E1HW<-M.V0/7,F[-7(=D>I&U6U[G;7)$9'YG-;F7L_QXK^OQNO=SR]O= BE
M!*:2 *99[>Q"48HS-@&OD$)M7+I)ICMR1-N-UZL<4;<,Z4H+[2X=_!2F^(Q
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M3=X@N1K>DH/N# 0;R=\PT2O/ \^N=8IFU\/.C[M(_T"T[TC]CQ&?%:L#DT:
M3:S>.1\<!/* P*N0O"=W1XO6*_*N\=GC'A[]\>FYK_J[IN>R7NLZ/B&BMED
MO2VUZXU7$'04] ZID&6)1976Y<K;H^O3P=,?GY[[JK\?,=%#W1=OL[$6+;"8
MR7UAR4+(J8")";EUW'AL3?#'\ZL/K(MK$->!WZ:(Y++"K"*H;'.]"IL"<5LD
MV)@YBBQU**V/C1YL<C]-=-/EVW5;-J=_U.N'E1OHPC5&,OT"F0)EC:L7X&A(
MKD0ME2[9-&]?M _@GR;0^6'>@ =1Y#%<2X=)R"0$:.8EO7I9@F<H(3@3= G:
M!G&@+F3WNI8/E\,[/ O?ZIG6V;*B>-6DR*5L@S7$@E1O[+:5#QQSO?C'NL +
MQN;9O;NP_ B=QO8ESLV[GAOHI66M;D+,BYJ5:VARD;;>!@1<%D(C9( 0LP>A
M=6;(2J!9MR_0O15+GRSW@4C21"V=;EO>,N,[UA_A8LZ.&7"N]HDIB^,+BAP<
MCM8AU]SP+N*;G0'W*>5T(+H=3L&=&*Y_A6D]W??B*T[3L-:K:\=<KO4UBX.H
M"@6])2Q(2,HEG@23I7GKLN_AZ5.6Z!$,V%[JZ80PKV:S\WH(]*0<3TY/)^/W
M\TGZ]X 931XQK;C1HZF)^@C1:0,9O7-"Z)1YZXCF7E _0/.Q+JFSOZ(ZX<\[
M)"5@?ANF\V^+AC$6@S>N7J2X*-K$*,AMTPJ"25X4B[JP#HXSW8GG@9W&?C;6
M[*6>9H19=_1O(&)HDV'2@&'&DQT4#()F]$<.RABELVI>4/L]/#]",[$N [&]
M]--M'_KW8803 IB^)?KK']^?Q]DP#\.4IO\^?<)\7G]=CQ&3=;S[H\]Q'H:C
MV77(V_6L;PN@27_[#F6R9R_\19U_)3 YQD3>Y:T&HG"BI=5@HN&@I#+@74A@
MG"LZZI+4YAW==QRNV'SR7H=#/DSF:YTQ\G7(087L9"D48QIZL\B'!U="(<C(
M4$O-I=[NV/_W1NG#KL3^&KMVQJ.94-L< 'I[8>+JJOCL_!M.!UYRB3*EVMHN
MD^^D(GCI$^3 D].\^!3*5GK=?'(?LC2-=;F7\-KH;T&G:].9#61,UDAK@"65
MZOG8!-$P#B+DHD5,A:*H[5_-ZP_?"^P-R>LL$R_20M;D?*FL'$1)WCKSP=.[
MX"0B:V#W'M%P[*N?:WS;2WX-^79U2<^JQ=>W@48BOQ,>3)$U\9@TA$3N%KK
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M5;'EVC@#KI1R3$FPH78L3C+7&[%D#723"1ABPN85^VOC[QW3K#WKS62<5H>
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MG-L.NE[ZD%-0\.[2NZM5V4"K?U]'/.62%#F1O5*<I4TG&G","W(VE9+D;ZK
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MSIN/OR2YIR$=?S$Y8Y(!7W*]X*XDMH:!3TR0!<5B\JUO%M:C.AF*-%9 'YT
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MU7[94O#:,,>!,4PQHR1GJ75I8#\K.4VB'I'VEY"ZP0ST<1G.ZB(&6D6)7D?
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MDX;>!G*5?NQ&>_,G5XUH(Y>1,0G&%#K:E&/@2A; (Y(R@T&G6N=6;([N=*R
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M)1>CMUHZ+F[7DZURC.Y^^/Y]G\;R'S<4WEYSGTS4=<1' 6WJI4;,&7QPM0Y
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M])>[Y#>(C!%XK*W84=()&D2&PF)**6+@H:]4B@=WN=M)[YM>[G:0_V$N=S<
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M.VKG.2N8!R.=( \^,O"I#MOC4BKO;?#[&&)V#+T[BDF*<110^'R,<Y$0@B[
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MOPW!?OA]? U6<NTEP0.3$IEN@@>(WCA0+.NDLXSZ]E#JW3CR[<F/D2/;B?U
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M,INY:ET^>K #4KI>A[100(<4U\V=_H< _#$39;0J1\^ZV$8/>YF)DKB7,:@
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M%<!+%VJ<G?PWY B,E9B42BR';4I&1L(X;J),K(8>Z8=KM\>__3LOXFR95_=
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M$3:4:T[%@S%R;C[H<TE&]TO\/+O$\[\OYE>?ZS3KV]&%5C,RPCVP(,@PUUE
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M?<I3UN<VPNM@OKW+YS5O:Y6RM:I)PUAEN_SIR_W?7(\Y]JH4HR585@?@6BL
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MSS3NSSD8?(TH36"2=[QZCL596+,K._PYD&8?9;0CRWR7O9GESLV0CH:31>1
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MO;)2,D@#I:;"HD/*-''14F*5\TEGKC3MM*'O*/)<]^S+M_:J2/TI"W0%%I0
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M'+OU_NW^S--;!4=H9M1>K!4-@Y+F=G_<_?8_-S-39?IEE-X,O\-D6A ^_2W
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M>VN=[5B4L/-1+UW%=659L79VAFX6VWL0?KH:IL<B6 Z6$4+A3J(X,0PHGB.
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MGEB?+%&2,\]\BC'6[A!T)J+LL ;.PY-]Q%_;-O@KC#Z/_?^\&2YO(PT(?"
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MU1,7T69'X$9K#LZY;JTTJL!Y\30ZDV9JU_WLM8(GR'TR$%44A+JD2[ ;B,_
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MXKQ 4SU$K7,(,7C:R6%Z]+&G=X&.D.^HBG!J%_N\ZH\*DN%H,+I>%A]Q'B$
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M%DG)LO19G18Z@L#0 =$L&T3B*:]=!O7@\1?(AT.%VV ?N=M-WPPC<K%DK/2
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M&M7VGUP#9\1Y=W713?;F>USN5HK+[\U%^NK6Y!\BN(S;WO4T\UGT&P<SAJP
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MS;0&/'FQM(8[!CX7O70@^3$4KB5Q(/T$D'UH:+QRF"QP/@A]C+BS"4K:?H7
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M-N@(G\;MKT[?ZFZ*I(R*W$SLR;6U5[JF*206KHFN+9QJ3_MF>9=#[-/D.4.
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M!]$+LIPDN"V6M*2]S-T/ALT/'3WO!4KZ*.>,=)'DSED]$UV]BLVV_:9$X4P
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M[RKYW/OYX]@$@Z@/+08SE3!ZT=O5O:7D<(+R.(7[!+L_7^@$G@#[WI*]KUK
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M:4O+#44'SR\COIV@5$EJ_A-/\W;IBFDO:Z;Q?;:+[\FZ<'D^4!31/)TQK1R
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MHXA=DS.!-$%%F7>(42&$OV!Z6/F92'VWA+V9=O<V"FA:-NR;<Z%0D%LB<G+
M%'5.*CEI W( OK[$[E!,+0?19[*,R8XWXB^74B-B!CR&H[N/C\JU_716SV"Y
M?WX#_Y2W@;UZ]Y;]YS-&Y1W20IN!^.UG@=*F^5F75*=Z)V2 4]3"5XQ;HFZO
M4'HBGCQ9?G[.N.D,DEV4J"M-LT-OK&]>CD %3CDG(PQ]$@B"NQ/'_/@<7[=Q
M"PI>>8)X.I@$E+MV D4-+K'<(@AV<.L*WC?(9OLE.*(W&BK3C82+JE&3#;TJ
M1^XS__^20HP14$_D0:3 *FNZ22$5@X4-Z&U5F>X;B6!P??0V7E6G<0HA\%,:
M P!<!*251D *'-/?)J%)R[M-ME>[*H--W,[X!"E;7ZF76 P!11BE"Q0\N!KP
M6A.+VO-EUA FT/F]-CT,H"?JHRZ:EYR+"T(#NK)TEBQ[B%G9\.G6\I]ISW9P
MV3YO.O+A@D^9*$RWAHD!4!\=Z^$98M!:MJ.( + (.-S^Q1FWGAM<CC0<[X07
M9UJ6\2/U$"W LJ;#HOI.(P&8 I&=4,O9_\&X[Z2E5KLRO!%+*;#Q'<M9980S
M5\:(!+;<QB:;G5VM4'R8,0[?Q"-62M]Z&$9C=33&HZQ;R=A9P4KQ$53T.F@G
MBO1STRL?D=W&,"O)7GD(VV:YJG=PE8%6\UA!.!Q0;I0$:R-PL)Z@MJW$1Q@C
MD?]2>V> QLSLV+V69]A;E>/=7":/#I9JGO6A8GX=T(T30W%LUD#[!8ZM0O91
M&>)W<-%[ZGJG#:X]>NGVSNF4G S%]6M]C4Q7Y<IA:[W31+LFA*J/J+/Y[5D[
MU&&);'&:28G\ T"G91C5-KY0@].TJGV=A1UM!?=+,MT#T)):E'WSVZ*BEOSX
M?"0K!&'A4^G&A-/0.0QM"-F#D^<5X'-FDG6,7P+..1A:UM^VBHU^:1\S$OKX
M4S-!MZW0_9-QG!U#Y6$^C\2WURMSZ CQCV\[X3&!_/_$+AI,7F-H7NZ)]8>5
M8K&<$$_4"ZG;1MLO>(ZVPR40O-MQL3:[/:'<ON+6SH(R*WJTDV/Q7^RC!*,,
M6GX;L<8<G;D,9X-Q1)XUO/M/  (;^HH*NNHYPO8\?JEC%[BX;C(S,JU?:3,O
M1A5F?HAR+60=";2T5)4-C^4]=KR :WK)G]>^C?#EHS'SRC%"CK!O@AS;U0N<
M(L6^]/?4&S[X9DWO[NT&21$.^M_#,)0OI14N]U8+U-D@;G-<)G16U6%%.\5R
MW,4[62 "?<EQ*/89Z@#>=Y2A#=)L&V,1@XI#R2)6/;Y*4#6[8<FUZ<.X3-D8
M?[H$MT<QL=DV,^.K%XB =[0][Z*P1G;]W>TN^+,\Q8F_ZL7Z>$H$:$&I-5+*
MOJPN.,U,"YH.<;K<A>JV=!-8;G6@FQSGCL0.>"CA"7".=A$PL[BY%6KPZ61V
M:^S)'*GV1B$),!QRX+WS5I,17"BD(8G=R-YZ DS\F>X9"\I;0O)L7B:]M3 O
MB5PL[9I7:.NL/V[%:TY:3!A"_XJW\I^5?A47Z8U&W0/5AP,V7CJ92=%I(NC/
MP<9D9[U;"'AVIZRC7[UHPESRJ**C.57T8N<L4\.SI"G8<-[UU'8":B[Z=CYU
M!8>+BQ3TXRPBMDUD/XCT3'?24XCZW3-QEF=M75K/Z]S_39I<?Y(FTL$2[8G;
M7$5MA\^,B/KZV]A6(Y\)]D_-I5>YPHI8?W)HM69VT SUZ%[)N-_V)?=QLYYW
M^-EMR;G1;RHEB7N%<3Y3(28[HGK4T\XK#3T2.Q<4A>5[(@E$EM>091&.IW&[
M?\Z,;>Q.-%/'8IE=VU<Z/J8O=>(_SE#DQ%I4-![3=55UF%Z,YTI21R_QN1G;
MSS8I'XELVW;?XK^ (Q4ERVRK^\L),JGE__YZD(J?8)>MW&6+1Z#LO7).L?T8
M][6AD@_$]8B!=/7 DVD ^1"QC_2K%B,_Q2U5O>&=P2JO_JY.GNQ/A7,GX) \
MOBYDIJBGZ$>B&"D2R?O(PV(>$9/YD<=\Q;J*RTQW4(RG@IS<, ?#3 2*[<?@
M[W& UV@3TEA'VQ>9VD6]/FT?5H![\UM!_CDCM9KQ+CE_6'P4Q3!U.>R*\WBY
M#[-9O&KW,589,=G(>@)89$H-QD0H]<L[>[?8M;$-][UHJ"O.:UX[E3HS"P1\
M>D_2AOS<OD40$VH9:)MN)=5=Q:$V3)WMY_$RC6F1@=-0/U')SYQJ59KEE%08
MT=8'A=I]"D+\"!'C2'"^$G9%HG@<UA*9B>I!I=E,-G_+D4;CQQ;Z[!)HW!I)
MBNV+T)MHY@PU'PW^G,73+Z+3S0Y6_25(KRS3(67U 0IZ/P*F+8P'B^G,<Z]M
M_V#EGY#@"R1!#B>79+F-_;R+A[X-,>##*M.KAZ@=]&1DK<BA\X;.5A51&,'U
MY-S[\\K+%"C,,YE[;-&ZQ!AN^!>TB5X)]<3^0"#_N-71LKU%ROJMD]5E&D;6
M;F76;Z*9*9L$&66L[VA+EFOGKS\+F!#_XD=($OT^FT0G5;=Z5T17Z6@!OZU)
M$<+<5/(J.)FU$)M D\S$C08!ADW5'2.H8PCVU%.OO^8>^SZQ9]XLL)!,V@_/
MG]=QW!'7W[U#-#6ED.:F$=54M&.M]Z9A8A6-,W;>HCP19S35N6HD40>L,Y\(
MGX);D?4)SO*D[^6B.#2 P$N@U]/+6"03^F)\!H*=2UPEY5.5RBZWGY';&^,&
M9#H*G1!:2,UBU/^,?%M\T>%B/ZMYFM\YZ=9&<[3/E9F7LS/PP5=HZDCT1HR8
M#F'E&(,AVJ'0/?P$VJI3IKV;GAM]>?WA$CPOF$KO'&PDU#&6$/N:!%X%YF/<
M9H=6?9;)O.9N1[BKVWJ15>I+K6Q5#(DI8D9OEK7KKEFG;7\XP$ $4,GW26['
MN*E*<NFK6@;/5>LL:TX/6PO59PLUN\&I3O"G$C?!]E\W_D1BGF39"?O<3[.4
MJ7.)\('M4,T[[_/UV)F#4"#L -R&[5-N58%8RH U2#R$&/<LU6Y*R]]F5A(U
M^TC?!;24V<^@&E2.8A[=]K1>QBXD1=/Z?4S;+=>U%]+*$.]/+74NNR'E3CS'
M6W+M_)1*I.6%>N#DI_U*<\NC4^:^\P[C\L-"P.P5^[GJ7<^%I6C5[.6GY5S(
MG*WW:O!%_4:R1(A7QZ"!C-VK?9!84C+X%F0,9 )\R^&HA#6N0LKI"D5IK%EJ
MLC.2,Q[9]5.55&8!@HU/@,0PCO6X@>&(7M,'NT28=9F7 $-F[4I:4_G!;#'-
M'@^-8,@;79!/,B4U7. <3LNVBD!T65]^2P.71T)0P\&=Q-@?"WCRW@KS?96B
M*DM$:G_G@"[/.6 C#!\,"8\T5EAP4KK&'5L9L*!O[;DV0%YQ"?--.;^NN6G&
M*O4QR#U1S-_+BG/M$EA9X)[1G^;NN-;KF>5+J9HCFR$V1/L5(RBGLJ5$_Z>W
MN_';VTW_T]OUEYQ__,O;_85@.LXR_ 1()[Q*FU?X=<;6="$MDN#3^&ZZUV!J
M/.<H+EJ=MY-==3WSB.KHW$5_"M6[X0F0$6M%FC#FV54=4M@6MW0<,C@ODO*=
M9, $!1%=5&;,$KWVF3.EA*@YPC%8RUI3':Q(4U5:C])GE/)FH,GR\B_!&^^8
M4$CWWM-''$1J-F1OUQKDK26N]Z -JN098"?:LK;&$!D8I2>Q[2'$O&!%IHB9
M,T7HL\#RM9Y-9YH-JG5#D:+?)@6P1J3TQE3'>A9^)RC,&"]M_?PX_88TIH2(
MQVA= 5189)Z554I)^0.SWHC!RP(%V#;3FN.33V/>D=-E%+DV 1VITFUE5$F#
MJ"-8Y4#&)SF? *[MB96S98K\"0DY7_$WA MT+NPJW+H4K!? 8X^?M.L;6?&7
M_;^G%HJMS%0"R6X$/V*L8WV4T4#UE.H]:,L!7=3_O/P%7T"KFF3MEOT$>.74
M]P+@>^_HN\DYP3;8UOJ?RFR#" 9/@)RT!R>5]U=_ 9+U,R#Y"_*V._(<_]J-
M6\##);<B)[!3ODS).U[ QU:9I40>CHJ\?^%-??MFB;P_"MBA&W^-$K>3]]^-
MYP'.$>RZ<U9@?8FAT^OZ+#-[!EIJJ+PKG\@NLT031/7,J+5OI>Z5&\2WOM=H
M*1D@8T>397JVA>D@<]";V$9@K3O6W*@OWUZ,#XM4$XOC& J/.A"-%J%M/LCT
MKN31ZDCB$5-,S?#D<61D7->5!7WAXW]=^DU"<U@#AC:HW6+.)$2KB;OZ=?:>
ML\1\][N2O:-#Y=8Z5D)T7W7AG:*>A\(2L,E:A]*@EF$/F'$#\O:7'P72,AQ+
M[:&_^P;H\SR?5BTH":PPI/%"ZREX IQ$/XQ4DCT!6-;%'C<T#][C[T)6!>:"
M^<18-F<=L<,2947?<9&;.U-KPY)J+\OJV&:7A:BFRO38\VN<:+EDRV?G.)'%
MDZ)?OW;9(G[[K@?I\WL=Z+]2U2@^:,'Y4J'8^^P[8V:*;6*-W9]SY0XKJZ@-
ME(M&Z+UDA\=Y=K?TC^HV8E :T9XM8XN'TZJ)?UO4".3E&E4N<7/EVC9<_^4_
M<_5Q_,,<V\ITP, SJ!9"*I9.G5/*N!O<LUIW;+[$VKY4_=%Y>IOAL<(FS"(V
MJ?CE@9Y1J0W5LV#78_;GG77$UBBF:$\.PZW^Y6\F.1M4"BO.6OJ;)[X,X@QY
M2S<*N!-\\\*0>>Y3YR9*&%H/7KE7X34)>E?<)Y=Q"V5/ ,LH0G*XT^MKMJ7+
M ,P57G8,6:R4&<.W;YX <QAW5 KAHU;5::^> 'MA#PF51TI<2YVM?AO?C2_V
MH*I5HZ)L.E9[]ZFM\D G?-NZS:WBG.IAG\*^$O+I&\L#9RRR/=YJ[5954!-)
M<[%$Q78OR#I0R2G=3+"$CD33<QCT?A4QZW0#&W4",]_SM535U<C2CO*^]ZE>
M)O0X5DZ?IWX=#ZFD&-M4+\L&Q0IWH^W&,;X"X3[+BY+D^R%K'O>>'NHJQ5$6
M"<FW7]07X1:F-D0& ]-,S/(*>N=,90AJ7GP^@6XOLWTZ=4BZ";Y.8HCZ&)M'
MV5LAV@04-F]9DC)N#7XK.PBH)*:(<7!-O>G>59I3[;(6MBLH,(A3ZO1M(]\%
M8V0A#UR8U&(5FO\R93I60JX5P4/BLV]_L*"^,HR$>1'4^N%N/6KL+\P[BYG=
M7/M UKTT8G.[1?G>[#X:?5%Y/"52_X=AU]KN_JO/"I1]WE#^V*CHTR\MOU'-
M42)K?V_Q?6Z?[%A*0!P!3%TG:N^J>3P$69\FN9(:;R0[E8=.EOW6W;LSIM^Z
M6V<7UJ[*7;<GY5<L$/?F\J0^U>E.Y*3Y":#F\^>:@\^"P\CB<,CB")'M.+C5
M!A>0^QD[QTIKT13KF#++B5706)-ZOOX1+Z&??$R?X-KI5N]T4 X-B>2LX4<3
M+>^KRMQM]_E9[OUQE;W"NME;KZ*\.HZYF2';D-I-9:ZDK[*,0\>QCL8>6ML8
M%N)+]A=S40XJ/RPNBU>K]M0/9AL$*SD^^*'+#8.4"SJARK'T%!]? KY2"QM?
M+\[7-R19J+#^XF%TKB^C,]71N:>EK4>$]]TAW-B.;*IQN"=0]UP8"&'V;J3!
M.@E%''IDGW>\9Q@,^;Z%_XOLM1ELC'IN!#-82N+_S2H<!@)4;E.]K$LZZ<$K
M/-,UZ4?M^&V*W H5)5NB(7:EPJUP[OZ8Q')A+D^*PVRMP086WO[SD -UU-];
M-VI?)AA:8;FJ?L.0 !W^MP,OZUO5_'VXPWYR==E*FI+DC__+)Y.::_7FL5Z^
MYA.OE'$G^/!EL,WGIZ[_O^7$_4+I'C(?4"CC%S+0%VU)\*#3X)+E7ZDSJIWY
M#RN,,B:W4V_?H4J5K%]BDF39TQ-RZ;4HPOE/@[WT7R4MHT=OM[!= :#?O_SU
MP"O<4^G?Q:TYG,$405\1[A]CE,AYSQV,-)2?[ -4I&;RRR#"GRJ#8)A)Y.D]
MN#_[!*B7C([<J2D)J_#O4+J3T!JZP8@+:'%?+[\)W:CQ]):);LSX];'KL31@
M"=M62E?!M]OPN?>*'<0X.'OEC%_.'&-0ORG12,SFU3EUFE'2_-X!-599/^LS
MK)V,2LGP[J(]2B(C+D3]6;ZTS+SF9HVG:)^@:L3BIIK(SEBBDOJ.7UF $.N!
M/#3!YDPIN74EN4,J%S+[0X56,<'(A8M+B726$PH'FB]8!"#F2DA$+/-]4/-W
M9>U1Y+AW]+><ZZL?OW/2'4=YT&RG*]HI4ET8Z5#1K>1/+ND$)N:+)[[_BHAI
M,E8N"0-Y*-B;N&+U-A>%L3]F>:>OM7'+]XT]CA]C?.*;H,72YY8LR7%<$<FL
M7P.O7^-6OH1U,<Q!QM:N56@9N3KW,\N8-)#2&57NI^E?X/3&_>0HR&#+5-)-
MIH-P1S66R)9RR]H[OR\V6Y-ZC^361\%@BLU/MICH:G[>]3-3=A=/U %4!=D6
M+-?#/N=TN:3'AT[A9.'N()*<<=Q^.W[]VGL+/6*''<-A0V2WK=&[L3(_/-)J
M,M/AVW>IIENY^S]<"_;*UAN(R<A>VX05=@T@ 44AV7<JWP])B2Y<[,ZW%Y\
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MIT<S,J6DITDW?EU[J>3+'3X:7G\QHL1"<M(HY76U_F:V]#!":X]U*;G%3#8
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MB>;KXZ42^;?^\[\&Z9_Y_P!02P,$%     @ /85\6C8O;V^C>0  SGP  !4
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M;>(J7G92=:2*8-SU@:]LKFQO+>@S](\:6?W47,]7WLB-9A%/)B193M2M3\*
M[$\6*V<K?&Z!^9K*SDOZ#?"]7,T3%R9,Q]NE5GY-^REAF&UW;]G!JTH1=T]/
ML+\)OEN!<,R7'G:$NGA5NE9-.?AO]++3D<A*351$$F,Z5PTS9_]8Q#4W!GH]
MS$7I6]2>MQ<^I3>Q&?P5CHM=:I*G&,"&3J9$]>?H) @P-R8-(3Z_789JI*(2
M [7%:8;$V2,3)0OV9X[$]YHIIHU4AZ-MX"%&EN:>?_B77<V->$-!OPVE 4D7
MRR?=C-EAR3Y8*3]?_$"YJSAS7:-!\ P9X7'*?0H6T\#YU9TS.*;CC8MN,)T2
M%_-R2D(<WYD QO!3I1GC+GG,/96.^>\3$9#Z(;#,M:5(PNL9<&1<?GS\H?(?
M!A;\-]"HC3N_VFWZUV[**,4C#OG;^)C?6CXV;8%^W4K98RJ$I$=9][?W/T$Q
MCBOB^Q\>37^]9A-J'8C#AUS/]MUL]FVO"S>5N":=,Q_=#0NB1P!!@8-%G[B:
M+.^HIH38C&NSF7S0##SNVM\F_IRCY'USD$.OMASW(QD,WYS<U5=S*6XM/HR)
MD<KHJBXH+/F>M3K" 7\@'NYVO2CAK/;.-?YK]J7_N('[G:#1RDHH:4O*%3]+
M/D//5JQ\9V+W1$&5^'6\B/_HIYX1;D*74::.SHV==-X.0P1S7""36^NBGIB?
MNK*:'7Y!^X49R:(M!.LR2J^DK*P$EA$MTF9[Y">/Z&8>_4FV6H\GL]:M)3^,
M/-YY\PR8W?:?: <K+90NK@:/S78 L<8*3V/;_03%+'SW/(&40-FD[&EE,_!@
M&N#NQ"CIBM2N^WHK][MBYMQI-4->9$IU\%Y)\/8KNO(/39W6>1T-Y;@FW:2]
MKKA<+G3P+?_;1,83%A<B%)?-ELUP/Q9<$'DRO#@ENQGX[6*I7<5):U'KO*''
MK26*64+V? 5JW%IFJ+$Y"L:14>^]4P%E8E-#-;NAB5T#^W^V25X\EA* ]W%'
MQ"H'SCP3WPVF9=HFBTWB,VZ\&HMG2S[SV%$Q@L<3%C%[@8+4/WEB^B16M6B_
M'A:%18=RZ4U?N$1;89S)3; E.I1-2!#NA_8)%V'0#/2V%+1^/*XER+8SS,YA
M4J_3XY6)@^1<'$HW]^P06JE ^AI'C?ZB-J$J85H6*4XW22HN8#J_1&(.D,2I
MMW;'FS ABTR(@V8I9&;;9,X(SF*)?R$:CZ6/"W*0W[B__]N-K(K2J*27QP?F
M@X?PJ'(P"<4W1L&#"^?C5Y2XX&9C.S0<:K'B#.\F6GMI4/(/+^IY-_R\8T(A
M'T_<SVJ,J7D-Z!T['^/+5R].AGE)&VA@]>O.P0R<QPK;/S G"AC$IKLHFY7F
M2U62Q>3>+"HLKT!^!+.Y E84/XG'O^_0,X#:M#PQV+<MUXB$I]SJ-C*X&7M/
M20 :ZE$#EX\+I)60'L0 ]#F.VGD,>:VV\+YB\W>0"YIVQ4[E0<8P*^D')E[!
M\^D:E%00+$2XJ!2ECCK0"SGJ]YEJ#V?;?XA[86NP?J+9;&F0D8&/8\Z8F9.$
M6)M:2>T90!"=Y_<#^(X8Y4@$O0886R4I;?MXPV%#_2VI-^%K(L-B76$>-S8O
MG-1$185CXP0?9TNC@%BA[[L)/,,&9[PJ]2VKF+D)6.35D1Y6J8&A$:3(&Q:/
M#41J.3(?;?TNQ^OZ[U.=I&I./2)IUR(78#/U B?*/Z<$)?>5HC57J7Q/YHKC
MO?=YJ$"!7%^5XW@<V3ZHGA,<J'C]_0;JENN.%$YX!EBO/P.@!0'V,FN%$M__
M3J\\Y6G739ULQ, "$"T!6WEL5'J$50<2I2A_BPM7U*;\V/2SFMM3#?R370&&
M%A6K)E_R^#[GG[([=1/MGI=A0GK*GP%S=$:B!,H"_'_N8%R'_6N$?S<>\<A*
M@N3D48SOVF*ZVCR1 88_G:,W-H7<(9=_(Y<,(^$YC@)&@H<+&</G9G_QIKF2
M4_R4R#'!;VD=\M,/QR#]M85;M<F5L(1S^LCI.G7KG5?6W8KI'MTF EAX)QM&
M,.%0C>/?W]J0#'*?O0XA7,#[2RJ29\!I^N"?H>XG'8_3SL8,Z8K^_E;] >.Y
M,JPO/Z&S2@<>VX0UI*((/W07!@DE4*NCUV8SA,/YD7L+ME=1O3GSZ[([;JJ(
M4_ J<3OE:0:";&_:^F7Q_NMJ%,"S]_X9H#_R6.0E5E38<4FCSTKB! XM['8B
MW.!YA(9F9(V.WLXK'R9QWTA.VE7)(67RF9\!0_^EBYIW-XB]ZS+[OFJ=KWQD
MO"?-J3?!-SJ$HJJ='T[>;(1/>IQ49N/HZ[GF@PBATLYTCC3%6M]OR6DW(<,S
M\9Y5X<KX^&A >\4T/6">8.6Z_5LY]%K<1WY@W:5Q*)Z"_[BZGQO[92(R:IBI
M3[U@ZM6=?=7T$:S5_;"0QW(IS7..ZWV]E0MK>E7\I6<BI0"AD>04//I3?M>Z
MC.V&UXO&EY-E#A68<="WYK.5%MJ)=.1MIL:Y=G"X5+#/&\7 YB@^GB;A/= T
M84$R-'NF90W<#&S:.8/,V3OR@R<=VFI>@,LM[R*_@\F;CR+M>T_5GAB_EWD
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M-$KPN2+7O/U,.O"5ST3^9L8:.9FU&Q:&=;\CS!QQ.%9U-7I#1/,VDTL[+$V
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M?N8OF]"F* C($2?VY$*.'1F'5&Y5B;DE:5LXT78^$@0\B%8X5TE5J,@V'NB
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M?90<:"*?JM#5^02W]/R9U^W6UO<A-"AT,Q[8LW@C.>A_A;*=4VNE9D,C[,&
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M__<"YZV#GM)"Q0?Q:#:TJ1V!B)>B$DE+TZ2)SP!4KN.:LKS_KUM+'?,'7,\
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MTOJ:E=&#PXA-K(!'5[*88]DAZC[JY7 \XU[Z+7+<HNJ=F2J8\L=R7S>CZ&<
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MEW$T]+?WH<I"BT 23"B0K6!6D+>^@/ZX/$)@I%3X8X3^D5(BFF;4%%YKF"
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M,C0*C[*H2[!VV2Z^4B[9S!R\%Q#A=G)2#!YXSC7C4=%$,[N3)<H8!* !JV^
M8ZL:KFW?S;3FO;K%@/<82NRBW2G+&G=MS?,QX_)8$WL.Y#3D9O,2V[%M@0 0
M9IM-7FI_X?.>D3>!-E>E;E!5Q$I-\-%PH2[&(*O;;*6& ,>6X@(T3]D9E14;
M#(\MORGF2)QE;"VX\IGX!GG0L?O595.-9Z8LL4C[L?DW2:4D[+)NK'IDA1"U
M*O5T$ "!%U<)B@HHH9BH"^7IJ=4AJ+,AZ!>TZV&L@Y<[P\I]TJG.P&VL\JJD
M"7[J\F)-Z4U/^O<:X*^M^SB.I$NTQADT7C;'S4&%8G,S+YX8#,A,.9>G"&+4
M)P2(7$\KP(N+BF\-VIO7MR9:> ;VX':HT=<,ACS>BONZ7"2I=P+S8=9T'K<3
M#:J<K847?62@</GG;9],?#6MR[8[H:V]@OA:7?D$1ZC*53BDV1R;OBO6F[/.
M"4]EU:4P1J_LF<JG%SJ%46_" GY=*L?1=>4+\8K*-5::MO>OU'?$7P(;<QA[
MS;A=]L4($$<*MEOH>X#X$!^B9/!,,/T7F.^*)@]Q4$:?8IUDXW=)31OBS- _
M:W=-SP8FJ^Z8J%H:OZ"G*W#2,F7P>0%[A.FUKKMD,^7*#JZZ9>UB-FO@NP?D
M[*E[Y)9Q%O6^<++!A>8CY=B<N@N#\G"Q8#9VA(/L0W;)HNGN^H%H\E&H5!F/
MN9(C_0N4KI0UZJK(1D'BE.F[LC7:^:?G^./RT0+M/MT1':;=;]58TX)OG4\F
MVL\67,U@GJPBA+<PLED &_ZD@>K057XG;]]L</1<8:H[YV=HXS+)<ZU,CEY@
MEGV21Z,"M1.[ZI=X6/J I :*K2#CRVGT<JG>4]N/]-87#?EBVU4W(1SP&T%D
M&JU9D0K#D6;M[_>T_+0)Y'+RJ:!D@YH]@=XCJC-17M+FD? DIO<%!1%5AEAY
MULA+8"!8U1D&DRCK<RME%'$OC:M3,[8T8XE)*M-ZM&#/\&+;@6NB='HL38"N
M>YP_M3\I)ZF1<CM\8CN,U09$;W.(@TT0"HTI>FI1LF.>)F>Q'&7$,/B$QQ:I
M3;X)__1+VG.2H[8@7K4C@94><#.U]:"B363\L93&(=4=_]?9[RA.BI]W8V:U
M\:SK 21)> $HH0S6E99+YB^S9T6+ABL!AEZL4Z4U&D<]3H65?-L"HN[U_77F
M-&?7^/WT _$I=DC4N7-""$3=I:BS,3">))-K,0$Y?D1?"?Q]'C OU4I^XPE=
M@E[OM=[YWKF66-VE^ZT+NYIV=1^A84R3O4WYFUXN;UC7L&GH;0"8W2"@;QB-
M:X,6VGAZU7<;N&W[OF KXQO3H16BM\&(BT)(6]%6XYN&TQ,FC>_YJ-C:&WEK
MX)'VP@B2 +&8%USQ!45P]T.P< =_ZIHPU])S\3E*<-7P%?KG;&+7V3A^D5/6
M#H\>5=QR7!^C0?26SEPSBNP>\*279MM(N T]W:8'%52*4\YE4@TVXWHYX1'A
M]*66OINO93H!<0AXB\TF]S(W.M6E29U/\L"WW=[=K=J7.VB>NKN\QNSIQR_!
M+)^QU_8.OU>*48#<Z(A@ID,3N8\+P%[Y@P?G(I^0%G%&V7I&#1#HZ(5S^=%+
M[)!53NL+I#FS>6$@'D*.!A(1,&%<>T@CA;#A_/)1-<$BOEC]OQ$)0< 8D92:
MNQZ%SV+[1(^JTX^9-R6E1MAS7//@QV>_0L'F;%R_8I[QD8+E]E"7>V"!?)M$
M[ERA^*%,[J8Z\RII%L4):JCM(S8U!5E2C)P&L8 S5,:/2:G<%BE0PLZ^3LA@
MLUZ%[M[( NW+CO+I).)5DF7 \_A^)V!P(S*+Y9PY(B, +VU7H)\8S56^<!)X
M^5G_U^;'4X>"6XGDJ>H9W^9FVL;5<V9W@BKZ'P\@MFHL]!*L>+MNXH;C%5).
M9+:D4#4;5&%*A",%U,U,)W[<O+H,?CB6,5($L(.5G2WMJLQK%61',=;8./.6
M^ FM@2(^MB:\:PB+SIY/01(S/@JX,![#G8.X'6-ZI<,R&&Q:UJIB!<HK&/K+
M=*.*KO/V-PE'H1\P=OL/OH= 4+N">E\PFB2S1&WJ3EL**%!M!-W.MH0@"M!U
M9'/^.2]^QIAK&NK#1%3]K%T@Z39)*S20J N$X?:0S&SW*F<LUU4\WPWQ^MO7
M>O<TZ>F#1-P^)QYH-1#N;B=GYRPU#!- ?>YUEEEU-,F(/'C*#](_?<HYQ9^_
M4"[05[9Z])JOA^.U=1VCSS@<E^UP[#B<G>N(SEF.^@NS.EI<[36'>R&(/T:&
M>Z<>G>&*Y]NS&=A*=O#,[&*9T88S8U=@.R;TQQG;55- >D6M-P>3O8/^5T)A
M+B*^$(/$1!BU4RU,+9@;.O 6_ 5K]\WS$JQ]X68=Y2H1>O2H:7)WQH_=]>/X
M]7),]01Z(T$\DC>TXJ([IK,/WE,7J>523H6J#Z*/\>O:'BY.[H;2U0M:UI:O
M57?#14*)+"WDCJQS/_=%7;*;X!01DU<J3)4Q5W=8&C@(^!K_U$^8/2O]ZM9D
M52=N#HG.Z70AG\2O&CB3!QY4T4#.&^;.,(TG43*;D6;3<&YR4!QCRJLU@O$_
M^?1=(&$7BSL6!EO^J@&]#>1XU=K/*#7[/(N<M115-MRPN.<L24[>#0?? [8I
M]3#" Q9, Z@>5,NYB!F\02L*]M<-F>N%VB/T6C</:O9_\R"QITQ\3[G))TC>
MX%)5/4G>RZL>B/=T A"$AY>)L><FW[%GFGM^DUEKB5T+!'TT5X@M\. ;4- S
MS\T8AK]AU=?8T%2VAV;1@QY47A*QW;*ATC=))$E4\S2_9>K5/37@G^ 8OV7I
MAZ;:+Y+/:WDT+4&+4L0^#EY]B2#H$/\<,^!SF< <8X(+/P6<<D]H7*6]1'[[
M-4/_9?M,"&\7<=;3YRLZD*U >Q+)73][T/N5H4J-MRO/H25=?NK]Y<A3GQXH
M2=TYU6>'*,Z+&AU"0D@$Y??-]^:R+KW<1?3X0"*>C!^QS%%$:"YR[CS*,M@-
M;;7\J&$<VZ%I;[G]RR4;Q9WWYQX0K) SJ+5D8GRTCRH47GX/*("2]K^^WCO0
MX.>QLTTL7/LY%\79Y+CZ<(*@6G/RV6J#FKQ(?+4\N$U@PUW5^+T[\7:5OMY,
M\*I;$P&,RNU:N9K7<>6=[7;M. E)4,P03KJK<$FAHTN.*L_CCG5RERURJXC$
M$V\[5W'ZKH*?CVBO^V>!]O* IQ!S/P<^:LG8W&!@U!<&WVZ3@['"7($%B6UW
M_@G=^;DO:T*^*Q.,#S=IE5:D%)<=0ZYK3KZ()+  :23L8BO!XC 7JT;">P!X
MNEE2YFGX?%+V&^K@&.<DYX:*Q4/9*4?]DNQ4LV#6?M6&WSA@65JB(:!=$801
MK0JN1?(URH[Y9!/2?]J(T'.8;ACV**P2J:@01D6=X>N]50T]E8R/6\.AXLR]
M,C?_N2=2:>RQPVXQ;!&9/(2CU=]]F<!I.:6@#@Z[+)Q60,)N":/T""('6C[H
M>.XT+%@L<PA-?=>A^AP3L((D2"$,]G_^6X).J'SUZ^4D++J_=.],PZ;K)>(4
M-,EX#R <=FQA:T_"FTG_HX>)4346*1*ZF^-G2[4+E /9A3S8EUN?#3#YEF]8
ML)+Z-11]5S-<8WF&7.@:;*\I/#O&%MC]E&AP;I'_SNH0[*X.]FEGF#%Y:L4_
M*ND4Y?\CWV1.24NX,YQ(.NU%D/PG>G'U,XJ-X-RKJZAVU/-@OH@"9>WFC=F]
M3LC1;(IHC6HN][Y!FA<>V4?_, 6NCV&@)-A\,U_.6# +3)[M)<*T ,V=%YE&
M.4RW_=#;,B;,[&SP0TU1!.,RV"_3I7Y[#67/#L#1W)X9?@2*O\Q8IA=05:R-
MH1VW0L!+E>6X#?=C%NUYF?HTPTCRA&49RVSVW1ZPRAT]H-/>GO<H@,*S6[^?
M%"O2QC=$MD>O'E%+<<#?</:2DL3'I#!7DN&=/IWD&&:WI*DS)>_3:2Z@EVX@
M3G!)VH?W?36I-HSCTOC%'F$E@\2*FI2C+L;?SI9R-\RILO,V>/*2*P!%I:BM
M]3867C9>OGG$M?/GM*6E"$GO$(F7G_.V';$B]8'H'HE]<T)EK+E,"'>;+3+\
MD+H[9B;Q1"!GX7DPWZD5$A'>.6EHFTE.>).,XL-0V^YR41UTHDL/52%""<2:
M^K/>[,J\,*;<SL.!A7&C0,IWA%M69AE!Y0K*=<,#$$3]0C_5LA?^.0$G2EJ8
MU1!\/^;S)EQ<:S-5+P72+U;DI)P0"+(KOCHQE7PV80L=U[K:+5WE;:$^>"/:
M@\\ISD^/*_G^D<0<G"0(R%C6=\SL+%_$@X1&605VL:BGA!(*DTR\7LVBAX]]
MK?[[+PF &T#;H*_K*MBGI$'6'N)$1O^==4P3B6V-KTMCQNS;1_O:Z*'A'CK2
M9+?9Z8NS0W_X<L!PMXVT>5O7A?$4D S+&>G;PCY:1OGS!5&1+>$'?A)T[*QP
M2DT?9&:P&;T3)3;P&UBY"Z1_V^8DAXQY N]M#$'SX]GY*IU:GMP#VN8*5F?J
MYY5/NIKX4#'/FEJ>WTU4:HIN>W/PQ=T0@O)8WK^_B.Z%PG$*:R2'7""%Z;23
M9C;*;=J5I6L%!!8;G8_L]P1X\U1ZG>X!CW_#GH&]FP%@L)SNI?L\8\XEA?;%
M0X;"]X2>PF/7B7/U?C)3^50*,7'(U(R5B$*]T%\^SH)Z8T1\^R#/J3G$LC8[
M1"#?>([S)V5M,!,JY"7\TV,6)S6S!Q>O9$U[H;WI6F:R<0V2@(.==7UXMDRG
MS;#T'U)4^!^S(X6*]-\6XHON9+X[657[ULE]&>'$5852?$IKSUXA';B-6$$>
M$<-")MV.F!'K4 UM=0O#M]&H/:MZI3HN.TL&W+--3&?3A-R"+FMIXH0"W_;9
M78EB^D\6ST;E/>KN 6^]/M4BU</$:30'M363L=6=D]<2A$/''S YHHAX\FA
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MV0N4/UWDZVJRB!@3CI/(@YA\0>6 MZ;9_3U0?C$C.$EH[@=(,93+.<N;7\G
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M&B1Y(0#$<O=V<K0\O.,E.GFR:L),=\J7:V:I.!<0N.)VPIAPWTJ\?(>8  :
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MH<;U"20(.[6G*QL<IXJT():[@!"3H'.^^!^7UE'IT6$)'B.%$&5!4V?19UL
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M'DM,RF3\MN^Q4R[S[IZ>?7#)F2], %\@2@ZB8J6/=]^/XU^2^+]622E4G'3
MPTJTVTEHH@VQ&I B+Y5YV)/$R?OY[UHWD 2(9!H"3%Q;-$"'VZ5[CRI]X5X;
M^4:8\&S9U51!7ZKOD0Y-C7XDL<+B':ZKI-8X[ZWQZ10/?*ZR%=E70!MH#8=V
M[M%G'57X,C>TDLA6XB-,C14--[MD^GF_EN,>\%6":Y;V82F)ROF*$!7!L.(<
M_NF,#8?<=[(P\E0L.!66S19,FE# ^/8L!J7Q\B9^UU&V!?]=0BU5>EXE1Z7,
M/UWP;PX;WA3&'$U0CMMAVV$AC7ZHXXHX7'= *DW\Q!1\<KC[<\,UAPZ7+ZE!
MF)ZY$@M=H+_9_=<3*&'.Y9EB']ZR_D@K]!'GET"RGT/W)[#9JM'D]%D6\>VI
M552"A3@_V]?$/(E*[=V\,C"#KT?\^<,&?^.LGRQ6KGVA@3FR5O?X;4)>QZ-7
MA?OT8]@5/*->D5-X4%BQXA!I\<3=B4GNR^I+N-0P!U@0WRDD M,ODY\(SNXE
M#H\*7'2) KE<2>C& []84L+D!0<Y%(P;YO@EVLJVH5,_6:PCK;IM\[Q6:)^Y
M6I+F]"K[^O5WB K<U[,%0'(/"8]C\D\I4ZJ]\?][L0S=N6NKNF2HSNBIZYY:
M.Q4ST\#KYL,O9,WV 67BQ!G3N7HY2FT'*-05&WE;TQ^5'13+ -:2=I%NU\A]
MOT&9Z!3YC7+59(V8DPK/9^>^QDK^]5ITPOXY-2DD6<,A-;U<"%K[)51KF5VP
M_[D]P-"7W[TE)%>0WF*LW1;W8:O=;/U"P6YN+#&..4XR>0:JQ>-+:T*?^YK*
M:9C5- BF5/Z1TYOI(/CR!6YV0CU-3O+UCIX[FLOI/8L,Z9^G@'!=0 8IVUFX
M5PRST_,$'\<L)6;,**\^_2?E?Y<D21+"17V+LG+Q_-H%VM9S>U'&SB#P\&#/
MRG\D(9$D#H>\@^RII#UQN5*K-[$>I%C LWNI)VGA.#/9.STR%UG=AJ/5"&0.
MWC!>=$14M*)X1&5!TE^:)HG/9X$Q-&CPL4@OA)B^,5UK/=S9V?BA)9*D6S6W
MV.JL)2&!G%O"JI1XD7H:HF4J9:4/&I9SVF\Y?3YI,CZU!8RAJ$U>KL>5RP^1
MORYY XQ\E)F63CR^R,MG!M*T*;\]F:Y9'<Y)58:Q+N+R0:R \Q%R?5*H1@TG
M3I-5$GZ]UP M+HZ7OW&\7[NTV(".0$_$30M7RH%\/KHNN*1RJ9"B8N/%=KYO
M*MF2H-P $^]8KC)&*4N]<K[4$#6WO\GWO-CW2]?KSB0Y:$:0Z=;U;$<Q5#]&
M1X ,RO8IO4+LJZS+=*=[EQSVNJ(/#/R]I17890;F\U(MQ6%<0<95%;IO@WZA
M:@KC5*IB2;:6G5M9MBW)6]>5VM.-! 1[^[1MF/Q'I=J"_+E<G['/.DR[D5C$
MKP<WHY,G ^+@R:OVRN0"9G=_77@^&;I&;=4WYL-@/\SC#9VU=NYKT;=M[,20
M<_?&G:I=Y$AQF>,V,)*^#/FY+IV_>),6/:NP#5RJ8*7T]N"H"C_Z^/I[2A/2
MPEIY *C0%M6Z$(IT'H')J7S%\;]:%\C*$*PK)FOQ:QD" IDVXOXWA;)V!HW
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MU9MU2^O9+,2RO_,+1ZGMN8,*R$S0@(S6>!0\-Q]+IEDLDTH@*):9/YI)X4N
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M/HE5;R'<Z4?!]RDT=EP<RLS"=?N+5GWOI R8[7YVJ#D$ 1?Q;CYF6P:)TU"
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M&[PVGL'6_LA%7KMLQ?[=+/TR4*</*[+KM(0G2M[C*7P.+S0EG9G ?H(T#LO
M@QDR#F)X-Z,E[FP"<5@M7N7603T4[[-EDSY7A]A& 8Q;Z3M1#60$%E*-\0$$
M?Z:VYOK&ZM$2*7S&K<-D4#Z0 @3PIMTD^&SXY(5U5HZ1W)K/4I+-DO-(QE:D
M@H9]0^(7\.F\$[V\-;D#X9><&T- !8$1/P_$K:BU1MJ)N^1SZ[ZF;(3ON%&1
M!A8MGLYSV0)'4E'8ZY^EVQA$E9S, *J0V2;H(1B!'A<?KC8?]E,P@MR#9 39
M-R1)1NZMC%MBYZ8JCXT:PJ_%Q]=00CX0-A*K\.\#2Y_<<EK<YIM-SKRX,%N*
M\:2 '(PN9@OOO5/$X"2( 1!0$[&;F9F](4[TG0W<,VJN<>0HKQCVK#H9Z5X9
MQ^H]P$=.-7V$%'F1*45IH-\LK60>88E,#H9$5W2QX7 !]TI Y.NMPX( P2'&
MR)IT<,*-RKD7$E2<Q<=WHBWP5$ #@JTD?V@_DK4M)"_#-S$IMDQ@_*TETOFI
M, NYR7R-QZ76M,Y?)_V7C_J7_)GL#IH%671 D_9MN)"V/6$*<GOX*KMH!@$+
M<9)9_8A+ADG?\PRK1VV;VWIA3GX*HG[@^W59[]YQ"EA^>[O_)/,NGZ;&:C_[
M ^6UF0*GY[\)S >M\Q2XN.BKY1I1+R3\%2<_30Z#VQ3]%+20*LL-H0>WPCP=
MCX)WX%\9G%]]U?GYIQ&VX_*5W3G\Z]A/SSO#ZYK/(W NGY)Z%M[\D_#XOQ!@
M_W\27#XA_B<A_/K/W/78R=_<![R144S"C?+[_, "EHMV\/?./X8T_%(FM%!%
MPF#$.B=1QU5^3Y86YB1% I/"HDY_NN-R \9*'#!> 3(9)8B4M"DFD07[O!I-
MCIRI2+3G^8VH%$&QGM\$\@=FO*]T,%VGU!3,+'*0@+M7VZ 3<&<F?X2$_2V"
M*0ZS>U-?5U.R%23]U-U8%Z,O@Z,LKY' M\P_CCS:1H;39X5'=XF=WYH<PPSJ
M:$:'C7:NWTZQLP''AW\3S,%^X6@</_$^ZEV1OAJR/;2[?/A9^@=5XZ-GZ%\X
M^<N'?G\UVA7^:^-?74;_#UT^_WL7J?\ZBL2S_SG\_QWA/P:Y[W1)_'8W%\<B
MH;5<D:,3+\8(A9V[M(YY!VZ$:M0QX]+'Z9C]2K+/:@R^[A<DM^45U"-GG5ZE
M;2S?T0M&=(AAN'/#D:.V5*<W!A*3O6@H"QU-&%GXG?NLD-DPGL6]44T[)NR0
MS>4FI^PSINU4M.[(6'XKM0D?L<<)[O%4\&&U8$]#65E:"R=2%8JX=E?5GK9*
MSKBY_@-X%-/EX81MGPHLXT^YL*#R>D_:%[STF#4XUIE[,7],* I#Y1^D#>JJ
MA</MGJBQ]33&?POMFWF#JW7HHO!>)_$</:IT#Z56>K  ;9]NH[[5[H'2.D'K
M8K4ME2%Z<;Q&MS\<W:F0OJ2!LGZ_67GKY\OY&^%O#EX^LKM0>5WWM.C=DI*A
MR[_=<&?P*WWWEOS7)<JM?R"4S+V,_)/'MC4-#U7^F*MDJU3G(O%Q^EV&\*E1
MNAG0OL3J]T_A/><QS4]51C,*X<4E363=1E[K]>74;Q/J@\8ACT/\;Y7GWD1!
M)!RHKM(K?M;?W![*]X-!JNML[ EX^LPM^W7R.?M^MO34/*JT6W:Q#.P;-:QW
M$.]MV^C[H%^S30?7H;GQ9Z6P=37I.GQTV*9U7:Z'H[F6&<K [:P-CH#_QT_'
MD8]RSW<+4Q=Y/\.4Z%KT0BM5LO]7O>3%[7_6\>(1V=5&5F5>*E)=.Q=4N3WO
M-J"6W&-2:,_?MPCDUO&T$0X$D%"3 M@(3R^\4J;5"WQY[&%9^9Y6^:-D+9#&
MP$^+6\GN<$4T7]FHP.TZG_)7SS A,R;8:&R.![:7F=,0]Z5Z%0_%+]F- FF
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MT$!/Q6K7>3]]L3"0WE,CF=4OVH[/PD4>*1OYO2'XU.-5EVA6!$06WUIUMLE
MM7AP+K=XQ]B$NKR23VL+\4-58P9.F-FL,S3+%H Q!T%N4IBDA$PKL,D+\)&*
MWI>%A9XWKF8%R\]ZW0#0GL2*I"J="*ZE3[-?-\B"4^TA&PX497QARWWB&=(!
MWCXE81P\K<?W,ZHG](VN*]7S8.[:IO[^3HID2@R]G'(G"1A3E+Z1, .]].<3
ML%Y=2:R%CSDJ=?N9VW]"3?_7(,#!H(R3P0+]5DPQ(C$"[XBM)+ 3JA).]PW
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MD_(CEF%:(' 9KI__\+2@='*VP!  =MXUQ2-HB!C3:.Z4%FW3,4LL4QP@YN_
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M:J;Q)NV>30#[8/$;_0)J5/1#FB(::P 0S^'U\7$G.>URI387"P3$FSQ,%2C
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M_"9@3])@OXV:=>O0T11]Y2W ^<9OTL&R<6@0B&S/=5[5J<64]05OZ*D;6=M
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ME^X;YE_E$[<<+]MY1R\BT&''1ZDK+XXM"Z(%K%-DBV+T_C*L^XOY#+=FR:Y
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M2M>G;B:WIIW27]11Y^JA&)_*7J%/Q/&"ET.KXVD0QEEMU5%9",) OK1",>?
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M?Y'?MW^&>!1;XO 0)C%UP3N@XSZDVCP0'^@)C,87YVC.+D_LE_[;Z&>07Z0
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MX9_^;*NATGW>Q2X''ATC8.7BL26NV5;4P;V"7?M9(LBQWICB"^JF'I_/#H<
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MAX-K$\J?0Y'YEXEEWSYKKL3#.52B3D:P\?P>Q0UCI6]Y$$-MJ+*(UV?7L=^
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MW)-V:,S/4BC1G.^]8[VB=Q!]^2M="FFOBK-4AI!>HL@3H/.PAL*;H5G?QF/
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M"6L,>G9)1.R&$<$<V?IB/:=$K+_")05#/:9NS)R;E6M5X.&L-<QR(<UM(6'
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MNZ#\M8H7-I@D)8Z<N,@6>(T]OZBNO/8B0*/=9\#^K2^_,FBL7_NVO:OX.A&
M G[MPVIX55.-W1[&X:7DK,C,%H&<_^)["R!Q:OS;53,?=*$%?X"A[:4K*/;K
M;NWIC+ !\"]+L60*77UI+@0R5X^-5%X1#>>9,JC<))$PJL9IDA@1*=7,F_F1
M"'W!-W/\1QZBK.I9E54O#MJ]AG3HGIM!(CAZ3")O 528Z5L *?1"9"5D>;*C
M]%/\X_TNG5ZX%93TOIV+SI00@)V@39@+UT7L?(P&SRX $[- NE0QFG+O%H"F
M";]+N=IN =WR 9YIASI+(H;*8D\GSG #MX];6&Z8_-<7 NFJ5\+?832FA-.O
MO"MW7IA]ZZWN'P37)\<GL2U*.N.J897%@MA+O3(+C^'O\N<XRKDJ'J$KW\<T
MQV58[5BK,?\<@O4RQ B:Y2VPOANPT=Z#?E6 [LJ/)&0XDQ-\P^0P16AV^WS(
M&5X\??AB4&WK^UU@6;E!*CZB (MY3:C:&L5L73,\Z6%>UWK*YBMV!*Z'*'-*
M7\(X1,^76+-L!A"S>H[CVK7E ET_WT?')]:C#.WB227E$7B'.H.-/!1G890:
M-O@>.RKHF4:H)@N\C:\Q&@R"/+ &2EAZ^ AWO1H]//O>^0A3NTGL!<=B%>'W
M&SRGIL%\GU@; KAP:JYP7=MA;@%$F!8)R_P,QJ5#IH7H-.U:^C#ZLA^P<;8&
M9#F^CGU"1JC"]"B3L XIDQ#:?%R?F,Q>W1VWQW3#(;!*X5-#R.<&>[3-&J,;
M1/F<$[N],+=L:-WY2.ENU]KGSTS7+II=*GH596J<3+%11@G"?R:VU*.S&CS*
M'^/>*P8>^<4*<K"Y=1_D8'LZY]+BM"P5/@QD"#PF1ZQMGQ=\OFZ^ Q&4'%]W
M;HL&ZKG=%"W:-88:2=-]+,\_^@75_M3P9M5O0-2WD_5X)BPZT,<?CF4&U+0(
M5VL?\R@ZY81X]IO02<<Q=6]M*@K,0.!9KT^P,];_7S\,-14S?$V(.($$/8S+
MWXXRT?%1*:$==X^DRPW]\\,,;Z33QZ50;4KIH38>MU93 ?VA4]9%=(&!R_O-
M3^77'L;QA=J*6:+CBGO]EM/.<$^UZF>[,F^#.9H8(Q;&9PLG_?>&C,5.=GUA
M\VDK41C/Q[H'&-M"/&H&W1]C"34]&!["^F]'@_??+G/YYM:V88\O2FT=CEG>
M MJ8N(IFX0D/IE&E9:4N?802,RZ2G!5.QLY"QUI]IZCLW]]JV+##+CW2(A+Y
M3G+#E%!1%R94D^LEYQB;D<CFU.<I;;XGJ3R;$CD.!K+YFNF<QI*A68HKU(P-
MT_S(>JKF-_#<6X R@:QM5W<>Z7+^PONE#\O4@V.VF1ZT<P,,[!PMB'+6?6(^
MH^,3=MBE^<BEX4GU+2"R1L-S8F-CXF9]ZGJ\1:;QZ8*3/=Y@SB9G.&K802/A
M,#'-RN/B<$9-PJ47JV<'?(@O,5PY7AAE:6B868(W]H"_!EP__X@19SQ-YU ^
M:4UK\++\%N!J=L,]TF/&Q,PRQ=9RXG@$VLRV67V'"3AUDX'!Y;\HZ?TA*B!P
M^6!5(Q#Z/MG?U=U9K%'^Q>K2,0#4TW39G#5?2[XPD&9!79:1:W[QO;QD= )*
MJ\6^W=(GI'G@2&I?@TP(_%-\\Z1%C:*9I7B73B"=[Q*XZ[/F37 +.&L5+C<X
M)?6*^,ESIOQA9VG4E*"=F],7+CQ<,TF5T$/(YL4VD2A1I6IPEY%0C4]$DWJ/
M)5S9?>NN#GR_>9<'MH^V93=7!7J;'"J51K?@0+^2>WY6JH-P(#R<- :O;TP+
MG-;T4!WXLML [SU$JU;$TRU=E9_.CYUE<T[!93&+1?<&9::R@&Z8JSFU1W^&
MTSDY5DMEGN=74]P"]FYV3<?.:DOUC\;Z>RX;;V!_& KR>&EP==X>>A>L/=).
M*1_DI<+ ]>W<.7#XYUV''8V?JPN8,D%DU) <;*1I39#?UP<TBT<Z>8>M/;)Q
M@\C#4<;IEUV:M)6C(),, 5]%;,WH%=?2EY?,PU#]+BU.,$0FMRXH__)(2T [
MJYDO;Z2-\,=.-T%;(+NAY"-N9AMB+K\6P]UU.X5/Q%A)2&^VW3VF\325R.0\
M7M3B)P_*(6U;_ V]@E1Y2!(( "_6R"'"BIPH-!.XA-C_0-H7O<XU>Q2C*V[K
M;D:%U8<]23])39[[?$RH^PRL:"<0-R@6=&?XY;FHB9JRQT ZD'HKSK3Q@;'V
M"*,T))XJ_KGT*K%L/;5L](U>T1?PM7B[)>.83@?SCYG%NFF%R(4!"M'D+]&&
M^\Z]'[_!AMW31<1[1.:F[&OG4"UKJ@^(MYUG>V"H,]R@O6>,S L:F5SMXL)Y
MY;0(#U%-@2YNA_!EE! &,\/B1CG,,:41W<%,_6**[#2@JU)8H\.RTH<>GS_L
M,L"'\""AUZ6_/2Q=)2[YY%W%#HX93#H1-]2%PZ43'X>9<=")_]D2<\P89DNN
MOP9A!'&K&1]>[X6;-X5%'W.)M4KZ99GF&M(>OJG9WR32<1Q10'_CRSEDGWDH
M\T-')'Z8E37+^_"@E1_?_!1O0_Q<M.*]I][7</4M78]2<]_&J 8:/B_V#[G
MATK>>J*MRJT<V571NA7B\3YQ"8NVLWI5Q0\[WLBQ40XDJX)P.D4MOS9:%\>=
M!;H$V[>0AW(OCHR%<> !(?$Y:A7W7 $GU K;'Y'^47X&2^#LT#1+K<Y A,#O
M][N2],,/:"T@OW@]'KFV+D.^8LD,8-MR/SE(T9&=/(4R@H4+&-^A3 UVU:C2
M$^1](9>"7S8$D.QL\0 AQ@;++ZTM;.?T IM1,+3CB#L-RAGA+X661TU@X;#+
M)00Y=P<?:L5#@0" ,$F2V^?Y8H-9/>;6 LVL(R67LC$*6V(?O1YTXG_=.P 4
MJG>.37#S2!;9^VA=R]HGF)IB&2*&?VDZY$$'R#0V$^)J?AS1[5$M\O^IN@NU
MM@S9S;_]P62:^^%]5^Y5N5QD2<&_)B^Z _NC!N>&)))3IG#T_'1GKG=P-JP_
M0 IB/?](39C0"$KZ2EWHFY@36QR8N9Y6DR+SV$$ INM8_I2.O]DJW6^J)(_,
M7"5O'.\8/T*"\'",;$D"=]ZXK-T"FM&W "AT:TO73V>F><OQ0I]U).<92<"W
MD_ ._[Z_A$[.59Y5-OAB\$:&Z9,8XLQ)2+Z.KU40<1O_"3ZN_M;"_WZCG3#[
M+Q@Y'RW!-^8D$G?,@82[ 7_JKL$\%<UO#M[\/2UQ4%1;-^.U_Q;I1\*4YAS_
M?P^Z_#7(#TJOK,*3-$EK#>R_$SQQ"T"6^=^11ERF_"\V;DA,!?HO!G3+!H+8
MO4R":]?X7T+(-]3D@[LF)_Z>Y_S=K+[5A'>$_8UR)Q;__BW A+YE\>O2GD'@
MR(1F!7_\R^B'AG_I,0;R]ME?2B;RCW0(^&M)W?1]BYUK>]8L4#D(G(+DYC]]
MZ'9PV;=G?Y/)(:5P6JKN5YU];KB\T\W(Y2-;GH]W&WBW+G*@&F#OOTC_B0@0
M_2]2GO\@#%,D ?Z_$?:YXB3V%I#^;[Z*:XOL+8O_HW']TR:#\ +_8X?(_S+/
M)QHY6//_(47X_P?A?6(15CYTEIO6]W6<ZQ=QTZ1FY>?S_H6) +&DAAJ@V,62
M<*'/_KR_;P[I[=3_ %!+ P04    "  ]A7Q:-;I5>:T@   "(@  %0   &%L
M=',M,C R-#$R,CA?9S$U+FIP9Y5W=5A47=?^T"TA@TA)2HDH@G3W(#7 @$,H
M(4BG="LIG=(Y=(G,T)V"@'3G $-W"L(W/N_SO._W7K_OG]\^YYI]SK7OM>ZU
MUE[KK#UWTW?+ #*0@K("  ,# _ 6?0'NY@"R "Q,S#\W>F"C;QQ\'!QL;!Q"
M/#Q<?&)"8F(B0B(BDGL49"3WR.\1$9%1D9'?IP0"@<2D#ZBI**DI*(&4?Y1@
M8*%EL'$(<' (*$F(2"C_O\==&X <'Z"$48^%P0S ),? (L>XZP+0 S  :-/0
MYOY[X.)AX6-@XF 3H)?UR  86%@8V)@DN 0X) 3H50Q,+&P #CDN'@73<_S[
ME ^8I36UC1UC$_-&1H%4D/BQ<6J6QWP* 4%Q.:S\,G+5;"\$7LJ#M4R<71+:
M#V5US)Q</^;7'*$UTZ$I__#^+V(T#18.+AX^>E6<'$V$C8F+0XB#C?6O130:
M&X<\=@27BNDY6 N/ OA FE)63M/8,2 N)_<^L_;70Y87_.U.*T=WLP!B+#2<
M'(L<( E8VH/ME+:DM;R@P8K,2>2C<DLC%&:-OM+6MG76N@=FN47@^*19K93H
M/;HTNP-8ZF"NI]YXP5(5=>/+!Z4"^,_A%=-8H5AOSRN+P9;'7\URF@_;6>VK
MOYS/CR\^I]W&:\FH%1",4/@5<%#D:FFDJ,_=6A9V0C>E7[U6K]K^RLMNV^XF
M] YPB%S2Y)X"B:XG[3Q>;#3L42FK6LO\^MGK72VM@F!"G %V1!'QZM?8CMS:
M/4X)5%&R@[F9@DF:W&=[,)((W+' &+3&04PRTOE06,Q#%Y(%TU$4"TOI/;/M
M6;GF(;=T0M KR>*\G151[&^",LZG-<WIF^A)R>A.!-*!93Y:--P<4O*)P1=:
M8BMYNA 9RN9:X5P83#UA;(R)I@T' .?E;NOAY?FNJ_,9M]J]9-?L<IRZS^''
M-'W&P;77R=)+N"+:+Q(N0-A. J>+KN*N]B#]%:(RW2]P5[FO5#RU$;4$/M+4
M7,-D^YMJCK&9M]RCKIV9YW#X^ZPO>[,VO-ZVU=>U);ZRQ$;'@[7U-D0^C.O-
M]+RU?C7U]&H?F,8Y<^-:3YR;(X[HQ/(ZW[!&Q=-_GL[Q3!TB+B0;$RVQ"2HV
MEJ=FO.C0^3@0< AIFA614!AW<.D>UA0@O]),C:@M=\IMF.-)>#9F6J\2QC2>
MU,X:%^=N"MSMG/XT[<0LPON5ZHO5>[[1/=0')9FUV!:WRSC6&,?.^F$_K/NO
M743A$^^;C5><[0/FO/&^2L5^DN_ZIG.!9>^FO,_?Z69MM2'4YZU@@UB](#T-
MWEK-%.LEO-+? @I[!B+-=3I$M1CEY6I_36_)&L,I!&O#>C%QO1\^1.G8_4!\
M>&%Q.$8R<VC10Y+7*"? -%Y'(VO&)J]($C.K)GSQ+?RH8NY1HX&YL(/\5;R(
M@?4GX;ZX@:@>QV)& *V]MQTE93:*G4U\V2J->TQ!3($FK9.GZBRC]0Z T[QN
MRW_Y*,2/W?9W_Z&BTFLN2SMV#:CVIYHW7(OV&%4.NAG[KP^F<N[;7&P=0>.I
M7(3)%Y7T[6I&M8/RCQD_!G(;E<\1VDT5Y5MQ')?? 7@K*-U_S!L%(S]'Z5LB
MDA(8Z^OKLB..E,'*8JIJKGZPY-R:H(:>M>$$( &WHIF='3!P-8F/S_U";SBN
M5'V+>(W:T!*4H-B -&9UIUVI>M-SG>10/'KP(0LCVRLQ;\Y9R[W+OHCAE^L_
M19(S/NBQ8%-Q6\W^PUE7]*E*PCQE+V*CX"AT24/\=*^^N,E$<)S41_;;J[&_
M"VCLG_JQLJ>./,-:4IMK2'".I0UKNU43/[LWZ."'2OW>\-J W69-_<M&WE_@
M#_#3VD0'3Q%6SAT5OC>^+R@JGL6,W6OXKJOG7U6-@4'(XO40@!0XZ-XB9;;$
M?)G[K<5)BJ08SD"P*)9X^W[QQ'%=6[[7)%ET,5,G==W+?^WE8L93D8>!+;S?
M[^5S=L#281CK9 E(5DQUS\;MR'BU+^,IJH/&:_BV3 ZSGT"+4&9AND\91_XR
M'4TLU-\K;7[M*M;A:J_R9VF%T9[;,[#@_#C&MYU;VV.9!UY;SL%'KQ^";9.]
M/G2(0#0,0Q.$_'-^O&.-B,;Q::[](.@IYX>.7<'YZW>)IF-17WF(=C(3UA*;
MD&Q!+?#E8BN;6^,^%BRL8"EDS[O4XY-?*GK)*=X<6B-T/VU(]38J90KZQ0.&
M G_Z])O.>8$#XA\_NP-, X&-+K LX]:G,X[07*9[?/T5]SJE0A,;*/5QO&8>
MSNM2/'O>4\5@<'UFL&T8V38^F_O;-_4'WOX+GBQV*9]S W#NNUH*&*?H]>=A
M/?6--=. 4I=FCJPP\D5#4;*7<T^07O.D;YKN +E5D:^226X3J);F@2-$]L[[
M]U[.ZT]4@.>E/Y!\G2@K!RP7 =S]O<ZH,T8GWQ7L/28>5PX>]]B;RZ@3Q: /
MGRNUX:$=(&)ES8_:C"".6"U5H>K,AIYYI<9>I#IMU#V1E=O,F33KY:E*HGP(
MN9+1R/:OX.3"+@W#"UG,2%-SVG/5KC]\/+/OU#G*(M$).X-/!S^7=O;"D3.6
MUT-E J?-8^2"+XSR@(/;'^%#N+>,T(NJLUG4="FABR!)%0W);UDVD3<J*HW.
MNN20TI)%6=X^/:O9V<,QM0]VO!@_8DC=,976N PMYX+VSVS#'#Y*L(;RS:CL
MBH0BB62"P3DHW*)&2'\EU&-:8:K(I$B^5M)6Y62%9RK0P*OLG@,4K!U# 6")
MXK-RAIV>&K(7\B3I@:"Y<TC!AW A)QAVA%D6 4J;"ZHJU"?5/RSWM/5C1J/=
M]?YA[81M@*J_X=5R+:!,$[Z@\O$F5_!&Z&+\@=9I<T;^0IV@A%@;<Y,I7CQ&
M2S'*LZ+6D7!I0[^_SO\9J6\+^D>D[&".\K-/_?9U1Q?VXL$3_*_LY<G:1>4?
M+&WR"\L6-)E8UP#NL>F0$H4$=0F61AE7=DC'I..2X]Z"+<PF^E4RP)?R\7)%
MCZ?4@$_?7JT/7&C-'_9L5GM&*T=X<0'#P/%CNE/[H>[[.>\L'ANFSPM?U_NP
MJY-^P1](H1H_]C* <H9Z*RK[PV8$^YAI'PC:*7"_/(ZI1ND14I;_7LV84NI1
M(&7P;M@J#U2HV;XVRJD;B/9,MGWWI-,@R6"'F0W'4,]2^BW#NCQK72*#GL#/
M#TXOC.O"RV1L;#!$U>9($.=O)I9+P_#U>9[, P]([9/#:G<B<VI_/FZS3,Y8
M"OE$6=_< "Z[>/.E#!D+W$+WZB9%,P66W_X7$X;V8Z,FUBJ#>TY0)_YI1R23
M_VS@3^A3^M6R9529&& E $R,2O28*><H_8H\M# A-_;[X3;]9KNB.H7#WIVG
MC=-YSGB\K J98<V]/:K3$(KTT$,&]&9(,[KT.=D,>%M ]N#.%,G@TD^0&15;
M'IC0W&?1-;LB)BG'(44ZW3&FISPA9#,@ [ 2*(E 26@E1CB\*'7SFF$B;P^A
M_R)ISB7I4Y!:7-%0 YO0K@7USK-" C61CC(+NF> 05=+J*H !6W7Z:E"PS+I
M#U<;07:,9;<@(P$^ ,OA<LT-51MO/C$B/2Z$=S+_Z7/0&]!GJ1J=JQQ9KV"O
MF;*^.=A"-TA6ET.]D?+=1HHE-U0X-N%CIM"*-O9@^,*^[@/VOO&O8SP(&G-F
M9*>6B4@:Y)@*H.OB7D2_7+[L/E7Y[7=LU\S9L(;!RCGME'5)$GQ>>R  Y994
M"'#Y$$0-2FQCXES1-YTR[?R$DBWI<@XJ>VJC-C!_27+;>@Y'R!"E8R39-O=/
MP$_C,YQH*]0C;9)G0)^8#5[+\G*.+R? V RG<%@OA#>XI.?<M.[1Q_YI&$76
MF8.5R44.U+Y7F$+1 O>SGF>7>ER K^TQM6%Q?!K9X&="A3>++R6<E _3I_AR
M\A,YI"N2LD*5FWM?SXGKN]I#F+1@Z4K>5,L%AK4?F/#0G]1+QX,BX$X!\0!E
M,G+07(O+#KJ2T]UN\_(D=)X;'W('. 6O0IRC&(R 9U'"ASK&W":Q,+4)W;<\
M6^,/ZD/=#2@'2K>GE=^?R>,,CK5G"\;=3S]:AW"*: H=HYMI1BCNP.M>GSO
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M1E/0+J[!%RUDWWB=3F?UV/-)4[)"C2LN#L92:B)A[+<!,:0TIP>5(DP[U<5
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M+++_<M0O"XBS>$R#X[!F]>%DYRWJ=$#MUXPDT!']? =X58,JCS_2:FBH?<G
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MXY6 ; -@805YB-CG^:; "PY+LSU/3Z^_)<N)("OY3 ]$0BAF!0V6*0I^@NJ
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MSBJSLS059 ]S4X5B?9J133@%DQBTQ4-9]7%)R"&7EQ>J*EW#[)"JF;D;Q.F
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M&<O,1E"260D6HAS !%);M;^ILN++R9+3]I!%B+.>8=WQ,2NF-=C!)=)L+1$
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M68O( 0DRVH*"'3S03OX8L-0F$4%J6U^W3_ULW)5#;^=U%!YYK[6:F]-UY?Z
M$0F<'1&JGXVU9.@PW6FGRB)Z&0>"[>KA2I&-7BXI.J-K%:IH.:U5KEO#C^Z3
M+Y7<%#C@YU#H'^R[C'3,7<[J?JMC*I-\P#W[$..0HJ* A9XIY=/=AQEP9$FK
MXN-GX_0*I<Q*RX3?O;+^;LIYL-KW&R(\%,K^=O\.%5HJFW^$H8KY,/!U#PON
M$8U;!%(B4A2^,7"V&;:Q>C6V3HI63W*-T#=U]<JW_Y+@P(I7<VA35]_"M5K$
M.'PWCQE_DKWMT5R&)O(.@6JE\2&'+6!/QH$JO9"B\*R"E,46K05><>5]2IUI
MK[_:FYL_06=4[=\PEWYH9GK&66=7U8;5\<*B7A'[535O"PJ!\MI,40BCN">8
M;N)ZK"<,W &/(FOP.#(%0$.<$%L4C:"^FM*VOE?]+@D?'* J^M&T_*'M4$3L
MTID#!YZ6$$[DDF"@8D TED01=*+'%G5A28]P_/#U7Q#K"(7J,9\S2*UW/3A
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M2R;BBHC,E4D$J G%CZ\)+@;3CIV?A+)74CN4=F2EP@80MX*\H:NXXUBJ<EH
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M'$ :HUP6AB!+O]<:0M:7.AB$AR\DW357W>LOX?&I6;5SQWU7A;20F])V%[?
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M"?0=(07.<N[5"""(6WB6@OAF?01+\VEFK@KI8=5T0XANXT>G,-_-1(J+DV_
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M$K0O5Y''3AR&F0*S DDH:+0>((=[S 'LYL/\) N9$H 3U-Y0-[A053$;<NU
M4D)94F1NX#61'YK&UPYK3V57ZO VQPLD^TWFEN 7?^(N$J5JR;%L.$_;@<:)
M.W4QN^B^#_=D.:_DYT6BF*Q#AX/1DIZ"2!?O B#/"N+<!GQQ+"0SBZPAWYZK
M\)GN3ER2B7!UR@D\8[_+T73KP;LJ[CX945NC18B:_$P<+0V,F<3A(H8H!L%_
M0+JH+X5&MG7LWI[DG6I67CZ?UC'D[O<FW3;J8'I1MVZ&MJ:DXE*P@@B+.F?'
MW<2[?D\@5<1=F^KM3+J,7$>,)QJ!,1 -HW$2=CX/"M/VWE+ECNFQ3FFH*+7]
M[GXAS?="12?WXTQ>,_'-_P#(_?M"S)HC!> HJ/;<70.&\'6!-4-"R/DW=PU_
M^_;.<>NU%RZNU9!(:QL,F,ZDE=<V.LQ3%D)V)_S;U/F_KCDNWO<9\0'.>H6[
M EN5PRT^(*S-VO_W5Y!(C3]%_2GJ3U%_BOI3U%\>=+-+ K&,/H74[/9Q'.BT
MJ>UGO+YVM[$C.\I<)'T#M! 2Z61SBK4\MYH5/Q>JEK^Q5NFJPS91T9"M.LM&
MU_[UZ>%G)\=4"$E_PW0%E 7WC2(UD*:"3M@BPB)0"%DGA'R*>P(M^.O9^0U#
M#-?Y6*XA1A-8H!%'LAAA[?,&Q]B];7ZO46+3RMW;FTJ^)+]]U579+3.L>[!R
ML^+1S>LA-\\HM@D^PJO\6Y COO1NGB? 9W;C9( ;EK:?6I;-<\+]K*^&'K(6
MB[A@]VM#>:+L?H,NT6P0(55EM:BA*(>@(ZHXV"BQ+8BPH3:1SFJIS>D)UKC2
M]/;*RMPBYZ<0LG.<^^/#6,AAC79%,N\J_VF3A*#G)=IMBAF&+UL28]>F[+78
M0;_TNC;;M78642_HOM1TTGCP7C?&(-BZ-E.!($X*A$?#8" Q4 $\Z3#\_/)C
M._I"X@Z0 <XQ:[)W&S8Z&KD%J#LFU4^>/_KLRWFLFZ'(6)^W)PO/&>!G-IGS
M4.S>N7$6GKGS83F:2B_M4D[A60:I=^_+_/[^B<$A,<S!#"M/XW[R^31/;PW^
M4ZPDNI;9>T<(N:0O W F?G1ZR_7-+;MN1F/5 I.^<;+.<BW2'2J[-S@_O;W1
M4]2T$WS9W_\&'8YKZQUUXG@"9MS#:'V.._"8G>/8)]B*.9:*8*'BKMQNNO'T
MU?>Q,QE2.QT/EG.\Y@H15QE1ED<2=;L%&E@*O(+:3J3H=" K4&1\,L6MC"U/
MYS>< LBM@ZU(N$NJM8K;I8L2P ]?F5<YOJ9N%/03Z/&_SS?H?]GNS8F&G\MC
M?4(FPZMT\&4\(_KK4&E/E5#/DO!"F]=O'OK<,FY-'0G7.*U^WC]=?*U19ZK+
M?)U9''P8<=;DB+2Y6N"^?5/G[5.U3[YOVW@O2I+1T.W(?P._^!C)<8OGC"<Q
M/\0$L_*9KD'3&-3S]X,W@B$/R/4K,ZF2&;]<+@PSV/1"<NLFJ%M^TRE !,3D
MI+]0BGZJ0A4UFBH.#QK?OM!&&<O7DW8>-'1VLA=\OOMHCT=7L>=1C>X#=+>=
M%SICQ88&[O]U#UMO#37\MV]))]CPA.O0]4#0"38^<3E@KV'CSHZ@'D?!)*<S
M&+59.=W.,N.,D_RT;A+_P=HQU+.<7L AD#W*\0'R?!E"B.3$>&\PJF38;N_E
M2['O'-2TB].U=&63"[9&'Y30%OU83"0((4&]P![4G#A7 LAR9=G-.W'MON5J
M#"T[H:J&@6O]SHT#1KNW=JWS#?39^*/T8@ED[I:#;8NYRZ'>$7/.&/\^_ IN
MW1C/GG_/RBP@U_C3KU=LFO)7+Z;>&WYO>RQ,:?&%\Y6V=8?3%.Y*JK1#;A;^
MW5D_B$>"SZ3JVKDIK@)/)X>)GW=@GR2W"!2C5]5,!HB,3!N3S>E:*2<5PFZ8
MZD@5B3B80NZ*3'\^XR5]KH_GFG\6R")3'IG48?."-'I2)JMN,7-5% [9)YON
M>6<M%KKA#6QDE),.:''=>?NJ@7ZN!;!*;9M0;FBHJZH9* O^FJ"=/1$6?7'T
MH-:D7\KG+^?GF5K9D.^ZS4(("O]3X3J4*^DDA.3/4O^V9EJ4PM,00K:G9H"X
M=AB^Y#&8XH\V%]AHZ I:7N*FJ\M4__7GOTW!AID"QZD4. VY>GQ@*13#Y*KC
MNLZQBWC20HBC:I15:CFLDU!%:";&:6X%N:80PKCRL/#R[LUO![-<6EI-]J#%
MR\(4OR!5X!?@MY :#4$Z>![.YWE7<1=*?>-@7=*QG$T^V..6LP52+\N+N$<O
M6[DU"OR-=S,&]#G7'Q$YQ"!,$H%%(540^<HR\H*U=6[RWGKL(@ZM"GC(^,H2
M;^Y-J3.Y?;UQM]5 .(-_UE,U]AVFCV*M<K)C>[.DMFZT07*J-DC!Z<,P4,2Z
M4!)/O19 )&$"^7$6&BQH>P_#7J Z*S!A88MS;3*>96"[B@-KY]M.O#G3=O?M
MEWW\^JS?/MBO<PU9[ZH=VMCET)V?GD+\:4)9Q<RA36<>SA0L=.PQ&6A_Q_EY
M.2LB:-&21"/R% QH\2D6VXGLH^VK8?%&7)-%(UV[C.P)?_7PE_9/XE/J;CTB
M'DV+NT(6J"$X9T ST_-QU$&PWX(ZL%(@-]MGI59[&^$&4#7H@T3"AV!]I\^.
MUD7;)L_+=#N2@0?I!LT?3$Q\0%+<S,_ 3<N7@6QWDM3ZDNBZ]4QAH,N$@^<D
M-@ZX^>C(=/N[38UUM;C'=;GC-/@=K!1 H"^S$5$6=J@7WWIU;6MOE#HJ>V^Y
M)N[((X(!90S;84RH+>(I)G%P?$(9+RB"'GG3-0:[?Z!!D=%H16=F'1OZ]5G5
MFY<-ZV4=G[*?T<QV>0;*5,=_ U4FQ8#2Y6G%/!&:Q#ZM_H+7Z6!HC-%=",G\
MB?_4(,KTG[O'CN]$LA#0:%B-\2V_\Q-2+!@9+S\]L377DU8K&1KYY:?(]@XO
MEXYN_T3VBQ>.!9RPR6^1\U\C[C]&.$0XA7AZ!N.T:/C1' Z+[3H/NH.8"QL6
M;04/"*0OI"(EL09HDU:J*F;7D><U Q>&@M<ACQ7$!-U(O)0P]$7G_9F]\E>7
M\*,QS(5VTDBW0/80BY0JV(A]Y[T+:"]QY:IV^>G'-NPH]ACU.BH*Y/L'U404
MG3Y08GOGL'GE'F94$$H@#>(<L5- "_<2[Q2K=]Z$*S]["'N/,7\$](!/3?H!
MB"'&I_[V0WH9<R:96;*.&4$E9X/[3J>]89ZOCTK6C51Y(7@+4RD'[?1:%3'/
ME,D$ Z*4H)]S(:?YQSDU-B>OQ)C$H>6K7^S\\H-DVJOX,(_5R5,00CBC_&)X
M@!"B+.C*70_T@3I\!%)8(8XU_*H&D4CQ1 NO\L!:XR'YTI5=-8DU%08)*A?#
M1;2N;/OU41KR&!K9::7,OX6C55*K)@J93H17:'-&%N@)SWCGPDW=\UZS@"R7
MSP,&M[X:ZFU<F)&XTM&($TBU<[?R_/C$)<+(8B^M)Y-@SC/E/[?8QB3)XP*0
M=]8%K%ZMXSK9W<5TB6?G'+\VMHK(PK7<@-,>$JH0\UP?5K<;/V.YT>"7P:79
M,L_67-,Z4J/29(-6F6>G4OYIVL_R.,KF5RO[AA?N0M=^H\G%R5J<Y6IBL/P4
M,.ZA[MQX-NK.)QKV*@?"E8F/-A&?SPZ=1.<<$=.LT'@F0G@ B=@L/H1DV>J9
M")2A;0N4'(&4],VF0. ->V+%EC6P<B*43I75X3@G)T9N3 AK9K)[PH00UAG7
MX1*&R;PB5\:=MY^?IE?5:," D5$*Z)!VF(0SCZ'FJ>%DWQ!+/]EICIAK1<=S
MF1:7&J4%DEU</=+<&:X43Y>?A?+0^8S91IMU"KX9H#UQ;R:U*73I!;5-<^;L
MF'S7> \DPNO?\LP6(603=BN@3T=$+\/N$.0L;%!/I[.=WQ!.?B[ODAOMD%C_
M( K=I<@@L9;Q@ Z*KT&\#:JXW56PO=&?Z=^RL &# TZ58U2 A/5MV3IW?G5^
M5JA1V))HFWS790AV_8MLT!<A!(A?$4B."B%'J$EP5O$](23A"3033BN LX[C
MH(*/!-9)*"@4A G^)$!7B<A*HG?DL9CN)#8RP6)SGSV)LO\#R3_5)O>@R<%T
MJ^B733M;_.G0.,$VMG\<CC;MFG@SL[!P.BSL)O;1X V(EZOZ/G:;?;Q6R"YD
M1\."0,J2NT[0"G]9Q%.@TF6+F,3;,*505*Q'/-DRL.&H24S5[+CWC*5=KTW-
MN>;;^6F/\!T537O0)('$V1>\_6S-AS37D2G.TT.3'V+"E9+W835F&/#J*MEM
M$[^@1QO*(XM%%V# #CA/<903Q+;CR5?2=>[ +^-&Y>WK@/A0NBFU/4MUO#NR
MW(ET8-&/\F \I5'W&RD>[,$3N.$8!C'%<"$>)RN$!,)E+U,FRG[;VG]]U&&L
MZ^HVL=CCIT.B@FA(0)O V_2# P>*0&<: ^!L*!-UJP'IR^CQ;#W06TYQ*ND)
MZ'.Y>'>3S\4-5A#:T"!N/9R61'HEW@Q-I, ZD/$WE>\P!GF6F'U+(_MX1Q8[
M*B"'QV*Q/M$@?BP-8IWB9 *W6)Z<15<*5R"EZ,<]@9:V!EWV1T>V<]9<K6\)
MT-$A#6QC_5J&7C'^V+7G;7?Q6,\-K2TJ^M^&.)X<9C\NH#&$<P1(H/>.:'9\
M0B5X$&/+JX00<4M.?@T(L,_II]?N=*/_LHWB,W-!M!&],A<#MN,2_Q;)OW<D
MI!FV'A/!5>?M8"/O6)C0G73AF] YGD#XLXGQR]G1;<^^TK]F;TA;>7_1Y_6C
MW=(?I2"S%MM ,+D=T&.X CMWD'@*@J#;^%8<JQ36GE638*JG\,JSTKDH;N'@
MF-:H;T.,J-%/%98KH[,%/^S?"JL@\10]$?PB"]$2C N;T!;LP>0\Z5O";1EQ
MCMB7QE2);4F/N)Y1>.)9@]NQ]N22YV]%?K.*K0/SC+E@W V^L<$5U)ST\3H.
MJC/73L3V<[#[XD\CY?+'/ "Y*<''AH^;/T/>=8>KFT.WWM/5E"""O1"H#VCA
M>?(D)FF.SW2-.:0\Y\_*:EV-3^ 91!0%-NWX*% /S,S*=G[_LH(<MO%E<SE>
M/?;<IO#1F+OV3Z#/%3,^']J_Q]9:/'IW4"N)]E @RW]NI89MI<H(E+$C@TIR
M&%L6,;Z@+W1D:?P$RJ?!Z>3YVC<_HM1RG:['4K?"]I,^<\O^U[E?=EYLXQCZ
M@P*"]\#V:@?WTN#=W,[R/<N^ +F9 DT-SJL:*LA(%]>'9>R<L&__[=*U]WFW
M<IIM]]6.G JV74'4>\Q'UF5_/*UQ9C[GQ&SP.RJK6J"!^S@.DM)(&*NT=PO&
MCY5)H'<_Y\&)HV/4+1R/=A4XAK5E*EF6%&L@4%FA#_&X7F#T!(F\%,,(*H&Q
M[,>$AA9Y!]Y\V:^W3>YYM$[:,P+\P'BJPO65[23]WLI>N8-CJJG;32]C!Q9W
M[W9A!\,CO)3W(.IG_2Y17"=:?:Y='M 7-[LV&Z2':?+W8C$9O?%T%N.;U5[V
MCCIO][?G#0PRE26LYJ*8N:93N0=O@DB%IX>+1RZ9>."H=CS=[E"8+,8T.,SY
MD/&]TAR=!YW%G98-B6=<'11?#2]KM(<16+TD6=(490%DW7C S<+D,?I68FO#
M3CF?%UQ9]S=F/36EC[P&5P,F4MEA7@MJL5W?/I_9$]*9^WW0(VQI8?K#O2-L
M?)R%\]Z[ 8<^F[ANCDN[H#.I88 4P[7T#F4=PO$V(]J4.3<Q62'63)"+="D^
M/2;^,.ML]3:%7!'M\_Z#3;,L'!FU$:WZ-:AQP^Z,J</IX95*-/6A'A++ S\B
MSC29[^)*S< @6-&S@2N:VU^S\?'+NPH^+[17>=OD%JUOZPP7NVBG=C[, C%S
M]MB/<-J%'Z:M1M5U,5>,FS)17K4_+#8ZDE\0AXV94R1:.+2="/*<^<D7&%VV
M\<-(<(@; $.^ZSOC%RYD<U"* ;%Z?4]^NWA>ITM*UL6LF4C 7:(.=S)Q\R @
MV$#%OLO&S;']Z?/(=K@,QO<9P.ENP>K?[WP*O+D^?^J$WE.O&@GW27G_J9_2
MMGF),8TX+ZM= :KX1($J.JF5<J3 :\9#<;RL.*WF>;J]E[+.RR[UH2DDF0#L
M")L?8?T02#IP37F[P9CG;\="=%)'9A'!0:X5C0,Z!'+=K%%/7XX3R1@X:&UH
MH/-!X;Y?\^CKNM5+XAK<<R"\L[9:C_U(E5W"C^0(I/W!5M& 'NXA]VY&I'$D
MC/'K.AE7ZX]&Z'URM$PJLO*DGM?#&R@YN<GZ[W[G7O+/)[H7)5R*L[D>NC&U
M:-NM:>L%9#:\:@4$)C4$UBEDU&K1G!'['D<?.,,ZU8H]X!FAK\ESR&)$ XE'
MS]_KW-OIW$^OM748[5:S6-D6LI+Q<G;5DK8@'>B]@96:07LLW<-5PC]K\?6?
MZFKD%1>X]X?@Y"@%.F^>R.SYWQ-UX%LPH8 -32:PP9RIKSD<.%2B^G9P2/;H
M^BOQMR9>&A$H*YR;GPR_&8D!28'ADXOG*\R?:@VK^T^;%0($[B[,=J"14<O.
M2BY=F%BFV3\L6T@.JK85AR LA9"-HEQS(>2CB1O8106XV&O.S'#"GI0F_YX+
M+Z[ZUV236[-V4'6O(&J=EMY,D:KLYNOI)$7@"MD&,(^X7OFL4/%KWM4PY;0[
MM- ,K7./TC^4]%>D330:6//KX/X]-U?-18CC9[-4 HEE%L7],VV"F)T-SW"
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M<&6G$#):2^G LXTIO?-9!^V/[=ZC_O_,6(QAJK+%6=CD%4_AQ^)_W>[_7'9
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M!;HU\+@NS:MB^U9VK_E!I5$!YJ0-P7E/,X9X.<>DE.",]-/JEA'IJ;XZ+VD
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M?K37Q/K_<5$\?%.J8Y5;EA%Y!!;W]L#J?9*=HCKZR@D#GFN)02=6G*Q?<@]
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M=WAAQQPU&=_&[+;T3M^5E[T4%J+O[5RJV.MRZD"")!A8*W7 4XOYF?%D=9<
M!X2>2RJKGP ^JG/WIHA%)B,$'++AGA,[+&$C$'9I\-D44+,1A7M;6-J^&([3
MZRU  N<O-)7=2-9G.5)!+,PUO)MARZW=T;'2,3 2$RD=2'U?E'=L<@.C DJO
M.#-I_O<'> ]IOX\Y-$EUSUI9%ZWLVAWR+?H^>2M-M5\X.L:+!_;MG(X.1'K'
M;7;="/&GG@!:^3/!PQ'<M7.N5KN%H>.C]#L\UFUS>-(A/"UF)7ESKF.3U) 9
M$(^,IO^LB)&B9B.MBFE]3X^&_E8Z/Z2[Y?H1T;8(X6W8G'09?%A_>;5X$[:=
M<TN5340/QZC16=]ZR*XJS%FV9->%-3I>W[6[4+,PU<J?#!X1.= &^@Y*C!0%
M=+!.6NC=M@=)APN[L;C1[62DU__DN4 JI>03P=;N 6Z*.1/DPEM"SSA=;VHA
MW=W[RBJ%NR)G#'72O0Q#6Z@^X>0KR;95Z1H\B8*VY]M&6UB_]^A'PW^>UI)Q
M_^U?,Y=I"R=".N7<LCW9/NI<Y9&+\ &G;H9##(8/MK  7:N.#(F?<I<K)Z^3
M!V'W ".*R8>9,.%W^&[.$_L1!T;>B7DMM'!HCB@Q 9^D3Y3]I@ GI_%,-_ X
MJ,U3ZWL1/OZX3,:LJ&=11IZUHYR]X>80QK96THG['UU)QW\:Q",!ID[HN=0&
M#[WC2=N_![SU'G;C4/06L3F7]60KJT0:V=C#$$@I1\>'&GA>7&T2V)0K+1BA
MK*'#+249#$>C:"_F,O.TQC3&I9X[B^]/O]QMB'*7"A8XVU_H<-E6_NUL\C=)
M5,[=^NW?[S???(0B(TZE;<?-&>*//^[:3,QLN =4<=U24=R"M-+E1W.-MV:,
M&GDZ=,?U"K=+A^J&5(";"_3,F_)'BEP1I@T8>=IJDGIB^G'\#0>=+E6(QTT>
M%VNOMV73CDW%<NY&W9B4O2HS1NX!UIB[(*BQJ8633P!@ RU Q8\,YQY@-707
MZGCYR_=O\52[L=I4,>GX834Y_%%>+A1&G"[AJQY6=U7=__D [OE=L<\-8@Z#
MCV<L+/SCR^X+^HK;0.578FG$5B2J;@9?;JJAY^>LX*\;J0MM#9A7[(3%/$,"
M;?[.;CH97BW7US%&^VJV]N,"S[S8MX6]"^\!KZU^=.V!#;0L,QS][M;.BW;I
M;P9V%M*"7BC0TB0L0S%3-49>;8B8G/"1X,P%RDH[QM11T6<_JMHIAUD5D/?9
M*[G^^B@SM&42VC'WL5&H5F4"+[(ZZ5O-F(:"X[@38DP2]#*)^O5AZVOWZLQG
M!T):I!,W\R7*UFX?2S%B:1)6Z[SV%MKHSV1>C42/NX>BR"93R?;?I";*IZ96
M69E' :C1")Y*IJ\T!5CMZ@Y6(JY WK_7[GFQR* "%X5D"6U/6H!U]! R;7%#
M-*EZJ A](>.$.MPAB^Q<"'2LQU%H0X63]C"6CF9T+_U7M(>C=\,[H%NC[>"W
M1R(EI$X:PT?ZR\[&/M'<R<:Q!Q5D]X!_IHS$+RRHJ/]X +4PF_Z/I*Q2;!8*
MEPR)SM_>]DQ8>*V?H_8E_UTH:URUQV*<_ D98HV#W<8L[-TV>T2DB_0+IUE?
M8P9$]O]RD/IOW6"Z%"2EMI8:#W]"37W0V+5YG1];$*",)G2S6&,0#I(#(48,
MW(TK)B;DU'2W5I*HOA& GALO;@02ZD*)%;;"S[./H;OB;&,4*)GU\RD?[=;4
MQJL7D+.3>X!GNH#;B>'*WM;=(7;4U];,NW*!-JGEZJO\:8^)M[6A)63C-[V5
MB0P_(*%-QA#K'TW0:[*$_=)"+Y>3M14O"!K<=1$_+>/1LXG$4;6J6#BUWS'=
M;$1^2&T1P3[S(HW"/>"0S'Y,8%ABPNO5G2]1V/5?",!Z63 GIN+D$MI5EU[_
M@L,T7Q_-*Y%/O6%IKP?X7*&2S!3C&O';]!&[DI/Y+^;#!U 5%P5OC5HH4A=,
M#@VO''8V6[IFQFZ77><F1Z#1=077/Z6+6:8GPX3,?3FVS(.]&.)86\J>] N*
M="Z3I>2,D4ZXGKB5E^:Y/4\D&U.>RCAK&+!-CXT;E?5S\_P0\(6V.X22MN?#
M[)\]'P^DZ#WNP0D!$>0CK7-@25C"-AOP_=5YG3@,,_S8>3@'BX-#3K4<6)$L
M*2F?%3S$P[)Q#53RB?+L<R<D)/+&]=G1OLP?NLUAG>.T;[!)KH?7[@!#!!GT
MYYU\DV%N6TI*FW,OSKY<P_%=%R&L;\>:G@Q0-5FBS;ZZH2=Z%*A0-F'\P#Y)
M%;=]H%>E45,[E79#=;[D_&$Q^.L$_]>($:S9S#4S)Z?5>DOS!8%2)5YMJ=@)
M73OZ\SJB^ -H@F4/I';6?F^[&922_[Y;OG'5O,3EP'F0TOKR(*S!WJ\8*I5J
M5R54\(&"#4?B*/D'9$()HW'&C%)0J$'"XR8/0]W@D\B3;;B0*7^MBWN/@[*R
M:-3I$N(Z-6V2EDUI-<(TK\ZGH'L^<!B\O<P-XG>6R#6[SCM/M[D'\$[? VI^
M3WJ3BM74-6HI:];$^UQ:)E\I'V=.E+6PPEIH\N[&Z-U#THT;^CRK) UX"0*U
MD^&'E=<F>>4@04$J.A7G:C#U^^"BF0(8K/A=IR:V_'FMP!Y6LMA@NR#5RFSI
M\'__'PWLK\QF7(T*= BN'$Z7* !=U3?7B>)!5[^#(3*%Z^Q)-54KV_"=W_F2
M1W0E1P0J!J\<H306QQIMBC*$0TJ2ZN0XI*;V+2F[13HNGCUUG?N')NE6L79:
MX>U2!KL$N.;\2ZG?!GV@FYZ*5]CD/N2"(79,JUQ([?J'J$9^J:%SSGFP9QFM
MUMC\>_AUFA_>QM\*N+1\-L>)],T\OU2WH?!:Y<]3]>HB%EMH@ND%Z*S^9/83
M]F+K'$8-78M5C8APA6G,F F]TH3OMFD@^O:9M0]ID0.GD=W\KT]MNM;8)3PM
MP_Y$I?DG*AIK>['H;JTVE^@.X=*"YE^VYX(WQ/)_(6;["YRF7[$UBDOW=E "
M8[LVXYBL?';E0)+I-V*7/X@+E'2;-^10^(=J5W_9H/C*BT@+9I6_IJW@"ZC/
ML*1;E"@*1+*99CSM(XV,$\"']S,$'1&WE$3OVQM)&F5OS3DD"720'E<XVT_;
M^C]<!E#2?O3ET/\':\J>U"\$Q?*_N4+:R,^ZZVZMV1EG+"H Q_.BQ\^!FKH_
MWJIJ]Y D>5EP_6"&ZGE%U)A":.3IA?&B:JW;Y$&&U_1(Y;]'ZE>,T^M7*L8+
M&)OAEJE_CDF(I7<L4D\")U"5MWE2OA/"T/R:W>Q+>Q>FDICF*EC4-!8NEC*1
M%_J&;D9(K5=K_)1 !S1L1@K]QW).0>1*T-?'DK<?,+4-3MHR]^8/QG=:DX]O
MF^:IR[WX_8+\/JY.7Q%<$:NY+2A>WLVA" Q@?!89Y<5127''4GS2!?B1\0\V
M:"P!/@'%?DJ960O?S-T^(6=LRL8J)P:[Z?D&TKZ Q+4H#YO06P:N5&U)L#%>
M24MC2/]+AZE89%.T];Q)$_PTQ8O=>NDQ%M_:AR-X;L#>S\4,]BU+>$)EAXE9
M5??4BKD;4]IY&M8'$6X%T0>$8/+4.3'1> FM2;O.T94P=F</?S6MT*):26%D
MC0.2Z4M'O??-IVSA9!6AO+*6&1R1$#X(ZK;XX^2 L$E\;#.2BLT:WU\H'+(K
MJJIJ ,I?L7,#];U3X2.3DG0QRPXR_R%$=232M:L.><?"=3I?[C0H0TIYY4[A
M;EBHQS#3-K5NC)DEGOWDPY2']S6%X M>NRGNA5V5'\$S7IX!3GN7I-HA#:NK
M.*<M.IR"].W&"[>_MD^E"D'N[-<?O<M*4?D%<1;P<=<+B*U"QY&@@S;!.+5U
MTXQ'371<O@293I$;690]DV<8QT##D7B8%CRRR(23Y3, '\6>?;0"!HEG%!='
MMBO1<JQ9=SHM?I=%):H/ZY:?NF_;?+9!MF^]-^TF=;WH =Q]+M69NP=,4-\#
MUKG]DS13!5:%B=9_<ZM18M7?+\72P]HWD4;Z",'=P&>PP7O ;R[Y!0Q'G,UB
MBMB>1ARY>$V+OGY#*1JJ=R!_)!A1ZM:/P.(=:_Q:0O/VAJ>="%D\#;*;AIK!
MDV1Y&$R&W!7FFN!DNIV(EFLFO8G5&"PKXWF54[+/D@N^G*7GPOX5K=+;VW5)
M5/;<359BI8Z)U5$+NB,"(DRV5)TW#+T:?1ZU"]O/BLH?3?ZT+X<Y<F#8/8<:
M8NT%\-2?E9$WZIU:I&4WJA2S3UGDF4LA>]E]'JQ_)A:-UDUV^EWTLMQ]2KYI
M;]B*E'H?+3^]G'+L8#LCA6?8-?&2V!U+$B.;*<J/Q4X%X=8/_8PNI5)_;L9#
M]<I64?>PU%:19AE1K]HNR41U,Z3;M'7+4P4</4M#"Q#JA[;9A&K[UJ11BYQF
MO!QIB"H,Q]CP=]CK+M(SK\ZVK]08MMD.LY%B.J-$4@*0G)P>Z^[)EAOJ047'
M56XMQOZ;*90\)\XV"FUZ [)CCNY<.% 5EL%LA@@O.5%)+5-5ZPI)BG#EI>B3
M+S>J6NIJ!APIQTHEVZM3@N[/ML[I)+)RJG;<\D>IHZPY^D^3+@O"J)-_MCLA
M D=U =:=T,09-_*T"-KP@=*&E;#"3G^;/O'LAY$D)=L,*4(F;DH:J4PT-*/\
M>LTD#9B)8+'!,*OE0@2XQ&4F*5Y*)>AVD%THJ5#A#\BEH'[C']5SJQS'A34[
M2'04?YW#7E'$/6!.NMZHI$IC.>[8\E'\0:8:"<!7@O'A$0<0[ZE[?1%)&U3?
M*FN>6V[3.RR<KRE#>PRL:7/U67-$;/9CG&H[OOE !U/W'C Q0;N7N%L/=-1^
M1.<^)!C=8R&+[G%3G%H^3,)FCE+^_,B=1W5@@?,W%\7FIX91*_)-**"'KCLY
MW"U?=>@P*\<V+I>;1Q% UE4=((OBV&1C!58&>$A'<O(VZR:61"YC_+3#E::'
M,F1GDZ1E9 (S/,LN4L'L[S%$UE>.LH([$7T<[Z/U)EKV/8T)L@-0$N-:U-ZV
MX0YUX;Z^OTZ_)QXZ.XL_Y6H72I7V A"RJXX+V]&$_RH6&KIZZ\>.E5Z<7S:.
MC/)^$V+SY$7! WE#NE%I@R62?NYCMW&*D*PV%2D5!5Z('*GFB*CQS\E'BBDJ
M%&2L6:CY9*WK=(DI-?MSJ'F3QK;\C@-OPI#;6TZ"%/>*V&X>/URM6\L*KZ-I
M%.0BJP0&GX>Q98HV-M9S!3&'L;O,W'Q2 4O/?.;+*-?6[+:V6%MRV62X>=SN
M1'@!K'M4DZ@;U<>,66&T9^\G][TH(I"G&;(/+FD9X:>B8KGJ>N*"13O(B%E^
M#W@0=BF#V;NH:'V:;IN&Y:Y$)BB(NJ 1@+5@^YTTULUNW7V/EO')"H;%J?A7
M-919V_Y@-\7P,([J/_,)FRPY(Q+7$]N7()7F#&J],M#;=[T'F"B,)L(%"+BD
MP#HO0*IG=.I*,7/9-+). H1X!3HE=#ZUT%D_=KK/+D8YH#)K0ML<9F)G'*0S
MP</_1,^/+J8Y\)AM]<=^"IJ1;1'+;EZ]")/<35U,IY<YE!>+]R%-D 3F;+:R
M85<Y!KKZ4OQB.%,Z4%?#<(C.OLBEZVG%0[W,H6%C.+,_4"?!4$SG*+;G2XAM
M*/4Y$'^:[(0YP'2WG1%AD_*&VMO!U,J#Y;$I<J/*L1U=(NP41,V0E8A,L>IW
MUK/;-UDFL,MTS4[!^\W'ED& 73LS_:?8]"]8K[7RB,U7<EI_,3N:9P_2 L-3
MO&Z:0BEO=;_V;6<*(,7.5!JU0X(D)"4]DM6!Z;WLS]XA>901&OU;N"Q+TT*V
M3@(<?M$YOW$.M#Y\PQ Y<F)$&C0MT"'TB7)AX ]DS3F3>A4]/0+,,-TO,-:7
MPH8N0/0T "L@;:47YSKOR$J_R_IK+=THKKW/J\5S8E7(B"MOU.CXVGC%(_/,
M"-/3H5..N[_20)'[S-%;4:7+UCZNJB34Z$D2-$(9P@D1G/<P-CW+F'!3\VL9
MT^@33;%0[?YBN*OUJQT_8T$=K^PO]6+CT%C*U,= JN7A8>SAAF%P;>N"TKO.
MI"K/5 [=?09!]* 3& [37_E7_J?:?PQ*6#Q\.0;Z](+M6:" W(B/.I'9;_+Q
MSWN9FXTS]\_;2?$N*PPKZ1>0"=L+WXI^L9&1D%M=X\UM ]LR--KV"ZZAT*<_
M+J0Z3//=XNX!UWGZ(++H%)LP71S]*:E\8\N$HY75&$&AU!NR(?7?:_#GVCFL
M%8D79?+'>,R!9DI@<"R<7RSEG:S#VT%&^N+X\9;3IQV'0K[;CK7-"M]X9SNR
M];QB^&9>B6=K Z#G36%XE9(RT2=_=)7_LN$K.7IG:UD;O\>JZMJ6,KV7>RW_
MXB]4\J;4G<&5WTJ! >B Y[35WY[[-WI5SF2EX.;54AFV3]-TF2Q^-HL3-+-L
M<YY?]<AB-//(_K]4I^ZDTE2*!OJN@7=;5!PI.[FEHC%]GQ>G.WS,^*<97;Z%
M+5&&U-"I_<K!B,'RV*>\!V ^%9$Y"JY=8FEMG6<HAO&A58^V#%J#K)@87Q%U
M[.\9--""-_ D&A3/"XO.-?2D&2MJ%W?K'U#OQBSCNLL*'O9N<L"4HI8450CT
M^&%Y7GSH_NWB#RV9BIJ7+,_9_$XA15GCIZ[Q&JTK5@1) K+RV?$,)-&(K(JQ
MS.U?Q9=I$B>8%MDSUD*?RN*B'1U3OW?75D:6)GU(\^E59_CGP1^/"UYDE^:D
MVB\/6'9!?OZ'/3.2G\X;7[D5H HWPPV*2CH$"A^027LU-,!8 GZ\:+2+YK-H
M]8.=@:J1TK(6)B,EA=Z1T5WG(RQ[DS%+JI6?;!O:6X$*6S,6T,L?HJH:U,)6
MG"X(M_P6>%EH90]#09!UOVWZAXNR([]$_BA<VU6N,9N=A"ATJ[L':$V">Z&R
MT>IZ3 E"R.P1)O0412-1/]6;O47(OE:.]E9P6OA>!3U82E1-?Q=55C">#'13
MZO6>RLX/M)KC8;)-T=]"NR  -@>TV,#8,?E:'WHW_"Y ?51;Y7&(IH6Z,8)F
M<W0<>+65+#TR LNH"V7(.!27/%TDD5]6F.H\#?@^26NZ(AIALSH8 L^,F,X4
M".BTCC_*A:5+L(!X-MRSQHD(NN)ZIA06IE>?<8U)<M"LV]#*NNL:7'2>N?M@
MFO$A4KK6WMWEW%#,MUAG"G>=TB\&%NJR20^6QEWZVO5;A?0^C>PR2PN@H6IV
MZ+U@RA$1'&^,2,9?%&MJ-7KB:5%2]_DK8>Y'8DG\J9BZT&YQ94@@69=AS5"Z
MZ57T@8QG?@5UHY:F3"%JAH@*J%%!GV/B,3I42#R[M<V^4;0^<21%$Q]C5$4]
MBL9 >-1PNJ-D>E3BKW:'MQX-"Z[E^&4@<K:8LL:1X]>#]L,\B$F\0HU:^A\\
M7?)[655*X-<),I<N?! #1<L4%2O 9W7).S"?.LG^!Y.9P][>PL\'$B;8&ZKE
M[I,&A:;Y=OG/-:78H J$/^AHG.30/_RRX-0"%NAL6=BI:ZF&SO!?BJ-A/6F.
MKP_XKH#>BU$'QUISR?"$9?F,=4\M&_=E' >0:T4KZF/*,!7;FOJXEIH"*PP5
M:YF@ND>$>R7U(C1HM$UA**M*@^>(AT6>[#EQBS?.SF_/Q<6RAN>J^&5Q.T>
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MXH7*?\V];"G[=VL$Q'[@C?[KR_U^^O\ 4$L#!!0    ( #V%?%H.31M<8F<
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M7:[ 8UVSHO'?>KK7RT<%\[-QN]C")]YYO_72[*A=N>C8,;5H/^9=&4GPF,-
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MVD&+_8:Y1Y;P^3)&$[GQZ]6 .LQ8K*21-FH*-?&+2C;CQ.*/Z'I8^*XN^6'
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MVY+2-^L/3Z-O<X3SUE12"!&M9U81TG^>G0/R(0WXA8VV)\%TW?E7CZ__IRT
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MJA386BT7WWJV\Z.VZDOMWBCX"?A'F=1!^+F?LGO\4.JM(L^+K"6AI9@"&X.
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M04:>S#.2V\J-</X*TQ.3NW:M^)P*VQX_)Y*FL\]Z^W?Y_P%02P,$%     @
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M:0N\T^EF4U09N31R*]DZ1G1=\DJ59U?H@A[:>P8#-<=0AAJC[@RAO5;^O;D
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MI9 J-%Y<?N9XB,LR^1RE\0I([9+RQ,#O/9YE%A8D'>NL_CP,ZJ+HW,S->71
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M:#%*ZQL )U\+A6L'%C#G<WF@S.;,<6/"$!1#PN-#/I>5G=H=ILR)P6F5Q+;
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MY/&YMTB9A@/ 8QCVJ1(_'1: (^,V<ZK:>Z:F/\]96^.AV;'TM ZM&.QU,?\
M:+YK':J%YRAAY?J3ZC+MK?,A-WBZ-NK,XT[;7?BW>']*32>+TV[QYQI.D?\
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M3! A".\9P?/GS[%P7Q 1$A#A$SPG^-,)$/'I.TC(Z,C(Z 38F-@$_^?RV [
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M\0L0VI:)C$!U5G*F@ 4T.*;K+C;1,."H3Q:^0#1@T5#.X9Q;4 6KX'-FP81
M1 MI]_O1,-G<&ASO?>DD%"Z"]2M(6D=Y8K;:#\5,V/GU><D0N#0G;927<7N
M16#326DA1Q&RBXM"O1DS+K"*M.*!F(H8CH?_,AG,@($U*4=A<HSJ]A!\9J)!
M7T6OEB(MWIY 0)\GOAB/@[8YC/ >$V^ YUZ^="J"([ U9"FXE3@)KB<MATHB
M&?RQ6>ZZW;A@8\Z^QW!_A VB0?((Z(,XQNQ%*N8=:#6Y114Q1K'!(>:H..7H
MW>Q+O\\#A27'8ELJWU^+8-?M!6'^?'@M3V'+SS1/RR-KE)]J1A3I+?4$!3K
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M/#X8&!G+4_C>JVSF\=V>C7/<O>*YR..1;G!.NY>9]-V\GFZSXBW9E9X5GV3
MF+^TE>NOH#UOK-?_4!PB98(89E^MMZLH("W8V2TA<UDX-,PY<,!84DEB3Z\^
M'&]7B]ZAVK'!?X_'%MY#RT5FG6C9&9M#(TW'0&T1\%O63]@HE)V%^D)\+%\H
MFX^" PWL"L3L%$(@1,/8T[>9VSPSJY/_JGB#8N^(KD7J(J#7A6[',*P] L-U
MF'E^L9K]IH=WI;:H-M" T0"O,#E0@9^ST)PN794$FR^\P"XFIF>J=FRT'F0D
M!IOBDG$D Y=9[$6)P@;>SCQ3_Q(-+1^+C%#;9+0DD0($L 'H!-<Y[#\LEAK6
MFC+1E_+I)::DJY_?6&V]'<C17D7,9LVP34 H@3Y+13#N:O?!$B.A:J?$P'<+
M,$-"$4(@H,9:D>@ 2!@3HF$)4&_S+7%(52GZX ?D4D7+M9,CN74 HQ#L9/@[
MCZ.0F$%H^*@0(C(T;0H*MWE;K;)%[M)QVY H"<TM_)]P]WSFX^@U^</>=2/C
M].1Q;"TH]"@AOHP<7/9Y&I[8&,*F_D5!'@U2N]BOZRM//"^DOY[/3M%^+*92
M.QRDH5UF>;<(8=@J/->B*:::>*$QH;CZ;?PD?3_RN;,A7ZL$@@Q@[@4B^S=T
MWY6 %41!A_"O/GV^5 42 ;Y3F$A ))"8<0Z-F!\G+KLKD=@X/@ =@.U#$F"!
MA(#D.X7>GH%DAH1@%X7DHEA=1Y.FH,><*4[7YQ_\TP\QB2%%M&@20SB7BL&
MAQ!/!>:6%[(;&E8Y<#&./Y]TT9L0;U9U8%\[^@BPMKPLE)],,G=:2S*7OBZD
MLR"!FL'YB*4R%7YP8J#+&'8,OT%-?7='U8%"P?]5^^6,PJ<A.<W1LA09\>00
M!^Y9"0P2]S%2-)5.?37(V#H=:N,KVQ>:\/Z%2J> 8BWK@Z%I"7AO-=*M$E4[
M@7J%BA*0*CD$BL(1;*B"WBD$2D5?AMK'@XB.Z3J(Q9%0'V?_!U!+ P04
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M&Z=M # KH 3PF(GA$H 1S, $9CC] ! & ,Z8_4OW?W".F>6L&2,KVYG;C ?
M<$:;\8PWZSEFSC,O R,3$, ,/@<1/W^5A?<27-GF'A2;Q"JA[A=)J/_,=T$%
M==/7P#"O9EM26E7MOAO./XI4V_[SK!3T_VKR'_Q+  K^?YBG !Q,#&<DF<
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M]$:97@F\K/$*P#VNWD;M!,C&&Q&/Y&60W3HPX/1/DV,"L@D%$,/YLW)C3JW
M^3-?%C/ZR3A0C+X"DC[2%_/)'U+G:59%;CNWG_EHV:U][(B.N2\'SB_C*+6&
MY2=(TV??U^;>O$U*,;S53TE#Q>O]H6V3O_GUD*!3AI[U/C)Q#S\ T\A1]/ZB
M2C#CP]0^R4E"!!Q>CL<U2!;WB7X[7?5C[;C0&TN(@W/+#%=UUS[IUC'YBC3O
M/GJ97*;T*6/^9 Q135@KYWW_>9Q:[%ZJ%X37N1J2!"M $<LU^:;B0OLP!<HP
M<*/09'463[[#)/)IHP:GAIFP8G, N5%V6:^'5F4)AD2L,<MC.,F,O:QLVP6/
M-&RB_$*>.Q>T[J[8(-5>F:&:8<L%?!,NGC!QO#;5%+@N*#XSX+UH)DSSX'!K
M3E<H3^B+::%Q4N8+S7PQ)^?]<S)7YB4@1'$FDH&$\-7;J7^<X&#RH>_-W7*W
M=ES__XY5OG+^'Q&)@7@6'5DF3V6Y!<B4WQ5=YI>5%=:(<G!OJ;&1DTEFBON&
M._BXV6V5^&PZ!7/V-CF2VE+,& 7])Q-^RP%E(3DY+[Z\@\%GYY?OO;O)EZ4@
M*J8&OC#S!KZXN;XT]![C6;(6;_NU54J6A-_]CB_4'7&\TXT\1VU3WHCQ:98T
M+S4>*=KH$)02Z_JT5-N+2+Y^J6[WAZ$K0$'JPH?AG11"G>W>],W%NSZARB<
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MAHC8&CCEAX@=*I?AV'U1/BW>Y0M&GQ;5,ZE>ZEC9$2/!@A+MXE1S6RN;DM5
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M%%)PM*I-!;>,Q?<9FS#-Q!L44S>]T^.?\7G'T.X;N<JEX_A^1C,?R?!]A8.
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MQ4I1),9,!B)B[;ZHC$$3!!-?_]E02P,$%     @ /85\6@.%69]A3P  )%$
M !0   !A;'1S+3(P,C0Q,C(X7V<W+FIP9ZRZ=5!<3[<N/+@$")[@$)P)) 2'
MX#X09+ P6+ $=PD:G"3X, /!(3#XX#.X)K@[#.X6('B"A"_O[SWG.^=4G?O'
MK;J]=]7>:W?W7JN[JM=:3_=S/W>_"B 'J:BK +"PL !O_EZ ^P6 (@ '&_M?
M]]^"^_?&(\3#P\7%(R8@P"<D(28A>4#\X $I&24Y*1D%V8,'Y+3D%%34-#0T
M) \?/::E?DQ)34/]KY]@X?SM@XM'A(='1$WZ@)3Z_[K<=P H"+&(L4)QL)X
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MX\00KD[L([F\B):GPQO._?TF7MZ0AZ@IM>ZRU"]\U6'IPO_8N^$<>N@U+D;
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MSIK[=L6?_%33F9Q)A/O9APRG>4DI(Y#J73!*=ZB#!E 78RD X3!=JVIX%5V
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MOQX#_=0X(G:&1EZH]V(<OVM/ET[S[LW*?OQ3?GMRP-#]YVE;>2)W,7UYTCV
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M[*]U@ITR AV+)H/;RHX9AT GX!_C]_08M2O>SZ5Z1[?BA8+ZJD)GAN)5.>5
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M"=BZ=IZ:1%;=//,2$RQZ"43)X.]?V$D] TD-#'/E<; KN'5UELYY>(P>6XU
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MW3>/)OW,QZS'^OXA]8M<N%*WJIU(8LL-0Z/<J4TY2),@%QF$0[Z^A_> ]9.
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M.-EQ;I9:JP 7Y"7G[M/ FC:,WSU'J,?DB#N]7_P*7'B-:'P%C<,G:EK&333
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M-@I"R8&$*+?'GO@#UF>KK3&Z,O-B.C"T_U>8!!2SK0FUR23KJ\/3H[4<X:J
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M1.B7YY<*SS4 'QMGR1YFTON AR9T'\=@D "CCW-^NI0FM^JQRZ'*ULGQS-F
MO:T\*S+L6ES[V+BY'67#S7M#:3I=+)L:0;FB[$,>82G_*0SFJBIER(W"96!J
M'D?9RZA?[5NT(>.T(&%M/A ,KI$:]L <,]*2),AN!5PZ9DSK\\/#)Q^JZU;W
MOVE+,5T,39<K_H2((Q?@VQVQ&@D7KH^=/#8?>1@2XSGYANAFY?KU\&1M,)9"
MKFD$ A,&=:4R*@)YA:RC9*5GUDK/\%@90I->2=U.J_G7=3$AOMHW&]<X>@JL
M0)19V>D=$R(5A8=8VZ$]>'JGV\_DM*6? -;(NM]B]T\ I2]RQ^23-ZWUYM2_
MYUN2U&>H,K599AO+UV8H[0;5:A-W^BWXV3Y@<&%>%TCB.GNY*%DZ2H!R-#A6
MU3&? /0V<_0%P0;%P9O)3P!#8UM UK+<W&;P1,'CFS&N2N&6X)H?3X!\A;\-
MV09Z6.3Z\N3ZVB=7SM;W1L5F77TA/W>!#$I\2W'C8G_[N'B^:V&*;:8?;,'R
MV$@HX-+?B"@,  ;:Q>*VD,5FY$&V'_NIN@.V:1!^LH#Q9DSZ4.&7\A2@M-D
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ME'T9@)/&=2".7*MI>/02.,NPUY#_SP2M436U8OMF;17/;MY- 8O8$V!QRS1
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MG17@<KE?GW]/R_^!"5%V;.[W:J:\3C>N,'._QS=P\,I_PR =Q^>WU=(SD%5
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MI4]#)E;7+=LQ(+"XIK7K!0W0L)S1X?=W[=+ZS<]N;E;LA)$:N#!#=?7X1MJ
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MH(ANB'=;?4(DY=.Y'5'O0:>!_1RE^K4_X3C[X4\VTA_[Q.Q7](!4>%H)S+5
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MX^W*<<8SO@$:/][T#V\R#]U!I;*(E43]LUK.1*U*=9E&O100CA=R7L.I6FS
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M94%F+ @^04^OR>AC(.3$>DIOV=>1>R])83TC4"4BQ,_\[4G\G8MK]K>Y8Z1
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M<ZL3M]A8YJ4D^1J++H9!%7;Y'_Y&R298?.+P5S@3OORG[_?D>-W >."BY1.
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MIYR(E_KQR\AG$E-WP=%/ 'CQU1-@H80A<^ES[BPJK4*4,'W1NG6-254UMV7
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MD]085XS!ZX46JJW@AT*/QCNVDL*6U=Z1:*@5@RPKK+HP74+2>11U*P4-I6>
MS:B6W-S@Q"%GCA]5\79EY%<]>?(!A5.."#:4"*,<A)=6E<5"BXUD[3G+ITP$
M+U!OD8[FW/G@GU[=$=KV&Q+35,2GSA@:+T:[D?&@%SW2U#Y?_"'?V%J4@*W(
M=.Y)U9M9Y_OLKQXT!K0Z:!@:$10DATE&IGI*\R5S9<VABY<'H[YB'-;WI2>\
M 0?F^LY(Q9K24 ?)3(+/F-VG9ZT(QDQ&3QS2*(9#MZ>.FZ9*R<#)\L'8S2V;
M]3D_\8WV%V@:A1LC&]U,:=V T6=9>)<DO< (8*>PQR-8-K:U;?AGHZ3+^,@=
MKDI</;&4]]HP>VB0X@%K$2/]K![#FB>,.G9IF!K>O'*L0>6?V9LXN]AL9"6O
M14!/2CA25U3JJ32US*((%.USP7SYX;3KP\5QB7TB^73"NO'1(M>(11@O9^J&
MIDNCLH,6B"A8_JW2H@*3&!SK>B,+DH50U?PT??_=P"YR-E(H5^,M@PZG&7AG
MO3^6C 6'P5W1,%4Y&A39>0*@GD3Y_M\"(&=)E!#%Q8VZ<))?IV.Y[LDAT3ZY
M=!C3C>>W+<02FS:HFEF @:9T,CCS:7R6-)O%<P*SD9E0%Y%R_I[=04DI><VB
M]G=($<9';SXN&/4@!B!I'MT6(\C(O7B9'!7G;&4>WYSG"WUO;#4EI-A(20H4
MRL ;6@0 H-02OV6]_A'%IK$6R?76AYO)>I*Q>=I[!8BUTQ"P($_V;E&1EZ)1
MV)?7LFS$S'TR8UAYH+8'CK"4<=EUU++O-^[/W"=6/#@'*2/-A+'2"3KG:0,T
MJYY#S\UP;UHRM"#5]^8:BQR>#\@<N@]A?2PJW]GHJM6VZX4:N/*DPHD)5^'J
MYA+BC[)&4VJN<<_W390Q,S;8J)O[!16R2#82R'$H?P />CHX2(XJOKY/GRHZ
M-0=NBJ$S[7K[A@&_O0*EEA-^*1)DQ,W+$VSH'Q"SR4"]*DI"B8HN0$&=OVF%
M/[S'HO\F9DULPC/1WL$U81'-1O+1Q+DYS(9Q"8V;[F58O)8(II,PE+N3@$MX
MYI[&]\3PATX#V"0Q$YEYV;U0<"./G(D+A P%X>KLM;4OF=@\(YIPQY"N9J2<
M=6$RFT.)B/QJ=I^W"&N7J4^) 5^=6S@=7O8KBN*O&;!7T#0HR+LFQNSNT;(.
M#)0[T00DV"XU@V?&*T\-:!K[?7,L1T1 '>Q$?KF4(5EH,8G)GIT7192!!)Y@
M7#ZQKMW:R:6XU0_30A3J.N&F6X7==$PX;MK^\6S BSR:N-=4I6O<AMF\OHF^
MX70+^'I(?3!1FN(&ERW\NH1:)V&FCT_4)D.(HBVKH*K_4I7!*\<9WQS[5D8F
M6A+W*Q<MQ:FEHQM;4I>WA@>\7X.@^7$*9,?;N1Q"QC!@?^XGQ4KAQZ_X1TFK
M$:ES;*4G0D-4#'3*2HH*FE3G"=R:SPMM0M]UCZQ65JH,@P<ALVDE;+'#X$/G
M)"J[Y!K:N+H7X#626F\"*<Y@523Z/LX@5YW20/J^E%6'JHR=T[+ZF7Y]PR-^
MPGTMGGH/0I*9EU5@^0\.(B0F2/29LEB&+E"M7C OZ]&<KF-JNN?KQW9J+2;_
M#O!&-8N"QL UY:O%H.$UYH/_:/9\-?\&1P5SZE/FCJKME:!R^5=1]7"LD3<-
MU^73J<K7*8W[#SR^&0XNV3+],+;I-\*J]<8#(/P\HH+W@FN$",&J%YDUI>G3
M\1(I, N).%IA.K1I@8/NR(/SK>))#5!U B5(Z5F3JA1#^Z4.&%I_ZI'?M%PU
M(1OY5B3<G [DC^Q"4%25NC0DM4CIG4;<GRJ GDRY48 FG H&K3;(^O@8.H 6
M7[BSN:RE^$IL(77>).!-2-C;5+@X^7I>6R60LAE5?OS@$!;+,S([O=2WWGNI
MEQP)Q%92RG%G!T GE=H0S**MN'U!3C;%@D;[I5-F(1Q';E\=.Q[\.22SI,N4
M%0V]UBOS@F%AQ$%XLGXNV@D>]X0>O.SE;?PD:IF<;T@IT#4_29L7^W2GOY"X
M>^(12/"%O>@ZJT1&:9#UON*>]UO?83Y?TB#^SS^BJ*,D">*M#5"!9)_?&?A5
MV<UW^3V(U@OU [LNM\>%=;'P-WN3\^&,%@D4#DI!-LV(RP[) 'WT;XWB<A]X
M=3:EC:OBVC0MVHO]TB/_<6-MP:.?>RTR $KLH>XLK?CU$M#&.;^AH0$->Q>I
M3J/]^93Z(,(7BG2K"O_XM["IW)_Y*U@\KNW<KMH?-)8K9XN/JXS-$91)2(@=
M?^#+9BJ[+Y-0#(DU!>626<@X>2=&8A&#'3ILRA23O5-B>L[C9,H<@IA8 MJG
MP'8VRPB(&I,5O:JFJ_PBU',XCVG5 YF9(P35;.O_[:AHS-A^"9+9%V95E71,
MX5L+&X*6U66RD^KFZN"Q 5^CXOZD]3]8QB&V(NO1P2NIWOU=0>@0J,'@/_'/
MU8"E>3STT@L2G5^<MX,><D<KU**_T_X!&&81SF-D/;L[O%6V0M7;&G!GK1TB
MVHQC7:.C)5"\!Z!.^\^:L+0)'/H+.M>:W&BIB$*RXF*^&+8S"TUG[2+U3:>4
M-%%-R@*V!L=?K<RI5K$9OX9'VR;HD*\S)I/Z#-)2X[[,H;V;W3SVM-;[=(Q8
M#?')O#L('5,Y\^+ML=*L83,ER#2O%LJO.C$6I:\<E]/9-QC#]:(Q;<EYPM@(
MZ59;!,/M#0/=>:;MC+ -QQ$WVT,:S(*ZQMYV!J>G>HYT$J+A#O:[(XAO]Z=:
M@:(2B HYUYG6 *',T[%GBE6C6VZR)EDK;6O0HV="&H4S!M!088#V(:+70@-'
M[GP__=[(IJ%]9X[OE&#;X=MH&O&Y5VH!HJK?V4:/6$BR"XJ+2=_HX[;YG+ @
M.JC \,03>H[V@.H@?VJ[?<=2WQ+[9#]WAW);BF?X;^,M:?'0Q(#OH'/[4..7
M3L<L(@*RX(]!)6T<AYSVDWDMYJY*7^$Z4<(Q&Y"W.XR(.I?&H:6DHZ?>>FBK
M4&*O=3^)#5#+;>/G(QZB#V8<G:%[H8BMJ&#D@*LX(":/@>JM[9O]/3-T+/RI
M<3+A^-76 82]U/&*83DHJAG3;"M%09W @BNE21"NI%UYH8BM,$ Q1C/"%X^.
M^-8+5.2#ZO3@B14(YY8,Y?C#7X^3.YY8F&YI:KSK01\^^;)RJ[.JR&]WB9FP
MP\A54A)<7'X>$DZCE)QG#K14^/U"P!YE"T<=TO 4?[FZ-/!CH" (]-^=/7H.
MOGI;T4^0BZT1!WI\C7N*<,[YE69G18;4::@OTGR2LI!*P\.;H8?4U8N*/!'T
MA44G>=C*TVK%=W%A282PYA] V"KG[N(3_^_ZJH(@12IX?8)DME]_(_]^;G:5
M"0RQE_HDZI;BD!)@?/VF;<LINJ=?VQB3\;6D4QBUI  JY9W>E_7;6 15:3NO
M]:SAP6!QM</[KTR1+NFIQEI*S$@?:<R &@]]A6_W#_X ,!<'1Y1+5Y>BC6/E
MN83'& <6AUR!'&X#\B29_DSJ3CF=2+<V6!:C",/I(>SM5>0H2?&9P9 .\?,&
M+X2PQ.O+U@4:U6OK75ONX^H-+YG%UD//8]%F#_TY23+-H6T[+)>)7C]OW,PQ
M-K(K>3\+7\XD$ N$?TS"X7Z77N;@0:U4&S^$P8@A7)E.YIRY/]4I$ VIE@)B
M!_C,]1"R^V22>;=8LC@Y';CN.=;_]\LH+3*AFL18ZAXKEE:Q#4 OF:R$YE7*
M7O@KLO,I/;E#"[ 4!-ZA+$098BN Q^:>J^_S QE:]/"8_[4*UL&SR*CZBY,)
M?K%(2#=1Z&W3SPQ?X;8?N#^U[OE635+!^1>H6NA'>?'*"6X*P]E?*RU)95'I
M+APXTZ,D]*HT9^2J019Y>C_?(."/GQX\HE5XMI6<P6 E3/5&+&EK9C%]0%9B
M^DR;L%?O[]Z&J*U-9OA]:@-L3*)Y6+6S@0VW!MNR8%A$B)51"131CUR0@&MQ
M73+QS?W3T8F2\PY5@[KLD%"ZQFMOMJ;/.<M]5'J.Y4$*MKD$".^"&M+6#R?7
MEU@>'J#'#A@<E("<!:[DJZ^7+G_AGP!:T*22V45\03%:,3,)(%A.\:$,;4NQ
M:4V"O08Z8^F[V^R$A-$FEU(RH:PVE73LKD^TSCR?>S0=LAS=G&AL_-0")1+/
M&DIC*TW]?&$31%)4IHRR2YR$P.IQ_PJ?Q6FXE;L6F_L4FKYG)ZT6TSA;T)BK
MS.1>/!PM.IT7&KIU!P!T C0(Z[UU;"/IB2-=6[N^RVIGAL+IY!25M"_#D?&Q
MDPD2%(^A"B@KJDAIB:>%?_DZ;VM2Z7+'"U1_CFK[:VVL;4^@2?J$:2$Z%8#N
M'9W206H<KC#*ZKS;D>V(3/2"\[%121%/ZA)EX2BX]!"MT0?\LH)%:?)4GH6%
MMB2MG',)HR+A)DKD#P!'/I(\W/"MBA:%SN(OM_,#]]-O+E+ZCG%.<RZF'*ZB
M=4%9+W-&EY,,%_0;^;ZVI,X^QN2H^=@%U&XY^?771J',_0\ */HR.Q;K,L7Q
M@T :I*_39X/+55N?I>@JVLNRAWJR$5![]6YI07R@NGGSFR\5\U5="[H/SR_/
M).9>K/'U'_H(EF&@2%.KO5'DJ&NO'>B+DW8!]P><)<=9W**'3)8[XFG]L_ZB
M-[_.=N%XR?7:)QF-0(/Q+LU!,VJ',U'UB_:.@$4DNB>\)/&?"G\ E]'J@;>J
M#/SQGV!&?/%&OTR^QG71S^^T&),^$-R>FW7GL"U.-IA3*X*T_3YCM"OEUNK_
M6&IXI(K? 6'TH,?%$IKS$T^'HM&K&6L+[-$.#L3LB&F%EZU>KXR)6R(Q>M0G
MP1=5=L6G(P('"E*(4A:K'ZR+%'_S>5D+CETG@\J#)+R"GX+YZ6\:_C&(_2#W
M#+=[_/RH'?:_[^\-ICP/MB)>O=8&*I.SZ1FFDZ+X'24GL6]GC^"F9@  (MK6
MV#V/F)4%25]?$G7-#$2_H/(NEDWLI'BA,8\7DNBBE88YJ"?)I9M*P:CHW$](
M5D(-$K(U5%=%#:[/F7\;A/!RFO)@P_L^?JJ"J,KP6S)_M'37@1- SH4B%96R
M7TT>1MA-2XP14^MO%6@K5K5O]IA\J3T^#C?ZU3RHEMD!_"&9/M-^TTSG3=<+
MPV3\*QU!R6T C$!WGR,(#+S@+XQUR4U930"%%_0&L$#"@ 'EY D(AWQ:%B06
M*85^Y],9Q;-#1U='M]'H^-+J<U;==V_82O?WFKZ^$5/"O]==P&6H>0&D1U-0
MK_T4!&ZS.WE.G.W \TP5+;Y Q,O$;7_K&0 //,+HIL/J%]R!N F28^H)94!X
M-SF&&MX='\<%4VG*9F;WE_B&6\?E96LAH=/[&".-IJ1J,VQM=MR*>!E&()(I
M:ZU>, R7-E=;NQYA\A!8/-:Q0'I'I(%MV""/)79/O/0J]Z?B#MO-5]9P0A\E
MY-;/>PI'PM=WT\@F3^T>Q\+E)[.*N@CH'#H7C4K$>6IQMB$42KZ3E]H=G@,2
MS JM87@5<M"W)RJT8)=$/C.R8)LX%U=653(Q/@%DQOZ)2U"WZ!7SD2EW<:UL
MRJ8=3WA1+'><Z=G=+N G%=#"1P:?3(^OOY?U/NJJW>Q$K*7M1XO8;PFP/457
M],SJ1C\$KS\YY?UP-AE.6ZA00<+:%N=!OK($]A-<$? IV9[RA#)I.U,K<*BZ
M,JP09@0E)+$7Z&3$5+":G7R?[/=S_NY=!\9WT0KDE=Y)W)TJ0H9["\^C1^A>
M',5&40<2&<8/RYV@#YK:ZFDM%1)2R],3578<%!EAX3SWCD\X*';Z4IN=OB69
MH=^RE*6"QM(J0DZ/C?X ZE6<MQM9G]FF?J07G1S.VY.>4C1>GUY?G^#PYU5%
M@=GWT0[PD_9_(]'5\ZS;/PA^M#[5?3AV;Q1?VS)= \D_,")YSZ?/BY\ZC0;L
M[*_^FC3].9HKEW'NO(&\%&T+ =I2)41$VG*;D4'D=_J4C,C^ (C\O7E@PJZ-
M,@&-;_X D*'B"T#!M0.$?8-7T^H>/&(@$@F_,O]EHYE."E"4T?J2.2$X[GDR
M<7BLPU5"-?&X?$(6D#"56_/TX4KJ6=&MFEH[\?^+_AT!J]!99O!]T)F1XDJ2
MD(3T!RS4M,D9>)+U+$'@JJ*EA7MS[;C7G2G =:>89*8^(TN;^'VZA#S$9R5Y
M1J(;P12CQ,KJ%J7]PM<A!/3CU7-%B&H\!2>8"I>^]ZB"FG!IZN/@:[(C_YB=
M=<>WB./ B&&YA&D?W*7M@^='4C;24O@>W2;=;K2E0UD_P?K&+LI(?6E\T4;1
MT +X+*><H "J+8@T?T-V>MP7<&V#&=UDPL.QZ&IH6R&;TV^7Y!AZ9'/F0$#E
MKKAVL+YA!Q--H0)_378Z\F$6B1!-&/>D&AFXE8:_V3F.6K=T7F[WL9T!%J2?
MD+U*OGLI^/2-B=U)L[,+*JN6;]F8W)0K$P?:!(/!..^P[?VF7\7M4W?ZM6X4
MZ&X7T:]S+R1D 7C<I\V7N*Z0.&B:Y2W9S7:F-Y#NWF](Q3NR[_ZZ_GTS)>ZY
M8M?SY34!/-Z #MD(#8V;C8P=@T!#O*8M*@B]N;>IU;J(-S="] \@K12B&WG*
M7SX]F"AF%/N62P!>Y+ZD[C5@^"0WFU#W>T@9E8YYAU-O_<9N^C!2-W?*.9,Y
M0?<R,_-\?'#()UOGY:4/-<B)>$\F**[QC025\01%-+>V.+"B.+%UGZ@N.76I
M;3 T[XYAF^G2&S<KQN("90RAS&?J(*4( 3N+&4C5B6-6BWQ??X"@IJ=/7/=G
M:R>H>/WLSV'93]!_F1('\C*;PL^A"V; $&2",_;_%"40H<$EC9@00F8AK]Y"
MB$6<>Q<$%86>.07I9GDS!2G\O&?"*HQJ,)\1$!OJ^-=B3H+N.OC%>]:T'JX<
M+)."UA8YUT-FUR'-1X;)@W_<6^.]']K_X]Z*-=)[FN?.L31H.E"=5Q.>VFS/
MMP)DBL/HP?_1Y?H$$Q2GOS"XN7Q2>ZZQUSY<4I\E^2\(Q)H'M@39.ZQ@+AX[
MF4>C$A4 ES%K[R7>?^[/J_ 9UO\#^)E26C)0NLF#DC8NOM3_2 Y/]%WL\[ S
ML7R5\B29C2#/^_O(TK7P1>#3'X#>0_4"C*/8-G#YE6G7D?I?)E#D<*DZ+6WM
M/A]H4JWUME> 76!9H,XG\M*3*R>AL:@YEQU)HF*87C#O'=]L0%^+RL,Q_A]
MHBPSD*W!G,*NZ 'I22%\B_,)1CUFR6R#BA'!,4_O(NZKQS'X 3;M>&CU8X"F
M5\$4W[16;BO@NMH4VOJ7-L^.!":(1P5=_179V(1!?S&PP^($/;L1(H*_V]]2
MAJ=BUDT'IZ^?YJUK*-NHK9;.K'*64!RJ]47-&G#APBP.[TENIR_A<26/U[=)
M)Y]=<(0B'+XSSR_MFL/W-TK(E2/I!3$'&&GC'210L8]DI_X )IXGQ-ZL- ^I
M*++73#75E3 P[D:7:4J"0#FE^J@$G"&J'M_.C<I8C5XTDL-Y7BC//4FD9C?U
M^WZU$M^S+KH,!GFC"9$S2>K]2,7E5)^=-'5[+D$HXXPI(P+>35ULA--)<KYZ
MS;6B@+E//R/OY(N[O*]\KBT56CBQN!&<P@BTP443YXE;,5\XN=:@?#A7WK"]
MJ13A.;6$'A:5#)O97C*YLB;,'NKN$-7)EU0I76&R/9X)_U8O%_EUB!A4E1\G
MMQ$Z,'R[0$HE:R[^)MZ?.T!LHX'B9_5QJD8R*9NL'5!!G=<='SN^;0WWZG4'
M/ILX9'KDUKQA>8.;;_DMV@0'+U 6+B6#&9X4[[%')X"F?H,#T)7$>A.4T1K>
M 75C>ZJP8&N=N>_%Y4F3.1;JT=/'9HC[RJX@N<69A*#J]U'9&R-2M[4^5I%?
MA 02O)P#+3IHO>E2\8!J2SI;*#%C80C2$B*&FG^-=D*&V>6<L^G![C8^;Z"A
M ELPH7JXCPTX*,^R:>UJ(0);Y;JKB%$5AO9NY@?>@U,](XJ<A(8T3F$21"BO
MZ"I2^;._N@&,-76"94@ZKQM+*4%7XDB:6]_;C*UM<=HW%/8QXZ;:P$L3<8@>
M<NX/5YVWEYK^^IX7R_L:<D(7GIR*N)*!L89326HJ)P9+1A08:AI05I35(QD"
M:6H4I)_5 ^]T[7S_"?1-75>?=3)0O/[C(D>[<[U\!,^E()TQV49\@K>CV>^7
M;Y=MS4\6[E]<$,!QC<56W@V/'0X_<([GKOIS/K)]",S6<QCFG_-SL$7ZE.(<
M<S:NVU'6N%JX&$F=RTVF-2) >@7@O#GTW#.*?+J:_M%%U?@4%33AG[ZG?MJ1
M_DQ2_6.T4AV-L.J&ACCS^JEJ/KY+6Y@?@W9YN86G<$K7F7%2M^.Y^[=?N*W6
M/<GZ'X"_.\=9..0/X%,57DAN3-+&5,"4AX?1[RGT 4IC1*8>AOH@"YEW\7C*
M2V] XF=$.Q+?/R>UZ$K$3>];#\(>H?O&(F7T_S,JQ9[X*[.UQ>0JM,5YQO'E
MO2"->\_,K'-VU\$-O/C+5<Z+T[,WU6OE7,5<Z?O^-G'F5](1-D3$GW-H*[ %
M SQ/[=USFN:$/3VF7/#94A4W9/8JF@1)T_::'$@%BO#76;F!.<S'%\\;"HZ>
M!V>7IJ\,0?A"!G*0KB'ZP:]"PHXR^X.@7.FC)J)&[0.217VVS[VC7QG,W\H<
MC(Q/WI,<6C28.D2$"5W1R@4/91I&1[%(?ZR($"$P=B^^J\#:.B#,*D5&X6T2
MIO*>*]%>UK%*!#>9L%WO'5@ME!E;CN\:X"EWW28C0Q&0+09W@A2 YD"&Q?&]
MK][^:JBP>>'AB]Z.;39R7"V%6$A4,2*J_GV]2$(#4]FH&AH3T^;8:V+6!OZ(
M$:0BQ[1#WMFS1]_8V/13=0C)/CNLD+9(WIX-)[EJ)@67C2$E]\0Y(]YP]#>*
MQB,#!9DK7-G*#2N#>O.MR!<2HG!R)Z%Z5G]LI<\TDGFO@6&F$SAMXD!1Y@>!
M)B?.W+@T@@!V.16'?$R(!7):"CV6%IJ">7)PHI&=;99*J[/T34*EX0N[L+<$
M5'($7FXORC$5Y!_QA>\UQHK/!(9<+KO+5]LO>X@56&9'OU"0!"H2IM+7:\_;
M)5Q>3 ;H-R3?OQ7EGEWOV5H3)AOEF^*$F4>A9Q.J)!14)^Z[4J?LFZ=B 6\1
M\?23ZQ(6HH/#7J#A*/E>FVY0D(LXGJI8OI*8UH0@0=X\=3)#"FO)A)(.Z-U:
MV]@BOZY%!XP*[#$$8VMH"= 4G2T>E-1KRSM_)W"LV9SV&M=2K5@8#'1V4=_[
MF'I!P.BC%X"2\.J9JT];/N_\ROLKV9E^6,G'!JX/9II9Y'T'1%T%F&'?1P35
MI=_!XMESU&E8K_/>RAK^2*\IK_[76$X#\ZGR2;[M::4E0/^8M8RB(;>,-+>U
M\5]_.4#V_P!#Q;,1AU8:W-9/AO4'UH9"+DA2F]+?@ W(0\)%+6>N& N_T,Q_
MH8#FG%MMJ)1ON/0N6$IUUB>/NGW1X,<UZCU>)>J2ZAK'J7D9>A=85]%'>?!]
M,;]QKZPMCS=!/@%L;7\ WN[6C_UJSP$)OC>0EMCX)5E1FQD<OFQ1)V:C\4K)
M^L]DHP=L;7KQ@?CJ35;P5<J^/P#TO\6*ZI/VVRU\E:7UQ0+$+QE\&TOX,4<H
M<O%8&K_D4CB[>Y26KLW[MVFYR)@MLMFQZ9%=T>,?@.;Z@^M3/E%Y4?5,#*0:
M>O.HCG>'^K\*R9!SS-K8\"5H ;)<1C.!>JT/2WUK1%YI9>(2$=[&O\<TD7.&
M/HD8R[H<YFU*)!5\^5XGS$"FB4ACQ.-K(VKL33_;!G9ZL[R+P.H4''W_D(#Y
M\Z*XL*<H7@*1JVS,9]T5*\;RNY!]BU:@J<R5P^V#UJ\\P>Y$RB4EYX$;6F3T
M)!D$._\J-F9((?:QYU==Q9>=[ +%L[_"2#%<2H^2\=ONZF*HE^18%&$>2=H#
M"\O<,(Y$=IQ?GP-D0MO/AR-]J.J'C?([RJEW&MZ(DR@PFXX.@)IV4GV)R_.E
MSFY*&G F'B#PZ9%F5\I$:EN:F&$D90U-;Q9#G="/98J@SWJLA$H"#V,%#/L(
MJBNA.')(6O,;XN8Y1:FMP:XQ228-[(.XS*_V0?D_)3Z'2$@%D@@[M_+AX?J.
MT"$V=9=9#ZW\9CFP2,F^#V7K\:6[LZ.^[Y)7R#<FJ#Y0E,!"TU_AUS">SGF5
M>96\V6<.W ]-$V1G8 A>U+NP=?U1&NXTF1+:)(4=*VK"RR^N=#B&X3O;&WQ#
MLG5<1YZO)*T$9'(3R.E.%0P)"7L'%!!XA_[5D:*;/*3+"D04_/6G#>A%I),/
MD4@^!,_@LM2#E7[.C2#49X@(F7EM6'-M*3?AXFL\"7&?ULF E!&8K?;>R##7
MB*$%(1)Q&4[_'&&YPA0V$OS=!%<HIDS\K?97*'TE6R\:6B.1B NZA&\D6M_4
M!>9'V*PK4)G8;\:-UO@#I".D2C8=GA.3(NV> NL)%9@.BWN?!1:4UJ(:UMU*
MD?<C)4G2+>MU<0V) EZ&2SG=:R"CD"F;,5BRP;S=7ZD/O5_GIKPC+M*@4,>=
MG*RA](40FT11J^4V*UQ1^?V8\J!XX0C%W(-56A?5/[9&(($DW#9: HW[SJY&
MQ/BN>ZFL[Z5^N@,_+E%H2<JQH#E@AFQ3.%O/NFB*"D;=63E%[8\ =./D#R=)
MEV[^ %*L&E,*DA &W7H!;U9NQ[Y?SMK@K%V4SQ"X<.ODT5D=VK@?!E+X? Y%
MKO[RN:&F(9AJ_B;WO=\";:@_^,2_0ZHQI'MS_HDM\.=(TEW*86F1M'F_6/EE
ML^9&2.-L-7-"VH#X#%G@+>.[)YYM/TNKY\>_"O9*#V]T'"?\4DQ$O*'F5K#N
M#X KJ0/W<J.^)-K_$5Y!#T,?J*0P(CGE2PY4^(@^=16W^^NFI'^3A2]0EVWU
MOB)\%UQPU@G_<)Z]@:6Y#-[Q1^X-JTL#)5TP7^ 2U'398$7+$FE@X0C>_P',
MK&IS;*4IK6\K4OU_H83N/^.T^4>XOMA5?[<]7^N]/#J2K7W!S)*-V57?2<[+
MF1/>V <WNY8WBA^7"H&1OZJZ&4M,I!*2&5GH%*2&@LGO5AN2,B/KKG%^_=@_
MG)D>EGEXT:YO%W%G'V@LGR#XDO*Q4@[O&4PM,VEE^D69KVA9X/Y!9Z4Z WH*
M2?W*E]ZK$$Z"#'+YTF6@I'N&@7J56JN 03UTM?+ARM?V"AY:RV\M^[-*%L@F
M2M<_[$_RJRG17S-DT+@8]LO;R=(<D?PYMN*1R6;$TY^T8JADL)6Q1VRI;TE:
M+;\G?3<1A/\B*+V*FH49A:5/4#L@%V[H"@D@$$T/_]A8_(X-CYW[M$S684#%
MBI@,NA$_"C*$8(TU$OUV>!?AKPQSURUM6*CT4%6(MF""&EA1K6%A:DV22Z$\
MJ66"M6*K>O/K*Z_!@J9#1>B"%.E]VX_TK1S.D78M4G%NK,V8*4)T9F62.UF>
MK!>"=&BRV .H0 ;/W[1<-VD9<H^WP:#5F%#^2D5_AW9&H"6SM**DNVH.!&;7
M;<-9V] D1?/+0:J=0=7L"X/(U@ ;NO^[TI(B52D*)@$OUGKO0MB\"%F_LL#G
M(!V3.<'R^!\/\_5\%VD4QHJN3*V8Y5T;? O[PG\ 2+I_J4FKLN2E9@H32GJD
M;<P0EO'G"1G'R9K]" SI5&Q*YJ>7Z '*[^[3EC@H>Y&VT0PR0F%,SE+Z%CQC
ME1O9^VBI38(7LB<8I4;B^3Y>^D^D ].AM\PD8;<^T]B0OF6(8<L.:%/9V49_
M)XNH;,PXWMFTTK_]0(2Q1'MR8UO 1>A-3BD71;]>Q:$<!K/=NS<K& PUEPX"
M%2D*J\'+)QW=!VE<W\<,EG65ZWI@-\[B@NL+4Z?Z1S7B$"3.\IG'7G_MN=.Y
M2%6,];INA[;#P\SK8?\NQ7"JOC?"#&7C8:S!%*AQ@Z)C#M/=MAQAGN9'K@4R
MEE4?O%P,!1OW/$@IWCUJI"4O)OMWE-+_R$9Z^X\#[/E_.<"6"EK?ZGDHIFW+
MQ9:X]WP,3SY*R,1V&DHM@%5UID526\HW^E%B>WF$]*N-.Z9^^PR[]+_V>VC;
M,4FD(F C*(0?0EXV@39C0[.03N]%]C "G7_H"Z6)K_PCFO-IPD4ML:D[C[NQ
M9^'Z=G;J79)Q)VL#$? (,"U,I9@K1,:;*(R2>D',G>^&M"-H.M>5T?L/8$-/
M$Z,[))ZE^WHQ^5NSLOK\=AM#YPP<;IXXKD#U=BDCA8ZJ7;L,2/L1GS,*28EW
MFF89N?OQ[= ?@$61VIV=OOK1:+N4>R\4-&.6DURWLJ$ A251_>SA^53$FOM)
MD>QB1&AI]0]@+[/B#T#EF.;X,FPU3/PZ<8FU?ZFO<^H&9<CJ;[H-/.'N[D>H
MS  5;V! AKA. ALLHX;=N$6P>#/^4_KS9!3DQKHO;N(H[INKTB&;,C/"7T9N
MIYR%Q+LNR-)2DGEK6%GAK@2!(-J"Z/G73;Y[/9)#X_@'X!05:;B@I![W866C
M(/>F\)HRT-XGB.,/X 5U?_/;31N3W-G& 4NEJ(;&CU+I4&A2XL\Y4$'*.['R
M<2RR@<HGEK,Z>_=GE]>I?353WY3-P)DNM67V4.>? 'FCBJ'6\RLG)]\[:W=;
MY\ )E#)_]^=!C_7?\;<\:\5SLE724A /HOP+HT_"A$_=R:C?%O (*/PWWJ M
M.@1U"/O&VR:D3Q%MD;U25@.*!#M=$*B;'5&UU^].D]_RM9Y@1/[Z"P&>\7\7
M)OE*S1 Y?& *;1._M_UXD]R@U"-ZMJ!Y4#KU4'9RI]3?:<4')D(I'<< ^\#+
MB-%B(GCEJKY/%<MC=/X-U_$[2:MVNT2F6*[UUZQ?OMK>A P$6OV%=%L5$Q%(
M)M_!NTMFTLA!U4$3HX?Q>"_!V5KD*L3+536]&0/*OP3FG1W\IMO3*([RI/2@
MB9^/JBQ^O)BMB)LOD59N_Y5BJ]W_MNWWA#EI\F&%LV-9 \F8K*U6.="Y-H7W
M00JHZ8'O)V[O_W-8!ISVFMQD^K!2/HVM/\>-+X6)49VU3.G=BHNS:DN;_ &_
MAU5WN=EBI?KJEDF:5<#\UAS^VZ9(7.X(<]04P:D=[ %EFZT&8M2/04.W(V>^
M^?7A89#!]IK-%[U=<U3<QVJCR=Y2P"YD236A]M0Z[=TW!;XYTSGGHP)C9RW>
MZ D1I*#&Z3J$/8-1P?8<-4JR&ZVE4L+GD:+@C;_(7#47*TY49=PFXC ;W0;.
MK/",?)D^,6,;]S71,*8DE0SZ&"I0Q)=RJ?O>J;X4O^AEL-NS .A#VRW(DE'2
MD=O)K&X%Y:==R"L@:XI/I">#D]8/AI2/S0=H&C@7M7!0:--7XZ6H27.NBZ)J
MP^19H[@IEBM+83K:IFD]3(>UT'*9X#1\I"$IKF#\<-(O!GKO5]\7744HK\OO
M\FUT2'*IUS!.ISL AI#CLWJ:ILFJ70P-+<.+6O>CE"O=YND:V^EP<@HV4Q(L
MX)T<+:?$TG> \@(2_ 9&668FMWZZOEDB;839')=6D"E; J6S.&WI(X7UI88.
MH&R>J/*V;[%1!^<2IOLDEZNBTUR\: C](O55)<&[:?/=M LGE4#4'4E4 O<'
M)O?.2>SD:B *H_P\R]<<ZJWZ&O*'3YT.V"8D1MV[Q5-="I"!7V6UL%PHJW._
M)-:=&__!0'=S=81#X)%[.1?WDU+:T1_  :F$MZU_3R-X69QOJTLGT$-(L'@5
M[!^F&-CT6L*YYYWH[V7IH4SZC:HW2OK"!C4O8'5[E&R!/$P,6?>![=)G<^S7
M6N!+]C!$)LF&G2BCP^QLE;^]G;HAVRO# \5Z8P(AI6Q: F0*T#C,!36+B1);
M]P] :B<AL61JO:I5-)$"WM7!;7) HM[KP#GP8P+/[^0#+_JW?C)%&E6D62K&
M9KYCY9)"XZ+:DTSW%;^JQO#- F4Z9I"D/F2FR )7&ELT8A3/5J?NP 3,(A42
MJ8$*?$<;[\7;L[R]>(S4LHC^!]"2&5@(>?#_.,&W"]%C$W<RA['OLNEC)0])
MTBFB@:_B [6O?U>WW'JI4X4A/F=MJAE]\?\#R,_,HQ<[B>SOFWF4:,E4ZNBL
M"E,FS]*_BU?_BOAJME(R<[#Y(\?.L5LS\(O2,TGB\T]#JCVX0O/M0@<L(FF;
MR(;E4S+;]8-* ][$1>= 4QD0Y<<QKO]3F%4LT.GYMZWZO6!AH*B$O9!/]".7
MWEE][C7VY"VO=LKM]]5N=N>F#CH# @N*L;ZE#L4/H3F9?D$7_:_ZA]LMGZ*,
M1>'^"ABGKG+//@W/V.NM+WH]GNI^@PR<WU<VRPS4F@N)J0;8A"JC'"H._A;]
M+:&ZS<JP]J2=M 19GLB4=XAVFEW,6(:M#7GF]41GKB<+[&!M8%VO666,T> )
MTW05-QMQ"'5-TQ:6=I>#/S+[660!&5XE*!SY%^<=3UGPR!Y*M+_9M.#'((>_
MD7HY6$>%-%8'ZV)!4L,GWNODS?);1':4. ]9?U[U:UGJNP#KE'M9)UEMK;R:
M4E3HP_7=Y7DTY-"H@4?H&;D5%R.L:B,Y8>_SBI?!8&RI2?D,)07ZPVI7XT?:
MHT/R QFB/>&/45^N@B?'#S8YM5Y,_'!\JBEO"TQ1&NF?/R9M\+GX2:^T:/)=
MT''N7HC()*Q/4UJE[4*Z*A38E</<.:30QX1UG9284?6?24M0K0-)J1[I:^/2
M;UME8>[D6B.,E@WFE$D)3DX* S>SSE1ER:NJI$U"\<;'V]T*P\Z9JBU.'GO=
MKC(!72JR*0F!*NC"KF2;JVV?$60@">>I/+=QHQ,<<3!NQ[B9G6I[5MFW?DRQ
M&B>!=]^.#^*6R]D=E CFNBSK!A2PI-S<9X HM2@<'[&K?RQ274X;_M#_4/4=
MUE=OK"*_"'][]B5Y2Z,)IH&/M+&(V/\U=)%<40TP&.Q+^G K>XY4SJ\LX\"8
MZ>9VE:8)7N:E'@JW,M(!]@H5 ](;H#DL._O.$@FX1"*EZ%(^C,T;*-XO6 >=
M)ZJM7T=84> *W?>@#Y>9L5Q9E.'$.?#=85GFE7S=ND7^_J8W68OJU<92MH%J
M.QLZ;9]_/T;-'JQV?>/4Z$=AVGLKW(M;HN+&*3%<JKOL4G?1 [D3L/RNK4&!
M_X)27>5;K;(-#26)3BQ#@OK0-1>R>Q;9RD<4KY"ZWN!4]YWL:9MF8Z,PSO19
MZ0O(D"F9"]4 =?Y1">?2)ISI)88YC'/:1"O"3 ,?)G1Q;]](,>E$S5XXIQ)0
M;7B9\!)ZQCEPZ92B'7?+ON3\5T7/_G:H/6C(GJ\JF8>$XU<7N! A @J(1,O4
MRT7"S53I33'"(TA,\/C;A P:NSN@E"0ZUC7=);,G8G_7ZFE)XCCGLG 1#YWZ
MG0>'BGB)F\G5OK)J_G[<F+9KR?V\^R]B?%A1@K"W-7+0_",+-X\?#EL]E/>J
M9=USHNH@I7P?>[*#*\=Z?&7 _K>\W^9U]V%QH[;<3&W#\XK1U5,?\::W@WT8
MA/=D'!K]X6L!.MJ("$A;2<DOTQ=QE<9M="MSKMC4*,HIKN%HE=@D7GQ"0X9H
MWJ\/Y?L#0.,?5,3LZB>NJ*L#8EG<\O.?JH/9=$K>.+[-Y%M6JM;#;8<YM$+5
M?-1*B;_O;BVH(GTNH3LT:&EU*;#)3*;P6%\<3W%DF]Q.D?K!@[^./"E0FG<)
MO3WYXEM&U<>M>ZN?1+ZY(6_.3LZ=\L.R:(&7;L*#)7+;K1'&B.R5G*<S7,;
M!GDL. L6<TRQK8\/<GSEFPN_IS7E1YZ#$1=;B"V],'XP3 1B02[P&Y?L+2\K
M^5*"UG4)?A1M>Z-TDD94.%QRN)L[LJ>:ZP/#Y @HOB5T_=7%!:]HXE4%E>04
M% 9/=Y,DU$6[!<?)$ZS?;?Q#;0MNOC!=IW@Y+VX\)<Y1"5FM:'_+IX827V">
MSF#2_;J[0+T8]6^(=9J/?ZVG[%<*\CQ4%*165K:<]H_AXTIA*+K!'#A2Y3=T
M[>2(B&4I.9XU\CC?3\TSVBQ@]1B!;?;6OV0@S+E%#DJBCK7H/WBQ^G-J-;,(
M(^+U=?*1VF:JO4/^1 F[B*[;BTIGL9C=@'Q'S/X;DS%Q2T[N1S:ODO!FW:KW
M*QT-0_4CP8^-[A2ZX:($+!$"RBRG.7:CLHZG <B/LK;"C'U3PMYNPPDE\BXL
M>ZJP->W%25!^KO4G&ZRQ!EL:.U5&J/B_#2\8,8'[CT#*UO;XI?@_@-\^<)+L
MT/,0RP;I1IG5]K?3^C%OA)D>R*2B-$)#BRP*W]42)62O?>_9[C<UN<J*/9JL
MF";-Y.@AM'B!3K E4GK9)7".,:=7*3R.*UJTVX,+^P,8^M#X!^"Q5+PJ^^H:
MJZ%0?/&Z_[DPI70NAZS-P,8W(&_V.GOTFVV5U-)US<:"0RVM.)>1\],K$>2D
M'K,4EL;$/K]#KH6UP)YZ8=4<>HH)V.*GQ6CU KB](-NC,68$UN9JD.9H@.?Q
M=PE@!TZ!V-BCZO,? /4S?[F+A>]A;JO96F;/[-CHC"M/]=6^D5^VNK/.Y$[#
MO%"[ 4:JMF#1^5U_[;%6H;QDJU%]>P[;O9T>RR9^NH/?#OE^XQLI#91J1IH&
MI;1!"5]N"8>]@BB4D9W)0UNI2:(P9"(B+LQ[61N+/8@P%Z$FPWR5RZ<Z#8WA
M6D/0J_XZ)VC62U_1F?B66HX;T<;I<Y[O?6*%/DOW;&.,9FAXR?C!1+XH69ZB
M8?(LU]&KBKZ2L&/=K65STX+E;4$&BAZG@T]-#,SX1NTJK/)ZA:YD#.=7/ME[
M:/SQ=A;*CB&Q:\8*O_JTHS]E>ZO4)Y/J&LMI5YHGBOU.TMSL.^\K/$O($;G[
M&OO%QU_C_/UZT(3UJ#R7E#^EIV^:"KZ><I7_^A] #_7!\<K&7J%//:)J\8NI
M[)P[3\K0+@UTNN3-%T&W.I^ \LZ['SR^FA3Q:[F]N/O*$UP<#Y&-CBP*C--&
M!+^P<(+2*""PL/7*K/SZF&#,WZB4'U&UCH1ZP$K*5L(1GWR@%Q27C')L'0DE
MH2&)F'WB#&\3\NT'8XI*FQ/7UG8^D&D)I#!B*>5B;O;Q<XW1+**'#]_3N+Y.
M$H!2;A#GCE-MZ# :>Q(Z)CA)Z;*=EL(KXY@!]9(;Z.\K809#73-A.-319V8;
MOOK@^3D#H1IY\&Z.T2#?(:QJ=HLGN:F(@0D]_I/6M%*=ME2G)O!*@M3+#3JU
MPN\Q@J-R ..C*&BGXG^_(<\4@W]3X W_@"I@:4WH0H-$N]'"V;SZ;:7T.C=J
M>_,/0*/ELY!IYUCD,7T3'\3:<<F_775GBEK%J^VXAJ0S(1FVS>0FJ:F'[Z1&
MN)60N)A-43U].]ZVN&.T[>"P\'IRWD4XG\_S,]!022=DZG@^ YGN5N>P>V(O
MT$[:]89=+B-N]D>DQ]4GN5JWJ4D/NN/!YWB9Q!3/=PW W&B8>/YRM$4DUQ]
M7NMD=.(I).1:=O_)T@>&&I"V+]+_ZZ[I]!@F(QZ2VZ-3(@N.Y71<^H!E'V;F
M)_2KE).!FQWD#?P Y&#,*UF\^C9E .Q$>8W<MGKFN6%+_="3FOD<F41N6;4[
MK/B]I8J72C45@5-.HUZ<-DND"\5WT?B>=1>TXE6ET[=NG?3.-R':ZOQ;R:JC
MK%3M_?4=7R5+QA;+;'>>>_PH]>C,-![N&DXHPBDI.5;0H7]F;V0:S7%MZYRH
M':.T/FND;[S1AK^7X!&1!>:R?A\L9_1):I$%3%UZ12!QXK^3X\_Y/8";)S6S
M0;\*D0FW^6P?,<VT_R%_FXEO$9DP:?+$"<,'.?,;3=6FJP9>]-I87Q#<YWM]
M<NN]UI-&VE;$L*+]'T!,=?_KJMW>GL"5E9QG=$?3W"+N#G(_T__3VIE'0\'V
M?7S&4MF94(1L8Q]+=B([,V,=C!A$-V[;8(2L)9%(F88A2QC-V <Q,T2Y);*$
M&$/,6++O*2'57;T]S_N>Y[SG/>][GG_>/W___:YS7>?[^U[7.=_/I8&IVB[X
M8AOYQY98'$UM[V+?LP.""S.VW]G@X"FV^LS"+,;7ZQ? )O[]N)?>7LK]]D0/
MU[\XT_8AHF&H47B^.?MM*"35?>%28NJ59%^G'[LAOP#O0P^_;CD>ZP>W+K%N
MXJ[:9GSC'DK4"H^<89V7;UQ2W4*,EU_,6QB.J[-@WCP'6M3\-/="0-*1AB_P
M:>L23;.!N>^GW-W7)=!]19-1&W,O)Q.G^-?12WO,HO81;ZF\B)1>LIH\J4L9
MDMA^<F],H#IW;\=EZA? YZ^?X_=< G*_M./WCHO.?]_IB/JB\:KIWMST^'5)
MU9KKBN@RBM/F&7I?[=%48@2!L6C>.-\:\IV1:WHJV;%J;+5S-ZNM*Z>F1YF-
M(ZV1;2G"I,OI;:/3S\A0X,2+GX/7!%H)39>V6-NLWBO;KP%']P?'?@'>5!65
MG.@_[IQ$W:NO'&08V8S5&ZU=F%Q"XQE6'0HK+)7\FE[I?:X-@DGWRY-O=<B3
M-T23/<,,!PJC9U/:7'?GR&V4 G+D$Y!?C8KA#]6U-./<R$(\T/2"R:&77YPV
M]#B[95N1&-'5,M[V0\>?S-<[<;1^%BN/?Y(VE)]JD)YY07O-^M*3H7\F0$1@
M9&%.%0JRVG6KWB:'8AC;-5O)A-PGTV:+=,=8#K7]("9;?A(_W NAO>LLQ60/
M^#S@3R6'G8*9@V$&@*3!+VX!;?&-[=M\R[>K=1J4WCGH*F-*[V,<:*CL1T-S
M2@G>/]R:TV5X8@6PM#(N! )!+!Z=2]I=CEX=9DVBFHRNN1M1*1.\(B_".KT*
MGC(2HA$@,: RH%XYH9H;D?K^VKT'51.[DDUA:B<XS I7#3[G#A2-6UJOB[90
M:_12!>EN3P9HT_#D['P0]WW <REWKXJS!!B7F [ \82#=E+_DH?][F[M<=P;
M:L=F?3G(LPW%]B8K#JX"DPCLDUZD<BHK]3!*:Z&.-N;UU[=O-GR/Y7RCDT W
M'0P@F7.UU:F4I1D)F$IA0-X6P@:V47<^#_K+R__9/K61DCOAM1]NTM,50MOU
MZ*ST+,&T6<6K\,XH+7F6]$ND90-VXO%@*#_)FB+(7DY+; FBT#$?6LFGU7(-
MEFN$(H0\1)9^:R>I[\)?GEU^G.FJ\IQ_* [7U?7J">* ]1O<2,[YKR<&3],5
MWP3Q</;J2&&;TZ,1[<2 [U!IX,&4:,V4'EIV6'=>_2DZI 12HX4')R<VM3="
M*.6)4TWN<DP[]A?6$.MJB*E>(Z;Q6^ANU,1?HM [)2\ZWB]=";+7:;2["I<A
MD?E@%C_ TJK/S&48PI!6,U.63)?SEPQ]9!_YN^XHL_E*VKXW8MIB:LDYTZV*
MGG]IWXJ<CX_B-E^QN%6-H'@IVGA1^(MHT^$-C;HM\SURS?0YUW09:2!>"?<D
MU3CO( &(ZHE28M?-C']A]OOP?3ACV(!ZWVQHK.!ZB\82>^U6:<;>_B'E$$Y>
MDRS@:5FWBU"+>^VV7 ?@?\__<]\.D 1E9SDONQSCGD4XTH+ CS<\4I1-MZ;*
MQ4^L5B]H7%DTZ7L6S8L7P,9=^+;X6C0]'9S',(QM-3-,9/4A\IJ8$R4W0VPZ
M'_*YRLY)]_* A"#-H#?FMESHRD6E:',>N!6@0GN(:!F0+X\%]D>9W"E!UTR;
M0"C/9RE<UX)B7HC4?E'LH)_+%BF8WO(3(4FF(KZJI6))JG=?Y3_L]4MP%JES
M#_YGQJA*J0^9S?:H[AK7:$H9D[O'\5)V";EOKO-$[OU(GWG[NT:):\O-A;7+
M$ 61%Q_C21I&^,!&V JVQ8!3,?NNBIUT\)<O*1.4,?0.Z_2)]<1'Q^@HY%*A
MK#&GRG"^K6V3W"T@+% %QDAO=\&5BI1-;-7?H8XAD^:8LR4!FVA\[9V>'F%#
MP4)!4;8T)%:4[8X9DA^#&]AI?/6C8+1]>R3Z;P<GV8_;3J]CD5\(Y"-4##FC
M:Z)N8 DQ,4PD*F><81,EJ@$5QJ;-NO=';_P ICB7<G-UDQVK&;0?BM4?].N)
MMT!SD0]6:C4T!OD(8-@E)_]CS%Z%5NR-%Q-,<>;?VX=+DG7&O'46P]6XC!@Z
MD5C#%FV&&"O-#<695)9 'BW,H%IK(W:T0J)FA&1M*[RG<YY*8E (!.N.13YB
MJ6S%B8.D$DRC-("T'2:*K7\!A/<UA XYZRSU-G*+$B/=R(+NZO0BH1E,U&R
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M;_U=.]A8:H;R1U(M6#DX[]F]Q=@BUF!=K$(U=KYVHNWR;IV.9RKAZ I\=50
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M$^N4R06E.$PRYXPWL9N5?N>!$IN)?7\X3*N0>P^X"TV]%+0XF0";F[\H< #
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MHM2 F^C:9 X\/^YP#<O>[+43JG[3EY;M$)%@V7/$Z*@6;IG$9Z71FY:GDCR
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M.1"-Y\:1>YO9:/JLBGDNC;DO\]' VO(/%\4NW$606:V#PNZ_[I3[*(6>]1E
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M&9V*/>T]8+'$XVX.VT@:CX+)[_7;W_G N:<TN#<=<QW81!ZA!NI/@VSD\+M
M>8(18A/Y8YELV%?>/QHL>PS%?>"UHV34:%TB_D@5$H8_?34-VP0KS*19*<)I
M(EN21BN^-!J/E14Z2?L=<E4LHE>B6XAB!2-(T"?;1G!$\-M" CKMM%HV_(VR
MZ,Z\%V-!*>(E"S%LJ]M$*Y]7\"+4V,U$SJRZ[Q ^U;,G(3SY;N-WR6J?(6^M
MAGR/X$_'YM@\G7M <,\@W*>+7W-I3 A^M"&JP0C)#5&@RS6>^9I>T-L4WYXP
M [<$YDZV&AWJT;0!&Q3?EI0<EW_$']O6L_P<__!KZ.2?=1L4([4=AZXAAR2
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MI"K8P+316&L;6:23'ZGHR=4NCMA+#9NM(2&K1G";M^1N"*O[\:;R&_BI,-E
M@W\I"*G?-NZ4Y3T\5\204T]8,)U[_OG)U:R=R02.<+/UK%GKFG"?3L^ZV>_W
M3SO5'C<6.*B$M\TY1'^)%F,;9L[K?_E\P18TDJ.$L(9X<W:!LI$K/G4K>4!&
MCNJP(B)&LUMM_="25(^C5,,H6OV,R_K7/">[KC2I 06\M@2R:LH]QS^+GZCL
MU8[%GIK'L8GJ4X2";BL,Y#OM:;$NGZPL]3/D8@6RL"_BB";C9F@K5/F *"1%
MW$-L&F4/O9[0^)B/3J%*Z\:U!5Z+OXT/W1O+0[JB4I[,!T1J_AZ<K1OJ;79G
M96J@ 1*E%T\4]TW<[<7#:O_)- 9BG ?F9H2V;YTOT'N(EQ4M?=]S.;3[F?\'
MQ//?0CB:Q8_.E_F_J8]TU#HTQZF#-[3^>= ]'NK<'^)BK2AY!;PEW]?Z3Q44
M$C98]-% PVZPKK&:UCWXV8K?39'F3=SH-?WXQCT OW9[GTZ^?O'Y\UF;7&DT
M4 1]P/0VW4S*7<BR0G<$9S)=@\IE@BM2S']LNPO.J%W>I:$+G?\=%T?O?GSM
M&7Q@^*,4^-[!1O4985_7&Z\C(TF=^M4I Y;DD(2Q=4K;J 5R7*MXSY.'H3*?
M-@G6M(\#704T:X\YV6CKM,\7\9L0Y;'%BYNG.KTS^,3/??%JX?HFSE\7;9EH
MXL'#7# M>,!L(1&[^+>WP6__B?_R_2<]MJZ=(YSTQP.J#:WWS0F&T?K;+UFE
M$:[&"/Z).B8.\7(^_#AC.A64!8\Y:(#]I#2L7B61R'I/O^[PA-QQH8Z(1P(R
MK]D7GZU-E[).OOCEC5>"$BG-X@HG/KU9FNM,99U'QB,Q'$40\75[26TZ?(M4
M0!H#6#K>/2R%?<1\I?49FT=/S^5ZX9E["WPO)'*RBT7EU&^L_0CWQV6Y(M09
M!75B;KSS[IXGQ9C#,IMGV*P'7R]T)1*V!_WDO+BZ!_"HCT'WOV!3O' <\5C*
MQ#I?S]IU(QYK!<E0,J9K>]3;DJ%GY.&0EI"!J8VK.H&>*O 5N]X;N(:2[='G
MY^/ZUHC-06.KC9(/5WT>%K8:@+/!3T!U@W[H%TC$7/'[WMW%&H#W1DY>80'K
M<1BU;9@^S_'!4R9<3'8=[1>%3WKZ&'Q#V&E!ZHMQ[7J>S;D>W#(124\=Y.2\
M2Q=6C13+G^IE.Z\!SVFX25:#4-MD@#_ (P.6CC>C19TV=0!]:@3XM)510PWE
M2ZS5F,CP(QG_VG3C>\!&62'X[,U["0*B-8F3X5S-9BC6P$NIUMQY*^BRI:U'
M0K&\P2'VBSP/ZZF;%1X1_O!LO[1KUKY%?JI:6&-FYTM:^PD.5@4IV< 3E%\#
M:0W%!JE *MD_D5+)(9>)E6$L!4=H'+N$98BGM]RN8NAV@6+^JJ5/[4Z_9%?#
MFP2Y)];%^-C+>T"PJHEM=Z:O'HRD^N@>0);<_+Z#&>TUFG[A_ /-7!'UN_WG
M[5[] O4(B<K;@*[EKG^@-<[-8A(LTL<ZG)[TJ!"I_-+!%S7*9SDL26SDWC4U
M"<'*:U+AVB';Y[ 5W4_L.>$*4G-$ Q_X?NOJO_#SC! T,L>L))_\"@OK31+*
MHP064Q+N'I3$SS_W*G_1$"]3S%K\E)5 Q0I)SQ*C9U2=0 1-\_-%')08)'#W
MJ>O[D/8YM#I^^6G%P=$SK*E3D$TX&[JVF>8H$YP;RFA*7.UJ$6[;1>:3WC=<
MB=B1:/EUF7/NS31>B4U#2CU+=R\K>,EK.!>^W3-[5,T32M\"*H.4]!3%CHU@
M[!WL!:(&)KA&,\D>Q53PHOWB6)4Z).L&?0+A$75"916OZ=<:>,-%8@/)N$$X
MA3BBI<]%6)?*(5I3S+40OQXVG'S(;N'/J&4==9ZX\P)98,I(V=-7YIIEK25X
MRV8XB1OPYH'I2K6]#TKQBAZ3E&U];7Z](NO)>Z]K*$7Q@4Z,IX5FP:NOE\]?
M,Z'.+1_I@FD8N"/A7Q0.S TC=VCI/(Y+U.S.F)C>/E.7)I3^@AKEX?$C7E'0
M^RJ(</)]5/V^JWLF26UR*F[6G)]PXV/O;/R\OEM. >VRS!6MZ0WH"W&IF2:F
MFN)7Q^G3B+=Z;:-E;F@/?\WQV9 %1F,.W'3#(UVZ$ZWF@=C:T1!U#*HGVG]%
M_20"B6+]]IY:9=OS]AZ0E)&R/>*5"OZX7/CRP=3#5HA'*$-ZMH]%(4[:BI/B
M\O&WA.;R*T,MER6]^GT+<PO2&1&$THW#7,9:L?:B#NM62B^1"!75/<!N:M&>
M?+#+URS%_76_CZLC>&IJGG0E1R'2QTB/:KB/04B_FN%Y)KSX8YSC]Y7U\'
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M0"5!'&)#4I+C OZI_D&PX7HFI5O:6"@'Y^%XRH408:&S'0AZOLJMVOG@ZSA
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M_AP>TXUN[I7LKTS=@8;&FMU2_1I=?&0[4.CI@Z$.C<VT;][BV.XQHQVTF$Q
ME,?GH0;+QSBN?'H 5ELEFOWDG?V<21]G'/WI6F+;F,4,(QN=);XQG4PLJMFL
MZZ(*Z;.%G.AI4CF_;_*Z]1;D=^990%*F/"T-@PB15&OH_($3\LGX4QLO%@YY
MST;EWM:KW6 ^Y->>,SU3!NSW\#N$B_U(\+0A9D5590!8*RSO\7;)Z@$3,"/1
MN2AY/(F+/'J[\Q[ LD%:Q\L_/OM=$_?%P$3O5]BVRCI>\Q$@,C.0;;-$CI?"
M+A.3X31<-."7UO%W(^Z&FZ7JUV:'";^9[BO!5E1[ +=VFWU9RRJ7)M'J3T2;
M:IKNNG3HXJR8Y".+_0V,C6EA2,U9;Z,J-J0P2M?)TT=I07K$-C_4U?D>\-JV
MXAY@=G /V*HVFGKY6R_7 #H;<I<3W0AJ;P!\8J[5M2#4$:R3/^\J%[YLM82Z
M_J$IBI3,5UH@_!/?/-890J+U D:2HOC7'GRGD*WI)37&T_:5;RV&$.A#/LE;
M. Y*!!QO@)Y<[]G<ACRD+P&&O]W:_>NY/OR=81+?EQ_[%\7^$"W>$?OKV\:I
M!I)>;F]RT#Z[E,2L>1G63X2]OR6,Z)IAN^0YN./L6T]>5=;4IN6G@A^^*J8Z
MW[JI8XB>?%%0>OXX_(QYMK"O*A*##IQ__">^2.]=/BKRQE7G#YNG4.=,JX7R
M @G_,+E]HU[#6IDMV4R71ZC_Z22Y\/HKREM9AXGHYPV2V-.X&>DW?Y)K6> I
MQ_00VE'].C 18]F._H:BY$R$MM6!)FN;.)=BC1 ZO 9@1M!4;:SHE/F#%:?_
M'C!!B9I"R2P9BL]O5G>D*6^D-<^6(+;REZ@2Q+D*N#W;2I^(T$#2$32QT.B2
M)\>/,'?5H)A8K>@Q83BBTPX:6V;^Y7]VIH?'1VR;HNAL\OX'1S""LA/V]P%'
MN+:^!AF6 ZUM(Z,!^(^+%MF_*_SO_O/V/P;9?2R&//2/X]?.?2#S4!$?\N]/
M(0,LBR$XFZ9%2_\J6N>-_%U3S4I\^%?1[V/B^K^:_\<&WM\WV8G^&M$@Z_J/
M":\?_QWV>D4(V&@N_.^R "3W,_\/4$L#!!0    ( #V%?%HUPZ[=G[<! &[P
M$  5    86QT<RTR,#(T,3(R.%]L86(N>&ULY+UI<^0XDBCX?7X%MF=V7K69
MT,4#/-!S/%->]326E=*D5#5OK&PM#*>2W:$(-<G(2KU?OP"/N(,!($ J>]>L
MJU,*D? #X0YWAQ__^C^_/<W!5U%6Q7+Q;W\(_Q3\ 8@%6_)B\?AO?_CEX0/,
M__ ___T?_N%?_R\(__>;SQ_!NR5;/8E%#=Z6@M2"@]^+^@NHOPCP7\ORK\57
M N[FI);+\@G"?V]>>[M\?BF+QR\UB((HZ1_K_UK^.<KC@(=I#$40!Q!A'D*2
M1@%,8Q0FZH\B%\G5XY]YE)  1QR&,@TA2L,,$I)AR-6O/"4RDW&[Z+Q8_/7/
M^O\HJ010Y"VJYM=_^\.7NG[^\X\__O[[[W_Z1LOYGY;EXX]1$,0_]D__H7O\
MV\'SO\?-TR'&^,?FK^M'J^+8@VK9\,?__?/'>_9%/!%8+*J:+)@&4!5_KIH/
M/RX9J1NNG\4+G'Q"_P;[QZ#^"(81C,,_?:OX'_[]'P!HV5$NY^*SD$#_^\OG
MFY,@\8_ZB1\7XE'O[9THBR6_KTE9?R14S!7VS6KUR[/XMS]4Q=/S7/2??2F%
M/+[LO"QW5M588HUEF&HL__$4L!\O0-\3OO4AKAZ0:\C]Y O'(9Y^\H;N@](0
M8GR$M\!<C'+[A7J_X%-]=]>@+D9]?(Q]?2V6-9E/\+78@-E">:X_^*A^ZL#H
MA0:4:0.G4]U;J(IOM5APT6K+G:5!P?_M#^JGV:J"CX0\SZX96ZX6=76]X+?J
MQ"L_"R;444;GHE*2]G95ENI@G*4923F1#-($<8B0H@:CD, DQS@)\APQ+&;U
M^HL^$POXRWV/4P/8 >H?+'A0GY#E4E3+5<G:4U!AHBV %KE_?R@)%X L.%AJ
M%$"YP>$***7XKS]NL/?&1ZIL 2P)S&,F(0JS'&+)N;(+, F9XK!(DYFR7.CR
MU3BY#?V[YN7\=?@SMV),#[[A38, ^+S-&X7#%>BP.,FD)=L!-]=&UK+<)WK)
MW(C>:+)*4=U0+$E%&[*[!17Y$?I1S.NJ_P3J3QIU9@?SQX/=ORY[ZDC)SFQ
M]\2/;*GLSN<:[NR%+)=/%["A7E[PQ6DW1J'W![ LN2B5UW&$U/47G2A.SJ[G
MQ;=G91DNE.KZ^/'MS^*)BG*6L8B1&*<P(DHOH#2/(!$9A5(F.(\I3225)IKV
M-(B1U>HVS"N@H)K)_@!+A@7=#Z&64KU/(_BM!?G_7$PL[WS1QHT:F>@=6"-L
ML+'>.D].JZ3T<XWF":,H;[3/P)N3J)KSF/=ZQ>!)!R5R5RZ_%CK.\48LA"SJ
M6WFS8,LG\4"^B6H6)7E <I' 5 8Y1#*-(:9$0*:T2(8D$B'"LWIMB Y_W09!
M62F5$P;VD'VA7P$_T!;R'\%SCPM82E T:(!:XV$A?\.L,U ZWAABIWS68,$/
M;WI^W$K0P@8/7KE@H8V\<<--*UW"%3L]943HH+X:7F$ZO65$R8[^,GO#3H^M
M#2[^EU55ZYVO'I;*VE($%'.A;*T6Q,=EI3Y_2ZHO#1+*NWWS\DLE^,WB]EF4
MZLNR>+QF=?&UJ M17=.J+@FK9U$<)RQ& H9A1)7#%2C'-4,YC%(>Q5$6\BQ"
M5H[K"$B.;9!M4 ;U4KMF+=+:+P-SA;#^5/_,%-JM9E5X _H"ECW.@*R1_K.E
M*S?&IAIZ?J^\598FY>XNK?'5'F*OQ7[0./]1_UFC#>ZVMNH'C;HZ"9726V_:
M!GWP6T_ :0/5WLD<D;^^?-(Q4)S6A1V1R0<>[YBPW,Z$SV+>Q**5R?SR4))%
MI171<E&]*RJF5->J% _B6_U&<>ROLR3/&<9)"%G*$$0\83#7T4H9$2)QQ'".
MJ8VJMX ]L@;O, ':<RA,K3L7%IHIUI$88Z<O>YXT6(!M-, &#_";Q@0TJ'C4
M? X,\*30;"!/JJ<<6+*O?ER6<+0TJTK4ORS4"V_5^G6Y:@!U 9@@HBS,@AAF
M 6(013R'.0TQC%,6)A$2 8LR*XMQ -C(>D/IZ;\(I@R*E08/V!9\2RMNB&&&
MUI@G-EA:51IJ1_XVW//Q.GMSR(! 7V;-$*AIS1,#H@_,#)-W[ 2;BV+V=OE5
ME&L7(96Q)'&>*&- IDJ*B8!$"@0)CP-!D:0R-I+B@Y5'%MD&EHFY?H;^8:&\
MB"H["30FR%C@3B)_1+HJP?[TN/SZHWJG%2SUPT:>#E>:1'A.$M!+RND'W,Z[
MCT*)G%A;Z1\%45_+@M!B7M0O=^2E,?G?K<2U5-_8_Q:D_%!\%3.>D#R+,PX#
MD6;*GN81S&.1PE0D(LY"QCF.;0Y")RS&S@'X(DI!-$"[ ]&-HV8GY>A\LA/@
M%IVKK;A"@]$56.-TI2,25"A3O.!7H.$FT'@!C9B_ _8BOG@Z>=UPF/1(OHA-
M^V?U98NY:2L=8=#_O?_;JOA*YAK"9Z'T8,&4=Z#_<+W@NQ]L/=EFK=TL6*E1
M?2?:?]7O\Y5._WW_C7U17V[Q67D:[Z54QO%,"$PBFA 8IJ&R%"@AD.A8<<@"
MF8F8R) ADSNRUT%_Y'NWFT]O/[^_OG\/?GCWOOWIC^#F$WA[??^_P/6G=^T/
M[__SEYM?KS^^__1P;Z=%I]YIG5>1!Q0&41A"E D&28X$3&2&>"P"%(C0YD#[
MCG?:_B3L]_?O=WO-3M?O=],L[6J%V55[#["%X!78X [:1W3BV=Z'NV^T1(&>
M*B7J'5U_O )KTD!/&]#$@98Z?V?[Z^R*)Z-@8N0GM29>9V/VS9!7PL(A'^=>
MP;R5]_62_?6715&_73X]+ZM"!S@^K72 XU:JCYZ6B_LO1 GWS>(]85_T@S,6
MH%QPF4(>9#E$2<(A9LHJD4F>Q '"&;;(^W/%8N0SI@6N4W98 QY4#7Q0+(!0
M&("50@'\4/2?_]$BC<69[\.GQF3<M%/^&B/-Q@:G*Z"!@2VTKD#'Z5L)6M1
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M\'Z<S:W\F91_%4V%_KU@^C.E"F89E9G(E6\5"J:;5V0,8FVS90G+<\(RE(K
M)JQGC<'(5MP&4%=G9'IU[\Y2,WTV*J,LK;X.%:#E S1C_G2:[GKPE3*#-@B!
M#4;^=)<S,SPI+'OXDVHI9_;LJR;WA1R\0QUY?-L4X#^*!7OI;RW>?U.KUTH0
M;YN6,V53D:\3DY0^G"N'M)YQED<B142YBUHG93R&6*DI2$*& YPD*0G,[R-=
ML9CLWE+TF'0]>,H*+#0N.HV/]=A8>%_.;#?P2*=@IIWNTAB!+92VIY"NT0(]
M7DWD23<*!V^GY*R%WSL%A]W\XO$X;><]7\JA0>_:>?'IO.]+Z=_QSB]>S-%[
M%X_Z"_A9/"]+#;LMH=NOV,QS2=,,Y3!-!=>S$7.81YC ,$GB@.0T9X%16W8K
MJ*/;HPT.8(V$I:-MQ#A#C]HW.RQ=YWU.3%/O:D6U+W_8".:TCJ\-&PX\7*N7
M'5O =>$I/<VQF4JH?FC[<[XE9?DBEZ6^A*QFRJG#.,L$3+B^:D 1@3G+$AC0
MA(81"7*:2*N6;V9P1U83>I(H:Z!:)J.8LLU,18S ##LET2/0C%9M4;AJ?NY:
MM>Z@X;&7FQW=OGJW&4*=ME>;'2L.>K-9ONYH3VPFV-^5RF#I2_-G"2:$)JD>
M%I4D$$D:*2\R2"&BB$L69"SF=B;$"4!C6PVD'0C?38AZUJ#U%*@V6M_$[5<5
MWWQB&[X_Q3Y#0\(#4RQMAXX?]RT_&J@&?4/LC84SE/FR#TZ!F=8D.$/L@15P
M[GG'&+;:Z:V,EB2E88["#,HDS2!B$8,8H10F)*0Z/5U$)+0*4.\L/W8.@?K-
MH3_K'@L, \K.A%E&BWN:1NBA>IP&7T'>W<6GC> >)>P@/'O\J0O2NMLS]Y-"
MLFO9CYE$#,D8DBQ0XD3U",4T"=7_*5^;"25IV*X;S#$H(TO5.^5W5,HR;FXI
MEDW*<CNXW"%O^X!!9L)V,=EV,M?F9??V[P:BYQ3L4P3Y3+D^@#%]BO4I,H^F
M5)]\V$TJ/^I><=4UK>J2L'J64Y1E><(A#D@ 49HK<20A@22-<RICD1%B-!?I
M^/(CRV$+#/S6@S-,8SW!"C/!<R?0\E[!F#9K43M.@B<9VUM\4N$Z3MB^5)UX
MRDV<UCT+VB37-L>BS;V812S,2< )E+D0>N98 G&",&1ID.JL\9Q%5G,Y!F"-
M+&AOEXNOHJP+??W^O,[;VAT77#2(N*=P#7'23#0]\<=.3C>M3%JH?0Y6EY+E
M3VH-J/,DPD.0)I5G Y+WA=OD%3=)_U LBEI\U D\-XM:?06T-+2'<Y-6.@N2
M-)$DU>VRTDB)>RI@GNJ.!BC!&<V#7!*K&5_G (X= 5[61'%A#=G)Q#W+-#/)
M]LD*._%N(<,&--C 7IO"#7A_0FY*J"=)/PMN4G$W)7Y?YHW?<XP'M?FSU8=E
M^5$\DOF]J.MYV\!O%N-0$!ZITYT*)?,Q"R%!A, @IFJM+&0"<ZO@T&E88T>*
M.LC-'+JYA@VJ#7#+\-$ QPQC27[X8!E8VF9! Q;<&[# /LATGCA?$:<!2-.&
MG\Z3?!"+,GC%L:VYE(+5ZP+E!_+M,ZE%FX6R*A:/FUD]W9\^"TUF,2_:SIZ]
MPXA8GC,2,IC$A$)$E.],2<@AC428H3#5K8ZMVI_[P6MD1;$+5%^"/)?+KT6E
M?]&"4[3E^C7YIHS@WXOZ"Y!"[8W6)S6I5THT7H BP[:YNJ<],U,_K[ 3=JIJ
MC6#?'4%?26M$P"XF5Z K?QHED."93;Y:O'O":MI6\'Y9>= RWO/RCC.3NP$5
MGY:UJ#XNR:*Z7O"N+_+B<3.VXLW+YN<'!>KZ6U'-<A(PHJON68B4CQ7Q&!*9
M9U!(&F(<Y!E+K0I%+D%F?!7; 00:HI)=!=,RN'D1K\VTY%0<M%.-ELRSGZ+L
M@6I?0Y4O067:&<L>F'8P<MG'FLX3F'6'O#MM^'#!W[S\4FG?L].BB\=KK6O;
M8BPA""$\RV&&I=1J*X*8H 0RSIA@+$9(][;3L18SM64.VDI)K1$PEC,]S9CI
M=H[/'2J OH!ECP8@:SRL9SB;LM9,2XW#,#N=I'G5M+Z\V^+5#QH192[_$:QQ
M =?GN>8R&]J2 ?[&1IL"GGJBM"5#C@R;MEUA;$6S]G"(C%&:Q1RB3#FD**08
M$F4?*=6#\C@0228#JQM=>Q1&MHYN[]Y_OGZX^?03N'[[<//KS</-^_L_CZ5D
M+!W'<9DUNM(9Q4MTY\GD>NAU?#]W!KGKI0L]NNTF;&UCITWQCV%S_1.OCZP\
M=MKSM:#-.^F?HGA8-W@BUD[XC]#I>8R5 5D7]2#<7W/R+H0GB#K6A_#4H_9"
M]5 2/3K^NBS?O-PL^$,S0]90HHZ]._8E<0MRN[=,=:7/&05?:1J^(G-S\3I*
M^WG9NI1L.\$RH%@)FL;!DXP-D><D8$<7G$RZALC9%JW!YQR:0;PKJN=E1>:W
M\G/Q^*6^E>IH;.^(9P2%A*9Q  /.E<4L)84YC3+(8I(01!%BU"AQXPR<L8.&
M&AQ<2KBJ['(USK%G6 (]$FTGB#U,?0.U0_NU1]HM&B?XX8%;:P177M@U/CA/
MX6!K@X'7IVM><)Z&G?8$!H_;Z2(NBMG[15W4+V^73T_+15.]U&:IW:[JJB8+
MK?5F89C'69P*B*E.R^9A"BG/E2)/"4)A2!")C8J.S,"-K)E:!$"+05\RUV5)
M;F%A)K&&#!Q66O[98J>[+N6(L=S:$3I@3JB%6G-"_; Q)PR7GT2\[4CMI=SR
M+0?#X_Z)S.?_1;2Y6/\L='N362*RE(8XA5SD.FLL"R A1$(2X Q12L*$&-5
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M9QTROEG49;&H"M8$BM?)*E@R2D3"("8$*V,MRB E4L(@R5(1Q(G,$#/6/6>
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M*Q93R'$N&8E($ IAWJ#,'+#-%]:YK=B;=>\P2M0?F+ OF+)@92SC/ A$ /,
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MS4QI92X256!JQIR1@C/,LBC%B4B"F.8)$7$.RQ%Q9V;T/)'M:;R-4#A$)BZ
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M78$MX9%M5L=&G5IOVAW4?-0ES)_+!5UPDSRSU\#1O0&M-=)V]PYCX >S>Z-
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MP#P-0G.,3S&C1&"5<2:R-$R2")8SY9_'L6-Z!U>4J";LX\AQV7NYY- Q&=K
M(.()H$<8]S@B)J,>&R[C\"<X.'B!V.[HX(>4:Z:[-N[\AV;I^G$EZ^-+F^D<
MRT2%9DA.Q./,A'(4SHN"8!7'61*'611R^W-!'Z5)LMX[VFA+')H+?@XG"S_<
ME_3 P,@9P9VSX<\A ,V)]X#$)9GQ+H@XY,</2#F<)7]N@8ESY0?D>)LQ/_2
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MU9<E7=1-,#1O=4& R3*0U2PD09$G:8IYG)BBL#C%1:9];R&SF*24Y9E=LV,
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M'G4&W'(!S29YBXT(21&D88$S'@68)";@4RB&(T98FM%0\4AVV#Q 4F]\ /0
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M2S9)"]W 8L5S)6F.:4 9)DQ03'F>ZI_J(3&4T\P^^CQ(;F1KN$<?-0R@'0>
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M=:2(BI21$*N,*DQ4&N*"! $6J8FL1[$$CA7IH35ZKM&VZ*RK0VFF[ #+;7K
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MQP:PMY<5@':^DG=8@%:Q0Z3^88^#*T37J&,"U5QX; 8&$=I7;S KFM.V"H/
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MW;-_;QB(@F:1!D!BU&;7PQS\!3I9.T'DUJ;:;:DKPA26V$K],/3,VON\>&,
MV5RY>AI*S<&N?+KNIW;_\<Y82DW]SK[IUU>UN=>/[,^92KDHB$P0M0U7<:Q+
M1 DK4$J*7!89M>T.P5&.,3@=6=?="K%]WC:3HNL:7IN&LA>BO@7R"):,\LX
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M']FB-=_$'&:60O%S,TA'1 6FV1M&[/SC7>&+Y>5FI]Y?;VR.&5=U7Z&;IA^
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MD?&XI"4H2'H5-^.;E@1H6EZ%K:.A.15B0+/3L(4L7W9<^N8F:EE[;0W,^T7
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M_MWN@9]JM:ELP/UAU?5X: (BO=FW,"-K&%,W>RL84C#=NR/;3:,?\S+"2<9
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MSW54<VG_R? 9-8Q&;"';AC ]7B'WY,%>E$/0XUW@AZF2'?+W.CIJRM/B?W^
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M30O$<YDBD7.,XT)QFKLW[N^O/+;#M/I;9(D!SM(#N1V,"E]I8'NN$\0G$_I
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MUX++A.A<IZ5VNI&X0&?TW(F6:IV!5+=F@V9PG8;'[?P/(#1,X^SE_:Z>:@/
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M"Q\@(@=3"@XD)]8/[B"\516 9WV",/=W7V^?5JK.&>A=61I#8R%^J$?S4KI
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ME-6*ZA-&.2<R()820'2_@,HAX0MO&Q96N2#38&SEW+/3!5@N<'\09;GT6;]
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M85UJX[C$&G&B,N.SE$G!&4^55.X3QH9(C7T_V=*VELD!=<C@K4&HAO=X6 "
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M^W".WP.WX.R'_,S]PR\(UP77HDQ0DMA0."$,,4T+1 NBTCS/2\>0SLG51U8
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M57_LI3/?K;O*QDUR2W<KWE2A4S+!I=8)-KNVS' NS7&<FST:)T5:Y(5;C!=
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M^6=4;R7;.ST@G82 W8UN)@831D<[Y5 K$!F)]I)'H4,%9XAM4*<CVBGY\J&
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MQEEI)K=@F IA9GBA$I5'(F%"@_O)GQ4W\M1NNZ:W>;<SM%2.EQ..4+E-YW
MP&9T:WM?\+8UT4^=[("MG]V,#-D<_KRPZ5O"7S3\9"/XRT_Y3? /U9(MA1ET
MWP/\_?>N5NE->U[V<6DFDZHW-]K\UVR;5G_;=CD?5NNV5;B]!)UG2I:,J 1S
M$=E&\6930R5-L"))S)6.=5EPV/U'&,5&OS/9MQ3JV@C9N-*V94ZOQQ",20*]
M$S?&F1YG&#/M]#OH4K]3$74ZHJV2,\2LFFBG9Q..T^MJ'X['PD(7B.\"*34I
M+X8%\B5_!A[=MV! UPK\5@\DQ5.>)5+($BM&"":IYKA,HPCK6,HL9F6L1 2K
M'> @=62W:J>##8$XK"G0=8KVW3VY8>I&@\&1@K%<$) \R@X C Y6@<!%YL3%
M"  P'-<E@#SL>[1B_(C[RA!7F\W[N]KL&.R7U4K^72T6\YQDDM(LQV;;95PP
M0HP+EF8IED30U&S-$EDFL#.6RT)'/VS9JM"5)_#8ECEAYWK6$A81Z*'+#HR;
M#@Q;K^NGO2NTU2'@5@UB<K"#& >1$Y_(N(-P?#0#>-8WCV_KUM3[(D0JR\LR
M+G$FN8VT(C%F)4NPU#I3K"P(CYS:' [(&'GN]R1Z.PBGD'&;ZE?:"YO90%,]
M<O#.&A,L]>Y8PL09=V=-/$ZT._]1OPEHYO3EZF,WWUBU:$(S5F]7#P^K95.&
MK/,6FKID\RA5(E:TQ(59LXWW;YL49#S%N8Y*QFE&5,PADS:07B-/]&81.ZAY
M>+'F)(P%0KT>-^9X!=!A;&/Q=JV(B':*V@)HK:JHK^NL+9<8CJL"PQ>(WT)I
M-2DG!H;R)8^&'MZ/>]N$G.J;VMV!?3+[,</Q!J-J435:M.DY30G\6[WMR#!/
M."M+(16.>6I<)$4RS/,XP8D291PGI<X3"6%;;TW&WD0]/+(V&ZYF;5.*FT]O
M;^QIZK-8V.EN0V/?LB63#,:K_M"[,>DD@,*X<Z<2ZEV!6ZW0H5HSU%.LWP>D
M*3$KAA*?P(QY-4R!.-)?CTE9\6JX7O+@]0-Z1!MNQ^AU]VA/G+8GV1_KVJ8@
MKNU_+?]V7SMVKVYU^[N;I;S=WU UO%S/L[+4).82"Y(9%S2*S+ZQ*+AYVVD:
MY])6LW7:-XZIY,A\N5>BX<Q&)&+6A+62@-"]L5[1,'G^*,##>/54FZ39]N1[
MJS1J-3.3!&WUWM&I?5NW>OL)HSSJ:=]ZK)!PU+'>'2!4\P=XAW[AG:_[+F$Q
MHB.#/!A7.I;LZ6)11T;O('YU;%G7Q+SNKH#>M"$@G[\JM6F:^<I&4;;8Q^75
M;YX/&@/7PYV!ZU^-U1_-Z/4\+R)"DY3@)$U23/(HP2Q)%59*Q)S&D2H8Z&YX
M0MVGB<G=WZ%VMJ#&F(9!]N;T(E9K].9Y7Q&D->EBW^\:_67M0HUA7N&^TWQ=
M7*^T?L@O ?1F[/#]SUY\ =CY+P _^@)<[OSN^ WPC'6>]%T$C9V>1O-7B,6>
M])6<CNV>5@6_Q7"[1+]=/?!JV8QM-7S1A')W$<>%SC(I%2XBR3$1J<0TYP0+
ME90R(SPK"U#L.$S\R$O2S@GN:3-#1WU09PTW_<NJ,HO6G^;MVC2*#ZOU VM+
MZWI>>P)?A-M*,1Z\GEO%D9$%T[<?0($8&"A\4A+U ^8E#WJ.<D5[IW;7$,]S
M5G+!980IY4UJB\*ERE.L\Z+4J9:DE*">U/W!1X^]M W3JT:61^>F+0)N#.%K
M%VS^MR9]'#;)KP'3"]U#MES:#CU]DZ471IULJ_3R,S_J9KAM<9Y%B=8L(K:*
M%,6$2HU9J6.<9S)6N1*9S/(?:R,\1==YGVV,3]OYJ=[RC[)_!;\[&)V-\-I^
MP(WG 8C_SVPZ6ZW_?[;A/'@5TV\V#\7[!KSVRN.O'EBUG$<LHDDD--9,F<UD
MD0O,:<EPP0DKF4R4DJ"FF\<B1@]W[?5@@$:Y'L'A1I[7&0GCN:U]=E?V^VJY
M[IE;V;#75G[0H-=SQ@6+>3T2,''(ZSD#CR->SW[2(_3@LUJ;-_:O=^NN\5SC
M07:E:*)$EEHJ@26GVO9(+\VFB48X)XGD/(LRQ_RU2X+&WC8UDM&_HIULP-WQ
M$#X.=_>!K 9NJHX,;I/0?$H6#=D/N/\.A(/?'?8Y/ )=.SO8-GAU//3\=->_
M#E8<7.&Z?-ZG/64<O5TMORFSD-AK7Z-C5=>K]?/OJXWJOG9$IYG6Q&P6DSC#
MA- 8EZ106,<%B24IBRAW"O5TE#<R.\71_T ]#=!>!?2[<PLK5^@<&"LL(##B
MNH"%5]O+RZ! FF &!<>/S7R_,, 6F<Z6#C?,O#S,A.TSG6TZ;*;I_IA/I<GJ
MF^JN-.QN:[5^7*VM?[?UP7A29CIG6"M;9#V."2YC9<A.*$I*PHNR=._O-2QK
M9**SPK>7-TU@QDX\I(+B,%H._!8. QBWG3??JY+D, Z0(I+!\/"L'WD6EY]#
ME8YTLG"X:N3P$!,6C'2RY;!6I-LC'M1U,D5H*4\?%77?S*S@-"[B'.>*$]MB
M+#'.6T(P%RS2L4P2H9V:1O@J,#+)]?+N[-D(L"E5&(@=2'!DX&#,>"97\2Q\
M7J5W?8 $L.C(@/I1*QC80(1[!1B#+.PS[G34?(75!WQ]S3@>)-[K=F;[')O]
M<U8*9@_<DQB3++(M( T_1P4K$BFR2!5.U[$GQA[[RG2HT_%%NQU(T]\:STM$
MV]7P*J, !.9OG!\W.1L)HY[39@RRRHM'IB.,T[H><,&9C_A=M/WRQ-9LN5'J
MEB^J^Y8_WCZMU^;=O67K];-AG#_9XDG-LS+/%(D*3&1I_DA%@9F0Y@\6J3SB
M>4$9A97_=!4-^=YY%?C<UI>\WRH$;!ODC*%44N=QE.&2$V;V[89,*4T*G!:)
M(%IG7%!0/OH8"'J0;*?&:HU6>SUF2+2:(-&I@KY974:"=IBJQP0,QN-[K&[[
M6'5*H*T6Z,]!K,!7I5## UV@.HN=]%H5"L;+RU;P\\&"[6W*^?VR^B\E/THC
MK=(5VY4=N^GREXU;^*OY<;6H[+6[^9U9B/L_F8L\SPM2&A^.V&#7E*282:UQ
MH<J<%UF1Z134#6XD/4<FK2^KC7$T%GMYMOZ@5>'J0/P@+\F-SWX Z&'T=SJT
M?Z\SZBO=%4%$6[6;TY.>FJC3?-;_X:C1_B'!'2\M((B6KYT_$!)JAT2#H.)\
M>PZWE^:[(B.]H7]7FWD9%9%@<8R+-%9F%TYS7)(TQQDM2U(FG' -2E*X(&_T
MG7D7==%5A-NP[\JG^.LEU-R(-" 6P'W]%H9>M:&>[*8 ;,A>O$YF!FO,.RQM
MXBZ]3J8?M^QU>^SU7;S. ^W]XM?5\MXV&6Z.?5A61K%("4Y%1#')8XXI)PK+
M)&,\2Q(67YV+.9+J/\P1X2N\M>G=P'#OXH?P#+<;ZP-.M19A:U*@4\;7>P\_
MH!-Y0?'_9_U*MQ<RIJOIJ,%X538_K-:JNE\>?.)=91ZT:E5L,<\XY8R4 DN9
MYYC(1&.>RQ1G*F%)GD1YFH!R-$(H-?+RT8E'-GP"R9[<\)4V+\+OMEI,#2IL
M'7"OO[E%_N7G^GJ^4C%.5_@FK,MY4:4?KD2G*X@^U3J=Q_;.DUXK5JMWJOWO
MQV73X>]VV]ZO)?NY$#)EJ<IPE)K-/$ED<Q)+S(X^CC2-<LG3:+Y4]S8RRXTP
MW00[S5[:SMZ^>.=)W/::;!NZ@'./79 S6Q92Y@8Y70J&2<0UIJED9J')4UI2
M%6DMMLA] >6)CP/?%_C",CJ&;JM%0$A\*W\U<M%/6PUL$P'4HK/3HML0!$V8
M!I@=+M_91>C4Z<H ($YD&T.>]@A5.I;PKKJO-FS1#KUO!3(GAFG3Q' &92EM
M(QA*E7.<RR3*,GM^FF4 SH!)GX8S.N$=:Z#U3CP@7,@=T&$"&0&?8 3R<8FV
M4'4G"9_&A0H0=#4*9'[Q6,&@@\5K@1$8#.5R'VVZ*"^PA0<!8/"G?4) %=]\
M7-:;=?.]N5T;"4NV:,H(-5&G3\O-^^^/;%F;+U17DH!3'8D\(YCE*L4DTQ(;
M)Y9AHT\4DS1GM'!J3^@I?X)S8K37:(:V.K65JM!6*]NYN-/K<LV#(+@[\/"X
M:$*OO'Y4("&AL:,"ZAD^"P<V5(2M-QK#4;CP82>,U/6V^3":UW\8O[.)P^3\
M7A)K^U<KYY/]WLU9ID5JG&:SLV8E)EHJS'.JL>(%T8)*GN0QY##75?#(/+ZO
M]U!;/6:V#5TG'C4)%+#-MC.<*6$Z*0J-BX)I3")-,1<%P4521JG,N.8\A@50
MCP&H5P#U14C13ZQ&C^U)[/G6M=?AZW:<,09FL.7O1;V163]O?_N/!KE/@U]&
M\(D&U/) 9QK.8B<]U8""\?)< _R\AP?>1*C^8@C_=OF9F3TD52S*\D3@++-%
M,87*;02'<;29BK3YGXQS-M_8AQS<ZQ>#@SAW)P(8;'MOQ"'SQ;9-Z@".W$L<
M'-S=*ZR#3>;6L%\ZPSY?9QC _;S"0#_?$F HS'4\8\F@7_CRF>F<OC/:'GAT
MYS[C78CMMY.%MA2)XC+F!9:41(8.:()Y$FF<:LER&IG_%6R^5!L',A@0 SNW
MW%SI-]1M4:[?$$:/;-TF#*'_'OT<1;%U']I6;3.4SHQ0Q)XV7U=K&T>Q^\E2
MHFC;SZTMB=W\;-5K+L4VZ)T2C6W_\[_%>?1_DG*&[%>LS<T_^%4:-;]*9\@,
M^-A>*BX<2S=>?']2RU+$J< %C0V=,T/L7!4<9PD1<522E$KW/GS7OL&K"^G]
MYEQ'#8922IFB493C2.3:;D)*S"3EYEO.TU2D(N&"N7G-(7'R\I*/D0J$D<."
M&,ANV.)X[JOA7W+PS$R"EAR\&H>K2@ZZ3Q6?DH.#MCF4'#S]_-0E!P>M.%%R
M</CS?@<E;UG]]68I[7]L'SJS&)DW7M^M%I5X_J*^;]X8G?\QUTK2E-M:7"(K
M,%&RP%PF%*>*9P6A3":ETZ$W2.K(G&Z%=SVCS5]Z:L"V[FX NNW;@\,"H[*S
MB,Q0JP/ZJ_NO508UV@2L= RR/M#&W4WFI+MV$ POM^RPASTI8_7P4&WLRF"K
ML[1%6^[54AB&VM=3WW_UXX1)D1G:B")FPV5+@<M(F3^,6R]B0HO$S07T$S\V
MB>R5:6=.7QT@D<!@=624T< "4LL03KU.ANBO<:C%"X90' ,3/BW9> %SQ#I^
MHUS=T^K=T]H(NC/.T4HVQ0C:'W]8K8W#]*T2JIZS1 HJ:82+R.:3:E9@*G2*
M21(I1;79;R7<L^G59>D3D(\]:>PUQT)ZM;87$_73HHD89/=KU;3 \.Z:Y8"Q
M&Q6-AAQPO];KNX5:15"KR:RM1S+;_M)"N=5GE Y=[C"$;^'E(/NU>GRYPS+0
M! PPR'6)[(?9LF:']L@J^?[[HUK69FKD(LF9$H9T=&%#N G'/(UC3$K->*32
M.$U*6/"[DUS8@:9'['LG#ZE.H%\Z^S!V;K02#H_K4MN/<MJW$+V_!)%W@KN3
MR8'3W(=EODJRNQ,,YU+>W1Z&4802<OZ;8M;IN?E>U2[NQ8M'1G8<.DG_[#9K
M7YHS/"^OL 0V\SHAZ"\K)L!>X8SB)^9/K<3/]ZMO_]L\T4T=(?<SYN4XD\R)
M,\IOO_7G?AW> _]L[Z7>L%J9;<"#G47=>75!N<J2%*>D2#!AN=G_%S3#69YP
MF7(>$P;*F86K,/8-D16*N)5J_.^]V'!^]QEDKW>^K\<+Z(&W5Y>M-CNGN_DI
M;M1 =^S9[EG0S7IM'E1MG"?3YK78?%BM*EO2?1J7?!B<"?SR,PK\,,[Y,$ 0
M#_W"2)Y<90>]6QN'?UYD29S%,L<T(@J35*>X)"K&B8[3O"01+PBL__5NZ$FX
MY=%*0C]52_14RWV@ ##2L(>'(W-X6>G!"*@1$G!6'RD>:K;N!YYV%AX9=#2[
MCC\1(GRZ)>R;723*O)!I$A5YA@63D=W+QI@))7!2LDRSN% D Y7X'18W^BG:
MOJ/4XV&LSO\^CMUIUZY]5$XS(=N?7A7S>X2QV^P,AQQLQA[%]W:+^E[V6#&]
MYVP<)9+W2-@KQN^>,WPX:O?L4T%=_U;*[^KOYE?U/%8)ITQ27"8YPX3+$I=9
M3'"D2LV*B)G_@>JPN8E]I>-V]9]/U>89Z6K)EL(>)WM3@B.Z5[G\5V 6[J"]
M5<+6??R[_<3X!^QG[![7@W\I]$?PVL\ X>BIGWO:(^[W]]6RM_:^4[QMU?6F
MNM_]O8M]*V-.$THY5IDJ,!&,8)KI$HLT+G-.14D*I],#F-B1Z<0(1#N)@"!!
M=]B&>6(\,& \853 ?1]L)WB&#B#R":ATQPH07CD*9G[!EJ[8!0J^!%L^&(KI
M/MIT@9E@"P_"-.%/PVA3JFK^?KDQWL;[![6^-Z3\RWKU]^:K/2]AR^=YS%*9
MRTQAEO 2DUPR\S<28Z49U3HJA!9.;M<%.2,38RL9;46C5C;JA+O-_DM(#5-C
M0/MA7.AINO,L=C1LX,[#C-#Z0^8O>S?HTKB33&!'X[8SUO7C'IY-R'JH7=^F
MWB^Z"JES%>DDC9C&D:3*;+*B&'-9Q#@M%8UYH0@%-!2=1.61B6/;XJK7[P3@
M*TSSTAQ\LA_N5< X;*0:U]N7>Q!CT1GSP[UE@#?YP[UM/T_T1WKK,*=VTA<P
MZ!!/H\ETSO2DR!XXXM-*]O 0;N)DMR6H?V.;YH3E7YZ6*HWL]Z+;E,8T2=(X
MIC@5I<9$$8)Y:=;ZA!0TCH0N=1$YK_!.(D=>H>/D?^PWI37::H&L&JA+1"8
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MR%.LD8PZT6VE,\ 9^A! #M<*@<R&3;P3%C=GXSYI1$/V ^X. N'@=V=P#H]
M]P,.M@W>"PP]/]U]@(,5!_< +I^'$5*]WLP;+T&M']EZ\_P[>VB[;<LTU464
MECA/M=DEIZG9)4>BP"GA69'R2)>:NQ#1.0$C$U!?)+(RW:;?63B&:2>$D<!#
M\I?V!>M'?LF6H07?/-M;[,V_]@O]V6$GF6V7C-K.LHN?\_2>J_MEI2MA:SRT
M:="VL=EJ40F;]+P[,I4B3B->2%Q26[PK+0N;NB.Q+*F(8]M(ITA 7K63V+&]
M[:>'!QNO:V,X]OJ@O4)HJQ'0#7?#U-$]#XX4T&T?1B;PD;2?U:$\?3>AT^X
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MGW?C@^\V/?9U29E(F,14F=U/J"QQF<0ICC6/TSPJS*]AHZ,!Q <W+=8VM/_
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M)2YE3G"I8MN,/>8T TVH[Z$UO,NXI=RDYS>4D24-'HY\%B\WW1L(!9C&W ?
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M9O;M_,3L"1<E15;F$O-"$TQB$N-2V?9_D12B5'',5+0^X7IP_$XX4?8X\'J
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M4DH"*BR\BINAK=^VD^<-CG>Z?(J6D2XQ<:8>S9:OU6HU4^Y1V3"/PC$(,!;
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M,R,L%IR72G"F>5+"XK*G"0T>;;5DT1[=[F0;V _@#$YN1NCULL/4EH?0\!%
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M"-2E3B/[L)'<30U; '/O_)%V4/-#XP?3\BUT+3OHEXZA7Y%EZ5QZG7%@.[;
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M6UV^PQ;J^#IHC;I&UQH-&^:\!TOZP@P=-CD"W-<,H/2$/>1<RBL1NCRKTI?
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MV^=?B/WQ?_S[O_S+G_\?0O[GSY_>__!F%B_/8;K\X7@.?@GIA]_'RR\_++_
M#W^?S?\Q_NI_^#CQRSR;GQ/R[]VO'<\NOL_'9U^6/W#*U=6/7?WK_%^Y%30Q
M+0A008ETB1&O.25:2*;P'\&"^O_._C5QY:GCB;"L&9&:&>*]<23A7Y/VV62Q
M^M#)>/J/?RU_!+^ 'Y"]Z:+[Z[_]^&6YO/C7GW[Z_???__0MS"=_FLW/?N*4
MBI^N?OK']8]_N_?SOXONIYES[J?N7Z]_=#'>]H/XL>RG__GK^]/X!<X]&4\7
M2S^-98'%^%\7W3??SZ)?=E)_DJX?'OR)\C=R]6.D?(LP3@3[T[=%^O'?_^6'
M'U;BF,\F\ GR#^6_OWUZ=VM)/UFJQ?CLW/\ISLY_*C_QT_$,$8&T=K^[_'X!
M__;C8GQ^,8&K[WV90_ZW'_$W%[@FEXQS6U;\?U>_^-/-PA=S6"!:.D;?XS?6
MOU]6V8,(^+:$:8(59U=+3&;QU@]-BEQGU[\Y\0$FW7='"<:C[E./PF(Y]W$Y
M AJY#M&1*%Q"4"6+H J!!&D]93E0R_EMG@O-"R2Z4\,"XI_.9E]_P@_^J<BA
M?-$)I!/&O>56@MF/[JM]]QE_=@29NF"H)89Y)-M)3WR0BEB?K!7:(-7J(+(W
M5[M-]:9"C^;QA]D\P1P-Q]5R?A[O*?<V9-<_\=.%G^,'D?AE/$E7OYWGL_,:
MNEK.*DANI18D]\<?D.L,\SFD]RNM/,A<Q]D2S2ET/UE#XT?3Z:6??(*+V7PY
M8BXK%B,C5B8TEDIPXB0-)*4L38"L3*!5-+^YZDX(X.TC8&])#HR$X\MY$=0O
MXT7TD_\%?OYVFM[@X3NR/@@O@1$7DB?2<B"6<D&$X$DI(8.W\3#S]<#*.R%"
MM(N(*A)MQ#Y\A/EXEJX8< Y8]"$2#\D0Z7DH$LG$&@C<9X$,Y"H&XM:R.^%!
MMHN'PV79"!@^S_UT,2Z"7YLYJ612SEO"E!?%;<X(;2,)1]NG1/22TSIXN+OR
M3I!0[4/B((D.C(JWT^5X^?V7\00^7)X'F(^$XAF1&XA50J-YDWKE_FCA+$M4
M6QG206BXN^).*-#MHN @"3:A_4]P-BY"F"X_^',8Z>R%,V!(U!3='I8S\2JC
M RR953G[Y&0-!-Q>=2<4F-91<( DFT#"NVF<S=&$=8(_1?G#\>QRNIQ_/YXE
M&&%<!-H9B\)( 8'M)/%.6")<B)Q9RT0(%8#Q*!$[X<2VCI-Z<FX"-I_]MW<)
MQ3?.XU7":FT)4_)6,6D)9#2"4F2/YZ!2)!JP(+2B4AWF63RZ_$Y0<:U#I89L
MFP#)44JH@L7Z/^_'4V CP0OAV1 E;'&? 8@WEA+C=:)!B)C<8='I@TOOEK*B
MK:/C4*&VA(QC_/)D_GGV^W2DJ>!4RT24SY+(*#"BRHAUY71"88&B!R9='UAX
M-U0TG,FL(="6,-&=C2?SC_/9U_$TPHC++%-2*(C$.?*A4"Y1.A*4-2&;E%,Z
M++GYV.J[H:/A+&<UT;8$D8^SQ=)/_O?XHO.=',^16N.)!AF)5,81+V(F,B<6
M*,;D5)AZ +FU]F[P:#CE64FL0Z?""P]S\!W=4@$S*C'"))1DK8O$2\V(HL(Y
MKG3,<%C(LKG:;@!H.,>YM^@&5GFY)Y]\_#*;7J5@&)C$K3?$E=R;C(X3RS0G
MF7$ELC)).G:0VN^NN)OJ&\YE'B3"@=5_"O%RCM!E/'P>+R<P4IDSE2,0YC$B
MDAD<L<I1XI+C%"(Z/>*P#-;=%7=3?\-)S(-$.+#Z/\]]J44Z_7X>9I-1S,;3
MD-!OT0J(3$P0YY!P#(@,C4QD\'"0[F\MMYOB&\Y;[B^\1C;]VV_QBY^>09=P
M3=:&S-$YX5X((IE.!#F/)$:.#HS5.FM;9>-OKKH;!AK.21XLRB;"@;_#9/(?
M4PQV3\$O\!Q+[Q:+2SS(/+5.41J)B1P/,ALX"< P$C8B&G1P)(V'8>+1Y7<#
M1_-9R!K";0(E?YM-+E$!\^[";KX8,2JY,)22R()>B258""0+KRV>>#P&5P$=
M=Y;=K5RJ^>SC(<)L @WK(I_5M7TY!E$)EXN1L:R8.$8$U\A'%H#1+O5$616R
MX$9[7N/>8OOJNV&C^1QD!=$V 9%W4_PT%,?X*[SQ2[]F:Z0\6&Z%)"K3$AU;
M33Q'.R@#1L9:N9 .K*]];/7=(-)\(K*":)N 2&?]COT2SF;S[R-!'4(<K9[/
MU*$/'0WQ$ .15(!SS DI=05DW%IT-T TGWK<7Y!-X.#TW$\F/U\NQE-8+/#[
MU$"P LF7&$&#L\1YBC8O&080!+<'EM5M670W'#2<@3Q4D$W@X.TYS,_PR/O+
M?/;[\LOQ[/S"3[^/(,F8+5?$VTB)] Y($"D2'HR42AF)WE,%/&Q=?#=<-)R>
MK"78@?'Q+N;YT64:XT\<+9>P6.G@EXD_&VD)@:5BWI+A1 J#CA%EC#AG'"@O
M0G:''1L/K[T;.AK.7E82:R,%VK^,IZ?+\^7;^7PV/YXA$?&:F\!35C8*HG6Y
MDV'>$\>M1:C3*#P3&'[5>=7U, V[@:7AC&=E,3=QXIQ^@<GDRAX*QU-PT1)J
M;;FY*:]E#0_$,(Y<66E#/BP#?G_-W4#1< KT0#$V 8*/EV$RCK],9AYCJ!PD
MAW)ER]#82:,$L<)IXD!$H:'D\FLX&QM+[@:!YA.=^PJQ"00@=,]+/?$L_N/T
M"XIM<7*Y+*_*RPW/2"0JLS(1C[Z2>:&<$V>T(ER"DDE(8WB-RIC':-CM36#S
M:<]J8AX8-$=X#*;N*.P.O?*J$20E.?E2=2X2<<(;(FCR: E#I <^^[BUW&Y0
M:#C+N;_PVC 52/G<3]Y-$WS[#_@^2I%Z+8,AR8$A,J#+XY,'0H6Q.@26A:WQ
MMN/.LKNAH/E$YB'";";HN'KG_ M^I^3I%8!)0+(QI8B<%A:2(9H+C*>YT$(?
M=EH\L/!NB&@XDUE#H$UA8O7@><6$TBG:I#V:N8S1-)-HYG)P)%&>HG&)*7V8
ME7APZ=UPT7!FLXY0JR'CSS_=$^1[_,;>_8"Z],N[:>GJU'W8;8)W:PUT[S/J
M= EZG+0#&P85+D97N:<KC%"79-;2DI!U*$DG2VR*DAC<Y:Z[_O3T*6%L^^"#
MG+W51_TRGI^_2R,?M4XI9!(,MZ5O 2W%_HAGE43(E-%\X WWK>6&Z0]TL&IN
MN7M[BV]H)W]%>%?3%1U0I9!BF@$M#66*>,5*ICP[!U9 R**&UG>NBJONV?6A
M\V>+K@V-OU\WCQM)+52D+A(#I:@SR(@GEHXD<>#:VJ0$JZ+UJP6'Z?S3A^;W
M$F&S1_3QR8?3D_?OWAQ]?OOFYZ/W1Q^.WY[^]>W;SZ?[G-4/?UBEUGZ[$7O@
MZ7VY(&?>7XRZMW#%.SO)OXRG?AK'Z*+-5CU=KL'$.%IUSSG1'A!,I=&DY481
M1RE"B5JJW&/.;_:+T&E\O>AJ,P%*]NH[-[OJ.73M:RKNK?'9APF,+*([ER85
M6N9,I$0G-S@IT.ZI(!)N&DI]7UQV% SC+/2&A"NS4D'< YXK5]1_@DEIZ?K1
MSY??N[9'OKLU6_S\??-?CKZ-%R,JE,P1;29UY<EQH"@DRRP!X/A=Q[+2CSW5
MW0=(NU/7",CVP,#L1132&-3>S,[]>#H2043KA28^^])/QW+BA,2O(K*0N++F
M)E?8 Z165 P+G;[T_0BL]A!^8_#Y%;HGC5$QG:GA)%-1]EG4)-! B2K_PS,$
M]6C_HD/ALZ*B'?CLH]='8+*'D!N R;4I/I[XQ>(D=[=ZW?9QSFAFH&,$(_MD
M%;$9(@%K?5112.2T+T?H+C'#!-,]'%=UQ-T ;C;I7V^D!%HJ% 'AQA9[B_ZA
MU\J1F$625H/(YK%F1OL YCX5C3@VAZEW5E76 Z*E2TJ<PGP,BR-V/)M^A?ER
MC'OHXQ4='4]KRXDBRHJ+\MJZ)!5!4>)XS(1C1*$$CYR'.][- UGC'1<<%BJ'
M*G76LX3W1@U2$&:U3J>.L9^W,I-,% "JW$$IC:<UE<3'@.$HC]XP*F0RU=,1
M#Y,S[ E5"4RUQ?Y\#+D5AJ:PK&5WWCVU*<!Z%EP&PJ)W>)PS0ZPTB@BK,B]/
M+VP*SS [3ZTW3':X/ZM35;Z#&IT-IG[=RHG 0!)L8"0&$XGT!DBPUI)@7 C.
M685QYC.0LG618=K$]P>/PR79@A'YSZ= +FT4/$7TYW+I.:F#)I8RCE&?E (#
M/^FI?08TGEIOF,[Q_:&DJGQ;,2*G3S'E0P@)P!-FRWP5*17!G1")HR ,+_\;
M\S- \]1ZPS2:[P\T5>7;@I7YVU,,4>,]Y=P0'ZPGDD(F/J$#)M!S-SH8)H1_
M!F">6F^8GO3] ::J?-N(CZ[R#>_'4WB'7RY&03,G1#1H*<N#OX3A7? RDJ03
M3RFZ2.ECA:L'I>VNJ1C6R>TC7[>?@!M(U!TM%K!<7%_=2NTQ]L^)>* *J0=.
MG+6!!)V22-P_\0I['WC<IJ"1!-V>^IQ5$VX#T#CVBR]'TU3^\_:_+L=?_00%
MLSA:'OOY_/MX>O8W/[F$40Q4&N8T,4)BF _,H7E$<3'ID%7K8WRT5'*OM.XN
MA T+I$,T?S>]6UT-#6#K*,8RT6.!C)TLO\#\$T1 UM >+S[ \JK5#8W!"<4Q
M!#3,$JDT)]:#(E10P1U@),@>ZSZVES7:A;!ALWD5L55?#4/?)ES-3CZY@'GY
MN>/Y]XOEK!/97V&2?IG-?UO _(JSH"PMPX^)8:HDG\IH.C3L1#NMH_>2!A [
M><S/6G98]Z<"?'J6= /V"?W_"S].;[]=P'0!5]MC);HKEGB,QBJ;"&X!E)S7
M&F7H#5$Q1(PF04E6N]QF![*&S1!6M$VU5=  JFX3GZ.PN>2[A2OCSYQG)!@3
M24Y:<Y$!7'BLI<W^OO9SD-);EK#F*;:W6/?'Q&SI)Y4LS0P-Z/([FM,R7SD5
M'^^BA"!X (\H]Q$4^G*XLB22EMY-&22AP3C&$Q[*KK9S_1@]PZ8(J]J62D)O
M(LVS.H$Q%'@/?@&?QF=?EB<9#]].8".-$6J2F1-?$N32)$Y"5XTMDP:C,EK*
MQ_K=[(.A1PD:-FU8$43UQ-[ T?0.=3 ]*ZG/E81P([S]%B>7I6G'7V:S]/MX
M,AEE*05%*TI<+AU?O,<@,R%/&B+-U%/F;>V:]5WH&F;H90^(JJZ$!H#UJY__
M Y8EI%SWT1]C;#F;QBL/3N*1S!0>SU&PTL-6EL(W3P15WJN<C8RUW],\3M$P
M8S%[ %-%P0\=U+^!B_+&:'$["-A@QAH00B$SD7(@$J(CS@AD)B=F>#1"TCO%
MR _$\4^M--!<S-JQ>U6!-F!DKHTCE9K%\M3<,]!H'#,0YR,C98RCSE0J:6K'
MY,\ZA>H/Q^S!<NPES090L!+!2.;28"IF0FUI05(>]C@?).$B.&6%%-KW<X<U
MT #,WB+J9TFR@5#Z_=B'\:0[Z-"P=3?W7V83E/JBQ'?+[]>B$5JSI+@A46E+
MI':1A)A]N3N)R3IIF:L=$NU*6R-/6>K<?_:BD 8,S29?U[T4/$\F>T6 )T<D
MLH,;#QSAH(%'%6FZV]2F*J::N#[O1]^/@&H?X3> GZMKMX_^>_'/K^_9? XF
MIN)T.3QNF='$4QX(@QP30_9$JIX0WDI).RC:2\$/7'(>(.TV,#._Q%5O;;'.
M>=_XUH@%*QQ#P6@M2A\>J<HU&R56<.5H1NO]: NC/2'T-&'#'FL](*JR+@:/
ML,=G8W3#.K_OBH>K&56CE""J!))89P6& 9:1(#$BY$G9Z*5&3_#)ACA/KC+L
MI7@MA-059@-FYRZJK]@ '0,:2%=L)B42N"9.*$-2\"%0QT*BU6\5MI,R[(5W
M;=-20]X-P&:CE/H-A.M*(NY*T* E,:X$$TYB,"$<_L&%07LH(I./#1O=JUAP
M*R7#WGW7!DT%:3=XD7G/=()EE);J,VI+RMKR4D.4,S'1A"RT3[)Z!X''*1KV
M/KRZZ:DG_08LT(?9$NZZ_ ZLSD)1XA.7JVE'MDPO83E;Y,(G*VM?-FTA8]@+
M\-JH.53.#4!ERW%+8U"<"DIX" K!+LO "A$*]@,S#F)@/68(GP.4WNZU:P/E
M0"DWD%]^LU[VW33.SN&S_[;!4BD<*KT/& @\8#-WI5A:$J=,R9Q&6P;M66IJ
MEZL_0=*PE]FU$513_@V8G96K/YN>?8;Y^:89'<7,G&00B0J^],]VC-C2'8%V
M&06>37AT/-7^P=468@:^\>XGOCI4Z V@9RL/7#GOE4R$@?9$JA"("\X0%B7E
MB5FE9>WK[_TQ\VH2R >+N@&X/.#<;Y1\>,\4M0%(U+8\A^>&6.\BB=$)"?CW
MY&I?8#U)U, WZB\48>VIA!90=2=;M<$)I,@8%Y9DG<LPZNQ)L$:1E$T,R>JD
MJM^Q/TS-;CAJ/KM<6>P- &CSOD2A\\:U\,2STAK5.$VL4W@>.ZZRPP"2Z>J'
MUS-OJ-BKR2/O*]@&PJPR/W*\/(?5N]3CV;183)C&CI62/,@HC8!6$N'M\-0U
M+!*!&(^*QRQ5;:OR"#GMW&KV5FU12QG#=UWZ%?[Y3S\=3^&.=$( S8WA1,72
MU:4;AZ)QBZ00E?&6V737[#QPN_G  NU<;%8'236Y-G 2?8;SB]G<S[^OV+CJ
MKG!T7FI'CI;+^3A<=M7TGV<?.\FCQ)P*&GVU9#DGTL:,$8!!5K,+H%BP+M<N
MUWDVD0..%JN"B]E+*JD!%#ZR05F@2+X'/+:U+,78@@21%<:?C#-A,AKCVD??
M@66J+^(L]7;R55)% Z"ZW<QLU2]&9O"9(@M>TJZ762369$FR$<H+S0,7M=&T
MA8RANSW5T?#]Q@4'B;L!Q&R,<%_1CQ;44HEAI7"E!0P5A@3&(W$IA!RRLC34
MKBN\2\/0E?&]8.4@03=1LW&44C?]RT\^^G%Z-SWV%Z7X;8.QD308)U@I2-;E
M#-:F%$+ZTJ(U<!N9H"Y6KVM^DJJA>Q#V J?*RFC $GV"I4<?,KWU<_0ESQ9'
M,5Z>7W9C==Y 'L<Q'O(A6JVC)BZG4IA2MHS1E+A(.?J8-$17^[;L::J&=9!Z
M@E=E930 KPT.NJ0J[A0DY0M,%^.OL+IG?C];E-OED_S9?QM%%:PW@.8Y4S3/
M D5H91!$>6U<]D$H5;N"Z)DD#EO9V)==ZU%-#:#POM1&-FO+J!9$,Y^)+)T=
M Y.4Z(S!<E(:#77M6L?[5 Q;W]@3E@X4=@,)\E_'T]D<Z7XW10C"8CG2$*AB
M01'.RL!5CP%OR#8A$\Y)7:H89&T'ZRX-PQ8U]@25@P3=I%U!6[EJ)_-Q-N^4
M<RMG5NX19],E4H&?>';--<L:PU?CB.$"1<A*J8.CF7!P7GFE$N3:=6UU*!^V
M@/+%[%?O2FW YCV5\ANIZ(T75!$:5;'AR)E3Q0/@D(RQD$+U*. IFMIY9/(B
MC[$/5DLUF/WYIWL2?X_?Z/ZI^Y?R6Y\@_U#^^]NG=[<^WT^6:C$^._=_0K=R
M]?G')Q].3]Z_>W/T^>V;GX_>'WTX?GOZU[=O/Y^N+AF^P'(<_>0V&XOQ^<7D
MR6>1.W[R3S>DWV5JO< ]Z%1B [XM89H@_5AI$L5C<^.#9@P@ L+/E-@139+-
MV1 5DI>,20FLMANS"UW5IG"LYDTH:YVV21"&U!!I%$<N:2(J*^%RF2KLZI^F
MFQ0,G72OC(0'9W(\7]Q-N&P/C8@-S@9C@R8Y"%]BVD"\=HQPD023"=U25KL7
M[&$#E_N'T!X:WGG@\G/$W0!NMHQ#BM1:H)21")"(!.U(T!R(UED9"DZ)^-]W
MX/*SU/OTP.7GR'KH7@^[C@-.7D0.,:$C6.:Y4N>)Y0&(9U)DCOP:39_R;U[U
MP.5G*76?@<O/D7 #-N:QN;\<_7NI$B>ZF[TFJ24!$B7>@X&0+3BHGJ]\1>.6
M]X%2;;&W87>>' CLJ4F9NC)ESXE2'T9)D R_XIHA3U2G9\U*?74#EP^T.E7E
MVP9DM@\)-C$E@Y(B6H6(U%.,%L "0:<O>A-S GC.>-37,6[Y0' <+LDV$/'D
M0&";)-.TE#48FHET(A.?RP6/XLB9<<H^:Q;WJQNX?"!.JLJW#<@\.0[8BL04
M!4.$#Z4^6&<2;%9$"/R'S#P-RCP#,J]NW/*!D*DJW^%?B^PX$CBFS*F2G 3F
M ^X#E%P +TDRB25CG-=WRVC_6".7#P1-5?FV$"'=[Y^L,\@@&">):B R*8/N
ME@SEA-4T1@W&-C)PN?^NTA7S=?L)N &(W'G"\M'/3^8=5ZDK /X(\],O*-61
M )6S"HIX$=$YIR@J&]!7%\"X==($%6KC9D?2&DGI[8F QU\455%'>RCK>%@<
M72Z_S.;C?T(: 8.8N'*$)8P$92@6UEM!(A6!"9>8B:I?=-TEJ1$3U0NJ#A)_
MJVAZMUA<(BN"@M F&>)T0&L>?#FAA2,BQ"B82B!\SW9JDYRAJ_K[1]$>8F\5
M02>7R\723TOETHAK;WWDCE >+9$R4^(-:-P6:%^C]D)4[R?\%$U#E_#WCZ5]
M%=  H&Y'"P\>VRQC **,)2R@H&3.F=C(,C&4<2&RX^!ZF-&\ V5#E^E7!5</
MRF@.8O?.<&.= (JQ+M5"8^AKRU[QC$@6&:4Z6U.]Z/IQBH:NUN\14@<)OU$H
M71WD05"/&X(XR121CCIBJ5?$!(.RR]QI4;L<[&%JAJ[B[QU">PB]4?ALGMV@
M)5=,EFFPA1UJ*+$6$LE69JTRU9&E%\#0<WVG'BOO>P?2ON)OXLWVQGO@!P_K
M8!/GP6NBE:-$\M)65V2)9C:XG(5P4+T'[0YD#=O0N#*N:JNA 4NUP=*],SLQ
M"M1*1Y+@Y2F BL1;2TE@ABD,,%0RM7-.CY S<%_C_J!TD-Q;A-#ZS$8>HF92
M$L[*FU[C\?2.@9&LA8^)6\Z@1X/T;"^IO_;&?4-G#WFW")O-$UIY(T%'3X0)
M&"Y8[TAP/!!EM&(F6,]E[23E8_0,W-:X;P#M*_EJ*.KS_=?I9_SSU[<?/I^>
M_'+R\>VGH\_O\%^//KPY/OGUXZ>W?WW[X?3=W]Z^/SD]O<W6\]^#/6.E^N_#
M]F6STGNQ54^':Z!>/PSB+!J>T<%FM%1,@X+R]CJ3!*"D0%];^=KYO =(.;RQ
MS5>87L(ON#M+5]7RD7\?+[\<7RZ6N-S\[;?UF]XR11#_+Y6V%CQEYKTP&*R6
M1PME'%QPN*T$]T"C5QSCC\K<[T'FL/?#-9!SO^]-O[IJXOA<+$_RFM$1V,R,
M39;X8 VZC*4!F9) *$-;)5%8KGKS]EL$#'L9W >$]I=O ^#XRWRV6'R<SW)I
M\ 0F!!8L<DTED:$\5RF.0TPV.:,0V[RV*[6Q_+#WNWT 8U_9-M"3X7J<Q=MO
M%S!=;'2N1\H#FK]$DK88.S@G2X]P37CD04,6 ;W"RB!YD)AAKW'[@$P=N3=@
M5TZAZTGR%Y@B0Y.C:3I*Y^/IN#"S''^%-7LCHW+6$?>!*N,G)0-!K#::&,L=
M'K,ZN.J7N+M1-JRG4PD&]UZ;5==) TCK9G&_.[_PXWGW'!CCU#-8C')6E-$D
MB"O=X:1PFGC@GJ"<C)%42TUK'V;;*1G6X>D'215DWL1MR3WIC$0L+W/!$LI=
M*G,K&7$F2&*%,BYDRIGM_7@;UA/J!S&'2;HEC^BF)^5(:L&U9Y[0TEY+THC4
M0V'&4":Y0T.9:[?.WD+&L/5&O7I!>\JZ ;A\F$UGM[E8 _]:0$9"$@[92*(\
MS30F$\>T(3EI[AG-UJE0&3Q/$C5LG5$?4*JKAP;<G:LN?[>8V>2RC,OEBFG%
M@!-O<R RTFY<KB0T<%#.9 FV=N71+G0-ZU17AL*L9[T,_U#R$_A)N6;^BQ]/
MBPT^F;[]%K_XZ1E\GOOI B6&FD.OSS/00E!"8^AFA94F@T(2D:BRC"5-TYW^
M( \\E-QMO6']Z7Y U)>X&[!7O_KY/Z#K5WH*\7+>]9/\;3J_P^N(.6>!*SS>
M Z#4@&EB49 DEE&\'!W"5/TMY6Z4#>N,]VNS>M!- XCKVL@_*+@11&&30<OK
M37E>HUD@7J9(H@\A>NMB4-6=]D<I&C:+V2_"*NJB 60]S$APW 9&/1&T='VV
MWF-H+ 7N$YDA22\]?3%G?MAXL%\\U=%  _'A361[=?4\GEXB4^O0%P_ZGR'/
MYNL)&)_]-UB\_8;R0_6-IW[^O:OM>:#_MP*5DXH8)=N,\5*Y9@H>-YG1I0,Y
M_I^+M2U<C^P,&Y/V'32T@8)F-@2RN);OSS"%<G'*3!EK%2A)QN(1H8(A7H!#
MYR-E*B!F+6MW'WR E&%?T+P$$ ^3?@,']-/[:92YM!&%@\PHC=L"3&G,&8A&
M5F30EGK'7MPX#ONF9F@;]RR=-&"JWHP7<<4&I&LNKJ*EPB3^P,5LX2<G>>N/
MWK'I(YLYT&PT$48JE %0$H!GHF6VNI2'<%E[\EAE%H9]N],O?H?4=A.7I%NY
M*D=%SA"7)_GV!G]"&B,A=?"<4T)+);J4%-G'4(^ -<X%0ZV1M>UO508&?EPT
M -9?1-5-(/T>>_>9NAY$>'L2TR>X* .:IF=O\1>6WT< U&>!2@@\E(=9B1&O
M8B)<4R44Z."JH[P:\0._@7I);^2E5-R TX),;=RF9Z:I3*"(B"5"+,/"').&
M.,B&AYBMD+8R/F\1,/ SJ9Z35'N+N@&<7 T OGJF?"T1,)KS3 $=%85^B_:9
M6(M?">YC I%,5K0R9!ZB93?TO-)+F2H*>!6Q.'+XLU^,X^HYO*,\"6. Q-*;
M2GJ6T%O@H60>'&X2*$4^+QZ8WR)QV/*%.KAX=G"^OY)>"P;?C">72TCK9J!1
M"QHH0R=5\57W<Z<S+X>\!NMTF;XQ! HWB1RV F(X'.ZMJ :0N-73W,$9O?)%
M;V]#&ED6BG+BHI%$0NGHYQ(EZ'3Z*/"$X;9V@[*J# Q;5-$+@H=3<!.A<P7V
M;VUO:B17W":"8A"XO?'(<1H8L9):ZKW7O'J/[,HL#%O6T2K&]U9R S;\KDR[
M_3HRF4F,ZCP)BE-DPBL\@Y"=%$.9-&A9XK4[M&TE9-BRCU[P=KC &T3->@>,
M<M#!0&#$1X<QHM8(?J"!T Q,V2R*@],S;M:D#%MA\2+(V4?H#6#G[S ^^X)T
M'^%1[<_@PV69G'*2[_7BN999M-IZXP11BN+>\-:6H2V!."H]."DE#;7;B#R7
MQF'+*'I!6Z]J>D4P7-EGCQ"Q- (14.9IY-*+%3+*E!LPW&3PU?N]/XO 8=,X
M_6)E3V ^7W'MHG+3P[S5KTPF&06-N;P;+,]7\12P# "=3Z.IQ[,@TQ>RC0^1
M.&QBIP5D5E'>JVLV=_S7HP]_>7OZ[L/IYY/C__CKR?LW;S^=OOW/W]Y]_E]O
MWO[R[OC=Y]NL'=9P;H?5^FTZ]UQV*S6>NWY8NIYS]V4VP0VU6$W-N &U8<PK
M49ZX1$^DDH:$8#1A*BKP4D8K:E]S[418M?EUJTEM*3LMLQ>$2FV(C+DT3+>:
M@&(.?6"---;.(-ZFH)%18]6P\. XN^?+NX&S]9KZS<&01]_&BU$*VGDFNEM-
M9,2'1!SCF:@,X'466=T=BUD/.'>):01#>VCX(; <).X&<+-ECB@UU(4 MDR"
M[,;K)>*I L)X8%RXS*VLWG#P'A6-(.4P]=[M.WB8K-N8W7S$M@Z'E2Q9(4"2
M;@*MI&4:FF,>?3XAK7-2)_&<"?#;5QD6%(>J[_[(W0JR?#XHW H44UC6@L3I
M#1MK#EC"?9!PEYC$)9%EL(L%DXEVT43)K(*[ET&/S^^^N\"P<5=](!PFP0:.
MD14;/V^%,TTN^!@#\;&T'1=H,FT6DE#M9(Z F.;5/=>'R1GV)KL2=&J+??C6
M)2M.WFWE1$L#,@8T@%"ZU$GN2; >>3*)8I2IJ([N&=9DZR+#7O[6MRB'2[(-
M=^/7K7Q$DP!<F4(ORQ^0!+%6*I20]6@:O6;^.8C8NLBPU[/U$7&X)%NQ$O^Y
ME1,F3=#>4:)T*EWFDB4N<,1V0A:$4\YE^@Q,;%UDV(O7^I@X7))M6(F_;>5#
M*>[ <8H1&J!P0GGP$00GSKM@39 IW>V<_R@BMBXR[.5H?40<+LD&O-'5%)Q.
M.$=K#A('*C1SA&</1#)FB,<_R]ME&K35&@UA[:3&/2J&?35>V?<\4,@-P.0Z
MR[/*(B-#%[,I_G7197HL38+3((EWK+1MTV6LK1/$:,=L, PHK_TB\%&"AHUY
M^\B='BSV!C!TAX?UOO(Y!9VM+VZ4+E5+D@1C'6'H?@,&]M39VEWRMQ+22!;U
M<$7?K18[6.H-0&?K26LCM>B.1Y*#*M?F6926W8%DDUPL3]+N138'(Z>]3&L%
M]3XZ-G@/63> EXW9?E>)XDR5+HD=3<O$XZ@PL!=,DZ2D!J8=#:K'*:XMI&+K
M(^4P*3< DZ.4QD7\?O+1C].[Z;&_&"_]9,U,YB Q@ OH\:'IE3YKC/>S)31!
MQ+C.VA!S9<@\2M# #XNJPZ>>]!N TB=8HCP@7=7@KKEP41@;DT1O+WGD0A@2
MF%"$.9J]#,$H6MN[V4[)P"]VJH.G@KP;0,U1C)?GEY,R/[WK)ELD-(<O,%V,
MOZ[;*ETQEGD(7E*2N43&+'!BRQPC8R4OO>K0Z-:^&=J9N(%?Y]0W3+UHI0&X
M;>^F><4+:)]T"(1[%M'%PR##&;2_+EI9>J]3;FL?=X_1,_##G>J@JB;[!G#4
MC<@ZBBBC17>"=T$J9 '"&B"VY,.ED8F$K%%68"W57 E%J[M+6^@8UDNJF/LY
M6,@- N4JEXIA(R]C]S!>X*MHTBKC2&GJJZ72S(;:^<+ME P;NQ^NX2<@LX>X
MA[ZD^L]9@NEGB%^FL\GL; R+]^^/UT82O(U6> P&4K*EJ# 2;X,A !0-<!!&
M[%@I]? :;>%A'_7-ZLNR 3MR;5;?H\_?-08?69-!<"X('LG(0="!>,TH8=%E
M;9-)LOIKT/M4#!M5]7'1L)^ &X (^N5S\ MX ZO_OIO>?_SP"9VO7V;SW_T\
MC5QB)@>.AC53E)9VFI0M03AWG )+EO<P1NQ9)#9R([$G(NXW0>I-/4TTB;F=
M-K__R(_S9"*Z]\084RJ5J2 A1$JT<SE3F:3,M>W5$R0-BZ]> ?'HE<9ANMD;
M;!<P'\^0 C\_K)K\9H/>%1>*=')9&/I8FKFB&F_U>'U@E ;5@F7<N82%4HA@
MC24^:$<R*"<D 'A9_TU@#<J'O4UY2?@.H.EF4+YQQW1_WZHDHM-4$G1='9&>
MEVPO+^^H!15.BVAB/Y5*!QC4WE(/+XG(:EII!F</)7I+[Z_5E(,RWR!9QH'K
M3$0L@YH3QRWD\-Q D=FL4C3<U^[<MA-AP\8A+XF\^GIJ(';IQ/5NL;B$].9R
M7LSZ"MW=UOH OW?_M!AA4![1S5;$Y>")+,TB@HO(&@M<)J$3L[6[".]&V>!3
MVE_V**ZKJ7;Q]S<_N80;IE106<4$)'&%=MVETCM )J(XMP%="\NK3Y?:B;#!
M![L/C;X#]#1TNO<H_9_+Q;++8<T>J ?Y!+$43H_S.*ZZ)9_DSW!^,9O[^??/
ML_=C'\:3,K-"HK<1,D@2R@V=#(+B[G.,*!VU!VETL+L]:JE'T[ O'EX"F4,J
M\8#WW&?E;O]SQ>*?Q[C#37KNI]>UO2/+0_8I2A(YE&FN5A&K(L9A.@;.J+4R
MUG8BGT7@L$\O7M*>]J>W=@_UE:MRU7(64O&ET9%>3;7BSC*6#25(,AX=)C 2
M$N#1(9P$3W46NGX#G&>3.>Q$O@8._&HZ;!>FG4_S (<NNDA3:?/@,F[$[#5!
MEX>30*/!@ \#O>K35)Y/Y<"S]!I :2T5M@O2U3X\GDV_XDK(UDE>?;T<APF<
M0L0?78[1(W<RZT2])* M1:\F6SPY4B9<*^!16AFD?$FS^B3% X_):P"\?:BV
M72!W6_5I9L%$+[(.) =&2Y\4UO5#)<J8I%@(7IO:=^8'$3SP)+X&8-R#8MM%
M\6-N$<HXP[BTR5<A:<U](H)W@SFX(T[%B-O6,RN9I5G$X7W<:WH'G@?8 (;K
MJ[6=S,&C+*^^CRR>POSK..(^#8X"=U&@V^3+\Y;$B>5=1YI +8_!&%:_Z.TY
M%.Z&UC_$352/JFO7Q';GR7WF+ ,J ^XVT*6T0%%7[MN T @I<Q/ I-JU_\\B
M<#=8_I%OJ"HH;NB[@ATVW+OI^S%<GN0/LR4L/OKO75TL\FADM(&(TL1-*J6)
M0X^&"&MM--&99.]$7P_U-MJ/@-W ]ZHOJ%Y,/XUB<&-W;671*:^5]HI$]%&(
MC.AI6PP;B=!1<F%9$D(? L$GUM\-@:__(NH%M-/NT;S:9QO/1Q8CI9.+F0%Q
MUJGRRB.0((L+PK-/T/D<M5^?[TS<;IC\0UPS]:.P=I'8[;=;?&6(( 4X L$Z
M(@$]8*LC_A'1P%LPX/A+9NR?C\,_\FW28>IJ%X:K_?7Q<AZ_H&!/<O>\;C%B
MD3J68GF_K=#E]5#::FG\(RC/+7/"\!<UBG<)W*VN_8]\<51!<>VBLMMM]WB#
M:"1N-@R\4O&!!7K#GL=,((4$FD81JO?<? Y]NV'RCWP?=+C:&F@)_>AVF\-%
M5[&U?BT2I0UX!F@2D1,B64S$=T]*8TQ)8$RF:#HD9-FZZFXX>]47-OUJHN7X
M^"Y?U <7(OH6/'E&I!-Q-:_84,E,]#Q;90]!V+9%=P/8J[Y-Z54/C>)KM7'^
M[N=S/UTNWGZ#>1PO((VD28I[9@@&\;'T[=<D,)70KW5..(S[312'&[%[Z^Z&
MLE=]"]*W-AH%6K>![G.F%7.FS)W"K40Q8 HEC1X=L1!S%A$8Y(,.R^W+[@:S
M5WVKT;,N&@@3'GO0AI*#\=GT^!+IFL;OGY'3A8^=@J>I^]MDI>[K OP/L#S)
MY06<R5'XB'O-R3*80G!6.M-9HC655$O!:*S]K+L?3G8#^:N^/6D("@ULB(_S
M61XO"\\C)8, IP(!+TMB/EOB\)P@QGD01ENC1.T79S>K[P:\5WUI<J#(7T7?
M%>55,N75!J @B#2Q[ .E"#<<66)*6%6[<6J-OBO\#W'S45,Y![8*>#M-+;5=
ML8JS2',FPBCDG*,]#C$)$F0*&G3*NI^7-B_4=N6/<U_RLJIN!.2/]O=(6N@H
MDB',NS(/T4L2D@V$"AYL ,%CJGV!<GC7E3_$?4DUM52%V9]_NB?Y]_B-[I^Z
M?RF_^0GR#^6_OWUZ=VL-#/#48GQV[O^$GNYJC>.3#Z<G[]^].?K\]LWI9_SS
MU[<?/I^>_')\=/K77]Z?_/WT-A>+\?G%Y,GA=$]_Z$\W!-]E9?W9]W!S./'P
M;0G3A*%\I?Z8)_G8+[[\,IG]OC@*B^4<0X11\&A_7,PD<6^)]"Z@_0F,4(W?
M5A"85O4O/!^FY^ FYK LGXD^Z]<Q2N[G[[\M2EW/"4(3%38].\*HZ&OWK.%:
M EQ$C'6<)]$4I]8IW'.&*@*0)'H?4:E0^W;M^50VTN[Q4 3=ZWO>K[H:"%@W
M@G04ZS%Z ./I)7*V9K$45# ) C#>)E1)1R0UB93K:N*8UP:,MTS6#D*>IFI8
MP/6-B_O]1VLJJ0'8W61Z%I]GGP ]SSB> (KUAM7/L^>*6'%P"3@G#'=VF5Z*
M(@;%2BNW[$U2F;K:CZ/ZX&/8WI O#.W!@=# 9G@#N'(<=RK&KR>PSHP>G9=
M[9^K1^>64R>B=<3H6$9*B4"L4'B6I2"$IYHR6[OQRBYT#=QT?G#TS'I690/P
M[&2W6+U7?#.[#,M\.3F*<7:)4A]IYIB3I1NKIJ597"Y?64XH ZH$E+*W^AG*
MA^D9UG8V!\=JJFL AK^,IQ[EZ2=_N?3EUA3@W71QB5_%\D:\DU6I/CH?7YXO
M4/8P_EH26\CMO-N$)_G->-%Q?C)=_]C-3XT8^)P3RQ@5V%*>Z3-QP !E$1G*
M@R6C?648]\G/L,U\F]L&S4#GT+?;=2X!MG>U"5EJ3V4B%#0*&%VW,E7%$1$A
M>"8]RUE4W@('-!_JK?ZH.?!64%<#UGOS)'H_\]/W)=V,CE%7-E"$"HL15=%'
M@$R4+),,<F08PU)#$L853C 1\9][]"4>(&O8_L#-P;&V(AO 9KGZ0@EV1T&Y
M$$/FWGXK.PU&@7'0T0,1Z X1R0,0KY(ERD7@06?/8^VF00]3,VROX.:06$EM
M#0#P+WX\7:SVS@GR4&1U.5Y\666TWT!8CJ2/24O.B!'.H).ARO.A4&:3I\2=
M]LS:VKU3GB1JV ;!S<&QKA+;Z?*#ON_%;(&^\WQV>?%AMNQ\X2X##>DZ 5WX
M+@(XF?Y]/E["F]GOTY%/()CU%&U_Z/IR*6(S#P30+?:6@9#5^_WL2^NP78.;
M@_*+J'SH(OE">^%A3?])SNO."ANQ76! G== 4J#E+;$H;XG+@/;@#=<RJ\#O
M>*0/E,;OL-BPC8&;P6 ONFG'FO[JY_^ KN3JIH/A;],Y^,GXGY"N^!Y%2%;:
M[(@+HK2812_&)D&)\BA12[ESM':V?S?*!NX,W Q,>]1G$TFB:WEU\=VG\=D7
M]&)0E*LQOQNW&5<N-XTLJ(#;48E@B51!$EMR82IS3YV0.MG:P?MS:1RX,7!S
MV.U5QPV$5<?S[Q?+6<?-_2UYS?S( ;614T/0/6>%*TU<TI[PTE9.4*=#]8<:
MNU$V< ?@YO#:@S[;<0S>K%=?"?>S_[;>=#_#%/)X.3)&>)D8E(NZTJN[\$?1
MYTE*&R8$%2'7OFA]@J2!F_LV!\^:&FSB==+]ZO!KT:TG(UW+3;@L77*E_(P*
M(AEZY(X"^C?6V!2Y8US8RNC<G;J!^_HV!]2>]-K B7^?LZMJAXW $:)/7F11
M^M[@/J2Y/&(HPUX#4\(DCH='[8$6N]#5VD3S.IAX$GH'*FC08*G+5=QGZ<WX
MK!-8UV9I,V-1!AAIE0D-'5\ZD> @$<HM9R8"_N,=1_.!;-+.2[8V9KPJIGJ4
M?CMNX7W^UAUPKKR-M9-Q=0.[[NV%L9A+5$8"GJK2=DD3G[(CH"RE0>12W]6[
MC=N%TM;&CK^0U:NNQ":21EO$6=BY\6/6C>> 1Z-S( ;W'9'>6!)\>4(=0PX!
M/$/_N']G<0MEK4TB?R$P'JRD1L%WY5JL6V67,NP8YY>XWGID:YD>)(6E281
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M[A84121@="IC5CQQ02F"GD!@V>.7N?;CU(=H&;9L84 /;6^%-%&KM:/4'DA
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M5^3WDS 9GZUN$M>,)H7^4#*"@$XH7!0L<: 9"4I(&IV5,NR6+CZ$BF'3.JV
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MU%N/D!)X=/51@9">PI'"FU^M'E=(=H+97B<XN=HHI -D/5 DDYAB/HL ;MW
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M28&+ULT2]B"O#[ -Z_0,I:V^@7C-V#O\MMV[)24ZYGT";8T&Y64"EV4$RY+
M$*01O+5;M">)XQZ*@T%E=T@>K;<.8/GF?+F:?\N+];#8FF;Z.OV^O#3UVC)!
M_R)8I#\4HS\050)9O, D,VK9NNCS"7*ZA=OQ,+A;2-%()UV45'Q>8,I5,%L.
MC,C&Y6A E,A E>  C4U0>\G;(AW7S;O W*5AW*/TE% Z2OI=X.>W_".?S;_7
MAVZ7[NC%Q^F7KZLM0RZH**72()E<E[45"%IK<*JX4$=)8FA=EO,,2>,639P2
M72UUTP78]KNA5);DEH0&K ,QE*[];R-M*"DI" H%9;X[K>M7]<Y0:=+V&NO
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M(JALMX^QSB)Y$A M*Z#J+&0G B,>@TV88E1\-T=^_[7'O>[N &,'JF%LE-4
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MZ!-3EUM,67+VE!&0HJ+-87(&'[@B#XW\-.F-RLX,CZH>[DN:J/IY^!P@]_X
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M/;Q/MZ=(R,Q1Q$40<1Z4BL1U40$LMU(GIW4P94CL[4EOM[ \!#I/ 7-(/7:
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M0\D2B]:&$X*TA[>V32&P=_>L??31 <!VZ=.D@RDR" ^%)0XJ: U>TJ9D0<;
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M.IN?S;],<^V;>]D8P5FI;>$*M.&V%H8F\(["U^*0>XH@F K^.3_IZ27& \9
MNIPW%^S8\/CW/^V;^>+[?-,F^9(!Z[E)47$0064*(6LCJRP$>%.*-=8ANQOI
M/X*,ASY]G/OH$X'B:'%VD()\?;Z<SFH^H0["7JY[A:_M:N8YIV(%&*OI8%8E
M0/#, E.VH,DAF=PZ;GB$E%YZC0SOV+342:?0VHQ;W^X\%+9H8P*4>FZ3D#+X
M.ER(%]IRV17T=P<\#P*R6T2-ZT<W4?T.<#I<#V.?8?_(\\\+_)_K YAEJ7D(
M#(3*Y %FQ2 HK\"5A-YD'X,W.YU?=S^Y/R0<H;5Y*Q%V8%AJ(S&RQXM%+>%>
M=\:H6\05)95@!E(V='AKHA^53"!E\(YKIF5J72#U("'C%D&-<5X=KX\.0'6#
M_"JH=_,97G^'MLMLB>M&<\O+/:.LCLJX!()L;QW[8^J(O 2.$7<2:0NRUG#;
MD\1Q[5<#4-QM_#>@AL8^U3ZMYO&_/]P-6"X9X3(%ZY4'*VIM(?H"SE%<P;1G
MB;G"BWWVCN/95<9%RZ"ZG0\AZ!Y,UDT+3U);&_EKP_[VJEE=9-Z$.@U::EFG
M0=L 6 JKW2ZDB9(9I5O7K>]*V[A%FV.<EH-H;6S[M6;FAI3RXMLD*&.X=]4A
MK4(JJ,$'CE D$UY:;RFFV<EL/?#A(UNK050X;RC/'O!P3?X?&/-EP4KAPCJK
M GA%<E!8RZC67>Q21%]K1<7=YUQ/@.*A%<9-%YT&&4=+MB]XK(<7IC]K;C8O
MUQT%*+857+JBP7)%)W'))!Y3I64H1&6VSK(7!\#D_DKC1FNGALN1DN[ YZDM
MEG#Y]?WB RY6EU_<2)%<?N?RX,:S]XO:/G-U\>>Z4_CF$F"VG*;+29&?OI*:
MEG\NE^<Y\4DH+$@ZUB&'8&@'E0(A*@W9VX#6"UWNWI$=[28-R,ZXGM6@R.X-
M#!WLBZL]?27B27;&)Z\0."8.RIM:YY<8)**^A!B$5:VSZ_>I&/==S$E0>*3H
MQSZ+_X'3V=OY<OE^]G\7TQ6%0N5]N>-^3J1%"JNY@9(%\9-DJFD;!CYKK:+1
MV<H=<^S/+S;N$Y;A3^36\NZBK'N[!S;3J+=?_8Z+VI]LTZQ5$S_6I=IBNK[-
M\61:0ZJ>:E0F!HJ;36Q]H_P\5>.^7CFI>6JDF@[.N@?2,K__=3D@G$2Z.+]V
M<=?/PUZ=G<W_4R?H_C%?O"%RIZNZ_R;1D'M++()A.I#GNWXL9A5(P:+*VLMP
M-ZUZ-"#;4#[NFY>3@'8$%7?1UW?[SJRR,?_V;;I<KN?9%\?H2+!T"F"0H!2Y
M$I[35C4<M4Z28XZN,50?IF3<QS$G@5X#%8SMTGW,/Z;+G+8]&B\31(ZA]+4]
M.K+B0#D7P;&0**R1)19AA>.[E8 ^^/&[9639BX1&(Z%V<'1>.Y_$Q_?Y)DY^
M7S8C(OA$A)RRU0XDMQZ4<1F<T A9*&09K2Z9-;8S3U.T&ZI>9J)_ )UTVXB0
M#FN<?9F2S'#-UG7OO>N?7 X9/_P=W_Z+M'GB=R1SC5[__6,^3_^9GIT13.\M
M>W]P>PF8>$YU?%#MU$:V"H)U#*3*/.12L@RMKX3W(K#=BT%R)2G,?CO]D>\M
MN[G,M:R8(H,AU[ F:[*-X(76P))V%!G%I)O' ;M3-^Y%YW"8>OS%8%-]=7#D
M/L'/ZXM_XG^1FWE&=F,S=-=:YY!SX,+3,2)D A_I;QJ3-:A95J%UCF0/\GIY
M8M@6(?<CST'4U3<2KQF[\3 &>9#9U]J6(#0HK@5@\HG$*->';L;FY?E[DC@N
M(@>#RNZ0/%IO8X>JG^;3V353V_(^+SW32B=PL9:V)T[NM,8(1M9FGK'H>+=?
M^F,5CP]]?+>H.5Z;\Z:B'1L<;Q87WU?SS4BE>+%MVOYI7E;_(5%?\[8MW^2.
MJ"\*K$G$6D %WA8+(B6>O.,EWNU1^0AJ]EMWW(JCD\%I0&6,C;,/N+HL/-X(
M:;M72L3(F-> IKZ+T4%#X!8AB!C(:'MN)-\)4(\L,&[QT<F0TT*\';A/GQ>8
M<I7'\NK9%,>LF0$3C*1X1UMR,Z6#&*U@*@GFW4[=/O9Y<72'AG&+?$Z!H";2
M[P ];\Z7J_FWO/B8S];Z67Z=?M^R(C,W/F$"8:.I32PRA(@>$C>6_LM2**W?
M$CU!SK@E.Z?$5"N== "OW_*/?#;_GM-5EXJ+]?2;+3LFL>P3$T .'H7$M@@(
M:#SH%)+7G"ABK1O8/D/2N'4^IX192]UT +4G1'=](5*RR3ECG7]:+T30.4#&
M$5(6+OHL,IGNT^4.WN[UW.@$S23&2F$=IJ"^0?>/12WU<$$9Y76&VA"ACIY1
M$%B]J<^&)9%"-KIU ]'G:.HVSW @"G:'V?XJZ1MBKV(\_W9^5LLE7WV;+U;3
M_UVK<<*=X5EI"4R%0*>"<K6)4 3GB^-**<^:C^7:G\IN\Q.#P["%VKHHKWV"
MQW=Y-;%!29-2 !_)=U#U3:IS5H-4B#$:SDSSYLE/4]1M8F-PR.VKCF8-XH>N
MV&@Q _[9SQRF'N,D<^'WNRIW(FOK*8@0)F10M;8_H!+ ,H80.9.Z^3R17LLO
M?'+2:^L@^DB[)58[G!0'[KQ(J5@94NO)4C]G^<4^F#JB_&(??77@U:U)O]M.
MS42T+%3C3S:_MJ&AN%Y2B,4CL6*P).9:;[^'Z'@Q!15[Z?QNOXMC%= AB"Z3
M0MESX05ZL+I.WS", ?J(8!W&1#]S[9,<#U,R<CN,HS7\#&0.$/?85XK_9Y[R
M[&;'X+=OWVP[Q J;G<D1LBR:/$\KP%M#,G*24<!,D;'9[9KZ\37ZPL,AZINW
MEV4'=F2?BJ&B@V*1XM.BHR6&DMT,H*<37NL0>%"Y]=##UK6 /212CSFZAE)7
MWTA\\/XCYZ143@@NA-KQRG) %S70OA5)2N&C/F%EZLNN!=P+*D?6 NZCMR[.
MS'N%1$[8D)$$%02O'!AR*813D!US67G-[KT;?^JX/*AXJYM:P+VT>>\(/4JT
M'=BL>R4@GADK&8_ A$$Z_8D3[RGBY5FB0#0F-N]K>% !3C?%?X?@IXGT.T#/
M4\4>R+,H20M@Z[8'6=*6B-Q"PI*Y8=IGV[K2_=@"G&[* H_!5"N== "O9XL\
M6!11^P*%(AU0PBKPCO9-B<X8P5.FH+C# IQN:@>/@5E+W8SM)#U<U5]"JK&N
M!B-]KHTNJG0R G*IDQ*EE(P[.4F'/YCHIB+P8"?I>-%V8(<>FR B54(1>8:D
M$&OWV S!*@6I]OCA%))PU?J5ZS$#?4XP(&'0U$$+-72*IMM32!+W,@85("=+
M0I(*P2?M@''.HZ$0PF#K0>$O=(;/7JK?>X;//GH8^PQ[]?:S_G0>EM,TQ<7%
MUM_#(.D,+L!L3>7*VFJ'TY;#@CPE&8PK>J<C[*%/[P\11VAOWE*4'1B9G>IU
M5!"!1U=W3YWX$%,"LLT9F&:,3G6>LVX]RKE90?$)YA>,E0<_3$$=@.YF0>#[
M>XU:)BIZE!1E@F&B#JIAGJ)/$IS)F3.A6?:Y=2_HIRGJ-E%Y( +N7OFV4T<'
MX'I<7/]:YG)^]G9:\L08)DLM0 W:)>*)(A:,T5$0BDYF&U+9;5AX$XMV35>W
M&<TV0&NNFK&=J7?G]<RO$VS6'L4]L4V")J'P[,!E)4&1+P'U6\!5D"D49B/;
M[0+EN96ZS5L>AYSV4NZV3=L_<?'?>;6>%)'C^8(\U7RCF]E#/SVB&OCPQ=J4
M"3=BME']\$/K795VDO.FG%$9<D1RWCA*"%X2BG6*(1M;F&Y=K_@4/>VJ@]?C
MV%Y?K%-X&S\5F77$D@$KL;[-T!+0<02MG2I2":-C:U:?(&=<KZL9)AXO]SU.
M 1VX6NN1-NM9'I6%2X;6^18ZM357(H%S]<ENXIH"8%FG!0;'6+'%Y=:/LQXE
MII=*WR/5?1=&363? 8ANTG^9D6%,H,^Z0"%?$)24'K#&'L)%D8RUPLG6M07W
MJ1@9-FW4>_?.]SA9C^UN?\H+LL+_>#.?_<@4L=(6^K E8\W290HN1^L%QP01
MR413P&K!&=1 O(4@DBS6[);-W&V]<8%RK$KGP\IWU,[^F]Y9\V_?+@=,U1%4
M/_"L-D3:5F&5')B(%K@OMG:6Y^"+4T#!A$;GI<MZM[[L3ZTR;E3?$B#-9-G%
MP(>;DKD.4ZV0,D;)P1J3:COQ#"YZ7_O+%^61*>9;OXG[_]E[LR:W<F-=]*_<
MN._IC7F(N"]JM=M7.]HM'4GM'>>I D-"8KA$:I-5;6O_^I-@D:I235R+Q.)"
MV<<.2S7(!)#Y(0?D].A&>LGR;FNVG$[S#DR6OZ[^V.KF-\M7U]O1V#?.PJVP
MO/5IMW/MWEY?;:["L@Y0>;^ZO/QEM?Y'6.<+X;D+6GNPP<E:IL,A:A*KUHF0
M)+JH=.LJ@S8[[T?C'0FAU>S\G-N4>O0!YO[A+K120C(9 66=?X"I#F5G&J)D
M*HBB)/?#>L$.6FYFAW\&$*PFY<C1&/M*=N"*3+ZPOFKP1O[(H-"?%W_@YFIQ
M=;W&'\: WHSW(%IOSWVA1,E".@')*+(HN"571R<'3ACN4\F>[O:PU_.C]S"O
M%IX;DV?B77?"\-M^/.3N,"*H['1-092L-B1DOH8N,AG,FAD=@C5JV$CL0RO-
M&\:9&VY-^7!J\Z"/YU2T29>L8A+@HJ\D2PJ"2 RR#CPD*[7%877)[13M9(DS
MW:'L9(Z<J&C_O&S3J>KV..^NU^ESV&#^?4F\?/5IC5N*;SZNWA.O+R\?']EX
ME[H^BL!+*;4_='UE)#LC8!1@(^,JJ1A3\]32AMOOY\6EC8,R%V=[\+4?N:T7
MTA9=DD;(0?J:2F#!,ZR)O1IM"#I*WSJ\]-@^9@X1S 6*^][SJ1R:W4_9G^3=
M>I40\^87HO6'<(FOEOFOX6IKB+Q]-"GA(F&Q/.D 3%FR<KTW0&K) +<Q!F>T
M*Z9U\>+H3<[\D-@)2J?E;:>"<C_>\OO\YK=7GW']\7-8?L0O7U?KL/[VYLO7
ML%AO&7&1C/,Q^$0G3E4Q(9G7/D9@.1MD7H:BSI'J,F[7,Y<T=0+O,W._4[R_
MQW"Y^!_,(T]>L!BNK(;"C (E,B>K7WB(!J64W#GO6M<'M]O]S%40'>/_#&CH
M]!Y<2(F*NUI]BXF,KHPU%BMKBQ&!)G/O1/,>IT>;'I,5+_>,S5$<:OJ^<(Z\
MY18-BP=][G39R&=I7/QLDBDKDC1R#F1PACJV4A=PS"0H43!M@I*Q>2+"7(G'
M3'B=/-G6D=>CJBIMR=Z@;WFTPGE)MOC_33P>B8DQB<=C&-"!SGLZ.U)(X;$D
M!5S6MEHI*@@LD ]7M$V:6Z)2Z\*N%YAX/(K=@Q./Q]"^ Q ]DAAG;!88C0=I
M61W0*N@$,6BZ;2YG;KWTJ76A\\M)/![%WL.)QV-H/7> >&!BK- QZ^(CB%CS
M*@/6+A.NFG@L*6V,%_?A\Z^5>#R*I4<D'H^A[]R0>3Y5-H7B:BFD<G0:Y16#
M6,BE2(EKQEW4@0\;;ONBTHZ/AD<S6G:F=6Z#@]E)<B"%!N=Y!E6D!9?I#ZFU
M#%+)S">M>/FU_Z3C4TR6TVG> 7!^E(AW1.7-EYN:@E4Y=<&C#YE\4\B",[IF
MDJ2DH7.A2YX5ZVSBK2=2#=U;/QKK2!@\""I-P).Y-=<)27_)RLB-)0IZ:6HK
M)4$2GCDP7DL?O)?L_C"T?[&$S780.R<KYD;<DW;?S5G>;#;750?\_G6UO+U8
M%U'7<29< $N6J$IZ !QI @@ZLF1\LF$@V(Y:?MZP8V.<3<^ #A3H8P]KOR_7
M]X)$%]$2I2*7$(1WY.8Z#P[)ZS6L<%0^:Y]:#Q8:MK-Y WWME><$_)@_YW>"
M>*1RO#@? @B)U>N5!>A_#+R(TE@50\!SQ/(FC$Y/%@$\#VC/P-?6P&X=!/P9
MOZXVBZM-6.95/?3-\,\3HG_/?V";L-^(33>*]_V\8]WKU>9J\SI\75S=((>4
M+N$BOUKF+62>'#,98D*M";39U/;:V4;PV7-0-F.L?=.D;*V;3MSRJ7+TSH=7
M^_=Z7:_]18R>[ N6P$57LTM=;25F+*3B Q)I=+E?&'8R'1[=R+S^[#G1=%\.
MGLZ7N9V._>W_D4QW#H,^E!(S \%=HL,0>9S. BRWGA=+UJ^U@_R+0RO-Z[+.
M@:+V#&C84**U;GR5TOH:\^4BQ,7EJ8W[GOZP-CIQX&8;Z<-WX5LUI2H$M@N'
MR]M4![+[?<E>@#(^D'?)(H0HR%1SV1H5BV*A]9/X,]LY58_]F9B[^H:XG;9#
MT+RE[^L=VKG5:(((P%D]K[ "(I8(,A8C!">3E;5.0CVXJ7GU6RMTW-==;7G1
MP<O&7Z[#.BRO$-_&R\6GFVE.NZ.\#NOU-W)%_A8NK_%""H5>ZTC.<R#]K (1
M3!D#QH3B8]12Y=9U4T/W-J\2G IJDW"FB^9).T7Q9DFJ S^&?]Y>GA 9CXH9
MR$0Y4)Z^"HZ<VT2W*@:F/;O?\_CT]NU/;6;>5]JI4-6&]AT(KC=T-8@G5SM"
MW8K?6*KQ",X@ ^6$(S=":DA&,.LEC^A;(^CQG<S[Y#H5?!I0?6[G;7<#_OS/
MK[C<$(7N33W_?B1->T<5(*-V)%5-@2B\!RUC\N1;2.;C(8M[Q'KS/G:VALM4
MA.Y [OQ*F_^TBYIN</W']SN09?0I5\.OA'H'O ;O9  B#_.JH(S-G8ZG]C((
M3.:E@*DIY3M T,V+Q<WE>,2!4#RE5$PD/1P5T8F1+)4E0U(YNU*0]''KB7_/
M[V@0FNQ+0U-#+O1D5-\YROYQ[,Z/+IBSFHY5:\5B 969A"#1;>>,R5PT\_>[
M\K4RL)_?V"",N9>&L?8\.5Y\K:["Y:11O$B?<[V^.XOC]F=WNB.=%-@;N4:K
M6-\I1VL6_HM7C[R@8W&9L)/!HQ"U\-Z -\9!LDZ34:ZL:CY>[_&=G#Z'.UZ]
M6=)G7=<(]TW>+B]D#6J!$$.=AZC)OP@V!@A!&BF0C,;8ND/*(]N8.U!W,M\?
MCM4^C=0=F% _'F%;8H2N>*](=L:L$@GKX&J/+ 4Q9=+8(D>FV\>W[^]B?JR<
MQ-AG@3*:RMWAY,ZP<8,"G:&-&\?)O$-KB$#:0E;9!I8X#]BZUO.IO?2$F?$\
M?A8R1Q)\]A<BKF_U^TVGI^6G_[Q>HF3$5;TK'DI8FXAJ 88V4.=":PC,9Q!8
M#-;I\Z8,B_$/6JXGE!S+UM6D-.Y W/RZ6GZB3_M2R?61_C_;ZU1%K#!2 E>(
M=(;:M\.G1-?)1>YC)!._=3O,Q_8Q=Z9(6]5T,J4[1,ON2H7$&)=TA]#74S#D
MX,@?A"2RU^0HIN+<Q'CI03&=SN$#D#F"W',KICL2\T8^6IVYD/7E4]A4IY=Z
MB"X$4*G0WGVH)<X#\\Q^_.2^>'\,JU:MZ-:!I/A1>OYZFXV>C8^R.&!2U(D.
M=6Q2"!S09,^,1*7#M [RKZ.*?R<+ED_K^!Q'[^Y@LP_=O@]7N.W4D=_A.E4V
M?<(++6I;<LN@!&- D8D//CI!]\L+Q[,PWD[QCC1L=SW9OD>"X5F ->-,!YBK
MHOOC3G1?:++^E98.LJRERS*IVG1# KD, GU)V;C67O;=]7LR>=O@YFCJ=CNZ
M_%8UMVC\]\RGM8X%G*7)WQ.OOX9L'QF4!V.#(S-8.1('V0+902(Q)[42K=O[
MG>_57Y!?+U#1A2A<@ K.0N1&0TE6AL1=X=@Z1/E27OW'\'W(J_\84G>B6QZX
MA%B4U63H@=.)TQFT@E"B B,")L^%2;+U73CZ>>6L+_^CF#OD>64,I3M$R_[%
M4ACMH[5@356_DB4(2M>>4BPY)1AG]^=Q_?L\KXSB\+#GE3'D[NYY)6I'YE@1
MP#DKH+P5M/D<(0F/O':/PCBTC.\%/*^,8M6SSRMCZ-:!I'@D!I:S#;'PFH[C
M:PR,6?#2*R"[/0<IC69I"@OKB&CR69_L3]$I)U*Y.YS<B8(A]Y[X64>AEYK"
M7!1XI01HH8N7=$C#6Z=LOIAH\B@>#XTFCR'XW%KE%1?/1#K5/M)9RY-3C;>+
M6K!<Z@M/K-W]T5B!FNQ^,VQ>[:#E>D+)L6Q=34KCOE&SCX]C=L&SH$$X)((9
M(TD>NP"EH&,RY,Q3:H":,3D(9])'TZ/F&!IWIZ1NGQV3D4Z1]06:1TDWP&2(
M0EC A'0;4D:O6Z<AO)A843NSYCAZSRUL[EVMZXK[MW=RG&L3/\P77$7F?6'U
MA9FD9IUP&V3FM0T61Z62#FQPM'G >CTIJ2/YNIJ6R-V)FV<C6:P8*3E/(%.=
MYJE$ A_0@V8FQV*#=T9/*H%.CC&>/59T#-@FYDSOLNK]MO70A<R:NUJ^7ND$
MBJ4,(44'W$?A2C02[Z=&'"FK;M;K2:>=058=0>0.9%7=];=M \7M6:XN4*/.
MG-P 7X.GRCH//A-];**_9"8KLOG$G_M[F+=-P!1RYR0J=QNGOAMYORT#N_O3
M$\+6PS^\313[R,-,&]3.]8$Y>83":RIY<@5"(8E"UI#P2'K(B]:]:L\7U"Z)
M!RVE J[(S5"D72&R8FE+'E42&:.=]CVYWZ#V&+X/"6J/(74'2NF1)]/ R/@*
M2H&P]00Z;=^I#-1YH62+>1?CM(9RGP'M48P]''P80^7N<'+G^<O+$+7P"82Q
MU6$L&J+F%C1I:9MT<C)-BY:.@P^C>#PT^#"&X'-[2[_BIY"^?;B.FT5>A/6W
M7Q;_Q+SOGKI/AH]DU\=B0'"F017!P"?)@00O#Y:+$+,Z9,$,7:PGA!S+TM6$
M].T-+[^NPG)WC!RS$2XHL$$X4"XYNDL\@_ V>OI-BCX<!9/;-7IZA)D"'4=2
MLP]0_+X,I2PN%]N9 )\7ZUP'"WW[;77U/>T#?3V535 D'4=E6X?T2092VA(U
M$\6'8>DR Q?LZ=&E'5S:TGEN[-QTN]D>;'N$7:N=W4F*8CS7YT:7?.TYF1&"
MEQY8RJJHK#USPZ:>/KM,3V\L+7#2CJ8=V+6[3LI;D']<A^6&?,+:ZO:G;W=_
ML[7FC$2B5[:0Q+;^CS.(,BK(G,0G^00V\M:9X<-WUY/N.MU?FH@KG>%MG_C(
M+"=".2)4;?%E>9U#Q@($P22JJ)5H7J;T<!?S6L93\?L96!U!_,[@LQ.X03KC
M/=>T95U[,9%_Z00F4-QQ$5T@63XE?'IPK$[EZS,P.8+('<#DJ<!*1.V<T&2Z
M155 &4T$L223C59:F!2T95,\<K^(+)QV[WO'T;L#V/Q0WVF*1U9*@,PT&7+,
MV=H74H&S502;P&.>HG',J.K9LZ??C&+H<]6S8ZC;K.MF&V3L>]0*A8X[Z\ K
MM*!09OI*2B#'@DD7"Y-FBM*W>]OHR?!MCY-C:'WJQ,7F@+DS&"M(9E0I!DHE
MB<*$-1@OR$7TR:KBG%>MYR,\OI.>]$][V!Q)\1>1_M"B4/_9SVN?Y#!GL3ZS
M0<K$$V1+1JM2M9.BMPEX<HQL'"0#]N7F-:C C:/S <- 9KG. 1Q:#MXE5,B,
MIPOS;YK7,(;O0_(:QI!Z1E,VXV+[D'WYY^758O=D(+T)CM<F)6AB'?$A(9 T
M!)FER$KXP/"YFNL-IC]]6OWQ'_31-P"A+VYQ\<B"\^/A).:MVE!R9A#<['KW
M&A"5M%:C!V9-!B6C@6AS;6H4+<_6,:>>ZR]U& %W5YN'_2>S:]6 =G.'>U[]
M^E'?QCMW;S?2DN$L)(/D:P65Y 5B4@&,L#XQJ[,7[)#!\.2GS\?LXYFT:DFQ
M#IXM'LF\<5:6M'W^LTC(SXD,:98+V))S,:)V[YWVH:O/F,PQ>J 1E;O#R9U0
MJ(J._F-JBDP@6RE%!;YP X@JI/HLZ)LW\7DQ.6RC>#PTAVT,P>?6*4-RK$BA
M>FN\ 9M==;)KH$"["$':J$/BM>G>OW@.VRB6CLUA&T/?WO!R)^M*L\RP6 ,I
M1JRUW 5\S@B<"1.]0(OWW=5_E1RV9N@XDIIS@^)-^E1S978[]\%*ILFJ<LH5
M4*74AUSE0485;!U<H/DP<?'#Q_;TI-F"]<?3;&YN_[KX ^]LW1J!N1I</&[[
M)EJRNE1,X$I4FN?DC1[67.7'S^TTK^SXJWX\U>9F^&^KY>O5\@]<7RW(S/Y>
MJ/K3XM.K9?[P)5Q>?O_9]ZSLY,F@BN!$3<"5@;Z2CCPN(E (0@1G\B!,C%YZ
MWE&_[6$S+>W[1=;]4Z7B0M B0M[F^2=>!Z@[,IDDDCY$X>7]>/UH1!V#I.:6
MZ#F8/@Q?IW"@4UP]2CJ&4I>" 7Q*EEQ [L%9IT%JC4IR(U(Z&'$;N^@\=FPG
MV#J9"W.CZZX/]^K3&K$*^^^^7-88&*-;4B(HH<F70\'(EY/1%RV-EV(0FIY9
M9-X)Y.UU7"MZSHV+=T2KQ6:S6G^[:^AIK@17'#07Y,?5SE=.*'+NLQ;HC5,I
M#*OL>NS3YYT>WAX))U.P@W?81YL_!QY)C#H%SF&NL2H&WK( C->Q2TEYDUJ/
M@#FZD?I9\U)/>;,_F=(=HF5W@QPSSNK(@ DZB@H.P6N#1)LL$Q,BJS!%)MF+
M:*0^BL/#&JF/(??<6N8Y;9E2U$8G!7);O"A]!F^D@2@TTR0GR7@;5O)WJO5Q
M[O;JHQ@XU/880\TN1$E8WBM7#%IQE>OH<@RD.K4/I#5YANAK>70Q19K6&60/
M=S'OHWU#P#0B]-P"Y%$C*W(9HXJD?9VH0K7.I1;L9FAC*D9PZX:5EQ]MIDYF
M=K06&2?3KP-9\?MR@XF\[UR)LCN"T:$XF6OXP1*&4=3T;.V!B&%]-CH+W3I/
MX)%MS/ON/X&T.)74':!E1 &KML$FX21X5KN=1DG.6CVHU2P%:RTKS4'4N(S\
M3#&ET]V?B;C2&=YV-] *CJ6VY9#.1E"6:.22C*1O2<#6CAU2APEQU8,S-!6_
M#Y>1CR%^9_#9JV=KHXR"0S"23'DN#/B2)&2?N1>"Q8+_AF7DH_AZN(Q\#)$[
M@\F=^[2]0"DKQY75Q-;L07E>P&-$*-X4'S*SBK=^KWMF.ST%M2?36Z/IWB^$
M=M=+DK#%C :0##I0DFY6U":#U"PFR6/AYP)1Q^IK/-N'P>D('LSMF-_M-_5?
MBZO/-67H;S=1TLVK97[S^B][05O[=$3%P(I8*U]BAABY@I!2%()DKM+#9H4,
M7;%+Y!S#X=74Y)X10YOUU<7KU76=1?%UV]4N?+EY,.<&.:+T$$4A[[7>,Z^%
MA3J)*0O!$\N#7@%I@3LRB+Z[E3]/K=U3J/IXS=6$LC,CXSU^O5ZGSV&#WY^Y
M[Q]IWSK/.<Y#\B2"?0&%.4$0R8&V7BM7B.?(&\!E\(;F$3YM>+Z:F@%SZZPW
MRS]P0[]_N]R_A#I-^ZQS*#363!Z971WIEL")% T69DDL#TO_OO_1\P%A(MZM
MFA&R%QA\_,>JJL[]=\3?_6ETC,BTD""<RB1W%3F'GKZ2WGA#ZCOQ/"Q-_.!2
M\\2;S@R3-H2>&S:/UN=Z*P+)5P="Q3JS(B!X5MO,FU0)8]$J-P@I1U<T-P]%
MG0D<)Y-S;CQ\^/NWG]:+_ E??<'U(H5]A9Q24B56 OAHR#]TS%3:&##:"1]4
MRKH,TRE/+#!/8.!,J&A!U+F!\7C?[GU39IFX+F3(BVU"$.,"H@H)C-!1<(E(
MMOT@=#RWRCQO<&>"2#/R=O F]_HR;#9ORW_5KE3+J[?K]XM/GV^*O0U:AH54
MH75(@"\U1L^+A9)9"-YE$9OWDGUR,SUE[I[^I-N&YKV"9W^[1'8H)=TI76H+
M5;+,72FU][MC@:&*@K6>!?3,=N9]DFO$\"$P.H+Z'0!I=X;]4(F BIF:$"\2
M"68N+80L.&2/-B>CC-&M(P$_;*!#L!S#UE4K&L]MSORT^/3CYF-2,0K:LM1U
MK@3J#$Z+ MD8#-)HCG)8>>/]3YZ7\R=P:-6*7'/S>EON]N/V>77->5$0D?"N
MN"/+.U8/+6@3+?,Z*#V(VP\_>]YDVT;\/I%D<W/\1^OJ[7KQ:;$,E]L1]+65
M9;7=__S/KV&YV8<_)4>K:TFETU;L.MEE)4%8K1WI3.;BL'C>V)4'H<7U;H5.
M3_27A*B=8@V)Y<1=),.K*E8M(] E\1"BEEDG83 -Z\(R?NT9*^>G1<&Q>#N"
M)2\)<;<AB\A*<4HY"(;+.HW10919@2 J6A;)G+M?MM8 =#/'A\Z"AF.1=QQK
M7A+X/OYCM6\A$*507HK:!MZ""N1^.A]+?>@F;'E,/ TKO3]J^1E;.O0*ON-8
MTQ?X7J_^P"69H>]PO5CEFP2 D!/&C&2B"$,W2;K:C39"C$X6CX)^/,Q7.[32
M($CY%VB=G4C4GA&RNU^<^^R<SV!S'8#C0AU)H2-1RW"G-6HCAGEXA]?J1NN=
MRM6A>#F"Q#TCYN;/6T6M,@NZ]J/VJ09QBJ"O3/'D-6NAN4[%#>QT-6+13C%T
M#*>'HN@4LO</IUO5BW3%E"X%O.*NC@JLJ=5U%K:TM=&@,\8.*^P=L6@WMM"Y
MX70<V5\ G.[D%YG(60Q2D]+G"$I(#I%\"BA2>\$M9PJ']9@8M>P\>3L]0.I(
MTL^<;OSKXFKQ:<N?US5Q8?O4HHI6D5F0A67:O2MD!Y0(P3H4Z'-(:M#4@@-Y
MQ0]7'J;=6.^&= .R=@6*._7US"1C>%;DA%I3IY-:B"ESR*&X>C9IA@W.&P6-
MN9L<M>#GD] XDKASJZ(/?_\6M[EJMZ?9R3YR)%SDJ,#:Q$#EFK?&!(+P6EH4
M 4V1@]3.DTOT@H)C6;=J3L<.\BA^76TVKU?+J\7R$R[3 C<_??LMU!*MM^7V
MQS=%[RF*XF)-;RW1U#ZE$ES)'@QGM5]^U9EIB! 9U>QHZ.Z&@:O[L6D3LZ4[
MP.U.M;N.R$)1ANADT1#%HMD.ZE @/5GU='L22^V[\CVYG;D;L4V#@&>!=CP[
MYE9LV^%UOR#NDZ^3-E$EQB"8V@;(2@'1.?K6Q5P<$YZ;86UA[WUP3Z X@5OW
MAZ0<2[JYBRX#$6)[!S )4N',0*D25P56(' 50-HH;2J2M/R@>?.'BBKW"P[#
M0??CV8XG8@^<WX=>34;%:G,5S>C@A>PN%Y6 9+P2!%FG["##9 COYS9ECV36
M?78?0;F9&?[7Q7+QY?K+OF;"&::3<^#II'7C#H(P%IAEK+CLM=;8@.4_+#HS
MTX]AV:H%_>9F?/CGG8VG*%'(PH%K6ZLO'8? & =RKLB=+]X5W^*1ZX=%9RQX
M;<'XH^G7@;?PHY[[=;'$-U?XA4Q>JX/G/D$*(9'C7A"<R:8J/$:6,)DPPWHH
M'#US\_M6ADF%%]/SO07!N\/-+R'AJR\U=X;.$;QW7D'656LBF;D.<P3A2Y&)
MQ!]/K3LV/[67GD9Q'LGH9\%S)-6[0\^;6@J*FZOWX0H_7&T[)>$Z55Y]PMK#
MO KF ,9X1^1"DL^H,D3MLA-&E)P&^1U'X^FYW?4TSG,*A#7C3 >8JYV1/^XZ
M(U\XH8,T9)EIPR+I>MJV=S$!9R@]N>56V4'F[<CQ%/OU>QICT@8W1U/W:&3\
M@>NXFD0>W9GY=?-ES05]MUXDY!<D294IKH"NW?')(B2GT&(&F:4P]+_LE9Q4
M'#VSN9ZZ0T\AC5KQI0-A5 ]V>X9]%G+]Z8U"YUNR:>82Z,@**.89>.48Q,"C
M"DH'?K_$K@G0GMU43VU<VP&L'1^Z ];NQF"^I=N'ST3LS3;?/?,+),\VRF*!
M>6- &1$@9N=KC07=(R^<MFY2E!W:84_]%Z> 7%,.=8*_.Q([K-??%LM/.R]%
MD468@E+ LZ"[)(NOSV,.HF(A*V:DD5.@[:G]]-3"9!)]>3SUN[#*[@7C?@Y?
MR.W8O/I'(,[DOX7+:[S@)6(R@<1QC.3W"OHJ(..0HT@<%<M63!S0?F17/14E
MM[+NFW)B[ECV;]?UJ?9M>;QKU+XGX8:,2I.%(HU?M Z@LG80.+FY6@D57?'T
MU[U9,$^UJ1ZV8$_U4J<!9S(R=Z#B'NT&LS_KASHJ:7&UP,WK<'F)^:=ONW^W
MV?W#S87"F+3T$@2/%I0J H*S 3)=E(+<"-?\[>'$+7>5?]Q&HIV3B1U@]D<2
MTH7\LB)'^G\P[VM>+W*(04;FH7#-Z4#>0F3* R=#(5B?9+Z?GMK8-GMD4UWE
M'$YAH9W*B+D5Z8!BZOV=>K>ZHG^R")>O<EYLQSY=6.UDM"J"ER[6,!JYUH$'
M8*RDK%1F&(\IQ!FYC:X2C1IHW?/QI .Y]J@8__,_<9T6&]P^#7[_Y7?9S2]<
M,)HI94"[&.K$#21WNC8FMU*(9$.TO+6L.VJC786^)]2[31DVMTQ\_H3;DKB+
MDDIQ.6IRD6KGXFP3Q-IMTF:#B6G&3!SF6 Q8;!B(7D188!+ZSHV7VXCJV_(;
M7OV\NKP,Z_>8</$'N4NKG_#F)?#CBBB)V^$^___JDIBV>;M\]6Z]>A^NPD]A
ML]A<.&9CUG0_C(XU?\DJ"$IAC<S:0H:#0#X,5*UV- QY+R)>,!^GYH;GAZM5
M^OO-P7XFIVCYZ>:*W3Q2[R7U_OKEBYPQHY6*?/EMHQR;(7AIH<9)2DP<T_T*
MDZ>JW$:M.PQJ+R).,#75.[#:[N74X?K+1=;*!B%8'4O-0#D=P'-&3G7@3JHD
M$5WKL<L/=S$,12\X(C":U WC /_??SR@*AWQ[]M?;7]3_W_OL?P_]>_?W[_Y
M806Z%'JS^/0E_"FMOMRL\,,X6#KEA_09\_4EKLK=7)3=>+RKU9U_OL#-SW@5
M%I>;'X^Y67SY>HF'I%.3=?_C]MCW";);_@&RSD("_"=YA"1,_M_3+WAU-B]7
M&]*"KR+A+Z2KBVB<YR);*$H3\I*0X)2-0,)+%ROH#]=Z!O;C.VDLP+9)P=:K
M%"*YREP@R>!(/K1SR,$+Z5CV7G(W;<;T=AOSY[R>R/<# FPTJ;M3=]O:(JNT
MD,PYLOOJ##Y-NCJ:'(%Q%"5IJU"TC@$\W,7\6#F)L<\"9325N\/)G;$XS-64
MCSK7W.H"RF@!3F8)29E<C*6#R"GDYF-[Z0DSXWG\+&2.)/C<#MJ;#5F%K\/7
MQ56X_,MZ=?VUC@7>C]*SFI&5Z(%%09:C1@&Q!#I1XB2)C;=J8 #[F45Z0L2Q
M+%Q-0,^Y<5&WO3/]/JX>'&H_E2!X2_]U(!PWH'+B];G?@]..*)23LVG8J,(A
MJ_54+=$"*<TIW!5D[DP3?[-,J_77U;IZ#]\'F!@LQG/0K); Y>C 6<?)PN/9
MLX)!#'QL'+YF3T43S>'3CMIS@^C!1?CP>;6^NG%&OX1E?I7_",NTEZA>:F>K
M")7(D"2JII,)1!#"*"]-YDX-FQPR:MF>*B4FT5G-:#XWFGY;_1$N__[JZ]?-
MAU>O?OWUW;,'0X5H<JC!GMJJ70H%T2=5NS6C+5Y[NC@#A=+P57LJBF@CEB:B
M> <>5GT6N]H]B]4N=5L/0EB/KB;<!%[(J)/1@X\U+YIHYI6U=?I?\QSBA_OH
MR3HZW1L_F=(=HF5WLX@0.K&H :.HF<[2U-<L#E)'G\FH*RRU?NA[?"=SM\HZ
ME<,'(',$N3L 3;7J-CNS[NW59USOOMXW_S+>F%3B=E0DR65M&50/@>1R4/0C
M94KS&I@#6^H+1L=P?34="[HHA+D;Y_FX#LM-2-MLO9^^W?W-S< *%AUCA@AE
MB%K*& &>B[CM+2=JN4]HWBYA^.YZ\N!.5W$3<:4#&?9#7'%W'[-)/)'+Z6IO
M(Y4S@J]M$&W<CC(MP>?63] /=S&OI)J*W\_ Z@CB=P:?G<B5.3 I#+F<W&D@
M0P#!^>3ILM7Q64F7V+PKT,-=] .?8_CZ#$R.('(','DJW:48%0H:A! 4R>2D
M&?A2% A#0EHX)BR;MN//KZ-:CYWIF:AU@/0X>G<'FWLUSD+ZP%S6X'W0-=/
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MZH ]I'/5Z>#.>.T5S\&9?]?RQ3%\'Q,(&4/R#G3<4Z^RH13&>&$@<IU2P'D
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M_-MJ&6Y_<K>M[BX!P)##4.J@-6N" 96]AZ@9F79UO'*V";UJ+21';G%>@=0
M%*OS<6CN9X57ZZM%NB3GH9"MN%I7(ZX>97<2*ZW-T7K@UHAZ.6N(F-=>F4)$
M5:QQ: >IKF>7F1<ODW)W-0FIYP;-0UE^FU40@Q \* M"5 / &P1?' >7I%!T
MVX*( T?>/[W(/('%YFJL*2T[T&0/RGA?75]]7JT7_X/D7#J>.*OSA%VMW35*
M@0^R/O/;(B-CG#R^UOE>3V^G*SOH2'X_F 35AO@]XF@_[MP);D1BX#"0#B^.
MCA%=A, ,B\Q:M*'UR(4GMM*5 )H(/T<0O4?LW'T55;:8+(L&4P>&*AGJ"Y<5
MI+J]<U(Q%,V39I[;SSQ)"N=%T;'D[[9D\.%;V<V?;PMMDDZY:?KD]\1G3_7L
M-^0HC9[^'B[^V^H*O[\C9:=BX>B R;(=YDI6MB+9XYSCG'!2DF_]8O+\CB9Y
M&G3)1&FC@!#H'J@LZ)22USXXFF,(A'LYL+5^CT^##5D\Z*EP##4[4%4?KN-F
MD1=A_>U#^%X"<#,1U$INZDR*Q&2LCQ41G"\>O(I<<IY9SJW+VY_<3%>F\A%\
MOE^YUX3H/:#G=OMU/N#;<N>I8E>*9"UC#)&.$!E=,-21%+E/P'/,PC#A#&M>
M0WQP5S.+I#;LOP^JMKSH %WOUHL_PA6^NPPWS1_WXR*%L[7V:/LJ1<Y O8.>
M:8@V.6<=_:E+8T0]OI.94=28WP]:;YQ,_ X@=".Q?U\NKMY=K]/GL,%7G]9X
M\\ZZ.Y$J)189#=BLR"%@T4(@PD!*P61$&9EH[8\=WM7,%8'30JLQ4^9^B/[X
M>;&^F?CWYW_2:9:?\)?5^J?UZN^X#I_P Z[_6"3<'ZRV0"HNA]HW(H%RD4%T
M2D/BCH2\8L'P8<;VF%5GGO0Z#9JFI7T'LFM7,/E?VTC0U=OU^\6GSS=Q1"&"
MX/0?HH]FH!(B>)L4Z*A9<-H)E5IKP"<WT]4KY.FF>1NB]XJ>W773PLF PH%P
M(8"R64(T4H$H9&.F$'C&B;IK/+:=+LJ23V7X$!@=0?VY==N[-?YR71_:=B?Y
M/H3)6VX\%^!BE*!X(?UL$X)4)@=ON+0#$_N?6*!#3!S#O55C4G8@5YZ8M[V]
M,2I%Z9@PP$F3@E)<0<C!U'ZBB:L8,3>/KSZSG:XB&Z=KIE:$[Q=#NQO&N#*&
M!P0>O:@]^ATXYPU@39XR&/2#?)^I4-2#?FK&]F%P.H('<^NH-^E3?=+?B5,2
MQC*21 67K:GC*$F<DI0&KA&1_$BMBQNDF7[XV"XQ< RO5DT(-SO+-R&DUZOE
MYOKRJE9X[)\/]FELROD4,(!D5H,J1)$09" F:]1<9E<CAX,P\.PZ\S[23 6*
M=J2=&R6_K=97G__W:OWW7S_^O-M^R4R&0MY_-"0L%1ES$+!.K"W('1<L.3FL
M'<3#SY[WD64B-)Q(PGYMC<U/W^[^9JM.B^?%%466.*OJU :2@%(Q8#S1T;1V
M*I[)?'UD=_/T;3BW-7LJ6SH#W.[Z87 ,2^%U>"T#);R%R,C9DT0A;1TS.K?.
M(WFXBRY-F)/Y_0RLCB!^9_#925STVGMC%- Y$BBF+7A&-EI-9!.^B*!#ZQ+C
MA[OH!S['\/49F!Q!Y!EALEE?7;RN]<RX_EIW7R,J-[5%(5J'R4*2W()*@9&*
MIV^S5Q@3*]&*03*&%K@#$/KN%AQ/K3U/;Y?FJJD):6>&QGO\>C^D>O](N^NC
MF#3%U73\F%QM$>S YQ A9N&LM45H.:A[Y &\#-[0//*E#<]74S-@;D_JK^L_
M_>=JN74-][%43A<L2 .L5E<K'@L$3N? 6GKF:E*^'^9B/_CH^8 P$>]6S0@Y
M-PQ^7X92%I>+;8N?[Y'WW4&\*XDY)Z H1PJ4D^X,6I#9)DA]2N<M]WP0(IY;
M99XGES.!HQEY.S!C?\9X]6:YN5I?WU8_FR2T,1+(DB*D*S+I?4H((4<7O Q)
MV-8SV1[N8I[.8).YT2>2N3N@W+E&+'&-"AGH:+#VIZTOC4Z#L1Z3DE83H2:%
MR]RV22L>/PN9(PD^MR;Z,721@T2.,D!V8O\D*3$#V7!)E.",NM]WO_^83QLV
M/1WN&4.SN;G]VVIY9R()488H<KW&GQ:?7BWSAR_A\O+[SW:GT]8SKAB2YA5T
M09S1$ 3)U*1$L5J[@GF8,3)ZZ7F#0NU1,RWMYT;6.Z+@8K-9K;_=N1K.DTHV
M@=?I.9P4LJQM%-"#,XF'(E)*YF 5Y9.?/F^8J#T^3J;@W!!XQ=D/XXX>.0Z&
ME-%BG5E:BP2SBN"KK%3*NB2457B_1."I#C0'UYJW/7=[>#2F;@<&ZZ^KY2?Z
MM"^55K7-T]8@LUE;J94!ZZVL [$L1.43,,,3.7Q%!6P]^>>Q?<S3>78R[^9D
M4G<(E]V%2J[6.T@)3@59+Y0"5[0D[]Y:%YGTF%NG\#^^DWFMW-,Y?  R1Y![
M;H7TJ)#,6GB#KOIY-8-#T5=.Q 22>Q=+U)[=+_EH;9.<#0/'L.R@13*&?AU(
MC;KSS;OPK8K0MU>?<;W[>I\T7E0.)M1QYT;7\<.*]+%WI#,C8U9%6XIO/?OK
MP);F]7L:8F@*%G2 J%>UO?9W$1M,G=*)%K(J=!TD+W0Q= $TQ0>RYFR.K2N
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M/K]B8M[1C7V)F)@(>:OQ#;?EL-W=T4\,K#*G*5)-4J[2_?63X**%(JE#$H>
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M->OSO18LY=*;A S+/4BH "$J(8$S1U)BC,CB9?Z="&O$YO4%C\VGC,5UU0X
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MP'&W4JR7OU4W65,>*(6E6QLL2]S;F^'<CGZ;3FYO[G.=[^*U'8=5QG/%F6?
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M<75?8)T1;:44U![R['1ZEQLOKYP#RP6FAB$LG<HCSAWXF%$AJTS.36,9<.G
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M80S4R@0!HO-:.MXR(!8"6W E0<8&WBR\L7PIEKYG1].0?X497*NIY \@1D$
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M"$*@+S/ D]#2RUS>9KU9&:6E=:3-C*T+^3>_]CBJ8PO0TD/?FE9",Q<+"8/
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MQ&6#J:\F7%4STB4UA\QTR_'#@@#J5MEAMUYA?F@DG3CWU;0*'NQRG+#U)[-
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M/LF*/;7-6Z((:)MG_[(Z9W^#OX=[0CKL/704G#5B=.BN0!]%.I$R8#,N2(S
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M+TAZV;A%:MX7F\(^#'(E!.M8VT;VPNN>)'A#6N.&34MM\-1;II"1LNA)[&/
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MW2F<;SVX?<?RK\1'= >>G)P_WX%]SI5H'L >=KM @!XV)G[O(* J&&^^E*#
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M8OD393I<8L\$NZ!];Z::,7ZQB<_MJN->BX*;FV+^A0ZV<!&FXTVM5+PG[M+
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M9A?<D+NU*Q91$&;S>FHF'R7.6J%K8MSI20I;(L'6%:?>VLL9$ M'2:V*><!
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MC$*X:&LG" 6QE8>@+QKYGHZ=4NI\YR5M "TEBC&?>]T&4K?9@K]UL;[YJ'L
MIHOR];J:^A0"[@RXR0>P!A4Z&B: @*-D$ K-?C2\P5K+-?T]L=*G+,BL?JWV
MZ1E785\,P.X>U#3&>:"P,W#J" <$#([PQPQ\@/D:W$*-480\CW$6KBTG(@#R
MS"#,KDTS>X98QG18!!A;91FX@7^87KG>C2/M2X1L*.AW2GC)M@9VGFA81NQQ
M1^XX'D5C-"-1<A5E<(\$^Q^FH69U@K\MG5XPTAC<FNIB,;[&3FMIOHL<(DB#
M><00'+#NP;.RAQF=(H0]<;"\3S?]<^#X:C!^=QHM)AH(Y+EX2?61EZL3N#8G
M;9PZ/E19C4@QU/+!GRKB%ZF>"1,\"7*&(,]:)$T1K)0[82),6^CYZ?Z>KL16
M#98/?$;-3'L6:K6"*@(!Q$96*.\XXW&]Z6: %PVYOJY%/-WQ0OVMZL=KO6PW
M6Z<;Y,IT,ZO,^T%-0@M=*&5U_\)ZYQ^LP+7]S$59K^6LK^6L%:C4NE?UZFN9
MUFV/+;E \:CUQMH:V"H <;?Z6;FT21/'FUZMI8YZ2Y,RVJ@?-/;OFMP#TFQ3
MK.F>0%U;.L"?_#I5-(BQNII["P7*B<#O.)N>DP_<*^^Z7.W<>HR\6Q@Y[MX1
M.2X3G"_<\87U;8^WN%%O[Q_]Y2T>3O,%GIJ",_&F[. ;C]/^8?VHU<V=R"=8
MANVE"K3+'=SN0=;.U:]UD,H0JL!KG0Q'A.C6/SL=?3X9]T['(RX3$_>HN+KW
M47WE[T6+\$P\_,&[5'6&<GMFDCD9Y$:ZO8H9HPGKI&J^K0JIINHINN58T,$^
MN4EAOB&9X3'-(!SJ'LS;L9:!_-G\\3:W$7330ZI.#COU;J.#6Q3"R0KMW &O
MT^'^6VBO_]:J=]N;?VW4FQM_NVW4@WJ[V7WR40]Q=<L-^S=:!UX+6.U@:;E_
M?]-^D]NTGUO+;R)788W[6$Q&&Z-*[?6CO->J[[?OJ7T5W9D[\DV[U6P=?A<'
MJZ9UO= O; UAO%Q"V"VEU,^^J)BN].V[K6L.[K=1E!9ZZR%[3K[:KK<)4>3\
M\T7_8V\T.,8ZM4'IVK0"?(CMTDO?7RU#;QKY/H5_!J:QU,B;A3<686'K5ID%
MX9K[<*J&8+/L^Q!DMR!2WCP"-:!BRV^5<W6V";2QRF_3UD[^R5;X;[=ZA#7V
MJ0V4^.11-3KU7*(O@J478GR!/LPB5P<9*.7L?%@36!MFNE,ZZC\1W!52#R:P
M+N)LA:K+8G,<L"A.AMB,"A<!0WR7Z%&%-Z><.%+<X845=>:,@M"SE>7JE^]]
M.M'+)OV@X*TKQGVJ39U<KS[=S&X>K[I4\\7Y'-K?CRU5Y,V)"?WS][Z 6ZDQ
ME5HL'6(@2'WX@^$]&(2[H8R?(*%09$E$HGCE;518O3<W>SY:!:%< .]Q%59Y
MP5LS&PHVY'M5E)_P:G;J[8-J& 2:E>2#M'\"BM)O_E5.2#Y]\B;8716S";!I
M;KYF,#E.?R.WR-V9K'D5[RC>\;L+0Y^=E=R:3_+,3R\H#-6+;RV7@6#K)716
MPI9+QUOI-D/*A<_4K.P1Z1E%@?3#E)>O CMS*P["]]^9]Y%NOJQ57*W[[0RI
MXX+E+.<6-4FD5,2IM20_HS<##1>$#_R+]QC7?,#J\*56E5EEQHJ*1#DF;;(N
M!D&H%ER5$XINXR]4+P6JI]Q]S,9798MOQ4SX_EO<PU9<7N1/,7_+EC5A>],(
MB4PGF,*F6*S#3Z)+X4O:3A#!#^XS7:G-N!7C8#N;@<:FA!6\>@F%ZW^;>/8*
M_C</%\ZO_Q]02P,$%     @ /85\6M?(]RZ' @  7P@  !X   !E>#(S,5]C
M;VYS96YT;V9H=61G96YS8W!A<"YH=&W-5FU/VS 0_KY?<2O:&%)3FI>2DH9*
MJ!MB&V,(D/@X.8G3W$CLR'9:NE^_RTL%9>H&DS;1#U:M>^[N><YW=L+,%/DT
MS#A+IJ_"UY8%[V5<%5P8B!5GAB=0:11SN$FXO@7+ZE S6:X4SC,#SM 9P8U4
MM[A@K=V@R?ET'2?<;_?A?I,DC&2RFH8)+@"3HQY&GIVZGCNR#]Q#SW62R&>I
MG]I#;Y3$AYX7?;-[Y$KPUD>;5<Z/>@4**^-U_L!W2C-98F*RP!X.W_0V<4S-
M"1I)8V01C$M#YE0*0S04A6W_MM%_S?'8=V+XG;%8CG,1--J[8&N'6.92!3O#
MYC>I+5;*"LQ7P>XU%ES#.5_"I2R8V.UK)K2EN<*T!6K\P8D_)6FVRTX;Q<E1
M\+56VQF1P ]W&49(E7<']J:&I[*/Z5RXVEZ+OXKSO\LPDT+7?2I3^"@27G):
M:'O)YZB)%77N117E&,-Q',M*F+J+3U 56Z4^$/:]T@;3U3]7YCU69CND[(9#
M1@*B%<2=1B/!9!Q0Q%*54C&#4@#9%4\)*.+:U"!:]1W@RM  US.H@78G4A5P
M9;GP[EP.P'5=RZ&I\T9[P$2RMHYKJ^[,SH'OCQIKB_;&OKM7UUM6BE(3$0-)
M<T=\82K.P!GWV^M \9PU]>YXUS)DCBTV1<%$C"RGLM[S2^$3$U\%I[.,![#,
MD.*QLN1,M=)0P[$0%7E=MHG7BNRA]7GPI_8ULJ2NV6S>S3/^_12\A-9PZLOM
M[8[G3W2SGE;)G L-LXOC/ER<G<U>/OM32>FEZ,,UOV/ZY?/=;.OG\WWFU?HD
MKX?/7BDUUI,>M .WX%L?PB[)\-Z%1322E=GN\NRWLUO;!WZ_^;#X"5!+ 0(4
M Q0    ( #V%?%I:$+-[W <  'LG   7              "  0    !A;'0U
M+3(P,C0Q,C(X>&5X,S$Q+FAT;5!+ 0(4 Q0    ( #V%?%K=LTD!T@<  &@G
M   7              "  1$(  !A;'0U+3(P,C0Q,C(X>&5X,S$R+FAT;5!+
M 0(4 Q0    ( #V%?%K/ IAEJ04  *06   7              "  1@0  !A
M;'0U+3(P,C0Q,C(X>&5X,S(Q+FAT;5!+ 0(4 Q0    ( #V%?%KUA])+H 4
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M+3(P,C0Q,C(X7V1E9BYX;6Q02P$"% ,4    "  ]A7Q:-J;9)8,2   =%0
M%               @ 'L^00 86QT<RTR,#(T,3(R.%]G,2YJ<&=02P$"% ,4
M    "  ]A7Q:#/6P,@AJ  "$;   %0              @ &A# 4 86QT<RTR
M,#(T,3(R.%]G,3 N:G!G4$L! A0#%     @ /85\6GO.@F_.:P  E'$  !4
M             ( !W'8% &%L=',M,C R-#$R,CA?9S$Q+FIP9U!+ 0(4 Q0
M   ( #V%?%HV+V]OHWD  ,Y\   5              "  =WB!0!A;'1S+3(P
M,C0Q,C(X7V<Q,BYJ<&=02P$"% ,4    "  ]A7Q:57T;J,2;  "BI0  %0
M            @ &S7 8 86QT<RTR,#(T,3(R.%]G,3,N:G!G4$L! A0#%
M  @ /85\6IHK)QNW:0  !FP  !4              ( !JO@& &%L=',M,C R
M-#$R,CA?9S$T+FIP9U!+ 0(4 Q0    ( #V%?%HUNE5YK2    (B   5
M          "  91B!P!A;'1S+3(P,C0Q,C(X7V<Q-2YJ<&=02P$"% ,4
M"  ]A7Q:]RM)1JZ&  #<!@$ %0              @ %T@P< 86QT<RTR,#(T
M,3(R.%]G,38N:G!G4$L! A0#%     @ /85\6B)@S&/^,P  [S8  !4
M         ( !50H( &%L=',M,C R-#$R,CA?9S$W+FIP9U!+ 0(4 Q0    (
M #V%?%H.31M<8F<  .YK   4              "  88^" !A;'1S+3(P,C0Q
M,C(X7V<R+FIP9U!+ 0(4 Q0    ( #V%?%I&_@22<44   Q'   4
M      "  1JF" !A;'1S+3(P,C0Q,C(X7V<S+FIP9U!+ 0(4 Q0    ( #V%
M?%J? JWV2R,  %$D   4              "  ;WK" !A;'1S+3(P,C0Q,C(X
M7V<T+FIP9U!+ 0(4 Q0    ( #V%?%K9*4YX4Q0  )H4   4
M  "  3H/"0!A;'1S+3(P,C0Q,C(X7V<U+FIP9U!+ 0(4 Q0    ( #V%?%JZ
M2M9RP5(  '-4   4              "  ;\C"0!A;'1S+3(P,C0Q,C(X7V<V
M+FIP9U!+ 0(4 Q0    ( #V%?%H#A5F?84\  "11   4              "
M ;)V"0!A;'1S+3(P,C0Q,C(X7V<W+FIP9U!+ 0(4 Q0    ( #V%?%ID>8$P
MQ=D  *;<   4              "  47&"0!A;'1S+3(P,C0Q,C(X7V<X+FIP
M9U!+ 0(4 Q0    ( #V%?%J]<99/]7X  (&!   4              "  3R@
M"@!A;'1S+3(P,C0Q,C(X7V<Y+FIP9U!+ 0(4 Q0    ( #V%?%HUPZ[=G[<!
M &[P$  5              "  6,?"P!A;'1S+3(P,C0Q,C(X7VQA8BYX;6Q0
M2P$"% ,4    "  ]A7Q:LI$I]^D\ 0 OD X %0              @ $UUPP
M86QT<RTR,#(T,3(R.%]P<F4N>&UL4$L! A0#%     @ /85\6FK-5PU)2P
M.S\" !X              ( !410. &5X,3 Q,3E?<6]D;VYA<W-E='!U<F-H
M87-E+FAT;5!+ 0(4 Q0    ( #V%?%K7R/<NAP(  %\(   >
M  "  =9?#@!E>#(S,5]C;VYS96YT;V9H=61G96YS8W!A<"YH=&U02P4&
/ !X '@#G!P  F6(.

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>159
<FILENAME>alts-20241228_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:alts="http://www.alt5sigma.com/20241228"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="alts-20241228.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
        </entity>
        <period>
            <instant>2024-07-01</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
        </entity>
        <period>
            <instant>2025-03-25</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesSConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesSConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesA1ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesA1ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesMPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesMPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesQConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesQConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesVConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesVConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesA1PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesS1PreferredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesIPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesMPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesQPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesVPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesA1PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesA1PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesS1PreferredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesIPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesMPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesQPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesVPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesIPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesMPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesA1PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesVPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">alts:QodenTechnologiesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesQPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">alts:QodenTechnologiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesA1PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesS1PreferredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesIPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesMPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesQPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesVPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">alts:OtherSignificantNoncashTransactionBusinessAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">alts:OtherSignificantNoncashTransactionBusinessAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">alts:OtherSignificantNoncashTransactionConsultingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">alts:OtherSignificantNoncashTransactionConsultingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">alts:OtherSignificantNoncashTransactionLiabilityObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">alts:OtherSignificantNoncashTransactionLiabilityObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">alts:OtherSignificantNoncashTransactionInterestObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">alts:OtherSignificantNoncashTransactionInterestObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">alts:OtherSignificantNoncashTransactionPropertyAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">alts:OtherSignificantNoncashTransactionPropertyAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">alts:OtherSignificantNoncashTransactionIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">alts:OtherSignificantNoncashTransactionIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">alts:SubscriptionsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:MarketingRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:MarketingRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">alts:QodenTechnologiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-08</startDate>
            <endDate>2024-11-08</endDate>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">alts:QodenTechnologiesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesQConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-08</startDate>
            <endDate>2024-11-08</endDate>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">alts:QodenTechnologiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-08</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-15</startDate>
            <endDate>2024-05-15</endDate>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-15</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-09</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-15</startDate>
            <endDate>2024-05-15</endDate>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesMPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-15</startDate>
            <endDate>2024-05-15</endDate>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-15</startDate>
            <endDate>2024-05-15</endDate>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-30</startDate>
            <endDate>2024-09-28</endDate>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-15</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-15</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-15</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">us-gaap:ScenarioAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">us-gaap:ScenarioAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:SoinTherapeuticsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">alts:SoinAgreementConvertibleTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-24</startDate>
            <endDate>2024-01-24</endDate>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:SoinTherapeuticsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-24</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:SoinTherapeuticsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">alts:BusinessAcquisitionConsiderationTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-30</endDate>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:SoinTherapeuticsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">alts:BusinessAcquisitionConsiderationTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-30</endDate>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:SoinTherapeuticsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">alts:BusinessAcquisitionConsiderationTrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-30</endDate>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:DrSoinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:DrSoinMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:SoinTherapeuticsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">alts:SoinAgreementConvertibleTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-28</startDate>
            <endDate>2022-12-28</endDate>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:SoinTherapeuticsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">alts:SoinAgreementConvertibleTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-24</startDate>
            <endDate>2024-01-24</endDate>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:SoinTherapeuticsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">alts:SoinAgreementConvertibleTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-28</startDate>
            <endDate>2022-12-28</endDate>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:SoinTherapeuticsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">alts:SOINAgreementConvertibleTrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:SoinTherapeuticsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">alts:SOINAgreementConvertibleTrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-28</startDate>
            <endDate>2022-12-28</endDate>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:VM7CorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">alts:StockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-09</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:VM7CorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">alts:StockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-09</startDate>
            <endDate>2023-03-09</endDate>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:VM7CorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">alts:StockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">alts:ARCAAndSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-09</startDate>
            <endDate>2023-03-09</endDate>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">alts:ARCAAndSubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:RecyclingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">alts:ARCAAndSubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:RecyclingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">alts:ARCAAndSubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:RecyclingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">alts:ARCAAndSubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:RecyclingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">alts:ARCAAndSubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:RecyclingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetUnderConstructionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetUnderConstructionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:SpyrTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-24</startDate>
            <endDate>2022-05-24</endDate>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:GeoTraqIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-24</instant>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:SpyrTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:SpyrTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:SpyrTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:GeoTraqIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:GeoTraqIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">alts:SoinIntangiblesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">alts:SoinIntangiblesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">alts:CryptocurrencyExchangeSoftwareIntangibleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">alts:CryptocurrencyExchangeSoftwareIntangibleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">alts:PatentsAndDomainsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">alts:PatentsAndDomainsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">alts:QodenTechnologiesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">alts:QodenIntangibleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-08</instant>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:ALT5SubsidiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-14</instant>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:ALT5SubsidiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-14</instant>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:ALT5SubsidiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-14</instant>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">alts:SoinIntangiblesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-28</instant>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:CommonShareEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:CommonShareEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:CommonShareEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:CommonShareEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:CommonShareEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:A15DebenturesMaturingJune302025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:DebenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:A15DebenturesMaturingJune302025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:DebenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:DebenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:DebenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:DebenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:A12DebenturesMaturingJune302025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:DebenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:A12DebenturesMaturingJune302024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:DebenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:DebenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LegacySubsidiaryFixedDepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LegacySubsidiaryFixedDepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LegacySubsidiaryLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LegacySubsidiaryLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LegacyUnaffiliatedThirdPartyNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LegacyUnaffiliatedThirdPartyNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:OtherLegacyNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:OtherLegacyNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LegacySubsidiaryFixedDepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:FixedDepositAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">alts:ALT5SubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LegacySubsidiaryFixedDepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:FixedDepositAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">alts:ALT5SubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LegacySubsidiaryFixedDepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:FixedDepositAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">alts:ALT5SubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LegacySubsidiaryFixedDepositsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:FixedDepositAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">alts:ALT5SubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-22</startDate>
            <endDate>2024-03-22</endDate>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LegacySubsidiaryLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:NotesPayableWithLiveVenturesAndICGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-07</instant>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:NotesPayableWithLiveVenturesAndICGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:NotesPayableWithLiveVenturesAndICGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LiveNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:NotesPayableWithLiveVenturesAndICGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-07</instant>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LiveNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:NotesPayableWithLiveVenturesAndICGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LiveNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:NotesPayableWithLiveVenturesAndICGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:SkyBridgeAmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:SkybridgeLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-10</startDate>
            <endDate>2024-04-10</endDate>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:SkyBridgeAmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:SkybridgeLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">alts:LegalFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-10</startDate>
            <endDate>2024-04-10</endDate>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:SkybridgeLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:PromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-10</instant>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:UnaffiliatedThirdPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:SkybridgeLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:PromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-23</startDate>
            <endDate>2024-12-23</endDate>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NonConvertibleDebentureBigDebentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-20</instant>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:InvestorOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NonConvertibleDebentureBigDebentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-20</instant>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:InvestorOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">alts:BigWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-20</instant>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:InvestorTwoAndInvestorThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NonConvertibleDebentureSmallDebentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-20</instant>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:InvestorTwoAndInvestorThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-20</instant>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NonConvertibleDebentureBigAndSmallDebentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="alts:DebtInstrumentCovenantPeriodAxis">alts:DebtInstrumentCovenantPeriodPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-20</instant>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NonConvertibleDebentureBigAndSmallDebentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="alts:DebtInstrumentCovenantPeriodAxis">alts:DebtInstrumentCovenantPeriodPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-20</instant>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NonConvertibleDebentureBigAndSmallDebentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="alts:DebtInstrumentCovenantPeriodAxis">alts:DebtInstrumentCovenantPeriodPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-20</instant>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NonConvertibleDebentureBigDebentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="alts:DebtInstrumentOriginalIssueDiscountExpansionAxis">alts:DebtInstrumentOriginalIssueDiscountExpansionOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-20</instant>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NonConvertibleDebentureBigDebentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="alts:DebtInstrumentOriginalIssueDiscountExpansionAxis">alts:DebtInstrumentOriginalIssueDiscountExpansionTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-20</instant>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NonConvertibleDebentureSmallDebentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-20</instant>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NonConvertibleDebentureSmallDebentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="alts:DebtInstrumentOriginalIssueDiscountExpansionAxis">alts:DebtInstrumentOriginalIssueDiscountExpansionOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-20</instant>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NonConvertibleDebentureSmallDebentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="alts:DebtInstrumentOriginalIssueDiscountExpansionAxis">alts:DebtInstrumentOriginalIssueDiscountExpansionTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-20</instant>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">alts:BigWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-20</instant>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">alts:BigWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="alts:DebtInstrumentCovenantPeriodAxis">alts:DebtInstrumentCovenantPeriodPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-20</instant>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">alts:BigWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="alts:DebtInstrumentCovenantPeriodAxis">alts:DebtInstrumentCovenantPeriodPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-20</instant>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">alts:BigWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="alts:DebtInstrumentCovenantPeriodAxis">alts:DebtInstrumentCovenantPeriodPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-20</instant>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">alts:SmallWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-20</instant>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">alts:SmallWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="alts:DebtInstrumentCovenantPeriodAxis">alts:DebtInstrumentCovenantPeriodPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-20</instant>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">alts:SmallWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="alts:DebtInstrumentCovenantPeriodAxis">alts:DebtInstrumentCovenantPeriodPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-20</instant>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">alts:SmallWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="alts:DebtInstrumentCovenantPeriodAxis">alts:DebtInstrumentCovenantPeriodPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-20</instant>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
        </entity>
        <period>
            <startDate>2024-08-20</startDate>
            <endDate>2024-08-20</endDate>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">alts:BigWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-29</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">alts:SmallWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-29</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NonConvertibleDebentureBigAndSmallDebentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-22</startDate>
            <endDate>2024-03-22</endDate>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NonConvertibleDebentureBigAndSmallDebentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:ALT5SubsidiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:FixedDepositAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:FixedDepositAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-19</startDate>
            <endDate>2024-09-19</endDate>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:ALT5SubsidiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:FixedDepositAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:FixedDepositAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-19</instant>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:ALT5SubsidiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:FixedDepositAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:FixedDepositAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IsaacCapitalGroupNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IsaacCapitalGroupNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NotePayableToIsaacCapitalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NotePayableToIsaacCapitalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NotePayableToLiveVentureIncorporatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NotePayableToLiveVentureIncorporatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IsaacCapitalGroupShortTermDemandAdvanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IsaacCapitalGroupShortTermDemandAdvanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NovalkAppsSAALLPShortTermDemandAdvanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NovalkAppsSAALLPShortTermDemandAdvanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NotesPayableRelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-07</instant>
        </period>
    </context>
    <context id="c-253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IsaacCapitalGroupShortTermDemandAdvanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-18</startDate>
            <endDate>2024-04-18</endDate>
        </period>
    </context>
    <context id="c-257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IsaacCapitalGroupShortTermDemandAdvanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IsaacCapitalGroupShortTermDemandAdvanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-18</instant>
        </period>
    </context>
    <context id="c-259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IsaacCapitalGroupShortTermDemandAdvanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LiveNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:LiveVentureIncorporatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-07</instant>
        </period>
    </context>
    <context id="c-261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LiveNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:LiveVentureIncorporatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LiveNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:LiveVentureIncorporatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LiveNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:LiveVentureIncorporatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:Mr.JonIsaacMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:A10ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-04</startDate>
            <endDate>2024-03-04</endDate>
        </period>
    </context>
    <context id="c-265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:A10ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-04</startDate>
            <endDate>2024-03-04</endDate>
        </period>
    </context>
    <context id="c-266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:A10ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-04</instant>
        </period>
    </context>
    <context id="c-267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:Mr.JonIsaacMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-04</instant>
        </period>
    </context>
    <context id="c-268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:A10ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-23</startDate>
            <endDate>2024-12-23</endDate>
        </period>
    </context>
    <context id="c-269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:Mr.JonIsaacMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:NovalkAppsSAALLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:RelatedPartyTransactionShortTermAdvancesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-28</startDate>
            <endDate>2024-05-28</endDate>
        </period>
    </context>
    <context id="c-271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:NovalkAppsSAALLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:RelatedPartyTransactionShortTermAdvancesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-03</startDate>
            <endDate>2024-06-03</endDate>
        </period>
    </context>
    <context id="c-272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:NovalkAppsSAALLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:RelatedPartyTransactionShortTermAdvancesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-28</instant>
        </period>
    </context>
    <context id="c-273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:NovalkAppsSAALLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:RelatedPartyTransactionShortTermAdvancesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-03</instant>
        </period>
    </context>
    <context id="c-274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:NovalkAppsSAALLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:RelatedPartyTransactionShortTermAdvancesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:NovalkAppsSAALLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:RelatedPartyTransactionShortTermAdvancesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:Mr.TonyIsaacMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:RelatedPartyTransactionShortTermAdvancesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-03</startDate>
            <endDate>2024-06-03</endDate>
        </period>
    </context>
    <context id="c-277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:Mr.TonyIsaacMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:RelatedPartyTransactionShortTermAdvancesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:Mr.TonyIsaacMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:RelatedPartyTransactionShortTermAdvancesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:Mr.TonyIsaacMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:RelatedPartyTransactionShortTermAdvancesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-03</instant>
        </period>
    </context>
    <context id="c-280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:GeoTraqIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-08-18</startDate>
            <endDate>2017-08-18</endDate>
        </period>
    </context>
    <context id="c-281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:GeoTraqIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">alts:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-08-18</startDate>
            <endDate>2017-08-18</endDate>
        </period>
    </context>
    <context id="c-282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:GeoTraqIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">alts:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-08-18</instant>
        </period>
    </context>
    <context id="c-283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">alts:SeriesA1ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">alts:SeriesA1ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">alts:SeriesA1ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">alts:SeriesA1ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:OwnersOfALT5SubsidiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-15</startDate>
            <endDate>2024-05-15</endDate>
        </period>
    </context>
    <context id="c-288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-02</startDate>
            <endDate>2024-12-02</endDate>
        </period>
    </context>
    <context id="c-289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:Alt5SigmaInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-02</instant>
        </period>
    </context>
    <context id="c-290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:QodenTechnologiesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-06</startDate>
            <endDate>2024-11-06</endDate>
        </period>
    </context>
    <context id="c-292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:QodenTechnologiesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesQConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-06</startDate>
            <endDate>2024-11-06</endDate>
        </period>
    </context>
    <context id="c-293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesQConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-06</startDate>
            <endDate>2024-11-06</endDate>
        </period>
    </context>
    <context id="c-294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:UnaffiliatedThirdPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesVConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-04</startDate>
            <endDate>2024-05-04</endDate>
        </period>
    </context>
    <context id="c-295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:SoinTherapeuticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesSConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-28</instant>
        </period>
    </context>
    <context id="c-296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:SoinTherapeuticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesSConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-28</startDate>
            <endDate>2022-12-28</endDate>
        </period>
    </context>
    <context id="c-297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:DrSoinMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">alts:StockConversion1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesSConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-28</startDate>
            <endDate>2022-12-28</endDate>
        </period>
    </context>
    <context id="c-298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:DrSoinMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">alts:StockConversion1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesSConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-28</instant>
        </period>
    </context>
    <context id="c-299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:DrSoinMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">alts:StockConversion2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesSConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-28</startDate>
            <endDate>2022-12-28</endDate>
        </period>
    </context>
    <context id="c-300">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:DrSoinMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">alts:StockConversion3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesSConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-28</instant>
        </period>
    </context>
    <context id="c-301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:DrSoinMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">alts:StockConversion3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesSConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-28</startDate>
            <endDate>2022-12-28</endDate>
        </period>
    </context>
    <context id="c-302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:DrSoinMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">alts:StockConversion3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-28</startDate>
            <endDate>2022-12-28</endDate>
        </period>
    </context>
    <context id="c-303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:DrSoinMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-28</startDate>
            <endDate>2022-12-28</endDate>
        </period>
    </context>
    <context id="c-304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesSConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesSConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">alts:ArticlesOfIncorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">alts:ArticlesOfIncorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-22</startDate>
            <endDate>2023-03-22</endDate>
        </period>
    </context>
    <context id="c-309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-22</instant>
        </period>
    </context>
    <context id="c-310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-18</startDate>
            <endDate>2023-08-18</endDate>
        </period>
    </context>
    <context id="c-311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-18</instant>
        </period>
    </context>
    <context id="c-312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">alts:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-18</instant>
        </period>
    </context>
    <context id="c-313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-314">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-23</instant>
        </period>
    </context>
    <context id="c-315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-23</startDate>
            <endDate>2024-02-23</endDate>
        </period>
    </context>
    <context id="c-316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-23</startDate>
            <endDate>2024-02-23</endDate>
        </period>
    </context>
    <context id="c-317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">alts:ThirdPartyExchangeForBrokerageServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-23</startDate>
            <endDate>2024-02-23</endDate>
        </period>
    </context>
    <context id="c-318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:Mr.JonIsaacMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-04</startDate>
            <endDate>2024-03-04</endDate>
        </period>
    </context>
    <context id="c-319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-22</startDate>
            <endDate>2024-03-22</endDate>
        </period>
    </context>
    <context id="c-320">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-22</startDate>
            <endDate>2024-03-22</endDate>
        </period>
    </context>
    <context id="c-321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-25</startDate>
            <endDate>2024-03-25</endDate>
        </period>
    </context>
    <context id="c-322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-25</startDate>
            <endDate>2024-03-25</endDate>
        </period>
    </context>
    <context id="c-323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-10</startDate>
            <endDate>2024-04-10</endDate>
        </period>
    </context>
    <context id="c-324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-10</startDate>
            <endDate>2024-04-10</endDate>
        </period>
    </context>
    <context id="c-325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-12</startDate>
            <endDate>2024-04-12</endDate>
        </period>
    </context>
    <context id="c-326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-12</startDate>
            <endDate>2024-04-12</endDate>
        </period>
    </context>
    <context id="c-327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-01</instant>
        </period>
    </context>
    <context id="c-328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-05-01</endDate>
        </period>
    </context>
    <context id="c-329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EquityUnitPurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-05-01</endDate>
        </period>
    </context>
    <context id="c-330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:NorthYorkLTDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-04</startDate>
            <endDate>2024-03-04</endDate>
        </period>
    </context>
    <context id="c-331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:NorthYorkLTDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">alts:SeriesVConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-04</startDate>
            <endDate>2024-03-04</endDate>
        </period>
    </context>
    <context id="c-332">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:NorthYorkLTDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-04</instant>
        </period>
    </context>
    <context id="c-333">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:NorthYorkLTDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-04</startDate>
            <endDate>2024-03-04</endDate>
        </period>
    </context>
    <context id="c-334">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-03</startDate>
            <endDate>2024-06-03</endDate>
        </period>
    </context>
    <context id="c-335">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-06</startDate>
            <endDate>2024-06-06</endDate>
        </period>
    </context>
    <context id="c-336">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-18</startDate>
            <endDate>2024-09-18</endDate>
        </period>
    </context>
    <context id="c-337">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-31</endDate>
        </period>
    </context>
    <context id="c-338">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-18</startDate>
            <endDate>2024-10-18</endDate>
        </period>
    </context>
    <context id="c-339">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:NonConvertibleDebentureBigAndSmallDebentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-29</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-340">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-01</endDate>
        </period>
    </context>
    <context id="c-341">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-03</startDate>
            <endDate>2024-12-03</endDate>
        </period>
    </context>
    <context id="c-342">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">alts:A2023EquityIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-343">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">alts:A2024EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-344">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">alts:A2024EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-345">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">alts:A2023EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-346">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">alts:A2023EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-347">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">alts:Plan2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-03</instant>
        </period>
    </context>
    <context id="c-348">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">alts:Plan2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-04</instant>
        </period>
    </context>
    <context id="c-349">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">alts:Plan2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-350">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">alts:Plan2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-351">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">alts:Plan2011Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-352">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">alts:Plan2011Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-353">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">alts:Plan2011Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-354">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
        </entity>
        <period>
            <startDate>2022-01-02</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-355">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">alts:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-356">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">alts:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-357">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">alts:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-358">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">alts:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-359">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-360">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-361">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-362">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-363">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-364">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-365">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-366">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-367">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:LiveVenturesIncorporatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-368">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:LiveVenturesIncorporatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-369">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:LiveVenturesIncorporatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-370">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LiveVenturesAndICGNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:NotesPayableWithLiveVenturesAndICGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-07</instant>
        </period>
    </context>
    <context id="c-371">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LiveVenturesAndICGNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:NotesPayableWithLiveVenturesAndICGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-07</startDate>
            <endDate>2024-02-07</endDate>
        </period>
    </context>
    <context id="c-372">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:LiveVenturesAndICGNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">alts:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:NotesPayableWithLiveVenturesAndICGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-373">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:Mr.JonIsaacMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">alts:UniversalLifeInsurancePolicyPolicyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-04</instant>
        </period>
    </context>
    <context id="c-374">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:Mr.JonIsaacMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">alts:UniversalLifeInsurancePolicyPolicyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-04</instant>
        </period>
    </context>
    <context id="c-375">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:A10ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-376">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">alts:A10ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-377">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:Mr.JonIsaacMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IsaacConsultingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-378">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-379">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">alts:ARCAAndSubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:BeneficialOwnerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:RecyclingSegmentAndTechnologySegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-28</instant>
        </period>
    </context>
    <context id="c-380">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">alts:JanOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">alts:ARCAAndSubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:BeneficialOwnerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:RecyclingSegmentAndTechnologySegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">alts:IsaacCapitalGroupLLCICGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-24</instant>
        </period>
    </context>
    <context id="c-381">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-382">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">alts:ARCAAndSubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:BeneficialOwnerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:RecyclingSegmentAndTechnologySegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="c-383">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">alts:ARCAAndSubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:BeneficialOwnerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:RecyclingSegmentAndTechnologySegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-24</startDate>
            <endDate>2023-05-24</endDate>
        </period>
    </context>
    <context id="c-384">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">alts:IcgNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-385">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:SECComplaintMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-02</instant>
        </period>
    </context>
    <context id="c-386">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:SECComplaintMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-28</startDate>
            <endDate>2024-05-28</endDate>
        </period>
    </context>
    <context id="c-387">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:SECComplaintMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-28</instant>
        </period>
    </context>
    <context id="c-388">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:Mr.SullivanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:GeoTraqIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-389">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:Mr.SullivanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">alts:GeoTraqIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-390">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:AlixpartnersLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:AlixpartnersLLCLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-19</startDate>
            <endDate>2022-10-19</endDate>
        </period>
    </context>
    <context id="c-391">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:AlixpartnersLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:AlixpartnersLLCLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-392">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:AlixpartnersLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:AlixpartnersLLCLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-393">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:TrusteesMain270LlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:Main270LLCLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-394">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:TrusteesMain270LlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:Main270LLCLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">alts:ApplianceSmartIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-395">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:WestervilleSquareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:WestervilleSquareLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-396">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">alts:WestervilleSquareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:WestervilleSquareLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-04</startDate>
            <endDate>2023-06-04</endDate>
        </period>
    </context>
    <context id="c-397">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:OtherCommitmentsAndLitigationCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">alts:ApplianceSmartIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-01</instant>
        </period>
    </context>
    <context id="c-398">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:OtherCommitmentsAndLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-30</instant>
        </period>
    </context>
    <context id="c-399">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:OtherCommitmentsAndLitigationCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">alts:ApplianceSmartIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-400">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">alts:OtherCommitmentsAndLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:FintechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:FintechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:BiotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:BiotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:RecyclingSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-408">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:RecyclingSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-409">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">alts:ContinuingOperationsAndDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <context id="c-410">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">alts:ContinuingOperationsAndDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-30</endDate>
        </period>
    </context>
    <context id="c-411">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:FintechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:FintechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-413">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:BiotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:BiotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-416">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-417">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:RecyclingSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">alts:RecyclingSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-419">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">alts:ContinuingOperationsAndDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-28</instant>
        </period>
    </context>
    <context id="c-420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">alts:ContinuingOperationsAndDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-30</instant>
        </period>
    </context>
    <context id="c-421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000862861</identifier>
        </entity>
        <period>
            <startDate>2024-09-29</startDate>
            <endDate>2024-12-28</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>alts:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="tranche">
        <measure>alts:tranche</measure>
    </unit>
    <unit id="patent">
        <measure>alts:patent</measure>
    </unit>
    <unit id="debenture">
        <measure>alts:debenture</measure>
    </unit>
    <unit id="investor">
        <measure>alts:investor</measure>
    </unit>
    <unit id="addition">
        <measure>alts:addition</measure>
    </unit>
    <unit id="consultant">
        <measure>alts:consultant</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="insurance_policy">
        <measure>alts:insurance_policy</measure>
    </unit>
    <unit id="trading_day">
        <measure>alts:trading_day</measure>
    </unit>
    <unit id="officer">
        <measure>alts:officer</measure>
    </unit>
    <unit id="payment">
        <measure>alts:payment</measure>
    </unit>
    <unit id="landlord">
        <measure>alts:landlord</measure>
    </unit>
    <unit id="guarantee">
        <measure>alts:guarantee</measure>
    </unit>
    <dei:AmendmentFlag contextRef="c-1" id="f-31">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-32">0000862861</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-33">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-34">FY</dei:DocumentFiscalPeriodFocus>
    <us-gaap:PreferredStockConvertibleConversionRatio contextRef="c-177" decimals="5" id="f-837" unitRef="number">0.00001</us-gaap:PreferredStockConvertibleConversionRatio>
    <us-gaap:PreferredStockConvertibleConversionRatio contextRef="c-14" decimals="3" id="f-1073" unitRef="number">0.125</us-gaap:PreferredStockConvertibleConversionRatio>
    <dei:DocumentType contextRef="c-1" id="f-1">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="c-1" id="f-2">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-4">2024-12-28</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-3">--12-28</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-5">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-6">000-19621</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-7">ALT5 Sigma Corporation</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-8">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-9">41-1454591</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-10">325 E. Warm Springs Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-11">Las Vegas</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-12">NV</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-13">89119</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-14">702</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-15">997-5968</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-16">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-17">ALTS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-18">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c-1" id="f-19">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c-1" id="f-20">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-21">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-22">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-23">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-24">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-25">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="c-1" id="f-26">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c-1" id="f-27">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="c-1" id="f-28">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="c-2" decimals="-5" id="f-29" unitRef="usd">26700000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-30" unitRef="shares">16078647</dei:EntityCommonStockSharesOutstanding>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock contextRef="c-1" id="f-36">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of our business, we collect, use, store, and digitally transmit confidential, sensitive, proprietary, and personal information. The secure maintenance of this information and our information technology systems are important to our operations and business strategy. The Audit Committee, which is composed solely of independent directors, has been designated by our Board to review and discuss with management the Company&#x2019;s risk assessment and risk management policies, including the steps that management has taken to monitor and control related cybersecurity risks and exposures. Management updates the Audit Committee and the Board as necessary about significant cybersecurity occurrences and measures the Company is taking to prevent the same.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock contextRef="c-1" id="f-35">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of our business, we collect, use, store, and digitally transmit confidential, sensitive, proprietary, and personal information. The secure maintenance of this information and our information technology systems are important to our operations and business strategy. The Audit Committee, which is composed solely of independent directors, has been designated by our Board to review and discuss with management the Company&#x2019;s risk assessment and risk management policies, including the steps that management has taken to monitor and control related cybersecurity risks and exposures. Management updates the Audit Committee and the Board as necessary about significant cybersecurity occurrences and measures the Company is taking to prevent the same.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c-1" id="f-37">The Audit Committee, which is composed solely of independent directors, has been designated by our Board to review and discuss with management the Company&#x2019;s risk assessment and risk management policies, including the steps that management has taken to monitor and control related cybersecurity risks and exposures. Management updates the Audit Committee and the Board as necessary about significant cybersecurity occurrences and measures the Company is taking to prevent the same.</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock contextRef="c-1" id="f-39">The Audit Committee, which is composed solely of independent directors, has been designated by our Board to review and discuss with management the Company&#x2019;s risk assessment and risk management policies, including the steps that management has taken to monitor and control related cybersecurity risks and exposures.</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock contextRef="c-1" id="f-38">The Audit Committee, which is composed solely of independent directors, has been designated by our Board to review and discuss with management the Company&#x2019;s risk assessment and risk management policies, including the steps that management has taken to monitor and control related cybersecurity risks and exposures.</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag contextRef="c-1" id="f-40">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c-1" id="f-42">Management updates the Audit Committee and the Board as necessary about significant cybersecurity occurrences and measures the Company is taking to prevent the same.</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag contextRef="c-1" id="f-41">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock contextRef="c-1" id="f-44">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We rely on our subsidiary-level information technology professionals to continuously monitor and update our IT networks and infrastructure. Their role is to prevent, detect, address, and mitigate risks related to unauthorized access, misuse, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;malware, and other security threats. To safeguard our data and business processes, as well as those of our subsidiaries, we invest in industry-standard security technologies to defend against cyber risks.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To further strengthen our cybersecurity efforts, with our subsidiary&#x2019;s assistance, we are establishing an &#x201c;IT Steering Committee&#x201d; composed of IT professionals from our subsidiary. This committee will meet quarterly to discuss cybersecurity threats, emerging attack methods, and best practices.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="c-1" id="f-43">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We rely on our subsidiary-level information technology professionals to continuously monitor and update our IT networks and infrastructure. Their role is to prevent, detect, address, and mitigate risks related to unauthorized access, misuse, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;malware, and other security threats. To safeguard our data and business processes, as well as those of our subsidiaries, we invest in industry-standard security technologies to defend against cyber risks.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To further strengthen our cybersecurity efforts, with our subsidiary&#x2019;s assistance, we are establishing an &#x201c;IT Steering Committee&#x201d; composed of IT professionals from our subsidiary. This committee will meet quarterly to discuss cybersecurity threats, emerging attack methods, and best practices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In fiscal year 2024, our crypto-processing subsidiary engaged an external consultant to conduct a cybersecurity risk assessment of our business operations. This assessment examined both internal and external threats to our systems and data handling processes, providing a structured framework for evaluating, prioritizing, and enhancing our cybersecurity initiatives. On a going-forward basis, in collaboration with our Audit Committee, management will determine and implement appropriate measures based on these findings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of our cybersecurity risk management program, we are working with our crypto-processing subsidiary to develop a cyber training curriculum for our employees. The training may cover topics such as phishing awareness, cybersecurity best practices, and e-mail security.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Despite our commitment to cybersecurity, no system can fully eliminate technology risks. As of now, we are unaware of any cybersecurity incidents that have had, or are reasonably likely to have, a material impact on our business or operations. However, the increasing volume and sophistication of cyberattacks&#x2014;including data breaches, ransomware, and similar threats&#x2014;pose ongoing risks. Incidents that occur could result in reputational, competitive, operational, or financial harm, as well as regulatory consequences. For a more detailed discussion of how cybersecurity threats may affect our business strategy, operations, or financial condition, see Item 1A, &#x201c;Risk Factors,&#x201d; which is incorporated by reference into Item 1C.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag contextRef="c-1" id="f-45">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag contextRef="c-1" id="f-46">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag contextRef="c-1" id="f-47">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock contextRef="c-1" id="f-48">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of our cybersecurity risk management program, we are working with our crypto-processing subsidiary to develop a cyber training curriculum for our employees. The training may cover topics such as phishing awareness, cybersecurity best practices, and e-mail security.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="c-1" id="f-49">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <dei:AuditorFirmId contextRef="c-1" id="f-50">6849</dei:AuditorFirmId>
    <dei:AuditorName contextRef="c-1" id="f-51">Hudgens CPA, PLLC</dei:AuditorName>
    <dei:AuditorLocation contextRef="c-1" id="f-52">Houston, Texas</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-53" unitRef="usd">7177000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-5" decimals="-3" id="f-54" unitRef="usd">5000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="c-4" decimals="-3" id="f-55" unitRef="usd">2530000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="c-5" decimals="-3" id="f-56" unitRef="usd">266000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <alts:PlatformOperatorCryptoAssetHeldForUserCurrent contextRef="c-4" decimals="-3" id="f-57" unitRef="usd">23776000</alts:PlatformOperatorCryptoAssetHeldForUserCurrent>
    <alts:PlatformOperatorCryptoAssetHeldForUserCurrent contextRef="c-5" decimals="-3" id="f-58" unitRef="usd">0</alts:PlatformOperatorCryptoAssetHeldForUserCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-59" unitRef="usd">1518000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-5" decimals="-3" id="f-60" unitRef="usd">75000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-3" id="f-61" unitRef="usd">35001000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-5" decimals="-3" id="f-62" unitRef="usd">346000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-63" unitRef="usd">1170000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-5" decimals="-3" id="f-64" unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-65" unitRef="usd">121000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-5" decimals="-3" id="f-66" unitRef="usd">0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-4" decimals="-3" id="f-67" unitRef="usd">34430000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-5" decimals="-3" id="f-68" unitRef="usd">17846000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:MarketableSecuritiesNoncurrent contextRef="c-4" decimals="-3" id="f-69" unitRef="usd">0</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent contextRef="c-5" decimals="-3" id="f-70" unitRef="usd">286000</us-gaap:MarketableSecuritiesNoncurrent>
    <alts:DepositsAndOtherAssetsNoncurrent contextRef="c-4" decimals="-3" id="f-71" unitRef="usd">0</alts:DepositsAndOtherAssetsNoncurrent>
    <alts:DepositsAndOtherAssetsNoncurrent contextRef="c-5" decimals="-3" id="f-72" unitRef="usd">9000</alts:DepositsAndOtherAssetsNoncurrent>
    <us-gaap:Goodwill contextRef="c-4" decimals="-3" id="f-73" unitRef="usd">11714000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-5" decimals="-3" id="f-74" unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-75" unitRef="usd">82436000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-5" decimals="-3" id="f-76" unitRef="usd">18487000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-3" id="f-77" unitRef="usd">3231000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-5" decimals="-3" id="f-78" unitRef="usd">2272000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities contextRef="c-4" decimals="-3" id="f-79" unitRef="usd">2553000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities contextRef="c-5" decimals="-3" id="f-80" unitRef="usd">3633000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <alts:DigitalAssetLiabilityCurrent contextRef="c-4" decimals="-3" id="f-81" unitRef="usd">30918000</alts:DigitalAssetLiabilityCurrent>
    <alts:DigitalAssetLiabilityCurrent contextRef="c-5" decimals="-3" id="f-82" unitRef="usd">0</alts:DigitalAssetLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-6" decimals="-3" id="f-83" unitRef="usd">2850000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-7" decimals="-3" id="f-84" unitRef="usd">0</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:ConvertibleDebtCurrent contextRef="c-4" decimals="-3" id="f-85" unitRef="usd">563000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent contextRef="c-5" decimals="-3" id="f-86" unitRef="usd">0</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-87" unitRef="usd">10000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-5" decimals="-3" id="f-88" unitRef="usd">0</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:NotesPayableCurrent contextRef="c-6" decimals="-3" id="f-89" unitRef="usd">812000</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent contextRef="c-7" decimals="-3" id="f-90" unitRef="usd">0</us-gaap:NotesPayableCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-91" unitRef="usd">40937000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-92" unitRef="usd">5905000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-4" decimals="-3" id="f-93" unitRef="usd">1041000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-5" decimals="-3" id="f-94" unitRef="usd">639000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLongTermNotesPayable contextRef="c-6" decimals="-3" id="f-95" unitRef="usd">0</us-gaap:OtherLongTermNotesPayable>
    <us-gaap:OtherLongTermNotesPayable contextRef="c-7" decimals="-3" id="f-96" unitRef="usd">707000</us-gaap:OtherLongTermNotesPayable>
    <us-gaap:LongTermNotesPayable contextRef="c-4" decimals="-3" id="f-97" unitRef="usd">11570000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable contextRef="c-5" decimals="-3" id="f-98" unitRef="usd">0</us-gaap:LongTermNotesPayable>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-99" unitRef="usd">113000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-5" decimals="-3" id="f-100" unitRef="usd">0</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-4" decimals="-3" id="f-101" unitRef="usd">108000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-5" decimals="-3" id="f-102" unitRef="usd">34000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-4" decimals="-3" id="f-103" unitRef="usd">53769000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-5" decimals="-3" id="f-104" unitRef="usd">7285000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-105" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-5" id="f-106" unitRef="usd" xsi:nil="true"/>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="c-8"
      decimals="INF"
      id="f-107"
      unitRef="usdPerShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="c-9"
      decimals="INF"
      id="f-108"
      unitRef="usdPerShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized contextRef="c-8" decimals="INF" id="f-109" unitRef="shares">200000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized contextRef="c-9" decimals="INF" id="f-110" unitRef="shares">200000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued contextRef="c-9" decimals="INF" id="f-111" unitRef="shares">100000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="c-9" decimals="INF" id="f-112" unitRef="shares">100000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="c-8" decimals="INF" id="f-113" unitRef="shares">100000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued contextRef="c-8" decimals="INF" id="f-114" unitRef="shares">100000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c-9" decimals="-3" id="f-115" unitRef="usd">3856000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c-8" decimals="-3" id="f-116" unitRef="usd">14510000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-10"
      decimals="INF"
      id="f-117"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-11"
      decimals="INF"
      id="f-118"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c-11"
      decimals="INF"
      id="f-119"
      unitRef="shares">2000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c-10"
      decimals="INF"
      id="f-120"
      unitRef="shares">2000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-10"
      decimals="INF"
      id="f-121"
      unitRef="shares">23480</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c-10"
      decimals="INF"
      id="f-122"
      unitRef="shares">23480</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c-11"
      decimals="INF"
      id="f-123"
      unitRef="shares">193730</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-11"
      decimals="INF"
      id="f-124"
      unitRef="shares">193730</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c-10" decimals="-3" id="f-125" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-11" decimals="-3" id="f-126" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-12"
      decimals="INF"
      id="f-127"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-13"
      decimals="INF"
      id="f-128"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c-13"
      decimals="INF"
      id="f-129"
      unitRef="shares">34250</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c-12"
      decimals="INF"
      id="f-130"
      unitRef="shares">34250</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c-12"
      decimals="INF"
      id="f-131"
      unitRef="shares">34207</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-12"
      decimals="INF"
      id="f-132"
      unitRef="shares">34207</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-13"
      decimals="INF"
      id="f-133"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c-13"
      decimals="INF"
      id="f-134"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue contextRef="c-12" decimals="-3" id="f-135" unitRef="usd">8552000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-13" decimals="-3" id="f-136" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-14"
      decimals="INF"
      id="f-137"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-15"
      decimals="INF"
      id="f-138"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c-14"
      decimals="INF"
      id="f-139"
      unitRef="shares">2000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c-15"
      decimals="INF"
      id="f-140"
      unitRef="shares">2000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c-14"
      decimals="INF"
      id="f-141"
      unitRef="shares">17000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-14"
      decimals="INF"
      id="f-142"
      unitRef="shares">17000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c-15"
      decimals="INF"
      id="f-143"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-15"
      decimals="INF"
      id="f-144"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c-14" decimals="-3" id="f-145" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-15" decimals="-3" id="f-146" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-16"
      decimals="INF"
      id="f-147"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-17"
      decimals="INF"
      id="f-148"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c-16"
      decimals="INF"
      id="f-149"
      unitRef="shares">3200</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c-17"
      decimals="INF"
      id="f-150"
      unitRef="shares">3200</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c-16"
      decimals="INF"
      id="f-151"
      unitRef="shares">3200</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-16"
      decimals="INF"
      id="f-152"
      unitRef="shares">3200</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c-17"
      decimals="INF"
      id="f-153"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-17"
      decimals="INF"
      id="f-154"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c-16" decimals="-3" id="f-155" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-17" decimals="-3" id="f-156" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-18"
      decimals="INF"
      id="f-157"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-19"
      decimals="INF"
      id="f-158"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c-19"
      decimals="INF"
      id="f-159"
      unitRef="shares">2000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c-18"
      decimals="INF"
      id="f-160"
      unitRef="shares">2000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c-18"
      decimals="INF"
      id="f-161"
      unitRef="shares">925212</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-18"
      decimals="INF"
      id="f-162"
      unitRef="shares">925212</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c-19"
      decimals="INF"
      id="f-163"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-19"
      decimals="INF"
      id="f-164"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c-18" decimals="-3" id="f-165" unitRef="usd">1321000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-19" decimals="-3" id="f-166" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-8"
      decimals="INF"
      id="f-167"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-9"
      decimals="INF"
      id="f-168"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-9" decimals="INF" id="f-169" unitRef="shares">200000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-8" decimals="INF" id="f-170" unitRef="shares">200000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-9" decimals="INF" id="f-171" unitRef="shares">100000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-8" decimals="INF" id="f-172" unitRef="shares">100000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-8" decimals="INF" id="f-173" unitRef="shares">100000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="c-9" decimals="INF" id="f-174" unitRef="shares">100000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-9" decimals="INF" id="f-175" unitRef="shares">100000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-8" decimals="INF" id="f-176" unitRef="shares">100000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-8" decimals="INF" id="f-177" unitRef="shares">100000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="c-9" decimals="INF" id="f-178" unitRef="shares">100000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue contextRef="c-9" decimals="-3" id="f-179" unitRef="usd">7993000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-8" decimals="-3" id="f-180" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-20"
      decimals="INF"
      id="f-181"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-21"
      decimals="INF"
      id="f-182"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c-20"
      decimals="INF"
      id="f-183"
      unitRef="shares">125000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c-21"
      decimals="INF"
      id="f-184"
      unitRef="shares">125000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c-20"
      decimals="INF"
      id="f-185"
      unitRef="shares">5000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-20"
      decimals="INF"
      id="f-186"
      unitRef="shares">5000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c-21"
      decimals="INF"
      id="f-187"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-21"
      decimals="INF"
      id="f-188"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c-20" decimals="-3" id="f-189" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-21" decimals="-3" id="f-190" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-191"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-192"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-5" decimals="INF" id="f-193" unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-194" unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="INF" id="f-195" unitRef="shares">15417693</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-196" unitRef="shares">15417693</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-5" decimals="INF" id="f-197" unitRef="shares">2827410</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-5" decimals="INF" id="f-198" unitRef="shares">2827410</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-199" unitRef="usd">9000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-5" decimals="-3" id="f-200" unitRef="usd">3000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-4" decimals="-3" id="f-201" unitRef="usd">62207000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-5" decimals="-3" id="f-202" unitRef="usd">47323000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-3" id="f-203" unitRef="usd">-56879000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-5" decimals="-3" id="f-204" unitRef="usd">-50634000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-3" id="f-205" unitRef="usd">-2317000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-5" decimals="-3" id="f-206" unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-207" unitRef="usd">20886000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-3" id="f-208" unitRef="usd">-3308000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="c-4" decimals="-3" id="f-209" unitRef="usd">3925000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="c-5" decimals="-3" id="f-210" unitRef="usd">0</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-4" decimals="-3" id="f-211" unitRef="usd">24811000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-212" unitRef="usd">-3308000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-3" id="f-213" unitRef="usd">82436000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-5" decimals="-3" id="f-214" unitRef="usd">18487000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-215" unitRef="usd">12532000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-22" decimals="-3" id="f-216" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue contextRef="c-1" decimals="-3" id="f-217" unitRef="usd">6238000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-22" decimals="-3" id="f-218" unitRef="usd">0</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit contextRef="c-1" decimals="-3" id="f-219" unitRef="usd">6294000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-22" decimals="-3" id="f-220" unitRef="usd">0</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-221" unitRef="usd">13856000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-22" decimals="-3" id="f-222" unitRef="usd">4746000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AssetImpairmentCharges contextRef="c-1" decimals="-3" id="f-223" unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges contextRef="c-22" decimals="-3" id="f-224" unitRef="usd">15100000</us-gaap:AssetImpairmentCharges>
    <us-gaap:OperatingExpenses contextRef="c-1" decimals="-3" id="f-225" unitRef="usd">13856000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-22" decimals="-3" id="f-226" unitRef="usd">19846000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-227" unitRef="usd">-7562000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-22" decimals="-3" id="f-228" unitRef="usd">-19846000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-1" decimals="-3" id="f-229" unitRef="usd">-879000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-22" decimals="-3" id="f-230" unitRef="usd">2250000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <alts:RealizedGainLossOnExchangeTransactions contextRef="c-1" decimals="-3" id="f-231" unitRef="usd">374000</alts:RealizedGainLossOnExchangeTransactions>
    <alts:RealizedGainLossOnExchangeTransactions contextRef="c-22" decimals="-3" id="f-232" unitRef="usd">0</alts:RealizedGainLossOnExchangeTransactions>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-1" decimals="-3" id="f-233" unitRef="usd">-1058000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-22" decimals="-3" id="f-234" unitRef="usd">-926000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-235" unitRef="usd">-161000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-22" decimals="-3" id="f-236" unitRef="usd">998000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-237" unitRef="usd">-1724000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-22" decimals="-3" id="f-238" unitRef="usd">2322000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-239" unitRef="usd">-9286000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-22" decimals="-3" id="f-240" unitRef="usd">-17524000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-241" unitRef="usd">-3041000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-22" decimals="-3" id="f-242" unitRef="usd">-429000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="c-1" decimals="-3" id="f-243" unitRef="usd">-6245000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="c-22" decimals="-3" id="f-244" unitRef="usd">-17095000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax contextRef="c-1" decimals="-3" id="f-245" unitRef="usd">0</us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax contextRef="c-22" decimals="-3" id="f-246" unitRef="usd">10254000</us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation contextRef="c-1" decimals="-3" id="f-247" unitRef="usd">0</us-gaap:DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation>
    <us-gaap:DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation contextRef="c-22" decimals="-3" id="f-248" unitRef="usd">971000</us-gaap:DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity contextRef="c-1" decimals="-3" id="f-249" unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity contextRef="c-22" decimals="-3" id="f-250" unitRef="usd">9283000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-251" unitRef="usd">-6245000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-22" decimals="-3" id="f-252" unitRef="usd">-7812000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="c-1"
      decimals="2"
      id="f-253"
      unitRef="usdPerShare">-0.56</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="c-1"
      decimals="2"
      id="f-254"
      unitRef="usdPerShare">-0.56</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="c-22"
      decimals="2"
      id="f-255"
      unitRef="usdPerShare">-4.27</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="c-22"
      decimals="2"
      id="f-256"
      unitRef="usdPerShare">-4.27</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
      contextRef="c-1"
      decimals="2"
      id="f-257"
      unitRef="usdPerShare">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
      contextRef="c-22"
      decimals="2"
      id="f-258"
      unitRef="usdPerShare">2.32</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="c-1"
      decimals="2"
      id="f-259"
      unitRef="usdPerShare">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="c-22"
      decimals="2"
      id="f-260"
      unitRef="usdPerShare">2.09</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-261"
      unitRef="usdPerShare">-0.56</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-262"
      unitRef="usdPerShare">-0.56</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-22"
      decimals="2"
      id="f-263"
      unitRef="usdPerShare">-1.95</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-22"
      decimals="2"
      id="f-264"
      unitRef="usdPerShare">-1.95</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-265" unitRef="shares">11148493</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-22" decimals="0" id="f-266" unitRef="shares">4005334</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-267" unitRef="shares">11148493</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-22" decimals="0" id="f-268" unitRef="shares">4444361</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-23" decimals="0" id="f-269" unitRef="shares">222588</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-23" decimals="-3" id="f-270" unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-24" decimals="0" id="f-271" unitRef="shares">100000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-24" decimals="-3" id="f-272" unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-25" decimals="0" id="f-273" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-25" decimals="-3" id="f-274" unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-26" decimals="0" id="f-275" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-26" decimals="-3" id="f-276" unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-27" decimals="0" id="f-277" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-27" decimals="-3" id="f-278" unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-28" decimals="0" id="f-279" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-28" decimals="-3" id="f-280" unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-29" decimals="0" id="f-281" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-29" decimals="-3" id="f-282" unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-30" decimals="0" id="f-283" unitRef="shares">3150230</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-30" decimals="-3" id="f-284" unitRef="usd">2000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-31" decimals="-3" id="f-285" unitRef="usd">45748000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-32" decimals="-3" id="f-286" unitRef="usd">-42822000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-33" decimals="-3" id="f-287" unitRef="usd">-621000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-34" decimals="-3" id="f-288" unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-35" decimals="-3" id="f-289" unitRef="usd">2307000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax contextRef="c-36" decimals="-3" id="f-290" unitRef="usd">621000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax contextRef="c-22" decimals="-3" id="f-291" unitRef="usd">621000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-37" decimals="0" id="f-292" unitRef="shares">779000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-37" decimals="-3" id="f-293" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-38" decimals="-3" id="f-294" unitRef="usd">792000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-22" decimals="-3" id="f-295" unitRef="usd">793000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-38" decimals="-3" id="f-296" unitRef="usd">14000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-22" decimals="-3" id="f-297" unitRef="usd">14000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="c-39" decimals="0" id="f-298" unitRef="shares">-27353</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="c-37" decimals="0" id="f-299" unitRef="shares">547069</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-38" decimals="-3" id="f-300" unitRef="usd">510000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-22" decimals="-3" id="f-301" unitRef="usd">510000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited contextRef="c-39" decimals="0" id="f-302" unitRef="shares">1505</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <alts:StockIssuedDuringPeriodSharesWarrantsExercised contextRef="c-37" decimals="0" id="f-303" unitRef="shares">481348</alts:StockIssuedDuringPeriodSharesWarrantsExercised>
    <alts:StockIssuedDuringPeriodValueWarrantsExercised contextRef="c-38" decimals="-3" id="f-304" unitRef="usd">259000</alts:StockIssuedDuringPeriodValueWarrantsExercised>
    <alts:StockIssuedDuringPeriodValueWarrantsExercised contextRef="c-22" decimals="-3" id="f-305" unitRef="usd">259000</alts:StockIssuedDuringPeriodValueWarrantsExercised>
    <us-gaap:ProfitLoss contextRef="c-40" decimals="-3" id="f-306" unitRef="usd">-7812000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-41" decimals="-3" id="f-307" unitRef="usd">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-22" decimals="-3" id="f-308" unitRef="usd">-7812000</us-gaap:ProfitLoss>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-42" decimals="0" id="f-309" unitRef="shares">193730</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-42" decimals="-3" id="f-310" unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-43" decimals="0" id="f-311" unitRef="shares">100000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-43" decimals="-3" id="f-312" unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-44" decimals="0" id="f-313" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-44" decimals="-3" id="f-314" unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-45" decimals="0" id="f-315" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-45" decimals="-3" id="f-316" unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-46" decimals="0" id="f-317" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-46" decimals="-3" id="f-318" unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-47" decimals="0" id="f-319" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-47" decimals="-3" id="f-320" unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-48" decimals="0" id="f-321" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-48" decimals="-3" id="f-322" unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-49" decimals="0" id="f-323" unitRef="shares">4957647</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-49" decimals="-3" id="f-324" unitRef="usd">3000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-50" decimals="-3" id="f-325" unitRef="usd">47323000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-51" decimals="-3" id="f-326" unitRef="usd">-50634000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-52" decimals="-3" id="f-327" unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-53" decimals="-3" id="f-328" unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-329" unitRef="usd">-3308000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <alts:AdjustmentToAdditionalPaidInCapitalReclassificationsOfTemporaryToLiability contextRef="c-54" decimals="-3" id="f-330" unitRef="usd">339000</alts:AdjustmentToAdditionalPaidInCapitalReclassificationsOfTemporaryToLiability>
    <alts:AdjustmentToAdditionalPaidInCapitalReclassificationsOfTemporaryToLiability contextRef="c-1" decimals="-3" id="f-331" unitRef="usd">339000</alts:AdjustmentToAdditionalPaidInCapitalReclassificationsOfTemporaryToLiability>
    <us-gaap:ReclassificationsOfTemporaryToPermanentEquity contextRef="c-1" decimals="-3" id="f-332" unitRef="usd">7993000</us-gaap:ReclassificationsOfTemporaryToPermanentEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c-55" decimals="0" id="f-333" unitRef="shares">1250027</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-54" decimals="-3" id="f-334" unitRef="usd">1656000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-1" decimals="-3" id="f-335" unitRef="usd">1656000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-55" decimals="0" id="f-336" unitRef="shares">1030478</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-55" decimals="-3" id="f-337" unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-54" decimals="-3" id="f-338" unitRef="usd">1031000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-1" decimals="-3" id="f-339" unitRef="usd">1033000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="c-55" decimals="0" id="f-340" unitRef="shares">477923</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c-55" decimals="-3" id="f-341" unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c-54" decimals="-3" id="f-342" unitRef="usd">1020000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c-1" decimals="-3" id="f-343" unitRef="usd">1022000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <alts:StockIssuedDuringPeriodSharesIssuedInLieuOfNotesPayable contextRef="c-55" decimals="0" id="f-344" unitRef="shares">2031595</alts:StockIssuedDuringPeriodSharesIssuedInLieuOfNotesPayable>
    <alts:StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable contextRef="c-55" decimals="-3" id="f-345" unitRef="usd">2000</alts:StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable>
    <alts:StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable contextRef="c-54" decimals="-3" id="f-346" unitRef="usd">2022000</alts:StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable>
    <alts:StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable contextRef="c-1" decimals="-3" id="f-347" unitRef="usd">2024000</alts:StockIssuedDuringPeriodValueIssuedInLieuOfNotesPayable>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions contextRef="c-56" decimals="0" id="f-348" unitRef="shares">1799115</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-56" decimals="-3" id="f-349" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-57" decimals="-3" id="f-350" unitRef="usd">7447000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-58" decimals="-3" id="f-351" unitRef="usd">7447000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions contextRef="c-59" decimals="0" id="f-352" unitRef="shares">34207</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-59" decimals="-3" id="f-353" unitRef="usd">8552000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions contextRef="c-60" decimals="0" id="f-354" unitRef="shares">17000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions contextRef="c-61" decimals="0" id="f-355" unitRef="shares">3200</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-62" decimals="-3" id="f-356" unitRef="usd">8552000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="c-63" decimals="0" id="f-357" unitRef="shares">-170250</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="c-55" decimals="0" id="f-358" unitRef="shares">3055000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets contextRef="c-64" decimals="0" id="f-359" unitRef="shares">5000</us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets>
    <us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets contextRef="c-55" decimals="0" id="f-360" unitRef="shares">300000</us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets>
    <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets contextRef="c-54" decimals="-3" id="f-361" unitRef="usd">1170000</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
    <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets contextRef="c-1" decimals="-3" id="f-362" unitRef="usd">1170000</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions contextRef="c-65" decimals="0" id="f-363" unitRef="shares">925212</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-65" decimals="-3" id="f-364" unitRef="usd">1321000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-66" decimals="-3" id="f-365" unitRef="usd">1321000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <alts:StockIssuedDuringPeriodSharesPrepaidInterest contextRef="c-55" decimals="0" id="f-366" unitRef="shares">225000</alts:StockIssuedDuringPeriodSharesPrepaidInterest>
    <alts:StockIssuedDuringPeriodValuePrepaidInterest contextRef="c-54" decimals="-3" id="f-367" unitRef="usd">380000</alts:StockIssuedDuringPeriodValuePrepaidInterest>
    <alts:StockIssuedDuringPeriodValuePrepaidInterest contextRef="c-1" decimals="-3" id="f-368" unitRef="usd">380000</alts:StockIssuedDuringPeriodValuePrepaidInterest>
    <alts:StockIssuedDuringPeriodSharesWarrantsExercised contextRef="c-55" decimals="0" id="f-369" unitRef="shares">290908</alts:StockIssuedDuringPeriodSharesWarrantsExercised>
    <alts:StockIssuedDuringPeriodValueWarrantsExercised contextRef="c-54" decimals="-3" id="f-370" unitRef="usd">497000</alts:StockIssuedDuringPeriodValueWarrantsExercised>
    <alts:StockIssuedDuringPeriodValueWarrantsExercised contextRef="c-1" decimals="-3" id="f-371" unitRef="usd">497000</alts:StockIssuedDuringPeriodValueWarrantsExercised>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-67" decimals="-3" id="f-372" unitRef="usd">-2317000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-1" decimals="-3" id="f-373" unitRef="usd">-2317000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ProfitLoss contextRef="c-68" decimals="-3" id="f-374" unitRef="usd">-6245000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-69" decimals="-3" id="f-375" unitRef="usd">3925000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-376" unitRef="usd">-2320000</us-gaap:ProfitLoss>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-70" decimals="0" id="f-377" unitRef="shares">23480</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-70" decimals="-3" id="f-378" unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-71" decimals="0" id="f-379" unitRef="shares">100000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-71" decimals="-3" id="f-380" unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-72" decimals="0" id="f-381" unitRef="shares">34207</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-72" decimals="-3" id="f-382" unitRef="usd">8552000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-73" decimals="0" id="f-383" unitRef="shares">17000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-73" decimals="-3" id="f-384" unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-74" decimals="0" id="f-385" unitRef="shares">3200</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-74" decimals="-3" id="f-386" unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-75" decimals="0" id="f-387" unitRef="shares">925212</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-75" decimals="-3" id="f-388" unitRef="usd">1321000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-76" decimals="0" id="f-389" unitRef="shares">5000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-76" decimals="-3" id="f-390" unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-77" decimals="0" id="f-391" unitRef="shares">15417693</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-77" decimals="-3" id="f-392" unitRef="usd">9000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-78" decimals="-3" id="f-393" unitRef="usd">62207000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-79" decimals="-3" id="f-394" unitRef="usd">-56879000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-80" decimals="-3" id="f-395" unitRef="usd">-2317000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-81" decimals="-3" id="f-396" unitRef="usd">3925000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-4" decimals="-3" id="f-397" unitRef="usd">24811000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="c-1" decimals="-3" id="f-398" unitRef="usd">-6245000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="c-22" decimals="-3" id="f-399" unitRef="usd">-17095000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-3" id="f-400" unitRef="usd">3402000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-22" decimals="-3" id="f-401" unitRef="usd">1452000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-1" decimals="-3" id="f-402" unitRef="usd">254000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-22" decimals="-3" id="f-403" unitRef="usd">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:FinancialGuaranteeInsuranceContractsPremiumsReceivableAccretionOfDiscountOnPremiumReceivable contextRef="c-1" decimals="-3" id="f-404" unitRef="usd">0</us-gaap:FinancialGuaranteeInsuranceContractsPremiumsReceivableAccretionOfDiscountOnPremiumReceivable>
    <us-gaap:FinancialGuaranteeInsuranceContractsPremiumsReceivableAccretionOfDiscountOnPremiumReceivable contextRef="c-22" decimals="-3" id="f-405" unitRef="usd">1223000</us-gaap:FinancialGuaranteeInsuranceContractsPremiumsReceivableAccretionOfDiscountOnPremiumReceivable>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-406" unitRef="usd">1657000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-22" decimals="-3" id="f-407" unitRef="usd">14000</us-gaap:ShareBasedCompensation>
    <us-gaap:ProvisionForLoanLeaseAndOtherLosses contextRef="c-1" decimals="-3" id="f-408" unitRef="usd">0</us-gaap:ProvisionForLoanLeaseAndOtherLosses>
    <us-gaap:ProvisionForLoanLeaseAndOtherLosses contextRef="c-22" decimals="-3" id="f-409" unitRef="usd">617000</us-gaap:ProvisionForLoanLeaseAndOtherLosses>
    <us-gaap:NoncashContributionExpense contextRef="c-1" decimals="-3" id="f-410" unitRef="usd">271000</us-gaap:NoncashContributionExpense>
    <us-gaap:NoncashContributionExpense contextRef="c-22" decimals="-3" id="f-411" unitRef="usd">0</us-gaap:NoncashContributionExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c-1" decimals="-3" id="f-412" unitRef="usd">-800000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c-22" decimals="-3" id="f-413" unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown contextRef="c-1" decimals="-3" id="f-414" unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown contextRef="c-22" decimals="-3" id="f-415" unitRef="usd">5320000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <alts:GainLossOnWriteOffOfNotesReceivable contextRef="c-1" decimals="-3" id="f-416" unitRef="usd">0</alts:GainLossOnWriteOffOfNotesReceivable>
    <alts:GainLossOnWriteOffOfNotesReceivable contextRef="c-22" decimals="-3" id="f-417" unitRef="usd">-9780000</alts:GainLossOnWriteOffOfNotesReceivable>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-1" decimals="-3" id="f-418" unitRef="usd">-1058000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-22" decimals="-3" id="f-419" unitRef="usd">-926000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-1" decimals="-3" id="f-420" unitRef="usd">32000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-22" decimals="-3" id="f-421" unitRef="usd">0</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:CryptoAssetUnrealizedGainLossOperating contextRef="c-1" decimals="-3" id="f-422" unitRef="usd">0</us-gaap:CryptoAssetUnrealizedGainLossOperating>
    <us-gaap:CryptoAssetUnrealizedGainLossOperating contextRef="c-22" decimals="-3" id="f-423" unitRef="usd">0</us-gaap:CryptoAssetUnrealizedGainLossOperating>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-424" unitRef="usd">-3229000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-22" decimals="-3" id="f-425" unitRef="usd">444000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="-3" id="f-426" unitRef="usd">-1876000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-22" decimals="-3" id="f-427" unitRef="usd">367000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <alts:IncreaseDecreaseInDigitalAssetsReceivable contextRef="c-1" decimals="-3" id="f-428" unitRef="usd">14694000</alts:IncreaseDecreaseInDigitalAssetsReceivable>
    <alts:IncreaseDecreaseInDigitalAssetsReceivable contextRef="c-22" decimals="-3" id="f-429" unitRef="usd">0</alts:IncreaseDecreaseInDigitalAssetsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-3" id="f-430" unitRef="usd">-780000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-22" decimals="-3" id="f-431" unitRef="usd">-320000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-1" decimals="-3" id="f-432" unitRef="usd">-12000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-22" decimals="-3" id="f-433" unitRef="usd">-8000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-1" decimals="-3" id="f-434" unitRef="usd">1648000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-22" decimals="-3" id="f-435" unitRef="usd">-1052000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <alts:IncreaseDecreaseInDigitalAssetsPayable contextRef="c-1" decimals="-3" id="f-436" unitRef="usd">14155000</alts:IncreaseDecreaseInDigitalAssetsPayable>
    <alts:IncreaseDecreaseInDigitalAssetsPayable contextRef="c-22" decimals="-3" id="f-437" unitRef="usd">0</alts:IncreaseDecreaseInDigitalAssetsPayable>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations contextRef="c-1" decimals="-3" id="f-438" unitRef="usd">0</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations contextRef="c-22" decimals="-3" id="f-439" unitRef="usd">2319000</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-440" unitRef="usd">1777000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-22" decimals="-3" id="f-441" unitRef="usd">1463000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:CashAcquiredFromAcquisition contextRef="c-1" decimals="-3" id="f-442" unitRef="usd">5853000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:CashAcquiredFromAcquisition contextRef="c-22" decimals="-3" id="f-443" unitRef="usd">0</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations contextRef="c-1" decimals="-3" id="f-444" unitRef="usd">0</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations contextRef="c-22" decimals="-3" id="f-445" unitRef="usd">-155000</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-446" unitRef="usd">5853000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-22" decimals="-3" id="f-447" unitRef="usd">-155000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromNotesPayable contextRef="c-1" decimals="-3" id="f-448" unitRef="usd">7237000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable contextRef="c-22" decimals="-3" id="f-449" unitRef="usd">0</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="c-1" decimals="-3" id="f-450" unitRef="usd">248000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="c-22" decimals="-3" id="f-451" unitRef="usd">0</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt contextRef="c-1" decimals="-3" id="f-452" unitRef="usd">603000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt contextRef="c-22" decimals="-3" id="f-453" unitRef="usd">0</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-1" decimals="-3" id="f-454" unitRef="usd">851000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-22" decimals="-3" id="f-455" unitRef="usd">792000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromWarrantExercises contextRef="c-1" decimals="-3" id="f-456" unitRef="usd">497000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises contextRef="c-22" decimals="-3" id="f-457" unitRef="usd">259000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:RepaymentsOfNotesPayable contextRef="c-1" decimals="-3" id="f-458" unitRef="usd">2847000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable contextRef="c-22" decimals="-3" id="f-459" unitRef="usd">274000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations contextRef="c-1" decimals="-3" id="f-460" unitRef="usd">0</us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations contextRef="c-22" decimals="-3" id="f-461" unitRef="usd">-2212000</us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-462" unitRef="usd">6093000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-22" decimals="-3" id="f-463" unitRef="usd">-1435000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-1" decimals="-3" id="f-464" unitRef="usd">-6551000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-22" decimals="-3" id="f-465" unitRef="usd">17000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-466" unitRef="usd">7172000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-22" decimals="-3" id="f-467" unitRef="usd">-110000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-5" decimals="-3" id="f-468" unitRef="usd">5000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-35" decimals="-3" id="f-469" unitRef="usd">115000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations contextRef="c-4" decimals="-3" id="f-470" unitRef="usd">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations contextRef="c-5" decimals="-3" id="f-471" unitRef="usd">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-472" unitRef="usd">7177000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-3" id="f-473" unitRef="usd">5000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <alts:NoncashRecognitionOfNewLeases contextRef="c-1" decimals="-3" id="f-474" unitRef="usd">121000</alts:NoncashRecognitionOfNewLeases>
    <alts:NoncashRecognitionOfNewLeases contextRef="c-22" decimals="-3" id="f-475" unitRef="usd">0</alts:NoncashRecognitionOfNewLeases>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="-3" id="f-476" unitRef="usd">296000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-22" decimals="-3" id="f-477" unitRef="usd">133000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-1" decimals="-3" id="f-478" unitRef="usd">17000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-22" decimals="-3" id="f-479" unitRef="usd">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:StockIssued1 contextRef="c-82" decimals="-3" id="f-480" unitRef="usd">16000000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="c-83" decimals="-3" id="f-481" unitRef="usd">0</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="c-84" decimals="-3" id="f-482" unitRef="usd">853000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="c-85" decimals="-3" id="f-483" unitRef="usd">0</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="c-86" decimals="-3" id="f-484" unitRef="usd">367000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="c-87" decimals="-3" id="f-485" unitRef="usd">0</us-gaap:StockIssued1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="c-1" decimals="-3" id="f-486" unitRef="usd">1660000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="c-22" decimals="-3" id="f-487" unitRef="usd">0</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:StockIssued1 contextRef="c-88" decimals="-3" id="f-488" unitRef="usd">380000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="c-89" decimals="-3" id="f-489" unitRef="usd">0</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="c-90" decimals="-3" id="f-490" unitRef="usd">1170000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="c-91" decimals="-3" id="f-491" unitRef="usd">0</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="c-92" decimals="-3" id="f-492" unitRef="usd">1321000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="c-93" decimals="-3" id="f-493" unitRef="usd">0</us-gaap:StockIssued1>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c-1" id="f-494">Background and Basis of Presentation&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements include the accounts of ALT5 Sigma Corporation, a Nevada corporation, and its subsidiaries (collectively, the &#x201c;Company&#x201d; or &#x201c;ALT5&#x201d;). Effective July 15, 2024, the Company changed its corporate name from &#x201c;JanOne Inc.&#x201d; to &#x201c;ALT5 Sigma Corporation,&#x201d; and also changed its Nasdaq common stock ticker symbol from &#x201c;JAN&#x201d; to &#x201c;ALTS&#x201d;. The corporate name change was effected through a parent/subsidiary short-form merger of ALT5 Sigma Corporation, the Company&#x2019;s wholly-owned Nevada subsidiary formed solely for the purpose of effectuating the name change), whereby it merged with and into the Company, with the Company being the surviving entity, albeit with its new name.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had three operating segments &#x2013; Fintech, Biotechnology, and Corporate and Other. In connection with the sale of ARCA Recycling, Inc. (&#x201c;ARCA Recycling&#x201d;), the accounts for the Recycling segment have been presented as discontinued operations in the accompanying consolidated financial statements (See Note 4).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Fintech&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 15, 2024, the Company acquired ALT5 Sigma, Inc. (&#x201c;ALT5 Subsidiary&#x201d;). ALT5 Subsidiary is a fintech company that provides next generation blockchain-powered technologies to enable a migration to a new global financial paradigm. ALT5 Subsidiary, through its respective subsidiaries, offers two main platforms to its customers: &#x201c;ALT5 Pay&#x201d; and &#x201c;ALT5 Prime.&#x201d; ALT5 Pay is a crypto-currency payment gateway that enables registered and approved global merchants to accept and make crypto-currency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay&#x2019;s checkout widgets and APIs. Merchants have the option to convert to fiat currency (US Dollars, Canadian Dollars, Euros, and British Pounds Sterling) automatically or to receive their payment in digital assets (see Note 3).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Biotechnology&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During September 2019, ALT5 Sigma Corporation, through its biotechnology segment, broadened its business perspectives to become a pharmaceutical company focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. Effective December 28, 2022, the Company acquired Soin Therapeutics LLC, a Delaware limited liability company (&#x201c;STLLC&#x201d;), and its product, a patent-pending, novel formulation of low-dose naltrexone, (&#x201c;JAN123&#x201d;). The product is being developed for the treatment of Complex Regional Pain Syndrome (CRPS), an indication that causes severe, chronic pain generally affecting the arms or legs. At present, there are no truly effective treatments for CRPS. Because of the relatively small number of patients afflicted with CRPS, the FDA has granted Orphan Drug Designation for any product approved for treatment of CRPS. This designation will provide the Company with tax credits for its clinical trials, exemption of user fees, and the potential of seven years of market exclusivity following approval. In addition, development of orphan drugs currently also involves smaller trials and quicker times to approval, given the limited number of patients available to study. However, there can be no assurance that the product will receive FDA approval or that it will result in material sales. In that regard, we have previously announced our intention to capitalize a subsidiary with certain of our biotechnology assets, acquire an additional biotechnology asset, and then engage in a financing of that subsidiary. The short-term intended result of that series of transactions would be for us to own a controlling interest in that subsidiary, but to decouple it from us so that it would operate on a stand-alone basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Recycling&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Recycling Subsidiaries constituted the Company&#x2019;s Recycling segment and provided turnkey recycling services for electric utility energy efficiency programs in the United States. ARCA Recycling and ARCA Canada recycled major household appliances in North America by providing turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs. Connexx provided call center services for ARCA Recycling and ARCA Canada. On March 9, 2023, retroactive to March 1, 2023, the Company entered into a Stock Purchase Agreement (the &#x201c;Recycling Purchase Agreement&#x201d; with VM7 Corporation (&#x201c;VM7&#x201d;), under which it agreed to acquire all of the outstanding equity interests of the Recycling Subsidiaries. The principal of VM7 is Virland A. Johnson, our Chief Financial Officer. The sale of all of the outstanding equity interests of the Recycling Subsidiaries to VM7 under the Recycling Purchase Agreement was consummated simultaneously with the execution of the Recycling Purchase Agreement (see Note 4). The Company&#x2019;s Board of Directors unanimously approved the Recycling Purchase Agreement and the Disposition Transaction. In connection with the disposition of the Recycling Subsidiaries, accounts for the Recycling segment have been presented as discontinued operations in the accompanying consolidated financial statements (See Note 4).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Corporate and Other&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Corporate and Other segment consists of certain corporate general and administrative costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reports on a 52- or 53-week fiscal year. The Company's 2024 fiscal year (&#x201c;2024&#x201d;) ended on December&#160;28, 2024, and our fiscal year (&#x201c;2022&#x201d;) ended on December&#160;30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Going concern&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying financial statements have been prepared under the assumption that the Company will continue as a going concern. Such assumption contemplates the realization of assets and satisfaction of liabilities in the normal course of business, however, the issues described below raise substantial doubt about the Company&#x2019;s ability to do so.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company currently faces a challenging competitive environment and is focused on improving its overall profitability, which includes managing expenses. The Company reported a net loss from continuing operations of approximately $6.2 million for the year ended December&#160;28, 2024, and net loss from continuing operations of approximately $17.1 million for the fiscal year ended December&#160;30, 2023. Additionally, as of December&#160;28, 2024, the Company has total current assets of approximately $35.0 million and total current liabilities of approximately $40.9 million resulting in a net negative working capital of approximately $5.9 million. Cash provided by operations was approximately $1.0 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company intends to raise funds to support future development of JAN 123 and JAN 101 and through a combination of cash flows derived from its acquisition of ALT5 (see Note 3), capital raises, and/or structured arrangements. However, the success of such funding cannot be assured. We currently expect that the biotechnology subsidiary transaction discussed above will allow us to finance our Phase III clinical trial for JAN123. No assurance can be given any financing obtained may not further dilute or otherwise impair the ownership interest of our existing stockholders or our ownership interest in the to-be-effectuated biotechnology subsidiary. The short-term intended result of that transaction would be for us to own a controlling interest in that subsidiary, but to decouple it from us so that it would operate on a stand-alone basis.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c-1"
      decimals="INF"
      id="f-495"
      unitRef="segment">3</us-gaap:NumberOfOperatingSegments>
    <alts:PotentialMarketExclusivityPeriod contextRef="c-1" id="f-496">P7Y</alts:PotentialMarketExclusivityPeriod>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="c-1" decimals="-5" id="f-497" unitRef="usd">-6200000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="c-22" decimals="-5" id="f-498" unitRef="usd">-17100000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-5" id="f-499" unitRef="usd">35000000.0</us-gaap:AssetsCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-5" id="f-500" unitRef="usd">40900000</us-gaap:LiabilitiesCurrent>
    <alts:CurrentAssetsCurrentLiabilitiesNet contextRef="c-4" decimals="-5" id="f-501" unitRef="usd">-5900000</alts:CurrentAssetsCurrentLiabilitiesNet>
    <alts:NetCashProvidedByOperatingActivitiesContinuingOperations contextRef="c-1" decimals="-5" id="f-502" unitRef="usd">1000000.0</alts:NetCashProvidedByOperatingActivitiesContinuingOperations>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-503">Summary of Significant Accounting Policies&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financial Statement Reclassification&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain account balances from prior periods have been reclassified in these consolidated financial statements to conform to current period classifications.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumption that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant estimates made in connection with the accompanying consolidated financial statements include the fair values in connection with the GeoTraq promissory note, analysis of other intangibles and long-lived assets for impairment, valuation allowance against deferred tax assets, lease terminations, and estimated useful lives for intangible assets and property and equipment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments consist primarily of cash equivalents, trade and other receivables, notes receivables, and obligations under accounts payable, accrued expenses and notes payable. The carrying amounts of cash equivalents, trade receivables and other receivables, accounts payable, accrued expenses and short-term notes payable approximate fair value because of the short maturity of these instruments. The fair value of the long-term debt is calculated based on interest rates available for debt with terms and maturities similar to the Company&#x2019;s existing debt arrangements, unless quoted market prices were &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;available (Level 2 inputs). The carrying amounts of long-term debt at December&#160;28, 2024 and December&#160;30, 2023 approximate fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents consist of highly liquid investments with a maturity of three months or less at the time of purchase. Fair value of cash equivalents approximates carrying value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Digital Assets and other Receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;s&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Digital assets and other receivables are the Company&#x2019;s digital assets and its customer prepayments in the form of digital assets. The Company holds all digital assets in secure non-custodial wallets through the wallet services from Fireblocks. As of December&#160;28, 2024, the outstanding balance of digital assets and other receivables was approximately $23.8 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Receivables and Allowance for Doubtful Accounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company carries unsecured other receivables at the original invoice amount less an estimate made for doubtful accounts based on a monthly review of all outstanding amounts. Management determines the allowance for doubtful accounts by regularly evaluating receivables based on current economic conditions. The Company writes off receivables when it deems them to be uncollectible. The Company records recoveries of receivables previously written off when payment is received. The Company considers a receivable to be past due if any portion of the receivable balance is outstanding for more than ninety days. The Company does not charge interest on past due receivables. The Company had no allowance for doubtful accounts for the years ended December&#160;28, 2024 and December&#160;30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table details the Company's trade and other receivables as of December&#160;28, 2024 and December&#160;30, 2023 (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.393%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.893%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.162%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.409%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.162%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.409%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.165%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade and other receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;28, 2024, other receivables includes approximately $2.2&#160;million in subscriptions receivable (see Note 18).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s intangible assets consist of customer relationship intangibles, favorable leases, trade names, licenses for the use of internet domain names, Universal Resource Locators, or URL&#x2019;s, software, patents, and marketing and technology related intangibles. Upon acquisition, estimates are made in valuing acquired intangible assets, which include but are not limited to, future expected cash flows from customer contracts, customer lists, and estimating cash flows from projects when completed; tradename and market position, as well as assumptions about the period of time that customer relationships will continue; and discount rates. Management's estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from the assumptions used in determining the fair values. All intangible assets are capitalized at their original cost and amortized over their estimated useful lives as follows: domain name and marketing &#x2013; 3-to-20 years; software &#x2013; 3-to-5 years; technology intangibles &#x2013; 7 years; customer relationships &#x2013; 7-to-15 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Digital Assets and other Payables&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Digital assets and other payables are liabilities that represent the Company&#x2019;s obligation to deliver the settlement of transactions in the form of digital assets and or cash. The Company safeguards these digital assets and cash for customers and is obligated to safeguard them from loss, theft, or other misuse. The Company recognizes digital assets and other payables, on initial recognition and at each reporting date, at fair value of the digital assets. Any loss, theft, or other misuse would impact the measurement of digital assets and other payables. As of December&#160;28, 2024, the outstanding balance of digital assets and other payables was approximately $30.9 million, of which approximately $23.8 million was digital assets and $7.1 million was cash deposits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue recognition applies to the Company&#x2019;s Fintech segment only, as the Company&#x2019;s Biotech segment has not recognized revenue to date. Revenue is recognized under Topic 606 in a manner that reasonably reflects the delivery of its services and products to customers in return for expected consideration and includes the following elements:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;Executed contracts with the Company&#x2019;s customers that it believes are legally enforceable;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;Identification of performance obligations in the respective contract;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;Determination of the transaction price for each performance obligation in the respective contract;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;Allocation of the transaction price to each performance obligation; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;Recognition of revenue only when the Company satisfies each performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Fintech Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The five elements above, as applied to each of the Fintech segment's revenue categories, is summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;Product sales &#x2013; revenue is recognized at the time of sale of equipment to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;Service sales &#x2013; revenue is recognized based on when the service has been provided to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s service is comprised of a single performance obligation to buy and sell or convert digital assets to currencies. That is, the Company is the counter party to all transactions between customers and liquidity providers and presents revenue for the fees earned on a net basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is acting as principal in all transactions, and control the digital assets being provided before it is transferred to the buyer, and has risk related to the digital assets, and is responsible for the fulfillment of the digital asset transactions. The Company sets the price for the digital assets by aggregating prices from several liquidity providers and displays them on the Company&#x2019;s platform. As a result, the Company acts as a price discovery service and acts as a principal facilitating the ability for a customer to purchase or sell digital assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers its performance obligation satisfied, and recognizes revenue, at the point in time the transaction is processed. Contracts with customers are usually open-ended and can be terminated by either party without a termination penalty. Therefore, contracts are defined at the transaction level and do not extend beyond the service already provided.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company charges a fee at the transaction level. The transaction price, represented by the trading fee, is calculated based on volume and varies depending on payment type and the value of the transaction. Digital asset purchases or sale transactions executed by a customer on the Company&#x2019;s platform is based on tiered pricing that is driven primarily by transaction volume processed for a specific historical period. The Company has concluded that this volume-based pricing approach does not constitute a future material right since the discount is within a range typically offered to a class of customers with similar volume. The transaction fee is collected from the customer at the time the transaction is executed. In certain instances, the transaction fee can be collected in digital assets, with revenue measured based on the amount of digital assets received and the fair value of the digital assets at the time of the transaction. The Company also marks up or down the digital asset prices and earns revenue from the spread between the buying and selling price. The Company also earns a fee from transfers of currencies and or digital assets. The transfer fees are nominal and are set to offset the fees associated with banking and or blockchain mining fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Biotechnology Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company currently generates no revenue from its Biotechnology segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Discontinued Operations Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 9, 2023, retroactive to March 1, 2023, the Company entered into the Recycling Purchase Agreement with VM7, under which VM7 agreed to acquire all of the outstanding equity interests of the Recycling Subsidiaries. As discussed &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;previously, the accounts for the Recycling segment have been presented as discontinued operations in the accompanying consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC Topic 820, &#x201c;Fair Value Measurements and Disclosures,&#x201d; requires disclosure of the fair value of financial instruments held by the Company. ASC Topic 825, &#x201c;Financial Instruments,&#x201d; defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The three levels of valuation hierarchy are defined as follows: Level 1 - inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets. Level 2 &#x2013; to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. Level 3 &#x2013; inputs to the valuation methodology are unobservable and significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for income taxes using the asset and liability method. The asset and liability method requires recognition of deferred tax assets and liabilities for expected future tax consequences of temporary differences that currently exist between tax bases and financial reporting bases of the Company's assets and liabilities. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is provided on deferred taxes if it is determined that it is more likely than not that the asset will not be realized. The Company recognizes penalties and interest accrued related to income tax liabilities in the provision for income taxes in its Consolidated Statements of Income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant management judgment is required to determine the amount of benefit to be recognized in relation to an uncertain tax position. The Company uses a two-step process to evaluate tax positions. The first step requires an entity to determine whether it is more likely than not (greater than 50% chance) that the tax position will be sustained. The second step requires an entity to recognize in the financial statements the benefit of a tax position that meets the more-likely-than-not recognition criterion. The amounts ultimately paid upon resolution of issues raised by taxing authorities may differ materially from the amounts accrued and may materially impact the financial statements of the Company in future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company from time to time grants stock options to employees, non-employees and Company executives and directors. Such awards are valued based on the grant date fair-value of the instruments. The value of each award is amortized on a straight-line basis over the vesting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Earnings Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per share is calculated in accordance with ASC 260, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Earnings Per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;. Under ASC 260 basic earnings per share is computed using the weighted average number of common shares outstanding during the period except that it does not include unvested restricted stock subject to cancellation. Diluted earnings per share is computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of warrants, options, restricted shares and convertible preferred stock. The dilutive effect of outstanding restricted shares, options and warrants is reflected in diluted earnings per share by application of the treasury stock method. Convertible preferred stock is reflected on an if-converted basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Segment Reporting&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC Topic 280, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#x201d; requires use of the &#x201c;management approach&#x201d; model for segment reporting. The management approach model is based on the way a Company&#x2019;s management organizes segments within the Company for making operating decisions and assessing performance. The Company determined it had three reportable segments. The Recycling segment has been presented as discontinued operations (see Note 23).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains cash balances at banks in Nevada and Minnesota. The account is insured by the Federal Deposit Insurance Corporation up to $250,000. At times, balances may exceed federally insured limits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update ("ASU") 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures ("ASU 2023-07"). ASU 2023-07 requires, among other updates, enhanced disclosures about significant segment expenses that are regularly provided to the CODM, as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and requires retrospective adoption. Early adoption is permitted. The Company is evaluating the impact of this guidance on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU No. 2023-08, Intangibles&#x2014;Goodwill and Other&#x2014;Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets. The amendments in ASU No. 2023-08 are intended to improve the accounting for certain crypto assets by requiring an entity to measure those crypto assets at fair value each reporting period with changes in fair value recognized in net income. The amendments also improve the information provided to investors about an entity&#x2019;s crypto asset holdings by requiring disclosure about significant holdings, contractual sale restrictions, and changes during the reporting period. The amendments are effective for all entities for fiscal years beginning after December 15, 2024, including interim periods within those fiscal years. The Company is evaluating the impact of this guidance on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures ("ASU 2023-09"). ASU 2023-09 requires enhanced annual disclosures regarding the rate reconciliation and income taxes paid information. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, and may be adopted on a prospective or retrospective basis. Early adoption is permitted. The Company is evaluating the impact of this guidance on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-504">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="c-1" id="f-505">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financial Statement Reclassification&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain account balances from prior periods have been reclassified in these consolidated financial statements to conform to current period classifications.&lt;/span&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-506">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumption that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant estimates made in connection with the accompanying consolidated financial statements include the fair values in connection with the GeoTraq promissory note, analysis of other intangibles and long-lived assets for impairment, valuation allowance against deferred tax assets, lease terminations, and estimated useful lives for intangible assets and property and equipment.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c-1" id="f-507">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments consist primarily of cash equivalents, trade and other receivables, notes receivables, and obligations under accounts payable, accrued expenses and notes payable. The carrying amounts of cash equivalents, trade receivables and other receivables, accounts payable, accrued expenses and short-term notes payable approximate fair value because of the short maturity of these instruments. The fair value of the long-term debt is calculated based on interest rates available for debt with terms and maturities similar to the Company&#x2019;s existing debt arrangements, unless quoted market prices were &lt;/span&gt;&lt;/div&gt;available (Level 2 inputs). The carrying amounts of long-term debt at December&#160;28, 2024 and December&#160;30, 2023 approximate fair value.</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c-1" id="f-508">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents consist of highly liquid investments with a maturity of three months or less at the time of purchase. Fair value of cash equivalents approximates carrying value.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <alts:DigitalAssetsAndOtherReceivablesPolicyPolicyTextBlock contextRef="c-1" id="f-509">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Digital Assets and other Receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;s&lt;/span&gt;&lt;/div&gt;Digital assets and other receivables are the Company&#x2019;s digital assets and its customer prepayments in the form of digital assets. The Company holds all digital assets in secure non-custodial wallets through the wallet services from Fireblocks.</alts:DigitalAssetsAndOtherReceivablesPolicyPolicyTextBlock>
    <alts:PlatformOperatorCryptoAssetHeldForUserCurrent contextRef="c-4" decimals="-5" id="f-510" unitRef="usd">23800000</alts:PlatformOperatorCryptoAssetHeldForUserCurrent>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="c-1" id="f-511">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Receivables and Allowance for Doubtful Accounts&lt;/span&gt;&lt;/div&gt;The Company carries unsecured other receivables at the original invoice amount less an estimate made for doubtful accounts based on a monthly review of all outstanding amounts. Management determines the allowance for doubtful accounts by regularly evaluating receivables based on current economic conditions. The Company writes off receivables when it deems them to be uncollectible. The Company records recoveries of receivables previously written off when payment is received. The Company considers a receivable to be past due if any portion of the receivable balance is outstanding for more than ninety days. The Company does not charge interest on past due receivables.</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-4" decimals="-3" id="f-512" unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-5" decimals="-3" id="f-513" unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock contextRef="c-1" id="f-514">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table details the Company's trade and other receivables as of December&#160;28, 2024 and December&#160;30, 2023 (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.393%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.893%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.162%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.409%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.162%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.409%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.165%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade and other receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c-4" decimals="-3" id="f-515" unitRef="usd">2530000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c-5" decimals="-3" id="f-516" unitRef="usd">266000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c-35" decimals="-3" id="f-517" unitRef="usd">106000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="c-4" decimals="-3" id="f-518" unitRef="usd">2530000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="c-5" decimals="-3" id="f-519" unitRef="usd">266000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="c-35" decimals="-3" id="f-520" unitRef="usd">106000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c-94" decimals="-5" id="f-521" unitRef="usd">2200000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="c-1" id="f-522">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s intangible assets consist of customer relationship intangibles, favorable leases, trade names, licenses for the use of internet domain names, Universal Resource Locators, or URL&#x2019;s, software, patents, and marketing and technology related intangibles. Upon acquisition, estimates are made in valuing acquired intangible assets, which include but are not limited to, future expected cash flows from customer contracts, customer lists, and estimating cash flows from projects when completed; tradename and market position, as well as assumptions about the period of time that customer relationships will continue; and discount rates. Management's estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from the assumptions used in determining the fair values. All intangible assets are capitalized at their original cost and amortized over their estimated useful lives as follows: domain name and marketing &#x2013; 3-to-20 years; software &#x2013; 3-to-5 years; technology intangibles &#x2013; 7 years; customer relationships &#x2013; 7-to-15 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-95" id="f-523">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-96" id="f-524">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-97" id="f-525">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-98" id="f-526">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-99" id="f-527">P7Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-100" id="f-528">P7Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-101" id="f-529">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <alts:DigitalAssetsAndOtherPayablesPolicyPolicyTextBlock contextRef="c-1" id="f-530">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Digital Assets and other Payables&lt;/span&gt;&lt;/div&gt;Digital assets and other payables are liabilities that represent the Company&#x2019;s obligation to deliver the settlement of transactions in the form of digital assets and or cash. The Company safeguards these digital assets and cash for customers and is obligated to safeguard them from loss, theft, or other misuse. The Company recognizes digital assets and other payables, on initial recognition and at each reporting date, at fair value of the digital assets. Any loss, theft, or other misuse would impact the measurement of digital assets and other payables.</alts:DigitalAssetsAndOtherPayablesPolicyPolicyTextBlock>
    <alts:DigitalAssetLiabilityCurrent contextRef="c-4" decimals="-5" id="f-531" unitRef="usd">30900000</alts:DigitalAssetLiabilityCurrent>
    <alts:DigitalAssetLiabilityCurrentDigitalAssets contextRef="c-4" decimals="-5" id="f-532" unitRef="usd">23800000</alts:DigitalAssetLiabilityCurrentDigitalAssets>
    <alts:DigitalAssetLiabilityCurrentCashDeposits contextRef="c-4" decimals="-5" id="f-533" unitRef="usd">7100000</alts:DigitalAssetLiabilityCurrentCashDeposits>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="c-1" id="f-534">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue recognition applies to the Company&#x2019;s Fintech segment only, as the Company&#x2019;s Biotech segment has not recognized revenue to date. Revenue is recognized under Topic 606 in a manner that reasonably reflects the delivery of its services and products to customers in return for expected consideration and includes the following elements:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;Executed contracts with the Company&#x2019;s customers that it believes are legally enforceable;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;Identification of performance obligations in the respective contract;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;Determination of the transaction price for each performance obligation in the respective contract;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;Allocation of the transaction price to each performance obligation; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;Recognition of revenue only when the Company satisfies each performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Fintech Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The five elements above, as applied to each of the Fintech segment's revenue categories, is summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;Product sales &#x2013; revenue is recognized at the time of sale of equipment to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;Service sales &#x2013; revenue is recognized based on when the service has been provided to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s service is comprised of a single performance obligation to buy and sell or convert digital assets to currencies. That is, the Company is the counter party to all transactions between customers and liquidity providers and presents revenue for the fees earned on a net basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is acting as principal in all transactions, and control the digital assets being provided before it is transferred to the buyer, and has risk related to the digital assets, and is responsible for the fulfillment of the digital asset transactions. The Company sets the price for the digital assets by aggregating prices from several liquidity providers and displays them on the Company&#x2019;s platform. As a result, the Company acts as a price discovery service and acts as a principal facilitating the ability for a customer to purchase or sell digital assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers its performance obligation satisfied, and recognizes revenue, at the point in time the transaction is processed. Contracts with customers are usually open-ended and can be terminated by either party without a termination penalty. Therefore, contracts are defined at the transaction level and do not extend beyond the service already provided.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company charges a fee at the transaction level. The transaction price, represented by the trading fee, is calculated based on volume and varies depending on payment type and the value of the transaction. Digital asset purchases or sale transactions executed by a customer on the Company&#x2019;s platform is based on tiered pricing that is driven primarily by transaction volume processed for a specific historical period. The Company has concluded that this volume-based pricing approach does not constitute a future material right since the discount is within a range typically offered to a class of customers with similar volume. The transaction fee is collected from the customer at the time the transaction is executed. In certain instances, the transaction fee can be collected in digital assets, with revenue measured based on the amount of digital assets received and the fair value of the digital assets at the time of the transaction. The Company also marks up or down the digital asset prices and earns revenue from the spread between the buying and selling price. The Company also earns a fee from transfers of currencies and or digital assets. The transfer fees are nominal and are set to offset the fees associated with banking and or blockchain mining fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Biotechnology Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company currently generates no revenue from its Biotechnology segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Discontinued Operations Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 9, 2023, retroactive to March 1, 2023, the Company entered into the Recycling Purchase Agreement with VM7, under which VM7 agreed to acquire all of the outstanding equity interests of the Recycling Subsidiaries. As discussed &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;previously, the accounts for the Recycling segment have been presented as discontinued operations in the accompanying consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c-1" id="f-535">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC Topic 820, &#x201c;Fair Value Measurements and Disclosures,&#x201d; requires disclosure of the fair value of financial instruments held by the Company. ASC Topic 825, &#x201c;Financial Instruments,&#x201d; defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The three levels of valuation hierarchy are defined as follows: Level 1 - inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets. Level 2 &#x2013; to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. Level 3 &#x2013; inputs to the valuation methodology are unobservable and significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c-1" id="f-536">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for income taxes using the asset and liability method. The asset and liability method requires recognition of deferred tax assets and liabilities for expected future tax consequences of temporary differences that currently exist between tax bases and financial reporting bases of the Company's assets and liabilities. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is provided on deferred taxes if it is determined that it is more likely than not that the asset will not be realized. The Company recognizes penalties and interest accrued related to income tax liabilities in the provision for income taxes in its Consolidated Statements of Income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant management judgment is required to determine the amount of benefit to be recognized in relation to an uncertain tax position. The Company uses a two-step process to evaluate tax positions. The first step requires an entity to determine whether it is more likely than not (greater than 50% chance) that the tax position will be sustained. The second step requires an entity to recognize in the financial statements the benefit of a tax position that meets the more-likely-than-not recognition criterion. The amounts ultimately paid upon resolution of issues raised by taxing authorities may differ materially from the amounts accrued and may materially impact the financial statements of the Company in future periods.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c-1" id="f-537">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company from time to time grants stock options to employees, non-employees and Company executives and directors. Such awards are valued based on the grant date fair-value of the instruments. The value of each award is amortized on a straight-line basis over the vesting period.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c-1" id="f-538">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Earnings Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per share is calculated in accordance with ASC 260, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Earnings Per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;. Under ASC 260 basic earnings per share is computed using the weighted average number of common shares outstanding during the period except that it does not include unvested restricted stock subject to cancellation. Diluted earnings per share is computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of warrants, options, restricted shares and convertible preferred stock. The dilutive effect of outstanding restricted shares, options and warrants is reflected in diluted earnings per share by application of the treasury stock method. Convertible preferred stock is reflected on an if-converted basis.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="c-1" id="f-539">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Segment Reporting&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC Topic 280, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#x201d; requires use of the &#x201c;management approach&#x201d; model for segment reporting. The management approach model is based on the way a Company&#x2019;s management organizes segments within the Company for making operating decisions and assessing performance. The Company determined it had three reportable segments. The Recycling segment has been presented as discontinued operations (see Note 23).&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-540"
      unitRef="segment">3</us-gaap:NumberOfReportableSegments>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c-1" id="f-541">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains cash balances at banks in Nevada and Minnesota. The account is insured by the Federal Deposit Insurance Corporation up to $250,000. At times, balances may exceed federally insured limits.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-542">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update ("ASU") 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures ("ASU 2023-07"). ASU 2023-07 requires, among other updates, enhanced disclosures about significant segment expenses that are regularly provided to the CODM, as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and requires retrospective adoption. Early adoption is permitted. The Company is evaluating the impact of this guidance on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU No. 2023-08, Intangibles&#x2014;Goodwill and Other&#x2014;Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets. The amendments in ASU No. 2023-08 are intended to improve the accounting for certain crypto assets by requiring an entity to measure those crypto assets at fair value each reporting period with changes in fair value recognized in net income. The amendments also improve the information provided to investors about an entity&#x2019;s crypto asset holdings by requiring disclosure about significant holdings, contractual sale restrictions, and changes during the reporting period. The amendments are effective for all entities for fiscal years beginning after December 15, 2024, including interim periods within those fiscal years. The Company is evaluating the impact of this guidance on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures ("ASU 2023-09"). ASU 2023-09 requires enhanced annual disclosures regarding the rate reconciliation and income taxes paid information. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, and may be adopted on a prospective or retrospective basis. Early adoption is permitted. The Company is evaluating the impact of this guidance on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock contextRef="c-1" id="f-543">Mergers and Acquisitions&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Qoden&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 8, 2024, the Company acquired the Qodex Cryptocurrency Exchange Software platform and other related assets from Qoden Technologies, LLC, a provider of technology solutions for the blockchain industry. The purchase price was $2.2 million, consisting of $2.0 million, or 771,010 shares, of the Company&#x2019;s Series Q Convertible Preferred Stock and $0.2 million in cash. The Series Q Convertible Stock was valued at $2.594 per share on the date issued, and is subject to a mandatory eight-calendar-quarter leak-out, such that no more than twelve-and-one-half percent of the shares may be converted into shares of the Company&#x2019;s common stock on a trailing quarterly basis over a period of two years, and are subject to vesting provisions. The $0.2 million in cash is payable in increments of $10,000 per month for 24 months, commencing on the first day of the month following closing. The acquisition was determined to be an asset acquisition for accounting purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;ALT5&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May&#160;14, 2024, the Company acquired its ALT5 Subsidiary, which is a fintech company that provides next generation blockchain-powered technologies to enable a migration to a new global financial paradigm. ALT5 Subsidiary, through its respective subsidiaries, offers two main platforms to its customers: &#x201c;ALT5 Pay&#x201d; and &#x201c;ALT5 Prime.&#x201d; ALT5 Pay is a crypto-currency payment gateway that enables registered and approved global merchants to accept and make crypto-currency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay&#x2019;s checkout widgets and APIs. Merchants have the option to convert to fiat currency (US Dollars, Canadian Dollars, Euros, and British Pounds Sterling) automatically or to receive their payment in digital assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As consideration under the acquisition, the Company issued 1,799,100 shares of its common stock to the legacy equity holders of the capital stock of ALT5 Subsidiary. Those shares represented approximately 19.9% of the Company's then-issued and outstanding shares of common stock. Each of the shares of the Company's newly-issued common stock was valued at $4.14, which was the Nasdaq Historical NOCP on Thursday, May 9, 2024, the day immediately prior to the date on which the agreement was executed. The Company also issued 34,207 shares of its newly-designated Series B Preferred &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock (the &#x201c;Series B Stock&#x201d;) to the legacy equity holders of the capital stock of ALT5. In connection with the closing of the acquisition of ALT5 Subsidiary, the Company also issued 3,200 shares of its newly-designated Series M Preferred Stock (the &#x201c;Series M Stock&#x201d;) to two entities that acted as finders for the transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the purchase price components outlined above was $16.0 million due to fair value adjustments for the shares of Series B Stock and Series M Stock, as detailed below (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:78.293%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.901%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Series B preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total purchase price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the preliminary purchase price allocation, the Company recognized goodwill of approximately $11.7 million, which is calculated as the excess of both the consideration exchanged and liabilities assumed as compared to the fair value of the identifiable assets acquired. The values assigned to the assets acquired and liabilities assumed are based on their estimates of fair value available as of May&#160;10, 2024, as calculated by an independent third-party firm. Because the transaction was considered a stock purchase for tax purposes, none of the goodwill arising from the acquisition will be deductible for tax purposes. During the thirteen weeks ended September&#160;28, 2024, the Company recorded a noncash fair value adjustment related to deferred tax liabilities and other liabilities acquired in the aggregate amount of approximately $7.9 million, which was recorded to goodwill. The table below outlines the purchase price allocation of the purchase for ALT5 Subsidiary to the acquired identifiable assets, liabilities assumed and goodwill (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.515%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.874%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.427%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total purchase price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Digital assets payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;48,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Digital assets receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subtotal intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Proforma Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents selected proforma information for the Company for the years ended December&#160;28, 2024 and December&#160;30, 2023, assuming that the acquisition had occurred on January 1, 2023 (the beginning of the Company&#x2019;s 2023 fiscal year), pursuant to ASC 805-10-50 (in $000&#x2019;s). This proforma information does not purport to represent what the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;actual results of operations of the Company would have been had the acquisition occurred on that date, nor does it purport to predict the results of operations for future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended&lt;br/&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Proforma&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;ALT5 Sigma Corporation (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;ALT5 Subsidiary (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Adjustments (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,343)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7,517)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per basic common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per basic diluted share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended&lt;br/&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Proforma&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;ALT5 Sigma Corporation (4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;ALT5 Subsidiary (5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Adjustments (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7,812)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,601)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per basic common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per basic diluted share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;ALT5 Sigma Corporation for the year ended December&#160;28, 2024. Includes ALT5 Subsidiary from May 15, 2024 through December&#160;28, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;ALT5 Subsidiary from December 31, 2023 through the acquisition date of May&#160;14, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Reflects adjustments for amortization expense of definite-lived intangible assets has been adjusted based on the preliminary fair value at the acquisition date..&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;ALT5 Sigma Corporation for the year ended December&#160;30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;    ALT5 Subsidiary for the year ended December&#160;30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Soin Pharmaceuticals&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective January&#160;24, 2024, the Company, Amol Soin (&#x201c;Dr. Soin&#x201d;), and Soin Therapeutics LLC, a wholly-owned subsidiary of the Company that we had acquired from Dr. Soin, entered into an amendment (the &#x201c;Soin Amendment&#x201d;) to the parties&#x2019; Agreement and Plan of Merger that was dated as of December 28, 2022 (the &#x201c;Soin Agreement&#x201d;). With reference to the Soin Agreement, the parties to the Soin Amendment agreed that the $3.0 million convertible tranche (the first of the three original conversion tranches under the Soin Agreement) would be payable to Dr. Soin in cash rather than through his conversion of shares of the Series S Convertible Preferred Stock (the &#x201c;Soin Preferred&#x201d;) that constituted the consideration under the Soin Agreement. We tendered the first $0.1 million amended tranche cash payment to Dr. Soin in March 2024; the second amended tranche cash payment to Dr. Soin, also in the amount of $0.1 million, was due on July 1, 2024; and the third amended tranche cash payment to Dr. Soin, in the amount of $2.8 million, was due on December 31, 2024. During the pendency of the amended cash tranche period, Dr. Soin agreed that he would not convert any of his shares of Soin Preferred. After we have tendered the second and third amended tranche cash payments to Dr. Soin, his conversion rights for the second and third original conversion tranches will remain convertible under the original provisions of the Soin Agreement and the related Certificate of Designation for the Soin Preferred. If we do not tender the second and third amended tranche cash payments to Dr. Soin, we agreed that we will transfer to him the membership interests of Soin Therapeutics LLC, and he will transfer to us the shares of Soin Preferred for cancellation. During the year ended December&#160;28, 2024, we tendered an aggregate of $150,000 to Dr. Soin and during February 2025, we tendered an additional $350,000.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Soin Amendment, the Company reclassified the $3.0 million convertible tranche, originally valued at approximately $2.7 million on our balance sheet, from mezzanine equity to current liabilities, and reclassified the $10.0 million convertible tranche, originally valued at approximately $8.0 million on our balance sheet, to permanent equity. As of December&#160;28, 2024, the outstanding balance in mezzanine equity relates to the $17.0 million convertible tranche originally valued at approximately $3.9 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:AssetAcquisitionConsiderationTransferred contextRef="c-102" decimals="-5" id="f-544" unitRef="usd">2200000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable contextRef="c-102" decimals="-5" id="f-545" unitRef="usd">2000000.0</us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable>
    <alts:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares contextRef="c-103" decimals="0" id="f-546" unitRef="shares">771010</alts:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares>
    <alts:AssetAcquisitionConsiderationCashPayable contextRef="c-104" decimals="-5" id="f-547" unitRef="usd">200000</alts:AssetAcquisitionConsiderationCashPayable>
    <alts:AssetAcquisitionConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare
      contextRef="c-103"
      decimals="3"
      id="f-548"
      unitRef="usdPerShare">2.594</alts:AssetAcquisitionConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare>
    <alts:AssetAcquisitionEquityInstrumentsIssuableValidConversionPeriod contextRef="c-102" id="f-549">P2Y</alts:AssetAcquisitionEquityInstrumentsIssuableValidConversionPeriod>
    <alts:AssetAcquisitionConsiderationCashPayable contextRef="c-104" decimals="-5" id="f-550" unitRef="usd">200000</alts:AssetAcquisitionConsiderationCashPayable>
    <alts:AssetAcquisitionConsiderationPeriodicCashPayment contextRef="c-102" decimals="-3" id="f-551" unitRef="usd">10000</alts:AssetAcquisitionConsiderationPeriodicCashPayment>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-105"
      decimals="INF"
      id="f-552"
      unitRef="shares">1799100</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <alts:BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfIssuedAndOutstandingShares contextRef="c-106" decimals="3" id="f-553" unitRef="number">0.199</alts:BusinessAcquisitionEquityInterestIssuedOrIssuablePercentageOfIssuedAndOutstandingShares>
    <us-gaap:SharePrice
      contextRef="c-107"
      decimals="2"
      id="f-554"
      unitRef="usdPerShare">4.14</us-gaap:SharePrice>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-108"
      decimals="INF"
      id="f-555"
      unitRef="shares">34207</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-109"
      decimals="INF"
      id="f-556"
      unitRef="shares">3200</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock contextRef="c-1" id="f-557">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the purchase price components outlined above was $16.0 million due to fair value adjustments for the shares of Series B Stock and Series M Stock, as detailed below (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:78.293%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.901%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Series B preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total purchase price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="c-105" decimals="-5" id="f-558" unitRef="usd">16000000.0</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="c-110" decimals="-3" id="f-559" unitRef="usd">7448000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="c-108" decimals="-3" id="f-560" unitRef="usd">8552000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="c-106" decimals="-3" id="f-561" unitRef="usd">16000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill contextRef="c-106" decimals="-5" id="f-562" unitRef="usd">11700000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount contextRef="c-106" decimals="-5" id="f-563" unitRef="usd">0</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-111" decimals="-5" id="f-564" unitRef="usd">-7900000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="c-1" id="f-565">The table below outlines the purchase price allocation of the purchase for ALT5 Subsidiary to the acquired identifiable assets, liabilities assumed and goodwill (in $000&#x2019;s):&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.515%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.874%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.427%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total purchase price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Digital assets payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;48,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Digital assets receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subtotal intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="c-106" decimals="-3" id="f-566" unitRef="usd">16000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable contextRef="c-106" decimals="-3" id="f-567" unitRef="usd">267000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <alts:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent contextRef="c-106" decimals="-3" id="f-568" unitRef="usd">7866000</alts:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilitiesCurrent>
    <alts:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsPayable contextRef="c-106" decimals="-3" id="f-569" unitRef="usd">16763000</alts:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt contextRef="c-106" decimals="-3" id="f-570" unitRef="usd">7613000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities contextRef="c-106" decimals="-3" id="f-571" unitRef="usd">32509000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="c-105" decimals="-3" id="f-572" unitRef="usd">48509000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents contextRef="c-106" decimals="-3" id="f-573" unitRef="usd">5853000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables contextRef="c-106" decimals="-3" id="f-574" unitRef="usd">2917000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <alts:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsReceivable contextRef="c-106" decimals="-3" id="f-575" unitRef="usd">9082000</alts:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDigitalAssetsReceivable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="c-112" decimals="-3" id="f-576" unitRef="usd">13925000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="c-113" decimals="-3" id="f-577" unitRef="usd">2675000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="c-114" decimals="-3" id="f-578" unitRef="usd">1850000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="c-106" decimals="-3" id="f-579" unitRef="usd">18450000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets contextRef="c-106" decimals="-3" id="f-580" unitRef="usd">493000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="c-106" decimals="-3" id="f-581" unitRef="usd">36795000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:Goodwill contextRef="c-106" decimals="-3" id="f-582" unitRef="usd">11714000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock contextRef="c-1" id="f-583">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents selected proforma information for the Company for the years ended December&#160;28, 2024 and December&#160;30, 2023, assuming that the acquisition had occurred on January 1, 2023 (the beginning of the Company&#x2019;s 2023 fiscal year), pursuant to ASC 805-10-50 (in $000&#x2019;s). This proforma information does not purport to represent what the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;actual results of operations of the Company would have been had the acquisition occurred on that date, nor does it purport to predict the results of operations for future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended&lt;br/&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Proforma&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;ALT5 Sigma Corporation (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;ALT5 Subsidiary (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Adjustments (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,343)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7,517)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per basic common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per basic diluted share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended&lt;br/&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Proforma&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;ALT5 Sigma Corporation (4)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;ALT5 Subsidiary (5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Adjustments (3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7,812)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,601)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per basic common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per basic diluted share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;ALT5 Sigma Corporation for the year ended December&#160;28, 2024. Includes ALT5 Subsidiary from May 15, 2024 through December&#160;28, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;ALT5 Subsidiary from December 31, 2023 through the acquisition date of May&#160;14, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;Reflects adjustments for amortization expense of definite-lived intangible assets has been adjusted based on the preliminary fair value at the acquisition date..&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt"&gt;ALT5 Sigma Corporation for the year ended December&#160;30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;    ALT5 Subsidiary for the year ended December&#160;30, 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:Revenues contextRef="c-1" decimals="-3" id="f-584" unitRef="usd">12532000</us-gaap:Revenues>
    <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="c-115" decimals="-3" id="f-585" unitRef="usd">2918000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:Revenues contextRef="c-116" decimals="-3" id="f-586" unitRef="usd">15450000</us-gaap:Revenues>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-587" unitRef="usd">-6245000</us-gaap:NetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="c-115" decimals="-3" id="f-588" unitRef="usd">71000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-117" decimals="-3" id="f-589" unitRef="usd">-1343000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-116" decimals="-3" id="f-590" unitRef="usd">-7517000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-591"
      unitRef="usdPerShare">-0.56</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-116"
      decimals="2"
      id="f-592"
      unitRef="usdPerShare">-0.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-593"
      unitRef="usdPerShare">-0.56</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-116"
      decimals="2"
      id="f-594"
      unitRef="usdPerShare">-0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:Revenues contextRef="c-22" decimals="-3" id="f-595" unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="c-118" decimals="-3" id="f-596" unitRef="usd">7145000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:Revenues contextRef="c-119" decimals="-3" id="f-597" unitRef="usd">7145000</us-gaap:Revenues>
    <us-gaap:NetIncomeLoss contextRef="c-22" decimals="-3" id="f-598" unitRef="usd">-7812000</us-gaap:NetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="c-118" decimals="-3" id="f-599" unitRef="usd">3359000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-120" decimals="-3" id="f-600" unitRef="usd">-2148000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-119" decimals="-3" id="f-601" unitRef="usd">-6601000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-22"
      decimals="2"
      id="f-602"
      unitRef="usdPerShare">-1.95</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-119"
      decimals="2"
      id="f-603"
      unitRef="usdPerShare">-1.65</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-22"
      decimals="2"
      id="f-604"
      unitRef="usdPerShare">-1.95</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-119"
      decimals="2"
      id="f-605"
      unitRef="usdPerShare">-1.65</us-gaap:EarningsPerShareDiluted>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="c-121" decimals="-5" id="f-606" unitRef="usd">3000000.0</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <alts:NumberOfTranches
      contextRef="c-122"
      decimals="INF"
      id="f-607"
      unitRef="tranche">3</alts:NumberOfTranches>
    <us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities contextRef="c-123" decimals="-5" id="f-608" unitRef="usd">100000</us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred contextRef="c-124" decimals="-5" id="f-609" unitRef="usd">100000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred contextRef="c-125" decimals="-5" id="f-610" unitRef="usd">2800000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:PaymentsForLegalSettlements contextRef="c-126" decimals="-3" id="f-611" unitRef="usd">150000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:PaymentsForLegalSettlements contextRef="c-127" decimals="-3" id="f-612" unitRef="usd">350000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="c-121" decimals="-5" id="f-613" unitRef="usd">3000000.0</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="c-128" decimals="-5" id="f-614" unitRef="usd">2700000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="c-129" decimals="-5" id="f-615" unitRef="usd">10000000.0</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="c-130" decimals="-5" id="f-616" unitRef="usd">8000000.0</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="c-131" decimals="-5" id="f-617" unitRef="usd">17000000.0</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="c-132" decimals="-5" id="f-618" unitRef="usd">3900000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock contextRef="c-1" id="f-619">Sale of Recycling Subsidiaries&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 9, 2023, the Company entered into a Stock Purchase Agreement (the &#x201c;Recycling Purchase Agreement&#x201d;) with VM7 Corporation, a Delaware corporation (&#x201c;VM7&#x201d;), under which it agreed to acquire all of the outstanding equity interests of the Recycling Subsidiaries, consisting of: (a) ARCA Recycling, (b) ARCA Canada, and (c) Connexx. The principal of VM7 is Virland A. Johnson, our Chief Financial Officer. The sale of all of the outstanding equity interests of the Recycling Subsidiaries to VM7 under the Recycling Purchase Agreement was consummated simultaneously with the execution of the Recycling Purchase Agreement. The Recycling Purchase Agreement is retroactive to March 1, 2023 (see Note 4).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The valuation, factoring in the discount rate that the Company used, yielded a present value of approximately $6.0 million, which, in addition to the $3,000 paid at close, comprised the approximately 6.0 million of net consideration. The amount of the revised discount amount, or approximately $18.0 million, was recorded as an offset to the principal amount of the Note, and was to have been accreted ratably to interest income over the term of the Note. During the year ended December&#160;30, 2023, approximately $720,000 of the discount was recorded as interest income. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of fiscal 2023, VM7 determined that, after expending significant amounts of time and resources, it was unable to obtain sufficient equity or debt financing to continue the operations of the Recycling Subsidiaries. Accordingly, the Company was advised that the operations of the Recycling Subsidiaries were wound down and, ultimately, ceased. For a variety of related reasons, the Company determined fully to impair the $5.3 million carrying value of the Disposition Transaction on its balance sheet and determined not to exercise any of its remedies under the Recycling Purchase Agreement so that it could maintain its focus on its clinical-stage biopharmaceutical activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preliminary calculation of the gain on sale was approximately $15.8 million. The following table details the final calculation of the gain on sale of the Recycling Subsidiaries, as shown on the income statement (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.151%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:82.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.824%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total minimum consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payment from buyer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities - California state sales tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(604)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total disposal of liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total disposal of assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total gain on sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Discontinued Operations&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;30, 2023, the Company discontinued operations of its Recycling segment as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 9, 2023, the Company executed a Recycling Purchase Agreement with VM7, under which, as of March 1, 2023, it agreed to acquire all of the outstanding equity interests of the Recycling Subsidiaries, consisting of (a) ARCA Recycling, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b) ARCA Canada, and (c) Connexx. The principal of VM7 is Virland A. Johnson, our Chief Financial Officer. The sale of all of the outstanding equity interests of the Recycling Subsidiaries to VM7 under the Recycling Purchase Agreement was consummated simultaneously with the execution of the Recycling Purchase Agreement (See Note 4).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with the provisions of ASC 205-20, the Company has not included in the results of continuing operations the results of operations of the discontinued operations in the consolidated statements of operations and comprehensive income (loss). The results of operations for these entities for the year ended December&#160;28, 2024 and December&#160;30, 2023, respectively, have been reflected as discontinued operations in the consolidated statements of operations and comprehensive income (loss) and consist of the following (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating expenses from discontinued operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gain on sale of ARCA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(12,102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total operating expenses from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(10,635)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other expense from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income before provision for income taxes from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with the provisions of ASC 205-20, the Company has separately reported the cash flow activity of the discontinued operations in the consolidated statements of cash flows. The cash flow activity from discontinued operations for the year ended December&#160;28, 2024 and December&#160;30, 2023 have been reflected as discontinued operations in the consolidated statements of cash flows and consist of the following (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DISCONTINUED OPERATING ACTIVITIES:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gain on sale of ARCA, net of cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(12,248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in assets and liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net cash provided by operating activities from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DISCONTINUED INVESTING ACTIVITIES:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchases of property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchase of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net cash used in investing activities from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DISCONTINUED FINANCING ACTIVITIES:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Proceeds from note payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payments on related party note&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payments on notes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7,336)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net cash used in financing activities from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effect of changes in exchange rate on cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DECREASE IN CASH AND CASH EQUIVALENTS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CASH AND CASH EQUIVALENTS, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CASH AND CASH EQUIVALENTS, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <alts:DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount contextRef="c-133" decimals="-5" id="f-620" unitRef="usd">6000000.0</alts:DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount>
    <us-gaap:PaymentsForCommissions contextRef="c-134" decimals="-3" id="f-621" unitRef="usd">3000</us-gaap:PaymentsForCommissions>
    <alts:DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount contextRef="c-133" decimals="-5" id="f-622" unitRef="usd">6000000.0</alts:DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount>
    <alts:RevisedDiscountAmount contextRef="c-133" decimals="-5" id="f-623" unitRef="usd">18000000.0</alts:RevisedDiscountAmount>
    <us-gaap:InterestIncomeInterestEarningAsset contextRef="c-135" decimals="-3" id="f-624" unitRef="usd">720000</us-gaap:InterestIncomeInterestEarningAsset>
    <us-gaap:GainLossOnDispositionOfAssets1 contextRef="c-136" decimals="-5" id="f-625" unitRef="usd">5300000</us-gaap:GainLossOnDispositionOfAssets1>
    <alts:DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag contextRef="c-1" id="f-626">gain on sale</alts:DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal contextRef="c-137" decimals="-5" id="f-627" unitRef="usd">15800000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock contextRef="c-1" id="f-628">The following table details the final calculation of the gain on sale of the Recycling Subsidiaries, as shown on the income statement (in $000&#x2019;s):&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.151%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:82.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.824%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total minimum consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payment from buyer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities - California state sales tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(604)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total disposal of liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total disposal of assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total gain on sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The results of operations for these entities for the year ended December&#160;28, 2024 and December&#160;30, 2023, respectively, have been reflected as discontinued operations in the consolidated statements of operations and comprehensive income (loss) and consist of the following (in $000&#x2019;s):&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating expenses from discontinued operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gain on sale of ARCA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(12,102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total operating expenses from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(10,635)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other expense from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income before provision for income taxes from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The cash flow activity from discontinued operations for the year ended December&#160;28, 2024 and December&#160;30, 2023 have been reflected as discontinued operations in the consolidated statements of cash flows and consist of the following (in $000&#x2019;s):&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DISCONTINUED OPERATING ACTIVITIES:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gain on sale of ARCA, net of cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(12,248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in assets and liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net cash provided by operating activities from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DISCONTINUED INVESTING ACTIVITIES:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchases of property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchase of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net cash used in investing activities from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DISCONTINUED FINANCING ACTIVITIES:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Proceeds from note payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payments on related party note&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payments on notes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7,336)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net cash used in financing activities from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effect of changes in exchange rate on cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DECREASE IN CASH AND CASH EQUIVALENTS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CASH AND CASH EQUIVALENTS, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CASH AND CASH EQUIVALENTS, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <alts:TotalGuaranteedConsideration contextRef="c-137" decimals="-3" id="f-629" unitRef="usd">6023000</alts:TotalGuaranteedConsideration>
    <alts:PaymentFromBuyer contextRef="c-137" decimals="-3" id="f-630" unitRef="usd">3000</alts:PaymentFromBuyer>
    <alts:NetConsideration contextRef="c-137" decimals="-3" id="f-631" unitRef="usd">6026000</alts:NetConsideration>
    <alts:DisposalOfAccountsPayable contextRef="c-137" decimals="-3" id="f-632" unitRef="usd">5323000</alts:DisposalOfAccountsPayable>
    <alts:DisposalOfAccruedLiability contextRef="c-137" decimals="-3" id="f-633" unitRef="usd">1857000</alts:DisposalOfAccruedLiability>
    <alts:DisposalOfAccruedLiabilityCaliforniaStateSalesTax contextRef="c-137" decimals="-3" id="f-634" unitRef="usd">6320000</alts:DisposalOfAccruedLiabilityCaliforniaStateSalesTax>
    <alts:DisposalOfLeaseLiability contextRef="c-137" decimals="-3" id="f-635" unitRef="usd">5285000</alts:DisposalOfLeaseLiability>
    <alts:DisposalOfDebt contextRef="c-137" decimals="-3" id="f-636" unitRef="usd">2139000</alts:DisposalOfDebt>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax contextRef="c-137" decimals="-3" id="f-637" unitRef="usd">-604000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <alts:TotalDisposalOfLiability contextRef="c-137" decimals="-3" id="f-638" unitRef="usd">20320000</alts:TotalDisposalOfLiability>
    <alts:TotalConsiderations contextRef="c-137" decimals="-3" id="f-639" unitRef="usd">26346000</alts:TotalConsiderations>
    <alts:CashDisposal contextRef="c-137" decimals="-3" id="f-640" unitRef="usd">145000</alts:CashDisposal>
    <alts:DisposalOfAccountsReceivable contextRef="c-137" decimals="-3" id="f-641" unitRef="usd">4884000</alts:DisposalOfAccountsReceivable>
    <alts:DisposalOfInventory contextRef="c-137" decimals="-3" id="f-642" unitRef="usd">67000</alts:DisposalOfInventory>
    <alts:DisposalOfPropertyPlantAndEquipment contextRef="c-137" decimals="-3" id="f-643" unitRef="usd">2767000</alts:DisposalOfPropertyPlantAndEquipment>
    <alts:DisposalOfIntangibleAssets contextRef="c-137" decimals="-3" id="f-644" unitRef="usd">732000</alts:DisposalOfIntangibleAssets>
    <alts:DisposalOfRightOfUseAssets contextRef="c-137" decimals="-3" id="f-645" unitRef="usd">5075000</alts:DisposalOfRightOfUseAssets>
    <alts:DisposalOfOtherAssets contextRef="c-137" decimals="-3" id="f-646" unitRef="usd">574000</alts:DisposalOfOtherAssets>
    <alts:TotalDisposalOfAssets contextRef="c-137" decimals="-3" id="f-647" unitRef="usd">14244000</alts:TotalDisposalOfAssets>
    <alts:TotalGainOnSale contextRef="c-137" decimals="-3" id="f-648" unitRef="usd">12102000</alts:TotalGainOnSale>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue contextRef="c-138" decimals="-3" id="f-649" unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue contextRef="c-139" decimals="-3" id="f-650" unitRef="usd">3795000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold contextRef="c-138" decimals="-3" id="f-651" unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold contextRef="c-139" decimals="-3" id="f-652" unitRef="usd">3992000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss contextRef="c-138" decimals="-3" id="f-653" unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss contextRef="c-139" decimals="-3" id="f-654" unitRef="usd">-197000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense contextRef="c-138" decimals="-3" id="f-655" unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense contextRef="c-139" decimals="-3" id="f-656" unitRef="usd">1467000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense>
    <us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax contextRef="c-138" decimals="-3" id="f-657" unitRef="usd">0</us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax contextRef="c-139" decimals="-3" id="f-658" unitRef="usd">12102000</us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax>
    <alts:DisposalGroupIncludingDiscontinuedOperationTotalOperatingIncomeExpensesFromDiscontinuedOperations contextRef="c-138" decimals="-3" id="f-659" unitRef="usd">0</alts:DisposalGroupIncludingDiscontinuedOperationTotalOperatingIncomeExpensesFromDiscontinuedOperations>
    <alts:DisposalGroupIncludingDiscontinuedOperationTotalOperatingIncomeExpensesFromDiscontinuedOperations contextRef="c-139" decimals="-3" id="f-660" unitRef="usd">10635000</alts:DisposalGroupIncludingDiscontinuedOperationTotalOperatingIncomeExpensesFromDiscontinuedOperations>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss contextRef="c-138" decimals="-3" id="f-661" unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss contextRef="c-139" decimals="-3" id="f-662" unitRef="usd">10438000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense contextRef="c-138" decimals="-3" id="f-663" unitRef="usd">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense contextRef="c-139" decimals="-3" id="f-664" unitRef="usd">181000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense>
    <alts:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet contextRef="c-138" decimals="-3" id="f-665" unitRef="usd">0</alts:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet>
    <alts:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet contextRef="c-139" decimals="-3" id="f-666" unitRef="usd">3000</alts:DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet>
    <alts:DisposalGroupIncludingDiscontinuedOperationsTotalOtherIncomeLossNet contextRef="c-138" decimals="-3" id="f-667" unitRef="usd">0</alts:DisposalGroupIncludingDiscontinuedOperationsTotalOtherIncomeLossNet>
    <alts:DisposalGroupIncludingDiscontinuedOperationsTotalOtherIncomeLossNet contextRef="c-139" decimals="-3" id="f-668" unitRef="usd">-184000</alts:DisposalGroupIncludingDiscontinuedOperationsTotalOtherIncomeLossNet>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax contextRef="c-138" decimals="-3" id="f-669" unitRef="usd">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax contextRef="c-139" decimals="-3" id="f-670" unitRef="usd">10254000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation contextRef="c-138" decimals="-3" id="f-671" unitRef="usd">0</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation contextRef="c-139" decimals="-3" id="f-672" unitRef="usd">971000</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity contextRef="c-138" decimals="-3" id="f-673" unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity contextRef="c-139" decimals="-3" id="f-674" unitRef="usd">9283000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity contextRef="c-138" decimals="-3" id="f-675" unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity contextRef="c-139" decimals="-3" id="f-676" unitRef="usd">9283000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-138" decimals="-3" id="f-677" unitRef="usd">0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-139" decimals="-3" id="f-678" unitRef="usd">96000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-138" decimals="-3" id="f-679" unitRef="usd">0</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-139" decimals="-3" id="f-680" unitRef="usd">11000</us-gaap:AmortizationOfFinancingCosts>
    <alts:AmortizationOfRightOfUseAssets contextRef="c-138" decimals="-3" id="f-681" unitRef="usd">0</alts:AmortizationOfRightOfUseAssets>
    <alts:AmortizationOfRightOfUseAssets contextRef="c-139" decimals="-3" id="f-682" unitRef="usd">52000</alts:AmortizationOfRightOfUseAssets>
    <alts:GainOnSaleNetOfCash contextRef="c-138" decimals="-3" id="f-683" unitRef="usd">0</alts:GainOnSaleNetOfCash>
    <alts:GainOnSaleNetOfCash contextRef="c-139" decimals="-3" id="f-684" unitRef="usd">12248000</alts:GainOnSaleNetOfCash>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-138" decimals="-3" id="f-685" unitRef="usd">0</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-139" decimals="-3" id="f-686" unitRef="usd">-2932000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-138" decimals="-3" id="f-687" unitRef="usd">0</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-139" decimals="-3" id="f-688" unitRef="usd">-299000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="c-138" decimals="-3" id="f-689" unitRef="usd">0</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="c-139" decimals="-3" id="f-690" unitRef="usd">-56000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="c-138" decimals="-3" id="f-691" unitRef="usd">0</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="c-139" decimals="-3" id="f-692" unitRef="usd">1837000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-138" decimals="-3" id="f-693" unitRef="usd">0</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-139" decimals="-3" id="f-694" unitRef="usd">-1000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-138" decimals="-3" id="f-695" unitRef="usd">0</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations contextRef="c-138" decimals="-3" id="f-696" unitRef="usd">0</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations contextRef="c-139" decimals="-3" id="f-697" unitRef="usd">2319000</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-139" decimals="-3" id="f-698" unitRef="usd">2319000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-138" decimals="-3" id="f-699" unitRef="usd">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-139" decimals="-3" id="f-700" unitRef="usd">123000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c-138" decimals="-3" id="f-701" unitRef="usd">0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c-139" decimals="-3" id="f-702" unitRef="usd">32000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations contextRef="c-138" decimals="-3" id="f-703" unitRef="usd">0</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations contextRef="c-139" decimals="-3" id="f-704" unitRef="usd">-155000</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
    <us-gaap:ProceedsFromNotesPayable contextRef="c-138" decimals="-3" id="f-705" unitRef="usd">0</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable contextRef="c-139" decimals="-3" id="f-706" unitRef="usd">5162000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="c-138" decimals="-3" id="f-707" unitRef="usd">0</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="c-139" decimals="-3" id="f-708" unitRef="usd">38000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfNotesPayable contextRef="c-138" decimals="-3" id="f-709" unitRef="usd">0</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable contextRef="c-139" decimals="-3" id="f-710" unitRef="usd">7336000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations contextRef="c-138" decimals="-3" id="f-711" unitRef="usd">0</us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-138" decimals="-3" id="f-712" unitRef="usd">0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-139" decimals="-3" id="f-713" unitRef="usd">-2212000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations contextRef="c-139" decimals="-3" id="f-714" unitRef="usd">-2212000</us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-138" decimals="-3" id="f-715" unitRef="usd">0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-139" decimals="-3" id="f-716" unitRef="usd">-5000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-138" decimals="-3" id="f-717" unitRef="usd">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-139" decimals="-3" id="f-718" unitRef="usd">-53000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-140" decimals="-3" id="f-719" unitRef="usd">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-141" decimals="-3" id="f-720" unitRef="usd">53000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-142" decimals="-3" id="f-721" unitRef="usd">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-140" decimals="-3" id="f-722" unitRef="usd">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:OtherCurrentAssetsTextBlock contextRef="c-1" id="f-723">Prepaids and other current assets&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaids and other current assets as of December&#160;28, 2024 and December&#160;30, 2023 consist of the following (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.849%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.120%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.408%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.123%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid insurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherCurrentAssetsTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock contextRef="c-1" id="f-724">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaids and other current assets as of December&#160;28, 2024 and December&#160;30, 2023 consist of the following (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.849%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.120%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.408%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.123%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid insurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <us-gaap:PrepaidInsurance contextRef="c-4" decimals="-3" id="f-725" unitRef="usd">1000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance contextRef="c-5" decimals="-3" id="f-726" unitRef="usd">3000</us-gaap:PrepaidInsurance>
    <us-gaap:OtherPrepaidExpenseCurrent contextRef="c-4" decimals="-3" id="f-727" unitRef="usd">1517000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent contextRef="c-5" decimals="-3" id="f-728" unitRef="usd">72000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-729" unitRef="usd">1518000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-5" decimals="-3" id="f-730" unitRef="usd">75000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c-1" id="f-731">Property and Equipment&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment as of December&#160;28, 2024 and December&#160;30, 2023 consist of the following (in $000&#x2019;s):&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:65.006%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.235%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.239%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Projects under construction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded no depreciation expense from continuing operations for the years ended December&#160;28, 2024 and December&#160;30, 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-732">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment as of December&#160;28, 2024 and December&#160;30, 2023 consist of the following (in $000&#x2019;s):&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:65.006%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.235%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.239%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Projects under construction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-143" decimals="-3" id="f-733" unitRef="usd">1170000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-144" decimals="-3" id="f-734" unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-735" unitRef="usd">1170000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-5" decimals="-3" id="f-736" unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation contextRef="c-22" decimals="0" id="f-737" unitRef="usd">0</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-1" decimals="0" id="f-738" unitRef="usd">0</us-gaap:Depreciation>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-739">Leases&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with its acquisition of ALT5 Subsidiary (see Note 3), the Company leases commercial office space. These assets and properties are leased under noncancelable agreements that expire at various future dates. The agreements, which have been classified as operating leases, provide for minimum rent and require the Company to pay all insurance, taxes, and other maintenance costs. As a result, the Company recognizes assets and liabilities for leases with lease terms greater than 12 months. The amounts recognized reflect the present value of remaining lease payments for all leases. The discount rate used is an estimate of the Company&#x2019;s blended incremental borrowing rate based on information available associated with each subsidiary&#x2019;s debt outstanding at lease commencement. In considering the lease asset value, the Company considers fixed and variable payment terms, prepayments and options to extend, terminate or purchase. Renewal, termination, or purchase options affect the lease term used for determining lease asset value only if the option is reasonably certain to be exercised.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table details the Company&#x2019;s right of use assets and lease liabilities as of December&#160;28, 2024 and December&#160;30, 2023 (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.636%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:65.413%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.336%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.414%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.337%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right of use asset - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current - operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long term - operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;28, 2024, the weighted average remaining lease term for operating leases is 4.9 years. The Company&#x2019;s weighted average discount rate for operating leases is 12.8%. No cash payments for operating leases were made during the years ended December&#160;28, 2024 and December&#160;30, 2023. Additionally, the Company recognized approximately $123,000 in right of use assets and liabilities upon commencement of operating leases during the year ended December&#160;28, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total present value of future lease payments of operating leases as of September&#160;28, 2024 (in $000&#x2019;s): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.809%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.991%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Twelve months ended:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Less implied interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Present value of payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <alts:ScheduleOfOperatingLeaseRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock contextRef="c-1" id="f-740">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table details the Company&#x2019;s right of use assets and lease liabilities as of December&#160;28, 2024 and December&#160;30, 2023 (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.636%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:65.413%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.336%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.414%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.337%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right of use asset - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current - operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long term - operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</alts:ScheduleOfOperatingLeaseRightOfUseAssetsAndLeaseLiabilitiesTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-741" unitRef="usd">121000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-5" decimals="-3" id="f-742" unitRef="usd">0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-743" unitRef="usd">10000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-5" decimals="-3" id="f-744" unitRef="usd">0</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-745" unitRef="usd">113000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-5" decimals="-3" id="f-746" unitRef="usd">0</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-4" id="f-747">P4Y10M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-4" decimals="3" id="f-748" unitRef="number">0.128</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeasePayments contextRef="c-22" decimals="0" id="f-749" unitRef="usd">0</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="0" id="f-750" unitRef="usd">0</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-751" unitRef="usd">123000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-752">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total present value of future lease payments of operating leases as of September&#160;28, 2024 (in $000&#x2019;s): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.809%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.991%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Twelve months ended:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Less implied interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Present value of payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-4" decimals="-3" id="f-753" unitRef="usd">27000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-4" decimals="-3" id="f-754" unitRef="usd">34000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-4" decimals="-3" id="f-755" unitRef="usd">36000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-4" decimals="-3" id="f-756" unitRef="usd">37000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="c-4" decimals="-3" id="f-757" unitRef="usd">36000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive contextRef="c-4" decimals="-3" id="f-758" unitRef="usd">0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-4" decimals="-3" id="f-759" unitRef="usd">170000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-4" decimals="-3" id="f-760" unitRef="usd">47000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-4" decimals="-3" id="f-761" unitRef="usd">123000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinancingReceivablesTextBlock contextRef="c-1" id="f-762">Notes receivable &lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;SPYR Note&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May&#160;24, 2022, the Company entered into an Asset Purchase Agreement with SPYR Technologies Inc. (&#x201c;SPYR&#x201d;), pursuant to which the Company sold to SPYR substantially all of the assets and none of the specified liabilities of GeoTraq. In connection with the Purchase Agreement, SPYR delivered to the Company a five-year Promissory Note in the initial principal amount of $12.6 million. The Promissory Note bears simple interest at the rate of 8.0% per annum, provides quarterly interest payments due on the first day of each calendar quarter, and may be prepaid at any time without penalty. Interest payments may be remitted in either restricted shares of common stock or restricted shares of Series G Convertible Preferred Stock of SPYR, or in cash. The Promissory Note matures on May 24, 2027. The Company had received restricted shares of Series G Convertible Preferred Stock of SPYR equivalent to approximately 26,253,900,000 shares of its common stock during the year ended December&#160;28, 2024, and 922,442,000 shares of SPYR's common stock during the year ended December&#160;30, 2023. As of December&#160;30, 2023, the Company had no accrued receivables related to the Promissory Note.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;30, 2023, the Company performed a qualitative analysis of the SPYR note receivable and concluded that, due to a number of triggering factors, it was probable that SPYR would be unable to fulfill its obligation to repay the principal amount under the promissory note on or before the maturity date. Consequently, the Company recorded an impairment charge of approximately $9.8&#160;million for the fiscal year ended December&#160;30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fiscal years ended December&#160;28, 2024 and December&#160;30, 2023, approximately $0 and $806,000, respectively, of the discount was recorded as interest income. As of December&#160;28, 2024 and December&#160;30, 2023, no principal balance on the Note was outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;VM7 Note&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 9, 2023, the Company entered into a Stock Purchase Agreement (the &#x201c;Recycling Purchase Agreement&#x201d;) with VM7 Corporation, a Delaware corporation (&#x201c;VM7&#x201d;), under which it agreed to acquire all of the outstanding equity interests of the Recycling Subsidiaries, consisting of: (a) ARCA Recycling, (b) ARCA Canada, and (c) Connexx. The principal of VM7 is Virland A. Johnson, our Chief Financial Officer. The sale of all of the outstanding equity interests of the Recycling Subsidiaries to VM7 under the Recycling Purchase Agreement was consummated simultaneously with the execution of the Recycling Purchase Agreement. The Recycling Purchase Agreement is retroactive to March 1, 2023 (see Note 4).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The valuation, factoring in the discount rate that the Company used, yielded a present value of approximately $6.0 million, which, in addition to the $3,000 paid at close, comprised the approximately 6.0 million of net consideration. The amount of the revised discount amount, or approximately $18.0 million, was recorded as an offset to the principal amount of the Note, and was to have been accreted ratably to interest income over the term of the Note. During the year ended December&#160;30, 2023, approximately $720,000 of the discount was recorded as interest income. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of fiscal 2023, VM7 determined that, after expending significant amounts of time and resources, it was unable to obtain sufficient equity or debt financing to continue the operations of the Recycling Subsidiaries. Accordingly, the Company was advised that the operations of the Recycling Subsidiaries were wound down and, ultimately, ceased. For a variety of related reasons, the Company determined fully to impair the $5.3 million carrying value of the Disposition Transaction on its balance sheet and determined not to exercise any of its remedies under the Recycling Purchase Agreement so that it could maintain its focus on its clinical-stage biopharmaceutical activities.&lt;/span&gt;&lt;/div&gt;</us-gaap:FinancingReceivablesTextBlock>
    <alts:NotesReceivableTerm contextRef="c-145" id="f-763">P5Y</alts:NotesReceivableTerm>
    <alts:NoteReceivableFaceAmount contextRef="c-146" decimals="-5" id="f-764" unitRef="usd">12600000</alts:NoteReceivableFaceAmount>
    <alts:NoteReceivableStatedInterestRate contextRef="c-146" decimals="2" id="f-765" unitRef="number">0.080</alts:NoteReceivableStatedInterestRate>
    <us-gaap:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1
      contextRef="c-147"
      decimals="-3"
      id="f-766"
      unitRef="shares">26253900000</us-gaap:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1>
    <us-gaap:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1
      contextRef="c-148"
      decimals="-3"
      id="f-767"
      unitRef="shares">922442000</us-gaap:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1>
    <us-gaap:InterestReceivable contextRef="c-149" decimals="0" id="f-768" unitRef="usd">0</us-gaap:InterestReceivable>
    <alts:GainLossOnWriteOffOfNotesReceivable contextRef="c-22" decimals="-5" id="f-769" unitRef="usd">-9800000</alts:GainLossOnWriteOffOfNotesReceivable>
    <us-gaap:InterestIncomeInterestEarningAsset contextRef="c-150" decimals="-3" id="f-770" unitRef="usd">0</us-gaap:InterestIncomeInterestEarningAsset>
    <us-gaap:InterestIncomeInterestEarningAsset contextRef="c-151" decimals="-3" id="f-771" unitRef="usd">806000</us-gaap:InterestIncomeInterestEarningAsset>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss contextRef="c-5" decimals="INF" id="f-772" unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss contextRef="c-4" decimals="INF" id="f-773" unitRef="usd">0</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <alts:DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount contextRef="c-133" decimals="-5" id="f-774" unitRef="usd">6000000.0</alts:DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount>
    <us-gaap:PaymentsForCommissions contextRef="c-134" decimals="-3" id="f-775" unitRef="usd">3000</us-gaap:PaymentsForCommissions>
    <alts:DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount contextRef="c-133" decimals="-5" id="f-776" unitRef="usd">6000000.0</alts:DisposalGroupIncludingDiscontinuedOperationsPresentValueOfDiscountRecordedAsOffsetToThePrincipalAmount>
    <alts:RevisedDiscountAmount contextRef="c-133" decimals="-5" id="f-777" unitRef="usd">18000000.0</alts:RevisedDiscountAmount>
    <us-gaap:InterestIncomeInterestEarningAsset contextRef="c-135" decimals="-3" id="f-778" unitRef="usd">720000</us-gaap:InterestIncomeInterestEarningAsset>
    <us-gaap:GainLossOnDispositionOfAssets1 contextRef="c-136" decimals="-5" id="f-779" unitRef="usd">5300000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="c-1" id="f-780">Intangible assets&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets as of consist of the following (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Soin intangibles&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Qoden intangible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Patents and domains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;39,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4,853)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,451)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;34,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible amortization expense for continuing operations was approximately $3.4&#160;million and $1.5 million, respectively, for the fiscal years ended December&#160;28, 2024 and December&#160;30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Qoden Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 8, 2024, the Company acquired the Qodex Cryptocurrency Exchange Software platform and other related assets from Qoden Technologies, LLC, a provider of technology solutions for the blockchain industry. The Company will amortize the intangible assets over a two-year period (see Note 3).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;ALT5 Subsidiary Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May&#160;14, 2024, the Company acquired its ALT5 Subsidiary, which is a fintech company that provides next generation blockchain-powered technologies to enable a migration to a new global financial paradigm. As part of the acquisition, the Company acquired trade names, customer relationships, and developed technology, which will be amortized over a period of seven years, 10 years, and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;five&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; years, respectively (see Note 3). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Soin Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective as of December 28, 2022, the Company acquired Soin Therapeutics LLC, a Delaware limited liability company (&#x201c;STLLC&#x201d;), and its product, a patent-pending, novel formulation of low-dose naltrexone. The assets acquired by the Company consist of 1) three pending patents related to the methods of using low-dose Naltrexone to treat chronic pain, 2) final formula for Naltrexone, and 3) orphan drug designation as approved by the FDA. The Company reviewed the assets acquired and determined that no in-process research and development costs were acquired as part of the transaction, and, thus, all assets acquired represent intellectual property and should be capitalized. The Company will amortize the intangible assets ratably over a 10-year period.&lt;/span&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="c-1" id="f-781">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets as of consist of the following (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Soin intangibles&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Qoden intangible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Patents and domains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;39,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4,853)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,451)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;34,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-152" decimals="-3" id="f-782" unitRef="usd">19293000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-153" decimals="-3" id="f-783" unitRef="usd">19293000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-154" decimals="-3" id="f-784" unitRef="usd">1536000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-155" decimals="-3" id="f-785" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-156" decimals="-3" id="f-786" unitRef="usd">4000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-157" decimals="-3" id="f-787" unitRef="usd">4000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-158" decimals="-3" id="f-788" unitRef="usd">2675000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-159" decimals="-3" id="f-789" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-160" decimals="-3" id="f-790" unitRef="usd">13925000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-161" decimals="-3" id="f-791" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-162" decimals="-3" id="f-792" unitRef="usd">1850000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-163" decimals="-3" id="f-793" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-4" decimals="-3" id="f-794" unitRef="usd">39283000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-5" decimals="-3" id="f-795" unitRef="usd">19297000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-4" decimals="-3" id="f-796" unitRef="usd">4853000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-5" decimals="-3" id="f-797" unitRef="usd">1451000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-4" decimals="-3" id="f-798" unitRef="usd">34430000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-5" decimals="-3" id="f-799" unitRef="usd">17846000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-5" id="f-800" unitRef="usd">3400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-22" decimals="-5" id="f-801" unitRef="usd">1500000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-164" id="f-802">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-165" id="f-803">P7Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-166" id="f-804">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-167" id="f-805">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <alts:NumberOfAcquiredIntangibleAssets
      contextRef="c-168"
      decimals="INF"
      id="f-806"
      unitRef="patent">3</alts:NumberOfAcquiredIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-168" id="f-807">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock contextRef="c-1" id="f-808">Marketable Securities&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketable securities consist of the following (in $000&#x2019;s, except shares):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.921%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.141%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.426%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.141%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.426%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.145%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Series G Convertible Preferred Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Common Shares Equivalent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Amount &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30,000,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Securities received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,224&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;922,442,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mark-to-market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(926)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning balance, December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,224&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;952,442,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;286&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Securities received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33,876&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26,253,900,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mark-to-market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Write-off marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(43,100)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(27,206,342,000)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(434)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ending balance, December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketable securities reflect shares of SPYR stock received by the Company in connection with the sale of GeoTraq. Quarterly interest payments may be remitted in either restricted shares of common stock or restricted shares of Series G Convertible Preferred Stock of SPYR, or in cash. Shares of Series G Convertible Preferred Stock are convertible into the SPYR&#x2019;s common shares at a ratio of 1:100,000. Shares held are marked to fair market value as of each balance sheet date, with the resulting change recorded as an unrealized gain or loss. For the year ended December&#160;28, 2024, the Company received 33,876 shares of Series G Convertible Preferred Stock, which are convertible into approximately 26,253,900,000 shares of SPYR&#x2019;s common stock. For the year ended December&#160;30, 2023, the Company received 9,224 shares of Series G Convertible Preferred Stock, which are convertible into approximately 922,442,000 shares of SPYR&#x2019;s common stock. Unrealized loss was approximately $1.1 million and $926,000 for the years ended December&#160;28, 2024 and December&#160;30, 2023, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;28, 2024, the Company was notified that SPYR Technologies, Inc. (&#x201c;SPYR&#x201d;) had ceased operations, and that no future quarterly interest payments on the promissory note, which may be remitted in either restricted shares of common stock or restricted shares of Series G Convertible Preferred Stock of SPYR, or in cash, would be made. Consequently, the Company recorded a full write-off of approximately $434,000 of its Series G Convertible Preferred shares of SPYR.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock>
    <us-gaap:MarketableSecuritiesTextBlock contextRef="c-1" id="f-809">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketable securities consist of the following (in $000&#x2019;s, except shares):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.666%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.921%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.141%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.426%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.141%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.426%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.145%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Series G Convertible Preferred Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Common Shares Equivalent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Amount &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30,000,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Securities received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,224&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;922,442,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mark-to-market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(926)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning balance, December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,224&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;952,442,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;286&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Securities received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33,876&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26,253,900,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mark-to-market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Write-off marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(43,100)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(27,206,342,000)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(434)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ending balance, December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesTextBlock>
    <alts:MarketableSecuritiesSharesOutstanding contextRef="c-169" decimals="0" id="f-810" unitRef="shares">0</alts:MarketableSecuritiesSharesOutstanding>
    <alts:MarketableSecuritiesSharesOutstanding contextRef="c-170" decimals="0" id="f-811" unitRef="shares">30000000</alts:MarketableSecuritiesSharesOutstanding>
    <us-gaap:MarketableSecurities contextRef="c-35" decimals="-3" id="f-812" unitRef="usd">315000</us-gaap:MarketableSecurities>
    <alts:NoncashOrPartNoncashDivestitureConsiderationReceivedShares contextRef="c-171" decimals="0" id="f-813" unitRef="shares">9224</alts:NoncashOrPartNoncashDivestitureConsiderationReceivedShares>
    <alts:NoncashOrPartNoncashDivestitureConsiderationReceivedShares contextRef="c-172" decimals="0" id="f-814" unitRef="shares">922442000</alts:NoncashOrPartNoncashDivestitureConsiderationReceivedShares>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="c-22" decimals="-3" id="f-815" unitRef="usd">897000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments contextRef="c-22" decimals="-3" id="f-816" unitRef="usd">-926000</us-gaap:MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments>
    <alts:MarketableSecuritiesSharesOutstanding contextRef="c-173" decimals="0" id="f-817" unitRef="shares">9224</alts:MarketableSecuritiesSharesOutstanding>
    <alts:MarketableSecuritiesSharesOutstanding contextRef="c-174" decimals="0" id="f-818" unitRef="shares">952442000</alts:MarketableSecuritiesSharesOutstanding>
    <us-gaap:MarketableSecurities contextRef="c-5" decimals="-3" id="f-819" unitRef="usd">286000</us-gaap:MarketableSecurities>
    <alts:NoncashOrPartNoncashDivestitureConsiderationReceivedShares contextRef="c-175" decimals="0" id="f-820" unitRef="shares">33876</alts:NoncashOrPartNoncashDivestitureConsiderationReceivedShares>
    <alts:NoncashOrPartNoncashDivestitureConsiderationReceivedShares contextRef="c-176" decimals="0" id="f-821" unitRef="shares">26253900000</alts:NoncashOrPartNoncashDivestitureConsiderationReceivedShares>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="c-1" decimals="-3" id="f-822" unitRef="usd">518000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments contextRef="c-1" decimals="-3" id="f-823" unitRef="usd">-370000</us-gaap:MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments>
    <alts:MarketableSecurityWriteOffShares
      contextRef="c-175"
      decimals="INF"
      id="f-824"
      unitRef="shares">43100</alts:MarketableSecurityWriteOffShares>
    <alts:MarketableSecurityWriteOffShares
      contextRef="c-176"
      decimals="INF"
      id="f-825"
      unitRef="shares">27206342000</alts:MarketableSecurityWriteOffShares>
    <us-gaap:MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments contextRef="c-1" decimals="-3" id="f-826" unitRef="usd">-434000</us-gaap:MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments>
    <alts:MarketableSecuritiesSharesOutstanding contextRef="c-177" decimals="0" id="f-827" unitRef="shares">0</alts:MarketableSecuritiesSharesOutstanding>
    <alts:MarketableSecuritiesSharesOutstanding contextRef="c-178" decimals="0" id="f-828" unitRef="shares">0</alts:MarketableSecuritiesSharesOutstanding>
    <us-gaap:MarketableSecurities contextRef="c-4" decimals="-3" id="f-829" unitRef="usd">0</us-gaap:MarketableSecurities>
    <alts:NoncashOrPartNoncashDivestitureConsiderationReceivedShares
      contextRef="c-175"
      decimals="INF"
      id="f-830"
      unitRef="shares">33876</alts:NoncashOrPartNoncashDivestitureConsiderationReceivedShares>
    <alts:ConvertiblePreferredStockSharesIssuableUponConversion
      contextRef="c-178"
      decimals="-5"
      id="f-831"
      unitRef="shares">26253900000</alts:ConvertiblePreferredStockSharesIssuableUponConversion>
    <alts:NoncashOrPartNoncashDivestitureConsiderationReceivedShares
      contextRef="c-171"
      decimals="INF"
      id="f-832"
      unitRef="shares">9224</alts:NoncashOrPartNoncashDivestitureConsiderationReceivedShares>
    <alts:ConvertiblePreferredStockSharesIssuableUponConversion
      contextRef="c-174"
      decimals="-3"
      id="f-833"
      unitRef="shares">922442000</alts:ConvertiblePreferredStockSharesIssuableUponConversion>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-1" decimals="-5" id="f-834" unitRef="usd">-1100000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-22" decimals="-3" id="f-835" unitRef="usd">-926000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments contextRef="c-1" decimals="-3" id="f-836" unitRef="usd">-434000</us-gaap:MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments>
    <us-gaap:OtherAssetsDisclosureTextBlock contextRef="c-1" id="f-838">Deposits and other assets&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deposits and other assets consist of the following (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deposits and other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total deposits and other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherAssetsTableTextBlock contextRef="c-1" id="f-839">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deposits and other assets consist of the following (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deposits and other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total deposits and other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherAssetsTableTextBlock>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-3" id="f-840" unitRef="usd">0</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-5" decimals="-3" id="f-841" unitRef="usd">9000</us-gaap:OtherAssetsNoncurrent>
    <alts:DepositsAndOtherAssetsNoncurrent contextRef="c-4" decimals="-3" id="f-842" unitRef="usd">0</alts:DepositsAndOtherAssetsNoncurrent>
    <alts:DepositsAndOtherAssetsNoncurrent contextRef="c-5" decimals="-3" id="f-843" unitRef="usd">9000</alts:DepositsAndOtherAssetsNoncurrent>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="c-1" id="f-844">Accrued liabilities&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities of continuing consist of the following (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued guarantees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued Qoden payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued litigation/legal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-845">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities of continuing consist of the following (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued guarantees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued Qoden payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued litigation/legal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-846" unitRef="usd">204000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-847" unitRef="usd">37000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue contextRef="c-4" decimals="-3" id="f-848" unitRef="usd">309000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue contextRef="c-5" decimals="-3" id="f-849" unitRef="usd">3049000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="c-4" decimals="-3" id="f-850" unitRef="usd">362000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="c-5" decimals="-3" id="f-851" unitRef="usd">102000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:InterestPayableCurrent contextRef="c-4" decimals="-3" id="f-852" unitRef="usd">789000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent contextRef="c-5" decimals="-3" id="f-853" unitRef="usd">0</us-gaap:InterestPayableCurrent>
    <alts:AccruedExpensesAssetAcquisitionCurrent contextRef="c-4" decimals="-3" id="f-854" unitRef="usd">109000</alts:AccruedExpensesAssetAcquisitionCurrent>
    <alts:AccruedExpensesAssetAcquisitionCurrent contextRef="c-5" decimals="-3" id="f-855" unitRef="usd">0</alts:AccruedExpensesAssetAcquisitionCurrent>
    <us-gaap:LitigationReserveCurrent contextRef="c-4" decimals="-3" id="f-856" unitRef="usd">50000</us-gaap:LitigationReserveCurrent>
    <us-gaap:LitigationReserveCurrent contextRef="c-5" decimals="-3" id="f-857" unitRef="usd">397000</us-gaap:LitigationReserveCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-858" unitRef="usd">730000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-859" unitRef="usd">48000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities contextRef="c-4" decimals="-3" id="f-860" unitRef="usd">2553000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities contextRef="c-5" decimals="-3" id="f-861" unitRef="usd">3633000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:LongTermDebtTextBlock contextRef="c-1" id="f-862">Debentures&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debentures outstanding as of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;28, 2024 and December&#160;30, 2023 consisted for the following (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest rate of 15%, maturity date of June 30, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total debentures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ALT5 Subsidiary issued 39 debentures over a period from October 2018 through September 2019. The debentures bear interest at 12% per annum and mature as of June&#160;30, 2024 or June&#160;30, 2025. During the year ended December&#160;28, 2024, ALT5 Subsidiary repaid 33 of the debentures in the amount of approximately $1.1 million.&lt;/span&gt;&lt;/div&gt; Long-Term Debt&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt as of December&#160;28, 2024 and December&#160;30, 2023 consisted of the following (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Legacy subsidiary fixed deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Legacy subsidiary loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unaffiliated third-party&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total notes payable, related parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total long-term notes payable, related parties&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Legacy Subsidiary Fixed Deposits&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;28, 2024, ALT5 Subsidiary entered into several Corporate Fixed Deposit Agreements with otherwise unaffiliated third-parties, pursuant to which the Company became obligated for an aggregate of $4.7 million, as set forth in the respective agreements. Each obligation bears interest at a rate of 13% or 15% per annum, and has a maturity date range of March&#160;18, 2026 to March&#160;13, 2027. During the year ended December&#160;28, 2024, several of these unaffiliated third-parties agreed to convert their respective investments into Future Equity Agreements for shares of the Company&#x2019;s subsidiary, Alyea Therapeutic and, consequently, approximately $475,000 of these deposits were reclassified as non-controlling interest. As of December&#160;28, 2024, the outstanding aggregate obligations totaled approximately $4.2 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Legacy Subsidiary Loan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 10, 2023, ALT5 Subsidiary entered into an extension agreement for a Bitcoin promissory note with an otherwise unaffiliated third-party. The Bitcoin promissory note is denominated in Bitcoin and, thus, is adjusted to its fair value each period. Pursuant to the terms of an extension agreement, the maturity date is August&#160;29, 2025. The promissory note bears interest at 15% per annum. As of December&#160;28, 2024, the outstanding balance of the note was approximately $3.8 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Unaffiliated Third-Party Loans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline"&gt;ICG Note&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 7, 2024, the Company amended its outstanding related party promissory obligations (the &#x201c;ICG Note&#x201d;) in favor of Isaac Capital Group LLC (&#x201c;ICG&#x201d;) to add a convertibility provision. In accordance with Nasdaq Rules, the per-share conversion price was set at $0.61, subject to standard adjustments for (i) stock dividends and splits, (ii) subsequent rights offerings, and (iii) pro rata distributions. The Company&#x2019;s board of directors provided its approvals of the amendments on February 7, 2024. On March 6, 2024, ICG entered into a Note Purchase Agreement with an otherwise unaffiliated third party, under which the third party acquired the ICG Note. The terms and conditions of the ICG Note were not modified in connection with its acquisition by the third party. The principal amount of the ICG Note on the date of acquisition was approximately $1.2 million. During the year ended December&#160;28, 2024, the third party converted $548,900 of the Company&#x2019;s obligations under the ICG Note into 900,000 shares of the Company&#x2019;s common stock. As of December&#160;28, 2024, the amount outstanding on the ICG Note was approximately $0.7 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline"&gt;Live Note&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 7, 2024, the Company amended its outstanding related party promissory obligations (the &#x201c;Live Note&#x201d;) in favor of Live Ventures Incorporated (&#x201c;Live&#x201d;) to add a convertibility provision. In accordance with Nasdaq Rules, the per-share conversion price for each obligation, as amended, was set at $0.61, subject to standard adjustments for (i) stock dividends and splits, (ii) subsequent rights offerings, and (iii) pro rata distributions. The Company&#x2019;s board of directors provided its final approvals of the amendments on February 7, 2024. On March 6, 2024, Live entered into a Note Purchase Agreement with another otherwise unaffiliated third party, under which the third party acquired the Live Note. The terms and conditions of the acquired Live Note were not modified in connection with its acquisition by the third party. The principal amount of the Live Note on the date of acquisition was approximately $1.0 million. During the year ended &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;28, 2024, the third party converted $243,900 of the Company&#x2019;s obligations under the Live Note into 400,000 shares of the Company&#x2019;s common stock. As of December&#160;28, 2024, the amount outstanding on the Live Note was approximately $0.8 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline"&gt;Skybridge Obligation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April&#160;10, 2024, Skybridge Americas, Inc. (&#x201c;SA&#x201d;) sold its judgment to an otherwise unaffiliated third party for the face value of the judgment and the interest accrued thereon through that date (an aggregate of $433,920), plus accrued legal fees (in the amount of $18,124) to which SA was entitled in accordance with the terms of the underlying agreement with the Company and with the judgment. The purchaser agreed to forbear from enforcing the judgment, subject to the Company&#x2019;s repayment or his conversion thereof. In connection with the third-party&#x2019;s forbearance, the Company issued its promissory note to such person in the initial principal amount of $147,956, which bears interest at the rate of 10% per annum, and, as with the underlying judgment, is convertible into shares of the Company&#x2019;s common stock at a fixed per-share conversion price of $2.60 (see Note 21).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December&#160;23, 2024, pursuant to the terms of the agreement, the unaffiliated third party converted the obligation, plus accrued interest under the agreements, in the amount of approximately $691,000, into 265,842 shares of the Company&#x2019;s common stock (see Note 18). As of December&#160;28, 2024, there was no balance outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline"&gt;Big/Small Debentures&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August&#160;20, 2024, the Company entered into three Purchase Agreements with three otherwise unaffiliated third-party investors (the &#x201c;Investors&#x201d;), pursuant to which (1) one Investor agreed to purchase a unit (the &#x201c;Unit&#x201d;), consisting of (i) a non-convertible debenture in the principal amount of up to approximately $1.8 million (the &#x201c;Big Debenture&#x201d;), and (ii) a warrant (the &#x201c;Big Warrant&#x201d;) for the purchase of up to 400,000 shares of the Company&#x2019;s Common Stock and (2) the two other Investors each agreed to purchase a Unit, consisting of (i) a non-convertible debenture in the principal amount of up to $404,454 (the &#x201c;Small Debenture&#x201d;, and, together with the Big Debenture, the &#x201c;Debentures&#x201d;) and (ii) a warrant (the &#x201c;Small Warrant&#x201d;, and, together with the Big Warrant, the &#x201c;Warrants&#x201d;) for the purchase of up 90,909 shares of Common Stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Debentures are unsecured and subordinated to any existing or future debt.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Debentures bear interest at a rate of (i) 1% per month from and after August 20, 2024 (&#x201c;Original Issue Date&#x201d;) through and including October 31, 2024, (ii) 3% per month from and after November 1, 2024 through and including January 29, 2025, and (iii) 4% per month from and after January 30, 2025 through and including the date of repayment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Big Debenture was issued with an original issue discount (an &#x201c;OID&#x201d;) initially of $171,000, which OID can be expanded with up to two potential additions, the first in the amount of $171,000 and, thereafter, in the amount of $342,000, which OIDs will increase the principal amount owing on the Big Debenture.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With the original OID, the initial principal amount owing under the Big Debenture is approximately $1.3 million; if, expanded, the principal amount would increase to approximately $1.4 million and, thereafter, potentially to approximately $1.8 million. The first potential increase in the Big Debenture OID would occur if the initial principal amount and interest accrued thereon is not paid in full on or before October 31, 2024. The second potential increase in the OID would occur if the initial principal amount (including the first potential increase in the OID) and interest accrued thereon is not paid in full on or before January 29, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Small Debentures were issued with an OID initially of $38,863, which OID can be expanded with up to two potential additions, the first in the amount of $38,863 and, thereafter, in the amount of $77,728, which OIDs will increase the principal amount owing on the Small Debentures.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With the original OID, the initial principal amount owing under a Small Debenture is $288,864; if, expanded, the principal amount would increase to $327,726 and, thereafter, potentially to $404,454.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The first potential increase in the Small Debenture OID would occur if the initial principal amount and interest accrued thereon is not paid in full on or before October 31, 2024.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The second potential increase in the OID would occur if the initial principal amount (including the first potential increase in the OID) and interest accrued thereon is not paid in full on or before January 29, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of November&#160;1, 2024, the first of the two additional OIDs was effective.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The final maturity date for each of the Debentures is April 28, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Big Warrant is exercisable, at an exercise price of $1.71 per share, as follows: (i) 100,000 shares of Common Stock as of Original Issue Date, (ii) contingently for an additional 100,000 shares of Common Stock as of October 31, 2024, if, as of such date, the Company has not repaid in full its obligations under the Big Debenture, and (iii) contingently for an &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;additional 200,000 shares of Common Stock as of January 29, 2025, if, as of such date, the Company has not repaid in full its obligations under the Big Debenture.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Small Warrant is exercisable, at an exercise price of $1.71 per share, as follows: (i) 22,727 shares of Common Stock as of Original Issue Date, (ii) contingently for an additional 22,727 shares of Common Stock as of October 31, 2024, if, as of such date, the Company has not repaid in full its obligations under the Small Debenture, and (iii) 45,455 shares of Common Stock as of January 29, 2025, if, as of such date, the Company has not repaid in full its obligations under the Small Debenture.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of November 1, 2024, the contingent second tranche of the Warrants vested.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each Investor is required to exercise the initial tranche of each Warrant within 15 days of the Original Issue Date.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon the vesting of each contingent tranche of a Warrant vest, each Investor shall exercise such vested, contingent tranche within 15 days of the vesting of such contingent tranche.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the Company consummates any equity or debt financing before satisfying in full its obligations under the Debentures, then 50% of every net dollar received by the Company from any such financing transaction shall be paid by the Company to the holders of the Debentures, on a pro rata basis, as a mandatory pre-payment thereof.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the event the Company has repaid all sums owing under a Debenture to the Investor, except for an amount equal to any non-conditional OID, the Company has the right, not the obligation, to exercise the vested portion of the Warrant held by the Debenture holder through a set-off of any or all such unpaid OID, on a dollar-for-dollar basis.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Warrants also feature a &#x201c;cashless&#x201d; exercise provision.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In lieu of making the cash payment otherwise contemplated to be made to the Company upon exercise of a Warrant in payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the net number of shares of Common Stock determined according to a formula set forth in the Warrant. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of the year ended December&#160;28, 2024, the non-affiliated Investor exercised the Big Warrant for a total of 200,000 shares of the Company&#x2019;s common stock, and the other two non-affiliated Investors exercised the Small Warrant for a total of 90,908 shares (see Note 18). Additionally, during the fourth quarter of the year ended December&#160;28, 2024, these unaffiliated third-parties agreed to convert a portion their respective investment into Future Equity Agreements of the Company&#x2019;s subsidiary, Alyea Therapeutics and, consequently, approximately $1.3 million was reclassified as non-controlling interest. As of December&#160;28, 2024, the outstanding balance due on the debentures was approximately $500,000, consisting of principal and accrued interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline"&gt;Corporate Fixed Deposit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September&#160;19, 2024, ALT5 Subsidiary and an investor entered into a 12-month Corporate Fixed Deposit Agreement, pursuant to which ALT5 Subsidiary borrowed $1.5 million at an interest rate of 12% per annum, payable monthly, calculated on the then-unpaid principal amount.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon maturity, ALT5 Subsidiary is obligated to repay the principal amount in full and any accrued and unpaid interest.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The principal may be repaid in full, but not in part, with a pre-payment penalty equivalent to three month&#x2019;s of interest. As of December&#160;28, 2024, the outstanding balance was $1.5 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="c-1" id="f-863">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debentures outstanding as of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;28, 2024 and December&#160;30, 2023 consisted for the following (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest rate of 15%, maturity date of June 30, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total debentures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt as of December&#160;28, 2024 and December&#160;30, 2023 consisted of the following (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Legacy subsidiary fixed deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Legacy subsidiary loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unaffiliated third-party&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total notes payable, related parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total long-term notes payable, related parties&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-179" decimals="2" id="f-864" unitRef="number">0.15</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-180" decimals="2" id="f-865" unitRef="number">0.15</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt contextRef="c-179" decimals="-3" id="f-866" unitRef="usd">563000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-180" decimals="-3" id="f-867" unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-181" decimals="-3" id="f-868" unitRef="usd">563000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-182" decimals="-3" id="f-869" unitRef="usd">0</us-gaap:LongTermDebt>
    <alts:DebtInstrumentNumberOfDebenturesIssued
      contextRef="c-183"
      decimals="INF"
      id="f-870"
      unitRef="debenture">39</alts:DebtInstrumentNumberOfDebenturesIssued>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-184" decimals="2" id="f-871" unitRef="number">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-185" decimals="2" id="f-872" unitRef="number">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <alts:DebtInstrumentNumberOfDebenturesRepaid
      contextRef="c-186"
      decimals="INF"
      id="f-873"
      unitRef="debenture">33</alts:DebtInstrumentNumberOfDebenturesRepaid>
    <us-gaap:RepaymentsOfDebt contextRef="c-186" decimals="-5" id="f-874" unitRef="usd">1100000</us-gaap:RepaymentsOfDebt>
    <us-gaap:LongTermDebt contextRef="c-187" decimals="-3" id="f-875" unitRef="usd">4247000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-188" decimals="-3" id="f-876" unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-189" decimals="-3" id="f-877" unitRef="usd">3782000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-190" decimals="-3" id="f-878" unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-191" decimals="-3" id="f-879" unitRef="usd">3508000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-192" decimals="-3" id="f-880" unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-193" decimals="-3" id="f-881" unitRef="usd">33000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-194" decimals="-3" id="f-882" unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-6" decimals="-3" id="f-883" unitRef="usd">11570000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-7" decimals="-3" id="f-884" unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent contextRef="c-6" decimals="-3" id="f-885" unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c-7" decimals="-3" id="f-886" unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-6" decimals="-3" id="f-887" unitRef="usd">11570000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-7" decimals="-3" id="f-888" unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-195" decimals="-5" id="f-889" unitRef="usd">4700000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-196" decimals="2" id="f-890" unitRef="number">0.13</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-197" decimals="2" id="f-891" unitRef="number">0.15</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="c-198" decimals="-3" id="f-892" unitRef="usd">475000</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:LongTermDebt contextRef="c-195" decimals="-5" id="f-893" unitRef="usd">4200000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-199" decimals="2" id="f-894" unitRef="number">0.15</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt contextRef="c-199" decimals="-5" id="f-895" unitRef="usd">3800000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c-200"
      decimals="INF"
      id="f-896"
      unitRef="usdPerShare">0.61</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-200" decimals="-5" id="f-897" unitRef="usd">1200000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="c-201" decimals="-2" id="f-898" unitRef="usd">548900</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="c-201"
      decimals="-3"
      id="f-899"
      unitRef="shares">900000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-202" decimals="-5" id="f-900" unitRef="usd">700000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c-203"
      decimals="INF"
      id="f-901"
      unitRef="usdPerShare">0.61</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-203" decimals="-5" id="f-902" unitRef="usd">1000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="c-204" decimals="-2" id="f-903" unitRef="usd">243900</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="c-204"
      decimals="-3"
      id="f-904"
      unitRef="shares">400000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-205" decimals="-5" id="f-905" unitRef="usd">800000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LossContingencyDamagesAwardedValue contextRef="c-206" decimals="0" id="f-906" unitRef="usd">433920</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue contextRef="c-207" decimals="0" id="f-907" unitRef="usd">18124</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-208" decimals="0" id="f-908" unitRef="usd">147956</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-208" decimals="2" id="f-909" unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c-208"
      decimals="2"
      id="f-910"
      unitRef="usdPerShare">2.60</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="c-209" decimals="-3" id="f-911" unitRef="usd">691000</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="c-209" decimals="0" id="f-912" unitRef="shares">265842</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <alts:NumberOfUnaffiliatedThirdPartyInvestors
      contextRef="c-210"
      decimals="INF"
      id="f-913"
      unitRef="investor">3</alts:NumberOfUnaffiliatedThirdPartyInvestors>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-211" decimals="-5" id="f-914" unitRef="usd">1800000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-212"
      decimals="-3"
      id="f-915"
      unitRef="shares">400000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-213" decimals="0" id="f-916" unitRef="usd">404454</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-214" decimals="0" id="f-917" unitRef="shares">90909</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-215" decimals="2" id="f-918" unitRef="number">0.01</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-216" decimals="2" id="f-919" unitRef="number">0.03</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-217" decimals="2" id="f-920" unitRef="number">0.04</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-210" decimals="-3" id="f-921" unitRef="usd">171000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <alts:DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions
      contextRef="c-210"
      decimals="INF"
      id="f-922"
      unitRef="addition">2</alts:DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-218" decimals="-3" id="f-923" unitRef="usd">171000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-219" decimals="-3" id="f-924" unitRef="usd">342000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt contextRef="c-210" decimals="-5" id="f-925" unitRef="usd">1300000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-218" decimals="-5" id="f-926" unitRef="usd">1400000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-219" decimals="-5" id="f-927" unitRef="usd">1800000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-220" decimals="0" id="f-928" unitRef="usd">38863</us-gaap:DebtInstrumentUnamortizedDiscount>
    <alts:DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions
      contextRef="c-220"
      decimals="INF"
      id="f-929"
      unitRef="addition">2</alts:DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-221" decimals="0" id="f-930" unitRef="usd">38863</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-222" decimals="0" id="f-931" unitRef="usd">77728</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt contextRef="c-220" decimals="0" id="f-932" unitRef="usd">288864</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-221" decimals="0" id="f-933" unitRef="usd">327726</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-222" decimals="0" id="f-934" unitRef="usd">404454</us-gaap:LongTermDebt>
    <alts:DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions
      contextRef="c-210"
      decimals="INF"
      id="f-935"
      unitRef="addition">2</alts:DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions>
    <alts:DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions
      contextRef="c-220"
      decimals="INF"
      id="f-936"
      unitRef="addition">2</alts:DebtInstrumentOriginalIssueDiscountNumberOfPotentialAdditions>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-223"
      decimals="2"
      id="f-937"
      unitRef="usdPerShare">1.71</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-224"
      decimals="-3"
      id="f-938"
      unitRef="shares">100000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-225"
      decimals="-3"
      id="f-939"
      unitRef="shares">100000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-226"
      decimals="-3"
      id="f-940"
      unitRef="shares">200000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-227"
      decimals="2"
      id="f-941"
      unitRef="usdPerShare">1.71</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-228" decimals="0" id="f-942" unitRef="shares">22727</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-229" decimals="0" id="f-943" unitRef="shares">22727</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-230" decimals="0" id="f-944" unitRef="shares">45455</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <alts:ClassOfWarrantOrRightExercisePeriod contextRef="c-231" id="f-945">P15D</alts:ClassOfWarrantOrRightExercisePeriod>
    <alts:ClassOfWarrantOrRightExercisePeriod contextRef="c-231" id="f-946">P15D</alts:ClassOfWarrantOrRightExercisePeriod>
    <alts:PercentageOfNetDollarReceivedToBeIssuedToDebentureHoldersOnAProRataBasis contextRef="c-231" decimals="2" id="f-947" unitRef="number">0.50</alts:PercentageOfNetDollarReceivedToBeIssuedToDebentureHoldersOnAProRataBasis>
    <alts:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="c-232"
      decimals="-3"
      id="f-948"
      unitRef="shares">200000</alts:StockIssuedDuringPeriodSharesWarrantsExercised>
    <alts:StockIssuedDuringPeriodSharesWarrantsExercised contextRef="c-233" decimals="0" id="f-949" unitRef="shares">90908</alts:StockIssuedDuringPeriodSharesWarrantsExercised>
    <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="c-234" decimals="-5" id="f-950" unitRef="usd">1300000</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:LongTermDebt contextRef="c-235" decimals="-3" id="f-951" unitRef="usd">500000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentTerm contextRef="c-236" id="f-952">P12M</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-237" decimals="-5" id="f-953" unitRef="usd">1500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-237" decimals="2" id="f-954" unitRef="number">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt contextRef="c-238" decimals="-5" id="f-955" unitRef="usd">1500000</us-gaap:LongTermDebt>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-956">Related Party Debt&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt payable to related parties (see Note 20) as of December&#160;28, 2024 and December&#160;30, 2023 consisted of the following (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Isaac Capital Group&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Isaac Capital Group, 10% interest rate, matures December 31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Live Ventures Incorporated, 10% interest rate, matures December 31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Isaac Capital Group short-term demand advance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Novalk Apps SAA, LLP  short-term demand advance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total notes payable, related parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(812)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total long-term notes payable, related parties&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total future maturities of long-term debt to related parties is as follows (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:83.748%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Twelve months ending September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total future maturities of long-term debt, related parties&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Isaac Capital Group LLC&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February&#160;7, 2024, the Company amended its outstanding related party promissory obligations (the &#x201c;ICG Note&#x201d;) in favor of ICG to add a convertibility provision. In accordance with Nasdaq Rules, the per-share conversion price was set at $0.61, subject to standard adjustments for (i) stock dividends and splits, (ii) subsequent rights offerings, and (iii) pro rata distributions. The Company&#x2019;s board of directors provided its approvals of the amendments on February&#160;7, 2024. On March&#160;6, 2024, ICG entered into a Note Purchase Agreement with an otherwise unaffiliated third party, under which the third party acquired the ICG Note. The terms and conditions of the ICG Note were not modified in connection with its acquisition by the third party. The principal amount of the ICG Note on the date of acquisition was approximately $1.2 million. As of December&#160;28, 2024, the third party converted $183,000 of the Company&#x2019;s obligation under the ICG Note into 300,000 shares of the Company&#x2019;s common stock. As of December&#160;28, 2024, the amount outstanding on the ICG Note was approximately $0.3 million (see Note 20).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April&#160;18, 2024, ICG made a short-term demand advance to the Company in the amount of $100,000. The advance bears interest at a rate of 10% per annum until repaid. As of December&#160;28, 2024, the principal amount outstanding was $48,000 (see Note 20).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Live Ventures Incorporated&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February&#160;7, 2024, the Company amended its outstanding related party promissory obligations (the &#x201c;Live Note&#x201d;) in favor of Live Ventures to add a convertibility provision. In accordance with Nasdaq Rules, the per-share conversion price for each obligation, as amended, was set at $0.61, subject to standard adjustments for (i) stock dividends and splits, (ii) subsequent rights offerings, and (iii) pro rata distributions. The Company&#x2019;s board of directors provided its final approvals of the amendments on February&#160;7, 2024. On March&#160;6, 2024, Live Ventures entered into a Note Purchase Agreement with another otherwise unaffiliated third party, under which under which the third party acquired the Live Note. The terms and conditions of the acquired Live Note were not modified in connection with its acquisition by the third party. The principal amount of the Live Note on the date of acquisition was approximately $1.0 million. As of December&#160;28, 2024, the third party converted $183,000 of the Company&#x2019;s obligation under the Live Note into 300,000 shares of the Company&#x2019;s common stock. As of December&#160;28, 2024, the amount outstanding on the Live Note was approximately $0.3 million (see Note 20).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Jon Isaac&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March&#160;4, 2024, the Company entered into a two-year Consulting Agreement with Jon Isaac, pursuant to which he will provide to the Company (the &#x201c;Services&#x201d;): (i) strategic financial advice, including growth strategies, capital allocation, and financial restructuring; (ii) sales and business development advice, including for the acquisition of new clients and new products through networking, referrals, and marketing efforts for our prospective products; (iii) in-depth research and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;market intelligence on specific industries, sectors, and market trends; (iv) financial models and financial analysis to support strategic decision-making; (v) assistance, through site visits, in the preparation of new client offers and bids for proposed projects; (vi) weekly update calls with management to align on progress of objectives and goals; (vii) enhanced non-confidential materials; (viii) business risk management support; and (ix) other services to which the Company and he may agree that will be memorialized in writing if, when, and as needed during the two-year term. In connection with the Consulting Agreement, the Company entered into a a two-year, straight 10% convertible promissory note in the initial principal amount of $500,000, and a per-share conversion price equivalent to the per-share value of the restricted common stock that he was granted ($1.16). The maturity date of the promissory note is March&#160;4, 2026. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December&#160;23, 2024, pursuant to the terms of his Consulting Agreement, Mr. Isaac converted the principal and accrued interest on the convertible promissory note, in the amount of approximately $540,000, into 465,753 shares of the Company&#x2019;s common stock. As of December&#160;28, 2024, there was no principal balance outstanding on the promissory note (see Note 20).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Novalk Apps SAA, LLP&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May&#160;28, 2024 and June&#160;3, 2024, Novalk Apps SAA, LLP (&#x201c;Novalk&#x201d;) made short-term demand advances in the amount of $120,000 and $100,000, respectively, to the Company. The advances bears interest at a rate of 10% per annum until repaid. As of December&#160;28, 2024, the principal amount outstanding was $110,000 (see Note 20).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Tony Isaac&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During June&#160;3, 2024, Tony Isaac made a number of short-term demand advances in the aggregate amount of $62,000 to the Company. The advances bears interest at a rate of 10% per annum until repaid. As of December&#160;28, 2024, the principal amount outstanding was fully repaid (see Note 20).&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="c-1" id="f-957">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt payable to related parties (see Note 20) as of December&#160;28, 2024 and December&#160;30, 2023 consisted of the following (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Isaac Capital Group&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Isaac Capital Group, 10% interest rate, matures December 31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Live Ventures Incorporated, 10% interest rate, matures December 31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Isaac Capital Group short-term demand advance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Novalk Apps SAA, LLP  short-term demand advance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total notes payable, related parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(812)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total long-term notes payable, related parties&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-239" decimals="-3" id="f-958" unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-240" decimals="-3" id="f-959" unitRef="usd">707000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-241" decimals="2" id="f-960" unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-242" decimals="2" id="f-961" unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-241" decimals="-3" id="f-962" unitRef="usd">327000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-242" decimals="-3" id="f-963" unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-243" decimals="2" id="f-964" unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-244" decimals="2" id="f-965" unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-243" decimals="-3" id="f-966" unitRef="usd">327000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-244" decimals="-3" id="f-967" unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-245" decimals="-3" id="f-968" unitRef="usd">48000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-246" decimals="-3" id="f-969" unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-247" decimals="-3" id="f-970" unitRef="usd">110000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-248" decimals="-3" id="f-971" unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-249" decimals="-3" id="f-972" unitRef="usd">812000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-250" decimals="-3" id="f-973" unitRef="usd">707000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebtCurrent contextRef="c-249" decimals="-3" id="f-974" unitRef="usd">812000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c-250" decimals="-3" id="f-975" unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-249" decimals="-3" id="f-976" unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-250" decimals="-3" id="f-977" unitRef="usd">707000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="c-1" id="f-978">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total future maturities of long-term debt to related parties is as follows (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:83.748%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Twelve months ending September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total future maturities of long-term debt, related parties&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="c-251" decimals="-3" id="f-979" unitRef="usd">812000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebt contextRef="c-251" decimals="-3" id="f-980" unitRef="usd">812000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c-252"
      decimals="INF"
      id="f-981"
      unitRef="usdPerShare">0.61</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-252" decimals="-5" id="f-982" unitRef="usd">1200000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="c-253" decimals="-3" id="f-983" unitRef="usd">183000</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="c-254"
      decimals="-3"
      id="f-984"
      unitRef="shares">300000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-255" decimals="-5" id="f-985" unitRef="usd">300000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:ProceedsFromShortTermDebt contextRef="c-256" decimals="-3" id="f-986" unitRef="usd">100000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-257" decimals="2" id="f-987" unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-258" decimals="2" id="f-988" unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-259" decimals="2" id="f-989" unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-257" decimals="-3" id="f-990" unitRef="usd">48000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c-260"
      decimals="INF"
      id="f-991"
      unitRef="usdPerShare">0.61</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-260" decimals="-5" id="f-992" unitRef="usd">1000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="c-261" decimals="-3" id="f-993" unitRef="usd">183000</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="c-262"
      decimals="-3"
      id="f-994"
      unitRef="shares">300000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-263" decimals="-3" id="f-995" unitRef="usd">300000</us-gaap:DebtInstrumentCarryingAmount>
    <alts:RelatedPartyTransactionConsultingAgreementTerm contextRef="c-264" id="f-996">P2Y</alts:RelatedPartyTransactionConsultingAgreementTerm>
    <alts:RelatedPartyTransactionConsultingAgreementTerm contextRef="c-264" id="f-997">P2Y</alts:RelatedPartyTransactionConsultingAgreementTerm>
    <us-gaap:DebtInstrumentTerm contextRef="c-265" id="f-998">P2Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-266" decimals="2" id="f-999" unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-266" decimals="-3" id="f-1000" unitRef="usd">500000</us-gaap:DebtInstrumentFaceAmount>
    <alts:RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice
      contextRef="c-267"
      decimals="2"
      id="f-1001"
      unitRef="usdPerShare">1.16</alts:RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice>
    <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="c-268" decimals="-3" id="f-1002" unitRef="usd">540000</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="c-268"
      decimals="0"
      id="f-1003"
      unitRef="shares">465753</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-269" decimals="-3" id="f-1004" unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:ProceedsFromShortTermDebt contextRef="c-270" decimals="-3" id="f-1005" unitRef="usd">120000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt contextRef="c-271" decimals="-3" id="f-1006" unitRef="usd">100000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-272"
      decimals="2"
      id="f-1007"
      unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-273"
      decimals="2"
      id="f-1008"
      unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-274"
      decimals="2"
      id="f-1009"
      unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-275"
      decimals="2"
      id="f-1010"
      unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ShortTermBorrowings contextRef="c-274" decimals="-3" id="f-1011" unitRef="usd">110000</us-gaap:ShortTermBorrowings>
    <us-gaap:ProceedsFromShortTermDebt contextRef="c-276" decimals="-3" id="f-1012" unitRef="usd">62000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-277"
      decimals="2"
      id="f-1013"
      unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-278"
      decimals="2"
      id="f-1014"
      unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-279"
      decimals="2"
      id="f-1015"
      unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:PreferredStockTextBlock contextRef="c-1" id="f-1016">Preferred Stock&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Series A-1 Convertible Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;History&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August&#160;18, 2017, the Company acquired GeoTraq by way of merger. In connection with this transaction, the Company tendered to the owners of GeoTraq $200,000, issued to them an aggregate of 288,588 shares (number of shares specific &#x2013; not rounded) of the Company&#x2019;s Series A Convertible Preferred Stock valued at $12.3 million, including the beneficial conversion feature of $2.6 million, and entered into one-year unsecured promissory notes in the aggregate principal amount of $800,000.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Conversion&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The &#x201c;Conversion Ratio&#x201d; per share of the Series A-1 Convertible Preferred Stock in connection with any conversion shall be at a ratio of 20:1, one share of Series A-1 Convertible Preferred Stock, if and when converted into shares of Common Stock, shall convert into twenty shares Common Stock. Each holder shall have the right, exercisable at any time and from time to time (unless otherwise prohibited by law, rule, or regulation, or as restricted below), to convert any or all of such holder&#x2019;s shares of Series A-1 Convertible Preferred Stock into shares of Common Stock at the Conversion Ratio.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;28, 2024 and December&#160;30, 2023, 0 and 27,353 shares of the Company&#x2019;s Series A-1 Convertible Preferred Stock were converted into 0 and 547,069 shares, respectively, of the Company&#x2019;s common stock. Additionally, during the year ended December&#160;28, 2024, 0 shares of the Company&#x2019;s Series A-1 Convertible Preferred Stock were forfeited. As of December&#160;28, 2024 and December&#160;30, 2023, there were 23,480 and 193,730 shares, respectively, of Series A-1 Convertible Preferred Stock outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company cannot declare, pay or set aside any dividends on shares of any other class or series of our capital stock unless (in addition to the obtaining of any consents required by our Articles of Incorporation) the holders of the Series A Convertible Preferred Stock then outstanding shall first receive, or simultaneously receive, a dividend in the aggregate amount of one dollar, regardless of the number of then-issued and outstanding shares of Series A Convertible Preferred Stock. Any remaining dividends allocated by the Board of Directors shall be distributed in an equal amount per share to the holders of outstanding common stock and Series A-1 Convertible Preferred Stock (on an as-if-converted to common stock basis pursuant to the Conversion Ratio as defined below).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Voting Rights&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each holder of a share of Series A Convertible Preferred Stock has a number of votes as is determined by multiplying (i) the number of shares of Series A Preferred Stock held by such holder, and (ii) 17. The holders of Series A-1 Convertible Preferred Stock vote together with all other classes and series of common and preferred stock of the Company as a single class on all actions to be taken by the common stockholders of the Company, except to the extent that voting as a separate class or series is required by law.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Redemption&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Series A-1 Convertible Preferred Stock has no redemption rights by the Company, or any other entity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Preemptive Rights&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the Series A-1 Convertible Preferred Stock and holders of ALT5 Sigma Corporation&#x2019;s common stock are not entitled to any preemptive, subscription, or similar rights in respect of any securities of the Company, except as set forth in the Amended and Restated Series A-1 Certificate of Designation or in any other document agreed to by ALT5 Sigma Corporation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Protective Provisions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Without first obtaining the affirmative approval of a majority of the holders of the shares of Series A-1 Convertible Preferred Stock, the Company may not directly or indirectly (i) increase or decrease (other than by redemption or conversion) the total number of authorized shares of Series A-1 Convertible Preferred Stock; (ii) effect an exchange, reclassification, or cancellation of all or a part of the Series A-1 Convertible Preferred Stock, but excluding a stock split or &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;reverse stock split or combination of the common stock or preferred stock; (iii) effect an exchange, or create a right of exchange, of all or part of the shares of another class of shares into shares of Series A-1 Convertible Preferred Stock; or (iv) alter or change the rights, preferences or privileges of the shares of Series A-1 Convertible Preferred Stock so as to affect adversely the shares of such series, including the rights set forth in this Designation; provided, however, that we may, without any vote of the holders of shares of the Series A-1 Convertible Preferred Stock, make technical, corrective, administrative or similar changes to the Amended and Restated Series A-1 Certificate of Designation that do not, individually or in the aggregate, materially adversely affect the rights or preferences of the holders of shares of the Series A-1 Convertible Preferred Stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Series B Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;History&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May&#160;15, 2024 the Company acquired acquired its ALT5 Subsidiary by way of merger (see Note 3). the Company tendered to the owners of ALT5 Subsidiary 34,250 shares of the Company&#x2019;s Series B Preferred Stock valued at approximately $8.6 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Conversion&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Series B Preferred Stock are not be convertible into any class or series of capital stock of the Company. As of the year ended December&#160;28, 2024, 34,207 shares of Series B Preferred Stock were outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company shall not declare, pay, or set aside any dividends on shares of Series B Preferred Stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Voting Rights&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Except as required by the General Corporation Law of the State of Nevada, the Series B Preferred Stock shall not have any voting rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Redemption&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Series B Preferred Stock has no redemption rights by ALT5 Sigma Corporation, or any other entity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Preemptive Rights&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of Series B Preferred Stock and holders of Common Stock are not be entitled to any preemptive, subscription, or similar rights in respect of any securities of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Protective Provisions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Without first obtaining the affirmative approval of a majority of the holders of the shares of Series B Preferred Stock, the Company may not directly or indirectly (i) increase or decrease (other than by redemption or conversion) the total number of authorized shares of Series B Preferred Stock; (ii) effect an exchange, reclassification, or cancellation of all or a part of the Series B Preferred Stock, but excluding a stock split or reverse stock split or combination of the common stock or preferred stock; (iii) effect an exchange, or create a right of exchange, of all or part of the shares of another class of shares into shares of Series B Preferred Stock; (iv) permit the convertibility, whether mandatory or permissible, of some or all of the then-outstanding shares of Series B Preferred Stock, or (v) alter or change the rights, preferences or privileges of the shares of Series B Preferred Stock so as to affect adversely the shares of such series, including the rights set forth in this Designation; provided, however, that we may, without any vote of the holders of shares of the Series B Preferred Stock, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;make technical, corrective, administrative or similar changes that do not, individually or in the aggregate, materially adversely affect the rights or preferences of the holders of shares of the Series B Preferred Stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Series I Convertible Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;History&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with its acquisition of ALT5 Subsidiary (see Note 3), on December&#160;2, 2024, the Company tendered 17,000 shares of Series I Convertible Preferred Stock to two consultants of ALT5 Subsidiary.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Conversion&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Series I Convertible Preferred Stock is subject to a mandatory eight-calendar-quarter leak-out, such that no more than twelve-and-one-half percent of the shares may be converted into shares of the Company&#x2019;s common stock on a trailing quarterly basis over a period of two years, and are subject to vesting provisions. The conversion ratio per share of the Series I Convertible Preferred Stock shall be one hundred shares of the Company&#x2019;s common stock for each share of Series &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;I Convertible Preferred Stock subject to certain adjustments. As of the year ended December&#160;28, 2024, 17,000 shares of Series I Convertible Preferred Stock were outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following the Original Issue Date, the holders of this series of Preferred Stock shall be entitled to receive dividends on an as-converted into-Common Stock basis contemporaneously with the declaration and payment to the holders of Common Stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Voting Rights&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Except as required by the General Corporation Law of the State of Nevada, the Series I Convertible Preferred Stock shall not have any voting rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Redemption&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Certificate of Designation for the Series I Convertible Preferred Stock does not provide any redemption rights by ALT5 Sigma Corporation, or any other entity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Preemptive Rights&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Certificate of Designation for the Series I Convertible Preferred Stock does not provide the holders thereof with any preemptive, subscription, or similar rights in respect of any securities of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Protective Provisions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Certificate of Designation for the Series I Convertible Preferred Stock does not provide the holders thereof with any protective provisions in their favor for so long as shares of such series remain outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Series M Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;History&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with its acquisition of ALT5 Subsidiary (see Note 3), the Company issued 3,200 shares of Series M Preferred Stock to two entities that acted as finders for the transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Conversion&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Series M Preferred Stock shall not be convertible into any class or series of capital stock of the Company. As of the year ended December&#160;28, 2024, 3,200 shares of Series M Preferred Stock were outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company shall not declare, pay, or set aside any dividends on shares of Series M Preferred Stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Voting Rights&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Except as required by the General Corporation Law of the State of Nevada, the Series M Preferred Stock shall not have any voting rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Redemption&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Series M Preferred Stock has no redemption rights by ALT5 Sigma Corporation, or any other entity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Preemptive Rights&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of Series M Preferred Stock and holders of Common Stock shall not be entitled to any preemptive, subscription, or similar rights in respect of any securities of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Protective Provisions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Without first obtaining the affirmative approval of a majority of the holders of the shares of Series M Preferred Stock, the Company may not directly or indirectly (i) increase or decrease (other than by redemption or conversion) the total number of authorized shares of Series M Preferred Stock; (ii) effect an exchange, reclassification, or cancellation of all or a part of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Series M Preferred Stock, but excluding a stock split or reverse stock split or combination of the common stock or preferred stock; (iii) effect an exchange, or create a right of exchange, of all or part of the shares of another class of shares into shares of Series M Preferred Stock; (iv) permit the convertibility, whether mandatory or permissible, of some or all of the then-outstanding shares of Series M Preferred Stock, or (v) alter or change the rights, preferences or privileges of the shares of Series M Preferred Stock so as to affect adversely the shares of such series, including the rights set forth in this Designation; provided, however, that we may, without any vote of the holders of shares of the Series M Preferred Stock, make technical, corrective, administrative or similar changes that do not, individually or in the aggregate, materially adversely affect the rights or preferences of the holders of shares of the Series M Preferred Stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Series Q Convertible Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;History&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November&#160;6, 2024 acquired the Qodex Cryptocurrency Exchange Software platform and other related assets from Qoden Technologies, LLC by way of an asset purchase agreement (see Note 3). The Company tendered to the owners of Qoden Technologies, LLC 771,010 shares of the Company&#x2019;s Series Q Convertible Preferred Stock valued at approximately $1.3 million. Additionally, the Company tendered and additional 154,202 shares of the Company&#x2019;s Series Q Convertible Preferred Stock to a third-party contractor to act as a consultant in implementing and enhancing the platform.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Conversion&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Series Q Convertible Preferred Stock was valued at $2.594 per share on the date issued, and is subject to a mandatory eight-calendar-quarter leak-out, such that no more than twelve-and-one-half percent of the shares may be converted into shares of the Company&#x2019;s common stock on a trailing quarterly basis over a period of two years, and are subject to vesting provisions. The conversion ratio per share of the Series Q Convertible Preferred Stock shall be one share of the Company&#x2019;s common stock for each share of Series Q Convertible Preferred Stock subject to certain adjustments. As of the year ended December&#160;28, 2024, 925,212 shares of Series Q Convertible Preferred Stock were outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following the Original Issue Date, holders of Series Q Convertible Preferred Stock shall not be entitled to receive any dividends.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Voting Rights&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Except as required by the General Corporation Law of the State of Nevada, the Series Q Convertible Preferred Stock shall not have any voting rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Redemption&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Series Q Convertible Preferred Stock has no redemption rights by ALT5 Sigma Corporation, or any other entity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Preemptive Rights&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of Series Q Convertible Preferred Stock and holders of Common Stock shall not be entitled to any preemptive, subscription, or similar rights in respect of any securities of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Protective Provisions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Without first obtaining the affirmative approval of a majority of the holders of the shares of Series Q Convertible Preferred Stock, the Company may not directly or indirectly (i) increase or decrease (other than by redemption or conversion) the total number of authorized shares of Series Q Convertible Preferred Stock; (ii) effect an exchange, reclassification, or cancellation of all or a part of the Series Q Convertible Preferred Stock, but excluding a stock split or reverse stock split or combination of the common stock or preferred stock; (iii) effect an exchange, or create a right of exchange, of all or part of the shares of another class of shares into shares of Series Q Preferred Stock; (iv) permit the convertibility, whether mandatory or permissible, of some or all of the then-outstanding shares of Series B Preferred Stock, or (v) alter or change the rights, preferences or privileges of the shares of Series Q Convertible Preferred Stock so as to affect adversely the shares of such series, including the rights set forth in this Designation; provided, however, that we may, without any vote of the holders of shares of the Series Q Convertible Preferred Stock, make technical, corrective, administrative or similar &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;changes that do not, individually or in the aggregate, materially adversely affect the rights or preferences of the holders of shares of the Series Q Convertible Preferred Stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Series V Convertible Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;History&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May&#160;4, 2024, entered into an Asset Purchase Agreement for the purchase of specified assets of an unaffiliated third-party (see Note 18). In connection with this transaction, the Company tendered 5,000 shares of the Company's Series V Convertible Preferred Stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Conversion&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The conversion ratio per share of the Series V Convertible Preferred Stock in connection with any Conversion shall be at a ratio of 1:1, meaning every one share of Series V Convertible Preferred Stock, if and when converted into shares of Common Stock, shall convert into one share of Common Stock. Each Holder shall have the right, exercisable at any time and from time to time, unless otherwise prohibited by law, rule, or regulation, to convert any or all of such Holder&#x2019;s shares of Series V Convertible Preferred Stock into shares of Common Stock at the Conversion Ratio. As of the year ended December&#160;28, 2024, 5,000 shares of Series Q Convertible Preferred Stock were outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares of Series V Convertible Preferred Stock do not have dividend rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Voting Rights&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Holder of each share of Series V Convertible Preferred Stock shall have such number of votes as is determined by multiplying (a) the number of shares of Series V Convertible Preferred Stock held by such Holder by (b) one. Such voting calculation is hereby authorized by the Company and the Company acknowledges such calculation may result in the total number of possible votes cast by the Series V Convertible Preferred Stock Holders and all other classes of the Company&#x2019;s Common Stock in any given voting matter exceeding the total aggregate number of shares that this Company shall have authority to issue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Redemption&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Series V Convertible Preferred Stock has no redemption rights by ALT5 Sigma Corporation, or any other entity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Preemptive Rights&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of Series V Convertible Preferred Stock and holders of Common Stock shall not be entitled to any preemptive, subscription, or similar rights in respect of any securities of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Protective Provisions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Without first obtaining the affirmative approval of a majority of the holders of the shares of Series V Convertible Preferred Stock, the Company may not directly or indirectly (i) increase or decrease (other than by redemption or conversion) the total number of authorized shares of Series V Convertible Preferred Stock; (ii) effect an exchange, reclassification, or cancellation of all or a part of the Series V Convertible Preferred Stock, but excluding a stock split or reverse stock split or combination of the common stock or preferred stock; (iii) effect an exchange, or create a right of exchange, of all or part of the shares of another class of shares into shares of Series V Preferred Stock; (iv) permit the convertibility, whether mandatory or permissible, of some or all of the then-outstanding shares of Series V Preferred Stock, or (v) alter or change the rights, preferences or privileges of the shares of Series V Convertible Preferred Stock so as to affect adversely the shares of such series, including the rights set forth in this Designation; provided, however, that we may, without any vote of the holders of shares of the Series V Convertible Preferred Stock, make technical, corrective, administrative or similar &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;changes that do not, individually or in the aggregate, materially adversely affect the rights or preferences of the holders of shares of the Series V Convertible Preferred Stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Series S Convertible Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;History&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 28, 2022 the Company acquired Soin Therapeutics by way of merger. In connection with this transaction, with a potential value of up to $30 million, the Company tendered 100,000 shares of the Company's Series S Convertible Preferred Stock. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Conversion&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Initially, Dr. Soin was entitled to convert up to three million dollars of value of the Series S Stock into shares of the Company&#x2019;s common stock commencing one year from the closing and may also convert up to an additional $10 million of value of the Series S Stock into shares of the Company's common stock from and after the sooner of (y) the issuance by the FDA of New Drug Approval for low-dose naltrexone for treating pain or (z) 10 years from the closing. Further, during the 10-year period following the closing, Dr. Soin may convert up to an additional $17 million of value at a rate of five percent of the gross revenues that the Company receives in connection with sales or license revenue from the product.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dr. Soin further agreed to certain restrictions on the maximum number of shares of Series S Stock that he may ultimately keep or that he may convert into shares of our common stock or sell into the public markets at any given time: (i) Dr. Soin may not convert shares of Series S Stock into shares of the Company's common stock in an amount such that, upon any such conversion, he beneficially own shares of the Company's common stock in excess of 4.99% of the Company's then-outstanding common stock and (ii) during the five-year period that commences on the date that Dr. Soin is first eligible to convert any shares of Series S Stock into shares of the Company's common stock, he will not dispose of any of such shares into the public markets in an amount that exceeds five percent of the daily trading volume of the Company's common stock during any trading day.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares of Series S Convertible Preferred Stock are convertible into the Company&#x2019;s common shares at a ratio of 1:1. During the year ended December&#160;28, 2024, in connection with the amended agreement disclosed in Note 3, the Company reclassified approximately $2.7&#160;million from mezzanine equity to current liabilities, and approximately $8.0&#160;million from mezzanine equity to permanent equity (see Note 3). As of December&#160;28, 2024 and December&#160;30, 2023, there were 100,000 shares of Series S Convertible Preferred Stock outstanding, as reflected in the following (dollars in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Series S Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance, December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,510&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reclassification to permanent equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7,993)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reclassification to current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,661)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance, December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares of Series S Convertible Preferred Stock do not have dividend rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Voting Rights&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Holder of each share of Series S Convertible Preferred Stock shall have one vote for such share. With respect to any stockholder vote, the Holder shall have full voting rights and powers equal to the voting rights and powers of the Common Stock stockholders, and shall be entitled to notice of any stockholders' meeting in accordance with the Bylaws of the Company, and shall be entitled to vote, together with Common Stock stockholders, with respect to any question upon which the Common Stock stockholders have the right to vote. The Holders of Series S Convertible Preferred Stock shall vote together with all other classes and series of common and preferred stock of the Company as a single class on all actions to be taken by the Common Stock stockholders, except to the extent that voting as a separate class or series is required by law.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Redemption&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Series S Convertible Preferred Stock has no redemption rights by ALT5 Sigma Corporation, or any other entity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Preemptive Rights&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the Series S Convertible Preferred Stock and holders of ALT5 Sigma Corporation common stock are not entitled to any preemptive, subscription, or similar rights in respect of any securities of ALT5 Sigma Corporation, except as set forth in the Amended and Restated Series A-1 Certificate of Designation or in any other document agreed to by ALT5 Sigma Corporation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Protective Provisions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Without first obtaining the affirmative approval of a majority of the holders of the shares of Series S Convertible Preferred Stock, the Company may not directly or indirectly (i) increase or decrease (other than by redemption or conversion) the total number of authorized shares of Series S Convertible Preferred Stock; (ii) effect an exchange, reclassification, or cancellation of all or a part of the Series S Convertible Preferred Stock, but excluding a stock split or reverse stock split or combination of the common stock or preferred stock; (iii) effect an exchange, or create a right of exchange, of all or part of the shares of another class of shares into shares of Series S Convertible Preferred Stock; (iv) issue additional shares of Series S Convertible Preferred Stock other than in connection with the merger agreement, or (v) alter or change the rights, preferences or privileges of the shares of Series S Convertible Preferred Stock so as to affect adversely the shares of such series, including the rights set forth in this Designation; provided, however, that we may, without any vote of the holders of shares of the Series S Convertible Preferred Stock, make technical, corrective, administrative or similar changes to the Amended and Restated Series S Certificate of Designation that do not, individually or in the aggregate, materially adversely affect the rights or preferences of the holders of shares of the Series S Convertible Preferred Stock.&lt;/span&gt;&lt;/div&gt;</us-gaap:PreferredStockTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="c-280" decimals="-3" id="f-1017" unitRef="usd">200000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-280"
      decimals="0"
      id="f-1018"
      unitRef="shares">288588</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="c-281" decimals="-5" id="f-1019" unitRef="usd">12300000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <alts:BusinessCombinationConsiderationTransferredBeneficialConversionFeatureValue contextRef="c-282" decimals="-5" id="f-1020" unitRef="usd">2600000</alts:BusinessCombinationConsiderationTransferredBeneficialConversionFeatureValue>
    <alts:BusinessCombinationConsiderationTransferredLiabilitiesIncurredTerm contextRef="c-280" id="f-1021">P1Y</alts:BusinessCombinationConsiderationTransferredLiabilitiesIncurredTerm>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred contextRef="c-280" decimals="-3" id="f-1022" unitRef="usd">800000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:PreferredStockConvertibleConversionRatio
      contextRef="c-283"
      decimals="INF"
      id="f-1023"
      unitRef="number">20</us-gaap:PreferredStockConvertibleConversionRatio>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="c-283"
      decimals="0"
      id="f-1024"
      unitRef="shares">0</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="c-284"
      decimals="0"
      id="f-1025"
      unitRef="shares">27353</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="c-285"
      decimals="0"
      id="f-1026"
      unitRef="shares">0</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="c-286"
      decimals="0"
      id="f-1027"
      unitRef="shares">547069</us-gaap:ConversionOfStockSharesIssued1>
    <alts:ConversionOfStockSharesForfeited
      contextRef="c-285"
      decimals="0"
      id="f-1028"
      unitRef="shares">0</alts:ConversionOfStockSharesForfeited>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-283"
      decimals="0"
      id="f-1029"
      unitRef="shares">23480</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-284"
      decimals="0"
      id="f-1030"
      unitRef="shares">193730</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-287"
      decimals="INF"
      id="f-1031"
      unitRef="shares">34250</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="c-108" decimals="-5" id="f-1032" unitRef="usd">8600000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-12"
      decimals="INF"
      id="f-1033"
      unitRef="shares">34207</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-288"
      decimals="0"
      id="f-1034"
      unitRef="shares">17000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <alts:NumberOfConsultants
      contextRef="c-289"
      decimals="INF"
      id="f-1035"
      unitRef="consultant">2</alts:NumberOfConsultants>
    <alts:CommonStockConversionValidConversionPeriod contextRef="c-290" id="f-1036">P2Y</alts:CommonStockConversionValidConversionPeriod>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-14" decimals="0" id="f-1037" unitRef="shares">17000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-109"
      decimals="-2"
      id="f-1038"
      unitRef="shares">3200</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-16"
      decimals="-2"
      id="f-1039"
      unitRef="shares">3200</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-291"
      decimals="INF"
      id="f-1040"
      unitRef="shares">771010</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="c-292" decimals="-5" id="f-1041" unitRef="usd">1300000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-292"
      decimals="INF"
      id="f-1042"
      unitRef="shares">154202</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <alts:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare
      contextRef="c-293"
      decimals="3"
      id="f-1043"
      unitRef="usdPerShare">2.594</alts:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuablePerShare>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-18"
      decimals="INF"
      id="f-1044"
      unitRef="shares">925212</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-294"
      decimals="INF"
      id="f-1045"
      unitRef="shares">5000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-20"
      decimals="INF"
      id="f-1046"
      unitRef="shares">5000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned contextRef="c-295" decimals="-6" id="f-1047" unitRef="usd">30000000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-296"
      decimals="0"
      id="f-1048"
      unitRef="shares">100000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <alts:ConversionOfStockAmountConvertible contextRef="c-297" decimals="-6" id="f-1049" unitRef="usd">3000000</alts:ConversionOfStockAmountConvertible>
    <alts:ConversionOfStockCommencementPeriod contextRef="c-298" id="f-1050">P1Y</alts:ConversionOfStockCommencementPeriod>
    <alts:ConversionOfStockAmountConvertible contextRef="c-299" decimals="-6" id="f-1051" unitRef="usd">10000000</alts:ConversionOfStockAmountConvertible>
    <alts:ConversionOfStockPeriodFollowingClosing contextRef="c-300" id="f-1052">P10Y</alts:ConversionOfStockPeriodFollowingClosing>
    <alts:ConversionOfStockPeriodFollowingClosing contextRef="c-300" id="f-1053">P10Y</alts:ConversionOfStockPeriodFollowingClosing>
    <alts:ConversionOfStockAmountConvertible contextRef="c-301" decimals="-6" id="f-1054" unitRef="usd">17000000</alts:ConversionOfStockAmountConvertible>
    <alts:PercentageOfGrossRevenue
      contextRef="c-302"
      decimals="3"
      id="f-1055"
      unitRef="number">0.05</alts:PercentageOfGrossRevenue>
    <alts:CommonStockSharesOutstandingPercentage
      contextRef="c-303"
      decimals="4"
      id="f-1056"
      unitRef="number">0.0499</alts:CommonStockSharesOutstandingPercentage>
    <alts:ReclassificationOfTemporaryToCurrentLiabilities contextRef="c-304" decimals="-5" id="f-1057" unitRef="usd">2700000</alts:ReclassificationOfTemporaryToCurrentLiabilities>
    <us-gaap:ReclassificationsOfTemporaryToPermanentEquity contextRef="c-304" decimals="-5" id="f-1058" unitRef="usd">8000000</us-gaap:ReclassificationsOfTemporaryToPermanentEquity>
    <us-gaap:TemporaryEquityTableTextBlock contextRef="c-1" id="f-1059">As of December&#160;28, 2024 and December&#160;30, 2023, there were 100,000 shares of Series S Convertible Preferred Stock outstanding, as reflected in the following (dollars in $000&#x2019;s):&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Series S Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance, December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,510&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reclassification to permanent equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7,993)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reclassification to current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,661)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance, December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-9" decimals="0" id="f-1060" unitRef="shares">100000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-8" decimals="0" id="f-1061" unitRef="shares">100000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c-305"
      decimals="INF"
      id="f-1062"
      unitRef="shares">100000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c-305" decimals="-3" id="f-1063" unitRef="usd">14510000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c-8"
      decimals="INF"
      id="f-1064"
      unitRef="shares">100000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c-8" decimals="-3" id="f-1065" unitRef="usd">14510000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <alts:ReclassificationsOfTemporaryToPermanentEquityShares
      contextRef="c-304"
      decimals="INF"
      id="f-1066"
      unitRef="shares">0</alts:ReclassificationsOfTemporaryToPermanentEquityShares>
    <us-gaap:ReclassificationsOfTemporaryToPermanentEquity contextRef="c-304" decimals="-3" id="f-1067" unitRef="usd">7993000</us-gaap:ReclassificationsOfTemporaryToPermanentEquity>
    <alts:ReclassificationOfTemporaryToCurrentLiabilitiesShares
      contextRef="c-304"
      decimals="INF"
      id="f-1068"
      unitRef="shares">0</alts:ReclassificationOfTemporaryToCurrentLiabilitiesShares>
    <alts:ReclassificationOfTemporaryToCurrentLiabilities contextRef="c-304" decimals="-3" id="f-1069" unitRef="usd">2661000</alts:ReclassificationOfTemporaryToCurrentLiabilities>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c-9"
      decimals="INF"
      id="f-1070"
      unitRef="shares">100000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c-9" decimals="-3" id="f-1071" unitRef="usd">3856000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockConvertibleConversionRatio
      contextRef="c-9"
      decimals="INF"
      id="f-1072"
      unitRef="number">1</us-gaap:PreferredStockConvertibleConversionRatio>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock contextRef="c-1" id="f-1074">Stockholders&#x2019; Equity&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Common Stock&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: The Company's Articles of Incorporation authorize 200,000,000 shares of common stock that may be issued from time to time having such rights, powers, preferences and designations as the Board of Directors may determine. As of December&#160;28, 2024, and December&#160;30, 2023, there were 15,417,687 and 4,957,647&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;shares, respectively, of common stock issued and outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Equity Offerings:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March&#160;22, 2023, the Company entered into a Securities Purchase Agreement with certain institutional investors for the sale by the Company in a registered direct offering of 361,000 shares of the Company&#x2019;s common stock, par value $0.001 per share, at a purchase price per share of Common Stock of $1.17. The offering closed on March&#160;24, 2023. The aggregate gross proceeds for the sale of the shares of Common Stock were approximately $422,000, before deducting the placement agent fees and related expenses. The Company utilized the net proceeds for working capital and general corporate purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August&#160;18, 2023, the Company entered into a Securities Purchase Agreement with a certain institutional investor for the sale by the Company in a registered direct offering of: (i) 418,000 shares of the Company&#x2019;s common stock, par value $0.001 per share, at an offering price of $0.8811 per share and (ii) pre-funded warrants exercisable for up to 481,348 shares of Common Stock to the Investor at an offering price equal to $0.8801 per pre-funded Warrant. In connection with the Securities Purchase Agreement, during the year ended December&#160;28, 2024, the Company issued 27,738 shares of its common stock to three third-parties in exchange for brokerage services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February&#160;23, 2024, the Company entered into Unit Purchase Agreements with two otherwise unaffiliated third-party investors, pursuant to which each Investor agreed to purchase 408,163 units of securities from the Company, at a price per Unit of $0.7350, for an aggregate purchase price of $300,000 per investor for an aggregate price of $600,000. Each Unit consists of one share of the Company&#x2019;s common stock and one warrant to purchase an additional share of common stock. The per-Unit price is allocated as follows: $0.61 per share of common stock and $0.125 per Warrant. The Warrant has a three-year term and will be immediately exercisable. Each Warrant is exercisable at $0.61 per share. The Company utilized the proceeds from the Unit Purchases for its working capital needs. Further, the Company issued an additional 81,632 shares of its common stock to another party in exchange for brokerage services rendered.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March&#160;4, 2024, the Company entered into a two-year Consulting Agreement (the &#x201c;Consulting Agreement&#x201d;) with Jon Isaac, pursuant to which he will provide a variety of services to the Company. In connection with the Consulting Agreement, the Company issued to Mr. Isaac 200,000 restricted shares of its common stock (see Note 20).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March&#160;22, 2024, pursuant to the terms and conditions of a promissory note, the Company converted $183,000 of obligations into 300,000 shares of the Company&#x2019;s common stock (see Note 20).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March&#160;25, 2024, pursuant to the terms and conditions of a promissory note, the Company converted $183,000 of obligations into 300,000 shares of the Company&#x2019;s common stock (see Note 20).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April&#160;10, 2024, pursuant to the terms and conditions of a promissory note, the Company converted $60,900 of obligations into 100,000 shares of the Company&#x2019;s common stock (see Note 20).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April&#160;12, 2024, pursuant to the terms and conditions of a promissory note, the Company converted $60,900 of obligations into 100,000 shares of the Company&#x2019;s common stock (see Note 20).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May&#160;1, 2024, the Company entered into a Securities Purchase Agreement with two institutional investors for the sale by the Company of 79,782 units of the Company&#x2019;s securities at a purchase price of $3.775 per unit, each unit consisting of one share of the Company&#x2019;s common stock and one common stock purchase warrant for the purchase of an additional share of Common Stock. Each three-year warrant is exercisable immediately at an exercise price of $3.63 per share. The gross proceeds were approximately $300,000, before deducting related expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May&#160;4, 2024, the Company entered into an Asset Purchase Agreement for the purchase of specified assets of an unaffiliated third-party. For the purchase of the assets, the Company (i) issued 300,000 restricted shares of its common stock, (ii) issued 5,000 shares of its Series V Convertible Preferred Stock, and (iii) granted a three-year warrant for the purchase of up to 125,000 shares of its common stock at an exercise price of $1.25 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May&#160;15, 2024, the Company acquired ALT5 Subsidiary. As consideration under the acquisition, the Company issued 1,799,100 shares of its common stock to the legacy equity holders of the capital stock of ALT5 (see Note 3).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June&#160;3, 2024, the Company entered into a six-month marketing agreement with a non-affiliated third-party, pursuant to which the third-party will provide a variety of marketing-related services to the Company. In connection with the marketing agreement, the Company issued to the third-party 47,923 shares of its common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June&#160;6, 2024, the Company entered into a one-year consulting agreement with a non-affiliated third-party, pursuant to which the third party will provide a variety of finance and investor-related services to the Company. In connection with the marketing agreement, the Company issued to the third-party 150,000 shares of its common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September&#160;18, 2024, the Company entered into a six-month marketing agreement with a non-affiliated third-party, pursuant to which the third-party will provide a variety of marketing-related services to the Company. In connection with the marketing agreement, the Company issued to the third-party 20,000 shares of its common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During October 2024, the Company issued 225,000 shares of its common stock as prepayment of one year&#x2019;s interest on its Bitcoin loan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Big/Small Debenture (see Note 15), on October&#160;18, 2024, the Company issued an additional 25,000 shares of its common stock to another party in exchange for brokerage services rendered.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of the fiscal year ended December&#160;28, 2024, the Company issued 290,908 shares of its common stock related to the exercise of warrants under Big/Small Debenture (see Note 15).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July&#160;1, 2024, the Company entered into a one-year consulting agreement with a non-affiliated third-party, pursuant to which the third-party will provide a variety of communication-related consulting services to the Company. In connection with the marketing agreement, on December&#160;3, 2024&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company issued to the third-party 60,000 shares of its common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December&#160;23, 2024, pursuant to the terms of his Consulting Agreement, Mr. Isaac converted the existing obligation on the convertible promissory note, in the amount of approximately $540,000, into 465,753 shares of the Company&#x2019;s common stock (see Note 16).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December&#160;23, 2024, pursuant to the terms of the judgment and forbearance agreements, a non-affiliated third-party converted the existing obligation plus accrued interest due under the agreements, in the amount of approximately $691,000, into 265,842 shares of the Company&#x2019;s common stock (see Note 15).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;28, 2024, the Company issued an aggregate of 341,175 shares of its common stock to four individuals under the Company&#x2019;s 2023 Equity Incentive Plan. The aggregate value of the shares at issuance was approximately $1.3 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Equity Incentives&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: The Company&#x2019;s 2024 Plan, which was adopted by the Board in November 2024 and approved by the stockholders at the 2024 annual meeting of stockholders, replaces the 2023 Plan, which replaced the 2016 Plan, which replaced the 2011 Plan. Under the 2024 Plan, the maximum aggregate number of shares, which may be subject to or delivered under Awards granted under the Plan is 2,800,000 shares. Awards may be in the form of a Stock Award, Option, Stock Appreciation Right, Stock Unit, or Other Stock-based Award granted in accordance with the terms of the respective Plan. During the year ended December&#160;28, 2024, there were no grants under the 2024 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s 2023 Plan, which was adopted by the Board in August 2023 and approved by the stockholders at the 2023 Annual Meeting of Stockholders, replaces the 2016 Plan, which replaced the 2011 Plan. Under the 2023 Plan, the maximum aggregate number of shares, which may be subject to or delivered under Awards granted under the Plan is two million (2,000,000) shares. Awards may be in the form of a Stock Award, Option, Stock Appreciation Right, Stock Unit, or Other Stock-based Award granted in accordance with the terms of the respective Plan. During the year ended December&#160;28, 2024, the Company recognized $1.2 million and in share-based compensation expense related to the 908,852 RSU&#x2019;s that were awarded and immediately vested, as well as 295,000 shares of the Company&#x2019;s common stock issued (see above).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s 2016 Plan authorizes the granting of awards in any of the following forms: (i) incentive stock options, (ii) nonqualified stock options, (iii) restricted stock awards, and (iv) restricted stock units, and expires on the earlier of October&#160;28, 2026, or the date that all shares reserved under the 2016 Plan are issued or no longer available. On November&#160;4, 2020, the Company amended the 2016 Plan to increase the issuance of common shares from 400,000 to 800,000. The vesting period is determined by the Board of Directors at the time of the stock option grant. As of December&#160;28, 2024 and December&#160;30, 2023, 100,000 options were outstanding under the 2016 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s 2011 Plan authorizes the granting of awards in any of the following forms: (i) stock options, (ii) stock appreciation rights, and (iii) other share-based awards, including but not limited to, restricted stock, restricted stock units or performance shares, and expired on the earlier of May&#160;12, 2021, or the date that all shares reserved under the 2011 Plan are issued or no longer available. As of December&#160;28, 2024 and December&#160;30, 2023, 8,000 and 14,000 options, respectively, were outstanding under the 2011 Plan. No additional awards will be granted under the 2011 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock option activity for the fiscal years ended December&#160;28, 2024, and December&#160;30, 2023 (Aggregate Intrinsic Value in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Options &lt;br/&gt;Outstanding &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;110,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cancelled/expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,000)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding at December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;114,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cancelled/expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,000)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding at December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;108,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Exercisable at December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;60,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The exercise price for stock options outstanding and exercisable outstanding at December&#160;28, 2024 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.445%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.445%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.445%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.447%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Exercisable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Number of Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Exercise Price ($)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Number of Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Exercise Price ($)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;42,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$5.70 to $9.90&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$5.70 to $9.90&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;66,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$3.54 to $5.25&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$3.54 to $5.25&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;108,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;60,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized share-based compensation expense related to equity incentive awards of approximately $1.7 million and approximately $14,000 for the fiscal years ended December&#160;28, 2024, and December&#160;30, 2023, respectively. As of December&#160;28, 2024, the Company had no unrecognized share-based compensation expense, and there were no non-vested shares associated with stock option awards.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c-306"
      decimals="INF"
      id="f-1075"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-306"
      decimals="INF"
      id="f-1076"
      unitRef="shares">15417687</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-307"
      decimals="INF"
      id="f-1077"
      unitRef="shares">4957647</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-308"
      decimals="INF"
      id="f-1078"
      unitRef="shares">361000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-309"
      decimals="INF"
      id="f-1079"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-309"
      decimals="INF"
      id="f-1080"
      unitRef="usdPerShare">1.17</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromSaleOfInterestInPartnershipUnit contextRef="c-308" decimals="-3" id="f-1081" unitRef="usd">422000</us-gaap:ProceedsFromSaleOfInterestInPartnershipUnit>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-310"
      decimals="INF"
      id="f-1082"
      unitRef="shares">418000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-311"
      decimals="INF"
      id="f-1083"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-311"
      decimals="INF"
      id="f-1084"
      unitRef="usdPerShare">0.8811</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-312"
      decimals="INF"
      id="f-1085"
      unitRef="shares">481348</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-312"
      decimals="INF"
      id="f-1086"
      unitRef="usdPerShare">0.8801</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="c-313"
      decimals="INF"
      id="f-1087"
      unitRef="shares">27738</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <alts:NumberOfAgreementsToBePurchased
      contextRef="c-314"
      decimals="INF"
      id="f-1088"
      unitRef="investor">2</alts:NumberOfAgreementsToBePurchased>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-315"
      decimals="INF"
      id="f-1089"
      unitRef="shares">408163</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-314"
      decimals="3"
      id="f-1090"
      unitRef="usdPerShare">0.7350</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction contextRef="c-316" decimals="-3" id="f-1091" unitRef="usd">300000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-316" decimals="-3" id="f-1092" unitRef="usd">600000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <alts:SaleOfStockUnitCompositionNumberOfCommonSharesInEachUnit
      contextRef="c-316"
      decimals="INF"
      id="f-1093"
      unitRef="shares">1</alts:SaleOfStockUnitCompositionNumberOfCommonSharesInEachUnit>
    <alts:SaleOfStockUnitCompositionNumberOfWarrantsIssuedInEachUnit
      contextRef="c-316"
      decimals="INF"
      id="f-1094"
      unitRef="shares">1</alts:SaleOfStockUnitCompositionNumberOfWarrantsIssuedInEachUnit>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-314"
      decimals="2"
      id="f-1095"
      unitRef="usdPerShare">0.61</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <alts:ClassOfWarrantPricePerShare
      contextRef="c-316"
      decimals="3"
      id="f-1096"
      unitRef="usdPerShare">0.125</alts:ClassOfWarrantPricePerShare>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-314" id="f-1097">P3Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-314"
      decimals="2"
      id="f-1098"
      unitRef="usdPerShare">0.61</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-317"
      decimals="INF"
      id="f-1099"
      unitRef="shares">81632</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <alts:RelatedPartyTransactionConsultingAgreementTerm contextRef="c-318" id="f-1100">P2Y</alts:RelatedPartyTransactionConsultingAgreementTerm>
    <alts:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares
      contextRef="c-318"
      decimals="0"
      id="f-1101"
      unitRef="shares">200000</alts:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares>
    <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="c-319" decimals="-3" id="f-1102" unitRef="usd">183000</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="c-320"
      decimals="0"
      id="f-1103"
      unitRef="shares">300000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="c-321" decimals="-3" id="f-1104" unitRef="usd">183000</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="c-322"
      decimals="0"
      id="f-1105"
      unitRef="shares">300000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="c-323" decimals="-2" id="f-1106" unitRef="usd">60900</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="c-324"
      decimals="0"
      id="f-1107"
      unitRef="shares">100000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="c-325" decimals="-2" id="f-1108" unitRef="usd">60900</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="c-326"
      decimals="0"
      id="f-1109"
      unitRef="shares">100000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <alts:NumberOfAgreementsToBePurchased
      contextRef="c-327"
      decimals="INF"
      id="f-1110"
      unitRef="investor">2</alts:NumberOfAgreementsToBePurchased>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-328"
      decimals="INF"
      id="f-1111"
      unitRef="shares">79782</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-327"
      decimals="3"
      id="f-1112"
      unitRef="usdPerShare">3.775</us-gaap:SaleOfStockPricePerShare>
    <alts:SaleOfStockUnitCompositionNumberOfCommonSharesInEachUnit
      contextRef="c-329"
      decimals="INF"
      id="f-1113"
      unitRef="shares">1</alts:SaleOfStockUnitCompositionNumberOfCommonSharesInEachUnit>
    <alts:SaleOfStockUnitCompositionNumberOfWarrantsIssuedInEachUnit
      contextRef="c-329"
      decimals="INF"
      id="f-1114"
      unitRef="shares">1</alts:SaleOfStockUnitCompositionNumberOfWarrantsIssuedInEachUnit>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-327" id="f-1115">P3Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-327"
      decimals="2"
      id="f-1116"
      unitRef="usdPerShare">3.63</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-329" decimals="-3" id="f-1117" unitRef="usd">300000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-330"
      decimals="INF"
      id="f-1118"
      unitRef="shares">300000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-331"
      decimals="INF"
      id="f-1119"
      unitRef="shares">5000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-332" id="f-1120">P3Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-333"
      decimals="INF"
      id="f-1121"
      unitRef="shares">125000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-332"
      decimals="2"
      id="f-1122"
      unitRef="usdPerShare">1.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-105"
      decimals="INF"
      id="f-1123"
      unitRef="shares">1799100</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <alts:RelatedPartyTransactionConsultingAgreementTerm contextRef="c-334" id="f-1124">P6M</alts:RelatedPartyTransactionConsultingAgreementTerm>
    <alts:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares
      contextRef="c-334"
      decimals="0"
      id="f-1125"
      unitRef="shares">47923</alts:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares>
    <alts:RelatedPartyTransactionConsultingAgreementTerm contextRef="c-335" id="f-1126">P1Y</alts:RelatedPartyTransactionConsultingAgreementTerm>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="c-335"
      decimals="INF"
      id="f-1127"
      unitRef="shares">150000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <alts:RelatedPartyTransactionConsultingAgreementTerm contextRef="c-336" id="f-1128">P6M</alts:RelatedPartyTransactionConsultingAgreementTerm>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="c-336"
      decimals="INF"
      id="f-1129"
      unitRef="shares">20000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <alts:StockIssuedDuringPeriodSharesPrepaidInterest
      contextRef="c-337"
      decimals="0"
      id="f-1130"
      unitRef="shares">225000</alts:StockIssuedDuringPeriodSharesPrepaidInterest>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="c-338"
      decimals="0"
      id="f-1131"
      unitRef="shares">25000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <alts:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="c-339"
      decimals="0"
      id="f-1132"
      unitRef="shares">290908</alts:StockIssuedDuringPeriodSharesWarrantsExercised>
    <alts:RelatedPartyTransactionConsultingAgreementTerm contextRef="c-340" id="f-1133">P1Y</alts:RelatedPartyTransactionConsultingAgreementTerm>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="c-341"
      decimals="INF"
      id="f-1134"
      unitRef="shares">60000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="c-268" decimals="-3" id="f-1135" unitRef="usd">540000</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="c-268"
      decimals="0"
      id="f-1136"
      unitRef="shares">465753</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="c-209" decimals="-3" id="f-1137" unitRef="usd">691000</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="c-209"
      decimals="0"
      id="f-1138"
      unitRef="shares">265842</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-342"
      decimals="INF"
      id="f-1139"
      unitRef="shares">341175</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-342" decimals="-5" id="f-1140" unitRef="usd">1300000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-343"
      decimals="INF"
      id="f-1141"
      unitRef="shares">2800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="c-344"
      decimals="INF"
      id="f-1142"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-345"
      decimals="INF"
      id="f-1143"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-346" decimals="-5" id="f-1144" unitRef="usd">1200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="c-346"
      decimals="0"
      id="f-1145"
      unitRef="shares">908852</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="c-342"
      decimals="0"
      id="f-1146"
      unitRef="shares">295000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-347"
      decimals="0"
      id="f-1147"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-348"
      decimals="0"
      id="f-1148"
      unitRef="shares">800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-349"
      decimals="-3"
      id="f-1149"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-350"
      decimals="-3"
      id="f-1150"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-351"
      decimals="-3"
      id="f-1151"
      unitRef="shares">8000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-352"
      decimals="-3"
      id="f-1152"
      unitRef="shares">14000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="c-353"
      decimals="-3"
      id="f-1153"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-1154">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock option activity for the fiscal years ended December&#160;28, 2024, and December&#160;30, 2023 (Aggregate Intrinsic Value in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Options &lt;br/&gt;Outstanding &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;110,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cancelled/expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,000)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding at December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;114,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cancelled/expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,000)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding at December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;108,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Exercisable at December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;60,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-35" decimals="0" id="f-1155" unitRef="shares">110000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-35"
      decimals="2"
      id="f-1156"
      unitRef="usdPerShare">6.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-35" decimals="-3" id="f-1157" unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-354" id="f-1158">P6Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-22" decimals="0" id="f-1159" unitRef="shares">10000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-22"
      decimals="2"
      id="f-1160"
      unitRef="usdPerShare">1.53</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="c-22" decimals="0" id="f-1161" unitRef="shares">6000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-5" decimals="0" id="f-1162" unitRef="shares">114000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-5"
      decimals="2"
      id="f-1163"
      unitRef="usdPerShare">5.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-5" decimals="-3" id="f-1164" unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-22" id="f-1165">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="c-1" decimals="0" id="f-1166" unitRef="shares">6000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-1167"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-4" decimals="0" id="f-1168" unitRef="shares">108000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-1169"
      unitRef="usdPerShare">5.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-4" decimals="-3" id="f-1170" unitRef="usd">68000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-1" id="f-1171">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="c-4" decimals="0" id="f-1172" unitRef="shares">60000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-1173"
      unitRef="usdPerShare">3.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-4" decimals="-3" id="f-1174" unitRef="usd">68000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-1" id="f-1175">P5Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="c-1" id="f-1176">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The exercise price for stock options outstanding and exercisable outstanding at December&#160;28, 2024 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.445%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.445%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.445%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.447%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Exercisable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Number of Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Exercise Price ($)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Number of Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Exercise Price ($)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;42,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$5.70 to $9.90&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$5.70 to $9.90&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;66,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$3.54 to $5.25&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$3.54 to $5.25&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;108,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;60,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="c-355"
      decimals="0"
      id="f-1177"
      unitRef="shares">42000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c-356"
      decimals="2"
      id="f-1178"
      unitRef="usdPerShare">5.70</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="c-356"
      decimals="2"
      id="f-1179"
      unitRef="usdPerShare">9.90</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="c-355"
      decimals="0"
      id="f-1180"
      unitRef="shares">10000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c-356"
      decimals="2"
      id="f-1181"
      unitRef="usdPerShare">5.70</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="c-356"
      decimals="2"
      id="f-1182"
      unitRef="usdPerShare">9.90</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="c-357"
      decimals="0"
      id="f-1183"
      unitRef="shares">66000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c-358"
      decimals="2"
      id="f-1184"
      unitRef="usdPerShare">3.54</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="c-358"
      decimals="2"
      id="f-1185"
      unitRef="usdPerShare">5.25</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="c-357"
      decimals="0"
      id="f-1186"
      unitRef="shares">50000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c-358"
      decimals="2"
      id="f-1187"
      unitRef="usdPerShare">3.54</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="c-358"
      decimals="2"
      id="f-1188"
      unitRef="usdPerShare">5.25</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="c-4" decimals="0" id="f-1189" unitRef="shares">108000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="c-4" decimals="0" id="f-1190" unitRef="shares">60000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-359" decimals="-5" id="f-1191" unitRef="usd">1700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-360" decimals="-3" id="f-1192" unitRef="usd">14000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="c-361" decimals="0" id="f-1193" unitRef="usd">0</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="c-361"
      decimals="0"
      id="f-1194"
      unitRef="shares">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-1195">Income taxes&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For fiscal years ended December&#160;28, 2024, and December&#160;30, 2023, the Company recorded an income tax benefit from continuing operations of approximately $3.0 million and an income tax benefit of $0.4&#160;million, respectively, and an income tax provision from discontinued operations of $0 and approximately $1.0 million, respectively, which consisted of the following (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current tax expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax (benefit) provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total (benefit) provision of income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3,041)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the Company's income tax benefit (provision) with the federal statutory tax rate for the fiscal years ended December&#160;28, 2024, and December&#160;30, 2023, respectively, is shown below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Years Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;State tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Permanent differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Impact of sale of ARCA Recycling and Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-25.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income (loss) before provision of income taxes was derived from the following sources for fiscal years December&#160;28, 2024 and December&#160;30, 2023, respectively, as shown below (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Years Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(12,825)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,613)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(657)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(9,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7,270)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of net deferred tax assets (liabilities) as of December&#160;28, 2024 and December&#160;30, 2023, respectively, are as follows (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets (liabilities):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Allowance for bad debts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Section 174 expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,909)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3,747)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Installment sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Section 163(j) interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,919)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,773)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,041)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(639)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;28, 2024, the Company has net operating loss carryforwards of approximately $19.5 million for federal income tax purposes, and approximately $11.8 million for state income tax purposes, which will be available to offset future taxable income. Due to recent tax legislation, the federal net operating losses are eligible for indefinite carryforward, limited by certain taxable income limitations. State net operating losses begin to expire in 2032. The Company evaluates all available evidence to determine if a valuation allowance is needed to reduce its deferred tax assets. During the fourth quarter of fiscal year 2023, management concluded that a valuation allowance is necessary for the state net operating loss carryforward and a portion of the federal net operating loss carryforward. Due to the 2023 sale of ARCA Canada (as part of the Recycling Subsidiaries transaction), the valuation allowance was released. The Company has recorded a valuation allowance of approximately $2.9 million as of December&#160;28, 2024, and December&#160;30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company annually conducts an analysis of its uncertain tax positions and has concluded that it has no uncertain tax positions as of December&#160;28, 2024. The Company&#x2019;s policy is to record uncertain tax positions as a component of income tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files U.S. and state income tax returns in jurisdictions with differing statutes of limitations. The 2021 through 2024 tax years remain subject to selection for examination as of December&#160;28, 2024. None of the Company&#x2019;s income tax returns are currently under audit.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c-1" id="f-1196">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For fiscal years ended December&#160;28, 2024, and December&#160;30, 2023, the Company recorded an income tax benefit from continuing operations of approximately $3.0 million and an income tax benefit of $0.4&#160;million, respectively, and an income tax provision from discontinued operations of $0 and approximately $1.0 million, respectively, which consisted of the following (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current tax expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax (benefit) provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total (benefit) provision of income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3,041)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-362" decimals="-5" id="f-1197" unitRef="usd">-3000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-22" decimals="-5" id="f-1198" unitRef="usd">-400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-363" decimals="-5" id="f-1199" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-364" decimals="-5" id="f-1200" unitRef="usd">1000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1201" unitRef="usd">-102000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-22" decimals="-3" id="f-1202" unitRef="usd">0</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1203" unitRef="usd">-44000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-22" decimals="-3" id="f-1204" unitRef="usd">98000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1205" unitRef="usd">334000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-22" decimals="-3" id="f-1206" unitRef="usd">0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1207" unitRef="usd">188000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-22" decimals="-3" id="f-1208" unitRef="usd">98000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1209" unitRef="usd">-3229000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-22" decimals="-3" id="f-1210" unitRef="usd">444000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <alts:ProvisionBenefitOfIncomeTaxes contextRef="c-1" decimals="-3" id="f-1211" unitRef="usd">-3041000</alts:ProvisionBenefitOfIncomeTaxes>
    <alts:ProvisionBenefitOfIncomeTaxes contextRef="c-22" decimals="-3" id="f-1212" unitRef="usd">542000</alts:ProvisionBenefitOfIncomeTaxes>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c-1" id="f-1213">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the Company's income tax benefit (provision) with the federal statutory tax rate for the fiscal years ended December&#160;28, 2024, and December&#160;30, 2023, respectively, is shown below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Years Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;State tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Permanent differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Impact of sale of ARCA Recycling and Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-25.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;-7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c-1" decimals="3" id="f-1214" unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c-22" decimals="3" id="f-1215" unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c-1" decimals="3" id="f-1216" unitRef="number">0.009</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c-22" decimals="3" id="f-1217" unitRef="number">0.015</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c-1" decimals="3" id="f-1218" unitRef="number">0.044</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c-22" decimals="3" id="f-1219" unitRef="number">0.005</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <alts:EffectiveIncomeTaxRateReconciliationPermanentDifferences contextRef="c-1" decimals="3" id="f-1220" unitRef="number">0.067</alts:EffectiveIncomeTaxRateReconciliationPermanentDifferences>
    <alts:EffectiveIncomeTaxRateReconciliationPermanentDifferences contextRef="c-22" decimals="3" id="f-1221" unitRef="number">0.001</alts:EffectiveIncomeTaxRateReconciliationPermanentDifferences>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness contextRef="c-1" decimals="3" id="f-1222" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness contextRef="c-22" decimals="3" id="f-1223" unitRef="number">-0.044</us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-1" decimals="3" id="f-1224" unitRef="number">0.129</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-22" decimals="3" id="f-1225" unitRef="number">-0.257</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="c-1" decimals="3" id="f-1226" unitRef="number">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="c-22" decimals="3" id="f-1227" unitRef="number">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="3" id="f-1228" unitRef="number">0.327</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-22" decimals="3" id="f-1229" unitRef="number">-0.073</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="c-1" id="f-1230">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income (loss) before provision of income taxes was derived from the following sources for fiscal years December&#160;28, 2024 and December&#160;30, 2023, respectively, as shown below (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Years Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(12,825)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,613)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(657)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(9,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7,270)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-1" decimals="-3" id="f-1231" unitRef="usd">-12825000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-22" decimals="-3" id="f-1232" unitRef="usd">-6613000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-1" decimals="-3" id="f-1233" unitRef="usd">3539000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-22" decimals="-3" id="f-1234" unitRef="usd">-657000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <alts:IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes contextRef="c-1" decimals="-3" id="f-1235" unitRef="usd">-9286000</alts:IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes>
    <alts:IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes contextRef="c-22" decimals="-3" id="f-1236" unitRef="usd">-7270000</alts:IncomeLossFromContinuingOperationsBeforeProvisionBenefitOfIncomeTaxes>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c-1" id="f-1237">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of net deferred tax assets (liabilities) as of December&#160;28, 2024 and December&#160;30, 2023, respectively, are as follows (in $000&#x2019;s):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets (liabilities):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Allowance for bad debts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Section 174 expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,909)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3,747)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Installment sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Section 163(j) interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,919)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,773)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,041)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(639)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities contextRef="c-4" decimals="-3" id="f-1238" unitRef="usd">152000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities contextRef="c-5" decimals="-3" id="f-1239" unitRef="usd">7000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts contextRef="c-4" decimals="-3" id="f-1240" unitRef="usd">53000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts contextRef="c-5" decimals="-3" id="f-1241" unitRef="usd">0</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation contextRef="c-4" decimals="-3" id="f-1242" unitRef="usd">35000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation contextRef="c-5" decimals="-3" id="f-1243" unitRef="usd">3000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <alts:Section174Expenses contextRef="c-4" decimals="-3" id="f-1244" unitRef="usd">43000</alts:Section174Expenses>
    <alts:Section174Expenses contextRef="c-5" decimals="-3" id="f-1245" unitRef="usd">61000</alts:Section174Expenses>
    <us-gaap:DeferredTaxLiabilitiesPrepaidExpenses contextRef="c-4" decimals="-3" id="f-1246" unitRef="usd">128000</us-gaap:DeferredTaxLiabilitiesPrepaidExpenses>
    <us-gaap:DeferredTaxLiabilitiesPrepaidExpenses contextRef="c-5" decimals="-3" id="f-1247" unitRef="usd">16000</us-gaap:DeferredTaxLiabilitiesPrepaidExpenses>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-4" decimals="-3" id="f-1248" unitRef="usd">7586000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-5" decimals="-3" id="f-1249" unitRef="usd">5360000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <alts:DeferredTaxAssetsLeaseLiability contextRef="c-4" decimals="-3" id="f-1250" unitRef="usd">33000</alts:DeferredTaxAssetsLeaseLiability>
    <alts:DeferredTaxAssetsLeaseLiability contextRef="c-5" decimals="-3" id="f-1251" unitRef="usd">0</alts:DeferredTaxAssetsLeaseLiability>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="c-4" decimals="-3" id="f-1252" unitRef="usd">0</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="c-5" decimals="-3" id="f-1253" unitRef="usd">3000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c-4" decimals="-3" id="f-1254" unitRef="usd">114000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c-5" decimals="-3" id="f-1255" unitRef="usd">136000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets contextRef="c-4" decimals="-3" id="f-1256" unitRef="usd">6909000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets contextRef="c-5" decimals="-3" id="f-1257" unitRef="usd">3747000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <alts:DeferredTaxLiabilitiesRightOfUseAssets contextRef="c-4" decimals="-3" id="f-1258" unitRef="usd">33000</alts:DeferredTaxLiabilitiesRightOfUseAssets>
    <alts:DeferredTaxLiabilitiesRightOfUseAssets contextRef="c-5" decimals="-3" id="f-1259" unitRef="usd">0</alts:DeferredTaxLiabilitiesRightOfUseAssets>
    <alts:DeferredTaxLiabilitiesInstallmentSale contextRef="c-4" decimals="-3" id="f-1260" unitRef="usd">0</alts:DeferredTaxLiabilitiesInstallmentSale>
    <alts:DeferredTaxLiabilitiesInstallmentSale contextRef="c-5" decimals="-3" id="f-1261" unitRef="usd">0</alts:DeferredTaxLiabilitiesInstallmentSale>
    <us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses contextRef="c-4" decimals="-3" id="f-1262" unitRef="usd">794000</us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses>
    <us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses contextRef="c-5" decimals="-3" id="f-1263" unitRef="usd">327000</us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses>
    <alts:DeferredTaxAssetsInterest contextRef="c-4" decimals="-3" id="f-1264" unitRef="usd">138000</alts:DeferredTaxAssetsInterest>
    <alts:DeferredTaxAssetsInterest contextRef="c-5" decimals="-3" id="f-1265" unitRef="usd">0</alts:DeferredTaxAssetsInterest>
    <alts:DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance contextRef="c-4" decimals="-3" id="f-1266" unitRef="usd">1878000</alts:DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance>
    <alts:DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance contextRef="c-5" decimals="-3" id="f-1267" unitRef="usd">2134000</alts:DeferredTaxAssetsLiabilitiesGrossBeforeValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-4" decimals="-3" id="f-1268" unitRef="usd">2919000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-5" decimals="-3" id="f-1269" unitRef="usd">2773000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxLiabilities contextRef="c-4" decimals="-3" id="f-1270" unitRef="usd">1041000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities contextRef="c-5" decimals="-3" id="f-1271" unitRef="usd">639000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:OperatingLossCarryforwards contextRef="c-365" decimals="-5" id="f-1272" unitRef="usd">19500000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-366" decimals="-5" id="f-1273" unitRef="usd">11800000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwardsValuationAllowance contextRef="c-5" decimals="-5" id="f-1274" unitRef="usd">2900000</us-gaap:OperatingLossCarryforwardsValuationAllowance>
    <us-gaap:OperatingLossCarryforwardsValuationAllowance contextRef="c-4" decimals="-5" id="f-1275" unitRef="usd">2900000</us-gaap:OperatingLossCarryforwardsValuationAllowance>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c-1" id="f-1276">Related parties&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Shared Services&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tony Isaac, the Company&#x2019;s President, is the father of Jon Isaac, President and Chief Executive Officer of Live Ventures and managing member of ICG. Tony Isaac and Richard Butler, Board of Directors members of the Company, are members of the Board of Directors of Live Ventures. The Company also shares certain executive, accounting and legal services with Live Ventures. The total services shared were approximately $144,000 and approximately $203,000 for fiscal years ending December&#160;28, 2024 and December&#160;30, 2023, respectively. Customer Connexx rented approximately 9,900 square feet of office space from Live Ventures in Las Vegas, Nevada. Effective August 2023, due to the winding down of operations of the Recycling Subsidiaries, the Company ceased leasing office space in the Las Vegas, Nevada facility. The total rent and common area expenses for Connexx at the Las Vegas, Nevada office were approximately $17,000 and approximately $103,000 for fiscal years ending December&#160;28, 2024 and December&#160;30, 2023, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During Q4 2023, operations of the Recycling Subsidiaries were wound down and, ultimately, ceased. See Note 4. Consequently, outstanding liabilities for shared rent and services for the Recycling Subsidiaries reverted to the Company. As such, the Company has recorded a liability in the amount of approximately $258,000, which was offset against the gain on sale of the Recycling Subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Notes with Live Ventures and ICG&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February&#160;7, 2024, the Company entered into a promissory notes with each of Live Ventures and ICG. The initial principal amount of each note is $300,000, with an interest rate of 10% per annum. Pursuant to an amendment to each note, $100,000 of principal, and accrued interest thereon, is due on September&#160;7, 2024 for each note, and the balance of each note is due on December&#160;31, 2024. At the Company&#x2019;s option, the obligation under each note is convertible after the six-month anniversary thereof at a per-share conversion price of $0.61, subject to standard adjustments for (i) stock dividends and splits, (ii) subsequent rights offerings, and (iii) pro rata distributions. The Company&#x2019;s board of directors approved the issuance of the two notes on February&#160;7, 2024. As of December&#160;28, 2024, the principal balances outstanding on each of the promissory notes was $327,000.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Isaac Consulting Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March&#160;4, 2024, the Company entered into a two-year Consulting Agreement with Jon Isaac, pursuant to which he will provide to the Company (the &#x201c;Services&#x201d;): (i) strategic financial advice, including growth strategies, capital allocation, and financial restructuring; (ii) sales and business development advice, including for the acquisition of new clients and new products through networking, referrals, and marketing efforts for our prospective products; (iii) in-depth research and market intelligence on specific industries, sectors, and market trends; (iv) financial models and financial analysis to support strategic decision-making; (v) assistance, through site visits, in the preparation of new client offers and bids for proposed projects; (vi) weekly update calls with management to align on progress of objectives and goals; (vii) enhanced non-confidential materials; (viii) business risk management support; and (ix) other services to which the Company and he may agree that will be memorialized in writing if, when, and as needed during the two-year term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As compensation for the Services, the Company (i) assigned to him two universal life insurance policies that relate to the life of one of the founders of our now-disposed legacy recycling business (as of March 4, 2024, the first policy had an accumulated value/surrender value of approximately $3,854 and the second had an accumulated value/surrender value of approximately $468); (ii) agreed to tender to him funds in our Canadian counsel&#x2019;s trust account in the event that the prospective Order of the Court of Appeal for Ontario Canada in the matter styled, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Amtim Capital Inc. and Appliance Recycling Centers of America&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Case No. COA-23-CV-0156, became the final Order of the Court, which amount we received during the reporting period and tendered to Mr. Isaac $220,000; (iii) issued to him 200,000 restricted shares of our common stock with the per-share value being the average of the Nasdaq Historical NOCP closing price during the five trading days prior to our board approving the Consulting Agreement, which shares were awarded from our 2023 Equity Incentive Plan; and (iv) issued to him a two-year, straight 10.0% convertible promissory note in the initial principal amount of $500,000, with an interest rate of 10.0% and a per-share conversion price equivalent to the per-share value of the restricted common stock that he was granted ($1.16). The maturity date of the promissory note is March&#160;4, 2026. The value of the restricted shares was $232,000 on the date issued. As of December&#160;28, 2024, there was no principal balance outstanding on the promissory note.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Short-Term Advances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April&#160;18, 2024, ICG made a short-term demand advance to the Company in the amount of $100,000. The advance bears interest at a rate of 10% per annum until repaid. As of December&#160;28, 2024, the principal amount outstanding was $48,000.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May&#160;28, 2024 and June&#160;3, 2024, Novalk made short-term demand advances in the amount of $120,000 and $100,000, respectively, to the Company. Juan Yunis, an employee of Live Ventures, is the managing member of Novalk. The advances bears interest at a rate of 10% per annum until repaid. As of December&#160;28, 2024, the principal amount outstanding was $110,000.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During June&#160;3, 2024, Tony Isaac made a number of short-term demand advances in the aggregate amount of $62,000 to the Company. The advances bears interest at a rate of 10% per annum until repaid. As of December&#160;28, 2024, the Company had repaid the advance in full (see Note 20).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Sale of Recycling Subsidiaries&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 9, 2023, the Company entered into a Stock Purchase Agreement (the &#x201c;Recycling Purchase Agreement&#x201d;) with VM7 Corporation, a Delaware corporation (&#x201c;VM7&#x201d;), under which it agreed to acquire all of the outstanding equity interests of the Recycling Subsidiaries consisting of: (a) ARCA Recycling, Inc., (b) ARCA Canada, and (c) Connexx. The principal of VM7 is Virland A. Johnson, our Chief Financial Officer. The sale of all of the outstanding equity interests of the Recycling Subsidiaries to VM7 under the Recycling Purchase Agreement was consummated simultaneously with the execution of the Recycling Agreement. The Company's Board of Directors unanimously approved the Recycling Purchase Agreement and the Disposition Transaction. The Recycling Purchase Agreement is retroactively effective as of March 1, 2023. During the fourth quarter of fiscal 2023, VM7 determined that, after expending significant amounts of time and resources, it was unable to obtain sufficient equity or debt financing to continue the operations of the Recycling Subsidiaries. Accordingly, the Company was advised that the operations of the Recycling Subsidiaries were wound down and, ultimately, ceased. Because the Company did not receive all of the economic benefits of the Disposition Transaction and understands that it will not receive any future benefits of the Disposition Transaction, the Company determined to fully impair the $5.3&#160;million carrying value of the Disposition Transaction on its balance sheet. The Company also determined not to exercise any of its remedies under the Recycling Purchase Agreement so that the Company could maintain its focus on its clinical-stage biopharmaceutical activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;ICG Note&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August&#160;28, 2019, ARCA Recycling entered into and delivered to ICG a secured revolving line of credit promissory note, whereby ICG agreed to provide ARCA Recycling with a $2.5 million revolving credit facility (the &#x201c;ICG Note&#x201d;). Jon Isaac is the manager and sole member of ICG, and the son of Tony Isaac, the President of ALT5 Sigma Corporation and, previously, ARCA Recycling. ICG is a record and beneficial owner of 13.6% of the outstanding common stock of the Company. The ICG Note was originally a component of the sale of the Recycling Subsidiaries in March 2023; however, because of the winding down of operations of the Recycling Subsidiaries during Q4 2023, and because the ICG Note was guaranteed by the Company, it recorded a liability in the amount of approximately $690,000 for the principal balance due on the note, which was offset against the gain on sale of the Recycling Subsidiaries (see Note 4). Additionally, effective February 2024, the ICG Note was amended to reflect the Company as co-maker on the ICG Note (see Note 20). The ICG Note matures in March 2026, and bears interest at 8.75% per annum. Monthly payments on the note are approximately $24,767. As of December&#160;28, 2024 and December&#160;30, 2023, the balance outstanding was $0 and $706,000, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty contextRef="c-367" decimals="-3" id="f-1277" unitRef="usd">144000</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty contextRef="c-368" decimals="-3" id="f-1278" unitRef="usd">203000</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:NetRentableArea contextRef="c-369" decimals="0" id="f-1279" unitRef="sqft">9900</us-gaap:NetRentableArea>
    <us-gaap:OperatingLeaseExpense contextRef="c-367" decimals="-3" id="f-1280" unitRef="usd">17000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c-368" decimals="-3" id="f-1281" unitRef="usd">103000</us-gaap:OperatingLeaseExpense>
    <us-gaap:AccruedRentCurrentAndNoncurrent contextRef="c-7" decimals="-3" id="f-1282" unitRef="usd">258000</us-gaap:AccruedRentCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-370" decimals="-3" id="f-1283" unitRef="usd">300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-370"
      decimals="2"
      id="f-1284"
      unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPeriodicPayment contextRef="c-371" decimals="-3" id="f-1285" unitRef="usd">100000</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c-370"
      decimals="INF"
      id="f-1286"
      unitRef="usdPerShare">0.61</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-372" decimals="-3" id="f-1287" unitRef="usd">327000</us-gaap:DebtInstrumentCarryingAmount>
    <alts:RelatedPartyTransactionConsultingAgreementTerm contextRef="c-264" id="f-1288">P2Y</alts:RelatedPartyTransactionConsultingAgreementTerm>
    <alts:RelatedPartyTransactionConsultingAgreementTerm contextRef="c-264" id="f-1289">P2Y</alts:RelatedPartyTransactionConsultingAgreementTerm>
    <alts:RelatedPartyTransactionConsultingAgreementNumberOfLifeInsurancePoliciesAssigned
      contextRef="c-267"
      decimals="INF"
      id="f-1290"
      unitRef="insurance_policy">2</alts:RelatedPartyTransactionConsultingAgreementNumberOfLifeInsurancePoliciesAssigned>
    <us-gaap:CashSurrenderValueOfLifeInsurance contextRef="c-373" decimals="0" id="f-1291" unitRef="usd">3854</us-gaap:CashSurrenderValueOfLifeInsurance>
    <us-gaap:CashSurrenderValueOfLifeInsurance contextRef="c-374" decimals="0" id="f-1292" unitRef="usd">468</us-gaap:CashSurrenderValueOfLifeInsurance>
    <alts:RelatedPartyTransactionConsultingAgreementContingentlyTenderedFunds contextRef="c-318" decimals="-3" id="f-1293" unitRef="usd">220000</alts:RelatedPartyTransactionConsultingAgreementContingentlyTenderedFunds>
    <alts:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares
      contextRef="c-318"
      decimals="0"
      id="f-1294"
      unitRef="shares">200000</alts:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares>
    <alts:NumberOfTradingDaysBeforeBoardApproval
      contextRef="c-267"
      decimals="INF"
      id="f-1295"
      unitRef="trading_day">5</alts:NumberOfTradingDaysBeforeBoardApproval>
    <alts:RelatedPartyTransactionConsultingAgreementTerm contextRef="c-264" id="f-1296">P2Y</alts:RelatedPartyTransactionConsultingAgreementTerm>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-266"
      decimals="3"
      id="f-1297"
      unitRef="number">0.100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-375"
      decimals="3"
      id="f-1298"
      unitRef="number">0.100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-376"
      decimals="3"
      id="f-1299"
      unitRef="number">0.100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-266" decimals="-3" id="f-1300" unitRef="usd">500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-266"
      decimals="3"
      id="f-1301"
      unitRef="number">0.100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-375"
      decimals="3"
      id="f-1302"
      unitRef="number">0.100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-376"
      decimals="3"
      id="f-1303"
      unitRef="number">0.100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <alts:RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice
      contextRef="c-267"
      decimals="2"
      id="f-1304"
      unitRef="usdPerShare">1.16</alts:RelatedPartyTransactionConsultingAgreementConvertibleDebtConversionPrice>
    <alts:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares
      contextRef="c-377"
      decimals="-3"
      id="f-1305"
      unitRef="shares">232000</alts:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-269" decimals="-3" id="f-1306" unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:ProceedsFromShortTermDebt contextRef="c-256" decimals="-3" id="f-1307" unitRef="usd">100000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-257"
      decimals="2"
      id="f-1308"
      unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-258"
      decimals="2"
      id="f-1309"
      unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-259"
      decimals="2"
      id="f-1310"
      unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-257" decimals="-3" id="f-1311" unitRef="usd">48000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:ProceedsFromShortTermDebt contextRef="c-270" decimals="-3" id="f-1312" unitRef="usd">120000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt contextRef="c-271" decimals="-3" id="f-1313" unitRef="usd">100000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-272"
      decimals="2"
      id="f-1314"
      unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-273"
      decimals="2"
      id="f-1315"
      unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-274"
      decimals="2"
      id="f-1316"
      unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-275"
      decimals="2"
      id="f-1317"
      unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ShortTermBorrowings contextRef="c-274" decimals="-3" id="f-1318" unitRef="usd">110000</us-gaap:ShortTermBorrowings>
    <us-gaap:ProceedsFromShortTermDebt contextRef="c-276" decimals="-3" id="f-1319" unitRef="usd">62000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-277"
      decimals="2"
      id="f-1320"
      unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-278"
      decimals="2"
      id="f-1321"
      unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-279"
      decimals="2"
      id="f-1322"
      unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown contextRef="c-378" decimals="-5" id="f-1323" unitRef="usd">5300000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-379" decimals="-5" id="f-1324" unitRef="usd">2500000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="c-380"
      decimals="3"
      id="f-1325"
      unitRef="number">0.136</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue contextRef="c-381" decimals="-3" id="f-1326" unitRef="usd">690000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-382"
      decimals="4"
      id="f-1327"
      unitRef="number">0.0875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPeriodicPayment contextRef="c-383" decimals="0" id="f-1328" unitRef="usd">24767</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:OtherLiabilities contextRef="c-384" decimals="-3" id="f-1329" unitRef="usd">0</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities contextRef="c-381" decimals="-3" id="f-1330" unitRef="usd">706000</us-gaap:OtherLiabilities>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-1331">Commitments and Contingencies&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;SEC Complaint&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 2, 2021, the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) filed a civil complaint (the &#x201c;SEC Complaint&#x201d;) in the United States District Court for the District of Nevada naming the Company and one of its executive officers, Virland Johnson, the Company's Chief Financial Officer, as defendants (collectively, the &#x201c;Defendants&#x201d;). Pursuant to an agreed-upon Order of the Court, on May 28, 2024, the Company settled its litigation with the SEC. The Settlement Agreement provided, in pertinent part: &#x201c;Without admitting or denying the allegations of the complaint (except as provided herein in paragraph 12 and except as to personal and subject matter jurisdiction, which [the Company] admits), [the Company] hereby consents to the entry of the final Judgment in the form attached hereto (the &#x201c;Final Judgment&#x201d;) and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;incorporated by reference herein, which, among other things: &#x201c;(a) permanently restrains and enjoins [the Company] from violation of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder [15 U.S.C. &#xa7; 78j(b) and 17 C.F.R. &#xa7;&#xa7; 240.10b-5]; and (c)[sic] orders [the Company] to pay a civil penalty in the amount of $250,000 under Section 21(d)(3) of the Exchange Act [15 U.S.C. &#xa7; 78u(d)(3)).&#x201d; The SEC has agreed to accept four quarterly payments from the Company, each in the amount of $62,500. The Settlement Agreement is attached to the Order as Exhibit 1, both of which documents may be viewed at https://ecf.nvd.uscourts.gov/doc1/115110470966.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The SEC Complaint's remaining allegations relate to financial, disclosure and reporting violations against the executive officer under Section 10(b) of the Securities Exchange Act of 1934 (the &#x201c;Exchange Act&#x201d;) and Rule 10b-5. The SEC Complaint also alleges various claims against the executive officer under Sections 13(a), 13(b)(2)(A), 13(b)(2)(B) and 13(b)(5) of the Exchange Act and Rules 12b-20, 13a-1, 13a-13, 13a-14, 13b2-1, and 13b2-2. The SEC continues to seek a permanent injunction, civil penalties, and an officer-and-director bar against the executive officer. The foregoing is only a general summary of the SEC Complaint, which may be accessed on the SEC&#x2019;s website at https://www.sec.gov/litigation/litreleases/2021/lr25155.htm.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Skybridge&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 29, 2016, the Company served a Minnesota state court complaint for breach of contract on Skybridge Americas, Inc. (&#x201c;SA&#x201d;), the Company&#x2019;s primary call center vendor throughout 2015 and most of 2016. On April 10 2024, subsequent to the conclusion of litigation at the trial court and appellate court levels, SA sold its judgment to an otherwise unaffiliated third party for the face value of the judgment and the interest accrued thereon through that date (an aggregate of $433,920), plus accrued legal fees (in the amount of $18,124) to which SA was entitled in accordance with the terms of the underlying agreement with the Company and with the judgment. The purchaser agreed to forbear from enforcing the judgment, subject to the Company&#x2019;s repayment or his conversion thereof. In connection with the third-party&#x2019;s forbearance, the Company issued its promissory note to such person in the initial principal amount of $147,956, which bears interest at the rate of 10% per annum, and, as with the underlying judgment, is convertible into shares of the Company&#x2019;s common stock at a fixed per-share conversion price of $2.60. On December&#160;23, 2024, pursuant to the terms of the agreement, the unaffiliated third party converted the obligation, plus accrued interest under the agreements, in the amount of approximately $691,000, into 265,842 shares of the Company&#x2019;s common stock (see Note 18). As of December&#160;28, 2024, there was no balance outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;GeoTraq&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On or about April&#160;9, 2021, GeoTraq, Gregg Sullivan, Tony Isaac, and the Company, among others, resolved all of the claims that related to, among other items, the Company's acquisition of GeoTraq in August 2017, all post-acquisition activities, and Mr. Sullivan&#x2019;s post-acquisition employment relationship with GeoTraq (all of such claims, the &#x201c;GeoTraq Matters&#x201d;). The resolution was effectuated through the parties&#x2019; execution and delivery of a Settlement Agreement and Mutual Agreement of Claims (the &#x201c;GeoTraq Settlement Agreement&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The parties to the Settlement Agreement released and forever discharged one another from any and all known and unknown claims that were asserted or could have been asserted arising out of the GeoTraq Litigation Matters. The accrued liability for payments due to Mr. Sullivan is $0 and $510,000 as of December&#160;28, 2024 and December&#160;30, 2023, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Alixpartners, LLC&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October&#160;19, 2022, Alixpartners, LLC filed a complaint in the Supreme Court of the State of New York, County of New York, styled &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Alixpartners, LLC, plaintiff/petitioner, against JanOne Inc.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Index No. 653877/2022. Plaintiff alleged the breach of an agreement and sought damages in the amount of approximately $345,000. The Company denied that obligation. After extensive negotiations, the parties reached a settlement, pursuant to which the Company agreed to pay to Alixpartners the sum of $125,000 in two tranches and to provide a confession of judgment in its favor in the amount of approximately $450,000, which represented the amount sought in the complaint plus interest thereon. The confession of judgment will be null and void and the complaint will be dismissed with prejudice upon the Company tendering both tranches timely. The Company tendered both settlement payments in May 2023, and the complaint was subsequently dismissed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Sieggreen&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In a matter pending in the United States District Court for the District Of Nevada, Case No. 2:21-cv-01517-CDS-EJY, styled as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sieggreen, Individually and On Behalf of All Others Similarly Situated, Plaintiff, v. Live Ventures Incorporated, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Jon Isaac, and Virland A. Johnson, Defendants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company was added as a defendant on March 6, 2023, and was served on March 23, 2023. Plaintiff has alleged causes of action against the Company for (i) violation of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder and (ii) violation of Section 10(b) of the Securities Exchange Act of 1934 and Rules 10b-5(a) and 10b-5(c) promulgated thereunder. In June 2023 the Company filed a Motion to Dismiss, regarding which, as of the date of these financial statements, the Court has not ruled. The Company strongly disputes and denies all of the allegations contained therein and will continue to defend itself vigorously against the claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Main/270&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a defendant in an action filed on April 11, 2022, in the U.S. District Court Southern District of Ohio, Eastern Division, styled, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trustees Main/270, LLC, Plaintiff, vs ApplianceSmart, Inc. and JANONE, Inc., Defendant&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Case no.: 2:22-cv-01938-ALM-EPD. The Company was a guarantor of the lease between the Plaintiff and ApplianceSmart, Inc. Plaintiff alleged a cause of action against the Company in respect of the guaranty and seeks approximately $90,000 therefor. Plaintiff also seeks approximately $1,420,000 against ApplianceSmart and the Company on a joint and several basis. The Company does not believe that it is obligated to Plaintiff in that amount and the parties continue to negotiate a potential settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Westerville Square&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In an attempt to recover payments due under a lease, in 2022, Westerville Square, Inc., as the landlord, initiated a civil action against the Company, styled &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Westerville Square, Inc. v. Appliance Recycling Centers Of America, Inc., et al., &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in the Court of Common Pleas of Franklin County, Ohio, Case No. 19 CV 8627. The case was stayed during the bankruptcy proceedings of ApplianceSmart, Inc., and was reinstated on June 7, 2021. The landlord is currently seeking $120,000, which amount is disputed by the Company. Effective June 4, 2023, the parties settled the matter, pursuant to which settlement the Company tendered the sum of $110,000 to the landlord, the parties entered into a Settlement Agreement and Release, and the case was dismissed with prejudice.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 30, 2017, the Company disposed of its retail appliance segment and sold ApplianceSmart to Live Ventures, a related party. In connection with that sale, as of January&#160;1, 2022, the Company accrued an aggregate amount of future real property lease payments of approximately $767,000 which represented amounts guaranteed or which may have been owed under certain lease agreements to three third party landlords in which the Company either remained the counterparty, was a guarantor, or had agreed to remain contractually liable under the lease (&#x201c;ApplianceSmart Leases&#x201d;). A final decree was issued by the court on February 28, 2022, upon the full satisfaction of the Plan, at which time ApplianceSmart emerged from Chapter 11. During the year ended December&#160;28, 2024, the Company reversed approximately $637,000 of the accrual, as the Company is no longer liable for two of these guarantees upon ApplianceSmart's emergence from bankruptcy. As of December&#160;28, 2024, a balance of approximately $130,000 remains as an accrued liability due to an ongoing dispute concerning one of the leases. The Company and Live Ventures have agreed to divide in half between them any ultimate balance owing thereunder and any attorneys&#x2019; fees expended in relation thereto.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is party from time to time to other ordinary course disputes that we do not believe to be material to our financial condition as of December&#160;28, 2024.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <alts:LossContingencyNumberOfExecutiveOfficersNamedInComplaint
      contextRef="c-385"
      decimals="INF"
      id="f-1332"
      unitRef="officer">1</alts:LossContingencyNumberOfExecutiveOfficersNamedInComplaint>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty contextRef="c-386" decimals="INF" id="f-1333" unitRef="usd">250000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <alts:LitigationSettlementAmountAwardedToOtherPartyNumberOfPeriodicPayments
      contextRef="c-387"
      decimals="INF"
      id="f-1334"
      unitRef="payment">4</alts:LitigationSettlementAmountAwardedToOtherPartyNumberOfPeriodicPayments>
    <alts:LitigationSettlementAmountAwardedToOtherPartyPeriodicPayments contextRef="c-386" decimals="INF" id="f-1335" unitRef="usd">62500</alts:LitigationSettlementAmountAwardedToOtherPartyPeriodicPayments>
    <us-gaap:LossContingencyDamagesAwardedValue contextRef="c-206" decimals="0" id="f-1336" unitRef="usd">433920</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue contextRef="c-207" decimals="0" id="f-1337" unitRef="usd">18124</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-208" decimals="0" id="f-1338" unitRef="usd">147956</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-208"
      decimals="2"
      id="f-1339"
      unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c-208"
      decimals="2"
      id="f-1340"
      unitRef="usdPerShare">2.60</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="c-209" decimals="-3" id="f-1341" unitRef="usd">691000</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="c-209"
      decimals="0"
      id="f-1342"
      unitRef="shares">265842</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent contextRef="c-388" decimals="-3" id="f-1343" unitRef="usd">0</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent contextRef="c-389" decimals="-3" id="f-1344" unitRef="usd">510000</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:LossContingencyDamagesSoughtValue contextRef="c-390" decimals="-3" id="f-1345" unitRef="usd">345000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty contextRef="c-391" decimals="-3" id="f-1346" unitRef="usd">125000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <alts:NumberOfTranches
      contextRef="c-392"
      decimals="INF"
      id="f-1347"
      unitRef="tranche">2</alts:NumberOfTranches>
    <us-gaap:LossContingencyDamagesAwardedValue contextRef="c-391" decimals="-3" id="f-1348" unitRef="usd">450000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesSoughtValue contextRef="c-393" decimals="-3" id="f-1349" unitRef="usd">90000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LossContingencyDamagesSoughtValue contextRef="c-394" decimals="-3" id="f-1350" unitRef="usd">1420000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LossContingencyDamagesSoughtValue contextRef="c-395" decimals="-3" id="f-1351" unitRef="usd">120000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:PaymentsForLegalSettlements contextRef="c-396" decimals="-3" id="f-1352" unitRef="usd">110000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-397" decimals="-3" id="f-1353" unitRef="usd">767000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <alts:OtherCommitmentsNumberOfLandlordsOriginallyPurportedToBeLiableFor
      contextRef="c-398"
      decimals="INF"
      id="f-1354"
      unitRef="landlord">3</alts:OtherCommitmentsNumberOfLandlordsOriginallyPurportedToBeLiableFor>
    <alts:OperatingLeasesFutureMinimumPaymentsDue1 contextRef="c-399" decimals="-3" id="f-1355" unitRef="usd">637000</alts:OperatingLeasesFutureMinimumPaymentsDue1>
    <alts:OtherCommitmentsNumberOfLandlordsCompanyIsNoLongerLiableFor
      contextRef="c-400"
      decimals="INF"
      id="f-1356"
      unitRef="guarantee">2</alts:OtherCommitmentsNumberOfLandlordsCompanyIsNoLongerLiableFor>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent contextRef="c-399" decimals="-3" id="f-1357" unitRef="usd">130000</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-1358">Earnings (Loss) per share&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss per share is calculated using the weighted average number of shares of common stock outstanding during the applicable period. Basic weighted average common shares outstanding do not include shares of restricted stock that have not yet vested, although such shares are included as outstanding shares in the Company&#x2019;s Consolidated Balance Sheet. Diluted net earnings per share is computed using the weighted average number of common shares outstanding, and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the additional common shares issuable with respect to restricted share awards, stock options and convertible preferred stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the computation of basic and diluted net loss per share (in $000&#x2019;s, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;For the Years Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Continuing Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net (loss) income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(17,095)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;11,148,493&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,005,334&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Basic and diluted (loss) income per share from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(0.56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4.27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Discontinued Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;11,148,493&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,005,334&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Basic income per share from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;11,148,493&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,444,361&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Diluted income per share from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(7,812)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;11,148,493&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,005,334&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Basic and diluted (loss) income per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(0.56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1.95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Potentially dilutive securities totaling approximately 9.0&#160;million and 3.9&#160;million shares, respectively, were excluded from the calculation of diluted net earnings (loss) per share for the years ended December&#160;28, 2024 and December&#160;30, 2023 because the effects were anti-dilutive based on the application of the treasury stock method.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-1359">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the computation of basic and diluted net loss per share (in $000&#x2019;s, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;For the Years Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Continuing Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net (loss) income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(17,095)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;11,148,493&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,005,334&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Basic and diluted (loss) income per share from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(0.56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4.27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Discontinued Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;11,148,493&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,005,334&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Basic income per share from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;11,148,493&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,444,361&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Diluted income per share from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(7,812)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;11,148,493&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,005,334&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Basic and diluted (loss) income per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(0.56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1.95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic contextRef="c-1" decimals="-3" id="f-1360" unitRef="usd">-6245000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted contextRef="c-1" decimals="-3" id="f-1361" unitRef="usd">-6245000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted contextRef="c-22" decimals="-3" id="f-1362" unitRef="usd">-17095000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic contextRef="c-22" decimals="-3" id="f-1363" unitRef="usd">-17095000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-1364" unitRef="shares">11148493</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-22" decimals="0" id="f-1365" unitRef="shares">4005334</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="c-1"
      decimals="2"
      id="f-1366"
      unitRef="usdPerShare">-0.56</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="c-1"
      decimals="2"
      id="f-1367"
      unitRef="usdPerShare">-0.56</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="c-22"
      decimals="2"
      id="f-1368"
      unitRef="usdPerShare">-4.27</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="c-22"
      decimals="2"
      id="f-1369"
      unitRef="usdPerShare">-4.27</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic contextRef="c-1" decimals="-3" id="f-1370" unitRef="usd">0</us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic contextRef="c-22" decimals="-3" id="f-1371" unitRef="usd">9283000</us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-1372" unitRef="shares">11148493</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-22" decimals="0" id="f-1373" unitRef="shares">4005334</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
      contextRef="c-1"
      decimals="2"
      id="f-1374"
      unitRef="usdPerShare">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
      contextRef="c-22"
      decimals="2"
      id="f-1375"
      unitRef="usdPerShare">2.32</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare>
    <us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted contextRef="c-1" decimals="-3" id="f-1376" unitRef="usd">0</us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted>
    <us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted contextRef="c-22" decimals="-3" id="f-1377" unitRef="usd">9283000</us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-1378" unitRef="shares">11148493</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-22" decimals="0" id="f-1379" unitRef="shares">4444361</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="c-1"
      decimals="2"
      id="f-1380"
      unitRef="usdPerShare">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="c-22"
      decimals="2"
      id="f-1381"
      unitRef="usdPerShare">2.09</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c-1" decimals="-3" id="f-1382" unitRef="usd">-6245000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-1" decimals="-3" id="f-1383" unitRef="usd">-6245000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c-22" decimals="-3" id="f-1384" unitRef="usd">-7812000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-22" decimals="-3" id="f-1385" unitRef="usd">-7812000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-1386" unitRef="shares">11148493</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-1387" unitRef="shares">11148493</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-22" decimals="0" id="f-1388" unitRef="shares">4005334</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-1389"
      unitRef="usdPerShare">-0.56</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-1390"
      unitRef="usdPerShare">-0.56</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-22"
      decimals="2"
      id="f-1391"
      unitRef="usdPerShare">-1.95</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-22"
      decimals="2"
      id="f-1392"
      unitRef="usdPerShare">-1.95</us-gaap:EarningsPerShareBasic>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="-5" id="f-1393" unitRef="shares">9000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-22"
      decimals="-5"
      id="f-1394"
      unitRef="shares">3900000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-1395">Segment information&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates within targeted markets through three reportable segments for continuing operations: Fintech, Biotech, and Corporate and Other. Due the sale of Company&#x2019;s Recycling segment during March 2023, it is being presented as discontinued operations for the years ended December&#160;28, 2024 and December&#160;30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present our segment information (in $000&#x2019;s): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;For the Years Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fintech&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Biotech&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fintech&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Biotech&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fintech&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Biotech&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,531)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(18,315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7,562)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7,562)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(9,408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fintech&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Biotech&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Interest (expense) income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fintech&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(499)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Biotech&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(380)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total Interest (expense) income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(879)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net loss after provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fintech&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Biotech&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,086)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,532)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(15,563)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total net loss after provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7,812)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of &lt;br/&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of &lt;br/&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fintech&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;64,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Biotech&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Discontinue operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;82,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill and other intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fintech&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Biotech&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total goodwill and other intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;46,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-1396"
      unitRef="segment">3</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-1397">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present our segment information (in $000&#x2019;s): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;For the Years Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fintech&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Biotech&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fintech&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Biotech&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fintech&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Biotech&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,531)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(18,315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7,562)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7,562)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(9,408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fintech&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Biotech&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Interest (expense) income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fintech&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(499)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Biotech&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(380)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total Interest (expense) income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(879)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net loss after provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fintech&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Biotech&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,086)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,532)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(15,563)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total net loss after provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7,812)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of &lt;br/&gt;December 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of &lt;br/&gt;December 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fintech&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;64,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Biotech&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Discontinue operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;82,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill and other intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fintech&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Biotech&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total goodwill and other intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;46,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-401" decimals="-3" id="f-1398" unitRef="usd">12532000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-402" decimals="-3" id="f-1399" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-403" decimals="-3" id="f-1400" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-404" decimals="-3" id="f-1401" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-405" decimals="-3" id="f-1402" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-406" decimals="-3" id="f-1403" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-407" decimals="-3" id="f-1404" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-408" decimals="-3" id="f-1405" unitRef="usd">3795000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-409" decimals="-3" id="f-1406" unitRef="usd">12532000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-410" decimals="-3" id="f-1407" unitRef="usd">3795000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit contextRef="c-401" decimals="-3" id="f-1408" unitRef="usd">6294000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-402" decimals="-3" id="f-1409" unitRef="usd">0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-403" decimals="-3" id="f-1410" unitRef="usd">0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-404" decimals="-3" id="f-1411" unitRef="usd">0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-405" decimals="-3" id="f-1412" unitRef="usd">0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-406" decimals="-3" id="f-1413" unitRef="usd">0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-407" decimals="-3" id="f-1414" unitRef="usd">0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-408" decimals="-3" id="f-1415" unitRef="usd">-197000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-409" decimals="-3" id="f-1416" unitRef="usd">6294000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-410" decimals="-3" id="f-1417" unitRef="usd">-197000</us-gaap:GrossProfit>
    <us-gaap:OperatingIncomeLoss contextRef="c-401" decimals="-3" id="f-1418" unitRef="usd">905000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-402" decimals="-3" id="f-1419" unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-403" decimals="-3" id="f-1420" unitRef="usd">-2148000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-404" decimals="-3" id="f-1421" unitRef="usd">-1531000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-405" decimals="-3" id="f-1422" unitRef="usd">-6319000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-406" decimals="-3" id="f-1423" unitRef="usd">-18315000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-407" decimals="-3" id="f-1424" unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-408" decimals="-3" id="f-1425" unitRef="usd">10438000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-409" decimals="-3" id="f-1426" unitRef="usd">-7562000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-410" decimals="-3" id="f-1427" unitRef="usd">-9408000</us-gaap:OperatingIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-401" decimals="-3" id="f-1428" unitRef="usd">1316000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-402" decimals="-3" id="f-1429" unitRef="usd">0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-403" decimals="-3" id="f-1430" unitRef="usd">2086000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-404" decimals="-3" id="f-1431" unitRef="usd">1452000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-405" decimals="-3" id="f-1432" unitRef="usd">0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-406" decimals="-3" id="f-1433" unitRef="usd">0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-407" decimals="-3" id="f-1434" unitRef="usd">0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-408" decimals="-3" id="f-1435" unitRef="usd">96000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-409" decimals="-3" id="f-1436" unitRef="usd">3402000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-410" decimals="-3" id="f-1437" unitRef="usd">1548000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-401" decimals="-3" id="f-1438" unitRef="usd">-499000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-402" decimals="-3" id="f-1439" unitRef="usd">0</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-403" decimals="-3" id="f-1440" unitRef="usd">0</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-404" decimals="-3" id="f-1441" unitRef="usd">0</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-405" decimals="-3" id="f-1442" unitRef="usd">-380000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-406" decimals="-3" id="f-1443" unitRef="usd">2250000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-407" decimals="-3" id="f-1444" unitRef="usd">0</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-408" decimals="-3" id="f-1445" unitRef="usd">-181000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-409" decimals="-3" id="f-1446" unitRef="usd">-879000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-410" decimals="-3" id="f-1447" unitRef="usd">2069000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-401" decimals="-3" id="f-1448" unitRef="usd">469000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-402" decimals="-3" id="f-1449" unitRef="usd">0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-403" decimals="-3" id="f-1450" unitRef="usd">-2086000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-404" decimals="-3" id="f-1451" unitRef="usd">-1532000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-405" decimals="-3" id="f-1452" unitRef="usd">-4628000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-406" decimals="-3" id="f-1453" unitRef="usd">-15563000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-407" decimals="-3" id="f-1454" unitRef="usd">0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-408" decimals="-3" id="f-1455" unitRef="usd">9283000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-409" decimals="-3" id="f-1456" unitRef="usd">-6245000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-410" decimals="-3" id="f-1457" unitRef="usd">-7812000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:Assets contextRef="c-411" decimals="-3" id="f-1458" unitRef="usd">64217000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-412" decimals="-3" id="f-1459" unitRef="usd">0</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-413" decimals="-3" id="f-1460" unitRef="usd">16926000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-414" decimals="-3" id="f-1461" unitRef="usd">17846000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-415" decimals="-3" id="f-1462" unitRef="usd">1293000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-416" decimals="-3" id="f-1463" unitRef="usd">641000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-417" decimals="-3" id="f-1464" unitRef="usd">0</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-418" decimals="-3" id="f-1465" unitRef="usd">0</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-419" decimals="-3" id="f-1466" unitRef="usd">82436000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-420" decimals="-3" id="f-1467" unitRef="usd">18487000</us-gaap:Assets>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill contextRef="c-411" decimals="-3" id="f-1468" unitRef="usd">30385000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill contextRef="c-412" decimals="-3" id="f-1469" unitRef="usd">0</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill contextRef="c-413" decimals="-3" id="f-1470" unitRef="usd">15755000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill contextRef="c-414" decimals="-3" id="f-1471" unitRef="usd">17846000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill contextRef="c-415" decimals="-3" id="f-1472" unitRef="usd">4000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill contextRef="c-416" decimals="-3" id="f-1473" unitRef="usd">0</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill contextRef="c-417" decimals="-3" id="f-1474" unitRef="usd">0</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill contextRef="c-418" decimals="-3" id="f-1475" unitRef="usd">0</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill contextRef="c-419" decimals="-3" id="f-1476" unitRef="usd">46144000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill contextRef="c-420" decimals="-3" id="f-1477" unitRef="usd">17846000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:SubsequentEventsTextBlock contextRef="c-1" id="f-1478">Subsequent events&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has evaluated subsequent events through the filing of this Form 10-K, and determined that there have been no events that have occurred that would require adjustments to disclosures in its consolidated financial statements other than as discussed below:&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-421" id="f-1479">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-421" id="f-1480">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-421" id="f-1481">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-421" id="f-1482">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c-1" id="f-1483">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
